{
  "Status Epilepticus": {
    "id": "status-epilepticus",
    "title": "Status Epilepticus",
    "version": "1.2",
    "icd10": [
      "** G40.901 (Epilepsy",
      "unspecified",
      "not intractable",
      "with status epilepticus)",
      "G41.0 (Grand mal status epilepticus)",
      "G41.1 (Petit mal status epilepticus)",
      "G41.2 (Complex partial status epilepticus)",
      "G41.8 (Other status epilepticus)",
      "G41.9 (Status epilepticus",
      "unspecified)"
    ],
    "scope": "** Management of convulsive status epilepticus (CSE) and non-convulsive status epilepticus (NCSE) in adults. Covers staged treatment protocol from emergent benzodiazepines through refractory and super-refractory phases. Includes diagnostic workup to identify underlying etiology and specific protocols for NORSE/FIRES. Excludes pediatric status epilepticus, neonatal seizures, and psychogenic non-epileptic status.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Point-of-care glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Hypoglycemia is immediately reversible cause",
            "target": ">70 mg/dL"
          },
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Infection screen, baseline before ASMs",
            "target": "Normal"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Electrolyte abnormalities, renal/hepatic function for ASM dosing",
            "target": "Normal"
          },
          {
            "item": "Magnesium",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Hypomagnesemia lowers seizure threshold",
            "target": ">1.8 mg/dL"
          },
          {
            "item": "Calcium (ionized if available)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Hypocalcemia can cause seizures",
            "target": "Ionized 4.5-5.3 mg/dL"
          },
          {
            "item": "Phosphorus",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Hypophosphatemia lowers seizure threshold",
            "target": ">2.5 mg/dL"
          },
          {
            "item": "Blood gas (ABG or VBG)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Acidosis, oxygenation, ventilation status",
            "target": "pH >7.2; correct severe acidosis"
          },
          {
            "item": "Lactate",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Elevated in prolonged seizure; marker of severity",
            "target": "Will be elevated; trending useful"
          },
          {
            "item": "Urine drug screen",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Illicit drugs, withdrawal states",
            "target": "Identify triggers"
          },
          {
            "item": "Blood alcohol level",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Alcohol withdrawal common cause",
            "target": "Correlate with history"
          },
          {
            "item": "ASM levels (if on therapy)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Subtherapeutic levels as precipitant",
            "target": "Therapeutic range"
          },
          {
            "item": "Pregnancy test (women of childbearing age)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Eclampsia; affects ASM choice",
            "target": "Document status"
          }
        ],
        "Extended Workup": [
          {
            "item": "Ammonia",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Hepatic encephalopathy, valproate toxicity, urea cycle disorders",
            "target": "<35 μmol/L"
          },
          {
            "item": "TSH",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Thyroid storm/myxedema",
            "target": "Normal"
          },
          {
            "item": "Troponin",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Cardiac stress from prolonged seizure",
            "target": "May be elevated"
          },
          {
            "item": "CPK/CK",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Rhabdomyolysis from prolonged convulsions",
            "target": "Elevated; monitor trend"
          },
          {
            "item": "Cortisol (random)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Adrenal insufficiency",
            "target": "Normal stress response"
          },
          {
            "item": "Serum osmolality",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Hypo/hyperosmolar states",
            "target": "280-295 mOsm/kg"
          },
          {
            "item": "Procalcitonin",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "CNS infection if suspected",
            "target": "<0.5 ng/mL"
          },
          {
            "item": "Coagulation panel (PT/INR, PTT)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Pre-LP, hemorrhage risk",
            "target": "Normal"
          },
          {
            "item": "Type and screen",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Anticipate possible surgical intervention",
            "target": "Available"
          },
          {
            "item": "Urinalysis",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "UTI as precipitant (especially elderly)",
            "target": "Negative"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Autoimmune encephalitis panel (serum)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Anti-NMDAR, LGI1, CASPR2 in NORSE",
            "target": "Negative"
          },
          {
            "item": "Paraneoplastic panel (serum)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Subacute onset, smoking history, weight loss",
            "target": "Negative"
          },
          {
            "item": "HIV",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "HIV-associated CNS disease",
            "target": "Negative"
          },
          {
            "item": "RPR/VDRL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "Neurosyphilis",
            "target": "Negative"
          },
          {
            "item": "Ceruloplasmin, serum copper",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "rationale": "Wilson disease (young patients)",
            "target": "Normal"
          },
          {
            "item": "Porphyrins (urine/serum)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "rationale": "Acute intermittent porphyria",
            "target": "Normal"
          },
          {
            "item": "Mitochondrial DNA testing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT",
            "rationale": "MELAS, other mitochondrial disorders",
            "target": "Normal"
          },
          {
            "item": "Pyridoxine trial (empiric)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Pyridoxine-dependent seizures (rare, usually pediatric)",
            "target": "Response to treatment"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Elevated ICP",
            "target": "10-20 cm H2O"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Infection, inflammation",
            "target": "WBC <5; RBC 0"
          },
          {
            "item": "Protein",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Elevated in infection, inflammation",
            "target": "15-45 mg/dL"
          },
          {
            "item": "Glucose with serum glucose",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Low in bacterial/fungal meningitis",
            "target": ">60% serum"
          },
          {
            "item": "Gram stain and culture",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Bacterial meningitis",
            "target": "No organisms"
          },
          {
            "item": "BioFire FilmArray ME Panel",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Rapid pathogen identification",
            "target": "Negative"
          },
          {
            "item": "HSV-1/2 PCR",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "HSV encephalitis",
            "target": "Negative"
          },
          {
            "item": "Autoimmune encephalitis panel (CSF)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "NORSE, limbic encephalitis",
            "target": "Negative"
          },
          {
            "item": "Cytology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "Carcinomatous meningitis",
            "target": "Negative"
          },
          {
            "item": "Oligoclonal bands",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "Demyelinating disease",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Immediately after stabilization",
            "target": "Mass, hemorrhage, stroke, herniation, hydrocephalus",
            "contraindications": "None in emergency"
          },
          {
            "item": "Continuous EEG (cEEG) monitoring",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "As soon as available; mandatory in RSE/SRSE",
            "target": "Seizure burden, treatment response, NCSE detection",
            "contraindications": "None significant"
          },
          {
            "item": "Chest X-ray",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Aspiration risk, ETT placement confirmation",
            "target": "Aspiration, ETT position",
            "contraindications": "None"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain with and without contrast",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "When stable; within 24-48h",
            "target": "Encephalitis, stroke, tumor, cortical injury from SE",
            "contraindications": "Hemodynamic instability, pacemaker"
          },
          {
            "item": "CT angiography head/neck",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "If stroke suspected",
            "target": "Large vessel occlusion, dissection",
            "contraindications": "Contrast allergy, renal insufficiency"
          },
          {
            "item": "MRA/MRV brain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "timing": "If vascular etiology suspected",
            "target": "Venous thrombosis, vascular malformation",
            "contraindications": "Same as MRI"
          },
          {
            "item": "CT chest/abdomen/pelvis",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "timing": "If paraneoplastic suspected",
            "target": "Occult malignancy",
            "contraindications": "Contrast allergy"
          },
          {
            "item": "Echocardiogram",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "timing": "If embolic stroke suspected, endocarditis",
            "target": "Vegetation, thrombus",
            "contraindications": "None"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "PET-CT (whole body)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "timing": "Occult malignancy workup",
            "target": "Tumor identification",
            "contraindications": "Hemodynamic instability"
          },
          {
            "item": "Brain biopsy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "timing": "Refractory cases, suspected encephalitis",
            "target": "Histopathologic diagnosis",
            "contraindications": "Coagulopathy, critical location"
          }
        ]
      },
      "Treatment": {
        "Stabilization (Time 0)": [
          {
            "item": "Airway positioning/management",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "instructions": "Head-tilt chin-lift, oral airway, prepare for intubation",
              "orderSentence": "Airway positioning/management - PO - see dosing"
            },
            "contraindications": "None",
            "monitoring": "O2 sat, airway patency",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Supplemental oxygen",
            "route": "INH",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15 L/min",
                  "orderSentence": "Supplemental oxygen 15 L/min INH"
                }
              ],
              "route": "INH",
              "instructions": "Non-rebreather 15 L/min or bag-valve-mask",
              "orderSentence": "Supplemental oxygen 15 L/min INH"
            },
            "contraindications": "None",
            "monitoring": "O2 sat >94%",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "IV access (two large-bore)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "18G or larger x2",
              "orderSentence": "IV access (two large-bore) - IV - see dosing"
            },
            "contraindications": "None",
            "monitoring": "IV patency",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Cardiac monitoring",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Continuous telemetry",
              "orderSentence": "Cardiac monitoring - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Rhythm, HR, BP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Dextrose 50% IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mL",
                  "orderSentence": "Dextrose 50% IV 50 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "50 mL IV push (25g) if glucose <70 or unknown",
              "orderSentence": "Dextrose 50% IV 50 mL IV"
            },
            "contraindications": "Document hyperglycemia",
            "monitoring": "Glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Thiamine IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100-500 mg",
                  "orderSentence": "Thiamine IV 100-500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "100-500 mg IV BEFORE or WITH glucose",
              "orderSentence": "Thiamine IV 100-500 mg IV"
            },
            "contraindications": "None",
            "monitoring": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Isotonic fluids",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "NS or LR wide open initially",
              "orderSentence": "Isotonic fluids - - - see dosing"
            },
            "contraindications": "Pulmonary edema",
            "monitoring": "BP, I/O",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Emergent/First-Line - Benzodiazepines (Time 0-5 min)": [
          {
            "item": "Lorazepam IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg/kg",
                  "orderSentence": "Lorazepam IV 0.1 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.1 mg/kg IV (max 4 mg/dose); may repeat x1 in 5 min if still seizing; total max 8 mg",
              "orderSentence": "Lorazepam IV 0.1 mg/kg IV"
            },
            "contraindications": "Acute narrow-angle glaucoma",
            "monitoring": "RR, O2 sat, BP, sedation; airway equipment ready",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam IM",
            "route": "IM",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Midazolam IM 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg IM (≥40 kg) or 0.2 mg/kg IM (if no IV access); single dose",
              "orderSentence": "Midazolam IM 10 mg IV"
            },
            "contraindications": "Respiratory compromise",
            "monitoring": "RR, O2 sat; prepare IV access",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.2 mg/kg",
                  "orderSentence": "Midazolam IV 0.2 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.2 mg/kg IV (max 10 mg); may repeat x1",
              "orderSentence": "Midazolam IV 0.2 mg/kg IV"
            },
            "contraindications": "Same as lorazepam",
            "monitoring": "RR, O2 sat, BP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam intranasal",
            "route": "IN",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Midazolam intranasal 5 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "5 mg per nostril (10 mg total) if no IV/IM access",
              "orderSentence": "Midazolam intranasal 5 mg IV"
            },
            "contraindications": "Nasal obstruction",
            "monitoring": "RR, O2 sat",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam buccal",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Midazolam buccal 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "10 mg buccal (if available)",
              "orderSentence": "Midazolam buccal 10 mg PO"
            },
            "contraindications": "Oral trauma",
            "monitoring": "RR, O2 sat",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Diazepam IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.15 mg/kg",
                  "orderSentence": "Diazepam IV 0.15 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.15 mg/kg IV (max 10 mg); may repeat x1 in 5 min",
              "orderSentence": "Diazepam IV 0.15 mg/kg IV"
            },
            "contraindications": "Acute narrow-angle glaucoma",
            "monitoring": "RR, O2 sat; short duration - requires follow-up ASM",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Diazepam rectal",
            "route": "PR",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.2-0.5 mg/kg",
                  "orderSentence": "Diazepam rectal 0.2-0.5 mg/kg PR"
                }
              ],
              "route": "PR",
              "instructions": "0.2-0.5 mg/kg PR (max 20 mg); use rectal gel formulation",
              "orderSentence": "Diazepam rectal 0.2-0.5 mg/kg PR"
            },
            "contraindications": "Rectal pathology",
            "monitoring": "RR, O2 sat",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Urgent/Second-Line ASMs (Time 5-20 min)": [
          {
            "item": "Levetiracetam IV (ESETT dosing)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg/kg",
                  "orderSentence": "Levetiracetam IV (ESETT dosing) 60 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "60 mg/kg IV (max 4500 mg) over 10-15 min",
              "orderSentence": "Levetiracetam IV (ESETT dosing) 60 mg/kg IV"
            },
            "contraindications": "None absolute; reduce if CrCl <50",
            "monitoring": "Generally well tolerated; agitation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Levetiracetam IV (conservative)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg/kg",
                  "orderSentence": "Levetiracetam IV (conservative) 40 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "40 mg/kg IV (max 4500 mg) over 10-15 min",
              "orderSentence": "Levetiracetam IV (conservative) 40 mg/kg IV"
            },
            "contraindications": "None absolute; reduce if CrCl <50",
            "monitoring": "Generally well tolerated; agitation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Fosphenytoin IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "Fosphenytoin IV 20 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "20 mg PE/kg IV at 150 mg PE/min; may give additional 5-10 mg PE/kg if needed",
              "orderSentence": "Fosphenytoin IV 20 mg IV"
            },
            "contraindications": "2nd/3rd degree AV block, sinus bradycardia, allergy",
            "monitoring": "Continuous cardiac monitor, BP q5min during infusion",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Valproate IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg/kg",
                  "orderSentence": "Valproate IV 40 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "40 mg/kg IV (max 3000 mg) over 10 min",
              "orderSentence": "Valproate IV 40 mg/kg IV"
            },
            "contraindications": "Pregnancy, hepatic disease, mitochondrial disease, urea cycle disorders, pancreatitis",
            "monitoring": "Ammonia, LFTs; avoid in unknown pregnancy status",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Lacosamide IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg",
                  "orderSentence": "Lacosamide IV 400 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "400 mg IV over 15 min (can give 200 mg over 5 min if urgent)",
              "orderSentence": "Lacosamide IV 400 mg IV"
            },
            "contraindications": "PR >200 ms, 2nd/3rd degree AV block, severe hepatic impairment",
            "monitoring": "ECG for PR interval",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Brivaracetam IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100-200 mg",
                  "orderSentence": "Brivaracetam IV 100-200 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "100-200 mg IV over 2-5 min; no titration needed",
              "orderSentence": "Brivaracetam IV 100-200 mg IV"
            },
            "contraindications": "Hepatic impairment (reduce dose)",
            "monitoring": "Faster onset than levetiracetam; fewer behavioral effects",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Phenytoin IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg/kg",
                  "orderSentence": "Phenytoin IV 20 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "20 mg/kg IV at max 50 mg/min (if fosphenytoin unavailable)",
              "orderSentence": "Phenytoin IV 20 mg/kg IV"
            },
            "contraindications": "AV block, sinus bradycardia",
            "monitoring": "Cardiac monitor; MUST use large vein, tissue necrosis risk",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Phenobarbital IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15-20 mg/kg",
                  "orderSentence": "Phenobarbital IV 15-20 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "15-20 mg/kg IV at 50-100 mg/min",
              "orderSentence": "Phenobarbital IV 15-20 mg/kg IV"
            },
            "contraindications": "Severe respiratory disease, porphyria",
            "monitoring": "Respiratory depression; often requires intubation at this dose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Refractory SE - Anesthetic Infusions (Time 20-60 min)": [
          {
            "item": "Midazolam infusion",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.2 mg/kg",
                  "orderSentence": "Midazolam infusion 0.2 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "Load: 0.2 mg/kg IV bolus; Infusion: start 0.1 mg/kg/hr, titrate by 0.1 mg/kg/hr q15min to seizure suppression; max 2 mg/kg/hr; target burst suppression on cEEG",
              "orderSentence": "Midazolam infusion 0.2 mg/kg IV"
            },
            "contraindications": "Hemodynamic instability (relative)",
            "monitoring": "cEEG, BP (hypotension common), sedation scale",
            "ED": "URGENT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Propofol infusion",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2 mg/kg",
                  "orderSentence": "Propofol infusion 1-2 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "Load: 1-2 mg/kg IV bolus (may repeat x1); Infusion: start 20 mcg/kg/min, titrate by 10 mcg/kg/min q5min; max 200 mcg/kg/min; target burst suppression",
              "orderSentence": "Propofol infusion 1-2 mg/kg IV"
            },
            "contraindications": "Propofol infusion syndrome risk (limit to <48h at high dose), egg/soy allergy, pregnancy",
            "monitoring": "cEEG, triglycerides q24-48h, CPK, metabolic acidosis, BP",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Ketamine infusion",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2 mg/kg",
                  "orderSentence": "Ketamine infusion 1-2 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "Load: 1-2 mg/kg IV bolus; Infusion: start 1 mg/kg/hr, titrate by 0.5 mg/kg/hr q15-30min; max 5 mg/kg/hr",
              "orderSentence": "Ketamine infusion 1-2 mg/kg IV"
            },
            "contraindications": "Uncontrolled hypertension, elevated ICP (relative - actually may be neuroprotective)",
            "monitoring": "cEEG, BP (may increase), HR; less hypotension than other anesthetics",
            "ED": "URGENT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Ketamine + Midazolam (combination)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg/kg",
                  "orderSentence": "Ketamine + Midazolam (combination) 1 mg/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "Ketamine load 1 mg/kg + Midazolam load 0.2 mg/kg; then dual infusions per above",
              "orderSentence": "Ketamine + Midazolam (combination) 1 mg/kg PO"
            },
            "contraindications": "Per individual agents",
            "monitoring": "2024 data: combination may reduce SE duration faster than midazolam alone",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Pentobarbital infusion",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-15 mg/kg",
                  "orderSentence": "Pentobarbital infusion 5-15 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "Load: 5-15 mg/kg IV at 50 mg/min; Infusion: start 0.5-1 mg/kg/hr, titrate to burst suppression; max 5 mg/kg/hr",
              "orderSentence": "Pentobarbital infusion 5-15 mg/kg IV"
            },
            "contraindications": "Severe cardiac dysfunction",
            "monitoring": "cEEG, BP (significant hypotension - need pressors), cardiac output; longest half-life",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Super-Refractory SE - Additional Agents": [
          {
            "item": "Add second anesthetic",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Combine midazolam + propofol, or add ketamine to either",
              "orderSentence": "Add second anesthetic - - - see dosing"
            },
            "contraindications": "Per agent",
            "monitoring": "cEEG, hemodynamics",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Topiramate (enteral)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300-400 mg",
                  "orderSentence": "Topiramate (enteral) 300-400 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Load 300-400 mg via NGT; then 200-400 mg BID; max 1600 mg/day",
              "orderSentence": "Topiramate (enteral) 300-400 mg PO"
            },
            "contraindications": "Metabolic acidosis, kidney stones",
            "monitoring": "Bicarbonate, renal function",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Lacosamide (if not tried)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg",
                  "orderSentence": "Lacosamide (if not tried) 400 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "400 mg IV, then 200-400 mg BID",
              "orderSentence": "Lacosamide (if not tried) 400 mg IV"
            },
            "contraindications": "PR prolongation",
            "monitoring": "ECG",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Perampanel (enteral)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4-8 mg",
                  "orderSentence": "Perampanel (enteral) 4-8 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "4-8 mg via NGT daily; titrate to 12 mg daily",
              "orderSentence": "Perampanel (enteral) 4-8 mg PO"
            },
            "contraindications": "None absolute",
            "monitoring": "Aggression, sedation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Magnesium sulfate infusion",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4-6 g",
                  "orderSentence": "Magnesium sulfate infusion 4-6 g IV"
                }
              ],
              "route": "IV",
              "instructions": "4-6 g IV over 20 min, then 1-2 g/hr infusion; target Mg 3.5-4 mg/dL",
              "orderSentence": "Magnesium sulfate infusion 4-6 g IV"
            },
            "contraindications": "Renal failure (relative), myasthenia",
            "monitoring": "Mg levels, reflexes, respiratory status",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Pyridoxine (empiric trial)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100-500 mg",
                  "orderSentence": "Pyridoxine (empiric trial) 100-500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "100-500 mg IV; may try single dose empirically",
              "orderSentence": "Pyridoxine (empiric trial) 100-500 mg IV"
            },
            "contraindications": "None",
            "monitoring": "Response to treatment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Ketogenic diet",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Initiate within 7 days per NORSE consensus; requires nutrition support",
              "orderSentence": "Ketogenic diet - - - see dosing"
            },
            "contraindications": "Pyruvate carboxylase deficiency, fatty acid oxidation disorders",
            "monitoring": "Ketones, glucose, lipids",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Hypothermia (32-35°C)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Targeted temperature management x 24-48h",
              "orderSentence": "Hypothermia (32-35°C) - - - see dosing"
            },
            "contraindications": "Coagulopathy, severe infection",
            "monitoring": "Temperature, coagulation, infection",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT"
          },
          {
            "item": "Electroconvulsive therapy",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "If all else fails; requires anesthesia",
              "orderSentence": "Electroconvulsive therapy - - - see dosing"
            },
            "contraindications": "Raised ICP, recent stroke",
            "monitoring": "Per ECT protocol",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT"
          },
          {
            "item": "Epilepsy surgery (emergent)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Resection if focal lesion identified",
              "orderSentence": "Epilepsy surgery (emergent) - - - see dosing"
            },
            "contraindications": "Eloquent cortex, multifocal",
            "monitoring": "Per surgical team",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT"
          }
        ],
        "NORSE/FIRES Immunotherapy Protocol": [
          {
            "timing": "**Day 0-3**",
            "dosing": "See below"
          },
          {
            "timing": "**Day 3-7**",
            "dosing": "Add remaining first-line agents"
          },
          {
            "timing": "**Day 7**",
            "dosing": "Initiate with nutrition support"
          },
          {
            "timing": "**Day 7+**",
            "dosing": "If first-line inadequate"
          }
        ],
        "Symptomatic/Supportive ICU Care": [
          {
            "item": "Norepinephrine",
            "route": "PO",
            "indication": "Hypotension from anesthetics",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mcg/kg",
                  "orderSentence": "Norepinephrine 0.1 mcg/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.1 mcg/kg/min; titrate to MAP ≥65",
              "orderSentence": "Norepinephrine 0.1 mcg/kg PO"
            },
            "contraindications": "Hypovolemia (correct first)",
            "monitoring": "Arterial line, MAP",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Vasopressin",
            "route": "-",
            "indication": "Adjunct pressor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.04 units",
                  "orderSentence": "Vasopressin 0.04 units -"
                }
              ],
              "route": "-",
              "instructions": "0.04 units/min fixed dose",
              "orderSentence": "Vasopressin 0.04 units -"
            },
            "contraindications": "Cardiac ischemia",
            "monitoring": "MAP, cardiac status",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Fentanyl infusion",
            "route": "PO",
            "indication": "Analgesia/sedation adjunct",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-100 mcg/hr",
                  "orderSentence": "Fentanyl infusion 25-100 mcg/hr PO"
                }
              ],
              "route": "PO",
              "instructions": "25-100 mcg/hr; titrate to comfort",
              "orderSentence": "Fentanyl infusion 25-100 mcg/hr PO"
            },
            "contraindications": "Hemodynamic instability",
            "monitoring": "Pain scale, respiratory status",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Propofol (sub-anesthetic)",
            "route": "PO",
            "indication": "Sedation during cEEG",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-50 mcg/kg",
                  "orderSentence": "Propofol (sub-anesthetic) 5-50 mcg/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "5-50 mcg/kg/min",
              "orderSentence": "Propofol (sub-anesthetic) 5-50 mcg/kg PO"
            },
            "contraindications": "Same as anesthetic use",
            "monitoring": "Sedation scale",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Dexmedetomidine",
            "route": "PO",
            "indication": "Sedation, possible antiseizure",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.2-1.5 mcg/kg",
                  "orderSentence": "Dexmedetomidine 0.2-1.5 mcg/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.2-1.5 mcg/kg/hr",
              "orderSentence": "Dexmedetomidine 0.2-1.5 mcg/kg PO"
            },
            "contraindications": "Bradycardia, heart block",
            "monitoring": "HR, BP",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pantoprazole",
            "route": "IV",
            "indication": "Stress ulcer prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Pantoprazole 40 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "40 mg IV daily",
              "orderSentence": "Pantoprazole 40 mg IV"
            },
            "contraindications": "None significant",
            "monitoring": "GI bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Enoxaparin",
            "route": "SC",
            "indication": "DVT prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Enoxaparin 40 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily (start when stable)",
              "orderSentence": "Enoxaparin 40 mg SC"
            },
            "contraindications": "Active bleeding, recent LP",
            "monitoring": "Platelets, bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Insulin infusion",
            "route": "-",
            "indication": "Stress hyperglycemia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "140-180 mg",
                  "orderSentence": "Insulin infusion 140-180 mg -"
                }
              ],
              "route": "-",
              "instructions": "Per ICU protocol; target glucose 140-180 mg/dL",
              "orderSentence": "Insulin infusion 140-180 mg -"
            },
            "contraindications": "Hypoglycemia",
            "monitoring": "Glucose q1-4h",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology/Epilepsy STAT consult",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "All cases of SE"
          },
          {
            "item": "Neurocritical care consult",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "RSE/SRSE, need for anesthetic infusions"
          },
          {
            "item": "ICU admission",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-",
            "indication": "All SE requiring second-line agents or ongoing seizures"
          },
          {
            "item": "EEG technologist/cEEG initiation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Mandatory for RSE/SRSE; strongly recommended for all SE"
          },
          {
            "item": "Infectious disease consult",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "indication": "Suspected CNS infection"
          },
          {
            "item": "Rheumatology/Neuroimmunology consult",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "indication": "NORSE/FIRES, suspected autoimmune encephalitis"
          },
          {
            "item": "Pharmacy consult",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "indication": "Complex ASM dosing, drug interactions"
          },
          {
            "item": "Nutrition/Dietitian consult",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "indication": "Enteral feeding, ketogenic diet initiation (by Day 7 in NORSE)"
          },
          {
            "item": "Palliative care consult",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "ROUTINE",
            "indication": "SRSE with poor prognosis, goals of care discussion"
          },
          {
            "item": "Social work consult",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "indication": "Family support, discharge planning"
          },
          {
            "item": "Epilepsy surgery evaluation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT",
            "indication": "Focal lesion on imaging, refractory to medical therapy"
          },
          {
            "item": "PT/OT/Speech evaluation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "ROUTINE",
            "indication": "Once stabilized; assess for deficits"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Explain SE is a medical emergency requiring ICU care",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-"
          },
          {
            "item": "Discuss prognosis based on etiology and duration of SE",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-"
          },
          {
            "item": "Educate on importance of ASM adherence (if applicable)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Seizure first aid education for family",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Rescue medication training (rectal diazepam, nasal midazolam)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Driving restrictions (minimum 3-6 months seizure-free, varies by state)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Medical alert bracelet recommendation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Seizure action plan development",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Discuss goals of care if SRSE with poor prognosis",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE (ICU)"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Medication adherence counseling",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Avoid abrupt ASM discontinuation (common SE precipitant)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Alcohol cessation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Sleep hygiene (sleep deprivation lowers threshold)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Avoid known seizure triggers",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Drug interaction review (OTC, supplements)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Pregnancy planning counseling (women of childbearing potential)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Psychogenic non-epileptic status",
        "features": "Preserved awareness, asynchronous movements, eye closure, pelvic thrusting, prolonged duration with minimal post-ictal period",
        "tests": "Video EEG, normal cEEG during event"
      },
      {
        "diagnosis": "Convulsive syncope",
        "features": "Brief (< 30 sec), occurs with LOC, myoclonic jerks possible",
        "tests": "History of prodrome, rapid recovery, normal EEG"
      },
      {
        "diagnosis": "Movement disorders (dystonia, chorea)",
        "features": "Non-rhythmic, preserved awareness, stereotyped pattern",
        "tests": "EEG normal during movements"
      },
      {
        "diagnosis": "Rigors (sepsis, transfusion reaction)",
        "features": "Associated with fever/chills, rhythmic shaking, preserves awareness",
        "tests": "Infectious workup, temperature, EEG normal"
      },
      {
        "diagnosis": "Decerebrate/decorticate posturing",
        "features": "Associated with structural brain injury, sustained posturing",
        "tests": "Imaging, cEEG"
      },
      {
        "diagnosis": "Drug-induced dyskinesia",
        "features": "Medication history, stereotyped movements",
        "tests": "Drug levels, history, EEG normal"
      },
      {
        "diagnosis": "Neuroleptic malignant syndrome",
        "features": "Rigidity, hyperthermia, AMS, autonomic instability",
        "tests": "CPK, medication history"
      },
      {
        "diagnosis": "Serotonin syndrome",
        "features": "Hyperreflexia, clonus, agitation, fever",
        "tests": "Medication history, clinical features"
      },
      {
        "diagnosis": "Tetanus",
        "features": "Sustained muscle contraction, trismus, opisthotonos",
        "tests": "History of wound, vaccination status"
      },
      {
        "diagnosis": "Strychnine poisoning",
        "features": "Opisthotonus with preserved consciousness",
        "tests": "Toxicology"
      }
    ],
    "evidence": [
      {
        "recommendation": "Benzodiazepines first-line for SE",
        "evidenceLevel": "Class I, Level A",
        "source": "[NCS Guidelines 2012](https://pubmed.ncbi.nlm.nih.gov/22528274/); [AES Guidelines 2016](https://pubmed.ncbi.nlm.nih.gov/26900382/)"
      },
      {
        "recommendation": "Lorazepam preferred IV benzodiazepine",
        "evidenceLevel": "Class I, Level A",
        "source": "[Alldredge et al. NEJM 2001](https://pubmed.ncbi.nlm.nih.gov/11547716/)"
      },
      {
        "recommendation": "IM midazolam non-inferior to IV lorazepam",
        "evidenceLevel": "Class I, Level A",
        "source": "[RAMPART Trial, Silbergleit et al. NEJM 2012](https://pubmed.ncbi.nlm.nih.gov/22335736/)"
      },
      {
        "recommendation": "Second-line agents (LEV, VPA, fPHT) equivalent efficacy",
        "evidenceLevel": "Class I, Level A",
        "source": "[ESETT Trial, Kapur et al. NEJM 2019;381:2103-2113](https://pubmed.ncbi.nlm.nih.gov/31774955/)"
      },
      {
        "recommendation": "Levetiracetam 60 mg/kg dosing",
        "evidenceLevel": "Class I, Level A",
        "source": "[ESETT Trial](https://pubmed.ncbi.nlm.nih.gov/31774955/) - higher than traditional 20-40 mg/kg"
      },
      {
        "recommendation": "Levetiracetam 40 mg/kg may be adequate",
        "evidenceLevel": "Class II, Level B",
        "source": "Meta-analysis, pharmacokinetic modeling 2023-2024"
      },
      {
        "recommendation": "cEEG monitoring in RSE",
        "evidenceLevel": "Class I, Level B",
        "source": "[NCS Guidelines 2012](https://pubmed.ncbi.nlm.nih.gov/22528274/)"
      },
      {
        "recommendation": "Burst suppression target for RSE",
        "evidenceLevel": "Class IIb, Level C",
        "source": "Expert consensus"
      },
      {
        "recommendation": "Ketamine in RSE/SRSE",
        "evidenceLevel": "Class IIb, Level B",
        "source": "Multiple case series; 2024 systematic reviews"
      },
      {
        "recommendation": "Earlier ketamine = better outcomes",
        "evidenceLevel": "Class II, Level B",
        "source": "2024 two-center study; systematic reviews"
      },
      {
        "recommendation": "NORSE first-line immunotherapy within 72h",
        "evidenceLevel": "Class IIa, Level C",
        "source": "[Wickström et al. Epilepsia 2022](https://pubmed.ncbi.nlm.nih.gov/35951466/)"
      },
      {
        "recommendation": "Ketogenic diet by Day 7 in NORSE",
        "evidenceLevel": "Class IIa, Level C",
        "source": "[International Consensus 2022](https://pubmed.ncbi.nlm.nih.gov/35997591/); FIRES case series"
      },
      {
        "recommendation": "Second-line immunotherapy by Day 7 if first-line fails",
        "evidenceLevel": "Class IIb, Level C",
        "source": "[International Consensus 2022](https://pubmed.ncbi.nlm.nih.gov/35997591/)"
      },
      {
        "recommendation": "Brivaracetam for SE",
        "evidenceLevel": "Class IIb, Level C",
        "source": "Emerging evidence; case series"
      }
    ],
    "monitoring": [
      {
        "item": "Continuous EEG",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "Continuous",
        "action": "Adjust ASMs/anesthetics"
      },
      {
        "item": "Cardiac telemetry",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "Continuous",
        "action": "Treat arrhythmia; assess ASM effect"
      },
      {
        "item": "Pulse oximetry",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "Continuous",
        "action": "Increase O2, assess airway"
      },
      {
        "item": "Blood pressure",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q5min during treatment, then q1h",
        "action": "Pressors or antihypertensives"
      },
      {
        "item": "Neurologic exam",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q1-2h when off sedation",
        "action": "Imaging, reassess etiology"
      },
      {
        "item": "Glucose",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q1-4h",
        "action": "Insulin or dextrose"
      },
      {
        "item": "Electrolytes (Na, K, Mg, Ca, Phos)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q6-12h",
        "action": "Replete deficiencies"
      },
      {
        "item": "ABG/VBG",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q4-6h (RSE), PRN",
        "action": "Adjust ventilator, treat acidosis"
      },
      {
        "item": "Lactate",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q6-12h",
        "action": "Treat underlying cause"
      },
      {
        "item": "ASM levels",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "URGENT",
        "frequency": "24h after load, then PRN",
        "action": "Adjust dosing"
      },
      {
        "item": "Ammonia",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q24h if on valproate",
        "action": "Reduce/stop valproate"
      },
      {
        "item": "LFTs",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "ROUTINE",
        "frequency": "q24-48h",
        "action": "Adjust hepatically-metabolized ASMs"
      },
      {
        "item": "Renal function",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q24h",
        "action": "Adjust renally-cleared ASMs"
      },
      {
        "item": "CPK",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q12-24h if prolonged convulsions",
        "action": "Aggressive hydration, monitor renal"
      },
      {
        "item": "Triglycerides",
        "ED": "-",
        "HOSP": "-",
        "OPD": "-",
        "ICU": "ROUTINE",
        "frequency": "q24-48h if on propofol",
        "action": "Reduce propofol dose"
      },
      {
        "item": "Temperature",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q4h",
        "action": "Infection workup; cooling if hyperthermic"
      },
      {
        "item": "ICP (if monitored)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "Continuous",
        "action": "ICP management protocol"
      }
    ],
    "disposition": [
      {
        "disposition": "ICU admission (REQUIRED)",
        "criteria": "All SE requiring second-line ASMs; all RSE/SRSE; altered mental status; need for airway management; hemodynamic instability"
      },
      {
        "disposition": "Step-down/Telemetry",
        "criteria": "Seizures controlled x 24h, off anesthetics x 24h, stable neuro exam, no airway concerns"
      },
      {
        "disposition": "General floor",
        "criteria": "Seizures controlled, off continuous monitoring, stable on oral ASMs, resolved AMS"
      },
      {
        "disposition": "Discharge home",
        "criteria": "Seizures controlled, stable on oral ASM regimen, etiology identified and addressed, family educated, follow-up arranged"
      },
      {
        "disposition": "Transfer to higher level care",
        "criteria": "Need for services unavailable (cEEG, neurocritical care, epilepsy surgery evaluation)"
      },
      {
        "disposition": "Long-term care/Rehab",
        "criteria": "Persistent deficits after prolonged SE, need for ongoing rehabilitation"
      },
      {
        "disposition": "Palliative/Hospice",
        "criteria": "SRSE with irreversible brain injury, goals of care established"
      }
    ]
  },
  "New Onset Seizure": {
    "id": "new-onset-seizure",
    "title": "New Onset Seizure",
    "version": "1.1",
    "icd10": [
      "** R56.9 (Unspecified convulsions)",
      "G40.909 (Epilepsy",
      "unspecified",
      "not intractable",
      "without status epilepticus)"
    ],
    "scope": "** Initial evaluation and management of first-time unprovoked seizure or first presentation of seizure activity in adults. Covers immediate stabilization, diagnostic workup to identify etiology, acute treatment, and framework for anti-seizure medication (ASM) initiation. Excludes status epilepticus (see \"Status Epilepticus\" template), pediatric seizures, febrile seizures, and known epilepsy with breakthrough seizures.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Point-of-care glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Hypoglycemia is immediately reversible cause",
            "target": ">70 mg/dL"
          },
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Infection screen, baseline before ASMs",
            "target": "Normal"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Electrolyte abnormalities (Na, Ca, Mg, glucose), renal/hepatic function for ASM dosing",
            "target": "Normal"
          },
          {
            "item": "Magnesium",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hypomagnesemia lowers seizure threshold",
            "target": ">1.8 mg/dL"
          },
          {
            "item": "Calcium (ionized if available)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hypocalcemia can cause seizures",
            "target": "Normal (ionized 4.5-5.3 mg/dL)"
          },
          {
            "item": "Urine drug screen",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Illicit drugs (cocaine, amphetamines) and withdrawal states",
            "target": "Negative"
          },
          {
            "item": "Blood alcohol level",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Alcohol intoxication or withdrawal",
            "target": "Correlate with history"
          },
          {
            "item": "Urinalysis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "UTI can provoke seizures (especially elderly)",
            "target": "Negative"
          },
          {
            "item": "Prolactin level",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Elevated if drawn within 10-20 min of event; helps distinguish seizure from non-epileptic event",
            "target": "Elevated 2-3Ã— baseline (if drawn <20 min)"
          },
          {
            "item": "Phosphorus",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hypophosphatemia lowers seizure threshold (especially alcohol withdrawal)",
            "target": ">2.5 mg/dL"
          }
        ],
        "Extended Workup": [
          {
            "item": "TSH",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Thyroid dysfunction can affect seizure threshold",
            "target": "Normal"
          },
          {
            "item": "Ammonia",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Hepatic encephalopathy, urea cycle disorders",
            "target": "Normal (<35 Î¼mol/L)"
          },
          {
            "item": "Troponin",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Cardiac ischemia as cause or consequence",
            "target": "Negative"
          },
          {
            "item": "ECG",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Arrhythmia, prolonged QTc (some ASMs), Brugada",
            "target": "Normal"
          },
          {
            "item": "Lactate",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Elevated post-ictal; also metabolic acidosis",
            "target": "Mild elevation acceptable post-ictal"
          },
          {
            "item": "Blood gas (ABG or VBG)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Acidosis, hypoxia",
            "target": "Normal or mild post-ictal acidosis"
          },
          {
            "item": "Serum osmolality",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Hypo/hyperosmolar states",
            "target": "280-295 mOsm/kg"
          },
          {
            "item": "Pregnancy test (urine or serum Î²-hCG)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Eclampsia; affects imaging and ASM choice",
            "target": "Negative (or explains eclampsia if positive)"
          },
          {
            "item": "B12 level",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency associated with seizures",
            "target": "Normal (>300 pg/mL)"
          },
          {
            "item": "Folate level",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency can lower threshold; important for women of childbearing potential",
            "target": "Normal"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Serum/urine toxicology (expanded panel)",
            "ED": "URGENT",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "URGENT",
            "rationale": "Synthetic drugs, medications not on standard screen",
            "target": "Negative"
          },
          {
            "item": "Heavy metals (lead, mercury)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Occupational exposure, pica",
            "target": "Normal"
          },
          {
            "item": "Ceruloplasmin, serum copper",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Wilson disease (young patients)",
            "target": "Normal"
          },
          {
            "item": "HIV",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HIV-associated CNS disease",
            "target": "Negative"
          },
          {
            "item": "RPR/VDRL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurosyphilis",
            "target": "Negative"
          },
          {
            "item": "Autoimmune encephalitis panel (serum)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Anti-NMDAR, LGI1, CASPR2, GABA-B if clinical suspicion",
            "target": "Negative"
          },
          {
            "item": "Paraneoplastic panel (serum)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Subacute onset, smoking, weight loss",
            "target": "Negative"
          },
          {
            "item": "Porphyrins (urine/serum)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Acute intermittent porphyria",
            "target": "Normal"
          },
          {
            "item": "Genetic epilepsy panel",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Young onset, family history, refractory",
            "target": "Variable"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Elevated ICP, mass effect",
            "target": "10-20 cm H2O"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Infection, inflammation",
            "target": "WBC <5; RBC 0"
          },
          {
            "item": "Protein",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Elevated in infection, inflammation",
            "target": "15-45 mg/dL"
          },
          {
            "item": "Glucose with serum glucose",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Low in bacterial/fungal/TB meningitis",
            "target": ">60% serum"
          },
          {
            "item": "Gram stain and culture",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Bacterial meningitis",
            "target": "No organisms"
          },
          {
            "item": "BioFire FilmArray ME Panel",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Rapid pathogen identification (14 pathogens)",
            "target": "Negative"
          },
          {
            "item": "HSV-1/2 PCR",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "HSV encephalitis (most common treatable cause)",
            "target": "Negative"
          },
          {
            "item": "Autoimmune encephalitis panel (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "If clinical suspicion for autoimmune etiology",
            "target": "Negative"
          },
          {
            "item": "Cytology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Carcinomatous meningitis",
            "target": "Negative"
          },
          {
            "item": "VDRL (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Neurosyphilis",
            "target": "Negative"
          },
          {
            "item": "Oligoclonal bands",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "If demyelinating disease suspected",
            "target": "Negative or matched with serum"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Immediate in ED",
            "target": "Mass, hemorrhage, stroke, calcification, hydrocephalus",
            "contraindications": "Pregnancy (relative - benefit usually outweighs risk)"
          },
          {
            "item": "MRI brain with and without contrast (epilepsy protocol)*",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Within 24-48h if inpatient; within 2 weeks if outpatient",
            "target": "Tumor, mesial temporal sclerosis, cortical dysplasia, encephalitis, stroke, vascular malformation",
            "contraindications": "GFR <30, gadolinium allergy, pacemaker"
          },
          {
            "item": "EEG (routine)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Within 24h if possible; ideally within 24-48h of seizure",
            "target": "Epileptiform discharges (spikes, sharp waves), focal slowing",
            "contraindications": "None significant"
          }
        ],
        "Extended": [
          {
            "item": "Continuous EEG (cEEG) monitoring",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "If altered mental status persists, suspected non-convulsive status",
            "target": "Non-convulsive seizures, non-convulsive status epilepticus",
            "contraindications": "None significant"
          },
          {
            "item": "Prolonged ambulatory EEG (24-72h)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Outpatient if routine EEG non-diagnostic",
            "target": "Capture interictal or ictal activity",
            "contraindications": "None significant"
          },
          {
            "item": "Video-EEG monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If diagnosis uncertain (vs. psychogenic)",
            "target": "Correlate clinical events with EEG",
            "contraindications": "None significant"
          },
          {
            "item": "MRA/MRV brain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If vascular etiology suspected",
            "target": "AVM, aneurysm, venous thrombosis",
            "contraindications": "Same as MRI"
          },
          {
            "item": "CT angiography head",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "If MRA unavailable and vascular cause suspected",
            "target": "Vascular malformation, aneurysm",
            "contraindications": "Contrast allergy, renal insufficiency"
          },
          {
            "item": "Echocardiogram",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If embolic stroke suspected as cause",
            "target": "Thrombus, PFO, vegetation",
            "contraindications": "None significant"
          },
          {
            "item": "Chest X-ray",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "Aspiration risk post-ictal, lung cancer screening if paraneoplastic suspected",
            "target": "Clear lungs or mass",
            "contraindications": "None significant"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "PET-CT brain (interictal FDG)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Epilepsy surgery workup",
            "target": "Focal hypometabolism",
            "contraindications": "Pregnancy, uncontrolled diabetes"
          },
          {
            "item": "SPECT (ictal/interictal)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Epilepsy surgery workup",
            "target": "Ictal hyperperfusion",
            "contraindications": "Requires seizure capture"
          },
          {
            "item": "MEG (magnetoencephalography)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Epilepsy surgery workup",
            "target": "Localize epileptogenic focus",
            "contraindications": "Metallic implants"
          },
          {
            "item": "Neuropsychological testing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Pre-surgical evaluation, cognitive concerns",
            "target": "Lateralizing deficits",
            "contraindications": "Patient cooperation"
          },
          {
            "item": "Wada test (intracarotid amobarbital)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Pre-surgical language/memory lateralization",
            "target": "Language and memory dominance",
            "contraindications": "Contrast allergy, vascular anomaly"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Lorazepam IV/IM (if actively seizing)",
            "route": "IM",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg/kg",
                  "orderSentence": "Lorazepam IV/IM (if actively seizing) 0.1 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.1 mg/kg IV (max 4 mg); may repeat once in 5 min",
              "orderSentence": "Lorazepam IV/IM (if actively seizing) 0.1 mg/kg IV"
            },
            "contraindications": "Respiratory depression, severe hypotension",
            "monitoring": "RR, O2 sat, BP; have airway equipment ready",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam IM (if no IV access)",
            "route": "IM",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Midazolam IM (if no IV access) 10 mg IM"
                }
              ],
              "route": "IM",
              "instructions": "10 mg IM (if >40 kg) or 0.2 mg/kg IM",
              "orderSentence": "Midazolam IM (if no IV access) 10 mg IM"
            },
            "contraindications": "Respiratory depression",
            "monitoring": "RR, O2 sat; have airway equipment ready",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam intranasal (if no IV access)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Midazolam intranasal (if no IV access) 5 mg -"
                }
              ],
              "route": "-",
              "instructions": "5 mg per nostril (total 10 mg)",
              "orderSentence": "Midazolam intranasal (if no IV access) 5 mg -"
            },
            "contraindications": "Respiratory depression",
            "monitoring": "RR, O2 sat",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Dextrose 50% IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-50 mL",
                  "orderSentence": "Dextrose 50% IV 25-50 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "25-50 mL IV if hypoglycemia confirmed or suspected",
              "orderSentence": "Dextrose 50% IV 25-50 mL IV"
            },
            "contraindications": "Hyperglycemia",
            "monitoring": "Glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Thiamine IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100-500 mg",
                  "orderSentence": "Thiamine IV 100-500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "100-500 mg IV BEFORE glucose if alcohol use suspected",
              "orderSentence": "Thiamine IV 100-500 mg IV"
            },
            "contraindications": "None significant",
            "monitoring": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Supplemental oxygen",
            "route": "INH",
            "indication": "-",
            "dosing": {
              "instructions": "2-4 L NC or non-rebreather as needed",
              "orderSentence": "Supplemental oxygen - INH - see dosing"
            },
            "contraindications": "None",
            "monitoring": "O2 sat >94%",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "IV fluids (isotonic)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "NS or LR bolus if hypotensive; maintenance if euvolemic",
              "orderSentence": "IV fluids (isotonic) - IV - see dosing"
            },
            "contraindications": "Fluid overload, severe hyponatremia",
            "monitoring": "I/O, BP, Na",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Flumazenil (rescue only)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.2 mg",
                  "orderSentence": "Flumazenil (rescue only) 0.2 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.2 mg IV over 30 sec; may repeat 0.2 mg q1min to max 1 mg",
              "orderSentence": "Flumazenil (rescue only) 0.2 mg IV"
            },
            "contraindications": "Chronic benzodiazepine use; seizure history; tricyclic overdose",
            "monitoring": "**CAUTION:** May lower seizure threshold and precipitate seizures; use only if severe respiratory depression unresponsive to supportive care",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Anti-Seizure Medications (ASMs) - Acute Loading": [
          {
            "item": "Levetiracetam IV",
            "route": "IV",
            "indication": "First-line acute loading",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40-60 mg/kg",
                  "orderSentence": "Levetiracetam IV 40-60 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "40-60 mg/kg IV (max 4500 mg) over 15 min; OR 1500-3000 mg IV",
              "orderSentence": "Levetiracetam IV 40-60 mg/kg IV"
            },
            "contraindications": "None significant; reduce dose if CrCl <50",
            "monitoring": "Somnolence, agitation (rare)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Levetiracetam PO",
            "route": "PO",
            "indication": "Acute loading if stable",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1500-3000 mg",
                  "orderSentence": "Levetiracetam PO 1500-3000 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "1500-3000 mg PO Ã— 1, then start maintenance",
              "orderSentence": "Levetiracetam PO 1500-3000 mg PO"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "URGENT",
            "ICU": "-"
          },
          {
            "item": "Fosphenytoin IV",
            "route": "IV",
            "indication": "Alternative first-line",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "Fosphenytoin IV 20 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "20 mg PE/kg IV at 150 mg PE/min (max rate)",
              "orderSentence": "Fosphenytoin IV 20 mg IV"
            },
            "contraindications": "AV block, sinus bradycardia, pregnancy (relative)",
            "monitoring": "Continuous cardiac monitoring, BP; purple glove syndrome rare with fosphenytoin",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Phenytoin IV",
            "route": "IV",
            "indication": "If fosphenytoin unavailable",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg/kg",
                  "orderSentence": "Phenytoin IV 20 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "20 mg/kg IV at max 50 mg/min",
              "orderSentence": "Phenytoin IV 20 mg/kg IV"
            },
            "contraindications": "AV block, sinus bradycardia, pregnancy",
            "monitoring": "Cardiac monitor, BP; give via large vein (tissue necrosis risk)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Valproate IV",
            "route": "IV",
            "indication": "Alternative (broad-spectrum)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg/kg",
                  "orderSentence": "Valproate IV 40 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "40 mg/kg IV over 10 min (max 3000 mg)",
              "orderSentence": "Valproate IV 40 mg/kg IV"
            },
            "contraindications": "Pregnancy (teratogenic - neural tube defects), hepatic disease, mitochondrial disease, urea cycle disorders",
            "monitoring": "LFTs, ammonia, platelets; pancreatitis risk",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Lacosamide IV",
            "route": "IV",
            "indication": "Alternative first-line",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200-400 mg",
                  "orderSentence": "Lacosamide IV 200-400 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "200-400 mg IV over 15-30 min",
              "orderSentence": "Lacosamide IV 200-400 mg IV"
            },
            "contraindications": "PR prolongation >200 ms, 2nd/3rd degree AV block",
            "monitoring": "ECG for PR interval; dizziness",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          }
        ],
        "Anti-Seizure Medications (ASMs) - Maintenance Therapy": [
          {
            "item": "Levetiracetam",
            "route": "IV",
            "indication": "First-line maintenance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500-1500 mg",
                  "orderSentence": "Levetiracetam 500-1500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "500-1500 mg PO/IV BID; start 500 mg BID, may increase by 500 mg/dose weekly; max 3000 mg/day",
              "orderSentence": "Levetiracetam 500-1500 mg IV"
            },
            "contraindications": "Renal impairment (adjust per CrCl)",
            "monitoring": "Behavioral changes (irritability, depression - \"Keppra rage\"); renal function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Lamotrigine",
            "route": "-",
            "indication": "First-line (especially women of childbearing potential)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Lamotrigine 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily Ã— 2 weeks; then 50 mg daily Ã— 2 weeks; then 100 mg daily; target 200-400 mg/day in divided doses",
              "orderSentence": "Lamotrigine 25 mg PO"
            },
            "contraindications": "Slow titration required (SJS/TEN risk)",
            "monitoring": "Rash (stop if any rash; SJS/TEN risk higher with fast titration or valproate co-therapy)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lacosamide",
            "route": "PO",
            "indication": "First-line alternative",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Lacosamide 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg PO BID; increase by 100 mg/day weekly; target 200-400 mg BID; max 400 mg BID",
              "orderSentence": "Lacosamide 100 mg PO"
            },
            "contraindications": "PR prolongation, 2nd/3rd degree AV block, severe hepatic impairment",
            "monitoring": "ECG at baseline and dose changes; dizziness, diplopia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Oxcarbazepine",
            "route": "PO",
            "indication": "Focal seizures",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Oxcarbazepine 300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg PO BID; increase by 300-600 mg/day every week; target 1200-2400 mg/day in divided doses",
              "orderSentence": "Oxcarbazepine 300 mg PO"
            },
            "contraindications": "Hypersensitivity to carbamazepine",
            "monitoring": "Sodium (hyponatremia in 2-3%); HLA-B*1502 screening in at-risk populations",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbamazepine",
            "route": "PO",
            "indication": "Focal seizures",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mg",
                  "orderSentence": "Carbamazepine 200 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 200 mg PO BID; increase by 200 mg/day weekly; target 800-1200 mg/day; max 1600 mg/day",
              "orderSentence": "Carbamazepine 200 mg PO"
            },
            "contraindications": "AV block; bone marrow suppression; concurrent MAOIs",
            "monitoring": "CBC, LFTs, sodium at baseline and periodically; HLA-B*1502 screening",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valproate/Divalproex",
            "route": "PO",
            "indication": "Generalized seizures",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-15 mg/kg",
                  "orderSentence": "Valproate/Divalproex 10-15 mg/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-15 mg/kg/day in divided doses; increase by 5-10 mg/kg/week; target 1000-2000 mg/day; max 60 mg/kg/day",
              "orderSentence": "Valproate/Divalproex 10-15 mg/kg PO"
            },
            "contraindications": "Pregnancy (teratogenic); hepatic disease; mitochondrial disease; pancreatitis history",
            "monitoring": "LFTs, ammonia, CBC, platelets at baseline, then q3-6mo; weight gain, hair loss, tremor",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Phenytoin",
            "route": "PO",
            "indication": "Focal or generalized",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300-400 mg",
                  "orderSentence": "Phenytoin 300-400 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "300-400 mg daily (extended release) or divided TID (immediate release); adjust by level",
              "orderSentence": "Phenytoin 300-400 mg PO"
            },
            "contraindications": "Pregnancy (relative - fetal hydantoin syndrome); AV block",
            "monitoring": "Free phenytoin level (target 1-2 Î¼g/mL); total level 10-20 Î¼g/mL; CBC, LFTs; gingival hyperplasia, hirsutism",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Brivaracetam",
            "route": "PO",
            "indication": "Alternative to levetiracetam",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Brivaracetam 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg PO BID; may increase to 100 mg BID; max 200 mg/day",
              "orderSentence": "Brivaracetam 50 mg PO"
            },
            "contraindications": "Hepatic impairment (reduce dose)",
            "monitoring": "Less behavioral side effects than levetiracetam; somnolence",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Zonisamide",
            "route": "PO",
            "indication": "Adjunctive or monotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Zonisamide 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg daily; increase by 100 mg every 2 weeks; target 300-400 mg daily; max 600 mg/day",
              "orderSentence": "Zonisamide 100 mg PO"
            },
            "contraindications": "Sulfonamide allergy; kidney stones",
            "monitoring": "Kidney stones (carbonic anhydrase inhibitor); oligohidrosis (pediatric); metabolic acidosis",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Topiramate",
            "route": "PO",
            "indication": "Adjunctive or monotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Topiramate 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg BID; increase by 50 mg/day weekly; target 200-400 mg/day in divided doses; max 400 mg/day",
              "orderSentence": "Topiramate 25 mg PO"
            },
            "contraindications": "Kidney stones; metabolic acidosis; glaucoma",
            "monitoring": "Cognitive impairment (\"dopamax\"); paresthesias; kidney stones; weight loss",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clobazam",
            "route": "PO",
            "indication": "Adjunctive therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-10 mg",
                  "orderSentence": "Clobazam 5-10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5-10 mg daily; increase by 5-10 mg weekly; max 40 mg/day in divided doses",
              "orderSentence": "Clobazam 5-10 mg PO"
            },
            "contraindications": "Severe hepatic impairment; sleep apnea (untreated)",
            "monitoring": "Sedation; tolerance may develop; CYP2C19 poor metabolizers need lower dose",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Perampanel",
            "route": "PO",
            "indication": "Adjunctive for focal or GTCS",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg",
                  "orderSentence": "Perampanel 2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2 mg qHS; increase by 2 mg weekly; target 8-12 mg qHS; max 12 mg/day",
              "orderSentence": "Perampanel 2 mg PO"
            },
            "contraindications": "None absolute",
            "monitoring": "Psychiatric effects (aggression, hostility); dizziness; take at bedtime; Schedule III",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cenobamate",
            "route": "PO",
            "indication": "Adjunctive for focal",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg",
                  "orderSentence": "Cenobamate 12.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5 mg daily Ã— 2 weeks; titrate slowly per package insert; target 200-400 mg daily",
              "orderSentence": "Cenobamate 12.5 mg PO"
            },
            "contraindications": "Familial short QT syndrome",
            "monitoring": "Very slow titration required (DRESS risk); QT shortening; titration pack available",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Phenobarbital",
            "route": "IV",
            "indication": "Refractory or resource-limited",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15-20 mg/kg",
                  "orderSentence": "Phenobarbital 15-20 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "Load 15-20 mg/kg IV; maintenance 1-3 mg/kg/day (60-180 mg/day); target level 15-40 Î¼g/mL",
              "orderSentence": "Phenobarbital 15-20 mg/kg IV"
            },
            "contraindications": "Porphyria; severe respiratory disease",
            "monitoring": "Sedation; cognitive effects; drug interactions (CYP inducer); level monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Acetaminophen",
            "route": "IV",
            "indication": "Post-ictal headache",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650-1000 mg",
                  "orderSentence": "Acetaminophen 650-1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "650-1000 mg PO/IV q6h PRN; max 3000 mg/day (2000 mg if liver disease)",
              "orderSentence": "Acetaminophen 650-1000 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Severe hepatic impairment",
            "monitoring": "LFTs if chronic use",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Ibuprofen",
            "route": "PO",
            "indication": "Post-ictal headache",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400-600 mg",
                  "orderSentence": "Ibuprofen 400-600 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "400-600 mg PO q6-8h PRN; max 2400 mg/day",
              "orderSentence": "Ibuprofen 400-600 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Renal impairment; GI bleed; post-CABG",
            "monitoring": "Renal function if prolonged use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ondansetron",
            "route": "IV",
            "indication": "Post-ictal nausea",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4-8 mg",
                  "orderSentence": "Ondansetron 4-8 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "4-8 mg IV/PO q8h PRN",
              "orderSentence": "Ondansetron 4-8 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "QT prolongation; severe hepatic impairment",
            "monitoring": "QTc if multiple doses",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Lorazepam",
            "route": "IV",
            "indication": "Post-ictal agitation (if severe)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5-2 mg",
                  "orderSentence": "Lorazepam 0.5-2 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-2 mg IV/PO PRN; use with caution",
              "orderSentence": "Lorazepam 0.5-2 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Respiratory depression; altered mental status",
            "monitoring": "RR, sedation level; avoid if post-ictal confusion resolving",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Sertraline",
            "route": "PO",
            "indication": "Depression/anxiety (chronic)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Sertraline 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg daily; increase by 25-50 mg q1-2 weeks; max 200 mg daily",
              "orderSentence": "Sertraline 50 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Concurrent MAOIs",
            "monitoring": "Suicidality monitoring weeks 1-4",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Escitalopram",
            "route": "PO",
            "indication": "Depression/anxiety (chronic)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Escitalopram 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg daily; max 20 mg daily",
              "orderSentence": "Escitalopram 10 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Concurrent MAOIs; QT prolongation",
            "monitoring": "QTc if risk factors",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "Sleep disturbance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3-5 mg",
                  "orderSentence": "Melatonin 3-5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "3-5 mg PO qHS",
              "orderSentence": "Melatonin 3-5 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "None significant",
            "monitoring": "Well tolerated; may help with ASM-related sleep disruption",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Insomnia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-100 mg",
                  "orderSentence": "Trazodone 25-100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "25-100 mg PO qHS",
              "orderSentence": "Trazodone 25-100 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Concurrent MAOIs",
            "monitoring": "Orthostatic hypotension; priapism (rare)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Add second ASM",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Choose complementary mechanism; see maintenance options",
              "orderSentence": "Add second ASM - - - see dosing"
            },
            "contraindications": "Per specific agent",
            "monitoring": "Per specific agent",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Epilepsy surgery evaluation referral",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "For drug-resistant epilepsy (failed 2+ appropriately chosen ASMs)",
              "orderSentence": "Epilepsy surgery evaluation referral - - - see dosing"
            },
            "contraindications": "N/A",
            "monitoring": "N/A",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Vagus nerve stimulator (VNS)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "For drug-resistant epilepsy not surgical candidates",
              "orderSentence": "Vagus nerve stimulator (VNS) - - - see dosing"
            },
            "contraindications": "N/A",
            "monitoring": "Device checks",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Dietary therapy (ketogenic diet, modified Atkins)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "For drug-resistant epilepsy",
              "orderSentence": "Dietary therapy (ketogenic diet, modified Atkins) - - - see dosing"
            },
            "contraindications": "Fatty acid oxidation disorders; pyruvate carboxylase deficiency",
            "monitoring": "Metabolic panels; lipids; kidney function",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consult",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "All new onset seizures for evaluation and management"
          },
          {
            "item": "Epilepsy specialist referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Diagnostic uncertainty, refractory seizures, surgical candidacy"
          },
          {
            "item": "EEG technologist/neurodiagnostics",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "EEG scheduling; continuous EEG if indicated"
          },
          {
            "item": "Neurosurgery consult",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "EXT",
            "ICU": "URGENT",
            "indication": "Structural lesion requiring intervention (tumor, AVM, SDH)"
          },
          {
            "item": "Medical toxicology consult",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "indication": "Suspected drug/toxin-induced seizure"
          },
          {
            "item": "Infectious disease consult",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "indication": "CNS infection confirmed or suspected"
          },
          {
            "item": "Oncology consult",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Brain tumor identified"
          },
          {
            "item": "Psychiatry consult",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Depression, anxiety post-diagnosis; psychogenic non-epileptic spells suspected"
          },
          {
            "item": "Social work consult",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Driving restrictions impact, employment concerns, insurance navigation"
          },
          {
            "item": "Occupational therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Work safety evaluation, activity modification"
          },
          {
            "item": "Physical therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "If post-ictal weakness, falls, injury from seizure"
          },
          {
            "item": "Neuropsychology referral",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Cognitive complaints, pre-surgical evaluation"
          },
          {
            "item": "Women's health/OB-GYN",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Contraception counseling (ASM interactions), pregnancy planning"
          },
          {
            "item": "Epilepsy monitoring unit (EMU) admission",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "indication": "Characterize seizure type, video-EEG monitoring, pre-surgical evaluation"
          },
          {
            "item": "Driving evaluation/rehabilitation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "indication": "Return to driving assessment when eligible"
          }
        ],
        "Patient Instructions": [
          {
            "item": "**Return to ED immediately if:** recurrent seizure, prolonged seizure >5 minutes, head injury, persistent confusion, difficulty breathing, or status epilepticus",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Do NOT drive until cleared by neurology (driving restrictions per state guidelines; typically require seizure-free interval)",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Avoid operating heavy machinery, working at heights, or swimming alone",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Do not bathe alone; showers preferred over baths; keep bathroom door unlocked",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Inform employer if job involves safety-sensitive duties",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Take ASM exactly as prescribed; do NOT stop abruptly (risk of breakthrough seizures or status epilepticus)",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Avoid common seizure triggers: sleep deprivation, alcohol, illicit drugs, missed medications",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Keep a seizure diary: date, time, duration, description, triggers, post-ictal symptoms",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Wear medical identification (bracelet or necklace)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Educate family/coworkers on seizure first aid: stay with person, protect head, do NOT put anything in mouth, time the seizure, call 911 if >5 minutes",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Follow up with neurology within 1-2 weeks of discharge",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "-"
          },
          {
            "item": "Bring list of all medications (including OTC and supplements) to all appointments - many interact with ASMs",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Women: discuss contraception with provider; some ASMs reduce efficacy of hormonal contraception",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Report side effects (mood changes, rash, dizziness, cognitive issues) promptly; do NOT stop medication without calling",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Avoid flashing/strobe lights if photosensitive seizures suspected",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Sleep hygiene: aim for 7-9 hours nightly; maintain regular sleep schedule",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Avoid alcohol (lowers seizure threshold; interacts with ASMs)",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Avoid illicit drugs (especially stimulants: cocaine, amphetamines)",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Stress management techniques",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Regular moderate exercise (not extreme sleep deprivation from overtraining)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Medication adherence: use pill organizers, phone alarms, refill reminders",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Folic acid supplementation 1-4 mg daily for women of childbearing potential (especially if on enzyme-inducing ASMs)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Bone health: vitamin D 1000-2000 IU daily; calcium as needed (enzyme-inducing ASMs affect bone density)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Avoid known personal triggers (flashing lights, certain foods, stress, if identified)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Home safety modifications: pad sharp furniture corners, avoid glass shower doors, use microwave instead of stovetop when alone",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Seizure alert devices or apps for those living alone (optional)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Smoking cessation (increases ASM metabolism; general health)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Syncope (convulsive syncope)",
        "features": "Brief (<15 sec), triggered by standing/Valsalva/micturition, rapid recovery, no post-ictal confusion, possible prodrome (lightheaded, tunnel vision)",
        "tests": "ECG, orthostatic vitals, tilt table test, echocardiogram"
      },
      {
        "diagnosis": "Psychogenic non-epileptic spells (PNES)",
        "features": "Variable/atypical semiology, prolonged duration, preserved awareness with bilateral movements, eye closure, pelvic thrusting, no post-ictal confusion, psychiatric comorbidity",
        "tests": "Video-EEG capturing event; normal prolactin"
      },
      {
        "diagnosis": "Transient ischemic attack (TIA)",
        "features": "Negative symptoms (weakness, numbness), no LOC, no convulsive activity",
        "tests": "MRI DWI, vascular imaging"
      },
      {
        "diagnosis": "Migraine with aura",
        "features": "Gradual onset, spreading symptoms, headache follows, stereotyped",
        "tests": "Clinical history, normal EEG"
      },
      {
        "diagnosis": "Hypoglycemia",
        "features": "Diaphoresis, tremor, confusion, rapid glucose corrects symptoms",
        "tests": "Fingerstick glucose"
      },
      {
        "diagnosis": "Cardiac arrhythmia",
        "features": "Palpitations, sudden LOC without warning, rapid recovery",
        "tests": "ECG, Holter monitor, event recorder, EP study"
      },
      {
        "diagnosis": "Transient global amnesia",
        "features": "Isolated anterograde amnesia, repetitive questioning, no convulsive activity",
        "tests": "Clinical presentation (self-limited), MRI DWI (hippocampal)"
      },
      {
        "diagnosis": "Sleep disorders (parasomnias, cataplexy)",
        "features": "Occur from sleep, specific features (cataplexy with emotion)",
        "tests": "Sleep study, clinical history"
      },
      {
        "diagnosis": "Movement disorders (dystonia, tics)",
        "features": "Stereotyped, no LOC, suppressible (tics), may have sensory urge",
        "tests": "Clinical history, video"
      },
      {
        "diagnosis": "Drug intoxication/withdrawal",
        "features": "History of substance use, known withdrawal timeline",
        "tests": "Toxicology screen, history"
      },
      {
        "diagnosis": "Metabolic encephalopathy",
        "features": "Gradual onset, diffuse abnormality, asterixis, no discrete seizures",
        "tests": "Labs (ammonia, glucose, Na), EEG (diffuse slowing)"
      }
    ],
    "evidence": [
      {
        "recommendation": "ILAE 2017 seizure classification",
        "evidenceLevel": "Class I",
        "source": "[Fisher RS et al. Epilepsia 2017](https://pubmed.ncbi.nlm.nih.gov/28276060/)"
      },
      {
        "recommendation": "ILAE 2014 practical definition of epilepsy",
        "evidenceLevel": "Class I",
        "source": "[Fisher RS et al. Epilepsia 2014](https://pubmed.ncbi.nlm.nih.gov/24730690/)"
      },
      {
        "recommendation": "EEG within 24-48h increases yield",
        "evidenceLevel": "Class II, Level B",
        "source": "[AAN Practice Parameter 2007](https://pubmed.ncbi.nlm.nih.gov/18025394/)"
      },
      {
        "recommendation": "MRI superior to CT for epilepsy evaluation",
        "evidenceLevel": "Class I, Level A",
        "source": "[ILAE Neuroimaging Task Force 2019](https://pubmed.ncbi.nlm.nih.gov/31135062/)"
      },
      {
        "recommendation": "Levetiracetam non-inferior to phenytoin for acute seizure cessation",
        "evidenceLevel": "Class I, Level A",
        "source": "[ESETT Trial, Kapur et al. NEJM 2019](https://pubmed.ncbi.nlm.nih.gov/31774955/)"
      },
      {
        "recommendation": "Risk of recurrence after first unprovoked seizure ~40-50%",
        "evidenceLevel": "Class I",
        "source": "[Hauser et al. NEJM 1998](https://pubmed.ncbi.nlm.nih.gov/9459646/)"
      },
      {
        "recommendation": "Starting ASM after first seizure reduces recurrence but not long-term remission",
        "evidenceLevel": "Class I, Level A",
        "source": "[FIRST Trial](https://pubmed.ncbi.nlm.nih.gov/8450987/); [MESS Trial, Marson et al. Lancet 2005](https://pubmed.ncbi.nlm.nih.gov/15950714/)"
      },
      {
        "recommendation": "Lamotrigine and levetiracetam preferred in women of childbearing potential",
        "evidenceLevel": "Class II, Level B",
        "source": "[AAN/AES Guidelines 2009](https://pubmed.ncbi.nlm.nih.gov/19398681/); [MONEAD Study](https://pubmed.ncbi.nlm.nih.gov/31806691/)"
      },
      {
        "recommendation": "Driving restrictions reduce accident risk",
        "evidenceLevel": "Class II, Level B",
        "source": "Multiple observational studies"
      },
      {
        "recommendation": "Prolactin elevation supports diagnosis of epileptic seizure (if drawn <20 min)",
        "evidenceLevel": "Class II, Level B",
        "source": "[Chen et al. Neurology 2005](https://pubmed.ncbi.nlm.nih.gov/16157897/)"
      },
      {
        "recommendation": "Continuous EEG detects non-convulsive status in altered patients",
        "evidenceLevel": "Class II, Level B",
        "source": "[Claassen et al. Neurology 2004](https://pubmed.ncbi.nlm.nih.gov/15159471/)"
      },
      {
        "recommendation": "Folate supplementation reduces teratogenicity risk",
        "evidenceLevel": "Class II, Level B",
        "source": "[AAN/AES Practice Parameter 2009](https://pubmed.ncbi.nlm.nih.gov/19398681/)"
      }
    ],
    "monitoring": [
      {
        "item": "Neurologic exam (level of consciousness, focal deficits)",
        "frequency": "Q1-2h in ED; Q4h inpatient; each visit OPD",
        "action": "If prolonged post-ictal state: continuous EEG to rule out non-convulsive status"
      },
      {
        "item": "Vital signs",
        "frequency": "Continuous in ED/ICU; Q4h floor",
        "action": "Treat hyperthermia, hypotension, hypoxia"
      },
      {
        "item": "Glucose",
        "frequency": "On arrival; repeat if altered",
        "action": "Dextrose if low"
      },
      {
        "item": "Electrolytes (Na, Ca, Mg)",
        "frequency": "On arrival; daily if abnormal",
        "action": "Correct deficiencies; identify cause"
      },
      {
        "item": "ASM level (phenytoin, valproate, phenobarbital, carbamazepine)",
        "frequency": "Trough level 5-7 days after initiation or dose change; PRN",
        "action": "Adjust dose; check free level for phenytoin"
      }
    ],
    "disposition": [
      {
        "disposition": "**Discharge home**",
        "criteria": "Single, self-limited seizure; returned to baseline; no dangerous etiology identified on initial workup; reliable adult supervision for 24h; ASM initiated or deferred with close follow-up; outpatient EEG and MRI arranged; understands return precautions and driving restriction"
      },
      {
        "disposition": "**Admit to floor (observation)**",
        "criteria": "Prolonged post-ictal period; multiple seizures; new structural lesion requiring monitoring; ASM loading requiring observation; social situation preventing safe discharge; need for inpatient EEG; new focal neurologic deficit"
      },
      {
        "disposition": "**Admit to ICU**",
        "criteria": "Status epilepticus (current or recent); recurrent seizures despite treatment; need for continuous EEG monitoring; airway compromise; hemodynamic instability; significant aspiration; large structural lesion with mass effect; CNS infection"
      },
      {
        "disposition": "**Transfer to higher level**",
        "criteria": "MRI unavailable; EEG unavailable; neurology not available for consultation; need for neurosurgical intervention unavailable at facility"
      }
    ]
  },
  "Multiple Sclerosis - New Diagnosis": {
    "id": "ms-new-diagnosis",
    "title": "Multiple Sclerosis - New Diagnosis",
    "version": "2.2",
    "icd10": [
      "** G35 (Multiple sclerosis)"
    ],
    "scope": "** Initial diagnostic workup and management of suspected or newly confirmed MS. Covers diagnostic criteria evaluation, mimics exclusion, acute symptom treatment, and DMT initiation framework. For established MS with acute relapse, use \"MS - Exacerbation\" template. For ongoing DMT management and monitoring, use \"MS - Maintenance\" template.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Infection screen, baseline before steroids",
            "target": "Normal"
          },
          {
            "item": "CMP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Metabolic screen, renal function",
            "target": "Normal"
          },
          {
            "item": "TSH",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Thyroid disease mimics MS",
            "target": "Normal"
          },
          {
            "item": "Vitamin B12",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "B12 deficiency causes myelopathy",
            "target": "Normal (>300 pg/mL)"
          },
          {
            "item": "Folate",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Folate deficiency causes myelopathy",
            "target": "Normal"
          },
          {
            "item": "ESR",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Inflammatory/vasculitis screen",
            "target": "Normal (<20 mm/hr)"
          },
          {
            "item": "CRP",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Inflammatory marker",
            "target": "Normal"
          },
          {
            "item": "Urinalysis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "UTI as symptom trigger",
            "target": "Negative"
          },
          {
            "item": "Blood glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Pre-steroid baseline",
            "target": "Normal"
          },
          {
            "item": "HbA1c",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Glycemic status before steroids",
            "target": "<5.7%"
          }
        ],
        "Extended Workup": [
          {
            "item": "Vitamin D (25-OH)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Low levels associated with MS risk/activity",
            "target": ">30 ng/mL"
          },
          {
            "item": "ANA",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Lupus/connective tissue disease screen",
            "target": "Negative or low titer"
          },
          {
            "item": "Anti-dsDNA",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If ANA positive, lupus evaluation",
            "target": "Negative"
          },
          {
            "item": "**Mayo CDS1 Panel** (AQP4-IgG + MOG-IgG by FACS)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Combined NMO/MOGAD screen; cell-based assay is gold standard",
            "target": "Both negative"
          },
          {
            "item": "HIV",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HIV-associated myelopathy/encephalopathy",
            "target": "Negative"
          },
          {
            "item": "RPR/VDRL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurosyphilis mimics MS",
            "target": "Negative"
          },
          {
            "item": "Lyme serology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Endemic areas; neuroborreliosis",
            "target": "Negative"
          },
          {
            "item": "ACE level",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurosarcoidosis",
            "target": "Normal"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Anti-SSA/SSB (Ro/La)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "SjÃ¶gren syndrome",
            "target": "Negative"
          },
          {
            "item": "ANCA panel",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "CNS vasculitis",
            "target": "Negative"
          },
          {
            "item": "Copper, ceruloplasmin",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Wilson disease (young patients)",
            "target": "Normal"
          },
          {
            "item": "Very long chain fatty acids",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Adrenomyeloneuropathy",
            "target": "Normal"
          },
          {
            "item": "Mitochondrial DNA studies",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Leber hereditary optic neuropathy",
            "target": "Normal"
          },
          {
            "item": "Genetic testing (HLA-DRB1)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Research/prognostic, not diagnostic",
            "target": "Variable"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Rule out elevated ICP",
            "target": "10-20 cm H2O"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Inflammation, rule out infection",
            "target": "WBC <50 (mild pleocytosis acceptable); RBC 0"
          },
          {
            "item": "Protein",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Elevated in inflammation",
            "target": "Normal to mildly elevated (<100 mg/dL)"
          },
          {
            "item": "Glucose with serum glucose",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Low in infection/carcinomatous",
            "target": "Normal (>60% serum)"
          },
          {
            "item": "Gram stain and culture",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Rule out infection",
            "target": "No organisms"
          },
          {
            "item": "Oligoclonal bands (CSF AND serum)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Intrathecal IgG synthesis",
            "target": "â‰¥2 CSF-specific bands (not in serum)"
          },
          {
            "item": "IgG index",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Intrathecal antibody synthesis",
            "target": ">0.7 = elevated"
          },
          {
            "item": "Myelin basic protein",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Active demyelination marker",
            "target": "May be elevated acutely"
          },
          {
            "item": "Cytology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Rule out malignancy",
            "target": "Negative"
          },
          {
            "item": "VDRL (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Neurosyphilis",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI brain with and without contrast (MS protocol)*",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Within 24-48h if acute; within 2 weeks if stable",
            "target": "Periventricular, juxtacortical, infratentorial, or cord lesions; gadolinium enhancement = active",
            "contraindications": "GFR <30, gadolinium allergy, pacemaker"
          },
          {
            "item": "MRI C-spine with and without contrast",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "With brain MRI",
            "target": "Cord lesions (short segment, peripheral, dorsal)",
            "contraindications": "Same as above"
          },
          {
            "item": "MRI T-spine with and without contrast",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "With brain/C-spine",
            "target": "Cord lesions",
            "contraindications": "Same as above"
          }
        ],
        "Extended": [
          {
            "item": "Visual evoked potentials (VEP)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "During workup",
            "target": "Prolonged P100 latency (subclinical optic nerve involvement)",
            "contraindications": "None significant"
          },
          {
            "item": "OCT (Optical coherence tomography)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Baseline",
            "target": "RNFL thinning (prior optic neuritis)",
            "contraindications": "None significant"
          },
          {
            "item": "MRI orbits with contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If optic neuritis suspected",
            "target": "Optic nerve enhancement, swelling",
            "contraindications": "Gadolinium contraindications"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CT chest",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If sarcoidosis suspected",
            "target": "Hilar lymphadenopathy",
            "contraindications": "Contrast allergy"
          },
          {
            "item": "PET-CT",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If CNS lymphoma or paraneoplastic suspected",
            "target": "FDG-avid lesions",
            "contraindications": "Pregnancy, uncontrolled diabetes"
          },
          {
            "item": "Conventional angiography",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If CNS vasculitis suspected",
            "target": "Beading, stenosis",
            "contraindications": "Contrast allergy, renal failure"
          },
          {
            "item": "Brain biopsy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-",
            "timing": "Atypical cases, tumefactive lesions",
            "target": "Demyelination vs neoplasm vs other",
            "contraindications": "Coagulopathy, inaccessible location"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Methylprednisolone IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Methylprednisolone IV 1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg IV daily Ã— 3-5 days",
              "orderSentence": "Methylprednisolone IV 1000 mg IV"
            },
            "contraindications": "Active untreated infection, uncontrolled diabetes, psychosis history",
            "monitoring": "Glucose q6h (target <180), BP, mood, sleep, I/O",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Omeprazole",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20-40 mg",
                  "orderSentence": "Omeprazole 20-40 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "20-40 mg daily during steroids",
              "orderSentence": "Omeprazole 20-40 mg PO"
            },
            "contraindications": "PPI allergy",
            "monitoring": "None routine",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Insulin sliding scale",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "180 mg",
                  "orderSentence": "Insulin sliding scale 180 mg -"
                }
              ],
              "route": "-",
              "instructions": "Per protocol if glucose >180 mg/dL",
              "orderSentence": "Insulin sliding scale 180 mg -"
            },
            "contraindications": "Hypoglycemia risk",
            "monitoring": "Glucose q6h",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Prednisone oral taper (optional)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg",
                  "orderSentence": "Prednisone oral taper (optional) 60 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "60 mg daily Ã— 7 days, then taper over 2 weeks",
              "orderSentence": "Prednisone oral taper (optional) 60 mg PO"
            },
            "contraindications": "Same as IV steroids",
            "monitoring": "Glucose, BP, mood",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments - First-line": [
          {
            "item": "Baclofen",
            "route": "PO",
            "indication": "Spasticity",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Baclofen 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg TID; increase by 5 mg/dose every 3 days; max 80 mg/day in divided doses",
              "orderSentence": "Baclofen 5 mg PO"
            },
            "contraindications": "Renal impairment (reduce dose)",
            "monitoring": "Sedation, weakness; do NOT stop abruptly (withdrawal risk)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Tizanidine",
            "route": "PO",
            "indication": "Spasticity",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg",
                  "orderSentence": "Tizanidine 2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2 mg qHS or TID; increase by 2-4 mg every 3-4 days; max 36 mg/day in 3 divided doses",
              "orderSentence": "Tizanidine 2 mg PO"
            },
            "contraindications": "Hepatic impairment; concurrent ciprofloxacin or fluvoxamine (CYP1A2 inhibitors)",
            "monitoring": "LFTs at baseline, 1, 3, 6 months; sedation; hypotension",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Gabapentin 300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; increase by 300 mg every 1-3 days; target 900-1800 mg TID; max 3600 mg/day",
              "orderSentence": "Gabapentin 300 mg PO"
            },
            "contraindications": "Renal impairment (adjust dose per CrCl)",
            "monitoring": "Sedation, dizziness, peripheral edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "Neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg",
                  "orderSentence": "Pregabalin 75 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 75 mg BID; increase to 150 mg BID after 1 week; max 300 mg BID",
              "orderSentence": "Pregabalin 75 mg PO"
            },
            "contraindications": "Renal impairment (adjust dose per CrCl)",
            "monitoring": "Sedation, weight gain, peripheral edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Duloxetine",
            "route": "PO",
            "indication": "Neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg",
                  "orderSentence": "Duloxetine 30 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 30 mg daily Ã— 1 week; increase to 60 mg daily; max 120 mg/day",
              "orderSentence": "Duloxetine 30 mg PO"
            },
            "contraindications": "Hepatic impairment; concurrent MAOIs; uncontrolled narrow-angle glaucoma",
            "monitoring": "Nausea (usually transient), BP, discontinuation syndrome",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "-",
            "indication": "Neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-25 mg",
                  "orderSentence": "Amitriptyline 10-25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg qHS; increase by 10-25 mg weekly; max 150 mg qHS",
              "orderSentence": "Amitriptyline 10-25 mg PO"
            },
            "contraindications": "Cardiac conduction abnormality; recent MI; urinary retention; narrow-angle glaucoma",
            "monitoring": "Anticholinergic effects; ECG if dose >100 mg/day",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbamazepine",
            "route": "PO",
            "indication": "Trigeminal neuralgia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Carbamazepine 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg BID; increase by 200 mg/day every 3-7 days; max 1200 mg/day",
              "orderSentence": "Carbamazepine 100 mg PO"
            },
            "contraindications": "AV block; bone marrow suppression; concurrent MAOIs",
            "monitoring": "CBC, LFTs, sodium at baseline and periodically; HLA-B*1502 screening in at-risk populations",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxcarbazepine",
            "route": "PO",
            "indication": "Trigeminal neuralgia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Oxcarbazepine 300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg BID; increase by 300 mg every 3 days; max 1200 mg BID",
              "orderSentence": "Oxcarbazepine 300 mg PO"
            },
            "contraindications": "Hypersensitivity to carbamazepine",
            "monitoring": "Sodium (hyponatremia risk); HLA-B*1502 screening",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxybutynin IR",
            "route": "PO",
            "indication": "Bladder urgency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Oxybutynin IR 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg BID-TID; max 5 mg QID",
              "orderSentence": "Oxybutynin IR 5 mg PO"
            },
            "contraindications": "Urinary retention; uncontrolled narrow-angle glaucoma; GI obstruction",
            "monitoring": "Dry mouth, constipation, cognitive impairment (especially elderly)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxybutynin ER",
            "route": "PO",
            "indication": "Bladder urgency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-10 mg",
                  "orderSentence": "Oxybutynin ER 5-10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5-10 mg daily; max 30 mg daily",
              "orderSentence": "Oxybutynin ER 5-10 mg PO"
            },
            "contraindications": "Same as IR",
            "monitoring": "Same; fewer anticholinergic side effects than IR",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Solifenacin",
            "route": "PO",
            "indication": "Bladder urgency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Solifenacin 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; may increase to 10 mg daily",
              "orderSentence": "Solifenacin 5 mg PO"
            },
            "contraindications": "Urinary retention; gastric retention; uncontrolled narrow-angle glaucoma; severe hepatic impairment",
            "monitoring": "Dry mouth, constipation; preferred over oxybutynin if cognitive concerns",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirabegron",
            "route": "PO",
            "indication": "Bladder urgency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Mirabegron 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; may increase to 50 mg daily",
              "orderSentence": "Mirabegron 25 mg PO"
            },
            "contraindications": "Uncontrolled hypertension",
            "monitoring": "BP monitoring; fewer anticholinergic effects (beta-3 agonist)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tamsulosin",
            "route": "PO",
            "indication": "Urinary retention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 mg",
                  "orderSentence": "Tamsulosin 0.4 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.4 mg daily 30 minutes after same meal each day",
              "orderSentence": "Tamsulosin 0.4 mg PO"
            },
            "contraindications": "Severe sulfonamide allergy (use caution)",
            "monitoring": "Orthostatic hypotension; retrograde ejaculation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Bethanechol",
            "route": "PO",
            "indication": "Urinary retention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-50 mg",
                  "orderSentence": "Bethanechol 10-50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "10-50 mg TID-QID",
              "orderSentence": "Bethanechol 10-50 mg PO"
            },
            "contraindications": "Asthma; bradycardia; hypotension; GI/GU obstruction",
            "monitoring": "GI cramping, bronchospasm",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Desmopressin",
            "route": "PO",
            "indication": "Nocturia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1-0.4 mg",
                  "orderSentence": "Desmopressin 0.1-0.4 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.1-0.4 mg qHS (oral) or 10-40 mcg intranasal",
              "orderSentence": "Desmopressin 0.1-0.4 mg PO"
            },
            "contraindications": "Hyponatremia risk; age >65 (relative); CHF; polydipsia",
            "monitoring": "Sodium at baseline, 1 week, 1 month, then periodically; fluid restrict evening",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amantadine",
            "route": "PO",
            "indication": "Fatigue",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Amantadine 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "100 mg every morning; may add 100 mg early afternoon (before 2 PM); max 200 mg/day",
              "orderSentence": "Amantadine 100 mg PO"
            },
            "contraindications": "Renal impairment (adjust dose); uncontrolled seizures",
            "monitoring": "Livedo reticularis; ankle edema; insomnia; hallucinations",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Modafinil",
            "route": "PO",
            "indication": "Fatigue",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Modafinil 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg every morning; may increase to 200 mg; max 400 mg/day",
              "orderSentence": "Modafinil 100 mg PO"
            },
            "contraindications": "Cardiac arrhythmia; LV hypertrophy; hepatic impairment",
            "monitoring": "BP, HR; may reduce efficacy of hormonal contraception; Schedule IV",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Armodafinil",
            "route": "PO",
            "indication": "Fatigue",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150 mg",
                  "orderSentence": "Armodafinil 150 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 150 mg every morning; max 250 mg daily",
              "orderSentence": "Armodafinil 150 mg PO"
            },
            "contraindications": "Same as modafinil",
            "monitoring": "Same as modafinil; longer half-life; Schedule IV",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Methylphenidate",
            "route": "PO",
            "indication": "Fatigue",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Methylphenidate 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg BID (morning and noon); max 60 mg/day",
              "orderSentence": "Methylphenidate 5 mg PO"
            },
            "contraindications": "Marked anxiety; glaucoma; tics/Tourette; concurrent MAOIs",
            "monitoring": "BP, HR, mood; Schedule II",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dalfampridine",
            "route": "-",
            "indication": "Walking impairment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Dalfampridine 10 mg -"
                }
              ],
              "route": "-",
              "instructions": "10 mg q12h (must be exactly 12 hours apart); do NOT exceed 20 mg/day",
              "orderSentence": "Dalfampridine 10 mg -"
            },
            "contraindications": "Seizure history; CrCl <50 mL/min",
            "monitoring": "Seizure risk (dose-dependent); UTI; insomnia",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sertraline",
            "route": "PO",
            "indication": "Depression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Sertraline 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg daily; increase by 25-50 mg every 1-2 weeks; max 200 mg daily",
              "orderSentence": "Sertraline 50 mg PO"
            },
            "contraindications": "Concurrent MAOIs; pimozide",
            "monitoring": "Suicidality monitoring (especially weeks 1-4); serotonin syndrome; QTc at high doses",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Escitalopram",
            "route": "PO",
            "indication": "Depression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Escitalopram 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg daily; may increase to 20 mg after 1 week; max 20 mg daily",
              "orderSentence": "Escitalopram 10 mg PO"
            },
            "contraindications": "Concurrent MAOIs; pimozide; QT prolongation",
            "monitoring": "QTc if risk factors or dose >10 mg; suicidality monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fluoxetine",
            "route": "PO",
            "indication": "Depression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "Fluoxetine 20 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 20 mg daily; may increase after several weeks; max 80 mg daily",
              "orderSentence": "Fluoxetine 20 mg PO"
            },
            "contraindications": "Concurrent MAOIs; pimozide; thioridazine",
            "monitoring": "Long half-life (washout important); suicidality monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Bupropion SR/XL",
            "route": "PO",
            "indication": "Depression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150 mg",
                  "orderSentence": "Bupropion SR/XL 150 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 150 mg SR daily; increase to 150 mg SR BID after 3 days (or 300 mg XL daily); max 400 mg/day",
              "orderSentence": "Bupropion SR/XL 150 mg PO"
            },
            "contraindications": "Seizure disorder; eating disorders; abrupt alcohol/benzo withdrawal",
            "monitoring": "Seizure risk; insomnia; no sexual side effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "Depression/pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5-75 mg",
                  "orderSentence": "Venlafaxine XR 37.5-75 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5-75 mg daily; increase by 75 mg every 4 days; max 225 mg daily",
              "orderSentence": "Venlafaxine XR 37.5-75 mg PO"
            },
            "contraindications": "Uncontrolled hypertension; concurrent MAOIs",
            "monitoring": "BP monitoring; discontinuation syndrome (taper slowly)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirtazapine",
            "route": "PO",
            "indication": "Depression/insomnia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15 mg",
                  "orderSentence": "Mirtazapine 15 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 15 mg qHS; may increase by 15 mg every 1-2 weeks; max 45 mg daily",
              "orderSentence": "Mirtazapine 15 mg PO"
            },
            "contraindications": "Concurrent MAOIs",
            "monitoring": "Weight gain; sedation (lower at higher doses); agranulocytosis (rare)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Polyethylene glycol 3350",
            "route": "-",
            "indication": "Constipation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "17 g",
                  "orderSentence": "Polyethylene glycol 3350 17 g -"
                }
              ],
              "route": "-",
              "instructions": "17 g (1 capful) in 8 oz liquid once daily; adjust to effect",
              "orderSentence": "Polyethylene glycol 3350 17 g -"
            },
            "contraindications": "Bowel obstruction; ileus",
            "monitoring": "Electrolytes if prolonged use; may take 1-3 days for effect",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Docusate sodium",
            "route": "PO",
            "indication": "Constipation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Docusate sodium 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "100 mg BID; max 500 mg/day",
              "orderSentence": "Docusate sodium 100 mg PO"
            },
            "contraindications": "Intestinal obstruction; concurrent mineral oil",
            "monitoring": "Minimal efficacy as monotherapy; best for stool softening",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Senna",
            "route": "PO",
            "indication": "Constipation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "8.6-17.2 mg",
                  "orderSentence": "Senna 8.6-17.2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "8.6-17.2 mg qHS; max 34.4 mg/day",
              "orderSentence": "Senna 8.6-17.2 mg PO"
            },
            "contraindications": "Intestinal obstruction; acute abdominal pain",
            "monitoring": "Cramping; dependency with chronic daily use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Bisacodyl",
            "route": "PO",
            "indication": "Constipation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-10 mg",
                  "orderSentence": "Bisacodyl 5-10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10 mg PO qHS or 10 mg PR PRN",
              "orderSentence": "Bisacodyl 5-10 mg PO"
            },
            "contraindications": "Intestinal obstruction; acute abdominal pain",
            "monitoring": "Cramping; electrolyte disturbance with overuse",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lubiprostone",
            "route": "PO",
            "indication": "Constipation (refractory)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "24 mcg",
                  "orderSentence": "Lubiprostone 24 mcg PO"
                }
              ],
              "route": "PO",
              "instructions": "24 mcg BID with food",
              "orderSentence": "Lubiprostone 24 mcg PO"
            },
            "contraindications": "Mechanical GI obstruction",
            "monitoring": "Nausea (common); dyspnea; diarrhea",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Propranolol",
            "route": "PO",
            "indication": "Tremor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "Propranolol 20 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 20 mg BID; increase by 20-40 mg every 3-7 days; max 320 mg/day in divided doses",
              "orderSentence": "Propranolol 20 mg PO"
            },
            "contraindications": "Asthma/COPD; bradycardia <50; heart block; decompensated CHF",
            "monitoring": "HR, BP; fatigue; depression; bronchospasm",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Primidone",
            "route": "PO",
            "indication": "Tremor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Primidone 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS; increase by 25 mg every week to 250 mg TID; usual dose 50-250 mg TID",
              "orderSentence": "Primidone 25 mg PO"
            },
            "contraindications": "Porphyria; hypersensitivity to phenobarbital",
            "monitoring": "Severe sedation initially (start very low); ataxia; nausea",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clonazepam",
            "route": "PO",
            "indication": "Tremor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25-0.5 mg",
                  "orderSentence": "Clonazepam 0.25-0.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25-0.5 mg BID; increase by 0.5 mg every 3 days; max 6 mg/day",
              "orderSentence": "Clonazepam 0.25-0.5 mg PO"
            },
            "contraindications": "Severe hepatic impairment; myasthenia gravis; untreated narrow-angle glaucoma",
            "monitoring": "Sedation; dependence; falls risk; do NOT stop abruptly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Topiramate",
            "route": "PO",
            "indication": "Tremor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Topiramate 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; increase by 25 mg weekly; max 400 mg/day in divided doses",
              "orderSentence": "Topiramate 25 mg PO"
            },
            "contraindications": "Metabolic acidosis; kidney stones",
            "monitoring": "Cognitive slowing (\"dopamax\"); paresthesias; kidney stones; weight loss",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dextromethorphan-quinidine",
            "route": "PO",
            "indication": "Pseudobulbar affect",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Dextromethorphan-quinidine 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "20/10 mg daily Ã— 7 days, then 20/10 mg q12h",
              "orderSentence": "Dextromethorphan-quinidine 10 mg PO"
            },
            "contraindications": "QT prolongation; concurrent MAOIs; concurrent quinidine/quinine; CYP2D6 substrate drugs",
            "monitoring": "ECG at baseline; QTc monitoring; multiple drug interactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory (Acute Treatment)": [
          {
            "item": "Plasmapheresis (PLEX)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "5-7 exchanges over 10-14 days",
              "orderSentence": "Plasmapheresis (PLEX) - - - see dosing"
            },
            "contraindications": "Hemodynamic instability, sepsis, line contraindication",
            "monitoring": "BP, electrolytes, coags, fibrinogen, line infection",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "IVIG",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg",
                  "orderSentence": "IVIG 0.4 g/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.4 g/kg/day Ã— 5 days",
              "orderSentence": "IVIG 0.4 g/kg PO"
            },
            "contraindications": "IgA deficiency, renal failure, thrombosis risk",
            "monitoring": "Renal function, headache, thrombosis",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Extended IV steroids",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "Additional 2-5 days methylprednisolone (total 5-10 days)",
              "orderSentence": "Extended IV steroids - IV - see dosing"
            },
            "contraindications": "As above",
            "monitoring": "As above",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "ACTH gel (H.P. Acthar)",
            "route": "IM",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "80 units",
                  "orderSentence": "ACTH gel (H.P. Acthar) 80 units IM"
                }
              ],
              "route": "IM",
              "instructions": "80 units IM/SC daily Ã— 2-3 weeks",
              "orderSentence": "ACTH gel (H.P. Acthar) 80 units IM"
            },
            "contraindications": "Similar to corticosteroids",
            "monitoring": "Glucose, BP, electrolytes",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Disease-Modifying Therapies (DMT) - OPD ONLY": [
          {
            "item": "**INJECTABLE - MODERATE EFFICACY**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**INJECTABLE - MODERATE EFFICACY** - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Interferon beta-1a (Avonex)",
            "route": "IM",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mcg",
                  "orderSentence": "Interferon beta-1a (Avonex) 30 mcg IM"
                }
              ],
              "route": "IM",
              "instructions": "30 mcg IM once weekly",
              "orderSentence": "Interferon beta-1a (Avonex) 30 mcg IM"
            },
            "pretreatment": "-",
            "contraindications": "Depression (relative); decompensated liver disease",
            "monitoring": "CBC, LFTs q3-6mo; TSH annually; flu-like symptoms common (pretreat with NSAIDs/acetaminophen)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Interferon beta-1a (Rebif)",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "44 mcg",
                  "orderSentence": "Interferon beta-1a (Rebif) 44 mcg SC"
                }
              ],
              "route": "SC",
              "instructions": "22 or 44 mcg SC three times weekly (titrate over 4 weeks)",
              "orderSentence": "Interferon beta-1a (Rebif) 44 mcg SC"
            },
            "pretreatment": "-",
            "contraindications": "Same as Avonex",
            "monitoring": "Same; injection site reactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Interferon beta-1b (Betaseron/Extavia)",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mcg",
                  "orderSentence": "Interferon beta-1b (Betaseron/Extavia) 250 mcg SC"
                }
              ],
              "route": "SC",
              "instructions": "250 mcg SC every other day (titrate over 6 weeks)",
              "orderSentence": "Interferon beta-1b (Betaseron/Extavia) 250 mcg SC"
            },
            "pretreatment": "-",
            "contraindications": "Same as Avonex",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Peginterferon beta-1a (Plegridy)",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "125 mcg",
                  "orderSentence": "Peginterferon beta-1a (Plegridy) 125 mcg SC"
                }
              ],
              "route": "SC",
              "instructions": "125 mcg SC every 14 days (titrate over first 4 doses)",
              "orderSentence": "Peginterferon beta-1a (Plegridy) 125 mcg SC"
            },
            "pretreatment": "-",
            "contraindications": "Same as Avonex",
            "monitoring": "Same; less frequent dosing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glatiramer acetate (Copaxone) 20mg",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "Glatiramer acetate (Copaxone) 20mg 20 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "20 mg SC daily",
              "orderSentence": "Glatiramer acetate (Copaxone) 20mg 20 mg SC"
            },
            "pretreatment": "-",
            "contraindications": "Hypersensitivity",
            "monitoring": "Injection site reactions; post-injection systemic reaction (rare, self-limited)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glatiramer acetate (Copaxone) 40mg",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Glatiramer acetate (Copaxone) 40mg 40 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC three times weekly (â‰¥48 hours apart)",
              "orderSentence": "Glatiramer acetate (Copaxone) 40mg 40 mg SC"
            },
            "pretreatment": "-",
            "contraindications": "Hypersensitivity",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glatiramer acetate (Glatopa)",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "Glatiramer acetate (Glatopa) 20 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "20 mg SC daily or 40 mg SC three times weekly",
              "orderSentence": "Glatiramer acetate (Glatopa) 20 mg SC"
            },
            "pretreatment": "-",
            "contraindications": "Hypersensitivity",
            "monitoring": "Same (generic)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**ORAL - MODERATE EFFICACY**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**ORAL - MODERATE EFFICACY** - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Dimethyl fumarate (Tecfidera)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "120 mg",
                  "orderSentence": "Dimethyl fumarate (Tecfidera) 120 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "120 mg BID Ã— 7 days, then 240 mg BID",
              "orderSentence": "Dimethyl fumarate (Tecfidera) 120 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Lymphopenia <500 (discontinue)",
            "monitoring": "CBC q6mo (lymphocytes); LFTs; GI side effects (take with food); flushing (aspirin 30 min prior)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Diroximel fumarate (Vumerity)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "231 mg",
                  "orderSentence": "Diroximel fumarate (Vumerity) 231 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "231 mg BID Ã— 7 days, then 462 mg BID",
              "orderSentence": "Diroximel fumarate (Vumerity) 231 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Same as Tecfidera",
            "monitoring": "Same; less GI side effects than Tecfidera",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Monomethyl fumarate (Bafiertam)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "95 mg",
                  "orderSentence": "Monomethyl fumarate (Bafiertam) 95 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "95 mg BID Ã— 7 days, then 190 mg BID",
              "orderSentence": "Monomethyl fumarate (Bafiertam) 95 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Same as Tecfidera",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Teriflunomide (Aubagio)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "14 mg",
                  "orderSentence": "Teriflunomide (Aubagio) 14 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "7 or 14 mg once daily",
              "orderSentence": "Teriflunomide (Aubagio) 14 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Pregnancy (Category X - teratogenic); severe hepatic impairment; concurrent leflunomide",
            "monitoring": "LFTs monthly Ã— 6 months, then periodically; BP; hair thinning; requires cholestyramine washout if pregnancy desired",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**ORAL - HIGH EFFICACY (S1P MODULATORS)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**ORAL - HIGH EFFICACY (S1P MODULATORS)** - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Fingolimod (Gilenya)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg",
                  "orderSentence": "Fingolimod (Gilenya) 0.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.5 mg once daily",
              "orderSentence": "Fingolimod (Gilenya) 0.5 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Bradycardia <55; 2nd/3rd degree AV block; sick sinus syndrome; QTc >500 ms; recent MI/stroke/TIA (within 6 months)",
            "monitoring": "First-dose observation 6 hours (HR, BP q1h, ECG at 6h); macular edema screen at 3-4 months; lymphocytes; LFTs",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Siponimod (Mayzent)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg",
                  "orderSentence": "Siponimod (Mayzent) 2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Titration pack days 1-5, then 2 mg daily (1 mg if CYP2C9 *1/*3 or *2/*3)",
              "orderSentence": "Siponimod (Mayzent) 2 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Same plus CYP2C9 *3/*3 genotype (contraindicated)",
            "monitoring": "Same; genotype required before starting",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ozanimod (Zeposia)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.23 mg",
                  "orderSentence": "Ozanimod (Zeposia) 0.23 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.23 mg daily Ã— 4 days, 0.46 mg daily Ã— 3 days, then 0.92 mg daily",
              "orderSentence": "Ozanimod (Zeposia) 0.23 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Same; concurrent MAOIs",
            "monitoring": "Similar to fingolimod; no first-dose observation required (slower titration); macular edema screen",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ponesimod (Ponvory)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "Ponesimod (Ponvory) 20 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "14-day titration pack, then 20 mg daily",
              "orderSentence": "Ponesimod (Ponvory) 20 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Same",
            "monitoring": "Similar; no first-dose observation required",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**ORAL - HIGH EFFICACY (OTHER)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**ORAL - HIGH EFFICACY (OTHER)** - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Cladribine (Mavenclad)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1.75 mg/kg",
                  "orderSentence": "Cladribine (Mavenclad) 1.75 mg/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "Year 1: 1.75 mg/kg divided into 2 treatment weeks (week 1 and week 5); Year 2: repeat same dosing; no treatment years 3-4",
              "orderSentence": "Cladribine (Mavenclad) 1.75 mg/kg PO"
            },
            "pretreatment": "-",
            "contraindications": "Active infection; HIV; active malignancy; pregnancy/breastfeeding; CrCl <30",
            "monitoring": "CBC at months 2 and 6 of each treatment year; lymphopenia expected and desired; screen for malignancy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**INFUSION - HIGH EFFICACY**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**INFUSION - HIGH EFFICACY** - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Natalizumab (Tysabri)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Natalizumab (Tysabri) 300 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "300 mg IV every 4 weeks (or extended interval q6 weeks if stable and JCV negative)",
              "orderSentence": "Natalizumab (Tysabri) 300 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "JCV antibody positive with index >1.5 and prior immunosuppression (high PML risk); active infection",
            "monitoring": "JCV antibody q6mo; MRI for PML surveillance q6-12mo; infusion reactions; REMS program required",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ocrelizumab (Ocrevus)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Ocrelizumab (Ocrevus) 300 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Initial: 300 mg IV Ã— 2 doses 14 days apart; Maintenance: 600 mg IV every 6 months",
              "orderSentence": "Ocrelizumab (Ocrevus) 300 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Active Hepatitis B; active infection",
            "monitoring": "Immunoglobulins annually; infection monitoring; infusion reactions (premedicate with methylprednisolone, antihistamine, acetaminophen)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ofatumumab (Kesimpta)",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "Ofatumumab (Kesimpta) 20 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "Initial: 20 mg SC at weeks 0, 1, 2; Maintenance: 20 mg SC monthly starting week 4",
              "orderSentence": "Ofatumumab (Kesimpta) 20 mg SC"
            },
            "pretreatment": "-",
            "contraindications": "Active Hepatitis B; active infection",
            "monitoring": "Same as ocrelizumab; self-administered at home",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ublituximab (Briumvi)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150 mg",
                  "orderSentence": "Ublituximab (Briumvi) 150 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Initial: 150 mg IV day 1, 450 mg IV day 15; Maintenance: 450 mg IV every 24 weeks",
              "orderSentence": "Ublituximab (Briumvi) 150 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Active Hepatitis B; active infection",
            "monitoring": "Same as ocrelizumab; 1-hour infusion (faster)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Alemtuzumab (Lemtrada)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12 mg",
                  "orderSentence": "Alemtuzumab (Lemtrada) 12 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Year 1: 12 mg IV daily Ã— 5 consecutive days; Year 2: 12 mg IV daily Ã— 3 consecutive days (12 months after year 1)",
              "orderSentence": "Alemtuzumab (Lemtrada) 12 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Active infection; HIV; ongoing autoimmune disease other than MS",
            "monitoring": "CBC monthly Ã— 48 months; TSH q3mo Ã— 48 months; creatinine/urinalysis monthly Ã— 48 months; REMS program; secondary autoimmunity risk (thyroid, ITP, nephropathy)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**MODERATE EFFICACY - SPECIAL POPULATIONS**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**MODERATE EFFICACY - SPECIAL POPULATIONS** - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Glatiramer acetate (Copaxone)",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "Glatiramer acetate (Copaxone) 20 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "20 mg daily or 40 mg TIW",
              "orderSentence": "Glatiramer acetate (Copaxone) 20 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Hypersensitivity",
            "monitoring": "Preferred in pregnancy (no evidence of harm)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "MS specialist/Neuroimmunology referral",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "All new MS diagnoses for DMT discussion"
          },
          {
            "item": "Neuro-ophthalmology referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Optic neuritis, visual symptoms, OCT baseline"
          },
          {
            "item": "Physical therapy consult for gait and balance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "indication": "Gait dysfunction, lower extremity weakness, falls"
          },
          {
            "item": "Occupational therapy consult for ADL assessment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Upper extremity dysfunction, ADL impairment, energy conservation"
          },
          {
            "item": "Speech therapy for swallow evaluation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Brainstem involvement, dysphagia, dysarthria"
          },
          {
            "item": "Speech therapy for cognitive rehabilitation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Cognitive complaints affecting function"
          },
          {
            "item": "Urology referral for bladder dysfunction",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Urgency, frequency, retention, recurrent UTI"
          },
          {
            "item": "Psychiatry/Psychology referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Depression, anxiety, adjustment to diagnosis"
          },
          {
            "item": "Social work consult",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Insurance navigation, disability questions, support resources"
          },
          {
            "item": "Rehabilitation medicine consult",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Significant functional impairment, comprehensive rehab needs"
          },
          {
            "item": "Infusion center coordination",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "PLEX scheduling; future DMT infusion planning"
          },
          {
            "item": "Ophthalmology referral (pre-DMT)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Baseline macular exam before S1P modulator initiation"
          },
          {
            "item": "Genetic counseling",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "indication": "If atypical features, family history concerns"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return to ED if rapid vision loss, sudden weakness, difficulty breathing, or urinary retention",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Avoid driving until cleared by neurology",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Heat may temporarily worsen symptoms (Uhthoff phenomenon) - this is not a new attack",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Expect temporary steroid side effects: insomnia, mood changes, increased appetite, metallic taste",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "-"
          },
          {
            "item": "Keep symptom diary noting new or worsening symptoms",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Do not stop steroids abruptly if on oral taper",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Do not stop baclofen or tizanidine abruptly - risk of withdrawal/rebound spasticity",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Monitor blood sugars if diabetic - steroids elevate glucose",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Avoid sick contacts while on high-dose steroids",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "-"
          },
          {
            "item": "Contact MS specialist before starting any new medications (drug interactions with DMTs)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Vaccinations should be completed before DMT initiation (especially live vaccines)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Pregnancy planning requires DMT discussion (some DMTs teratogenic, washout periods vary)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Report any signs of infection (fever, cough, dysuria) promptly",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Post-void residual check if difficulty emptying bladder or recurrent UTIs",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Smoking cessation (smoking accelerates MS progression and disability)",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Vitamin D supplementation 2000-5000 IU daily (target serum 25-OH vitamin D >40 ng/mL)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Regular aerobic exercise 150 min/week as tolerated (improves fatigue, mood, function)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Resistance training 2-3Ã—/week",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Stress management and adequate sleep (7-8 hours nightly)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Avoid excessive heat exposure (hot tubs, saunas, prolonged direct sun, exercising in heat)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Cooling vest for outdoor activities in warm weather",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Maintain healthy weight (obesity associated with worse outcomes)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Limit alcohol intake (can worsen balance, cognition, bladder symptoms)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Ensure vaccinations up to date before DMT initiation (live vaccines contraindicated on many DMTs)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Fall prevention: remove loose rugs, ensure adequate lighting, use assistive devices if needed",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Energy conservation techniques for fatigue management (pacing, prioritization, positioning)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Neuromyelitis optica spectrum disorder (NMOSD)",
        "features": "Longitudinally extensive transverse myelitis (â‰¥3 segments), severe optic neuritis (often bilateral), area postrema syndrome (intractable nausea/vomiting), brain lesions in NMOSD-typical locations",
        "tests": "AQP4-IgG positive (Mayo CDS1 or NMOFS); MRI pattern different"
      },
      {
        "diagnosis": "MOG antibody disease (MOGAD)",
        "features": "Bilateral optic neuritis, ADEM-like presentation, longitudinally extensive myelitis, cortical encephalitis, better steroid response, more favorable prognosis",
        "tests": "MOG-IgG positive (Mayo CDS1 or MOGFS)"
      },
      {
        "diagnosis": "Acute disseminated encephalomyelitis (ADEM)",
        "features": "Monophasic (usually), encephalopathy, post-infectious, large poorly-defined lesions, pediatric predominance",
        "tests": "Clinical course, MRI pattern, MOG-IgG status"
      },
      {
        "diagnosis": "CNS vasculitis",
        "features": "Headache, encephalopathy, stroke-like episodes, multifocal infarcts",
        "tests": "Elevated ESR/CRP, angiography, brain/leptomeningeal biopsy"
      },
      {
        "diagnosis": "Neurosarcoidosis",
        "features": "Cranial neuropathies (especially VII), hypothalamic involvement, leptomeningeal enhancement, hilar adenopathy",
        "tests": "ACE level, chest CT, biopsy (non-caseating granulomas)"
      },
      {
        "diagnosis": "CNS lymphoma",
        "features": "Progressive course, deep gray matter/periventricular involvement, homogeneous enhancement, older/immunocompromised",
        "tests": "CSF cytology/flow, FDG-PET, biopsy"
      },
      {
        "diagnosis": "Susac syndrome",
        "features": "Encephalopathy, hearing loss, branch retinal artery occlusions, corpus callosum \"snowball\" lesions",
        "tests": "Audiogram, fluorescein angiography, MRI pattern"
      },
      {
        "diagnosis": "Neurosyphilis",
        "features": "Progressive cognitive decline, tabes dorsalis, Argyll Robertson pupils, positive serology",
        "tests": "RPR/VDRL, CSF VDRL, FTA-ABS"
      },
      {
        "diagnosis": "HIV-associated myelopathy/encephalopathy",
        "features": "Risk factors, vacuolar myelopathy, cognitive impairment",
        "tests": "HIV testing, CD4 count"
      },
      {
        "diagnosis": "B12 deficiency myelopathy",
        "features": "Subacute combined degeneration, dorsal column signs, peripheral neuropathy, macrocytic anemia",
        "tests": "B12, MMA, homocysteine"
      },
      {
        "diagnosis": "Migraine with white matter lesions",
        "features": "Headache history, non-specific white matter changes, no enhancement, no cord lesions",
        "tests": "Clinical history, MRI pattern"
      },
      {
        "diagnosis": "Small vessel ischemic disease",
        "features": "Older age, vascular risk factors, periventricular caps/halos, no enhancement, no cord lesions",
        "tests": "Risk factor profile, MRI pattern"
      }
    ],
    "evidence": [
      {
        "recommendation": "2017 McDonald Criteria for MS diagnosis",
        "evidenceLevel": "Class I",
        "source": "[Thompson AJ et al. Lancet Neurol 2018](https://pubmed.ncbi.nlm.nih.gov/29275977/)"
      },
      {
        "recommendation": "MRI brain/spine with contrast for diagnosis",
        "evidenceLevel": "Class I, Level A",
        "source": "[MAGNIMS-CMSC-NAIMS Consensus 2021](https://pubmed.ncbi.nlm.nih.gov/34139157/)"
      },
      {
        "recommendation": "CSF OCBs can substitute for dissemination in time",
        "evidenceLevel": "Class II, Level B",
        "source": "2017 McDonald Criteria"
      },
      {
        "recommendation": "IV methylprednisolone 1g Ã— 3-5 days for acute attacks",
        "evidenceLevel": "Class I, Level A",
        "source": "AAN Practice Guideline 2022"
      },
      {
        "recommendation": "PLEX for steroid-refractory attacks",
        "evidenceLevel": "Class II, Level B",
        "source": "Cochrane Review 2016"
      },
      {
        "recommendation": "Cell-based assay (FACS) for NMO/MOG antibodies",
        "evidenceLevel": "Class I, Level B",
        "source": "[Waters et al. 2015](https://pubmed.ncbi.nlm.nih.gov/25821844/); Pittock et al."
      },
      {
        "recommendation": "Vitamin D supplementation",
        "evidenceLevel": "Class II, Level B",
        "source": "Multiple observational studies; CHOLINE, SOLAR trials"
      },
      {
        "recommendation": "Smoking cessation reduces progression",
        "evidenceLevel": "Class II, Level B",
        "source": "Observational studies"
      },
      {
        "recommendation": "Early DMT initiation improves outcomes",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs, long-term extension studies"
      },
      {
        "recommendation": "Dalfampridine for walking impairment",
        "evidenceLevel": "Class I, Level A",
        "source": "[Goodman et al. Lancet 2009](https://pubmed.ncbi.nlm.nih.gov/19249634/)"
      },
      {
        "recommendation": "Exercise improves fatigue and function",
        "evidenceLevel": "Class I, Level B",
        "source": "[Cochrane Review 2015](https://pubmed.ncbi.nlm.nih.gov/26358158/)"
      }
    ],
    "monitoring": [
      {
        "item": "Blood glucose",
        "frequency": "Q6h during IV steroids",
        "action": "Insulin sliding scale; endocrine consult if persistent >250"
      },
      {
        "item": "Blood pressure",
        "frequency": "Q shift during steroids",
        "action": "Antihypertensives PRN"
      },
      {
        "item": "Mood and sleep",
        "frequency": "Daily during steroids",
        "action": "Psychiatry consult; consider dose adjustment"
      },
      {
        "item": "Temperature",
        "frequency": "Q shift",
        "action": "Infection workup if febrile"
      },
      {
        "item": "Neurologic exam",
        "frequency": "Daily (inpatient); each visit (OPD)",
        "action": "If worsening: re-image, consider PLEX"
      },
      {
        "item": "I/O and weight",
        "frequency": "Daily (inpatient)",
        "action": "Diuretics if fluid overload"
      },
      {
        "item": "Respiratory status",
        "frequency": "Q shift if cervical myelitis",
        "action": "ICU transfer if NIF >-20 (critical)"
      },
      {
        "item": "Post-void residual",
        "frequency": "If retention suspected",
        "action": "Intermittent catheterization if >200 mL; urology referral"
      },
      {
        "item": "MRI (follow-up)",
        "frequency": "3-6 months after baseline, then annually",
        "action": "DMT escalation discussion if new activity"
      },
      {
        "item": "Vitamin D level",
        "frequency": "Annually",
        "action": "Increase supplementation if low"
      },
      {
        "item": "JCV antibody (if on natalizumab)",
        "frequency": "Every 6 months",
        "action": "If positive/rising: PML risk stratification, consider DMT switch"
      }
    ],
    "disposition": [
      {
        "disposition": "**Discharge home**",
        "criteria": "Mild symptoms; able to ambulate safely; reliable follow-up within 1-2 weeks; no IV steroids needed OR completing outpatient infusion; stable baseline function; understands return precautions"
      },
      {
        "disposition": "**Admit to floor**",
        "criteria": "Moderate-severe symptoms; needs IV steroids; functional decline requiring therapy; diagnostic uncertainty requiring expedited workup; unable to care for self at home"
      },
      {
        "disposition": "**Admit to ICU**",
        "criteria": "Severe myelitis with respiratory compromise (NIF >-30 declining toward -20); brainstem involvement with airway risk or autonomic instability; severe encephalopathy"
      },
      {
        "disposition": "**Transfer to higher level**",
        "criteria": "PLEX needed but unavailable; MS specialist not available for complex decision-making; MRI unavailable for urgent imaging"
      }
    ]
  },
  "Peripheral Neuropathy - New Diagnosis/Evaluation": {
    "id": "peripheral-neuropathy",
    "title": "Peripheral Neuropathy - New Diagnosis/Evaluation",
    "version": "1.2",
    "icd10": [
      "** G62.9 (Polyneuropathy",
      "unspecified)",
      "G60.9 (Hereditary and idiopathic neuropathy",
      "unspecified)",
      "G62.0 (Drug-induced polyneuropathy)",
      "G62.1 (Alcoholic polyneuropathy)",
      "G63 (Polyneuropathy in diseases classified elsewhere)"
    ],
    "scope": "** Initial diagnostic workup and symptomatic management of suspected or newly diagnosed peripheral neuropathy. Covers etiologic evaluation, electrodiagnostic testing, pain management, and lifestyle modifications. For acute inflammatory neuropathies (GBS, CIDP), use dedicated templates. For diabetic neuropathy-specific management, this template applies but see also diabetes care protocols for glycemic optimization.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Anemia (B12), infection, malignancy screen",
            "target": "Normal"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Renal dysfunction (uremic neuropathy), hepatic disease, electrolytes",
            "target": "Normal"
          },
          {
            "item": "Fasting glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Diabetes screening",
            "target": "<100 mg/dL"
          },
          {
            "item": "HbA1c",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Diabetes/prediabetes (most common cause)",
            "target": "<5.7%"
          },
          {
            "item": "Vitamin B12",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "B12 deficiency neuropathy",
            "target": ">300 pg/mL"
          },
          {
            "item": "Methylmalonic acid (MMA)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If B12 borderline (200-400); more sensitive",
            "target": "Normal"
          },
          {
            "item": "Folate",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Folate deficiency",
            "target": "Normal"
          },
          {
            "item": "TSH",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Hypothyroidism causes neuropathy",
            "target": "Normal (0.4-4.0 mIU/L)"
          },
          {
            "item": "ESR",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Inflammatory/vasculitic process",
            "target": "Normal (<20 mm/hr)"
          },
          {
            "item": "CRP",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Inflammatory marker",
            "target": "Normal"
          }
        ],
        "Extended Workup": [
          {
            "item": "Oral glucose tolerance test (2-hour)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Detects IGT missed by FBG/HbA1c; high yield in idiopathic neuropathy (34-62% have abnormal OGTT)",
            "target": "<140 mg/dL at 2h"
          },
          {
            "item": "Serum protein electrophoresis (SPEP) with immunofixation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Monoclonal gammopathy (MGUS, myeloma)",
            "target": "No M-spike"
          },
          {
            "item": "24-hour urine protein electrophoresis (UPEP)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Light chain disease",
            "target": "No monoclonal protein"
          },
          {
            "item": "Free light chains (kappa/lambda)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "AL amyloidosis, light chain deposition",
            "target": "Normal ratio (0.26-1.65)"
          },
          {
            "item": "Vitamin B1 (thiamine)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Alcoholism, malnutrition, bariatric surgery",
            "target": "Normal"
          },
          {
            "item": "Vitamin B6 (pyridoxine)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency OR toxicity (>200 mg/day) causes neuropathy",
            "target": "Normal (5-50 ng/mL)"
          },
          {
            "item": "Vitamin E",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Malabsorption, cholestasis",
            "target": "Normal"
          },
          {
            "item": "Copper",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Copper deficiency (zinc excess, bariatric surgery)",
            "target": "Normal"
          },
          {
            "item": "Zinc",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Zinc excess suppresses copper",
            "target": "Normal"
          },
          {
            "item": "HIV antibody",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HIV-associated distal sensory polyneuropathy",
            "target": "Negative"
          },
          {
            "item": "Hepatitis B surface antigen/antibody",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hepatitis B-associated PAN, cryoglobulinemia",
            "target": "Negative"
          },
          {
            "item": "Hepatitis C antibody",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HCV-associated cryoglobulinemia, vasculitic neuropathy",
            "target": "Negative"
          },
          {
            "item": "Lyme serology (endemic areas)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Lyme neuroborreliosis",
            "target": "Negative"
          },
          {
            "item": "ANA",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Connective tissue disease screen",
            "target": "Negative or low titer"
          },
          {
            "item": "RPR/VDRL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Syphilitic neuropathy",
            "target": "Negative"
          },
          {
            "item": "Rheumatoid factor",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rheumatoid vasculitis",
            "target": "Negative"
          },
          {
            "item": "Anti-SSA/SSB (Ro/La)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "SjÃƒÂ¶gren syndrome (small fiber)",
            "target": "Negative"
          },
          {
            "item": "ACE level",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Sarcoidosis",
            "target": "Normal"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Anti-MAG antibody",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "IgM paraproteinemic neuropathy",
            "target": "Negative"
          },
          {
            "item": "Anti-ganglioside antibodies (GM1, GD1a, GD1b, GQ1b)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If motor-predominant or acute onset (GBS variants)",
            "target": "Negative"
          },
          {
            "item": "Paraneoplastic panel",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Subacute sensory neuronopathy, weight loss, smoking",
            "target": "Negative (Anti-Hu, CV2)"
          },
          {
            "item": "Cryoglobulins",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Hepatitis C, autoimmune, vasculitic neuropathy",
            "target": "Negative"
          },
          {
            "item": "Anti-CASPR2, Anti-LGI1",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Neuromyotonia, Morvan syndrome",
            "target": "Negative"
          },
          {
            "item": "Fat pad or sural nerve biopsy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Amyloidosis, vasculitis, CIDP variants",
            "target": "No amyloid or vasculitis"
          },
          {
            "item": "Genetic testing (CMT panel, TTR gene)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Hereditary neuropathy, familial amyloidosis",
            "target": "No pathogenic variant"
          },
          {
            "item": "Skin punch biopsy for IENFD",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Small fiber neuropathy confirmation",
            "target": ">8.8 fibers/mm (varies by site/age)"
          },
          {
            "item": "Heavy metal panel (lead, arsenic, thallium, mercury)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Occupational/environmental exposure",
            "target": "Normal"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Rule out elevated ICP",
            "target": "10-20 cm H2O"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Inflammation, infection",
            "target": "WBC <5, RBC 0"
          },
          {
            "item": "Protein",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Albuminocytologic dissociation in GBS/CIDP",
            "target": "Normal 15-45 mg/dL; elevated in GBS/CIDP"
          },
          {
            "item": "Glucose with serum glucose",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Infection, carcinomatous meningitis",
            "target": "Normal (>60% serum)"
          },
          {
            "item": "Gram stain and culture",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Rule out infection",
            "target": "No organisms"
          },
          {
            "item": "Cytology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Leptomeningeal carcinomatosis",
            "target": "Negative"
          },
          {
            "item": "VDRL (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Neurosyphilis",
            "target": "Negative"
          },
          {
            "item": "Lyme PCR/antibody index",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Endemic areas",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Nerve conduction studies (NCS) and EMG",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Optimal 3-4 weeks after symptom onset (allows Wallerian degeneration to manifest); can be done earlier if acute weakness suspected",
            "target": "Pattern determines axonal vs demyelinating, distribution, severity",
            "contraindications": "Pacemaker (relative); anticoagulation for needle EMG (relative)"
          }
        ],
        "Extended": [
          {
            "item": "MRI spine (cervical/lumbar) with and without contrast",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "If radiculopathy, myelopathy, or polyradiculopathy suspected",
            "target": "Nerve root enhancement (radiculopathy), cord signal change",
            "contraindications": "GFR <30, pacemaker, gadolinium allergy"
          },
          {
            "item": "MRI lumbar plexus with contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Lumbosacral plexopathy, asymmetric proximal weakness",
            "target": "Plexus enhancement, mass lesion",
            "contraindications": "Same as above"
          },
          {
            "item": "MRI brachial plexus with contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Brachial plexopathy, Parsonage-Turner syndrome",
            "target": "Plexus enhancement, denervation changes",
            "contraindications": "Same as above"
          },
          {
            "item": "Autonomic function testing (QSART, tilt table, HRV)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Autonomic symptoms (orthostasis, anhidrosis, GI dysmotility)",
            "target": "Abnormal sudomotor or cardiovagal function",
            "contraindications": "None significant"
          },
          {
            "item": "Quantitative sensory testing (QST)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Small fiber neuropathy evaluation",
            "target": "Abnormal thermal thresholds",
            "contraindications": "None significant"
          },
          {
            "item": "Chest X-ray",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Lung cancer (paraneoplastic), sarcoidosis",
            "target": "Normal",
            "contraindications": "Pregnancy (relative)"
          },
          {
            "item": "CT chest/abdomen/pelvis",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Occult malignancy if paraneoplastic suspected",
            "target": "No mass",
            "contraindications": "Contrast allergy, renal impairment"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "PET-CT",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Occult malignancy, amyloidosis",
            "target": "No FDG-avid lesions",
            "contraindications": "Pregnancy, uncontrolled diabetes"
          },
          {
            "item": "Nerve ultrasound",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "CIDP (nerve enlargement), entrapment",
            "target": "Normal nerve caliber",
            "contraindications": "None"
          },
          {
            "item": "MR neurography",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Focal nerve pathology, plexopathy",
            "target": "Normal nerve signal/caliber",
            "contraindications": "Same as MRI"
          },
          {
            "item": "Sural nerve biopsy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-",
            "timing": "Vasculitic neuropathy, amyloidosis, CIDP",
            "target": "No vasculitis or amyloid deposits",
            "contraindications": "Coagulopathy"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Thiamine IV (if alcoholic or malnourished)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Thiamine IV (if alcoholic or malnourished) 500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "500 mg IV TID Ãƒâ€” 3 days, then 250 mg IV daily Ãƒâ€” 3-5 days, then oral",
              "orderSentence": "Thiamine IV (if alcoholic or malnourished) 500 mg IV"
            },
            "contraindications": "None significant",
            "monitoring": "Anaphylaxis (rare)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Vitamin B12 IM (if deficient)",
            "route": "IM",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mcg",
                  "orderSentence": "Vitamin B12 IM (if deficient) 1000 mcg IM"
                }
              ],
              "route": "IM",
              "instructions": "1000 mcg IM daily Ãƒâ€” 7 days, then weekly Ãƒâ€” 4 weeks, then monthly",
              "orderSentence": "Vitamin B12 IM (if deficient) 1000 mcg IM"
            },
            "contraindications": "Cobalt allergy",
            "monitoring": "Reticulocyte count at 1 week; B12 level at 1-2 months",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Glucose control optimization",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7%",
                  "orderSentence": "Glucose control optimization 7% -"
                }
              ],
              "route": "-",
              "instructions": "Per diabetes protocol; target HbA1c <7%",
              "orderSentence": "Glucose control optimization 7% -"
            },
            "contraindications": "Hypoglycemia risk",
            "monitoring": "Glucose monitoring",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Symptomatic Treatments - Neuropathic Pain": [
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Neuropathic pain (first-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Gabapentin 300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; increase by 300 mg every 1-3 days; target 900-1800 mg TID; max 3600 mg/day",
              "orderSentence": "Gabapentin 300 mg PO"
            },
            "contraindications": "Renal impairment (adjust dose per CrCl: CrCl 30-59: max 900-1400 mg/day; CrCl 15-29: max 600 mg/day; CrCl <15: max 300 mg/day)",
            "monitoring": "Sedation, dizziness, peripheral edema; taper to discontinue",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "Neuropathic pain (first-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg",
                  "orderSentence": "Pregabalin 75 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 75 mg BID; increase to 150 mg BID after 1 week; max 300 mg BID",
              "orderSentence": "Pregabalin 75 mg PO"
            },
            "contraindications": "Renal impairment (adjust dose per CrCl); Class V controlled substance",
            "monitoring": "Sedation, weight gain, peripheral edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Duloxetine",
            "route": "PO",
            "indication": "Neuropathic pain (first-line, especially diabetic)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg",
                  "orderSentence": "Duloxetine 30 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 30 mg daily Ãƒâ€” 1 week; increase to 60 mg daily; max 120 mg/day",
              "orderSentence": "Duloxetine 30 mg PO"
            },
            "contraindications": "Hepatic impairment; CrCl <30; concurrent MAOIs; uncontrolled narrow-angle glaucoma",
            "monitoring": "Nausea (usually transient), BP; discontinuation syndrome (taper over 2+ weeks)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "Neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5-75 mg",
                  "orderSentence": "Venlafaxine XR 37.5-75 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5-75 mg daily; increase by 75 mg every 4-7 days; max 225 mg daily",
              "orderSentence": "Venlafaxine XR 37.5-75 mg PO"
            },
            "contraindications": "Uncontrolled hypertension; concurrent MAOIs",
            "monitoring": "BP monitoring; discontinuation syndrome",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "-",
            "indication": "Neuropathic pain (second-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-25 mg",
                  "orderSentence": "Amitriptyline 10-25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg qHS; increase by 10-25 mg weekly; max 150 mg qHS",
              "orderSentence": "Amitriptyline 10-25 mg PO"
            },
            "contraindications": "Cardiac conduction abnormality; recent MI; urinary retention; narrow-angle glaucoma; elderly (anticholinergic burden)",
            "monitoring": "ECG if dose >100 mg/day; anticholinergic effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nortriptyline",
            "route": "-",
            "indication": "Neuropathic pain (second-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-25 mg",
                  "orderSentence": "Nortriptyline 10-25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg qHS; increase by 10-25 mg weekly; max 150 mg qHS",
              "orderSentence": "Nortriptyline 10-25 mg PO"
            },
            "contraindications": "Same as amitriptyline",
            "monitoring": "Same; fewer anticholinergic effects than amitriptyline",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Desipramine",
            "route": "PO",
            "indication": "Neuropathic pain (second-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Desipramine 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS; increase by 25 mg weekly; max 150 mg daily",
              "orderSentence": "Desipramine 25 mg PO"
            },
            "contraindications": "Same as amitriptyline",
            "monitoring": "Same; least anticholinergic TCA",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbamazepine",
            "route": "PO",
            "indication": "Trigeminal neuralgia, lancinating pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Carbamazepine 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg BID; increase by 200 mg/day every 3-7 days; max 1200 mg/day",
              "orderSentence": "Carbamazepine 100 mg PO"
            },
            "contraindications": "AV block; bone marrow suppression; concurrent MAOIs",
            "monitoring": "CBC, LFTs, sodium at baseline and periodically; HLA-B*1502 screening in at-risk populations",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxcarbazepine",
            "route": "PO",
            "indication": "Trigeminal neuralgia, lancinating pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Oxcarbazepine 300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg BID; increase by 300 mg every 3 days; max 1200 mg BID",
              "orderSentence": "Oxcarbazepine 300 mg PO"
            },
            "contraindications": "Hypersensitivity to carbamazepine",
            "monitoring": "Sodium (hyponatremia risk); HLA-B*1502 screening",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Capsaicin cream 0.025-0.075%",
            "route": "-",
            "indication": "Localized neuropathic pain",
            "dosing": {
              "instructions": "Apply TID-QID to affected area; takes 2-4 weeks for effect",
              "orderSentence": "Capsaicin cream 0.025-0.075% - - - see dosing"
            },
            "contraindications": "Open wounds; avoid eyes/mucous membranes",
            "monitoring": "Initial burning (decreases with continued use); wash hands after application",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Capsaicin 8% patch (Qutenza)",
            "route": "Transdermal",
            "indication": "Localized neuropathic pain (refractory)",
            "dosing": {
              "instructions": "Applied by healthcare provider for 30-60 minutes; may repeat every 3 months",
              "orderSentence": "Capsaicin 8% patch (Qutenza) - Transdermal - see dosing"
            },
            "contraindications": "Same as above",
            "monitoring": "Must be applied in clinic; pretreat area with topical lidocaine",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lidocaine 5% patch",
            "route": "Transdermal",
            "indication": "Localized neuropathic pain",
            "dosing": {
              "instructions": "Apply 1-3 patches to painful area for 12 hours on, 12 hours off",
              "orderSentence": "Lidocaine 5% patch - Transdermal - see dosing"
            },
            "contraindications": "Severe hepatic impairment; application to broken skin",
            "monitoring": "Minimal systemic absorption; local irritation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Tramadol",
            "route": "PO",
            "indication": "Moderate neuropathic pain (adjunct)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Tramadol 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg q6h PRN; may use ER 100 mg daily; max 400 mg/day",
              "orderSentence": "Tramadol 50 mg PO"
            },
            "contraindications": "Seizure disorder; concurrent MAOIs; concurrent SSRIs (serotonin syndrome)",
            "monitoring": "Serotonin syndrome; seizures; dependence (Schedule IV)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tapentadol ER",
            "route": "PO",
            "indication": "Moderate-severe neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Tapentadol ER 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg BID; increase by 50 mg BID every 3 days; max 250 mg BID",
              "orderSentence": "Tapentadol ER 50 mg PO"
            },
            "contraindications": "Same as tramadol",
            "monitoring": "Same; Schedule II",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Morphine ER",
            "route": "-",
            "indication": "Severe refractory pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15 mg",
                  "orderSentence": "Morphine ER 15 mg -"
                }
              ],
              "route": "-",
              "instructions": "Start 15 mg q12h; titrate every 1-2 days; no max (titrate to effect)",
              "orderSentence": "Morphine ER 15 mg -"
            },
            "contraindications": "Respiratory depression; paralytic ileus; concurrent MAOIs",
            "monitoring": "Sedation, constipation, respiratory status; naloxone available",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Oxycodone ER",
            "route": "PO",
            "indication": "Severe refractory pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Oxycodone ER 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg q12h; titrate every 1-2 days",
              "orderSentence": "Oxycodone ER 10 mg PO"
            },
            "contraindications": "Same as morphine",
            "monitoring": "Same; Schedule II",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Methadone",
            "route": "PO",
            "indication": "Severe refractory neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5-5 mg",
                  "orderSentence": "Methadone 2.5-5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5-5 mg TID; titrate slowly (long half-life); specialist management",
              "orderSentence": "Methadone 2.5-5 mg PO"
            },
            "contraindications": "QT prolongation; concurrent QT-prolonging drugs",
            "monitoring": "ECG at baseline and with dose changes; QTc monitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments - Other Symptoms": [
          {
            "item": "Midodrine",
            "route": "-",
            "indication": "Orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg",
                  "orderSentence": "Midodrine 2.5 mg -"
                }
              ],
              "route": "-",
              "instructions": "Start 2.5 mg TID (upon awakening, midday, mid-afternoon); increase by 2.5 mg every 1-2 weeks; max 10 mg TID; do NOT take within 4 hours of bedtime",
              "orderSentence": "Midodrine 2.5 mg -"
            },
            "contraindications": "Severe heart disease; urinary retention; pheochromocytoma",
            "monitoring": "Supine hypertension (avoid lying flat within 4 hours); urinary retention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Fludrocortisone",
            "route": "PO",
            "indication": "Orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg",
                  "orderSentence": "Fludrocortisone 0.1 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.1 mg daily; increase by 0.1 mg every 1-2 weeks; max 0.3 mg daily",
              "orderSentence": "Fludrocortisone 0.1 mg PO"
            },
            "contraindications": "CHF; hypertension",
            "monitoring": "Potassium, BP, edema; hypokalemia; supine hypertension",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Droxidopa (Northera)",
            "route": "PO",
            "indication": "Neurogenic orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Droxidopa (Northera) 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg TID; increase by 100 mg TID every 24-48 hours; max 600 mg TID",
              "orderSentence": "Droxidopa (Northera) 100 mg PO"
            },
            "contraindications": "Concurrent ergot alkaloids; hypersensitivity",
            "monitoring": "Supine hypertension (do not take within 3 hours of bedtime); use caution with MAOIs and triptans (hypertensive risk)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pyridostigmine",
            "route": "PO",
            "indication": "Orthostatic hypotension (off-label)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30-60 mg",
                  "orderSentence": "Pyridostigmine 30-60 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "30-60 mg TID",
              "orderSentence": "Pyridostigmine 30-60 mg PO"
            },
            "contraindications": "Mechanical GI/GU obstruction; asthma (relative)",
            "monitoring": "Cholinergic effects; less supine hypertension than midodrine",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Polyethylene glycol 3350",
            "route": "-",
            "indication": "Constipation (autonomic)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "17 g",
                  "orderSentence": "Polyethylene glycol 3350 17 g -"
                }
              ],
              "route": "-",
              "instructions": "17 g daily; adjust to effect",
              "orderSentence": "Polyethylene glycol 3350 17 g -"
            },
            "contraindications": "Bowel obstruction",
            "monitoring": "Electrolytes with prolonged use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Docusate sodium",
            "route": "PO",
            "indication": "Constipation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Docusate sodium 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "100 mg BID; max 500 mg/day",
              "orderSentence": "Docusate sodium 100 mg PO"
            },
            "contraindications": "Intestinal obstruction",
            "monitoring": "Minimal efficacy alone",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Senna",
            "route": "PO",
            "indication": "Constipation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "8.6-17.2 mg",
                  "orderSentence": "Senna 8.6-17.2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "8.6-17.2 mg qHS; max 34.4 mg/day",
              "orderSentence": "Senna 8.6-17.2 mg PO"
            },
            "contraindications": "Intestinal obstruction; acute abdominal pain",
            "monitoring": "Cramping",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Metoclopramide",
            "route": "PO",
            "indication": "Gastroparesis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-10 mg",
                  "orderSentence": "Metoclopramide 5-10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10 mg 30 minutes before meals and qHS; max 40 mg/day; limit to 12 weeks (FDA black box: tardive dyskinesia risk)",
              "orderSentence": "Metoclopramide 5-10 mg PO"
            },
            "contraindications": "Bowel obstruction; Parkinson disease; tardive dyskinesia history",
            "monitoring": "Tardive dyskinesia (limit duration); QT prolongation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Domperidone",
            "route": "PO",
            "indication": "Gastroparesis (if metoclopramide contraindicated)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Domperidone 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "10 mg TID before meals; max 30 mg/day",
              "orderSentence": "Domperidone 10 mg PO"
            },
            "contraindications": "QT prolongation; concurrent QT-prolonging drugs",
            "monitoring": "ECG at baseline; not FDA-approved (requires special access)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Oxybutynin IR",
            "route": "PO",
            "indication": "Bladder urgency (anticholinergic caution in neuropathy)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Oxybutynin IR 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg BID-TID; max 5 mg QID",
              "orderSentence": "Oxybutynin IR 5 mg PO"
            },
            "contraindications": "Urinary retention; narrow-angle glaucoma",
            "monitoring": "Dry mouth, constipation, cognitive impairment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirabegron",
            "route": "PO",
            "indication": "Bladder urgency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Mirabegron 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; may increase to 50 mg daily",
              "orderSentence": "Mirabegron 25 mg PO"
            },
            "contraindications": "Uncontrolled hypertension",
            "monitoring": "BP monitoring; fewer anticholinergic effects",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tamsulosin",
            "route": "PO",
            "indication": "Urinary retention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 mg",
                  "orderSentence": "Tamsulosin 0.4 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.4 mg daily 30 minutes after same meal each day",
              "orderSentence": "Tamsulosin 0.4 mg PO"
            },
            "contraindications": "Severe sulfonamide allergy",
            "monitoring": "Orthostatic hypotension (caution if already orthostatic)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sildenafil",
            "route": "PO",
            "indication": "Erectile dysfunction",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Sildenafil 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "50 mg 30-60 min before activity; may adjust 25-100 mg; max 100 mg/day",
              "orderSentence": "Sildenafil 50 mg PO"
            },
            "contraindications": "Concurrent nitrates; recent MI/stroke",
            "monitoring": "Hypotension; priapism",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tadalafil",
            "route": "PO",
            "indication": "Erectile dysfunction",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Tadalafil 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "10 mg before activity (max once daily) OR 2.5-5 mg daily",
              "orderSentence": "Tadalafil 10 mg PO"
            },
            "contraindications": "Same as sildenafil",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hydroxyzine",
            "route": "PO",
            "indication": "Anxiety, pruritus",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-50 mg",
                  "orderSentence": "Hydroxyzine 25-50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "25-50 mg TID-QID PRN; max 400 mg/day",
              "orderSentence": "Hydroxyzine 25-50 mg PO"
            },
            "contraindications": "QT prolongation (high doses)",
            "monitoring": "Sedation; anticholinergic effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Buspirone",
            "route": "PO",
            "indication": "Generalized anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Buspirone 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg TID; increase by 5 mg every 2-3 days; max 60 mg/day",
              "orderSentence": "Buspirone 5 mg PO"
            },
            "contraindications": "Concurrent MAOIs",
            "monitoring": "Takes 2-4 weeks for effect; no dependence",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Insomnia with chronic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-50 mg",
                  "orderSentence": "Trazodone 25-50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg qHS; increase to 100-150 mg; max 200 mg qHS",
              "orderSentence": "Trazodone 25-50 mg PO"
            },
            "contraindications": "Concurrent MAOIs; QT prolongation",
            "monitoring": "QTc; priapism (rare); sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "Insomnia (adjunct)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3-5 mg",
                  "orderSentence": "Melatonin 3-5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "3-5 mg qHS 30 minutes before bed",
              "orderSentence": "Melatonin 3-5 mg PO"
            },
            "contraindications": "None significant",
            "monitoring": "Generally well-tolerated",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Disease-Specific Treatments": [
          {
            "item": "IVIG",
            "route": "PO",
            "indication": "CIDP, MMN, GBS",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g/kg",
                  "orderSentence": "IVIG 2 g/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "2 g/kg divided over 2-5 days (induction); maintenance 0.4-1 g/kg every 2-4 weeks",
              "orderSentence": "IVIG 2 g/kg PO"
            },
            "pretreatment": "-",
            "contraindications": "IgA deficiency (use IgA-depleted product); renal failure; thrombosis risk",
            "monitoring": "Renal function, headache, thrombosis, infusion reactions",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Plasma exchange (PLEX)",
            "route": "-",
            "indication": "CIDP, GBS",
            "dosing": {
              "instructions": "5-7 exchanges over 10-14 days",
              "orderSentence": "Plasma exchange (PLEX) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "Hemodynamic instability, sepsis",
            "monitoring": "BP, electrolytes, coags, fibrinogen",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Prednisone",
            "route": "PO",
            "indication": "CIDP, vasculitic neuropathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg/kg",
                  "orderSentence": "Prednisone 1 mg/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "1 mg/kg/day (max 80 mg) Ãƒâ€” 4-6 weeks; taper over 3-6 months",
              "orderSentence": "Prednisone 1 mg/kg PO"
            },
            "pretreatment": "-",
            "contraindications": "Active untreated infection, uncontrolled diabetes, psychosis",
            "monitoring": "Glucose, BP, mood, bone density with prolonged use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rituximab",
            "route": "IV",
            "indication": "Anti-MAG neuropathy, vasculitic neuropathy, refractory CIDP",
            "dosing": {
              "doseOptions": [
                {
                  "text": "375 mg",
                  "orderSentence": "Rituximab 375 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "375 mg/mÃ‚Â² IV weekly Ãƒâ€” 4 weeks OR 1000 mg IV Ãƒâ€” 2 doses 14 days apart",
              "orderSentence": "Rituximab 375 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Active hepatitis B; active infection",
            "monitoring": "Hepatitis B serology, infusion reactions, infection monitoring",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Azathioprine",
            "route": "PO",
            "indication": "Steroid-sparing for CIDP, vasculitis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Azathioprine 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg daily; increase to 2-3 mg/kg/day over weeks",
              "orderSentence": "Azathioprine 50 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "TPMT deficiency (test before starting); pregnancy",
            "monitoring": "CBC weekly Ãƒâ€” 1 month, then q2-4 weeks; LFTs monthly; TPMT genotype",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mycophenolate mofetil",
            "route": "PO",
            "indication": "Steroid-sparing for CIDP, vasculitis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Mycophenolate mofetil 500 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "500 mg BID Ãƒâ€” 2 weeks, then 1000 mg BID",
              "orderSentence": "Mycophenolate mofetil 500 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Pregnancy (teratogenic); concurrent azathioprine",
            "monitoring": "CBC q2 weeks Ãƒâ€” 3 months, then monthly; GI upset",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cyclophosphamide",
            "route": "IV",
            "indication": "Vasculitic neuropathy (severe)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2 mg/kg",
                  "orderSentence": "Cyclophosphamide 1-2 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "1-2 mg/kg/day PO OR 500-1000 mg/mÃ‚Â² IV monthly Ãƒâ€” 6 months",
              "orderSentence": "Cyclophosphamide 1-2 mg/kg IV"
            },
            "pretreatment": "-",
            "contraindications": "Pregnancy; bone marrow suppression; active infection",
            "monitoring": "CBC weekly; urinalysis (hemorrhagic cystitis); cumulative dose limit",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Tafamidis (Vyndamax/Vyndaqel)",
            "route": "PO",
            "indication": "Hereditary transthyretin (hATTR) amyloidosis with polyneuropathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "61 mg",
                  "orderSentence": "Tafamidis (Vyndamax/Vyndaqel) 61 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "61 mg (Vyndamax) or 80 mg (Vyndaqel) daily",
              "orderSentence": "Tafamidis (Vyndamax/Vyndaqel) 61 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "None absolute",
            "monitoring": "LFTs; clinical response",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Patisiran (Onpattro)",
            "route": "IV",
            "indication": "hATTR amyloidosis with polyneuropathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.3 mg/kg",
                  "orderSentence": "Patisiran (Onpattro) 0.3 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.3 mg/kg IV every 3 weeks",
              "orderSentence": "Patisiran (Onpattro) 0.3 mg/kg IV"
            },
            "pretreatment": "-",
            "contraindications": "None absolute",
            "monitoring": "Vitamin A supplementation at RDA required (patisiran reduces serum vitamin A via TTR reduction); infusion reactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Inotersen (Tegsedi)",
            "route": "SC",
            "indication": "hATTR amyloidosis with polyneuropathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "284 mg",
                  "orderSentence": "Inotersen (Tegsedi) 284 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "284 mg SC once weekly",
              "orderSentence": "Inotersen (Tegsedi) 284 mg SC"
            },
            "pretreatment": "-",
            "contraindications": "Platelet count <100,000; prior glomerulonephritis from inotersen",
            "monitoring": "Platelet count weekly throughout treatment (more frequent if <75 Ãƒâ€” 10Ã¢ÂÂ¹/L); continue monitoring 8 weeks post-discontinuation; renal function q2 weeks; REMS program required",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neuromuscular neurology referral",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "All new neuropathy diagnoses for etiology workup and management"
          },
          {
            "item": "Electrodiagnostic medicine/EMG referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "NCS/EMG for characterization (axonal vs demyelinating, pattern)"
          },
          {
            "item": "Physical therapy consult for balance and gait",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "indication": "Gait instability, weakness, falls prevention"
          },
          {
            "item": "Occupational therapy consult for hand function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Fine motor impairment, ADL difficulty"
          },
          {
            "item": "Podiatry referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Diabetic neuropathy, foot care education, orthotics, wound prevention"
          },
          {
            "item": "Endocrinology referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Diabetes management optimization if HbA1c not at goal"
          },
          {
            "item": "Pain management/Anesthesia referral",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Refractory neuropathic pain, spinal cord stimulator evaluation"
          },
          {
            "item": "Rheumatology referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Suspected vasculitic neuropathy, connective tissue disease"
          },
          {
            "item": "Hematology/Oncology referral",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Paraproteinemic neuropathy, suspected malignancy, amyloidosis"
          },
          {
            "item": "Genetic counseling referral",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Suspected hereditary neuropathy (CMT, hATTR), family history"
          },
          {
            "item": "Psychiatry/Psychology referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Chronic pain management, depression, anxiety"
          },
          {
            "item": "Social work consult",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Disability resources, insurance navigation, DME assistance"
          },
          {
            "item": "Wound care referral",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Diabetic foot ulcers, non-healing wounds"
          },
          {
            "item": "Orthotics/Prosthetics",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "AFOs for foot drop, custom orthotics"
          },
          {
            "item": "Nutrition/Dietitian referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Alcoholic neuropathy, nutritional deficiencies, bariatric surgery patients"
          },
          {
            "item": "Addiction medicine/Psychiatry",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Alcohol use disorder, opioid risk mitigation"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return to ED if sudden severe weakness, difficulty breathing, or rapid symptom progression",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Inspect feet daily for cuts, blisters, or wounds (use mirror for soles)",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Wear well-fitting, protective footwear at all times (never barefoot)",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Test bath water temperature with elbow or thermometer before entering (avoid burns)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Avoid prolonged hot or cold exposure to affected extremities (impaired sensation increases injury risk)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Use night lights and handrails to prevent falls",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Report new numbness, weakness, or autonomic symptoms (dizziness, bladder changes)",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Keep pain medication diary to track effectiveness and side effects",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Do not stop gabapentin/pregabalin abruptly - taper under medical guidance",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Neuropathic pain medications take 2-4 weeks to reach full effect",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Avoid alcohol (worsens neuropathy, interacts with pain medications)",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Rise slowly from sitting/lying position if orthostatic hypotension present",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Increase salt and fluid intake if orthostatic (unless contraindicated by cardiac/renal disease)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Wear compression stockings for orthostatic hypotension",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Do not drive until cleared if significant sensory loss or weakness affects pedal control",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "B12 injections: if self-administering, use proper technique and rotate injection sites",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Strict glycemic control (HbA1c <7% or individualized target) - most important modifiable factor",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Complete alcohol cessation (alcoholic neuropathy is reversible if early)",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Smoking cessation (microvascular disease worsens neuropathy)",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Regular exercise as tolerated (improves circulation, glycemic control, reduces pain)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Balance exercises and strength training (PT-guided) to prevent falls",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Pool therapy/aquatic exercise (reduces fall risk while exercising)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Vitamin B12 supplementation if vegan/vegetarian or on metformin",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Review medications for neurotoxic agents (metronidazole, nitrofurantoin, chemotherapy, amiodarone, statins)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Avoid excessive vitamin B6 supplementation (>100 mg/day can cause neuropathy)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Blood pressure control (target <130/80 for diabetic patients)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Weight loss if obese (reduces pressure on nerves, improves metabolic syndrome)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Fall prevention: remove throw rugs, ensure adequate lighting, use assistive devices",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Annual foot exams by podiatry or primary care for diabetic patients",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Regular ophthalmology exams if diabetic (concurrent retinopathy common)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "Ã¢Å“â€œ"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Diabetic polyneuropathy",
        "features": "Symmetric, length-dependent, sensory-predominant, feet before hands, burning/tingling",
        "tests": "HbA1c >6.5% (or 2-hour OGTT >200); NCS shows axonal sensorimotor polyneuropathy"
      },
      {
        "diagnosis": "Alcoholic neuropathy",
        "features": "History of chronic alcohol use, nutritional deficiency, burning feet",
        "tests": "History, thiamine level, liver function tests"
      },
      {
        "diagnosis": "Vitamin B12 deficiency",
        "features": "Subacute combined degeneration, myelopathy features (ataxia, Romberg), macrocytic anemia",
        "tests": "B12 <200 pg/mL or MMA elevated; may have cord signal changes on MRI"
      },
      {
        "diagnosis": "Chronic inflammatory demyelinating polyneuropathy (CIDP)",
        "features": "Progressive or relapsing weakness >8 weeks, proximal and distal, areflexia",
        "tests": "NCS shows demyelination; CSF protein elevated; nerve enlargement on ultrasound"
      },
      {
        "diagnosis": "Guillain-BarrÃƒÂ© syndrome (GBS)",
        "features": "Acute ascending weakness <4 weeks, areflexia, post-infectious",
        "tests": "NCS early may be normal then demyelinating; CSF albuminocytologic dissociation"
      },
      {
        "diagnosis": "Hereditary neuropathy (CMT)",
        "features": "Family history, pes cavus, hammertoes, childhood onset, slowly progressive",
        "tests": "Genetic testing; NCS shows uniform slowing in CMT1"
      },
      {
        "diagnosis": "Hereditary transthyretin amyloidosis (hATTR)",
        "features": "Autonomic dysfunction, carpal tunnel, cardiac involvement, family history",
        "tests": "TTR gene mutation; tissue biopsy with amyloid"
      },
      {
        "diagnosis": "Monoclonal gammopathy-associated neuropathy",
        "features": "Distal sensory-predominant, ataxia (IgM anti-MAG), older patient",
        "tests": "SPEP/UPEP; anti-MAG antibody; may need bone marrow biopsy"
      },
      {
        "diagnosis": "Vasculitic neuropathy",
        "features": "Mononeuritis multiplex pattern (asymmetric, stepwise), pain, systemic symptoms",
        "tests": "Elevated ESR/CRP; ANCA; nerve/muscle biopsy shows necrotizing vasculitis"
      },
      {
        "diagnosis": "Paraneoplastic sensory neuronopathy",
        "features": "Subacute onset, asymmetric, dorsal root ganglia involvement, weight loss",
        "tests": "Anti-Hu antibody; CT chest for small cell lung cancer"
      },
      {
        "diagnosis": "Radiculopathy",
        "features": "Dermatomal distribution, unilateral, neck/back pain, preserved reflexes outside affected root",
        "tests": "MRI spine; NCS/EMG shows radicular pattern"
      },
      {
        "diagnosis": "Lumbosacral plexopathy (diabetic amyotrophy)",
        "features": "Acute/subacute proximal weakness, thigh pain, unilateral then contralateral",
        "tests": "NCS/EMG; MRI lumbosacral plexus; diagnosis of exclusion"
      },
      {
        "diagnosis": "Small fiber neuropathy",
        "features": "Pain/autonomic symptoms with normal NCS, preserved reflexes",
        "tests": "Skin biopsy for IENFD; autonomic testing"
      },
      {
        "diagnosis": "Charcot-Marie-Tooth disease",
        "features": "Childhood/adolescent onset, pes cavus, distal atrophy, family history",
        "tests": "Genetic testing (PMP22 duplication most common)"
      },
      {
        "diagnosis": "Chemotherapy-induced peripheral neuropathy (CIPN)",
        "features": "Temporal relationship to neurotoxic chemotherapy (platinum, taxanes, vincristine)",
        "tests": "History; dose-dependent; may improve after discontinuation"
      },
      {
        "diagnosis": "HIV-associated distal sensory polyneuropathy",
        "features": "HIV+ patient, distal symmetric painful neuropathy",
        "tests": "HIV testing; CD4 count"
      },
      {
        "diagnosis": "Lyme disease",
        "features": "Endemic area, prior tick bite, radiculopathy, cranial neuropathy, polyradiculopathy",
        "tests": "Lyme serology; may need CSF analysis"
      },
      {
        "diagnosis": "Sarcoidosis",
        "features": "Multifocal neuropathy, cranial neuropathy (especially VII), pulmonary symptoms",
        "tests": "ACE level; chest imaging; biopsy (non-caseating granulomas)"
      },
      {
        "diagnosis": "Leprosy",
        "features": "Endemic areas, skin lesions, enlarged palpable nerves, anesthetic patches",
        "tests": "Skin smear/biopsy for AFB; nerve biopsy"
      }
    ],
    "evidence": [
      {
        "recommendation": "Diabetes is most common cause of polyneuropathy in developed countries",
        "evidenceLevel": "Class I",
        "source": "[Dyck PJ et al. Neurology 1993](https://pubmed.ncbi.nlm.nih.gov/8469345/)"
      },
      {
        "recommendation": "HbA1c <7% reduces neuropathy incidence in Type 1 DM",
        "evidenceLevel": "Class I, Level A",
        "source": "DCCT/EDIC"
      },
      {
        "recommendation": "Gabapentin, pregabalin, duloxetine first-line for painful diabetic neuropathy",
        "evidenceLevel": "Class I, Level A",
        "source": "AAN/AANEM Practice Guideline 2011, 2022 update"
      },
      {
        "recommendation": "Tricyclic antidepressants effective for neuropathic pain",
        "evidenceLevel": "Class I, Level A",
        "source": "[Finnerup NB et al. Lancet Neurol 2015](https://pubmed.ncbi.nlm.nih.gov/25575710/)"
      },
      {
        "recommendation": "NCS/EMG for characterization of peripheral neuropathy",
        "evidenceLevel": "Class I, Level B",
        "source": "AAN Practice Parameter"
      },
      {
        "recommendation": "SPEP indicated in idiopathic neuropathy workup",
        "evidenceLevel": "Class II, Level B",
        "source": "[England JD et al. Neurology 2009](https://pubmed.ncbi.nlm.nih.gov/19056666/)"
      },
      {
        "recommendation": "OGTT detects IGT in 34-62% of idiopathic neuropathy patients",
        "evidenceLevel": "Class II, Level B",
        "source": "[Singleton et al. Diabetes Care 2001](https://pubmed.ncbi.nlm.nih.gov/11473085/); [Hoffman-Snyder et al. Arch Neurol 2006](https://pubmed.ncbi.nlm.nih.gov/16769858/)"
      },
      {
        "recommendation": "Skin biopsy (IENFD) for small fiber neuropathy",
        "evidenceLevel": "Class II, Level B",
        "source": "[Lauria G et al. Eur J Neurol 2010](https://pubmed.ncbi.nlm.nih.gov/20642627/)"
      },
      {
        "recommendation": "IVIG first-line for CIDP",
        "evidenceLevel": "Class I, Level A",
        "source": "Cochrane Review, EFNS/PNS Guidelines"
      },
      {
        "recommendation": "Thiamine supplementation in alcoholic neuropathy",
        "evidenceLevel": "Class II, Level B",
        "source": "AAN Practice Parameter"
      },
      {
        "recommendation": "Foot care reduces amputations in diabetic neuropathy",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs, ADA Guidelines"
      },
      {
        "recommendation": "Capsaicin 8% patch effective for localized neuropathic pain",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs"
      },
      {
        "recommendation": "Tafamidis for hATTR polyneuropathy",
        "evidenceLevel": "Class I, Level A",
        "source": "[ATTR-ACT Trial](https://pubmed.ncbi.nlm.nih.gov/22843282/), Adams et al. NEJM"
      },
      {
        "recommendation": "Patisiran/inotersen for hATTR polyneuropathy",
        "evidenceLevel": "Class I, Level A",
        "source": "APOLLO, NEURO-TTR Trials"
      },
      {
        "recommendation": "Combination therapy for neuropathic pain improves outcomes",
        "evidenceLevel": "Class II, Level B",
        "source": "Multiple RCTs"
      }
    ],
    "monitoring": [
      {
        "item": "HbA1c",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Every 3 months until stable, then every 6 months",
        "action": "Intensify glycemic therapy; endocrinology referral"
      },
      {
        "item": "Vitamin B12",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "1-2 months after starting supplementation, then annually",
        "action": "Continue supplementation; rule out malabsorption"
      },
      {
        "item": "Pain scores (0-10 NRS)",
        "ED": "ROUTINE",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE",
        "frequency": "Each visit",
        "action": "Titrate medications; consider adjuncts or referral"
      },
      {
        "item": "Foot exam",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Every visit; comprehensive annually",
        "action": "Podiatry referral; wound care"
      },
      {
        "item": "Blood pressure (supine and standing)",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE",
        "frequency": "Each visit if orthostatic symptoms",
        "action": "Adjust orthostatic hypotension medications; consider compression"
      },
      {
        "item": "Gait and fall risk assessment",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "PT referral; assistive devices; home safety evaluation"
      },
      {
        "item": "Creatinine clearance",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "Baseline; with renal disease, elderly, or gabapentinoid use; with dose changes",
        "action": "Adjust gabapentin: CrCl 30-59 max 900-1400 mg/day; CrCl 15-29 max 600 mg/day; CrCl <15 max 300 mg/day"
      },
      {
        "item": "LFTs (if on high-dose gabapentinoid)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Baseline, then annually",
        "action": "Dose adjustment if hepatic impairment"
      },
      {
        "item": "Renal function",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Every 6-12 months",
        "action": "Adjust renally cleared medications (gabapentin, pregabalin)"
      },
      {
        "item": "CBC (if on immunotherapy)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE",
        "frequency": "Per medication protocol",
        "action": "Adjust immunosuppression dose; infection evaluation"
      },
      {
        "item": "NCS/EMG follow-up",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "6-12 months if treatment initiated; PRN for symptom change",
        "action": "If progressive despite treatment, reconsider diagnosis or escalate therapy"
      },
      {
        "item": "ECG (if on TCAs)",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "URGENT",
        "frequency": "Baseline; with dose increases >100 mg",
        "action": "Reduce dose or switch medication"
      },
      {
        "item": "Weight (if on gabapentinoid)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "Diet/exercise counseling; consider switch"
      },
      {
        "item": "Depression/anxiety screening (PHQ-9, GAD-7)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Annually or with symptom concern",
        "action": "Psychiatry referral; pharmacotherapy"
      },
      {
        "item": "Respiratory function (if GBS/CIDP suspected)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "Q4h if concern; FVC and NIF",
        "action": "ICU transfer if FVC <20 or NIF >-30; intubation if declining"
      }
    ],
    "disposition": [
      {
        "disposition": "**Discharge home**",
        "criteria": "Stable symptoms; chronic/slowly progressive course; ambulatory; reliable follow-up with neurology within 2-4 weeks; pain controlled; able to perform ADLs; no fall risk requiring inpatient therapy"
      },
      {
        "disposition": "**Admit to floor**",
        "criteria": "Acute/subacute progression concerning for GBS or CIDP; significant functional decline; falls requiring therapy evaluation; severe uncontrolled pain; new autonomic instability; workup requiring inpatient procedures (nerve biopsy, LP)"
      },
      {
        "disposition": "**Admit to ICU**",
        "criteria": "GBS with respiratory compromise (FVC <20 mL/kg, NIF >-30, or declining trajectory); autonomic instability with cardiac arrhythmia or BP lability; aspiration risk"
      },
      {
        "disposition": "**Transfer to higher level**",
        "criteria": "EMG/NCS not available urgently; neuromuscular specialist not available; PLEX/IVIG needed but not available; rehabilitation services not available"
      }
    ]
  },
  "Acute Ischemic Stroke": {
    "id": "acute-ischemic-stroke",
    "title": "Acute Ischemic Stroke",
    "version": "1.0",
    "icd10": [
      "** I63.9 (Cerebral infarction",
      "unspecified)",
      "I63.50 (Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebral artery)",
      "I63.3 (Cerebral infarction due to thrombosis of cerebral arteries)",
      "I63.4 (Cerebral infarction due to embolism of cerebral arteries)"
    ],
    "scope": "** Acute ischemic stroke in adults — covers initial stabilization, thrombolytic therapy (IV alteplase/tenecteplase), endovascular thrombectomy criteria, blood pressure management, stroke etiology workup, secondary prevention initiation, and early rehabilitation. Excludes hemorrhagic stroke (see Intracerebral Hemorrhage template), transient ischemic attack (see TIA template), pediatric stroke, and chronic post-stroke management.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Point-of-care glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Hypoglycemia mimics stroke; must rule out before tPA",
            "target": ">60 mg/dL"
          },
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Baseline; thrombocytopenia contraindicates tPA if <100K",
            "target": "Platelets >100,000"
          },
          {
            "item": "BMP (Na, K, Cr, glucose, BUN)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Electrolyte abnormalities, renal function for contrast/medication dosing",
            "target": "Normal"
          },
          {
            "item": "PT/INR",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Anticoagulant use; INR >1.7 contraindicates tPA",
            "target": "INR ≤1.7 for tPA eligibility"
          },
          {
            "item": "aPTT",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Heparin use; elevated aPTT contraindicates tPA",
            "target": "Normal range"
          },
          {
            "item": "Troponin",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Acute MI can cause cardioembolic stroke; stress cardiomyopathy",
            "target": "Normal"
          },
          {
            "item": "Type and screen",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Potential need for blood products, surgical intervention",
            "target": "On file"
          },
          {
            "item": "Lipid panel (fasting or non-fasting)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Baseline for statin therapy; cardiovascular risk assessment",
            "target": "LDL target <70 mg/dL"
          },
          {
            "item": "HbA1c",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes screening/management; cardiovascular risk factor",
            "target": "<7.0% (individualized)"
          }
        ],
        "Extended Workup": [
          {
            "item": "Hepatic function panel (AST, ALT, albumin)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Liver disease affects anticoagulation, medication metabolism",
            "target": "Normal"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Thyroid dysfunction as cardiovascular risk factor; atrial fibrillation workup",
            "target": "Normal"
          },
          {
            "item": "ESR / CRP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Vasculitis screen, inflammatory stroke etiology",
            "target": "Normal"
          },
          {
            "item": "Urine drug screen",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Cocaine/amphetamine-associated vasospasm or stroke",
            "target": "Negative"
          },
          {
            "item": "Pregnancy test (β-hCG)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Affects treatment decisions (tPA risk-benefit), imaging choices",
            "target": "Negative"
          },
          {
            "item": "Blood alcohol level",
            "ED": "URGENT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Intoxication as stroke mimic; affects exam reliability",
            "target": "Correlate with clinical picture"
          },
          {
            "item": "Magnesium",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Hypomagnesemia associated with arrhythmia, vascular risk",
            "target": "Normal (>1.8 mg/dL)"
          },
          {
            "item": "Phosphorus",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Refeeding risk if malnourished; metabolic panel",
            "target": "Normal"
          },
          {
            "item": "Prealbumin",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "Nutritional status for rehabilitation planning",
            "target": "Normal"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Hypercoagulable panel (protein C, protein S, antithrombin III, Factor V Leiden, prothrombin gene mutation)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Young stroke (<50), cryptogenic stroke, venous thrombosis history",
            "target": "Normal"
          },
          {
            "item": "Antiphospholipid antibody panel (lupus anticoagulant, anticardiolipin, β2-glycoprotein I)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Young stroke, recurrent stroke, systemic lupus",
            "target": "Negative"
          },
          {
            "item": "Homocysteine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Elevated homocysteine as independent stroke risk factor",
            "target": "Normal (<15 µmol/L)"
          },
          {
            "item": "RPR/VDRL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Syphilitic vasculitis",
            "target": "Negative"
          },
          {
            "item": "HIV",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HIV-associated vasculopathy",
            "target": "Negative"
          },
          {
            "item": "ANA, dsDNA",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Lupus cerebritis, vasculitis",
            "target": "Negative"
          },
          {
            "item": "ANCA (c-ANCA, p-ANCA)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "CNS vasculitis",
            "target": "Negative"
          },
          {
            "item": "Complement levels (C3, C4)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Complement-mediated vasculitis",
            "target": "Normal"
          },
          {
            "item": "Hemoglobin electrophoresis",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Sickle cell disease (young patients, African descent)",
            "target": "Normal (HbAA)"
          },
          {
            "item": "JAK2 mutation",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Polycythemia vera, myeloproliferative disorders",
            "target": "Negative"
          },
          {
            "item": "Fibrinogen",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "DIC screen, coagulopathy evaluation",
            "target": "Normal (200-400 mg/dL)"
          },
          {
            "item": "D-dimer",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "DIC, paradoxical embolism through PFO, cancer-associated",
            "target": "Normal"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Door-to-CT <25 minutes",
            "target": "Exclude hemorrhage; may show early ischemic changes (loss of gray-white differentiation, sulcal effacement)",
            "contraindications": "Pregnancy (relative)"
          },
          {
            "item": "CT angiography head and neck (CTA)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "With initial CT; door-to-CTA <25 min",
            "target": "Large vessel occlusion (LVO) for thrombectomy; carotid/vertebral stenosis or dissection",
            "contraindications": "Contrast allergy (premedicate), eGFR <30 (benefit outweighs risk in acute setting)"
          },
          {
            "item": "CT perfusion (CTP)",
            "ED": "STAT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "With CTA if extended window (6-24h) or wake-up stroke",
            "target": "Ischemic penumbra (mismatch between core infarct and hypoperfused tissue); target mismatch ratio >1.8",
            "contraindications": "Same as CTA"
          },
          {
            "item": "MRI brain with DWI (diffusion-weighted imaging)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Within 24h; STAT if diagnosis uncertain",
            "target": "Acute ischemic infarct (restricted diffusion); stroke location and extent; ASPECTS scoring",
            "contraindications": "Pacemaker, metallic implants, severe claustrophobia"
          },
          {
            "item": "ECG (12-lead)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "Immediate",
            "target": "Atrial fibrillation, acute MI, LVH, ST changes",
            "contraindications": "None"
          }
        ],
        "Extended": [
          {
            "item": "MRA head and neck",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Within 24-48h",
            "target": "Intracranial stenosis, vertebrobasilar disease, dissection",
            "contraindications": "Same as MRI"
          },
          {
            "item": "Transthoracic echocardiogram (TTE)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "timing": "Within 24-48h",
            "target": "LV thrombus, PFO, valvular disease, cardiomyopathy, akinetic segments",
            "contraindications": "None significant"
          },
          {
            "item": "Transesophageal echocardiogram (TEE) with bubble study",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Within 48-72h if TTE nondiagnostic or cryptogenic stroke",
            "target": "PFO with right-to-left shunt, atrial septal aneurysm, left atrial appendage thrombus, aortic arch atheroma",
            "contraindications": "Esophageal pathology, uncooperative patient"
          },
          {
            "item": "Carotid duplex ultrasound",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Within 24-48h",
            "target": "Carotid stenosis ≥50%, plaque characterization",
            "contraindications": "None significant"
          },
          {
            "item": "Transcranial Doppler (TCD)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Within 24-48h",
            "target": "Intracranial stenosis, vasospasm, microembolic signals, right-to-left shunt (bubble study)",
            "contraindications": "Absent temporal bone window (~10% patients)"
          },
          {
            "item": "Continuous cardiac telemetry",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Minimum 24h; ideally ≥48-72h",
            "target": "Paroxysmal atrial fibrillation, other arrhythmias",
            "contraindications": "None"
          },
          {
            "item": "Extended cardiac monitoring (Holter 30-day or implantable loop recorder)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Arrange before discharge if cryptogenic stroke",
            "target": "Paroxysmal atrial fibrillation (detected in 12-30% with prolonged monitoring)",
            "contraindications": "None significant"
          },
          {
            "item": "Chest X-ray",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "Within 24h",
            "target": "Cardiomegaly, pulmonary edema, aspiration pneumonia",
            "contraindications": "None significant"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Conventional cerebral angiography (DSA)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "EXT",
            "timing": "If vasculitis, dissection, or Moyamoya suspected",
            "target": "Beading pattern (vasculitis), intimal flap (dissection), Moyamoya collaterals",
            "contraindications": "Contrast allergy, severe renal impairment, coagulopathy"
          },
          {
            "item": "MRI vessel wall imaging",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If intracranial stenosis or vasculitis suspected",
            "target": "Vessel wall enhancement (vasculitis, unstable plaque), dissection",
            "contraindications": "Same as MRI"
          },
          {
            "item": "Fat-saturated MRI neck",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If cervical dissection suspected",
            "target": "Intramural hematoma (crescent sign)",
            "contraindications": "Same as MRI"
          },
          {
            "item": "Cardiac MRI",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If cardiomyopathy or cardiac mass suspected",
            "target": "Myocardial fibrosis, thrombus, tumor",
            "contraindications": "Same as MRI"
          },
          {
            "item": "PET-CT",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If occult malignancy suspected (Trousseau syndrome)",
            "target": "Occult cancer, hypercoagulable etiology",
            "contraindications": "Pregnancy, uncontrolled diabetes"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "IV alteplase (tPA)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.9 mg/kg",
                  "orderSentence": "IV alteplase (tPA) 0.9 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.9 mg/kg IV (max 90 mg); 10% as bolus over 1 min, remaining 90% infused over 60 min. Door-to-needle target <45 min",
              "orderSentence": "IV alteplase (tPA) 0.9 mg/kg IV"
            },
            "contraindications": ">4.5h from last known well (relative 3-4.5h window with additional exclusions); BP >185/110 despite treatment; platelets <100K; INR >1.7; active bleeding; recent surgery <14 days; recent stroke <3 months; intracranial hemorrhage history",
            "monitoring": "Neuro checks q15min during infusion, q30min x 6h, then q1h x 18h; BP q15min x 2h, q30min x 6h, then q1h; hold anticoagulants/antiplatelets 24h",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Tenecteplase IV (if available)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg/kg",
                  "orderSentence": "Tenecteplase IV (if available) 0.25 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.25 mg/kg IV single bolus (max 25 mg); preferred if LVO planned for thrombectomy",
              "orderSentence": "Tenecteplase IV (if available) 0.25 mg/kg IV"
            },
            "contraindications": "Same as alteplase",
            "monitoring": "Same as alteplase",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Endovascular thrombectomy",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "For LVO (ICA, M1, M1-M2 junction, basilar); within 24h if eligible per DAWN/DEFUSE-3 criteria. 0-6h: NIHSS ≥6, ASPECTS ≥6. 6-24h: clinical-core mismatch on perfusion imaging",
              "orderSentence": "Endovascular thrombectomy - - - see dosing"
            },
            "contraindications": "Large established infarct core (ASPECTS <6 in 0-6h window); no LVO; poor premorbid function (mRS >2 relative); life expectancy <6 months",
            "monitoring": "Continuous monitoring in neuro-ICU post-procedure; groin check; BP per post-thrombectomy protocol",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Aspirin",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "325 mg",
                  "orderSentence": "Aspirin 325 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "325 mg PO/PR load (give within 24-48h of onset); if tPA given, wait 24h and obtain CT before starting. Maintenance: 81-325 mg daily",
              "orderSentence": "Aspirin 325 mg PO"
            },
            "contraindications": "Active GI bleed, true aspirin allergy, within 24h of tPA (wait for post-tPA CT)",
            "monitoring": "GI symptoms, bleeding signs",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Blood pressure management PRE-tPA: Labetalol IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-20 mg",
                  "orderSentence": "Blood pressure management PRE-tPA: Labetalol IV 10-20 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10-20 mg IV over 1-2 min; may repeat once; target BP <185/110 before tPA",
              "orderSentence": "Blood pressure management PRE-tPA: Labetalol IV 10-20 mg IV"
            },
            "contraindications": "Heart block (2nd/3rd degree), severe bradycardia, decompensated HF, asthma/severe COPD",
            "monitoring": "Heart rate, BP continuous",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Blood pressure management PRE-tPA: Nicardipine IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg/h",
                  "orderSentence": "Blood pressure management PRE-tPA: Nicardipine IV 5 mg/h IV"
                }
              ],
              "route": "IV",
              "instructions": "5 mg/h IV infusion; increase by 2.5 mg/h q5-15min; max 15 mg/h; target BP <185/110",
              "orderSentence": "Blood pressure management PRE-tPA: Nicardipine IV 5 mg/h IV"
            },
            "contraindications": "Severe aortic stenosis",
            "monitoring": "BP continuous monitoring",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Blood pressure management PRE-tPA: Clevidipine IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2 mg/h",
                  "orderSentence": "Blood pressure management PRE-tPA: Clevidipine IV 1-2 mg/h IV"
                }
              ],
              "route": "IV",
              "instructions": "1-2 mg/h IV; titrate by doubling q90sec initially; max 32 mg/h",
              "orderSentence": "Blood pressure management PRE-tPA: Clevidipine IV 1-2 mg/h IV"
            },
            "contraindications": "Soy/egg allergy, severe lipid disorders, defective lipid metabolism",
            "monitoring": "BP continuous monitoring",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Blood pressure management POST-tPA (24h)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "Target BP <180/105 x 24h post-tPA; use nicardipine or labetalol drip as above",
              "orderSentence": "Blood pressure management POST-tPA (24h) - IV - see dosing"
            },
            "contraindications": "See individual agents above",
            "monitoring": "Neuro checks with each BP check; hold if SBP <100",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Permissive hypertension (no tPA given)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15%",
                  "orderSentence": "Permissive hypertension (no tPA given) 15% -"
                }
              ],
              "route": "-",
              "instructions": "Allow BP up to 220/120; treat only if >220/120 or end-organ damage (ACS, aortic dissection, hypertensive encephalopathy). Lower by 15% in first 24h",
              "orderSentence": "Permissive hypertension (no tPA given) 15% -"
            },
            "contraindications": "N/A",
            "monitoring": "Neuro checks; avoid precipitous drops",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "IV normal saline",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "Isotonic fluids; avoid dextrose-containing solutions (hyperglycemia worsens outcomes); avoid hypotonic solutions (cerebral edema risk)",
              "orderSentence": "IV normal saline - IV - see dosing"
            },
            "contraindications": "Volume overload",
            "monitoring": "I/O, electrolytes",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Supplemental oxygen",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "94%",
                  "orderSentence": "Supplemental oxygen 94% -"
                }
              ],
              "route": "-",
              "instructions": "Only if SpO2 <94%; nasal cannula or mask as needed",
              "orderSentence": "Supplemental oxygen 94% -"
            },
            "contraindications": "N/A",
            "monitoring": "SpO2 target ≥94%; avoid routine supplemental O2 if normoxic",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Acetaminophen",
            "route": "PO",
            "indication": "Fever (temp >38°C worsens outcomes)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650-1000 mg",
                  "orderSentence": "Acetaminophen 650-1000 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "650-1000 mg PO/PR q6h; max 4g/day (2g if hepatic impairment)",
              "orderSentence": "Acetaminophen 650-1000 mg PO"
            },
            "contraindications": "Severe hepatic disease",
            "monitoring": "Temperature q4h; LFTs if prolonged use",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Insulin (regular)",
            "route": "IV",
            "indication": "Hyperglycemia (glucose >180 worsens outcomes)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "140-180 mg",
                  "orderSentence": "Insulin (regular) 140-180 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Sliding scale or insulin drip for persistent hyperglycemia; target glucose 140-180 mg/dL; avoid hypoglycemia (<60 mg/dL)",
              "orderSentence": "Insulin (regular) 140-180 mg IV"
            },
            "contraindications": "Hypoglycemia risk",
            "monitoring": "BG q1h if drip; q6h if sliding scale",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Ondansetron",
            "route": "IV",
            "indication": "Nausea/vomiting (posterior circulation stroke)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg",
                  "orderSentence": "Ondansetron 4 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "4 mg IV/PO q6h PRN",
              "orderSentence": "Ondansetron 4 mg IV"
            },
            "contraindications": "QT prolongation, serotonin syndrome risk",
            "monitoring": "QTc if risk factors",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Enoxaparin",
            "route": "SC",
            "indication": "DVT prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Enoxaparin 40 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily; start within 24-48h if not receiving therapeutic anticoagulation; after post-tPA imaging clears hemorrhage",
              "orderSentence": "Enoxaparin 40 mg SC"
            },
            "contraindications": "Active bleeding, platelets <50K, CrCl <30 (use UFH 5000u SC q8-12h)",
            "monitoring": "Platelets q3 days; renal function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Heparin (unfractionated) SC",
            "route": "SC",
            "indication": "DVT prophylaxis (alternative)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5000 units",
                  "orderSentence": "Heparin (unfractionated) SC 5000 units SC"
                }
              ],
              "route": "SC",
              "instructions": "5000 units SC q8-12h",
              "orderSentence": "Heparin (unfractionated) SC 5000 units SC"
            },
            "contraindications": "Active bleeding, HIT",
            "monitoring": "Platelets q3 days",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pneumatic compression devices",
            "route": "-",
            "indication": "DVT prophylaxis (non-pharmacologic)",
            "dosing": {
              "instructions": "Apply to both legs immediately on admission; use in addition to or instead of pharmacologic prophylaxis",
              "orderSentence": "Pneumatic compression devices - - - see dosing"
            },
            "contraindications": "Acute DVT, severe peripheral vascular disease",
            "monitoring": "Skin checks daily",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Pantoprazole",
            "route": "IV",
            "indication": "GI prophylaxis (stress ulcer)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Pantoprazole 40 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "40 mg IV/PO daily",
              "orderSentence": "Pantoprazole 40 mg IV"
            },
            "contraindications": "C. difficile risk with prolonged use",
            "monitoring": "GI symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Dual antiplatelet therapy (DAPT): Aspirin + Clopidogrel",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "81 mg",
                  "orderSentence": "Dual antiplatelet therapy (DAPT): Aspirin + Clopidogrel 81 mg -"
                }
              ],
              "route": "-",
              "instructions": "Aspirin 81 mg + Clopidogrel 75 mg daily x 21 days (minor stroke NIHSS ≤3 or high-risk TIA ABCD2 ≥4); then single antiplatelet long-term. Load clopidogrel 300 mg if not previously on it",
              "orderSentence": "Dual antiplatelet therapy (DAPT): Aspirin + Clopidogrel 81 mg -"
            },
            "contraindications": "Major stroke (NIHSS >3), high bleeding risk, planned surgery",
            "monitoring": "Bleeding signs; CBC",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "URGENT",
            "ICU": "-"
          },
          {
            "item": "Dual antiplatelet therapy: Aspirin + Ticagrelor",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "81 mg",
                  "orderSentence": "Dual antiplatelet therapy: Aspirin + Ticagrelor 81 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Aspirin 81 mg daily + Ticagrelor 90 mg BID x 30 days (THALES trial: minor stroke NIHSS ≤5); then single antiplatelet",
              "orderSentence": "Dual antiplatelet therapy: Aspirin + Ticagrelor 81 mg PO"
            },
            "contraindications": "Intracranial stenosis (may use), high bleeding risk, hepatic impairment",
            "monitoring": "Bleeding signs; dyspnea (common side effect)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "URGENT",
            "ICU": "-"
          },
          {
            "item": "Heparin IV drip (therapeutic)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60-80 units/kg",
                  "orderSentence": "Heparin IV drip (therapeutic) 60-80 units/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "Bolus 60-80 units/kg (max 5000u); infusion 12-18 units/kg/h; target aPTT 1.5-2.5x control. Use for: cardiac source with high re-embolization risk, arterial dissection, crescendo TIA, free-floating thrombus",
              "orderSentence": "Heparin IV drip (therapeutic) 60-80 units/kg IV"
            },
            "contraindications": "Large infarct (hemorrhagic transformation risk), uncontrolled BP, within 24h of tPA",
            "monitoring": "aPTT q6h until stable, then q12-24h; platelets q3 days; neuro checks",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Decompressive craniectomy (malignant MCA infarct)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50%",
                  "orderSentence": "Decompressive craniectomy (malignant MCA infarct) 50% -"
                }
              ],
              "route": "-",
              "instructions": "For malignant MCA syndrome with >50% MCA territory infarct, age <60 preferred; within 48h of onset; reduces mortality from 70-80% to ~20%",
              "orderSentence": "Decompressive craniectomy (malignant MCA infarct) 50% -"
            },
            "contraindications": "Age >60 (relative — DESTINY II showed benefit up to age 80 but with higher disability); bilateral infarcts; hemorrhagic transformation",
            "monitoring": "Post-operative neuro checks, ICP monitoring, wound care",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Osmotherapy: Mannitol 20%",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-1.5 g/kg",
                  "orderSentence": "Osmotherapy: Mannitol 20% 1-1.5 g/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "1-1.5 g/kg IV bolus for acute herniation; 0.25-0.5 g/kg q4-6h maintenance",
              "orderSentence": "Osmotherapy: Mannitol 20% 1-1.5 g/kg IV"
            },
            "contraindications": "Anuria, severe dehydration",
            "monitoring": "Serum osmolality (hold if >320 mOsm/kg), osmolar gap, renal function, I/O",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Osmotherapy: Hypertonic saline 23.4%",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mL",
                  "orderSentence": "Osmotherapy: Hypertonic saline 23.4% 30 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "30 mL IV bolus via central line over 10-20 min for acute herniation",
              "orderSentence": "Osmotherapy: Hypertonic saline 23.4% 30 mL IV"
            },
            "contraindications": "No central access for 23.4%; hypokalemia",
            "monitoring": "Serum sodium (target 145-155 mEq/L), osmolality, central line integrity",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Hypertonic saline 3% infusion",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150-500 mL",
                  "orderSentence": "Hypertonic saline 3% infusion 150-500 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "150-500 mL IV bolus or continuous infusion 0.5-1 mL/kg/h; target Na 145-155",
              "orderSentence": "Hypertonic saline 3% infusion 150-500 mL IV"
            },
            "contraindications": "Hypernatremia, volume overload",
            "monitoring": "Serum sodium q4-6h, osmolality",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Disease-Modifying / Chronic Therapies": [
          {
            "item": "Atorvastatin",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "80 mg",
                  "orderSentence": "Atorvastatin 80 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "80 mg PO daily (high-intensity); start within 24-48h regardless of baseline LDL",
              "orderSentence": "Atorvastatin 80 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Active liver disease, pregnancy, breastfeeding",
            "monitoring": "LFTs at 12 weeks then annually; lipid panel at 4-12 weeks; CK if myalgia",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Rosuvastatin",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20-40 mg",
                  "orderSentence": "Rosuvastatin 20-40 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "20-40 mg PO daily (high-intensity alternative)",
              "orderSentence": "Rosuvastatin 20-40 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Active liver disease, pregnancy, CrCl <30 for 40mg",
            "monitoring": "Same as atorvastatin",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Apixaban",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Apixaban 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "5 mg PO BID (2.5 mg BID if ≥2 of: age ≥80, weight ≤60kg, Cr ≥1.5); start 4-14 days post-stroke for AF (timing based on infarct size). Preferred DOAC per guidelines",
              "orderSentence": "Apixaban 5 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Renal function; bleeding signs; CBC",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivaroxaban",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "Rivaroxaban 20 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "20 mg PO daily with evening meal (15 mg daily if CrCl 15-50); start 4-14 days post-stroke for AF",
              "orderSentence": "Rivaroxaban 20 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Renal function q6-12 months; bleeding signs",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dabigatran",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150 mg",
                  "orderSentence": "Dabigatran 150 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "150 mg PO BID (75 mg BID if CrCl 15-30); start 4-14 days post-stroke for AF",
              "orderSentence": "Dabigatran 150 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Renal function q6-12 months; bleeding signs; GI side effects",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Warfarin",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Warfarin 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "5 mg PO daily initial (2-3 mg if elderly, low weight, or interacting drugs); target INR 2.0-3.0 for AF; 2.5-3.5 for mechanical valve. Bridge with heparin",
              "orderSentence": "Warfarin 5 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "INR daily until stable, then weekly, then monthly; diet counseling (vitamin K)",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lisinopril",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-10 mg",
                  "orderSentence": "Lisinopril 5-10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5-10 mg PO daily; titrate to 20-40 mg daily; target BP <130/80 after acute phase",
              "orderSentence": "Lisinopril 5-10 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Cr and K+ at 1-2 weeks after initiation; BP",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amlodipine",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Amlodipine 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg PO daily; max 10 mg daily",
              "orderSentence": "Amlodipine 5 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "BP, peripheral edema",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Losartan",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Losartan 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg PO daily; max 100 mg daily",
              "orderSentence": "Losartan 50 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Cr, K+, BP",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Metoprolol succinate",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Metoprolol succinate 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg PO daily; titrate to 200 mg daily",
              "orderSentence": "Metoprolol succinate 25 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "HR, BP",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ezetimibe",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Ezetimibe 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "10 mg PO daily; add if LDL not at goal on max statin",
              "orderSentence": "Ezetimibe 10 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "LFTs, lipid panel",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "PCSK9 inhibitor (evolocumab)",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "140 mg",
                  "orderSentence": "PCSK9 inhibitor (evolocumab) 140 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "140 mg SC q2 weeks or 420 mg SC monthly; if LDL not at goal on max statin + ezetimibe",
              "orderSentence": "PCSK9 inhibitor (evolocumab) 140 mg SC"
            },
            "pretreatment": "-",
            "contraindications": "Lipid panel q4-12 weeks; injection site reactions",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consultation (stroke team)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "All acute stroke presentations; tPA decision; stroke workup"
          },
          {
            "item": "Neurointerventional/endovascular consultation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Large vessel occlusion on CTA for thrombectomy"
          },
          {
            "item": "Neurosurgery consultation",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Malignant MCA edema, posterior fossa stroke with hydrocephalus, hemorrhagic transformation requiring intervention"
          },
          {
            "item": "Cardiology consultation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "indication": "Newly detected atrial fibrillation, acute MI, cardiomyopathy, PFO evaluation"
          },
          {
            "item": "Vascular surgery consultation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Symptomatic carotid stenosis ≥50% (NASCET) for endarterectomy; ideally within 2 weeks"
          },
          {
            "item": "Speech-language pathology (SLP)",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Dysphagia screening before any PO intake; aphasia evaluation; cognitive-communication assessment"
          },
          {
            "item": "Physical therapy (PT)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Early mobilization within 24-48h (AVERT trial: avoid very early aggressive mobilization <24h); gait and balance training"
          },
          {
            "item": "Occupational therapy (OT)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "ADL assessment, upper extremity function, adaptive equipment, cognitive rehabilitation"
          },
          {
            "item": "Rehabilitation medicine (physiatry)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Determine rehabilitation disposition (inpatient rehab, SNF, home health, outpatient)"
          },
          {
            "item": "Social work",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Discharge planning, insurance, DME, caregiver support, advance directives"
          },
          {
            "item": "Nutrition/dietitian",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Dysphagia diet recommendations, cardiovascular risk diet (Mediterranean, DASH)"
          },
          {
            "item": "Palliative care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "indication": "Large territory stroke with poor prognosis, goals of care discussion"
          },
          {
            "item": "Smoking cessation counseling",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Active smokers"
          },
          {
            "item": "Case management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Rehabilitation placement, follow-up coordination"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Call 911 immediately if new symptoms: sudden weakness, numbness, vision changes, speech difficulty, severe headache, loss of balance",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do NOT drive until cleared by neurology (minimum 2 weeks; state-specific laws apply)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take all medications as prescribed; do NOT stop antiplatelet or anticoagulant without medical advice",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Swallowing precautions per SLP recommendations (sit upright 90° for meals, specific diet texture)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Fall prevention: clear pathways, use assistive devices, adequate lighting, non-slip surfaces",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Blood pressure monitoring at home (target <130/80 per physician guidance)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stroke signs education for patient and family: F.A.S.T. (Face drooping, Arm weakness, Speech difficulty, Time to call 911)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Medication list: carry updated list including all prescriptions, OTC, and supplements",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Follow-up appointment with neurology in 1-2 weeks; primary care in 2-4 weeks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report any bleeding (bruising, blood in stool/urine, gum bleeding) if on anticoagulation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Smoking cessation (absolute)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Blood pressure target <130/80 mmHg",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Mediterranean or DASH diet",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Sodium restriction <2.3 g/day (ideally <1.5 g if hypertensive)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular aerobic exercise: 40 min moderate intensity, 3-4 days/week (after medical clearance)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Weight management (BMI 18.5-24.9)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Alcohol limitation: ≤1 drink/day women, ≤2 drinks/day men; cessation if heavy use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Glycemic control target HbA1c <7% (individualized)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "LDL target <70 mg/dL (high-intensity statin)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Obstructive sleep apnea screening (Berlin questionnaire or STOP-BANG); CPAP if diagnosed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management and emotional support (depression common post-stroke)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Influenza and pneumococcal vaccination",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Hypoglycemia",
        "features": "Glucose <60; symptoms resolve with dextrose; diaphoresis, tremor",
        "tests": "POC glucose STAT"
      },
      {
        "diagnosis": "Seizure with Todd's paralysis",
        "features": "Witnessed seizure, post-ictal confusion, resolves within 24h; may have known epilepsy",
        "tests": "EEG, clinical observation, MRI (DWI negative)"
      },
      {
        "diagnosis": "Complicated migraine (hemiplegic)",
        "features": "Headache history, aura preceding deficit, gradual onset (\"marching\"), younger patient, family history",
        "tests": "MRI DWI (negative), clinical history"
      },
      {
        "diagnosis": "Intracerebral hemorrhage",
        "features": "CT shows hemorrhage; more severe headache, rapid progression, vomiting",
        "tests": "CT head without contrast"
      },
      {
        "diagnosis": "Brain tumor/mass",
        "features": "Subacute onset over days-weeks, progressive symptoms, headache worse in morning",
        "tests": "MRI with contrast (enhancing mass)"
      },
      {
        "diagnosis": "Subdural hematoma",
        "features": "History of trauma or anticoagulation; subacute confusion, headache, fluctuating symptoms",
        "tests": "CT head (crescent-shaped extra-axial collection)"
      },
      {
        "diagnosis": "Hypertensive encephalopathy / PRES",
        "features": "Severely elevated BP, headache, confusion, visual changes, seizures; typically posterior involvement",
        "tests": "MRI FLAIR (posterior white matter edema), BP >220/120"
      },
      {
        "diagnosis": "CNS infection (abscess, meningitis)",
        "features": "Fever, meningismus, subacute course, immunocompromise",
        "tests": "MRI with contrast, LP, blood cultures"
      },
      {
        "diagnosis": "Conversion disorder / functional neurological disorder",
        "features": "Non-anatomic distribution, Hoover sign positive, give-way weakness, distractible exam findings",
        "tests": "Normal imaging, clinical exam findings"
      },
      {
        "diagnosis": "Peripheral vertigo (for posterior circulation symptoms)",
        "features": "Isolated vertigo, positive HINTS peripheral pattern, no other neurologic deficits",
        "tests": "HINTS exam, MRI DWI"
      },
      {
        "diagnosis": "Multiple sclerosis exacerbation",
        "features": "Young patient, prior episodes, symptoms disseminated in space and time",
        "tests": "MRI (periventricular/juxtacortical lesions), oligoclonal bands"
      },
      {
        "diagnosis": "Metabolic encephalopathy",
        "features": "Bilateral, non-focal exam (usually); abnormal metabolic labs; confusion predominates",
        "tests": "BMP, ammonia, TSH, LFTs, UDS"
      }
    ],
    "evidence": [
      {
        "recommendation": "IV alteplase within 4.5h",
        "evidenceLevel": "Class I, Level A",
        "source": "[AHA/ASA 2019 Guidelines (Powers et al.)](https://pubmed.ncbi.nlm.nih.gov/31662037/); [NINDS trial (NEJM 1995)](https://pubmed.ncbi.nlm.nih.gov/7477192/); [ECASS III (Hacke et al. NEJM 2008)](https://pubmed.ncbi.nlm.nih.gov/18815396/)"
      },
      {
        "recommendation": "Tenecteplase non-inferior to alteplase for LVO",
        "evidenceLevel": "Class IIa, Level B-R",
        "source": "[AcT trial (Menon et al. Lancet 2022)](https://pubmed.ncbi.nlm.nih.gov/35779553/); EXTEND-IA TNK"
      },
      {
        "recommendation": "Thrombectomy for LVO 0-6h",
        "evidenceLevel": "Class I, Level A",
        "source": "[MR CLEAN (Berkhemer et al. NEJM 2015)](https://pubmed.ncbi.nlm.nih.gov/25517348/), ESCAPE, EXTEND-IA, SWIFT-PRIME, REVASCAT"
      },
      {
        "recommendation": "Thrombectomy for LVO 6-24h (selected patients)",
        "evidenceLevel": "Class I, Level A",
        "source": "[DAWN trial (Nogueira et al. NEJM 2018)](https://pubmed.ncbi.nlm.nih.gov/29129157/); [DEFUSE-3 (Albers et al. NEJM 2018)](https://pubmed.ncbi.nlm.nih.gov/29364767/)"
      },
      {
        "recommendation": "DAPT 21 days for minor stroke/high-risk TIA",
        "evidenceLevel": "Class I, Level A",
        "source": "[CHANCE trial (Wang et al. NEJM 2013)](https://pubmed.ncbi.nlm.nih.gov/23803136/); POINT trial"
      },
      {
        "recommendation": "Aspirin + ticagrelor 30 days for minor stroke",
        "evidenceLevel": "Class IIa, Level B-R",
        "source": "THALES trial"
      },
      {
        "recommendation": "High-intensity statin therapy",
        "evidenceLevel": "Class I, Level A",
        "source": "[SPARCL trial (Amarenco et al. NEJM 2006)](https://pubmed.ncbi.nlm.nih.gov/16899775/); AHA/ASA 2021"
      },
      {
        "recommendation": "Anticoagulation for AF-related stroke",
        "evidenceLevel": "Class I, Level A",
        "source": "RE-LY, ROCKET-AF, ARISTOTLE, ENGAGE AF"
      },
      {
        "recommendation": "BP target <130/80 for secondary prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "SPS3 trial; AHA/ASA 2021"
      },
      {
        "recommendation": "Early mobilization (24-48h, not aggressive)",
        "evidenceLevel": "Class IIa, Level B-R",
        "source": "AVERT trial (very early <24h aggressive mobilization harmful)"
      },
      {
        "recommendation": "Decompressive craniectomy for malignant MCA",
        "evidenceLevel": "Class I, Level A (age <60)",
        "source": "DESTINY, DECIMAL, HAMLET pooled analysis"
      },
      {
        "recommendation": "Extended cardiac monitoring for cryptogenic stroke",
        "evidenceLevel": "Class IIa, Level B-R",
        "source": "CRYSTAL-AF, EMBRACE trials"
      },
      {
        "recommendation": "Dysphagia screening before PO intake",
        "evidenceLevel": "Class I, Level B-NR",
        "source": "AHA/ASA 2019 Guidelines"
      },
      {
        "recommendation": "Carotid endarterectomy for symptomatic stenosis ≥50%",
        "evidenceLevel": "Class I, Level A",
        "source": "NASCET, ECST trials"
      },
      {
        "recommendation": "PFO closure for cryptogenic stroke age 18-60",
        "evidenceLevel": "Class IIa, Level B-R",
        "source": "CLOSE, RESPECT, REDUCE trials"
      },
      {
        "recommendation": "Permissive hypertension (up to 220/120 if no tPA)",
        "evidenceLevel": "Class I, Level B-R",
        "source": "AHA/ASA 2019 Guidelines"
      },
      {
        "recommendation": "Target glucose 140-180 mg/dL",
        "evidenceLevel": "Class I, Level C",
        "source": "AHA/ASA 2019 Guidelines"
      },
      {
        "recommendation": "DVT prophylaxis within 24-48h",
        "evidenceLevel": "Class I, Level A",
        "source": "AHA/ASA 2019 Guidelines"
      },
      {
        "recommendation": "Depression screening post-stroke",
        "evidenceLevel": "Class I, Level B-NR",
        "source": "AHA/ASA 2019 Guidelines"
      },
      {
        "recommendation": "Normothermia maintenance",
        "evidenceLevel": "Class I, Level C",
        "source": "AHA/ASA 2019 Guidelines"
      }
    ],
    "monitoring": [
      {
        "item": "NIHSS (NIH Stroke Scale)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "q1h x 24h (post-tPA: q15min x 2h, q30min x 6h, q1h x 16h), then q4h x 48h, then q shift",
        "action": "If NIHSS increases ≥4 points: STAT CT head, call stroke team; consider hemorrhagic transformation, re-occlusion, or new stroke"
      },
      {
        "item": "Blood pressure",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "Post-tPA: q15min x 2h, q30min x 6h, q1h x 16h; non-tPA: q1h x 24h, then q4h",
        "action": "Titrate antihypertensives; avoid SBP <100 (hypoperfusion risk)"
      },
      {
        "item": "Heart rate and rhythm (telemetry)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "Continuous x 48-72h minimum",
        "action": "Cardiology consult; anticoagulation if AF"
      },
      {
        "item": "Temperature",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q4h x 48h, then q8h",
        "action": "Acetaminophen; cooling measures; infection workup if >38°C"
      },
      {
        "item": "Blood glucose",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "q6h x 48h (q1h if insulin drip)",
        "action": "Insulin; D50W for hypoglycemia"
      },
      {
        "item": "Oxygen saturation (SpO2)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "Continuous x 24h, then q4h",
        "action": "Supplemental O2; if <90% consider intubation for large strokes"
      },
      {
        "item": "Neurologic exam (level of consciousness, pupils)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q1-4h depending on severity",
        "action": "Declining LOC: STAT CT, ICP management"
      },
      {
        "item": "Swallowing screen",
        "ED": "URGENT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "URGENT",
        "frequency": "Before any PO intake",
        "action": "NPO until formal SLP evaluation"
      },
      {
        "item": "INR (if on warfarin)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Daily until stable, then per protocol",
        "action": "Dose adjustment"
      },
      {
        "item": "Renal function (Cr, BUN)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q24-48h if contrast given or on new medications",
        "action": "Hydration; hold nephrotoxic agents"
      },
      {
        "item": "Lipid panel",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Fasting within 24-48h; repeat at 4-12 weeks on statin",
        "action": "Intensify statin; add ezetimibe or PCSK9i"
      },
      {
        "item": "Depression screening (PHQ-9)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "At 1 month, 3 months, annually",
        "action": "SSRI initiation; psychology/psychiatry referral"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Minor stroke (NIHSS 0-3) with stable exam, adequate support at home, able to perform ADLs or with home health, completed workup or reliable outpatient follow-up arranged, medications filled"
      },
      {
        "disposition": "Admit to stroke unit/floor",
        "criteria": "Moderate stroke (NIHSS 4-15), requires IV medications or ongoing monitoring, incomplete workup, dysphagia requiring NPO/modified diet, new atrial fibrillation requiring anticoagulation initiation"
      },
      {
        "disposition": "Admit to ICU/neuro-ICU",
        "criteria": "Post-tPA monitoring (first 24h), post-thrombectomy, large territory infarct with edema risk, posterior fossa stroke with herniation risk, unstable BP requiring IV antihypertensives, declining neurologic exam, respiratory compromise"
      },
      {
        "disposition": "Transfer to higher level of care",
        "criteria": "LVO needing thrombectomy (transfer to comprehensive stroke center), need for neurosurgical intervention not available, need for neuro-ICU not available"
      },
      {
        "disposition": "Inpatient rehabilitation",
        "criteria": "Moderate-severe deficits (NIHSS >4), able to participate in 3h/day therapy, expected to benefit from intensive rehab, medically stable"
      },
      {
        "disposition": "Skilled nursing facility (SNF)",
        "criteria": "Unable to tolerate 3h/day rehab, needs skilled nursing care, medically complex requiring ongoing monitoring"
      },
      {
        "disposition": "Home with outpatient therapy",
        "criteria": "Mild deficits, safe home environment, reliable follow-up, family support available"
      }
    ]
  },
  "Guillain-Barré Syndrome": {
    "id": "guillain-barre-syndrome",
    "title": "Guillain-Barré Syndrome",
    "version": "1.1",
    "icd10": [
      "** G61.0 (Guillain-Barré syndrome)"
    ],
    "scope": "** Evaluation and management of acute Guillain-Barré Syndrome in adults, including all major variants (AIDP, AMAN, AMSAN, Miller Fisher). Covers respiratory monitoring protocols, immunotherapy (IVIg and plasmapheresis), autonomic dysfunction management, and ICU care. Excludes CIDP (chronic inflammatory demyelinating polyneuropathy) and pediatric GBS.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Baseline, infection screen",
            "target": "Normal or mild leukocytosis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "rationale": "Electrolytes, renal function for IVIg",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Magnesium",
            "rationale": "Hypomagnesemia worsens weakness",
            "target": ">1.8 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phosphorus",
            "rationale": "Hypophosphatemia causes weakness",
            "target": ">2.5 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "ESR, CRP",
            "rationale": "Inflammatory markers",
            "target": "May be mildly elevated",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Urinalysis",
            "rationale": "UTI as trigger",
            "target": "Document",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Blood glucose",
            "rationale": "Hyperglycemia worsens outcomes",
            "target": "<180 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid myopathy in differential",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "CPK",
            "rationale": "Myopathy in differential",
            "target": "Normal or mildly elevated",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "PT/INR, PTT",
            "rationale": "Pre-LP, pre-PLEX",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Extended Workup": [
          {
            "item": "Anti-ganglioside antibodies (GM1, GD1a, GD1b, GQ1b)",
            "rationale": "Variant classification, prognosis",
            "target": "Document positivity",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Campylobacter jejuni serology",
            "rationale": "Most common trigger",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "CMV IgM/IgG",
            "rationale": "Viral trigger",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "EBV panel",
            "rationale": "Viral trigger",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Mycoplasma pneumoniae IgM",
            "rationale": "Bacterial trigger",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "HIV",
            "rationale": "HIV-associated GBS",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Hepatitis B surface antigen",
            "rationale": "Pre-IVIg screening",
            "target": "Negative",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Hepatitis C antibody",
            "rationale": "Pre-PLEX screening",
            "target": "Negative",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "COVID-19 PCR/antigen",
            "rationale": "COVID-associated GBS",
            "target": "Document",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Quantitative immunoglobulins",
            "rationale": "IgA deficiency (IVIg contraindication)",
            "target": "IgA >7 mg/dL",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Type and screen",
            "rationale": "Pre-PLEX",
            "target": "Available",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Zika virus serology",
            "rationale": "Travel to endemic area",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "West Nile virus serology",
            "rationale": "Endemic area, summer months",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Lyme serology",
            "rationale": "Endemic area, tick exposure",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Porphyrins (urine)",
            "rationale": "Motor neuropathy with abdominal pain",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Heavy metals (lead, arsenic, thallium)",
            "rationale": "Toxic neuropathy differential",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Serum protein electrophoresis",
            "rationale": "Paraproteinemic neuropathy",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Anti-acetylcholine receptor antibodies",
            "rationale": "MG in differential",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "rationale": "Exclude elevated ICP",
            "target": "Normal (10-20 cmH2O)",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "rationale": "Albuminocytologic dissociation",
            "target": "WBC <10 (usually <5)",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Protein",
            "rationale": "Elevated in GBS",
            "target": "Elevated (>45 mg/dL; often >100)",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Glucose",
            "rationale": "Exclude infection",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Gram stain and culture",
            "rationale": "Exclude bacterial meningitis",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cytology",
            "rationale": "If malignancy suspected",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Oligoclonal bands",
            "rationale": "Atypical cases",
            "target": "Usually negative (positive in <10%)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Chest X-ray",
            "timing": "On admission",
            "target": "Aspiration, atelectasis",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "ECG",
            "timing": "On admission",
            "target": "Autonomic dysfunction (arrhythmia)",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Forced vital capacity (FVC)",
            "timing": "Serial q4-6h",
            "target": "FVC >20 mL/kg (stable)",
            "contraindications": "Facial weakness limiting seal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Negative inspiratory force (NIF)",
            "timing": "Serial q4-6h",
            "target": "NIF more negative than -30 cmH2O",
            "contraindications": "Facial weakness",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Nerve conduction studies/EMG",
            "timing": "Within 48-72 hours",
            "target": "Demyelination, conduction block",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "Extended": [
          {
            "item": "MRI spine with contrast",
            "timing": "If diagnostic uncertainty",
            "target": "Nerve root enhancement (spinal roots)",
            "contraindications": "Pacemaker, hemodynamic instability",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "MRI brain with contrast",
            "timing": "Miller Fisher variant",
            "target": "Cranial nerve enhancement",
            "contraindications": "Pacemaker",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Swallow evaluation",
            "timing": "If bulbar weakness",
            "target": "Aspiration risk",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Echocardiogram",
            "timing": "If autonomic instability",
            "target": "Takotsubo, cardiac dysfunction",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Repetitive nerve stimulation",
            "timing": "If MG suspected",
            "target": "Normal (vs decrement in MG)",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Autonomic function testing",
            "timing": "Persistent dysautonomia",
            "target": "Abnormal heart rate variability",
            "contraindications": "Unstable patient",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent - Respiratory Support": [
          {
            "item": "Supplemental oxygen",
            "route": "INH",
            "indication": "Hypoxemia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-6 L/min NC",
                  "orderSentence": "Supplemental oxygen 2-6 L/min NC INH"
                },
                {
                  "text": "15 L/min NRB",
                  "orderSentence": "Supplemental oxygen 15 L/min NRB INH"
                }
              ],
              "route": "INH",
              "instructions": "Titrate to O2 sat >94%; escalate to high-flow if needed",
              "orderSentence": "Supplemental oxygen 2-6 L/min NC INH"
            },
            "contraindications": "None",
            "monitoring": "O2 sat, RR",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Endotracheal intubation",
            "route": "—",
            "indication": "Respiratory failure",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Endotracheal intubation N/A —"
                }
              ],
              "route": "—",
              "instructions": "Intubate if FVC <20 mL/kg, NIF >-30 cmH2O, or clinical deterioration; avoid succinylcholine (hyperkalemia risk)",
              "orderSentence": "Endotracheal intubation N/A —"
            },
            "contraindications": "—",
            "monitoring": "ETT position, ventilator settings",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Mechanical ventilation",
            "route": "—",
            "indication": "Respiratory failure",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Mechanical ventilation N/A —"
                }
              ],
              "route": "—",
              "instructions": "Lung-protective ventilation; TV 6-8 mL/kg IBW; PEEP 5-8 cmH2O",
              "orderSentence": "Mechanical ventilation N/A —"
            },
            "contraindications": "—",
            "monitoring": "ABG, ventilator parameters",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Immunotherapy - First-line": [
          {
            "item": "IVIg (immune globulin IV) - 5-day protocol",
            "route": "IV",
            "indication": "Primary immunotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg/day x 5 days",
                  "orderSentence": "IVIg (immune globulin IV) - 5-day protocol 0.4 g/kg/day x 5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "0.4 g/kg/day IV for 5 days (total 2 g/kg); infuse slowly day 1 (start 0.5-1 mL/kg/hr, advance to max 4 mL/kg/hr)",
              "orderSentence": "IVIg (immune globulin IV) - 5-day protocol 0.4 g/kg/day x 5 days IV"
            },
            "contraindications": "IgA deficiency (<7 mg/dL) with anti-IgA antibodies; severe renal impairment",
            "monitoring": "Renal function, headache, infusion reactions; pre-medicate with acetaminophen/diphenhydramine",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "IVIg (immune globulin IV) - 2-day protocol",
            "route": "IV",
            "indication": "Primary immunotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 g/kg/day x 2 days",
                  "orderSentence": "IVIg (immune globulin IV) - 2-day protocol 1 g/kg/day x 2 days IV"
                }
              ],
              "route": "IV",
              "instructions": "1 g/kg/day IV for 2 days (total 2 g/kg); alternative accelerated protocol; same total dose",
              "orderSentence": "IVIg (immune globulin IV) - 2-day protocol 1 g/kg/day x 2 days IV"
            },
            "contraindications": "IgA deficiency (<7 mg/dL) with anti-IgA antibodies; severe renal impairment",
            "monitoring": "Renal function, headache, infusion reactions; higher daily dose may increase infusion reactions",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Plasmapheresis (PLEX)",
            "route": "—",
            "indication": "Primary immunotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 exchanges over 1-2 weeks",
                  "orderSentence": "Plasmapheresis (PLEX) 5 exchanges over 1-2 weeks —"
                }
              ],
              "route": "—",
              "instructions": "5 exchanges (200-250 mL/kg per exchange) over 7-14 days; typically QOD",
              "orderSentence": "Plasmapheresis (PLEX) 5 exchanges over 1-2 weeks —"
            },
            "contraindications": "Hemodynamic instability; severe sepsis; IV access issues",
            "monitoring": "BP, electrolytes (Ca, Mg, K), coagulation, fibrinogen",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Autonomic Dysfunction Management": [
          {
            "item": "Normal saline",
            "route": "IV",
            "indication": "Hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mL",
                  "orderSentence": "Normal saline 250 mL IV"
                },
                {
                  "text": "500 mL",
                  "orderSentence": "Normal saline 500 mL IV"
                },
                {
                  "text": "1000 mL",
                  "orderSentence": "Normal saline 1000 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "250-500 mL bolus for SBP <90; avoid overhydration",
              "orderSentence": "Normal saline 250 mL IV"
            },
            "contraindications": "Heart failure",
            "monitoring": "BP, I/O, JVD",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phenylephrine",
            "route": "IV",
            "indication": "Refractory hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100-200 mcg bolus",
                  "orderSentence": "Phenylephrine 100-200 mcg bolus IV"
                },
                {
                  "text": "0.5-2 mcg/kg/min",
                  "orderSentence": "Phenylephrine 0.5-2 mcg/kg/min IV"
                }
              ],
              "route": "IV",
              "instructions": "Start 0.5 mcg/kg/min; titrate to MAP >65",
              "orderSentence": "Phenylephrine 100-200 mcg bolus IV"
            },
            "contraindications": "Severe bradycardia",
            "monitoring": "Continuous BP, HR",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Esmolol",
            "route": "IV",
            "indication": "Hypertensive crisis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mcg/kg load",
                  "orderSentence": "Esmolol 500 mcg/kg load IV"
                },
                {
                  "text": "50-200 mcg/kg/min",
                  "orderSentence": "Esmolol 50-200 mcg/kg/min IV"
                }
              ],
              "route": "IV",
              "instructions": "Load 500 mcg/kg over 1 min, then 50-200 mcg/kg/min; short-acting preferred in GBS",
              "orderSentence": "Esmolol 500 mcg/kg load IV"
            },
            "contraindications": "Bradycardia, heart block, decompensated HF",
            "monitoring": "HR, BP",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Atropine",
            "route": "IV",
            "indication": "Symptomatic bradycardia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg",
                  "orderSentence": "Atropine 0.5 mg IV"
                },
                {
                  "text": "1 mg",
                  "orderSentence": "Atropine 1 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-1 mg IV push for HR <50 with symptoms; may repeat q3-5min; max 3 mg",
              "orderSentence": "Atropine 0.5 mg IV"
            },
            "contraindications": "Tachycardia",
            "monitoring": "HR, rhythm",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Temporary pacing",
            "route": "—",
            "indication": "Complete heart block",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Temporary pacing N/A —"
                }
              ],
              "route": "—",
              "instructions": "Transcutaneous or transvenous pacing for refractory bradycardia/asystole",
              "orderSentence": "Temporary pacing N/A —"
            },
            "contraindications": "—",
            "monitoring": "Continuous telemetry",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Fludrocortisone",
            "route": "PO",
            "indication": "Orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg daily",
                  "orderSentence": "Fludrocortisone 0.1 mg daily PO"
                },
                {
                  "text": "0.2 mg daily",
                  "orderSentence": "Fludrocortisone 0.2 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "0.1-0.2 mg PO daily for persistent orthostatic hypotension",
              "orderSentence": "Fludrocortisone 0.1 mg daily PO"
            },
            "contraindications": "Hypertension, heart failure",
            "monitoring": "BP (supine and standing), edema, K+",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Midodrine",
            "route": "PO",
            "indication": "Orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg TID",
                  "orderSentence": "Midodrine 2.5 mg TID PO"
                },
                {
                  "text": "5 mg TID",
                  "orderSentence": "Midodrine 5 mg TID PO"
                },
                {
                  "text": "10 mg TID",
                  "orderSentence": "Midodrine 10 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5-5 mg TID; max 10 mg TID; avoid evening dose",
              "orderSentence": "Midodrine 2.5 mg TID PO"
            },
            "contraindications": "Supine hypertension, urinary retention",
            "monitoring": "BP (supine and standing)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Symptomatic/Supportive Care": [
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg qHS",
                  "orderSentence": "Gabapentin 300 mg qHS PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Gabapentin 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Gabapentin 600 mg TID PO"
                },
                {
                  "text": "900 mg TID",
                  "orderSentence": "Gabapentin 900 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; titrate by 300 mg/day q1-3d; max 3600 mg/day in 3 divided doses",
              "orderSentence": "Gabapentin 300 mg qHS PO"
            },
            "contraindications": "Severe renal impairment (adjust dose)",
            "monitoring": "Sedation, dizziness; reduce dose if CrCl <60",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "Neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg BID",
                  "orderSentence": "Pregabalin 75 mg BID PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Pregabalin 150 mg BID PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Pregabalin 300 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 75 mg BID; may increase to 150 mg BID after 1 week; max 600 mg/day",
              "orderSentence": "Pregabalin 75 mg BID PO"
            },
            "contraindications": "Severe renal impairment (adjust dose)",
            "monitoring": "Sedation, edema, weight gain",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Morphine",
            "route": "IV",
            "indication": "Severe pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg q4h PRN",
                  "orderSentence": "Morphine 2 mg q4h PRN IV"
                },
                {
                  "text": "4 mg q4h PRN",
                  "orderSentence": "Morphine 4 mg q4h PRN IV"
                }
              ],
              "route": "IV",
              "instructions": "2-4 mg IV q4h PRN for severe pain; use cautiously with respiratory compromise",
              "orderSentence": "Morphine 2 mg q4h PRN IV"
            },
            "contraindications": "Respiratory depression",
            "monitoring": "RR, sedation, O2 sat",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Enoxaparin",
            "route": "SC",
            "indication": "DVT prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg daily",
                  "orderSentence": "Enoxaparin 40 mg daily SC"
                },
                {
                  "text": "30 mg BID",
                  "orderSentence": "Enoxaparin 30 mg BID SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily (BMI <40) or 30 mg BID (BMI >40); hold if CrCl <30; **HOLD if LP planned within 12 hours**",
              "orderSentence": "Enoxaparin 40 mg daily SC"
            },
            "contraindications": "Active bleeding, HIT, CrCl <30 (use UFH), pending LP",
            "monitoring": "Platelet count, signs of bleeding",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Heparin (UFH)",
            "route": "SC",
            "indication": "DVT prophylaxis (renal impairment)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5000 units q8h",
                  "orderSentence": "Heparin (UFH) 5000 units q8h SC"
                },
                {
                  "text": "5000 units q12h",
                  "orderSentence": "Heparin (UFH) 5000 units q12h SC"
                }
              ],
              "route": "SC",
              "instructions": "5000 units SC q8-12h if CrCl <30; **HOLD if LP planned within 4-6 hours**",
              "orderSentence": "Heparin (UFH) 5000 units q8h SC"
            },
            "contraindications": "Active bleeding, HIT, pending LP",
            "monitoring": "Platelet count, signs of bleeding",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "SCDs (sequential compression devices)",
            "route": "—",
            "indication": "DVT prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "SCDs (sequential compression devices) N/A —"
                }
              ],
              "route": "—",
              "instructions": "Bilateral lower extremity SCDs; use in addition to pharmacologic prophylaxis",
              "orderSentence": "SCDs (sequential compression devices) N/A —"
            },
            "contraindications": "Acute DVT in that extremity",
            "monitoring": "Skin integrity",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Bisacodyl",
            "route": "PO/PR",
            "indication": "Constipation (autonomic)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg daily",
                  "orderSentence": "Bisacodyl 10 mg daily PO/PR"
                },
                {
                  "text": "10 mg suppository",
                  "orderSentence": "Bisacodyl 10 mg suppository PO/PR"
                }
              ],
              "route": "PO/PR",
              "instructions": "10 mg PO or PR daily as needed",
              "orderSentence": "Bisacodyl 10 mg daily PO/PR"
            },
            "contraindications": "Bowel obstruction",
            "monitoring": "Bowel movements",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Polyethylene glycol",
            "route": "PO",
            "indication": "Constipation (autonomic)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "17 g daily",
                  "orderSentence": "Polyethylene glycol 17 g daily PO"
                },
                {
                  "text": "17 g BID",
                  "orderSentence": "Polyethylene glycol 17 g BID PO"
                }
              ],
              "route": "PO",
              "instructions": "17 g (1 capful) PO daily-BID; titrate to 1-2 BMs daily",
              "orderSentence": "Polyethylene glycol 17 g daily PO"
            },
            "contraindications": "Bowel obstruction",
            "monitoring": "Bowel movements",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Metoclopramide",
            "route": "IV/PO",
            "indication": "Gastroparesis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg q6h AC",
                  "orderSentence": "Metoclopramide 10 mg q6h AC IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "10 mg IV/PO before meals and at bedtime; max 40 mg/day; limit to 5 days",
              "orderSentence": "Metoclopramide 10 mg q6h AC IV/PO"
            },
            "contraindications": "Parkinson disease, GI obstruction",
            "monitoring": "EPS, tardive dyskinesia",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Ondansetron",
            "route": "IV/PO",
            "indication": "Nausea",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg q6h PRN",
                  "orderSentence": "Ondansetron 4 mg q6h PRN IV/PO"
                },
                {
                  "text": "8 mg q8h PRN",
                  "orderSentence": "Ondansetron 8 mg q8h PRN IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "4-8 mg IV/PO q6-8h PRN",
              "orderSentence": "Ondansetron 4 mg q6h PRN IV/PO"
            },
            "contraindications": "QT prolongation",
            "monitoring": "QTc if repeated dosing",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Acetaminophen",
            "route": "PO/IV",
            "indication": "Fever, mild pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650 mg q6h",
                  "orderSentence": "Acetaminophen 650 mg q6h PO/IV"
                },
                {
                  "text": "1000 mg q6h",
                  "orderSentence": "Acetaminophen 1000 mg q6h PO/IV"
                }
              ],
              "route": "PO/IV",
              "instructions": "650-1000 mg PO/IV q6h; max 4 g/day (3 g if hepatic impairment)",
              "orderSentence": "Acetaminophen 650 mg q6h PO/IV"
            },
            "contraindications": "Severe hepatic impairment",
            "monitoring": "LFTs if prolonged use",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Treatment of GBS Variants": [
          {
            "item": "IVIg (Miller Fisher)",
            "route": "IV",
            "indication": "Miller Fisher syndrome",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg/day x 5 days",
                  "orderSentence": "IVIg (Miller Fisher) 0.4 g/kg/day x 5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "Same as standard GBS; benefit less clear for pure MFS without weakness",
              "orderSentence": "IVIg (Miller Fisher) 0.4 g/kg/day x 5 days IV"
            },
            "contraindications": "IgA deficiency",
            "monitoring": "Renal function, infusion reactions",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Observation only (MFS)",
            "route": "—",
            "indication": "Pure MFS (mild)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Observation only (MFS) N/A —"
                }
              ],
              "route": "—",
              "instructions": "Consider observation without immunotherapy for pure MFS with mild symptoms and no limb weakness",
              "orderSentence": "Observation only (MFS) N/A —"
            },
            "contraindications": "If weakness present, treat",
            "monitoring": "Serial neuro exam, FVC",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Refractory/Treatment Failure": [
          {
            "item": "Second course IVIg",
            "route": "IV",
            "indication": "Treatment-related fluctuation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg/day x 5 days",
                  "orderSentence": "Second course IVIg 0.4 g/kg/day x 5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "Consider if deterioration during/after IVIg or PLEX; typically 2-3 weeks after first course",
              "orderSentence": "Second course IVIg 0.4 g/kg/day x 5 days IV"
            },
            "contraindications": "IgA deficiency",
            "monitoring": "Renal function",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "PLEX after IVIg failure",
            "route": "—",
            "indication": "IVIg non-response",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 exchanges over 1-2 weeks",
                  "orderSentence": "PLEX after IVIg failure 5 exchanges over 1-2 weeks —"
                }
              ],
              "route": "—",
              "instructions": "Consider if no improvement 2-4 weeks post-IVIg; wait at least 2 weeks after IVIg completion",
              "orderSentence": "PLEX after IVIg failure 5 exchanges over 1-2 weeks —"
            },
            "contraindications": "Hemodynamic instability",
            "monitoring": "BP, coagulation",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consult for diagnosis confirmation, immunotherapy initiation, and prognosis discussion",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Pulmonology consult for respiratory function monitoring and ventilator management if FVC declining",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Critical care consult for ICU admission given FVC <30 mL/kg or rapidly declining respiratory function",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Physical therapy for mobility assessment, fall prevention, and early mobilization when stable",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Occupational therapy for ADL assessment and adaptive equipment to maintain independence",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Speech therapy for swallow evaluation given bulbar weakness and aspiration risk",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Respiratory therapy for airway clearance techniques and ventilator management if intubated",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Pain management consult for refractory neuropathic pain not responding to gabapentin/pregabalin",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Physiatry/PM&R for rehabilitation planning and discharge disposition to optimize functional recovery",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Social work for discharge planning, caregiver support, and GBS Foundation resources",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if worsening weakness or breathing difficulty develops (may indicate disease progression requiring intubation)",
            "ED": "STAT",
            "HOSP": "—",
            "OPD": "STAT"
          },
          {
            "item": "Use fall precautions including walker and assistance due to proximal weakness and areflexia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Do not drive until cleared by neurology due to unpredictable weakness and impaired reflexes",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Perform physical therapy exercises as prescribed to maintain range of motion and prevent contractures",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Expect gradual recovery over weeks to months; most patients recover but pace varies by severity",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report fevers, severe headache, or new symptoms immediately as these may indicate infection or relapse",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Contact GBS-CIDP Foundation (www.gbs-cidp.org) for patient support and educational resources",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Aspiration precautions including thickened liquids and upright positioning given bulbar weakness",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—"
          },
          {
            "item": "Early mobilization when medically stable to prevent DVT and deconditioning (with PT guidance)",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—"
          },
          {
            "item": "Frequent repositioning every 2 hours to prevent pressure ulcers during immobility",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Monitor for urinary retention and catheterize if needed due to autonomic dysfunction",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—"
          },
          {
            "item": "Use energy conservation techniques including scheduled rest periods to manage post-GBS fatigue",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Gradual return to activities as strength permits; avoid overexertion which may worsen fatigue",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE"
          },
          {
            "item": "Discuss future vaccination timing with neurologist; avoid live vaccines if on immunotherapy",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Myasthenia gravis",
        "features": "Fatigable weakness, ptosis, diplopia; reflexes preserved",
        "tests": "AChR/MuSK antibodies, repetitive nerve stimulation, edrophonium test"
      },
      {
        "diagnosis": "Transverse myelitis",
        "features": "Sensory level, bowel/bladder dysfunction early, UMN signs",
        "tests": "MRI spine with contrast, CSF"
      },
      {
        "diagnosis": "Spinal cord compression",
        "features": "Sensory level, UMN signs below lesion, back pain",
        "tests": "MRI spine emergent"
      },
      {
        "diagnosis": "Botulism",
        "features": "Descending paralysis, pupil involvement, GI symptoms",
        "tests": "Stool/serum toxin assay, EMG (incremental response)"
      },
      {
        "diagnosis": "Poliomyelitis/West Nile",
        "features": "Asymmetric weakness, fever, CSF pleocytosis",
        "tests": "CSF PCR, serology"
      },
      {
        "diagnosis": "Tick paralysis",
        "features": "Recent tick exposure, ascending paralysis",
        "tests": "Physical exam (find tick), rapid improvement with tick removal"
      },
      {
        "diagnosis": "Critical illness polyneuropathy",
        "features": "ICU setting, sepsis, prolonged weakness",
        "tests": "EMG/NCS, clinical context"
      },
      {
        "diagnosis": "Hypokalemic periodic paralysis",
        "features": "Episodic weakness, low K+ during attacks",
        "tests": "Serum K+ during attack, genetic testing"
      },
      {
        "diagnosis": "Acute porphyria",
        "features": "Abdominal pain, psychiatric symptoms, motor neuropathy",
        "tests": "Urine porphyrins, ALA, PBG"
      },
      {
        "diagnosis": "Heavy metal poisoning",
        "features": "Exposure history, other systemic symptoms",
        "tests": "Heavy metal levels"
      },
      {
        "diagnosis": "Diphtheria",
        "features": "Pharyngitis, palatal weakness, cardiac involvement",
        "tests": "Throat culture, toxin assay"
      },
      {
        "diagnosis": "HIV-associated neuropathy",
        "features": "Risk factors, may have CSF pleocytosis",
        "tests": "HIV testing"
      },
      {
        "diagnosis": "CIDP",
        "features": "Chronic course (>8 weeks), relapsing",
        "tests": "Clinical course, EMG/NCS, CSF"
      }
    ],
    "evidence": [
      {
        "recommendation": "IVIg or PLEX equally effective for GBS",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hughes et al. Cochrane 2014](https://pubmed.ncbi.nlm.nih.gov/25238327/)"
      },
      {
        "recommendation": "IVIg 0.4 g/kg x 5 days standard dosing",
        "evidenceLevel": "Class I, Level A",
        "source": "[van der Meché et al. NEJM 1992](https://pubmed.ncbi.nlm.nih.gov/1557426/)"
      },
      {
        "recommendation": "PLEX effective within 4 weeks of onset",
        "evidenceLevel": "Class I, Level A",
        "source": "[Raphaël et al. Cochrane 2012](https://pubmed.ncbi.nlm.nih.gov/22786476/)"
      },
      {
        "recommendation": "Combined IVIg + PLEX not superior",
        "evidenceLevel": "Class I, Level A",
        "source": "[Plasma Exchange/Sandoglobulin GBS Trial Group 1997](https://pubmed.ncbi.nlm.nih.gov/9008066/)"
      },
      {
        "recommendation": "Corticosteroids ineffective in GBS",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hughes et al. Cochrane 2016](https://pubmed.ncbi.nlm.nih.gov/27775812/)"
      },
      {
        "recommendation": "FVC and NIF for respiratory monitoring",
        "evidenceLevel": "Class II, Level B",
        "source": "[Lawn et al. Arch Neurol 2001](https://pubmed.ncbi.nlm.nih.gov/11405803/)"
      },
      {
        "recommendation": "Anti-GQ1b associated with Miller Fisher",
        "evidenceLevel": "Class II, Level B",
        "source": "[Chiba et al. Ann Neurol 1992](https://pubmed.ncbi.nlm.nih.gov/1514781/)"
      },
      {
        "recommendation": "Campylobacter most common antecedent",
        "evidenceLevel": "Class II, Level B",
        "source": "[Jacobs et al. Neurology 1998](https://pubmed.ncbi.nlm.nih.gov/9781538/)"
      },
      {
        "recommendation": "Early IVIg (within 2 weeks) improves outcomes",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hughes et al. Cochrane 2014](https://pubmed.ncbi.nlm.nih.gov/25238327/)"
      },
      {
        "recommendation": "20/30/40 rule for intubation",
        "evidenceLevel": "Class III, Level C",
        "source": "[Lawn et al. Arch Neurol 2001](https://pubmed.ncbi.nlm.nih.gov/11405803/)"
      }
    ],
    "monitoring": [
      {
        "item": "Forced vital capacity (FVC)",
        "frequency": "q4-6h initially; q2h if declining",
        "action": "Intubate if <20 mL/kg or >30% decline",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Negative inspiratory force (NIF)",
        "frequency": "q4-6h initially; q2h if declining",
        "action": "Intubate if weaker than -30 cmH2O",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Oxygen saturation",
        "frequency": "Continuous",
        "action": "Supplement oxygen, consider intubation",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Heart rate",
        "frequency": "Continuous",
        "action": "Treat bradycardia <50 or tachy >120",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Blood pressure",
        "frequency": "q1-4h",
        "action": "Treat hypo/hypertension",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Neurological exam (strength)",
        "frequency": "q4-8h",
        "action": "Escalate care if worsening",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Swallow function",
        "frequency": "Daily if bulbar symptoms",
        "action": "NPO, NG tube if unsafe",
        "ED": "—",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Urine output",
        "frequency": "q4-8h",
        "action": "Bladder scan, catheterize if needed",
        "ED": "—",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Renal function",
        "frequency": "Daily during IVIg",
        "action": "Hold IVIg, hydrate if rising",
        "ED": "—",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Skin integrity",
        "frequency": "q shift",
        "action": "Reposition, pressure relief",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "ROUTINE"
      },
      {
        "item": "Bowel function",
        "frequency": "Daily",
        "action": "Bowel regimen if constipated",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "ROUTINE"
      }
    ],
    "disposition": [
      {
        "disposition": "**ICU admission**",
        "criteria": "FVC <30 mL/kg; NIF weaker than -40 cmH2O; rapid progression; autonomic instability; bulbar dysfunction; need for intubation"
      },
      {
        "disposition": "**Step-down/telemetry**",
        "criteria": "Stable FVC >30 mL/kg; improving or stable exam; no autonomic instability; on telemetry monitoring"
      },
      {
        "disposition": "**General floor**",
        "criteria": "Mild weakness (ambulatory); stable FVC >40 mL/kg; no bulbar symptoms; no autonomic dysfunction"
      },
      {
        "disposition": "**Acute rehabilitation**",
        "criteria": "Medically stable; significant residual weakness requiring intensive therapy; FVC stable >25 mL/kg"
      },
      {
        "disposition": "**Discharge home**",
        "criteria": "Ambulatory or near-ambulatory; stable >48-72 hours; adequate home support; outpatient PT arranged; no respiratory compromise"
      },
      {
        "disposition": "**Skilled nursing facility**",
        "criteria": "Unable to participate in intensive rehab; requires ongoing nursing care; medically stable"
      }
    ]
  },
  "Myasthenia Gravis - Exacerbation/Crisis": {
    "id": "myasthenia-gravis-crisis",
    "title": "Myasthenia Gravis - Exacerbation/Crisis",
    "version": "1.0",
    "icd10": [
      "** G70.01 (Myasthenia gravis with exacerbation)"
    ],
    "scope": "** Acute exacerbation and myasthenic crisis in adults with known or suspected myasthenia gravis. Covers respiratory monitoring, emergent immunotherapy (IVIG/PLEX), cholinesterase inhibitor management, distinguishing myasthenic from cholinergic crisis, and medications to avoid. Excludes new diagnosis workup (see MG - New Diagnosis template), Lambert-Eaton syndrome, and chronic stable management.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Baseline; infection screen (common trigger); leukocytosis suggests infection",
            "target": "Normal"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Electrolytes, renal/hepatic function for medication dosing; hypokalemia worsens weakness",
            "target": "Normal"
          },
          {
            "item": "Magnesium",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hypomagnesemia worsens NMJ transmission; CONTRAINDICATED to give IV Mg in MG crisis",
            "target": "Confirm normal BEFORE any magnesium replacement"
          },
          {
            "item": "TSH",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Thyroid disease coexists in 10-15% of MG; thyrotoxicosis precipitates crisis",
            "target": "Normal"
          },
          {
            "item": "Blood glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Steroid-induced hyperglycemia management",
            "target": "Normal"
          },
          {
            "item": "Urinalysis + urine culture",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "UTI as precipitant for exacerbation",
            "target": "Negative"
          },
          {
            "item": "Blood cultures x2",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "If febrile; infection is #1 trigger for crisis",
            "target": "No growth"
          },
          {
            "item": "Pregnancy test (β-hCG)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Affects treatment choices; MG can fluctuate in pregnancy",
            "target": "Document result"
          },
          {
            "item": "PT/INR, aPTT",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Coagulation before procedures; PLEX circuit anticoagulation",
            "target": "Normal"
          },
          {
            "item": "ABG or VBG",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Respiratory failure assessment; hypercapnia is LATE finding — do not wait for this",
            "target": "Normal; rising pCO2 = imminent failure"
          }
        ],
        "Extended Workup": [
          {
            "item": "AChR binding antibody",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Confirm diagnosis if not previously tested; positive in 85% generalized MG",
            "target": "Positive supports MG diagnosis"
          },
          {
            "item": "AChR modulating antibody",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Additional sensitivity when binding Ab equivocal",
            "target": "Positive supports diagnosis"
          },
          {
            "item": "AChR blocking antibody",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Part of full AChR panel",
            "target": "Positive supports diagnosis"
          },
          {
            "item": "MuSK antibody",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If AChR negative; MuSK-positive MG has different treatment implications (poor response to pyridostigmine, PLEX preferred over IVIG)",
            "target": "Check if AChR negative"
          },
          {
            "item": "Anti-striated muscle antibody (anti-titin)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Associated with thymoma; especially in young patients",
            "target": "If positive, image for thymoma"
          },
          {
            "item": "Procalcitonin",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Differentiate bacterial infection trigger from other causes of decompensation",
            "target": "<0.5 ng/mL"
          },
          {
            "item": "Chest X-ray",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Aspiration pneumonia, atelectasis; baseline for ventilator",
            "target": "Clear lungs"
          },
          {
            "item": "Lactate",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Sepsis screen if febrile",
            "target": "Normal (<2 mmol/L)"
          },
          {
            "item": "Drug level of immunosuppressant (if applicable)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Check azathioprine metabolites (6-TGN), mycophenolate levels, tacrolimus levels if on these agents",
            "target": "Therapeutic range"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "LRP4 antibody",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Triple-seronegative MG (AChR-/MuSK-/LRP4+)",
            "target": "Check if double seronegative"
          },
          {
            "item": "Agrin antibody",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Emerging biomarker in seronegative MG",
            "target": "Research use"
          },
          {
            "item": "Anti-Kv1.4 antibody",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Associated with myocarditis in MG; cardiac risk stratification",
            "target": "Check if cardiac symptoms"
          },
          {
            "item": "Complement levels (C3, C4)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Complement-mediated MG pathophysiology; pre-eculizumab evaluation",
            "target": "Baseline"
          },
          {
            "item": "Quantitative immunoglobulins (IgG, IgA, IgM)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypogammaglobulinemia from rituximab or chronic IVIG; IgA deficiency before IVIG",
            "target": "Normal"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Chest X-ray",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Immediate in ED",
            "target": "Pneumonia, aspiration, atelectasis, mediastinal mass (thymoma)",
            "contraindications": "None significant"
          },
          {
            "item": "ECG (12-lead)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "On admission",
            "target": "Arrhythmia, myocarditis (rare but reported in MG, especially anti-Kv1.4+)",
            "contraindications": "None"
          },
          {
            "item": "Bedside spirometry (FVC and NIF)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "Immediately on presentation; serial monitoring",
            "target": "FVC >20 mL/kg; NIF more negative than -30 cmH2O",
            "contraindications": "Patient cooperation required"
          }
        ],
        "Extended": [
          {
            "item": "CT chest with contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "During admission if not recently done",
            "target": "Thymoma (present in 10-15%); thymic hyperplasia",
            "contraindications": "Contrast allergy, renal impairment"
          },
          {
            "item": "MRI chest (alternative to CT)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If CT contraindicated",
            "target": "Thymoma evaluation",
            "contraindications": "Pacemaker, metallic implants"
          },
          {
            "item": "Repetitive nerve stimulation (RNS)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If diagnosis not confirmed; avoid during acute crisis (deferred to stable phase)",
            "target": "Decremental response >10% at 2-3 Hz in affected muscle",
            "contraindications": "None significant"
          },
          {
            "item": "Single-fiber EMG (SFEMG)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Most sensitive test (95-99%); defer to outpatient stable phase",
            "target": "Increased jitter, blocking",
            "contraindications": "Patient cooperation"
          },
          {
            "item": "CT head",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "If altered mental status to rule out other causes",
            "target": "Normal (MG does not affect brain parenchyma)",
            "contraindications": "None significant"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "PET-CT",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If thymoma on CT; staging",
            "target": "Metabolic activity, metastatic disease",
            "contraindications": "Pregnancy"
          },
          {
            "item": "Echocardiogram",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "timing": "If cardiac symptoms or anti-Kv1.4 positive",
            "target": "Myocarditis, cardiomyopathy",
            "contraindications": "None significant"
          },
          {
            "item": "Pulmonary function tests (formal)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Outpatient baseline after recovery",
            "target": "FVC baseline for future comparisons",
            "contraindications": "Patient cooperation"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "IVIG (intravenous immunoglobulin)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg",
                  "orderSentence": "IVIG (intravenous immunoglobulin) 0.4 g/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.4 g/kg/day IV x 5 days (total 2 g/kg) OR 1 g/kg/day x 2 days (faster option). Start within 24h of crisis recognition",
              "orderSentence": "IVIG (intravenous immunoglobulin) 0.4 g/kg IV"
            },
            "contraindications": "IgA deficiency (anaphylaxis risk — use IgA-depleted product); renal failure; thrombotic risk",
            "monitoring": "Vital signs q15min first infusion; renal function daily; headache (aseptic meningitis); thrombotic events",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Plasmapheresis (PLEX)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "5 exchanges over 10-14 days (every other day); 1-1.5 plasma volumes per exchange. PREFERRED for MuSK-positive MG. Faster onset than IVIG (days vs 1-2 weeks)",
              "orderSentence": "Plasmapheresis (PLEX) - - - see dosing"
            },
            "contraindications": "Hemodynamic instability, severe sepsis, heparin allergy, poor vascular access",
            "monitoring": "BP continuous during exchange; Ca2+ (citrate toxicity); fibrinogen; electrolytes; line infection",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Intubation and mechanical ventilation",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mL/kg",
                  "orderSentence": "Intubation and mechanical ventilation 20 mL/kg -"
                }
              ],
              "route": "-",
              "instructions": "Indications: FVC <20 mL/kg, NIF >-30 cmH2O (weaker), >30% FVC decline, clinical distress, inability to handle secretions. Use NON-DEPOLARIZING agents at REDUCED DOSE (MG patients are sensitive). Avoid succinylcholine (unpredictable response)",
              "orderSentence": "Intubation and mechanical ventilation 20 mL/kg -"
            },
            "contraindications": "N/A (life-saving)",
            "monitoring": "Ventilator per ICU protocol; daily SBT when improving",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Hold pyridostigmine during crisis",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "HOLD cholinesterase inhibitors during intubation/crisis — excess cholinergic stimulation increases secretions and complicates ventilator management. Resume at reduced dose during weaning",
              "orderSentence": "Hold pyridostigmine during crisis - - - see dosing"
            },
            "contraindications": "N/A",
            "monitoring": "Secretion management; restart when extubation approaching",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Supplemental oxygen",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "94%",
                  "orderSentence": "Supplemental oxygen 94% -"
                }
              ],
              "route": "-",
              "instructions": "As needed for SpO2 <94%",
              "orderSentence": "Supplemental oxygen 94% -"
            },
            "contraindications": "N/A",
            "monitoring": "SpO2 monitoring",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "IV fluids (isotonic)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "NS maintenance; hydration for IVIG renal protection",
              "orderSentence": "IV fluids (isotonic) - IV - see dosing"
            },
            "contraindications": "Volume overload",
            "monitoring": "I/O, electrolytes",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Pyridostigmine (when stable/recovering)",
            "route": "PO",
            "indication": "Symptomatic weakness improvement",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg",
                  "orderSentence": "Pyridostigmine (when stable/recovering) 30 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Resume at 30 mg PO TID during recovery; titrate by 30 mg/dose q3-5 days to 60 mg PO q4-6h; max 120 mg q4h (rarely needed). Take 30-60 min before meals for dysphagia",
              "orderSentence": "Pyridostigmine (when stable/recovering) 30 mg PO"
            },
            "contraindications": "Cholinergic crisis (excessive dosing), mechanical bowel obstruction",
            "monitoring": "GI symptoms (diarrhea, cramping, salivation = cholinergic excess); reduce dose if muscarinic symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Glycopyrrolate",
            "route": "IV",
            "indication": "Cholinergic side effects of pyridostigmine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2 mg",
                  "orderSentence": "Glycopyrrolate 1-2 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1-2 mg PO BID-TID; or 0.2 mg IV PRN for excessive secretions",
              "orderSentence": "Glycopyrrolate 1-2 mg IV"
            },
            "contraindications": "Angle-closure glaucoma, urinary retention, tachycardia",
            "monitoring": "Heart rate; urinary retention; dry mouth",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Acetaminophen",
            "route": "PO",
            "indication": "Headache (IVIG-related or general)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650-1000 mg",
                  "orderSentence": "Acetaminophen 650-1000 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "650-1000 mg PO q6h; max 4g/day",
              "orderSentence": "Acetaminophen 650-1000 mg PO"
            },
            "contraindications": "Severe liver disease",
            "monitoring": "LFTs if prolonged",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Ondansetron",
            "route": "IV",
            "indication": "Nausea (IVIG-related)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg",
                  "orderSentence": "Ondansetron 4 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "4 mg IV/PO q6h PRN",
              "orderSentence": "Ondansetron 4 mg IV"
            },
            "contraindications": "QT prolongation",
            "monitoring": "QTc monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Diphenhydramine",
            "route": "IV",
            "indication": "IVIG premedication",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-50 mg",
                  "orderSentence": "Diphenhydramine 25-50 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "25-50 mg IV/PO 30 min before IVIG infusion",
              "orderSentence": "Diphenhydramine 25-50 mg IV"
            },
            "contraindications": "Angle-closure glaucoma; avoid in elderly (anticholinergic)",
            "monitoring": "Sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Enoxaparin",
            "route": "SC",
            "indication": "DVT prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Enoxaparin 40 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily",
              "orderSentence": "Enoxaparin 40 mg SC"
            },
            "contraindications": "Active bleeding, CrCl <30 (use UFH)",
            "monitoring": "Platelets q3 days",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pneumatic compression devices",
            "route": "-",
            "indication": "DVT prophylaxis",
            "dosing": {
              "instructions": "Apply bilaterally on admission",
              "orderSentence": "Pneumatic compression devices - - - see dosing"
            },
            "contraindications": "Acute DVT",
            "monitoring": "Skin checks",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Pantoprazole",
            "route": "IV",
            "indication": "GI prophylaxis (if on steroids)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Pantoprazole 40 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "40 mg IV/PO daily",
              "orderSentence": "Pantoprazole 40 mg IV"
            },
            "contraindications": "Prolonged use risks (C. diff, osteoporosis)",
            "monitoring": "GI symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Insulin sliding scale",
            "route": "-",
            "indication": "Steroid-induced hyperglycemia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "140-180 mg",
                  "orderSentence": "Insulin sliding scale 140-180 mg -"
                }
              ],
              "route": "-",
              "instructions": "Per institutional protocol; target glucose 140-180 mg/dL",
              "orderSentence": "Insulin sliding scale 140-180 mg -"
            },
            "contraindications": "Hypoglycemia",
            "monitoring": "Blood glucose q6h or more frequent",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "IV methylprednisolone",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "IV methylprednisolone 1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg IV daily x 3-5 days. CAUTION: steroids can transiently worsen MG in first 5-10 days — only initiate in monitored setting with respiratory support available. Some centers use slow oral prednisone uptitration instead",
              "orderSentence": "IV methylprednisolone 1000 mg IV"
            },
            "contraindications": "Uncontrolled diabetes (relative), active infection (relative)",
            "monitoring": "FVC/NIF closely; glucose q6h; BP; GI prophylaxis",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Prednisone (oral uptitration)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-20 mg",
                  "orderSentence": "Prednisone (oral uptitration) 10-20 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-20 mg PO daily; increase by 10 mg every 3-5 days to target 1 mg/kg/day (max 60-80 mg); maintain for 4-8 weeks, then slow taper over months",
              "orderSentence": "Prednisone (oral uptitration) 10-20 mg PO"
            },
            "contraindications": "Active infection, uncontrolled DM (relative)",
            "monitoring": "Glucose, BP, weight, bone density, mood; GI prophylaxis; PJP prophylaxis if prolonged high-dose",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Second course IVIG or PLEX",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Repeat standard dosing if inadequate response to first course; wait 2-4 weeks between courses",
              "orderSentence": "Second course IVIG or PLEX - - - see dosing"
            },
            "contraindications": "Same as initial",
            "monitoring": "Same as initial",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Eculizumab",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "900 mg",
                  "orderSentence": "Eculizumab 900 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "900 mg IV q1 week x 4 weeks, then 1200 mg IV q2 weeks; for AChR-positive refractory generalized MG",
              "orderSentence": "Eculizumab 900 mg IV"
            },
            "contraindications": "Unresolved Neisseria meningitidis infection; must vaccinate ≥2 weeks before starting",
            "monitoring": "Meningococcal infection; complement levels; CBC",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Efgartigimod (Vyvgart)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg",
                  "orderSentence": "Efgartigimod (Vyvgart) 10 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV weekly x 4 weeks per cycle; repeat cycles based on clinical response; for AChR-positive generalized MG",
              "orderSentence": "Efgartigimod (Vyvgart) 10 mg/kg IV"
            },
            "contraindications": "Active infection, IgG <2 g/L",
            "monitoring": "IgG levels (target reduction); infection signs; CBC",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rituximab",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "375 mg/m2",
                  "orderSentence": "Rituximab 375 mg/m2 IV"
                }
              ],
              "route": "IV",
              "instructions": "375 mg/m2 IV weekly x 4 weeks OR 1000 mg IV x 2 doses 2 weeks apart; especially effective in MuSK-positive MG",
              "orderSentence": "Rituximab 375 mg/m2 IV"
            },
            "contraindications": "Active infection, hepatitis B (reactivation risk — screen first)",
            "monitoring": "CD20 count, immunoglobulins q3 months; hepatitis B screening; PML risk (rare)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Disease-Modifying or Chronic Therapies": [
          {
            "item": "Azathioprine",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Azathioprine 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg PO daily; increase by 50 mg every 1-2 weeks to target 2-3 mg/kg/day; onset of effect 6-12 months",
              "orderSentence": "Azathioprine 50 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "TPMT deficiency; pregnancy; concurrent allopurinol (dose reduce by 75%)",
            "monitoring": "CBC weekly x 4 weeks, then biweekly x 2 months, then monthly; LFTs monthly x 3, then q3 months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mycophenolate mofetil",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Mycophenolate mofetil 500 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 500 mg PO BID; increase to 1000 mg PO BID after 2 weeks; max 1500 mg BID; onset 6-12 months",
              "orderSentence": "Mycophenolate mofetil 500 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Pregnancy (Category D), breastfeeding",
            "monitoring": "CBC q1 week x 1 month, then biweekly x 2 months, then monthly; LFTs q3 months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tacrolimus",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3 mg",
                  "orderSentence": "Tacrolimus 3 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "3 mg PO daily in 2 divided doses; target trough 5-10 ng/mL; onset 3-6 months",
              "orderSentence": "Tacrolimus 3 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Renal failure, uncontrolled hypertension",
            "monitoring": "Trough level q1 week initially, then monthly; Cr, K+, glucose, BP; drug interactions (CYP3A4)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cyclosporine",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-3 mg/kg",
                  "orderSentence": "Cyclosporine 2-3 mg/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2-3 mg/kg/day PO in 2 divided doses; target trough 100-200 ng/mL; onset 3-6 months",
              "orderSentence": "Cyclosporine 2-3 mg/kg PO"
            },
            "pretreatment": "-",
            "contraindications": "Renal failure, uncontrolled HTN, malignancy",
            "monitoring": "Trough levels, Cr, BP, Mg, lipids monthly",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consultation (neuromuscular specialist if available)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "All myasthenic crisis; treatment decisions; medication management"
          },
          {
            "item": "Pulmonology / Critical care",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Declining respiratory function; ventilator management"
          },
          {
            "item": "Thoracic surgery",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Thymoma evaluation; thymectomy planning (if not previously done)"
          },
          {
            "item": "Respiratory therapy",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Bedside FVC/NIF monitoring; pulmonary toilet"
          },
          {
            "item": "Speech-language pathology (SLP)",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Dysphagia evaluation; aspiration prevention (bulbar weakness common in crisis)"
          },
          {
            "item": "Physical therapy (PT)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "indication": "Prevent deconditioning; safe mobilization; fall prevention"
          },
          {
            "item": "Occupational therapy (OT)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "indication": "ADL assessment; energy conservation techniques; adaptive equipment"
          },
          {
            "item": "Pharmacy (clinical pharmacist)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Medication reconciliation — review ALL medications for MG-unsafe drugs"
          },
          {
            "item": "Social work",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Discharge planning; support resources; insurance for IVIG/PLEX"
          },
          {
            "item": "Palliative care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "indication": "Goals of care discussion for refractory or elderly patients"
          },
          {
            "item": "Infectious disease",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "indication": "If infection trigger unclear or complex; immunosuppressed patient management"
          },
          {
            "item": "Endocrinology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "If concurrent thyroid disease; steroid-induced diabetes management"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Call 911 / Return to ED if: increasing difficulty breathing, trouble swallowing, choking on food or saliva, unable to hold head up, rapidly worsening weakness",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Carry MG crisis card / MedicAlert bracelet at all times",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Bring complete medication list to every medical visit; alert ALL providers about MG diagnosis",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "NEVER take antibiotics, pain medications, or new prescriptions without checking with neurology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take pyridostigmine 30-60 minutes before meals for best swallowing function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid extreme heat (worsens weakness), overexertion, and sleep deprivation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report any new medication prescribed by other providers to your neurologist",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Infection prevention: hand hygiene, avoid sick contacts, up-to-date vaccinations (inactivated only if immunosuppressed; NO live vaccines)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Follow-up with neurology 1-2 weeks post-discharge; sooner if symptoms worsen",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Infection avoidance (number one trigger for crisis)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Influenza vaccination annually (inactivated)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Pneumococcal vaccination",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "COVID-19 vaccination (inactivated/mRNA; coordinate timing with immunosuppression cycle)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "NO live vaccines if on immunosuppression (MMR, varicella, live zoster, yellow fever)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate sleep (fatigue worsens MG)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management (emotional stress triggers exacerbation)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Moderate exercise as tolerated; avoid overexertion; rest periods during activity",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Heat avoidance (hot weather, hot tubs, saunas worsen NMJ transmission)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Alcohol limitation (alcohol worsens weakness)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Eye protection (sunglasses, patching for diplopia; artificial tears for incomplete lid closure)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Cholinergic crisis",
        "features": "EXCESSIVE pyridostigmine; salivation, lacrimation, urination, diarrhea, emesis (SLUDE); miosis; fasciculations; weakness WORSENS with additional pyridostigmine",
        "tests": "Hold pyridostigmine — if strength improves, cholinergic; if worsens, myasthenic crisis. Clinical distinction is key"
      },
      {
        "diagnosis": "Guillain-Barré syndrome",
        "features": "Ascending paralysis, areflexia, albuminocytologic dissociation, preceding infection, no fatigability",
        "tests": "NCS/EMG (demyelinating neuropathy vs NMJ); LP (elevated protein); no response to pyridostigmine"
      },
      {
        "diagnosis": "Lambert-Eaton myasthenic syndrome",
        "features": "Proximal weakness IMPROVES with repeated use; autonomic dysfunction (dry mouth); associated with small cell lung cancer; hyporeflexia",
        "tests": "VGCC antibodies; NCS (incremental response with high-rate repetitive stimulation — opposite of MG)"
      },
      {
        "diagnosis": "Botulism",
        "features": "Descending paralysis (cranial → limbs); dilated pupils; foodborne or wound exposure; autonomic dysfunction",
        "tests": "Stool/serum botulinum toxin; NCS (incremental); clinical history"
      },
      {
        "diagnosis": "ALS",
        "features": "Progressive weakness without fluctuation; upper AND lower motor neuron signs; no fatigability pattern; fasciculations",
        "tests": "NCS/EMG (denervation); no response to IVIG/PLEX; no AChR antibodies"
      },
      {
        "diagnosis": "Brainstem stroke",
        "features": "Acute onset; cranial nerve findings; crossed findings (ipsilateral cranial nerve + contralateral limb); no fatigability",
        "tests": "MRI DWI (restricted diffusion); CTA"
      },
      {
        "diagnosis": "MS exacerbation",
        "features": "CNS symptoms (optic neuritis, sensory level, cerebellar ataxia); dissemination in space and time; no NMJ findings",
        "tests": "MRI brain/spine; LP (oligoclonal bands); no AChR antibodies"
      },
      {
        "diagnosis": "Thyroid storm",
        "features": "Severe weakness, tachycardia, fever, agitation, lid lag; thyroid hormone excess",
        "tests": "TSH (suppressed), free T4 (elevated)"
      },
      {
        "diagnosis": "Periodic paralysis (hypo/hyperkalemic)",
        "features": "Episodic weakness triggered by meals, exercise, rest; normal between attacks",
        "tests": "Serum potassium during attack; genetic testing"
      },
      {
        "diagnosis": "Conversion disorder / FND",
        "features": "Non-physiologic weakness; Hoover sign; distractible; no fatigable pattern",
        "tests": "Normal NCS/EMG; normal antibodies; clinical exam"
      }
    ],
    "evidence": [
      {
        "recommendation": "IVIG (2 g/kg over 2-5 days) for myasthenic crisis",
        "evidenceLevel": "Class I, Level A",
        "source": "[Zinman et al. (2007)](https://pubmed.ncbi.nlm.nih.gov/17353471/); [Gajdos et al. Cochrane (2012)](https://pubmed.ncbi.nlm.nih.gov/23235588/)"
      },
      {
        "recommendation": "PLEX (5 exchanges) for myasthenic crisis",
        "evidenceLevel": "Class I, Level A",
        "source": "Cortese et al. (2011); Cochrane Review"
      },
      {
        "recommendation": "IVIG and PLEX are equivalent for crisis",
        "evidenceLevel": "Class I, Level A",
        "source": "[Barth et al. (2011)](https://pubmed.ncbi.nlm.nih.gov/21562253/)"
      },
      {
        "recommendation": "PLEX preferred for MuSK-positive MG",
        "evidenceLevel": "Class IIa, Level C",
        "source": "Expert consensus; [Evoli et al. (2003)](https://pubmed.ncbi.nlm.nih.gov/12821509/)"
      },
      {
        "recommendation": "Hold pyridostigmine during intubation/crisis",
        "evidenceLevel": "Class IIa, Level C",
        "source": "Expert consensus"
      },
      {
        "recommendation": "Avoid aminoglycosides, fluoroquinolones in MG",
        "evidenceLevel": "Class III (Harm)",
        "source": "FDA safety communication; multiple case reports"
      },
      {
        "recommendation": "Avoid IV magnesium in MG",
        "evidenceLevel": "Class III (Harm)",
        "source": "NMJ blockade; case reports of respiratory failure"
      },
      {
        "recommendation": "Steroids can transiently worsen MG (monitor closely when initiating)",
        "evidenceLevel": "Class IIa, Level B",
        "source": "Multiple observational studies"
      },
      {
        "recommendation": "Thymectomy benefit in non-thymomatous MG",
        "evidenceLevel": "Class I, Level B",
        "source": "MGTX trial ([Wolfe et al. NEJM 2016](https://pubmed.ncbi.nlm.nih.gov/27509100/))"
      },
      {
        "recommendation": "Eculizumab for refractory AChR+ generalized MG",
        "evidenceLevel": "Class I, Level A",
        "source": "REGAIN trial ([Howard et al. Lancet Neurol 2017](https://pubmed.ncbi.nlm.nih.gov/29066163/))"
      },
      {
        "recommendation": "Efgartigimod for AChR+ generalized MG",
        "evidenceLevel": "Class I, Level A",
        "source": "ADAPT trial ([Howard et al. Lancet Neurol 2021](https://pubmed.ncbi.nlm.nih.gov/34146511/))"
      },
      {
        "recommendation": "Rituximab for MuSK-positive MG",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[Hehir et al. (2017)](https://pubmed.ncbi.nlm.nih.gov/28801338/); [Díaz-Manera et al. (2012)](https://pubmed.ncbi.nlm.nih.gov/22218276/)"
      },
      {
        "recommendation": "20/30/40 rule for intubation",
        "evidenceLevel": "Class IIa, Level C",
        "source": "Wijdicks & Klein (2017)"
      },
      {
        "recommendation": "Bedside FVC superior to ABG for monitoring",
        "evidenceLevel": "Class I, Level B",
        "source": "Multiple studies; ABG changes are LATE findings"
      },
      {
        "recommendation": "Azathioprine as first-line steroid-sparing",
        "evidenceLevel": "Class I, Level B",
        "source": "[Palace et al. (1998)](https://pubmed.ncbi.nlm.nih.gov/9633727/)"
      },
      {
        "recommendation": "Mycophenolate as steroid-sparing",
        "evidenceLevel": "Class II, Level B",
        "source": "Mixed trial results but widely used"
      }
    ],
    "monitoring": [
      {
        "item": "Forced Vital Capacity (FVC)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "q4-6h on floor; q2-4h in ICU; q1-2h if declining",
        "action": "If <20 mL/kg → intubate electively; if declining >30% → prepare for intubation"
      },
      {
        "item": "Negative Inspiratory Force (NIF)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "With FVC measurements",
        "action": "If weaker than -30 → intubate"
      },
      {
        "item": "Single breath count",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q4h as screening",
        "action": "If <15 → correlate with FVC; if <10 → imminent failure"
      },
      {
        "item": "Oxygen saturation",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "Continuous in ICU; q4h on floor",
        "action": "LATE finding; do not rely on alone"
      },
      {
        "item": "Blood pressure",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "q4h on floor; continuous in ICU",
        "action": "Autonomic dysregulation possible (less common than GBS)"
      },
      {
        "item": "Heart rate and rhythm",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "Continuous telemetry in ICU; q4h on floor",
        "action": "Arrhythmia: cardiology consult"
      },
      {
        "item": "Neurologic exam (strength, bulbar function)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "q4-8h; MGFA post-intervention status at discharge",
        "action": "If worsening → re-evaluate treatment; consider repeat IVIG/PLEX"
      },
      {
        "item": "Swallowing assessment",
        "ED": "URGENT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "Daily",
        "action": "NPO; NG tube; modified diet"
      },
      {
        "item": "Blood glucose",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE",
        "frequency": "q6h if on steroids; BID if stable",
        "action": "Insulin; reduce steroid if possible"
      },
      {
        "item": "Renal function (Cr, BUN)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "ROUTINE",
        "frequency": "Daily during IVIG; q48h otherwise",
        "action": "Hold IVIG; hydration"
      },
      {
        "item": "CBC",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE",
        "frequency": "Weekly during immunosuppression initiation; q3 months chronic",
        "action": "Dose adjust or hold immunosuppressant"
      },
      {
        "item": "LFTs",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Monthly x3 for azathioprine/mycophenolate, then q3 months",
        "action": "Dose adjust or hold"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Exacerbation resolved; FVC >60% predicted and stable; able to swallow safely; adequate oral medications; no respiratory distress; stable immunotherapy regimen; follow-up within 1-2 weeks"
      },
      {
        "disposition": "Admit to floor (monitored bed)",
        "criteria": "Moderate exacerbation; FVC 20-30 mL/kg; requires IVIG or PLEX; dysphagia requiring modified diet; unable to maintain medications orally"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Myasthenic crisis; FVC <20 mL/kg or declining rapidly; intubated; bulbar weakness with aspiration risk; post-operative thymectomy with respiratory concerns"
      },
      {
        "disposition": "Transfer to higher level",
        "criteria": "Need for PLEX not available; neuromuscular specialist consultation; need for ICU with neurology expertise"
      },
      {
        "disposition": "Inpatient rehabilitation",
        "criteria": "Significant weakness; unable to perform ADLs independently; able to tolerate 3h/day therapy"
      }
    ]
  },
  "Bacterial Meningitis": {
    "id": "bacterial-meningitis",
    "title": "Bacterial Meningitis",
    "version": "1.0",
    "icd10": [
      "** G00.9 (Bacterial meningitis",
      "unspecified)",
      "G00.1 (Pneumococcal meningitis)",
      "G00.0 (Hemophilus meningitis)",
      "A39.0 (Meningococcal meningitis)",
      "G00.3 (Staphylococcal meningitis)"
    ],
    "scope": "** Acute community-acquired bacterial meningitis in adults. Covers emergency empiric antibiotics, dexamethasone adjunctive therapy, LP and CSF analysis, targeted therapy by organism, and complications management. Excludes viral meningitis, fungal meningitis, TB meningitis, healthcare-associated/post-surgical meningitis, and pediatric meningitis.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Blood cultures x2 (different sites)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "MUST be drawn BEFORE antibiotics but do NOT delay antibiotics to obtain; positive in 50-70% of bacterial meningitis",
            "target": "Organism identification and sensitivities"
          },
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Leukocytosis with left shift; baseline; thrombocytopenia (DIC risk)",
            "target": "WBC elevated; neutrophilia"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Electrolytes (SIADH: hyponatremia), renal/hepatic function for antibiotic dosing",
            "target": "Normal; watch Na"
          },
          {
            "item": "Procalcitonin",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Highly sensitive for bacterial infection; helps distinguish bacterial from viral meningitis (>0.5 strongly suggests bacterial)",
            "target": "Elevated (>0.5 ng/mL bacterial; typically >2.0)"
          },
          {
            "item": "CRP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Inflammatory marker; helps monitor treatment response",
            "target": "Elevated"
          },
          {
            "item": "Lactate",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Sepsis assessment; elevated in bacterial meningitis",
            "target": "<2 mmol/L (elevated suggests sepsis)"
          },
          {
            "item": "Coagulation panel (PT/INR, aPTT, fibrinogen)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "DIC screening (meningococcemia); coagulopathy before LP",
            "target": "Normal; DIC: elevated PT/aPTT, low fibrinogen, elevated D-dimer"
          },
          {
            "item": "D-dimer",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "DIC assessment (especially meningococcemia)",
            "target": "Normal"
          },
          {
            "item": "Blood glucose (concurrent with LP)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Calculate CSF:serum glucose ratio",
            "target": "Paired with CSF glucose"
          },
          {
            "item": "Type and screen",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Potential need for blood products (DIC, sepsis)",
            "target": "On file"
          },
          {
            "item": "Point-of-care glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Hypoglycemia assessment; sepsis",
            "target": ">60 mg/dL"
          }
        ],
        "Extended Workup": [
          {
            "item": "Serum osmolality",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "SIADH assessment (common complication)",
            "target": "280-295 mOsm/kg"
          },
          {
            "item": "Urine osmolality and sodium",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "Confirm SIADH if hyponatremia",
            "target": "Urine osm >100, urine Na >40 in SIADH"
          },
          {
            "item": "Serum cortisol (random or AM)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Adrenal insufficiency (Waterhouse-Friderichsen in meningococcemia)",
            "target": ">18 µg/dL (random stress level)"
          },
          {
            "item": "HIV 1/2 antigen/antibody",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Immunocompromise affects empiric coverage and differential",
            "target": "Negative"
          },
          {
            "item": "Complement levels (C5-C9, CH50, AH50)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Terminal complement deficiency predisposes to recurrent Neisseria meningitidis",
            "target": "Normal"
          },
          {
            "item": "Immunoglobulin levels (IgG, IgA, IgM)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypogammaglobulinemia predisposes to encapsulated organisms",
            "target": "Normal"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Thyroid dysfunction screen (critical illness)",
            "target": "Normal"
          },
          {
            "item": "Troponin",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Sepsis-associated myocardial injury",
            "target": "Normal"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Metagenomic next-generation sequencing (mNGS) of CSF",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "rationale": "Culture-negative meningitis; prior antibiotic exposure; atypical organisms",
            "target": "Pathogen identification"
          },
          {
            "item": "Beta-D-glucan (serum)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "rationale": "If fungal meningitis suspected (immunocompromised)",
            "target": "Negative (<60 pg/mL)"
          },
          {
            "item": "Galactomannan (serum)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "rationale": "Aspergillus (immunocompromised)",
            "target": "Negative"
          },
          {
            "item": "Cryptococcal antigen (serum)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "HIV/immunocompromised; chronic meningitis",
            "target": "Negative"
          },
          {
            "item": "RPR/VDRL (serum)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurosyphilis in differential",
            "target": "Negative"
          },
          {
            "item": "QuantiFERON-TB Gold",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "TB meningitis in high-risk patients",
            "target": "Negative"
          },
          {
            "item": "Skull base/sinus CT",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Recurrent meningitis: skull base fracture, CSF leak, sinusitis",
            "target": "No fracture or defect"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Elevated in bacterial meningitis; monitor for elevated ICP",
            "target": "Typically 200-500 mm H2O (normal <200); markedly elevated suggests edema/hydrocephalus"
          },
          {
            "item": "Cell count with differential (tubes 1 AND 4)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Bacterial: neutrophilic pleocytosis; tube 1 vs 4 differentiates traumatic tap",
            "target": "WBC >1000 cells/µL with >80% neutrophils (bacterial); WBC 100-10,000 typical"
          },
          {
            "item": "Protein",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Elevated in bacterial meningitis",
            "target": "Elevated (>100 mg/dL typical; often 100-500)"
          },
          {
            "item": "Glucose with paired serum glucose",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "CSF:serum ratio <0.4 strongly suggests bacterial meningitis",
            "target": "Low (<40 mg/dL; CSF:serum ratio <0.4)"
          },
          {
            "item": "Gram stain",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Rapid identification; positive in 60-90% of untreated bacterial meningitis",
            "target": "Organisms identified (gram-positive diplococci = pneumococcus; gram-negative diplococci = meningococcus; gram-positive rods = Listeria; gram-negative rods = E. coli/Haemophilus)"
          },
          {
            "item": "Bacterial culture and sensitivity",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Gold standard for organism identification and antibiotic sensitivities; may be negative after antibiotics",
            "target": "Organism identified with sensitivities"
          },
          {
            "item": "BioFire FilmArray Meningitis/Encephalitis Panel",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Rapid multiplex PCR (14 pathogens in ~1 hour); especially valuable if prior antibiotics given",
            "target": "Identifies E. coli K1, H. influenzae, L. monocytogenes, N. meningitidis, S. agalactiae, S. pneumoniae, plus viruses (HSV, enterovirus, VZV, etc.) and Cryptococcus"
          },
          {
            "item": "Lactate (CSF)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "CSF lactate >3.5 mmol/L highly suggestive of bacterial (sensitivity ~93%, specificity ~96%); useful post-antibiotics when cultures may be negative",
            "target": "<3.5 mmol/L (bacterial typically >4.0)"
          },
          {
            "item": "HSV 1/2 PCR",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Exclude concurrent HSV encephalitis; do not miss treatable cause",
            "target": "Negative"
          },
          {
            "item": "Cryptococcal antigen (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "If immunocompromised or subacute presentation",
            "target": "Negative"
          },
          {
            "item": "AFB smear and culture",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "If TB meningitis suspected (subacute, basilar enhancement, HIV)",
            "target": "Negative"
          },
          {
            "item": "VDRL (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Neurosyphilis screen",
            "target": "Negative"
          },
          {
            "item": "Cytology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "If malignancy in differential",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "ONLY if LP delay indications present (see below). Do NOT delay antibiotics for CT. CT BEFORE LP only if: immunocompromised, history of CNS disease, new seizure, papilledema, altered consciousness (GCS <10), focal neurologic deficit",
            "target": "Mass effect, hydrocephalus, abscess, herniation risk",
            "contraindications": "Pregnancy (relative)"
          },
          {
            "item": "Chest X-ray",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "Within first hours",
            "target": "Pneumonia (S. pneumoniae source), ARDS",
            "contraindications": "None significant"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain with and without contrast",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "Within 24-48h or sooner if complications suspected",
            "target": "Meningeal enhancement, abscess, empyema, cerebritis, venous sinus thrombosis, hydrocephalus",
            "contraindications": "Pacemaker, metallic implants"
          },
          {
            "item": "CT head with contrast",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "If MRI not available",
            "target": "Same as MRI (lower sensitivity)",
            "contraindications": "Contrast allergy, renal impairment"
          },
          {
            "item": "MRV (MR venography)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "timing": "If cerebral venous thrombosis suspected (persistent headache, focal signs, seizures)",
            "target": "Venous sinus thrombosis",
            "contraindications": "Same as MRI"
          },
          {
            "item": "CT temporal bones / skull base",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Recurrent meningitis; suspected CSF leak",
            "target": "Fracture, tegmen dehiscence, cholesteatoma",
            "contraindications": "None significant"
          },
          {
            "item": "Echocardiogram",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "timing": "If S. aureus or endocarditis suspected",
            "target": "Vegetations, embolic risk",
            "contraindications": "None significant"
          },
          {
            "item": "Continuous EEG",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "If altered mental status persists despite treatment; suspected non-convulsive seizures",
            "target": "Seizure activity, status epilepticus",
            "contraindications": "None significant"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CT cisternogram",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Recurrent meningitis with suspected CSF leak",
            "target": "CSF leak localization",
            "contraindications": "Contrast allergy"
          },
          {
            "item": "Beta-2 transferrin (nasal/ear drainage)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Suspected CSF rhinorrhea or otorrhea",
            "target": "Positive = CSF leak",
            "contraindications": "None"
          },
          {
            "item": "Intrathecal fluorescein",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "CSF leak localization (surgical planning)",
            "target": "Fluorescent leakage site",
            "contraindications": "Allergy"
          },
          {
            "item": "ICP monitoring (EVD)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "If signs of elevated ICP, declining consciousness despite treatment",
            "target": "ICP <22 mmHg; CPP >60",
            "contraindications": "Coagulopathy (correct first)"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent — Empiric Therapy": [
          {
            "item": "Dexamethasone (adjunctive — give BEFORE or WITH first antibiotic dose)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.15 mg/kg",
                  "orderSentence": "Dexamethasone (adjunctive — give BEFORE or WITH first antibiotic dose) 0.15 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.15 mg/kg IV q6h x 4 days (typically 10 mg IV q6h). MUST be given BEFORE or simultaneously with first antibiotic dose. Greatest benefit for S. pneumoniae (reduces mortality and hearing loss). Discontinue if organism is NOT S. pneumoniae (some centers continue regardless)",
              "orderSentence": "Dexamethasone (adjunctive — give BEFORE or WITH first antibiotic dose) 0.15 mg/kg IV"
            },
            "contraindications": "Not proven beneficial if antibiotics already started >1h prior",
            "monitoring": "Glucose q6h; GI prophylaxis; BP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Vancomycin IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15-20 mg/kg",
                  "orderSentence": "Vancomycin IV 15-20 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "15-20 mg/kg IV q8-12h (target trough 15-20 µg/mL or AUC/MIC 400-600); loading dose 25-30 mg/kg if severe. Covers penicillin-resistant S. pneumoniae, MRSA",
              "orderSentence": "Vancomycin IV 15-20 mg/kg IV"
            },
            "contraindications": "Red man syndrome (infuse over ≥1h); renal impairment (dose adjust)",
            "monitoring": "Trough levels before 4th dose; renal function daily; watch for nephrotoxicity and ototoxicity",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Ceftriaxone IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g",
                  "orderSentence": "Ceftriaxone IV 2 g IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV q12h. Covers S. pneumoniae (penicillin-sensitive), N. meningitidis, H. influenzae, gram-negative organisms",
              "orderSentence": "Ceftriaxone IV 2 g IV"
            },
            "contraindications": "Cephalosporin allergy (cross-reactivity low with penicillin allergy); neonatal hyperbilirubinemia",
            "monitoring": "CBC; LFTs; biliary sludge with prolonged use",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Ampicillin IV (add if Listeria risk)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g",
                  "orderSentence": "Ampicillin IV (add if Listeria risk) 2 g IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV q4h. ADD to vancomycin + ceftriaxone if: age >50, immunocompromised, alcoholism, pregnancy. Covers Listeria monocytogenes (resistant to cephalosporins)",
              "orderSentence": "Ampicillin IV (add if Listeria risk) 2 g IV"
            },
            "contraindications": "Penicillin anaphylaxis (use TMP-SMX as alternative for Listeria)",
            "monitoring": "Rash; renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Acyclovir IV (empiric — until HSV excluded)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg",
                  "orderSentence": "Acyclovir IV (empiric — until HSV excluded) 10 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV q8h. Add empirically if ANY suspicion of encephalitis (confusion, focal signs, seizures, temporal lobe changes). Discontinue when HSV PCR negative",
              "orderSentence": "Acyclovir IV (empiric — until HSV excluded) 10 mg/kg IV"
            },
            "contraindications": "Renal impairment (dose adjust); ensure adequate hydration",
            "monitoring": "Renal function daily; adequate IV hydration (1 mL/kg/h); crystal nephropathy prevention",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "IV normal saline",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "Isotonic fluid resuscitation for sepsis; maintenance fluids. Avoid hypo/hypernatremia",
              "orderSentence": "IV normal saline - IV - see dosing"
            },
            "contraindications": "Volume overload",
            "monitoring": "I/O; electrolytes q6-12h; watch for SIADH",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Vasopressors: Norepinephrine",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "0.1-0.5 µg/kg/min IV; first-line for septic shock after fluid resuscitation",
              "orderSentence": "Vasopressors: Norepinephrine - IV - see dosing"
            },
            "contraindications": "Only via central line",
            "monitoring": "MAP target ≥65 mmHg; continuous arterial monitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Targeted Therapy by Organism (Once Identified)": [
          {
            "item": "Penicillin G (if penicillin-sensitive S. pneumoniae, MIC <0.06)",
            "route": "IV",
            "indication": "S. pneumoniae (sensitive)",
            "dosing": {
              "instructions": "4 million units IV q4h",
              "orderSentence": "Penicillin G (if penicillin-sensitive S. pneumoniae, MIC <0.06) - IV - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Renal function; CBC",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Ceftriaxone (if intermediate or unknown sensitivity)",
            "route": "IV",
            "indication": "S. pneumoniae (intermediate)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g",
                  "orderSentence": "Ceftriaxone (if intermediate or unknown sensitivity) 2 g IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV q12h; continue vancomycin until sensitivities confirm",
              "orderSentence": "Ceftriaxone (if intermediate or unknown sensitivity) 2 g IV"
            },
            "contraindications": "-",
            "monitoring": "Same as empiric",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Penicillin G or ceftriaxone",
            "route": "IV",
            "indication": "N. meningitidis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2g",
                  "orderSentence": "Penicillin G or ceftriaxone 2g IV"
                }
              ],
              "route": "IV",
              "instructions": "Penicillin G 4 MU IV q4h OR Ceftriaxone 2g IV q12h",
              "orderSentence": "Penicillin G or ceftriaxone 2g IV"
            },
            "contraindications": "-",
            "monitoring": "Renal function",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Ampicillin",
            "route": "IV",
            "indication": "L. monocytogenes",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g",
                  "orderSentence": "Ampicillin 2 g IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV q4h (+ gentamicin 5 mg/kg/day IV for synergy in first 7-10 days, if renal function allows)",
              "orderSentence": "Ampicillin 2 g IV"
            },
            "contraindications": "-",
            "monitoring": "Renal function (especially with gentamicin); gentamicin levels",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Ceftriaxone",
            "route": "IV",
            "indication": "H. influenzae",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g",
                  "orderSentence": "Ceftriaxone 2 g IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV q12h",
              "orderSentence": "Ceftriaxone 2 g IV"
            },
            "contraindications": "-",
            "monitoring": "Standard",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Ceftriaxone",
            "route": "IV",
            "indication": "E. coli / gram-negative",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g",
                  "orderSentence": "Ceftriaxone 2 g IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV q12h; adjust per sensitivities",
              "orderSentence": "Ceftriaxone 2 g IV"
            },
            "contraindications": "-",
            "monitoring": "Standard",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Cefepime",
            "route": "IV",
            "indication": "Pseudomonas (nosocomial, immunocompromised)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g",
                  "orderSentence": "Cefepime 2 g IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV q8h",
              "orderSentence": "Cefepime 2 g IV"
            },
            "contraindications": "-",
            "monitoring": "Renal function; neurotoxicity",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Meropenem",
            "route": "IV",
            "indication": "Extended-spectrum beta-lactamase (ESBL) producers or multi-drug resistant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g",
                  "orderSentence": "Meropenem 2 g IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV q8h",
              "orderSentence": "Meropenem 2 g IV"
            },
            "contraindications": "-",
            "monitoring": "Renal function; seizure threshold",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Levetiracetam",
            "route": "IV",
            "indication": "Seizure management (if seizures occur; NOT routine prophylaxis)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000-1500 mg",
                  "orderSentence": "Levetiracetam 1000-1500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1000-1500 mg IV load; then 500-1000 mg IV/PO BID; max 3000 mg/day",
              "orderSentence": "Levetiracetam 1000-1500 mg IV"
            },
            "contraindications": "Severe renal impairment (dose adjust)",
            "monitoring": "Renal function; mood/behavioral changes",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Lorazepam",
            "route": "IV",
            "indication": "Active seizure (rescue)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg/kg",
                  "orderSentence": "Lorazepam 0.1 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.1 mg/kg IV (max 4 mg); may repeat x1",
              "orderSentence": "Lorazepam 0.1 mg/kg IV"
            },
            "contraindications": "Respiratory depression",
            "monitoring": "RR, SpO2",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Acetaminophen",
            "route": "IV",
            "indication": "Fever reduction, headache",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650-1000 mg",
                  "orderSentence": "Acetaminophen 650-1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "650-1000 mg PO/IV q6h; max 4g/day",
              "orderSentence": "Acetaminophen 650-1000 mg IV"
            },
            "contraindications": "Severe hepatic disease",
            "monitoring": "Temperature; LFTs",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Ibuprofen",
            "route": "PO",
            "indication": "Headache (once stable)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400-600 mg",
                  "orderSentence": "Ibuprofen 400-600 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "400-600 mg PO q6h with food",
              "orderSentence": "Ibuprofen 400-600 mg PO"
            },
            "contraindications": "Renal impairment, GI bleed risk, coagulopathy",
            "monitoring": "Renal function; GI symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Ondansetron",
            "route": "IV",
            "indication": "Nausea/vomiting",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg",
                  "orderSentence": "Ondansetron 4 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "4 mg IV/PO q6h PRN",
              "orderSentence": "Ondansetron 4 mg IV"
            },
            "contraindications": "QT prolongation",
            "monitoring": "QTc",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Mannitol 20%",
            "route": "IV",
            "indication": "Elevated ICP management",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-1.5 g/kg",
                  "orderSentence": "Mannitol 20% 1-1.5 g/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "1-1.5 g/kg IV bolus; then 0.25-0.5 g/kg q4-6h",
              "orderSentence": "Mannitol 20% 1-1.5 g/kg IV"
            },
            "contraindications": "Anuria",
            "monitoring": "Serum osm (<320); osmolar gap; renal function",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Hypertonic saline 23.4%",
            "route": "IV",
            "indication": "Elevated ICP (acute herniation)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mL",
                  "orderSentence": "Hypertonic saline 23.4% 30 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "30 mL IV via central line over 10-20 min",
              "orderSentence": "Hypertonic saline 23.4% 30 mL IV"
            },
            "contraindications": "No central access",
            "monitoring": "Serum Na (target 145-155); osmolality",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Pantoprazole",
            "route": "IV",
            "indication": "GI prophylaxis (steroids + critical illness)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Pantoprazole 40 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "40 mg IV/PO daily",
              "orderSentence": "Pantoprazole 40 mg IV"
            },
            "contraindications": "Prolonged use risks",
            "monitoring": "GI symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Enoxaparin",
            "route": "SC",
            "indication": "DVT prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Enoxaparin 40 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily (start 24-48h after stable)",
              "orderSentence": "Enoxaparin 40 mg SC"
            },
            "contraindications": "Active bleeding, DIC, coagulopathy",
            "monitoring": "Platelets; coags",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          }
        ],
        "Close Contacts Prophylaxis (Public Health)": [
          {
            "dosing": "500 mg PO x 1 dose (adults)",
            "indication": "Close contacts within 7 days (household, kissing, shared utensils, healthcare workers with unprotected airway exposure)"
          },
          {
            "dosing": "600 mg PO q12h x 2 days (adults)",
            "indication": "Alternative; avoid in pregnancy"
          },
          {
            "dosing": "250 mg IM x 1 dose",
            "indication": "Preferred in pregnancy"
          },
          {
            "dosing": "20 mg/kg PO daily x 4 days (max 600 mg)",
            "indication": "Household with child <4 years not fully vaccinated"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Infectious disease consultation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "All bacterial meningitis; antibiotic optimization; complicated cases"
          },
          {
            "item": "Neurology consultation",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Seizures, altered consciousness, focal deficits, ICP management"
          },
          {
            "item": "Neurosurgery consultation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Hydrocephalus (EVD), brain abscess, subdural empyema, ICP management"
          },
          {
            "item": "Critical care/ICU team",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Septic shock, respiratory failure, DIC, ICP management"
          },
          {
            "item": "ENT / Otolaryngology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Recurrent meningitis (CSF leak), concurrent sinusitis/mastoiditis source"
          },
          {
            "item": "Audiology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Hearing assessment before discharge (hearing loss in up to 30% S. pneumoniae)"
          },
          {
            "item": "Public health department",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-",
            "indication": "Meningococcal meningitis — mandatory reporting; contact tracing and prophylaxis"
          },
          {
            "item": "Speech-language pathology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Swallowing assessment if altered consciousness; cognitive assessment"
          },
          {
            "item": "Physical therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Mobilization, deconditioning prevention"
          },
          {
            "item": "Social work",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Family support, discharge planning"
          },
          {
            "item": "Palliative care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "indication": "Severe cases with poor prognosis; goals of care"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return to ED if: worsening headache, fever recurrence, new confusion, seizure, neck stiffness, rash, vision changes",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Complete full antibiotic course (do NOT stop early even if feeling better)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Hearing test recommended 2-4 weeks after discharge",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Vaccination: pneumococcal and meningococcal vaccines after recovery if not previously immunized",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Close contacts should receive prophylactic antibiotics if N. meningitidis (public health will coordinate)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Follow-up with infectious disease and neurology in 2-4 weeks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report any new neurologic symptoms (hearing loss, balance problems, cognitive changes)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid alcohol during antibiotic therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Pneumococcal vaccination (PCV20 or PCV15 + PPSV23) if not previously completed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Meningococcal vaccination (MenACWY + MenB) for at-risk groups",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation (upper respiratory tract colonization risk)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Alcohol moderation/cessation (immunocompromise, Listeria risk)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Splenectomy patients: ensure vaccinated (encapsulated organism risk)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Complement-deficient patients: meningococcal vaccination and booster schedule",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Hand hygiene and respiratory etiquette education",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Skull base fracture/CSF leak patients: surgical repair to prevent recurrence",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Viral meningitis",
        "features": "Less toxic; CSF: lymphocytic pleocytosis, normal glucose, mildly elevated protein; self-limited",
        "tests": "CSF cell count (lymphocytes), normal glucose, BioFire ME panel (enterovirus most common), procalcitonin low"
      },
      {
        "diagnosis": "HSV encephalitis",
        "features": "Encephalitis (confusion, personality change, seizures, focal signs); temporal lobe involvement",
        "tests": "MRI (temporal T2/FLAIR), CSF HSV PCR, EEG (PLEDs)"
      },
      {
        "diagnosis": "Tuberculous meningitis",
        "features": "Subacute (weeks), basilar meningitis, cranial neuropathies, HIV risk; CSF: lymphocytic, low glucose, very high protein",
        "tests": "AFB smear/culture, TB PCR (GeneXpert), adenosine deaminase (ADA), chest X-ray (miliary pattern), PPD/IGRA"
      },
      {
        "diagnosis": "Fungal meningitis (Cryptococcus)",
        "features": "Subacute/chronic; immunocompromised (HIV CD4 <100); headache predominant; minimal CSF pleocytosis",
        "tests": "CSF cryptococcal antigen (CrAg), India ink, fungal culture"
      },
      {
        "diagnosis": "Subarachnoid hemorrhage",
        "features": "Thunderclap headache; meningismus; NOT febrile initially; xanthochromia",
        "tests": "CT head (blood), CSF RBC (tube 1 = tube 4), xanthochromia"
      },
      {
        "diagnosis": "Brain abscess",
        "features": "Focal deficits; fever + headache + focal signs (triad); subacute; seizures",
        "tests": "MRI with contrast (ring-enhancing lesion with restricted diffusion), CT with contrast"
      },
      {
        "diagnosis": "Subdural empyema",
        "features": "Post-sinusitis/otitis; rapid deterioration; focal deficits; seizures",
        "tests": "MRI/CT with contrast (extra-axial collection)"
      },
      {
        "diagnosis": "Autoimmune encephalitis",
        "features": "Subacute onset; psychiatric symptoms; seizures; young women; no fever initially",
        "tests": "Autoimmune antibody panel (serum + CSF); MRI; EEG"
      },
      {
        "diagnosis": "Drug-induced aseptic meningitis",
        "features": "NSAID, IVIG, TMP-SMX, isoniazid exposure; self-limited after drug withdrawal",
        "tests": "Drug history; CSF lymphocytic pleocytosis; sterile cultures; resolves with drug removal"
      },
      {
        "diagnosis": "Carcinomatous/leptomeningeal meningitis",
        "features": "Subacute; cranial neuropathies; known malignancy; CSF: low glucose, elevated protein, positive cytology",
        "tests": "CSF cytology (repeat x3 for sensitivity); MRI with contrast (leptomeningeal enhancement)"
      },
      {
        "diagnosis": "Neurosarcoidosis",
        "features": "Chronic headache; cranial neuropathies (CN VII); hilar adenopathy; ACE level",
        "tests": "Chest CT; serum ACE; CSF ACE; biopsy"
      }
    ],
    "evidence": [
      {
        "recommendation": "Empiric vancomycin + ceftriaxone +/- ampicillin",
        "evidenceLevel": "Class I, Level A",
        "source": "IDSA Guidelines ([Tunkel et al. CID 2004](https://pubmed.ncbi.nlm.nih.gov/15494903/); [van de Beek et al. NEJM 2006](https://pubmed.ncbi.nlm.nih.gov/16394301/))"
      },
      {
        "recommendation": "Dexamethasone before or with first antibiotic dose",
        "evidenceLevel": "Class I, Level A",
        "source": "[de Gans & van de Beek (NEJM 2002)](https://pubmed.ncbi.nlm.nih.gov/12432041/) — reduces mortality and hearing loss in S. pneumoniae"
      },
      {
        "recommendation": "Do NOT delay antibiotics for imaging",
        "evidenceLevel": "Class I, Level A",
        "source": "IDSA Guidelines; multiple observational studies showing increased mortality with delay"
      },
      {
        "recommendation": "CT before LP only for specific indications",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hasbun et al. (NEJM 2001)](https://pubmed.ncbi.nlm.nih.gov/11742046/) — criteria for when to CT before LP"
      },
      {
        "recommendation": "Blood cultures before antibiotics (if obtainable without delay)",
        "evidenceLevel": "Class I, Level B",
        "source": "IDSA Guidelines"
      },
      {
        "recommendation": "BioFire ME Panel for rapid diagnosis",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[Leber et al. (JCM 2016)](https://pubmed.ncbi.nlm.nih.gov/27335149/); FDA-cleared multiplex PCR"
      },
      {
        "recommendation": "CSF lactate >3.5 mmol/L for bacterial vs viral",
        "evidenceLevel": "Class IIa, Level B",
        "source": "Meta-analysis: [Sakushima et al. (J Infect 2011)](https://pubmed.ncbi.nlm.nih.gov/21382412/)"
      },
      {
        "recommendation": "Targeted antibiotic therapy by organism",
        "evidenceLevel": "Class I, Level A",
        "source": "IDSA Guidelines; organism-specific duration data"
      },
      {
        "recommendation": "Close contact prophylaxis for meningococcal",
        "evidenceLevel": "Class I, Level A",
        "source": "CDC MMWR recommendations"
      },
      {
        "recommendation": "Hearing assessment post-meningitis",
        "evidenceLevel": "Class I, Level B",
        "source": "High incidence of hearing loss (up to 30% S. pneumoniae)"
      },
      {
        "recommendation": "Seizure treatment (not routine prophylaxis)",
        "evidenceLevel": "Class IIb, Level C",
        "source": "Expert consensus; no clear data supporting prophylaxis"
      },
      {
        "recommendation": "Procalcitonin to differentiate bacterial from viral",
        "evidenceLevel": "Class IIa, Level B",
        "source": "Meta-analyses showing high sensitivity/specificity"
      },
      {
        "recommendation": "Repeat LP at 48h if no clinical improvement",
        "evidenceLevel": "Class IIa, Level C",
        "source": "IDSA Guidelines"
      }
    ],
    "monitoring": [
      {
        "item": "Neurologic exam (GCS, pupils, motor, meningismus)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q1h x 24h then q2-4h; more frequent if declining",
        "action": "If GCS declining: STAT CT, ICP assessment, consider EVD"
      },
      {
        "item": "Temperature",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q4h (q1h if febrile)",
        "action": "If persistent fever >72h: repeat cultures, imaging for abscess/empyema, drug fever, new infection"
      },
      {
        "item": "Blood pressure",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q1h if sepsis; q4h if stable",
        "action": "Fluid resuscitation; vasopressors"
      },
      {
        "item": "Heart rate",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q1-4h",
        "action": "Sepsis management"
      },
      {
        "item": "Serum sodium",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q6-8h x 48h, then q12h",
        "action": "If <130: SIADH likely → fluid restriction (1-1.2 L/day); if <120: 3% saline"
      },
      {
        "item": "Serum creatinine",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "ROUTINE",
        "frequency": "Daily",
        "action": "Adjust antibiotics if rising; vancomycin nephrotoxicity"
      },
      {
        "item": "Vancomycin trough or AUC",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "ROUTINE",
        "frequency": "Before 4th dose; then q24-48h until stable",
        "action": "Adjust dosing; pharmacy consult"
      },
      {
        "item": "CBC",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "ROUTINE",
        "frequency": "Daily x 3, then q48h",
        "action": "If platelets dropping: DIC panel; if WBC not improving: reassess antibiotics"
      },
      {
        "item": "Coagulation panel (DIC monitoring)",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q6-12h if meningococcemia/DIC; daily otherwise",
        "action": "FFP for INR >1.5; cryoprecipitate for fibrinogen <100; platelet transfusion if <50K with bleeding"
      },
      {
        "item": "CRP / procalcitonin",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE",
        "frequency": "q48-72h during treatment",
        "action": "If not declining by day 3-5: reassess; repeat LP; imaging"
      },
      {
        "item": "Seizure monitoring",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "Clinical observation; cEEG if altered consciousness",
        "action": "Levetiracetam load; if refractory → status epilepticus protocol"
      },
      {
        "item": "Hearing assessment",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Before discharge; repeat at 2-4 weeks",
        "action": "Audiology referral; hearing aid evaluation if deficit"
      },
      {
        "item": "ICP (if EVD in place)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "Continuous",
        "action": "Tiered ICP management: CSF drainage, osmotherapy, sedation"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Never discharge directly from ED with suspected bacterial meningitis. Discharge from hospital when: afebrile ≥48h, improving neurologic exam, able to take oral medications (IV-to-PO switch criteria met for some organisms), adequate outpatient IV access if completing IV course, reliable follow-up"
      },
      {
        "disposition": "Admit to floor (monitored)",
        "criteria": "Hemodynamically stable; GCS ≥13; no respiratory compromise; no DIC; no seizures"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Septic shock; GCS <13 or declining; respiratory failure; DIC; refractory seizures; signs of elevated ICP; meningococcemia with purpura fulminans; need for vasopressors"
      },
      {
        "disposition": "Transfer to higher level",
        "criteria": "Need for neurosurgery (abscess, empyema, EVD); need for neuro-ICU expertise not available"
      }
    ]
  },
  "HSV Encephalitis": {
    "id": "hsv-encephalitis",
    "title": "HSV Encephalitis",
    "version": "1.0",
    "icd10": [
      "** B00.4 (Herpesviral encephalitis)",
      "G05.1 (Encephalitis in diseases classified elsewhere)"
    ],
    "scope": "** Acute HSV-1 encephalitis in adults — the most common cause of sporadic fatal encephalitis. Covers emergent empiric acyclovir, LP with HSV PCR, MRI findings, seizure management, and monitoring for complications (cerebral edema, SIADH, refractory status epilepticus). Excludes neonatal HSV, HSV-2 meningitis (Mollaret), CMV/EBV/VZV encephalitis, and autoimmune encephalitis (though post-HSV autoimmune encephalitis is addressed).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Baseline; infection markers; lymphopenia may be present",
            "target": "Normal or mild leukocytosis"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Renal function for acyclovir dosing (nephrotoxic); electrolytes (SIADH); hepatic function",
            "target": "Normal; watch Na and Cr"
          },
          {
            "item": "Blood cultures x2",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Exclude bacterial meningitis; concurrent bacteremia",
            "target": "No growth"
          },
          {
            "item": "Coagulation panel (PT/INR, aPTT)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Before LP; coagulopathy workup if DIC suspected",
            "target": "Normal"
          },
          {
            "item": "Blood glucose (paired with CSF)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "CSF:serum glucose ratio interpretation",
            "target": "Document paired with LP"
          },
          {
            "item": "Procalcitonin",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Low procalcitonin argues against bacterial meningitis",
            "target": "Low (<0.5 ng/mL favors viral)"
          },
          {
            "item": "CRP",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Inflammatory marker; lower in viral than bacterial",
            "target": "Mild elevation"
          },
          {
            "item": "Serum sodium",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "SIADH is common complication of HSV encephalitis",
            "target": "135-145 mEq/L; watch for hyponatremia"
          },
          {
            "item": "Serum osmolality",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "SIADH evaluation",
            "target": "280-295 mOsm/kg"
          },
          {
            "item": "Type and screen",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Potential surgical intervention for mass effect",
            "target": "On file"
          }
        ],
        "Extended Workup": [
          {
            "item": "HSV-1/2 IgG and IgM (serum)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Seroconversion supports diagnosis; IgG positive in most adults (not diagnostic alone); IgM suggests acute infection",
            "target": "Rising titers on paired sera (acute + convalescent at 2-4 weeks)"
          },
          {
            "item": "HIV 1/2 antigen/antibody",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Immunocompromise affects prognosis and treatment duration",
            "target": "Document result"
          },
          {
            "item": "Urine osmolality and sodium",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "SIADH confirmation (urine osm >100, urine Na >40 with low serum Na)",
            "target": "Evaluate if hyponatremic"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Thyroid dysfunction in encephalopathy differential",
            "target": "Normal"
          },
          {
            "item": "Ammonia",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Hepatic encephalopathy in differential",
            "target": "Normal"
          },
          {
            "item": "Troponin",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Stress cardiomyopathy; myocarditis in systemic viral illness",
            "target": "Normal"
          },
          {
            "item": "Toxicology screen (urine)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Altered mental status differential",
            "target": "Negative"
          },
          {
            "item": "Blood alcohol level",
            "ED": "URGENT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Altered mental status differential",
            "target": "Negative"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Autoimmune encephalitis panel (serum) — NMDAR, LGI1, CASPR2",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "rationale": "Post-HSV autoimmune encephalitis occurs in 20-27% (especially anti-NMDAR); also primary differential",
            "target": "Negative initially; recheck at 2-4 weeks if relapse"
          },
          {
            "item": "Paraneoplastic panel (serum)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If atypical features or oncologic history",
            "target": "Negative"
          },
          {
            "item": "VZV IgG/IgM (serum)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "VZV encephalitis in differential (especially immunocompromised)",
            "target": "Negative"
          },
          {
            "item": "Arboviral serologies (West Nile, EEE, St. Louis)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Geographic/seasonal risk; summer-fall encephalitis",
            "target": "Negative"
          },
          {
            "item": "Rabies antibodies",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Animal exposure history with rapidly progressive encephalitis",
            "target": "Negative"
          },
          {
            "item": "Bartonella serology",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Cat exposure; neuroretinitis",
            "target": "Negative"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Elevated in some cases; monitor for ICP issues",
            "target": "Normal or mildly elevated (usually <300 mm H2O)"
          },
          {
            "item": "Cell count with differential (tubes 1 and 4)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Lymphocytic pleocytosis typical; RBCs may be present (hemorrhagic encephalitis); tube comparison for traumatic tap",
            "target": "WBC 10-500 cells/µL (lymphocyte predominant); RBC may be elevated (hemorrhagic necrosis)"
          },
          {
            "item": "Protein",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Mildly to moderately elevated",
            "target": "Elevated (50-200 mg/dL typical; can be higher)"
          },
          {
            "item": "Glucose with paired serum",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Usually NORMAL in HSV (distinguishes from bacterial/TB/fungal)",
            "target": "Normal (>60% serum glucose ratio); low glucose argues against HSV"
          },
          {
            "item": "HSV-1/2 PCR (CSF)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "GOLD STANDARD diagnostic test; sensitivity 96-98%, specificity ~99%. May be NEGATIVE in first 72h — if clinical suspicion high and initial PCR negative, REPEAT at 3-7 days",
            "target": "Positive (HSV-1 in >90% adult cases; HSV-2 in neonatal/meningitis)"
          },
          {
            "item": "Gram stain and bacterial culture",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Exclude bacterial meningitis",
            "target": "No organisms"
          },
          {
            "item": "BioFire FilmArray ME Panel",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Rapid multiplex PCR — includes HSV-1/2, VZV, enterovirus, CMV, HHV-6, and bacterial pathogens; result in ~1 hour",
            "target": "HSV-1 detected (or other pathogen identified)"
          },
          {
            "item": "VZV PCR (CSF)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "VZV encephalitis in differential; especially immunocompromised and elderly",
            "target": "Negative (positive → VZV encephalitis — treat with IV acyclovir)"
          },
          {
            "item": "CMV PCR (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "If immunocompromised (HIV/transplant)",
            "target": "Negative"
          },
          {
            "item": "EBV PCR (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "If immunocompromised; CNS lymphoma differential",
            "target": "Negative"
          },
          {
            "item": "HHV-6 PCR (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Post-transplant encephalitis; temporal lobe involvement similar to HSV",
            "target": "Negative"
          },
          {
            "item": "Enterovirus PCR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Viral meningitis differential",
            "target": "Negative"
          },
          {
            "item": "Autoimmune encephalitis panel (CSF) — NMDAR, LGI1, CASPR2, GABA-B",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Primary differential diagnosis; also detect post-HSV autoimmune encephalitis",
            "target": "Negative initially; recheck if relapse"
          },
          {
            "item": "Oligoclonal bands, IgG index",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Intrathecal antibody production; MS differential",
            "target": "May be positive (non-specific)"
          },
          {
            "item": "Cytology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Exclude leptomeningeal malignancy",
            "target": "Negative"
          },
          {
            "item": "AFB smear and culture",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "TB meningitis if subacute or basilar",
            "target": "Negative"
          },
          {
            "item": "VDRL (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Neurosyphilis screen",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Immediate — before LP to exclude mass effect; CT may be NORMAL early in HSV encephalitis",
            "target": "Temporal lobe hypodensity, edema, hemorrhage (late); may be normal in first 48-72h",
            "contraindications": "Pregnancy (relative)"
          },
          {
            "item": "MRI brain with and without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Within 24h; STAT if available. MOST SENSITIVE imaging study — abnormal in >90% within 48h",
            "target": "T2/FLAIR hyperintensity in medial temporal lobes (unilateral or bilateral), insular cortex, inferior frontal gyri, cingulate gyrus. DWI restriction in acute phase. Hemorrhagic transformation. Leptomeningeal enhancement",
            "contraindications": "Pacemaker, metallic implants"
          },
          {
            "item": "EEG (routine or continuous)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Within 24h; continuous EEG if altered consciousness",
            "target": "Periodic lateralizing epileptiform discharges (PLEDs/LPDs) from temporal region — highly suggestive of HSV encephalitis; focal slowing; electrographic seizures; diffuse slowing",
            "contraindications": "None significant"
          },
          {
            "item": "ECG (12-lead)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "On admission",
            "target": "Baseline; myocarditis screen; QTc for medication interactions",
            "contraindications": "None"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain with MRA/MRV",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "timing": "If vascular complication suspected",
            "target": "Venous sinus thrombosis; vasculopathy; large vessel occlusion",
            "contraindications": "Same as MRI"
          },
          {
            "item": "Repeat MRI brain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "timing": "At 48-72h if initial MRI negative but suspicion high; at 7-14 days to assess extent of damage",
            "target": "Evolving temporal changes; hemorrhagic transformation; extent of necrosis",
            "contraindications": "Same as MRI"
          },
          {
            "item": "Continuous EEG (cEEG) monitoring",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "24-72h minimum if altered consciousness, seizures, or post-ictal state",
            "target": "Non-convulsive seizures, non-convulsive status epilepticus (NCSE), PLEDs",
            "contraindications": "None"
          },
          {
            "item": "Chest X-ray",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "On admission",
            "target": "Aspiration; baseline for ventilator management",
            "contraindications": "None"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Brain biopsy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT",
            "timing": "Only if: PCR negative, MRI atypical, no response to acyclovir, alternative diagnosis likely",
            "target": "Cowdry type A inclusions; viral culture; PCR on tissue",
            "contraindications": "Neurosurgical risk; coagulopathy"
          },
          {
            "item": "PET-CT brain",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If autoimmune encephalitis relapse suspected post-HSV",
            "target": "Mesial temporal hypermetabolism (seizure focus) or hypometabolism",
            "contraindications": "Pregnancy"
          },
          {
            "item": "ICP monitoring (EVD)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "If clinical signs of elevated ICP; declining GCS despite treatment",
            "target": "ICP <22 mmHg; CPP >60",
            "contraindications": "Coagulopathy"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Acyclovir IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg",
                  "orderSentence": "Acyclovir IV 10 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV q8h (infuse over 1h). Base on IDEAL body weight (IBW). Duration: minimum 14-21 days. Dose adjust for renal impairment: CrCl 25-50: 10 mg/kg q12h; CrCl 10-25: 10 mg/kg q24h; HD: 10 mg/kg after each dialysis session",
              "orderSentence": "Acyclovir IV 10 mg/kg IV"
            },
            "contraindications": "True acyclovir allergy (extremely rare). Renal impairment — dose adjust, do NOT withhold",
            "monitoring": "Renal function (BUN, Cr) daily; ensure adequate hydration (1-1.5 mL/kg/h IV fluids); urine output; acyclovir crystal nephropathy (maintain urine output); CBC (rare neutropenia); LFTs",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "IV normal saline (aggressive hydration)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-1.5 mL/kg",
                  "orderSentence": "IV normal saline (aggressive hydration) 1-1.5 mL/kg -"
                }
              ],
              "route": "-",
              "instructions": "1-1.5 mL/kg/h continuous to prevent acyclovir nephrotoxicity; bolus 500-1000 mL if dehydrated",
              "orderSentence": "IV normal saline (aggressive hydration) 1-1.5 mL/kg -"
            },
            "contraindications": "Volume overload, CHF",
            "monitoring": "I/O; Cr daily; urine output >0.5 mL/kg/h",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Empiric antibiotics (vancomycin + ceftriaxone)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Standard meningitis dosing. Continue until bacterial meningitis excluded by CSF results (Gram stain negative, BioFire negative, cultures negative at 48-72h). See Bacterial Meningitis template for dosing",
              "orderSentence": "Empiric antibiotics (vancomycin + ceftriaxone) - - - see dosing"
            },
            "contraindications": "See Bacterial Meningitis template",
            "monitoring": "Standard",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Dexamethasone",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.15 mg/kg",
                  "orderSentence": "Dexamethasone 0.15 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.15 mg/kg IV q6h x 4 days — give empirically with antibiotics until bacterial meningitis excluded. Discontinue when bacterial excluded. Role in HSV encephalitis itself is CONTROVERSIAL — some evidence for reducing edema but no clear mortality benefit; not standard of care for isolated HSV",
              "orderSentence": "Dexamethasone 0.15 mg/kg IV"
            },
            "contraindications": "Uncontrolled infection (relative)",
            "monitoring": "Glucose; GI prophylaxis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Levetiracetam (if seizures)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000-1500 mg",
                  "orderSentence": "Levetiracetam (if seizures) 1000-1500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1000-1500 mg IV load; then 500-1000 mg IV/PO BID; max 3000 mg/day. Seizures occur in 40-60% of HSV encephalitis",
              "orderSentence": "Levetiracetam (if seizures) 1000-1500 mg IV"
            },
            "contraindications": "Severe renal impairment (dose adjust)",
            "monitoring": "Renal function; behavioral side effects",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Lorazepam (seizure rescue)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg/kg",
                  "orderSentence": "Lorazepam (seizure rescue) 0.1 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.1 mg/kg IV (max 4 mg); repeat x1 in 5 min if needed",
              "orderSentence": "Lorazepam (seizure rescue) 0.1 mg/kg IV"
            },
            "contraindications": "Respiratory depression",
            "monitoring": "RR, SpO2; airway equipment ready",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Supplemental oxygen",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "94%",
                  "orderSentence": "Supplemental oxygen 94% -"
                }
              ],
              "route": "-",
              "instructions": "If SpO2 <94% or intubated",
              "orderSentence": "Supplemental oxygen 94% -"
            },
            "contraindications": "N/A",
            "monitoring": "SpO2 target ≥94%",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Acetaminophen",
            "route": "IV",
            "indication": "Fever (temperature goal <38°C); headache",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650-1000 mg",
                  "orderSentence": "Acetaminophen 650-1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "650-1000 mg PO/IV q6h; max 4g/day",
              "orderSentence": "Acetaminophen 650-1000 mg IV"
            },
            "contraindications": "Severe hepatic disease",
            "monitoring": "Temperature; LFTs",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Mannitol 20%",
            "route": "IV",
            "indication": "Cerebral edema / elevated ICP",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-1.5 g/kg",
                  "orderSentence": "Mannitol 20% 1-1.5 g/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "1-1.5 g/kg IV bolus; then 0.25-0.5 g/kg q4-6h",
              "orderSentence": "Mannitol 20% 1-1.5 g/kg IV"
            },
            "contraindications": "Anuria",
            "monitoring": "Serum osm <320; renal function; I/O",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Hypertonic saline 23.4%",
            "route": "IV",
            "indication": "Acute herniation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mL",
                  "orderSentence": "Hypertonic saline 23.4% 30 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "30 mL IV via central line over 10-20 min",
              "orderSentence": "Hypertonic saline 23.4% 30 mL IV"
            },
            "contraindications": "No central access",
            "monitoring": "Na (target 145-155); osmolality",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Hypertonic saline 3% infusion",
            "route": "-",
            "indication": "ICP management (less acute)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5-1 mL/kg",
                  "orderSentence": "Hypertonic saline 3% infusion 0.5-1 mL/kg -"
                }
              ],
              "route": "-",
              "instructions": "0.5-1 mL/kg/h continuous; target Na 145-155",
              "orderSentence": "Hypertonic saline 3% infusion 0.5-1 mL/kg -"
            },
            "contraindications": "Hypernatremia",
            "monitoring": "Na q4-6h; osmolality",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Phenytoin/Fosphenytoin",
            "route": "IV",
            "indication": "Refractory seizures (second-line after levetiracetam)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "Phenytoin/Fosphenytoin 20 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Fosphenytoin 20 mg PE/kg IV at 150 mg PE/min; maintenance 100 mg PE q8h; target level 10-20 µg/mL",
              "orderSentence": "Phenytoin/Fosphenytoin 20 mg IV"
            },
            "contraindications": "Bradycardia, heart block, hypotension (infusion rate-related)",
            "monitoring": "Continuous telemetry during load; free phenytoin level; LFTs",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Lacosamide",
            "route": "IV",
            "indication": "Seizure management (adjunctive)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mg",
                  "orderSentence": "Lacosamide 200 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "200 mg IV/PO load; then 100-200 mg BID; max 400 mg/day",
              "orderSentence": "Lacosamide 200 mg IV"
            },
            "contraindications": "PR prolongation, AV block",
            "monitoring": "ECG; PR interval",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Ondansetron",
            "route": "IV",
            "indication": "Nausea/vomiting",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg",
                  "orderSentence": "Ondansetron 4 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "4 mg IV/PO q6h PRN",
              "orderSentence": "Ondansetron 4 mg IV"
            },
            "contraindications": "QT prolongation",
            "monitoring": "QTc",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Pantoprazole",
            "route": "IV",
            "indication": "GI prophylaxis (if steroids or critical illness)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Pantoprazole 40 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "40 mg IV/PO daily",
              "orderSentence": "Pantoprazole 40 mg IV"
            },
            "contraindications": "C. diff risk long-term",
            "monitoring": "GI symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Enoxaparin",
            "route": "SC",
            "indication": "DVT prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Enoxaparin 40 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily (start when not actively seizing and no hemorrhagic transformation)",
              "orderSentence": "Enoxaparin 40 mg SC"
            },
            "contraindications": "Active bleeding, hemorrhagic transformation, coagulopathy, platelets <50K",
            "monitoring": "Platelets q3 days",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pneumatic compression devices",
            "route": "-",
            "indication": "DVT prophylaxis",
            "dosing": {
              "instructions": "Apply bilaterally on admission",
              "orderSentence": "Pneumatic compression devices - - - see dosing"
            },
            "contraindications": "Acute DVT",
            "monitoring": "Skin checks",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Fluid restriction",
            "route": "-",
            "indication": "SIADH management",
            "dosing": {
              "instructions": "1-1.2 L/day if Na <130 with clinical SIADH",
              "orderSentence": "Fluid restriction - - - see dosing"
            },
            "contraindications": "Dehydration (balance with acyclovir hydration needs)",
            "monitoring": "Na q6-8h; urine osm/Na; I/O",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Foscarnet IV (acyclovir-resistant HSV)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg/kg",
                  "orderSentence": "Foscarnet IV (acyclovir-resistant HSV) 60 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "60 mg/kg IV q8h or 90 mg/kg IV q12h; infuse over 1-2h with aggressive hydration. For proven or suspected acyclovir resistance (immunocompromised, HIV)",
              "orderSentence": "Foscarnet IV (acyclovir-resistant HSV) 60 mg/kg IV"
            },
            "contraindications": "Renal failure (major nephrotoxin); electrolyte abnormalities",
            "monitoring": "Cr daily; Ca, Mg, K, PO4 BID (causes severe electrolyte wasting); hydration 1-2 L NS before each dose",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT"
          },
          {
            "item": "Decompressive craniectomy",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "For malignant cerebral edema with impending herniation, unresponsive to medical ICP management; consider if age appropriate and prognosis not already dismal",
              "orderSentence": "Decompressive craniectomy - - - see dosing"
            },
            "contraindications": "Bilateral massive necrosis; moribund patient",
            "monitoring": "Post-op neuro checks; ICP monitoring; wound care",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Immunotherapy for post-HSV autoimmune encephalitis",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1g/day",
                  "orderSentence": "Immunotherapy for post-HSV autoimmune encephalitis 1g/day IV"
                }
              ],
              "route": "IV",
              "instructions": "If relapse at 2-6 weeks with new anti-NMDAR antibodies: IV methylprednisolone 1g/day x 5 days + IVIG 0.4 g/kg/day x 5 days; second-line: rituximab",
              "orderSentence": "Immunotherapy for post-HSV autoimmune encephalitis 1g/day IV"
            },
            "contraindications": "Active HSV infection (ensure viral replication controlled)",
            "monitoring": "NMDAR antibody titers; clinical response; viral PCR to confirm HSV not reactivated",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consultation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "All suspected encephalitis; seizure management; EEG interpretation; post-HSV autoimmune evaluation"
          },
          {
            "item": "Infectious disease consultation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Antimicrobial management; acyclovir-resistant HSV; duration of therapy"
          },
          {
            "item": "Neurosurgery consultation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Cerebral edema with mass effect; ICP monitoring (EVD placement); decompressive craniectomy"
          },
          {
            "item": "Critical care/ICU",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Altered consciousness (GCS <12); respiratory failure; ICP management; status epilepticus"
          },
          {
            "item": "Speech-language pathology (SLP)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Dysphagia evaluation; aphasia assessment (temporal lobe involvement); cognitive-communication evaluation"
          },
          {
            "item": "Physical therapy (PT)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Early mobilization; prevent deconditioning; gait/balance training"
          },
          {
            "item": "Occupational therapy (OT)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "ADL assessment; cognitive rehabilitation; memory aids"
          },
          {
            "item": "Neuropsychology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Cognitive assessment (memory deficits common with temporal lobe damage); rehabilitation planning"
          },
          {
            "item": "Psychiatry",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Behavioral changes; depression; anxiety; personality changes (frontal/temporal damage)"
          },
          {
            "item": "Rehabilitation medicine (physiatry)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Rehabilitation planning; disposition (inpatient rehab, SNF)"
          },
          {
            "item": "Social work",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Family support; discharge planning; long-term care needs"
          },
          {
            "item": "Epilepsy specialist",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Post-encephalitis epilepsy management; temporal lobe epilepsy"
          },
          {
            "item": "Palliative care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "indication": "Goals of care for severe cases; prognostication"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return to ED if: new confusion, seizure, fever recurrence, worsening headache, personality change, speech difficulty, new weakness",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "HSV encephalitis can cause long-term memory and cognitive deficits; rehabilitation is important",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Seizures may develop weeks to months after infection; report any episodic symptoms (staring, jerking, déjà vu, loss of awareness)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Post-HSV autoimmune encephalitis can occur 2-6 weeks later with new psychiatric/neurologic symptoms — report immediately",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take all medications as prescribed; do NOT stop antiepileptic drugs without neurologist guidance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Follow-up with neurology in 2-4 weeks; neuropsychology testing at 3-6 months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cognitive rehabilitation and therapy are critical for recovery",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Driving restrictions until seizure-free per state law (typically 3-12 months)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "HSV encephalitis is NOT contagious in the traditional sense; no isolation needed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Long-term suppressive antiviral therapy is NOT standard after encephalitis (unlike genital HSV)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cognitive rehabilitation: memory strategies, organizational tools, speech therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Seizure safety: avoid heights, swimming alone, operating heavy machinery until seizure-free",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Mental health support (depression, anxiety, PTSD common after encephalitis)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate sleep and stress management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Gradual return to work/school with accommodations as needed",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Autoimmune encephalitis (anti-NMDAR)",
        "features": "Subacute; psychiatric symptoms (psychosis, agitation); orofacial dyskinesias; seizures; young women; often post-HSV",
        "tests": "Anti-NMDAR antibody (CSF > serum); MRI may be normal or temporal; ovarian teratoma screen"
      },
      {
        "diagnosis": "Bacterial meningitis",
        "features": "Fever + meningismus; CSF neutrophilic pleocytosis with low glucose; more acute; no temporal preference on imaging",
        "tests": "CSF Gram stain, culture, BioFire; procalcitonin elevated; CSF glucose low"
      },
      {
        "diagnosis": "Viral meningitis (enterovirus)",
        "features": "Headache + fever + meningismus; LESS confusion/focal deficits; CSF lymphocytic but fewer WBC; MRI normal",
        "tests": "Enterovirus PCR (CSF); BioFire panel; normal MRI"
      },
      {
        "diagnosis": "VZV encephalitis",
        "features": "Immunocompromised; may have rash (but not always); vasculopathy pattern on MRI; cranial neuropathies",
        "tests": "VZV PCR (CSF); VZV IgG intrathecal antibody"
      },
      {
        "diagnosis": "Temporal lobe seizures / Status epilepticus",
        "features": "Seizures may cause MRI signal change in temporal lobes mimicking encephalitis; fever if convulsive SE",
        "tests": "EEG; HSV PCR negative; MRI DWI pattern; clinical course"
      },
      {
        "diagnosis": "Limbic encephalitis (paraneoplastic: LGI1, GABA-B)",
        "features": "Subacute memory loss, seizures, psychiatric changes; often >40 years; associated malignancy",
        "tests": "Antibody panel (serum + CSF); CT chest/abdomen/pelvis; PET-CT"
      },
      {
        "diagnosis": "Cerebral venous thrombosis",
        "features": "Headache, seizures, focal deficits; papilledema; risk factors (OCPs, hypercoagulable)",
        "tests": "MRV; CT venogram; D-dimer"
      },
      {
        "diagnosis": "Brain abscess",
        "features": "Focal symptoms + fever; ring-enhancing lesion; subacute",
        "tests": "MRI with contrast (ring enhancement, restricted DWI centrally); blood cultures"
      },
      {
        "diagnosis": "Acute disseminated encephalomyelitis (ADEM)",
        "features": "Post-infectious; multifocal white matter lesions; children > adults",
        "tests": "MRI (multifocal white matter); clinical context"
      },
      {
        "diagnosis": "Tuberculosis meningitis",
        "features": "Subacute (weeks); basilar meningitis; CSF low glucose, lymphocytic, very high protein",
        "tests": "AFB culture; TB PCR; ADA; chest imaging"
      },
      {
        "diagnosis": "Neurosyphilis",
        "features": "Subacute; psychiatric symptoms; pupillary abnormalities; history of STI",
        "tests": "CSF VDRL; FTA-ABS; RPR"
      },
      {
        "diagnosis": "Primary CNS lymphoma",
        "features": "Immunocompromised; progressive focal deficits; periventricular enhancing lesion",
        "tests": "MRI with contrast; CSF cytology; EBV PCR (CSF); brain biopsy"
      }
    ],
    "evidence": [
      {
        "recommendation": "IV acyclovir 10 mg/kg q8h x 14-21 days",
        "evidenceLevel": "Class I, Level A",
        "source": "[Whitley et al. (NEJM 1986)](https://pubmed.ncbi.nlm.nih.gov/3001520/) — acyclovir vs placebo landmark trial; reduced mortality from 70% to 20%"
      },
      {
        "recommendation": "Start acyclovir empirically; do NOT delay for diagnostics",
        "evidenceLevel": "Class I, Level A",
        "source": "IDSA Encephalitis Guidelines ([Tunkel et al. CID 2008](https://pubmed.ncbi.nlm.nih.gov/18582201/)); every hour of delay worsens outcomes"
      },
      {
        "recommendation": "CSF HSV PCR as gold standard (sensitivity 96-98%)",
        "evidenceLevel": "Class I, Level A",
        "source": "[Lakeman & Whitley (JID 1995)](https://pubmed.ncbi.nlm.nih.gov/7706811/)"
      },
      {
        "recommendation": "Repeat HSV PCR if initially negative with high clinical suspicion",
        "evidenceLevel": "Class I, Level B",
        "source": "False negative rate ~5% in first 72h; Roullet (2007)"
      },
      {
        "recommendation": "MRI with DWI is most sensitive imaging",
        "evidenceLevel": "Class I, Level A",
        "source": "Sensitivity >90% within 48h; temporal lobe predilection"
      },
      {
        "recommendation": "EEG showing PLEDs supports diagnosis",
        "evidenceLevel": "Class IIa, Level B",
        "source": "Periodic lateralizing discharges in ~80% of HSV encephalitis"
      },
      {
        "recommendation": "Post-HSV autoimmune encephalitis (anti-NMDAR) in 20-27%",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[Armangue et al. (Ann Neurol 2014)](https://pubmed.ncbi.nlm.nih.gov/24318406/); [Prüss et al. (Ann Neurol 2012)](https://pubmed.ncbi.nlm.nih.gov/23280840/)"
      },
      {
        "recommendation": "Dexamethasone for HSV encephalitis: NOT standard of care",
        "evidenceLevel": "Class IIb, Level C",
        "source": "DexEnceph trial (ongoing); animal data supportive; no clear human mortality benefit"
      },
      {
        "recommendation": "Foscarnet for acyclovir-resistant HSV",
        "evidenceLevel": "Class IIa, Level C",
        "source": "Expert consensus; primarily in immunocompromised"
      },
      {
        "recommendation": "Aggressive hydration to prevent acyclovir nephrotoxicity",
        "evidenceLevel": "Class I, Level B",
        "source": "Well-established; crystal nephropathy prevention"
      },
      {
        "recommendation": "Empiric bacterial coverage until excluded",
        "evidenceLevel": "Class I, Level A",
        "source": "Standard practice; cannot clinically distinguish bacterial meningitis from encephalitis at presentation"
      },
      {
        "recommendation": "Repeat LP at end of treatment to confirm PCR negativity",
        "evidenceLevel": "Class IIa, Level C",
        "source": "Expert consensus; immunocompromised patients especially"
      },
      {
        "recommendation": "14-day treatment minimum; 21 days for severe/immunocompromised",
        "evidenceLevel": "Class I, Level B",
        "source": "IDSA Guidelines; relapse rate higher with <14 days"
      }
    ],
    "monitoring": [
      {
        "item": "GCS / Neurologic exam",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "q1h x 24h, then q2h x 48h, then q4h",
        "action": "If declining: STAT CT; ICP assessment; consider EVD"
      },
      {
        "item": "Temperature",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q4h (q1h if febrile)",
        "action": "Acetaminophen; cooling measures; reassess if persistent fever >72h on acyclovir"
      },
      {
        "item": "Serum sodium",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "q6-8h x 48h, then q12h",
        "action": "If <130: SIADH → fluid restriction (balance with acyclovir hydration); if <120: 3% saline"
      },
      {
        "item": "Serum creatinine",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "Daily (twice daily if rising)",
        "action": "If rising: increase hydration; consider dose adjustment; hold if severe (rare); monitor urine output"
      },
      {
        "item": "BUN",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "ROUTINE",
        "frequency": "Daily",
        "action": "Dehydration; renal impairment"
      },
      {
        "item": "Urine output",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q1h in ICU; q4h shift on floor",
        "action": "Increase IV fluids; if oliguria: renal assessment"
      },
      {
        "item": "Seizure monitoring (EEG)",
        "ED": "-",
        "HOSP": "URGENT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "cEEG 24-72h if altered consciousness; routine EEG daily if improving",
        "action": "If seizures: load/adjust AEDs; if NCSE: aggressive treatment per SE protocol"
      },
      {
        "item": "Blood pressure",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q1-4h based on severity",
        "action": "Fluids; vasopressors if septic"
      },
      {
        "item": "Oxygen saturation",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "Continuous in ICU; q4h on floor",
        "action": "Supplemental O2; intubation if respiratory failure"
      },
      {
        "item": "Repeat MRI brain",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE",
        "frequency": "At 48-72h (evolution); day 7-14 (extent of damage); 3-6 months (chronic changes)",
        "action": "If worsening edema: ICP management; neurosurgery consult"
      },
      {
        "item": "Repeat LP (HSV PCR)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "ROUTINE",
        "frequency": "At end of treatment (day 14-21) to confirm PCR negativity; earlier if clinical suspicion of treatment failure",
        "action": "If still positive: extend acyclovir 7+ more days; consider resistance"
      },
      {
        "item": "Autoimmune antibodies (follow-up)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Recheck at 2-4 weeks if relapse or new psychiatric/neurologic symptoms",
        "action": "If positive (especially NMDAR): immunotherapy protocol"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "NOT appropriate directly from ED for suspected HSV encephalitis — always admit. Discharge from hospital when: completing IV acyclovir course (or transitioned to monitoring); improved consciousness (GCS 15); no active seizures; stable neurologic exam; safe swallowing; rehabilitation arranged; follow-up confirmed"
      },
      {
        "disposition": "Admit to floor (monitored bed)",
        "criteria": "Mild encephalitis (GCS 13-15); stable; low seizure burden; able to cooperate with neuro checks"
      },
      {
        "disposition": "Admit to ICU / Neuro-ICU",
        "criteria": "GCS <13; active seizures or status epilepticus; need for continuous EEG; respiratory compromise; signs of elevated ICP; hemodynamic instability"
      },
      {
        "disposition": "Transfer to higher level",
        "criteria": "Need for neuro-ICU not available; need for neurosurgery (decompressive craniectomy); continuous EEG not available"
      },
      {
        "disposition": "Inpatient rehabilitation",
        "criteria": "Moderate-severe cognitive deficits (memory impairment, aphasia); motor deficits; able to participate in 3h/day therapy"
      },
      {
        "disposition": "Skilled nursing facility",
        "criteria": "Unable to tolerate intensive rehabilitation; requires ongoing nursing care"
      }
    ]
  },
  "Autoimmune Encephalitis": {
    "id": "autoimmune-encephalitis",
    "title": "Autoimmune Encephalitis",
    "version": "1.0",
    "icd10": [
      "** G04.81 (Other autoimmune encephalitis)"
    ],
    "scope": "** Diagnostic workup, acute treatment, and long-term management of suspected or confirmed autoimmune encephalitis. Covers antibody-mediated encephalitis (anti-NMDAR, LGI1, CASPR2, GABA-B, AMPA, DPPX, IgLON5, GABA-A, GAD65), first-line immunotherapy, second-line escalation, seizure management, psychiatric symptom management, ICU considerations, tumor screening, and long-term immunosuppression. For infectious encephalitis, use \"HSV Encephalitis\" template. For paraneoplastic syndromes without encephalitis, use \"Paraneoplastic Syndrome\" template. For status epilepticus management, use \"Status Epilepticus\" template.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Baseline; infection screen; pre-immunotherapy",
            "target": "Normal"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Metabolic screen; renal/hepatic baseline for immunotherapy",
            "target": "Normal"
          },
          {
            "item": "TSH",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Thyroid encephalopathy mimic; Hashimoto encephalopathy screen",
            "target": "Normal"
          },
          {
            "item": "ESR",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Inflammatory/vasculitis screen",
            "target": "Normal (<20 mm/hr)"
          },
          {
            "item": "CRP",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Inflammatory marker; infection screen",
            "target": "Normal"
          },
          {
            "item": "Urinalysis with culture",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "UTI as encephalopathy trigger",
            "target": "Negative"
          },
          {
            "item": "Blood cultures (x2 sets)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Rule out septic encephalopathy",
            "target": "No growth"
          },
          {
            "item": "Blood glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Metabolic encephalopathy screen; pre-steroid baseline",
            "target": "Normal"
          },
          {
            "item": "HbA1c",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Glycemic status before high-dose steroids",
            "target": "<5.7%"
          },
          {
            "item": "Ammonia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Hepatic encephalopathy mimic",
            "target": "Normal"
          },
          {
            "item": "Lactate",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Sepsis screen; metabolic screen",
            "target": "Normal (<2.0 mmol/L)"
          },
          {
            "item": "PT/INR, aPTT",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Coagulopathy screen pre-LP; DIC screen",
            "target": "Normal"
          },
          {
            "item": "Magnesium",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Seizure threshold; metabolic screen",
            "target": "Normal"
          },
          {
            "item": "Phosphorus",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Metabolic screen",
            "target": "Normal"
          },
          {
            "item": "Procalcitonin",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Distinguish bacterial vs autoimmune etiology",
            "target": "Normal (<0.1 ng/mL)"
          },
          {
            "item": "Troponin",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Cardiac involvement; autonomic instability assessment",
            "target": "Normal"
          },
          {
            "item": "CPK",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Rhabdomyolysis from prolonged seizures/catatonia",
            "target": "Normal"
          },
          {
            "item": "Urine drug screen",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Toxic/drug-induced encephalopathy mimic",
            "target": "Negative"
          },
          {
            "item": "Alcohol level",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Alcohol-related encephalopathy",
            "target": "Negative"
          },
          {
            "item": "Pregnancy test (females of childbearing age)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Eclampsia mimic; treatment planning (teratogenicity)",
            "target": "As applicable"
          },
          {
            "item": "Peripheral blood smear",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "TTP/HUS screen if thrombocytopenia",
            "target": "Normal"
          },
          {
            "item": "LDH",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Hemolysis screen; tumor marker",
            "target": "Normal"
          },
          {
            "item": "Uric acid",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Tumor lysis risk if malignancy suspected",
            "target": "Normal"
          },
          {
            "item": "Lipase",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Pancreatitis-related encephalopathy",
            "target": "Normal"
          }
        ],
        "Extended Workup": [
          {
            "item": "**Anti-NMDAR antibody (serum AND CSF)**",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Most common autoimmune encephalitis; CSF more sensitive than serum; cell-based assay (CBA) preferred",
            "target": "Negative"
          },
          {
            "item": "**Anti-LGI1 antibody (serum AND CSF)**",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Limbic encephalitis; faciobrachial dystonic seizures (FBDS); hyponatremia",
            "target": "Negative"
          },
          {
            "item": "**Anti-CASPR2 antibody (serum AND CSF)**",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Limbic encephalitis; Morvan syndrome; neuromyotonia; neuropathic pain",
            "target": "Negative"
          },
          {
            "item": "**Anti-GABA-B antibody (serum AND CSF)**",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Limbic encephalitis with prominent seizures; 50% associated with SCLC",
            "target": "Negative"
          },
          {
            "item": "**Anti-AMPA antibody (serum AND CSF)**",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Limbic encephalitis; relapsing course; associated with thymoma, lung, breast",
            "target": "Negative"
          },
          {
            "item": "**Anti-DPPX antibody (serum AND CSF)**",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Encephalitis with hyperexcitability, GI symptoms, PERM",
            "target": "Negative"
          },
          {
            "item": "**Anti-IgLON5 antibody (serum AND CSF)**",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Sleep disorder, bulbar dysfunction, gait instability, tau pathology",
            "target": "Negative"
          },
          {
            "item": "**Anti-GABA-A antibody (serum AND CSF)**",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Refractory seizures/status epilepticus; often with thymoma",
            "target": "Negative"
          },
          {
            "item": "**Anti-GAD65 antibody (serum AND CSF)**",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Limbic encephalitis, stiff-person spectrum, cerebellar ataxia; high titers (>20 nmol/L) significant",
            "target": "Negative or low titer"
          },
          {
            "item": "**Mayo Autoimmune Evaluation - Encephalopathy (serum)**",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Comprehensive panel: NMDAR, LGI1, CASPR2, GABA-B, AMPA, DPPX",
            "target": "All negative"
          },
          {
            "item": "**Mayo Autoimmune Evaluation - Encephalopathy (CSF)**",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "CSF panel: NMDAR, LGI1, CASPR2, GABA-B, AMPA, DPPX",
            "target": "All negative"
          },
          {
            "item": "ANA",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Lupus cerebritis screen",
            "target": "Negative or low titer"
          },
          {
            "item": "Anti-dsDNA",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If ANA positive; lupus evaluation",
            "target": "Negative"
          },
          {
            "item": "Anti-SSA/SSB (Ro/La)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Sjogren syndrome with CNS involvement",
            "target": "Negative"
          },
          {
            "item": "Anti-TPO antibodies",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Hashimoto encephalopathy (SREAT)",
            "target": "Negative"
          },
          {
            "item": "Anti-thyroglobulin antibodies",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Hashimoto encephalopathy (SREAT)",
            "target": "Negative"
          },
          {
            "item": "AQP4-IgG (NMO antibody)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "NMOSD overlap; cell-based assay preferred",
            "target": "Negative"
          },
          {
            "item": "MOG-IgG",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "MOGAD overlap; ADEM-like presentation",
            "target": "Negative"
          },
          {
            "item": "Complement C3, C4",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Lupus; complement-mediated disease",
            "target": "Normal"
          },
          {
            "item": "Quantitative immunoglobulins (IgG, IgA, IgM)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Baseline before immunotherapy; IgA deficiency (IVIG contraindication)",
            "target": "Normal"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Anti-neuronal nuclear antibody type 1 (ANNA-1/anti-Hu)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Paraneoplastic; SCLC, neuroblastoma",
            "target": "Negative"
          },
          {
            "item": "Anti-neuronal nuclear antibody type 2 (ANNA-2/anti-Ri)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Paraneoplastic; breast, SCLC",
            "target": "Negative"
          },
          {
            "item": "Anti-CV2/CRMP5",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Paraneoplastic; SCLC, thymoma",
            "target": "Negative"
          },
          {
            "item": "Anti-amphiphysin",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Paraneoplastic; breast, SCLC; stiff-person overlap",
            "target": "Negative"
          },
          {
            "item": "Anti-Ma2/Ta",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Paraneoplastic limbic encephalitis; testicular germ cell tumor",
            "target": "Negative"
          },
          {
            "item": "Anti-SOX1",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "SCLC-associated; Lambert-Eaton overlap",
            "target": "Negative"
          },
          {
            "item": "Anti-Kelch-like protein 11 (KLHL11)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Testicular seminoma; brainstem/cerebellar syndrome",
            "target": "Negative"
          },
          {
            "item": "Anti-GlyR (glycine receptor)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Progressive encephalomyelitis with rigidity and myoclonus (PERM)",
            "target": "Negative"
          },
          {
            "item": "Anti-mGluR5",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Ophelia syndrome; Hodgkin lymphoma",
            "target": "Negative"
          },
          {
            "item": "Anti-mGluR1",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Cerebellar ataxia; Hodgkin lymphoma",
            "target": "Negative"
          },
          {
            "item": "Anti-neurexin-3-alpha",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Rapid-onset encephalitis; seizures; confusion",
            "target": "Negative"
          },
          {
            "item": "Anti-D2R (dopamine-2 receptor)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Basal ganglia encephalitis; movement disorders",
            "target": "Negative"
          },
          {
            "item": "Paraneoplastic evaluation panel (comprehensive)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If standard panels negative and paraneoplastic suspected",
            "target": "All negative"
          },
          {
            "item": "14-3-3 protein (CSF)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Prion disease mimic; rapidly progressive dementia",
            "target": "Negative"
          },
          {
            "item": "RT-QuIC (CSF)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Prion disease exclusion in rapidly progressive cases",
            "target": "Negative"
          },
          {
            "item": "Next-generation sequencing (CSF metagenomics)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Occult infection when standard testing negative",
            "target": "No pathogens detected"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Elevated ICP assessment",
            "target": "10-20 cm H2O"
          },
          {
            "item": "Cell count with differential (tubes 1 and 4)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "rationale": "Lymphocytic pleocytosis supports autoimmune",
            "target": "WBC 5-80 (lymphocyte-predominant); RBC 0"
          },
          {
            "item": "Protein",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "rationale": "Mildly elevated in autoimmune; markedly elevated suggests infection/GBS",
            "target": "Normal to mildly elevated (usually <100 mg/dL)"
          },
          {
            "item": "Glucose with paired serum glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "rationale": "Low in infection/carcinomatous meningitis",
            "target": "Normal (>60% of serum)"
          },
          {
            "item": "Gram stain and bacterial culture",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "rationale": "Rule out bacterial meningitis",
            "target": "No organisms"
          },
          {
            "item": "HSV 1/2 PCR",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "rationale": "Rule out HSV encephalitis (most important mimic)",
            "target": "Negative"
          },
          {
            "item": "VZV PCR",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "rationale": "Varicella encephalitis",
            "target": "Negative"
          },
          {
            "item": "EBV PCR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "EBV-associated encephalitis; lymphoma screen",
            "target": "Negative"
          },
          {
            "item": "CMV PCR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Immunocompromised patients",
            "target": "Negative"
          },
          {
            "item": "HHV-6 PCR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Post-transplant; limbic encephalitis mimic",
            "target": "Negative"
          },
          {
            "item": "Enterovirus PCR",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "rationale": "Viral meningitis/encephalitis",
            "target": "Negative"
          },
          {
            "item": "West Nile virus IgM/IgG",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Endemic areas; flaccid paralysis",
            "target": "Negative"
          },
          {
            "item": "Cryptococcal antigen",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Immunocompromised; chronic meningitis",
            "target": "Negative"
          },
          {
            "item": "VDRL (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Neurosyphilis",
            "target": "Negative"
          },
          {
            "item": "Oligoclonal bands (CSF AND paired serum)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Intrathecal IgG synthesis; MS/NMOSD overlap",
            "target": "May show CSF-specific bands"
          },
          {
            "item": "IgG index",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Intrathecal antibody synthesis",
            "target": "May be elevated"
          },
          {
            "item": "Cytology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Carcinomatous/lymphomatous meningitis",
            "target": "Negative"
          },
          {
            "item": "Flow cytometry",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "CNS lymphoma",
            "target": "Normal"
          },
          {
            "item": "**Autoimmune encephalitis antibody panel (CSF)**",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "rationale": "NMDAR, LGI1, CASPR2, GABA-B, AMPA, DPPX -- CBA method",
            "target": "All negative"
          },
          {
            "item": "**Anti-NMDAR IgG (CSF)**",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "rationale": "CSF more sensitive than serum for NMDAR",
            "target": "Negative"
          },
          {
            "item": "AFB culture and smear",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "TB meningitis if risk factors",
            "target": "Negative"
          },
          {
            "item": "Fungal culture",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Immunocompromised",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Immediate (ED triage)",
            "target": "Rule out mass, hemorrhage, hydrocephalus",
            "contraindications": "None significant"
          },
          {
            "item": "MRI brain with and without contrast",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Within 24h",
            "target": "Mesial temporal T2/FLAIR hyperintensity (limbic encephalitis); cortical/subcortical signal changes; leptomeningeal enhancement",
            "contraindications": "GFR <30, gadolinium allergy, pacemaker"
          },
          {
            "item": "EEG (routine or continuous)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "Within 24h; continuous if ICU or altered consciousness",
            "target": "Extreme delta brush (anti-NMDAR); focal/generalized slowing; epileptiform discharges; subclinical seizures",
            "contraindications": "None significant"
          },
          {
            "item": "ECG (12-lead)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "Immediate",
            "target": "Autonomic dysfunction; arrhythmia; QTc prolongation (medication safety)",
            "contraindications": "None"
          },
          {
            "item": "Chest X-ray",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Immediate",
            "target": "Mediastinal mass (thymoma); pulmonary mass (SCLC)",
            "contraindications": "Pregnancy (relative)"
          },
          {
            "item": "Continuous telemetry",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Continuous in hospital",
            "target": "Arrhythmia from autonomic instability",
            "contraindications": "None"
          }
        ],
        "Extended": [
          {
            "item": "MRI spine (cervical and thoracic) with and without contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "timing": "Within 48-72h",
            "target": "Concurrent myelitis; overlap syndromes",
            "contraindications": "GFR <30, gadolinium allergy"
          },
          {
            "item": "CT chest/abdomen/pelvis with contrast",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Within 48h",
            "target": "Occult malignancy: thymoma, lung cancer, ovarian teratoma, lymphoma",
            "contraindications": "Contrast allergy, renal insufficiency"
          },
          {
            "item": "Pelvic/transvaginal ultrasound (females)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Within 48h",
            "target": "Ovarian teratoma (anti-NMDAR)",
            "contraindications": "None significant"
          },
          {
            "item": "Testicular ultrasound (males <50)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Within 48h",
            "target": "Testicular germ cell tumor (anti-Ma2, KLHL11)",
            "contraindications": "None significant"
          },
          {
            "item": "FDG-PET/CT (whole body)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Within 1-2 weeks",
            "target": "Occult malignancy not seen on CT; FDG-avid tumor",
            "contraindications": "Uncontrolled diabetes, pregnancy"
          },
          {
            "item": "Video-EEG monitoring (prolonged)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "As needed",
            "target": "Characterize seizure semiology; subclinical seizures; extreme delta brush pattern",
            "contraindications": "None"
          },
          {
            "item": "FDG-PET brain",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Within 1-2 weeks",
            "target": "Mesial temporal hypermetabolism (early) or hypometabolism (late); cortical metabolic changes",
            "contraindications": "Same as PET/CT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "MRI brain with epilepsy protocol",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If seizures refractory",
            "target": "Subtle cortical lesions; hippocampal sclerosis",
            "contraindications": "Gadolinium contraindications"
          },
          {
            "item": "Brain biopsy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-",
            "timing": "Last resort",
            "target": "Inflammatory infiltrate; exclusion of other pathology",
            "contraindications": "Coagulopathy, inaccessible location"
          },
          {
            "item": "CT-guided biopsy (tumor)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "After tumor identified",
            "target": "Histopathological confirmation",
            "contraindications": "Coagulopathy, tumor location"
          },
          {
            "item": "Mammography/breast MRI",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If AMPA, amphiphysin positive",
            "target": "Breast malignancy",
            "contraindications": "Implants (relative for MRI)"
          },
          {
            "item": "Polysomnography",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If IgLON5 suspected",
            "target": "REM/NREM parasomnias; sleep disordered breathing",
            "contraindications": "None significant"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Empiric acyclovir IV (until HSV ruled out)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg",
                  "orderSentence": "Empiric acyclovir IV (until HSV ruled out) 10 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV q8h; continue until HSV PCR negative x2 (48h apart) or alternative diagnosis confirmed",
              "orderSentence": "Empiric acyclovir IV (until HSV ruled out) 10 mg/kg IV"
            },
            "contraindications": "Renal impairment (adjust dose); adequate hydration required",
            "monitoring": "Renal function daily; hydration status; crystal nephropathy prevention",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Empiric antibiotics (if bacterial meningitis not excluded)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2g",
                  "orderSentence": "Empiric antibiotics (if bacterial meningitis not excluded) 2g IV"
                }
              ],
              "route": "IV",
              "instructions": "Ceftriaxone 2g IV q12h + vancomycin 15-20 mg/kg IV q8-12h + dexamethasone 0.15 mg/kg q6h x 4 days",
              "orderSentence": "Empiric antibiotics (if bacterial meningitis not excluded) 2g IV"
            },
            "contraindications": "Per individual drug allergies",
            "monitoring": "Cultures; clinical response; renal function; vancomycin troughs",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Lorazepam (acute seizure)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg/kg",
                  "orderSentence": "Lorazepam (acute seizure) 0.1 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.1 mg/kg IV (max 4 mg/dose); may repeat x1 in 5 minutes",
              "orderSentence": "Lorazepam (acute seizure) 0.1 mg/kg IV"
            },
            "contraindications": "Respiratory depression; acute narrow-angle glaucoma",
            "monitoring": "Respiratory status; sedation level; airway patency",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam (if no IV access)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Midazolam (if no IV access) 10 mg IM"
                }
              ],
              "route": "IM",
              "instructions": "10 mg IM (adults >40 kg) or 0.2 mg/kg intranasal",
              "orderSentence": "Midazolam (if no IV access) 10 mg IM"
            },
            "contraindications": "Respiratory depression",
            "monitoring": "Same as lorazepam",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Lorazepam (catatonia challenge)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2 mg",
                  "orderSentence": "Lorazepam (catatonia challenge) 1-2 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1-2 mg IV; observe 15-30 min for response; if improvement, continue 1-2 mg IV/PO q4-8h (up to 8-24 mg/day)",
              "orderSentence": "Lorazepam (catatonia challenge) 1-2 mg IV"
            },
            "contraindications": "Respiratory compromise; prior paradoxical response",
            "monitoring": "Bush-Francis Catatonia Rating Scale; respiratory status; sedation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "First-Line Immunotherapy": [
          {
            "item": "Methylprednisolone IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Methylprednisolone IV 1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg IV daily x 5 days; infuse over 1-2 hours",
              "orderSentence": "Methylprednisolone IV 1000 mg IV"
            },
            "contraindications": "Active untreated infection; uncontrolled diabetes; psychosis from steroids",
            "monitoring": "Glucose q6h (target <180); BP; mood/sleep; I/O; GI prophylaxis",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Omeprazole (GI prophylaxis during steroids)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Omeprazole (GI prophylaxis during steroids) 40 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "40 mg IV/PO daily during steroid course",
              "orderSentence": "Omeprazole (GI prophylaxis during steroids) 40 mg IV"
            },
            "contraindications": "PPI allergy",
            "monitoring": "None routine",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Insulin sliding scale",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "180 mg",
                  "orderSentence": "Insulin sliding scale 180 mg -"
                }
              ],
              "route": "-",
              "instructions": "Per protocol if glucose >180 mg/dL",
              "orderSentence": "Insulin sliding scale 180 mg -"
            },
            "contraindications": "Hypoglycemia risk",
            "monitoring": "Glucose q6h; adjust per response",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "IVIG (intravenous immunoglobulin)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg",
                  "orderSentence": "IVIG (intravenous immunoglobulin) 0.4 g/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.4 g/kg/day IV x 5 days (total 2 g/kg); infuse per weight-based protocol; premedicate with acetaminophen, diphenhydramine",
              "orderSentence": "IVIG (intravenous immunoglobulin) 0.4 g/kg IV"
            },
            "contraindications": "IgA deficiency (anaphylaxis risk); recent thromboembolic event; renal failure",
            "monitoring": "Renal function daily; headache (aseptic meningitis); thrombosis; volume overload; check IgA level before first dose",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Plasmapheresis (PLEX)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "5-7 exchanges over 10-14 days; 1-1.5 plasma volumes per exchange; albumin replacement",
              "orderSentence": "Plasmapheresis (PLEX) - - - see dosing"
            },
            "contraindications": "Hemodynamic instability; sepsis; coagulopathy; poor vascular access",
            "monitoring": "BP during exchanges; electrolytes (Ca, K, Mg); coagulation (fibrinogen); line site; citrate reactions",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Second-Line Immunotherapy": [
          {
            "item": "Rituximab",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "375 mg/m2",
                  "orderSentence": "Rituximab 375 mg/m2 IV"
                }
              ],
              "route": "IV",
              "instructions": "375 mg/m2 IV weekly x 4 doses OR 1000 mg IV x 2 doses (day 0 and day 14); premedicate with methylprednisolone 100 mg, acetaminophen, diphenhydramine",
              "orderSentence": "Rituximab 375 mg/m2 IV"
            },
            "contraindications": "Active hepatitis B; severe active infection; live vaccines within 4 weeks",
            "monitoring": "Hepatitis B serology (before first dose); CBC with differential q2-4 weeks; immunoglobulin levels q3 months; CD19/CD20 B-cell counts; infusion reactions; PML surveillance",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Cyclophosphamide",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "750 mg/m2",
                  "orderSentence": "Cyclophosphamide 750 mg/m2 IV"
                }
              ],
              "route": "IV",
              "instructions": "750 mg/m2 IV monthly x 6 cycles; pre-hydrate with 1L NS; administer with MESNA (uroprotection)",
              "orderSentence": "Cyclophosphamide 750 mg/m2 IV"
            },
            "contraindications": "Pregnancy; active infection; bone marrow failure; bladder outlet obstruction",
            "monitoring": "CBC weekly x 4 weeks after each cycle (nadir day 10-14); urinalysis; BMP; LFTs; fertility counseling; hemorrhagic cystitis prevention",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Tocilizumab (third-line)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "8 mg/kg",
                  "orderSentence": "Tocilizumab (third-line) 8 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "8 mg/kg IV every 4 weeks (max 800 mg/dose)",
              "orderSentence": "Tocilizumab (third-line) 8 mg/kg IV"
            },
            "contraindications": "Active infection; hepatic impairment (ALT >5x ULN); diverticulitis; concurrent live vaccines",
            "monitoring": "CBC, LFTs, lipids q4-8 weeks; infection surveillance; GI perforation risk; neutropenia",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "EXT"
          },
          {
            "item": "Bortezomib (third-line)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1.3 mg/m2",
                  "orderSentence": "Bortezomib (third-line) 1.3 mg/m2 IV"
                }
              ],
              "route": "IV",
              "instructions": "1.3 mg/m2 SC/IV on days 1, 4, 8, 11 of 21-day cycles x 4-6 cycles",
              "orderSentence": "Bortezomib (third-line) 1.3 mg/m2 IV"
            },
            "contraindications": "Severe hepatic impairment; peripheral neuropathy grade 2+",
            "monitoring": "CBC; peripheral neuropathy assessment (dose-reduce or hold if worsens); herpes zoster prophylaxis (acyclovir 400 mg BID)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "EXT"
          },
          {
            "item": "Repeated IVIG or PLEX cycles",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg",
                  "orderSentence": "Repeated IVIG or PLEX cycles 0.4 g/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "IVIG 0.4 g/kg/day x 5 days (repeat q4 weeks) or PLEX 5 exchanges (repeat as needed)",
              "orderSentence": "Repeated IVIG or PLEX cycles 0.4 g/kg PO"
            },
            "contraindications": "Same as first-line",
            "monitoring": "Same as first-line",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Oral prednisone taper (following IV methylprednisolone)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg/kg",
                  "orderSentence": "Oral prednisone taper (following IV methylprednisolone) 1 mg/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "1 mg/kg/day (max 60 mg) x 2 weeks; taper by 10 mg/week to 20 mg; then taper by 5 mg/week to discontinuation OR low-dose maintenance",
              "orderSentence": "Oral prednisone taper (following IV methylprednisolone) 1 mg/kg PO"
            },
            "contraindications": "Active infection; uncontrolled diabetes; avascular necrosis",
            "monitoring": "Glucose; BP; bone density if prolonged; mood; weight; adrenal insufficiency on taper",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Seizure Management": [
          {
            "item": "Levetiracetam (first-line ASM)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000-1500 mg",
                  "orderSentence": "Levetiracetam (first-line ASM) 1000-1500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Load: 1000-1500 mg IV; Maintenance: 500-1500 mg IV/PO BID (max 3000 mg/day)",
              "orderSentence": "Levetiracetam (first-line ASM) 1000-1500 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Renal impairment (adjust dose per CrCl)",
            "monitoring": "Behavioral changes (rage, irritability); suicidality; renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Lacosamide (second-line ASM)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200-400 mg",
                  "orderSentence": "Lacosamide (second-line ASM) 200-400 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Load: 200-400 mg IV; Maintenance: 100-200 mg IV/PO BID (max 400 mg/day)",
              "orderSentence": "Lacosamide (second-line ASM) 200-400 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Second/third degree AV block; severe hepatic impairment",
            "monitoring": "ECG (PR prolongation); dizziness; cardiac monitoring during load",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Valproic acid",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20-40 mg/kg",
                  "orderSentence": "Valproic acid 20-40 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "Load: 20-40 mg/kg IV (max rate 6 mg/kg/min); Maintenance: 250-500 mg IV/PO q8h (target level 50-100 mcg/mL)",
              "orderSentence": "Valproic acid 20-40 mg/kg IV"
            },
            "pretreatment": "-",
            "contraindications": "Pregnancy (teratogenic -- Category X); hepatic disease; urea cycle disorders; mitochondrial disease (POLG)",
            "monitoring": "LFTs; ammonia; CBC (thrombocytopenia); drug level; pancreatitis",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Brivaracetam",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Brivaracetam 100 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Load: 100 mg IV; Maintenance: 50-100 mg IV/PO BID (max 200 mg/day)",
              "orderSentence": "Brivaracetam 100 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Hepatic impairment (reduce dose)",
            "monitoring": "Behavioral changes; sedation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Clobazam",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-10 mg",
                  "orderSentence": "Clobazam 5-10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5-10 mg BID; titrate to 20-40 mg/day in divided doses",
              "orderSentence": "Clobazam 5-10 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Severe hepatic impairment; myasthenia gravis",
            "monitoring": "Sedation; CYP2C19 poor metabolizers (reduce dose); tolerance; dependence",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Phenytoin/fosphenytoin (refractory)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "Phenytoin/fosphenytoin (refractory) 20 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Fosphenytoin: 20 mg PE/kg IV (max rate 150 mg PE/min); Maintenance: 5-7 mg/kg/day divided BID-TID (target level 10-20 mcg/mL)",
              "orderSentence": "Phenytoin/fosphenytoin (refractory) 20 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "AV block; bradycardia",
            "monitoring": "Continuous cardiac monitoring during load; drug level; purple glove syndrome (peripheral IV); gingival hyperplasia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Phenobarbital (refractory)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15-20 mg/kg",
                  "orderSentence": "Phenobarbital (refractory) 15-20 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "Load: 15-20 mg/kg IV (max rate 60 mg/min); Maintenance: 1-3 mg/kg/day (target level 15-40 mcg/mL)",
              "orderSentence": "Phenobarbital (refractory) 15-20 mg/kg IV"
            },
            "pretreatment": "-",
            "contraindications": "Severe respiratory depression; porphyria",
            "monitoring": "Respiratory depression; sedation; hypotension; drug level",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Midazolam infusion (refractory SE)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.2 mg/kg",
                  "orderSentence": "Midazolam infusion (refractory SE) 0.2 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "Bolus: 0.2 mg/kg IV; Infusion: 0.1-2.0 mg/kg/hr; titrate to EEG burst suppression",
              "orderSentence": "Midazolam infusion (refractory SE) 0.2 mg/kg IV"
            },
            "pretreatment": "-",
            "contraindications": "Unprotected airway (requires intubation)",
            "monitoring": "Continuous EEG; respiratory status; hemodynamics; tachyphylaxis",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Propofol infusion (refractory SE)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2 mg/kg",
                  "orderSentence": "Propofol infusion (refractory SE) 1-2 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "Bolus: 1-2 mg/kg IV; Infusion: 20-80 mcg/kg/min (max 5 mg/kg/hr to avoid PRIS)",
              "orderSentence": "Propofol infusion (refractory SE) 1-2 mg/kg IV"
            },
            "pretreatment": "-",
            "contraindications": "Propofol infusion syndrome risk (prolonged use >48h at high doses); egg/soy allergy",
            "monitoring": "Continuous EEG; triglycerides q48h; CPK; lactate; hemodynamics; PRIS surveillance",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Ketamine infusion (super-refractory SE)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-3 mg/kg",
                  "orderSentence": "Ketamine infusion (super-refractory SE) 1-3 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "Bolus: 1-3 mg/kg IV; Infusion: 0.5-5 mg/kg/hr",
              "orderSentence": "Ketamine infusion (super-refractory SE) 1-3 mg/kg IV"
            },
            "pretreatment": "-",
            "contraindications": "Uncontrolled hypertension; raised ICP (relative)",
            "monitoring": "Continuous EEG; BP; HR; hepatic function; laryngospasm risk",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Psychiatric Symptom Management": [
          {
            "item": "Haloperidol (acute agitation)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5-2 mg",
                  "orderSentence": "Haloperidol (acute agitation) 0.5-2 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-2 mg IV/IM q4-6h PRN (lowest effective dose); max 20 mg/day",
              "orderSentence": "Haloperidol (acute agitation) 0.5-2 mg IV"
            },
            "contraindications": "QTc >500 ms; Parkinson disease; prior NMS",
            "monitoring": "ECG (QTc); EPS; NMS surveillance; temperature; CPK if NMS suspected",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Olanzapine (agitation/psychosis)",
            "route": "IM",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5-5 mg",
                  "orderSentence": "Olanzapine (agitation/psychosis) 2.5-5 mg IM"
                }
              ],
              "route": "IM",
              "instructions": "2.5-5 mg PO/IM BID (start low); max 20 mg/day",
              "orderSentence": "Olanzapine (agitation/psychosis) 2.5-5 mg IM"
            },
            "contraindications": "QTc prolongation; metabolic syndrome",
            "monitoring": "Glucose; lipids; QTc; weight; sedation; EPS",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Quetiapine (psychosis/insomnia)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-50 mg",
                  "orderSentence": "Quetiapine (psychosis/insomnia) 25-50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg qHS; titrate to 200-400 mg/day in divided doses",
              "orderSentence": "Quetiapine (psychosis/insomnia) 25-50 mg PO"
            },
            "contraindications": "QTc prolongation; severe hepatic impairment",
            "monitoring": "QTc; metabolic parameters; orthostatic BP; sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lorazepam (catatonia -- first-line)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2 mg",
                  "orderSentence": "Lorazepam (catatonia -- first-line) 1-2 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Start 1-2 mg IV/PO; if response, 1-2 mg q4-8h (escalate to 8-24 mg/day as needed for catatonia)",
              "orderSentence": "Lorazepam (catatonia -- first-line) 1-2 mg IV"
            },
            "contraindications": "Respiratory compromise (high doses)",
            "monitoring": "Bush-Francis Catatonia Rating Scale; respiratory rate; sedation; airway",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Dexmedetomidine (agitation in ICU)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mcg/kg",
                  "orderSentence": "Dexmedetomidine (agitation in ICU) 1 mcg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "Load: 1 mcg/kg IV over 10 min (optional); Infusion: 0.2-0.7 mcg/kg/hr (max 1.5 mcg/kg/hr)",
              "orderSentence": "Dexmedetomidine (agitation in ICU) 1 mcg/kg IV"
            },
            "contraindications": "Severe bradycardia; advanced heart block",
            "monitoring": "HR (bradycardia); BP (hypotension); sedation level (RASS)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Valproic acid (mood stabilization/agitation)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250-500 mg",
                  "orderSentence": "Valproic acid (mood stabilization/agitation) 250-500 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "250-500 mg PO BID; titrate to level 50-100 mcg/mL (dual benefit: mood + seizure)",
              "orderSentence": "Valproic acid (mood stabilization/agitation) 250-500 mg PO"
            },
            "contraindications": "Pregnancy; hepatic disease",
            "monitoring": "LFTs; ammonia; CBC; drug level",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Melatonin (sleep-wake disturbance)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3-10 mg",
                  "orderSentence": "Melatonin (sleep-wake disturbance) 3-10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "3-10 mg PO qHS",
              "orderSentence": "Melatonin (sleep-wake disturbance) 3-10 mg PO"
            },
            "contraindications": "None significant",
            "monitoring": "Sleep quality; no significant drug interactions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Trazodone (insomnia)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-100 mg",
                  "orderSentence": "Trazodone (insomnia) 25-100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "25-100 mg PO qHS",
              "orderSentence": "Trazodone (insomnia) 25-100 mg PO"
            },
            "contraindications": "Concurrent MAOIs; QTc prolongation",
            "monitoring": "Orthostatic hypotension; priapism (rare); sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Electroconvulsive therapy (ECT) (refractory catatonia)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Per psychiatry protocol; typically 3x/week",
              "orderSentence": "Electroconvulsive therapy (ECT) (refractory catatonia) - - - see dosing"
            },
            "contraindications": "Pheochromocytoma; raised ICP (relative)",
            "monitoring": "Anesthesia monitoring; cognitive function; post-procedure seizure threshold",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "EXT"
          }
        ],
        "ICU-Specific Treatments": [
          {
            "item": "Intubation and mechanical ventilation",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "RSI: avoid succinylcholine if hyperkalemia risk; maintain normocapnia",
              "orderSentence": "Intubation and mechanical ventilation - - - see dosing"
            },
            "contraindications": "As per standard airway management",
            "monitoring": "Ventilator parameters; ABG; daily SBT when appropriate",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Labetalol IV (autonomic hypertensive crisis)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-20 mg",
                  "orderSentence": "Labetalol IV (autonomic hypertensive crisis) 10-20 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10-20 mg IV q10-15min PRN; or infusion 0.5-2 mg/min; target SBP <180",
              "orderSentence": "Labetalol IV (autonomic hypertensive crisis) 10-20 mg IV"
            },
            "contraindications": "Severe bradycardia; AV block; decompensated CHF; asthma",
            "monitoring": "Continuous BP; HR; I/O",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Esmolol IV (autonomic tachycardia)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mcg/kg",
                  "orderSentence": "Esmolol IV (autonomic tachycardia) 500 mcg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "Bolus: 500 mcg/kg over 1 min; Infusion: 50-200 mcg/kg/min",
              "orderSentence": "Esmolol IV (autonomic tachycardia) 500 mcg/kg IV"
            },
            "contraindications": "Severe bradycardia; decompensated CHF; cardiogenic shock",
            "monitoring": "Continuous HR/BP; ECG",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Atropine (autonomic bradycardia)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5-1 mg",
                  "orderSentence": "Atropine (autonomic bradycardia) 0.5-1 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-1 mg IV q3-5min (max 3 mg total)",
              "orderSentence": "Atropine (autonomic bradycardia) 0.5-1 mg IV"
            },
            "contraindications": "Tachycardia; thyrotoxicosis",
            "monitoring": "HR; rhythm",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Isoproterenol drip (severe autonomic bradycardia)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-10 mcg",
                  "orderSentence": "Isoproterenol drip (severe autonomic bradycardia) 2-10 mcg IV"
                }
              ],
              "route": "IV",
              "instructions": "2-10 mcg/min IV infusion; titrate to HR >60",
              "orderSentence": "Isoproterenol drip (severe autonomic bradycardia) 2-10 mcg IV"
            },
            "contraindications": "Tachyarrhythmia; digoxin toxicity",
            "monitoring": "Continuous ECG; HR; BP",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Temporary transvenous pacemaker",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Per cardiology if pharmacologic measures fail",
              "orderSentence": "Temporary transvenous pacemaker - - - see dosing"
            },
            "contraindications": "Active infection at insertion site",
            "monitoring": "Capture; sensing; threshold checks",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Norepinephrine (autonomic hypotension)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1-0.5 mcg/kg",
                  "orderSentence": "Norepinephrine (autonomic hypotension) 0.1-0.5 mcg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.1-0.5 mcg/kg/min IV; titrate to MAP >65",
              "orderSentence": "Norepinephrine (autonomic hypotension) 0.1-0.5 mcg/kg IV"
            },
            "contraindications": "Peripheral ischemia risk at high doses",
            "monitoring": "Arterial line; MAP; lactate; urine output",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "DVT prophylaxis (enoxaparin)",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "DVT prophylaxis (enoxaparin) 40 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily (adjust for renal function: 30 mg SC daily if CrCl <30)",
              "orderSentence": "DVT prophylaxis (enoxaparin) 40 mg SC"
            },
            "contraindications": "Active bleeding; HIT; severe thrombocytopenia",
            "monitoring": "Platelet count; anti-Xa if renal impairment; bleeding signs",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Temperature management (hyperthermia)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1g",
                  "orderSentence": "Temperature management (hyperthermia) 1g IV"
                }
              ],
              "route": "IV",
              "instructions": "Targeted temperature: 36-37C; cooling blankets; acetaminophen 1g IV/PO q6h PRN",
              "orderSentence": "Temperature management (hyperthermia) 1g IV"
            },
            "contraindications": "Avoid overcooling; avoid shivering (increases metabolic demand)",
            "monitoring": "Continuous temperature; shivering assessment (BSAS)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Sodium correction (hyponatremia -- LGI1)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100-150 mL",
                  "orderSentence": "Sodium correction (hyponatremia -- LGI1) 100-150 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "If Na <125: 3% NaCl 100-150 mL IV over 10-20 min (repeat up to 3x); Target correction: 4-6 mEq/L in first 6h, max 8 mEq/L in 24h",
              "orderSentence": "Sodium correction (hyponatremia -- LGI1) 100-150 mL IV"
            },
            "contraindications": "Avoid overcorrection (osmotic demyelination risk)",
            "monitoring": "Sodium q2-4h during correction; urine output; neurologic status",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Fludrocortisone (chronic hyponatremia -- LGI1)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.05-0.2 mg",
                  "orderSentence": "Fludrocortisone (chronic hyponatremia -- LGI1) 0.05-0.2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.05-0.2 mg PO daily",
              "orderSentence": "Fludrocortisone (chronic hyponatremia -- LGI1) 0.05-0.2 mg PO"
            },
            "contraindications": "CHF; hypertension",
            "monitoring": "Sodium; potassium; BP; edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fluid restriction (SIADH-related hyponatremia)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Restrict to 1-1.2 L/day if SIADH suspected (LGI1)",
              "orderSentence": "Fluid restriction (SIADH-related hyponatremia) - - - see dosing"
            },
            "contraindications": "Dehydration risk",
            "monitoring": "Sodium; I/O; daily weight; urine osmolality",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          }
        ],
        "Long-Term Immunosuppression / Maintenance": [
          {
            "item": "Mycophenolate mofetil (CellCept)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Mycophenolate mofetil (CellCept) 500 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 500 mg PO BID; increase to 1000 mg PO BID over 2-4 weeks (target 1500-3000 mg/day)",
              "orderSentence": "Mycophenolate mofetil (CellCept) 500 mg PO"
            },
            "contraindications": "Pregnancy (Category D -- teratogenic); active infection",
            "monitoring": "CBC q2 weeks x 3 months, then monthly; LFTs; GI symptoms; infection surveillance; pregnancy prevention",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Azathioprine (Imuran)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Azathioprine (Imuran) 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg PO daily; increase by 50 mg every 2 weeks to target 2-3 mg/kg/day",
              "orderSentence": "Azathioprine (Imuran) 50 mg PO"
            },
            "contraindications": "TPMT deficiency (check before starting); pregnancy (relative)",
            "monitoring": "TPMT genotype/activity before starting; CBC q2 weeks x 2 months, then monthly; LFTs; pancreatitis",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rituximab (maintenance)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500-1000 mg",
                  "orderSentence": "Rituximab (maintenance) 500-1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "500-1000 mg IV every 6 months; re-dose based on CD19/CD20 B-cell repopulation or clinical relapse",
              "orderSentence": "Rituximab (maintenance) 500-1000 mg IV"
            },
            "contraindications": "Active hepatitis B; severe active infection",
            "monitoring": "CD19/CD20 counts q3 months; immunoglobulin levels q3-6 months; hepatitis B surveillance; infection monitoring; PML surveillance",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oral prednisone (low-dose maintenance)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-10 mg",
                  "orderSentence": "Oral prednisone (low-dose maintenance) 5-10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10 mg PO daily; aim to taper off within 3-6 months if on steroid-sparing agent",
              "orderSentence": "Oral prednisone (low-dose maintenance) 5-10 mg PO"
            },
            "contraindications": "Poorly controlled diabetes; active infection; avascular necrosis",
            "monitoring": "Glucose; BP; bone density (DEXA if >3 months); weight; mood; cataracts; adrenal assessment on taper",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "IVIG (maintenance)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg",
                  "orderSentence": "IVIG (maintenance) 0.4 g/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.4 g/kg IV every 4 weeks OR 1-2 g/kg IV every 4-6 weeks (adjust per response)",
              "orderSentence": "IVIG (maintenance) 0.4 g/kg IV"
            },
            "contraindications": "IgA deficiency; thromboembolic history",
            "monitoring": "Renal function; headache; IgG trough levels; infusion reactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Calcium + Vitamin D (bone protection with steroids)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000-1200 mg/day",
                  "orderSentence": "Calcium + Vitamin D (bone protection with steroids) 1000-1200 mg/day PO"
                }
              ],
              "route": "PO",
              "instructions": "Calcium 1000-1200 mg/day + Vitamin D 1000-2000 IU/day",
              "orderSentence": "Calcium + Vitamin D (bone protection with steroids) 1000-1200 mg/day PO"
            },
            "contraindications": "Hypercalcemia; kidney stones",
            "monitoring": "25-OH Vitamin D level; calcium; DEXA baseline if anticipated steroid use >3 months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology (autoimmune/neuroimmunology)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "indication": "All suspected autoimmune encephalitis cases; immunotherapy management"
          },
          {
            "item": "Epilepsy/EEG service",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "indication": "Seizure management; continuous EEG monitoring; extreme delta brush interpretation"
          },
          {
            "item": "Psychiatry",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Psychiatric manifestations (psychosis, catatonia, agitation); antipsychotic management; NMS risk"
          },
          {
            "item": "Critical care/ICU",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "indication": "Autonomic instability; respiratory failure; refractory status epilepticus; altered consciousness"
          },
          {
            "item": "Gynecologic oncology (females with anti-NMDAR)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "URGENT",
            "ICU": "URGENT",
            "indication": "Ovarian teratoma screening and surgical resection"
          },
          {
            "item": "Oncology",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Any identified malignancy; tumor screening guidance; chemotherapy planning"
          },
          {
            "item": "Urology (males <50 with anti-Ma2/KLHL11)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Testicular germ cell tumor screening"
          },
          {
            "item": "Hematology/apheresis",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "indication": "PLEX coordination; catheter placement"
          },
          {
            "item": "Physical therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "indication": "Motor rehabilitation; gait training; fall prevention"
          },
          {
            "item": "Occupational therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "indication": "ADL assessment; cognitive rehabilitation; adaptive strategies"
          },
          {
            "item": "Speech-language pathology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "indication": "Swallowing evaluation; language/communication rehabilitation; cognitive-linguistic therapy"
          },
          {
            "item": "Neuropsychology",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Formal cognitive assessment; rehabilitation planning; serial monitoring"
          },
          {
            "item": "Social work",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Family support; insurance navigation; disability resources; long-term care planning"
          },
          {
            "item": "Rehabilitation medicine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Comprehensive inpatient or outpatient rehab program coordination"
          },
          {
            "item": "Palliative care",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "EXT",
            "indication": "Refractory cases; prolonged ICU stay; family support; goals of care discussion"
          },
          {
            "item": "Infectious disease",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "indication": "Rule out infection; antimicrobial guidance; post-immunosuppression infection management"
          },
          {
            "item": "Endocrinology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Steroid-induced hyperglycemia management; thyroid evaluation if Hashimoto suspected"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return to ED immediately for new seizures, sudden behavioral changes, fever, difficulty breathing, or loss of consciousness",
            "ED": "Y",
            "HOSP": "Y",
            "OPD": "Y"
          },
          {
            "item": "Autoimmune encephalitis is a treatable condition -- recovery may be slow (months to years) but significant improvement is expected with appropriate immunotherapy",
            "ED": "Y",
            "HOSP": "Y",
            "OPD": "Y"
          },
          {
            "item": "Do NOT drive until seizure-free for state-mandated period AND cleared by neurology",
            "ED": "Y",
            "HOSP": "Y",
            "OPD": "Y"
          },
          {
            "item": "Keep seizure diary (date, time, type, duration, triggers)",
            "ED": "-",
            "HOSP": "Y",
            "OPD": "Y"
          },
          {
            "item": "Behavioral and psychiatric symptoms are part of the disease, not a primary psychiatric disorder -- immunotherapy is the treatment",
            "ED": "Y",
            "HOSP": "Y",
            "OPD": "Y"
          },
          {
            "item": "Report any signs of infection (fever >100.4F, cough, dysuria, rash) immediately while on immunotherapy",
            "ED": "-",
            "HOSP": "Y",
            "OPD": "Y"
          },
          {
            "item": "Avoid live vaccines while on immunosuppressive therapy (inform all physicians of immunosuppression status)",
            "ED": "-",
            "HOSP": "Y",
            "OPD": "Y"
          },
          {
            "item": "Do not stop anti-seizure medications abruptly",
            "ED": "-",
            "HOSP": "Y",
            "OPD": "Y"
          },
          {
            "item": "Avoid alcohol and recreational drugs (lower seizure threshold, interact with medications)",
            "ED": "-",
            "HOSP": "Y",
            "OPD": "Y"
          },
          {
            "item": "Pregnancy must be avoided during immunotherapy; discuss contraception with neurology and OB/GYN",
            "ED": "-",
            "HOSP": "Y",
            "OPD": "Y"
          },
          {
            "item": "Expect gradual improvement -- anti-NMDAR recovery typically occurs in reverse order of symptom onset (psychiatric symptoms resolve last)",
            "ED": "-",
            "HOSP": "Y",
            "OPD": "Y"
          },
          {
            "item": "Cognitive rehabilitation exercises as directed by speech and occupational therapy",
            "ED": "-",
            "HOSP": "Y",
            "OPD": "Y"
          },
          {
            "item": "Safety modifications at home (remove sharp objects, secure stairways, fall prevention)",
            "ED": "-",
            "HOSP": "Y",
            "OPD": "Y"
          },
          {
            "item": "Medical alert bracelet recommended (autoimmune encephalitis, seizure risk, immunosuppressed)",
            "ED": "-",
            "HOSP": "Y",
            "OPD": "Y"
          },
          {
            "item": "Follow-up appointments are critical -- relapse monitoring requires regular visits",
            "ED": "-",
            "HOSP": "Y",
            "OPD": "Y"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "frequency": "At diagnosis; repeat q6 months x 2 years if initially negative"
          },
          {
            "frequency": "At diagnosis; repeat if relapse"
          },
          {
            "frequency": "At diagnosis; repeat if relapse"
          },
          {
            "frequency": "At diagnosis; q6 months x 4 years"
          },
          {
            "frequency": "At diagnosis; q6 months x 4 years"
          },
          {
            "frequency": "At diagnosis"
          },
          {
            "frequency": "At diagnosis; q6 months x 4 years"
          },
          {
            "frequency": "At diagnosis; q6 months x 4 years"
          },
          {
            "frequency": "At diagnosis; q6 months x 4 years"
          },
          {
            "frequency": "At diagnosis; q6 months x 4 years"
          },
          {
            "frequency": "At diagnosis; repeat if relapse"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "HSV encephalitis",
        "features": "Acute fever, temporal lobe hemorrhagic necrosis, CSF lymphocytic pleocytosis with RBCs",
        "tests": "HSV PCR (CSF); MRI temporal lobe changes; often more acute onset"
      },
      {
        "diagnosis": "Other viral encephalitis (EBV, CMV, HHV-6, enterovirus, West Nile)",
        "features": "Fever, CSF pleocytosis, specific exposure/season, immunocompromised status",
        "tests": "Specific viral PCR/serology; CSF studies"
      },
      {
        "diagnosis": "Bacterial meningitis/encephalitis",
        "features": "Acute fever, meningismus, CSF neutrophilic pleocytosis, low glucose",
        "tests": "CSF Gram stain, culture, procalcitonin, bacterial PCR"
      },
      {
        "diagnosis": "Neurosyphilis",
        "features": "Cognitive decline, psychiatric symptoms, Argyll Robertson pupils, positive serology",
        "tests": "RPR/VDRL; CSF VDRL; FTA-ABS"
      },
      {
        "diagnosis": "Prion disease (CJD)",
        "features": "Rapidly progressive dementia, myoclonus, akinetic mutism; cortical ribboning on MRI (DWI)",
        "tests": "14-3-3 protein; RT-QuIC; MRI DWI cortical ribboning; EEG periodic discharges"
      },
      {
        "diagnosis": "CNS lymphoma",
        "features": "Progressive encephalopathy, mass lesion, periventricular enhancement, immunocompromised",
        "tests": "CSF cytology/flow cytometry; FDG-PET; brain biopsy"
      },
      {
        "diagnosis": "CNS vasculitis",
        "features": "Headache, stroke-like episodes, multifocal infarcts, elevated ESR/CRP",
        "tests": "Angiography; brain/leptomeningeal biopsy; ESR/CRP"
      },
      {
        "diagnosis": "Neurosarcoidosis",
        "features": "Cranial neuropathies, hypothalamic dysfunction, leptomeningeal enhancement",
        "tests": "ACE level; chest CT (hilar adenopathy); biopsy"
      },
      {
        "diagnosis": "Hashimoto encephalopathy (SREAT)",
        "features": "Encephalopathy with very high anti-TPO; steroid-responsive; diagnosis of exclusion",
        "tests": "Anti-TPO; anti-thyroglobulin; dramatic steroid response"
      },
      {
        "diagnosis": "Acute disseminated encephalomyelitis (ADEM)",
        "features": "Post-infectious/post-vaccination, multifocal large white matter lesions, encephalopathy",
        "tests": "MRI pattern; MOG-IgG; monophasic course"
      },
      {
        "diagnosis": "NMO spectrum disorder (NMOSD)",
        "features": "Optic neuritis, longitudinally extensive myelitis, area postrema syndrome",
        "tests": "AQP4-IgG; MRI pattern"
      },
      {
        "diagnosis": "Drug/toxin-induced encephalopathy",
        "features": "Temporal correlation with drug exposure; resolves with discontinuation",
        "tests": "Urine drug screen; medication review; drug levels"
      },
      {
        "diagnosis": "Metabolic encephalopathy",
        "features": "Hepatic, uremic, thyroid, electrolyte disturbances",
        "tests": "CMP; LFTs; ammonia; TSH; specific metabolic panels"
      },
      {
        "diagnosis": "Psychiatric disorder (new-onset psychosis, catatonia)",
        "features": "No CSF pleocytosis; normal MRI/EEG; isolated psychiatric symptoms (caution: AE can present as pure psychiatric)",
        "tests": "LP mandatory to differentiate; EEG; MRI; antibody testing before assuming primary psychiatric"
      },
      {
        "diagnosis": "Seizure-related encephalopathy (post-ictal/non-convulsive SE)",
        "features": "Prolonged post-ictal confusion; non-convulsive status on EEG",
        "tests": "Continuous EEG monitoring; resolves with ASM treatment"
      },
      {
        "diagnosis": "Neuro-Behcet disease",
        "features": "Oral/genital ulcers; brainstem predominance; CSF neutrophilic pleocytosis",
        "tests": "Clinical criteria; pathergy test; HLA-B51"
      }
    ],
    "evidence": [
      {
        "recommendation": "Graus 2016 diagnostic criteria for autoimmune encephalitis",
        "evidenceLevel": "Expert Consensus, Class III",
        "source": "[Graus F et al. Lancet Neurol 2016;15:391-404](https://pubmed.ncbi.nlm.nih.gov/26906964/)"
      },
      {
        "recommendation": "CSF antibody testing more sensitive than serum for anti-NMDAR",
        "evidenceLevel": "Class II",
        "source": "[Dalmau J et al. Lancet Neurol 2008;7:1091-1098](https://pubmed.ncbi.nlm.nih.gov/18851928/)"
      },
      {
        "recommendation": "Cell-based assay (CBA) is gold standard for antibody detection",
        "evidenceLevel": "Class II",
        "source": "Waters P et al. J Neurol Neurosurg Psychiatry 2014"
      },
      {
        "recommendation": "First-line immunotherapy: IV steroids + IVIG or PLEX",
        "evidenceLevel": "Class III, Expert Consensus",
        "source": "[Titulaer MJ et al. Lancet Neurol 2013;12:157-165](https://pubmed.ncbi.nlm.nih.gov/23290630/)"
      },
      {
        "recommendation": "Early immunotherapy improves outcomes",
        "evidenceLevel": "Class II",
        "source": "[Titulaer MJ et al. Lancet Neurol 2013;12:157-165](https://pubmed.ncbi.nlm.nih.gov/23290630/)"
      },
      {
        "recommendation": "Rituximab as second-line therapy",
        "evidenceLevel": "Class III, Retrospective",
        "source": "[Lee WJ et al. Neurology 2016;86:1683-1691](https://pubmed.ncbi.nlm.nih.gov/27037228/)"
      },
      {
        "recommendation": "Early second-line (rituximab) improves anti-NMDAR outcomes",
        "evidenceLevel": "Class III",
        "source": "[Titulaer MJ et al. Lancet Neurol 2013;12:157-165](https://pubmed.ncbi.nlm.nih.gov/23290630/)"
      },
      {
        "recommendation": "Cyclophosphamide as second-line therapy",
        "evidenceLevel": "Class III, Expert Consensus",
        "source": "[Dalmau J & Graus F. N Engl J Med 2018;378:840-851](https://pubmed.ncbi.nlm.nih.gov/29490181/)"
      },
      {
        "recommendation": "Tocilizumab for refractory autoimmune encephalitis",
        "evidenceLevel": "Class IV, Case Series",
        "source": "[Lee WJ et al. Neurotherapeutics 2016;13:824-832](https://pubmed.ncbi.nlm.nih.gov/27215218/)"
      },
      {
        "recommendation": "Bortezomib for refractory autoimmune encephalitis",
        "evidenceLevel": "Class IV, Case Series",
        "source": "[Scheibe F et al. Neurology 2017;88:366-370](https://pubmed.ncbi.nlm.nih.gov/28003505/)"
      },
      {
        "recommendation": "Ovarian teratoma resection is essential in anti-NMDAR",
        "evidenceLevel": "Class II",
        "source": "[Titulaer MJ et al. Lancet Neurol 2013](https://pubmed.ncbi.nlm.nih.gov/23290630/)"
      },
      {
        "recommendation": "Tumor screening by antibody type",
        "evidenceLevel": "Expert Consensus",
        "source": "[Graus F et al. Lancet Neurol 2016](https://pubmed.ncbi.nlm.nih.gov/26906964/)"
      },
      {
        "recommendation": "Extreme delta brush on EEG in anti-NMDAR",
        "evidenceLevel": "Class III",
        "source": "[Schmitt SE et al. Neurology 2012;79:1094-1100](https://pubmed.ncbi.nlm.nih.gov/22933737/)"
      },
      {
        "recommendation": "Faciobrachial dystonic seizures precede LGI1 encephalitis",
        "evidenceLevel": "Class III",
        "source": "[Irani SR et al. Ann Neurol 2011;69:892-900](https://pubmed.ncbi.nlm.nih.gov/21416487/)"
      },
      {
        "recommendation": "Hyponatremia in LGI1 encephalitis (SIADH mechanism)",
        "evidenceLevel": "Class III",
        "source": "[Lai M et al. Lancet Neurol 2010;9:776-785](https://pubmed.ncbi.nlm.nih.gov/20580615/)"
      },
      {
        "recommendation": "GABA-B encephalitis and SCLC association (~50%)",
        "evidenceLevel": "Class III",
        "source": "[Lancaster E et al. Lancet Neurol 2010;9:67-76](https://pubmed.ncbi.nlm.nih.gov/19962348/)"
      },
      {
        "recommendation": "Anti-NMDAR encephalitis staging and recovery pattern",
        "evidenceLevel": "Class II",
        "source": "[Dalmau J et al. Lancet Neurol 2019;18:1045-1057](https://pubmed.ncbi.nlm.nih.gov/31326280/)"
      },
      {
        "recommendation": "Modified Rankin Scale for outcome tracking",
        "evidenceLevel": "Validated Scale",
        "source": "[van Swieten JC et al. Stroke 1988;19:604-607](https://pubmed.ncbi.nlm.nih.gov/3363593/)"
      },
      {
        "recommendation": "CASE score for autoimmune encephalitis assessment",
        "evidenceLevel": "Validated Scale",
        "source": "[Lim JA et al. Ann Neurol 2019;85:352-358](https://pubmed.ncbi.nlm.nih.gov/30675918/)"
      },
      {
        "recommendation": "Catatonia in anti-NMDAR encephalitis (~40%)",
        "evidenceLevel": "Class III",
        "source": "[Al-Diwani A et al. Lancet Psychiatry 2019;6:235-246](https://pubmed.ncbi.nlm.nih.gov/30765329/)"
      },
      {
        "recommendation": "Lorazepam challenge for catatonia",
        "evidenceLevel": "Expert Consensus",
        "source": "[Bush G et al. Acta Psychiatr Scand 1996;93:129-136](https://pubmed.ncbi.nlm.nih.gov/8686483/)"
      },
      {
        "recommendation": "NMS risk with antipsychotics in anti-NMDAR",
        "evidenceLevel": "Class IV, Case Reports",
        "source": "[Lejuste F et al. Neurol Neuroimmunol Neuroinflamm 2016;3:e280](https://pubmed.ncbi.nlm.nih.gov/27606355/)"
      },
      {
        "recommendation": "Levetiracetam as preferred ASM in autoimmune encephalitis",
        "evidenceLevel": "Expert Consensus",
        "source": "[Britton J. Handb Clin Neurol 2016;133:219-245](https://pubmed.ncbi.nlm.nih.gov/27112680/)"
      },
      {
        "recommendation": "Avoid carbamazepine in LGI1 (worsens hyponatremia)",
        "evidenceLevel": "Expert Consensus",
        "source": "[Irani SR et al. Brain 2010;133:2734-2748](https://pubmed.ncbi.nlm.nih.gov/20663977/)"
      },
      {
        "recommendation": "Long-term rituximab maintenance prevents relapse",
        "evidenceLevel": "Class III",
        "source": "[Nosadini M et al. Expert Rev Neurother 2015;15:1391-1419](https://pubmed.ncbi.nlm.nih.gov/26559389/)"
      },
      {
        "recommendation": "Anti-NMDAR relapse rate 12-20%",
        "evidenceLevel": "Class II",
        "source": "[Titulaer MJ et al. Lancet Neurol 2013](https://pubmed.ncbi.nlm.nih.gov/23290630/)"
      },
      {
        "recommendation": "Mycophenolate as steroid-sparing agent",
        "evidenceLevel": "Class IV",
        "source": "Expert practice; no large trials"
      },
      {
        "recommendation": "Autonomic instability management in anti-NMDAR",
        "evidenceLevel": "Expert Consensus",
        "source": "[Dalmau J & Graus F. N Engl J Med 2018](https://pubmed.ncbi.nlm.nih.gov/29490181/)"
      },
      {
        "recommendation": "Repeat tumor screening q6 months x 2-4 years",
        "evidenceLevel": "Expert Consensus",
        "source": "[Graus F et al. Lancet Neurol 2016](https://pubmed.ncbi.nlm.nih.gov/26906964/)"
      },
      {
        "recommendation": "Central hypoventilation in severe anti-NMDAR requiring prolonged ventilation",
        "evidenceLevel": "Class III",
        "source": "[Florance NR et al. Ann Neurol 2009;66:11-18](https://pubmed.ncbi.nlm.nih.gov/19670433/)"
      },
      {
        "recommendation": "Neuropsychological recovery trajectory in autoimmune encephalitis",
        "evidenceLevel": "Class III",
        "source": "[Finke C et al. JAMA Neurol 2017;74:50-59](https://pubmed.ncbi.nlm.nih.gov/27893017/)"
      }
    ],
    "monitoring": [
      {
        "item": "Neurologic examination (GCS, orientation, cranial nerves, motor, reflexes)",
        "frequency": "Q4-6h (ICU); Q8-12h (floor)",
        "action": "If worsening: urgent re-imaging; escalate immunotherapy; consider ICU transfer"
      },
      {
        "item": "Modified Rankin Scale (mRS)",
        "frequency": "Baseline, then weekly",
        "action": "Document trajectory; guide treatment escalation; long-term disability tracking"
      },
      {
        "item": "Bush-Francis Catatonia Rating Scale",
        "frequency": "Daily if catatonia features",
        "action": "If not responding to lorazepam: increase dose; consider ECT; escalate immunotherapy"
      },
      {
        "item": "Blood glucose",
        "frequency": "Q6h during IV steroids",
        "action": "Insulin sliding scale; endocrine consult if persistent >250"
      },
      {
        "item": "Blood pressure",
        "frequency": "Q1h (ICU); Q4h (floor)",
        "action": "Autonomic dysregulation: labetalol/esmolol for hypertension; norepinephrine for hypotension"
      },
      {
        "item": "Heart rate and rhythm",
        "frequency": "Continuous telemetry (ICU/floor)",
        "action": "Autonomic instability: treat per protocol (3F); cardiology consult if sustained arrhythmia"
      },
      {
        "item": "Temperature",
        "frequency": "Q4h; continuous in ICU",
        "action": "Central hyperthermia: cooling measures; acetaminophen; rule out infection"
      },
      {
        "item": "Respiratory rate and NIF",
        "frequency": "Q4h (ICU); Q shift (floor)",
        "action": "NIF worsening toward -20: intubation; ICU transfer; evaluate for neuromuscular respiratory failure"
      },
      {
        "item": "Seizure log",
        "frequency": "Continuous",
        "action": "If increasing: escalate ASMs; re-assess immunotherapy; continuous EEG"
      },
      {
        "item": "EEG (continuous)",
        "frequency": "24-72h minimum; longer if ICU",
        "action": "If persistent seizures: escalate per Section 3D"
      },
      {
        "item": "Sodium (Na)",
        "frequency": "Q6-12h (if LGI1 or hyponatremia)",
        "action": "Correct per protocol (3F); fluid restriction if SIADH"
      },
      {
        "item": "I/O and daily weight",
        "frequency": "Daily",
        "action": "Adjust fluids; diuretics if fluid overload; free water restriction if SIADH"
      },
      {
        "item": "Renal function (BUN/Cr)",
        "frequency": "Daily during IVIG; q48h otherwise",
        "action": "Hold IVIG if Cr rising; hydration; nephrology consult"
      },
      {
        "item": "CBC with differential",
        "frequency": "Q48h during immunotherapy; daily if on cyclophosphamide",
        "action": "Hold immunotherapy if critically low; growth factor support; hematology consult"
      },
      {
        "item": "LFTs",
        "frequency": "Q48-72h during acute treatment",
        "action": "Dose adjustment or hold hepatotoxic medications"
      },
      {
        "item": "Fibrinogen (during PLEX)",
        "frequency": "Before each exchange",
        "action": "Hold PLEX if <100; FFP replacement"
      }
    ],
    "disposition": [
      {
        "disposition": "**Discharge home**",
        "criteria": "Mild symptoms; stable or improving on established immunotherapy; no active seizures; able to perform basic ADLs; reliable follow-up within 1-2 weeks; no significant autonomic instability; family/caregiver education completed; outpatient infusion arranged if needed"
      },
      {
        "disposition": "**Admit to floor (medical/neurology)**",
        "criteria": "New-onset encephalitis requiring workup and immunotherapy initiation; seizures requiring medication adjustment; moderate behavioral symptoms manageable on floor; needs IV steroids/IVIG; diagnostic uncertainty requiring expedited workup"
      },
      {
        "disposition": "**Admit to ICU**",
        "criteria": "Refractory status epilepticus; altered consciousness (GCS <12); severe autonomic instability (hemodynamic swings, arrhythmias, central hypoventilation); need for continuous EEG monitoring; requirement for mechanical ventilation; severe catatonia unresponsive to lorazepam; frequent or prolonged seizures requiring IV anesthetic infusions"
      },
      {
        "disposition": "**Transfer to higher level of care**",
        "criteria": "PLEX or continuous EEG not available; neurology/neuroimmunology specialist not available; need for tumor resection (gynecologic oncology for teratoma); requires ICU care not available at current facility"
      },
      {
        "disposition": "**Inpatient rehabilitation**",
        "criteria": "Medically stable; significant functional deficits requiring intensive therapy (cognitive, motor, speech); unable to safely return home; expected to benefit from structured rehabilitation program"
      },
      {
        "disposition": "**Long-term acute care (LTAC)**",
        "criteria": "Prolonged ventilator dependence (common in severe anti-NMDAR); medically complex care needs; ongoing immunotherapy requirements; unable to participate in intensive rehab"
      },
      {
        "disposition": "**Skilled nursing facility**",
        "criteria": "Stable but unable to perform ADLs independently; requires ongoing nursing care; awaiting rehabilitation bed; chronic disability"
      },
      {
        "disposition": "**Outpatient follow-up**",
        "criteria": "All discharged patients: neurology follow-up within 1-2 weeks; infusion center for ongoing immunotherapy; neuropsychology referral; rehab services; tumor surveillance per protocol"
      },
      {
        "disposition": "**Readmission criteria**",
        "criteria": "New seizures after period of control; behavioral/cognitive regression; fever or signs of infection on immunotherapy; suspected relapse (any new neurologic/psychiatric symptoms)"
      }
    ]
  },
  "Migraine": {
    "id": "migraine",
    "title": "Migraine",
    "version": "1.0",
    "icd10": [
      "** G43.909 (Migraine",
      "unspecified",
      "not intractable)",
      "G43.919 (Migraine",
      "unspecified",
      "intractable)",
      "G43.901 (Migraine",
      "unspecified",
      "not intractable",
      "with status migrainosus)",
      "G43.911 (Migraine",
      "unspecified",
      "intractable",
      "with status migrainosus)",
      "G43.109 (Migraine with aura",
      "not intractable)",
      "G43.709 (Chronic migraine without aura",
      "not intractable)"
    ],
    "scope": "** Evaluation and management of acute migraine, status migrainosus, and chronic migraine in adults. Covers abortive therapy, rescue treatment for refractory attacks, and preventive medication initiation. Includes special considerations for pregnancy and medication overuse. Excludes secondary headache disorders, cluster headache, and tension-type headache.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out anemia, infection",
            "target": "Normal"
          },
          {
            "item": "CMP",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Electrolyte abnormalities, renal function",
            "target": "Normal"
          },
          {
            "item": "hCG (women of childbearing age)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Pregnancy status affects treatment options",
            "target": "Document status"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Thyroid dysfunction can cause headache",
            "target": "Normal"
          },
          {
            "item": "Magnesium",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Low levels may contribute to migraines",
            "target": ">1.8 mg/dL"
          }
        ],
        "Extended Workup": [
          {
            "item": "ESR/CRP",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If GCA or inflammatory cause suspected (>50 years, new onset)",
            "target": "Normal"
          },
          {
            "item": "Vitamin D",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency associated with migraine frequency",
            "target": ">30 ng/mL"
          },
          {
            "item": "Ferritin",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Iron deficiency associated with migraine",
            "target": ">50 ng/mL"
          },
          {
            "item": "Homocysteine",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Elevated levels associated with migraine with aura",
            "target": "Normal"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Lumbar puncture",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Thunderclap headache, suspected SAH, IIH, meningitis",
            "target": "See LP section"
          },
          {
            "item": "Autoimmune panel (ANA, etc.)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If vasculitis or autoimmune cause suspected",
            "target": "Negative"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "IIH diagnosis",
            "target": "10-20 cm H2O (elevated >25 suggests IIH)"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Infection, SAH",
            "target": "WBC <5; RBC 0 or clearing"
          },
          {
            "item": "Protein",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Infection, inflammation",
            "target": "15-45 mg/dL"
          },
          {
            "item": "Glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Infection",
            "target": ">60% serum"
          },
          {
            "item": "Xanthochromia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "SAH if CT negative",
            "target": "Negative"
          },
          {
            "item": "Gram stain and culture",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Bacterial meningitis",
            "target": "No organisms"
          },
          {
            "item": "CSF meningitis panel",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Viral/bacterial pathogens",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "ED": "STAT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "timing": "If thunderclap, worst headache, focal deficits, altered mental status",
            "target": "Rule out hemorrhage, mass",
            "contraindications": "None in emergency"
          },
          {
            "item": "MRI brain without contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "New headache pattern, focal features, refractory to treatment",
            "target": "Normal; rule out structural cause",
            "contraindications": "Pacemaker, metal implants"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain with and without contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If mass, infection, or inflammation suspected",
            "target": "Rule out enhancement",
            "contraindications": "Contrast allergy, renal disease"
          },
          {
            "item": "MRV or CT venogram",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "timing": "Suspected cerebral venous thrombosis",
            "target": "Patent venous sinuses",
            "contraindications": "Per modality"
          },
          {
            "item": "MRA head",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Suspected vasculopathy, aneurysm",
            "target": "Normal vasculature",
            "contraindications": "Per modality"
          },
          {
            "item": "ECG",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-",
            "timing": "Prior to DHE or triptan use",
            "target": "Normal QTc, no ischemia",
            "contraindications": "None"
          }
        ]
      },
      "Treatment": {
        "Acute/Abortive Treatment - Mild-Moderate Attacks": [
          {
            "item": "Acetaminophen",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Acetaminophen 1000 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "1000 mg PO once, max 3000 mg/day",
              "orderSentence": "Acetaminophen 1000 mg PO"
            },
            "contraindications": "Hepatic disease, chronic alcohol use",
            "monitoring": "LFTs if frequent use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ibuprofen",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400-800 mg",
                  "orderSentence": "Ibuprofen 400-800 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "400-800 mg PO once",
              "orderSentence": "Ibuprofen 400-800 mg PO"
            },
            "contraindications": "Renal disease, GI bleeding, aspirin allergy",
            "monitoring": "Renal function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Naproxen sodium",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500-825 mg",
                  "orderSentence": "Naproxen sodium 500-825 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "500-825 mg PO once",
              "orderSentence": "Naproxen sodium 500-825 mg PO"
            },
            "contraindications": "Same as ibuprofen",
            "monitoring": "Renal function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Aspirin",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "900-1000 mg",
                  "orderSentence": "Aspirin 900-1000 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "900-1000 mg PO once",
              "orderSentence": "Aspirin 900-1000 mg PO"
            },
            "contraindications": "Bleeding disorder, aspirin allergy",
            "monitoring": "Bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Excedrin (ASA/APAP/caffeine)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "instructions": "2 tablets PO once",
              "orderSentence": "Excedrin (ASA/APAP/caffeine) - PO - see dosing"
            },
            "contraindications": "Per components",
            "monitoring": "Risk of MOH",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Acute/Abortive Treatment - Moderate-Severe Attacks (Triptans)": [
          {
            "item": "Sumatriptan SC",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "6 mg",
                  "orderSentence": "Sumatriptan SC 6 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "6 mg SC once; may repeat in 2h; max 12 mg/24h",
              "orderSentence": "Sumatriptan SC 6 mg SC"
            },
            "contraindications": "CAD, stroke/TIA, uncontrolled HTN, hemiplegic/basilar migraine, pregnancy",
            "monitoring": "Chest tightness, BP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Sumatriptan PO",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50-100 mg",
                  "orderSentence": "Sumatriptan PO 50-100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "50-100 mg PO once; may repeat in 2h; max 200 mg/24h",
              "orderSentence": "Sumatriptan PO 50-100 mg PO"
            },
            "contraindications": "Same as SC",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sumatriptan nasal",
            "route": "IN",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "Sumatriptan nasal 20 mg IN"
                }
              ],
              "route": "IN",
              "instructions": "20 mg intranasal; may repeat in 2h; max 40 mg/24h",
              "orderSentence": "Sumatriptan nasal 20 mg IN"
            },
            "contraindications": "Same as SC",
            "monitoring": "Same",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rizatriptan",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-10 mg",
                  "orderSentence": "Rizatriptan 5-10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10 mg PO (ODT available); may repeat in 2h; max 30 mg/24h",
              "orderSentence": "Rizatriptan 5-10 mg PO"
            },
            "contraindications": "Same; 5 mg if on propranolol",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Eletriptan",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Eletriptan 40 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "40 mg PO; may repeat in 2h; max 80 mg/24h",
              "orderSentence": "Eletriptan 40 mg PO"
            },
            "contraindications": "Same; severe hepatic impairment",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Zolmitriptan",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5-5 mg",
                  "orderSentence": "Zolmitriptan 2.5-5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "2.5-5 mg PO or nasal; may repeat in 2h; max 10 mg/24h",
              "orderSentence": "Zolmitriptan 2.5-5 mg PO"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Acute/Abortive Treatment - CGRP Antagonists (Gepants)": [
          {
            "item": "Ubrogepant",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50-100 mg",
                  "orderSentence": "Ubrogepant 50-100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "50-100 mg PO; may repeat in 2h; max 200 mg/24h",
              "orderSentence": "Ubrogepant 50-100 mg PO"
            },
            "contraindications": "CYP3A4 inhibitors; no cardiovascular contraindications",
            "monitoring": "LFTs periodically",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rimegepant",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg",
                  "orderSentence": "Rimegepant 75 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "75 mg PO once daily; ODT formulation",
              "orderSentence": "Rimegepant 75 mg PO"
            },
            "contraindications": "CYP3A4 inhibitors",
            "monitoring": "LFTs periodically",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Zavegepant nasal",
            "route": "IN",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Zavegepant nasal 10 mg IN"
                }
              ],
              "route": "IN",
              "instructions": "10 mg intranasal once daily",
              "orderSentence": "Zavegepant nasal 10 mg IN"
            },
            "contraindications": "None significant",
            "monitoring": "Local irritation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "ED/Inpatient Treatment - Status Migrainosus (\"Headache Cocktail\")": [
          {
            "item": "IV fluids",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75-125 mL/hr",
                  "orderSentence": "IV fluids 75-125 mL/hr -"
                }
              ],
              "route": "-",
              "instructions": "NS or LR 1L bolus, then 75-125 mL/hr",
              "orderSentence": "IV fluids 75-125 mL/hr -"
            },
            "pretreatment": "-",
            "contraindications": "Heart failure, volume overload",
            "monitoring": "I/O",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Prochlorperazine IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Prochlorperazine IV 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg IV slow push over 5-10 min; may repeat in 30 min",
              "orderSentence": "Prochlorperazine IV 10 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "QT prolongation, Parkinson's",
            "monitoring": "QTc, akathisia, dystonia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Metoclopramide IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-20 mg",
                  "orderSentence": "Metoclopramide IV 10-20 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10-20 mg IV over 15-30 min; may repeat in 30 min",
              "orderSentence": "Metoclopramide IV 10-20 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "QT prolongation, Parkinson's, seizures",
            "monitoring": "QTc, akathisia, dystonia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Diphenhydramine IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-50 mg",
                  "orderSentence": "Diphenhydramine IV 25-50 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "25-50 mg IV to prevent akathisia (give with antiemetic)",
              "orderSentence": "Diphenhydramine IV 25-50 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Glaucoma, urinary retention",
            "monitoring": "Sedation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Ketorolac IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg",
                  "orderSentence": "Ketorolac IV 30 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "30 mg IV (15 mg if >65y or CrCl <50); max 2 doses",
              "orderSentence": "Ketorolac IV 30 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Renal disease, GI bleeding, anticoagulation",
            "monitoring": "Renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Dexamethasone IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Dexamethasone IV 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg IV once (reduces recurrence)",
              "orderSentence": "Dexamethasone IV 10 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Active infection, uncontrolled DM",
            "monitoring": "Glucose",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Magnesium sulfate IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g",
                  "orderSentence": "Magnesium sulfate IV 2 g IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV over 20-30 min",
              "orderSentence": "Magnesium sulfate IV 2 g IV"
            },
            "pretreatment": "-",
            "contraindications": "Renal failure, myasthenia",
            "monitoring": "Mg levels, reflexes",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Valproate sodium IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500-1000 mg",
                  "orderSentence": "Valproate sodium IV 500-1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "500-1000 mg IV over 15-30 min",
              "orderSentence": "Valproate sodium IV 500-1000 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Pregnancy, hepatic disease, mitochondrial disease",
            "monitoring": "Ammonia, LFTs",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "ED/Inpatient - Refractory/Second-Line Therapy (DHE Protocol)": [
          {
            "item": "Dihydroergotamine (DHE)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Dihydroergotamine (DHE) 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Premedicate: metoclopramide 10 mg IV + diphenhydramine 25 mg IV; Test dose: 0.5 mg IV over 1 min; If tolerated: 0.5-1 mg IV q8h",
              "orderSentence": "Dihydroergotamine (DHE) 10 mg IV"
            },
            "contraindications": "Pregnancy, CAD, CVA, uncontrolled HTN, triptan <24h, ergot allergy",
            "monitoring": "BP, chest pain, nausea",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "DHE nasal",
            "route": "IN",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg",
                  "orderSentence": "DHE nasal 0.5 mg -"
                }
              ],
              "route": "-",
              "instructions": "0.5 mg per nostril (1 mg total); may repeat once in 15 min; max 3 mg/24h",
              "orderSentence": "DHE nasal 0.5 mg -"
            },
            "contraindications": "Same as IV",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Pregnancy-Safe Options": [
          {
            "item": "Acetaminophen",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Acetaminophen 1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg PO/IV q8h; max 3000 mg/day",
              "orderSentence": "Acetaminophen 1000 mg IV"
            },
            "contraindications": "Hepatic disease",
            "monitoring": "LFTs",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Metoclopramide",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Metoclopramide 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg IV/PO q8h",
              "orderSentence": "Metoclopramide 10 mg IV"
            },
            "contraindications": "Parkinson's",
            "monitoring": "Akathisia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ondansetron",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4-8 mg",
                  "orderSentence": "Ondansetron 4-8 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "4-8 mg IV/PO q8h",
              "orderSentence": "Ondansetron 4-8 mg IV"
            },
            "contraindications": "QT prolongation (caution 1st trimester)",
            "monitoring": "QTc",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Magnesium sulfate",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g",
                  "orderSentence": "Magnesium sulfate 2 g IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV once",
              "orderSentence": "Magnesium sulfate 2 g IV"
            },
            "contraindications": "Renal failure",
            "monitoring": "Reflexes, respiratory",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Nerve block (occipital)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-3 mL",
                  "orderSentence": "Nerve block (occipital) 2-3 mL -"
                }
              ],
              "route": "-",
              "instructions": "Lidocaine 1% or bupivacaine 0.25%, 2-3 mL per side",
              "orderSentence": "Nerve block (occipital) 2-3 mL -"
            },
            "contraindications": "Local anesthetic allergy",
            "monitoring": "Local reaction",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sumatriptan (if refractory)",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "6 mg",
                  "orderSentence": "Sumatriptan (if refractory) 6 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "6 mg SC x1 (pregnancy registry data reassuring)",
              "orderSentence": "Sumatriptan (if refractory) 6 mg SC"
            },
            "contraindications": "Per triptan list; discuss risks",
            "monitoring": "Standard",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Preventive Medications - First-Line": [
          {
            "item": "Propranolol",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40-80 mg/day",
                  "orderSentence": "Propranolol 40-80 mg/day PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 40-80 mg/day in divided doses; target 80-240 mg/day",
              "orderSentence": "Propranolol 40-80 mg/day PO"
            },
            "contraindications": "Asthma, heart block, bradycardia, depression",
            "monitoring": "HR, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Metoprolol",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-50 mg",
                  "orderSentence": "Metoprolol 25-50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg BID; target 100-200 mg/day",
              "orderSentence": "Metoprolol 25-50 mg PO"
            },
            "contraindications": "Same as propranolol",
            "monitoring": "HR, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Topiramate",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Topiramate 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg QHS; increase by 25 mg/week to 50-100 mg BID",
              "orderSentence": "Topiramate 25 mg PO"
            },
            "contraindications": "Kidney stones, pregnancy (teratogenic), glaucoma",
            "monitoring": "Bicarbonate, cognitive effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-25 mg",
                  "orderSentence": "Amitriptyline 10-25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg QHS; target 50-150 mg QHS",
              "orderSentence": "Amitriptyline 10-25 mg PO"
            },
            "contraindications": "Glaucoma, urinary retention, cardiac arrhythmia",
            "monitoring": "QTc, anticholinergic effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5 mg",
                  "orderSentence": "Venlafaxine XR 37.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5 mg daily; target 75-150 mg daily",
              "orderSentence": "Venlafaxine XR 37.5 mg PO"
            },
            "contraindications": "Uncontrolled HTN, MAOI use",
            "monitoring": "BP, serotonin syndrome",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consult",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "indication": "Status migrainosus, refractory to ED treatment"
          },
          {
            "item": "Headache specialist referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Chronic migraine, medication overuse, refractory disease"
          },
          {
            "item": "Ophthalmology consult",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Papilledema, visual symptoms suggesting IIH"
          },
          {
            "item": "Pain management referral",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Refractory chronic migraine, nerve block consideration"
          },
          {
            "item": "Behavioral health referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Comorbid anxiety/depression, biofeedback interest"
          },
          {
            "item": "Physical therapy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Cervicogenic component, trigger point therapy"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Keep headache diary (frequency, severity, triggers, medications)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Treat migraine early - medications more effective within first hour",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid medication overuse: limit triptans to ≤9 days/month, NSAIDs to ≤14 days/month",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Identify and avoid personal triggers",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Follow up with neurologist in 2-4 weeks if new diagnosis",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Follow up with PCP or neurologist for preventive medication monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return to ED if: worst headache of life, fever, neurologic deficits, altered mental status",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Maintain regular sleep schedule (7-8 hours)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular exercise (30 min, 5 days/week)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management (biofeedback, relaxation techniques, CBT)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stay well-hydrated (64+ oz water daily)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid known triggers: alcohol, aged cheese, MSG, processed meats, irregular meals",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit caffeine to consistent moderate intake (<200 mg/day)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Consider migraine glasses (FL-41 tint) for photophobia",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Tension-type headache",
        "features": "Bilateral, pressing/tightening, mild-moderate, no nausea/vomiting",
        "tests": "Clinical history; no photophobia"
      },
      {
        "diagnosis": "Cluster headache",
        "features": "Unilateral periorbital, autonomic features (tearing, rhinorrhea), short duration (15-180 min), circadian pattern",
        "tests": "Clinical pattern; response to O2/triptans"
      },
      {
        "diagnosis": "Medication overuse headache",
        "features": "Chronic daily headache, >15 days/month, frequent analgesic use",
        "tests": "Medication diary; improves with withdrawal"
      },
      {
        "diagnosis": "Subarachnoid hemorrhage",
        "features": "Thunderclap onset, \"worst headache of life,\" neck stiffness",
        "tests": "CT head, LP if CT negative"
      },
      {
        "diagnosis": "Idiopathic intracranial hypertension",
        "features": "Papilledema, visual obscurations, pulsatile tinnitus, bilateral pressure",
        "tests": "LP with elevated OP (>25 cm H2O)"
      },
      {
        "diagnosis": "Giant cell arteritis",
        "features": "Age >50, new headache, jaw claudication, scalp tenderness, visual symptoms",
        "tests": "ESR/CRP elevated, temporal artery biopsy"
      },
      {
        "diagnosis": "Cerebral venous thrombosis",
        "features": "Progressive headache, seizures, focal deficits, pregnancy/OCP",
        "tests": "MRV/CTV"
      },
      {
        "diagnosis": "Cervicogenic headache",
        "features": "Neck pain, limited ROM, triggered by neck movement",
        "tests": "Cervical exam, imaging"
      },
      {
        "diagnosis": "Trigeminal autonomic cephalalgia",
        "features": "Short attacks, autonomic features, response to indomethacin (some types)",
        "tests": "Clinical pattern"
      },
      {
        "diagnosis": "Brain tumor",
        "features": "Progressive headache, worse in morning/with Valsalva, focal deficits",
        "tests": "MRI brain"
      }
    ],
    "evidence": [
      {
        "recommendation": "Triptans effective for acute migraine",
        "evidenceLevel": "Class I, Level A",
        "source": "Cochrane Reviews; AHS Guidelines"
      },
      {
        "recommendation": "Prochlorperazine/metoclopramide effective for acute migraine",
        "evidenceLevel": "Class I, Level A",
        "source": "[Friedman et al. Ann Emerg Med 2008](https://pubmed.ncbi.nlm.nih.gov/18006188/); [AHS Evidence Assessment 2016](https://pubmed.ncbi.nlm.nih.gov/27300483/)"
      },
      {
        "recommendation": "Dexamethasone reduces headache recurrence",
        "evidenceLevel": "Class I, Level A",
        "source": "[Singh et al. Acad Emerg Med 2008](https://pubmed.ncbi.nlm.nih.gov/18976336/)"
      },
      {
        "recommendation": "DHE effective for status migrainosus",
        "evidenceLevel": "Class II, Level B",
        "source": "[Raskin, Neurology 1986](https://pubmed.ncbi.nlm.nih.gov/3520384/)"
      },
      {
        "recommendation": "Beta-blockers effective for prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "[AAN/AHS Guidelines, Silberstein et al. Neurology 2012](https://pubmed.ncbi.nlm.nih.gov/22529202/)"
      },
      {
        "recommendation": "Topiramate effective for prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "[AAN/AHS Guidelines, Silberstein et al. Neurology 2012](https://pubmed.ncbi.nlm.nih.gov/22529202/)"
      },
      {
        "recommendation": "CGRP mAbs effective for prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs; FDA approved 2018+"
      },
      {
        "recommendation": "OnabotulinumtoxinA for chronic migraine",
        "evidenceLevel": "Class I, Level A",
        "source": "[PREEMPT pooled analysis, Dodick et al. 2010](https://pubmed.ncbi.nlm.nih.gov/20487038/); [Aurora et al. Cephalalgia 2010](https://pubmed.ncbi.nlm.nih.gov/20647170/)"
      },
      {
        "recommendation": "Gepants effective for acute and preventive treatment",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs 2019-2023"
      },
      {
        "recommendation": "Avoid medication overuse",
        "evidenceLevel": "Class II, Level B",
        "source": "[ICHD-3, Cephalalgia 2018](https://pubmed.ncbi.nlm.nih.gov/29368949/)"
      }
    ],
    "monitoring": [
      {
        "item": "Pain scale (0-10)",
        "ED": "STAT",
        "HOSP": "q4h",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "Per assessment",
        "action": "Escalate treatment"
      },
      {
        "item": "Vital signs",
        "ED": "STAT",
        "HOSP": "q4h",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "Per assessment",
        "action": "Address abnormalities"
      },
      {
        "item": "ECG (if using DHE/triptans)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "-",
        "frequency": "Before administration",
        "action": "Avoid vasoactive drugs"
      },
      {
        "item": "Headache diary",
        "ED": "-",
        "HOSP": "Daily",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "Ongoing",
        "action": "Adjust preventive"
      },
      {
        "item": "MIDAS score",
        "ED": "-",
        "HOSP": "-",
        "OPD": "q3 months",
        "ICU": "-",
        "frequency": "Quarterly",
        "action": "Adjust treatment"
      },
      {
        "item": "Medication use tracking",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "Ongoing",
        "action": "Address MOH"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge from ED",
        "criteria": "Pain controlled, able to tolerate PO, no red flags, close follow-up arranged"
      },
      {
        "disposition": "Admit to hospital",
        "criteria": "Status migrainosus unresponsive to ED treatment, need for DHE protocol, unable to tolerate PO, severe dehydration, concern for secondary headache"
      },
      {
        "disposition": "ICU admission",
        "criteria": "Rare - suspected intracranial pathology, hemodynamic instability"
      },
      {
        "disposition": "Discharge from hospital",
        "criteria": "Pain controlled on oral medications, tolerating PO, ambulatory"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "New diagnosis: 2-4 weeks; Chronic migraine: q1-3 months; On preventive: q3-6 months after stable"
      }
    ]
  },
  "Transient Ischemic Attack (TIA)": {
    "id": "tia",
    "title": "Transient Ischemic Attack (TIA)",
    "version": "1.0",
    "icd10": [
      "** G45.9 (Transient cerebral ischemic attack",
      "unspecified)"
    ],
    "scope": "** Urgent evaluation, risk stratification (ABCD2), and secondary stroke prevention. Excludes completed stroke (see Acute Ischemic Stroke protocol).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Polycythemia, thrombocytosis as stroke risk; anemia evaluation",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP",
            "rationale": "Electrolytes; glucose for hypoglycemia mimic; creatinine for contrast",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glucose (fingerstick)",
            "rationale": "Rule out hypoglycemia as TIA mimic",
            "target": "70-180 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "PT/INR, PTT",
            "rationale": "Baseline coagulation; evaluate if on anticoagulation",
            "target": "Normal or therapeutic",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lipid panel (fasting)",
            "rationale": "LDL target <70 for secondary prevention",
            "target": "LDL <70 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HbA1c",
            "rationale": "Diabetes assessment; target <7%",
            "target": "<7%",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Hyperthyroidism associated with atrial fibrillation",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Troponin",
            "rationale": "Concurrent cardiac ischemia; AF with rapid rate",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Homocysteine",
            "rationale": "Elevated levels increase stroke risk",
            "target": "<15 μmol/L",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lipoprotein(a)",
            "rationale": "Independent cardiovascular risk marker",
            "target": "<30 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "hsCRP",
            "rationale": "Inflammatory marker; guides statin intensity",
            "target": "<2 mg/L",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BNP/NT-proBNP",
            "rationale": "Heart failure; cardiac strain; AF risk",
            "target": "Age-adjusted normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Uric acid",
            "rationale": "Elevated associated with increased stroke risk",
            "target": "<6 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Hypercoagulability panel",
            "rationale": "Age <50, cryptogenic, recurrent events; includes Factor V Leiden, prothrombin mutation, protein C/S, antithrombin III",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Antiphospholipid antibodies",
            "rationale": "Lupus anticoagulant, anticardiolipin, anti-β2GP1; young stroke",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Hemoglobin electrophoresis",
            "rationale": "Sickle cell disease if not known",
            "target": "No sickling",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "ESR, ANA",
            "rationale": "Suspected vasculitis",
            "target": "Normal/Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Fabry disease testing (α-galactosidase A)",
            "rationale": "Young cryptogenic stroke, family history, angiokeratomas",
            "target": "Normal enzyme activity",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT Head non-contrast",
            "timing": "Immediate",
            "target": "No hemorrhage; rule out stroke mimic",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "MRI Brain with DWI",
            "timing": "Within 24 hours",
            "target": "No restricted diffusion (DWI+/ADC-) confirming infarct vs true TIA",
            "contraindications": "MRI-incompatible devices",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "CTA Head and Neck",
            "timing": "Same visit",
            "target": "No significant stenosis (>50%) in carotid, vertebral, or intracranial vessels",
            "contraindications": "Contrast allergy, CKD (relative)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "MRA Head and Neck",
            "timing": "Alternative to CTA",
            "target": "Patent vessels; no stenosis >50%",
            "contraindications": "MRI contraindications",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carotid duplex ultrasound",
            "timing": "Within 24-48 hours",
            "target": "<50% stenosis bilaterally",
            "contraindications": "None",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ECG (12-lead)",
            "timing": "Immediate",
            "target": "Sinus rhythm; no AF, LVH, or acute changes",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Transthoracic echocardiogram",
            "timing": "Within 24-48 hours",
            "target": "No thrombus, PFO, or significant valvular disease",
            "contraindications": "None",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "Cardiac telemetry (continuous)",
            "timing": "24-72 hours minimum",
            "target": "No atrial fibrillation or flutter",
            "contraindications": "None",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Holter monitor (24-48 hour)",
            "timing": "Outpatient",
            "target": "No paroxysmal AF",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Extended cardiac monitoring (14-30 day)",
            "timing": "Cryptogenic stroke/TIA",
            "target": "Detect paroxysmal AF",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Transesophageal echocardiogram",
            "timing": "Cryptogenic, young, embolic",
            "target": "No PFO, LAA thrombus, aortic arch atheroma",
            "contraindications": "Esophageal pathology",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Bubble study (TTE or TEE)",
            "timing": "Suspected paradoxical embolism",
            "target": "No right-to-left shunt",
            "contraindications": "None specific",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CT/MR perfusion",
            "timing": "Uncertain timing, large vessel occlusion symptoms",
            "target": "No mismatch suggesting salvageable tissue",
            "contraindications": "Contrast issues",
            "ED": "EXT",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Vessel wall MRI",
            "timing": "Suspected intracranial vasculitis or dissection",
            "target": "No vessel wall enhancement",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "DSA (cerebral angiogram)",
            "timing": "Vasculitis workup, moyamoya, uncertain vessel status",
            "target": "Define vascular anatomy",
            "contraindications": "Contrast allergy, bleeding risk",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Implantable loop recorder",
            "timing": "Recurrent cryptogenic events after negative workup",
            "target": "Detect occult AF",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Aspirin",
            "route": "PO",
            "indication": "Immediate antiplatelet therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "325 mg PO x1 load",
                  "orderSentence": "Aspirin 325 mg PO x1 load PO"
                },
                {
                  "text": "81 mg PO daily",
                  "orderSentence": "Aspirin 81 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "325 mg loading dose, then 81 mg daily ongoing",
              "orderSentence": "Aspirin 325 mg PO x1 load PO"
            },
            "contraindications": "Active GI bleed; aspirin allergy; planned thrombolysis",
            "monitoring": "GI symptoms, bleeding",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clopidogrel (DAPT with aspirin)",
            "route": "PO",
            "indication": "ABCD2 ≥4 or minor stroke; first 21 days",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg PO x1 load",
                  "orderSentence": "Clopidogrel (DAPT with aspirin) 300 mg PO x1 load PO"
                },
                {
                  "text": "75 mg PO daily",
                  "orderSentence": "Clopidogrel (DAPT with aspirin) 75 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "300 mg load then 75 mg daily with aspirin x21 days (POINT/CHANCE protocol)",
              "orderSentence": "Clopidogrel (DAPT with aspirin) 300 mg PO x1 load PO"
            },
            "contraindications": "Active bleeding; planned surgery within 7 days",
            "monitoring": "Bleeding, bruising",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ticagrelor (alternative DAPT)",
            "route": "PO",
            "indication": "Aspirin + ticagrelor if clopidogrel contraindicated",
            "dosing": {
              "doseOptions": [
                {
                  "text": "180 mg PO x1 load",
                  "orderSentence": "Ticagrelor (alternative DAPT) 180 mg PO x1 load PO"
                },
                {
                  "text": "90 mg PO BID",
                  "orderSentence": "Ticagrelor (alternative DAPT) 90 mg PO BID PO"
                }
              ],
              "route": "PO",
              "instructions": "180 mg load then 90 mg BID with aspirin x30 days (THALES protocol)",
              "orderSentence": "Ticagrelor (alternative DAPT) 180 mg PO x1 load PO"
            },
            "contraindications": "Active bleeding; prior ICH; severe hepatic impairment",
            "monitoring": "Bleeding, dyspnea",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Atorvastatin",
            "route": "PO",
            "indication": "High-intensity statin for LDL <70",
            "dosing": {
              "doseOptions": [
                {
                  "text": "80 mg PO daily",
                  "orderSentence": "Atorvastatin 80 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "80 mg daily (high-intensity); target LDL <70 mg/dL",
              "orderSentence": "Atorvastatin 80 mg PO daily PO"
            },
            "contraindications": "Active liver disease; pregnancy",
            "monitoring": "LFTs at baseline; myalgias",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Blood pressure management",
            "route": "-",
            "indication": "Permissive hypertension acutely; goal <140/90 long-term",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Target <180/110 first 24h",
                  "orderSentence": "Blood pressure management Target <180/110 first 24h -"
                },
                {
                  "text": "<140/90 after",
                  "orderSentence": "Blood pressure management <140/90 after -"
                }
              ],
              "route": "-",
              "instructions": "Do NOT lower BP aggressively in first 24h unless >220/120 or end-organ damage",
              "orderSentence": "Blood pressure management Target <180/110 first 24h -"
            },
            "contraindications": "Symptomatic hypotension",
            "monitoring": "BP q1h x24h, then q4h",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "IV fluids (isotonic saline)",
            "route": "IV",
            "indication": "Maintain euvolemia; avoid hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75-125 mL/hr NS",
                  "orderSentence": "IV fluids (isotonic saline) 75-125 mL/hr NS IV"
                }
              ],
              "route": "IV",
              "instructions": "75-125 mL/hr; adjust to maintain euvolemia; avoid D5W",
              "orderSentence": "IV fluids (isotonic saline) 75-125 mL/hr NS IV"
            },
            "contraindications": "Fluid overload, CHF",
            "monitoring": "Fluid balance, I/Os",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Pantoprazole",
            "route": "IV/PO",
            "indication": "GI protection with DAPT",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg IV daily",
                  "orderSentence": "Pantoprazole 40 mg IV daily IV/PO"
                },
                {
                  "text": "40 mg PO daily",
                  "orderSentence": "Pantoprazole 40 mg PO daily IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "40 mg daily",
              "orderSentence": "Pantoprazole 40 mg IV daily IV/PO"
            },
            "contraindications": "None",
            "monitoring": "None",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Cilostazol (triple antiplatelet)",
            "route": "PO",
            "indication": "Asian populations; high-risk stenosis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg PO BID",
                  "orderSentence": "Cilostazol (triple antiplatelet) 100 mg PO BID PO"
                }
              ],
              "route": "PO",
              "instructions": "100 mg BID; add to aspirin in select cases",
              "orderSentence": "Cilostazol (triple antiplatelet) 100 mg PO BID PO"
            },
            "contraindications": "Heart failure; bleeding",
            "monitoring": "Bleeding, headache, palpitations",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Prasugrel",
            "route": "PO",
            "indication": "Clopidogrel resistance or failure",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg PO x1 load",
                  "orderSentence": "Prasugrel 60 mg PO x1 load PO"
                },
                {
                  "text": "10 mg PO daily",
                  "orderSentence": "Prasugrel 10 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "60 mg load then 10 mg daily; avoid if >75y or <60 kg",
              "orderSentence": "Prasugrel 60 mg PO x1 load PO"
            },
            "contraindications": "Prior TIA/stroke (black box); bleeding risk",
            "monitoring": "Bleeding",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Disease-Modifying or Chronic Therapies (Secondary Prevention)": [
          {
            "item": "Aspirin (long-term)",
            "route": "PO",
            "indication": "Lifelong secondary prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "81 mg PO daily",
                  "orderSentence": "Aspirin (long-term) 81 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "81 mg daily indefinitely",
              "orderSentence": "Aspirin (long-term) 81 mg PO daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Active GI bleed",
            "monitoring": "GI symptoms; annual CBC",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clopidogrel (monotherapy)",
            "route": "PO",
            "indication": "Alternative to aspirin if aspirin-intolerant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg PO daily",
                  "orderSentence": "Clopidogrel (monotherapy) 75 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "75 mg daily",
              "orderSentence": "Clopidogrel (monotherapy) 75 mg PO daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Active bleeding",
            "monitoring": "Bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Aspirin + extended-release dipyridamole (Aggrenox)",
            "route": "PO",
            "indication": "Alternative antiplatelet regimen",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25/200 mg PO BID",
                  "orderSentence": "Aspirin + extended-release dipyridamole (Aggrenox) 25/200 mg PO BID PO"
                }
              ],
              "route": "PO",
              "instructions": "One capsule (25 mg ASA/200 mg ER dipyridamole) BID",
              "orderSentence": "Aspirin + extended-release dipyridamole (Aggrenox) 25/200 mg PO BID PO"
            },
            "pretreatment": "None",
            "contraindications": "Coronary stenosis (coronary steal); severe headache",
            "monitoring": "Headache (often limits use); GI",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Apixaban",
            "route": "PO",
            "indication": "Atrial fibrillation-related TIA",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg PO BID",
                  "orderSentence": "Apixaban 5 mg PO BID PO"
                },
                {
                  "text": "2.5 mg PO BID",
                  "orderSentence": "Apixaban 2.5 mg PO BID PO"
                }
              ],
              "route": "PO",
              "instructions": "5 mg BID (2.5 mg BID if ≥2 of: age ≥80, weight ≤60 kg, Cr ≥1.5)",
              "orderSentence": "Apixaban 5 mg PO BID PO"
            },
            "pretreatment": "Active major bleeding; mechanical valve",
            "contraindications": "CrCl, bleeding signs",
            "monitoring": "-",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Rivaroxaban",
            "route": "PO",
            "indication": "AF-related TIA",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg PO daily",
                  "orderSentence": "Rivaroxaban 20 mg PO daily PO"
                },
                {
                  "text": "15 mg PO daily",
                  "orderSentence": "Rivaroxaban 15 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "20 mg daily with food (15 mg if CrCl 15-50)",
              "orderSentence": "Rivaroxaban 20 mg PO daily PO"
            },
            "pretreatment": "Active major bleeding; mechanical valve",
            "contraindications": "CrCl, bleeding",
            "monitoring": "-",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Dabigatran",
            "route": "PO",
            "indication": "AF-related TIA",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150 mg PO BID",
                  "orderSentence": "Dabigatran 150 mg PO BID PO"
                },
                {
                  "text": "110 mg PO BID",
                  "orderSentence": "Dabigatran 110 mg PO BID PO"
                }
              ],
              "route": "PO",
              "instructions": "150 mg BID (110 mg BID if CrCl 30-50 or age >80)",
              "orderSentence": "Dabigatran 150 mg PO BID PO"
            },
            "pretreatment": "Active bleeding; CrCl <30; mechanical valve",
            "contraindications": "CrCl, bleeding",
            "monitoring": "-",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Warfarin",
            "route": "PO",
            "indication": "Mechanical valve; some hypercoagulable states",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-10 mg PO daily adjusted",
                  "orderSentence": "Warfarin 2-10 mg PO daily adjusted PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; adjust to INR 2-3 (2.5-3.5 for mechanical valve)",
              "orderSentence": "Warfarin 2-10 mg PO daily adjusted PO"
            },
            "pretreatment": "Baseline INR",
            "contraindications": "Pregnancy; active bleeding; frequent falls",
            "monitoring": "INR weekly then monthly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lisinopril",
            "route": "PO",
            "indication": "Blood pressure control for secondary prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg PO daily",
                  "orderSentence": "Lisinopril 5 mg PO daily PO"
                },
                {
                  "text": "10 mg PO daily",
                  "orderSentence": "Lisinopril 10 mg PO daily PO"
                },
                {
                  "text": "20 mg PO daily",
                  "orderSentence": "Lisinopril 20 mg PO daily PO"
                },
                {
                  "text": "40 mg PO daily",
                  "orderSentence": "Lisinopril 40 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5-10 mg daily; titrate to goal BP <130/80; max 40 mg",
              "orderSentence": "Lisinopril 5 mg PO daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Angioedema; pregnancy; bilateral RAS; hyperkalemia",
            "monitoring": "K+, Cr, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amlodipine",
            "route": "PO",
            "indication": "BP control; add-on therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg PO daily",
                  "orderSentence": "Amlodipine 5 mg PO daily PO"
                },
                {
                  "text": "10 mg PO daily",
                  "orderSentence": "Amlodipine 10 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; may increase to 10 mg daily",
              "orderSentence": "Amlodipine 5 mg PO daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Severe aortic stenosis (relative)",
            "monitoring": "Peripheral edema, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Chlorthalidone",
            "route": "PO",
            "indication": "BP control; thiazide-like diuretic",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg PO daily",
                  "orderSentence": "Chlorthalidone 12.5 mg PO daily PO"
                },
                {
                  "text": "25 mg PO daily",
                  "orderSentence": "Chlorthalidone 25 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5 mg daily; may increase to 25 mg daily",
              "orderSentence": "Chlorthalidone 12.5 mg PO daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Severe hypokalemia; severe hyponatremia",
            "monitoring": "K+, Na+, uric acid, glucose",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ezetimibe",
            "route": "PO",
            "indication": "Add-on for LDL not at goal on statin",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg PO daily",
                  "orderSentence": "Ezetimibe 10 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "10 mg daily",
              "orderSentence": "Ezetimibe 10 mg PO daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Severe hepatic impairment",
            "monitoring": "LFTs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "PCSK9 inhibitor (evolocumab, alirocumab)",
            "route": "SC",
            "indication": "LDL >70 despite maximal statin + ezetimibe",
            "dosing": {
              "doseOptions": [
                {
                  "text": "140 mg SC q2wk",
                  "orderSentence": "PCSK9 inhibitor (evolocumab, alirocumab) 140 mg SC q2wk SC"
                },
                {
                  "text": "420 mg SC monthly",
                  "orderSentence": "PCSK9 inhibitor (evolocumab, alirocumab) 420 mg SC monthly SC"
                }
              ],
              "route": "SC",
              "instructions": "Evolocumab 140 mg q2wk or 420 mg monthly; alirocumab 75-150 mg q2wk",
              "orderSentence": "PCSK9 inhibitor (evolocumab, alirocumab) 140 mg SC q2wk SC"
            },
            "pretreatment": "LFTs, lipid panel",
            "contraindications": "None",
            "monitoring": "Injection site reactions; LDL",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Icosapent ethyl (Vascepa)",
            "route": "PO",
            "indication": "Triglycerides ≥150 despite statin; reduces CV events",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g PO BID",
                  "orderSentence": "Icosapent ethyl (Vascepa) 2 g PO BID PO"
                }
              ],
              "route": "PO",
              "instructions": "2 g BID with meals",
              "orderSentence": "Icosapent ethyl (Vascepa) 2 g PO BID PO"
            },
            "pretreatment": "None",
            "contraindications": "Seafood/fish allergy (relative)",
            "monitoring": "AF monitoring (slightly increased risk)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carotid endarterectomy (CEA)",
            "route": "Surgical",
            "indication": "Symptomatic carotid stenosis 70-99%; 50-69% in select",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Surgery",
                  "orderSentence": "Carotid endarterectomy (CEA) Surgery Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Perform within 2 weeks of TIA if stable; high-volume surgeon",
              "orderSentence": "Carotid endarterectomy (CEA) Surgery Surgical"
            },
            "pretreatment": "None",
            "contraindications": "Unstable plaque with delay; total occlusion",
            "monitoring": "Surgical complications; stroke",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Carotid artery stenting (CAS)",
            "route": "Endovascular",
            "indication": "CEA high-risk; radiation neck; recurrent stenosis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Stenting",
                  "orderSentence": "Carotid artery stenting (CAS) Stenting Endovascular"
                }
              ],
              "route": "Endovascular",
              "instructions": "Alternative to CEA; requires DAPT",
              "orderSentence": "Carotid artery stenting (CAS) Stenting Endovascular"
            },
            "pretreatment": "None",
            "contraindications": "Tortuous anatomy; heavy calcification",
            "monitoring": "Hyperperfusion syndrome; stroke",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "PFO closure",
            "route": "Endovascular",
            "indication": "Age <60, PFO with shunt, cryptogenic stroke/TIA",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Device closure",
                  "orderSentence": "PFO closure Device closure Endovascular"
                }
              ],
              "route": "Endovascular",
              "instructions": "Consider after comprehensive evaluation; DAPT post-procedure",
              "orderSentence": "PFO closure Device closure Endovascular"
            },
            "pretreatment": "None",
            "contraindications": "Small PFO without shunt",
            "monitoring": "AF (transient); device complications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology/Stroke consult for urgent evaluation, risk stratification, and secondary prevention optimization",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cardiology consultation for atrial fibrillation management, anticoagulation decisions, and PFO evaluation",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vascular surgery consultation for symptomatic carotid stenosis ≥50% to evaluate for endarterectomy timing",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Interventional neurology for carotid stenting evaluation if CEA high-risk or anatomically unsuitable",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cardiac electrophysiology for recurrent AF management and potential ablation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Registered dietitian for Mediterranean diet counseling and sodium restriction education",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Smoking cessation counseling and pharmacotherapy initiation if current smoker",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Call 911 immediately if symptoms return as this indicates high stroke risk (up to 10% in first 48 hours)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive for at least 2-4 weeks after TIA per state regulations and stroke risk",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take all medications as prescribed especially antiplatelet therapy which significantly reduces stroke risk",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Know stroke warning signs (FAST: Face drooping, Arm weakness, Speech difficulty, Time to call 911)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep follow-up appointments as early intervention reduces stroke risk by up to 80%",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Blood pressure target <130/80 mmHg to significantly reduce stroke recurrence risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "LDL target <70 mg/dL with high-intensity statin for secondary prevention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation (reduces stroke risk by 50% within 1 year of quitting)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Mediterranean diet emphasizing fruits, vegetables, whole grains, fish, and olive oil",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol to ≤1 drink/day for women, ≤2 drinks/day for men",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular aerobic exercise (150 min/week moderate or 75 min/week vigorous)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Weight management with target BMI 18.5-24.9 kg/m²",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Sodium restriction <2300 mg/day (ideally <1500 mg if hypertensive)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Migraine with aura",
        "features": "Gradual onset (minutes), visual scintillations, headache follows; younger patient",
        "tests": "Clinical history; normal DWI"
      },
      {
        "diagnosis": "Seizure with Todd's paralysis",
        "features": "Preceding convulsion; confusion; gradual resolution over hours",
        "tests": "EEG; clinical history"
      },
      {
        "diagnosis": "Hypoglycemia",
        "features": "Altered mentation, diaphoresis, tremor; resolves with glucose",
        "tests": "Fingerstick glucose"
      },
      {
        "diagnosis": "Peripheral vertigo (BPPV, vestibular neuritis)",
        "features": "Isolated vertigo with nystagmus; positive Dix-Hallpike",
        "tests": "HINTS exam; no central signs"
      },
      {
        "diagnosis": "Transient global amnesia",
        "features": "Isolated anterograde amnesia; repetitive questioning; resolves <24h",
        "tests": "Clinical criteria; DWI may show hippocampal lesions"
      },
      {
        "diagnosis": "Functional neurological disorder",
        "features": "Inconsistent exam; incongruent symptoms; often with psychiatric comorbidity",
        "tests": "Clinical exam; normal workup"
      },
      {
        "diagnosis": "Bell's palsy",
        "features": "Peripheral facial weakness (forehead involved); no other deficits",
        "tests": "Clinical exam"
      },
      {
        "diagnosis": "Hypertensive encephalopathy",
        "features": "Severe HTN; headache; confusion; visual changes",
        "tests": "BP, posterior MRI findings"
      },
      {
        "diagnosis": "Demyelinating disease (MS)",
        "features": "Younger patient; prior episodes; MRI with characteristic lesions",
        "tests": "MRI brain/spine; CSF"
      }
    ],
    "evidence": [
      {
        "recommendation": "Dual antiplatelet therapy (DAPT) for 21 days after minor stroke/TIA",
        "evidenceLevel": "Class I, Level A",
        "source": "[Wang et al. NEJM 2021 (CHANCE-2)](https://pubmed.ncbi.nlm.nih.gov/34265411/); [Johnston et al. NEJM 2018 (POINT)](https://pubmed.ncbi.nlm.nih.gov/29766749/)"
      },
      {
        "recommendation": "High-intensity statin for LDL <70 mg/dL",
        "evidenceLevel": "Class I, Level A",
        "source": "[Amarenco et al. NEJM 2006 (SPARCL)](https://pubmed.ncbi.nlm.nih.gov/16899775/)"
      },
      {
        "recommendation": "CEA for symptomatic carotid stenosis 70-99%",
        "evidenceLevel": "Class I, Level A",
        "source": "[NASCET Collaborators. NEJM 1991](https://pubmed.ncbi.nlm.nih.gov/1852179/)"
      },
      {
        "recommendation": "ABCD2 score for TIA risk stratification",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[Johnston et al. Lancet 2007](https://pubmed.ncbi.nlm.nih.gov/17258668/)"
      },
      {
        "recommendation": "Extended cardiac monitoring for cryptogenic stroke",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[Sanna et al. NEJM 2014 (CRYSTAL-AF)](https://pubmed.ncbi.nlm.nih.gov/24963567/)"
      },
      {
        "recommendation": "PFO closure in cryptogenic stroke <60 years",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[Mas et al. NEJM 2017 (CLOSE)](https://pubmed.ncbi.nlm.nih.gov/28902593/)"
      },
      {
        "recommendation": "BP target <130/80 for secondary prevention",
        "evidenceLevel": "Class I, Level B",
        "source": "[AHA/ASA Guidelines 2021](https://pubmed.ncbi.nlm.nih.gov/34024117/)"
      },
      {
        "recommendation": "Urgent TIA evaluation reduces stroke risk",
        "evidenceLevel": "Class I, Level B",
        "source": "[Rothwell et al. Lancet 2007 (EXPRESS)](https://pubmed.ncbi.nlm.nih.gov/17928046/)"
      },
      {
        "recommendation": "DOACs preferred over warfarin for NVAF",
        "evidenceLevel": "Class I, Level A",
        "source": "[Ruff et al. Lancet 2014 (meta-analysis)](https://pubmed.ncbi.nlm.nih.gov/24315724/)"
      }
    ],
    "monitoring": [
      {
        "item": "Neurological exam",
        "frequency": "q1h x 24h then q4h",
        "action": "Immediate imaging if worsening",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "-"
      },
      {
        "item": "Blood pressure",
        "frequency": "q1h x 24h then q4h",
        "action": "Titrate antihypertensives",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Cardiac rhythm (telemetry)",
        "frequency": "Continuous x 24-72h",
        "action": "Anticoagulation if AF detected",
        "ED": "URGENT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "-"
      },
      {
        "item": "Extended cardiac monitoring",
        "frequency": "14-30 days outpatient",
        "action": "Anticoagulation if AF detected",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ABCD2 score",
        "frequency": "At presentation",
        "action": "High-risk patients need admission or rapid TIA clinic",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "-"
      },
      {
        "item": "LDL cholesterol",
        "frequency": "Baseline, 6 weeks, then annually",
        "action": "Intensify statin or add ezetimibe/PCSK9i",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "HbA1c",
        "frequency": "Baseline, then q3mo if diabetic",
        "action": "Optimize diabetes management",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Creatinine/eGFR",
        "frequency": "With contrast; then annually",
        "action": "Dose-adjust medications",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Rapid TIA clinic (<24-48h)",
        "criteria": "ABCD2 <4; no acute findings on imaging; reliable patient with close follow-up"
      },
      {
        "disposition": "Admit to stroke unit",
        "criteria": "ABCD2 ≥4; DWI positive (minor stroke); symptomatic carotid stenosis; new AF; unable to complete workup as outpatient"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Rare for isolated TIA; only if concurrent acute coronary syndrome or hemodynamic instability"
      },
      {
        "disposition": "Discharge with urgent follow-up",
        "criteria": "Completed rapid workup; started on secondary prevention; ABCD2 <4; no high-risk features"
      }
    ]
  },
  "Dementia Evaluation": {
    "id": "dementia-evaluation",
    "title": "Dementia Evaluation",
    "version": "1.0",
    "icd10": [
      "** R41.81 (Age-related cognitive decline)",
      "F03.90 (Unspecified dementia without behavioral disturbance)",
      "G30.9 (Alzheimer's disease",
      "unspecified)",
      "F01.50 (Vascular dementia without behavioral disturbance)",
      "G31.83 (Dementia with Lewy bodies)",
      "G31.09 (Other frontotemporal dementia)",
      "G31.84 (Mild cognitive impairment)"
    ],
    "scope": "** Systematic evaluation of cognitive impairment and dementia in adults. Covers comprehensive workup to identify reversible causes and establish etiology. Includes initiation of symptomatic treatment. Excludes pediatric intellectual disability, acute delirium (separate entity), and rapidly progressive dementia (separate template for urgent workup).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Anemia, infection, hematologic disease",
            "target": "Normal"
          },
          {
            "item": "CMP (includes glucose, renal, hepatic)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Metabolic encephalopathy, hepatic/renal failure, glucose",
            "target": "Normal"
          },
          {
            "item": "TSH",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypothyroidism is reversible cause",
            "target": "Normal (0.4-4.0 mIU/L)"
          },
          {
            "item": "Vitamin B12",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "B12 deficiency is reversible cause",
            "target": ">400 pg/mL (>300 per some guidelines)"
          },
          {
            "item": "Folate",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Folate deficiency can contribute",
            "target": "Normal"
          },
          {
            "item": "Ammonia",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Hepatic encephalopathy if liver disease",
            "target": "<35 μmol/L"
          },
          {
            "item": "Urinalysis",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "UTI common cause of delirium/worsening",
            "target": "Negative"
          }
        ],
        "Extended Workup": [
          {
            "item": "RPR/VDRL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurosyphilis in differential",
            "target": "Negative"
          },
          {
            "item": "HIV",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HIV-associated neurocognitive disorder (HAND)",
            "target": "Negative"
          },
          {
            "item": "Thiamine (Vitamin B1)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Wernicke-Korsakoff if alcohol history",
            "target": "Normal"
          },
          {
            "item": "Vitamin D",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency associated with cognitive decline",
            "target": ">30 ng/mL"
          },
          {
            "item": "Homocysteine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Elevated levels associated with dementia risk",
            "target": "<15 μmol/L"
          },
          {
            "item": "HbA1c",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes and cognitive impairment",
            "target": "<7% ideally"
          },
          {
            "item": "Lipid panel",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Vascular risk factors",
            "target": "Per guidelines"
          },
          {
            "item": "ESR/CRP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Inflammatory/vasculitic cause",
            "target": "Normal"
          },
          {
            "item": "ANA",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "CNS lupus, autoimmune",
            "target": "Negative"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Serum ceruloplasmin, copper",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Wilson disease if <50 years",
            "target": "Normal"
          },
          {
            "item": "Heavy metals (lead, mercury, arsenic)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Occupational/environmental exposure",
            "target": "Negative"
          },
          {
            "item": "Paraneoplastic panel",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Subacute onset, smoking history, cancer history",
            "target": "Negative"
          },
          {
            "item": "Autoimmune encephalitis panel (serum)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Subacute onset, psychiatric features, seizures",
            "target": "Negative"
          },
          {
            "item": "Lyme serology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Endemic areas, tick exposure",
            "target": "Negative"
          },
          {
            "item": "West Nile serology",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Endemic areas, summer/fall onset",
            "target": "Negative"
          },
          {
            "item": "Genetic testing (APOE, APP, PSEN1/2)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Strong family history, early onset",
            "target": "Risk assessment"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "NPH evaluation",
            "target": "10-20 cm H2O"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Infection, inflammation",
            "target": "WBC <5"
          },
          {
            "item": "Protein",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Infection, inflammation",
            "target": "15-45 mg/dL"
          },
          {
            "item": "Glucose",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Infection",
            "target": ">60% serum"
          },
          {
            "item": "VDRL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Neurosyphilis",
            "target": "Negative"
          },
          {
            "item": "CSF meningitis panel",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Infectious etiology",
            "target": "Negative"
          },
          {
            "item": "Aβ42, total tau, phospho-tau",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "AD biomarkers (AT profile)",
            "target": "Aβ42↓, tau↑, p-tau↑ in AD"
          },
          {
            "item": "RT-QuIC (Real-Time Quaking-Induced Conversion)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "CJD if rapid progression",
            "target": "Negative"
          },
          {
            "item": "14-3-3 protein",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "CJD if rapid progression",
            "target": "Negative"
          },
          {
            "item": "Oligoclonal bands",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "MS, inflammatory conditions",
            "target": "Negative"
          },
          {
            "item": "Cytology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Carcinomatous meningitis",
            "target": "Negative"
          },
          {
            "item": "Autoimmune encephalitis panel (CSF)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If autoimmune suspected",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI brain without contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Initial workup",
            "target": "Atrophy pattern, vascular changes, masses, NPH",
            "contraindications": "Pacemaker, metal"
          },
          {
            "item": "CT head without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "If MRI unavailable or contraindicated",
            "target": "Masses, hemorrhage, hydrocephalus",
            "contraindications": "None"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain with contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If mass, infection, or inflammation suspected",
            "target": "Enhancing lesions",
            "contraindications": "Contrast allergy, renal disease"
          },
          {
            "item": "FDG-PET brain",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Distinguish AD from FTD; atypical presentations",
            "target": "AD: temporoparietal hypometabolism; FTD: frontal hypometabolism",
            "contraindications": "Per PET"
          },
          {
            "item": "Amyloid PET (Amyvid, Neuraceq)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Diagnostic uncertainty; young onset",
            "target": "Positive in AD and preclinical AD",
            "contraindications": "Per PET"
          },
          {
            "item": "Tau PET (Tauvid)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "AD staging, atypical presentations",
            "target": "Pattern correlates with symptoms",
            "contraindications": "Per PET"
          },
          {
            "item": "DaTscan",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If parkinsonian features; DLB vs AD",
            "target": "Reduced in DLB; normal in AD",
            "contraindications": "Pregnancy, iodine allergy"
          },
          {
            "item": "EEG",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Subclinical seizures, CJD (triphasic waves), delirium",
            "target": "Normal or diffuse slowing",
            "contraindications": "None"
          },
          {
            "item": "Polysomnography",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If REM sleep behavior disorder suspected (DLB)",
            "target": "Confirm RBD",
            "contraindications": "None"
          }
        ]
      },
      "Treatment": {
        "Reversible Causes - Treatment": [
          {
            "item": "Vitamin B12 replacement",
            "route": "IM",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mcg",
                  "orderSentence": "Vitamin B12 replacement 1000 mcg IM"
                }
              ],
              "route": "IM",
              "instructions": "1000 mcg IM daily × 7 days, then weekly × 4, then monthly; OR oral 1000-2000 mcg daily",
              "orderSentence": "Vitamin B12 replacement 1000 mcg IM"
            },
            "contraindications": "None",
            "monitoring": "B12 levels",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Levothyroxine (hypothyroidism)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-50 mcg",
                  "orderSentence": "Levothyroxine (hypothyroidism) 25-50 mcg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mcg daily; titrate per TSH",
              "orderSentence": "Levothyroxine (hypothyroidism) 25-50 mcg PO"
            },
            "contraindications": "CAD (start low)",
            "monitoring": "TSH q6-8 weeks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Thiamine (Wernicke-Korsakoff)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Thiamine (Wernicke-Korsakoff) 500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "500 mg IV TID × 3 days, then 250 mg IV daily × 5 days, then 100 mg PO daily",
              "orderSentence": "Thiamine (Wernicke-Korsakoff) 500 mg IV"
            },
            "contraindications": "None",
            "monitoring": "Clinical response",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "NPH treatment (large volume LP)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30-50 mL",
                  "orderSentence": "NPH treatment (large volume LP) 30-50 mL -"
                }
              ],
              "route": "-",
              "instructions": "Diagnostic LP removing 30-50 mL CSF; assess gait before/after",
              "orderSentence": "NPH treatment (large volume LP) 30-50 mL -"
            },
            "contraindications": "Per LP",
            "monitoring": "Gait improvement suggests shunt candidacy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "VP shunt (NPH)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Neurosurgical placement",
              "orderSentence": "VP shunt (NPH) - - - see dosing"
            },
            "contraindications": "Coagulopathy, infection",
            "monitoring": "Shunt complications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Treat depression (pseudodementia)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-50 mg",
                  "orderSentence": "Treat depression (pseudodementia) 25-50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "SSRI (sertraline 25-50 mg, escitalopram 5-10 mg)",
              "orderSentence": "Treat depression (pseudodementia) 25-50 mg PO"
            },
            "contraindications": "Per agent",
            "monitoring": "Mood, cognition",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Discontinue offending medications",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Stop anticholinergics, sedatives, opioids",
              "orderSentence": "Discontinue offending medications - - - see dosing"
            },
            "contraindications": "N/A",
            "monitoring": "Cognitive reassessment",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          }
        ],
        "Alzheimer's Disease - Cholinesterase Inhibitors": [
          {
            "item": "Donepezil (Aricept)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Donepezil (Aricept) 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg QHS × 4-6 weeks, then increase to 10 mg QHS; 23 mg available for moderate-severe",
              "orderSentence": "Donepezil (Aricept) 5 mg PO"
            },
            "contraindications": "Bradycardia, sick sinus, GI bleeding",
            "monitoring": "Bradycardia, GI upset, nightmares",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine patch (Exelon)",
            "route": "Transdermal",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4.6 mg",
                  "orderSentence": "Rivastigmine patch (Exelon) 4.6 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 4.6 mg/24h patch; increase monthly to 9.5-13.3 mg/24h",
              "orderSentence": "Rivastigmine patch (Exelon) 4.6 mg PO"
            },
            "contraindications": "Same; skin reactions",
            "monitoring": "Skin irritation, GI, bradycardia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine oral",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1.5 mg",
                  "orderSentence": "Rivastigmine oral 1.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1.5 mg BID with food; titrate to 6 mg BID",
              "orderSentence": "Rivastigmine oral 1.5 mg PO"
            },
            "contraindications": "Same",
            "monitoring": "GI side effects more common than patch",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Galantamine (Razadyne)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg",
                  "orderSentence": "Galantamine (Razadyne) 4 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 4 mg BID with food × 4 weeks; titrate to 8-12 mg BID; ER: 8 mg daily to 24 mg daily",
              "orderSentence": "Galantamine (Razadyne) 4 mg PO"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Alzheimer's Disease - NMDA Antagonist": [
          {
            "item": "Memantine (Namenda)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Memantine (Namenda) 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; increase by 5 mg/week to 10 mg BID",
              "orderSentence": "Memantine (Namenda) 5 mg PO"
            },
            "contraindications": "Severe renal impairment",
            "monitoring": "Confusion, dizziness, constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Memantine XR (Namenda XR)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7 mg",
                  "orderSentence": "Memantine XR (Namenda XR) 7 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 7 mg daily; increase weekly to 28 mg daily",
              "orderSentence": "Memantine XR (Namenda XR) 7 mg PO"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Donepezil/Memantine XR (Namzaric)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Donepezil/Memantine XR (Namzaric) 10 mg -"
                }
              ],
              "route": "-",
              "instructions": "For patients on both; 7/10 mg to 28/10 mg daily",
              "orderSentence": "Donepezil/Memantine XR (Namzaric) 10 mg -"
            },
            "contraindications": "Per components",
            "monitoring": "Per components",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Alzheimer's Disease - Disease-Modifying Therapy (Amyloid-Targeted)": [
          {
            "item": "Lecanemab (Leqembi)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg",
                  "orderSentence": "Lecanemab (Leqembi) 10 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV q2 weeks; confirm amyloid-positive before starting",
              "orderSentence": "Lecanemab (Leqembi) 10 mg/kg IV"
            },
            "pretreatment": "-",
            "contraindications": "Anticoagulation (relative), ARIA risk factors",
            "monitoring": "MRI at baseline, week 6, 12; ARIA monitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Donanemab (Kisunla)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "700 mg",
                  "orderSentence": "Donanemab (Kisunla) 700 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "700 mg IV q4 weeks × 3, then 1400 mg q4 weeks until amyloid clearance; discontinue when cleared",
              "orderSentence": "Donanemab (Kisunla) 700 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Same",
            "monitoring": "Same; discontinue at clearance",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Aducanumab (Aduhelm)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-10 mg/kg",
                  "orderSentence": "Aducanumab (Aduhelm) 1-10 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "Titration from 1-10 mg/kg IV q4 weeks; limited use",
              "orderSentence": "Aducanumab (Aduhelm) 1-10 mg/kg IV"
            },
            "pretreatment": "-",
            "contraindications": "Same",
            "monitoring": "MRI monitoring for ARIA",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Behavioral and Psychological Symptoms of Dementia (BPSD)": [
          {
            "item": "Non-pharmacologic interventions",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Music therapy, validation therapy, redirection, environmental modification",
              "orderSentence": "Non-pharmacologic interventions - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "First-line for all BPSD",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sertraline (depression, anxiety)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Sertraline (depression, anxiety) 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; target 50-100 mg",
              "orderSentence": "Sertraline (depression, anxiety) 25 mg PO"
            },
            "contraindications": "Bleeding risk, QT prolongation",
            "monitoring": "GI bleeding, hyponatremia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Citalopram (agitation)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Citalopram (agitation) 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg daily; max 20 mg (QT risk at higher doses)",
              "orderSentence": "Citalopram (agitation) 10 mg PO"
            },
            "contraindications": "QT prolongation",
            "monitoring": "QTc, hyponatremia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trazodone (sleep, agitation)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-100 mg",
                  "orderSentence": "Trazodone (sleep, agitation) 25-100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "25-100 mg QHS",
              "orderSentence": "Trazodone (sleep, agitation) 25-100 mg PO"
            },
            "contraindications": "Orthostasis",
            "monitoring": "Sedation, falls",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirtazapine (sleep, appetite, mood)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7.5-15 mg",
                  "orderSentence": "Mirtazapine (sleep, appetite, mood) 7.5-15 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "7.5-15 mg QHS",
              "orderSentence": "Mirtazapine (sleep, appetite, mood) 7.5-15 mg PO"
            },
            "contraindications": "None significant",
            "monitoring": "Weight gain, sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Quetiapine (psychosis, agitation)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5-100 mg",
                  "orderSentence": "Quetiapine (psychosis, agitation) 12.5-100 mg -"
                }
              ],
              "route": "-",
              "instructions": "12.5-100 mg QHS; lowest effective dose",
              "orderSentence": "Quetiapine (psychosis, agitation) 12.5-100 mg -"
            },
            "contraindications": "QT prolongation, metabolic syndrome",
            "monitoring": "Black box: increased mortality in dementia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Risperidone (psychosis, aggression)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25-1 mg",
                  "orderSentence": "Risperidone (psychosis, aggression) 0.25-1 mg -"
                }
              ],
              "route": "-",
              "instructions": "0.25-1 mg BID; lowest effective dose",
              "orderSentence": "Risperidone (psychosis, aggression) 0.25-1 mg -"
            },
            "contraindications": "Same; EPS",
            "monitoring": "Same; EPS higher than quetiapine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pimavanserin (DLB psychosis)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "34 mg",
                  "orderSentence": "Pimavanserin (DLB psychosis) 34 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "34 mg daily",
              "orderSentence": "Pimavanserin (DLB psychosis) 34 mg PO"
            },
            "contraindications": "QT prolongation",
            "monitoring": "QTc",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dextromethorphan/Quinidine (Nuedexta)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "1 capsule daily × 7 days, then BID; for pseudobulbar affect",
              "orderSentence": "Dextromethorphan/Quinidine (Nuedexta) - - - see dosing"
            },
            "contraindications": "QT prolongation, CYP2D6 interactions",
            "monitoring": "QTc",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbamazepine (aggression)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100-400 mg",
                  "orderSentence": "Carbamazepine (aggression) 100-400 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "100-400 mg BID",
              "orderSentence": "Carbamazepine (aggression) 100-400 mg PO"
            },
            "contraindications": "Aplastic anemia risk, drug interactions",
            "monitoring": "CBC, LFTs, drug levels",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Other Dementia-Specific Treatments": [
          {
            "item": "Aspirin (vascular dementia)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "81 mg",
                  "orderSentence": "Aspirin (vascular dementia) 81 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "81 mg daily; secondary prevention",
              "orderSentence": "Aspirin (vascular dementia) 81 mg PO"
            },
            "contraindications": "Bleeding",
            "monitoring": "Bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Statin (vascular dementia)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Per cardiovascular guidelines",
              "orderSentence": "Statin (vascular dementia) - - - see dosing"
            },
            "contraindications": "Hepatic disease",
            "monitoring": "LFTs, myopathy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BP control (vascular dementia)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Target <130/80 per guidelines",
              "orderSentence": "BP control (vascular dementia) - - - see dosing"
            },
            "contraindications": "Per agent",
            "monitoring": "BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbidopa/Levodopa (DLB, PDD)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Start low 25/100 TID; titrate cautiously",
              "orderSentence": "Carbidopa/Levodopa (DLB, PDD) - - - see dosing"
            },
            "contraindications": "May worsen psychosis",
            "monitoring": "Hallucinations, dyskinesia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Avoid anticholinergics (DLB)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Contraindicated in DLB due to severe sensitivity",
              "orderSentence": "Avoid anticholinergics (DLB) - - - see dosing"
            },
            "contraindications": "N/A",
            "monitoring": "N/A",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Avoid antipsychotics (DLB)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Can cause severe parkinsonism, NMS-like reaction; if needed, quetiapine safest",
              "orderSentence": "Avoid antipsychotics (DLB) - - - see dosing"
            },
            "contraindications": "Relative contraindication",
            "monitoring": "Severe reactions",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology/Memory specialist",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "All patients with dementia for diagnosis confirmation and management"
          },
          {
            "item": "Neuropsychology",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "MCI vs dementia distinction, pattern analysis, baseline assessment"
          },
          {
            "item": "Geriatric psychiatry",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "BPSD, depression, complex behavioral management"
          },
          {
            "item": "Social work",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Resources, placement, caregiver support"
          },
          {
            "item": "Physical therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Mobility, fall prevention"
          },
          {
            "item": "Occupational therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "ADL assessment, home safety evaluation"
          },
          {
            "item": "Speech therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Swallowing evaluation, communication strategies"
          },
          {
            "item": "Palliative care",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Goals of care, symptom management in advanced dementia"
          },
          {
            "item": "Elder law attorney",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Power of attorney, healthcare proxy, estate planning"
          },
          {
            "item": "Driving evaluation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Driving safety assessment"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Dementia is a progressive condition; treatments can help symptoms but not cure",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Establish healthcare proxy and advance directives early while patient can participate",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Home safety: remove rugs, improve lighting, stove safety, medication management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Driving assessment needed; may need to stop driving",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Caregiver support is essential; respite care, support groups (Alzheimer's Association)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Medical alert bracelet, GPS tracking if wandering risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain routines, social engagement, cognitive stimulation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return to ED if: sudden worsening, new weakness, fever, falls, inability to care for self",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Regular physical exercise (30 min, 5 days/week)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cognitive engagement (puzzles, reading, social activities)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Mediterranean or MIND diet",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cardiovascular risk factor management (BP, diabetes, cholesterol)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Hearing aids if hearing impaired (hearing loss increases dementia risk)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate sleep (treat sleep apnea)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid excessive alcohol",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Social engagement and purpose",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Delirium",
        "features": "Acute onset, fluctuating, inattention, often reversible cause",
        "tests": "Duration, attention testing, underlying cause"
      },
      {
        "diagnosis": "Depression (pseudodementia)",
        "features": "Depressed mood, \"I don't know\" responses, rapid onset, prior psychiatric history",
        "tests": "Depression screening, response to antidepressants"
      },
      {
        "diagnosis": "Normal aging",
        "features": "Mild forgetfulness, no functional impairment",
        "tests": "Neuropsychological testing; MCI vs normal"
      },
      {
        "diagnosis": "B12 deficiency",
        "features": "Macrocytic anemia, neuropathy, subacute combined degeneration",
        "tests": "B12 level, MMA, MRI spine"
      },
      {
        "diagnosis": "Hypothyroidism",
        "features": "Fatigue, weight gain, cold intolerance",
        "tests": "TSH"
      },
      {
        "diagnosis": "Normal pressure hydrocephalus",
        "features": "Gait apraxia, urinary incontinence, dementia (triad)",
        "tests": "MRI (ventriculomegaly), large volume LP response"
      },
      {
        "diagnosis": "Medication effects",
        "features": "Anticholinergics, sedatives, opioids",
        "tests": "Medication review; improvement after discontinuation"
      },
      {
        "diagnosis": "Wernicke-Korsakoff",
        "features": "Alcohol history, confabulation, ataxia, ophthalmoplegia",
        "tests": "History, thiamine trial, MRI (mammillary body changes)"
      },
      {
        "diagnosis": "Creutzfeldt-Jakob disease",
        "features": "Rapid progression, myoclonus, MRI changes",
        "tests": "MRI (cortical ribboning), EEG (periodic complexes), CSF RT-QuIC"
      },
      {
        "diagnosis": "Autoimmune encephalitis",
        "features": "Subacute, psychiatric symptoms, seizures",
        "tests": "Antibody panels, MRI, EEG"
      },
      {
        "diagnosis": "CNS lymphoma/tumor",
        "features": "Focal deficits, headache, progressive",
        "tests": "MRI with contrast"
      }
    ],
    "evidence": [
      {
        "recommendation": "MRI recommended in dementia workup",
        "evidenceLevel": "Class I, Level A",
        "source": "[AAN Practice Parameters (Knopman et al., Neurology 2001)](https://pubmed.ncbi.nlm.nih.gov/11342678/)"
      },
      {
        "recommendation": "B12, TSH, metabolic panel in all patients",
        "evidenceLevel": "Class I, Level A",
        "source": "[AAN Practice Parameters (Knopman et al., Neurology 2001)](https://pubmed.ncbi.nlm.nih.gov/11342678/)"
      },
      {
        "recommendation": "Cholinesterase inhibitors for mild-moderate AD",
        "evidenceLevel": "Class I, Level A",
        "source": "Cochrane Reviews"
      },
      {
        "recommendation": "Memantine for moderate-severe AD",
        "evidenceLevel": "Class I, Level A",
        "source": "Cochrane Reviews"
      },
      {
        "recommendation": "Combination ChEI + memantine",
        "evidenceLevel": "Class I, Level A",
        "source": "[DOMINO trial (Howard et al., NEJM 2012)](https://pubmed.ncbi.nlm.nih.gov/22397651/)"
      },
      {
        "recommendation": "Lecanemab slows cognitive decline in early AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Clarity AD trial (van Dyck et al., NEJM 2023)](https://pubmed.ncbi.nlm.nih.gov/36449413/); FDA approved 2023"
      },
      {
        "recommendation": "Donanemab slows decline in early AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[TRAILBLAZER-ALZ 2 (Sims et al., JAMA 2023)](https://pubmed.ncbi.nlm.nih.gov/37459141/); FDA approved 2024"
      },
      {
        "recommendation": "Non-pharmacologic interventions for BPSD first-line",
        "evidenceLevel": "Class I, Level A",
        "source": "APA Guidelines"
      },
      {
        "recommendation": "Antipsychotics increase mortality in dementia",
        "evidenceLevel": "Class I, Level A",
        "source": "FDA black box warning"
      },
      {
        "recommendation": "CSF biomarkers (Aβ42, tau, p-tau) support AD diagnosis",
        "evidenceLevel": "Class II, Level A",
        "source": "AT(N) framework"
      },
      {
        "recommendation": "Amyloid PET useful for diagnostic uncertainty",
        "evidenceLevel": "Class II, Level B",
        "source": "Appropriate Use Criteria"
      },
      {
        "recommendation": "Exercise may slow cognitive decline",
        "evidenceLevel": "Class II, Level B",
        "source": "Multiple RCTs"
      }
    ],
    "monitoring": [
      {
        "item": "Cognitive testing (MoCA, MMSE)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q6-12 months",
        "action": "Adjust medications, reassess diagnosis"
      },
      {
        "item": "Functional status (ADL/IADL)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q6-12 months",
        "action": "OT, increase support"
      },
      {
        "item": "BPSD assessment (NPI)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "Behavioral interventions, medications"
      },
      {
        "item": "Caregiver stress (Zarit Burden)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q6-12 months",
        "action": "Respite, support services"
      },
      {
        "item": "Weight",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "Nutrition, dysphagia evaluation"
      },
      {
        "item": "Falls assessment",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "PT, home safety"
      },
      {
        "item": "Driving safety",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Annually or with decline",
        "action": "Driving evaluation, cessation"
      },
      {
        "item": "Medication reconciliation",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "D/C anticholinergics, sedatives"
      },
      {
        "item": "MRI (if on anti-amyloid therapy)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Per protocol",
        "action": "Hold therapy if ARIA"
      }
    ],
    "disposition": [
      {
        "disposition": "Outpatient workup",
        "criteria": "Most patients; mild-moderate symptoms, safe home environment, caregiver present"
      },
      {
        "disposition": "Admit to hospital",
        "criteria": "Acute behavioral crisis, unable to care for self, unsafe home environment, need for IV therapies, rapid progression needing urgent workup"
      },
      {
        "disposition": "Discharge from hospital",
        "criteria": "Reversible causes treated, behavior stable, safe disposition, follow-up arranged"
      },
      {
        "disposition": "Memory care/Assisted living",
        "criteria": "Unable to live independently, unsafe with current support level"
      },
      {
        "disposition": "Skilled nursing facility",
        "criteria": "Advanced dementia, 24-hour care needs, complex medical needs"
      },
      {
        "disposition": "Hospice",
        "criteria": "End-stage dementia, FAST stage 7, goals of care focused on comfort"
      }
    ]
  },
  "Essential Tremor": {
    "id": "essential-tremor",
    "title": "Essential Tremor",
    "version": "1.0",
    "icd10": [
      "** G25.0 (Essential tremor)",
      "G25.1 (Drug-induced tremor)",
      "G25.2 (Other specified forms of tremor)",
      "G25.9 (Extrapyramidal and movement disorder",
      "unspecified)"
    ],
    "scope": "** Diagnosis and management of essential tremor in adults. Covers diagnostic workup to differentiate from Parkinson's disease and other tremor disorders, pharmacologic and non-pharmacologic treatment options. Excludes enhanced physiologic tremor, drug-induced tremor, psychogenic tremor, and tremor as part of other movement disorders (PD, dystonia, cerebellar disease).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hyperthyroidism causes tremor",
            "target": "Normal (0.4-4.0 mIU/L)"
          },
          {
            "item": "Free T4",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If TSH abnormal",
            "target": "Normal"
          },
          {
            "item": "CMP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Electrolyte abnormalities, hepatic/renal function",
            "target": "Normal"
          },
          {
            "item": "Glucose",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypoglycemia can cause tremor",
            "target": "Normal"
          }
        ],
        "Extended Workup": [
          {
            "item": "Serum ceruloplasmin",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Wilson disease if <50 years or atypical features",
            "target": "20-40 mg/dL"
          },
          {
            "item": "24-hour urine copper",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If ceruloplasmin low/borderline",
            "target": "<100 mcg/24h"
          },
          {
            "item": "Liver function tests",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Wilson disease, hepatic encephalopathy",
            "target": "Normal"
          },
          {
            "item": "Serum copper",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Wilson disease",
            "target": "Normal"
          },
          {
            "item": "Vitamin B12",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency can cause tremor",
            "target": ">400 pg/mL"
          },
          {
            "item": "Drug/toxin screen",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Drug-induced tremor",
            "target": "Negative"
          },
          {
            "item": "Caffeine intake assessment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Excessive caffeine exacerbates tremor",
            "target": "Assess"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Genetic testing (LINGO1, ETM1/2)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Family history, research interest",
            "target": "Informational"
          },
          {
            "item": "Anti-neuronal antibodies",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If autoimmune cause suspected",
            "target": "Negative"
          },
          {
            "item": "Heavy metal levels",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Mercury, lead exposure",
            "target": "Normal"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Clinical examination",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At diagnosis",
            "target": "Bilateral action tremor, no rest tremor, no parkinsonism",
            "contraindications": "None"
          },
          {
            "item": "Handwriting sample",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At diagnosis, follow-up",
            "target": "Large, tremulous writing (vs micrographia in PD)",
            "contraindications": "None"
          },
          {
            "item": "Spiral drawing test",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At diagnosis, follow-up",
            "target": "Objective tremor assessment",
            "contraindications": "None"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain without contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If atypical features or diagnostic uncertainty",
            "target": "Rule out structural cause, cerebellar lesions",
            "contraindications": "Pacemaker, metal"
          },
          {
            "item": "DaTscan (I-123 ioflupane SPECT)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Differentiate ET from PD if uncertain",
            "target": "Normal in ET; reduced striatal uptake in PD",
            "contraindications": "Pregnancy, iodine allergy"
          },
          {
            "item": "Accelerometry/Tremor analysis",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Objective quantification, research",
            "target": "Characterize tremor frequency (4-12 Hz)",
            "contraindications": "None"
          },
          {
            "item": "EMG",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If neuropathic tremor suspected",
            "target": "Rule out neuropathy",
            "contraindications": "None"
          },
          {
            "item": "MRI with susceptibility-weighted imaging",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If Wilson disease suspected",
            "target": "Rule out basal ganglia T2 hypointensity",
            "contraindications": "Per MRI"
          }
        ]
      },
      "Treatment": {
        "First-Line Pharmacologic Treatment": [
          {
            "item": "Propranolol (Inderal)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20-40 mg",
                  "orderSentence": "Propranolol (Inderal) 20-40 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 20-40 mg BID-TID; titrate to 120-320 mg/day in divided doses",
              "orderSentence": "Propranolol (Inderal) 20-40 mg PO"
            },
            "contraindications": "Asthma, COPD, bradycardia, AV block, decompensated heart failure, depression",
            "monitoring": "HR, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Propranolol LA",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60-80 mg",
                  "orderSentence": "Propranolol LA 60-80 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 60-80 mg daily; titrate to 160-320 mg daily",
              "orderSentence": "Propranolol LA 60-80 mg PO"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Primidone (Mysoline)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5-25 mg",
                  "orderSentence": "Primidone (Mysoline) 12.5-25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5-25 mg QHS; titrate very slowly by 12.5-25 mg/week to 250-750 mg/day in divided doses",
              "orderSentence": "Primidone (Mysoline) 12.5-25 mg PO"
            },
            "contraindications": "Porphyria, severe sedation",
            "monitoring": "Sedation, ataxia, nausea (start very low)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-Line Pharmacologic Treatment": [
          {
            "item": "Topiramate (Topamax)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Topiramate (Topamax) 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; titrate by 25-50 mg/week to 100-400 mg/day in divided doses",
              "orderSentence": "Topiramate (Topamax) 25 mg PO"
            },
            "contraindications": "Kidney stones, glaucoma, pregnancy",
            "monitoring": "Cognitive effects, paresthesias, weight loss",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gabapentin (Neurontin)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Gabapentin (Neurontin) 300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg daily; titrate to 300-600 mg TID (900-1800 mg/day)",
              "orderSentence": "Gabapentin (Neurontin) 300 mg PO"
            },
            "contraindications": "Renal impairment (adjust dose)",
            "monitoring": "Sedation, dizziness, edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Alprazolam (Xanax)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25-0.5 mg",
                  "orderSentence": "Alprazolam (Xanax) 0.25-0.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.25-0.5 mg TID; max 3 mg/day; use cautiously",
              "orderSentence": "Alprazolam (Xanax) 0.25-0.5 mg PO"
            },
            "contraindications": "Respiratory depression, addiction potential, elderly falls",
            "monitoring": "Sedation, dependence, falls",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clonazepam (Klonopin)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg",
                  "orderSentence": "Clonazepam (Klonopin) 0.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.5 mg TID; titrate to 2-4 mg/day",
              "orderSentence": "Clonazepam (Klonopin) 0.5 mg PO"
            },
            "contraindications": "Same as alprazolam",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Atenolol",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50-100 mg",
                  "orderSentence": "Atenolol 50-100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "50-100 mg daily; less CNS penetration than propranolol",
              "orderSentence": "Atenolol 50-100 mg PO"
            },
            "contraindications": "Same as propranolol",
            "monitoring": "HR, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nadolol",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40-160 mg",
                  "orderSentence": "Nadolol 40-160 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "40-160 mg daily; long-acting, once daily",
              "orderSentence": "Nadolol 40-160 mg PO"
            },
            "contraindications": "Same as propranolol",
            "monitoring": "HR, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Third-Line and Adjunctive Treatments": [
          {
            "item": "Botulinum toxin (OnabotulinumtoxinA)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50-100 units",
                  "orderSentence": "Botulinum toxin (OnabotulinumtoxinA) 50-100 units -"
                }
              ],
              "route": "-",
              "instructions": "50-100 units per arm for hand tremor; 40-400 units for head tremor; q3 months",
              "orderSentence": "Botulinum toxin (OnabotulinumtoxinA) 50-100 units -"
            },
            "contraindications": "Infection at injection site, myasthenia",
            "monitoring": "Weakness, dysphagia (head/voice injections)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Propranolol + Primidone combination",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Use lower doses of each; synergistic effect",
              "orderSentence": "Propranolol + Primidone combination - - - see dosing"
            },
            "contraindications": "Per individual agents",
            "monitoring": "Per individual agents",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nimodipine",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg",
                  "orderSentence": "Nimodipine 30 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "30 mg TID; limited evidence",
              "orderSentence": "Nimodipine 30 mg PO"
            },
            "contraindications": "Hypotension",
            "monitoring": "BP",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Zonisamide",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100-200 mg",
                  "orderSentence": "Zonisamide 100-200 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "100-200 mg daily; off-label",
              "orderSentence": "Zonisamide 100-200 mg PO"
            },
            "contraindications": "Sulfa allergy, kidney stones",
            "monitoring": "Kidney stones, cognitive",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Interventional Treatments": [
          {
            "item": "Deep brain stimulation (DBS)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "VIM thalamus target; bilateral or unilateral",
              "orderSentence": "Deep brain stimulation (DBS) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "Bleeding risk, active infection, severe cognitive impairment",
            "monitoring": "Speech, gait, stimulator function",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "MRI-guided focused ultrasound (MRgFUS)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "VIM thalamotomy; unilateral only",
              "orderSentence": "MRI-guided focused ultrasound (MRgFUS) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "Skull density ratio issues, intracranial lesions",
            "monitoring": "Speech, gait, sensory changes",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Gamma Knife thalamotomy",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "VIM target; unilateral; delayed effect",
              "orderSentence": "Gamma Knife thalamotomy - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "Per radiosurgery",
            "monitoring": "Same as MRgFUS",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Non-Pharmacologic Treatments": [
          {
            "item": "Weighted utensils",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Reduce tremor amplitude during eating",
              "orderSentence": "Weighted utensils - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "OT can assist with selection",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Wrist weights",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Dampen tremor during activities",
              "orderSentence": "Wrist weights - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "May cause fatigue",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Adaptive devices",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Two-handled cups, rocker knives, button hooks",
              "orderSentence": "Adaptive devices - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "OT referral",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cala Trio device",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "FDA-approved wrist-worn peripheral nerve stimulation; 2x daily for 40 min",
              "orderSentence": "Cala Trio device - - - see dosing"
            },
            "contraindications": "Pacemaker/implanted device, pregnancy",
            "monitoring": "Prescription medical device",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Limit caffeine",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Caffeine exacerbates tremor",
              "orderSentence": "Limit caffeine - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Patient education",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Avoid triggers",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Stress, fatigue, stimulants worsen tremor",
              "orderSentence": "Avoid triggers - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Patient education",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Stress management",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Relaxation techniques, biofeedback",
              "orderSentence": "Stress management - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Tremor worsens with anxiety",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Movement disorder specialist",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Diagnostic uncertainty, treatment-refractory tremor, DBS candidacy"
          },
          {
            "item": "Occupational therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Adaptive equipment, handwriting strategies, ADL assistance"
          },
          {
            "item": "Physical therapy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Balance, gait training if affected"
          },
          {
            "item": "Speech therapy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Voice tremor management"
          },
          {
            "item": "Neurosurgery",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "DBS candidacy evaluation"
          },
          {
            "item": "Interventional radiology/MRgFUS center",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Focused ultrasound evaluation"
          },
          {
            "item": "Neuropsychology",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Pre-DBS cognitive assessment"
          }
        ],
        "Patient Instructions": [
          {
            "item": "ET is a chronic condition but does not reduce life expectancy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Tremor may worsen slowly over time but many patients do well with treatment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Alcohol provides temporary relief but is not a recommended treatment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Medications work best when taken consistently",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid caffeine and stimulants which worsen tremor",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Get adequate sleep; fatigue worsens tremor",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Join International Essential Tremor Foundation support network",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Inform doctors of ET before procedures (tremor may complicate surgery)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Reduce or eliminate caffeine intake",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain regular sleep schedule",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress reduction techniques",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol to social amounts (not as tremor treatment)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular exercise for overall health",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use adaptive equipment for functional independence",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Parkinson's disease",
        "features": "Rest tremor (4-6 Hz), asymmetric onset, bradykinesia, rigidity, postural instability",
        "tests": "Clinical exam; DaTscan reduced in PD"
      },
      {
        "diagnosis": "Enhanced physiologic tremor",
        "features": "Low amplitude, high frequency (8-12 Hz), associated with anxiety, caffeine, medications, hyperthyroidism",
        "tests": "TSH, medication review, resolves with trigger removal"
      },
      {
        "diagnosis": "Drug-induced tremor",
        "features": "Temporal relationship to medication (lithium, valproate, SSRIs, stimulants, bronchodilators)",
        "tests": "Medication review; improves with dose reduction"
      },
      {
        "diagnosis": "Dystonic tremor",
        "features": "Irregular, jerky, \"null point\" present, associated dystonic posturing",
        "tests": "Clinical features; may respond to botox"
      },
      {
        "diagnosis": "Cerebellar tremor",
        "features": "Intention tremor worse at target, associated ataxia, dysmetria, other cerebellar signs",
        "tests": "MRI brain; cerebellar atrophy/lesion"
      },
      {
        "diagnosis": "Wilson disease",
        "features": "Young onset (<50), KF rings, liver disease, psychiatric symptoms, varied movement disorders",
        "tests": "Ceruloplasmin, 24h urine copper, slit lamp exam"
      },
      {
        "diagnosis": "Psychogenic tremor",
        "features": "Variable frequency, distractible, entrainment, inconsistent pattern, sudden onset",
        "tests": "Clinical observation; psychiatric assessment"
      },
      {
        "diagnosis": "Orthostatic tremor",
        "features": "High frequency (13-18 Hz), occurs only when standing, relief with sitting/walking",
        "tests": "EMG shows characteristic high frequency"
      },
      {
        "diagnosis": "Hyperthyroidism",
        "features": "Associated hyperthyroid symptoms (weight loss, palpitations, heat intolerance)",
        "tests": "TSH, free T4"
      },
      {
        "diagnosis": "Rubral (Holmes) tremor",
        "features": "Combination of rest, postural, and action tremor; large amplitude; midbrain lesion",
        "tests": "MRI brain showing midbrain pathology"
      }
    ],
    "evidence": [
      {
        "recommendation": "Propranolol effective for ET",
        "evidenceLevel": "Class I, Level A",
        "source": "Cochrane Reviews; AAN Guidelines 2011"
      },
      {
        "recommendation": "Primidone effective for ET",
        "evidenceLevel": "Class I, Level A",
        "source": "Cochrane Reviews; AAN Guidelines 2011"
      },
      {
        "recommendation": "Propranolol + Primidone combination",
        "evidenceLevel": "Class II, Level B",
        "source": "AAN Guidelines 2011"
      },
      {
        "recommendation": "Topiramate effective for ET",
        "evidenceLevel": "Class I, Level B",
        "source": "AAN Guidelines 2011"
      },
      {
        "recommendation": "Gabapentin possibly effective",
        "evidenceLevel": "Class II, Level U",
        "source": "AAN Guidelines 2011"
      },
      {
        "recommendation": "Botulinum toxin for hand tremor",
        "evidenceLevel": "Class II, Level B",
        "source": "AAN Guidelines 2011"
      },
      {
        "recommendation": "DBS effective for medically refractory ET",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs"
      },
      {
        "recommendation": "MRgFUS (focused ultrasound) effective",
        "evidenceLevel": "Class I, Level A",
        "source": "[Elias et al., NEJM 2016](https://pubmed.ncbi.nlm.nih.gov/27557301/)"
      },
      {
        "recommendation": "DaTscan differentiates ET from PD",
        "evidenceLevel": "Class II, Level B",
        "source": "FDA approved 2011"
      },
      {
        "recommendation": "Cala Trio wrist device",
        "evidenceLevel": "Class II, Level B",
        "source": "FDA approved 2018"
      }
    ],
    "monitoring": [
      {
        "item": "Tremor severity (clinical rating scale)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "Adjust medications"
      },
      {
        "item": "Functional impact (FTM, QUEST)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q6-12 months",
        "action": "Add therapy, consider surgery"
      },
      {
        "item": "Handwriting sample/spiral drawing",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "Objective tracking"
      },
      {
        "item": "Heart rate",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit if on beta-blocker",
        "action": "Reduce dose if bradycardic"
      },
      {
        "item": "Blood pressure",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit if on beta-blocker",
        "action": "Reduce dose if hypotensive"
      },
      {
        "item": "Sedation/cognitive effects",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "Reduce dose or switch agent"
      },
      {
        "item": "Mood",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "Monitor; beta-blockers can cause depression"
      },
      {
        "item": "TSH",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Annually if on medications",
        "action": "Adjust thyroid replacement if applicable"
      }
    ],
    "disposition": [
      {
        "disposition": "Outpatient management",
        "criteria": "Most patients; diagnosis confirmed, treatment initiated"
      },
      {
        "disposition": "Movement disorder referral",
        "criteria": "Diagnostic uncertainty, DaTscan consideration, treatment-refractory, surgical candidacy"
      },
      {
        "disposition": "DBS evaluation",
        "criteria": "Moderate-severe tremor refractory to medications, adequate cognitive function, no surgical contraindications"
      },
      {
        "disposition": "MRgFUS evaluation",
        "criteria": "Unilateral tremor dominant, medications failed, not DBS candidate, meets skull density criteria"
      },
      {
        "disposition": "Occupational therapy",
        "criteria": "Functional impairment with ADLs; need for adaptive equipment"
      }
    ]
  },
  "Diabetic Neuropathy": {
    "id": "diabetic-neuropathy",
    "title": "Diabetic Neuropathy",
    "version": "1.0",
    "icd10": [
      "** E11.40 (Type 2 diabetes with diabetic neuropathy",
      "unspecified)",
      "E11.41 (Type 2 diabetes with diabetic mononeuropathy)",
      "E11.42 (Type 2 diabetes with diabetic polyneuropathy)",
      "E10.40-E10.42 (Type 1 equivalents)",
      "G63.2 (Diabetic polyneuropathy)"
    ],
    "scope": "** Evaluation and management of diabetic neuropathy in adults including distal symmetric polyneuropathy (most common), painful diabetic neuropathy, diabetic autonomic neuropathy, and focal/multifocal neuropathies. Applies to ED, hospital, and outpatient settings.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "HbA1c",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Glycemic control; correlates with neuropathy risk",
            "target": "<7% (individualized)"
          },
          {
            "item": "Fasting glucose",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Current glycemic status",
            "target": "80-130 mg/dL"
          },
          {
            "item": "BMP (electrolytes, creatinine, BUN)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "rationale": "Renal function; uremic neuropathy",
            "target": "Normal"
          },
          {
            "item": "CBC",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Anemia (B12 deficiency)",
            "target": "Normal"
          },
          {
            "item": "Vitamin B12",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Metformin causes B12 deficiency; coexistent deficiency",
            "target": ">400 pg/mL"
          },
          {
            "item": "Methylmalonic acid (MMA)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If B12 borderline (200-400)",
            "target": "Normal"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypothyroid neuropathy",
            "target": "Normal"
          },
          {
            "item": "Lipid panel",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Dyslipidemia contributes to neuropathy",
            "target": "LDL <100 (or <70 if ASCVD)"
          }
        ],
        "Extended Workup": [
          {
            "item": "SPEP/UPEP with immunofixation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Monoclonal gammopathy-associated neuropathy",
            "target": "No M-spike"
          },
          {
            "item": "Serum free light chains",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If SPEP negative but suspicion",
            "target": "Normal ratio"
          },
          {
            "item": "Liver function tests",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hepatic disease, alcohol",
            "target": "Normal"
          },
          {
            "item": "HIV",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If risk factors",
            "target": "Negative"
          },
          {
            "item": "RPR/VDRL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Syphilis if atypical",
            "target": "Nonreactive"
          },
          {
            "item": "ESR, CRP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Inflammatory/vasculitic neuropathy",
            "target": "Normal"
          },
          {
            "item": "ANA",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If connective tissue disease suspected",
            "target": "Negative"
          },
          {
            "item": "Anti-GAD65, IA-2 antibodies",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If type uncertain; LADA",
            "target": "Document"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CSF analysis",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Elevated protein in DLRPN; r/o inflammatory",
            "target": "Mild protein elevation in DLRPN"
          },
          {
            "item": "Paraneoplastic panel",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If rapid progression, weight loss",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Nerve conduction studies (NCS)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Baseline; atypical cases",
            "target": "Axonal sensorimotor polyneuropathy",
            "contraindications": "Pacemaker (relative); anticoagulation (relative)"
          },
          {
            "item": "Electromyography (EMG)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If motor involvement; amyotrophy",
            "target": "Denervation in affected muscles",
            "contraindications": "Active infection at site"
          },
          {
            "item": "Quantitative sensory testing (QST)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Small fiber neuropathy; research",
            "target": "Abnormal thermal thresholds",
            "contraindications": "None"
          }
        ],
        "Extended": [
          {
            "item": "Cardiovascular autonomic reflex tests",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If CAN suspected",
            "target": "Abnormal HR variability, Valsalva ratio",
            "contraindications": "Arrhythmias"
          },
          {
            "item": "Tilt table test",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Orthostatic hypotension evaluation",
            "target": "Orthostatic BP drop without HR rise",
            "contraindications": "Severe coronary disease"
          },
          {
            "item": "Sudomotor function (QSART)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Sudomotor dysfunction",
            "target": "Reduced sweat output",
            "contraindications": "None"
          },
          {
            "item": "Gastric emptying study",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If gastroparesis suspected",
            "target": "Delayed emptying",
            "contraindications": "None"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Skin punch biopsy (IENFD)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Small fiber neuropathy; normal NCS",
            "target": "Reduced intraepidermal nerve fiber density",
            "contraindications": "Anticoagulation (relative)"
          },
          {
            "item": "Corneal confocal microscopy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Non-invasive small fiber assessment",
            "target": "Reduced corneal nerve fiber density",
            "contraindications": "None"
          }
        ]
      },
      "Treatment": {
        "Glycemic Control (Foundation of Treatment)": [
          {
            "item": "Intensive glycemic control",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7%",
                  "orderSentence": "Intensive glycemic control 7% -"
                }
              ],
              "route": "-",
              "instructions": "Target HbA1c <7% (individualized); avoid hypoglycemia",
              "orderSentence": "Intensive glycemic control 7% -"
            },
            "contraindications": "Hypoglycemia unawareness with CAN",
            "monitoring": "HbA1c q3 months until stable",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Continuous glucose monitoring",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "If hypoglycemia unawareness",
              "orderSentence": "Continuous glucose monitoring - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Sensor accuracy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Neuropathic Pain - First-Line Agents": [
          {
            "item": "Duloxetine (Cymbalta)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg",
                  "orderSentence": "Duloxetine (Cymbalta) 30 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "30 mg daily × 1 week, then 60 mg daily; max 120 mg/day",
              "orderSentence": "Duloxetine (Cymbalta) 30 mg PO"
            },
            "contraindications": "MAOIs, uncontrolled glaucoma, hepatic impairment",
            "monitoring": "Nausea, BP; serotonin syndrome",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pregabalin (Lyrica)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Pregabalin (Lyrica) 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "50 mg TID or 75 mg BID; titrate to 300 mg/day; max 600 mg/day",
              "orderSentence": "Pregabalin (Lyrica) 50 mg PO"
            },
            "contraindications": "CrCl <60: reduce dose",
            "monitoring": "Sedation, edema, weight gain; renal dosing",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gabapentin (Neurontin)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Gabapentin (Neurontin) 300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "300 mg QHS, titrate by 300 mg q3-7 days; target 1800-3600 mg/day divided TID",
              "orderSentence": "Gabapentin (Neurontin) 300 mg PO"
            },
            "contraindications": "CrCl <60: reduce dose",
            "monitoring": "Sedation, edema; renal dosing",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Neuropathic Pain - Second-Line Agents": [
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5-75 mg",
                  "orderSentence": "Venlafaxine XR 37.5-75 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "37.5-75 mg daily; titrate to 150-225 mg/day",
              "orderSentence": "Venlafaxine XR 37.5-75 mg PO"
            },
            "contraindications": "MAOIs, uncontrolled HTN",
            "monitoring": "BP; serotonin syndrome",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-25 mg",
                  "orderSentence": "Amitriptyline 10-25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "10-25 mg QHS; titrate to 50-100 mg QHS",
              "orderSentence": "Amitriptyline 10-25 mg PO"
            },
            "contraindications": "Cardiac disease, glaucoma, urinary retention",
            "monitoring": "ECG if >100 mg; anticholinergic effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nortriptyline",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-25 mg",
                  "orderSentence": "Nortriptyline 10-25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "10-25 mg QHS; titrate to 75 mg QHS",
              "orderSentence": "Nortriptyline 10-25 mg PO"
            },
            "contraindications": "Same as amitriptyline",
            "monitoring": "Same; fewer anticholinergic effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Neuropathic Pain - Topical Agents": [
          {
            "item": "Capsaicin 8% patch (Qutenza)",
            "route": "Transdermal",
            "indication": "-",
            "dosing": {
              "instructions": "Apply to painful area × 30-60 min q3 months; in-office",
              "orderSentence": "Capsaicin 8% patch (Qutenza) - Transdermal - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "Open wounds; capsaicin allergy",
            "monitoring": "BP during application; pain",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lidocaine 5% patch",
            "route": "Transdermal",
            "indication": "-",
            "dosing": {
              "instructions": "Up to 3 patches daily; 12h on/12h off",
              "orderSentence": "Lidocaine 5% patch - Transdermal - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "Allergy to local anesthetics",
            "monitoring": "Local irritation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Capsaicin cream 0.075%",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Apply TID-QID; takes 2-4 weeks for effect",
              "orderSentence": "Capsaicin cream 0.075% - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "Open wounds",
            "monitoring": "Initial burning (improves)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Neuropathic Pain - Third-Line/Refractory": [
          {
            "item": "Tramadol",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50-100 mg",
                  "orderSentence": "Tramadol 50-100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "50-100 mg q4-6h PRN; max 400 mg/day",
              "orderSentence": "Tramadol 50-100 mg PO"
            },
            "contraindications": "Seizure disorder, opioid dependence, MAOIs",
            "monitoring": "Seizures; serotonin syndrome; dependence",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tapentadol ER",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Tapentadol ER 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "50 mg BID; titrate by 50 mg q3 days; max 500 mg/day",
              "orderSentence": "Tapentadol ER 50 mg PO"
            },
            "contraindications": "Respiratory depression, severe hepatic impairment",
            "monitoring": "Respiratory; GI effects",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Spinal cord stimulation",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Referral to interventional pain for refractory cases",
              "orderSentence": "Spinal cord stimulation - - - see dosing"
            },
            "contraindications": "Infection, coagulopathy",
            "monitoring": "Device complications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Combination Therapy": [
          {
            "item": "Duloxetine + Pregabalin",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "If monotherapy inadequate; use lower doses of each",
              "orderSentence": "Duloxetine + Pregabalin - - - see dosing"
            },
            "contraindications": "Per individual agents",
            "monitoring": "Per individual agents",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gabapentinoid + TCA",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "If monotherapy inadequate",
              "orderSentence": "Gabapentinoid + TCA - - - see dosing"
            },
            "contraindications": "Per individual agents",
            "monitoring": "Sedation; anticholinergic",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Diabetic Autonomic Neuropathy Treatment": [
          {
            "item": "Midodrine",
            "dosing": {
              "instructions": "2.5-10 mg TID (last dose before 6 PM)",
              "orderSentence": null
            },
            "monitoring": "Supine HTN; avoid at night"
          },
          {
            "item": "Metoclopramide",
            "dosing": {
              "instructions": "5-10 mg before meals; max 12 weeks",
              "orderSentence": null
            },
            "monitoring": "Tardive dyskinesia (black box)"
          },
          {
            "item": "Sildenafil",
            "dosing": {
              "instructions": "25-100 mg PRN",
              "orderSentence": null
            },
            "monitoring": "Nitrate contraindication"
          },
          {
            "item": "Timed voiding",
            "dosing": {
              "instructions": "q3-4 hour schedule",
              "orderSentence": null
            },
            "monitoring": "Residual volumes"
          },
          {
            "item": "Glycopyrrolate",
            "dosing": {
              "instructions": "1-2 mg BID-TID",
              "orderSentence": null
            },
            "monitoring": "Anticholinergic effects"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Atypical presentation, diagnosis confirmation, refractory pain"
          },
          {
            "item": "Endocrinology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Diabetes optimization"
          },
          {
            "item": "Podiatry",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Foot care, ulcer prevention, nail care"
          },
          {
            "item": "Pain management",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Refractory neuropathic pain"
          },
          {
            "item": "Physical therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Balance, gait, strengthening"
          },
          {
            "item": "Occupational therapy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Hand function, adaptive equipment"
          },
          {
            "item": "Gastroenterology",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Gastroparesis evaluation/management"
          },
          {
            "item": "Urology",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Bladder dysfunction, erectile dysfunction"
          },
          {
            "item": "Cardiology",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Cardiovascular autonomic neuropathy"
          },
          {
            "item": "Wound care",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Diabetic foot ulcers"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Daily foot inspection (patient or caregiver)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Monofilament testing annually (10-g Semmes-Weinstein)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Protective footwear; never walk barefoot",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Custom orthotics/diabetic shoes for high-risk feet",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep feet clean and dry; moisturize (not between toes)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid heating pads; test water temperature with elbow",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Trim toenails straight across; professional care if needed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Immediate evaluation for any wound, blister, or color change",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "URGENT"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Neuropathy is common in diabetes; can be slowed with good control",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report new numbness, tingling, weakness, or pain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Daily foot inspection is critical; use mirror if needed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Never walk barefoot; check shoes for objects before wearing",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Fall prevention: good lighting, remove rugs, use handrails",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report dizziness on standing, early satiety, urinary symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "American Diabetes Association (diabetes.org) resources",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "B12 deficiency neuropathy",
        "features": "Macrocytic anemia; subacute combined degeneration",
        "tests": "B12, MMA; may coexist with DPN"
      },
      {
        "diagnosis": "Alcohol-related neuropathy",
        "features": "Alcohol history; nutritional deficiency",
        "tests": "History; thiamine; may coexist"
      },
      {
        "diagnosis": "Chronic inflammatory demyelinating polyneuropathy",
        "features": "Proximal + distal weakness; demyelinating NCS",
        "tests": "NCS pattern; CSF protein"
      },
      {
        "diagnosis": "Uremic neuropathy",
        "features": "ESRD; improves with dialysis",
        "tests": "Creatinine; dialysis status"
      },
      {
        "diagnosis": "Hypothyroid neuropathy",
        "features": "Carpal tunnel; myopathy; slow relaxation reflexes",
        "tests": "TSH"
      },
      {
        "diagnosis": "Monoclonal gammopathy neuropathy",
        "features": "Often sensory > motor; may have ataxia",
        "tests": "SPEP/UPEP; free light chains"
      },
      {
        "diagnosis": "Hereditary neuropathy (CMT)",
        "features": "Family history; high arches; hammer toes",
        "tests": "Genetic testing; NCS pattern"
      },
      {
        "diagnosis": "Vasculitic neuropathy",
        "features": "Mononeuritis multiplex; stepwise; systemic symptoms",
        "tests": "ESR, CRP; nerve biopsy"
      },
      {
        "diagnosis": "Chemotherapy-induced neuropathy",
        "features": "Temporal relationship to chemo (platinum, taxanes, vincristine)",
        "tests": "History"
      },
      {
        "diagnosis": "HIV neuropathy",
        "features": "Risk factors; CD4 count",
        "tests": "HIV testing"
      }
    ],
    "evidence": [
      {
        "recommendation": "Intensive glycemic control prevents/slows neuropathy",
        "evidenceLevel": "Class I, Level A",
        "source": "[DCCT (DCCT Research Group, NEJM 1993)](https://pubmed.ncbi.nlm.nih.gov/8366922/); [UKPDS 33 (Lancet 1998)](https://pubmed.ncbi.nlm.nih.gov/9742976/)"
      },
      {
        "recommendation": "Duloxetine effective for painful DPN",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs; FDA-approved"
      },
      {
        "recommendation": "Pregabalin effective for painful DPN",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs; FDA-approved"
      },
      {
        "recommendation": "Gabapentin effective for painful DPN",
        "evidenceLevel": "Class I, Level B",
        "source": "Multiple RCTs"
      },
      {
        "recommendation": "TCAs effective for painful DPN",
        "evidenceLevel": "Class I, Level B",
        "source": "Multiple RCTs"
      },
      {
        "recommendation": "Capsaicin 8% patch effective for localized pain",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs; FDA-approved"
      },
      {
        "recommendation": "Midodrine for orthostatic hypotension",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs"
      },
      {
        "recommendation": "Annual foot screening reduces amputation risk",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple studies"
      },
      {
        "recommendation": "Multifactorial risk reduction (lipids, BP, glucose) improves outcomes",
        "evidenceLevel": "Class I, Level B",
        "source": "Multiple studies"
      }
    ],
    "monitoring": [
      {
        "item": "HbA1c",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q3 months until stable, then q6 months",
        "action": "Intensify diabetes management"
      },
      {
        "item": "Foot exam (monofilament)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Every visit; comprehensive annually",
        "action": "Podiatry; protective footwear"
      },
      {
        "item": "Symptom assessment (pain scores)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Every visit",
        "action": "Adjust pain medications"
      },
      {
        "item": "Renal function",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Annually; more if on gabapentinoids",
        "action": "Dose adjust medications"
      },
      {
        "item": "B12 level",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Annually if on metformin",
        "action": "Supplement"
      },
      {
        "item": "Orthostatic vitals",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "If CAN suspected; every visit",
        "action": "Autonomic treatment"
      },
      {
        "item": "Fall risk assessment",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Every visit",
        "action": "PT; home safety evaluation"
      }
    ],
    "disposition": [
      {
        "disposition": "Outpatient management",
        "criteria": "Stable neuropathy; adequate pain control; no active ulcers"
      },
      {
        "disposition": "Admit to hospital",
        "criteria": "Severe uncontrolled pain; infected diabetic foot ulcer; diabetic amyotrophy with functional decline"
      },
      {
        "disposition": "ICU admission",
        "criteria": "Sepsis from foot infection; autonomic crisis"
      },
      {
        "disposition": "Neurology follow-up",
        "criteria": "q3-6 months during treatment optimization; annually when stable"
      },
      {
        "disposition": "Podiatry follow-up",
        "criteria": "q3 months if high-risk feet; annually if low-risk"
      },
      {
        "disposition": "Urgent follow-up",
        "criteria": "New weakness, new ulcer, worsening pain despite treatment"
      }
    ]
  },
  "Parkinson's Disease": {
    "id": "parkinsons-disease",
    "title": "Parkinson's Disease",
    "version": "1.0",
    "icd10": [
      "** G20 (Parkinson's disease)"
    ],
    "scope": "** Diagnosis confirmation, dopaminergic therapy initiation and optimization, motor fluctuation management, and non-motor symptom treatment. Excludes Parkinson-plus syndromes (MSA, PSP, CBD, DLB - separate protocols).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC",
            "rationale": "Baseline; rule out anemia contributing to fatigue",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP",
            "rationale": "Renal function for medication dosing; electrolytes",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatic panel (LFTs)",
            "rationale": "Baseline before COMT inhibitors",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Rule out hypothyroidism mimicking bradykinesia",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "Deficiency can cause parkinsonism; common in elderly",
            "target": ">300 pg/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin D, 25-hydroxy",
            "rationale": "Deficiency common; associated with falls and disease severity",
            "target": ">30 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Ceruloplasmin, serum copper",
            "rationale": "Wilson's disease if age <50",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "24-hour urine copper",
            "rationale": "Wilson's disease confirmation",
            "target": "<100 μg/24hr",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Ferritin, iron studies",
            "rationale": "Neurodegeneration with brain iron accumulation",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "RPR or VDRL",
            "rationale": "Syphilis can cause parkinsonism",
            "target": "Nonreactive",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "HIV testing",
            "rationale": "HIV-associated parkinsonism",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Genetic testing (LRRK2, GBA, SNCA, PARK2, PINK1, DJ-1)",
            "rationale": "Family history or early-onset (<50 years)",
            "target": "Identifies genetic form",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "CSF biomarkers (alpha-synuclein, tau, amyloid)",
            "rationale": "Research/atypical; synuclein seed amplification assay",
            "target": "Abnormal synuclein aggregation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Skin biopsy for alpha-synuclein",
            "rationale": "Research; confirms synucleinopathy",
            "target": "Phosphorylated synuclein deposits",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain without contrast",
            "timing": "At diagnosis",
            "target": "Normal (rules out structural causes, vascular parkinsonism, NPH)",
            "contraindications": "MRI-incompatible devices",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "DaTscan (ioflupane I-123 SPECT)",
            "timing": "Diagnostic uncertainty; essential tremor vs PD",
            "target": "Reduced dopamine transporter uptake in striatum",
            "contraindications": "Hypersensitivity to iodine",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRI Brain with SWI sequence",
            "timing": "Suspected atypical parkinsonism or iron deposition",
            "target": "No \"hot cross bun\" (MSA) or \"hummingbird\" (PSP) signs",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cardiac MIBG scan",
            "timing": "Differentiate PD from MSA",
            "target": "Reduced uptake in PD (preserved in MSA)",
            "contraindications": "Recent MI; drugs affecting uptake",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Sleep study (polysomnography)",
            "timing": "REM sleep behavior disorder evaluation",
            "target": "Confirms RBD (prodromal marker)",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Autonomic function testing",
            "timing": "Dysautonomia assessment",
            "target": "Orthostatic hypotension, abnormal HR variability",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "FDG-PET",
            "timing": "Atypical parkinsonism differentiation",
            "target": "Pattern recognition for PD vs PSP vs MSA",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Transcranial ultrasound",
            "timing": "Screening tool",
            "target": "Hyperechogenicity of substantia nigra",
            "contraindications": "Inadequate bone window",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Carbidopa-Levodopa (continue home dose)",
            "route": "PO/NG",
            "indication": "Admitted PD patient; DO NOT HOLD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Home dose, same timing",
                  "orderSentence": "Carbidopa-Levodopa (continue home dose) Home dose, same timing PO"
                }
              ],
              "route": "PO",
              "instructions": "Give at EXACT same times as home; crushing allowed; use NG if NPO",
              "orderSentence": "Carbidopa-Levodopa (continue home dose) Home dose, same timing PO"
            },
            "contraindications": "Active psychosis; MAOIs within 14 days",
            "monitoring": "Dyskinesias, confusion",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Carbidopa-Levodopa (NPO protocol)",
            "route": "IV/NG",
            "indication": "Patient NPO >4 hours",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Home dose equivalent",
                  "orderSentence": "Carbidopa-Levodopa (NPO protocol) Home dose equivalent NG"
                }
              ],
              "route": "NG",
              "instructions": "Crush tablets; give via NG at home schedule; consult neurology for IV options if unavailable",
              "orderSentence": "Carbidopa-Levodopa (NPO protocol) Home dose equivalent NG"
            },
            "contraindications": "Same as PO",
            "monitoring": "Same as PO",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Apomorphine SC",
            "route": "SC",
            "indication": "Off episode in clinic/ED; NPO patient",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg SC",
                  "orderSentence": "Apomorphine SC 2 mg SC SC"
                },
                {
                  "text": "3 mg SC",
                  "orderSentence": "Apomorphine SC 3 mg SC SC"
                },
                {
                  "text": "4 mg SC",
                  "orderSentence": "Apomorphine SC 4 mg SC SC"
                },
                {
                  "text": "5 mg SC",
                  "orderSentence": "Apomorphine SC 5 mg SC SC"
                },
                {
                  "text": "6 mg SC",
                  "orderSentence": "Apomorphine SC 6 mg SC SC"
                }
              ],
              "route": "SC",
              "instructions": "Test dose 2 mg; titrate by 1 mg to effect; max 6 mg; pretreat with trimethobenzamide",
              "orderSentence": "Apomorphine SC 2 mg SC SC"
            },
            "contraindications": "Concurrent 5-HT3 antagonists (ondansetron); severe hypotension",
            "monitoring": "BP, nausea; may cause severe hypotension",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rotigotine patch",
            "route": "TD",
            "indication": "NPO patient; bridge therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg/24hr",
                  "orderSentence": "Rotigotine patch 2 mg/24hr TD"
                },
                {
                  "text": "4 mg/24hr",
                  "orderSentence": "Rotigotine patch 4 mg/24hr TD"
                },
                {
                  "text": "6 mg/24hr patch",
                  "orderSentence": "Rotigotine patch 6 mg/24hr patch TD"
                }
              ],
              "route": "TD",
              "instructions": "Apply patch equivalent to oral dopamine agonist dose; onset 2-3 hours",
              "orderSentence": "Rotigotine patch 2 mg/24hr TD"
            },
            "contraindications": "Sulfite allergy (adhesive)",
            "monitoring": "Application site reactions",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Trimethobenzamide",
            "route": "IM/PO",
            "indication": "Pretreat before apomorphine to prevent nausea",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg IM/PO",
                  "orderSentence": "Trimethobenzamide 300 mg IM/PO IM/PO"
                }
              ],
              "route": "IM/PO",
              "instructions": "300 mg TID starting 3 days before apomorphine initiation",
              "orderSentence": "Trimethobenzamide 300 mg IM/PO IM/PO"
            },
            "contraindications": "Hypersensitivity",
            "monitoring": "Drowsiness",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Carbidopa-Levodopa IR (Sinemet)",
            "route": "PO",
            "indication": "Motor symptoms; first-line dopaminergic therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25/100 TID",
                  "orderSentence": "Carbidopa-Levodopa IR (Sinemet) 25/100 TID PO"
                },
                {
                  "text": "25/250 TID",
                  "orderSentence": "Carbidopa-Levodopa IR (Sinemet) 25/250 TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25/100 TID; titrate by 1 tablet q1-2wk; typical target 25/100-25/250 TID",
              "orderSentence": "Carbidopa-Levodopa IR (Sinemet) 25/100 TID PO"
            },
            "contraindications": "Active psychosis; MAOIs within 14 days",
            "monitoring": "Dyskinesias, nausea, orthostatic hypotension",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbidopa-Levodopa CR (Sinemet CR)",
            "route": "PO",
            "indication": "Nocturnal symptoms; wearing off",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25/100 CR qHS",
                  "orderSentence": "Carbidopa-Levodopa CR (Sinemet CR) 25/100 CR qHS PO"
                },
                {
                  "text": "50/200 CR BID",
                  "orderSentence": "Carbidopa-Levodopa CR (Sinemet CR) 50/200 CR BID PO"
                }
              ],
              "route": "PO",
              "instructions": "25/100 to 50/200 CR at bedtime or BID; 70% bioavailability vs IR",
              "orderSentence": "Carbidopa-Levodopa CR (Sinemet CR) 25/100 CR qHS PO"
            },
            "contraindications": "Same as IR",
            "monitoring": "Same as IR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbidopa-Levodopa ER (Rytary)",
            "route": "PO",
            "indication": "Motor fluctuations; extend levodopa effect",
            "dosing": {
              "doseOptions": [
                {
                  "text": "23.75/95 TID",
                  "orderSentence": "Carbidopa-Levodopa ER (Rytary) 23.75/95 TID PO"
                },
                {
                  "text": "36.25/145 TID",
                  "orderSentence": "Carbidopa-Levodopa ER (Rytary) 36.25/145 TID PO"
                },
                {
                  "text": "48.75/195 TID",
                  "orderSentence": "Carbidopa-Levodopa ER (Rytary) 48.75/195 TID PO"
                },
                {
                  "text": "61.25/245 TID",
                  "orderSentence": "Carbidopa-Levodopa ER (Rytary) 61.25/245 TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Convert from IR using manufacturer table; typically TID dosing",
              "orderSentence": "Carbidopa-Levodopa ER (Rytary) 23.75/95 TID PO"
            },
            "contraindications": "Same as IR",
            "monitoring": "Same as IR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pramipexole",
            "route": "PO",
            "indication": "Adjunct to levodopa; monotherapy in early PD; tremor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.125 mg TID",
                  "orderSentence": "Pramipexole 0.125 mg TID PO"
                },
                {
                  "text": "0.25 mg TID",
                  "orderSentence": "Pramipexole 0.25 mg TID PO"
                },
                {
                  "text": "0.5 mg TID",
                  "orderSentence": "Pramipexole 0.5 mg TID PO"
                },
                {
                  "text": "1 mg TID",
                  "orderSentence": "Pramipexole 1 mg TID PO"
                },
                {
                  "text": "1.5 mg TID",
                  "orderSentence": "Pramipexole 1.5 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.125 mg TID; titrate by 0.125-0.25 mg TID q5-7 days; max 1.5 mg TID",
              "orderSentence": "Pramipexole 0.125 mg TID PO"
            },
            "contraindications": "Impulse control history",
            "monitoring": "Impulse control disorders, somnolence, leg edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ropinirole",
            "route": "PO",
            "indication": "Adjunct or monotherapy; similar to pramipexole",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg TID",
                  "orderSentence": "Ropinirole 0.25 mg TID PO"
                },
                {
                  "text": "0.5 mg TID",
                  "orderSentence": "Ropinirole 0.5 mg TID PO"
                },
                {
                  "text": "1 mg TID",
                  "orderSentence": "Ropinirole 1 mg TID PO"
                },
                {
                  "text": "2 mg TID",
                  "orderSentence": "Ropinirole 2 mg TID PO"
                },
                {
                  "text": "3 mg TID",
                  "orderSentence": "Ropinirole 3 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25 mg TID; titrate weekly; max 8 mg TID",
              "orderSentence": "Ropinirole 0.25 mg TID PO"
            },
            "contraindications": "Same as pramipexole",
            "monitoring": "Same as pramipexole",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ropinirole XL",
            "route": "PO",
            "indication": "Extended-release option for adherence",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg daily",
                  "orderSentence": "Ropinirole XL 2 mg daily PO"
                },
                {
                  "text": "4 mg daily",
                  "orderSentence": "Ropinirole XL 4 mg daily PO"
                },
                {
                  "text": "6 mg daily",
                  "orderSentence": "Ropinirole XL 6 mg daily PO"
                },
                {
                  "text": "8 mg daily",
                  "orderSentence": "Ropinirole XL 8 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2 mg daily; titrate by 2 mg q1-2wk; max 24 mg daily",
              "orderSentence": "Ropinirole XL 2 mg daily PO"
            },
            "contraindications": "Same as IR",
            "monitoring": "Same as IR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Selegiline",
            "route": "PO",
            "indication": "MAO-B inhibitor; adjunct; mild neuroprotection theory",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg BID",
                  "orderSentence": "Selegiline 5 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "5 mg at breakfast and lunch (avoid evening due to insomnia); max 10 mg/day",
              "orderSentence": "Selegiline 5 mg BID PO"
            },
            "contraindications": "MAOIs; meperidine; TCAs (caution)",
            "monitoring": "Insomnia, hypertensive crisis with tyramine (rare at this dose)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rasagiline",
            "route": "PO",
            "indication": "MAO-B inhibitor; once daily; adjunct or monotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg daily",
                  "orderSentence": "Rasagiline 0.5 mg daily PO"
                },
                {
                  "text": "1 mg daily",
                  "orderSentence": "Rasagiline 1 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.5-1 mg daily; max 1 mg daily",
              "orderSentence": "Rasagiline 0.5 mg daily PO"
            },
            "contraindications": "Same as selegiline",
            "monitoring": "Hypertensive crisis (rare); serotonin syndrome with other serotonergics",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Safinamide",
            "route": "PO",
            "indication": "MAO-B inhibitor with additional mechanisms; adjunct in fluctuations",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg daily",
                  "orderSentence": "Safinamide 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Safinamide 100 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg daily; may increase to 100 mg daily after 2 weeks",
              "orderSentence": "Safinamide 50 mg daily PO"
            },
            "contraindications": "Severe hepatic impairment; MAOIs; opioids",
            "monitoring": "Same as rasagiline; may improve dyskinesia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Entacapone",
            "route": "PO",
            "indication": "COMT inhibitor; extends levodopa effect; wearing off",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mg with each levodopa dose",
                  "orderSentence": "Entacapone 200 mg with each levodopa dose PO"
                }
              ],
              "route": "PO",
              "instructions": "200 mg with each levodopa dose; max 8 doses (1600 mg)/day",
              "orderSentence": "Entacapone 200 mg with each levodopa dose PO"
            },
            "contraindications": "Hepatic impairment; concurrent MAOIs",
            "monitoring": "Diarrhea, orange urine, dyskinesias",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Opicapone",
            "route": "PO",
            "indication": "COMT inhibitor; once daily alternative to entacapone",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Opicapone 50 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "50 mg once daily at bedtime; take 1 hour before or after levodopa",
              "orderSentence": "Opicapone 50 mg qHS PO"
            },
            "contraindications": "Pheochromocytoma; paraganglioma",
            "monitoring": "Dyskinesias, constipation, dry mouth",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amantadine",
            "route": "PO",
            "indication": "Dyskinesia reduction; mild motor benefit",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg BID",
                  "orderSentence": "Amantadine 100 mg BID PO"
                },
                {
                  "text": "100 mg TID",
                  "orderSentence": "Amantadine 100 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg daily; titrate to 100 mg BID-TID; max 400 mg/day; dose-reduce in renal impairment",
              "orderSentence": "Amantadine 100 mg BID PO"
            },
            "contraindications": "End-stage renal disease; seizure history",
            "monitoring": "Livedo reticularis, ankle edema, confusion, hallucinations",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amantadine ER (Gocovri)",
            "route": "PO",
            "indication": "Dyskinesia; extended-release taken at bedtime",
            "dosing": {
              "doseOptions": [
                {
                  "text": "137 mg qHS",
                  "orderSentence": "Amantadine ER (Gocovri) 137 mg qHS PO"
                },
                {
                  "text": "274 mg qHS",
                  "orderSentence": "Amantadine ER (Gocovri) 274 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 137 mg qHS; increase to 274 mg qHS after 1 week",
              "orderSentence": "Amantadine ER (Gocovri) 137 mg qHS PO"
            },
            "contraindications": "Same as IR",
            "monitoring": "Same as IR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trihexyphenidyl",
            "route": "PO",
            "indication": "Tremor-dominant PD; younger patients",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg TID",
                  "orderSentence": "Trihexyphenidyl 1 mg TID PO"
                },
                {
                  "text": "2 mg TID",
                  "orderSentence": "Trihexyphenidyl 2 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1 mg TID; titrate by 2 mg/day q3-5 days; max 15 mg/day",
              "orderSentence": "Trihexyphenidyl 1 mg TID PO"
            },
            "contraindications": "Glaucoma; urinary retention; dementia; age >70",
            "monitoring": "Cognitive impairment, dry mouth, constipation, urinary retention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Benztropine",
            "route": "PO",
            "indication": "Alternative anticholinergic for tremor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg BID",
                  "orderSentence": "Benztropine 0.5 mg BID PO"
                },
                {
                  "text": "1 mg BID",
                  "orderSentence": "Benztropine 1 mg BID PO"
                },
                {
                  "text": "2 mg BID",
                  "orderSentence": "Benztropine 2 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.5 mg BID; titrate slowly; max 6 mg/day",
              "orderSentence": "Benztropine 0.5 mg BID PO"
            },
            "contraindications": "Same as trihexyphenidyl",
            "monitoring": "Same as trihexyphenidyl",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Istradefylline",
            "route": "PO",
            "indication": "Adenosine A2A antagonist; adjunct for OFF time",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg daily",
                  "orderSentence": "Istradefylline 20 mg daily PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Istradefylline 40 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 20 mg daily; may increase to 40 mg daily",
              "orderSentence": "Istradefylline 20 mg daily PO"
            },
            "contraindications": "Strong CYP3A4 inducers",
            "monitoring": "Dyskinesias, dizziness, constipation, hallucinations",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Non-Motor Symptom Treatments": [
          {
            "item": "Pimavanserin (Nuplazid)",
            "route": "PO",
            "indication": "Parkinson's disease psychosis (hallucinations, delusions)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "34 mg daily",
                  "orderSentence": "Pimavanserin (Nuplazid) 34 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "34 mg once daily; takes 4-6 weeks for effect; no titration needed",
              "orderSentence": "Pimavanserin (Nuplazid) 34 mg daily PO"
            },
            "contraindications": "Severe hepatic impairment; QT prolongation",
            "monitoring": "QTc, efficacy assessment at 6 weeks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Quetiapine",
            "route": "PO",
            "indication": "Psychosis; alternative if pimavanserin unavailable",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg qHS",
                  "orderSentence": "Quetiapine 12.5 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Quetiapine 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Quetiapine 50 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5-25 mg qHS; titrate slowly by 12.5-25 mg q3-7d; typical max 150 mg/day",
              "orderSentence": "Quetiapine 12.5 mg qHS PO"
            },
            "contraindications": "Dementia with Lewy bodies (black box)",
            "monitoring": "Sedation, metabolic effects, QTc",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clozapine",
            "route": "PO",
            "indication": "Refractory psychosis; best evidence but monitoring required",
            "dosing": {
              "doseOptions": [
                {
                  "text": "6.25 mg qHS",
                  "orderSentence": "Clozapine 6.25 mg qHS PO"
                },
                {
                  "text": "12.5 mg qHS",
                  "orderSentence": "Clozapine 12.5 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Clozapine 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Clozapine 50 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 6.25-12.5 mg qHS; titrate by 12.5 mg q1-2wk; max 50-100 mg/day in PD",
              "orderSentence": "Clozapine 6.25 mg qHS PO"
            },
            "contraindications": "REMS enrollment required",
            "monitoring": "ANC weekly x 6 mo, then q2wk x 6 mo, then monthly; agranulocytosis risk",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine (Exelon)",
            "route": "PO/Patch",
            "indication": "Parkinson's disease dementia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1.5 mg BID",
                  "orderSentence": "Rivastigmine (Exelon) 1.5 mg BID PO/Patch"
                },
                {
                  "text": "3 mg BID",
                  "orderSentence": "Rivastigmine (Exelon) 3 mg BID PO/Patch"
                },
                {
                  "text": "4.5 mg BID",
                  "orderSentence": "Rivastigmine (Exelon) 4.5 mg BID PO/Patch"
                },
                {
                  "text": "6 mg BID",
                  "orderSentence": "Rivastigmine (Exelon) 6 mg BID PO/Patch"
                },
                {
                  "text": "9.5 mg/24hr patch",
                  "orderSentence": "Rivastigmine (Exelon) 9.5 mg/24hr patch PO/Patch"
                },
                {
                  "text": "13.3 mg/24hr patch",
                  "orderSentence": "Rivastigmine (Exelon) 13.3 mg/24hr patch PO/Patch"
                }
              ],
              "route": "PO/Patch",
              "instructions": "Start 1.5 mg BID or 4.6 mg/24hr patch; titrate monthly; max 6 mg BID or 13.3 mg/24hr",
              "orderSentence": "Rivastigmine (Exelon) 1.5 mg BID PO/Patch"
            },
            "contraindications": "Severe hepatic impairment",
            "monitoring": "Nausea, weight loss, tremor worsening",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Donepezil",
            "route": "PO",
            "indication": "Parkinson's disease dementia; once daily option",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg qHS",
                  "orderSentence": "Donepezil 5 mg qHS PO"
                },
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Donepezil 10 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg qHS; increase to 10 mg after 4-6 weeks",
              "orderSentence": "Donepezil 5 mg qHS PO"
            },
            "contraindications": "GI bleeding; sick sinus syndrome",
            "monitoring": "Nausea, bradycardia, vivid dreams",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Memantine",
            "route": "PO",
            "indication": "Moderate-severe dementia; add to cholinesterase inhibitor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Memantine 5 mg daily PO"
                },
                {
                  "text": "10 mg BID",
                  "orderSentence": "Memantine 10 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; titrate by 5 mg/wk; target 10 mg BID",
              "orderSentence": "Memantine 5 mg daily PO"
            },
            "contraindications": "Severe renal impairment (dose adjust)",
            "monitoring": "Confusion, constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Midodrine",
            "route": "PO",
            "indication": "Orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg TID",
                  "orderSentence": "Midodrine 2.5 mg TID PO"
                },
                {
                  "text": "5 mg TID",
                  "orderSentence": "Midodrine 5 mg TID PO"
                },
                {
                  "text": "10 mg TID",
                  "orderSentence": "Midodrine 10 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5 mg TID (before arising, before lunch, mid-afternoon); titrate by 2.5 mg/dose; max 10 mg TID; last dose by 6 PM",
              "orderSentence": "Midodrine 2.5 mg TID PO"
            },
            "contraindications": "Supine hypertension; urinary retention; severe cardiac disease",
            "monitoring": "Supine BP (must avoid lying flat for 4 hours after dose)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Droxidopa (Northera)",
            "route": "PO",
            "indication": "Neurogenic orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg TID",
                  "orderSentence": "Droxidopa (Northera) 100 mg TID PO"
                },
                {
                  "text": "200 mg TID",
                  "orderSentence": "Droxidopa (Northera) 200 mg TID PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Droxidopa (Northera) 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Droxidopa (Northera) 600 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg TID; titrate by 100 mg/dose q24-48h; max 600 mg TID",
              "orderSentence": "Droxidopa (Northera) 100 mg TID PO"
            },
            "contraindications": "Supine hypertension",
            "monitoring": "Supine BP, headache",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fludrocortisone",
            "route": "PO",
            "indication": "Orthostatic hypotension adjunct",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg daily",
                  "orderSentence": "Fludrocortisone 0.1 mg daily PO"
                },
                {
                  "text": "0.2 mg daily",
                  "orderSentence": "Fludrocortisone 0.2 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.1 mg daily; may increase to 0.2 mg daily; max 0.3 mg",
              "orderSentence": "Fludrocortisone 0.1 mg daily PO"
            },
            "contraindications": "CHF; renal failure; severe hypertension",
            "monitoring": "K+, edema, supine BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sertraline",
            "route": "PO",
            "indication": "Depression in PD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Sertraline 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Sertraline 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Sertraline 100 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; titrate by 25 mg q1-2wk; typical 50-100 mg daily",
              "orderSentence": "Sertraline 25 mg daily PO"
            },
            "contraindications": "MAOIs within 14 days",
            "monitoring": "Serotonin syndrome (caution with MAO-B inhibitors)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "Depression; anxiety in PD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5 mg daily",
                  "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
                },
                {
                  "text": "75 mg daily",
                  "orderSentence": "Venlafaxine XR 75 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Venlafaxine XR 150 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5 mg daily; titrate q1-2wk; typical 75-150 mg daily",
              "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
            },
            "contraindications": "Same as sertraline",
            "monitoring": "BP at higher doses",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Polyethylene glycol (MiraLAX)",
            "route": "PO",
            "indication": "Constipation (ubiquitous in PD)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "17 g daily",
                  "orderSentence": "Polyethylene glycol (MiraLAX) 17 g daily PO"
                },
                {
                  "text": "17 g BID",
                  "orderSentence": "Polyethylene glycol (MiraLAX) 17 g BID PO"
                }
              ],
              "route": "PO",
              "instructions": "17 g (1 capful) in 8 oz liquid daily; may increase to BID",
              "orderSentence": "Polyethylene glycol (MiraLAX) 17 g daily PO"
            },
            "contraindications": "Bowel obstruction",
            "monitoring": "Diarrhea if excessive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Senna + docusate",
            "route": "PO",
            "indication": "Constipation stimulant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 tablets qHS",
                  "orderSentence": "Senna + docusate 2 tablets qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "2 tablets qHS; may increase to 4 tablets",
              "orderSentence": "Senna + docusate 2 tablets qHS PO"
            },
            "contraindications": "Bowel obstruction; undiagnosed abdominal pain",
            "monitoring": "Electrolytes with chronic use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clonazepam",
            "route": "PO",
            "indication": "REM sleep behavior disorder",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg qHS",
                  "orderSentence": "Clonazepam 0.25 mg qHS PO"
                },
                {
                  "text": "0.5 mg qHS",
                  "orderSentence": "Clonazepam 0.5 mg qHS PO"
                },
                {
                  "text": "1 mg qHS",
                  "orderSentence": "Clonazepam 1 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25-0.5 mg qHS; titrate to effect; typical 0.5-1 mg",
              "orderSentence": "Clonazepam 0.25 mg qHS PO"
            },
            "contraindications": "Severe sleep apnea; respiratory compromise",
            "monitoring": "Sedation, falls, cognitive effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "REM sleep behavior disorder; sleep disturbance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3 mg qHS",
                  "orderSentence": "Melatonin 3 mg qHS PO"
                },
                {
                  "text": "6 mg qHS",
                  "orderSentence": "Melatonin 6 mg qHS PO"
                },
                {
                  "text": "9 mg qHS",
                  "orderSentence": "Melatonin 9 mg qHS PO"
                },
                {
                  "text": "12 mg qHS",
                  "orderSentence": "Melatonin 12 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 3-6 mg qHS; may increase to 12 mg",
              "orderSentence": "Melatonin 3 mg qHS PO"
            },
            "contraindications": "None",
            "monitoring": "Generally well-tolerated",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glycopyrrolate",
            "route": "PO",
            "indication": "Sialorrhea (drooling)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg TID",
                  "orderSentence": "Glycopyrrolate 1 mg TID PO"
                },
                {
                  "text": "2 mg TID",
                  "orderSentence": "Glycopyrrolate 2 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1 mg TID; titrate to effect; max 2 mg TID",
              "orderSentence": "Glycopyrrolate 1 mg TID PO"
            },
            "contraindications": "Glaucoma; urinary retention; GI obstruction",
            "monitoring": "Dry mouth, constipation, urinary retention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "OnabotulinumtoxinA (salivary glands)",
            "route": "IM",
            "indication": "Sialorrhea refractory to oral therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 units total",
                  "orderSentence": "OnabotulinumtoxinA (salivary glands) 100 units total IM"
                }
              ],
              "route": "IM",
              "instructions": "30-50 units per parotid, 10-20 units per submandibular; repeat q3-4 months",
              "orderSentence": "OnabotulinumtoxinA (salivary glands) 100 units total IM"
            },
            "contraindications": "Infection at site",
            "monitoring": "Dysphagia (rare), dry mouth",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Advanced Therapies": [
          {
            "item": "Deep brain stimulation (DBS)",
            "route": "Surgical",
            "indication": "Motor fluctuations or tremor refractory to optimal medication",
            "dosing": {
              "doseOptions": [
                {
                  "text": "STN or GPi stimulation",
                  "orderSentence": "Deep brain stimulation (DBS) STN or GPi stimulation Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Unilateral or bilateral; programming done over weeks post-op",
              "orderSentence": "Deep brain stimulation (DBS) STN or GPi stimulation Surgical"
            },
            "pretreatment": "Neuropsych testing, MRI, off-medication evaluation",
            "contraindications": "Dementia; active psychiatric disease; medical comorbidities",
            "monitoring": "Programming optimization; battery checks",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Levodopa-carbidopa intestinal gel (Duopa)",
            "route": "Enteral",
            "indication": "Severe motor fluctuations; 4+ hours OFF/day",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Continuous infusion",
                  "orderSentence": "Levodopa-carbidopa intestinal gel (Duopa) Continuous infusion Enteral"
                }
              ],
              "route": "Enteral",
              "instructions": "Via PEG-J; 16-hour infusion; morning bolus + continuous rate + extra doses",
              "orderSentence": "Levodopa-carbidopa intestinal gel (Duopa) Continuous infusion Enteral"
            },
            "pretreatment": "GI tract accessible",
            "contraindications": "GI disease preventing PEG-J; coagulopathy",
            "monitoring": "Tube site, infections, GI complications",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Apomorphine continuous infusion",
            "route": "SC",
            "indication": "Severe motor fluctuations; not DBS candidate",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3-8 mg/hr continuous",
                  "orderSentence": "Apomorphine continuous infusion 3-8 mg/hr continuous SC"
                }
              ],
              "route": "SC",
              "instructions": "Via subcutaneous pump; typical 3-8 mg/hr during waking hours",
              "orderSentence": "Apomorphine continuous infusion 3-8 mg/hr continuous SC"
            },
            "pretreatment": "Caregiver training",
            "contraindications": "Same as SC apomorphine",
            "monitoring": "Same as SC apomorphine",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Movement disorders specialist for diagnosis confirmation and advanced therapy evaluation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for gait training, balance exercises, and LSVT BIG program",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for ADL adaptation and fine motor strategies",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech therapy (LSVT LOUD) for hypophonia and swallowing evaluation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuropsychology for cognitive assessment and DBS candidacy evaluation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatry for depression, anxiety, impulse control disorders, or psychosis management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Palliative care for advanced disease symptom management and goals of care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for caregiver support, community resources, and disability planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Urology for urinary symptoms not responsive to first-line treatment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gastroenterology for severe constipation or Duopa tube placement",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "CRITICAL: Do not skip or delay levodopa doses as this can cause severe OFF episodes and immobility",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take levodopa 30-60 minutes before meals for better absorption (protein competes with levodopa transport)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Rise slowly from sitting or lying to prevent falls from orthostatic hypotension",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Inform all healthcare providers about PD medications to avoid drug interactions (especially antipsychotics, antiemetics)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report any new impulsive behaviors (gambling, shopping, hypersexuality) which may indicate impulse control disorder from dopamine agonists",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report hallucinations early as these can be managed with medication adjustment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Engage in regular exercise which may slow disease progression and improves mobility",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Regular aerobic exercise (30-60 min, 3-5x/week) improves motor function and may be neuroprotective",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Tai chi or dance-based exercise programs improve balance and reduce falls",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "High-fiber diet and adequate hydration to prevent constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid medications that worsen parkinsonism (metoclopramide, prochlorperazine, haloperidol, risperidone)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Fall prevention: remove home hazards, adequate lighting, grab bars, non-slip surfaces",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Mediterranean diet may have protective benefits based on observational studies",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Coffee consumption associated with reduced PD risk; continued moderate use reasonable",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Drug-induced parkinsonism",
        "features": "Medication exposure (antipsychotics, metoclopramide); symmetric; no levodopa response",
        "tests": "DaTscan normal; history of causative medication"
      },
      {
        "diagnosis": "Vascular parkinsonism",
        "features": "Stepwise progression; lower body predominant; vascular risk factors; pyramidal signs",
        "tests": "MRI with subcortical/basal ganglia infarcts"
      },
      {
        "diagnosis": "Progressive supranuclear palsy (PSP)",
        "features": "Early falls; vertical gaze palsy; axial rigidity > limb; poor levodopa response",
        "tests": "MRI \"hummingbird sign\"; clinical criteria"
      },
      {
        "diagnosis": "Multiple system atrophy (MSA)",
        "features": "Severe dysautonomia; cerebellar signs; stridor; poor levodopa response",
        "tests": "MRI \"hot cross bun\" sign; MIBG preserved"
      },
      {
        "diagnosis": "Corticobasal degeneration (CBD)",
        "features": "Asymmetric rigidity; apraxia; alien limb; cortical sensory loss",
        "tests": "MRI asymmetric cortical atrophy"
      },
      {
        "diagnosis": "Dementia with Lewy bodies (DLB)",
        "features": "Dementia before or within 1 year of motor symptoms; fluctuating cognition; visual hallucinations",
        "tests": "Clinical criteria; DaTscan may be abnormal"
      },
      {
        "diagnosis": "Essential tremor",
        "features": "Action tremor > rest tremor; improves with alcohol; family history; no bradykinesia",
        "tests": "DaTscan normal; clinical criteria"
      },
      {
        "diagnosis": "Normal pressure hydrocephalus",
        "features": "Gait apraxia (\"magnetic gait\"); urinary incontinence; dementia",
        "tests": "MRI ventricular enlargement; LP with gait improvement"
      }
    ],
    "evidence": [
      {
        "recommendation": "Levodopa most effective symptomatic treatment",
        "evidenceLevel": "Class I, Level A",
        "source": "[Fahn et al. NEJM 2004 (ELLDOPA)](https://pubmed.ncbi.nlm.nih.gov/15590952/)"
      },
      {
        "recommendation": "MAO-B inhibitors provide mild motor benefit",
        "evidenceLevel": "Class I, Level A",
        "source": "[Rascol et al. NEJM 2005 (rasagiline)](https://pubmed.ncbi.nlm.nih.gov/15728780/)"
      },
      {
        "recommendation": "Pimavanserin for PD psychosis",
        "evidenceLevel": "Class I, Level A",
        "source": "[Cummings et al. Lancet 2014](https://pubmed.ncbi.nlm.nih.gov/24315521/)"
      },
      {
        "recommendation": "DBS improves motor fluctuations",
        "evidenceLevel": "Class I, Level A",
        "source": "[Weaver et al. JAMA 2009](https://pubmed.ncbi.nlm.nih.gov/19126699/)"
      },
      {
        "recommendation": "Rivastigmine for PD dementia",
        "evidenceLevel": "Class I, Level A",
        "source": "[Emre et al. NEJM 2004](https://pubmed.ncbi.nlm.nih.gov/15590953/)"
      },
      {
        "recommendation": "Exercise improves motor function",
        "evidenceLevel": "Class II, Level B",
        "source": "[Schenkman et al. JAMA Neurol 2018](https://pubmed.ncbi.nlm.nih.gov/29228079/)"
      },
      {
        "recommendation": "LSVT LOUD improves speech",
        "evidenceLevel": "Class I, Level B",
        "source": "[Ramig et al. JSLHR 2001](https://pubmed.ncbi.nlm.nih.gov/11407973/)"
      },
      {
        "recommendation": "Clonazepam and melatonin for RBD",
        "evidenceLevel": "Class II, Level B",
        "source": "[Aurora et al. AASM 2010](https://pubmed.ncbi.nlm.nih.gov/21135521/)"
      },
      {
        "recommendation": "Amantadine reduces dyskinesia",
        "evidenceLevel": "Class I, Level A",
        "source": "[Ory-Magne et al. Lancet Neurol 2014](https://pubmed.ncbi.nlm.nih.gov/24726067/)"
      },
      {
        "recommendation": "Duopa for motor fluctuations",
        "evidenceLevel": "Class I, Level A",
        "source": "[Olanow et al. Lancet Neurol 2014](https://pubmed.ncbi.nlm.nih.gov/24184024/)"
      }
    ],
    "monitoring": [
      {
        "item": "Motor function (UPDRS-III or MDS-UPDRS)",
        "frequency": "Every visit",
        "action": "Adjust medications if worsening",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ON/OFF time diary",
        "frequency": "Daily for 1 week before visits",
        "action": "Add adjunct therapy; consider advanced options",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Dyskinesia severity",
        "frequency": "Each visit",
        "action": "Reduce levodopa; add amantadine; adjust timing",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Orthostatic blood pressure",
        "frequency": "Each visit",
        "action": "Add midodrine or droxidopa",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Cognition (MoCA)",
        "frequency": "Annually, more often if concerns",
        "action": "Add cholinesterase inhibitor; adjust anticholinergics",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Mood (GDS, PHQ-9)",
        "frequency": "Annually",
        "action": "Add antidepressant; psychiatry referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Impulse control screen (QUIP)",
        "frequency": "Each visit if on dopamine agonist",
        "action": "Reduce or discontinue dopamine agonist",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Falls frequency",
        "frequency": "Each visit",
        "action": "PT referral; medication review; home safety evaluation",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Swallowing function",
        "frequency": "Annually or if symptoms",
        "action": "Speech therapy; modify diet",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ANC (if on clozapine)",
        "frequency": "Per REMS protocol",
        "action": "Hold clozapine if ANC <1000; discontinue if <500",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Stable motor status; able to take PO; adequate caregiver support; follow-up arranged"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Unable to take PO medications >24 hours; severe OFF episode; aspiration pneumonia; acute infection"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Neuroleptic malignant syndrome; severe rigidity with rhabdomyolysis; respiratory compromise"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Every 3-6 months for stable patients; more frequently during medication adjustments"
      }
    ]
  },
  "Cluster Headache": {
    "id": "cluster-headache",
    "title": "Cluster Headache",
    "version": "1.0",
    "icd10": [
      "** G44.009 (Cluster headache syndrome",
      "unspecified",
      "not intractable)",
      "G44.019 (Cluster headache syndrome",
      "unspecified",
      "intractable)",
      "G44.001 (Episodic cluster headache",
      "not intractable)",
      "G44.011 (Episodic cluster headache",
      "intractable)",
      "G44.009 (Chronic cluster headache)"
    ],
    "scope": "** Diagnosis and management of episodic and chronic cluster headache in adults. Covers acute abortive treatment, transitional therapy, and preventive medication. Excludes other trigeminal autonomic cephalalgias (paroxysmal hemicrania, SUNCT/SUNA, hemicrania continua), migraine, and secondary causes of headache.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Baseline",
            "target": "Normal"
          },
          {
            "item": "CMP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Baseline; before starting verapamil",
            "target": "Normal"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Thyroid dysfunction",
            "target": "Normal"
          }
        ],
        "Extended Workup": [
          {
            "item": "ESR/CRP",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If GCA suspected (older patient, new onset)",
            "target": "Normal"
          },
          {
            "item": "Pituitary hormone panel",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If pituitary lesion suspected",
            "target": "Normal"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Lumbar puncture",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Only if secondary cause suspected",
            "target": "Normal"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI brain with pituitary protocol",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At diagnosis (once)",
            "target": "Rule out secondary causes (pituitary lesion, cavernous sinus lesion)",
            "contraindications": "Pacemaker, metal"
          },
          {
            "item": "MRA head",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If vascular lesion suspected",
            "target": "Normal vasculature",
            "contraindications": "Per MRI"
          }
        ],
        "Extended": [
          {
            "item": "CT head",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-",
            "timing": "If acute concern (thunderclap, first presentation)",
            "target": "Rule out hemorrhage",
            "contraindications": "None"
          },
          {
            "item": "ECG",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Before verapamil; baseline",
            "target": "Normal rhythm, PR interval",
            "contraindications": "None"
          }
        ]
      },
      "Treatment": {
        "Acute/Abortive Treatment (During Attack)": [
          {
            "item": "High-flow oxygen",
            "route": "INH",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100%",
                  "orderSentence": "High-flow oxygen 100% INH"
                }
              ],
              "route": "INH",
              "instructions": "100% O2 at 12-15 L/min via non-rebreather mask × 15-20 min; can repeat",
              "orderSentence": "High-flow oxygen 100% INH"
            },
            "contraindications": "None; safe in COPD for acute use",
            "monitoring": "O2 sat; usually aborts attack in 15 min",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sumatriptan SC",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "6 mg",
                  "orderSentence": "Sumatriptan SC 6 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "6 mg SC; may use up to 2 doses/24h (minimum 1h apart); max 12 mg/24h",
              "orderSentence": "Sumatriptan SC 6 mg SC"
            },
            "contraindications": "CAD, uncontrolled HTN, recent stroke/TIA, hemiplegic migraine",
            "monitoring": "Chest tightness, BP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sumatriptan nasal",
            "route": "IN",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "Sumatriptan nasal 20 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "20 mg intranasal; less effective than SC",
              "orderSentence": "Sumatriptan nasal 20 mg SC"
            },
            "contraindications": "Same as SC",
            "monitoring": "Same",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Zolmitriptan nasal",
            "route": "IN",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Zolmitriptan nasal 5 mg IN"
                }
              ],
              "route": "IN",
              "instructions": "5 mg intranasal; may repeat in 2h; max 10 mg/24h",
              "orderSentence": "Zolmitriptan nasal 5 mg IN"
            },
            "contraindications": "Same as sumatriptan",
            "monitoring": "Same",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lidocaine intranasal",
            "route": "IN",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mL",
                  "orderSentence": "Lidocaine intranasal 1 mL -"
                }
              ],
              "route": "-",
              "instructions": "4% lidocaine 1 mL applied to ipsilateral nostril (head tilted back); can repeat",
              "orderSentence": "Lidocaine intranasal 1 mL -"
            },
            "contraindications": "Local anesthetic allergy",
            "monitoring": "May provide partial/temporary relief",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Octreotide SC",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mcg",
                  "orderSentence": "Octreotide SC 100 mcg SC"
                }
              ],
              "route": "SC",
              "instructions": "100 mcg SC; second-line if triptans contraindicated",
              "orderSentence": "Octreotide SC 100 mcg SC"
            },
            "contraindications": "None significant",
            "monitoring": "GI upset",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Transitional (Bridge) Therapy": [
          {
            "item": "Prednisone",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60-80 mg",
                  "orderSentence": "Prednisone 60-80 mg -"
                }
              ],
              "route": "-",
              "instructions": "60-80 mg daily × 5 days, then taper by 10 mg q3 days; OR 1 mg/kg × 5 days then rapid taper; total course ~2-3 weeks",
              "orderSentence": "Prednisone 60-80 mg -"
            },
            "contraindications": "Uncontrolled DM, active infection",
            "monitoring": "Glucose, GI prophylaxis",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dexamethasone",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4-8 mg",
                  "orderSentence": "Dexamethasone 4-8 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "4-8 mg BID × 1-2 weeks, then taper",
              "orderSentence": "Dexamethasone 4-8 mg PO"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Greater occipital nerve block (GON block)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mL",
                  "orderSentence": "Greater occipital nerve block (GON block) 2 mL -"
                }
              ],
              "route": "-",
              "instructions": "Lidocaine 2% (2 mL) + triamcinolone 40 mg or methylprednisolone 40 mg; inject ipsilateral or bilateral",
              "orderSentence": "Greater occipital nerve block (GON block) 2 mL -"
            },
            "contraindications": "Anticoagulation, local infection",
            "monitoring": "May provide 2-4 weeks relief",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Suboccipital steroid injection",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Similar to GON block; ipsilateral",
              "orderSentence": "Suboccipital steroid injection - - - see dosing"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "DHE protocol (inpatient)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5-1 mg",
                  "orderSentence": "DHE protocol (inpatient) 0.5-1 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "DHE 0.5-1 mg IV q8h × 3-5 days (with antiemetic pretreatment)",
              "orderSentence": "DHE protocol (inpatient) 0.5-1 mg IV"
            },
            "contraindications": "CAD, CVA, uncontrolled HTN, triptans <24h",
            "monitoring": "BP, nausea, peripheral vasoconstriction",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Preventive Therapy - First-Line": [
          {
            "item": "Verapamil",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "80 mg",
                  "orderSentence": "Verapamil 80 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 80 mg TID; increase by 80 mg q1-2 weeks to 240-960 mg/day in divided doses (some patients need >480 mg/day)",
              "orderSentence": "Verapamil 80 mg PO"
            },
            "contraindications": "Heart block (2nd/3rd degree), sick sinus, severe LV dysfunction, WPW",
            "monitoring": "ECG at baseline, after each dose increase; PR interval (hold if >280 ms)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lithium",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Lithium 300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg BID-TID; target serum level 0.6-1.0 mEq/L; usual dose 600-1200 mg/day",
              "orderSentence": "Lithium 300 mg PO"
            },
            "contraindications": "Renal impairment, thyroid disease, dehydration, sodium depletion",
            "monitoring": "Lithium level, renal function, TSH q3-6 months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Preventive Therapy - Second-Line": [
          {
            "item": "Topiramate",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Topiramate 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; titrate to 100-200 mg/day",
              "orderSentence": "Topiramate 25 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Kidney stones, glaucoma, pregnancy",
            "monitoring": "Cognitive effects, paresthesias, metabolic acidosis",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "9-10 mg",
                  "orderSentence": "Melatonin 9-10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "9-10 mg QHS (higher than sleep doses)",
              "orderSentence": "Melatonin 9-10 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "None significant",
            "monitoring": "Sedation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Galcanezumab (CGRP mAb)",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Galcanezumab (CGRP mAb) 300 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "300 mg SC monthly (FDA approved for episodic CH)",
              "orderSentence": "Galcanezumab (CGRP mAb) 300 mg SC"
            },
            "pretreatment": "-",
            "contraindications": "Hypersensitivity",
            "monitoring": "Injection site reactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valproate",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500-2000 mg/day",
                  "orderSentence": "Valproate 500-2000 mg/day PO"
                }
              ],
              "route": "PO",
              "instructions": "500-2000 mg/day in divided doses",
              "orderSentence": "Valproate 500-2000 mg/day PO"
            },
            "pretreatment": "-",
            "contraindications": "Pregnancy, hepatic disease",
            "monitoring": "LFTs, ammonia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "900-3600 mg/day",
                  "orderSentence": "Gabapentin 900-3600 mg/day PO"
                }
              ],
              "route": "PO",
              "instructions": "900-3600 mg/day; limited evidence",
              "orderSentence": "Gabapentin 900-3600 mg/day PO"
            },
            "pretreatment": "-",
            "contraindications": "Renal impairment",
            "monitoring": "Sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ergotamine (prophylactic)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2 mg",
                  "orderSentence": "Ergotamine (prophylactic) 1-2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "1-2 mg at bedtime if nocturnal attacks",
              "orderSentence": "Ergotamine (prophylactic) 1-2 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Same as DHE",
            "monitoring": "Limited to <2 weeks to avoid overuse",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Refractory Chronic Cluster Headache": [
          {
            "item": "Combination verapamil + lithium",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Use both at therapeutic doses",
              "orderSentence": "Combination verapamil + lithium - - - see dosing"
            },
            "contraindications": "Per individual agents",
            "monitoring": "Per individual agents",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "OnabotulinumtoxinA",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Off-label; pericranial injections",
              "orderSentence": "OnabotulinumtoxinA - - - see dosing"
            },
            "contraindications": "Infection at site",
            "monitoring": "Limited evidence",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Occipital nerve stimulation (ONS)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Implantable device; for refractory cases",
              "orderSentence": "Occipital nerve stimulation (ONS) - - - see dosing"
            },
            "contraindications": "Poor surgical candidate",
            "monitoring": "Specialist decision",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Sphenopalatine ganglion stimulation",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Implantable device (Pulsante)",
              "orderSentence": "Sphenopalatine ganglion stimulation - - - see dosing"
            },
            "contraindications": "Poor surgical candidate",
            "monitoring": "Specialist decision",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Deep brain stimulation (hypothalamus)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Research settings; highly refractory",
              "orderSentence": "Deep brain stimulation (hypothalamus) - - - see dosing"
            },
            "contraindications": "Multiple",
            "monitoring": "Specialist decision",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Headache specialist/Neurology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "All patients; diagnosis confirmation and management"
          },
          {
            "item": "Cardiology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Before high-dose verapamil if cardiac history"
          },
          {
            "item": "Pain management",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Refractory cases, nerve block expertise"
          },
          {
            "item": "Neurosurgery",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "indication": "Neuromodulation candidacy (ONS, DBS)"
          },
          {
            "item": "Home oxygen supply",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Arrange high-flow O2 for home use"
          },
          {
            "item": "Psychiatry",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Depression, suicide risk (cluster headache has high depression rate)"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Oxygen therapy is FIRST-LINE for acute attacks - keep tank accessible",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Sumatriptan SC auto-injector for breakthrough attacks; do not exceed 2/day",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid alcohol during cluster periods (potent trigger)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid napping or irregular sleep schedules (can trigger attacks)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Attacks often occur at same time daily (circadian pattern) - prepare",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do NOT use over-the-counter pain medications (ineffective, risk of MOH)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cluster periods may be seasonal - anticipate and start preventive early",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Depression is common; seek help if mood changes",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Clusterbusters.org and headache support groups for resources",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Complete alcohol abstinence during cluster periods",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain regular sleep schedule; avoid naps",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid high altitudes during cluster periods",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid vasodilators (nitroglycerin, sildenafil) during cluster periods",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid strong smells (perfumes, solvents) during cluster periods",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation (association with cluster headache)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep headache diary to identify patterns and triggers",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Migraine",
        "features": "Longer duration (4-72h), bilateral possible, photophobia/phonophobia, prefers rest vs restlessness",
        "tests": "Clinical criteria (ICHD-3)"
      },
      {
        "diagnosis": "Paroxysmal hemicrania",
        "features": "Shorter attacks (2-30 min), higher frequency (>5/day), ABSOLUTE response to indomethacin",
        "tests": "Indomethacin trial (completely responsive)"
      },
      {
        "diagnosis": "SUNCT/SUNA",
        "features": "Very short attacks (1-600 sec), very high frequency, conjunctival injection/tearing",
        "tests": "Clinical criteria; shorter duration"
      },
      {
        "diagnosis": "Hemicrania continua",
        "features": "Continuous baseline pain with exacerbations, responds to indomethacin",
        "tests": "Indomethacin trial"
      },
      {
        "diagnosis": "Trigeminal neuralgia",
        "features": "Electric shock-like, seconds duration, triggered by touch/chewing",
        "tests": "MRI for neurovascular compression; much shorter attacks"
      },
      {
        "diagnosis": "Pituitary tumor",
        "features": "Visual field deficits, hormonal abnormalities, progressive",
        "tests": "MRI pituitary"
      },
      {
        "diagnosis": "Cavernous sinus lesion",
        "features": "Persistent symptoms, cranial nerve palsies",
        "tests": "MRI/MRA"
      },
      {
        "diagnosis": "Giant cell arteritis",
        "features": "Age >50, jaw claudication, scalp tenderness, elevated ESR",
        "tests": "ESR/CRP, temporal artery biopsy"
      },
      {
        "diagnosis": "Primary stabbing headache",
        "features": "Brief (seconds), random location, no autonomic features",
        "tests": "Clinical"
      }
    ],
    "evidence": [
      {
        "recommendation": "High-flow oxygen effective for acute cluster",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs; Cochrane Reviews"
      },
      {
        "recommendation": "Sumatriptan SC effective for acute cluster",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs"
      },
      {
        "recommendation": "Verapamil effective for prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs"
      },
      {
        "recommendation": "Lithium effective for chronic cluster",
        "evidenceLevel": "Class II, Level B",
        "source": "RCTs with limitations"
      },
      {
        "recommendation": "Corticosteroids effective for transitional therapy",
        "evidenceLevel": "Class II, Level B",
        "source": "Multiple studies"
      },
      {
        "recommendation": "Greater occipital nerve block effective",
        "evidenceLevel": "Class II, Level B",
        "source": "Multiple studies"
      },
      {
        "recommendation": "Galcanezumab approved for episodic CH",
        "evidenceLevel": "Class I, Level A",
        "source": "FDA approved 2019; [GAAIN trial (Goadsby et al., NEJM 2019)](https://pubmed.ncbi.nlm.nih.gov/31291515/)"
      },
      {
        "recommendation": "Indomethacin response distinguishes paroxysmal hemicrania",
        "evidenceLevel": "Class I",
        "source": "Diagnostic criterion"
      }
    ],
    "monitoring": [
      {
        "item": "Attack frequency/severity diary",
        "ED": "ROUTINE",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Daily during bout",
        "action": "Adjust preventive"
      },
      {
        "item": "ECG (verapamil patients)",
        "ED": "-",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Baseline, after each dose increase",
        "action": "Hold/reduce verapamil"
      },
      {
        "item": "Lithium level",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Weekly until stable, then q3 months",
        "action": "Adjust dose"
      },
      {
        "item": "Renal function (lithium)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q3-6 months",
        "action": "May need to discontinue"
      },
      {
        "item": "TSH (lithium)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q6 months",
        "action": "Lithium-induced hypothyroidism"
      },
      {
        "item": "Blood pressure",
        "ED": "ROUTINE",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "Adjust verapamil"
      },
      {
        "item": "Depression screening",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "Refer psychiatry"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge from ED",
        "criteria": "Attack aborted with O2/triptan, preventive medication initiated or adjusted, home O2 arranged, follow-up planned"
      },
      {
        "disposition": "Admit to hospital",
        "criteria": "Severe refractory attacks, need for IV DHE protocol, unable to manage at home, new diagnosis requiring workup"
      },
      {
        "disposition": "Headache specialist referral",
        "criteria": "All patients; chronic cluster, refractory cases, neuromodulation consideration"
      },
      {
        "disposition": "Urgent follow-up",
        "criteria": "Within 1-2 weeks if in active cluster period"
      }
    ]
  },
  "Mild Cognitive Impairment (MCI)": {
    "id": "mild-cognitive-impairment",
    "title": "Mild Cognitive Impairment (MCI)",
    "version": "1.1",
    "icd10": [
      "** G31.84 (Mild cognitive impairment)",
      "F06.7 (Mild neurocognitive disorder)",
      "R41.81 (Age-related cognitive decline)"
    ],
    "scope": "** Outpatient-focused evaluation for MCI, identification of reversible causes, subtype classification (amnestic vs non-amnestic), risk factor modification, monitoring for progression, and symptomatic treatment. Includes guidance on disease-modifying therapy eligibility (anti-amyloid agents) and advance care planning.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Anemia, infection, or malignancy contributing to cognitive changes",
            "target": "Normal"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hyponatremia, uremia, hypercalcemia, hepatic encephalopathy as reversible causes",
            "target": "Normal electrolytes, renal, hepatic function"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypothyroidism is reversible cause of cognitive impairment",
            "target": "0.4-4.0 mIU/L"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency causes reversible cognitive impairment; common in elderly",
            "target": ">300 pg/mL (>400 pg/mL optimal for neurological function)"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency contributes to cognitive impairment; check with B12",
            "target": ">3 ng/mL"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes management affects cognition; vascular risk factor",
            "target": "<7% (individualize in elderly)"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Vascular risk factor assessment; hyperlipidemia accelerates cognitive decline",
            "target": "LDL <100 mg/dL; <70 if established CVD"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes screening; glycemic control affects cognition",
            "target": "70-100 mg/dL"
          }
        ],
        "Extended Workup": [
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurosyphilis is rare but treatable cause of cognitive impairment",
            "target": "Nonreactive"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HIV-associated neurocognitive disorder; if risk factors present",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency associated with cognitive decline and dementia risk",
            "target": ">30 ng/mL"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Elevated levels associated with Alzheimer's disease and vascular cognitive impairment",
            "target": "<15 μmol/L"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Inflammatory or autoimmune causes; vasculitis screen",
            "target": "Normal"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "UTI in elderly can present as cognitive changes; rule out reversible cause",
            "target": "Negative for infection"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "More sensitive than B12 level for functional B12 deficiency",
            "target": "<0.4 μmol/L"
          }
        ],
        "Rare/Specialized": [
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Toxic exposure history; occupational risk",
            "target": "Normal"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Wilson's disease if age <50; hepatic symptoms",
            "target": "Normal"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Autoimmune cognitive impairment; unexplained rapid progression",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Autoimmune encephalitis presenting as MCI",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Risk stratification for AD progression; anti-amyloid therapy planning",
            "target": "Informational (APOE4 increases risk)"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Familial early-onset AD (<65); family history of early-onset dementia",
            "target": "No pathogenic variants"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Endemic area; outdoor exposure; systemic symptoms",
            "target": "Negative"
          }
        ],
        "Lumbar Puncture": [
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out infection, inflammation",
            "target": "WBC <5, protein <45 mg/dL, glucose >60% serum"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Low in Alzheimer's pathology; biomarker confirmation",
            "target": "Low Aβ42 (<600 pg/mL) suggests AD pathology"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Elevated in neurodegeneration; nonspecific",
            "target": "Mildly elevated in MCI due to AD; marked elevation suggests rapid progression"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Specific for AD pathology; predictor of progression",
            "target": "Elevated p-tau with low Aβ42 = high risk of AD progression"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "More accurate than Aβ42 alone for amyloid status",
            "target": "<0.05-0.08 suggests amyloid positivity (assay-dependent)"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Nonspecific neurodegeneration marker; prognostic",
            "target": "Elevated suggests active neurodegeneration"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurosyphilis if RPR positive or high suspicion",
            "target": "Nonreactive"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At initial evaluation",
            "target": "Hippocampal volume, medial temporal atrophy (Scheltens scale), white matter disease burden, rule out structural causes (tumor, SDH, NPH)",
            "contraindications": "MRI-incompatible devices"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At diagnosis; gold standard for MCI characterization",
            "target": "Objective impairment 1-1.5 SD below age/education norms; preserved ADLs; characterize domain(s) affected",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Screening; serial monitoring",
            "target": "24-30 (MCI often 24-27); <24 suggests dementia",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "More sensitive than MMSE for MCI",
            "target": "<26 abnormal; typically 18-25 in MCI",
            "contraindications": "None"
          }
        ],
        "Extended": [
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If MRI contraindicated or unavailable",
            "target": "Rule out mass, hemorrhage, hydrocephalus",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Quantitative assessment; research/clinical trials",
            "target": "Hippocampal volume percentile for age; whole brain atrophy rate",
            "contraindications": "MRI contraindications"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Differentiate underlying pathology when diagnosis uncertain",
            "target": "AD pattern: temporoparietal hypometabolism; FTD: frontal/temporal hypometabolism",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Diagnostic uncertainty; early-onset; anti-amyloid therapy eligibility",
            "target": "Positive confirms amyloid pathology (at risk for AD); negative makes AD unlikely",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Sleep apnea screening; sleep disturbance affecting cognition",
            "target": "AHI <5 normal; treat if elevated",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Atypical features; concern for seizures or encephalopathy",
            "target": "Normal or mild nonspecific slowing in MCI",
            "contraindications": "None"
          }
        ],
        "Rare/Specialized": [
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Research; disease staging; clinical trial eligibility",
            "target": "Pattern correlates with clinical syndrome; elevated tau predicts faster progression",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "MCI with parkinsonism; differentiate DLB prodrome",
            "target": "Reduced uptake suggests Lewy body pathology",
            "contraindications": "Iodine hypersensitivity"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Alternative to PET if unavailable",
            "target": "Regional hypoperfusion patterns",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Cerebral amyloid angiopathy; microbleed assessment",
            "target": "Lobar microbleeds suggest CAA; affects anti-amyloid eligibility",
            "contraindications": "MRI contraindications"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Treat reversible causes",
            "route": "Various",
            "indication": "Identified metabolic, nutritional, or infectious etiology",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per cause",
                  "orderSentence": "Treat reversible causes Per cause Various"
                }
              ],
              "route": "Various",
              "instructions": "Correct hypothyroidism, replace B12/folate, treat infections, adjust medications",
              "orderSentence": "Treat reversible causes Per cause Various"
            },
            "contraindications": "Depends on intervention",
            "monitoring": "Cognitive reassessment 3-6 months after treatment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Thiamine",
            "route": "IV/PO",
            "indication": "Suspected Wernicke's; alcoholism; malnutrition",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Thiamine 500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "500 mg IV TID x 3 days if Wernicke suspected; then 100 mg PO daily maintenance",
              "orderSentence": "Thiamine 500 mg IV"
            },
            "contraindications": "None",
            "monitoring": "Clinical improvement",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "route": "IM/PO",
            "indication": "B12 deficiency (<300 pg/mL or elevated MMA)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mcg",
                  "orderSentence": "Vitamin B12 1000 mcg IM"
                }
              ],
              "route": "IM",
              "instructions": "1000 mcg IM daily x 7d, then weekly x 4wk, then monthly; or high-dose oral 1000-2000 mcg daily",
              "orderSentence": "Vitamin B12 1000 mcg IM"
            },
            "contraindications": "None",
            "monitoring": "B12 level, MMA at 3 months; neurological improvement over months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Folate",
            "route": "PO",
            "indication": "Folate deficiency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg",
                  "orderSentence": "Folate 1 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "1 mg PO daily; ensure B12 adequate before treating to avoid masking deficiency",
              "orderSentence": "Folate 1 mg PO"
            },
            "contraindications": "None",
            "monitoring": "Folate level at 3 months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Donepezil",
            "route": "PO",
            "indication": "MCI with high likelihood of AD pathology (amnestic MCI, positive biomarkers); modest symptomatic benefit",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Donepezil 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg qHS x 4-6 weeks; may increase to 10 mg qHS; limited evidence in MCI but may offer modest benefit",
              "orderSentence": "Donepezil 5 mg PO"
            },
            "contraindications": "Sick sinus syndrome; GI bleeding; severe COPD",
            "monitoring": "Bradycardia, GI symptoms, vivid dreams; limited efficacy data in MCI",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine patch",
            "route": "TD",
            "indication": "Alternative to donepezil; better GI tolerability; MCI with positive AD biomarkers",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4.6 mg/24hr",
                  "orderSentence": "Rivastigmine patch 4.6 mg/24hr TD"
                }
              ],
              "route": "TD",
              "instructions": "Start 4.6 mg/24hr; increase q4wk to 9.5 mg/24hr; limited evidence in MCI",
              "orderSentence": "Rivastigmine patch 4.6 mg/24hr TD"
            },
            "contraindications": "Sick sinus syndrome; GI bleeding; severe COPD; severe hepatic impairment",
            "monitoring": "Skin irritation, GI symptoms",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Citalopram",
            "route": "PO",
            "indication": "Depression contributing to cognitive symptoms (pseudodementia component)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Citalopram 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg daily; max 20 mg in elderly due to QT risk",
              "orderSentence": "Citalopram 10 mg PO"
            },
            "contraindications": "QT prolongation; concurrent QT-prolonging drugs",
            "monitoring": "QTc at baseline and if dose >20 mg",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sertraline",
            "route": "PO",
            "indication": "Depression; anxiety contributing to cognitive complaints",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Sertraline 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; titrate by 25 mg q1-2wk; typical 50-100 mg",
              "orderSentence": "Sertraline 25 mg PO"
            },
            "contraindications": "MAOIs; caution with bleeding risk",
            "monitoring": "GI upset initially; reassess cognition after mood improves",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Escitalopram",
            "route": "PO",
            "indication": "Depression; anxiety with cognitive symptoms",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Escitalopram 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; increase to 10 mg after 1 week; max 10 mg in elderly",
              "orderSentence": "Escitalopram 5 mg PO"
            },
            "contraindications": "QT prolongation; MAOIs",
            "monitoring": "QTc monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirtazapine",
            "route": "PO",
            "indication": "Depression with poor appetite, insomnia, and weight loss",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7.5 mg",
                  "orderSentence": "Mirtazapine 7.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 7.5-15 mg qHS; may increase to 30 mg qHS",
              "orderSentence": "Mirtazapine 7.5 mg PO"
            },
            "contraindications": "MAOIs",
            "monitoring": "Weight gain (may be beneficial), sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Bupropion",
            "route": "PO",
            "indication": "Depression with fatigue; avoid if seizure risk",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150 mg",
                  "orderSentence": "Bupropion 150 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg BID or 150 mg SR daily; increase after 1 week; max 300 mg/day",
              "orderSentence": "Bupropion 150 mg PO"
            },
            "contraindications": "Seizure disorder; eating disorder; abrupt alcohol/benzo withdrawal",
            "monitoring": "Seizure risk; may improve alertness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Insomnia in MCI patients",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Trazodone 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg qHS; titrate to effect; typical 50-100 mg qHS",
              "orderSentence": "Trazodone 25 mg PO"
            },
            "contraindications": "Concurrent MAOIs; QT prolongation",
            "monitoring": "Orthostatic hypotension, morning sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "Sleep disturbance; circadian rhythm support",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg",
                  "orderSentence": "Melatonin 1 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1-3 mg qHS; may increase to 5 mg; take 30 min before bed",
              "orderSentence": "Melatonin 1 mg PO"
            },
            "contraindications": "None",
            "monitoring": "Daytime sedation; limited long-term data",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Cardiovascular Risk Factor Management": [
          {
            "item": "Atorvastatin",
            "route": "PO",
            "indication": "Hyperlipidemia; vascular risk reduction; may slow cognitive decline",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Atorvastatin 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-20 mg daily; titrate to LDL goal; target LDL <100 (or <70 if established CVD)",
              "orderSentence": "Atorvastatin 10 mg PO"
            },
            "contraindications": "Active liver disease; pregnancy",
            "monitoring": "LFTs at baseline; lipid panel q3-6mo initially",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rosuvastatin",
            "route": "PO",
            "indication": "Hyperlipidemia; alternative statin",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Rosuvastatin 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5-10 mg daily; adjust to LDL goal",
              "orderSentence": "Rosuvastatin 5 mg PO"
            },
            "contraindications": "Active liver disease; severe renal impairment (dose adjust)",
            "monitoring": "LFTs, lipid panel",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lisinopril",
            "route": "PO",
            "indication": "Hypertension; target BP <130/80 for vascular protection",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Lisinopril 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5-10 mg daily; titrate q2wk to BP goal",
              "orderSentence": "Lisinopril 5 mg PO"
            },
            "contraindications": "Angioedema history; pregnancy; bilateral renal artery stenosis",
            "monitoring": "K+, Cr, BP; cough",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amlodipine",
            "route": "PO",
            "indication": "Hypertension; especially if ACE-I intolerant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg",
                  "orderSentence": "Amlodipine 2.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5-5 mg daily; increase q2wk; max 10 mg",
              "orderSentence": "Amlodipine 2.5 mg PO"
            },
            "contraindications": "Severe aortic stenosis",
            "monitoring": "Peripheral edema, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Losartan",
            "route": "PO",
            "indication": "Hypertension; alternative if ACE-I intolerant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Losartan 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg daily; titrate to BP goal; max 100 mg",
              "orderSentence": "Losartan 25 mg PO"
            },
            "contraindications": "Angioedema history; pregnancy; bilateral renal artery stenosis",
            "monitoring": "K+, Cr, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Metformin",
            "route": "PO",
            "indication": "Type 2 diabetes; potential neuroprotective effects",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Metformin 500 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 500 mg daily with meal; increase by 500 mg weekly; max 2000 mg/day",
              "orderSentence": "Metformin 500 mg PO"
            },
            "contraindications": "eGFR <30; risk of lactic acidosis",
            "monitoring": "HbA1c q3mo; B12 annually (metformin reduces absorption)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Aspirin (low-dose)",
            "route": "PO",
            "indication": "Secondary prevention if established CVD; not for primary prevention in MCI",
            "dosing": {
              "doseOptions": [
                {
                  "text": "81 mg",
                  "orderSentence": "Aspirin (low-dose) 81 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "81 mg daily; only if established CVD or high vascular risk",
              "orderSentence": "Aspirin (low-dose) 81 mg PO"
            },
            "contraindications": "Active bleeding; aspirin allergy; high bleeding risk",
            "monitoring": "GI symptoms; bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Disease-Modifying Therapies (Anti-Amyloid)": [
          {
            "item": "Lecanemab (Leqembi)",
            "route": "IV",
            "indication": "MCI due to AD with confirmed amyloid pathology (positive amyloid PET or CSF biomarkers)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg",
                  "orderSentence": "Lecanemab (Leqembi) 10 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV every 2 weeks; infuse over 1 hour; continue as long as benefit maintained",
              "orderSentence": "Lecanemab (Leqembi) 10 mg/kg IV"
            },
            "pretreatment": "Amyloid PET or CSF confirming amyloid positivity; MRI baseline (within 1 year); APOE genotyping recommended; informed consent for ARIA risk",
            "contraindications": ">4 microbleeds on MRI; superficial siderosis; anticoagulation (increased ARIA risk); recent stroke/TIA",
            "monitoring": "MRI at baseline, weeks 14, 52, 78; monitor for ARIA-E/H symptoms (headache, confusion, vision changes)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Donanemab (Kisunla)",
            "route": "IV",
            "indication": "MCI due to AD with confirmed amyloid and intermediate/high tau pathology",
            "dosing": {
              "doseOptions": [
                {
                  "text": "700 mg",
                  "orderSentence": "Donanemab (Kisunla) 700 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "700 mg q4wk x 3 doses, then 1400 mg q4wk until amyloid cleared (PET-guided discontinuation)",
              "orderSentence": "Donanemab (Kisunla) 700 mg IV"
            },
            "pretreatment": "Amyloid PET positive; tau PET intermediate/high; MRI baseline; APOE genotyping",
            "contraindications": "APOE4 homozygotes have higher ARIA risk; >4 microbleeds; anticoagulation",
            "monitoring": "MRI at baseline, weeks 16, 24, 52, 76; amyloid PET to guide discontinuation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology/Cognitive neurology for MCI subtype characterization, biomarker interpretation, and treatment planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuropsychology for comprehensive cognitive testing to establish baseline, characterize affected domains, and distinguish MCI subtypes",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Geriatrics for comprehensive geriatric assessment, polypharmacy review, and functional optimization",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for cognitive strategies, compensatory techniques, and home safety evaluation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy driving evaluation to assess fitness to drive given cognitive impairment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for community resources, support services, and early care planning guidance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech therapy for communication strategies if language domain affected (non-amnestic MCI)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sleep medicine for sleep apnea evaluation if symptoms present (snoring, daytime sleepiness, witnessed apneas)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatry for depression evaluation if significant mood symptoms confounding cognitive assessment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetics counseling if early-onset (<65), family history of early-onset dementia, or considering genetic testing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clinical trial referral for eligible patients interested in research studies targeting MCI and early AD",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Elder law attorney for advance directives, healthcare proxy, and financial planning while patient has full capacity",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "PCP follow-up for cardiovascular risk factor management and coordination of vascular prevention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return if sudden confusion worsens or new neurological symptoms develop which may indicate stroke or other acute process",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Complete advance directives and establish healthcare proxy NOW while you have full capacity to make decisions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Consider long-term care preferences, financial planning, and legal arrangements with family while fully competent",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Discuss driving safety with physician; formal driving evaluation recommended as MCI may affect reaction time and judgment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use memory aids (calendars, smartphone reminders, pill organizers, written lists) to compensate for memory difficulties",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep a consistent daily routine which helps with memory and reduces confusion",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take all medications as prescribed; bring medication list to all appointments",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return for follow-up cognitive testing every 6-12 months to monitor for progression",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report new memory concerns, personality changes, or functional difficulties to physician promptly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid anticholinergic medications (diphenhydramine, PM sleep aids) as they can worsen cognition",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Engage in regular aerobic exercise (150 minutes/week moderate intensity) which may slow cognitive decline and improve brain health",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Follow Mediterranean or MIND diet emphasizing vegetables, berries, fish, nuts, whole grains, and olive oil to reduce dementia risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Participate in cognitively stimulating activities (reading, puzzles, learning new skills, social engagement) to build cognitive reserve",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain active social connections and relationships as social isolation is a modifiable dementia risk factor",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Achieve adequate sleep (7-8 hours nightly) and treat sleep disorders (CPAP for sleep apnea) as poor sleep accelerates cognitive decline",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cardiovascular risk factor control with target BP <130/80, HbA1c <7%, LDL <100 to reduce vascular contribution to cognitive decline",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Address hearing loss with hearing aids as untreated hearing loss is a modifiable risk factor for cognitive decline",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol to maximum 1 drink daily as excess alcohol accelerates brain atrophy and cognitive decline",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation to reduce vascular risk and improve overall brain health",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Manage stress through relaxation techniques, mindfulness, or counseling as chronic stress impairs cognition",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Review all medications with physician to identify and discontinue drugs that impair cognition (anticholinergics, benzodiazepines, opioids)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Normal aging",
        "features": "Subjective memory concerns without objective impairment; no functional decline; normal neuropsych testing",
        "tests": "Neuropsychological testing within 1 SD of norms"
      },
      {
        "diagnosis": "Subjective cognitive decline",
        "features": "Memory complaints but normal objective testing; may be earliest preclinical stage",
        "tests": "Neuropsychological testing normal; monitor annually"
      },
      {
        "diagnosis": "Depression (pseudodementia)",
        "features": "Prominent mood symptoms; often aware of and distressed by deficits; improves with antidepressants",
        "tests": "GDS, PHQ-9; trial of antidepressant; reassess cognition"
      },
      {
        "diagnosis": "Medication-induced cognitive impairment",
        "features": "Temporal relationship to medication initiation; improvement with discontinuation",
        "tests": "Medication review; trial discontinuation of suspect agents"
      },
      {
        "diagnosis": "Sleep apnea-related cognitive impairment",
        "features": "Excessive daytime sleepiness; snoring; morning headaches; reversible with CPAP",
        "tests": "Polysomnography; cognitive reassessment after CPAP"
      },
      {
        "diagnosis": "Alzheimer's disease (dementia stage)",
        "features": "Functional impairment in ADLs (not just IADLs); more severe cognitive deficits",
        "tests": "Functional assessment; neuropsychological testing"
      },
      {
        "diagnosis": "Vascular cognitive impairment",
        "features": "Stepwise decline; focal findings; executive dysfunction prominent; significant white matter disease",
        "tests": "MRI with confluent white matter disease; vascular risk factors"
      },
      {
        "diagnosis": "Dementia with Lewy bodies (prodromal)",
        "features": "Visual hallucinations; REM sleep behavior disorder; parkinsonism; fluctuating cognition",
        "tests": "DaTscan; clinical features; sleep study for RBD"
      },
      {
        "diagnosis": "Frontotemporal dementia (prodromal)",
        "features": "Behavioral/personality changes; disinhibition; apathy; language variants; typically <65",
        "tests": "FDG-PET frontal/temporal hypometabolism; neuropsychological profile"
      },
      {
        "diagnosis": "Thyroid dysfunction",
        "features": "Fatigue, weight changes, cold/heat intolerance; reversible with treatment",
        "tests": "TSH, free T4; reassess after treatment"
      },
      {
        "diagnosis": "Vitamin B12 deficiency",
        "features": "Peripheral neuropathy; macrocytic anemia; reversible with replacement",
        "tests": "B12, MMA; improvement with supplementation"
      }
    ],
    "evidence": [
      {
        "recommendation": "MCI diagnostic criteria and subtypes",
        "evidenceLevel": "Class I, Level A",
        "source": "[Petersen et al. Arch Neurol 2004](https://pubmed.ncbi.nlm.nih.gov/15477521/); [Albert et al. Alzheimers Dement 2011](https://pubmed.ncbi.nlm.nih.gov/21514249/)"
      },
      {
        "recommendation": "Neuropsychological testing for MCI diagnosis",
        "evidenceLevel": "Class I, Level A",
        "source": "[AAN Practice Parameter 2018](https://pubmed.ncbi.nlm.nih.gov/29282327/)"
      },
      {
        "recommendation": "CSF biomarkers for AD pathology",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hansson et al. Lancet Neurol 2018](https://pubmed.ncbi.nlm.nih.gov/30244989/)"
      },
      {
        "recommendation": "Amyloid PET for AD diagnosis in MCI",
        "evidenceLevel": "Class I, Level A",
        "source": "[Johnson et al. Alzheimers Dement 2013](https://pubmed.ncbi.nlm.nih.gov/23360977/)"
      },
      {
        "recommendation": "Cholinesterase inhibitors limited benefit in MCI",
        "evidenceLevel": "Class I, Level B",
        "source": "[Petersen et al. NEJM 2005](https://pubmed.ncbi.nlm.nih.gov/15800226/); [Russ & Morling, Cochrane 2012](https://pubmed.ncbi.nlm.nih.gov/22972104/)"
      },
      {
        "recommendation": "Lecanemab slows decline in MCI due to AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[van Dyck et al. NEJM 2023 (Clarity AD)](https://pubmed.ncbi.nlm.nih.gov/36449413/)"
      },
      {
        "recommendation": "Donanemab slows decline in early AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Sims et al. JAMA 2023 (TRAILBLAZER-ALZ 2)](https://pubmed.ncbi.nlm.nih.gov/37459141/)"
      },
      {
        "recommendation": "Physical exercise may slow cognitive decline",
        "evidenceLevel": "Class II, Level B",
        "source": "[Livingston et al. Lancet 2020 (Lancet Commission on Dementia)](https://pubmed.ncbi.nlm.nih.gov/32738937/)"
      },
      {
        "recommendation": "Mediterranean/MIND diet reduces dementia risk",
        "evidenceLevel": "Class II, Level B",
        "source": "[Morris et al. Alzheimers Dement 2015](https://pubmed.ncbi.nlm.nih.gov/25681666/)"
      },
      {
        "recommendation": "Cardiovascular risk factor control protects cognition",
        "evidenceLevel": "Class I, Level A",
        "source": "[Ngandu et al. Lancet 2015 (FINGER trial)](https://pubmed.ncbi.nlm.nih.gov/25771249/)"
      },
      {
        "recommendation": "Sleep apnea treatment improves cognition",
        "evidenceLevel": "Class II, Level B",
        "source": "[Osorio et al. Neurology 2015](https://pubmed.ncbi.nlm.nih.gov/25878179/)"
      },
      {
        "recommendation": "MCI progression rate to dementia (~10-15%/year)",
        "evidenceLevel": "Epidemiological",
        "source": "[Mitchell & Shiri-Feshki, Acta Psychiatr Scand 2009](https://pubmed.ncbi.nlm.nih.gov/19327298/)"
      },
      {
        "recommendation": "Hearing loss as modifiable dementia risk factor",
        "evidenceLevel": "Class II, Level B",
        "source": "[Lin et al. Arch Neurol 2011](https://pubmed.ncbi.nlm.nih.gov/21320988/)"
      },
      {
        "recommendation": "Modifiable risk factors for dementia prevention",
        "evidenceLevel": "Class II, Level A",
        "source": "[Livingston et al. Lancet 2024 (Lancet Commission Update)](https://pubmed.ncbi.nlm.nih.gov/39096926/)"
      }
    ],
    "monitoring": [
      {
        "item": "MoCA or MMSE",
        "frequency": "Every 6-12 months",
        "action": "Decline >3 points or reaching dementia threshold warrants reassessment; consider biomarker workup if not done",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Full neuropsychological testing",
        "frequency": "Every 1-2 years or if significant change",
        "action": "Decline suggests progression to dementia; adjust care plan",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "IADL/ADL function (FAQ, Lawton)",
        "frequency": "Every 6-12 months",
        "action": "Functional decline suggests progression to dementia; increase supports",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Depression screening (GDS, PHQ-9)",
        "frequency": "Annually or if symptoms",
        "action": "Treat depression; reassess cognition after treatment",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Blood pressure",
        "frequency": "Each visit",
        "action": "Optimize antihypertensive therapy",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "HbA1c (if diabetic)",
        "frequency": "Every 3-6 months",
        "action": "Optimize glycemic control",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Lipid panel",
        "frequency": "Annually",
        "action": "Optimize statin therapy",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Vitamin B12",
        "frequency": "Annually",
        "action": "Supplement if low",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "TSH",
        "frequency": "Annually",
        "action": "Treat thyroid dysfunction",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "MRI (ARIA monitoring if on anti-amyloid)",
        "frequency": "Per protocol (baseline, weeks 14, 52, 78 for lecanemab)",
        "action": "Hold infusion per protocol; resume after resolution",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Driving safety",
        "frequency": "Annually or with decline",
        "action": "Recommend driving cessation or OT driving evaluation",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight",
        "frequency": "Each visit",
        "action": "Nutritional assessment if declining",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Caregiver/family concerns",
        "frequency": "Each visit",
        "action": "Investigate reported changes; adjust care plan",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Outpatient management (most MCI)",
        "criteria": "Stable MCI; reversible causes addressed; care plan established; follow-up arranged"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Acute delirium requiring workup; safety concerns at home; caregiver crisis"
      },
      {
        "disposition": "Outpatient neurology follow-up",
        "criteria": "Every 6-12 months for cognitive monitoring; sooner if concerns"
      },
      {
        "disposition": "Outpatient neuropsychology",
        "criteria": "At diagnosis for baseline; repeat in 1-2 years or if significant change"
      },
      {
        "disposition": "Referral to memory care program",
        "criteria": "Progressive decline; need for specialized multidisciplinary management"
      },
      {
        "disposition": "Clinical trial referral",
        "criteria": "Eligible patient interested in research; positive biomarkers; early stage"
      }
    ]
  },
  "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)": {
    "id": "cidp",
    "title": "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)",
    "version": "1.0",
    "icd10": [
      "** G61.81 (Chronic inflammatory demyelinating polyneuritis)",
      "G61.89 (Other inflammatory polyneuropathies)",
      "G61.9 (Inflammatory polyneuropathy",
      "unspecified)"
    ],
    "scope": "** Diagnosis and management of typical CIDP and CIDP variants in adults. Covers diagnostic criteria (EFNS/PNS), electrodiagnostic findings, immunotherapy options, and monitoring. Excludes acute inflammatory demyelinating polyneuropathy (Guillain-Barré syndrome), hereditary demyelinating neuropathies (CMT), and purely axonal chronic neuropathies.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Baseline, exclude hematologic disease",
            "target": "Normal"
          },
          {
            "item": "CMP",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Renal/hepatic function, glucose",
            "target": "Normal"
          },
          {
            "item": "HbA1c",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes-associated neuropathy",
            "target": "<6.5%"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Thyroid dysfunction",
            "target": "Normal"
          },
          {
            "item": "Vitamin B12",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency neuropathy",
            "target": ">400 pg/mL"
          },
          {
            "item": "Serum protein electrophoresis (SPEP)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Monoclonal gammopathy (MGUS, myeloma)",
            "target": "No M-spike"
          },
          {
            "item": "Immunofixation (serum)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Paraprotein identification",
            "target": "Negative"
          },
          {
            "item": "Free light chains (serum)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Light chain disease",
            "target": "Normal ratio"
          }
        ],
        "Extended Workup": [
          {
            "item": "HIV",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HIV-associated neuropathy",
            "target": "Negative"
          },
          {
            "item": "Hepatitis B/C",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Before immunotherapy; hepatitis-associated neuropathy",
            "target": "Negative"
          },
          {
            "item": "ANA",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Connective tissue disease",
            "target": "Negative"
          },
          {
            "item": "Anti-MAG antibody",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "MAG-associated neuropathy (DADS variant)",
            "target": "Negative"
          },
          {
            "item": "Anti-GM1, anti-GD1a antibodies",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "MMN, GBS variants",
            "target": "Negative"
          },
          {
            "item": "Anti-ganglioside panel",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Immune-mediated neuropathies",
            "target": "Negative"
          },
          {
            "item": "Urine protein electrophoresis (UPEP)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Multiple myeloma, POEMS",
            "target": "Negative"
          },
          {
            "item": "VEGF level",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "POEMS syndrome if suspected",
            "target": "Normal"
          },
          {
            "item": "IgG/IgA/IgM levels",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Before IVIG; IgA deficiency screening",
            "target": "Normal; document IgA level"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Anti-NF155, anti-CNTN1, anti-Caspr1 antibodies",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Nodal/paranodal antibody-associated CIDP",
            "target": "Negative"
          },
          {
            "item": "Genetic testing (PMP22, MPZ, GJB1)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If hereditary neuropathy suspected (CMT)",
            "target": "Negative"
          },
          {
            "item": "Bone marrow biopsy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If POEMS or myeloma suspected",
            "target": "Normal"
          },
          {
            "item": "Fat pad biopsy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Amyloidosis",
            "target": "Negative"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Baseline",
            "target": "Normal"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Exclude infection, malignancy",
            "target": "WBC <10/mm³ (albuminocytologic dissociation)"
          },
          {
            "item": "Protein",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Typically elevated in CIDP",
            "target": "Often >45-100 mg/dL"
          },
          {
            "item": "Glucose",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Infection",
            "target": "Normal"
          },
          {
            "item": "Cytology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Carcinomatous meningitis",
            "target": "Negative"
          },
          {
            "item": "Oligoclonal bands",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "MS, other inflammatory",
            "target": "Usually negative in CIDP"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Nerve conduction studies (NCS)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At diagnosis",
            "target": "Demyelinating features (see criteria)",
            "contraindications": "Anticoagulation (for needle EMG)"
          },
          {
            "item": "Electromyography (EMG)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At diagnosis",
            "target": "Secondary axonal changes; denervation",
            "contraindications": "Same"
          },
          {
            "item": "MRI spine with contrast (cervical/lumbar)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At diagnosis",
            "target": "Nerve root enlargement/enhancement",
            "contraindications": "Contrast allergy, renal disease"
          }
        ],
        "Extended": [
          {
            "item": "MRI brachial/lumbosacral plexus",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If plexopathy suspected",
            "target": "Plexus enlargement/enhancement",
            "contraindications": "Per MRI"
          },
          {
            "item": "Nerve ultrasound",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Emerging modality",
            "target": "Nerve enlargement (CSA increase)",
            "contraindications": "None"
          },
          {
            "item": "PET-CT",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "POEMS, lymphoma, malignancy workup",
            "target": "Sclerotic lesions, lymphadenopathy",
            "contraindications": "Per PET"
          },
          {
            "item": "Nerve biopsy (sural)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Diagnostic uncertainty; vasculitis suspected",
            "target": "Demyelination, inflammation",
            "contraindications": "Rarely needed"
          }
        ]
      },
      "Treatment": {
        "First-Line Immunotherapy": [
          {
            "item": "IVIG (Intravenous Immunoglobulin)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g/kg",
                  "orderSentence": "IVIG (Intravenous Immunoglobulin) 2 g/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "Induction: 2 g/kg divided over 2-5 days; Maintenance: 0.4-1 g/kg q3-4 weeks (adjust based on response)",
              "orderSentence": "IVIG (Intravenous Immunoglobulin) 2 g/kg PO"
            },
            "contraindications": "IgA deficiency (use IgA-depleted product), renal failure, thrombosis history",
            "monitoring": "Renal function, headache, aseptic meningitis, thrombosis",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "SCIG (Subcutaneous Immunoglobulin)",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "instructions": "Convert from IVIG at equivalent weekly dose (total monthly IVIG dose ÷ 4); administer weekly",
              "orderSentence": "SCIG (Subcutaneous Immunoglobulin) - SC - see dosing"
            },
            "contraindications": "Same (fewer systemic reactions)",
            "monitoring": "Local site reactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Plasma exchange (PLEX)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "5-7 exchanges over 2-3 weeks; 1-1.5 plasma volumes/exchange",
              "orderSentence": "Plasma exchange (PLEX) - - - see dosing"
            },
            "contraindications": "Hemodynamic instability, line access",
            "monitoring": "Hemodynamics, electrolytes (Ca, Mg), fibrinogen",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Corticosteroids",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60-80 mg",
                  "orderSentence": "Corticosteroids 60-80 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Prednisone 60-80 mg daily or 1 mg/kg/day × 4-8 weeks, then slow taper over 6-12 months; OR pulsed methylprednisolone 1000 mg IV × 3 days monthly",
              "orderSentence": "Corticosteroids 60-80 mg IV"
            },
            "contraindications": "Uncontrolled DM, active infection, osteoporosis (relative)",
            "monitoring": "Glucose, BP, bone density, weight, infection",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-Line / Steroid-Sparing Agents": [
          {
            "item": "Azathioprine",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Azathioprine 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg daily; increase by 50 mg q2 weeks to 2-3 mg/kg/day",
              "orderSentence": "Azathioprine 50 mg PO"
            },
            "contraindications": "TPMT deficiency (check before starting), pregnancy",
            "monitoring": "CBC, LFTs, TPMT level",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mycophenolate mofetil",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Mycophenolate mofetil 500 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 500 mg BID; increase to 1000-1500 mg BID",
              "orderSentence": "Mycophenolate mofetil 500 mg PO"
            },
            "contraindications": "Pregnancy, severe GI disease",
            "monitoring": "CBC, LFTs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rituximab",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "375 mg",
                  "orderSentence": "Rituximab 375 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "375 mg/m² IV weekly × 4 OR 1000 mg IV × 2 doses (days 1 and 15); repeat q6 months PRN",
              "orderSentence": "Rituximab 375 mg IV"
            },
            "contraindications": "Active infection, hepatitis B (screen)",
            "monitoring": "Infusion reactions, infection, B-cell counts",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cyclophosphamide",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500-1000 mg",
                  "orderSentence": "Cyclophosphamide 500-1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Pulse: 500-1000 mg/m² IV monthly × 6; rarely used due to toxicity",
              "orderSentence": "Cyclophosphamide 500-1000 mg IV"
            },
            "contraindications": "Severe cytopenias, active infection",
            "monitoring": "CBC, renal function, bladder toxicity",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Cyclosporine",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3-5 mg/kg",
                  "orderSentence": "Cyclosporine 3-5 mg/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "3-5 mg/kg/day in 2 divided doses; target trough 100-200 ng/mL",
              "orderSentence": "Cyclosporine 3-5 mg/kg PO"
            },
            "contraindications": "Renal impairment, uncontrolled HTN",
            "monitoring": "Renal function, BP, drug levels",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Anti-Nodal Antibody-Positive CIDP (Special Population)": [
          {
            "item": "Rituximab (first-line for anti-nodal CIDP)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "375 mg",
                  "orderSentence": "Rituximab (first-line for anti-nodal CIDP) 375 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "375 mg/m² weekly × 4 OR 1000 mg × 2 doses",
              "orderSentence": "Rituximab (first-line for anti-nodal CIDP) 375 mg PO"
            },
            "contraindications": "Per above",
            "monitoring": "Poor response to IVIG expected; rituximab preferred",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatment": [
          {
            "item": "Gabapentin (neuropathic pain)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100-300 mg",
                  "orderSentence": "Gabapentin (neuropathic pain) 100-300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100-300 mg TID; titrate to 900-3600 mg/day",
              "orderSentence": "Gabapentin (neuropathic pain) 100-300 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Renal impairment (adjust)",
            "monitoring": "Sedation, dizziness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pregabalin (neuropathic pain)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg",
                  "orderSentence": "Pregabalin (neuropathic pain) 75 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 75 mg BID; titrate to 150-300 mg BID",
              "orderSentence": "Pregabalin (neuropathic pain) 75 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Renal impairment (adjust)",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Duloxetine (neuropathic pain)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg",
                  "orderSentence": "Duloxetine (neuropathic pain) 30 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 30 mg daily; increase to 60 mg daily",
              "orderSentence": "Duloxetine (neuropathic pain) 30 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Severe hepatic/renal impairment, MAOIs",
            "monitoring": "Nausea, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline (neuropathic pain)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-25 mg",
                  "orderSentence": "Amitriptyline (neuropathic pain) 10-25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg QHS; titrate to 50-100 mg QHS",
              "orderSentence": "Amitriptyline (neuropathic pain) 10-25 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Cardiac arrhythmia, glaucoma",
            "monitoring": "QTc, anticholinergic effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neuromuscular specialist",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "All patients; diagnosis confirmation and management"
          },
          {
            "item": "Physical therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Strengthening, gait training, fall prevention"
          },
          {
            "item": "Occupational therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "ADL assistance, adaptive equipment"
          },
          {
            "item": "Physiatry/PM&R",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Comprehensive rehabilitation, orthotics"
          },
          {
            "item": "Hematology/Oncology",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "If monoclonal gammopathy or POEMS"
          },
          {
            "item": "Infusion center",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "IVIG administration"
          },
          {
            "item": "Home health nursing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "SCIG training"
          },
          {
            "item": "Pain management",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Refractory neuropathic pain"
          }
        ],
        "Patient Instructions": [
          {
            "item": "CIDP is a chronic condition requiring ongoing treatment; not curable but manageable",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "IVIG infusions will be needed regularly (typically monthly)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report any worsening weakness, numbness, or falls immediately",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do NOT stop immunotherapy abruptly without physician guidance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Fall prevention: remove rugs, improve lighting, use assistive devices",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Vaccination guidelines: avoid live vaccines on immunosuppression; IVIG may interfere with vaccine response",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep all neurology follow-up appointments for monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "GBS Foundation and similar resources for support",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Regular exercise within tolerance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Balance and fall prevention strategies",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Foot care (sensory loss increases injury risk)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid excessive alcohol",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain healthy weight",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Guillain-Barré syndrome (GBS)",
        "features": "Acute onset (<4 weeks), monophasic, nadir within 4 weeks",
        "tests": "Timing; CIDP requires >8 weeks progression"
      },
      {
        "diagnosis": "Multifocal motor neuropathy (MMN)",
        "features": "Pure motor, asymmetric, conduction block, anti-GM1+",
        "tests": "Anti-GM1; no sensory involvement; does not respond to steroids"
      },
      {
        "diagnosis": "POEMS syndrome",
        "features": "Polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes",
        "tests": "VEGF elevated; sclerotic bone lesions; lambda light chain"
      },
      {
        "diagnosis": "CMT (Charcot-Marie-Tooth)",
        "features": "Family history, foot deformities (pes cavus), slow progression since childhood",
        "tests": "Genetic testing; no CSF protein elevation"
      },
      {
        "diagnosis": "MAG-associated neuropathy",
        "features": "Distal, sensory predominant, IgM paraprotein, anti-MAG positive",
        "tests": "Anti-MAG antibody; IgM gammopathy"
      },
      {
        "diagnosis": "Diabetic lumbosacral radiculoplexus neuropathy",
        "features": "Diabetes, weight loss, severe pain, proximal > distal",
        "tests": "Clinical; self-limited course"
      },
      {
        "diagnosis": "Vasculitic neuropathy",
        "features": "Painful, asymmetric, mononeuritis multiplex pattern",
        "tests": "ESR/CRP elevated; nerve/muscle biopsy"
      },
      {
        "diagnosis": "Amyloidosis",
        "features": "Autonomic dysfunction, carpal tunnel, heart failure, neuropathy",
        "tests": "Fat pad/nerve biopsy; SPEP"
      },
      {
        "diagnosis": "Lymphoma/carcinomatous neuropathy",
        "features": "Weight loss, lymphadenopathy, progressive",
        "tests": "Imaging; CSF cytology"
      }
    ],
    "evidence": [
      {
        "recommendation": "EFNS/PNS Diagnostic Criteria",
        "evidenceLevel": "Class I",
        "source": "[Van den Bergh et al., Eur J Neurol 2021](https://pubmed.ncbi.nlm.nih.gov/34327760/)"
      },
      {
        "recommendation": "IVIG effective for CIDP",
        "evidenceLevel": "Class I, Level A",
        "source": "[ICE trial (Hughes et al., Lancet Neurol 2008)](https://pubmed.ncbi.nlm.nih.gov/18178525/); [Cochrane Reviews (Eftimov et al., 2013)](https://pubmed.ncbi.nlm.nih.gov/24379104/)"
      },
      {
        "recommendation": "SCIG non-inferior to IVIG",
        "evidenceLevel": "Class I, Level A",
        "source": "[PATH trial (van Schaik et al., Lancet Neurol 2018)](https://pubmed.ncbi.nlm.nih.gov/29122523/)"
      },
      {
        "recommendation": "Corticosteroids effective for CIDP",
        "evidenceLevel": "Class I, Level A",
        "source": "Cochrane Reviews"
      },
      {
        "recommendation": "Plasma exchange effective",
        "evidenceLevel": "Class I, Level A",
        "source": "Cochrane Reviews"
      },
      {
        "recommendation": "IVIG, steroids, PLEX equivalent efficacy",
        "evidenceLevel": "Class I",
        "source": "Multiple comparative studies"
      },
      {
        "recommendation": "Rituximab for anti-nodal CIDP",
        "evidenceLevel": "Class II, Level B",
        "source": "Case series; expert consensus"
      },
      {
        "recommendation": "Steroid-sparing agents",
        "evidenceLevel": "Class II-III, Level C",
        "source": "Limited controlled data"
      }
    ],
    "monitoring": [
      {
        "item": "MRC strength grading",
        "ED": "-",
        "HOSP": "Daily",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "Adjust immunotherapy"
      },
      {
        "item": "Functional scales (INCAT, ODSS)",
        "ED": "-",
        "HOSP": "Weekly",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "q3 months",
        "action": "Adjust treatment"
      },
      {
        "item": "Grip strength (dynamometry)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q3 months",
        "action": "Objective measure"
      },
      {
        "item": "NCS/EMG",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q6-12 months or with change",
        "action": "Treatment response"
      },
      {
        "item": "Renal function (IVIG patients)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Before each IVIG; q3 months",
        "action": "Hold/reduce IVIG if rising"
      },
      {
        "item": "IgG trough level",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q3-6 months",
        "action": "Adjust IVIG dose"
      },
      {
        "item": "Glucose (steroid patients)",
        "ED": "-",
        "HOSP": "Daily",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "Per steroid use",
        "action": "Adjust DM meds"
      },
      {
        "item": "Bone density (steroid patients)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "At baseline, q1-2 years",
        "action": "Calcium, vitamin D, bisphosphonate"
      },
      {
        "item": "CBC (immunosuppression)",
        "ED": "-",
        "HOSP": "Weekly",
        "OPD": "q3 months",
        "ICU": "-",
        "frequency": "Per agent",
        "action": "Adjust dose"
      },
      {
        "item": "Weight, BP (steroids)",
        "ED": "-",
        "HOSP": "Daily",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "Per steroid use",
        "action": "Address"
      }
    ],
    "disposition": [
      {
        "disposition": "Outpatient management",
        "criteria": "Most patients; stable disease, able to ambulate, no respiratory concerns"
      },
      {
        "disposition": "Admit to hospital",
        "criteria": "New diagnosis requiring urgent workup, significant weakness (unable to walk), respiratory concerns, severe relapse"
      },
      {
        "disposition": "ICU admission",
        "criteria": "Respiratory failure (FVC <20 mL/kg, NIF <-30 cmH2O), hemodynamic instability"
      },
      {
        "disposition": "Discharge from hospital",
        "criteria": "Diagnosis established, treatment initiated, functionally stable, follow-up arranged"
      },
      {
        "disposition": "Long-term monitoring",
        "criteria": "Every 3-6 months with neuromuscular specialist; more frequent if unstable"
      }
    ]
  },
  "Medication Overuse Headache": {
    "id": "medication-overuse-headache",
    "title": "Medication Overuse Headache",
    "version": "1.0",
    "icd10": [
      "** G44.40 (Drug-induced headache",
      "not elsewhere classified",
      "not intractable)",
      "G44.41 (Drug-induced headache",
      "not elsewhere classified",
      "intractable)"
    ],
    "scope": "** Diagnosis and management of medication overuse headache in adults. Covers identification of offending medications, withdrawal strategies, preventive medication initiation, and relapse prevention. Excludes primary headache disorders without overuse component, and headache due to medication side effects (not overuse).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Baseline; anemia can contribute to headache",
            "target": "Normal"
          },
          {
            "item": "CMP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Electrolytes, renal/hepatic function (chronic NSAID/acetaminophen use)",
            "target": "Normal"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Thyroid dysfunction",
            "target": "Normal"
          }
        ],
        "Extended Workup": [
          {
            "item": "LFTs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If chronic acetaminophen use",
            "target": "Normal"
          },
          {
            "item": "BUN/Creatinine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If chronic NSAID use",
            "target": "Normal"
          },
          {
            "item": "ESR/CRP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If inflammatory/secondary cause suspected",
            "target": "Normal"
          },
          {
            "item": "Urine drug screen",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If opioid overuse/diversion suspected",
            "target": "Document"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Lumbar puncture",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Only if secondary cause suspected (IIH, infection)",
            "target": "Normal"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI brain without contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If not previously done; red flags",
            "target": "Rule out secondary causes",
            "contraindications": "Pacemaker, metal"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain with contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If mass, infection suspected",
            "target": "Rule out structural cause",
            "contraindications": "Contrast allergy, renal disease"
          },
          {
            "item": "MRV",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If IIH suspected",
            "target": "Patent venous sinuses",
            "contraindications": "Per MRI"
          }
        ]
      },
      "Treatment": {
        "Withdrawal Strategies - Outpatient": [
          {
            "item": "Abrupt discontinuation (simple analgesics, triptans)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Stop all overused medications immediately; preferred for most patients",
              "orderSentence": "Abrupt discontinuation (simple analgesics, triptans) - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Headache diary; expect worsening days 2-10",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gradual taper (opioids, barbiturates)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25%",
                  "orderSentence": "Gradual taper (opioids, barbiturates) 25% -"
                }
              ],
              "route": "-",
              "instructions": "Reduce by 10-25% every 1-2 weeks; slower for long-term use",
              "orderSentence": "Gradual taper (opioids, barbiturates) 25% -"
            },
            "contraindications": "None",
            "monitoring": "Withdrawal symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Bridge therapy during withdrawal",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "See below",
              "orderSentence": "Bridge therapy during withdrawal - - - see dosing"
            },
            "contraindications": "Per agent",
            "monitoring": "Support through withdrawal phase",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Bridge Therapy During Withdrawal": [
          {
            "item": "Naproxen sodium (scheduled)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Naproxen sodium (scheduled) 500 mg -"
                }
              ],
              "route": "-",
              "instructions": "500 mg BID × 2-4 weeks (not PRN - scheduled dosing to prevent rebound)",
              "orderSentence": "Naproxen sodium (scheduled) 500 mg -"
            },
            "contraindications": "Renal disease, GI bleeding",
            "monitoring": "Limited to 2-4 weeks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Prednisone (short course)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg",
                  "orderSentence": "Prednisone (short course) 60 mg -"
                }
              ],
              "route": "-",
              "instructions": "60 mg × 3 days, 40 mg × 3 days, 20 mg × 3 days (total 9 days)",
              "orderSentence": "Prednisone (short course) 60 mg -"
            },
            "contraindications": "Uncontrolled DM, infection",
            "monitoring": "Glucose",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dexamethasone",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4-8 mg",
                  "orderSentence": "Dexamethasone 4-8 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "4-8 mg daily × 5-7 days",
              "orderSentence": "Dexamethasone 4-8 mg PO"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nerve block (GON)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2%",
                  "orderSentence": "Nerve block (GON) 2% -"
                }
              ],
              "route": "-",
              "instructions": "Lidocaine 2% + steroid, bilateral",
              "orderSentence": "Nerve block (GON) 2% -"
            },
            "contraindications": "Anticoagulation, local infection",
            "monitoring": "May reduce withdrawal severity",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Antiemetics PRN",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Antiemetics PRN 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Metoclopramide 10 mg q8h PRN or ondansetron 4-8 mg q8h PRN",
              "orderSentence": "Antiemetics PRN 10 mg PO"
            },
            "contraindications": "Per agent",
            "monitoring": "For nausea during withdrawal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Inpatient Withdrawal (Severe Cases)": [
          {
            "item": "IV DHE protocol",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5-1 mg",
                  "orderSentence": "IV DHE protocol 0.5-1 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "DHE 0.5-1 mg IV q8h × 3-5 days (with metoclopramide 10 mg IV pretreatment)",
              "orderSentence": "IV DHE protocol 0.5-1 mg IV"
            },
            "contraindications": "CAD, CVA, uncontrolled HTN, pregnancy, triptans <24h",
            "monitoring": "BP, nausea, EKG",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "IV magnesium",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2 g",
                  "orderSentence": "IV magnesium 1-2 g IV"
                }
              ],
              "route": "IV",
              "instructions": "1-2 g IV daily × 3-5 days",
              "orderSentence": "IV magnesium 1-2 g IV"
            },
            "contraindications": "Renal failure",
            "monitoring": "Mg levels",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "IV ketorolac",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15-30 mg",
                  "orderSentence": "IV ketorolac 15-30 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "15-30 mg IV q6h × 2-3 days (max 5 days)",
              "orderSentence": "IV ketorolac 15-30 mg IV"
            },
            "contraindications": "Renal disease, GI bleeding",
            "monitoring": "Renal function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "IV valproate",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500-1000 mg",
                  "orderSentence": "IV valproate 500-1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "500-1000 mg IV BID × 3-5 days",
              "orderSentence": "IV valproate 500-1000 mg IV"
            },
            "contraindications": "Pregnancy, hepatic disease",
            "monitoring": "Ammonia, LFTs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "IV diphenhydramine",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-50 mg",
                  "orderSentence": "IV diphenhydramine 25-50 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "25-50 mg IV q6h with antiemetics",
              "orderSentence": "IV diphenhydramine 25-50 mg IV"
            },
            "contraindications": "Glaucoma",
            "monitoring": "Sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Opioid taper protocol",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Structured taper with addiction medicine if significant dependence",
              "orderSentence": "Opioid taper protocol - - - see dosing"
            },
            "contraindications": "N/A",
            "monitoring": "Withdrawal symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Barbiturate taper",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Phenobarbital substitution and taper for butalbital dependence",
              "orderSentence": "Barbiturate taper - - - see dosing"
            },
            "contraindications": "N/A",
            "monitoring": "Sedation, withdrawal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Preventive Medication (Start During or After Withdrawal)": [
          {
            "item": "Topiramate",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Topiramate 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; titrate to 50-100 mg BID",
              "orderSentence": "Topiramate 25 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Kidney stones, glaucoma, pregnancy",
            "monitoring": "Cognitive effects, paresthesias",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-25 mg",
                  "orderSentence": "Amitriptyline 10-25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg QHS; titrate to 50-100 mg QHS",
              "orderSentence": "Amitriptyline 10-25 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Cardiac arrhythmia, glaucoma",
            "monitoring": "QTc, sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Propranolol",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Propranolol 40 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 40 mg BID; titrate to 80-160 mg/day",
              "orderSentence": "Propranolol 40 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Asthma, heart block, bradycardia",
            "monitoring": "HR, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5 mg",
                  "orderSentence": "Venlafaxine XR 37.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5 mg daily; titrate to 75-150 mg daily",
              "orderSentence": "Venlafaxine XR 37.5 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Uncontrolled HTN, MAOIs",
            "monitoring": "BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "OnabotulinumtoxinA",
            "route": "IM",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "155-195 units",
                  "orderSentence": "OnabotulinumtoxinA 155-195 units IM"
                }
              ],
              "route": "IM",
              "instructions": "155-195 units IM q12 weeks (if chronic migraine criteria met)",
              "orderSentence": "OnabotulinumtoxinA 155-195 units IM"
            },
            "pretreatment": "-",
            "contraindications": "Infection at site, myasthenia",
            "monitoring": "Spread of effect",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CGRP monoclonal antibodies",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "70-140 mg",
                  "orderSentence": "CGRP monoclonal antibodies 70-140 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "Erenumab 70-140 mg SC monthly; Fremanezumab 225 mg monthly or 675 mg quarterly; Galcanezumab 240 mg load then 120 mg monthly",
              "orderSentence": "CGRP monoclonal antibodies 70-140 mg SC"
            },
            "pretreatment": "-",
            "contraindications": "Hypersensitivity",
            "monitoring": "Constipation (erenumab), injection reactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valproate",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250-500 mg",
                  "orderSentence": "Valproate 250-500 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 250-500 mg BID; titrate to 500-1000 mg BID",
              "orderSentence": "Valproate 250-500 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Pregnancy, hepatic disease",
            "monitoring": "LFTs, ammonia, weight",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rescue Medications (Limited Use After Withdrawal)": [
          {
            "item": "Triptan (limited)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Max 2 days/week; max 9 days/month",
              "orderSentence": "Triptan (limited) - - - see dosing"
            },
            "contraindications": "CV disease",
            "monitoring": "Headache diary",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "NSAID (limited)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Max 2 days/week; max 14 days/month",
              "orderSentence": "NSAID (limited) - - - see dosing"
            },
            "contraindications": "Renal/GI disease",
            "monitoring": "Headache diary",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gepants (preferred rescue)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50-100 mg",
                  "orderSentence": "Gepants (preferred rescue) 50-100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Ubrogepant 50-100 mg or Rimegepant 75 mg; may have lower MOH risk",
              "orderSentence": "Gepants (preferred rescue) 50-100 mg PO"
            },
            "contraindications": "Per agent",
            "monitoring": "May be safer for frequent use",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Headache specialist/Neurology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "All patients; management and prevention"
          },
          {
            "item": "Pain psychology/Behavioral health",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "CBT for headache, coping strategies, anxiety/depression"
          },
          {
            "item": "Addiction medicine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Opioid or barbiturate dependence"
          },
          {
            "item": "Psychiatry",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Comorbid depression, anxiety"
          },
          {
            "item": "Physical therapy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Cervicogenic component, tension-type features"
          },
          {
            "item": "Biofeedback specialist",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Non-pharmacologic headache management"
          }
        ],
        "Patient Instructions": [
          {
            "item": "MOH is caused by frequent use of pain medications; stopping them is essential for improvement",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Expect headaches to WORSEN for 2-10 days during withdrawal before improving",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Most patients improve significantly within 2-3 months of stopping overused medications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "STRICT medication limits going forward: triptans ≤9 days/month, NSAIDs ≤14 days/month",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep detailed headache diary tracking medications and headache days",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Preventive medication takes 4-8 weeks to work; be patient",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Relapse is common (~40%); call if headache frequency increasing",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do NOT restart butalbital-containing medications (Fioricet, Fiorinal)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Opioids should NOT be used for primary headache disorders",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Regular sleep schedule (7-8 hours)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular meal schedule (don't skip meals)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular exercise (30 min, 5 days/week)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management techniques (biofeedback, relaxation, CBT)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit caffeine to consistent moderate intake (<200 mg/day)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stay well-hydrated",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid known migraine triggers",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Establish \"medication rules\" and stick to them",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Chronic migraine (without MOH)",
        "features": "≥15 headache days/month but NO medication overuse",
        "tests": "Medication diary"
      },
      {
        "diagnosis": "Chronic tension-type headache",
        "features": "Bilateral, pressing, mild-moderate, no nausea",
        "tests": "Clinical; no medication overuse"
      },
      {
        "diagnosis": "New daily persistent headache",
        "features": "Distinct onset date; daily from onset; no prior headache history",
        "tests": "Clinical history"
      },
      {
        "diagnosis": "Hemicrania continua",
        "features": "Continuous unilateral pain; responds to indomethacin",
        "tests": "Indomethacin trial"
      },
      {
        "diagnosis": "Idiopathic intracranial hypertension",
        "features": "Papilledema, visual obscurations, pulsatile tinnitus",
        "tests": "LP with elevated OP, fundoscopy"
      },
      {
        "diagnosis": "Secondary headache (tumor, CSF leak, etc.)",
        "features": "Red flags, focal deficits, progressive",
        "tests": "MRI brain"
      },
      {
        "diagnosis": "Cervicogenic headache",
        "features": "Neck pain, limited ROM, triggered by neck movement",
        "tests": "Cervical exam, imaging"
      }
    ],
    "evidence": [
      {
        "recommendation": "ICHD-3 diagnostic criteria for MOH",
        "evidenceLevel": "Class I",
        "source": "International Headache Society 2018"
      },
      {
        "recommendation": "Abrupt withdrawal effective for simple analgesics/triptans",
        "evidenceLevel": "Class II, Level B",
        "source": "Multiple studies"
      },
      {
        "recommendation": "Bridge therapy with corticosteroids",
        "evidenceLevel": "Class II, Level B",
        "source": "Multiple studies"
      },
      {
        "recommendation": "Preventive medication should be started with withdrawal",
        "evidenceLevel": "Class I, Level A",
        "source": "Expert consensus; multiple guidelines"
      },
      {
        "recommendation": "Topiramate effective for migraine prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs"
      },
      {
        "recommendation": "CGRP mAbs may have lower MOH risk",
        "evidenceLevel": "Class II, Level B",
        "source": "Emerging evidence"
      },
      {
        "recommendation": "Gepants may have lower MOH risk",
        "evidenceLevel": "Class II, Level C",
        "source": "Emerging evidence"
      },
      {
        "recommendation": "~40% relapse rate at 1 year",
        "evidenceLevel": "Class II",
        "source": "Observational studies"
      },
      {
        "recommendation": "Opioids and barbiturates have highest MOH risk",
        "evidenceLevel": "Class II, Level B",
        "source": "Multiple studies"
      }
    ],
    "monitoring": [
      {
        "item": "Headache frequency (days/month)",
        "ED": "-",
        "HOSP": "Daily",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "Monthly",
        "action": "Adjust preventive"
      },
      {
        "item": "Medication use (days/month)",
        "ED": "-",
        "HOSP": "Daily",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "Monthly",
        "action": "Counsel; adjust strategy"
      },
      {
        "item": "MIDAS or HIT-6 score",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q3 months",
        "action": "Adjust treatment"
      },
      {
        "item": "Headache diary review",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "Ongoing",
        "action": "Reinforce education"
      },
      {
        "item": "Preventive medication adherence",
        "ED": "-",
        "HOSP": "-",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "Address barriers"
      },
      {
        "item": "Depression/anxiety screening",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "q3-6 months",
        "action": "Refer if positive"
      },
      {
        "item": "Weight (if on topiramate/valproate)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "Adjust medication"
      }
    ],
    "disposition": [
      {
        "disposition": "Outpatient management",
        "criteria": "Most patients; mild-moderate disability, no significant opioid/barbiturate dependence"
      },
      {
        "disposition": "Admit to hospital",
        "criteria": "Failed outpatient withdrawal, severe disability, significant opioid/barbiturate dependence, psychiatric comorbidity requiring stabilization, need for IV protocol"
      },
      {
        "disposition": "Discharge from hospital",
        "criteria": "Withdrawal completed, preventive started, headache improving, follow-up arranged"
      },
      {
        "disposition": "Headache specialist follow-up",
        "criteria": "Within 2-4 weeks of withdrawal; then q1-3 months"
      },
      {
        "disposition": "Relapse management",
        "criteria": "May need repeat withdrawal; intensify preventive; consider CGRP mAbs"
      }
    ]
  },
  "Multiple Sclerosis - Chronic Management": {
    "id": "ms-chronic-management",
    "title": "Multiple Sclerosis - Chronic Management",
    "version": "1.0",
    "icd10": [
      "** G35 (Multiple sclerosis)"
    ],
    "scope": "** Long-term management of multiple sclerosis in adults including disease-modifying therapy (DMT) selection and monitoring, relapse management, symptom management, and pregnancy considerations. Excludes initial diagnosis workup (see MS New Diagnosis template) and acute relapse management as primary focus.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Baseline; many DMTs affect counts",
            "target": "Normal"
          },
          {
            "item": "CMP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hepatic/renal function",
            "target": "Normal"
          },
          {
            "item": "LFTs (AST, ALT, bilirubin)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Baseline for hepatotoxic DMTs",
            "target": "Normal"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Alemtuzumab causes thyroid disease",
            "target": "Normal"
          },
          {
            "item": "Urinalysis",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "UTI causes pseudorelapse",
            "target": "Negative"
          },
          {
            "item": "Vitamin D (25-OH)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency common; may affect MS",
            "target": ">30 ng/mL (target 40-60)"
          },
          {
            "item": "Hepatitis B/C serology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Reactivation risk with some DMTs",
            "target": "Document status"
          },
          {
            "item": "HIV",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Before immunosuppressive therapy",
            "target": "Negative"
          },
          {
            "item": "VZV IgG",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Vaccinate if seronegative before DMTs",
            "target": "Document; vaccinate if negative"
          },
          {
            "item": "JC virus antibody (anti-JCV)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "PML risk stratification for natalizumab",
            "target": "Document index"
          },
          {
            "item": "Pregnancy test",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Most DMTs contraindicated in pregnancy",
            "target": "Negative before starting DMT"
          }
        ],
        "Extended Workup": [
          {
            "item": "CBC",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Lymphopenia (many DMTs), cytopenias",
            "target": "Per DMT thresholds"
          },
          {
            "item": "LFTs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hepatotoxicity monitoring",
            "target": "Normal"
          },
          {
            "item": "Lymphocyte count",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Critical for many DMTs",
            "target": "Per DMT; usually >200-500"
          },
          {
            "item": "JCV antibody (if on natalizumab)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "PML risk; repeat q6 months",
            "target": "Monitor index"
          },
          {
            "item": "TSH (if on alemtuzumab)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Autoimmune thyroid disease",
            "target": "Normal; monthly × 48 months"
          },
          {
            "item": "Creatinine, urinalysis (alemtuzumab)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Autoimmune nephropathy",
            "target": "Normal; monthly × 48 months"
          },
          {
            "item": "Platelet count (alemtuzumab)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "ITP risk",
            "target": "Normal; monthly × 48 months"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI brain with and without contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Baseline, 6 months, then annually",
            "target": "No new/enlarging lesions",
            "contraindications": "Pacemaker, metal; gadolinium in renal disease"
          },
          {
            "item": "MRI cervical spine with and without contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Baseline, then PRN or q2-3 years",
            "target": "No new lesions",
            "contraindications": "Same"
          },
          {
            "item": "MRI thoracic spine (if indicated)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If thoracic symptoms",
            "target": "No new lesions",
            "contraindications": "Same"
          }
        ],
        "Extended": [
          {
            "item": "OCT (optical coherence tomography)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Baseline, annually",
            "target": "Stable RNFL thickness",
            "contraindications": "None"
          },
          {
            "item": "Evoked potentials (VEP, SSEP)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If clinical uncertainty",
            "target": "Baseline; monitor progression",
            "contraindications": "None"
          },
          {
            "item": "Urodynamic studies",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If bladder symptoms",
            "target": "Characterize dysfunction",
            "contraindications": "None"
          }
        ]
      },
      "Treatment": {
        "Disease-Modifying Therapies - Platform/Injectable (Moderate Efficacy)": [
          {
            "item": "Glatiramer acetate (Copaxone)",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "Glatiramer acetate (Copaxone) 20 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "20 mg SC daily or 40 mg SC 3×/week",
              "orderSentence": "Glatiramer acetate (Copaxone) 20 mg SC"
            },
            "pretreatment": "-",
            "contraindications": "Hypersensitivity",
            "monitoring": "Injection site reactions; lipoatrophy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Interferon beta-1a (Avonex)",
            "route": "IM",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mcg",
                  "orderSentence": "Interferon beta-1a (Avonex) 30 mcg IM"
                }
              ],
              "route": "IM",
              "instructions": "30 mcg IM weekly",
              "orderSentence": "Interferon beta-1a (Avonex) 30 mcg IM"
            },
            "pretreatment": "-",
            "contraindications": "Depression, hepatic disease",
            "monitoring": "CBC, LFTs q6 months; flu-like symptoms",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Interferon beta-1a (Rebif)",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "44 mcg",
                  "orderSentence": "Interferon beta-1a (Rebif) 44 mcg SC"
                }
              ],
              "route": "SC",
              "instructions": "22 or 44 mcg SC 3×/week (titrate)",
              "orderSentence": "Interferon beta-1a (Rebif) 44 mcg SC"
            },
            "pretreatment": "-",
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Interferon beta-1b (Betaseron, Extavia)",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mcg",
                  "orderSentence": "Interferon beta-1b (Betaseron, Extavia) 250 mcg SC"
                }
              ],
              "route": "SC",
              "instructions": "250 mcg SC every other day",
              "orderSentence": "Interferon beta-1b (Betaseron, Extavia) 250 mcg SC"
            },
            "pretreatment": "-",
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Peginterferon beta-1a (Plegridy)",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "125 mcg",
                  "orderSentence": "Peginterferon beta-1a (Plegridy) 125 mcg SC"
                }
              ],
              "route": "SC",
              "instructions": "125 mcg SC q2 weeks",
              "orderSentence": "Peginterferon beta-1a (Plegridy) 125 mcg SC"
            },
            "pretreatment": "-",
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Disease-Modifying Therapies - Oral (Moderate-High Efficacy)": [
          {
            "item": "Dimethyl fumarate (Tecfidera)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "120 mg",
                  "orderSentence": "Dimethyl fumarate (Tecfidera) 120 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "120 mg BID × 7 days, then 240 mg BID",
              "orderSentence": "Dimethyl fumarate (Tecfidera) 120 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Lymphopenia (<500), PML risk",
            "monitoring": "CBC q6 months; LFTs; GI symptoms, flushing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Diroximel fumarate (Vumerity)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "231 mg",
                  "orderSentence": "Diroximel fumarate (Vumerity) 231 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "231 mg BID × 7 days, then 462 mg BID",
              "orderSentence": "Diroximel fumarate (Vumerity) 231 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Same",
            "monitoring": "Same; less GI effects",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Monomethyl fumarate (Bafiertam)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "95 mg",
                  "orderSentence": "Monomethyl fumarate (Bafiertam) 95 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "95 mg BID × 7 days, then 190 mg BID",
              "orderSentence": "Monomethyl fumarate (Bafiertam) 95 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Teriflunomide (Aubagio)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "14 mg",
                  "orderSentence": "Teriflunomide (Aubagio) 14 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "14 mg daily",
              "orderSentence": "Teriflunomide (Aubagio) 14 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Pregnancy (teratogenic), hepatic disease",
            "monitoring": "LFTs monthly × 6mo; CBC; BP; pregnancy test; accelerated elimination available",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fingolimod (Gilenya)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg",
                  "orderSentence": "Fingolimod (Gilenya) 0.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.5 mg daily; first dose observation 6h",
              "orderSentence": "Fingolimod (Gilenya) 0.5 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Recent MI, unstable angina, heart block, bradycardia",
            "monitoring": "First-dose cardiac monitoring (6h); ophtho exam (macular edema); LFTs; varicella status; lymphocyte count",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Siponimod (Mayzent)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg",
                  "orderSentence": "Siponimod (Mayzent) 2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Titration pack, then 2 mg daily (1 mg if CYP2C9 *2/*3); approved for active SPMS",
              "orderSentence": "Siponimod (Mayzent) 2 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Same as fingolimod; CYP2C9 testing required",
            "monitoring": "Same as fingolimod; CYP2C9 genotype",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ozanimod (Zeposia)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.23 mg",
                  "orderSentence": "Ozanimod (Zeposia) 0.23 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Titration: 0.23 mg × 4d, 0.46 mg × 3d, then 0.92 mg daily",
              "orderSentence": "Ozanimod (Zeposia) 0.23 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Same as fingolimod",
            "monitoring": "Same; less first-dose effect",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ponesimod (Ponvory)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "Ponesimod (Ponvory) 20 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Titration over 14 days to 20 mg daily",
              "orderSentence": "Ponesimod (Ponvory) 20 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Same as fingolimod",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cladribine (Mavenclad)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3.5 mg/kg",
                  "orderSentence": "Cladribine (Mavenclad) 3.5 mg/kg -"
                }
              ],
              "route": "-",
              "instructions": "3.5 mg/kg total over 2 years (Year 1: 1.75 mg/kg in 2 cycles; Year 2: same); highly active RRMS",
              "orderSentence": "Cladribine (Mavenclad) 3.5 mg/kg -"
            },
            "pretreatment": "-",
            "contraindications": "Pregnancy, HIV, active infection, malignancy",
            "monitoring": "CBC q2 months Year 1, then q6 months; lymphocyte >500-800 to start",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Disease-Modifying Therapies - Infusion (High Efficacy)": [
          {
            "item": "Natalizumab (Tysabri)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Natalizumab (Tysabri) 300 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "300 mg IV q4 weeks",
              "orderSentence": "Natalizumab (Tysabri) 300 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "PML risk (JCV+, prior immunosuppression, duration >2y)",
            "monitoring": "JCV antibody q6 months; MRI q6-12 months; infusion reactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ocrelizumab (Ocrevus)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Ocrelizumab (Ocrevus) 300 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "300 mg IV × 2 doses (2 weeks apart), then 600 mg IV q6 months",
              "orderSentence": "Ocrelizumab (Ocrevus) 300 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Active Hep B, active infection",
            "monitoring": "Pre-infusion CBC, LFTs; HBV screening; infection monitoring; malignancy screening",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ofatumumab (Kesimpta)",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "Ofatumumab (Kesimpta) 20 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "20 mg SC weeks 0, 1, 2, then 20 mg SC monthly",
              "orderSentence": "Ofatumumab (Kesimpta) 20 mg SC"
            },
            "pretreatment": "-",
            "contraindications": "Same as ocrelizumab",
            "monitoring": "Same; self-administered SC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ublituximab (Briumvi)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150 mg",
                  "orderSentence": "Ublituximab (Briumvi) 150 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "150 mg IV day 1, 450 mg IV day 15, then 450 mg IV q6 months",
              "orderSentence": "Ublituximab (Briumvi) 150 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Same as ocrelizumab",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Alemtuzumab (Lemtrada)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12 mg",
                  "orderSentence": "Alemtuzumab (Lemtrada) 12 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Year 1: 12 mg IV daily × 5 days; Year 2: 12 mg IV daily × 3 days; highly active MS, REMS",
              "orderSentence": "Alemtuzumab (Lemtrada) 12 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Active infection, HIV, immunocompromised",
            "monitoring": "CBC, LFTs, creatinine, urinalysis, TSH monthly × 48 months after last dose; REMS program",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Treatment for Progressive MS": [
          {
            "item": "Ocrelizumab (PPMS)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Ocrelizumab (PPMS) 300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "300 mg × 2, then 600 mg q6 months",
              "orderSentence": "Ocrelizumab (PPMS) 300 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Per above",
            "monitoring": "Per above; only approved for PPMS",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Siponimod (active SPMS)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Per above",
              "orderSentence": "Siponimod (active SPMS) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "Per above",
            "monitoring": "Per above",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Acute Relapse Treatment": [
          {
            "item": "Methylprednisolone IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Methylprednisolone IV 1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg IV daily × 3-5 days",
              "orderSentence": "Methylprednisolone IV 1000 mg IV"
            },
            "contraindications": "Active infection (relative), uncontrolled DM",
            "monitoring": "Glucose, BP, sleep, psychiatric",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Prednisone oral (alternative)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1250 mg",
                  "orderSentence": "Prednisone oral (alternative) 1250 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1250 mg PO daily × 3-5 days (bioequivalent to IV)",
              "orderSentence": "Prednisone oral (alternative) 1250 mg IV"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Plasma exchange (PLEX)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "5-7 exchanges over 2 weeks; severe relapse not responding to steroids",
              "orderSentence": "Plasma exchange (PLEX) - - - see dosing"
            },
            "contraindications": "Hemodynamic instability",
            "monitoring": "Electrolytes, coagulation",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "ACTH gel (Acthar)",
            "route": "IM",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "80-120 units",
                  "orderSentence": "ACTH gel (Acthar) 80-120 units IM"
                }
              ],
              "route": "IM",
              "instructions": "80-120 units IM daily × 2-3 weeks; alternative to steroids",
              "orderSentence": "ACTH gel (Acthar) 80-120 units IM"
            },
            "contraindications": "Same as steroids",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptom Management": [
          {
            "item": "Amantadine",
            "dosing": {
              "instructions": "100 mg BID",
              "orderSentence": null
            },
            "monitoring": "Livedo reticularis"
          },
          {
            "item": "Baclofen",
            "dosing": {
              "instructions": "5 mg TID, titrate to 20 mg TID",
              "orderSentence": null
            },
            "monitoring": "Sedation, weakness"
          },
          {
            "item": "Dalfampridine (Ampyra)",
            "dosing": {
              "instructions": "10 mg BID",
              "orderSentence": null
            },
            "monitoring": "Seizures (discontinue if occurs)"
          },
          {
            "item": "Oxybutynin",
            "dosing": {
              "instructions": "5 mg BID-TID",
              "orderSentence": null
            },
            "monitoring": "Dry mouth, cognitive effects"
          },
          {
            "item": "Clean intermittent cath",
            "dosing": {
              "instructions": "Schedule-based",
              "orderSentence": null
            },
            "monitoring": "UTI prevention"
          },
          {
            "item": "Gabapentin",
            "dosing": {
              "instructions": "300-1200 mg TID",
              "orderSentence": null
            },
            "monitoring": "Sedation"
          },
          {
            "item": "SSRIs (sertraline, escitalopram)",
            "dosing": {
              "instructions": "Standard dosing",
              "orderSentence": null
            },
            "monitoring": "Per SSRI"
          },
          {
            "item": "Cognitive rehabilitation",
            "dosing": {
              "instructions": "PT/OT/neuropsych referral",
              "orderSentence": null
            },
            "monitoring": "Progress"
          },
          {
            "item": "Propranolol",
            "dosing": {
              "instructions": "40-160 mg/day",
              "orderSentence": null
            },
            "monitoring": "HR, BP"
          },
          {
            "item": "Sildenafil (male)",
            "dosing": {
              "instructions": "25-100 mg PRN",
              "orderSentence": null
            },
            "monitoring": "BP with nitrates"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "MS specialist/Neurologist",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "All patients; DMT selection and monitoring"
          },
          {
            "item": "Neuro-ophthalmology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Optic neuritis, visual symptoms"
          },
          {
            "item": "Physical therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Gait, balance, strengthening, spasticity"
          },
          {
            "item": "Occupational therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "ADLs, fatigue management, adaptive equipment"
          },
          {
            "item": "Speech therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Dysphagia, dysarthria, cognitive-communication"
          },
          {
            "item": "Neuropsychology",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Cognitive assessment, rehabilitation"
          },
          {
            "item": "Urology",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Bladder management, urodynamics"
          },
          {
            "item": "Psychiatry",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Depression, anxiety, pseudobulbar affect"
          },
          {
            "item": "Maternal-fetal medicine",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Pregnancy planning, high-risk pregnancy"
          },
          {
            "item": "Social work",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Disability services, resources"
          }
        ],
        "Patient Instructions": [
          {
            "item": "MS is a chronic condition requiring lifelong management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take DMT as prescribed; do not stop without consulting neurologist",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report new symptoms promptly (may be relapse)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid overheating (Uhthoff phenomenon); swimming and cooling vests help",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Vaccination: Get flu and COVID vaccines; avoid live vaccines on most DMTs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Infections can trigger pseudorelapses; treat promptly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Pregnancy planning: Many DMTs contraindicated; discuss before conception",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "National MS Society (nationalmssociety.org) for resources",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Regular exercise (aerobic + strength) improves fatigue, mood, function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain vitamin D levels (40-60 ng/mL); supplement if low",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "No smoking (worsens progression)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Healthy diet (Mediterranean-style)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate sleep",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid excessive heat exposure",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Neuromyelitis optica spectrum disorder",
        "features": "AQP4-IgG+, longitudinally extensive myelitis, bilateral optic neuritis",
        "tests": "AQP4-IgG, MOG-IgG; MRI pattern"
      },
      {
        "diagnosis": "MOG antibody disease",
        "features": "MOG-IgG+, optic neuritis, myelitis, ADEM-like",
        "tests": "MOG-IgG"
      },
      {
        "diagnosis": "CNS vasculitis",
        "features": "Progressive, multifocal; systemic symptoms",
        "tests": "Angiography, biopsy"
      },
      {
        "diagnosis": "Neurosarcoidosis",
        "features": "Leptomeningeal enhancement, systemic sarcoid",
        "tests": "ACE level, chest imaging, biopsy"
      },
      {
        "diagnosis": "Lyme disease",
        "features": "Endemic area, systemic symptoms",
        "tests": "Lyme serology"
      },
      {
        "diagnosis": "B12 deficiency myelopathy",
        "features": "Subacute combined degeneration, macrocytic anemia",
        "tests": "B12 level, MMA"
      },
      {
        "diagnosis": "Migraine with MRI lesions",
        "features": "Headache predominant; non-specific white matter lesions",
        "tests": "Clinical; lesion pattern different"
      }
    ],
    "evidence": [
      {
        "recommendation": "High-efficacy DMTs reduce relapses/progression",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs"
      },
      {
        "recommendation": "Ocrelizumab effective for PPMS",
        "evidenceLevel": "Class I, Level A",
        "source": "[ORATORIO trial](https://pubmed.ncbi.nlm.nih.gov/28002688/)"
      },
      {
        "recommendation": "Early high-efficacy treatment improves long-term outcomes",
        "evidenceLevel": "Class II, Level B",
        "source": "Observational data"
      },
      {
        "recommendation": "IV steroids for acute relapse",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs"
      },
      {
        "recommendation": "Vitamin D supplementation may reduce relapse",
        "evidenceLevel": "Class II, Level B",
        "source": "Observational data; RCTs ongoing"
      },
      {
        "recommendation": "Exercise improves fatigue and quality of life",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs"
      },
      {
        "recommendation": "Natalizumab PML risk stratification",
        "evidenceLevel": "Class I",
        "source": "JCV antibody testing; risk algorithms"
      },
      {
        "recommendation": "Siponimod for active SPMS",
        "evidenceLevel": "Class I, Level A",
        "source": "[EXPAND trial](https://pubmed.ncbi.nlm.nih.gov/29576505/)"
      }
    ],
    "monitoring": [
      {
        "item": "EDSS score",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q6-12 months",
        "action": "Assess treatment efficacy"
      },
      {
        "item": "MRI brain",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Baseline, 6mo, then annually",
        "action": "Treatment escalation"
      },
      {
        "item": "Relapse count",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Ongoing",
        "action": "Treatment escalation"
      },
      {
        "item": "CBC (most DMTs)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q3-6 months",
        "action": "Hold DMT if low"
      },
      {
        "item": "LFTs (hepatotoxic DMTs)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q3-6 months",
        "action": "Hold DMT if elevated"
      },
      {
        "item": "JCV antibody (natalizumab)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q6 months",
        "action": "Switch if high-risk"
      },
      {
        "item": "Vitamin D",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Annually",
        "action": "Supplement"
      },
      {
        "item": "Urinalysis",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "If relapse suspected",
        "action": "Treat UTI"
      }
    ],
    "disposition": [
      {
        "disposition": "Outpatient management",
        "criteria": "Stable MS, on appropriate DMT, routine monitoring"
      },
      {
        "disposition": "Admit to hospital",
        "criteria": "Acute relapse requiring IV steroids, severe relapse, functional decline"
      },
      {
        "disposition": "MS specialist follow-up",
        "criteria": "q3-6 months while adjusting DMT; q6-12 months once stable"
      },
      {
        "disposition": "Urgent follow-up",
        "criteria": "New relapse, DMT side effects, significant progression"
      }
    ]
  },
  "Restless Legs Syndrome": {
    "id": "restless-legs-syndrome",
    "title": "Restless Legs Syndrome",
    "version": "1.0",
    "icd10": [
      "** G25.81 (Restless legs syndrome)",
      "G25.89 (Other specified extrapyramidal and movement disorders)"
    ],
    "scope": "** Diagnosis and management of restless legs syndrome in adults. Covers diagnostic criteria, workup for secondary causes, pharmacologic and non-pharmacologic treatment, and prevention of augmentation. Excludes periodic limb movement disorder as separate entity, akathisia, and leg cramps.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Serum ferritin",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Iron deficiency is treatable cause; target >75 ng/mL",
            "target": ">75 ng/mL (>100 preferred)"
          },
          {
            "item": "Serum iron",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Iron deficiency assessment",
            "target": "Normal"
          },
          {
            "item": "TIBC",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Iron deficiency assessment",
            "target": "Normal"
          },
          {
            "item": "Transferrin saturation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Target >20%",
            "target": ">20%"
          },
          {
            "item": "CBC",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Anemia workup",
            "target": "Normal"
          },
          {
            "item": "CMP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Renal function (uremia can cause RLS), electrolytes",
            "target": "Normal"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Thyroid dysfunction",
            "target": "Normal"
          },
          {
            "item": "Glucose/HbA1c",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes can cause neuropathy mimicking RLS",
            "target": "Normal"
          }
        ],
        "Extended Workup": [
          {
            "item": "Vitamin B12",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency can cause neuropathy",
            "target": ">400 pg/mL"
          },
          {
            "item": "Folate",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency",
            "target": "Normal"
          },
          {
            "item": "Magnesium",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency can contribute",
            "target": "Normal"
          },
          {
            "item": "BUN/Creatinine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Uremic RLS",
            "target": "Normal"
          },
          {
            "item": "Pregnancy test",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "RLS common in pregnancy; affects treatment",
            "target": "Document"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Nerve conduction studies/EMG",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If neuropathy suspected",
            "target": "Rule out neuropathy mimics"
          },
          {
            "item": "ANA, anti-SSA/SSB",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If autoimmune neuropathy suspected",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Clinical diagnosis",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At evaluation",
            "target": "All 5 diagnostic criteria met",
            "contraindications": "None"
          }
        ],
        "Extended": [
          {
            "item": "Polysomnography (PSG)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If PLMD suspected or other sleep disorder",
            "target": "PLMS >15/hour supports diagnosis",
            "contraindications": "Not required for diagnosis"
          },
          {
            "item": "Actigraphy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Objective movement assessment",
            "target": "Document periodic movements",
            "contraindications": "None"
          },
          {
            "item": "MRI spine",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If radiculopathy suspected",
            "target": "Rule out structural cause",
            "contraindications": "Per MRI"
          },
          {
            "item": "Doppler ultrasound (legs)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If venous insufficiency suspected",
            "target": "Rule out venous disease",
            "contraindications": "None"
          }
        ]
      },
      "Treatment": {
        "Non-Pharmacologic Treatment (All Patients)": [
          {
            "item": "Sleep hygiene",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Regular sleep schedule, cool room, limit screen time",
              "orderSentence": "Sleep hygiene - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Foundation of treatment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Avoid triggers",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Avoid alcohol, caffeine, nicotine (especially evening)",
              "orderSentence": "Avoid triggers - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Critical",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Moderate exercise",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Regular exercise, but avoid intense exercise close to bedtime",
              "orderSentence": "Moderate exercise - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Helps symptoms",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Leg massage/stretching",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Gentle stretching, massage before bed",
              "orderSentence": "Leg massage/stretching - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "May provide relief",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hot bath",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Warm bath before bedtime",
              "orderSentence": "Hot bath - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Relaxation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mental alerting activities",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Crosswords, video games can distract during symptoms",
              "orderSentence": "Mental alerting activities - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Useful for mild cases",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pneumatic compression devices",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Sequential compression 1 hour before bed",
              "orderSentence": "Pneumatic compression devices - - - see dosing"
            },
            "contraindications": "DVT, arterial disease",
            "monitoring": "Limited evidence",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Iron Replacement (If Ferritin <75 ng/mL)": [
          {
            "item": "Ferrous sulfate",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "325 mg",
                  "orderSentence": "Ferrous sulfate 325 mg -"
                }
              ],
              "route": "-",
              "instructions": "325 mg (65 mg elemental iron) with vitamin C 100 mg, on empty stomach, daily or every other day",
              "orderSentence": "Ferrous sulfate 325 mg -"
            },
            "contraindications": "Iron overload, hemochromatosis",
            "monitoring": "Ferritin q3 months; GI side effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ferrous gluconate",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "324 mg",
                  "orderSentence": "Ferrous gluconate 324 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "324 mg (36 mg elemental iron) daily; better tolerated",
              "orderSentence": "Ferrous gluconate 324 mg PO"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "IV iron (ferric carboxymaltose)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "IV iron (ferric carboxymaltose) 1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg IV once (if oral intolerant or severe deficiency); may repeat",
              "orderSentence": "IV iron (ferric carboxymaltose) 1000 mg IV"
            },
            "contraindications": "Iron overload, infection",
            "monitoring": "Ferritin in 8 weeks; faster response",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "IV iron sucrose",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mg",
                  "orderSentence": "IV iron sucrose 200 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "200 mg IV × 5 doses over 2 weeks",
              "orderSentence": "IV iron sucrose 200 mg IV"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "First-Line Pharmacologic Treatment - Alpha-2-Delta Ligands (PREFERRED)": [
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Gabapentin 300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg QHS; titrate by 300 mg every few days to 900-1800 mg QHS",
              "orderSentence": "Gabapentin 300 mg PO"
            },
            "contraindications": "Renal impairment (adjust)",
            "monitoring": "Sedation, dizziness, edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gabapentin enacarbil (Horizant)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "600 mg",
                  "orderSentence": "Gabapentin enacarbil (Horizant) 600 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "600 mg daily at ~5 PM; FDA approved for RLS",
              "orderSentence": "Gabapentin enacarbil (Horizant) 600 mg PO"
            },
            "contraindications": "Renal impairment (adjust)",
            "monitoring": "Sedation, dizziness",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg",
                  "orderSentence": "Pregabalin 75 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 75 mg QHS; titrate to 150-300 mg QHS",
              "orderSentence": "Pregabalin 75 mg PO"
            },
            "contraindications": "Renal impairment (adjust)",
            "monitoring": "Sedation, dizziness, weight gain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-Line Pharmacologic Treatment - Dopamine Agonists": [
          {
            "item": "Pramipexole (Mirapex)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.125 mg",
                  "orderSentence": "Pramipexole (Mirapex) 0.125 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.125 mg 2-3h before bedtime; titrate by 0.125 mg q4-7 days; max 0.5 mg (keep dose LOW)",
              "orderSentence": "Pramipexole (Mirapex) 0.125 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Severe renal impairment",
            "monitoring": "AUGMENTATION, ICDs, sleepiness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ropinirole (Requip)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg",
                  "orderSentence": "Ropinirole (Requip) 0.25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25 mg 1-3h before bedtime; titrate by 0.25 mg q4-7 days; max 4 mg (keep dose LOW)",
              "orderSentence": "Ropinirole (Requip) 0.25 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Severe hepatic impairment",
            "monitoring": "AUGMENTATION, ICDs, sleepiness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rotigotine patch (Neupro)",
            "route": "Transdermal",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg",
                  "orderSentence": "Rotigotine patch (Neupro) 1 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1 mg/24h patch; titrate by 1 mg/week; max 3 mg/24h",
              "orderSentence": "Rotigotine patch (Neupro) 1 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Sulfite allergy",
            "monitoring": "AUGMENTATION, ICDs, skin reactions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Third-Line / Refractory Treatment": [
          {
            "item": "Low-dose opioids",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-15 mg",
                  "orderSentence": "Low-dose opioids 5-15 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Oxycodone 5-15 mg QHS or tramadol 50-100 mg QHS; RESERVE for refractory cases",
              "orderSentence": "Low-dose opioids 5-15 mg PO"
            },
            "contraindications": "Addiction risk, respiratory depression, apnea",
            "monitoring": "Dependence, respiratory",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Extended-release oxycodone",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-20 mg",
                  "orderSentence": "Extended-release oxycodone 10-20 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "10-20 mg QHS; for severe refractory RLS",
              "orderSentence": "Extended-release oxycodone 10-20 mg PO"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Methadone (specialist use)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-10 mg",
                  "orderSentence": "Methadone (specialist use) 5-10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10 mg QHS; specialist prescribing only",
              "orderSentence": "Methadone (specialist use) 5-10 mg PO"
            },
            "contraindications": "Same; QT prolongation",
            "monitoring": "QTc, respiratory",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Buprenorphine (specialist use)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.2-0.8 mg",
                  "orderSentence": "Buprenorphine (specialist use) 0.2-0.8 mg -"
                }
              ],
              "route": "-",
              "instructions": "0.2-0.8 mg SL QHS; may have lower abuse potential",
              "orderSentence": "Buprenorphine (specialist use) 0.2-0.8 mg -"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Managing Augmentation": [
          {
            "item": "Recognize augmentation",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Recognize augmentation - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Key to management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Discontinue dopamine agonist",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Discontinue dopamine agonist - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "\"Washout\" period difficult",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Bridge with opioid",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Bridge with opioid - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Temporary use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Switch to alpha-2-delta ligand",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Switch to alpha-2-delta ligand - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "New first-line",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "IV iron",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "IV iron - IV - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Helpful during transition",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Sleep medicine specialist",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Refractory RLS, PLMD evaluation, PSG needed"
          },
          {
            "item": "Neurology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Diagnostic uncertainty, refractory cases"
          },
          {
            "item": "Hematology",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Significant iron deficiency, iron infusion"
          },
          {
            "item": "Nephrology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Uremic RLS (ESRD patients)"
          },
          {
            "item": "Psychiatry",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Impulse control disorders on dopamine agonists"
          },
          {
            "item": "Pain management",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "indication": "Opioid management in refractory cases"
          }
        ],
        "Patient Instructions": [
          {
            "item": "RLS is a real neurological condition, not psychological",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Iron levels should be optimized (ferritin >75)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid caffeine, alcohol, and nicotine, especially in evening",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain regular sleep schedule",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report symptoms of augmentation: earlier onset, spreading to arms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report impulse control changes if on dopamine agonists (gambling, shopping)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Exercise regularly but not close to bedtime",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Many medications can worsen RLS - check with doctor before starting new meds",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "RLS Foundation (rls.org) for resources and support",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Antihistamines (diphenhydramine, hydroxyzine)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Antidopaminergic antiemetics (metoclopramide, prochlorperazine)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Antipsychotics (especially typical; atypical less so)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "SSRIs/SNRIs (may worsen in some patients)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "TCAs (may worsen in some patients)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Lithium",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Nocturnal leg cramps",
        "features": "Painful muscle contraction, sudden onset, relieved by stretching",
        "tests": "Clinical; no urge to move"
      },
      {
        "diagnosis": "Peripheral neuropathy",
        "features": "Numbness/tingling, burning, not worse at rest, not circadian",
        "tests": "EMG/NCS; different symptom pattern"
      },
      {
        "diagnosis": "Akathisia",
        "features": "Inner restlessness, not limb-specific, medication-induced (antipsychotics)",
        "tests": "Medication history; involves whole body"
      },
      {
        "diagnosis": "Positional discomfort",
        "features": "Relieved by position change; not circadian",
        "tests": "Clinical"
      },
      {
        "diagnosis": "Varicose veins/venous stasis",
        "features": "Visible veins, edema, worse with standing",
        "tests": "Doppler ultrasound"
      },
      {
        "diagnosis": "Arthritis",
        "features": "Joint pain, stiffness, not circadian",
        "tests": "Clinical; imaging"
      },
      {
        "diagnosis": "Peripheral artery disease",
        "features": "Claudication, worse with activity, cool extremities",
        "tests": "ABI, vascular studies"
      },
      {
        "diagnosis": "Radiculopathy",
        "features": "Dermatomal distribution, back pain",
        "tests": "MRI spine; EMG"
      },
      {
        "diagnosis": "Growing pains (children)",
        "features": "Bilateral, no urge to move, different demographics",
        "tests": "Clinical"
      },
      {
        "diagnosis": "Habitual foot tapping/leg bouncing",
        "features": "Voluntary, not uncomfortable, no urge",
        "tests": "Clinical"
      },
      {
        "diagnosis": "Periodic limb movement disorder",
        "features": "Movements during sleep; no awake symptoms",
        "tests": "PSG; RLS is awake symptom"
      }
    ],
    "evidence": [
      {
        "recommendation": "IRLSSG diagnostic criteria",
        "evidenceLevel": "Class I",
        "source": "[Allen et al., Sleep Med 2014](https://pubmed.ncbi.nlm.nih.gov/25023924/)"
      },
      {
        "recommendation": "Iron supplementation if ferritin <75",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs; AASM Guidelines"
      },
      {
        "recommendation": "Alpha-2-delta ligands first-line",
        "evidenceLevel": "Class I, Level A",
        "source": "Updated guidelines 2016; lower augmentation risk"
      },
      {
        "recommendation": "Gabapentin enacarbil FDA approved",
        "evidenceLevel": "Class I, Level A",
        "source": "FDA approval; multiple RCTs"
      },
      {
        "recommendation": "Pregabalin effective",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs"
      },
      {
        "recommendation": "Dopamine agonists effective but augmentation risk",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs; 70% augmentation at 10 years"
      },
      {
        "recommendation": "Low-dose opioids for refractory RLS",
        "evidenceLevel": "Class II, Level B",
        "source": "Limited RCTs"
      },
      {
        "recommendation": "Avoid antihistamines, antidopaminergics",
        "evidenceLevel": "Class II, Level B",
        "source": "Observational data"
      }
    ],
    "monitoring": [
      {
        "item": "IRLS severity scale",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "Adjust treatment"
      },
      {
        "item": "Ferritin",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q3-6 months until stable",
        "action": "Iron supplementation"
      },
      {
        "item": "Transferrin saturation",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "With ferritin",
        "action": "Iron supplementation"
      },
      {
        "item": "Augmentation screening",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit (if on DA)",
        "action": "Stop/switch dopamine agonist"
      },
      {
        "item": "Impulse control screening",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit (if on DA)",
        "action": "Stop dopamine agonist"
      },
      {
        "item": "Sleep quality",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "Adjust treatment"
      },
      {
        "item": "Renal function (if uremic)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Per nephrology",
        "action": "Dialysis optimization"
      }
    ],
    "disposition": [
      {
        "disposition": "Outpatient management",
        "criteria": "Most patients; mild-moderate RLS"
      },
      {
        "disposition": "Sleep medicine referral",
        "criteria": "Refractory RLS, PLMD suspected, PSG needed"
      },
      {
        "disposition": "Hematology referral",
        "criteria": "Significant iron deficiency, IV iron needed"
      },
      {
        "disposition": "Neurology referral",
        "criteria": "Diagnostic uncertainty, refractory cases, augmentation management"
      },
      {
        "disposition": "Follow-up frequency",
        "criteria": "q1-3 months initially; less frequent once stable"
      }
    ]
  },
  "Tension-Type Headache": {
    "id": "tension-headache",
    "title": "Tension-Type Headache",
    "version": "1.1",
    "icd10": [
      "** G44.209 (Tension-type headache",
      "unspecified",
      "not intractable)",
      "G44.219 (Episodic tension-type headache",
      "not intractable)",
      "G44.221 (Chronic tension-type headache",
      "not intractable)"
    ],
    "scope": "** Episodic and chronic tension-type headache diagnosis, acute treatment, and preventive therapy. Excludes secondary headaches, medication overuse headache (separate protocol), and trigeminal autonomic cephalalgias.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out anemia or infection as headache trigger",
            "target": "Normal"
          },
          {
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Electrolyte abnormalities can trigger headaches",
            "target": "Normal"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypothyroidism associated with chronic headache",
            "target": "Normal (0.4-4.0 mIU/L)"
          }
        ],
        "Extended Workup": [
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out giant cell arteritis if age >50 with new headache",
            "target": "Normal"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency associated with chronic pain and headache",
            "target": ">30 ng/mL"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Iron deficiency associated with headache",
            "target": ">50 ng/mL"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Low magnesium linked to headache disorders",
            "target": ">4.2 mg/dL"
          }
        ],
        "Rare/Specialized": [
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Rule out autoimmune disorder in atypical presentations",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Evaluate for sleep apnea contributing to chronic headache",
            "target": "AHI <5"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Consider in endemic areas with refractory symptoms",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Only if red flags present (see SNNOOP10 below)",
            "target": "Normal",
            "contraindications": "MRI-incompatible devices"
          },
          {
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-",
            "timing": "Acute severe headache or new neurological deficits",
            "target": "No hemorrhage, mass, or hydrocephalus",
            "contraindications": "Pregnancy (relative)"
          }
        ],
        "Extended": [
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Atypical features, focal deficits, suspected secondary cause",
            "target": "No enhancement or mass lesion",
            "contraindications": "Gadolinium allergy, severe renal impairment"
          },
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Suspected vascular etiology or cervical artery dissection",
            "target": "Patent vessels; no dissection",
            "contraindications": "MRI contraindications"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Cervicogenic component suspected",
            "target": "Normal alignment; no disc disease",
            "contraindications": "None"
          }
        ],
        "Rare/Specialized": [
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Suspected cerebral venous thrombosis",
            "target": "Patent venous sinuses",
            "contraindications": "MRI contraindications"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Suspected idiopathic intracranial hypertension",
            "target": "Normal (10-20 cm H2O)",
            "contraindications": "Coagulopathy; mass lesion"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Ketorolac",
            "route": "IV/IM",
            "indication": "Severe acute TTH in ED; NSAID-responsive headache",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg",
                  "orderSentence": "Ketorolac 30 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "30 mg IV x1 (15 mg if >65y, renal impairment, or <50 kg); do not exceed 5 days total NSAIDs",
              "orderSentence": "Ketorolac 30 mg IV"
            },
            "contraindications": "Renal impairment; GI bleed history; aspirin allergy; third trimester pregnancy",
            "monitoring": "Renal function if repeated dosing",
            "ED": "STAT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Metoclopramide",
            "route": "IV",
            "indication": "Acute headache with nausea; has anti-headache properties",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Metoclopramide 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg IV over 15 min; pretreat with diphenhydramine 25 mg to prevent akathisia",
              "orderSentence": "Metoclopramide 10 mg IV"
            },
            "contraindications": "Parkinson's disease; tardive dyskinesia history; bowel obstruction",
            "monitoring": "Akathisia, dystonic reaction",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Diphenhydramine",
            "route": "IV",
            "indication": "Adjunct to prevent akathisia from dopamine antagonists",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Diphenhydramine 25 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "25 mg IV prior to metoclopramide",
              "orderSentence": "Diphenhydramine 25 mg IV"
            },
            "contraindications": "Narrow-angle glaucoma; urinary retention",
            "monitoring": "Sedation",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Ibuprofen",
            "route": "PO",
            "indication": "First-line acute treatment for episodic TTH",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg",
                  "orderSentence": "Ibuprofen 400 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "400-800 mg PO at onset; may repeat q6-8h; max 2400 mg/day; limit to <10 days/month",
              "orderSentence": "Ibuprofen 400 mg PO"
            },
            "contraindications": "Renal impairment; GI bleed history; aspirin allergy; third trimester",
            "monitoring": "GI symptoms; renal function if prolonged use",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Naproxen",
            "route": "PO",
            "indication": "First-line acute treatment; longer duration than ibuprofen",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Naproxen 500 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "500-550 mg PO at onset; may repeat 250 mg in 12 hr; max 1250 mg/day; limit to <10 days/month",
              "orderSentence": "Naproxen 500 mg PO"
            },
            "contraindications": "Renal impairment; GI bleed history; aspirin allergy; third trimester",
            "monitoring": "GI symptoms; renal function if prolonged use",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Acetaminophen",
            "route": "PO",
            "indication": "First-line if NSAID contraindicated; mild-moderate TTH",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Acetaminophen 1000 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "1000 mg PO at onset; may repeat q6h; max 3000 mg/day (2000 mg if liver disease); limit to <10 days/month",
              "orderSentence": "Acetaminophen 1000 mg PO"
            },
            "contraindications": "Severe hepatic impairment; avoid if >3 alcoholic drinks/day",
            "monitoring": "LFTs if chronic use; total daily dose from all sources",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Aspirin",
            "route": "PO",
            "indication": "First-line acute treatment; anti-inflammatory",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650 mg",
                  "orderSentence": "Aspirin 650 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "650-1000 mg PO at onset; max 4000 mg/day; limit to <10 days/month",
              "orderSentence": "Aspirin 650 mg PO"
            },
            "contraindications": "Bleeding disorders; GI ulcer; aspirin allergy; children/teens (Reye syndrome); third trimester",
            "monitoring": "GI symptoms; bleeding",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Caffeine/Analgesic combination",
            "route": "PO",
            "indication": "Enhanced efficacy with caffeine adjunct",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 tablets",
                  "orderSentence": "Caffeine/Analgesic combination 2 tablets PO"
                }
              ],
              "route": "PO",
              "instructions": "Acetaminophen 250 mg/aspirin 250 mg/caffeine 65 mg: 2 tablets at onset; max 2 doses/24hr",
              "orderSentence": "Caffeine/Analgesic combination 2 tablets PO"
            },
            "contraindications": "Aspirin or acetaminophen contraindications",
            "monitoring": "Limit use to prevent caffeine dependence and MOH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Trigger point injection",
            "route": "IM",
            "indication": "Pericranial muscle tenderness; refractory to oral therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2 mL",
                  "orderSentence": "Trigger point injection 1-2 mL IM"
                }
              ],
              "route": "IM",
              "instructions": "Inject 1-2 mL 1% lidocaine into tender points in trapezius, temporalis, or cervical paraspinals; may repeat q2-4wk",
              "orderSentence": "Trigger point injection 1-2 mL IM"
            },
            "contraindications": "Local anesthetic allergy; infection at site",
            "monitoring": "Local bruising; vasovagal response",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Greater occipital nerve block",
            "route": "SC",
            "indication": "Occipital-predominant pain; refractory cases",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-3 mL",
                  "orderSentence": "Greater occipital nerve block 2-3 mL SC"
                }
              ],
              "route": "SC",
              "instructions": "2-3 mL 2% lidocaine with or without 40 mg triamcinolone at greater occipital nerve bilaterally",
              "orderSentence": "Greater occipital nerve block 2-3 mL SC"
            },
            "contraindications": "Local anesthetic allergy; infection at site",
            "monitoring": "Immediate pain relief; monitor for vasovagal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy",
            "route": "N/A",
            "indication": "Musculoskeletal dysfunction; postural abnormalities",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Physical therapy N/A N/A"
                }
              ],
              "route": "N/A",
              "instructions": "1-2 sessions/week for 6-8 weeks focusing on cervical/shoulder mobility, posture, and relaxation techniques",
              "orderSentence": "Physical therapy N/A N/A"
            },
            "contraindications": "None",
            "monitoring": "Symptom improvement over 6-8 weeks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Biofeedback/Relaxation therapy",
            "route": "N/A",
            "indication": "Stress-related TTH; patient preference for non-pharmacologic",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Biofeedback/Relaxation therapy N/A N/A"
                }
              ],
              "route": "N/A",
              "instructions": "Weekly sessions for 8-12 weeks; EMG biofeedback targeting frontalis/temporalis; may combine with CBT",
              "orderSentence": "Biofeedback/Relaxation therapy N/A N/A"
            },
            "contraindications": "None",
            "monitoring": "Symptom diary; headache frequency reduction",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cognitive behavioral therapy (CBT)",
            "route": "N/A",
            "indication": "Stress, anxiety, or depression contributing to headache",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Cognitive behavioral therapy (CBT) N/A N/A"
                }
              ],
              "route": "N/A",
              "instructions": "Weekly sessions for 8-12 weeks; focus on pain coping, stress management, and cognitive restructuring",
              "orderSentence": "Cognitive behavioral therapy (CBT) N/A N/A"
            },
            "contraindications": "None",
            "monitoring": "Symptom diary; validated headache disability measures",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Disease-Modifying or Chronic Therapies (Preventive Medications)": [
          {
            "item": "Amitriptyline",
            "route": "PO",
            "indication": "First-line prevention for chronic TTH; ≥15 days/month",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Amitriptyline 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg qHS; titrate by 10-25 mg every 1-2 weeks; target 25-75 mg qHS; max 150 mg qHS",
              "orderSentence": "Amitriptyline 10 mg PO"
            },
            "pretreatment": "ECG if age >50 or cardiac history",
            "contraindications": "Cardiac conduction abnormality (QTc >450 ms); recent MI; narrow-angle glaucoma; urinary retention; concurrent MAOIs",
            "monitoring": "Sedation, dry mouth, weight gain, constipation; ECG if dose >100 mg/day",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nortriptyline",
            "route": "PO",
            "indication": "Prevention if amitriptyline not tolerated (less sedating); chronic TTH",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Nortriptyline 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg qHS; titrate by 10-25 mg every 1-2 weeks; target 25-75 mg qHS; max 150 mg qHS",
              "orderSentence": "Nortriptyline 10 mg PO"
            },
            "pretreatment": "ECG if age >50 or cardiac history",
            "contraindications": "Cardiac conduction abnormality (QTc >450 ms); recent MI; narrow-angle glaucoma; urinary retention; concurrent MAOIs",
            "monitoring": "Sedation (less than amitriptyline), dry mouth, weight gain, constipation; ECG if dose >100 mg/day",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "Prevention; comorbid depression or anxiety; TCA intolerant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5 mg",
                  "orderSentence": "Venlafaxine XR 37.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5 mg daily; increase by 37.5-75 mg every 1 week; target 75-150 mg daily",
              "orderSentence": "Venlafaxine XR 37.5 mg PO"
            },
            "pretreatment": "None",
            "contraindications": "Uncontrolled hypertension; concurrent MAOIs; abrupt discontinuation (taper required)",
            "monitoring": "Blood pressure at higher doses (>150 mg); serotonin syndrome signs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirtazapine",
            "route": "PO",
            "indication": "Prevention; comorbid insomnia, depression, or poor appetite",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7.5 mg",
                  "orderSentence": "Mirtazapine 7.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 7.5-15 mg qHS; may increase to 30 mg qHS; more sedating at lower doses",
              "orderSentence": "Mirtazapine 7.5 mg PO"
            },
            "pretreatment": "None",
            "contraindications": "Concurrent MAOIs; severe hepatic impairment",
            "monitoring": "Sedation, increased appetite, weight gain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tizanidine",
            "route": "PO",
            "indication": "Prevention; prominent pericranial muscle tension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg",
                  "orderSentence": "Tizanidine 2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2 mg qHS; may increase by 2-4 mg every 3-7 days; max 36 mg/day in 3 divided doses",
              "orderSentence": "Tizanidine 2 mg PO"
            },
            "pretreatment": "LFTs at baseline",
            "contraindications": "Concurrent ciprofloxacin or fluvoxamine (CYP1A2 inhibitors); hepatic impairment",
            "monitoring": "LFTs monthly for first 6 months then periodically; sedation, hypotension, dry mouth",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Topiramate",
            "route": "PO",
            "indication": "Prevention; comorbid migraine or obesity",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Topiramate 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS; increase by 25 mg/week; target 50-100 mg BID",
              "orderSentence": "Topiramate 25 mg PO"
            },
            "pretreatment": "None",
            "contraindications": "Narrow-angle glaucoma; kidney stones; pregnancy (teratogen); metabolic acidosis",
            "monitoring": "Cognitive effects (word-finding), paresthesias, weight loss, kidney stones, bicarbonate",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Prevention; comorbid neuropathic pain or anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Gabapentin 300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; titrate by 300 mg every 3-5 days; target 900-1800 mg/day in 3 divided doses",
              "orderSentence": "Gabapentin 300 mg PO"
            },
            "pretreatment": "None",
            "contraindications": "Severe renal impairment (dose adjust for CrCl)",
            "monitoring": "Sedation, dizziness, peripheral edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology/Headache specialist referral for chronic TTH (≥15 days/month) not responding to first-line preventives",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for cervicogenic component, postural dysfunction, and pericranial muscle tension",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Behavioral medicine/Psychology for stress management, biofeedback, and cognitive behavioral therapy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sleep medicine evaluation if underlying sleep disorder (insomnia, apnea) contributing to chronic headache",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ophthalmology evaluation to rule out refractive error or eye strain as contributing factor",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dentistry/TMJ specialist if temporomandibular joint dysfunction contributing to headache",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatry referral for comorbid depression or anxiety requiring pharmacologic management beyond preventive therapy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately for sudden severe headache (\"worst headache of life\") which may indicate hemorrhage or other serious cause",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return immediately for headache with fever, stiff neck, or altered mental status which may indicate infection",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return if new neurological symptoms develop (weakness, numbness, vision changes, speech difficulty)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain headache diary tracking frequency, triggers, medication use, and response to guide treatment optimization",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit acute pain medication use to no more than 10 days per month to prevent medication overuse headache",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take acute medications early at headache onset for best efficacy rather than waiting for severe pain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Identify and modify personal triggers (stress, poor posture, inadequate sleep, screen time, skipped meals)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Regular sleep schedule (7-8 hours, consistent bedtime and wake time) as sleep disturbance is a common trigger",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management through relaxation techniques, mindfulness meditation, or progressive muscle relaxation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular aerobic exercise (30 minutes moderate activity 5 times/week) shown to reduce chronic headache frequency",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Ergonomic workplace assessment to optimize posture and reduce neck/shoulder strain during computer work",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit screen time and take regular breaks (20-20-20 rule: every 20 minutes, look 20 feet away for 20 seconds)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate hydration (at least 64 oz water daily) as dehydration can trigger headache",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular meals to avoid fasting-triggered headache; do not skip meals",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit caffeine to moderate consistent intake (≤200 mg/day or ~2 cups coffee) to prevent withdrawal headaches",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stretching exercises for neck and shoulders daily, especially if sedentary work",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Migraine",
        "features": "Unilateral, pulsating, moderate-severe intensity; nausea/vomiting; photo AND phonophobia; aggravated by physical activity",
        "tests": "Clinical criteria (ICHD-3); normal imaging"
      },
      {
        "diagnosis": "Medication overuse headache",
        "features": "Daily or near-daily headache; acute medication use ≥10-15 days/month for ≥3 months",
        "tests": "Headache diary documenting medication use; improves with withdrawal"
      },
      {
        "diagnosis": "Cervicogenic headache",
        "features": "Unilateral, starts in neck, radiates frontally; triggered by neck movement or sustained posture; reduced ROM",
        "tests": "Physical exam (decreased ROM, tenderness); C-spine imaging; diagnostic block"
      },
      {
        "diagnosis": "Temporomandibular joint dysfunction",
        "features": "Pain in jaw, temple, or preauricular area; worse with chewing; clicking/popping of jaw; bruxism history",
        "tests": "TMJ exam; panoramic dental X-ray; may need MRI TMJ"
      },
      {
        "diagnosis": "Giant cell arteritis",
        "features": "Age >50; new headache type; scalp tenderness; jaw claudication; visual changes; elevated ESR/CRP",
        "tests": "ESR, CRP; temporal artery biopsy (gold standard)"
      },
      {
        "diagnosis": "Idiopathic intracranial hypertension",
        "features": "Positional headache (worse lying flat); papilledema; pulsatile tinnitus; visual obscurations; obesity",
        "tests": "LP with opening pressure >25 cm H2O; MRI/MRV normal"
      },
      {
        "diagnosis": "Intracranial mass lesion",
        "features": "Progressive headache; worse in morning or with Valsalva; focal neurological signs",
        "tests": "MRI brain with contrast"
      },
      {
        "diagnosis": "Cervical artery dissection",
        "features": "Sudden severe headache or neck pain; may have Horner syndrome; history of trauma or neck manipulation",
        "tests": "MRA or CTA neck"
      },
      {
        "diagnosis": "Trigeminal neuralgia",
        "features": "Brief (seconds) electric shock-like pain; unilateral V2/V3 distribution; triggered by touch, chewing, or talking",
        "tests": "MRI for vascular loop; clinical criteria"
      },
      {
        "diagnosis": "Cluster headache",
        "features": "Unilateral, periorbital, severe; autonomic features (lacrimation, rhinorrhea, ptosis, miosis); 15-180 min duration",
        "tests": "Clinical history; attacks occur in clusters"
      }
    ],
    "evidence": [
      {
        "recommendation": "ICHD-3 diagnostic criteria for tension-type headache",
        "evidenceLevel": "Expert Consensus",
        "source": "[Headache Classification Committee. Cephalalgia 2018](https://pubmed.ncbi.nlm.nih.gov/29368949/)"
      },
      {
        "recommendation": "Amitriptyline effective for chronic TTH prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "[Bendtsen et al. Neurology 1996](https://pubmed.ncbi.nlm.nih.gov/8710059/)"
      },
      {
        "recommendation": "Simple analgesics (acetaminophen, NSAIDs, aspirin) for acute TTH",
        "evidenceLevel": "Class I, Level A",
        "source": "[Stephens et al. Cochrane 2016](https://pubmed.ncbi.nlm.nih.gov/27306653/)"
      },
      {
        "recommendation": "Tricyclic antidepressants for chronic TTH prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "[Jackson et al. Neurology 2017](https://pubmed.ncbi.nlm.nih.gov/28179565/)"
      },
      {
        "recommendation": "Biofeedback and relaxation training reduce headache frequency",
        "evidenceLevel": "Class II, Level B",
        "source": "[Nestoriuc et al. Pain 2008](https://pubmed.ncbi.nlm.nih.gov/18455618/)"
      },
      {
        "recommendation": "Physical therapy for tension-type headache",
        "evidenceLevel": "Class II, Level B",
        "source": "[Espi-Lopez et al. Phys Ther 2014](https://pubmed.ncbi.nlm.nih.gov/24903113/)"
      },
      {
        "recommendation": "Cognitive behavioral therapy reduces headache disability",
        "evidenceLevel": "Class I, Level B",
        "source": "[Holroyd et al. JAMA 2001](https://pubmed.ncbi.nlm.nih.gov/11565519/)"
      },
      {
        "recommendation": "Medication overuse headache prevalence and management",
        "evidenceLevel": "Expert Consensus",
        "source": "[Diener et al. Nat Rev Neurol 2016](https://pubmed.ncbi.nlm.nih.gov/27615420/)"
      },
      {
        "recommendation": "Ibuprofen 400-800 mg effective for acute TTH",
        "evidenceLevel": "Class I, Level A",
        "source": "[Steiner et al. Headache 2003](https://pubmed.ncbi.nlm.nih.gov/12656706/)"
      },
      {
        "recommendation": "Combination analgesics (aspirin/acetaminophen/caffeine) effective",
        "evidenceLevel": "Class I, Level A",
        "source": "[Diener et al. Cephalalgia 2006](https://pubmed.ncbi.nlm.nih.gov/16472332/)"
      },
      {
        "recommendation": "Venlafaxine for chronic TTH prevention",
        "evidenceLevel": "Class II, Level B",
        "source": "[Zissis et al. Headache 2007](https://pubmed.ncbi.nlm.nih.gov/17371352/)"
      },
      {
        "recommendation": "Topiramate for chronic TTH (limited evidence)",
        "evidenceLevel": "Class III, Level C",
        "source": "[Lampl et al. J Neurol 2006](https://pubmed.ncbi.nlm.nih.gov/16485112/)"
      },
      {
        "recommendation": "Greater occipital nerve block for refractory headache",
        "evidenceLevel": "Class II, Level B",
        "source": "[Afridi et al. Brain 2006](https://pubmed.ncbi.nlm.nih.gov/16330505/)"
      },
      {
        "recommendation": "SNNOOP10 red flags for secondary headache",
        "evidenceLevel": "Expert Consensus",
        "source": "[Do et al. Neurology 2019](https://pubmed.ncbi.nlm.nih.gov/30587518/)"
      }
    ],
    "monitoring": [
      {
        "item": "Headache diary (frequency, severity, duration, medication use)",
        "frequency": "Continuous at home; review each visit",
        "action": "Optimize preventive therapy; consider referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Acute medication use days per month",
        "frequency": "Monthly",
        "action": "Counsel on MOH risk; consider prevention; detox if MOH",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "HIT-6 disability score",
        "frequency": "Every 3 months",
        "action": "Escalate preventive therapy if disability persists",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "LFTs (if on tizanidine)",
        "frequency": "Baseline, monthly x 6 months, then q6mo",
        "action": "Hold or discontinue if >3x ULN",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ECG (if on TCA)",
        "frequency": "Baseline if age >50 or cardiac history; if dose >100 mg",
        "action": "Reduce dose or switch agent if QTc prolonged",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Blood pressure (if on venlafaxine or SNRI)",
        "frequency": "Each visit",
        "action": "Reduce dose or add antihypertensive",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight (if on TCA or mirtazapine)",
        "frequency": "Each visit",
        "action": "Dietary counseling; consider switching agent",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Cognitive function (if on topiramate)",
        "frequency": "Each visit",
        "action": "Reduce dose or switch agent",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Bicarbonate (if on topiramate)",
        "frequency": "Baseline, 3 months",
        "action": "Consider dose reduction or discontinuation if acidosis",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Pain controlled with oral medications; able to tolerate PO; no red flags; follow-up arranged; MOH counseling provided"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Rare; consider if: intractable headache requiring IV therapy; need for medication overuse headache detoxification protocol"
      },
      {
        "disposition": "Outpatient neurology follow-up",
        "criteria": "Within 4-8 weeks for chronic TTH not responding to first-line treatment; sooner if diagnostic uncertainty"
      },
      {
        "disposition": "Primary care follow-up",
        "criteria": "Within 2-4 weeks for new episodic TTH to assess response to acute treatment and need for prevention"
      }
    ]
  },
  "Migraine with Aura": {
    "id": "migraine-with-aura",
    "title": "Migraine with Aura",
    "version": "1.1",
    "icd10": [
      "** G43.109 (Migraine with aura",
      "not intractable",
      "without status migrainosus)",
      "G43.101 (with status migrainosus)",
      "G43.119 (intractable",
      "without status migrainosus)",
      "G43.111 (intractable",
      "with status migrainosus)",
      "G43.409 (Hemiplegic migraine",
      "not intractable)",
      "G43.419 (Hemiplegic migraine",
      "intractable)"
    ],
    "scope": "** Diagnosis and management of migraine with typical aura (visual, sensory, language) and hemiplegic migraine. Focuses on outpatient management with acute care considerations. Covers differentiation from TIA/stroke, contraceptive counseling, and preventive therapy. Excludes migraine with brainstem aura (separate protocol) and retinal migraine.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out anemia, infection; baseline before treatment",
            "target": "Normal"
          },
          {
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Electrolyte abnormalities; renal function for medication dosing",
            "target": "Normal"
          },
          {
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypoglycemia can mimic aura; hyperglycemia raises stroke risk",
            "target": "70-180 mg/dL"
          },
          {
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Coagulation screen if stroke consideration; before LP",
            "target": "Normal"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Vascular risk assessment",
            "target": "<7% optimal"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Vascular risk stratification",
            "target": "LDL <100 mg/dL"
          }
        ],
        "Extended Workup": [
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out GCA if age >50 with new visual symptoms",
            "target": "Normal"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Thyroid dysfunction can trigger headache/aura-like symptoms",
            "target": "Normal (0.4-4.0 mIU/L)"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency linked to migraine with aura specifically",
            "target": ">4.2 mg/dL"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Elevated levels associated with migraine with aura and stroke",
            "target": "<15 μmol/L"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency can elevate homocysteine; sensory symptoms",
            "target": "Normal"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency associated with increased migraine frequency",
            "target": ">30 ng/mL"
          }
        ],
        "Rare/Specialized": [
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Thrombophilia workup if young stroke or recurrent prolonged aura",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Hereditary thrombophilia if recurrent aura or stroke-like events",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "CNS lupus in atypical presentations",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Elevated homocysteine with aura",
            "target": "Wild type or heterozygous"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Hemiplegic migraine suspected; family history",
            "target": "Variant identified"
          },
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Rule out meningitis, SAH if atypical presentation",
            "target": "Normal; no xanthochromia"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "First presentation with aura; rule out stroke/structural lesion",
            "target": "Normal; no acute infarct; no WMH concerning for vasculopathy",
            "contraindications": "MRI-incompatible devices"
          },
          {
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-",
            "timing": "Acute presentation if MRI unavailable; rule out hemorrhage",
            "target": "No hemorrhage or mass",
            "contraindications": "Pregnancy (relative)"
          },
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "First aura or prolonged aura to assess intracranial vessels",
            "target": "No stenosis, aneurysm, or dissection",
            "contraindications": "MRI contraindications"
          }
        ],
        "Extended": [
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Atypical features; persistent deficits; concern for mass",
            "target": "No enhancement; no mass",
            "contraindications": "Gadolinium allergy; severe renal impairment"
          },
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Suspected cervical dissection (neck pain, Horner syndrome)",
            "target": "No dissection",
            "contraindications": "MRI contraindications"
          },
          {
            "ED": "STAT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "timing": "Acute vascular imaging if MRI unavailable",
            "target": "No aneurysm, dissection, occlusion",
            "contraindications": "Contrast allergy; CKD (eGFR <30)"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Evaluate for PFO if recurrent aura or cryptogenic stroke history",
            "target": "No PFO; if present, assess shunt size",
            "contraindications": "None"
          }
        ],
        "Rare/Specialized": [
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Detailed cardiac source evaluation if TTE positive or high suspicion",
            "target": "No cardiac thrombus; characterize PFO",
            "contraindications": "Esophageal pathology"
          },
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Prolonged aura to differentiate migrainous infarct from stroke",
            "target": "No DWI restriction",
            "contraindications": "MRI contraindications"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "PFO screening; noninvasive alternative to TTE bubble",
            "target": "No right-to-left shunt",
            "contraindications": "Inadequate acoustic windows"
          },
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Aura with altered consciousness; differentiate from seizure",
            "target": "No epileptiform activity",
            "contraindications": "None"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Ketorolac",
            "route": "IV/IM",
            "indication": "First-line acute migraine with aura in ED",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg",
                  "orderSentence": "Ketorolac 30 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "30 mg IV (15 mg if >65y, renal impairment, or <50 kg); max 5 days NSAIDs",
              "orderSentence": "Ketorolac 30 mg IV"
            },
            "contraindications": "Renal impairment (CrCl <30); active GI bleed; aspirin/NSAID allergy; third trimester",
            "monitoring": "Renal function if repeated dosing",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Metoclopramide",
            "route": "IV",
            "indication": "Antiemetic with anti-migraine properties",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Metoclopramide 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10-20 mg IV over 15 min; pretreat with diphenhydramine 25 mg IV to prevent akathisia",
              "orderSentence": "Metoclopramide 10 mg IV"
            },
            "contraindications": "Parkinson's disease; tardive dyskinesia history; bowel obstruction; pheochromocytoma",
            "monitoring": "Akathisia, dystonia; discontinue if EPS",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Prochlorperazine",
            "route": "IV",
            "indication": "Dopamine antagonist for acute migraine with prominent nausea",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Prochlorperazine 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg IV slowly over 2 min; pretreat with diphenhydramine 25 mg IV",
              "orderSentence": "Prochlorperazine 10 mg IV"
            },
            "contraindications": "QT prolongation (QTc >500ms); Parkinson's disease; neuroleptic malignant syndrome history",
            "monitoring": "QTc if baseline prolonged; EPS",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Diphenhydramine",
            "route": "IV",
            "indication": "Prevent akathisia from dopamine antagonists; sedation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Diphenhydramine 25 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "25-50 mg IV given concurrently with dopamine antagonist",
              "orderSentence": "Diphenhydramine 25 mg IV"
            },
            "contraindications": "Narrow-angle glaucoma; urinary retention; severe prostatic hypertrophy",
            "monitoring": "Sedation; anticholinergic effects",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Magnesium sulfate",
            "route": "IV",
            "indication": "Migraine with aura - particularly effective; refractory migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g",
                  "orderSentence": "Magnesium sulfate 2 g IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV in 50 mL NS over 20-30 min; may repeat x1 after 2 hr",
              "orderSentence": "Magnesium sulfate 2 g IV"
            },
            "contraindications": "Heart block; severe hypermagnesemia; myasthenia gravis; severe renal impairment",
            "monitoring": "BP, HR during infusion; flushing is common and benign",
            "ED": "STAT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Sumatriptan",
            "route": "SC/PO",
            "indication": "Acute migraine with TYPICAL aura (visual, sensory, language) - SAFE",
            "dosing": {
              "doseOptions": [
                {
                  "text": "6 mg",
                  "orderSentence": "Sumatriptan 6 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "6 mg SC (may repeat after 1 hr, max 12 mg/24hr) OR 50-100 mg PO (may repeat after 2 hr, max 200 mg/24hr); take AFTER aura resolves or at headache onset",
              "orderSentence": "Sumatriptan 6 mg SC"
            },
            "contraindications": "**HEMIPLEGIC MIGRAINE (motor aura)**; uncontrolled HTN; CAD; prior stroke/TIA; MAOIs within 14 days; ergots within 24 hr",
            "monitoring": "Chest tightness (triptan sensation vs cardiac); assess cardiovascular risk",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valproate sodium",
            "route": "IV",
            "indication": "Status migrainosus with aura; refractory to first-line",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Valproate sodium 500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "500-1000 mg IV over 5-10 min; may repeat 500 mg in 8 hr",
              "orderSentence": "Valproate sodium 500 mg IV"
            },
            "contraindications": "Hepatic disease; pregnancy (teratogenic); urea cycle disorders; pancreatitis history",
            "monitoring": "LFTs; ammonia if altered mental status",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Dexamethasone",
            "route": "IV",
            "indication": "Prevent headache recurrence after acute treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Dexamethasone 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg IV x1 at time of discharge or admission; single dose",
              "orderSentence": "Dexamethasone 10 mg IV"
            },
            "contraindications": "Active untreated infection; known hypersensitivity",
            "monitoring": "Glucose if diabetic",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Rizatriptan",
            "route": "PO",
            "indication": "Acute typical migraine with aura; fast onset",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Rizatriptan 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10 mg PO (use 5 mg if on propranolol); may repeat after 2 hr; max 30 mg/24hr",
              "orderSentence": "Rizatriptan 10 mg PO"
            },
            "contraindications": "**HEMIPLEGIC MIGRAINE (motor aura)**; uncontrolled HTN; CAD; prior stroke/TIA; MAOIs within 14 days; ergots within 24 hr; use 5 mg max if on propranolol",
            "monitoring": "Triptan sensation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Eletriptan",
            "route": "PO",
            "indication": "Acute typical migraine with aura; good for recurrence",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Eletriptan 40 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "40 mg PO; may repeat 40 mg after 2 hr if partial response; max 80 mg/24hr",
              "orderSentence": "Eletriptan 40 mg PO"
            },
            "contraindications": "**HEMIPLEGIC MIGRAINE (motor aura)**; uncontrolled HTN; CAD; prior stroke/TIA; MAOIs within 14 days; ergots within 24 hr; potent CYP3A4 inhibitors (ketoconazole, clarithromycin)",
            "monitoring": "Triptan sensation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Naratriptan",
            "route": "PO",
            "indication": "Migraine with aura; longer duration; menstrual migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg",
                  "orderSentence": "Naratriptan 2.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "2.5 mg PO; may repeat after 4 hr; max 5 mg/24hr; slower onset but longer lasting",
              "orderSentence": "Naratriptan 2.5 mg PO"
            },
            "contraindications": "**HEMIPLEGIC MIGRAINE (motor aura)**; uncontrolled HTN; CAD; prior stroke/TIA; MAOIs within 14 days; ergots within 24 hr; moderate-severe renal/hepatic impairment",
            "monitoring": "Triptan sensation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ubrogepant",
            "route": "PO",
            "indication": "CGRP antagonist; use if triptan contraindicated or cardiovascular risk",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Ubrogepant 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "50-100 mg PO; may repeat after 2 hr; max 200 mg/24hr",
              "orderSentence": "Ubrogepant 50 mg PO"
            },
            "contraindications": "Strong CYP3A4 inhibitors; severe hepatic impairment",
            "monitoring": "None routine; no cardiovascular contraindications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rimegepant",
            "route": "PO/ODT",
            "indication": "CGRP antagonist; can use for acute and prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg",
                  "orderSentence": "Rimegepant 75 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "75 mg ODT at onset; max 75 mg/24hr for acute; also approved 75 mg every other day for prevention",
              "orderSentence": "Rimegepant 75 mg PO"
            },
            "contraindications": "Strong CYP3A4 inhibitors/inducers; severe hepatic impairment",
            "monitoring": "None routine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lasmiditan",
            "route": "PO",
            "indication": "5-HT1F agonist; safe in cardiovascular disease; ditan class",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Lasmiditan 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "50-200 mg PO x1; max 200 mg/24hr; DO NOT DRIVE for 8 hours after dose",
              "orderSentence": "Lasmiditan 100 mg PO"
            },
            "contraindications": "Concurrent alcohol; CYP3A4 substrates with narrow TI",
            "monitoring": "CNS depression; dizziness; NO driving for 8 hr",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ibuprofen",
            "route": "PO",
            "indication": "Mild-moderate aura migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg",
                  "orderSentence": "Ibuprofen 400 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "400-800 mg PO at onset; max 2400 mg/day",
              "orderSentence": "Ibuprofen 400 mg PO"
            },
            "contraindications": "Renal impairment; active GI bleed; aspirin/NSAID allergy; third trimester",
            "monitoring": "GI symptoms; renal function if prolonged use",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Naproxen sodium",
            "route": "PO",
            "indication": "Mild-moderate aura migraine; menstrual migraine prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "550 mg",
                  "orderSentence": "Naproxen sodium 550 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "550 mg PO at onset; may add 275 mg in 12 hr; max 1375 mg day 1, then 1100 mg/day",
              "orderSentence": "Naproxen sodium 550 mg PO"
            },
            "contraindications": "Renal impairment; active GI bleed; aspirin/NSAID allergy",
            "monitoring": "GI symptoms",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Acetaminophen-Aspirin-Caffeine",
            "route": "PO",
            "indication": "Mild-moderate migraine with aura (OTC option)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 tablets",
                  "orderSentence": "Acetaminophen-Aspirin-Caffeine 2 tablets PO"
                }
              ],
              "route": "PO",
              "instructions": "2 tablets (250/250/65 mg each) at onset; max 2 doses/24hr",
              "orderSentence": "Acetaminophen-Aspirin-Caffeine 2 tablets PO"
            },
            "contraindications": "Aspirin allergy; hepatic impairment; avoid if using other acetaminophen sources",
            "monitoring": "Limit total acetaminophen <3 g/day",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ondansetron",
            "route": "IV/PO",
            "indication": "Nausea/vomiting with migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg",
                  "orderSentence": "Ondansetron 4 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "4 mg IV or 8 mg PO/ODT; may repeat q8h as needed",
              "orderSentence": "Ondansetron 4 mg IV"
            },
            "contraindications": "QT prolongation (QTc >500ms); severe hepatic impairment",
            "monitoring": "QTc if multiple doses or baseline prolongation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Dihydroergotamine (DHE)",
            "route": "IV/SC/Nasal",
            "indication": "Refractory migraine; status migrainosus; **NOT for hemiplegic**",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg",
                  "orderSentence": "Dihydroergotamine (DHE) 0.5 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "IV: 0.5-1 mg q8h for up to 3 days (pretreat with antiemetic); SC: 1 mg, may repeat in 1 hr; Nasal: 1 spray each nostril, repeat in 15 min",
              "orderSentence": "Dihydroergotamine (DHE) 0.5 mg IV"
            },
            "contraindications": "Pregnancy; CAD; uncontrolled HTN; peripheral vascular disease; **HEMIPLEGIC MIGRAINE**; triptan use within 24hr; severe hepatic/renal impairment",
            "monitoring": "BP; nausea; chest pain; continuous cardiac monitoring for IV",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Occipital nerve block",
            "route": "SC",
            "indication": "Refractory migraine; occipital-predominant pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mL",
                  "orderSentence": "Occipital nerve block 2.5 mL SC"
                }
              ],
              "route": "SC",
              "instructions": "Inject bupivacaine 0.5% 2-3 mL + triamcinolone 40 mg at greater occipital nerve bilaterally; may add lesser occipital, supraorbital",
              "orderSentence": "Occipital nerve block 2.5 mL SC"
            },
            "contraindications": "Local anesthetic allergy; infection at injection site; anticoagulation (relative)",
            "monitoring": "Vasovagal reaction; immediate pain assessment",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ketamine",
            "route": "IV",
            "indication": "Status migrainosus refractory to DHE",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg/kg/hr",
                  "orderSentence": "Ketamine 0.1 mg/kg/hr IV"
                }
              ],
              "route": "IV",
              "instructions": "0.1-0.3 mg/kg/hr continuous infusion for 24-48 hr; subanesthetic dosing only",
              "orderSentence": "Ketamine 0.1 mg/kg/hr IV"
            },
            "contraindications": "Uncontrolled HTN; psychosis history; elevated ICP; pregnancy",
            "monitoring": "Dissociation; BP; HR; requires continuous cardiac monitoring",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Verapamil",
            "route": "IV",
            "indication": "Hemiplegic migraine acute (if severe); status migrainosus",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Verapamil 5 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "5 mg IV over 2-3 min; may repeat in 30 min (max 20 mg)",
              "orderSentence": "Verapamil 5 mg IV"
            },
            "contraindications": "Heart block (2nd/3rd degree); severe LV dysfunction; hypotension",
            "monitoring": "Continuous ECG; BP; for hemiplegic migraine when triptans contraindicated",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Intranasal lidocaine",
            "route": "Intranasal",
            "indication": "Acute migraine with aura; rapid onset option",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mL",
                  "orderSentence": "Intranasal lidocaine 0.5 mL Intranasal"
                }
              ],
              "route": "Intranasal",
              "instructions": "4% lidocaine 0.5 mL per nostril directed at sphenopalatine fossa; may repeat x1 in 15 min",
              "orderSentence": "Intranasal lidocaine 0.5 mL Intranasal"
            },
            "contraindications": "Local anesthetic allergy",
            "monitoring": "Local numbness; cardiac arrhythmia (rare with low dose)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Disease-Modifying or Chronic Therapies (Preventive Medications)": [
          {
            "item": "Magnesium oxide",
            "route": "PO",
            "indication": "First-line supplement for migraine with aura prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg",
                  "orderSentence": "Magnesium oxide 400 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 400 mg daily; may increase to 400 mg BID; take with food to reduce GI upset",
              "orderSentence": "Magnesium oxide 400 mg PO"
            },
            "pretreatment": "None",
            "contraindications": "Renal impairment (CrCl <30) - dose reduce",
            "monitoring": "Diarrhea; check Mg level if symptomatic or renal disease",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Topiramate",
            "route": "PO",
            "indication": "First-line oral prevention; reduces aura frequency; weight loss",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Topiramate 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS; increase by 25 mg/wk; target 50-100 mg BID",
              "orderSentence": "Topiramate 25 mg PO"
            },
            "pretreatment": "None",
            "contraindications": "**PREGNANCY (teratogenic)**; glaucoma; kidney stones; metabolic acidosis",
            "monitoring": "Cognitive effects; paresthesias; weight; serum bicarbonate; kidney stones",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Propranolol",
            "route": "PO",
            "indication": "First-line prevention; comorbid HTN, anxiety, tremor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Propranolol 40 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 40 mg BID or 80 mg LA daily; titrate q2wk; target 80-240 mg/day",
              "orderSentence": "Propranolol 40 mg PO"
            },
            "pretreatment": "None",
            "contraindications": "Asthma; COPD with bronchospasm; bradycardia <50; 2nd/3rd degree heart block; decompensated HF",
            "monitoring": "HR (goal >50); BP; fatigue; depression; exercise intolerance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "PO",
            "indication": "Prevention with comorbid insomnia, depression, tension-type headache",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Amitriptyline 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg qHS; titrate by 10-25 mg q1-2wk; target 25-75 mg qHS",
              "orderSentence": "Amitriptyline 10 mg PO"
            },
            "pretreatment": "ECG if >50 y/o or cardiac history",
            "contraindications": "Cardiac conduction disease; recent MI; glaucoma; urinary retention; elderly (anticholinergic burden)",
            "monitoring": "Sedation; weight; dry mouth; ECG if dose >100 mg or cardiac history",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "Prevention with comorbid depression, anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5 mg",
                  "orderSentence": "Venlafaxine XR 37.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5 mg daily; increase by 37.5-75 mg q1wk; target 75-150 mg daily",
              "orderSentence": "Venlafaxine XR 37.5 mg PO"
            },
            "pretreatment": "None",
            "contraindications": "Uncontrolled HTN; MAOIs within 14 days; abrupt discontinuation risk",
            "monitoring": "BP at doses >150 mg; serotonin syndrome signs; taper to discontinue",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Candesartan",
            "route": "PO",
            "indication": "Prevention; comorbid HTN; beta-blocker intolerant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "8 mg",
                  "orderSentence": "Candesartan 8 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 8 mg daily; may increase to 16 mg daily after 4 wk",
              "orderSentence": "Candesartan 8 mg PO"
            },
            "pretreatment": "None",
            "contraindications": "**Pregnancy**; bilateral renal artery stenosis; hyperkalemia",
            "monitoring": "BP; potassium; creatinine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valproate/Divalproex",
            "route": "PO",
            "indication": "Prevention with comorbid bipolar or epilepsy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg",
                  "orderSentence": "Valproate/Divalproex 250 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 250 mg BID or 500 mg ER daily; titrate to 500-1000 mg/day",
              "orderSentence": "Valproate/Divalproex 250 mg PO"
            },
            "pretreatment": "LFTs; CBC",
            "contraindications": "**Pregnancy (teratogenic - neural tube defects)**; hepatic disease; urea cycle disorders; pancreatitis history",
            "monitoring": "LFTs q6mo; weight; hair loss; tremor; CBC",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Riboflavin (Vitamin B2)",
            "route": "PO",
            "indication": "Supplement for prevention; well-tolerated; may reduce aura",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg",
                  "orderSentence": "Riboflavin (Vitamin B2) 400 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "400 mg daily",
              "orderSentence": "Riboflavin (Vitamin B2) 400 mg PO"
            },
            "pretreatment": "None",
            "contraindications": "None",
            "monitoring": "Fluorescent yellow urine (reassure patient); benign",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Coenzyme Q10",
            "route": "PO",
            "indication": "Supplement; mitochondrial support",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Coenzyme Q10 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "100-300 mg daily",
              "orderSentence": "Coenzyme Q10 100 mg PO"
            },
            "pretreatment": "None",
            "contraindications": "None",
            "monitoring": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Erenumab (Aimovig)",
            "route": "SC",
            "indication": "CGRP mAb; failed 2+ oral preventives or intolerance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "70 mg",
                  "orderSentence": "Erenumab (Aimovig) 70 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "70 mg SC monthly; may increase to 140 mg monthly after 3 months if suboptimal response",
              "orderSentence": "Erenumab (Aimovig) 70 mg SC"
            },
            "pretreatment": "None",
            "contraindications": "Hypersensitivity to erenumab",
            "monitoring": "Constipation (can be severe - may need laxatives); injection site reactions; HTN monitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fremanezumab (Ajovy)",
            "route": "SC",
            "indication": "CGRP mAb; flexible dosing options",
            "dosing": {
              "doseOptions": [
                {
                  "text": "225 mg",
                  "orderSentence": "Fremanezumab (Ajovy) 225 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "225 mg SC monthly OR 675 mg SC quarterly (three 225 mg injections)",
              "orderSentence": "Fremanezumab (Ajovy) 225 mg SC"
            },
            "pretreatment": "None",
            "contraindications": "Hypersensitivity",
            "monitoring": "Injection site reactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Galcanezumab (Emgality)",
            "route": "SC",
            "indication": "CGRP mAb; requires loading dose",
            "dosing": {
              "doseOptions": [
                {
                  "text": "240 mg",
                  "orderSentence": "Galcanezumab (Emgality) 240 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "240 mg SC loading dose (2 x 120 mg injections), then 120 mg SC monthly",
              "orderSentence": "Galcanezumab (Emgality) 240 mg SC"
            },
            "pretreatment": "None",
            "contraindications": "Hypersensitivity",
            "monitoring": "Injection site reactions; vertigo",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Onabotulinumtoxin A (Botox)",
            "route": "IM",
            "indication": "Chronic migraine with aura (≥15 days/month); failed oral preventives",
            "dosing": {
              "doseOptions": [
                {
                  "text": "155 units",
                  "orderSentence": "Onabotulinumtoxin A (Botox) 155 units IM"
                }
              ],
              "route": "IM",
              "instructions": "155-195 units across 31-39 injection sites per PREEMPT protocol; repeat q12 weeks; effect may take 2-3 cycles",
              "orderSentence": "Onabotulinumtoxin A (Botox) 155 units IM"
            },
            "pretreatment": "None",
            "contraindications": "Infection at injection sites; myasthenia gravis; neuromuscular disorder",
            "monitoring": "Neck weakness; ptosis; antibody formation if loss of effect",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Flunarizine",
            "route": "PO",
            "indication": "Calcium channel blocker for prevention; especially hemiplegic migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Flunarizine 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg qHS; may increase to 10 mg qHS; especially useful for hemiplegic migraine (not available in US)",
              "orderSentence": "Flunarizine 5 mg PO"
            },
            "pretreatment": "None",
            "contraindications": "Depression; Parkinson's disease; extrapyramidal disorders",
            "monitoring": "Weight gain; depression; parkinsonism with prolonged use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lamotrigine",
            "route": "PO",
            "indication": "May reduce aura frequency specifically; hemiplegic migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Lamotrigine 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; increase by 25 mg q2wk to 50-100 mg BID; SLOW titration to prevent rash",
              "orderSentence": "Lamotrigine 25 mg PO"
            },
            "pretreatment": "None",
            "contraindications": "History of lamotrigine-related rash; interacting drugs (valproate halves dose)",
            "monitoring": "**RASH (stop immediately if rash develops - SJS risk)**; monitor closely during titration",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Acetazolamide",
            "route": "PO",
            "indication": "Hemiplegic migraine prevention; familial hemiplegic migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg",
                  "orderSentence": "Acetazolamide 250 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 250 mg BID; may increase to 500 mg BID",
              "orderSentence": "Acetazolamide 250 mg PO"
            },
            "pretreatment": "None",
            "contraindications": "Sulfa allergy; severe hepatic/renal disease; hypokalemia; acidosis",
            "monitoring": "Paresthesias; metabolic acidosis; K+; bicarbonate",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology/Headache specialist referral for aura characterization, preventive optimization, and differentiation from other neurological conditions",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "OB/GYN consultation for contraceptive counseling - **estrogen-containing contraceptives contraindicated** in migraine with aura due to elevated ischemic stroke risk",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cardiology referral if TTE shows PFO for discussion of closure in select cases (recurrent cryptogenic stroke or debilitating aura despite medical therapy)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetics consultation if hemiplegic migraine suspected for CACNA1A, ATP1A2, SCN1A testing and family counseling",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for cervicogenic component and trigger point management",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychology/Behavioral medicine for CBT addressing aura anxiety, attack anticipation, and comorbid mood disorders",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ophthalmology if visual aura atypical or concern for retinal pathology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sleep medicine if sleep disorder contributing to migraine frequency (OSA, insomnia)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately for new/different headache, \"worst headache of life,\" or thunderclap onset which may indicate subarachnoid hemorrhage",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return immediately if aura persists >60 minutes or if new weakness on one side of body develops (need to rule out stroke)",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return immediately for headache with fever, stiff neck, or altered mental status which may indicate CNS infection",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "**AVOID estrogen-containing contraceptives** (combined birth control pills, patch, ring) - use progestin-only methods (mini-pill, Depo-Provera, Mirena IUD, Nexplanon) or non-hormonal methods",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Triptans ARE safe for your typical visual/sensory aura - take at headache onset or when aura ends; do NOT take if you experience weakness (motor aura)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain headache/aura diary tracking aura type, duration, triggers, and medication use to guide treatment optimization",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit acute medication use to ≤10 days/month to prevent medication overuse headache which worsens both headache and aura",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Learn your personal aura warning signs and take acute medication promptly when headache begins",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive or operate machinery during visual or motor aura as vision and coordination may be impaired",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Regular sleep schedule (7-8 hours, consistent bedtime) as sleep changes are a major aura trigger",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid known aura triggers (bright/flashing lights, high altitude, significant sleep deprivation, extreme stress)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular aerobic exercise (30 min moderate activity 5x/week) reduces migraine frequency; avoid if currently in aura",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Magnesium-rich diet (leafy greens, nuts, whole grains) or supplementation as magnesium specifically helps aura",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management techniques (mindfulness, biofeedback, relaxation training) as stress is a major trigger",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate hydration (at least 64 oz water daily) as dehydration can trigger attacks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation to reduce vascular risk, particularly important given aura-associated stroke risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Caffeine moderation (≤200 mg/day) and consistent daily intake to avoid withdrawal triggers",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Blood pressure control (target <130/80) given elevated vascular risk with aura",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid high altitude or rapid altitude changes if altitude is a known aura trigger",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Transient ischemic attack (TIA)",
        "features": "Sudden onset (maximal at onset vs gradual aura spread); negative symptoms (vision loss vs positive scintillations); vascular risk factors; older age; duration usually <1 hr",
        "tests": "MRI DWI (no restriction in aura); MRA/CTA (no vessel occlusion); aura has visual \"march\""
      },
      {
        "diagnosis": "Ischemic stroke",
        "features": "Fixed deficit; sudden onset; vascular territory distribution; risk factors",
        "tests": "MRI DWI (shows restriction); CT may be normal early"
      },
      {
        "diagnosis": "Migraine with brainstem aura",
        "features": "Aura includes brainstem symptoms (vertigo, tinnitus, decreased hearing, diplopia, ataxia, dysarthria, decreased LOC)",
        "tests": "Clinical criteria; MRI to exclude posterior fossa lesion"
      },
      {
        "diagnosis": "Retinal migraine",
        "features": "Monocular visual symptoms (vs binocular in typical aura); complete vision loss in one eye",
        "tests": "Ophthalmology exam; cover/uncover test during symptoms"
      },
      {
        "diagnosis": "Focal seizure with visual phenomena",
        "features": "Shorter duration (seconds to minutes); positive phenomena; may have automatisms; post-ictal confusion",
        "tests": "EEG may show epileptiform activity; MRI for structural lesion"
      },
      {
        "diagnosis": "Transient global amnesia",
        "features": "Anterograde amnesia; repetitive questioning; no visual or motor symptoms; resolves <24 hr",
        "tests": "Clinical diagnosis; MRI may show hippocampal DWI changes"
      },
      {
        "diagnosis": "Giant cell arteritis",
        "features": "Age >50; scalp tenderness; jaw claudication; visual loss (not scintillations); elevated ESR/CRP",
        "tests": "ESR, CRP (elevated); temporal artery biopsy"
      },
      {
        "diagnosis": "Carotid/vertebral dissection",
        "features": "Neck pain; Horner syndrome; pulsatile tinnitus; stroke symptoms",
        "tests": "MRA/CTA neck showing dissection"
      },
      {
        "diagnosis": "CADASIL",
        "features": "Migraine with aura often first symptom; subcortical strokes; family history; cognitive decline",
        "tests": "MRI shows characteristic WMH (anterior temporal, external capsule); NOTCH3 mutation"
      },
      {
        "diagnosis": "Mitochondrial encephalopathy (MELAS)",
        "features": "Stroke-like episodes not following vascular territory; seizures; elevated lactate; short stature",
        "tests": "MRI (non-vascular stroke pattern); genetic testing; muscle biopsy"
      }
    ],
    "evidence": [
      {
        "recommendation": "Migraine with aura increases ischemic stroke risk, especially in women using combined oral contraceptives",
        "evidenceLevel": "Class II, Level B",
        "source": "[Etminan et al. BMJ 2005](https://pubmed.ncbi.nlm.nih.gov/15647264/)"
      },
      {
        "recommendation": "ACOG: Combined hormonal contraceptives contraindicated in migraine with aura",
        "evidenceLevel": "Class I (Guideline)",
        "source": "[ACOG Practice Bulletin 2019](https://pubmed.ncbi.nlm.nih.gov/31568397/)"
      },
      {
        "recommendation": "Triptans safe and effective in migraine with typical aura",
        "evidenceLevel": "Class I, Level A",
        "source": "[Marmura et al. Headache 2015](https://pubmed.ncbi.nlm.nih.gov/25600718/)"
      },
      {
        "recommendation": "Triptans contraindicated in hemiplegic migraine (expert consensus)",
        "evidenceLevel": "Class III, Level C",
        "source": "Expert consensus; [IHS Classification ICHD-3 2018](https://pubmed.ncbi.nlm.nih.gov/29368949/)"
      },
      {
        "recommendation": "Magnesium particularly effective for migraine with aura prevention",
        "evidenceLevel": "Class II, Level B",
        "source": "[Peikert et al. Cephalalgia 1996](https://pubmed.ncbi.nlm.nih.gov/8792038/)"
      },
      {
        "recommendation": "Lamotrigine may reduce aura frequency specifically",
        "evidenceLevel": "Class II, Level C",
        "source": "[Lampl et al. Neurology 2005](https://pubmed.ncbi.nlm.nih.gov/16087905/)"
      },
      {
        "recommendation": "Topiramate effective for migraine prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "[Silberstein et al. Arch Neurol 2004](https://pubmed.ncbi.nlm.nih.gov/15096395/)"
      },
      {
        "recommendation": "Propranolol effective for migraine prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "[Linde et al. Cochrane 2004](https://pubmed.ncbi.nlm.nih.gov/15106218/)"
      },
      {
        "recommendation": "CGRP monoclonal antibodies effective for prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "[Goadsby et al. NEJM 2017 (erenumab STRIVE)](https://pubmed.ncbi.nlm.nih.gov/29171821/)"
      },
      {
        "recommendation": "Gepants safe in patients with cardiovascular contraindications to triptans",
        "evidenceLevel": "Class I, Level B",
        "source": "[Dodick et al. JAMA 2019 (ubrogepant ACHIEVE I)](https://pubmed.ncbi.nlm.nih.gov/31742631/)"
      },
      {
        "recommendation": "Lasmiditan (ditan) does not have cardiovascular contraindications",
        "evidenceLevel": "Class I, Level A",
        "source": "[Kuca et al. Headache 2018](https://pubmed.ncbi.nlm.nih.gov/30091160/)"
      },
      {
        "recommendation": "IV magnesium effective for acute migraine with aura",
        "evidenceLevel": "Class II, Level B",
        "source": "[Bigal et al. Headache 2002](https://pubmed.ncbi.nlm.nih.gov/11903546/)"
      },
      {
        "recommendation": "Aura duration >60 minutes warrants stroke evaluation",
        "evidenceLevel": "Class III, Level C",
        "source": "Expert consensus; [Lipton et al. Headache 2004](https://pubmed.ncbi.nlm.nih.gov/15147249/)"
      },
      {
        "recommendation": "PFO closure may benefit select patients with migraine with aura",
        "evidenceLevel": "Class II, Level B",
        "source": "[Tobis et al. JACC 2017 (RESPECT trial long-term)](https://pubmed.ncbi.nlm.nih.gov/28359515/)"
      },
      {
        "recommendation": "Acetazolamide effective for familial hemiplegic migraine",
        "evidenceLevel": "Class III, Level C",
        "source": "[Battistini et al. Neurology 1999](https://pubmed.ncbi.nlm.nih.gov/10489058/)"
      },
      {
        "recommendation": "Verapamil may be used acutely in hemiplegic migraine",
        "evidenceLevel": "Class III, Level C",
        "source": "Expert consensus; [Mathew et al. Headache 2005](https://pubmed.ncbi.nlm.nih.gov/15836583/)"
      },
      {
        "recommendation": "OnabotulinumtoxinA effective for chronic migraine",
        "evidenceLevel": "Class I, Level A",
        "source": "[Dodick et al. Headache 2010 (PREEMPT pooled)](https://pubmed.ncbi.nlm.nih.gov/20487038/)"
      },
      {
        "recommendation": "Exercise as effective as topiramate for migraine prevention",
        "evidenceLevel": "Class II, Level B",
        "source": "[Varkey et al. Cephalalgia 2011](https://pubmed.ncbi.nlm.nih.gov/21816772/)"
      }
    ],
    "monitoring": [
      {
        "item": "Aura characteristics (type, duration, frequency)",
        "frequency": "Each visit; diary",
        "action": "Prolonged aura needs stroke rule-out; increasing frequency reassess prevention",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Headache days/month",
        "frequency": "Monthly",
        "action": "Escalate therapy if not meeting target; consider CGRP mAb or Botox",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Acute medication use days",
        "frequency": "Monthly",
        "action": "MOH education; consider preventive escalation; may need withdrawal",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Blood pressure",
        "frequency": "Each visit",
        "action": "Optimize BP control given elevated vascular risk with aura",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "HIT-6 or MIDAS disability score",
        "frequency": "Every 3 months",
        "action": "Escalate preventive therapy if severely disabled",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Topiramate: serum bicarbonate",
        "frequency": "Baseline, 3 months",
        "action": "Consider dose reduction or switch if metabolic acidosis",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Valproate: LFTs",
        "frequency": "Baseline, 3 months, then q6mo",
        "action": "Discontinue if significant elevation",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "CGRP mAb: constipation assessment",
        "frequency": "Each visit",
        "action": "Add fiber/laxatives; reduce dose or discontinue if severe",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Lamotrigine: rash monitoring",
        "frequency": "Weekly during titration",
        "action": "**STOP IMMEDIATELY if rash develops** - SJS risk",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Contraceptive status",
        "frequency": "Each visit (women of reproductive age)",
        "action": "Remove estrogen-containing contraceptives; counsel on alternatives",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Typical aura pattern confirmed; no stroke symptoms; pain controlled; able to tolerate PO; follow-up arranged; contraceptive counseling if needed"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Prolonged aura (>60 min) requiring observation; status migrainosus requiring IV therapy; first aura with abnormal imaging requiring further workup; hemiplegic migraine with prolonged weakness"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Migrainous infarction (stroke occurring during typical aura); hemodynamic instability; severe refractory status migrainosus requiring ketamine infusion"
      },
      {
        "disposition": "Transfer to higher level",
        "criteria": "Stroke mimicking aura requiring thrombectomy evaluation; complex hemiplegic migraine requiring tertiary headache center"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "New diagnosis: 2-4 weeks; Stable on prevention: 3-6 months; After preventive change: 4-8 weeks"
      }
    ]
  },
  "Trigeminal Neuralgia": {
    "id": "trigeminal-neuralgia",
    "title": "Trigeminal Neuralgia",
    "version": "1.0",
    "icd10": [
      "** G50.0 (Trigeminal neuralgia)",
      "G50.1 (Atypical facial pain)",
      "G44.847 (Trigeminal autonomic cephalalgia)"
    ],
    "scope": "** Evaluation and management of trigeminal neuralgia in adults including classical TN (with or without neurovascular compression), secondary TN, and painful trigeminal neuropathy. Covers medical management, procedural interventions, and surgical options. Applies to ED, hospital, and outpatient settings.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Baseline for carbamazepine (bone marrow suppression)",
            "target": "Normal"
          },
          {
            "item": "CMP (sodium, LFTs)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Carbamazepine: hyponatremia, hepatotoxicity",
            "target": "Normal"
          },
          {
            "item": "HLA-B*1502 (Asian ancestry)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "SJS/TEN risk with carbamazepine in Asian populations",
            "target": "Negative"
          }
        ],
        "Extended Workup": [
          {
            "item": "ESR, CRP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If vasculitis or GCA suspected (elderly, V1)",
            "target": "Normal"
          },
          {
            "item": "ANA, SSA/SSB",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Sjögren syndrome can cause trigeminal neuropathy",
            "target": "Negative"
          },
          {
            "item": "CSF analysis",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If MS or CNS infection suspected",
            "target": "Normal; or MS-consistent findings"
          },
          {
            "item": "ACE level",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Neurosarcoidosis",
            "target": "Normal"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI brain with dedicated trigeminal protocol",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "All patients; before treatment",
            "target": "Identify neurovascular compression, tumor, MS plaques",
            "contraindications": "Pacemaker, metal"
          },
          {
            "item": "MRA (if MRI equivocal)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Evaluate vascular loop",
            "target": "Define vessel relationship",
            "contraindications": "Same"
          },
          {
            "item": "CT head (if MRI unavailable)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "timing": "Emergent exclusion of mass",
            "target": "No mass",
            "contraindications": "None (contrast: renal)"
          }
        ],
        "Extended": [
          {
            "item": "3D-CISS/FIESTA sequence",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Pre-surgical planning",
            "target": "Define nerve-vessel relationship",
            "contraindications": "MRI contraindications"
          },
          {
            "item": "High-resolution MRI trigeminal nerve",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If painful neuropathy; atypical features",
            "target": "Nerve atrophy, enhancement, mass",
            "contraindications": "Same"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Trigeminal reflex testing (blink reflex)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If sensory loss; differentiate from neuropathy",
            "target": "Normal in classical TN; abnormal in secondary",
            "contraindications": "None"
          },
          {
            "item": "Dental/maxillofacial evaluation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Exclude dental pathology as pain source",
            "target": "No dental cause",
            "contraindications": "None"
          }
        ]
      },
      "Treatment": {
        "First-Line Pharmacotherapy": [
          {
            "item": "Carbamazepine (Tegretol)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100-200 mg",
                  "orderSentence": "Carbamazepine (Tegretol) 100-200 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "100-200 mg BID; increase by 100-200 mg q3-7 days; target 400-1200 mg/day divided BID-TID",
              "orderSentence": "Carbamazepine (Tegretol) 100-200 mg PO"
            },
            "contraindications": "AV block, bone marrow suppression, MAOIs, Asian ancestry (check HLA-B*1502)",
            "monitoring": "CBC, LFTs, Na q2-4 weeks initially, then q3-6 months; drug levels optional",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxcarbazepine (Trileptal)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150-300 mg",
                  "orderSentence": "Oxcarbazepine (Trileptal) 150-300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "150-300 mg BID; increase by 300 mg/week; target 600-1800 mg/day",
              "orderSentence": "Oxcarbazepine (Trileptal) 150-300 mg PO"
            },
            "contraindications": "Severe hyponatremia; less drug interactions than CBZ",
            "monitoring": "Na (hyponatremia more common); CBC, LFTs less critical",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-Line Pharmacotherapy": [
          {
            "item": "Baclofen",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Baclofen 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "5 mg TID; increase by 5 mg q3 days; target 30-80 mg/day divided TID",
              "orderSentence": "Baclofen 5 mg PO"
            },
            "contraindications": "Renal impairment (dose reduce)",
            "monitoring": "Sedation, weakness; taper slowly to avoid withdrawal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lamotrigine",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Lamotrigine 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "25 mg daily × 2 weeks, then 50 mg daily × 2 weeks, then increase by 50 mg q2 weeks; target 200-400 mg/day",
              "orderSentence": "Lamotrigine 25 mg PO"
            },
            "contraindications": "History of rash with AEDs",
            "monitoring": "Rash (SJS risk with rapid titration); slow titration mandatory",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gabapentin",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Gabapentin 300 mg -"
                }
              ],
              "route": "-",
              "instructions": "300 mg TID; titrate to 1800-3600 mg/day; less effective than CBZ/OXC",
              "orderSentence": "Gabapentin 300 mg -"
            },
            "contraindications": "CrCl <60: reduce dose",
            "monitoring": "Sedation; renal dosing",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg",
                  "orderSentence": "Pregabalin 75 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "75 mg BID; titrate to 150-300 mg BID",
              "orderSentence": "Pregabalin 75 mg PO"
            },
            "contraindications": "CrCl <60: reduce dose",
            "monitoring": "Sedation, weight gain; renal dosing",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Combination Therapy": [
          {
            "item": "Carbamazepine + Baclofen",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "If monotherapy inadequate; use lower doses",
              "orderSentence": "Carbamazepine + Baclofen - - - see dosing"
            },
            "contraindications": "Per individual agents",
            "monitoring": "Per individual agents",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbamazepine + Lamotrigine",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Additive efficacy; CBZ induces lamotrigine metabolism (need higher LTG dose)",
              "orderSentence": "Carbamazepine + Lamotrigine - - - see dosing"
            },
            "contraindications": "Per individual agents",
            "monitoring": "Drug interactions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxcarbazepine + Gabapentin",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "If CBZ not tolerated",
              "orderSentence": "Oxcarbazepine + Gabapentin - - - see dosing"
            },
            "contraindications": "Per individual agents",
            "monitoring": "Hyponatremia, sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Acute Exacerbation Management": [
          {
            "item": "Fosphenytoin (severe exacerbation)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15-20 mg",
                  "orderSentence": "Fosphenytoin (severe exacerbation) 15-20 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "15-20 mg PE/kg IV at 100-150 mg/min; then phenytoin 100 mg TID",
              "orderSentence": "Fosphenytoin (severe exacerbation) 15-20 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Sinus bradycardia, heart block, Adams-Stokes syndrome",
            "monitoring": "ECG, BP during infusion; phenytoin levels",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "IV lidocaine",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-3 mg/kg",
                  "orderSentence": "IV lidocaine 1-3 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "1-3 mg/kg IV over 20-30 min (monitored setting); for severe refractory pain",
              "orderSentence": "IV lidocaine 1-3 mg/kg IV"
            },
            "pretreatment": "-",
            "contraindications": "Cardiac conduction abnormalities",
            "monitoring": "Continuous cardiac monitoring",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Peripheral nerve block (V2/V3)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Lidocaine/bupivacaine at foramen rotundum/ovale",
              "orderSentence": "Peripheral nerve block (V2/V3) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "Infection, coagulopathy",
            "monitoring": "Short-term relief",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Interventional Procedures (Refractory to Medical Therapy)": [
          {
            "item": "Percutaneous balloon compression",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Outpatient/short-stay; compresses gasserian ganglion",
              "orderSentence": "Percutaneous balloon compression - - - see dosing"
            },
            "contraindications": "Coagulopathy",
            "monitoring": "Facial numbness; recurrence 20-30% at 5 years",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Percutaneous glycerol rhizolysis",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Injection into Meckel's cave",
              "orderSentence": "Percutaneous glycerol rhizolysis - - - see dosing"
            },
            "contraindications": "Same",
            "monitoring": "Same; less sensory loss",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Percutaneous radiofrequency thermocoagulation",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Thermal lesion of trigeminal ganglion",
              "orderSentence": "Percutaneous radiofrequency thermocoagulation - - - see dosing"
            },
            "contraindications": "Same",
            "monitoring": "Corneal anesthesia risk (V1); recurrence",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Stereotactic radiosurgery (Gamma Knife)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Single high-dose radiation to trigeminal root; effect delayed 1-3 months",
              "orderSentence": "Stereotactic radiosurgery (Gamma Knife) - - - see dosing"
            },
            "contraindications": "None absolute; prior radiation relative",
            "monitoring": "Delayed response; facial numbness (10-30%)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Microvascular decompression (MVD)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Definitive surgery; move offending vessel; craniotomy",
              "orderSentence": "Microvascular decompression (MVD) - - - see dosing"
            },
            "contraindications": "High surgical risk; no vascular compression",
            "monitoring": "Hearing loss (1-2%), facial numbness (3%), stroke (<1%), recurrence 15-20% at 10 years",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Diagnosis confirmation; medication management; atypical cases"
          },
          {
            "item": "Neurosurgery",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Refractory to medical therapy; MVD evaluation"
          },
          {
            "item": "Pain management",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Interventional procedures; multimodal pain"
          },
          {
            "item": "Dentistry/oral surgery",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Exclude dental pathology"
          },
          {
            "item": "Ophthalmology",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "V1 involvement; corneal protection if sensory loss"
          },
          {
            "item": "Neuro-oncology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "If tumor-related TN"
          },
          {
            "item": "MS specialist",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "If MS-related TN"
          }
        ],
        "Patient Instructions": [
          {
            "item": "TN is a chronic condition; medications can control but rarely cure",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Identify and avoid triggers (cold wind, chewing, talking, touching face)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take medications consistently; do not stop suddenly (taper)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report rash immediately (especially with carbamazepine, lamotrigine) - may indicate SJS",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report excessive drowsiness, confusion, difficulty walking",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Soft diet if chewing triggers attacks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Surgical options exist for medication-refractory cases",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Trigeminal Neuralgia Association (tna-support.org) resources",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Discuss risks/benefits of all surgical options",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "MVD: Craniotomy risks (hearing loss, stroke, infection, CSF leak, facial numbness)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Percutaneous procedures: Facial numbness expected (30-50%); anesthesia dolorosa rare",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Radiosurgery: Delayed onset (weeks-months); facial numbness (10-30%)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "V1 involvement: Discuss corneal protection if sensory loss anticipated",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Dental pain",
        "features": "Related to specific tooth; continuous; percussion tenderness",
        "tests": "Dental exam, X-ray"
      },
      {
        "diagnosis": "TMJ disorder",
        "features": "Jaw pain; clicking; related to chewing; bilateral possible",
        "tests": "Clinical exam; MRI TMJ"
      },
      {
        "diagnosis": "Cluster headache",
        "features": "Periorbital; autonomic features (tearing, rhinorrhea, ptosis); longer attacks",
        "tests": "History; ICHD-3 criteria"
      },
      {
        "diagnosis": "SUNCT/SUNA",
        "features": "Very brief attacks; prominent autonomic features",
        "tests": "History; ICHD-3 criteria"
      },
      {
        "diagnosis": "Post-herpetic neuralgia",
        "features": "History of zoster; dermatomal; continuous",
        "tests": "History; rash history"
      },
      {
        "diagnosis": "Glossopharyngeal neuralgia",
        "features": "Throat/ear pain; triggered by swallowing",
        "tests": "History; carbamazepine response"
      },
      {
        "diagnosis": "Migraine",
        "features": "Longer attacks; photophobia, phonophobia; nausea",
        "tests": "History"
      },
      {
        "diagnosis": "Atypical facial pain",
        "features": "Continuous; crosses trigeminal boundaries; psychiatric comorbidity",
        "tests": "Diagnosis of exclusion"
      },
      {
        "diagnosis": "Giant cell arteritis",
        "features": "Age >50; V1 distribution; jaw claudication; elevated ESR",
        "tests": "ESR, CRP; temporal artery biopsy"
      },
      {
        "diagnosis": "Nasopharyngeal carcinoma",
        "features": "Numbness (painful neuropathy); cranial nerve palsies",
        "tests": "MRI; biopsy"
      },
      {
        "diagnosis": "Acoustic neuroma",
        "features": "V5 distribution numbness; hearing loss",
        "tests": "MRI with IAC protocol"
      }
    ],
    "evidence": [
      {
        "recommendation": "Carbamazepine first-line for TN",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs; [AAN/EFNS Guidelines 2008](https://pubmed.ncbi.nlm.nih.gov/18716236/), reaffirmed"
      },
      {
        "recommendation": "Oxcarbazepine as effective alternative",
        "evidenceLevel": "Class I, Level B",
        "source": "Multiple RCTs"
      },
      {
        "recommendation": "MVD most effective long-term for classical TN with compression",
        "evidenceLevel": "Class II, Level B",
        "source": "Multiple case series; long-term outcome data"
      },
      {
        "recommendation": "Percutaneous procedures effective for refractory TN",
        "evidenceLevel": "Class II, Level B",
        "source": "Multiple case series"
      },
      {
        "recommendation": "Stereotactic radiosurgery effective",
        "evidenceLevel": "Class II, Level B",
        "source": "Multiple case series"
      },
      {
        "recommendation": "HLA-B*1502 testing before carbamazepine in Asians",
        "evidenceLevel": "Class I",
        "source": "FDA recommendation"
      },
      {
        "recommendation": "Lamotrigine effective as add-on therapy",
        "evidenceLevel": "Class II, Level B",
        "source": "RCTs"
      },
      {
        "recommendation": "Baclofen effective as add-on",
        "evidenceLevel": "Class III, Level C",
        "source": "Small studies"
      }
    ],
    "monitoring": [
      {
        "item": "Pain frequency/severity (diary)",
        "ED": "-",
        "HOSP": "Daily",
        "OPD": "Every visit",
        "ICU": "-",
        "frequency": "Ongoing",
        "action": "Adjust medications; consider procedures"
      },
      {
        "item": "CBC (carbamazepine)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "q2-4 weeks × 3 months, then q3-6 months",
        "ICU": "-",
        "frequency": "Per schedule",
        "action": "Hold CBZ if low"
      },
      {
        "item": "LFTs (carbamazepine)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "q2-4 weeks × 3 months, then q3-6 months",
        "ICU": "-",
        "frequency": "Per schedule",
        "action": "Hold if significantly elevated"
      },
      {
        "item": "Sodium (oxcarbazepine)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "q2-4 weeks initially, then q3 months",
        "ICU": "-",
        "frequency": "Per schedule",
        "action": "Reduce dose; fluid restrict"
      },
      {
        "item": "Carbamazepine level",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "If breakthrough pain, toxicity, or compliance concern",
        "action": "Adjust dose"
      },
      {
        "item": "Rash surveillance",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "Every visit",
        "ICU": "STAT",
        "frequency": "Ongoing",
        "action": "STOP carbamazepine/lamotrigine immediately; evaluate for SJS"
      },
      {
        "item": "Neurologic exam (post-procedure)",
        "ED": "-",
        "HOSP": "Daily",
        "OPD": "Every visit",
        "ICU": "-",
        "frequency": "Post-procedure",
        "action": "Evaluate for complications"
      }
    ],
    "disposition": [
      {
        "disposition": "Outpatient management",
        "criteria": "Diagnosis confirmed; pain controlled with oral medications"
      },
      {
        "disposition": "Admit to hospital",
        "criteria": "Severe uncontrolled pain requiring IV therapy; severe medication side effects; post-surgical monitoring"
      },
      {
        "disposition": "Neurology follow-up",
        "criteria": "q1-2 weeks during medication titration; q3-6 months when stable"
      },
      {
        "disposition": "Neurosurgery follow-up",
        "criteria": "If refractory to medical therapy; post-procedural"
      },
      {
        "disposition": "Urgent follow-up",
        "criteria": "Status trigeminus (continuous attacks); medication failure; new sensory loss"
      }
    ]
  },
  "Bell's Palsy": {
    "id": "bells-palsy",
    "title": "Bell's Palsy",
    "version": "1.0",
    "icd10": [
      "** G51.0 (Bell's palsy)",
      "G51.8 (Other disorders of facial nerve)",
      "G51.9 (Disorder of facial nerve",
      "unspecified)",
      "B02.21 (Postherpetic geniculate ganglionitis - Ramsay Hunt)"
    ],
    "scope": "** Diagnosis and management of Bell's palsy (idiopathic facial nerve palsy) in adults. Covers workup to exclude secondary causes, medical treatment, and eye protection. Includes Ramsay Hunt syndrome (herpes zoster oticus) which requires different treatment. Excludes central facial palsy (stroke), facial nerve tumors, traumatic facial nerve injury, and bilateral facial palsy workup.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Infection, leukemia (CN involvement)",
            "target": "Normal"
          },
          {
            "item": "CMP",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes (risk factor), electrolytes",
            "target": "Normal; glucose <126 fasting"
          },
          {
            "item": "Glucose / HbA1c",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes is major risk factor; affects prognosis",
            "target": "Normal"
          }
        ],
        "Extended Workup": [
          {
            "item": "Lyme serology (IgM/IgG)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Endemic areas; Lyme disease can cause facial palsy",
            "target": "Negative"
          },
          {
            "item": "ESR/CRP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Inflammatory conditions, vasculitis",
            "target": "Normal"
          },
          {
            "item": "HIV",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HIV-associated facial palsy",
            "target": "Negative"
          },
          {
            "item": "RPR/VDRL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Syphilis in differential",
            "target": "Negative"
          },
          {
            "item": "ANA",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Autoimmune etiology (SLE, Sjogren's)",
            "target": "Negative"
          },
          {
            "item": "SSA (Ro) / SSB (La)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Sjogren's syndrome",
            "target": "Negative"
          },
          {
            "item": "VZV serology (IgM)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Ramsay Hunt syndrome (if vesicles or suspicion)",
            "target": "Document status"
          },
          {
            "item": "ACE level",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Sarcoidosis if bilateral or recurrent",
            "target": "Normal"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CSF analysis (LP)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Atypical presentation, suspected Lyme neuroborreliosis, GBS, meningitis",
            "target": "See LP section"
          },
          {
            "item": "Serum glucose tolerance test",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If HbA1c borderline; diabetes evaluation",
            "target": "Normal"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Baseline; elevated in some conditions",
            "target": "10-20 cm H2O"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Infection, inflammation",
            "target": "WBC <5"
          },
          {
            "item": "Protein",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Elevated in GBS, Lyme",
            "target": "15-45 mg/dL"
          },
          {
            "item": "Glucose",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Infection",
            "target": ">60% serum"
          },
          {
            "item": "Lyme antibody (CSF)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Lyme neuroborreliosis",
            "target": "Negative"
          },
          {
            "item": "VDRL (CSF)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Neurosyphilis",
            "target": "Negative"
          },
          {
            "item": "Gram stain and culture",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Bacterial meningitis",
            "target": "No organisms"
          },
          {
            "item": "CSF meningitis panel",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Viral/bacterial pathogens",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Physical examination",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At presentation",
            "target": "Peripheral pattern (forehead involved); no other CN deficits",
            "contraindications": "None"
          },
          {
            "item": "Otoscopic examination",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At presentation",
            "target": "Vesicles (Ramsay Hunt); middle ear pathology",
            "contraindications": "None"
          },
          {
            "item": "Eye examination",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At presentation",
            "target": "Corneal exposure, lagophthalmos",
            "contraindications": "None"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain with IAC protocol",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If atypical, progressive, no recovery at 4-6 weeks",
            "target": "Facial nerve enhancement (may be normal in Bell's); exclude mass, stroke",
            "contraindications": "Pacemaker, metal"
          },
          {
            "item": "MRI with contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If tumor suspected",
            "target": "Rule out schwannoma, parotid tumor",
            "contraindications": "Contrast allergy"
          },
          {
            "item": "CT temporal bone",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If trauma or mastoid pathology suspected",
            "target": "Fracture, cholesteatoma",
            "contraindications": "None"
          },
          {
            "item": "Chest X-ray",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If sarcoidosis suspected",
            "target": "Hilar adenopathy",
            "contraindications": "None"
          },
          {
            "item": "Electrodiagnostic studies (ENoG, EMG)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Severe palsy (HB IV-VI) at 2-3 weeks; prognosis",
            "target": ">90% degeneration = poor prognosis",
            "contraindications": "None"
          }
        ]
      },
      "Treatment": {
        "Corticosteroids (All Patients)": [
          {
            "item": "Prednisone",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60-80 mg",
                  "orderSentence": "Prednisone 60-80 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "60-80 mg PO daily × 7 days (can taper over days 8-10 or stop); START WITHIN 72 HOURS of onset",
              "orderSentence": "Prednisone 60-80 mg PO"
            },
            "contraindications": "Active infection (relative), uncontrolled DM (relative)",
            "monitoring": "Glucose (especially diabetics), GI prophylaxis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Prednisolone",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60-80 mg",
                  "orderSentence": "Prednisolone 60-80 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "60-80 mg PO daily × 7 days (equivalent alternative)",
              "orderSentence": "Prednisolone 60-80 mg PO"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Methylprednisolone IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Methylprednisolone IV 1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg IV daily × 3-5 days (if unable to take PO or severe/Ramsay Hunt)",
              "orderSentence": "Methylprednisolone IV 1000 mg IV"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Dexamethasone",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Dexamethasone 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg IV/PO daily × 7-10 days (alternative)",
              "orderSentence": "Dexamethasone 10 mg IV"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Antiviral Therapy": [
          {
            "item": "Valacyclovir (moderate-severe Bell's)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Valacyclovir (moderate-severe Bell's) 1000 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "1000 mg PO TID × 7 days; ALWAYS with steroids",
              "orderSentence": "Valacyclovir (moderate-severe Bell's) 1000 mg PO"
            },
            "contraindications": "Renal impairment (reduce dose)",
            "monitoring": "Renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Acyclovir (alternative)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg",
                  "orderSentence": "Acyclovir (alternative) 400 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "400 mg PO 5× daily × 7-10 days; or 800 mg PO TID × 7 days",
              "orderSentence": "Acyclovir (alternative) 400 mg PO"
            },
            "contraindications": "Renal impairment",
            "monitoring": "Renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valacyclovir (Ramsay Hunt)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Valacyclovir (Ramsay Hunt) 1000 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "1000 mg PO TID × 7-10 days; MANDATORY with steroids",
              "orderSentence": "Valacyclovir (Ramsay Hunt) 1000 mg PO"
            },
            "contraindications": "Renal impairment",
            "monitoring": "Renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Acyclovir IV (severe Ramsay Hunt)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg",
                  "orderSentence": "Acyclovir IV (severe Ramsay Hunt) 10 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV q8h × 7-10 days",
              "orderSentence": "Acyclovir IV (severe Ramsay Hunt) 10 mg/kg IV"
            },
            "contraindications": "Renal impairment",
            "monitoring": "Renal function, hydration",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Eye Protection (CRITICAL - All Patients)": [
          {
            "item": "Artificial tears (preservative-free)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "1-2 drops affected eye q1-2h while awake",
              "orderSentence": "Artificial tears (preservative-free) - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Corneal status",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lubricating eye ointment (Lacri-Lube)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Thin strip in affected eye at bedtime (and up to TID)",
              "orderSentence": "Lubricating eye ointment (Lacri-Lube) - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Corneal status",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Eye patch or moisture chamber",
            "route": "Transdermal",
            "indication": "-",
            "dosing": {
              "instructions": "At night and in dusty/windy environments",
              "orderSentence": "Eye patch or moisture chamber - Transdermal - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Corneal status",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tape eyelid closed at night",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "If unable to close eye (use paper tape)",
              "orderSentence": "Tape eyelid closed at night - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Corneal status",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Wraparound glasses/sunglasses",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "During day for eye protection",
              "orderSentence": "Wraparound glasses/sunglasses - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Corneal status",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Pain Management": [
          {
            "item": "Acetaminophen",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650-1000 mg",
                  "orderSentence": "Acetaminophen 650-1000 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "650-1000 mg PO q6h PRN; max 3000 mg/day",
              "orderSentence": "Acetaminophen 650-1000 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Hepatic disease",
            "monitoring": "LFTs if prolonged use",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ibuprofen",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400-600 mg",
                  "orderSentence": "Ibuprofen 400-600 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "400-600 mg PO q6h PRN with food",
              "orderSentence": "Ibuprofen 400-600 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Renal disease, GI bleeding",
            "monitoring": "Renal function",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gabapentin (post-herpetic neuralgia)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100-300 mg",
                  "orderSentence": "Gabapentin (post-herpetic neuralgia) 100-300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "100-300 mg TID; titrate as needed for Ramsay Hunt",
              "orderSentence": "Gabapentin (post-herpetic neuralgia) 100-300 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Renal impairment",
            "monitoring": "Sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Lyme Disease Treatment (If Positive)": [
          {
            "item": "Doxycycline",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Doxycycline 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "100 mg PO BID × 14-21 days (isolated facial palsy)",
              "orderSentence": "Doxycycline 100 mg PO"
            },
            "contraindications": "Pregnancy, children <8",
            "monitoring": "GI upset",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ceftriaxone IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g",
                  "orderSentence": "Ceftriaxone IV 2 g IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV daily × 14-21 days (if CNS involvement)",
              "orderSentence": "Ceftriaxone IV 2 g IV"
            },
            "contraindications": "Cephalosporin allergy",
            "monitoring": "Standard",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Physical Therapy": [
          {
            "item": "Facial exercises",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Mirror exercises, gentle facial movements",
              "orderSentence": "Facial exercises - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Start when recovery begins",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Facial massage",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Gentle massage to maintain muscle tone",
              "orderSentence": "Facial massage - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Patient/family can perform",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Electrical stimulation",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Controversial; limited evidence",
              "orderSentence": "Electrical stimulation - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Not routinely recommended",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Neuromuscular retraining",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Specialized PT for synkinesis prevention",
              "orderSentence": "Neuromuscular retraining - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "If incomplete recovery",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Surgical Options (Refractory Cases)": [
          {
            "item": "Surgical decompression",
            "route": "-",
            "indication": ">90% degeneration on ENoG within 14 days; controversial",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Surgical decompression - - - see dosing"
            },
            "contraindications": "Poor surgical candidate",
            "monitoring": "Rarely performed; controversial benefit",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Gold weight/platinum chain eyelid implant",
            "route": "-",
            "indication": "Persistent lagophthalmos (>6-12 months)",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Gold weight/platinum chain eyelid implant - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Improves eye closure",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Tarsorrhaphy",
            "route": "-",
            "indication": "Persistent exposure keratopathy",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Tarsorrhaphy - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Temporary or permanent",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Static facial sling",
            "route": "-",
            "indication": "Permanent severe palsy",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Static facial sling - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Improves cosmesis",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Hypoglossal-facial nerve anastomosis",
            "route": "-",
            "indication": "Complete permanent paralysis",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Hypoglossal-facial nerve anastomosis - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Restores tone and some movement",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Cross-face nerve graft",
            "route": "-",
            "indication": "Permanent paralysis, younger patients",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Cross-face nerve graft - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Extended recovery time",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Ophthalmology",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Corneal exposure, inability to close eye, any eye pain/redness"
          },
          {
            "item": "ENT / Otolaryngology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Ramsay Hunt syndrome, atypical features, surgical consideration"
          },
          {
            "item": "Neurology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Atypical features, no recovery at 3-4 weeks, recurrent palsy"
          },
          {
            "item": "Physical therapy (facial)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Begin when recovery starts; synkinesis prevention"
          },
          {
            "item": "Plastic surgery / Facial nerve specialist",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "indication": "Permanent paralysis, reconstructive options"
          },
          {
            "item": "Infectious disease",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Lyme disease, atypical infection"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Eye protection is CRITICAL - use lubricating drops frequently and ointment at night",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Tape eye closed or use patch at night to prevent corneal injury",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Start steroids as soon as possible (ideally within 72 hours of symptom onset)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Most patients (70-80%) recover completely within 3-6 months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Recovery typically begins within 2-3 weeks; full recovery may take months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return immediately if: eye pain, vision changes, redness, or discharge",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Examine ear daily for vesicles (if develops, call immediately - may be Ramsay Hunt)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Follow up with neurologist or ENT if no improvement at 3-4 weeks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do NOT massage face vigorously or use electrical stimulation without guidance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Protect eye from wind, dust, and irritants",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid rubbing the affected eye",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Consider humidifier at night",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Chew carefully; may have food pocketing on affected side",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain diabetes control if diabetic (reduces risk and improves recovery)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Stroke (central facial palsy)",
        "features": "Forehead SPARED (upper motor neuron pattern), other neurologic deficits",
        "tests": "CT/MRI brain; emergent evaluation"
      },
      {
        "diagnosis": "Ramsay Hunt syndrome",
        "features": "Vesicles in ear canal/pinna, severe ear pain, may have hearing loss, vertigo",
        "tests": "Otoscopic exam; VZV serology"
      },
      {
        "diagnosis": "Lyme disease",
        "features": "Endemic area, tick bite history, erythema migrans rash, may be bilateral",
        "tests": "Lyme serology; LP if suspected"
      },
      {
        "diagnosis": "Acoustic neuroma",
        "features": "Gradual onset, hearing loss, tinnitus, other CN involvement",
        "tests": "MRI with IAC protocol"
      },
      {
        "diagnosis": "Parotid tumor",
        "features": "Mass in parotid region, progressive weakness",
        "tests": "CT/MRI parotid; biopsy"
      },
      {
        "diagnosis": "Guillain-Barré syndrome",
        "features": "Bilateral facial weakness, ascending weakness, areflexia",
        "tests": "LP (albuminocytologic dissociation), NCS/EMG"
      },
      {
        "diagnosis": "Sarcoidosis (Heerfordt syndrome)",
        "features": "Bilateral, parotid swelling, uveitis, fever",
        "tests": "Chest X-ray, ACE level, biopsy"
      },
      {
        "diagnosis": "Otitis media/Mastoiditis",
        "features": "Ear pain, fever, ear discharge, hearing loss",
        "tests": "Otoscopic exam, CT temporal bone"
      },
      {
        "diagnosis": "Cholesteatoma",
        "features": "Chronic ear drainage, hearing loss, progressive",
        "tests": "Otoscopic exam, CT temporal bone"
      },
      {
        "diagnosis": "Melkersson-Rosenthal syndrome",
        "features": "Recurrent facial palsy, facial edema, fissured tongue",
        "tests": "Clinical triad"
      },
      {
        "diagnosis": "Diabetes mellitus",
        "features": "May present as Bell's palsy; higher incidence in diabetics",
        "tests": "Glucose, HbA1c"
      },
      {
        "diagnosis": "HIV",
        "features": "Risk factors, other neurologic manifestations",
        "tests": "HIV test"
      },
      {
        "diagnosis": "Multiple sclerosis",
        "features": "Other neurologic symptoms, white matter lesions",
        "tests": "MRI brain"
      }
    ],
    "evidence": [
      {
        "recommendation": "Corticosteroids improve recovery",
        "evidenceLevel": "Class I, Level A",
        "source": "Scottish Bell's Palsy Study ([Sullivan et al. NEJM 2007](https://pubmed.ncbi.nlm.nih.gov/17942873/)); Cochrane Reviews"
      },
      {
        "recommendation": "Start steroids within 72 hours",
        "evidenceLevel": "Class I, Level A",
        "source": "[Sullivan et al. NEJM 2007](https://pubmed.ncbi.nlm.nih.gov/17942873/)"
      },
      {
        "recommendation": "Antivirals alone not effective",
        "evidenceLevel": "Class I, Level A",
        "source": "Cochrane Reviews 2015"
      },
      {
        "recommendation": "Antivirals + steroids for severe Bell's",
        "evidenceLevel": "Class II, Level B",
        "source": "[AAN Guidelines (Gronseth & Paduga, Neurology 2012)](https://pubmed.ncbi.nlm.nih.gov/23136264/)"
      },
      {
        "recommendation": "Antivirals mandatory for Ramsay Hunt",
        "evidenceLevel": "Class I, Level B",
        "source": "Multiple studies; AAN Guidelines"
      },
      {
        "recommendation": "Eye protection essential",
        "evidenceLevel": "Class I, Level C",
        "source": "Expert consensus"
      },
      {
        "recommendation": "ENoG for prognosis in severe cases",
        "evidenceLevel": "Class II, Level B",
        "source": "Multiple studies"
      },
      {
        "recommendation": "Surgical decompression controversial",
        "evidenceLevel": "Class III, Level U",
        "source": "Insufficient evidence"
      },
      {
        "recommendation": "Most patients recover without intervention",
        "evidenceLevel": "Class I, Level A",
        "source": "Natural history studies (70-80% full recovery)"
      }
    ],
    "monitoring": [
      {
        "item": "House-Brackmann grade",
        "ED": "STAT",
        "HOSP": "Daily",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "Track recovery",
        "action": "Consider imaging, EMG"
      },
      {
        "item": "Corneal status",
        "ED": "STAT",
        "HOSP": "Daily",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "At each assessment",
        "action": "Urgent ophthalmology"
      },
      {
        "item": "Eye closure (lagophthalmos)",
        "ED": "STAT",
        "HOSP": "Daily",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "At each assessment",
        "action": "Increase eye protection"
      },
      {
        "item": "Blood glucose",
        "ED": "STAT",
        "HOSP": "Daily",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "While on steroids",
        "action": "Adjust DM medications"
      },
      {
        "item": "Vesicle check (ear)",
        "ED": "STAT",
        "HOSP": "Daily",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "Daily × 7 days",
        "action": "Add/continue antivirals"
      },
      {
        "item": "Recovery timeline",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q2-4 weeks",
        "action": "Imaging, specialist referral"
      },
      {
        "item": "Synkinesis screening",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Starting at recovery",
        "action": "PT for neuromuscular retraining"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge from ED",
        "criteria": "Typical presentation, eye protection education, steroids prescribed, ophthalmology follow-up arranged if needed, close outpatient follow-up"
      },
      {
        "disposition": "Admit to hospital",
        "criteria": "Ramsay Hunt with severe symptoms, unable to protect eye, concern for stroke or other central cause, need for IV medications"
      },
      {
        "disposition": "Ophthalmology within 24-48h",
        "criteria": "Significant lagophthalmos, corneal exposure, any eye symptoms"
      },
      {
        "disposition": "Neurology follow-up",
        "criteria": "No improvement at 3-4 weeks, atypical features, recurrent episodes"
      },
      {
        "disposition": "ENT referral",
        "criteria": "Ramsay Hunt syndrome, surgical consideration, chronic cases"
      }
    ]
  },
  "Vertigo Evaluation": {
    "id": "vertigo-evaluation",
    "title": "Vertigo Evaluation",
    "version": "1.0",
    "icd10": [
      "** R42 (Dizziness and giddiness)"
    ],
    "scope": "** Evaluation of acute and chronic vertigo including differentiation of peripheral vs central causes. Covers BPPV, vestibular neuritis, labyrinthitis, and Meniere's disease workup. Includes red flag identification for posterior circulation stroke. Excludes presyncope, orthostatic hypotension, and cardiac causes of dizziness.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Glucose (fingerstick or serum)",
            "rationale": "Hypoglycemia can cause dizziness/lightheadedness mimicking vertigo",
            "target": "Normal (70-100 mg/dL)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "CBC",
            "rationale": "Rule out anemia (causes lightheadedness), infection (labyrinthitis)",
            "target": "Normal Hgb, WBC",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "BMP",
            "rationale": "Electrolyte disturbance can cause dizziness; assess renal function",
            "target": "Normal Na, K, glucose, creatinine",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid dysfunction can cause vestibular symptoms",
            "target": "Normal (0.4-4.0 mIU/L)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "HbA1c",
            "rationale": "Screen for diabetes if neuropathy suspected contributing to imbalance",
            "target": "<5.7% (normal); <7% (controlled DM)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "Deficiency causes peripheral neuropathy affecting balance",
            "target": ">300 pg/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "RPR/VDRL",
            "rationale": "Neurosyphilis can cause vestibular symptoms",
            "target": "Nonreactive",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ESR, CRP",
            "rationale": "Elevated in vasculitis, autoimmune inner ear disease",
            "target": "Normal ESR (<20 mm/hr), CRP (<3 mg/L)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lipid panel",
            "rationale": "Vascular risk assessment if central cause suspected",
            "target": "LDL <100 mg/dL; HDL >40 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "ANA, anti-dsDNA",
            "rationale": "Autoimmune inner ear disease (AIED) suspected",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-HSP70 antibody",
            "rationale": "Specific marker for autoimmune inner ear disease",
            "target": "Negative",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Lyme serology",
            "rationale": "Endemic area with vestibular and facial nerve involvement",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "FTA-ABS",
            "rationale": "Confirmatory test if RPR positive; otosyphilis",
            "target": "Nonreactive",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Genetic testing (COCH, MYO7A)",
            "rationale": "Familial vestibular disorders, Usher syndrome",
            "target": "No pathogenic variant",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT Head non-contrast",
            "timing": "Acute vertigo with concern for hemorrhage or when MRI unavailable",
            "target": "No hemorrhage, mass, or acute stroke",
            "contraindications": "Pregnancy (relative)",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "MRI Brain with DWI",
            "timing": "Central vertigo suspected; abnormal HINTS exam; risk factors for stroke",
            "target": "No acute infarct; normal brainstem/cerebellum",
            "contraindications": "MRI-incompatible devices, severe claustrophobia",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "MRA Head (Circle of Willis)",
            "timing": "Posterior circulation stroke suspected; vertebral/basilar stenosis",
            "target": "Patent posterior circulation; no stenosis",
            "contraindications": "MRI contraindications",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "MRI Internal Auditory Canals (IAC) with contrast",
            "timing": "Unilateral hearing loss with vertigo; acoustic neuroma suspected",
            "target": "No vestibular schwannoma or CPA lesion",
            "contraindications": "Gadolinium allergy, severe CKD",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CTA Head/Neck",
            "timing": "Vertebral dissection suspected; if MRA unavailable",
            "target": "No dissection; patent vertebral arteries",
            "contraindications": "Contrast allergy, CKD",
            "ED": "STAT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Audiometry",
            "timing": "Sensorineural hearing loss; Meniere's suspected",
            "target": "Symmetric hearing; low-frequency loss in Meniere's",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Videonystagmography (VNG)",
            "timing": "Quantify vestibular function; localize peripheral lesion",
            "target": "Identify unilateral weakness; canal paresis",
            "contraindications": "Acute severe vertigo (defer until improved)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Electrocochleography (ECoG)",
            "timing": "Meniere's disease confirmation",
            "target": "Elevated SP/AP ratio >0.4",
            "contraindications": "Recent ear surgery",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Vestibular evoked myogenic potentials (VEMP)",
            "timing": "Superior canal dehiscence; saccular function",
            "target": "Abnormal thresholds or amplitudes",
            "contraindications": "Hearing aids (remove first)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "High-resolution CT temporal bones",
            "timing": "Superior canal dehiscence; cholesteatoma",
            "target": "Identify bony abnormalities",
            "contraindications": "Pregnancy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Rotary chair testing",
            "timing": "Bilateral vestibular loss; compensation assessment",
            "target": "Assess VOR gain and phase",
            "contraindications": "Severe vertigo (defer)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Video head impulse test (vHIT)",
            "timing": "Quantify VOR for each semicircular canal",
            "target": "Normal gain >0.8; refixation saccades",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Meclizine",
            "route": "PO",
            "indication": "Acute vertigo; vestibular suppressant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg PO",
                  "orderSentence": "Meclizine 25 mg PO PO"
                },
                {
                  "text": "25 mg TID",
                  "orderSentence": "Meclizine 25 mg TID PO"
                },
                {
                  "text": "50 mg TID",
                  "orderSentence": "Meclizine 50 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "25-50 mg PO q6-8h PRN vertigo; max 150 mg/day",
              "orderSentence": "Meclizine 25 mg PO PO"
            },
            "contraindications": "Glaucoma; urinary retention; elderly (fall risk)",
            "monitoring": "Sedation, anticholinergic effects",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dimenhydrinate (Dramamine)",
            "route": "PO/IV",
            "indication": "Acute vertigo with significant nausea",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg PO",
                  "orderSentence": "Dimenhydrinate (Dramamine) 50 mg PO PO/IV"
                },
                {
                  "text": "50 mg IV",
                  "orderSentence": "Dimenhydrinate (Dramamine) 50 mg IV PO/IV"
                }
              ],
              "route": "PO/IV",
              "instructions": "50 mg PO q6h or 50 mg IV q6h PRN; max 400 mg/day",
              "orderSentence": "Dimenhydrinate (Dramamine) 50 mg PO PO/IV"
            },
            "contraindications": "Same as meclizine; IV form may cause hypotension",
            "monitoring": "Sedation, BP if IV",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ondansetron",
            "route": "IV/PO",
            "indication": "Nausea/vomiting with acute vertigo",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg IV",
                  "orderSentence": "Ondansetron 4 mg IV IV/PO"
                },
                {
                  "text": "8 mg PO",
                  "orderSentence": "Ondansetron 8 mg PO IV/PO"
                },
                {
                  "text": "4 mg ODT",
                  "orderSentence": "Ondansetron 4 mg ODT IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "4 mg IV or 4-8 mg PO/ODT q8h PRN",
              "orderSentence": "Ondansetron 4 mg IV IV/PO"
            },
            "contraindications": "QT prolongation; severe hepatic impairment",
            "monitoring": "QTc if multiple doses or risk factors",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Promethazine",
            "route": "IV/IM/PO",
            "indication": "Severe nausea with acute vertigo",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg IV",
                  "orderSentence": "Promethazine 12.5 mg IV IV/IM/PO"
                },
                {
                  "text": "25 mg IV",
                  "orderSentence": "Promethazine 25 mg IV IV/IM/PO"
                },
                {
                  "text": "25 mg PO",
                  "orderSentence": "Promethazine 25 mg PO IV/IM/PO"
                }
              ],
              "route": "IV/IM/PO",
              "instructions": "12.5-25 mg IV/IM/PO q4-6h PRN; max 100 mg/day",
              "orderSentence": "Promethazine 12.5 mg IV IV/IM/PO"
            },
            "contraindications": "Respiratory depression; Parkinson's; children <2 years",
            "monitoring": "Sedation, respiratory status, dystonia",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Lorazepam",
            "route": "IV/PO",
            "indication": "Severe acute vertigo refractory to antihistamines",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg IV",
                  "orderSentence": "Lorazepam 0.5 mg IV IV/PO"
                },
                {
                  "text": "1 mg IV",
                  "orderSentence": "Lorazepam 1 mg IV IV/PO"
                },
                {
                  "text": "0.5 mg PO",
                  "orderSentence": "Lorazepam 0.5 mg PO IV/PO"
                },
                {
                  "text": "1 mg PO",
                  "orderSentence": "Lorazepam 1 mg PO IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "0.5-1 mg IV/PO q8h PRN severe vertigo; short-term use only",
              "orderSentence": "Lorazepam 0.5 mg IV IV/PO"
            },
            "contraindications": "Respiratory depression; severe hepatic impairment; angle-closure glaucoma",
            "monitoring": "Sedation, respiratory status",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Diazepam",
            "route": "PO",
            "indication": "Vestibular suppressant; more sedating",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg PO",
                  "orderSentence": "Diazepam 2 mg PO PO"
                },
                {
                  "text": "5 mg PO",
                  "orderSentence": "Diazepam 5 mg PO PO"
                }
              ],
              "route": "PO",
              "instructions": "2-5 mg PO q8-12h PRN vertigo; limit to 3-5 days",
              "orderSentence": "Diazepam 2 mg PO PO"
            },
            "contraindications": "Same as lorazepam",
            "monitoring": "Sedation, respiratory status",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "IV Normal Saline",
            "route": "IV",
            "indication": "Dehydration from vomiting",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mL IV bolus",
                  "orderSentence": "IV Normal Saline 1000 mL IV bolus IV"
                },
                {
                  "text": "125 mL/hr IV",
                  "orderSentence": "IV Normal Saline 125 mL/hr IV IV"
                }
              ],
              "route": "IV",
              "instructions": "1-2 L bolus then maintenance as needed",
              "orderSentence": "IV Normal Saline 1000 mL IV bolus IV"
            },
            "contraindications": "Heart failure; volume overload",
            "monitoring": "Intake/output, signs of overload",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Epley maneuver (canalith repositioning)",
            "route": "Physical",
            "indication": "BPPV - posterior canal (most common)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Perform once",
                  "orderSentence": "Epley maneuver (canalith repositioning) Perform once Physical"
                },
                {
                  "text": "may repeat x2 same session",
                  "orderSentence": "Epley maneuver (canalith repositioning) may repeat x2 same session Physical"
                }
              ],
              "route": "Physical",
              "instructions": "Modified Epley: 5 positions held 30-60 sec each; may repeat if persistent nystagmus",
              "orderSentence": "Epley maneuver (canalith repositioning) Perform once Physical"
            },
            "contraindications": "Severe cervical spine disease; carotid stenosis (relative)",
            "monitoring": "Nystagmus resolution; post-maneuver restrictions controversial",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Semont maneuver",
            "route": "Physical",
            "indication": "BPPV - alternative to Epley",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Perform once",
                  "orderSentence": "Semont maneuver Perform once Physical"
                }
              ],
              "route": "Physical",
              "instructions": "Side-lying liberatory maneuver; faster but more uncomfortable",
              "orderSentence": "Semont maneuver Perform once Physical"
            },
            "contraindications": "Same as Epley",
            "monitoring": "Nystagmus resolution",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Brandt-Daroff exercises",
            "route": "Physical",
            "indication": "BPPV - home exercise; residual symptoms",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Twice daily home exercise",
                  "orderSentence": "Brandt-Daroff exercises Twice daily home exercise Physical"
                }
              ],
              "route": "Physical",
              "instructions": "Sit-to-side x5 each side, 30 sec holds, BID for 2 weeks",
              "orderSentence": "Brandt-Daroff exercises Twice daily home exercise Physical"
            },
            "contraindications": "Severe nausea (defer until improved)",
            "monitoring": "Symptom diary",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lempert maneuver (BBQ roll)",
            "route": "Physical",
            "indication": "BPPV - horizontal canal variant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Perform once",
                  "orderSentence": "Lempert maneuver (BBQ roll) Perform once Physical"
                },
                {
                  "text": "may repeat",
                  "orderSentence": "Lempert maneuver (BBQ roll) may repeat Physical"
                }
              ],
              "route": "Physical",
              "instructions": "Serial 90-degree rolls toward unaffected ear (360 total)",
              "orderSentence": "Lempert maneuver (BBQ roll) Perform once Physical"
            },
            "contraindications": "Cervical spine disease",
            "monitoring": "Nystagmus resolution",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Prochlorperazine",
            "route": "IV/PO",
            "indication": "Vertigo with significant nausea",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg IV",
                  "orderSentence": "Prochlorperazine 10 mg IV IV/PO"
                },
                {
                  "text": "10 mg PO",
                  "orderSentence": "Prochlorperazine 10 mg PO IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "5-10 mg IV/PO q6-8h PRN; max 40 mg/day",
              "orderSentence": "Prochlorperazine 10 mg IV IV/PO"
            },
            "contraindications": "Parkinson's; QT prolongation; tardive dyskinesia history",
            "monitoring": "Akathisia, dystonia, QTc",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Scopolamine patch",
            "route": "Transdermal",
            "indication": "Motion sickness; prolonged vertigo episodes",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 patch q72h",
                  "orderSentence": "Scopolamine patch 1 patch q72h Transdermal"
                }
              ],
              "route": "Transdermal",
              "instructions": "Apply 1 patch behind ear; replace q72h; remove if symptoms resolve",
              "orderSentence": "Scopolamine patch 1 patch q72h Transdermal"
            },
            "contraindications": "Glaucoma; urinary retention; elderly",
            "monitoring": "Anticholinergic effects, dry mouth",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Methylprednisolone",
            "route": "PO",
            "indication": "Vestibular neuritis - may improve recovery",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg daily x 3 days",
                  "orderSentence": "Methylprednisolone 100 mg daily x 3 days PO"
                },
                {
                  "text": "80 mg daily",
                  "orderSentence": "Methylprednisolone 80 mg daily PO"
                },
                {
                  "text": "60 mg daily",
                  "orderSentence": "Methylprednisolone 60 mg daily PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Methylprednisolone 40 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Methylprednisolone 20 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Methylprednisolone 10 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "100 mg daily x3 days, then taper over 3 weeks (total 22-day course)",
              "orderSentence": "Methylprednisolone 100 mg daily x 3 days PO"
            },
            "contraindications": "Active infection; uncontrolled diabetes; psychosis",
            "monitoring": "Glucose, BP, mood",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Prednisone",
            "route": "PO",
            "indication": "Vestibular neuritis - alternative steroid",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg daily",
                  "orderSentence": "Prednisone 60 mg daily PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Prednisone 40 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Prednisone 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "1 mg/kg/day (max 60 mg) x 5 days, taper over 2 weeks",
              "orderSentence": "Prednisone 60 mg daily PO"
            },
            "contraindications": "Same as methylprednisolone",
            "monitoring": "Glucose, BP, mood",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valacyclovir",
            "route": "PO",
            "indication": "Vestibular neuritis - if viral etiology suspected",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg TID x 7 days",
                  "orderSentence": "Valacyclovir 1000 mg TID x 7 days PO"
                }
              ],
              "route": "PO",
              "instructions": "1000 mg PO TID x 7 days; most effective if started within 72 hrs",
              "orderSentence": "Valacyclovir 1000 mg TID x 7 days PO"
            },
            "contraindications": "Renal impairment (dose adjust)",
            "monitoring": "Renal function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Betahistine",
            "route": "PO",
            "indication": "Meniere's disease - vestibular blood flow",
            "dosing": {
              "doseOptions": [
                {
                  "text": "16 mg TID",
                  "orderSentence": "Betahistine 16 mg TID PO"
                },
                {
                  "text": "24 mg TID",
                  "orderSentence": "Betahistine 24 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "8-16 mg PO TID; titrate to 24 mg TID if needed; not FDA approved in US",
              "orderSentence": "Betahistine 16 mg TID PO"
            },
            "contraindications": "Pheochromocytoma; active peptic ulcer",
            "monitoring": "GI upset, headache",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hydrochlorothiazide",
            "route": "PO",
            "indication": "Meniere's disease - reduce endolymphatic pressure",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Hydrochlorothiazide 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Hydrochlorothiazide 50 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "12.5-50 mg PO daily",
              "orderSentence": "Hydrochlorothiazide 25 mg daily PO"
            },
            "contraindications": "Sulfa allergy; hypokalemia; severe renal impairment",
            "monitoring": "K+, Na+, creatinine, glucose",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Triamterene/HCTZ",
            "route": "PO",
            "indication": "Meniere's disease - potassium-sparing diuretic",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5/25 mg daily",
                  "orderSentence": "Triamterene/HCTZ 37.5/25 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "37.5/25 mg PO daily",
              "orderSentence": "Triamterene/HCTZ 37.5/25 mg daily PO"
            },
            "contraindications": "Hyperkalemia; severe renal impairment",
            "monitoring": "K+, creatinine",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Intratympanic dexamethasone",
            "route": "IT",
            "indication": "Refractory Meniere's disease",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg/mL IT injection",
                  "orderSentence": "Intratympanic dexamethasone 4 mg/mL IT injection Intratympanic"
                }
              ],
              "route": "Intratympanic",
              "instructions": "0.4-0.8 mL of 4-24 mg/mL solution injected through TM; repeat x3-4 over 2 weeks",
              "orderSentence": "Intratympanic dexamethasone 4 mg/mL IT injection Intratympanic"
            },
            "contraindications": "Active ear infection; perforated TM",
            "monitoring": "Hearing, vertigo control",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Intratympanic gentamicin",
            "route": "IT",
            "indication": "Refractory Meniere's disease - ablative",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg/mL IT injection",
                  "orderSentence": "Intratympanic gentamicin 40 mg/mL IT injection Intratympanic"
                }
              ],
              "route": "Intratympanic",
              "instructions": "Chemical labyrinthectomy; 0.5 mL of 40 mg/mL; may repeat in 4 weeks",
              "orderSentence": "Intratympanic gentamicin 40 mg/mL IT injection Intratympanic"
            },
            "contraindications": "Only hearing ear; bilateral disease",
            "monitoring": "Hearing loss (expected), vertigo control",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Disease-Modifying or Chronic Therapies": [
          {
            "item": "Vestibular rehabilitation therapy",
            "route": "Physical",
            "indication": "Vestibular hypofunction; chronic imbalance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2x weekly sessions",
                  "orderSentence": "Vestibular rehabilitation therapy 1-2x weekly sessions Physical"
                }
              ],
              "route": "Physical",
              "instructions": "6-12 week program with home exercises; gaze stabilization, balance training, habituation",
              "orderSentence": "Vestibular rehabilitation therapy 1-2x weekly sessions Physical"
            },
            "pretreatment": "Audiometry, VNG to define deficit",
            "contraindications": "Acute vertigo (defer)",
            "monitoring": "Fall risk, symptom diary, DHI scores",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Low-sodium diet",
            "route": "Dietary",
            "indication": "Meniere's disease - reduce endolymph",
            "dosing": {
              "doseOptions": [
                {
                  "text": "<1500-2000 mg Na/day",
                  "orderSentence": "Low-sodium diet <1500-2000 mg Na/day Dietary"
                }
              ],
              "route": "Dietary",
              "instructions": "Strict sodium restriction; avoid processed foods, add no salt",
              "orderSentence": "Low-sodium diet <1500-2000 mg Na/day Dietary"
            },
            "pretreatment": "Dietitian consultation",
            "contraindications": "Hypotension if on diuretics",
            "monitoring": "BP, symptoms, dietary compliance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Caffeine/alcohol avoidance",
            "route": "Lifestyle",
            "indication": "Meniere's disease; vestibular migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Eliminate or minimize",
                  "orderSentence": "Caffeine/alcohol avoidance Eliminate or minimize Lifestyle"
                }
              ],
              "route": "Lifestyle",
              "instructions": "Avoid caffeine and alcohol which may trigger episodes",
              "orderSentence": "Caffeine/alcohol avoidance Eliminate or minimize Lifestyle"
            },
            "pretreatment": "None",
            "contraindications": "None",
            "monitoring": "Symptom diary",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Migraine preventive therapy",
            "route": "PO",
            "indication": "Vestibular migraine confirmed",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per migraine protocol",
                  "orderSentence": "Migraine preventive therapy Per migraine protocol PO"
                }
              ],
              "route": "PO",
              "instructions": "See Migraine plan for preventive options (topiramate, propranolol, amitriptyline)",
              "orderSentence": "Migraine preventive therapy Per migraine protocol PO"
            },
            "pretreatment": "HIS/Barany criteria for vestibular migraine",
            "contraindications": "Per specific medication",
            "monitoring": "Per specific medication",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consultation for central vertigo evaluation when HINTS exam suggests central lesion or stroke suspected",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "ENT/Otology referral for refractory BPPV, Meniere's disease management, or hearing loss evaluation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vestibular physical therapy for vestibular rehabilitation and balance retraining after acute vertigo resolves",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Audiology for formal hearing assessment and vestibular function testing (VNG, VEMP)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuro-ophthalmology if ocular motor abnormalities persist or skew deviation concerning for brainstem lesion",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Stroke neurology for urgent evaluation if HINTS-plus exam suggests posterior circulation stroke",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Cardiology if presyncope suspected or arrhythmia contributing to dizziness",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if vertigo associated with new headache, diplopia, dysarthria, dysphagia, or weakness (signs of stroke)",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return immediately if sudden hearing loss occurs which requires urgent treatment within 72 hours",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid driving, operating machinery, or working at heights until vertigo resolves completely due to fall and accident risk",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use assistive devices (cane, walker) if balance impaired to prevent falls",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Perform Brandt-Daroff exercises twice daily as instructed if diagnosed with BPPV",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep head elevated 30-45 degrees when sleeping for 24-48 hours after Epley maneuver (controversial but commonly recommended)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid sudden head movements and rapid position changes which may trigger vertigo",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain hydration and avoid skipping meals as dehydration and hypoglycemia can worsen symptoms",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Sodium restriction (<2000 mg/day) if Meniere's disease diagnosed to reduce attack frequency",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Caffeine reduction or elimination as caffeine can exacerbate vestibular symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Alcohol avoidance as alcohol directly affects vestibular function and can trigger episodes",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management through relaxation techniques as stress can trigger vestibular migraine and Meniere's attacks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular sleep schedule as sleep deprivation can worsen vestibular symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Fall prevention measures including removing throw rugs, installing grab bars, adequate lighting at home",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation to reduce vascular risk factors that contribute to central vertigo",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "BPPV (posterior canal)",
        "features": "Brief episodes (<1 min) triggered by position change; positive Dix-Hallpike with upbeat-torsional nystagmus",
        "tests": "Dix-Hallpike maneuver; resolves with Epley"
      },
      {
        "diagnosis": "BPPV (horizontal canal)",
        "features": "Horizontal nystagmus with supine roll test; direction-changing or direction-fixed",
        "tests": "Supine roll test; treat with BBQ roll maneuver"
      },
      {
        "diagnosis": "Vestibular neuritis",
        "features": "Acute severe vertigo lasting days; unidirectional horizontal nystagmus; normal hearing",
        "tests": "HINTS exam (peripheral pattern); MRI to rule out stroke"
      },
      {
        "diagnosis": "Labyrinthitis",
        "features": "Same as vestibular neuritis PLUS hearing loss; may follow URI",
        "tests": "Audiometry shows sensorineural loss; HINTS peripheral"
      },
      {
        "diagnosis": "Meniere's disease",
        "features": "Recurrent episodes (20 min - 12 hr) with hearing loss, tinnitus, aural fullness",
        "tests": "Audiometry (low-frequency loss); ECoG; MRI IAC"
      },
      {
        "diagnosis": "Vestibular migraine",
        "features": "Vertigo with migraine features; variable duration (5 min - 72 hr); motion sensitivity",
        "tests": "HIS/Barany criteria; diagnosis of exclusion; MRI normal"
      },
      {
        "diagnosis": "Posterior circulation stroke",
        "features": "Acute vertigo + neurological signs; HINTS central pattern; vascular risk factors",
        "tests": "MRI DWI (may be negative early); HINTS exam"
      },
      {
        "diagnosis": "Cerebellar hemorrhage/infarct",
        "features": "Severe imbalance; unable to walk; may have headache, vomiting",
        "tests": "CT head (hemorrhage); MRI DWI (infarct)"
      },
      {
        "diagnosis": "Multiple sclerosis",
        "features": "Vertigo with other demyelinating symptoms; younger patient",
        "tests": "MRI brain/spine with contrast; CSF oligoclonal bands"
      },
      {
        "diagnosis": "Acoustic neuroma",
        "features": "Progressive unilateral hearing loss, tinnitus; vertigo less prominent",
        "tests": "MRI IAC with gadolinium"
      },
      {
        "diagnosis": "Perilymphatic fistula",
        "features": "Vertigo/hearing loss after trauma, straining, or barotrauma",
        "tests": "History; may need surgical exploration"
      },
      {
        "diagnosis": "Superior canal dehiscence",
        "features": "Vertigo triggered by loud sounds (Tullio) or pressure; autophony",
        "tests": "High-resolution CT temporal bone; VEMP"
      },
      {
        "diagnosis": "Central positional vertigo",
        "features": "Down-beating nystagmus with Dix-Hallpike; doesn't fatigue",
        "tests": "MRI cerebellum; Dix-Hallpike pattern"
      },
      {
        "diagnosis": "Drug-induced vestibulotoxicity",
        "features": "Bilateral vestibular loss; aminoglycosides, loop diuretics, chemotherapy",
        "tests": "History; bilateral caloric weakness on VNG"
      },
      {
        "diagnosis": "Presyncope (cardiac)",
        "features": "Near-fainting rather than spinning; palpitations; exertional",
        "tests": "ECG, Holter, echocardiogram; orthostatic vitals"
      },
      {
        "diagnosis": "Orthostatic hypotension",
        "features": "Dizziness on standing; BP drop >20/10 mmHg",
        "tests": "Orthostatic vital signs"
      },
      {
        "diagnosis": "Anxiety/panic disorder",
        "features": "Chronic dizziness; associated anxiety; no objective vestibular findings",
        "tests": "Normal vestibular testing; psychiatric evaluation"
      }
    ],
    "evidence": [
      {
        "recommendation": "HINTS exam superior to early MRI for detecting stroke",
        "evidenceLevel": "Class II, Level B",
        "source": "[Kattah et al. Stroke 2009](https://pubmed.ncbi.nlm.nih.gov/19762709/)"
      },
      {
        "recommendation": "Epley maneuver effective for posterior canal BPPV",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hilton et al. Cochrane Database Syst Rev 2014](https://pubmed.ncbi.nlm.nih.gov/25513198/)"
      },
      {
        "recommendation": "Corticosteroids improve vestibular neuritis recovery",
        "evidenceLevel": "Class I, Level B",
        "source": "[Strupp et al. NEJM 2004](https://pubmed.ncbi.nlm.nih.gov/15254283/)"
      },
      {
        "recommendation": "Vestibular rehabilitation effective for chronic vestibular hypofunction",
        "evidenceLevel": "Class I, Level A",
        "source": "[McDonnell & Hillier Cochrane 2015](https://pubmed.ncbi.nlm.nih.gov/25581507/)"
      },
      {
        "recommendation": "HINTS-plus (HINTS + hearing) increases stroke detection",
        "evidenceLevel": "Class II, Level B",
        "source": "[Newman-Toker et al. Stroke 2013](https://pubmed.ncbi.nlm.nih.gov/23686976/)"
      },
      {
        "recommendation": "Betahistine for Meniere's disease symptoms",
        "evidenceLevel": "Class II, Level B",
        "source": "[James & Burton Cochrane 2001](https://pubmed.ncbi.nlm.nih.gov/11279756/)"
      },
      {
        "recommendation": "Intratympanic gentamicin for refractory Meniere's",
        "evidenceLevel": "Class II, Level B",
        "source": "[Pullens & van Benthem Cochrane 2011](https://pubmed.ncbi.nlm.nih.gov/21412877/)"
      },
      {
        "recommendation": "Meclizine comparable to diazepam for acute vertigo",
        "evidenceLevel": "Class II, Level B",
        "source": "[McClure & Willett Arch Otolaryngol 1980](https://pubmed.ncbi.nlm.nih.gov/6986909/)"
      },
      {
        "recommendation": "Low sodium diet for Meniere's disease management",
        "evidenceLevel": "Class III, Level C",
        "source": "[Luxford et al. Otolaryngol Head Neck Surg 2013](https://pubmed.ncbi.nlm.nih.gov/23886564/)"
      },
      {
        "recommendation": "Diagnostic criteria for vestibular migraine",
        "evidenceLevel": "Consensus",
        "source": "[Lempert et al. Barany Society/IHS 2012](https://pubmed.ncbi.nlm.nih.gov/22287185/)"
      },
      {
        "recommendation": "Video head impulse test for vestibular function",
        "evidenceLevel": "Class II, Level B",
        "source": "[MacDougall et al. Neurology 2009](https://pubmed.ncbi.nlm.nih.gov/19273827/)"
      },
      {
        "recommendation": "Central vs peripheral vertigo differentiation",
        "evidenceLevel": "Consensus",
        "source": "[Baloh & Honrubia. Clinical Neurophysiology of Vestibular System 2011](https://pubmed.ncbi.nlm.nih.gov/21332419/)"
      }
    ],
    "monitoring": [
      {
        "item": "HINTS exam (Head Impulse, Nystagmus, Test of Skew)",
        "frequency": "Initial presentation",
        "action": "Central pattern requires urgent MRI and neurology consult",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT"
      },
      {
        "item": "Nystagmus characteristics",
        "frequency": "Serial exam in ED",
        "action": "Direction-changing, vertical, or non-suppressing suggests central",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Gait and balance assessment",
        "frequency": "Each encounter",
        "action": "Unable to walk suggests central lesion or severe peripheral",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Hearing assessment (bedside)",
        "frequency": "Initial and follow-up",
        "action": "Asymmetric loss requires audiometry and MRI IAC",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Symptom severity (VAS or DHI)",
        "frequency": "Each visit",
        "action": "Persistent or worsening requires imaging, reassessment",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Dix-Hallpike test",
        "frequency": "If BPPV suspected; follow-up",
        "action": "Positive requires repositioning; recurrence common",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Fall risk assessment",
        "frequency": "Each encounter",
        "action": "High risk requires PT, home safety evaluation, assistive devices",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Vestibular function (VNG/VEMP)",
        "frequency": "After acute phase; follow-up",
        "action": "Persistent deficit requires vestibular rehabilitation",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Peripheral vertigo confirmed (HINTS peripheral); symptoms controlled; able to ambulate safely; able to tolerate PO; follow-up arranged; no red flags"
      },
      {
        "disposition": "Observation",
        "criteria": "Severe symptoms requiring IV fluids/medications; unable to ambulate safely; awaiting MRI to rule out central cause"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Central vertigo confirmed requiring workup; stroke suspected but stable; severe dehydration; unable to tolerate PO for >24 hours"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Cerebellar stroke with risk of herniation; cerebellar hemorrhage; posterior circulation stroke with fluctuating symptoms"
      },
      {
        "disposition": "Transfer to higher level",
        "criteria": "Central vertigo suspected and MRI/neurology not available; cerebellar stroke requiring neurosurgical evaluation"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Within 1-2 weeks for new vertigo; sooner if symptoms persist; ENT referral for Meniere's or hearing loss"
      }
    ]
  },
  "Syncope Evaluation": {
    "id": "syncope",
    "title": "Syncope Evaluation",
    "version": "1.0",
    "icd10": [
      "** R55 (Syncope and collapse)",
      "T67.1 (Heat syncope)",
      "G90.01 (Carotid sinus syncope)",
      "I95.1 (Orthostatic hypotension)"
    ],
    "scope": "** Evaluation and management of transient loss of consciousness (TLOC) due to syncope in adults. Includes risk stratification, etiologic workup, and treatment by type. Applies to ED, hospital, and outpatient settings. Excludes seizure, stroke, metabolic causes, and traumatic loss of consciousness.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Fingerstick glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hypoglycemia as cause",
            "target": "70-180 mg/dL"
          },
          {
            "item": "CBC",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "rationale": "Anemia; hemorrhage",
            "target": "Normal"
          },
          {
            "item": "BMP (electrolytes, creatinine)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "rationale": "Electrolyte abnormalities",
            "target": "Normal"
          },
          {
            "item": "Troponin",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Cardiac ischemia as trigger",
            "target": "Negative"
          },
          {
            "item": "BNP or NT-proBNP",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "Heart failure; risk stratification",
            "target": "Normal"
          },
          {
            "item": "Pregnancy test (if applicable)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Ectopic pregnancy; influences workup",
            "target": "Document"
          }
        ],
        "Extended Workup": [
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Thyroid dysfunction",
            "target": "Normal"
          },
          {
            "item": "Cortisol (AM)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Adrenal insufficiency if orthostatic",
            "target": "Normal"
          },
          {
            "item": "D-dimer",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "If PE suspected",
            "target": "Negative"
          },
          {
            "item": "Toxicology screen",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Drug/alcohol-induced",
            "target": "Negative"
          },
          {
            "item": "Blood cultures",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "If infection suspected",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "12-lead ECG",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "Immediate; ALL patients",
            "target": "No arrhythmia, normal intervals",
            "contraindications": "None"
          },
          {
            "item": "Continuous telemetry",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "timing": "If admitted",
            "target": "No arrhythmia",
            "contraindications": "None"
          },
          {
            "item": "Transthoracic echocardiogram",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "If cardiac cause suspected",
            "target": "Normal structure/function",
            "contraindications": "None"
          },
          {
            "item": "Exercise stress test",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If exertional syncope",
            "target": "No ischemia, no arrhythmia",
            "contraindications": "Acute MI, unstable angina"
          },
          {
            "item": "Cardiac MRI",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Suspected cardiomyopathy, ARVC",
            "target": "Normal or define pathology",
            "contraindications": "Pacemaker, metal"
          }
        ],
        "Extended": [
          {
            "item": "Holter monitor (24-48 hour)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Frequent symptoms",
            "target": "Correlate symptoms with rhythm",
            "contraindications": "None"
          },
          {
            "item": "Event recorder (2-4 weeks)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Intermittent symptoms",
            "target": "Symptom-rhythm correlation",
            "contraindications": "None"
          },
          {
            "item": "Insertable loop recorder (ILR)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Infrequent, unexplained recurrent syncope",
            "target": "Identify arrhythmia",
            "contraindications": "None"
          },
          {
            "item": "Electrophysiology study (EPS)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Suspected arrhythmic cause; structural heart disease",
            "target": "Identify inducible arrhythmia",
            "contraindications": "Active infection"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Orthostatic vital signs",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "Immediate; ALL patients",
            "target": "No orthostatic hypotension",
            "contraindications": "None"
          },
          {
            "item": "Tilt table test",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Suspected vasovagal if recurrent; dx uncertain",
            "target": "Positive = cardioinhibitory or vasodepressor",
            "contraindications": "Severe CAD, critical AS"
          },
          {
            "item": "Carotid sinus massage",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Age >40 with unexplained syncope (not if carotid bruit)",
            "target": "Negative (<3 sec pause, <50 mmHg drop)",
            "contraindications": "Carotid bruit, recent stroke/TIA"
          },
          {
            "item": "Autonomic function tests",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Suspected autonomic failure",
            "target": "Characterize dysautonomia",
            "contraindications": "Per test"
          }
        ]
      },
      "Treatment": {
        "Acute Management (ED/Hospital)": [
          {
            "item": "IV access",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "Establish if unstable",
              "orderSentence": "IV access - IV - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Access",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "IV fluid resuscitation",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500-1000 mL",
                  "orderSentence": "IV fluid resuscitation 500-1000 mL -"
                }
              ],
              "route": "-",
              "instructions": "NS 500-1000 mL bolus if hypovolemic/dehydrated",
              "orderSentence": "IV fluid resuscitation 500-1000 mL -"
            },
            "contraindications": "Heart failure",
            "monitoring": "Volume status",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Trendelenburg position",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Legs elevated if hypotensive",
              "orderSentence": "Trendelenburg position - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "BP",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Telemetry monitoring",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Continuous if high-risk",
              "orderSentence": "Telemetry monitoring - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Arrhythmia",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Correct reversible causes",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Treat hemorrhage, dehydration, arrhythmia, MI",
              "orderSentence": "Correct reversible causes - - - see dosing"
            },
            "contraindications": "Per condition",
            "monitoring": "Per condition",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Vasovagal Syncope Treatment": [
          {
            "item": "Education and reassurance",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Benign prognosis; triggers; warning signs",
              "orderSentence": "Education and reassurance - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "None",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trigger avoidance",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Identify and avoid (prolonged standing, heat, dehydration)",
              "orderSentence": "Trigger avoidance - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Recurrence",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Counter-pressure maneuvers",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Leg crossing, hand grip, arm tensing when prodrome felt",
              "orderSentence": "Counter-pressure maneuvers - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Effectiveness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Increased fluid/salt intake",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "6-9 g",
                  "orderSentence": "Increased fluid/salt intake 6-9 g PO"
                }
              ],
              "route": "PO",
              "instructions": "2-3 L fluid/day; 6-9 g salt/day (if no HTN/HF)",
              "orderSentence": "Increased fluid/salt intake 6-9 g PO"
            },
            "contraindications": "HTN, heart failure",
            "monitoring": "BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Compression stockings",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Waist-high, 30-40 mmHg",
              "orderSentence": "Compression stockings - - - see dosing"
            },
            "contraindications": "Peripheral vascular disease",
            "monitoring": "Compliance",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tilt training",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Progressive standing against wall; controversial efficacy",
              "orderSentence": "Tilt training - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Tolerance",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Fludrocortisone",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1-0.2 mg",
                  "orderSentence": "Fludrocortisone 0.1-0.2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.1-0.2 mg daily (refractory cases)",
              "orderSentence": "Fludrocortisone 0.1-0.2 mg PO"
            },
            "contraindications": "HTN, HF",
            "monitoring": "K+, BP, edema",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Midodrine",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5-10 mg",
                  "orderSentence": "Midodrine 2.5-10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "2.5-10 mg TID (refractory cases)",
              "orderSentence": "Midodrine 2.5-10 mg PO"
            },
            "contraindications": "Supine HTN, urinary retention",
            "monitoring": "Supine HTN",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Orthostatic Syncope Treatment": [
          {
            "item": "Identify/discontinue offending meds",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Review diuretics, vasodilators, antihypertensives",
              "orderSentence": "Identify/discontinue offending meds - - - see dosing"
            },
            "contraindications": "Clinical judgment",
            "monitoring": "BP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Volume repletion",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "IV fluids acutely; oral fluids long-term (2-3 L/day)",
              "orderSentence": "Volume repletion - IV - see dosing"
            },
            "contraindications": "Heart failure",
            "monitoring": "Volume status",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Salt supplementation",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "6-10 g/day",
                  "orderSentence": "Salt supplementation 6-10 g/day PO"
                }
              ],
              "route": "PO",
              "instructions": "6-10 g/day if no HTN/HF",
              "orderSentence": "Salt supplementation 6-10 g/day PO"
            },
            "contraindications": "HTN, HF",
            "monitoring": "BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Compression garments",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Waist-high stockings 30-40 mmHg; abdominal binder",
              "orderSentence": "Compression garments - - - see dosing"
            },
            "contraindications": "PVD",
            "monitoring": "Compliance",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Elevate head of bed",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "10-20 degrees at night (reduces nocturnal diuresis)",
              "orderSentence": "Elevate head of bed - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Tolerance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Midodrine",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5-10 mg",
                  "orderSentence": "Midodrine 2.5-10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "2.5-10 mg TID; last dose before 6 PM",
              "orderSentence": "Midodrine 2.5-10 mg PO"
            },
            "contraindications": "Supine HTN, urinary retention",
            "monitoring": "Supine BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fludrocortisone",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1-0.3 mg",
                  "orderSentence": "Fludrocortisone 0.1-0.3 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.1-0.3 mg daily",
              "orderSentence": "Fludrocortisone 0.1-0.3 mg PO"
            },
            "contraindications": "HTN, HF, hypokalemia",
            "monitoring": "K+, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Droxidopa (Northera)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100-600 mg",
                  "orderSentence": "Droxidopa (Northera) 100-600 mg -"
                }
              ],
              "route": "-",
              "instructions": "100-600 mg TID; for neurogenic orthostatic hypotension",
              "orderSentence": "Droxidopa (Northera) 100-600 mg -"
            },
            "contraindications": "Supine HTN",
            "monitoring": "Supine BP",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pyridostigmine",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30-60 mg",
                  "orderSentence": "Pyridostigmine 30-60 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "30-60 mg TID; augments ganglionic transmission",
              "orderSentence": "Pyridostigmine 30-60 mg PO"
            },
            "contraindications": "Asthma, GI obstruction",
            "monitoring": "Cholinergic effects",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Carotid Sinus Syncope Treatment": [
          {
            "item": "Avoid tight collars, neck pressure",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Patient education",
              "orderSentence": "Avoid tight collars, neck pressure - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "None",
            "monitoring": "Recurrence",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dual-chamber pacemaker",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "If cardioinhibitory type (pause >3 sec)",
              "orderSentence": "Dual-chamber pacemaker - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "None",
            "monitoring": "Device checks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Cardiac Syncope Treatment": [
          {
            "item": "Treat underlying arrhythmia",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Per arrhythmia type",
              "orderSentence": "Treat underlying arrhythmia - - - see dosing"
            },
            "contraindications": "Per treatment",
            "monitoring": "ECG, telemetry",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Pacemaker",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Sick sinus syndrome, high-grade AV block, bradycardia-induced syncope",
              "orderSentence": "Pacemaker - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Device checks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ICD (implantable cardioverter-defibrillator)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Ventricular arrhythmias; high-risk cardiomyopathy",
              "orderSentence": "ICD (implantable cardioverter-defibrillator) - - - see dosing"
            },
            "contraindications": "Terminal illness",
            "monitoring": "Device checks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Catheter ablation",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Arrhythmia amenable to ablation (SVT, VT)",
              "orderSentence": "Catheter ablation - - - see dosing"
            },
            "contraindications": "Extensive comorbidity",
            "monitoring": "Recurrence",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Treat structural heart disease",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Aortic valve replacement for AS; revascularization for ischemia",
              "orderSentence": "Treat structural heart disease - - - see dosing"
            },
            "contraindications": "Per condition",
            "monitoring": "Per condition",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ]
      },
      "Other Recommendations": {
        "Patient Instructions": [
          {
            "item": "Cardiology",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Suspected cardiac syncope; abnormal ECG; structural heart disease"
          },
          {
            "item": "Electrophysiology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Arrhythmia evaluation; device consideration"
          },
          {
            "item": "Neurology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-",
            "indication": "If seizure suspected; atypical features"
          },
          {
            "item": "Autonomic disorders specialist",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Refractory orthostatic hypotension; complex dysautonomia"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Recognize prodromal symptoms and immediately sit/lie down",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Counter-pressure maneuvers if prodrome (leg crossing, hand grip)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid known triggers (prolonged standing, dehydration, heat)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate hydration (2-3 L/day) and salt intake (if approved)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Rise slowly from lying/sitting; dangle legs before standing",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Driving restrictions per state law; typically no driving until cause determined/treated",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return if recurrent syncope, chest pain, palpitations, dyspnea",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Seizure",
        "features": "Tonic-clonic activity, tongue biting, prolonged postictal state, incontinence",
        "tests": "EEG; witness description"
      },
      {
        "diagnosis": "Stroke/TIA",
        "features": "Focal neurologic deficits; usually no LOC unless brainstem",
        "tests": "CT/MRI; neuro exam"
      },
      {
        "diagnosis": "Hypoglycemia",
        "features": "Diaphoresis, tremor, confusion; diabetes/insulin use",
        "tests": "Fingerstick glucose"
      },
      {
        "diagnosis": "Psychogenic pseudosyncope",
        "features": "Eyes closed (vs. open in true syncope); prolonged duration; normal vitals during event",
        "tests": "Tilt table with video EEG"
      },
      {
        "diagnosis": "Drop attack",
        "features": "Sudden fall without LOC; no prodrome",
        "tests": "History; normal during event"
      },
      {
        "diagnosis": "Cataplexy",
        "features": "Triggered by emotion; with narcolepsy",
        "tests": "Sleep study; history"
      },
      {
        "diagnosis": "Cardiac arrest",
        "features": "No pulse during event; does not spontaneously recover",
        "tests": "Witnessed event; no pulse"
      },
      {
        "diagnosis": "Concussion",
        "features": "Preceded by head trauma",
        "tests": "History"
      },
      {
        "diagnosis": "Vertebrobasilar insufficiency",
        "features": "Vertigo, diplopia, dysarthria; rare cause of syncope",
        "tests": "MRA; history"
      },
      {
        "diagnosis": "Pulmonary embolism",
        "features": "Dyspnea, pleuritic chest pain, hypoxia; syncope in massive PE",
        "tests": "D-dimer, CT-PA"
      },
      {
        "diagnosis": "Aortic dissection",
        "features": "Tearing chest/back pain; BP differential",
        "tests": "CT angiography"
      }
    ],
    "evidence": [
      {
        "recommendation": "ECG for all syncope patients",
        "evidenceLevel": "Class I, Level B",
        "source": "[ESC 2018 Syncope Guidelines](https://pubmed.ncbi.nlm.nih.gov/29562304/)"
      },
      {
        "recommendation": "Echo if cardiac cause suspected",
        "evidenceLevel": "Class I, Level B",
        "source": "[ESC 2018](https://pubmed.ncbi.nlm.nih.gov/29562304/); AHA/ACCF 2017"
      },
      {
        "recommendation": "Tilt test for recurrent vasovagal syncope",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[ESC 2018](https://pubmed.ncbi.nlm.nih.gov/29562304/)"
      },
      {
        "recommendation": "Pacemaker for cardioinhibitory carotid sinus syncope",
        "evidenceLevel": "Class I, Level B",
        "source": "[ESC 2018](https://pubmed.ncbi.nlm.nih.gov/29562304/)"
      },
      {
        "recommendation": "ILR for recurrent unexplained syncope",
        "evidenceLevel": "Class I, Level A",
        "source": "[ISSUE-3 trial](https://pubmed.ncbi.nlm.nih.gov/22565936/); [ESC 2018](https://pubmed.ncbi.nlm.nih.gov/29562304/)"
      },
      {
        "recommendation": "Counter-pressure maneuvers for vasovagal",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[PC-Trial](https://pubmed.ncbi.nlm.nih.gov/17045903/)"
      },
      {
        "recommendation": "Midodrine for refractory orthostatic hypotension",
        "evidenceLevel": "Class IIa, Level B",
        "source": "Multiple RCTs"
      },
      {
        "recommendation": "Risk stratification scores (Canadian Syncope Risk Score)",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[Thiruganasambandamoorthy et al.](https://pubmed.ncbi.nlm.nih.gov/27378464/)"
      }
    ],
    "monitoring": [
      {
        "item": "Vital signs (including orthostatics)",
        "ED": "STAT",
        "HOSP": "q4-8h",
        "OPD": "Every visit",
        "ICU": "Continuous",
        "frequency": "Per setting",
        "action": "Treat hypotension; volume"
      },
      {
        "item": "Continuous telemetry",
        "ED": "-",
        "HOSP": "Continuous",
        "OPD": "-",
        "ICU": "Continuous",
        "frequency": "Until risk stratified",
        "action": "Cardiology consult"
      },
      {
        "item": "ECG",
        "ED": "STAT",
        "HOSP": "Daily",
        "OPD": "Every visit if cardiac",
        "ICU": "STAT",
        "frequency": "Per clinical status",
        "action": "Cardiology; treatment"
      },
      {
        "item": "Troponin",
        "ED": "STAT",
        "HOSP": "q6-8h × 2 if initially elevated",
        "OPD": "-",
        "ICU": "Per cardiac status",
        "frequency": "Until ruled out",
        "action": "Cardiology"
      },
      {
        "item": "Recurrence",
        "ED": "-",
        "HOSP": "Ongoing",
        "OPD": "Every visit",
        "ICU": "-",
        "frequency": "Ongoing",
        "action": "Re-evaluate diagnosis/treatment"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge from ED",
        "criteria": "Low-risk syncope (vasovagal with clear trigger, normal ECG, normal vitals, no cardiac history); reliable follow-up"
      },
      {
        "disposition": "Admit to telemetry",
        "criteria": "High-risk features (abnormal ECG, cardiac history, exertional, no prodrome, abnormal vitals); unexplained syncope in elderly"
      },
      {
        "disposition": "ICU admission",
        "criteria": "Hemodynamically unstable; malignant arrhythmia; acute MI; massive PE"
      },
      {
        "disposition": "Syncope unit/observation",
        "criteria": "Intermediate risk; brief observation with monitoring"
      },
      {
        "disposition": "Cardiology follow-up",
        "criteria": "Suspected cardiac cause; abnormal echo; need for device evaluation"
      },
      {
        "disposition": "Neurology follow-up",
        "criteria": "Atypical features suggesting seizure or neurologic cause"
      },
      {
        "disposition": "Primary care follow-up",
        "criteria": "Low-risk vasovagal syncope; medication review for orthostatic"
      }
    ]
  },
  "Carpal Tunnel Syndrome": {
    "id": "carpal-tunnel-syndrome",
    "title": "Carpal Tunnel Syndrome",
    "version": "1.0",
    "icd10": [
      "** G56.00 (Carpal tunnel syndrome",
      "unspecified upper limb)",
      "G56.01 (Carpal tunnel syndrome",
      "right upper limb)",
      "G56.02 (Carpal tunnel syndrome",
      "left upper limb)",
      "G56.03 (Carpal tunnel syndrome",
      "bilateral upper limbs)"
    ],
    "scope": "** Evaluation and management of carpal tunnel syndrome from initial presentation through conservative treatment, injection therapy, and surgical referral. Covers clinical diagnosis, electrodiagnostic testing, severity grading, and treatment options. For acute median nerve injury or severe CTS with thenar atrophy, early surgical referral is indicated.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Fasting glucose (CPT 82947)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Screen for diabetes (common CTS risk factor)",
            "target": "<100 mg/dL"
          },
          {
            "item": "HbA1c (CPT 83036)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes/prediabetes screening (diabetic neuropathy overlap)",
            "target": "<5.7%"
          },
          {
            "item": "TSH (CPT 84443)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypothyroidism causes CTS (myxedematous tissue infiltration)",
            "target": "0.4-4.0 mIU/L"
          }
        ],
        "Extended Workup": [
          {
            "item": "Rheumatoid factor (CPT 86431)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "RA-associated CTS (synovial hypertrophy)",
            "target": "Negative"
          },
          {
            "item": "Anti-CCP antibody (CPT 86200)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "More specific for RA if RF negative",
            "target": "Negative"
          },
          {
            "item": "ESR (CPT 85652)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Inflammatory arthritis screen",
            "target": "<20 mm/hr"
          },
          {
            "item": "CRP (CPT 86140)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Inflammatory marker",
            "target": "<3.0 mg/L"
          },
          {
            "item": "Uric acid (CPT 84550)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Gout/tophaceous deposits in carpal tunnel",
            "target": "Normal (3.5-7.2 mg/dL male; 2.5-6.2 mg/dL female)"
          },
          {
            "item": "BUN/Creatinine (CPT 84520/82565)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Renal disease (dialysis-associated CTS from amyloid deposition)",
            "target": "Normal"
          },
          {
            "item": "CBC (CPT 85025)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Anemia workup, infection screen",
            "target": "Normal"
          },
          {
            "item": "Pregnancy test (CPT 81025/84702)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Pregnancy-associated CTS (common, often resolves postpartum)",
            "target": "Document status"
          },
          {
            "item": "Vitamin B12 (CPT 82607)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Concomitant peripheral neuropathy",
            "target": ">300 pg/mL"
          },
          {
            "item": "Serum protein electrophoresis (SPEP) (CPT 86335)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Amyloidosis, myeloma (bilateral CTS may be presenting sign of AL amyloid)",
            "target": "No M-spike"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Free light chains (kappa/lambda) (CPT 83883)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "AL amyloidosis if bilateral CTS with cardiac/renal involvement",
            "target": "Normal ratio (0.26-1.65)"
          },
          {
            "item": "TTR gene testing (CPT 81404)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Hereditary transthyretin amyloidosis if young onset bilateral CTS",
            "target": "No pathogenic variant"
          },
          {
            "item": "Fat pad biopsy (CPT 88305)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Confirm amyloidosis if strongly suspected",
            "target": "No amyloid deposits"
          },
          {
            "item": "Acromegaly workup (IGF-1, GH) (CPT 84305/83003)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Bilateral CTS in patient with acromegalic features",
            "target": "Normal"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Nerve conduction studies (NCS) (CPT 95907-95909) and EMG (CPT 95885)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Recommended for diagnosis confirmation and severity grading; optimal before surgery",
            "target": "Prolonged median sensory and/or motor distal latency; reduced SNAP amplitude; denervation in thenar muscles (severe)",
            "contraindications": "Anticoagulation for needle EMG (relative)"
          },
          {
            "item": "Wrist X-ray (CPT 73110)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If fracture, arthritis, or bony abnormality suspected",
            "target": "Normal or degenerative changes; exclude fracture",
            "contraindications": "None"
          }
        ],
        "Extended": [
          {
            "item": "Wrist/carpal tunnel ultrasound (CPT 76882)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Alternative to MRI; can measure median nerve CSA; operator-dependent",
            "target": "Median nerve CSA >10-12 mm² at pisiform level; flattening at tunnel",
            "contraindications": "None"
          },
          {
            "item": "MRI wrist without contrast (CPT 73221)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Mass lesion, ganglion cyst, tenosynovitis, anatomic variant",
            "target": "No mass, normal median nerve signal",
            "contraindications": "Pacemaker; claustrophobia"
          },
          {
            "item": "MRI cervical spine with and without contrast (CPT 72156)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Rule out cervical radiculopathy if double crush suspected or atypical presentation",
            "target": "No foraminal stenosis at C6-C7",
            "contraindications": "GFR <30; pacemaker; gadolinium allergy"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CT wrist (CPT 73200)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Bony pathology not visible on X-ray; post-traumatic",
            "target": "No fracture or bony deformity",
            "contraindications": "Pregnancy (relative)"
          },
          {
            "item": "MRI with contrast (CPT 73222)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Suspected tumor or inflammatory mass in carpal tunnel",
            "target": "No enhancing mass",
            "contraindications": "GFR <30; pacemaker; gadolinium allergy"
          },
          {
            "item": "Comparative NCS (ulnar and radial) (CPT 95907-95909)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Distinguish CTS from polyneuropathy or brachial plexopathy",
            "target": "Normal ulnar and radial studies",
            "contraindications": "None"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Wrist splinting (neutral position)",
            "route": "External",
            "indication": "First-line conservative therapy; nocturnal use prevents wrist flexion",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Neutral position splint",
                  "orderSentence": "Wrist splinting (neutral position) Neutral position splint External"
                }
              ],
              "route": "External",
              "instructions": "Wear nightly x 4-6 weeks; may use during day if symptomatic; neutral wrist position (0-5 degrees extension)",
              "orderSentence": "Wrist splinting (neutral position) Neutral position splint External"
            },
            "contraindications": "None",
            "monitoring": "Skin irritation; compliance",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "NSAID therapy (short-term)",
            "route": "PO",
            "indication": "Acute symptom relief; limited evidence for CTS-specific benefit",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg",
                  "orderSentence": "NSAID therapy (short-term) 400 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Ibuprofen 400 mg TID or Naproxen 500 mg BID; short course (7-14 days); take with food; not for long-term use",
              "orderSentence": "NSAID therapy (short-term) 400 mg PO"
            },
            "contraindications": "GI bleeding; renal impairment; cardiovascular disease; third trimester pregnancy",
            "monitoring": "GI symptoms; renal function",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Neuropathic pain/paresthesias (adjunctive)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Gabapentin 300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; increase by 300 mg q3-7d; max 1800 mg/day for CTS",
              "orderSentence": "Gabapentin 300 mg PO"
            },
            "contraindications": "Renal impairment (dose adjust per CrCl)",
            "monitoring": "Sedation, dizziness, edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "Neuropathic pain/paresthesias",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg",
                  "orderSentence": "Pregabalin 75 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 75 mg BID; may increase to 150 mg BID after 1 week",
              "orderSentence": "Pregabalin 75 mg PO"
            },
            "contraindications": "Renal impairment; Class V controlled",
            "monitoring": "Sedation, weight gain, edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Duloxetine",
            "route": "PO",
            "indication": "Neuropathic pain with comorbid anxiety/depression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg",
                  "orderSentence": "Duloxetine 30 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 30 mg daily; increase to 60 mg after 1 week",
              "orderSentence": "Duloxetine 30 mg PO"
            },
            "contraindications": "Hepatic impairment; CrCl <30; MAOIs; narrow-angle glaucoma",
            "monitoring": "Nausea, BP; taper to discontinue",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "PO",
            "indication": "Nocturnal paresthesias (second-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Amitriptyline 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg qHS; increase by 10 mg weekly; max 50 mg qHS",
              "orderSentence": "Amitriptyline 10 mg PO"
            },
            "contraindications": "Cardiac conduction abnormality; urinary retention; glaucoma; elderly",
            "monitoring": "ECG if >50 mg; anticholinergic effects",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Topical diclofenac",
            "route": "TOP",
            "indication": "Localized pain/inflammation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Apply gel",
                  "orderSentence": "Topical diclofenac Apply gel TOP"
                }
              ],
              "route": "TOP",
              "instructions": "Apply to wrist area TID-QID; max 4 weeks",
              "orderSentence": "Topical diclofenac Apply gel TOP"
            },
            "contraindications": "Aspirin-sensitive asthma; open wounds",
            "monitoring": "Local skin irritation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lidocaine 5% patch",
            "route": "TOP",
            "indication": "Localized pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 patch",
                  "orderSentence": "Lidocaine 5% patch 1 patch TOP"
                }
              ],
              "route": "TOP",
              "instructions": "Apply to wrist/forearm 12h on, 12h off",
              "orderSentence": "Lidocaine 5% patch 1 patch TOP"
            },
            "contraindications": "Broken skin; severe hepatic impairment",
            "monitoring": "Minimal systemic absorption",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory (Injection Therapy)": [
          {
            "item": "Methylprednisolone acetate injection",
            "route": "Local injection",
            "indication": "Moderate CTS failing conservative therapy; bridge to surgery; pregnancy-related CTS",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Methylprednisolone acetate injection 40 mg Local injection"
                }
              ],
              "route": "Local injection",
              "instructions": "40 mg (1 mL) injected into carpal tunnel under ultrasound guidance preferred; may repeat x1 at 4-6 weeks",
              "orderSentence": "Methylprednisolone acetate injection 40 mg Local injection"
            },
            "contraindications": "Local infection; bleeding disorder; uncontrolled diabetes",
            "monitoring": "Blood glucose (diabetics) 24-48h post-injection; tendon rupture (rare)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Triamcinolone acetonide injection",
            "route": "Local injection",
            "indication": "Alternative corticosteroid for injection",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20-40 mg",
                  "orderSentence": "Triamcinolone acetonide injection 20-40 mg Local injection"
                }
              ],
              "route": "Local injection",
              "instructions": "20-40 mg injected into carpal tunnel; ultrasound guidance recommended",
              "orderSentence": "Triamcinolone acetonide injection 20-40 mg Local injection"
            },
            "contraindications": "Local infection; bleeding disorder; uncontrolled diabetes",
            "monitoring": "Blood glucose (diabetics); skin depigmentation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dexamethasone injection",
            "route": "Local injection",
            "indication": "Alternative corticosteroid (shorter acting)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg",
                  "orderSentence": "Dexamethasone injection 4 mg Local injection"
                }
              ],
              "route": "Local injection",
              "instructions": "4 mg injected into carpal tunnel; shorter duration than triamcinolone",
              "orderSentence": "Dexamethasone injection 4 mg Local injection"
            },
            "contraindications": "Local infection; bleeding disorder",
            "monitoring": "Blood glucose (diabetics)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Platelet-rich plasma (PRP) injection",
            "route": "Local injection",
            "indication": "Experimental; refractory cases; patient preference to avoid surgery",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-3 mL PRP",
                  "orderSentence": "Platelet-rich plasma (PRP) injection 2-3 mL PRP Local injection"
                }
              ],
              "route": "Local injection",
              "instructions": "Single injection under ultrasound; emerging evidence",
              "orderSentence": "Platelet-rich plasma (PRP) injection 2-3 mL PRP Local injection"
            },
            "contraindications": "Infection; thrombocytopenia; malignancy",
            "monitoring": "Observe 15 min post-injection",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Definitive Surgical Treatment": [
          {
            "item": "Carpal tunnel release (CTR) - open",
            "route": "Surgical",
            "indication": "Moderate-severe CTS; thenar atrophy; failed conservative therapy x 3-6 months; constant numbness",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Surgical release",
                  "orderSentence": "Carpal tunnel release (CTR) - open Surgical release Outpatient surgery"
                }
              ],
              "route": "Outpatient surgery",
              "instructions": "Open technique; divide transverse carpal ligament; 15-30 min procedure",
              "orderSentence": "Carpal tunnel release (CTR) - open Surgical release Outpatient surgery"
            },
            "pretreatment": "NCS confirmation of diagnosis recommended; optimize diabetes; discuss expectations",
            "contraindications": "Active infection; unstable medical status; anticoagulation (relative)",
            "monitoring": "Post-op pain; wound healing; grip strength; pillar pain",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carpal tunnel release (CTR) - endoscopic",
            "route": "Surgical",
            "indication": "Same indications as open CTR; faster return to work; surgeon preference",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Surgical release",
                  "orderSentence": "Carpal tunnel release (CTR) - endoscopic Surgical release Outpatient surgery"
                }
              ],
              "route": "Outpatient surgery",
              "instructions": "Endoscopic technique (1 or 2 portal); divide transverse carpal ligament",
              "orderSentence": "Carpal tunnel release (CTR) - endoscopic Surgical release Outpatient surgery"
            },
            "pretreatment": "NCS confirmation recommended; optimize diabetes",
            "contraindications": "Active infection; prior carpal tunnel surgery (relative); anatomic variants",
            "monitoring": "Post-op pain; transient nerve injury (1-2%); wound healing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Hand surgery or orthopedic surgery referral for carpal tunnel release evaluation when conservative therapy fails or severe CTS present",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Electrodiagnostic medicine/neurology for NCS/EMG to confirm diagnosis and grade severity before surgical intervention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational medicine for workplace ergonomic assessment and work restrictions if occupational risk factors present",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical/occupational therapy for nerve gliding exercises, ergonomic training, and activity modification",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rheumatology referral if inflammatory arthritis suspected as underlying cause (RA, gout)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Endocrinology for diabetes optimization or hypothyroidism management if contributing to CTS",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Primary care for management of modifiable risk factors (diabetes, obesity, hypothyroidism)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain management if refractory neuropathic symptoms despite treatment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Wear wrist splint nightly in neutral position for minimum 4-6 weeks; may wear during day if symptoms persist with activities",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid prolonged wrist flexion or extension (typing, gripping tools, driving) as this increases carpal tunnel pressure",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take frequent breaks during repetitive hand activities (every 30-60 minutes) to rest wrists",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Perform nerve gliding exercises as instructed by therapist to improve median nerve mobility",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Apply ice for 10-15 minutes if wrist swelling present; avoid direct ice contact with skin",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report worsening numbness, weakness in thumb, or dropping objects (may indicate progression requiring surgery)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid sleeping with wrists curled under pillow; maintain neutral wrist position during sleep",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "If pregnant, symptoms often improve after delivery; conservative management preferred during pregnancy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "After corticosteroid injection, temporary increase in symptoms may occur first 24-48 hours before improvement",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Post-surgical: Keep incision clean and dry; elevate hand; start motion as directed; full grip strength recovery may take 3-6 months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Optimize glycemic control (HbA1c <7%) as diabetes worsens nerve function and CTS outcomes",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Weight loss if overweight/obese as obesity is modifiable risk factor for CTS",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Ergonomic workstation setup: keyboard at elbow height, wrists neutral, avoid resting wrists on hard surfaces",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use ergonomic keyboard, mouse, and tools if occupation involves repetitive hand use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation to improve microvascular circulation and nerve healing",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid prolonged use of vibrating tools or take breaks every 15-30 minutes when using such equipment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Reduce caffeine and alcohol intake as these may worsen paresthesias in some patients",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Treat underlying thyroid disease as hypothyroidism contributes to CTS through tissue edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stretch and warm up hands before repetitive activities",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Vitamin B6 supplementation not recommended (evidence does not support benefit; high doses cause neuropathy)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Cervical radiculopathy (C6-C7)",
        "features": "Neck pain, dermatomal pattern (not strictly median), reflex changes (C6: brachioradialis; C7: triceps), negative Phalen/Tinel",
        "tests": "MRI cervical spine; NCS/EMG shows radicular pattern; neck range of motion limited"
      },
      {
        "diagnosis": "Pronator syndrome",
        "features": "Forearm pain/tenderness at pronator teres, symptoms with resisted pronation, no nocturnal worsening, palmar cutaneous branch affected",
        "tests": "NCS/EMG; tenderness at pronator teres on exam; provocative testing"
      },
      {
        "diagnosis": "Anterior interosseous syndrome",
        "features": "Weakness only (FPL, FDP to index, pronator quadratus); no sensory loss; pinch weakness",
        "tests": "NCS/EMG; cannot make \"OK\" sign (pinch between thumb and index)"
      },
      {
        "diagnosis": "Thoracic outlet syndrome",
        "features": "Shoulder/arm pain, positional symptoms, vascular symptoms (pallor, cyanosis), C8-T1 distribution",
        "tests": "Adson test; ROOS test; X-ray for cervical rib; MRA; NCS"
      },
      {
        "diagnosis": "Ulnar neuropathy at elbow (cubital tunnel)",
        "features": "Numbness in ring and small finger, hand weakness, elbow symptoms, positive Tinel at elbow",
        "tests": "NCS/EMG shows ulnar slowing at elbow; sensory exam (ulnar digits spared in CTS)"
      },
      {
        "diagnosis": "Peripheral polyneuropathy",
        "features": "Symmetric symptoms, length-dependent, feet often affected first, multiple nerve territories",
        "tests": "NCS shows generalized abnormalities; HbA1c; B12; metabolic panel"
      },
      {
        "diagnosis": "De Quervain tenosynovitis",
        "features": "Radial wrist pain, positive Finkelstein test, no numbness, tenderness over 1st dorsal compartment",
        "tests": "Finkelstein test positive; ultrasound shows tendon thickening; no NCS abnormalities"
      },
      {
        "diagnosis": "Raynaud phenomenon",
        "features": "Color changes (white-blue-red), cold-triggered, bilateral, no weakness",
        "tests": "No NCS abnormalities; may have positive ANA; capillaroscopy"
      },
      {
        "diagnosis": "Brachial plexopathy",
        "features": "Shoulder/arm weakness and sensory loss in plexus pattern, may have Horner syndrome",
        "tests": "NCS/EMG; MRI brachial plexus; distribution beyond median nerve"
      },
      {
        "diagnosis": "Trigger finger",
        "features": "Finger locking/clicking, palm nodule, no numbness in median distribution",
        "tests": "Palpable nodule at A1 pulley; no NCS abnormalities; triggering on exam"
      },
      {
        "diagnosis": "Ganglion cyst (volar wrist)",
        "features": "Palpable mass, may transilluminate, compresses median nerve",
        "tests": "Ultrasound or MRI shows cystic structure; NCS may be normal or show CTS"
      },
      {
        "diagnosis": "Multiple sclerosis",
        "features": "Central demyelination; other neurologic symptoms; sensory symptoms may mimic CTS",
        "tests": "MRI brain/spine; CSF oligoclonal bands; NCS normal"
      },
      {
        "diagnosis": "Syringomyelia",
        "features": "Dissociated sensory loss (pain/temp preserved, vibration lost), cape distribution, central cord lesion",
        "tests": "MRI cervical spine shows syrinx cavity"
      },
      {
        "diagnosis": "Amyloidosis",
        "features": "Bilateral CTS, cardiac involvement, macroglossia, renal disease, family history (hATTR)",
        "tests": "SPEP/UPEP; free light chains; TTR gene; tissue biopsy"
      }
    ],
    "evidence": [
      {
        "recommendation": "Nocturnal wrist splinting is effective first-line treatment for CTS",
        "evidenceLevel": "Class I, Level A",
        "source": "[Page MJ et al. Cochrane Database Syst Rev 2012](https://pubmed.ncbi.nlm.nih.gov/22786497/)"
      },
      {
        "recommendation": "NCS/EMG recommended for diagnostic confirmation before surgery",
        "evidenceLevel": "Class II, Level B",
        "source": "[Werner RA et al. Muscle Nerve 2011](https://pubmed.ncbi.nlm.nih.gov/21922474/)"
      },
      {
        "recommendation": "Corticosteroid injection provides short-term symptom relief",
        "evidenceLevel": "Class I, Level A",
        "source": "[Marshall S et al. Cochrane Database Syst Rev 2007](https://pubmed.ncbi.nlm.nih.gov/17253462/)"
      },
      {
        "recommendation": "Carpal tunnel release surgery is effective for moderate-severe CTS",
        "evidenceLevel": "Class I, Level A",
        "source": "[Verdugo RJ et al. Cochrane Database Syst Rev 2008](https://pubmed.ncbi.nlm.nih.gov/18843658/)"
      },
      {
        "recommendation": "Ultrasound-guided injection improves accuracy and outcomes",
        "evidenceLevel": "Class II, Level B",
        "source": "[Ustun N et al. Arch Phys Med Rehabil 2013](https://pubmed.ncbi.nlm.nih.gov/23267555/)"
      },
      {
        "recommendation": "Diabetes mellitus is significant risk factor for CTS",
        "evidenceLevel": "Class II, Level B",
        "source": "[Pourmemari MH et al. Diabet Med 2016](https://pubmed.ncbi.nlm.nih.gov/26108553/)"
      },
      {
        "recommendation": "Clinical examination (Phalen, Tinel) has moderate sensitivity/specificity",
        "evidenceLevel": "Class II, Level B",
        "source": "[Middleton SD et al. J Hand Surg Eur Vol 2014](https://pubmed.ncbi.nlm.nih.gov/23824222/)"
      },
      {
        "recommendation": "Severe CTS with thenar atrophy should be referred for surgery",
        "evidenceLevel": "Class II, Level B",
        "source": "[Graham B et al. J Am Acad Orthop Surg 2016](https://pubmed.ncbi.nlm.nih.gov/26803543/)"
      },
      {
        "recommendation": "Endoscopic and open CTR have equivalent long-term outcomes",
        "evidenceLevel": "Class I, Level A",
        "source": "[Scholten RJ et al. Cochrane Database Syst Rev 2007](https://pubmed.ncbi.nlm.nih.gov/17943857/)"
      },
      {
        "recommendation": "Pregnancy-related CTS often resolves postpartum",
        "evidenceLevel": "Class III, Level C",
        "source": "[Padua L et al. Muscle Nerve 2010](https://pubmed.ncbi.nlm.nih.gov/20082417/)"
      },
      {
        "recommendation": "Median nerve CSA >10-12 mm² on ultrasound supports CTS diagnosis",
        "evidenceLevel": "Class II, Level B",
        "source": "[Cartwright MS et al. Muscle Nerve 2012](https://pubmed.ncbi.nlm.nih.gov/22334176/)"
      },
      {
        "recommendation": "Nerve gliding exercises may provide modest benefit as adjunct therapy",
        "evidenceLevel": "Class II, Level C",
        "source": "[Ballestero-Perez R et al. J Orthop Sports Phys Ther 2017](https://pubmed.ncbi.nlm.nih.gov/28622488/)"
      },
      {
        "recommendation": "AAOS Clinical Practice Guideline for CTS",
        "evidenceLevel": "Guideline",
        "source": "[AAOS Guideline 2016](https://pubmed.ncbi.nlm.nih.gov/26803543/)"
      },
      {
        "recommendation": "AANEM practice parameter for electrodiagnosis of CTS",
        "evidenceLevel": "Guideline",
        "source": "[Jablecki CK et al. Muscle Nerve 2002](https://pubmed.ncbi.nlm.nih.gov/12210353/)"
      }
    ],
    "monitoring": [
      {
        "item": "Symptom severity (numbness, tingling, nocturnal symptoms)",
        "frequency": "Each visit",
        "action": "Consider escalation: injection if splinting fails; surgery if injection fails",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Grip strength",
        "frequency": "Baseline and q4-8 weeks if weakness",
        "action": "Expedite surgical referral if progressive weakness",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Thenar muscle bulk",
        "frequency": "Each visit",
        "action": "If atrophy developing, urgent surgical referral (indicates severe CTS)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Two-point discrimination",
        "frequency": "Baseline and periodic",
        "action": "If abnormal/worsening, indicates sensory axonal loss; consider surgery",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Splint compliance",
        "frequency": "Each visit",
        "action": "Re-educate; consider injection if compliant but not improving",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "HbA1c (diabetic patients)",
        "frequency": "Every 3 months",
        "action": "Intensify diabetes management",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "TSH (if hypothyroid)",
        "frequency": "Every 6-12 months",
        "action": "Adjust thyroid replacement",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Post-injection response",
        "frequency": "2-4 weeks after injection",
        "action": "If no improvement, discuss surgical options",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Post-surgical wound healing",
        "frequency": "7-14 days post-op",
        "action": "If infection signs, antibiotics and wound care",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Post-surgical sensory/motor function",
        "frequency": "6 weeks, 3 months, 6 months post-op",
        "action": "If not improving, NCS/EMG; consider incomplete release or scarring",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Recurrence after surgery",
        "frequency": "Annual if risk factors present",
        "action": "NCS; consider revision surgery if confirmed recurrence",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "**Discharge home**",
        "criteria": "Mild-moderate CTS; can use splint; outpatient neurology/hand surgery follow-up arranged; no thenar atrophy; no progressive weakness"
      },
      {
        "disposition": "**Admit to floor**",
        "criteria": "Acute compartment syndrome of forearm/hand (rare); post-operative complication requiring observation; severe medical comorbidities requiring inpatient management"
      },
      {
        "disposition": "**Admit to ICU**",
        "criteria": "Not typical for CTS; only if concurrent critical illness"
      },
      {
        "disposition": "**Urgent surgical referral**",
        "criteria": "Thenar atrophy; progressive weakness; constant numbness with sensory loss; failed conservative therapy >6 months; severe CTS on NCS with denervation"
      },
      {
        "disposition": "**Routine surgical referral**",
        "criteria": "Moderate CTS with inadequate response to splinting and injection; patient preference; occupational impairment"
      },
      {
        "disposition": "**Outpatient follow-up**",
        "criteria": "Most patients; splinting trial with reassessment in 4-6 weeks; post-injection follow-up in 2-4 weeks"
      }
    ]
  },
  "Radiculopathy - Cervical and Lumbar": {
    "id": "radiculopathy",
    "title": "Radiculopathy - Cervical and Lumbar",
    "version": "1.1",
    "icd10": [
      "** M54.10 (Radiculopathy",
      "site unspecified)",
      "M54.12 (Radiculopathy",
      "cervical region)",
      "M54.13 (Radiculopathy",
      "cervicothoracic region)",
      "M54.16 (Radiculopathy",
      "lumbar region)",
      "M54.17 (Radiculopathy",
      "lumbosacral region)",
      "G55 (Nerve root and plexus compressions in diseases classified elsewhere)",
      "M50.10 (Cervical disc disorder with radiculopathy",
      "unspecified)",
      "M51.16 (Intervertebral disc disorders with radiculopathy",
      "lumbar region)"
    ],
    "scope": "** Evaluation and management of cervical (C5-T1) and lumbar (L2-S1) radiculopathy in adults. Covers red flag identification, diagnostic workup including imaging and electrodiagnostic testing, conservative management, interventional treatments, and surgical indications. Excludes spinal cord compression (myelopathy), cauda equina syndrome (requires emergent surgical evaluation), thoracic radiculopathy, and post-surgical radiculopathy.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Infection screen if fever, malignancy screen",
            "target": "Normal WBC; no anemia"
          },
          {
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Baseline renal/hepatic function for medications; metabolic causes",
            "target": "Normal"
          },
          {
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Inflammatory marker for infection, malignancy, spondyloarthropathy",
            "target": "<20 mm/hr (age-adjusted)"
          },
          {
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Inflammatory marker for infection, malignancy",
            "target": "<0.5 mg/dL"
          }
        ],
        "Extended Workup": [
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes increases neuropathy risk; affects surgical outcomes",
            "target": "<5.7%"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes screening",
            "target": "<100 mg/dL"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Combined neuropathy may confuse presentation",
            "target": ">300 pg/mL"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypothyroidism can cause myopathy, neuropathy",
            "target": "Normal (0.4-4.0 mIU/L)"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Ankylosing spondylitis, spondyloarthropathy if young patient with inflammatory back pain",
            "target": "Negative"
          },
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "UTI can mimic/exacerbate symptoms; pre-operative screen",
            "target": "Normal"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Prostate cancer metastases to spine",
            "target": "Age-appropriate normal"
          },
          {
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "If fever or infection suspected",
            "target": "No growth"
          }
        ],
        "Rare/Specialized": [
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Multiple myeloma with vertebral lesions",
            "target": "No M-spike"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Endemic areas with radiculopathy, polyradiculopathy",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Atypical presentation, weight loss, subacute course",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Connective tissue disease",
            "target": "Negative or low titer"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Sarcoidosis with multifocal radiculopathy",
            "target": "Normal"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "ED": "STAT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "STAT if red flags; otherwise after 4-6 weeks conservative treatment fails",
            "target": "Disc herniation, foraminal stenosis, nerve root compression",
            "contraindications": "MRI-incompatible pacemaker; cochlear implant; metallic foreign body"
          },
          {
            "ED": "STAT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "If infection, tumor, or inflammatory etiology suspected",
            "target": "Enhancement pattern (abscess rim, tumor, leptomeningeal)",
            "contraindications": "GFR <30 (for gadolinium); MRI-incompatible device; gadolinium allergy"
          },
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Initial screen for instability, spondylolisthesis, fracture, alignment",
            "target": "No fracture, normal alignment, no listhesis",
            "contraindications": "Pregnancy (shield abdomen)"
          }
        ],
        "Extended": [
          {
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "If MRI contraindicated; bony detail for fracture, foraminal stenosis",
            "target": "Foraminal narrowing, osteophytes, fracture",
            "contraindications": "Pregnancy (relative); contrast allergy (if contrast used)"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "MRI contraindicated and need for neural visualization",
            "target": "Filling defect at nerve root, cord compression",
            "contraindications": "Coagulopathy (for LP); intracranial mass"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "3-4 weeks after symptom onset to confirm radiculopathy, exclude peripheral neuropathy, localize level",
            "target": "Fibrillations/positive sharp waves in myotomal distribution; reduced recruitment",
            "contraindications": "Pacemaker (relative for needle EMG); anticoagulation (relative)"
          }
        ],
        "Rare/Specialized": [
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "To confirm symptomatic level when imaging shows multilevel disease",
            "target": ">50% pain relief confirms level",
            "contraindications": "Coagulopathy; infection at injection site; allergy to contrast/anesthetic"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Suspected occult fracture, metastatic disease, infection",
            "target": "No increased uptake",
            "contraindications": "Pregnancy"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Occult malignancy, extent of metastatic disease",
            "target": "No FDG-avid lesions",
            "contraindications": "Pregnancy; uncontrolled diabetes"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Identify painful disc level before fusion (controversial)",
            "target": "Concordant pain reproduction",
            "contraindications": "Coagulopathy; local infection; allergy"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Methylprednisolone",
            "route": "IV",
            "indication": "Severe acute radiculopathy with significant weakness",
            "dosing": {
              "doseOptions": [
                {
                  "text": "125 mg",
                  "orderSentence": "Methylprednisolone 125 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "125 mg IV once; may give for severe acute radicular symptoms",
              "orderSentence": "Methylprednisolone 125 mg IV"
            },
            "contraindications": "Active infection; uncontrolled diabetes; GI bleeding",
            "monitoring": "Glucose; BP; GI symptoms",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Dexamethasone",
            "route": "IV/PO",
            "indication": "Acute severe radiculopathy, disc herniation with inflammation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Dexamethasone 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg IV once, then 4 mg IV/PO q6h x 3-5 days; taper over 5-7 days",
              "orderSentence": "Dexamethasone 10 mg IV"
            },
            "contraindications": "Active infection; uncontrolled diabetes; GI bleeding",
            "monitoring": "Glucose; BP; psychiatric effects",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Prednisone",
            "route": "PO",
            "indication": "Acute radiculopathy with moderate-severe symptoms",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg",
                  "orderSentence": "Prednisone 60 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "60 mg daily x 5 days then taper; OR Medrol dose pack",
              "orderSentence": "Prednisone 60 mg PO"
            },
            "contraindications": "Active GI bleed; uncontrolled DM; active infection",
            "monitoring": "Glucose; BP; mood",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ketorolac",
            "route": "IV/IM",
            "indication": "Acute pain, anti-inflammatory",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg",
                  "orderSentence": "Ketorolac 30 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "30 mg IV/IM q6h; max 5 days; reduce to 15 mg if elderly/renal impairment",
              "orderSentence": "Ketorolac 30 mg IV"
            },
            "contraindications": "CrCl <30; active GI bleed; aspirin allergy; post-CABG",
            "monitoring": "Renal function; GI bleeding",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Morphine",
            "route": "IV",
            "indication": "Severe acute radicular pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-4 mg",
                  "orderSentence": "Morphine 2-4 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "2-4 mg IV q2-4h PRN severe pain; titrate to effect",
              "orderSentence": "Morphine 2-4 mg IV"
            },
            "contraindications": "Respiratory depression; severe asthma; paralytic ileus",
            "monitoring": "Respiratory status; sedation; pain scores",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Hydromorphone",
            "route": "IV",
            "indication": "Severe acute radicular pain (alternative to morphine)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5-1 mg",
                  "orderSentence": "Hydromorphone 0.5-1 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-1 mg IV q2-4h PRN; titrate to effect",
              "orderSentence": "Hydromorphone 0.5-1 mg IV"
            },
            "contraindications": "Respiratory depression; severe asthma; paralytic ileus",
            "monitoring": "Respiratory status; sedation; pain scores",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Diazepam",
            "route": "PO/IV",
            "indication": "Acute muscle spasm",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Diazepam 5 mg PO/IV"
                }
              ],
              "route": "PO/IV",
              "instructions": "5-10 mg PO/IV q6-8h PRN for muscle spasm; short course (1-2 weeks)",
              "orderSentence": "Diazepam 5 mg PO/IV"
            },
            "contraindications": "Severe respiratory insufficiency; myasthenia gravis; acute narrow-angle glaucoma",
            "monitoring": "Sedation; respiratory depression; dependence",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments - Pain Management": [
          {
            "item": "Ibuprofen",
            "route": "PO",
            "indication": "Radicular pain, inflammation (first-line OTC)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg",
                  "orderSentence": "Ibuprofen 400 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "400-800 mg TID with food; max 3200 mg/day; short-term use preferred",
              "orderSentence": "Ibuprofen 400 mg PO"
            },
            "contraindications": "CrCl <30; active GI bleed; aspirin allergy; third trimester pregnancy",
            "monitoring": "GI symptoms; renal function with prolonged use",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Naproxen",
            "route": "PO",
            "indication": "Radicular pain, inflammation (longer duration)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg",
                  "orderSentence": "Naproxen 250 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "250-500 mg BID with food; max 1500 mg/day",
              "orderSentence": "Naproxen 250 mg PO"
            },
            "contraindications": "CrCl <30; active GI bleed; aspirin allergy; third trimester pregnancy",
            "monitoring": "GI symptoms; renal function with prolonged use",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Meloxicam",
            "route": "PO",
            "indication": "Radicular pain (once daily dosing)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7.5 mg",
                  "orderSentence": "Meloxicam 7.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "7.5-15 mg daily; max 15 mg/day",
              "orderSentence": "Meloxicam 7.5 mg PO"
            },
            "contraindications": "CrCl <30; active GI bleed; aspirin allergy",
            "monitoring": "GI symptoms; renal function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Celecoxib",
            "route": "PO",
            "indication": "Radicular pain (GI-sparing COX-2)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Celecoxib 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "100-200 mg BID; max 400 mg/day",
              "orderSentence": "Celecoxib 100 mg PO"
            },
            "contraindications": "Sulfonamide allergy; CAD/CVD (increased CV risk); CrCl <30",
            "monitoring": "CV events; GI symptoms; renal function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Acetaminophen",
            "route": "PO",
            "indication": "Mild-moderate pain (adjunct, avoid hepatotoxicity)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650 mg",
                  "orderSentence": "Acetaminophen 650 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "650-1000 mg q6h; max 3000 mg/day (2000 mg/day if liver disease)",
              "orderSentence": "Acetaminophen 650 mg PO"
            },
            "contraindications": "Severe hepatic impairment; chronic alcohol use",
            "monitoring": "LFTs with prolonged use",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Neuropathic/radicular pain (first-line for radiculopathy)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Gabapentin 300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; increase by 300 mg q1-3d; target 900-1800 mg TID; max 3600 mg/day",
              "orderSentence": "Gabapentin 300 mg PO"
            },
            "contraindications": "Renal impairment (adjust: CrCl 30-59 max 1400 mg/day; CrCl 15-29 max 600 mg/day; CrCl <15 max 300 mg/day)",
            "monitoring": "Sedation; dizziness; edema; taper to discontinue",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "Neuropathic/radicular pain (first-line alternative)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg",
                  "orderSentence": "Pregabalin 75 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 75 mg BID; increase to 150 mg BID after 1 week; max 300 mg BID (600 mg/day)",
              "orderSentence": "Pregabalin 75 mg PO"
            },
            "contraindications": "Renal impairment (adjust per CrCl); Class V controlled",
            "monitoring": "Sedation; weight gain; edema; dizziness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Duloxetine",
            "route": "PO",
            "indication": "Neuropathic/radicular pain with depression/anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg",
                  "orderSentence": "Duloxetine 30 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 30 mg daily x 1 week; increase to 60 mg daily; max 120 mg/day",
              "orderSentence": "Duloxetine 30 mg PO"
            },
            "contraindications": "Hepatic impairment; CrCl <30; MAOIs; narrow-angle glaucoma",
            "monitoring": "Nausea; BP; discontinuation syndrome (taper over 2+ weeks)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cyclobenzaprine",
            "route": "PO",
            "indication": "Muscle spasm (short-term)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Cyclobenzaprine 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10 mg TID; max 30 mg/day; limit to 2-3 weeks",
              "orderSentence": "Cyclobenzaprine 5 mg PO"
            },
            "contraindications": "Arrhythmia; heart failure; MAOIs within 14 days; hyperthyroidism",
            "monitoring": "Sedation; anticholinergic effects; dry mouth",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tizanidine",
            "route": "PO",
            "indication": "Muscle spasm (alternative to cyclobenzaprine)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg",
                  "orderSentence": "Tizanidine 2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2 mg TID; increase by 2-4 mg q6-8h; max 36 mg/day in divided doses",
              "orderSentence": "Tizanidine 2 mg PO"
            },
            "contraindications": "Concurrent ciprofloxacin or fluvoxamine (CYP1A2 inhibitors); hepatic impairment",
            "monitoring": "LFTs at baseline, 1, 3, 6 months; sedation; hypotension",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Methocarbamol",
            "route": "PO",
            "indication": "Muscle spasm (less sedating)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1500 mg",
                  "orderSentence": "Methocarbamol 1500 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "1500 mg QID x 2-3 days, then 750 mg QID or 1500 mg TID",
              "orderSentence": "Methocarbamol 1500 mg PO"
            },
            "contraindications": "Renal impairment (use caution); myasthenia gravis",
            "monitoring": "Sedation; dizziness (less than other relaxants)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Baclofen",
            "route": "PO",
            "indication": "Muscle spasm (if other relaxants fail)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Baclofen 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg TID; increase by 5 mg/dose q3d; max 80 mg/day",
              "orderSentence": "Baclofen 5 mg PO"
            },
            "contraindications": "Withdrawal risk if stopped abruptly; renal impairment",
            "monitoring": "Sedation; weakness; must taper to discontinue (seizure risk)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lidocaine patch 5%",
            "route": "TOP",
            "indication": "Localized radicular pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-3 patches",
                  "orderSentence": "Lidocaine patch 5% 1-3 patches TOP"
                }
              ],
              "route": "TOP",
              "instructions": "Apply 1-3 patches to affected area for 12h on, 12h off",
              "orderSentence": "Lidocaine patch 5% 1-3 patches TOP"
            },
            "contraindications": "Severe hepatic impairment; broken skin",
            "monitoring": "Minimal systemic absorption; local skin irritation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Capsaicin cream 0.075%",
            "route": "TOP",
            "indication": "Localized radicular pain (adjunct)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Apply thin layer",
                  "orderSentence": "Capsaicin cream 0.075% Apply thin layer TOP"
                }
              ],
              "route": "TOP",
              "instructions": "Apply TID-QID to affected area; takes 2-4 weeks for effect",
              "orderSentence": "Capsaicin cream 0.075% Apply thin layer TOP"
            },
            "contraindications": "Open wounds; avoid eyes/mucous membranes",
            "monitoring": "Initial burning (decreases with use); wash hands after",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "PO",
            "indication": "Neuropathic pain (second-line, helps sleep)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Amitriptyline 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg qHS; increase by 10-25 mg weekly; max 150 mg qHS",
              "orderSentence": "Amitriptyline 10 mg PO"
            },
            "contraindications": "Cardiac conduction abnormality; recent MI; urinary retention; glaucoma; elderly",
            "monitoring": "ECG if dose >100 mg/day; anticholinergic effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nortriptyline",
            "route": "PO",
            "indication": "Neuropathic pain (second-line, less sedating than amitriptyline)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Nortriptyline 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg qHS; increase by 10-25 mg weekly; max 150 mg qHS",
              "orderSentence": "Nortriptyline 10 mg PO"
            },
            "contraindications": "Cardiac conduction abnormality; recent MI; urinary retention; glaucoma; elderly",
            "monitoring": "ECG if dose >100 mg/day; fewer anticholinergic effects than amitriptyline",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Tramadol",
            "route": "PO",
            "indication": "Moderate radicular pain not controlled by NSAIDs/gabapentinoids",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Tramadol 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg q6h PRN; may use ER 100 mg daily; max 400 mg/day",
              "orderSentence": "Tramadol 50 mg PO"
            },
            "contraindications": "Seizure disorder; MAOIs; SSRIs (serotonin syndrome); severe renal/hepatic impairment",
            "monitoring": "Serotonin syndrome; seizures; dependence (Schedule IV)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxycodone",
            "route": "PO",
            "indication": "Moderate-severe radicular pain (short-term)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Oxycodone 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10 mg PO q4-6h PRN; for short-term use only",
              "orderSentence": "Oxycodone 5 mg PO"
            },
            "contraindications": "Respiratory depression; paralytic ileus; MAOIs",
            "monitoring": "Sedation; constipation; respiratory status; dependence (Schedule II)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxycodone/Acetaminophen",
            "route": "PO",
            "indication": "Moderate-severe radicular pain (short-term)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5/325 mg",
                  "orderSentence": "Oxycodone/Acetaminophen 5/325 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10/325 mg q4-6h PRN; max acetaminophen 3000 mg/day",
              "orderSentence": "Oxycodone/Acetaminophen 5/325 mg PO"
            },
            "contraindications": "Respiratory depression; hepatic impairment; paralytic ileus",
            "monitoring": "Sedation; respiratory status; LFTs; total acetaminophen intake",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Epidural steroid injection (ESI)",
            "route": "Fluoroscopic",
            "indication": "Radicular pain refractory to conservative treatment x 4-6 weeks",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per protocol",
                  "orderSentence": "Epidural steroid injection (ESI) Per protocol Fluoroscopic"
                }
              ],
              "route": "Fluoroscopic",
              "instructions": "Transforaminal or interlaminar approach; up to 3 injections per year",
              "orderSentence": "Epidural steroid injection (ESI) Per protocol Fluoroscopic"
            },
            "contraindications": "Coagulopathy (INR >1.5, plt <100k); infection at site; allergy to contrast/steroids",
            "monitoring": "Post-procedure neuro exam; glucose (diabetics); headache",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Transforaminal ESI (TFESI)",
            "route": "Fluoroscopic",
            "indication": "Unilateral radicular symptoms, foraminal stenosis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per protocol",
                  "orderSentence": "Transforaminal ESI (TFESI) Per protocol Fluoroscopic"
                }
              ],
              "route": "Fluoroscopic",
              "instructions": "More selective nerve root coverage than interlaminar; up to 3 per year",
              "orderSentence": "Transforaminal ESI (TFESI) Per protocol Fluoroscopic"
            },
            "contraindications": "Coagulopathy; infection; severe foraminal stenosis",
            "monitoring": "Post-procedure neuro check; glucose monitoring",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Medial branch blocks",
            "route": "Fluoroscopic",
            "indication": "Facet-mediated pain component",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per protocol",
                  "orderSentence": "Medial branch blocks Per protocol Fluoroscopic"
                }
              ],
              "route": "Fluoroscopic",
              "instructions": "Diagnostic blocks before radiofrequency ablation consideration",
              "orderSentence": "Medial branch blocks Per protocol Fluoroscopic"
            },
            "contraindications": "Coagulopathy; infection at site",
            "monitoring": "Pain response documentation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Radiofrequency ablation (RFA)",
            "route": "Fluoroscopic",
            "indication": "Facet-mediated pain with positive diagnostic blocks",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per protocol",
                  "orderSentence": "Radiofrequency ablation (RFA) Per protocol Fluoroscopic"
                }
              ],
              "route": "Fluoroscopic",
              "instructions": "If >50% relief from diagnostic medial branch blocks x 2",
              "orderSentence": "Radiofrequency ablation (RFA) Per protocol Fluoroscopic"
            },
            "contraindications": "Coagulopathy; infection; pacemaker (relative)",
            "monitoring": "Neurologic exam post-procedure; pain scores",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Surgical Treatments (Specialist Decision)": [
          {
            "item": "Microdiscectomy",
            "route": "Surgical",
            "indication": "Herniated disc with refractory radiculopathy >6 weeks or progressive motor deficit",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Microdiscectomy N/A Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Standard of care for single-level disc herniation with radiculopathy",
              "orderSentence": "Microdiscectomy N/A Surgical"
            },
            "pretreatment": "MRI confirmation; failed conservative therapy (unless emergent); medical clearance",
            "contraindications": "Active infection; uncorrectable coagulopathy",
            "monitoring": "Post-op neuro checks; wound monitoring; pain control",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Anterior cervical discectomy and fusion (ACDF)",
            "route": "Surgical",
            "indication": "Cervical disc herniation with radiculopathy, cervical spondylosis with radiculopathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Anterior cervical discectomy and fusion (ACDF) N/A Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Most common cervical spine procedure for radiculopathy",
              "orderSentence": "Anterior cervical discectomy and fusion (ACDF) N/A Surgical"
            },
            "pretreatment": "MRI confirmation; medical clearance; discussion of fusion alternatives",
            "contraindications": "Active infection; severe osteoporosis (relative); uncorrectable coagulopathy",
            "monitoring": "Swallowing assessment; airway monitoring; neuro checks",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cervical disc arthroplasty",
            "route": "Surgical",
            "indication": "Single-level cervical disc herniation (alternative to ACDF)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Cervical disc arthroplasty N/A Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Motion-preserving alternative to fusion at appropriate levels (C3-7)",
              "orderSentence": "Cervical disc arthroplasty N/A Surgical"
            },
            "pretreatment": "MRI confirmation; intact facet joints; no significant instability",
            "contraindications": "Instability; facet arthropathy; osteoporosis; infection",
            "monitoring": "Post-op neuro checks; wound monitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Posterior cervical foraminotomy",
            "route": "Surgical",
            "indication": "Lateral/foraminal cervical disc herniation or foraminal stenosis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Posterior cervical foraminotomy N/A Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Motion-preserving option for lateral pathology",
              "orderSentence": "Posterior cervical foraminotomy N/A Surgical"
            },
            "pretreatment": "MRI confirmation; lateral/foraminal pathology",
            "contraindications": "Central disc herniation; instability",
            "monitoring": "Post-op neuro checks; wound monitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lumbar laminectomy/laminotomy",
            "route": "Surgical",
            "indication": "Lumbar stenosis with radiculopathy, large central disc",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Lumbar laminectomy/laminotomy N/A Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Decompression for stenosis or central disc",
              "orderSentence": "Lumbar laminectomy/laminotomy N/A Surgical"
            },
            "pretreatment": "MRI confirmation; failed conservative therapy",
            "contraindications": "Active infection; uncorrectable coagulopathy",
            "monitoring": "Post-op neuro checks; wound; urinary retention",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lumbar fusion (TLIF, PLIF, ALIF)",
            "route": "Surgical",
            "indication": "Radiculopathy with instability, spondylolisthesis, recurrent disc herniation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Lumbar fusion (TLIF, PLIF, ALIF) N/A Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Reserved for instability or recurrent pathology",
              "orderSentence": "Lumbar fusion (TLIF, PLIF, ALIF) N/A Surgical"
            },
            "pretreatment": "MRI/CT confirmation; bone density evaluation; medical clearance",
            "contraindications": "Active infection; severe osteoporosis (relative); uncorrectable coagulopathy",
            "monitoring": "Post-op neuro checks; hardware position; fusion assessment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Emergent decompression",
            "route": "Surgical",
            "indication": "Cauda equina syndrome (within 48h), severe/progressive motor deficit",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Emergent decompression N/A Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Within 24-48h of symptom onset for best outcomes",
              "orderSentence": "Emergent decompression N/A Surgical"
            },
            "pretreatment": "STAT MRI confirming compression",
            "contraindications": "None absolute if true CES",
            "monitoring": "Bladder function; motor recovery; wound",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Spine surgery (neurosurgery or orthopedic spine) consult STAT for cauda equina syndrome, progressive motor deficit, or myelopathic signs",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Spine surgery consult URGENT for significant weakness (<4/5) or radiculopathy refractory to 6+ weeks conservative treatment",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Physical therapy for core strengthening, McKenzie exercises, nerve gliding, and posture training",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain management/Interventional spine for epidural steroid injections if conservative treatment fails after 4-6 weeks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "PM&R (Physical Medicine & Rehabilitation) for comprehensive spine rehabilitation program",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "EMG/NCS referral to confirm radiculopathy level and exclude peripheral neuropathy or plexopathy (optimal timing 3-4 weeks after symptom onset)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oncology consult for suspected spinal metastases or pathologic fracture",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Infectious disease consult for suspected epidural abscess, discitis, or vertebral osteomyelitis",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Rheumatology for suspected inflammatory spondyloarthropathy (ankylosing spondylitis, psoriatic arthritis)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for ergonomic assessment, workplace modifications, and ADL training",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychology/Pain psychology for chronic pain management, CBT for pain, catastrophizing assessment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neurology for atypical presentation, polyradiculopathy, or suspected inflammatory/infectious etiology",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Social work for disability assistance, return-to-work planning, and insurance navigation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return to ED IMMEDIATELY if bladder or bowel incontinence, inability to urinate, saddle area numbness, or bilateral leg weakness (may indicate cauda equina syndrome)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Return to ED if fever develops with back/neck pain (may indicate infection)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Return if weakness is progressing or you are unable to lift foot/hand (progressive motor deficit requires urgent evaluation)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Most radiculopathy improves with conservative treatment over 4-6 weeks; surgery is rarely needed",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stay active within pain limits; prolonged bed rest (>1-2 days) is not recommended and may delay recovery",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Apply ice for first 48-72 hours (20 min on/off), then switch to heat for muscle relaxation",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid heavy lifting, twisting, and prolonged sitting; use proper body mechanics",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Sleep with pillow between knees (side) or under knees (back) to reduce spine stress",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "For cervical radiculopathy: avoid prolonged neck flexion (looking down at phone); use cervical pillow",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not stop gabapentin/pregabalin abruptly - taper under medical guidance to avoid withdrawal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Neuropathic pain medications (gabapentin, pregabalin) take 2-4 weeks to reach full effect",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Physical therapy exercises should be continued daily at home for best outcomes",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive while taking opioids or sedating muscle relaxants",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Follow up with primary care or neurology in 2-4 weeks to assess treatment response",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Smoking cessation to improve disc nutrition and surgical outcomes (smoking accelerates disc degeneration)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Weight loss if BMI >25 to reduce spinal load and improve symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Core strengthening exercises to support spine (plank, bird-dog, bridges)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Proper lifting technique: bend at knees, keep load close, avoid twisting",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Ergonomic workstation setup: monitor at eye level, lumbar support, feet flat",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take breaks every 30-60 minutes if seated for prolonged periods",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain good posture: shoulders back, chin tucked, avoid forward head position",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular low-impact exercise (walking, swimming, stationary bike) to maintain fitness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid high-impact activities (running, jumping) during acute phase",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Yoga or Pilates (modified) for flexibility and core strength after acute phase resolves",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use supportive mattress; avoid sleeping on stomach",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Manage stress as tension can worsen muscle spasm and pain perception",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Glycemic control if diabetic (HbA1c <7%) to reduce neuropathic component and improve surgical outcomes",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Peripheral neuropathy",
        "features": "Stocking-glove distribution, bilateral, length-dependent, not dermatomal",
        "tests": "NCS/EMG shows polyneuropathy; HbA1c; B12; no imaging abnormality"
      },
      {
        "diagnosis": "Lumbar spinal stenosis (neurogenic claudication)",
        "features": "Bilateral leg symptoms, worse with walking/standing, better with sitting/flexion, older patients",
        "tests": "MRI shows central stenosis; symptoms bilateral; walking tolerance limited"
      },
      {
        "diagnosis": "Piriformis syndrome",
        "features": "Buttock pain radiating to posterior thigh, negative straight leg raise, tenderness at piriformis",
        "tests": "MRI spine normal; tenderness at piriformis; FAIR test positive"
      },
      {
        "diagnosis": "Hip pathology (OA, AVN, labral tear)",
        "features": "Groin pain, limited hip ROM, pain with hip flexion/rotation, normal spine exam",
        "tests": "Hip X-ray/MRI; pain reproduced with hip exam, not spine"
      },
      {
        "diagnosis": "Sacroiliac joint dysfunction",
        "features": "Low back/buttock pain, positive SI joint provocative tests, pain at PSIS",
        "tests": "SI joint injection diagnostic; MRI may show SI joint changes"
      },
      {
        "diagnosis": "Greater trochanteric bursitis",
        "features": "Lateral hip pain, tender at greater trochanter, pain with side-lying",
        "tests": "Normal spine MRI; tenderness localized to trochanter"
      },
      {
        "diagnosis": "Diabetic amyotrophy (lumbosacral plexopathy)",
        "features": "Acute/subacute proximal thigh weakness and pain, weight loss, often bilateral sequential",
        "tests": "EMG shows plexopathy; MRI lumbosacral plexus may show enhancement"
      },
      {
        "diagnosis": "Meralgia paresthetica",
        "features": "Lateral thigh numbness/burning only (L2-L3 distribution), no weakness",
        "tests": "Normal EMG; may have abnormal lateral femoral cutaneous nerve conduction"
      },
      {
        "diagnosis": "Herpes zoster (shingles)",
        "features": "Dermatomal pain followed by vesicular rash, older/immunocompromised",
        "tests": "Clinical diagnosis; vesicular rash in dermatomal pattern"
      },
      {
        "diagnosis": "Vascular claudication",
        "features": "Calf pain with walking, relieved by rest (not position), diminished pulses",
        "tests": "ABI <0.9; Doppler shows arterial disease; spine MRI normal"
      },
      {
        "diagnosis": "Cauda equina syndrome",
        "features": "Saddle anesthesia, bladder/bowel dysfunction, bilateral leg weakness/numbness",
        "tests": "STAT MRI shows large central disc or mass compressing cauda equina"
      },
      {
        "diagnosis": "Spinal cord tumor (intra/extramedullary)",
        "features": "Progressive symptoms, night pain, myelopathic signs, weight loss",
        "tests": "MRI with contrast shows enhancing mass"
      },
      {
        "diagnosis": "Epidural abscess",
        "features": "Fever, severe localized back pain, rapid progression, risk factors (IVDU, diabetes)",
        "tests": "MRI with contrast shows rim-enhancing collection; elevated WBC, ESR, CRP"
      },
      {
        "diagnosis": "Vertebral metastases",
        "features": "History of cancer, night pain, weight loss, multiple levels",
        "tests": "MRI shows destructive lesions; bone scan; tumor markers; biopsy"
      },
      {
        "diagnosis": "Ankylosing spondylitis",
        "features": "Young male, morning stiffness >30 min, improves with activity, sacroiliitis",
        "tests": "HLA-B27; MRI shows sacroiliitis; ESR elevated"
      },
      {
        "diagnosis": "Spinal epidural hematoma",
        "features": "Post-procedure or anticoagulation, acute severe pain, rapid neuro decline",
        "tests": "STAT MRI shows epidural collection; coags abnormal"
      },
      {
        "diagnosis": "Arachnoiditis",
        "features": "Prior spine surgery or infection, diffuse radicular symptoms, clumped nerve roots",
        "tests": "MRI shows clumped/adherent nerve roots in thecal sac"
      },
      {
        "diagnosis": "Tarlov (perineural) cyst",
        "features": "Incidental finding on MRI, may cause radicular symptoms if large",
        "tests": "MRI shows sacral cyst; often asymptomatic"
      }
    ],
    "evidence": [
      {
        "recommendation": "MRI is imaging modality of choice for suspected radiculopathy",
        "evidenceLevel": "Class I, Level A",
        "source": "[Boden SD et al. J Bone Joint Surg Am 1990](https://pubmed.ncbi.nlm.nih.gov/2312537/)"
      },
      {
        "recommendation": "Most cervical and lumbar radiculopathy improves with conservative treatment",
        "evidenceLevel": "Class I, Level A",
        "source": "[Saal JA et al. Spine 1996](https://pubmed.ncbi.nlm.nih.gov/8961451/)"
      },
      {
        "recommendation": "NSAIDs effective for acute radiculopathy pain",
        "evidenceLevel": "Class I, Level A",
        "source": "[Roelofs PD et al. Cochrane 2008](https://pubmed.ncbi.nlm.nih.gov/18253976/)"
      },
      {
        "recommendation": "Gabapentin/pregabalin effective for radicular neuropathic pain",
        "evidenceLevel": "Class I, Level A",
        "source": "[Finnerup NB et al. Lancet Neurol 2015](https://pubmed.ncbi.nlm.nih.gov/25575710/)"
      },
      {
        "recommendation": "Oral steroids provide short-term benefit for lumbar radiculopathy",
        "evidenceLevel": "Class I, Level B",
        "source": "[Goldberg H et al. JAMA 2015](https://pubmed.ncbi.nlm.nih.gov/26151393/)"
      },
      {
        "recommendation": "Epidural steroid injections provide short-term pain relief for lumbar radiculopathy",
        "evidenceLevel": "Class I, Level B",
        "source": "[Manchikanti L et al. Pain Physician 2021](https://pubmed.ncbi.nlm.nih.gov/33400438/)"
      },
      {
        "recommendation": "EMG/NCS useful for confirming radiculopathy and excluding mimics after 3-4 weeks",
        "evidenceLevel": "Class II, Level B",
        "source": "[AANEM Practice Parameter 2010](https://pubmed.ncbi.nlm.nih.gov/20645032/)"
      },
      {
        "recommendation": "Surgery superior to conservative treatment for severe lumbar radiculopathy at 1 year",
        "evidenceLevel": "Class I, Level A",
        "source": "[SPORT Trial: Weinstein JN et al. JAMA 2006](https://pubmed.ncbi.nlm.nih.gov/17105757/)"
      },
      {
        "recommendation": "Cauda equina syndrome requires decompression within 48 hours for best outcomes",
        "evidenceLevel": "Class II, Level B",
        "source": "[Ahn UM et al. Spine 2000](https://pubmed.ncbi.nlm.nih.gov/10751293/)"
      },
      {
        "recommendation": "Physical therapy effective for cervical and lumbar radiculopathy",
        "evidenceLevel": "Class I, Level B",
        "source": "[Kuijper B et al. BMJ 2009](https://pubmed.ncbi.nlm.nih.gov/19818915/)"
      },
      {
        "recommendation": "Smoking cessation improves spine health and surgical outcomes",
        "evidenceLevel": "Class II, Level B",
        "source": "[Battie MC et al. Spine 1991](https://pubmed.ncbi.nlm.nih.gov/1836285/)"
      },
      {
        "recommendation": "Short-term muscle relaxants may help acute radiculopathy with spasm",
        "evidenceLevel": "Class II, Level B",
        "source": "[Chou R et al. Cochrane 2003](https://pubmed.ncbi.nlm.nih.gov/14973984/)"
      },
      {
        "recommendation": "ACDF effective for cervical radiculopathy refractory to conservative treatment",
        "evidenceLevel": "Class I, Level B",
        "source": "[Herkowitz HN et al. Spine 1990](https://pubmed.ncbi.nlm.nih.gov/2353855/)"
      },
      {
        "recommendation": "Microdiscectomy effective for lumbar disc herniation with radiculopathy",
        "evidenceLevel": "Class I, Level A",
        "source": "[Peul WC et al. NEJM 2007](https://pubmed.ncbi.nlm.nih.gov/17538085/)"
      },
      {
        "recommendation": "Duloxetine effective for chronic musculoskeletal pain including radiculopathy",
        "evidenceLevel": "Class I, Level A",
        "source": "[Skljarevski V et al. J Pain 2010](https://pubmed.ncbi.nlm.nih.gov/20338815/)"
      },
      {
        "recommendation": "Red flags warrant urgent imaging and evaluation for serious pathology",
        "evidenceLevel": "Class II, Level B",
        "source": "[Chou R et al. Ann Intern Med 2007](https://pubmed.ncbi.nlm.nih.gov/17909209/)"
      }
    ],
    "monitoring": [
      {
        "item": "Pain scores (0-10 NRS)",
        "frequency": "Each visit",
        "action": "Escalate therapy; consider interventional/surgical referral",
        "ED": "ROUTINE",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      },
      {
        "item": "Motor strength (MRC grading)",
        "frequency": "Each visit; more frequent if weakness present",
        "action": "Progressive weakness: urgent spine surgery consult; imaging",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Sensory exam (dermatomal)",
        "frequency": "Each visit",
        "action": "Document progression; correlate with imaging",
        "ED": "ROUTINE",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      },
      {
        "item": "Deep tendon reflexes",
        "frequency": "Each visit",
        "action": "Hyperreflexia suggests myelopathy: MRI cervical spine",
        "ED": "ROUTINE",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      },
      {
        "item": "Bladder function",
        "frequency": "Each visit; more frequent if any symptoms",
        "action": "Retention or incontinence: STAT catheterization, STAT MRI, emergent surgery consult",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Straight leg raise (lumbar) / Spurling test (cervical)",
        "frequency": "Each visit",
        "action": "Positive with worsening: consider imaging if not done",
        "ED": "ROUTINE",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      },
      {
        "item": "Gait assessment",
        "frequency": "Each visit",
        "action": "Foot drop: EMG, surgical consult; ataxia: cervical MRI for myelopathy",
        "ED": "ROUTINE",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      },
      {
        "item": "Functional status (ODI, NDI)",
        "frequency": "Baseline, 6 weeks, 3 months, 6 months",
        "action": "Not improving: reassess treatment strategy; consider surgery",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Renal function (if on NSAIDs >2 weeks)",
        "frequency": "Baseline, then q3 months",
        "action": "Decline: discontinue NSAIDs; switch to acetaminophen/other",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Glucose (if on steroids)",
        "frequency": "Daily if inpatient; before/after ESI",
        "action": "Adjust diabetes medications; short steroid courses",
        "ED": "ROUTINE",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "No red flags present; pain controlled with oral medications; able to ambulate; normal bladder function; motor strength >=4/5 and stable; reliable follow-up arranged within 2-4 weeks"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Severe pain requiring IV analgesia; significant motor weakness (<=3/5) requiring close monitoring; need for IV antibiotics (suspected infection); inability to ambulate safely; need for urgent MRI not available as outpatient"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Rapidly progressive motor deficit requiring emergent surgery; hemodynamic instability from sepsis (spinal infection); airway compromise (high cervical pathology); post-operative monitoring for complex spine surgery"
      },
      {
        "disposition": "Emergent surgery consult",
        "criteria": "Cauda equina syndrome (bladder dysfunction, saddle anesthesia, bilateral weakness); progressive motor deficit despite steroids; epidural abscess with neurologic deficit"
      },
      {
        "disposition": "Transfer to higher level",
        "criteria": "Spine surgery not available; MRI not available for emergent imaging; interventional spine services not available for ESI when indicated"
      }
    ]
  },
  "Small Fiber Neuropathy": {
    "id": "small-fiber-neuropathy",
    "title": "Small Fiber Neuropathy",
    "version": "1.1",
    "icd10": [
      "** G62.9 (Polyneuropathy",
      "unspecified)",
      "G62.89 (Other specified polyneuropathies)",
      "G90.09 (Other idiopathic peripheral autonomic neuropathy)"
    ],
    "scope": "** Diagnosis and management of small fiber neuropathy presenting with painful sensory and/or autonomic symptoms with normal or near-normal nerve conduction studies. Includes length-dependent and non-length-dependent (ganglionopathy) patterns. Covers etiologic workup for treatable causes, symptomatic pain management, and autonomic symptom treatment.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes and prediabetes are most common causes of SFN",
            "target": "<5.7% normal; ≥5.7% prediabetes"
          },
          {
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Current glycemic status; impaired fasting glucose",
            "target": "<100 mg/dL"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Impaired glucose tolerance causes SFN even with normal HbA1c",
            "target": "2-hr glucose <140 mg/dL normal"
          },
          {
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Renal function; medication dosing; uremic neuropathy",
            "target": "eGFR >60; normal electrolytes"
          },
          {
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Baseline; anemia evaluation",
            "target": "Normal"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "B12 deficiency causes SFN; common and treatable",
            "target": ">300 pg/mL (>400 optimal)"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypothyroidism causes neuropathy",
            "target": "0.4-4.0 mIU/L"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Inflammatory markers; vasculitis screen",
            "target": "Normal"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Autoimmune etiology; Sjogren's screen",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Sjogren syndrome is common cause of SFN (up to 40% of SFN)",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HCV-associated neuropathy; cryoglobulinemia",
            "target": "Negative"
          }
        ],
        "Extended Workup": [
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "More sensitive for B12 deficiency if B12 borderline (200-400)",
            "target": "Normal (<0.4 μmol/L)"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Celiac disease causes SFN even without GI symptoms",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "IgA deficiency causes false-negative TTG",
            "target": "Normal (not deficient)"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Paraproteinemia; monoclonal gammopathy",
            "target": "No monoclonal protein"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HIV-associated sensory neuropathy",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Metabolic syndrome associated with SFN",
            "target": "Normal/controlled"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency associated with neuropathic pain",
            "target": ">30 ng/mL"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency causes painful neuropathy",
            "target": "Normal"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Both deficiency and excess cause neuropathy",
            "target": "Normal (neither high nor low)"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Copper deficiency neuropathy (especially post-bariatric surgery)",
            "target": "Normal (70-140 μg/dL)"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Excessive zinc causes copper deficiency",
            "target": "Normal (not elevated)"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Sjogren syndrome if clinical suspicion high and serology negative",
            "target": "Negative for lymphocytic infiltration"
          }
        ],
        "Rare/Specialized": [
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Fabry disease screening (X-linked; consider in males and females)",
            "target": "Normal enzyme activity"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Confirm Fabry disease if enzyme low or high clinical suspicion",
            "target": "No pathogenic variants"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hereditary transthyretin amyloidosis; early SFN with autonomic symptoms",
            "target": "No pathogenic variants"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Amyloidosis if suspected (autonomic features, cardiomyopathy, CTS)",
            "target": "No amyloid deposits"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "AL amyloidosis screen",
            "target": "Normal kappa:lambda ratio"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Autoimmune SFN (especially ganglionopathy pattern)",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Autoimmune SFN marker",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Sarcoid neuropathy",
            "target": "Normal ACE; no hilar adenopathy"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Paraneoplastic sensory ganglionopathy (anti-Hu) if rapid onset",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Cryoglobulinemic neuropathy (especially with HCV)",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Objective dry eye for Sjogren diagnosis",
            "target": "Normal (>5mm in 5 min)"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Sodium channelopathies causing inherited SFN (erythromelalgia)",
            "target": "No pathogenic variants"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At initial evaluation",
            "target": "Normal or near-normal (SFN spares large fibers)",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "After NCS shows normal large fiber function",
            "target": "Reduced IENFD below normative threshold for age/sex/site",
            "contraindications": "Bleeding diathesis; anticoagulation (relative)"
          }
        ],
        "Extended": [
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Autonomic symptoms; suspected sudomotor dysfunction",
            "target": "Normal sweat volumes at all sites",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Screening for sudomotor dysfunction; non-invasive",
            "target": "Normal electrochemical skin conductance hands and feet",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Comprehensive autonomic evaluation; orthostatic symptoms",
            "target": "Normal cardiovagal, adrenergic, and sudomotor function",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Orthostatic intolerance; POTS evaluation",
            "target": "No excessive HR rise; no orthostatic hypotension",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Thermal threshold testing; research and specialized centers",
            "target": "Normal thermal detection thresholds",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Global sudomotor evaluation if QSART equivocal",
            "target": "Normal sweat distribution",
            "contraindications": "Cardiac instability"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Non-invasive small fiber assessment; research tool",
            "target": "Normal corneal nerve fiber density and length",
            "contraindications": "None"
          }
        ],
        "Rare/Specialized": [
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If large fiber involvement suspected; atypical features",
            "target": "Normal (SFN spares motor and large sensory fibers)",
            "contraindications": "Anticoagulation (relative)"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Ganglionopathy pattern; non-length-dependent SFN",
            "target": "Normal dorsal root ganglia; no dorsal column signal",
            "contraindications": "MRI contraindications"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Research; visualize small nerves",
            "target": "No nerve enlargement or signal abnormality",
            "contraindications": "MRI contraindications"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Sarcoidosis or malignancy suspected; paraneoplastic evaluation",
            "target": "No abnormal uptake",
            "contraindications": "Pregnancy"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Amyloidosis suspected (cardiomyopathy screening)",
            "target": "No infiltrative cardiomyopathy features",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Cardiac amyloidosis evaluation if echo abnormal",
            "target": "No amyloid infiltration",
            "contraindications": "MRI contraindications; devices"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "IV fluids",
            "route": "IV",
            "indication": "Acute orthostatic hypotension with symptoms",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500-1000 mL",
                  "orderSentence": "IV fluids 500-1000 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "500-1000 mL NS bolus for symptomatic orthostatic hypotension; avoid in heart failure",
              "orderSentence": "IV fluids 500-1000 mL IV"
            },
            "contraindications": "Heart failure; volume overload",
            "monitoring": "Volume status; BP response",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Pain crisis management",
            "route": "IV/PO",
            "indication": "Severe acute neuropathic pain flare not responding to outpatient regimen",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Multimodal",
                  "orderSentence": "Pain crisis management Multimodal IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "IV lidocaine infusion (1-3 mg/kg/hr) if refractory; avoid chronic opioids",
              "orderSentence": "Pain crisis management Multimodal IV/PO"
            },
            "contraindications": "Lidocaine: cardiac conduction abnormality",
            "monitoring": "Pain scores; cardiac monitoring for lidocaine",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Glucose management",
            "route": "Various",
            "indication": "Acute presentation with new diabetes diagnosis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per protocol",
                  "orderSentence": "Glucose management Per protocol Various"
                }
              ],
              "route": "Various",
              "instructions": "Initiate diabetes management; hypoglycemia causes SFN flare",
              "orderSentence": "Glucose management Per protocol Various"
            },
            "contraindications": "Per specific agent",
            "monitoring": "Glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Symptomatic Treatments (Neuropathic Pain - First-line)": [
          {
            "item": "Duloxetine",
            "route": "PO",
            "indication": "First-line for neuropathic pain; also treats depression/anxiety common in SFN",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg",
                  "orderSentence": "Duloxetine 30 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 30 mg daily x 1 week; increase to 60 mg daily; max 120 mg/day",
              "orderSentence": "Duloxetine 30 mg PO"
            },
            "contraindications": "MAOIs; uncontrolled narrow-angle glaucoma; severe renal impairment (CrCl <30)",
            "monitoring": "Hepatic function; BP; suicidal ideation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "First-line for neuropathic pain; FDA-approved for postherpetic neuralgia and DPN",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Pregabalin 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg TID or 75 mg BID; titrate q3-7d; max 300 mg/day; reduce if CrCl <60",
              "orderSentence": "Pregabalin 50 mg PO"
            },
            "contraindications": "Angioedema to pregabalin/gabapentin",
            "monitoring": "Dizziness, somnolence, weight gain, peripheral edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "First-line; less expensive alternative to pregabalin",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Gabapentin 300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; titrate by 300 mg q3-7d; target 1800-3600 mg/day divided TID; reduce if CrCl <60",
              "orderSentence": "Gabapentin 300 mg PO"
            },
            "contraindications": "Severe renal impairment (dose adjust required)",
            "monitoring": "Sedation, dizziness, ataxia, edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "PO",
            "indication": "TCA for neuropathic pain; helps insomnia; inexpensive",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Amitriptyline 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg qHS; titrate by 10-25 mg q1-2wk; typical 25-75 mg qHS; max 150 mg",
              "orderSentence": "Amitriptyline 10 mg PO"
            },
            "contraindications": "Cardiac conduction disease; recent MI; urinary retention; narrow-angle glaucoma; elderly (high anticholinergic burden)",
            "monitoring": "ECG if age >40 or cardiac history; anticholinergic side effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nortriptyline",
            "route": "PO",
            "indication": "TCA with less sedation and anticholinergic effects than amitriptyline",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Nortriptyline 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg qHS; titrate by 10-25 mg q1-2wk; typical 25-75 mg qHS",
              "orderSentence": "Nortriptyline 10 mg PO"
            },
            "contraindications": "Cardiac conduction disease; recent MI; urinary retention; narrow-angle glaucoma",
            "monitoring": "ECG if dose >100 mg/day or cardiac risk factors",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "SNRI alternative to duloxetine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5 mg",
                  "orderSentence": "Venlafaxine XR 37.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5 mg daily; increase by 37.5-75 mg q1wk; target 150-225 mg daily",
              "orderSentence": "Venlafaxine XR 37.5 mg PO"
            },
            "contraindications": "MAOIs; uncontrolled hypertension",
            "monitoring": "BP at higher doses; discontinuation syndrome if stopped abruptly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory (Neuropathic Pain)": [
          {
            "item": "Capsaicin 8% patch (Qutenza)",
            "route": "Topical",
            "indication": "Localized neuropathic pain; add-on therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 patch",
                  "orderSentence": "Capsaicin 8% patch (Qutenza) 1 patch Topical"
                }
              ],
              "route": "Topical",
              "instructions": "Applied by trained healthcare provider; pre-treat with topical anesthetic; may repeat q3mo",
              "orderSentence": "Capsaicin 8% patch (Qutenza) 1 patch Topical"
            },
            "contraindications": "Application to face/mucous membranes; broken skin",
            "monitoring": "Pain/burning during application; transient BP increase",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lidocaine 5% patch",
            "route": "Topical",
            "indication": "Localized pain; adjunctive therapy; allodynia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-3 patches",
                  "orderSentence": "Lidocaine 5% patch 1-3 patches Topical"
                }
              ],
              "route": "Topical",
              "instructions": "Apply to most painful area; up to 3 patches for 12h on/12h off",
              "orderSentence": "Lidocaine 5% patch 1-3 patches Topical"
            },
            "contraindications": "Allergy to local anesthetics; damaged skin",
            "monitoring": "Skin irritation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lamotrigine",
            "route": "PO",
            "indication": "Sodium channel blocker; some evidence in SFN",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Lamotrigine 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily x 2wk; then 50 mg daily x 2wk; increase by 50 mg q2wk; max 400 mg/day",
              "orderSentence": "Lamotrigine 25 mg PO"
            },
            "contraindications": "SJS/TEN history; valproate use (reduce dose by 50%)",
            "monitoring": "RASH (especially first 8 weeks) - stop immediately if rash",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lacosamide",
            "route": "PO",
            "indication": "Sodium channel blocker; well-tolerated",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Lacosamide 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg BID; increase by 50 mg/day weekly; max 400 mg/day",
              "orderSentence": "Lacosamide 50 mg PO"
            },
            "contraindications": "Second or third degree AV block (without pacemaker)",
            "monitoring": "ECG for PR prolongation; dizziness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbamazepine",
            "route": "PO",
            "indication": "Sodium channel blocker; limited evidence for SFN specifically",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Carbamazepine 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg BID; titrate by 200 mg/wk; max 1200 mg/day",
              "orderSentence": "Carbamazepine 100 mg PO"
            },
            "contraindications": "AV block; bone marrow suppression; HLA-B*1502 in Asian patients (SJS risk)",
            "monitoring": "CBC, LFTs, sodium; drug interactions (CYP3A4 inducer)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mexiletine",
            "route": "PO",
            "indication": "Sodium channel blocker; especially if SCN9A mutation suspected",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150 mg",
                  "orderSentence": "Mexiletine 150 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 150 mg TID; titrate by 150 mg q3d; max 1200 mg/day; take with food",
              "orderSentence": "Mexiletine 150 mg PO"
            },
            "contraindications": "Cardiomyopathy; second/third degree AV block",
            "monitoring": "ECG; arrhythmia monitoring",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Desipramine",
            "route": "PO",
            "indication": "TCA with minimal anticholinergic effects",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Desipramine 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS; titrate by 25 mg q1-2wk; target 50-100 mg",
              "orderSentence": "Desipramine 25 mg PO"
            },
            "contraindications": "Same as other TCAs",
            "monitoring": "ECG; drug levels available if needed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tramadol",
            "route": "PO",
            "indication": "Moderate pain; opioid-like with serotonergic properties",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Tramadol 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg q6h PRN; max 400 mg/day; reduce if renal/hepatic impairment",
              "orderSentence": "Tramadol 50 mg PO"
            },
            "contraindications": "Seizure disorder; concurrent MAOIs/SSRIs (serotonin syndrome risk)",
            "monitoring": "Seizures, serotonin syndrome, constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tapentadol ER",
            "route": "PO",
            "indication": "Refractory pain; mu-opioid agonist with norepinephrine reuptake inhibition",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Tapentadol ER 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg BID; titrate by 50 mg BID q3d; max 500 mg/day",
              "orderSentence": "Tapentadol ER 50 mg PO"
            },
            "contraindications": "Severe respiratory depression; MAOIs; paralytic ileus",
            "monitoring": "Respiratory status, constipation, sedation",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Combination therapy",
            "route": "Various",
            "indication": "Inadequate response to monotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per regimen",
                  "orderSentence": "Combination therapy Per regimen Various"
                }
              ],
              "route": "Various",
              "instructions": "Gabapentinoid + SNRI; TCA + gabapentinoid; use lower doses of each",
              "orderSentence": "Combination therapy Per regimen Various"
            },
            "contraindications": "Per individual agents",
            "monitoring": "Additive side effects; falls in elderly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Low-dose naltrexone (LDN)",
            "route": "PO",
            "indication": "Emerging evidence for neuropathic pain; anti-inflammatory",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1.5 mg",
                  "orderSentence": "Low-dose naltrexone (LDN) 1.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1.5 mg qHS; increase by 1.5 mg q2wk; max 4.5 mg; compounded",
              "orderSentence": "Low-dose naltrexone (LDN) 1.5 mg PO"
            },
            "contraindications": "Current opioid use; hepatic impairment",
            "monitoring": "Vivid dreams, insomnia (take in AM if occurs)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Spinal cord stimulation",
            "route": "Implant",
            "indication": "Refractory SFN pain; failed multiple medications",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per protocol",
                  "orderSentence": "Spinal cord stimulation Per protocol Implant"
                }
              ],
              "route": "Implant",
              "instructions": "Trial stimulation before permanent implant; high-frequency or burst stimulation preferred",
              "orderSentence": "Spinal cord stimulation Per protocol Implant"
            },
            "contraindications": "Infection; coagulopathy; psychiatric instability",
            "monitoring": "Device function; pain relief",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Autonomic Symptom Management": [
          {
            "item": "Fludrocortisone",
            "route": "PO",
            "indication": "Orthostatic hypotension; volume expansion",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg",
                  "orderSentence": "Fludrocortisone 0.1 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.1 mg daily; may increase to 0.2 mg daily; max 0.3 mg",
              "orderSentence": "Fludrocortisone 0.1 mg PO"
            },
            "pretreatment": "Check potassium; assess volume status",
            "contraindications": "Heart failure; hypertension; hypokalemia",
            "monitoring": "Weight, BP supine and standing, potassium, edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Midodrine",
            "route": "PO",
            "indication": "Orthostatic hypotension; alpha-1 agonist vasoconstrictor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg",
                  "orderSentence": "Midodrine 2.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5 mg TID (with meals); titrate to 5-10 mg TID; last dose 4h before bed",
              "orderSentence": "Midodrine 2.5 mg PO"
            },
            "pretreatment": "None specific",
            "contraindications": "Severe cardiac disease; urinary retention; supine hypertension",
            "monitoring": "Supine BP (check for supine hypertension); avoid at bedtime",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Droxidopa (Northera)",
            "route": "PO",
            "indication": "Neurogenic orthostatic hypotension; FDA-approved for autonomic failure",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Droxidopa (Northera) 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg TID; titrate by 100 mg/day q24-48h; max 600 mg TID",
              "orderSentence": "Droxidopa (Northera) 100 mg PO"
            },
            "pretreatment": "None specific",
            "contraindications": "Supine hypertension (severe)",
            "monitoring": "Supine BP; avoid lying flat for 2h after dose",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pyridostigmine",
            "route": "PO",
            "indication": "Orthostatic hypotension; enhances ganglionic transmission",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg",
                  "orderSentence": "Pyridostigmine 30 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 30 mg TID; may increase to 60 mg TID; modest BP effect but no supine hypertension",
              "orderSentence": "Pyridostigmine 30 mg PO"
            },
            "pretreatment": "None specific",
            "contraindications": "Mechanical GI/GU obstruction; bradyarrhythmia",
            "monitoring": "Cholinergic effects (diarrhea, salivation)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Compression stockings",
            "route": "External",
            "indication": "Orthostatic hypotension; venous pooling",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30-40 mmHg",
                  "orderSentence": "Compression stockings 30-40 mmHg External"
                }
              ],
              "route": "External",
              "instructions": "Waist-high preferred over knee-high; put on before rising; 30-40 mmHg compression",
              "orderSentence": "Compression stockings 30-40 mmHg External"
            },
            "pretreatment": "Peripheral arterial disease (ABI <0.5)",
            "contraindications": "None absolute if ABI >0.5",
            "monitoring": "Skin integrity; ABI if arterial disease suspected",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxybutynin",
            "route": "PO",
            "indication": "Bladder urgency/frequency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Oxybutynin 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg BID or 10 mg XL daily; max 30 mg/day",
              "orderSentence": "Oxybutynin 5 mg PO"
            },
            "pretreatment": "None specific",
            "contraindications": "Urinary retention; uncontrolled narrow-angle glaucoma; GI obstruction",
            "monitoring": "Anticholinergic effects; cognition in elderly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Solifenacin",
            "route": "PO",
            "indication": "Bladder urgency; better tolerated anticholinergic",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Solifenacin 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; may increase to 10 mg daily",
              "orderSentence": "Solifenacin 5 mg PO"
            },
            "pretreatment": "None specific",
            "contraindications": "Same as oxybutynin; severe hepatic impairment",
            "monitoring": "Anticholinergic effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirabegron",
            "route": "PO",
            "indication": "Bladder urgency; beta-3 agonist (non-anticholinergic)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Mirabegron 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; may increase to 50 mg daily",
              "orderSentence": "Mirabegron 25 mg PO"
            },
            "pretreatment": "None specific",
            "contraindications": "Uncontrolled hypertension; severe hepatic impairment",
            "monitoring": "BP; urinary retention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Metoclopramide",
            "route": "PO",
            "indication": "Gastroparesis; prokinetic",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Metoclopramide 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10 mg 30 min before meals and at bedtime; limit to <12 weeks",
              "orderSentence": "Metoclopramide 5 mg PO"
            },
            "pretreatment": "None specific",
            "contraindications": "Tardive dyskinesia (limit duration); GI obstruction; Parkinson disease",
            "monitoring": "Tardive dyskinesia; extrapyramidal symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Domperidone",
            "route": "PO",
            "indication": "Gastroparesis; prokinetic with less CNS effects",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Domperidone 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "10 mg TID before meals; not FDA-approved (requires IND or international pharmacy)",
              "orderSentence": "Domperidone 10 mg PO"
            },
            "pretreatment": "ECG baseline for QT",
            "contraindications": "QT prolongation; ventricular arrhythmia",
            "monitoring": "ECG for QT; arrhythmia",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Erythromycin",
            "route": "PO",
            "indication": "Gastroparesis; motilin receptor agonist",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg",
                  "orderSentence": "Erythromycin 250 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "250 mg PO TID before meals; short-term use due to tachyphylaxis",
              "orderSentence": "Erythromycin 250 mg PO"
            },
            "pretreatment": "ECG baseline for QT",
            "contraindications": "QT prolongation; drug interactions",
            "monitoring": "ECG; GI upset; tachyphylaxis limits long-term use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sildenafil",
            "route": "PO",
            "indication": "Erectile dysfunction in autonomic SFN",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Sildenafil 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg 1h before activity; max 100 mg; avoid with nitrates",
              "orderSentence": "Sildenafil 25 mg PO"
            },
            "pretreatment": "Cardiovascular assessment",
            "contraindications": "Nitrate use; severe cardiovascular disease",
            "monitoring": "Cardiovascular status; vision changes",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Disease-Modifying / Etiology-Targeted Therapies": [
          {
            "item": "Glycemic control optimization",
            "route": "Various",
            "indication": "Diabetes/prediabetes-associated SFN",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per guidelines",
                  "orderSentence": "Glycemic control optimization Per guidelines Various"
                }
              ],
              "route": "Various",
              "instructions": "Lifestyle first for prediabetes; HbA1c <7% target; tighter control slows progression",
              "orderSentence": "Glycemic control optimization Per guidelines Various"
            },
            "pretreatment": "Diabetes education",
            "contraindications": "Hypoglycemia risk",
            "monitoring": "HbA1c q3-6mo; glucose monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "IVIG",
            "route": "IV",
            "indication": "Autoimmune SFN (Sjogren-associated; anti-FGFR3+; idiopathic with evidence of inflammation)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g/kg",
                  "orderSentence": "IVIG 2 g/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g/kg divided over 2-5 days monthly; limited evidence; consider trial",
              "orderSentence": "IVIG 2 g/kg IV"
            },
            "pretreatment": "Check IgA level (IgA-deficient patients need IgA-depleted product)",
            "contraindications": "IgA deficiency (use IgA-depleted); renal impairment; hypercoagulable state",
            "monitoring": "Renal function; thrombotic risk; headache",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Enzyme replacement therapy — Fabry disease",
            "route": "IV",
            "indication": "Fabry disease-associated SFN",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg/kg",
                  "orderSentence": "Enzyme replacement therapy — Fabry disease 1 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "Agalsidase beta (Fabrazyme) 1 mg/kg IV q2wk; lifelong therapy; infusion reactions common early",
              "orderSentence": "Enzyme replacement therapy — Fabry disease 1 mg/kg IV"
            },
            "pretreatment": "Genetic confirmation of Fabry disease",
            "contraindications": "None absolute",
            "monitoring": "Infusion reactions; anti-drug antibodies",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tafamidis (Vyndamax/Vyndaqel)",
            "route": "PO",
            "indication": "Hereditary and wild-type TTR amyloidosis with polyneuropathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "80 mg",
                  "orderSentence": "Tafamidis (Vyndamax/Vyndaqel) 80 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "80 mg (Vyndamax) or 61 mg (Vyndaqel) PO daily; TTR stabilizer",
              "orderSentence": "Tafamidis (Vyndamax/Vyndaqel) 80 mg PO"
            },
            "pretreatment": "Genetic confirmation of TTR amyloidosis",
            "contraindications": "None",
            "monitoring": "Cardiac function; neuropathy progression",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Inotersen/Patisiran",
            "route": "SC/IV",
            "indication": "Hereditary TTR amyloidosis with polyneuropathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per protocol",
                  "orderSentence": "Inotersen/Patisiran Per protocol SC/IV"
                }
              ],
              "route": "SC/IV",
              "instructions": "Inotersen 284 mg SC weekly; Patisiran 0.3 mg/kg IV q3wk",
              "orderSentence": "Inotersen/Patisiran Per protocol SC/IV"
            },
            "pretreatment": "TTR gene mutation confirmed; specialist management",
            "contraindications": "Thrombocytopenia (inotersen); infusion reactions",
            "monitoring": "Platelets (inotersen); hepatic function",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Gluten-free diet",
            "route": "Diet",
            "indication": "Celiac disease-associated SFN",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Strict gluten-free",
                  "orderSentence": "Gluten-free diet Strict gluten-free Diet"
                }
              ],
              "route": "Diet",
              "instructions": "Lifelong strict gluten-free diet; dietitian referral; neuropathy may stabilize/improve",
              "orderSentence": "Gluten-free diet Strict gluten-free Diet"
            },
            "pretreatment": "Celiac confirmation (biopsy or serology)",
            "contraindications": "None",
            "monitoring": "TTG-IgA levels; symptom response",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "B12 supplementation",
            "route": "PO/IM",
            "indication": "B12 deficiency-associated SFN",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mcg",
                  "orderSentence": "B12 supplementation 1000 mcg PO"
                }
              ],
              "route": "PO",
              "instructions": "1000-2000 mcg PO daily; or 1000 mcg IM weekly x 4, then monthly if poor absorption",
              "orderSentence": "B12 supplementation 1000 mcg PO"
            },
            "pretreatment": "Confirmed B12 deficiency",
            "contraindications": "None",
            "monitoring": "B12 and MMA levels q3-6mo until stable",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Immunosuppression (Sjogren's)",
            "route": "Various",
            "indication": "Sjogren's-associated SFN with systemic disease activity",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per rheumatology",
                  "orderSentence": "Immunosuppression (Sjogren's) Per rheumatology Various"
                }
              ],
              "route": "Various",
              "instructions": "Hydroxychloroquine, methotrexate, rituximab; coordinate with rheumatology",
              "orderSentence": "Immunosuppression (Sjogren's) Per rheumatology Various"
            },
            "pretreatment": "Rheumatology co-management",
            "contraindications": "Per specific agent",
            "monitoring": "Per specific agent",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Alpha-lipoic acid",
            "route": "PO",
            "indication": "Antioxidant; some evidence in painful neuropathy; European guidelines",
            "dosing": {
              "doseOptions": [
                {
                  "text": "600 mg",
                  "orderSentence": "Alpha-lipoic acid 600 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "600 mg PO daily; may take 3-6 months for effect; limited evidence",
              "orderSentence": "Alpha-lipoic acid 600 mg PO"
            },
            "pretreatment": "None",
            "contraindications": "GI upset",
            "monitoring": "May enhance hypoglycemia in diabetics",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neuromuscular specialist for skin biopsy interpretation and complex SFN management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rheumatology if Sjogren's, lupus, or other connective tissue disease suspected",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Endocrinology if diabetes/prediabetes for glycemic optimization and metabolic management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetics counselor if hereditary etiology suspected (Fabry, TTR amyloidosis, SCN9A channelopathies)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gastroenterology for celiac confirmation, gastroparesis management, or liver biopsy if amyloid suspected",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cardiology if TTR amyloidosis suspected or autonomic symptoms with cardiac involvement",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain management for refractory neuropathic pain and interventional options (spinal cord stimulation)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for balance training, strengthening, and fall prevention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Autonomic disorders specialist if complex autonomic symptoms (POTS, orthostatic hypotension)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatry/psychology for chronic pain coping and comorbid depression/anxiety management",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hematology/oncology if amyloidosis confirmed for staging and treatment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Report any new weakness, gait difficulty, or falls as these may indicate progression to large fiber involvement",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Monitor for signs of infection in feet (redness, warmth, drainage) if sensation is impaired",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep a pain diary to track triggers, severity, and medication response",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Rise slowly from sitting or lying to prevent falls from orthostatic hypotension",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Increase salt and fluid intake (2-3L/day, 6-10g sodium) if orthostatic hypotension present (unless contraindicated)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Wear compression stockings before rising in the morning if orthostatic hypotension diagnosed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take all prescribed pain medications as directed; do not stop gabapentinoids or SNRIs abruptly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid excessive heat exposure which can worsen symptoms; stay hydrated in warm weather",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return if severe headache, vision changes, or syncope develop (may indicate medication side effects or disease progression)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Strict glycemic control (HbA1c <7% or <5.7% if prediabetes) to prevent progression; lifestyle modifications first",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Alcohol cessation as alcohol independently causes and worsens small fiber neuropathy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation as smoking impairs nerve regeneration and worsens outcomes",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular low-impact exercise (swimming, stationary bike, walking) to improve pain and maintain function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Healthy diet (Mediterranean or DASH) to optimize metabolic health and reduce inflammation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Weight management as metabolic syndrome is associated with SFN",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Sleep hygiene to improve sleep quality; chronic pain worsens with poor sleep",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress reduction techniques (mindfulness, meditation) as stress can amplify pain perception",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Fall prevention with home safety evaluation given proprioceptive deficits and orthostatic hypotension",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid B6 (pyridoxine) supplementation above RDA (1.3-2 mg/day) as excess causes neuropathy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Diabetic polyneuropathy (large fiber)",
        "features": "NCS abnormal; mixed sensorimotor findings; more numbness than pain",
        "tests": "EMG/NCS shows axonal polyneuropathy"
      },
      {
        "diagnosis": "Fibromyalgia",
        "features": "Widespread pain; tender points; normal skin biopsy; chronic fatigue",
        "tests": "ACR criteria; normal IENFD on skin biopsy"
      },
      {
        "diagnosis": "Complex regional pain syndrome (CRPS)",
        "features": "Regional rather than length-dependent; swelling, color changes, dystrophy",
        "tests": "Budapest criteria; regional distribution"
      },
      {
        "diagnosis": "Erythromelalgia",
        "features": "Intermittent burning with redness and warmth; triggered by heat; may have SCN9A mutation",
        "tests": "Clinical pattern; genetic testing if suspected"
      },
      {
        "diagnosis": "Central sensitization syndromes",
        "features": "Normal peripheral testing; pain out of proportion to objective findings",
        "tests": "QST pattern; skin biopsy normal"
      },
      {
        "diagnosis": "Psychogenic/functional sensory symptoms",
        "features": "Non-anatomical distribution; inconsistent findings; psychiatric comorbidity",
        "tests": "Careful neurological exam; normal objective testing"
      },
      {
        "diagnosis": "Vitamin B12 deficiency",
        "features": "May have subacute combined degeneration; cognitive changes; macrocytic anemia",
        "tests": "B12, MMA levels; MRI spine"
      },
      {
        "diagnosis": "Lyme disease",
        "features": "Endemic area; prior tick bite; rash history; may have radiculopathy",
        "tests": "Lyme serology (ELISA + Western blot)"
      },
      {
        "diagnosis": "Hereditary sensory neuropathy (HSAN)",
        "features": "Family history; anhidrosis; painless injuries; mutilating features",
        "tests": "Genetic testing (HSAN genes)"
      },
      {
        "diagnosis": "Burning mouth syndrome",
        "features": "Isolated to oral mucosa; taste changes; dry mouth",
        "tests": "Location-specific; oral exam"
      },
      {
        "diagnosis": "Restless legs syndrome",
        "features": "Urge to move legs; worse at rest/night; relief with movement",
        "tests": "Clinical criteria; may coexist with SFN"
      },
      {
        "diagnosis": "Vasculitic neuropathy",
        "features": "Asymmetric; mononeuritis multiplex pattern; systemic symptoms; rapid onset",
        "tests": "Nerve biopsy; inflammatory markers; angiography"
      },
      {
        "diagnosis": "Paraneoplastic sensory ganglionopathy",
        "features": "Subacute onset; asymmetric; non-length-dependent; cancer history/risk",
        "tests": "Anti-Hu antibodies; CT chest/abdomen/pelvis"
      }
    ],
    "evidence": [
      {
        "recommendation": "Skin biopsy (IENFD) as diagnostic standard for SFN",
        "evidenceLevel": "Class II, Level B",
        "source": "[Lauria et al. European Journal of Neurology 2010](https://pubmed.ncbi.nlm.nih.gov/20298428/)"
      },
      {
        "recommendation": "QSART for sudomotor function assessment in SFN",
        "evidenceLevel": "Class II, Level B",
        "source": "[Low et al. Muscle & Nerve 1983](https://pubmed.ncbi.nlm.nih.gov/6308464/)"
      },
      {
        "recommendation": "Impaired glucose tolerance as cause of SFN",
        "evidenceLevel": "Class II, Level B",
        "source": "[Singleton et al. Neurology 2001](https://pubmed.ncbi.nlm.nih.gov/11723275/)"
      },
      {
        "recommendation": "Sjogren syndrome associated with SFN",
        "evidenceLevel": "Class II, Level B",
        "source": "[Chai et al. Annals of Neurology 2005](https://pubmed.ncbi.nlm.nih.gov/15984030/)"
      },
      {
        "recommendation": "Duloxetine for neuropathic pain",
        "evidenceLevel": "Class I, Level A",
        "source": "[Lunn et al. Cochrane 2014](https://pubmed.ncbi.nlm.nih.gov/24399144/)"
      },
      {
        "recommendation": "Gabapentin for neuropathic pain",
        "evidenceLevel": "Class I, Level A",
        "source": "[Wiffen et al. Cochrane 2017](https://pubmed.ncbi.nlm.nih.gov/28597471/)"
      },
      {
        "recommendation": "Pregabalin for neuropathic pain",
        "evidenceLevel": "Class I, Level A",
        "source": "[Derry et al. Cochrane 2019](https://pubmed.ncbi.nlm.nih.gov/30673120/)"
      },
      {
        "recommendation": "TCAs for neuropathic pain",
        "evidenceLevel": "Class II, Level B",
        "source": "[Moore et al. Cochrane 2015](https://pubmed.ncbi.nlm.nih.gov/25879104/)"
      },
      {
        "recommendation": "Fludrocortisone for orthostatic hypotension",
        "evidenceLevel": "Class II, Level C",
        "source": "[Freeman et al. Neurology 2018 Consensus Statement](https://pubmed.ncbi.nlm.nih.gov/29666232/)"
      },
      {
        "recommendation": "Midodrine for orthostatic hypotension",
        "evidenceLevel": "Class I, Level A",
        "source": "[Wright et al. Am Heart J 1998](https://pubmed.ncbi.nlm.nih.gov/9463419/)"
      },
      {
        "recommendation": "Droxidopa for neurogenic orthostatic hypotension",
        "evidenceLevel": "Class I, Level A",
        "source": "[Biaggioni et al. Neurology 2015](https://pubmed.ncbi.nlm.nih.gov/25646278/)"
      },
      {
        "recommendation": "IVIG for autoimmune SFN",
        "evidenceLevel": "Class III, Level C",
        "source": "[Liu et al. J Periph Nerv Syst 2014](https://pubmed.ncbi.nlm.nih.gov/24750390/)"
      },
      {
        "recommendation": "Fabry disease as cause of SFN",
        "evidenceLevel": "Class II, Level B",
        "source": "[Biegstraaten et al. Orphanet J Rare Dis 2012](https://pubmed.ncbi.nlm.nih.gov/22452838/)"
      },
      {
        "recommendation": "TTR amyloidosis neuropathy treatment",
        "evidenceLevel": "Class I, Level A",
        "source": "[Adams et al. NEJM 2018 (Patisiran trial)](https://pubmed.ncbi.nlm.nih.gov/29972757/)"
      },
      {
        "recommendation": "Sodium channelopathies (SCN9A) in SFN",
        "evidenceLevel": "Class II, Level B",
        "source": "[Faber et al. Ann Neurol 2012](https://pubmed.ncbi.nlm.nih.gov/22522478/)"
      }
    ],
    "monitoring": [
      {
        "item": "Pain scores (NRS, VAS, BPI)",
        "frequency": "Each visit",
        "action": "Adjust medications; consider combination or referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "HbA1c (if diabetes/prediabetes)",
        "frequency": "Every 3-6 months",
        "action": "Intensify glycemic management",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Orthostatic vitals (lying, sitting, standing)",
        "frequency": "Each visit if autonomic symptoms",
        "action": "Adjust autonomic medications; hydration; compression",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Repeat skin biopsy (IENFD)",
        "frequency": "Every 1-2 years if monitoring disease course",
        "action": "Intensify etiology treatment if declining",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Autonomic symptoms inventory",
        "frequency": "Each visit",
        "action": "Adjust autonomic treatments; workup new symptoms",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ECG",
        "frequency": "Baseline if on TCAs or sodium channel blockers; periodically",
        "action": "Dose reduction or discontinuation if prolonged intervals",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Renal function (eGFR)",
        "frequency": "Every 6-12 months",
        "action": "Adjust medication doses; nephrology referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Potassium (if on fludrocortisone)",
        "frequency": "Monthly initially, then every 3-6 months",
        "action": "Supplement potassium; reduce fludrocortisone dose",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight and edema",
        "frequency": "Each visit",
        "action": "Adjust pregabalin/gabapentin or autonomic meds",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Depression screen (PHQ-9)",
        "frequency": "Every 6-12 months",
        "action": "Mental health referral; consider duloxetine/venlafaxine",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Falls assessment",
        "frequency": "Each visit",
        "action": "PT referral; home safety; reduce sedating medications",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Symptoms stable; pain controlled; autonomic symptoms not causing hemodynamic instability; follow-up arranged"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Severe uncontrolled pain requiring IV medications; syncope from orthostatic hypotension; new diagnosis requiring urgent workup (suspected amyloidosis with cardiac involvement)"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Hemodynamically unstable from autonomic dysfunction; severe symptomatic bradycardia or hypotension"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Every 3-6 months for medication optimization; annually for etiology reassessment if initially idiopathic"
      }
    ]
  },
  "Myasthenia Gravis - Outpatient Management": {
    "id": "myasthenia-gravis",
    "title": "Myasthenia Gravis - Outpatient Management",
    "version": "1.1",
    "icd10": [
      "** G70.00 (Myasthenia gravis without exacerbation)",
      "G70.01 (Myasthenia gravis with exacerbation)"
    ],
    "scope": "** Outpatient diagnosis, management, and monitoring of myasthenia gravis in adults. Covers antibody-positive (AChR, MuSK, LRP4) and seronegative MG, ocular and generalized subtypes, pyridostigmine optimization, immunotherapy initiation and monitoring, thymectomy evaluation, and crisis prevention. Excludes myasthenic crisis (see \"Myasthenia Gravis - Exacerbation/Crisis\"), Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes, and drug-induced myasthenia.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Primary diagnostic test; positive in 85% generalized, 50% ocular MG",
            "target": "Positive confirms diagnosis"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Increases sensitivity when combined with binding antibody",
            "target": "Positive supports diagnosis"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Additional AChR antibody; may be positive when binding negative",
            "target": "Positive supports diagnosis"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Order if AChR negative; positive in ~40% of AChR-negative patients",
            "target": "Positive confirms MuSK MG"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Order if AChR and MuSK negative; available at specialized labs",
            "target": "Positive confirms LRP4 MG"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Thymoma association; if positive, high likelihood of thymoma",
            "target": "Positive warrants urgent CT chest"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Autoimmune thyroid disease common comorbidity (10-15%)",
            "target": "Normal"
          },
          {
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Baseline before immunotherapy; infection assessment",
            "target": "Normal"
          },
          {
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Baseline renal/hepatic function; electrolytes",
            "target": "Normal"
          }
        ],
        "Extended Workup": [
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Required before azathioprine initiation; low activity increases toxicity risk",
            "target": "Normal or intermediate activity"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Before rituximab or other B-cell depleting therapy",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Before immunosuppressive therapy",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Baseline before IVIg or rituximab; IgA deficiency is IVIg contraindication",
            "target": "Normal; IgA >7 mg/dL"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Before immunosuppressive therapy",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Before chronic immunosuppression",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Baseline before chronic steroid therapy",
            "target": "Normal"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Steroid-induced osteoporosis prevention",
            "target": ">30 ng/mL"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If TSH abnormal; autoimmune thyroid disease",
            "target": "Normal"
          }
        ],
        "Rare/Specialized": [
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Seronegative MG; may detect low-affinity antibodies not seen on standard assay",
            "target": "Positive supports diagnosis in seronegative cases"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Occult malignancy concern; particularly if anti-striated muscle positive",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Adrenal insufficiency if on chronic steroids being tapered",
            "target": "Normal stress response"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Suspected secondary adrenal insufficiency from steroid withdrawal",
            "target": "Normal cortisol response"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Osteoporosis risk on chronic steroids",
            "target": "Normal"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "At diagnosis; exclude thymoma",
            "target": "No thymoma or thymic hyperplasia (or if present, surgical planning)",
            "contraindications": "Contrast allergy, renal impairment (CrCl <30)"
          },
          {
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "If contrast contraindicated",
            "target": "Thymic abnormality assessment",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Diagnostic confirmation; if antibodies negative or for monitoring",
            "target": "Decremental response >10% at 3 Hz (positive)",
            "contraindications": "None"
          },
          {
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Baseline respiratory function; symptom correlation",
            "target": "FVC >80% predicted; NIF more negative than -60 cmH2O",
            "contraindications": "Facial weakness limiting seal"
          }
        ],
        "Extended": [
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Most sensitive test; if RNS and antibodies negative",
            "target": "Increased jitter and blocking",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If CT indeterminate for thymoma; cystic thymic lesions",
            "target": "Characterize thymic mass",
            "contraindications": "Pacemaker, severe claustrophobia"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Suspected thymoma malignancy or metastasis",
            "target": "No FDG-avid lesions",
            "contraindications": "Pregnancy; hemodynamic instability"
          },
          {
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "Bedside diagnostic for ptosis; cooling improves neuromuscular transmission",
            "target": "Improvement in ptosis after 2 minutes of ice application",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Dysphagia symptoms; aspiration risk assessment",
            "target": "Safe swallow; define texture modifications",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Chronic steroid exposure; osteoporosis screening",
            "target": "T-score >-2.5",
            "contraindications": "None"
          }
        ],
        "Rare/Specialized": [
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Rarely used now; if diagnostic uncertainty and other tests unavailable",
            "target": "Improvement in weakness within 30-60 seconds",
            "contraindications": "Cardiac arrhythmia, asthma (relative)"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Sleep-disordered breathing; respiratory weakness; fatigue",
            "target": "AHI <5/hour; no nocturnal desaturation",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Suspected cardiac involvement (rare)",
            "target": "Normal",
            "contraindications": "Pacemaker"
          }
        ]
      },
      "Treatment": {
        "Cholinesterase Inhibitors (Symptomatic Treatment)": [
          {
            "item": "Pyridostigmine",
            "route": "PO",
            "indication": "First-line symptomatic treatment for all MG subtypes",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg",
                  "orderSentence": "Pyridostigmine 30 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 30 mg TID; increase by 30 mg/dose every 3-5 days as tolerated; usual maintenance 60 mg q4-6h (max 120 mg q4h); take 30-60 min before meals for swallowing",
              "orderSentence": "Pyridostigmine 30 mg PO"
            },
            "contraindications": "Mechanical bowel/bladder obstruction; known hypersensitivity",
            "monitoring": "Cholinergic symptoms (SLUDGE: salivation, lacrimation, urination, defecation, GI distress, emesis); bradycardia; if symptoms occur, reduce dose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Pyridostigmine SR (Mestinon Timespan)",
            "route": "PO",
            "indication": "Nocturnal symptoms; morning weakness on awakening",
            "dosing": {
              "doseOptions": [
                {
                  "text": "180 mg",
                  "orderSentence": "Pyridostigmine SR (Mestinon Timespan) 180 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "180 mg at bedtime for nocturnal weakness; do NOT crush; erratic absorption limits daytime use; max 1 tablet daily",
              "orderSentence": "Pyridostigmine SR (Mestinon Timespan) 180 mg PO"
            },
            "contraindications": "Mechanical bowel/bladder obstruction; known hypersensitivity",
            "monitoring": "Cholinergic symptoms (SLUDGE); bradycardia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glycopyrrolate",
            "route": "PO",
            "indication": "Cholinergic side effects from pyridostigmine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg",
                  "orderSentence": "Glycopyrrolate 1 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "1-2 mg PO BID-TID for secretions, diarrhea, or cramping from pyridostigmine; does not cross BBB",
              "orderSentence": "Glycopyrrolate 1 mg PO"
            },
            "contraindications": "Glaucoma; severe cardiac disease; GI obstruction",
            "monitoring": "Dry mouth; urinary retention; constipation; tachycardia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Corticosteroids": [
          {
            "item": "Prednisone (low-dose start)",
            "route": "PO",
            "indication": "Ocular or mild generalized MG; outpatient initiation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Prednisone (low-dose start) 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-20 mg daily; increase by 10 mg every 5-7 days to target 1 mg/kg/day (max 60-80 mg); LOW-DOSE START prevents transient worsening in outpatient setting",
              "orderSentence": "Prednisone (low-dose start) 10 mg PO"
            },
            "contraindications": "Active untreated infection; psychosis (relative); poorly controlled diabetes",
            "monitoring": "Glucose weekly during titration; BP; weight; mood; bone density annually",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Prednisone (high-dose)",
            "route": "PO",
            "indication": "Hospital setting with crisis protection (post-IVIg/PLEX)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg",
                  "orderSentence": "Prednisone (high-dose) 60 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "60-80 mg or 1 mg/kg daily; only start high-dose after IVIg/PLEX coverage in hospital or if admitted for monitoring",
              "orderSentence": "Prednisone (high-dose) 60 mg PO"
            },
            "contraindications": "Active infection (relative); NOT FOR OUTPATIENT INITIATION",
            "monitoring": "Glucose q6h; BP; K+; monitor for transient worsening days 5-10",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Prednisone (maintenance/taper)",
            "route": "PO",
            "indication": "Chronic MG on stable steroids",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per taper",
                  "orderSentence": "Prednisone (maintenance/taper) Per taper PO"
                }
              ],
              "route": "PO",
              "instructions": "Once stable on target dose x 2-4 weeks, begin slow taper: reduce by 10 mg q2-4 weeks until 20 mg, then by 5 mg q2-4 weeks until 10 mg, then by 2.5 mg q month; may need minimum maintenance dose indefinitely",
              "orderSentence": "Prednisone (maintenance/taper) Per taper PO"
            },
            "contraindications": "Adrenal insufficiency risk with abrupt stop",
            "monitoring": "Symptoms of adrenal insufficiency during taper; flare",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Steroid-Sparing Immunosuppressants (Disease-Modifying)": [
          {
            "item": "Azathioprine",
            "route": "PO",
            "indication": "Steroid-sparing; first-line maintenance immunosuppressant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Azathioprine 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg daily x 1-2 weeks; increase by 50 mg every 2-4 weeks to target 2-3 mg/kg/day (usually 150-200 mg/day); takes 6-12 months for full effect",
              "orderSentence": "Azathioprine 50 mg PO"
            },
            "pretreatment": "TPMT genotype or enzyme activity; CBC; LFTs; hepatitis panel",
            "contraindications": "TPMT deficiency (intermediate requires 50% dose reduction); pregnancy; concurrent allopurinol (75% dose reduction required)",
            "monitoring": "CBC weekly x 4 weeks, then monthly x 3 months, then q3 months; LFTs monthly x 3 months, then q3 months; flu-like symptoms on initiation (hypersensitivity, discontinue)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mycophenolate mofetil",
            "route": "PO",
            "indication": "Steroid-sparing; alternative to azathioprine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Mycophenolate mofetil 500 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 500 mg BID; increase to 1000 mg BID after 2 weeks; may increase to 1500 mg BID if needed; takes 3-6 months for effect",
              "orderSentence": "Mycophenolate mofetil 500 mg PO"
            },
            "pretreatment": "CBC; LFTs; hepatitis panel; pregnancy test",
            "contraindications": "Pregnancy (teratogenic); breastfeeding; hypersensitivity",
            "monitoring": "CBC every 2 weeks x 2 months, then monthly x 4 months, then q3 months; LFTs q3 months; GI side effects common",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mycophenolate sodium (Myfortic)",
            "route": "PO",
            "indication": "Alternative formulation with less GI side effects",
            "dosing": {
              "doseOptions": [
                {
                  "text": "360 mg",
                  "orderSentence": "Mycophenolate sodium (Myfortic) 360 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 360 mg BID; increase to 720 mg BID; 720 mg = 1000 mg mycophenolate mofetil",
              "orderSentence": "Mycophenolate sodium (Myfortic) 360 mg PO"
            },
            "pretreatment": "CBC; LFTs; hepatitis panel; pregnancy test",
            "contraindications": "Pregnancy (teratogenic); breastfeeding; hypersensitivity",
            "monitoring": "CBC every 2 weeks x 2 months, then monthly x 4 months, then q3 months; LFTs q3 months; GI side effects common",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tacrolimus",
            "route": "PO",
            "indication": "Steroid-sparing; faster onset than azathioprine (3-6 months)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3 mg",
                  "orderSentence": "Tacrolimus 3 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 3 mg daily; adjust to trough level 5-10 ng/mL; usual dose 3 mg BID; faster onset than azathioprine",
              "orderSentence": "Tacrolimus 3 mg PO"
            },
            "pretreatment": "Renal function; glucose; BP; drug interaction review",
            "contraindications": "Renal impairment; uncontrolled hypertension; concurrent potassium-sparing diuretics",
            "monitoring": "Tacrolimus trough level monthly; renal function monthly; glucose; BP; tremor; headache",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cyclosporine",
            "route": "PO",
            "indication": "Alternative to tacrolimus; similar efficacy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3 mg/kg",
                  "orderSentence": "Cyclosporine 3 mg/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "3-5 mg/kg/day divided BID; adjust to trough 100-200 ng/mL",
              "orderSentence": "Cyclosporine 3 mg/kg PO"
            },
            "pretreatment": "Renal function; BP; lipids",
            "contraindications": "Renal impairment; uncontrolled hypertension; concurrent nephrotoxins",
            "monitoring": "Cyclosporine trough monthly; renal function monthly; BP; lipids; gingival hyperplasia; hirsutism",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Biologic and Targeted Immunotherapies": [
          {
            "item": "Rituximab",
            "route": "IV",
            "indication": "MuSK-positive MG (often first-line after steroids); refractory AChR+ MG",
            "dosing": {
              "doseOptions": [
                {
                  "text": "375 mg/m2",
                  "orderSentence": "Rituximab 375 mg/m2 IV"
                }
              ],
              "route": "IV",
              "instructions": "Either 375 mg/m2 IV weekly x 4 weeks OR 1000 mg IV x 2 doses (2 weeks apart); premedicate with methylprednisolone 100 mg, acetaminophen, diphenhydramine; repeat courses as needed",
              "orderSentence": "Rituximab 375 mg/m2 IV"
            },
            "pretreatment": "Hepatitis B screening (HBsAg, anti-HBc); quantitative immunoglobulins; TB screen",
            "contraindications": "Active hepatitis B; active severe infection; live vaccines within 4 weeks",
            "monitoring": "Infusion reactions; CD19/CD20 B-cell count q3-6 months; immunoglobulins annually; infection monitoring",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Eculizumab (Soliris)",
            "route": "IV",
            "indication": "AChR+ refractory generalized MG; FDA approved",
            "dosing": {
              "doseOptions": [
                {
                  "text": "900 mg",
                  "orderSentence": "Eculizumab (Soliris) 900 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "900 mg IV weekly x 4 weeks (induction), then 1200 mg IV every 2 weeks (maintenance); infuse over 35 min",
              "orderSentence": "Eculizumab (Soliris) 900 mg IV"
            },
            "pretreatment": "Meningococcal vaccination (MenACWY and MenB) at least 2 weeks before; REMS enrollment",
            "contraindications": "Unresolved Neisseria meningitidis infection; not current with meningococcal vaccines",
            "monitoring": "Meningococcal infection risk (BLACK BOX); infusion reactions; headache; URI",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ravulizumab (Ultomiris)",
            "route": "IV",
            "indication": "AChR+ refractory generalized MG; longer dosing interval",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2700 mg",
                  "orderSentence": "Ravulizumab (Ultomiris) 2700 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Load: 40-60 kg: 2400 mg; 60-100 kg: 2700 mg; >100 kg: 3000 mg; Maintenance q8 weeks: 40-60 kg: 3000 mg; 60-100 kg: 3300 mg; >100 kg: 3600 mg",
              "orderSentence": "Ravulizumab (Ultomiris) 2700 mg IV"
            },
            "pretreatment": "Meningococcal vaccination; REMS enrollment",
            "contraindications": "Unresolved Neisseria meningitidis infection; not current with meningococcal vaccines",
            "monitoring": "Meningococcal infection risk (BLACK BOX); infusion reactions; less frequent infusions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Efgartigimod (Vyvgart)",
            "route": "IV",
            "indication": "AChR+ generalized MG; FcRn inhibitor; lowers IgG",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg",
                  "orderSentence": "Efgartigimod (Vyvgart) 10 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV infusion over 1 hour weekly x 4 weeks per treatment cycle; repeat cycles as needed based on clinical response",
              "orderSentence": "Efgartigimod (Vyvgart) 10 mg/kg IV"
            },
            "pretreatment": "Baseline immunoglobulins; infection screening",
            "contraindications": "Active serious infection; IgG <2 g/L (relative)",
            "monitoring": "IgG levels; infection; infusion reactions; headache",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Efgartigimod-fvhp + hyaluronidase (Vyvgart Hytrulo)",
            "route": "SC",
            "indication": "AChR+ generalized MG; subcutaneous administration",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1008 mg",
                  "orderSentence": "Efgartigimod-fvhp + hyaluronidase (Vyvgart Hytrulo) 1008 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "1008 mg SC injection weekly x 4 weeks per treatment cycle; self-administered at home after training",
              "orderSentence": "Efgartigimod-fvhp + hyaluronidase (Vyvgart Hytrulo) 1008 mg SC"
            },
            "pretreatment": "Baseline immunoglobulins; infection screening",
            "contraindications": "Active serious infection; IgG <2 g/L (relative)",
            "monitoring": "IgG levels; infection; injection site reactions; headache",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rozanolixizumab (Rystiggo)",
            "route": "SC",
            "indication": "AChR+ generalized MG; FcRn inhibitor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "420 mg",
                  "orderSentence": "Rozanolixizumab (Rystiggo) 420 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "420 mg SC injection weekly x 6 weeks per treatment cycle; repeat cycles as needed",
              "orderSentence": "Rozanolixizumab (Rystiggo) 420 mg SC"
            },
            "pretreatment": "Baseline immunoglobulins; infection screening",
            "contraindications": "Active serious infection",
            "monitoring": "IgG levels; infection; pyrexia; headache; diarrhea",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Zilucoplan (Zilbrysq)",
            "route": "SC",
            "indication": "AChR+ generalized MG; C5 complement inhibitor; daily SC",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.3 mg/kg",
                  "orderSentence": "Zilucoplan (Zilbrysq) 0.3 mg/kg SC"
                }
              ],
              "route": "SC",
              "instructions": "0.3 mg/kg SC daily; self-administered; meningococcal vaccination required",
              "orderSentence": "Zilucoplan (Zilbrysq) 0.3 mg/kg SC"
            },
            "pretreatment": "Meningococcal vaccination (MenACWY and MenB); REMS enrollment",
            "contraindications": "Unresolved Neisseria infection",
            "monitoring": "Meningococcal infection risk; injection site reactions; diarrhea; URI",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Supportive Care and Comorbidities": [
          {
            "item": "Calcium + Vitamin D",
            "route": "PO",
            "indication": "Bone protection on chronic steroids",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Calcium + Vitamin D 1000 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Calcium 500-600 mg BID with meals; Vitamin D 1000-2000 IU daily; target 25-OH Vitamin D >30 ng/mL",
              "orderSentence": "Calcium + Vitamin D 1000 mg PO"
            },
            "contraindications": "Hypercalcemia; kidney stones",
            "monitoring": "Vitamin D level annually; calcium as needed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Alendronate",
            "route": "PO",
            "indication": "Osteoporosis prevention/treatment on chronic steroids",
            "dosing": {
              "doseOptions": [
                {
                  "text": "70 mg",
                  "orderSentence": "Alendronate 70 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "70 mg PO weekly on empty stomach with full glass of water; remain upright 30 min; consider if steroids >3 months at prednisone >5 mg/day",
              "orderSentence": "Alendronate 70 mg PO"
            },
            "contraindications": "GFR <30-35; esophageal disorders; inability to remain upright",
            "monitoring": "DEXA at baseline and q1-2 years; jaw osteonecrosis rare",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Omeprazole",
            "route": "PO",
            "indication": "GI protection during high-dose steroids",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "Omeprazole 20 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "20-40 mg PO daily while on high-dose prednisone; consider tapering off when steroids reduced",
              "orderSentence": "Omeprazole 20 mg PO"
            },
            "contraindications": "Long-term use increases C. diff risk",
            "monitoring": "Limit duration; consider H2 blocker alternative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trimethoprim-sulfamethoxazole",
            "route": "PO",
            "indication": "PJP prophylaxis if on high-dose steroids + other immunosuppression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 DS tablet",
                  "orderSentence": "Trimethoprim-sulfamethoxazole 1 DS tablet PO"
                }
              ],
              "route": "PO",
              "instructions": "1 DS tablet (160/800 mg) PO Monday/Wednesday/Friday; or 1 SS tablet daily",
              "orderSentence": "Trimethoprim-sulfamethoxazole 1 DS tablet PO"
            },
            "contraindications": "Sulfa allergy; G6PD deficiency",
            "monitoring": "CBC periodically; rash",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neuromuscular specialist/MG center for diagnosis confirmation, treatment optimization, and clinical trial consideration",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Thoracic surgery consult for thymectomy evaluation in AChR+ generalized MG age 18-65 years without thymoma, or any patient with thymoma",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pulmonology consult for baseline pulmonary function testing and ongoing respiratory monitoring in patients with respiratory symptoms",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Neuro-ophthalmology for diplopia management, prism prescription, or ptosis surgery evaluation in stable ocular MG",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech therapy for swallow evaluation given bulbar symptoms and aspiration risk assessment",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Physical therapy for generalized weakness to maintain function and prevent deconditioning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for ADL assessment and energy conservation strategies given fatigable weakness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rheumatology if concurrent autoimmune disease suspected (thyroid, lupus, rheumatoid arthritis)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Infusion center for IVIg, rituximab, eculizumab, or other IV immunotherapy administration",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "High-risk OB for pregnancy planning in women with MG given medication adjustments and delivery planning",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Endocrinology for steroid-induced diabetes, osteoporosis, or adrenal insufficiency management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for disability planning, MG Foundation resources, and insurance navigation for expensive biologics",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatry for depression or anxiety related to chronic illness or steroid side effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if worsening weakness, breathing difficulty, or difficulty swallowing develops (may indicate crisis requiring hospitalization)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Carry MG medical alert card or bracelet listing diagnosis and medications to avoid (aminoglycosides, fluoroquinolones, beta-blockers, magnesium)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not stop prednisone or immunosuppressants abruptly; sudden discontinuation may trigger exacerbation or adrenal crisis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take pyridostigmine 30-60 minutes before meals to improve swallowing and reduce choking risk during eating",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report fever or signs of infection promptly as immunosuppression increases infection risk and infection can trigger MG exacerbation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid extreme heat as high temperatures worsen neuromuscular transmission and increase weakness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive if diplopia or ptosis impairs vision; symptoms may fluctuate throughout the day",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid overexertion; pace activities throughout the day with rest periods to manage fatigable weakness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report new medications (including over-the-counter) to neurologist before taking, as many common drugs worsen MG",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Women: Discuss pregnancy plans with MG specialist in advance as medication adjustments are needed before conception",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Contact Myasthenia Gravis Foundation of America (www.myasthenia.org) for patient support, educational resources, and community",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report symptoms of cholinergic overdose: excessive secretions, diarrhea, cramping, muscle twitching, bradycardia (reduce pyridostigmine dose)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Medication reconciliation before any new prescription to avoid MG-exacerbating drugs; bring medication list to all appointments",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid live vaccines while on immunosuppression (azathioprine, mycophenolate, rituximab, high-dose steroids); inactivated vaccines are safe",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Annual influenza vaccine (inactivated) to prevent respiratory infections that can trigger exacerbation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Pneumococcal vaccination (PCV15 or PCV20 + PPSV23) before starting immunosuppression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Aspiration precautions including upright positioning during and after meals, small bites, and avoiding mixed textures if bulbar symptoms present",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Energy conservation techniques including pacing activities, scheduled rest periods, and prioritizing important tasks for morning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid smoking as respiratory infections worsen MG and smoking reduces treatment efficacy",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol intake as it can worsen weakness and interact with medications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management as psychological stress can trigger MG exacerbations",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Good sleep hygiene as fatigue and sleep deprivation worsen MG symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Wear medical alert identification listing MG diagnosis and medications to avoid in emergencies",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Weight management to reduce respiratory load and minimize steroid side effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Lambert-Eaton myasthenic syndrome (LEMS)",
        "features": "Proximal weakness improves with exercise; autonomic symptoms (dry mouth); SCLC association; areflexia",
        "tests": "VGCC antibody; EMG with incremental response; CT chest for malignancy"
      },
      {
        "diagnosis": "Botulism",
        "features": "Descending paralysis; fixed dilated pupils; GI symptoms; recent wound or food exposure",
        "tests": "Stool/serum toxin assay; EMG (incremental response); clinical history"
      },
      {
        "diagnosis": "Oculopharyngeal muscular dystrophy",
        "features": "Ptosis, dysphagia; slowly progressive; no fluctuation; onset >45 years; family history",
        "tests": "Genetic testing (GCN repeat in PABPN1); muscle biopsy"
      },
      {
        "diagnosis": "Thyroid eye disease",
        "features": "Proptosis; lid retraction (not ptosis); restrictive ophthalmopathy; thyroid dysfunction",
        "tests": "TSH, free T4; orbital CT/MRI (extraocular muscle enlargement)"
      },
      {
        "diagnosis": "Chronic progressive external ophthalmoplegia (CPEO)",
        "features": "Slowly progressive ptosis and ophthalmoparesis; no fluctuation; may have systemic features",
        "tests": "Muscle biopsy; mitochondrial DNA analysis; lactate"
      },
      {
        "diagnosis": "Miller Fisher syndrome",
        "features": "Ataxia, areflexia, ophthalmoplegia; post-infectious; acute onset",
        "tests": "Anti-GQ1b antibody; CSF (albuminocytologic dissociation)"
      },
      {
        "diagnosis": "Brainstem lesion (stroke, tumor, MS)",
        "features": "Cranial nerve palsies; other brainstem signs; no fatigability",
        "tests": "MRI brain with contrast"
      },
      {
        "diagnosis": "Guillain-Barre syndrome",
        "features": "Ascending weakness; areflexia; no fluctuation; sensory symptoms",
        "tests": "CSF (elevated protein); EMG/NCS (demyelinating pattern)"
      },
      {
        "diagnosis": "Amyotrophic lateral sclerosis (ALS)",
        "features": "Upper and lower motor neuron signs; fasciculations; no fatigability; progressive",
        "tests": "EMG (denervation); no antibodies; clinical criteria"
      },
      {
        "diagnosis": "Drug-induced myasthenia",
        "features": "Temporal relationship to D-penicillamine, checkpoint inhibitors, aminoglycosides",
        "tests": "Medication history; may have positive AChR antibodies"
      }
    ],
    "evidence": [
      {
        "recommendation": "Pyridostigmine for symptomatic treatment of MG",
        "evidenceLevel": "Class I, Level A",
        "source": "[Mehndiratta MM et al. Cochrane 2014](https://pubmed.ncbi.nlm.nih.gov/25304970/)"
      },
      {
        "recommendation": "Thymectomy improves outcomes in AChR+ generalized MG age 18-65",
        "evidenceLevel": "Class I, Level B",
        "source": "[Wolfe GI et al. NEJM 2016 (MGTX Trial)](https://pubmed.ncbi.nlm.nih.gov/27509100/)"
      },
      {
        "recommendation": "Corticosteroids effective for MG",
        "evidenceLevel": "Class II, Level B",
        "source": "[Schneider-Gold C et al. Cochrane 2005](https://pubmed.ncbi.nlm.nih.gov/16034852/)"
      },
      {
        "recommendation": "Azathioprine as steroid-sparing agent",
        "evidenceLevel": "Class I, Level B",
        "source": "[Palace J et al. NEJM 1998](https://pubmed.ncbi.nlm.nih.gov/9771070/)"
      },
      {
        "recommendation": "Mycophenolate mofetil in MG (mixed evidence)",
        "evidenceLevel": "Class II, Level B",
        "source": "[Sanders DB et al. Muscle Nerve 2016](https://pubmed.ncbi.nlm.nih.gov/27438060/)"
      },
      {
        "recommendation": "Rituximab effective in MuSK-positive MG",
        "evidenceLevel": "Class II, Level B",
        "source": "[Nowak RJ et al. Neurology 2022](https://pubmed.ncbi.nlm.nih.gov/34986310/)"
      },
      {
        "recommendation": "Rituximab in refractory AChR+ MG",
        "evidenceLevel": "Class II, Level C",
        "source": "[Tandan R et al. Muscle Nerve 2017](https://pubmed.ncbi.nlm.nih.gov/27463434/)"
      },
      {
        "recommendation": "Eculizumab for refractory generalized AChR+ MG",
        "evidenceLevel": "Class I, Level A",
        "source": "[Howard JF et al. Lancet Neurol 2017 (REGAIN)](https://pubmed.ncbi.nlm.nih.gov/28969986/)"
      },
      {
        "recommendation": "Efgartigimod for generalized AChR+ MG",
        "evidenceLevel": "Class I, Level A",
        "source": "[Howard JF et al. Lancet Neurol 2021 (ADAPT)](https://pubmed.ncbi.nlm.nih.gov/34146511/)"
      },
      {
        "recommendation": "Medications that exacerbate MG",
        "evidenceLevel": "Class III, Level C",
        "source": "[Juel VC. Semin Neurol 2004](https://pubmed.ncbi.nlm.nih.gov/15257515/)"
      },
      {
        "recommendation": "AAN/MGFA guidelines for MG management",
        "evidenceLevel": "Expert consensus",
        "source": "[Sanders DB et al. Neurology 2016](https://pubmed.ncbi.nlm.nih.gov/27386767/)"
      },
      {
        "recommendation": "Ocular MG: 50-80% generalize within 2 years",
        "evidenceLevel": "Class II, Level B",
        "source": "[Kupersmith MJ et al. Arch Neurol 2003](https://pubmed.ncbi.nlm.nih.gov/12975292/)"
      },
      {
        "recommendation": "Low-dose steroid initiation prevents worsening",
        "evidenceLevel": "Class II, Level B",
        "source": "[Pascuzzi RM. Semin Neurol 2003](https://pubmed.ncbi.nlm.nih.gov/12865163/)"
      },
      {
        "recommendation": "Anti-striated muscle antibody and thymoma association",
        "evidenceLevel": "Class II, Level B",
        "source": "[Romi F et al. Arch Neurol 2005](https://pubmed.ncbi.nlm.nih.gov/15956157/)"
      },
      {
        "recommendation": "Ravulizumab for generalized AChR+ MG",
        "evidenceLevel": "Class I, Level A",
        "source": "[Vu T et al. NEJM 2022 (CHAMPION-MG)](https://pubmed.ncbi.nlm.nih.gov/36129997/)"
      },
      {
        "recommendation": "Rozanolixizumab for generalized AChR+ MG",
        "evidenceLevel": "Class I, Level A",
        "source": "[Bril V et al. Lancet Neurol 2023](https://pubmed.ncbi.nlm.nih.gov/37385280/)"
      },
      {
        "recommendation": "Zilucoplan for generalized AChR+ MG",
        "evidenceLevel": "Class I, Level A",
        "source": "[Howard JF et al. Lancet Neurol 2023 (RAISE)](https://pubmed.ncbi.nlm.nih.gov/37863588/)"
      }
    ],
    "monitoring": [
      {
        "item": "**CLINICAL**"
      },
      {
        "item": "MG composite or QMG score",
        "frequency": "Every visit",
        "action": "Escalate therapy if worsening",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Forced vital capacity (FVC)",
        "frequency": "Baseline; q3-6 months if respiratory symptoms; urgent if symptoms worsen",
        "action": "If FVC declining: hospitalize, consider IVIg/PLEX",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Negative inspiratory force (NIF)",
        "frequency": "With FVC; if respiratory symptoms",
        "action": "If NIF >-20 cmH2O: crisis, intubate",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Swallow function",
        "frequency": "Each visit if bulbar symptoms",
        "action": "Modified diet; speech therapy; consider PEG if severe",
        "ED": "-",
        "HOSP": "URGENT",
        "OPD": "ROUTINE",
        "ICU": "URGENT"
      },
      {
        "item": "Weight",
        "frequency": "Each visit",
        "action": "Monitor steroid side effects; nutritional assessment if losing",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "**LABORATORY**"
      },
      {
        "item": "CBC with differential",
        "frequency": "Weekly x 4 then monthly x 3 then q3 months (azathioprine/MMF)",
        "action": "Hold immunosuppressant if low; may resume at lower dose",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "LFTs",
        "frequency": "Monthly x 3 then q3 months",
        "action": "Reduce dose or discontinue if >3x with symptoms",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Glucose",
        "frequency": "Weekly during steroid titration; q3 months on maintenance",
        "action": "Initiate diabetes treatment if elevated",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Blood pressure",
        "frequency": "Each visit",
        "action": "Antihypertensive if elevated",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "TPMT level/genotype",
        "frequency": "Once before azathioprine",
        "action": "Reduce dose 50% if intermediate; avoid if deficient",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Tacrolimus trough",
        "frequency": "Monthly if on tacrolimus",
        "action": "Dose adjustment",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Immunoglobulins (IgG, IgA, IgM)",
        "frequency": "Baseline; annually on rituximab or anti-CD20",
        "action": "Consider IVIG replacement if low and recurrent infections",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "B-cell count (CD19/CD20)",
        "frequency": "q3-6 months on rituximab",
        "action": "Guide re-dosing",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "**BONE HEALTH**"
      },
      {
        "item": "DEXA scan",
        "frequency": "Baseline; q1-2 years if on chronic steroids",
        "action": "Bisphosphonate if osteopenia/osteoporosis",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Vitamin D, 25-OH",
        "frequency": "Baseline; annually",
        "action": "Supplement if low",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "**Manage outpatient**",
        "criteria": "Stable ocular or mild generalized MG; FVC >60% and stable; able to swallow safely; no respiratory symptoms; reliable follow-up"
      },
      {
        "disposition": "**Admit to floor**",
        "criteria": "Moderate-severe worsening not requiring ICU; initiation of high-dose steroids with IVIg/PLEX coverage; significant bulbar symptoms with aspiration risk; FVC 30-60% and declining; new diagnosis with moderate severity"
      },
      {
        "disposition": "**Admit to ICU**",
        "criteria": "FVC <30% or rapidly declining; NIF weaker than -30 cmH2O; impending respiratory failure; severe bulbar dysfunction with aspiration; need for intubation or BiPAP"
      },
      {
        "disposition": "**Emergency evaluation**",
        "criteria": "Acute worsening of weakness; new respiratory symptoms (dyspnea, orthopnea); difficulty swallowing or speaking; recent infection or medication change with weakness; FVC declining on outpatient checks"
      },
      {
        "disposition": "**Transfer to MG center**",
        "criteria": "Refractory MG not responding to standard therapy; thymectomy evaluation; clinical trial consideration; complex immunotherapy decisions"
      }
    ]
  },
  "Amyotrophic Lateral Sclerosis (ALS) / Motor Neuron Disease": {
    "id": "als",
    "title": "Amyotrophic Lateral Sclerosis (ALS) / Motor Neuron Disease",
    "version": "1.0",
    "icd10": [
      "** G12.21 (Amyotrophic lateral sclerosis)",
      "G12.20 (Motor neuron disease",
      "unspecified)",
      "G12.29 (Other motor neuron disease)"
    ],
    "scope": "** Comprehensive outpatient-focused management of ALS including diagnostic workup, El Escorial/Awaji criteria application, disease-modifying therapy (riluzole, edaravone, AMX0035), symptomatic management (sialorrhea, spasticity, pseudobulbar affect, pain, dyspnea), respiratory monitoring with BiPAP timing, nutritional support with PEG timing, multidisciplinary clinic model, and palliative care integration. Excludes primary lateral sclerosis (PLS), progressive muscular atrophy (PMA), and pediatric motor neuron disease.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential (CPT 85025)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Baseline; exclude infection",
            "target": "Normal"
          },
          {
            "item": "CMP (CPT 80053)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Baseline; monitor for riluzole hepatotoxicity",
            "target": "Normal; ALT <3x ULN"
          },
          {
            "item": "TSH (CPT 84443)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Thyroid disease can mimic weakness",
            "target": "Normal"
          },
          {
            "item": "Vitamin B12 (CPT 82607)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "B12 deficiency causes myelopathy",
            "target": ">300 pg/mL"
          },
          {
            "item": "CPK (CPT 82550)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Often mildly elevated in ALS; rule out myopathy",
            "target": "Mildly elevated OK; <5x ULN"
          },
          {
            "item": "ESR (CPT 85652) / CRP (CPT 86140)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Inflammatory markers",
            "target": "Normal or mildly elevated"
          },
          {
            "item": "Hemoglobin A1c (CPT 83036)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetic neuropathy in differential",
            "target": "<6.5%"
          },
          {
            "item": "Fasting lipid panel (CPT 80061)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Cardiovascular risk assessment",
            "target": "LDL goal per guidelines"
          },
          {
            "item": "Serum protein electrophoresis (SPEP) (CPT 86334)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Exclude monoclonal gammopathy",
            "target": "No monoclonal spike"
          },
          {
            "item": "Urinalysis (CPT 81003)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Baseline; UTI assessment",
            "target": "Normal"
          }
        ],
        "Extended Workup": [
          {
            "item": "HIV (CPT 87389)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HIV-associated motor neuron disease",
            "target": "Negative"
          },
          {
            "item": "Lyme serology (CPT 86618) (endemic areas)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Lyme disease causes neuropathy",
            "target": "Negative"
          },
          {
            "item": "Copper (CPT 82525) and ceruloplasmin (CPT 82390)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Wilson disease in younger patients",
            "target": "Normal"
          },
          {
            "item": "Parathyroid hormone (PTH) (CPT 83970)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hyperparathyroidism causes weakness",
            "target": "Normal"
          },
          {
            "item": "Anti-GM1 antibodies (CPT 86255)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Multifocal motor neuropathy (treatable mimic)",
            "target": "Negative"
          },
          {
            "item": "Anti-MAG antibodies (CPT 86255)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Demyelinating neuropathy",
            "target": "Negative"
          },
          {
            "item": "Lead level (CPT 83655)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Lead neuropathy mimics ALS",
            "target": "<10 mcg/dL"
          },
          {
            "item": "Hexosaminidase A (CPT 82762)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Adult Tay-Sachs (rare mimic)",
            "target": "Normal activity"
          },
          {
            "item": "Very long chain fatty acids (CPT 82726)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Adrenomyeloneuropathy (X-linked)",
            "target": "Normal"
          },
          {
            "item": "Serum immunofixation (CPT 86334)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Paraprotein-associated neuropathy",
            "target": "No monoclonal protein"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "SOD1 genetic testing (CPT 81405)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Familial ALS (10%); affects prognosis and therapy",
            "target": "Document mutation"
          },
          {
            "item": "C9orf72 repeat expansion (CPT 81401)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Most common familial ALS mutation; FTD link",
            "target": "<30 repeats normal"
          },
          {
            "item": "ALS gene panel (FUS, TARDBP, etc.) (CPT 81479)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Familial ALS with family history",
            "target": "Document variants"
          },
          {
            "item": "Muscle biopsy (CPT 88305)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Only if myopathy suspected",
            "target": "Neurogenic changes"
          },
          {
            "item": "CSF analysis (CPT 89051)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Atypical cases; exclude inflammatory",
            "target": "Protein mildly elevated OK"
          },
          {
            "item": "Anti-voltage-gated calcium channel Ab (CPT 86255)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Lambert-Eaton syndrome",
            "target": "Negative"
          },
          {
            "item": "Anti-acetylcholine receptor Ab (CPT 86235)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Myasthenia gravis",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "EMG (CPT 95886) with nerve conduction studies (CPT 95907-95913)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "At diagnosis; within 2 weeks",
            "target": "Widespread denervation (3+ regions), fibrillations, fasciculations, chronic reinnervation; normal sensory studies",
            "contraindications": "Anticoagulation (relative)"
          },
          {
            "item": "MRI brain without contrast (CPT 70551)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "timing": "At diagnosis",
            "target": "No mass, stroke, or demyelination",
            "contraindications": "Pacemaker"
          },
          {
            "item": "MRI cervical spine without contrast (CPT 72141)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "timing": "At diagnosis",
            "target": "No cord compression; mild spondylosis OK",
            "contraindications": "Pacemaker"
          },
          {
            "item": "Chest X-ray (CPT 71046)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "Baseline; aspiration screen",
            "target": "Clear or evidence of aspiration",
            "contraindications": "None"
          },
          {
            "item": "Pulmonary function tests (FVC sitting and supine) (CPT 94010)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Baseline respiratory status",
            "target": "FVC >80% predicted",
            "contraindications": "Severe bulbar dysfunction"
          }
        ],
        "Extended": [
          {
            "item": "MRI thoracic/lumbar spine (CPT 72146/72148)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If thoracic/lumbosacral symptoms predominant",
            "target": "Exclude cord compression",
            "contraindications": "Pacemaker"
          },
          {
            "item": "Videofluoroscopic swallow study (VFSS) (CPT 74230)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Bulbar symptoms; dysphagia",
            "target": "Quantify aspiration risk",
            "contraindications": "Severe aspiration (relative)"
          },
          {
            "item": "Fiberoptic endoscopic evaluation of swallowing (FEES) (CPT 92612)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Alternative to VFSS",
            "target": "Laryngeal function, aspiration",
            "contraindications": "Severe nasal obstruction"
          },
          {
            "item": "Sleep study (polysomnography) (CPT 95810)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Suspected nocturnal hypoventilation",
            "target": "Assess for REM hypoventilation, AHI",
            "contraindications": "None"
          },
          {
            "item": "Sniff nasal inspiratory pressure (SNIP)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "More sensitive for bulbar patients",
            "target": ">40 cmH2O normal",
            "contraindications": "Nasal obstruction"
          },
          {
            "item": "Arterial blood gas (CPT 82803)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "EXT",
            "ICU": "STAT",
            "timing": "Acute respiratory failure",
            "target": "pH, pCO2, pO2",
            "contraindications": "Severe coagulopathy"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Transcranial magnetic stimulation (TMS) (CPT 95928)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Research; UMN localization",
            "target": "Prolonged central motor conduction time",
            "contraindications": "Seizure history, pacemaker"
          },
          {
            "item": "PET-FDG brain (CPT 78816)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Cognitive symptoms, FTD evaluation",
            "target": "Frontotemporal hypometabolism",
            "contraindications": "Unable to cooperate"
          },
          {
            "item": "Neuropsychological testing (CPT 96132)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Cognitive concerns; FTD screening",
            "target": "Document cognitive profile",
            "contraindications": "Severe dysarthria (limited)"
          },
          {
            "item": "Diaphragm ultrasound (CPT 76604)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "EXT",
            "timing": "Assess diaphragm function",
            "target": "Reduced excursion",
            "contraindications": "None"
          },
          {
            "item": "Maximum inspiratory/expiratory pressure",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Additional respiratory metrics",
            "target": "MIP >60 cmH2O; MEP >40 cmH2O",
            "contraindications": "Poor mouth seal"
          }
        ]
      },
      "Treatment": {
        "Disease-Modifying Therapy": [
          {
            "item": "Riluzole (Rilutek)",
            "route": "PO",
            "indication": "Slows disease progression; extends survival 2-3 months",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Riluzole (Rilutek) 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "50 mg PO BID; take 1 hour before or 2 hours after meals for best absorption",
              "orderSentence": "Riluzole (Rilutek) 50 mg PO"
            },
            "pretreatment": "Baseline LFTs",
            "contraindications": "ALT >5x ULN; hepatic impairment",
            "monitoring": "LFTs monthly x 3 months, then q3 months; CBC if neutropenia suspected",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Edaravone (Radicava) - IV formulation",
            "route": "IV",
            "indication": "Antioxidant; slows functional decline in selected patients",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg",
                  "orderSentence": "Edaravone (Radicava) - IV formulation 60 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Initial cycle: 60 mg IV daily x 14 days, then 14 days off; subsequent cycles: 60 mg IV daily x 10 of 14 days, then 14 days off",
              "orderSentence": "Edaravone (Radicava) - IV formulation 60 mg IV"
            },
            "pretreatment": "Baseline renal function, IV access established",
            "contraindications": "Hypersensitivity to edaravone or sodium bisulfite",
            "monitoring": "Infusion reactions; renal function; gait (sulfite sensitivity)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Edaravone oral suspension (Radicava ORS)",
            "route": "PO",
            "indication": "Oral alternative to IV edaravone",
            "dosing": {
              "doseOptions": [
                {
                  "text": "105 mg",
                  "orderSentence": "Edaravone oral suspension (Radicava ORS) 105 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Initial cycle: 105 mg PO daily x 14 days, then 14 days off; subsequent cycles: 105 mg PO daily x 10 of 14 days, then 14 days off",
              "orderSentence": "Edaravone oral suspension (Radicava ORS) 105 mg PO"
            },
            "pretreatment": "Baseline renal function",
            "contraindications": "Hypersensitivity to edaravone or sodium bisulfite",
            "monitoring": "Infusion reactions; renal function; gait (sulfite sensitivity)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "~~AMX0035 / Relyvrio (sodium phenylbutyrate-taurursodiol)~~",
            "route": "PO",
            "indication": "**WITHDRAWN** — Voluntarily removed from US market April 2024 after PHOENIX trial failed to confirm benefit",
            "dosing": {
              "instructions": "N/A",
              "orderSentence": "~~AMX0035 / Relyvrio (sodium phenylbutyrate-taurursodiol)~~ - PO - see dosing"
            },
            "pretreatment": "N/A",
            "contraindications": "N/A",
            "monitoring": "N/A",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Tofersen (Qalsody) - for SOD1 mutations",
            "route": "IT",
            "indication": "SOD1-ALS only; reduces SOD1 protein",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Tofersen (Qalsody) - for SOD1 mutations 100 mg IT"
                }
              ],
              "route": "IT",
              "instructions": "Loading: 100 mg IT on Days 1, 15, 29; Maintenance: 100 mg IT q28 days",
              "orderSentence": "Tofersen (Qalsody) - for SOD1 mutations 100 mg IT"
            },
            "pretreatment": "SOD1 gene mutation confirmed; lumbar access",
            "contraindications": "No SOD1 mutation; contraindication to IT injection",
            "monitoring": "Neurofilament levels; CSF analysis; myelopathy monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Glycopyrrolate",
            "route": "PO",
            "indication": "Sialorrhea (excess saliva)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg",
                  "orderSentence": "Glycopyrrolate 1 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1 mg PO TID; may increase to 2 mg TID; max 8 mg/day",
              "orderSentence": "Glycopyrrolate 1 mg PO"
            },
            "contraindications": "Narrow-angle glaucoma; urinary retention; GI obstruction",
            "monitoring": "Dry mouth (paradoxical thick secretions), constipation, urinary retention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Atropine 1% ophthalmic drops (sublingual)",
            "route": "SL",
            "indication": "Sialorrhea (rescue)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2 drops",
                  "orderSentence": "Atropine 1% ophthalmic drops (sublingual) 1-2 drops SL"
                }
              ],
              "route": "SL",
              "instructions": "1-2 drops sublingual q4-6h as needed; max 4 doses/day",
              "orderSentence": "Atropine 1% ophthalmic drops (sublingual) 1-2 drops SL"
            },
            "contraindications": "Narrow-angle glaucoma; cardiac arrhythmia",
            "monitoring": "HR, dry mouth, urinary retention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Scopolamine transdermal patch",
            "route": "TOP",
            "indication": "Sialorrhea (continuous)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1.5 mg",
                  "orderSentence": "Scopolamine transdermal patch 1.5 mg TOP"
                }
              ],
              "route": "TOP",
              "instructions": "Apply 1.5 mg patch behind ear; replace every 72 hours",
              "orderSentence": "Scopolamine transdermal patch 1.5 mg TOP"
            },
            "contraindications": "Narrow-angle glaucoma; urinary retention; GI obstruction",
            "monitoring": "Confusion (especially elderly), dry mouth, constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Botulinum toxin A (salivary gland injection)",
            "route": "IM",
            "indication": "Refractory sialorrhea",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30-50 units per parotid",
                  "orderSentence": "Botulinum toxin A (salivary gland injection) 30-50 units per parotid IM"
                }
              ],
              "route": "IM",
              "instructions": "30-50 units per parotid gland + 10-20 units per submandibular gland (total 80-140 units); effects last 3-4 months",
              "orderSentence": "Botulinum toxin A (salivary gland injection) 30-50 units per parotid IM"
            },
            "contraindications": "Hypersensitivity; neuromuscular disease (use cautiously)",
            "monitoring": "Dysphagia worsening (rare); dry mouth",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dextromethorphan-quinidine (Nuedexta)",
            "route": "PO",
            "indication": "Pseudobulbar affect (PBA)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20/10 mg",
                  "orderSentence": "Dextromethorphan-quinidine (Nuedexta) 20/10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 20/10 mg (DM/Q) daily x 7 days, then increase to 20/10 mg BID",
              "orderSentence": "Dextromethorphan-quinidine (Nuedexta) 20/10 mg PO"
            },
            "contraindications": "QT prolongation; concurrent quinidine or CYP2D6 substrates; hepatic impairment",
            "monitoring": "Baseline ECG; QTc monitoring; avoid with other QT-prolonging drugs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Baclofen",
            "route": "PO",
            "indication": "Spasticity",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Baclofen 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg PO TID; increase by 5 mg/dose q3 days; max 80 mg/day in divided doses",
              "orderSentence": "Baclofen 5 mg PO"
            },
            "contraindications": "Abrupt withdrawal (risk of seizures, hallucinations)",
            "monitoring": "Sedation, weakness (may unmask underlying weakness); taper to discontinue",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Tizanidine",
            "route": "PO",
            "indication": "Spasticity (alternative to baclofen)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg",
                  "orderSentence": "Tizanidine 2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2 mg qHS; may increase by 2-4 mg q6-8h; max 36 mg/day",
              "orderSentence": "Tizanidine 2 mg PO"
            },
            "contraindications": "Concurrent CYP1A2 inhibitors (ciprofloxacin, fluvoxamine); hepatic impairment",
            "monitoring": "LFTs at baseline, 1 month, 3 months; sedation, hypotension, dry mouth",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Muscle cramps; neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Gabapentin 300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; titrate by 300 mg/day q1-3 days; max 3600 mg/day divided TID",
              "orderSentence": "Gabapentin 300 mg PO"
            },
            "contraindications": "Severe renal impairment (adjust dose)",
            "monitoring": "Sedation, dizziness; reduce dose if CrCl <60",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mexiletine",
            "route": "PO",
            "indication": "Muscle cramps (refractory)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150 mg",
                  "orderSentence": "Mexiletine 150 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 150 mg PO BID; may increase to 300 mg BID; max 1200 mg/day",
              "orderSentence": "Mexiletine 150 mg PO"
            },
            "contraindications": "Cardiogenic shock; 2nd/3rd degree AV block without pacemaker",
            "monitoring": "Baseline ECG; monitor for arrhythmia; GI upset",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Quinine sulfate",
            "route": "PO",
            "indication": "Muscle cramps (limited use)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200-300 mg",
                  "orderSentence": "Quinine sulfate 200-300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "200-300 mg PO at bedtime; FDA warns against off-label use for cramps",
              "orderSentence": "Quinine sulfate 200-300 mg PO"
            },
            "contraindications": "Thrombocytopenia; G6PD deficiency; prolonged QT; myasthenia",
            "monitoring": "CBC, cardiac rhythm; FDA black box warning for thrombocytopenia",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Lorazepam",
            "route": "PO/SL",
            "indication": "Anxiety; dyspnea (end of life)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg",
                  "orderSentence": "Lorazepam 0.5 mg PO/SL"
                }
              ],
              "route": "PO/SL",
              "instructions": "0.5-1 mg PO/SL q8h PRN for anxiety or dyspnea; use low doses due to respiratory depression risk",
              "orderSentence": "Lorazepam 0.5 mg PO/SL"
            },
            "contraindications": "Severe respiratory insufficiency (relative); acute narrow-angle glaucoma",
            "monitoring": "Respiratory status, sedation; paradoxical agitation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Morphine",
            "route": "PO/SL",
            "indication": "Dyspnea (palliative)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg",
                  "orderSentence": "Morphine 2.5 mg PO/SL"
                }
              ],
              "route": "PO/SL",
              "instructions": "Start 2.5-5 mg PO/SL q4h PRN for dyspnea; titrate to comfort; may reduce respiratory distress without significantly worsening ventilation",
              "orderSentence": "Morphine 2.5 mg PO/SL"
            },
            "contraindications": "Active respiratory failure without comfort focus",
            "monitoring": "Respiratory rate, comfort, sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Modafinil",
            "route": "PO",
            "indication": "Fatigue",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Modafinil 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg PO every morning; may increase to 200 mg; avoid afternoon dosing",
              "orderSentence": "Modafinil 100 mg PO"
            },
            "contraindications": "Hypersensitivity; cardiac arrhythmia",
            "monitoring": "Headache, insomnia, cardiac monitoring if history",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "PO",
            "indication": "Sialorrhea; insomnia; depression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Amitriptyline 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg PO qHS; increase by 10 mg weekly; max 75-100 mg qHS",
              "orderSentence": "Amitriptyline 10 mg PO"
            },
            "contraindications": "Cardiac conduction abnormality; recent MI; urinary retention",
            "monitoring": "ECG if dose >50 mg; anticholinergic effects; sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sertraline",
            "route": "PO",
            "indication": "Depression; anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Sertraline 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg PO daily; increase by 25-50 mg q1-2 weeks; max 200 mg/day",
              "orderSentence": "Sertraline 25 mg PO"
            },
            "contraindications": "Concurrent MAOIs; caution with QT-prolonging drugs",
            "monitoring": "Suicidality (first weeks), GI upset, sexual dysfunction",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Respiratory Support": [
          {
            "item": "BiPAP (noninvasive ventilation)",
            "route": "INH",
            "indication": "FVC <50% predicted OR symptoms of nocturnal hypoventilation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "IPAP 8-12 cmH2O",
                  "orderSentence": "BiPAP (noninvasive ventilation) IPAP 8-12 cmH2O INH"
                },
                {
                  "text": "EPAP 4-6 cmH2O",
                  "orderSentence": "BiPAP (noninvasive ventilation) EPAP 4-6 cmH2O INH"
                }
              ],
              "route": "INH",
              "instructions": "Start with nocturnal use; IPAP 8-12, EPAP 4-6; titrate for comfort; increase time as tolerated; extend to daytime as needed",
              "orderSentence": "BiPAP (noninvasive ventilation) IPAP 8-12 cmH2O INH"
            },
            "contraindications": "Severe bulbar dysfunction with aspiration (relative); inability to clear secretions",
            "monitoring": "Comfort, adherence, transcutaneous CO2 or ABG, mask fit",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Mechanical insufflation-exsufflation (Cough Assist)",
            "route": "-",
            "indication": "Weak cough; peak cough flow <270 L/min",
            "dosing": {
              "doseOptions": [
                {
                  "text": "+40/-40 cmH2O",
                  "orderSentence": "Mechanical insufflation-exsufflation (Cough Assist) +40/-40 cmH2O —"
                }
              ],
              "route": "—",
              "instructions": "Set insufflation +40 cmH2O, exsufflation -40 cmH2O; 2-4 cycles per session; 2-4 sessions daily; use before meals and PRN",
              "orderSentence": "Mechanical insufflation-exsufflation (Cough Assist) +40/-40 cmH2O —"
            },
            "contraindications": "Bullous emphysema; pneumothorax",
            "monitoring": "Secretion clearance, respiratory status",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Portable suction",
            "route": "-",
            "indication": "Secretion management",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Portable suction N/A —"
                }
              ],
              "route": "—",
              "instructions": "Oral or pharyngeal suction PRN for secretion management",
              "orderSentence": "Portable suction N/A —"
            },
            "contraindications": "None",
            "monitoring": "Secretion burden, mucosal trauma",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Oxygen supplementation",
            "route": "INH",
            "indication": "Hypoxemia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-4 L/min NC PRN",
                  "orderSentence": "Oxygen supplementation 1-4 L/min NC PRN INH"
                }
              ],
              "route": "INH",
              "instructions": "Use cautiously; O2 may suppress respiratory drive; BiPAP preferred; use only for hypoxemia with BiPAP",
              "orderSentence": "Oxygen supplementation 1-4 L/min NC PRN INH"
            },
            "contraindications": "May suppress respiratory drive in hypercapnic patients",
            "monitoring": "SpO2, pCO2, respiratory rate",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Diaphragm pacing (NeuRx)",
            "route": "-",
            "indication": "Diaphragm weakness",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Surgical implantation",
                  "orderSentence": "Diaphragm pacing (NeuRx) Surgical implantation —"
                }
              ],
              "route": "—",
              "instructions": "Laparoscopic implantation of intramuscular diaphragm electrodes; controversial efficacy; FDA approved but limited evidence",
              "orderSentence": "Diaphragm pacing (NeuRx) Surgical implantation —"
            },
            "contraindications": "Severe diaphragm atrophy; unable to tolerate surgery",
            "monitoring": "Diaphragm function, surgical complications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Nutritional Support": [
          {
            "item": "Oral nutritional supplements",
            "route": "PO",
            "indication": "Weight loss; inadequate oral intake",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-3 supplements daily",
                  "orderSentence": "Oral nutritional supplements 1-3 supplements daily PO"
                }
              ],
              "route": "PO",
              "instructions": "High-calorie, high-protein supplements (e.g., Ensure Plus, Boost Plus) 1-3 daily between meals",
              "orderSentence": "Oral nutritional supplements 1-3 supplements daily PO"
            },
            "contraindications": "Aspiration risk",
            "monitoring": "Weight, caloric intake, albumin",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Thickened liquids",
            "route": "PO",
            "indication": "Dysphagia with thin liquid aspiration",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Nectar to honey thick consistency",
                  "orderSentence": "Thickened liquids Nectar to honey thick consistency PO"
                }
              ],
              "route": "PO",
              "instructions": "Thicken all thin liquids per SLP recommendation; nectar, honey, or pudding thick consistency",
              "orderSentence": "Thickened liquids Nectar to honey thick consistency PO"
            },
            "contraindications": "None",
            "monitoring": "Hydration status, swallow function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Percutaneous endoscopic gastrostomy (PEG)",
            "route": "-",
            "indication": "Dysphagia with weight loss >10% or FVC declining toward 50%",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Percutaneous endoscopic gastrostomy (PEG) N/A —"
                }
              ],
              "route": "—",
              "instructions": "Place electively when FVC >50% predicted; allows continued oral intake for pleasure; start tube feeds gradually",
              "orderSentence": "Percutaneous endoscopic gastrostomy (PEG) N/A —"
            },
            "contraindications": "FVC <50% (higher risk; consider RIG or PIG); severe coagulopathy",
            "monitoring": "Weight, tube site, aspiration",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Radiologically-inserted gastrostomy (RIG)",
            "route": "-",
            "indication": "PEG contraindicated; FVC <50%",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Radiologically-inserted gastrostomy (RIG) N/A —"
                }
              ],
              "route": "—",
              "instructions": "Alternative to PEG when FVC <50% or unable to tolerate endoscopy; fluoroscopic placement",
              "orderSentence": "Radiologically-inserted gastrostomy (RIG) N/A —"
            },
            "contraindications": "Severe ascites; peritoneal adhesions",
            "monitoring": "Weight, tube site",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Per-oral image-guided gastrostomy (PIG)",
            "route": "-",
            "indication": "Alternative to PEG/RIG",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Per-oral image-guided gastrostomy (PIG) N/A —"
                }
              ],
              "route": "—",
              "instructions": "Transoral placement under endoscopic and radiologic guidance; may tolerate lower FVC",
              "orderSentence": "Per-oral image-guided gastrostomy (PIG) N/A —"
            },
            "contraindications": "Same as RIG",
            "monitoring": "Weight, tube site",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Acute/Emergent Care": [
          {
            "item": "Noninvasive ventilation (acute)",
            "route": "INH",
            "indication": "Acute respiratory failure",
            "dosing": {
              "doseOptions": [
                {
                  "text": "IPAP 12-20",
                  "orderSentence": "Noninvasive ventilation (acute) IPAP 12-20 INH"
                },
                {
                  "text": "EPAP 5-8",
                  "orderSentence": "Noninvasive ventilation (acute) EPAP 5-8 INH"
                }
              ],
              "route": "INH",
              "instructions": "IPAP 12-20 cmH2O, EPAP 5-8 cmH2O; FiO2 to maintain SpO2 >92%; close monitoring for escalation",
              "orderSentence": "Noninvasive ventilation (acute) IPAP 12-20 INH"
            },
            "contraindications": "Inability to protect airway; hemodynamic instability",
            "monitoring": "ABG, respiratory rate, work of breathing",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Intubation and mechanical ventilation",
            "route": "-",
            "indication": "Respiratory failure not responding to NIV",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Intubation and mechanical ventilation N/A —"
                }
              ],
              "route": "—",
              "instructions": "Discuss advance directives; many ALS patients decline invasive ventilation; if desired, standard intubation and ventilation",
              "orderSentence": "Intubation and mechanical ventilation N/A —"
            },
            "contraindications": "Patient declines; DNI documented",
            "monitoring": "Ventilator parameters, sedation",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "IV fluids",
            "route": "IV",
            "indication": "Dehydration",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000-2000 mL NS or LR daily",
                  "orderSentence": "IV fluids 1000-2000 mL NS or LR daily IV"
                }
              ],
              "route": "IV",
              "instructions": "1-2 L IV daily; adjust for cardiac status",
              "orderSentence": "IV fluids 1000-2000 mL NS or LR daily IV"
            },
            "contraindications": "Fluid overload",
            "monitoring": "I/O, electrolytes, edema",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Empiric antibiotics (aspiration pneumonia)",
            "route": "IV",
            "indication": "Suspected aspiration pneumonia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Ampicillin-sulbactam 3g IV q6h",
                  "orderSentence": "Empiric antibiotics (aspiration pneumonia) Ampicillin-sulbactam 3g IV q6h IV"
                }
              ],
              "route": "IV",
              "instructions": "3g IV q6h; alternative: piperacillin-tazobactam 4.5g q6h; cover oral flora and anaerobes",
              "orderSentence": "Empiric antibiotics (aspiration pneumonia) Ampicillin-sulbactam 3g IV q6h IV"
            },
            "contraindications": "Allergies",
            "monitoring": "WBC, fever curve, respiratory status",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology (ALS specialist/multidisciplinary clinic) for diagnosis confirmation, disease-modifying therapy, and comprehensive management coordination",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Pulmonology for respiratory function monitoring, BiPAP initiation, and ventilator management decisions",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Physical therapy for mobility assessment, strengthening (submaximal), range of motion, and assistive device prescription",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Occupational therapy for ADL assessment, adaptive equipment, energy conservation, and home modification",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Speech-language pathology for swallow evaluation, communication strategies, and AAC device assessment",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Respiratory therapy for BiPAP setup and titration, cough assist training, and secretion management",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Nutrition/dietitian for caloric needs assessment, weight optimization, and tube feeding management",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Palliative care for symptom management, goals of care discussions, and quality of life optimization",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Social work for financial resources (SSDI, Medicaid), caregiver support, and ALS Association resources",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Psychiatry/psychology for depression, anxiety, and adjustment disorder common in ALS",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Gastroenterology for PEG placement when FVC declining toward 50% or significant dysphagia",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hospice care for end-of-life care when prognosis <6 months and/or patient declines aggressive interventions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Genetic counseling for familial ALS, gene testing interpretation, and family planning implications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately for increased shortness of breath, choking episodes, or inability to clear secretions (may indicate respiratory failure requiring urgent intervention)",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "STAT"
          },
          {
            "item": "Return for fever, worsening cough, or change in sputum color (may indicate aspiration pneumonia)",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "STAT"
          },
          {
            "item": "Do not drive if experiencing significant weakness or fatigue that could impair vehicle control",
            "ED": "URGENT",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Continue eating foods that are safe to swallow; use thickened liquids if recommended by speech therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use BiPAP as prescribed, even if initially uncomfortable; adherence improves symptoms and survival",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Perform prescribed exercises but avoid exhaustion; rest before becoming overly fatigued",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Complete advance directives including healthcare proxy, living will, and decisions about mechanical ventilation and feeding tubes",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Contact ALS Association (www.als.org) for educational resources, support groups, and equipment loan programs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Attend multidisciplinary ALS clinic visits every 2-3 months for comprehensive care coordination",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Consider joining ALS research registries and clinical trials (www.clinicaltrials.gov)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Aspiration precautions including upright positioning during meals, small bites, and chin-tuck swallowing technique",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Energy conservation with scheduled rest periods and prioritization of activities to reduce fatigue",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Home safety evaluation to remove fall hazards, install grab bars, and ensure wheelchair accessibility",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain optimal nutrition with high-calorie, high-protein diet; weight loss accelerates decline",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Sleep with head of bed elevated 30 degrees if using BiPAP or experiencing orthopnea",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation is essential to optimize respiratory function and reduce aspiration risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol as it may worsen weakness, sedation, and respiratory depression",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Frequent repositioning if immobile to prevent pressure ulcers",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Emotional and spiritual support for patient and caregivers; caregiver burnout is common",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Consider assistive technology early (voice banking, eye-tracking devices) before speech becomes unintelligible",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Cervical spondylotic myelopathy",
        "features": "Sensory level, bladder dysfunction, neck pain; UMN signs only",
        "tests": "MRI cervical spine shows cord compression"
      },
      {
        "diagnosis": "Multifocal motor neuropathy (MMN)",
        "features": "Pure LMN; treatable with IVIg; no UMN signs; asymmetric",
        "tests": "Anti-GM1 antibodies; NCS shows conduction block"
      },
      {
        "diagnosis": "Kennedy disease (SBMA)",
        "features": "X-linked; gynecomastia; sensory involvement; slower progression",
        "tests": "Androgen receptor gene CAG repeat expansion"
      },
      {
        "diagnosis": "Primary lateral sclerosis (PLS)",
        "features": "Pure UMN for >4 years; no LMN signs; slower progression",
        "tests": "EMG normal; clinical course"
      },
      {
        "diagnosis": "Progressive muscular atrophy (PMA)",
        "features": "Pure LMN; no UMN signs; may evolve to ALS",
        "tests": "EMG; clinical follow-up"
      },
      {
        "diagnosis": "Myasthenia gravis",
        "features": "Fatigable weakness; ptosis, diplopia; reflexes preserved",
        "tests": "AChR antibodies; RNS decrement; edrophonium test"
      },
      {
        "diagnosis": "Lambert-Eaton myasthenic syndrome",
        "features": "Proximal weakness; autonomic symptoms; improves with exercise",
        "tests": "Anti-VGCC antibodies; RNS increment"
      },
      {
        "diagnosis": "Inclusion body myositis (IBM)",
        "features": "Finger flexor and quadriceps weakness; older males; inflammatory",
        "tests": "Muscle biopsy; CPK mildly elevated"
      },
      {
        "diagnosis": "Post-polio syndrome",
        "features": "History of polio; new weakness in previously affected limbs",
        "tests": "Clinical history; EMG"
      },
      {
        "diagnosis": "Hirayama disease",
        "features": "Young males; asymmetric hand weakness; self-limited",
        "tests": "Cervical MRI in flexion shows posterior dural detachment"
      },
      {
        "diagnosis": "Monomelic amyotrophy",
        "features": "Unilateral limb LMN findings; non-progressive after years",
        "tests": "EMG limited to one limb; clinical course"
      },
      {
        "diagnosis": "Hereditary spastic paraplegia",
        "features": "Pure UMN; family history; sensory neuropathy in some types",
        "tests": "Genetic testing"
      },
      {
        "diagnosis": "Adrenomyeloneuropathy",
        "features": "X-linked; adrenal insufficiency; sensory neuropathy",
        "tests": "Very long chain fatty acids elevated"
      },
      {
        "diagnosis": "Hexosaminidase A deficiency",
        "features": "Early onset; may have psychiatric symptoms; Jewish ancestry",
        "tests": "Hexosaminidase A enzyme level"
      },
      {
        "diagnosis": "Copper deficiency myelopathy",
        "features": "Sensory ataxia; prior gastric surgery; anemia",
        "tests": "Serum copper and ceruloplasmin low"
      }
    ],
    "evidence": [
      {
        "recommendation": "Riluzole extends survival by 2-3 months",
        "evidenceLevel": "Class I, Level A",
        "source": "[Bensimon et al. NEJM 1994](https://pubmed.ncbi.nlm.nih.gov/8302340/); [Miller et al. Cochrane 2012](https://pubmed.ncbi.nlm.nih.gov/22419278/)"
      },
      {
        "recommendation": "El Escorial diagnostic criteria",
        "evidenceLevel": "Consensus, Level U",
        "source": "[Brooks et al. ALS Other Motor Neuron Disord 2000](https://pubmed.ncbi.nlm.nih.gov/11464847/)"
      },
      {
        "recommendation": "Awaji-shima criteria enhance diagnostic sensitivity",
        "evidenceLevel": "Class III, Level C",
        "source": "[de Carvalho et al. Clin Neurophysiol 2008](https://pubmed.ncbi.nlm.nih.gov/18024169/)"
      },
      {
        "recommendation": "BiPAP improves survival and quality of life",
        "evidenceLevel": "Class I, Level A",
        "source": "[Bourke et al. Lancet Neurol 2006](https://pubmed.ncbi.nlm.nih.gov/16545749/)"
      },
      {
        "recommendation": "Early PEG placement (FVC >50%) safer than late",
        "evidenceLevel": "Class II, Level B",
        "source": "[ProGas Study Group. Lancet Neurol 2015](https://pubmed.ncbi.nlm.nih.gov/25476873/)"
      },
      {
        "recommendation": "Multidisciplinary clinics improve survival 7-10 months",
        "evidenceLevel": "Class II, Level B",
        "source": "[Van den Berg et al. Lancet Neurol 2005](https://pubmed.ncbi.nlm.nih.gov/16109360/)"
      },
      {
        "recommendation": "Dextromethorphan-quinidine for pseudobulbar affect",
        "evidenceLevel": "Class I, Level A",
        "source": "[Brooks et al. Neurology 2004](https://pubmed.ncbi.nlm.nih.gov/15365143/)"
      },
      {
        "recommendation": "Edaravone slows functional decline in selected patients",
        "evidenceLevel": "Class I, Level B",
        "source": "[Writing Group. Lancet Neurol 2017](https://pubmed.ncbi.nlm.nih.gov/28522181/)"
      },
      {
        "recommendation": "AMX0035 (Relyvrio) slowed ALSFRS-R decline in phase 2; PHOENIX trial negative; **withdrawn April 2024**",
        "evidenceLevel": "Class II, Level B (superseded)",
        "source": "[Paganoni et al. NEJM 2020](https://pubmed.ncbi.nlm.nih.gov/32897034/)"
      },
      {
        "recommendation": "Tofersen reduces SOD1 in SOD1-ALS",
        "evidenceLevel": "Class I, Level B",
        "source": "[Miller et al. NEJM 2022](https://pubmed.ncbi.nlm.nih.gov/35363263/)"
      },
      {
        "recommendation": "Glycopyrrolate effective for sialorrhea",
        "evidenceLevel": "Class II, Level B",
        "source": "[Arbouw et al. J Neurol 2010](https://pubmed.ncbi.nlm.nih.gov/19943165/)"
      },
      {
        "recommendation": "Botulinum toxin for refractory sialorrhea",
        "evidenceLevel": "Class II, Level B",
        "source": "[Jackson et al. ALS FTD 2009](https://pubmed.ncbi.nlm.nih.gov/19929742/)"
      },
      {
        "recommendation": "C9orf72 most common genetic cause",
        "evidenceLevel": "Class II, Level B",
        "source": "[DeJesus-Hernandez et al. Neuron 2011](https://pubmed.ncbi.nlm.nih.gov/21944778/)"
      },
      {
        "recommendation": "ALSFRS-R validated outcome measure",
        "evidenceLevel": "Class II, Level B",
        "source": "[Cedarbaum et al. J Neurol Sci 1999](https://pubmed.ncbi.nlm.nih.gov/10540002/)"
      },
      {
        "recommendation": "Early palliative care improves quality of life",
        "evidenceLevel": "Class I, Level A",
        "source": "[Temel et al. NEJM 2010](https://pubmed.ncbi.nlm.nih.gov/20818875/) (oncology; extrapolated)"
      },
      {
        "recommendation": "FVC and NIF for respiratory monitoring",
        "evidenceLevel": "Class II, Level B",
        "source": "[Lechtzin et al. ALS Other Motor Neuron Disord 2002](https://pubmed.ncbi.nlm.nih.gov/12430545/)"
      },
      {
        "recommendation": "Cough assist improves secretion clearance",
        "evidenceLevel": "Class III, Level C",
        "source": "[Sancho et al. ALS Other Motor Neuron Disord 2004](https://pubmed.ncbi.nlm.nih.gov/15512884/)"
      },
      {
        "recommendation": "AAN Practice Parameters for ALS",
        "evidenceLevel": "Guideline",
        "source": "[Miller et al. Neurology 2009](https://pubmed.ncbi.nlm.nih.gov/19770405/)"
      }
    ],
    "monitoring": [
      {
        "item": "Forced vital capacity (FVC) sitting and supine",
        "frequency": "Every clinic visit (q2-3 months); more often if declining",
        "action": "Initiate BiPAP when <50% or symptoms; discuss PEG when declining toward 50%",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "ALSFRS-R score",
        "frequency": "Every clinic visit",
        "action": "Adjust care intensity; prognostic indicator",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight",
        "frequency": "Every clinic visit",
        "action": "Nutrition consult; consider PEG if >10% loss",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "LFTs (ALT/AST)",
        "frequency": "Monthly x 3 months on riluzole, then q3 months",
        "action": "Hold riluzole if ALT >5x ULN; reduce dose if 3-5x ULN",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Respiratory symptoms (orthopnea, morning headache, daytime somnolence)",
        "frequency": "Every visit",
        "action": "Initiate or titrate BiPAP",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "SpO2 and EtCO2 (if on BiPAP)",
        "frequency": "Each visit",
        "action": "Adjust BiPAP settings",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Swallowing function",
        "frequency": "Every visit",
        "action": "SLP evaluation; diet modification; consider PEG",
        "ED": "-",
        "HOSP": "URGENT",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Peak cough flow",
        "frequency": "Every visit",
        "action": "Initiate cough assist if <270 L/min",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Mood screening (PHQ-9)",
        "frequency": "Every visit",
        "action": "Antidepressant; psychology referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Caregiver stress",
        "frequency": "Every visit",
        "action": "Social work; respite care; support groups",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Advance directive status",
        "frequency": "At diagnosis and annually",
        "action": "Complete/update advance directives",
        "ED": "URGENT",
        "HOSP": "URGENT",
        "OPD": "ROUTINE",
        "ICU": "URGENT"
      },
      {
        "item": "BiPAP adherence",
        "frequency": "Every visit",
        "action": "Education; mask refitting; troubleshoot",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "**ICU admission**",
        "criteria": "Acute respiratory failure (FVC <15 mL/kg, pCO2 >50, SpO2 <88% on supplemental O2); aspiration pneumonia with respiratory distress; need for invasive ventilation (if patient desires)"
      },
      {
        "disposition": "**Step-down/telemetry**",
        "criteria": "Respiratory compromise improving on BiPAP; autonomic instability; aspiration pneumonia responding to treatment"
      },
      {
        "disposition": "**General floor admission**",
        "criteria": "Aspiration pneumonia without respiratory distress; severe dehydration or malnutrition; new bulbar symptoms requiring evaluation; falls with injury"
      },
      {
        "disposition": "**Discharge home**",
        "criteria": "Stable respiratory status; adequate nutrition (oral or PEG); caregiver support in place; equipment needs met; follow-up arranged"
      },
      {
        "disposition": "**Discharge to skilled nursing facility**",
        "criteria": "Requires 24-hour care that cannot be provided at home; feeding tube with complex care needs; no available caregivers"
      },
      {
        "disposition": "**Discharge to hospice**",
        "criteria": "Prognosis <6 months; patient declines aggressive interventions; focus on comfort care; FVC <30% or continuous BiPAP dependence"
      },
      {
        "disposition": "**Multidisciplinary ALS clinic follow-up**",
        "criteria": "Every 2-3 months; sooner if rapid decline; coordinate all subspecialty care"
      }
    ]
  },
  "Dystonia": {
    "id": "dystonia",
    "title": "Dystonia",
    "version": "1.1",
    "icd10": [
      "** G24.9 (Dystonia",
      "unspecified)",
      "G24.1 (Genetic torsion dystonia)",
      "G24.2 (Idiopathic nonfamilial dystonia)",
      "G24.3 (Spasmodic torticollis)",
      "G24.5 (Blepharospasm)",
      "G24.8 (Other dystonia)"
    ],
    "scope": "** Diagnosis, classification, workup for secondary causes, and symptomatic management of dystonia. Covers focal (cervical, blepharospasm, writer's cramp), segmental, and generalized forms. Includes evaluation for Wilson's disease, dopa-responsive dystonia, and drug-induced dystonia.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential (CPT 85025)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Baseline; exclude systemic illness",
            "target": "Normal"
          },
          {
            "item": "BMP (CPT 80048)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Electrolyte abnormalities can exacerbate movement disorders",
            "target": "Normal"
          },
          {
            "item": "Hepatic panel (AST, ALT, Alk Phos, bilirubin, albumin) (CPT 80076)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Screen for hepatic dysfunction suggesting Wilson's disease",
            "target": "Normal"
          },
          {
            "item": "Ceruloplasmin (CPT 82390)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Wilson's disease screen; essential for age <50 with dystonia",
            "target": ">20 mg/dL (low suggests Wilson's)"
          },
          {
            "item": "TSH (CPT 84443)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hyperthyroidism can cause movement disorders",
            "target": "Normal (0.4-4.0 mIU/L)"
          }
        ],
        "Extended Workup": [
          {
            "item": "24-hour urine copper (CPT 82525)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Wilson's disease confirmation if ceruloplasmin low/borderline",
            "target": "<40 mcg/24hr (elevated in Wilson's)"
          },
          {
            "item": "Serum copper (CPT 82525)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Interpret with ceruloplasmin (low free copper ratio in Wilson's)",
            "target": "75-145 mcg/dL"
          },
          {
            "item": "Vitamin B12 (CPT 82607)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency causes myelopathy and movement disorders",
            "target": ">300 pg/mL"
          },
          {
            "item": "Ferritin (CPT 82728), serum iron (CPT 83540), TIBC (CPT 83550)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurodegeneration with brain iron accumulation (NBIA)",
            "target": "Normal"
          },
          {
            "item": "Uric acid (CPT 84550)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Low in ataxia-telangiectasia, Lesch-Nyhan",
            "target": "Normal"
          },
          {
            "item": "Lactate (CPT 83605), pyruvate (CPT 84210)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Mitochondrial disorders",
            "target": "Normal"
          },
          {
            "item": "Calcium (CPT 82310), magnesium (CPT 83735)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hypocalcemia, hypomagnesemia can cause movement disorders",
            "target": "Normal"
          },
          {
            "item": "CK (CPT 82550)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Elevated in dystonia crises, NMS, prolonged dystonic posturing",
            "target": "Normal or mildly elevated"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "ATP7B gene sequencing (CPT 81479)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Definitive Wilson's disease diagnosis",
            "target": "No pathogenic variants"
          },
          {
            "item": "GCH1 gene sequencing (CPT 81479)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Dopa-responsive dystonia (DYT5a)",
            "target": "No pathogenic variants"
          },
          {
            "item": "TOR1A gene sequencing (CPT 81479)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "DYT1 dystonia (early-onset generalized)",
            "target": "No GAG deletion"
          },
          {
            "item": "THAP1 gene sequencing (CPT 81479)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "DYT6 dystonia",
            "target": "No pathogenic variants"
          },
          {
            "item": "Dystonia gene panel (multi-gene NGS) (CPT 81479)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Atypical presentations; family history; early onset",
            "target": "No pathogenic variants"
          },
          {
            "item": "CSF neurotransmitter metabolites (HVA, 5-HIAA, pterins) (CPT 83519)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Dopa-responsive dystonia; neurotransmitter disorders",
            "target": "Normal ratios"
          },
          {
            "item": "Acanthocyte smear (CPT 85060)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Chorea-acanthocytosis, McLeod syndrome",
            "target": "No acanthocytes"
          },
          {
            "item": "Lysosomal enzyme panel (CPT 82657)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Lysosomal storage disorders (GM1, GM2 gangliosidosis)",
            "target": "Normal enzyme activity"
          },
          {
            "item": "Anti-neuronal antibodies (NMDAR, LGI1, CASPR2) (CPT 86255)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Autoimmune dystonia (rare)",
            "target": "Negative"
          },
          {
            "item": "Paraneoplastic antibody panel (CPT 86235)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Paraneoplastic dystonia",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain without and with contrast (CPT 70553)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "All new dystonia cases; rule out structural lesion",
            "target": "Normal; no basal ganglia lesions",
            "contraindications": "MRI-incompatible devices"
          }
        ],
        "Extended": [
          {
            "item": "MRI Brain with SWI/iron sequences (CPT 70553)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Suspected Wilson's disease or NBIA",
            "target": "No T2 hypointensity in basal ganglia",
            "contraindications": "MRI contraindications"
          },
          {
            "item": "Slit lamp examination by ophthalmology (CPT 92012)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Wilson's disease evaluation; Kayser-Fleischer rings",
            "target": "No KF rings",
            "contraindications": "None"
          },
          {
            "item": "EMG with dystonia protocol (CPT 95907-95913)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Confirm diagnosis; characterize pattern; guide botulinum toxin",
            "target": "Co-contraction of agonist/antagonist; overflow",
            "contraindications": "None"
          },
          {
            "item": "DaTscan (ioflupane I-123) (CPT 78607)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Differentiate dystonic tremor from PD; combined dystonia-parkinsonism",
            "target": "Normal in primary dystonia; abnormal if parkinsonism",
            "contraindications": "Iodine allergy"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "MRI Spine (cervical/thoracic) (CPT 72156)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Cervical dystonia with radiculopathy symptoms",
            "target": "Normal; no cord compression",
            "contraindications": "MRI contraindications"
          },
          {
            "item": "FDG-PET Brain (CPT 78816)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Atypical parkinsonism with dystonia",
            "target": "Pattern interpretation varies",
            "contraindications": "None significant"
          },
          {
            "item": "Liver MRI or ultrasound (CPT 74183/76700)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Wilson's disease staging if diagnosed",
            "target": "Assess hepatic involvement",
            "contraindications": "None significant"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Diphenhydramine",
            "route": "IV/IM",
            "indication": "Acute dystonic reaction (drug-induced)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Diphenhydramine 25 mg IV/IM"
                }
              ],
              "route": "IV/IM",
              "instructions": "25-50 mg IV/IM over 2-5 min; may repeat in 30 min if needed; max 100 mg",
              "orderSentence": "Diphenhydramine 25 mg IV/IM"
            },
            "contraindications": "Narrow-angle glaucoma; urinary retention",
            "monitoring": "Sedation, hypotension",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Benztropine",
            "route": "IV/IM",
            "indication": "Acute dystonic reaction (drug-induced)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg",
                  "orderSentence": "Benztropine 1 mg IV/IM"
                }
              ],
              "route": "IV/IM",
              "instructions": "1-2 mg IV/IM; may repeat in 30 min; follow with oral 1-2 mg BID x 2-3 days to prevent recurrence",
              "orderSentence": "Benztropine 1 mg IV/IM"
            },
            "contraindications": "Narrow-angle glaucoma; GI obstruction; myasthenia gravis",
            "monitoring": "Anticholinergic effects, confusion (elderly)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Lorazepam",
            "route": "IV/PO",
            "indication": "Status dystonicus; severe dystonic storm",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg",
                  "orderSentence": "Lorazepam 1 mg IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "1-2 mg IV slow push or 2-4 mg PO; may repeat q4-6h PRN; monitor respiratory status",
              "orderSentence": "Lorazepam 1 mg IV/PO"
            },
            "contraindications": "Severe respiratory depression; acute narrow-angle glaucoma",
            "monitoring": "Respiratory depression, sedation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Diazepam",
            "route": "IV/PO",
            "indication": "Status dystonicus; muscle spasm relief",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Diazepam 5 mg IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "5-10 mg IV slow push (2 mg/min) or PO; may repeat q4h PRN",
              "orderSentence": "Diazepam 5 mg IV/PO"
            },
            "contraindications": "Severe respiratory depression; acute narrow-angle glaucoma",
            "monitoring": "Respiratory depression, sedation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Symptomatic Treatments (First-line for Focal Dystonia)": [
          {
            "item": "OnabotulinumtoxinA (Botox) - Cervical dystonia",
            "route": "IM",
            "indication": "First-line for cervical dystonia/torticollis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 units",
                  "orderSentence": "OnabotulinumtoxinA (Botox) - Cervical dystonia 100 units IM"
                }
              ],
              "route": "IM",
              "instructions": "Start 100-200 units divided among affected muscles (SCM, splenius, trapezius, levator scapulae); adjust based on response; max 300 units/session; repeat q12wk",
              "orderSentence": "OnabotulinumtoxinA (Botox) - Cervical dystonia 100 units IM"
            },
            "contraindications": "Infection at site; myasthenia gravis; ALS",
            "monitoring": "Dysphagia (especially bilateral SCM); neck weakness; antibody formation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "OnabotulinumtoxinA (Botox) - Blepharospasm",
            "route": "IM",
            "indication": "First-line for blepharospasm",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 units",
                  "orderSentence": "OnabotulinumtoxinA (Botox) - Blepharospasm 25 units IM"
                }
              ],
              "route": "IM",
              "instructions": "1.25-5 units per site; inject orbicularis oculi at multiple points; total 25-50 units per eye; repeat q12wk",
              "orderSentence": "OnabotulinumtoxinA (Botox) - Blepharospasm 25 units IM"
            },
            "contraindications": "Infection at site; myasthenia gravis; ALS",
            "monitoring": "Ptosis, diplopia, dry eyes, lagophthalmos",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "OnabotulinumtoxinA (Botox) - Writer's cramp",
            "route": "IM",
            "indication": "Focal hand dystonia refractory to therapy modification",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 units",
                  "orderSentence": "OnabotulinumtoxinA (Botox) - Writer's cramp 50 units IM"
                }
              ],
              "route": "IM",
              "instructions": "10-50 units per muscle; EMG guidance required; target FCR, FCU, FDS as needed; repeat q12wk",
              "orderSentence": "OnabotulinumtoxinA (Botox) - Writer's cramp 50 units IM"
            },
            "contraindications": "Infection at site; myasthenia gravis; ALS",
            "monitoring": "Finger weakness (may impair function)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "AbobotulinumtoxinA (Dysport) - Cervical dystonia",
            "route": "IM",
            "indication": "Alternative to onabotulinum; different potency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 units",
                  "orderSentence": "AbobotulinumtoxinA (Dysport) - Cervical dystonia 500 units IM"
                }
              ],
              "route": "IM",
              "instructions": "Start 500 units divided among affected muscles; max 1000 units/session; repeat q12wk",
              "orderSentence": "AbobotulinumtoxinA (Dysport) - Cervical dystonia 500 units IM"
            },
            "contraindications": "Infection at site; myasthenia gravis; ALS",
            "monitoring": "Dysphagia (especially bilateral SCM); neck weakness; antibody formation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "IncobotulinumtoxinA (Xeomin) - Cervical dystonia",
            "route": "IM",
            "indication": "Alternative; no complexing proteins",
            "dosing": {
              "doseOptions": [
                {
                  "text": "120 units",
                  "orderSentence": "IncobotulinumtoxinA (Xeomin) - Cervical dystonia 120 units IM"
                }
              ],
              "route": "IM",
              "instructions": "Start 120-200 units divided; max 300 units/session; repeat q12wk; may have lower immunogenicity",
              "orderSentence": "IncobotulinumtoxinA (Xeomin) - Cervical dystonia 120 units IM"
            },
            "contraindications": "Infection at site; myasthenia gravis; ALS",
            "monitoring": "Dysphagia (especially bilateral SCM); neck weakness; antibody formation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "RimabotulinumtoxinB (Myobloc) - Cervical dystonia",
            "route": "IM",
            "indication": "Type A toxin non-responders; secondary non-response",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2500 units",
                  "orderSentence": "RimabotulinumtoxinB (Myobloc) - Cervical dystonia 2500 units IM"
                }
              ],
              "route": "IM",
              "instructions": "Start 2500-5000 units divided; max 10000 units; repeat q12wk; higher dry mouth rate",
              "orderSentence": "RimabotulinumtoxinB (Myobloc) - Cervical dystonia 2500 units IM"
            },
            "contraindications": "Infection at site; myasthenia gravis; ALS; type B protein allergy",
            "monitoring": "Dry mouth; dysphagia; neck weakness; antibody formation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Oral Medications": [
          {
            "item": "Trihexyphenidyl",
            "route": "PO",
            "indication": "First-line oral for generalized dystonia; young patients tolerate best",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg",
                  "orderSentence": "Trihexyphenidyl 1 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1 mg daily; increase by 1-2 mg q3-5d; typical target 6-30 mg/day divided TID; some patients require up to 60-80 mg/day",
              "orderSentence": "Trihexyphenidyl 1 mg PO"
            },
            "contraindications": "Narrow-angle glaucoma; GI obstruction; urinary retention; dementia",
            "monitoring": "Anticholinergic effects (dry mouth, constipation, urinary retention, confusion); cognitive effects in elderly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Benztropine",
            "route": "PO",
            "indication": "Alternative anticholinergic; maintenance after acute dystonic reaction",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg",
                  "orderSentence": "Benztropine 0.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.5 mg BID; increase by 0.5 mg q5-7d; typical 1-4 mg/day; max 6 mg/day",
              "orderSentence": "Benztropine 0.5 mg PO"
            },
            "contraindications": "Narrow-angle glaucoma; GI obstruction; urinary retention; dementia",
            "monitoring": "Anticholinergic effects (dry mouth, constipation, urinary retention, confusion); cognitive effects in elderly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Baclofen",
            "route": "PO",
            "indication": "Muscle relaxant; useful adjunct for dystonia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Baclofen 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg TID; increase by 5 mg/dose q3d; typical 30-80 mg/day divided TID; max 80-120 mg/day",
              "orderSentence": "Baclofen 5 mg PO"
            },
            "contraindications": "Severe renal impairment (dose adjust); abrupt withdrawal risk",
            "monitoring": "Sedation, weakness; taper slowly if discontinuing",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clonazepam",
            "route": "PO",
            "indication": "Adjunct for dystonia; myoclonus-dystonia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg",
                  "orderSentence": "Clonazepam 0.25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25 mg BID; increase by 0.25-0.5 mg q3-7d; typical 1-4 mg/day; max 6 mg/day",
              "orderSentence": "Clonazepam 0.25 mg PO"
            },
            "contraindications": "Respiratory depression; severe hepatic impairment; substance abuse history",
            "monitoring": "Sedation, dependence, falls; taper if discontinuing",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Diazepam",
            "route": "PO",
            "indication": "Alternative benzodiazepine; muscle relaxant properties",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg",
                  "orderSentence": "Diazepam 2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2 mg TID; increase by 2-5 mg/day q3-7d; typical 10-40 mg/day divided",
              "orderSentence": "Diazepam 2 mg PO"
            },
            "contraindications": "Respiratory depression; severe hepatic impairment; substance abuse history",
            "monitoring": "Sedation, dependence, falls; taper if discontinuing",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Levodopa/Carbidopa",
            "route": "PO",
            "indication": "Dopa-responsive dystonia (DRD); diagnostic trial for young-onset",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25/100 mg",
                  "orderSentence": "Levodopa/Carbidopa 25/100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25/100 mg TID; if DRD, dramatic response at low dose; may titrate to 50/200 mg TID; response confirms diagnosis",
              "orderSentence": "Levodopa/Carbidopa 25/100 mg PO"
            },
            "contraindications": "None absolute; use caution in psychosis",
            "monitoring": "Nausea, orthostatic hypotension; dramatic improvement suggests DRD",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tetrabenazine",
            "route": "PO",
            "indication": "Hyperkinetic movements including some dystonias",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg",
                  "orderSentence": "Tetrabenazine 12.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5 mg daily; increase by 12.5 mg q1wk; max 200 mg/day; CYP2D6 testing recommended",
              "orderSentence": "Tetrabenazine 12.5 mg PO"
            },
            "contraindications": "Depression; suicidality; Parkinsonism",
            "monitoring": "Depression, sedation, parkinsonism, akathisia; Black Box: suicidality",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Deutetrabenazine (Austedo)",
            "route": "PO",
            "indication": "Longer half-life alternative to tetrabenazine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "6 mg",
                  "orderSentence": "Deutetrabenazine (Austedo) 6 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 6 mg BID; increase by 6 mg/day weekly; max 48 mg/day",
              "orderSentence": "Deutetrabenazine (Austedo) 6 mg PO"
            },
            "contraindications": "Depression; suicidality; Parkinsonism",
            "monitoring": "Depression, sedation, parkinsonism, akathisia; Black Box: suicidality; may be better tolerated than tetrabenazine",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clonidine",
            "route": "PO",
            "indication": "Adjunct; may help in some patients",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg",
                  "orderSentence": "Clonidine 0.1 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.1 mg BID; increase by 0.1 mg q1wk; max 0.6 mg/day",
              "orderSentence": "Clonidine 0.1 mg PO"
            },
            "contraindications": "Severe bradycardia; renal impairment (adjust)",
            "monitoring": "Hypotension, bradycardia, sedation; rebound hypertension if stopped abruptly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbamazepine",
            "route": "PO",
            "indication": "Paroxysmal kinesigenic dystonia/dyskinesia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Carbamazepine 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg BID; increase by 100-200 mg q1wk; target 400-800 mg/day; check HLA-B*1502 in at-risk populations",
              "orderSentence": "Carbamazepine 100 mg PO"
            },
            "contraindications": "Bone marrow suppression; AV block; SJS risk (HLA-B*1502)",
            "monitoring": "CBC, LFTs, sodium; drug levels (4-12 mcg/mL)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Disease-Modifying/Specialized Therapies": [
          {
            "item": "Deep brain stimulation (GPi-DBS)",
            "route": "Surgical",
            "indication": "Medication-refractory generalized or segmental dystonia; DYT1 positive",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Bilateral GPi stimulation",
                  "orderSentence": "Deep brain stimulation (GPi-DBS) Bilateral GPi stimulation Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Bilateral GPi electrode placement; programming over weeks-months; full effect may take 6-12 months",
              "orderSentence": "Deep brain stimulation (GPi-DBS) Bilateral GPi stimulation Surgical"
            },
            "pretreatment": "MRI; neuropsych testing; multidisciplinary evaluation; genetic testing if indicated",
            "contraindications": "Cognitive impairment; coagulopathy; infection; unrealistic expectations",
            "monitoring": "Programming optimization; battery replacement q3-5yr; speech/swallowing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Deep brain stimulation (GPi-DBS)",
            "route": "Surgical",
            "indication": "Cervical dystonia refractory to botulinum toxin",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Bilateral GPi stimulation",
                  "orderSentence": "Deep brain stimulation (GPi-DBS) Bilateral GPi stimulation Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Bilateral GPi electrode placement; programming over weeks-months; full effect may take 6-12 months",
              "orderSentence": "Deep brain stimulation (GPi-DBS) Bilateral GPi stimulation Surgical"
            },
            "pretreatment": "MRI; neuropsych testing; multidisciplinary evaluation; genetic testing if indicated",
            "contraindications": "Cognitive impairment; coagulopathy; infection; unrealistic expectations",
            "monitoring": "Programming optimization; battery replacement q3-5yr; speech/swallowing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Intrathecal baclofen pump",
            "route": "Surgical",
            "indication": "Severe generalized dystonia with spasticity component; CP-related",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mcg",
                  "orderSentence": "Intrathecal baclofen pump 25 mcg IT"
                }
              ],
              "route": "IT",
              "instructions": "Test dose 25-100 mcg; maintenance typically 100-1000 mcg/day; titrate over months",
              "orderSentence": "Intrathecal baclofen pump 25 mcg IT"
            },
            "pretreatment": "IT baclofen trial with >50% improvement",
            "contraindications": "Infection; CSF obstruction; baclofen hypersensitivity",
            "monitoring": "Pump refills q1-3mo; withdrawal syndrome if interruption; MRI conditional pumps",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "D-penicillamine",
            "route": "PO",
            "indication": "Wilson's disease with neurological symptoms",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg",
                  "orderSentence": "D-penicillamine 250 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 250 mg daily; increase by 250 mg q4-7d; target 1000-1500 mg/day divided BID (take 1hr before meals); lifelong treatment",
              "orderSentence": "D-penicillamine 250 mg PO"
            },
            "pretreatment": "24h urine copper, LFTs, CBC, urinalysis",
            "contraindications": "Penicillin allergy (not absolute but caution); nephrotoxicity",
            "monitoring": "CBC weekly x1mo then monthly x6mo then q3mo; urinalysis monthly; LFTs monthly; neurologic worsening first 6 months possible",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trientine (Syprine)",
            "route": "PO",
            "indication": "Wilson's disease; D-penicillamine intolerant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg",
                  "orderSentence": "Trientine (Syprine) 250 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 250 mg TID; target 750-1250 mg/day divided TID; take 1hr before or 2hr after meals",
              "orderSentence": "Trientine (Syprine) 250 mg PO"
            },
            "pretreatment": "24h urine copper, LFTs, CBC, urinalysis",
            "contraindications": "Caution with iron supplements (separate by 2hr)",
            "monitoring": "CBC, LFTs, urinalysis monthly initially then q3mo; fewer side effects than D-penicillamine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Zinc acetate (Galzin)",
            "route": "PO",
            "indication": "Wilson's disease maintenance; presymptomatic; adjunct",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Zinc acetate (Galzin) 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "50 mg TID (elemental zinc); take between meals; blocks intestinal copper absorption",
              "orderSentence": "Zinc acetate (Galzin) 50 mg PO"
            },
            "pretreatment": "Take separately from copper chelators",
            "contraindications": "GI upset",
            "monitoring": "24h urine copper; serum zinc; 24h urine zinc",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Movement disorders neurology for diagnosis confirmation, classification, and treatment planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ophthalmology for slit lamp examination to evaluate for Kayser-Fleischer rings (Wilson's disease workup)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatology if Wilson's disease diagnosed for hepatic management and transplant evaluation if severe",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetic counseling if genetic dystonia confirmed or suspected (DYT1, DYT6, GCH1)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neurosurgery consultation for DBS evaluation if medication-refractory",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for posture correction, stretching, and range of motion exercises",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for adaptive techniques and assistive devices for ADLs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech therapy if oromandibular dystonia, laryngeal dystonia, or cervical dystonia affecting swallowing",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain management if chronic pain from dystonic posturing not controlled with primary treatment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychology/psychiatry for coping strategies, depression/anxiety management related to chronic dystonia",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "After botulinum toxin injection: avoid rubbing injection sites; effects develop over 3-14 days and last 10-12 weeks",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report any swallowing difficulty or breathing problems after botulinum toxin injection (may indicate spread)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use sensory tricks (geste antagoniste) such as touching chin or face which may temporarily reduce cervical dystonia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return to ED if severe muscle spasms with fever, confusion, or dark urine (possible dystonic storm or rhabdomyolysis)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Continue physical therapy exercises at home to maintain range of motion and prevent contractures",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid medications that worsen dystonia: metoclopramide, prochlorperazine, haloperidol, and other dopamine blockers",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "For Wilson's disease: strict adherence to copper chelation is lifelong; follow dietary copper restrictions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep a symptom diary noting triggers, sensory tricks that help, and response to medications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Stress management with relaxation techniques as stress can exacerbate dystonia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate sleep as fatigue worsens dystonia symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit caffeine and stimulants which may worsen tremor/dystonia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular gentle exercise (swimming, yoga) to maintain flexibility without overexertion",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Ergonomic workstation modifications for task-specific dystonia (writer's cramp, musician's dystonia)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "For Wilson's disease: avoid high-copper foods (liver, shellfish, chocolate, nuts, mushrooms) especially during initial treatment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid alcohol especially if on benzodiazepines or with hepatic involvement (Wilson's)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Heat application to affected muscles may provide temporary relief",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Support groups for dystonia provide coping strategies and community connection",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Drug-induced dystonia",
        "features": "Temporal relationship with dopamine blockers (antipsychotics, antiemetics); acute or tardive",
        "tests": "Medication history; resolves with withdrawal (acute) or persists (tardive)"
      },
      {
        "diagnosis": "Wilson's disease",
        "features": "Age <50; hepatic dysfunction; psychiatric symptoms; Kayser-Fleischer rings",
        "tests": "Ceruloplasmin (low), 24h urine copper (high), slit lamp exam, ATP7B testing"
      },
      {
        "diagnosis": "Dopa-responsive dystonia (DYT5/Segawa)",
        "features": "Childhood onset; diurnal fluctuation (worse evening); dramatic levodopa response",
        "tests": "Levodopa trial (dramatic improvement); GCH1 gene testing"
      },
      {
        "diagnosis": "Parkinson's disease with dystonia",
        "features": "Rest tremor; bradykinesia; rigidity; asymmetric; sustained postures",
        "tests": "DaTscan (abnormal); clinical exam; levodopa response"
      },
      {
        "diagnosis": "Psychogenic/functional dystonia",
        "features": "Inconsistent; distractible; fixed posture from onset; associated somatization",
        "tests": "Clinical features; psychiatric evaluation; resolution with distraction"
      },
      {
        "diagnosis": "Stiff-person syndrome",
        "features": "Axial rigidity; episodic spasms triggered by startle; anti-GAD antibodies",
        "tests": "Anti-GAD65 antibodies; EMG (continuous motor unit activity)"
      },
      {
        "diagnosis": "Tardive dystonia",
        "features": "Prolonged dopamine blocker exposure (months-years); may persist after withdrawal",
        "tests": "History of antipsychotic/antiemetic use; AIMS assessment"
      },
      {
        "diagnosis": "Cervical spondylotic myelopathy",
        "features": "Neck pain; sensory symptoms; hyperreflexia; Hoffmann sign",
        "tests": "MRI C-spine (cord compression, myelopathy signal)"
      },
      {
        "diagnosis": "Torticollis from posterior fossa tumor",
        "features": "Constant head tilt; headache; papilledema; cranial nerve signs",
        "tests": "MRI Brain with contrast (tumor, hydrocephalus)"
      },
      {
        "diagnosis": "Neuroacanthocytosis/chorea-acanthocytosis",
        "features": "Chorea; orofacial dystonia; lip/tongue biting; elevated CK",
        "tests": "Acanthocyte smear; CK; VPS13A gene testing"
      },
      {
        "diagnosis": "NBIA (neurodegeneration with brain iron accumulation)",
        "features": "Progressive; childhood/young adult onset; parkinsonism; retinopathy",
        "tests": "MRI (eye-of-the-tiger sign); genetic panels (PANK2, etc.)"
      },
      {
        "diagnosis": "Meige syndrome",
        "features": "Combined blepharospasm + oromandibular dystonia",
        "tests": "Clinical diagnosis; rule out secondary causes"
      },
      {
        "diagnosis": "Myoclonus-dystonia (DYT11)",
        "features": "Myoclonic jerks + dystonia; alcohol responsive; SGCE gene",
        "tests": "SGCE gene testing; alcohol response"
      },
      {
        "diagnosis": "Paroxysmal kinesigenic dyskinesia",
        "features": "Brief attacks (<1 min); triggered by sudden movement; responds to carbamazepine",
        "tests": "Clinical history; PRRT2 gene testing"
      }
    ],
    "evidence": [
      {
        "recommendation": "Botulinum toxin first-line for cervical dystonia",
        "evidenceLevel": "Class I, Level A",
        "source": "[Simpson DM et al. Neurology 2008 (AAN Guideline)](https://pubmed.ncbi.nlm.nih.gov/18458229/)"
      },
      {
        "recommendation": "Botulinum toxin for blepharospasm",
        "evidenceLevel": "Class I, Level A",
        "source": "[Simpson DM et al. Neurology 2008](https://pubmed.ncbi.nlm.nih.gov/18458229/)"
      },
      {
        "recommendation": "GPi-DBS effective for generalized dystonia",
        "evidenceLevel": "Class I, Level A",
        "source": "[Vidailhet M et al. NEJM 2005](https://pubmed.ncbi.nlm.nih.gov/15689584/)"
      },
      {
        "recommendation": "DBS superior effect in DYT1-positive patients",
        "evidenceLevel": "Class II, Level B",
        "source": "[Coubes P et al. J Neurosurg 2004](https://pubmed.ncbi.nlm.nih.gov/15540920/)"
      },
      {
        "recommendation": "Trihexyphenidyl for generalized dystonia",
        "evidenceLevel": "Class II, Level C",
        "source": "[Burke RE et al. Neurology 1986](https://pubmed.ncbi.nlm.nih.gov/3703234/)"
      },
      {
        "recommendation": "Levodopa trial for suspected dopa-responsive dystonia",
        "evidenceLevel": "Class II, Level B",
        "source": "[Nygaard TG et al. Neurology 1991](https://pubmed.ncbi.nlm.nih.gov/1891117/)"
      },
      {
        "recommendation": "Dystonia classification consensus",
        "evidenceLevel": "Expert consensus",
        "source": "[Albanese A et al. Mov Disord 2013](https://pubmed.ncbi.nlm.nih.gov/23649720/)"
      },
      {
        "recommendation": "Wilson's disease diagnosis and treatment",
        "evidenceLevel": "Class I, Level A",
        "source": "[Roberts EA, Schilsky ML. Hepatology 2008 (AASLD Guideline)](https://pubmed.ncbi.nlm.nih.gov/18506894/)"
      },
      {
        "recommendation": "D-penicillamine for Wilson's disease",
        "evidenceLevel": "Class I, Level A",
        "source": "[Roberts EA, Schilsky ML. Hepatology 2008](https://pubmed.ncbi.nlm.nih.gov/18506894/)"
      },
      {
        "recommendation": "Intrathecal baclofen for severe dystonia",
        "evidenceLevel": "Class II, Level B",
        "source": "[Albright AL et al. J Neurosurg 2001](https://pubmed.ncbi.nlm.nih.gov/11453401/)"
      },
      {
        "recommendation": "Benztropine/diphenhydramine for acute dystonic reaction",
        "evidenceLevel": "Class III, Level C",
        "source": "[van Harten PN et al. J Clin Psychiatry 1999](https://pubmed.ncbi.nlm.nih.gov/10401919/)"
      },
      {
        "recommendation": "Carbamazepine for paroxysmal kinesigenic dyskinesia",
        "evidenceLevel": "Class II, Level B",
        "source": "[Bruno MK et al. Brain 2004](https://pubmed.ncbi.nlm.nih.gov/14607786/)"
      },
      {
        "recommendation": "EFNS guidelines on dystonia diagnosis and treatment",
        "evidenceLevel": "Expert consensus",
        "source": "[Albanese A et al. Eur J Neurol 2011](https://pubmed.ncbi.nlm.nih.gov/20649898/)"
      },
      {
        "recommendation": "Tetrabenazine for hyperkinetic movement disorders",
        "evidenceLevel": "Class II, Level B",
        "source": "[Jankovic J, Beach J. Neurology 1997](https://pubmed.ncbi.nlm.nih.gov/9109891/)"
      }
    ],
    "monitoring": [
      {
        "item": "Dystonia severity (Burke-Fahn-Marsden scale, TWSTRS for cervical)",
        "frequency": "Each visit",
        "action": "Adjust botulinum toxin dose/muscles; add oral agent; consider DBS",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Functional status and disability",
        "frequency": "Each visit",
        "action": "OT/PT referral; adaptive devices; treatment escalation",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Anticholinergic side effects (dry mouth, constipation, urinary retention, cognition)",
        "frequency": "Each visit on anticholinergics",
        "action": "Reduce dose; switch agents; add symptomatic treatment",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Dysphagia screening (after cervical botulinum toxin)",
        "frequency": "2 weeks post-injection",
        "action": "Dietary modification; speech therapy; reduce dose next session",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "CK level (if severe dystonia or dystonic storm)",
        "frequency": "PRN",
        "action": "IV fluids; monitor renal function; treat underlying cause",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT"
      },
      {
        "item": "24-hour urine copper (Wilson's on chelation)",
        "frequency": "Every 3-6 months",
        "action": "Adjust chelator dose; assess compliance",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "CBC, urinalysis (on D-penicillamine)",
        "frequency": "Monthly initially then q3mo",
        "action": "Hold drug if cytopenias or proteinuria; switch to trientine",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "LFTs (Wilson's disease)",
        "frequency": "Monthly initially then q3mo",
        "action": "Hepatology consultation if worsening",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Depression screening (on tetrabenazine)",
        "frequency": "Each visit",
        "action": "Discontinue tetrabenazine; psychiatric referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "DBS parameters and battery",
        "frequency": "Every 6-12 months",
        "action": "Reprogram; schedule battery replacement if needed",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "New diagnosis with workup initiated; mild symptoms; treatment plan in place; follow-up scheduled"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Acute dystonic reaction requiring observation; new generalized dystonia requiring workup; Wilson's disease with hepatic decompensation"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Status dystonicus (dystonic storm); respiratory compromise; rhabdomyolysis; severe drug-induced dystonia with airway concern"
      },
      {
        "disposition": "Transfer to higher level",
        "criteria": "DBS programming issues requiring movement disorders center; refractory status dystonicus requiring specialized center"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "2-4 weeks after new medication started; 12 weeks for botulinum toxin reassessment; 6-12 months when stable"
      }
    ]
  },
  "Huntington's Disease": {
    "id": "huntingtons-disease",
    "title": "Huntington's Disease",
    "version": "1.1",
    "icd10": [
      "** G10 (Huntington disease)",
      "F02.80 (Dementia in HD without behavioral disturbance)",
      "F02.81 (Dementia in HD with behavioral disturbance)"
    ],
    "scope": "** Diagnosis confirmation via genetic testing, chorea management, psychiatric symptom treatment, cognitive decline management, dysphagia assessment, genetic counseling, and end-of-life planning. Focuses primarily on outpatient management. Excludes Huntington disease-like syndromes (HDL1-4) and other chorea etiologies.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Huntington gene test (HTT CAG repeat) (CPT 81401)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Definitive diagnosis; CAG repeat expansion",
            "target": "≥36 CAG repeats diagnostic (40+ fully penetrant)"
          },
          {
            "item": "CBC (CPT 85025)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Baseline; anemia contributes to fatigue; infection screen",
            "target": "Normal"
          },
          {
            "item": "BMP (CPT 80048)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Electrolytes; renal function for medication dosing",
            "target": "Normal"
          },
          {
            "item": "Hepatic panel (LFTs) (CPT 80076)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Baseline before tetrabenazine/deutetrabenazine; valproate if used",
            "target": "Normal"
          },
          {
            "item": "TSH (CPT 84443)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypothyroidism can mimic apathy and cognitive slowing",
            "target": "Normal"
          },
          {
            "item": "Vitamin B12 (CPT 82607)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency can worsen cognitive and psychiatric symptoms",
            "target": ">300 pg/mL"
          },
          {
            "item": "Vitamin D, 25-hydroxy (CPT 82306)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency common; contributes to falls and bone health",
            "target": ">30 ng/mL"
          }
        ],
        "Extended Workup": [
          {
            "item": "Iron studies (CPT 83540), ferritin (CPT 82728)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurodegeneration with brain iron accumulation if HD-negative",
            "target": "Normal"
          },
          {
            "item": "Ceruloplasmin (CPT 82390), serum copper (CPT 82525)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Wilson's disease if younger onset, HD gene-negative",
            "target": "Normal"
          },
          {
            "item": "ACTN3 gene test (CPT 81479)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Research; may modify age of onset",
            "target": "Research use"
          },
          {
            "item": "Acanthocyte screen (peripheral smear) (CPT 85060)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Chorea-acanthocytosis if HD gene-negative",
            "target": "No acanthocytes"
          },
          {
            "item": "Lipid panel (CPT 80061)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Cardiovascular risk; weight loss monitoring",
            "target": "Normal"
          },
          {
            "item": "Prealbumin (CPT 84134), albumin (CPT 82040)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Nutritional status assessment in advanced disease",
            "target": "Normal"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Genetic testing for HDL syndromes (PRNP, JPH3, TBP, ATN1) (CPT 81479)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "HD-like phenotype with negative HTT test",
            "target": "Identifies HD-like syndrome"
          },
          {
            "item": "CSF biomarkers (neurofilament light chain) (CPT 83519)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Disease progression monitoring; research",
            "target": "Elevated in active disease"
          },
          {
            "item": "Kynurenine pathway metabolites (CPT 82542)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Research; therapeutic target assessment",
            "target": "Research use"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain without contrast (CPT 70551)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At diagnosis",
            "target": "Caudate atrophy; lateral ventricle enlargement (\"boxcar\" ventricles)",
            "contraindications": "MRI-incompatible devices"
          }
        ],
        "Extended": [
          {
            "item": "MRI Brain volumetric (CPT 70553)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Baseline and annually for progression",
            "target": "Quantify caudate and striatal volume loss",
            "contraindications": "MRI contraindications"
          },
          {
            "item": "Swallowing evaluation (VFSS or FEES) (CPT 74230/92612)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At diagnosis and with dysphagia symptoms",
            "target": "Identify aspiration risk; guide diet modification",
            "contraindications": "None"
          },
          {
            "item": "ECG (CPT 93000)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Baseline before tetrabenazine/deutetrabenazine",
            "target": "QTc <450 ms",
            "contraindications": "None"
          },
          {
            "item": "Polysomnography (CPT 95810)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Sleep disturbance evaluation",
            "target": "Rule out sleep apnea; assess sleep architecture",
            "contraindications": "None"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "PET imaging (FDG or specific tracers) (CPT 78816)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Research; atypical presentation",
            "target": "Striatal hypometabolism",
            "contraindications": "None"
          },
          {
            "item": "Neuropsychological testing battery (CPT 96132)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At diagnosis and annually",
            "target": "Baseline cognitive profile; monitor decline",
            "contraindications": "None"
          },
          {
            "item": "Genetic modifier testing (research) (CPT 81479)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Prognosis; clinical trials",
            "target": "Identifies modifiers of age of onset",
            "contraindications": "None"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Lorazepam",
            "route": "IV/PO",
            "indication": "Severe chorea causing injury or exhaustion",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg",
                  "orderSentence": "Lorazepam 0.5 mg IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "0.5-2 mg IV/PO q4-6h PRN; short-term use only",
              "orderSentence": "Lorazepam 0.5 mg IV/PO"
            },
            "contraindications": "Respiratory depression; acute narrow-angle glaucoma",
            "monitoring": "Respiratory status, sedation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Haloperidol",
            "route": "IV/IM",
            "indication": "Severe psychosis with agitation; acute behavioral emergency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg",
                  "orderSentence": "Haloperidol 2 mg IM"
                }
              ],
              "route": "IM",
              "instructions": "2-5 mg IM; may repeat q4-6h; max 20 mg/day; transition to oral",
              "orderSentence": "Haloperidol 2 mg IM"
            },
            "contraindications": "QTc prolongation; history of NMS; worsens dystonia",
            "monitoring": "ECG, EPS, sedation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Olanzapine",
            "route": "IM/PO",
            "indication": "Acute agitation with psychosis; alternative to haloperidol",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Olanzapine 5 mg IM"
                }
              ],
              "route": "IM",
              "instructions": "5-10 mg IM; may repeat in 2 hours; max 30 mg/day",
              "orderSentence": "Olanzapine 5 mg IM"
            },
            "contraindications": "Concurrent benzodiazepines (caution); diabetes",
            "monitoring": "Glucose, sedation, EPS",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "IV fluids",
            "route": "IV",
            "indication": "Dehydration from dysphagia or decreased oral intake",
            "dosing": {
              "doseOptions": [
                {
                  "text": "NS at 75 mL/hr",
                  "orderSentence": "IV fluids NS at 75 mL/hr IV"
                }
              ],
              "route": "IV",
              "instructions": "NS at 75-125 mL/hr; correct dehydration; transition to oral when safe",
              "orderSentence": "IV fluids NS at 75 mL/hr IV"
            },
            "contraindications": "Fluid overload",
            "monitoring": "I/O, electrolytes",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Thiamine",
            "route": "IV",
            "indication": "Nutritional deficiency; altered mental status",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Thiamine 100 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "100 mg IV daily x 3-5 days; then oral",
              "orderSentence": "Thiamine 100 mg IV"
            },
            "contraindications": "None",
            "monitoring": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Symptomatic Treatments - Chorea": [
          {
            "item": "Tetrabenazine (Xenazine)",
            "route": "PO",
            "indication": "FDA-approved for HD chorea; first-line",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg",
                  "orderSentence": "Tetrabenazine (Xenazine) 12.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5 mg daily; increase by 12.5 mg q1wk; max 100 mg/day (25 mg per dose); CYP2D6 testing recommended",
              "orderSentence": "Tetrabenazine (Xenazine) 12.5 mg PO"
            },
            "contraindications": "Active suicidality; untreated depression; concurrent MAOIs; hepatic impairment",
            "monitoring": "Depression (PHQ-9 monthly), akathisia, parkinsonism, QTc",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Deutetrabenazine (Austedo)",
            "route": "PO",
            "indication": "FDA-approved for HD chorea; better tolerability than tetrabenazine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "6 mg",
                  "orderSentence": "Deutetrabenazine (Austedo) 6 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 6 mg daily; increase by 6 mg/wk; max 48 mg/day (24 mg per dose)",
              "orderSentence": "Deutetrabenazine (Austedo) 6 mg PO"
            },
            "contraindications": "Active suicidality; untreated depression; concurrent MAOIs; hepatic impairment",
            "monitoring": "Depression (PHQ-9 monthly), akathisia, parkinsonism, QTc",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valbenazine (Ingrezza)",
            "route": "PO",
            "indication": "Off-label for HD chorea; once daily dosing",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Valbenazine (Ingrezza) 40 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 40 mg daily; may increase to 80 mg after 1 week",
              "orderSentence": "Valbenazine (Ingrezza) 40 mg PO"
            },
            "contraindications": "Severe hepatic impairment; concurrent MAOIs; congenital long QT",
            "monitoring": "Depression, akathisia, QTc prolongation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Risperidone",
            "route": "PO",
            "indication": "Chorea with psychosis; antipsychotic with motor benefit",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg",
                  "orderSentence": "Risperidone 0.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.5 mg daily; titrate by 0.5 mg q1wk; max 6 mg/day",
              "orderSentence": "Risperidone 0.5 mg PO"
            },
            "contraindications": "QTc prolongation; history of NMS",
            "monitoring": "EPS, metabolic panel, prolactin",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Olanzapine",
            "route": "PO",
            "indication": "Chorea with weight loss; promotes weight gain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg",
                  "orderSentence": "Olanzapine 2.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5-5 mg qHS; titrate to effect; typical 5-15 mg/day",
              "orderSentence": "Olanzapine 2.5 mg PO"
            },
            "contraindications": "Diabetes; significant metabolic risk",
            "monitoring": "Weight, glucose, lipids",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clonazepam",
            "route": "PO",
            "indication": "Adjunct for chorea; also helps myoclonus and anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg",
                  "orderSentence": "Clonazepam 0.25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25 mg BID; titrate slowly; max 4 mg/day",
              "orderSentence": "Clonazepam 0.25 mg PO"
            },
            "contraindications": "Severe respiratory disease; falls risk",
            "monitoring": "Sedation, falls, cognitive effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amantadine",
            "route": "PO",
            "indication": "Mild chorea; may help fatigue",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Amantadine 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg daily; titrate to 100 mg TID; max 400 mg/day",
              "orderSentence": "Amantadine 100 mg PO"
            },
            "contraindications": "End-stage renal disease; seizure history",
            "monitoring": "Livedo reticularis, hallucinations, edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments - Psychiatric": [
          {
            "item": "Sertraline",
            "route": "PO",
            "indication": "Depression; anxiety; irritability",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Sertraline 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; titrate by 25-50 mg q1-2wk; max 200 mg/day",
              "orderSentence": "Sertraline 25 mg PO"
            },
            "contraindications": "MAOIs within 14 days",
            "monitoring": "Suicidality, serotonin syndrome",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Citalopram",
            "route": "PO",
            "indication": "Depression; anxiety; good tolerability",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Citalopram 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg daily; max 20 mg/day due to QTc risk",
              "orderSentence": "Citalopram 10 mg PO"
            },
            "contraindications": "QTc >500 ms; concurrent QT-prolonging drugs",
            "monitoring": "QTc if risk factors",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Escitalopram",
            "route": "PO",
            "indication": "Depression; anxiety; similar to citalopram",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Escitalopram 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5-10 mg daily; max 20 mg/day",
              "orderSentence": "Escitalopram 5 mg PO"
            },
            "contraindications": "QTc >500 ms; concurrent QT-prolonging drugs",
            "monitoring": "QTc if risk factors",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "Depression with fatigue; dual mechanism",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5 mg",
                  "orderSentence": "Venlafaxine XR 37.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5 mg daily; titrate q1wk; max 225 mg/day",
              "orderSentence": "Venlafaxine XR 37.5 mg PO"
            },
            "contraindications": "Uncontrolled hypertension",
            "monitoring": "BP at higher doses",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirtazapine",
            "route": "PO",
            "indication": "Depression with insomnia and weight loss; promotes appetite",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7.5 mg",
                  "orderSentence": "Mirtazapine 7.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 7.5-15 mg qHS; titrate q1-2wk; max 45 mg",
              "orderSentence": "Mirtazapine 7.5 mg PO"
            },
            "contraindications": "None significant",
            "monitoring": "Weight, sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Quetiapine",
            "route": "PO",
            "indication": "Psychosis; irritability; insomnia; less EPS than other antipsychotics",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Quetiapine 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS; titrate by 25-50 mg q3d; typical 150-400 mg/day",
              "orderSentence": "Quetiapine 25 mg PO"
            },
            "contraindications": "Uncontrolled diabetes",
            "monitoring": "Glucose, lipids, QTc",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Aripiprazole",
            "route": "PO",
            "indication": "Psychosis; irritability; weight-neutral",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg",
                  "orderSentence": "Aripiprazole 2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2-5 mg daily; titrate by 5 mg q1wk; max 30 mg/day",
              "orderSentence": "Aripiprazole 2 mg PO"
            },
            "contraindications": "None significant",
            "monitoring": "Akathisia, EPS",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lamotrigine",
            "route": "PO",
            "indication": "Mood stabilization; irritability",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Lamotrigine 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily x 2wk; then 50 mg daily x 2wk; titrate by 50 mg q2wk; max 400 mg/day",
              "orderSentence": "Lamotrigine 25 mg PO"
            },
            "contraindications": "History of severe rash with lamotrigine",
            "monitoring": "Rash (SJS risk); slow titration mandatory",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valproic acid",
            "route": "PO",
            "indication": "Irritability; aggression; mood stabilization",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg",
                  "orderSentence": "Valproic acid 250 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 250 mg BID; titrate to level 50-100 mcg/mL",
              "orderSentence": "Valproic acid 250 mg PO"
            },
            "contraindications": "Hepatic disease; pregnancy (teratogenic); mitochondrial disease",
            "monitoring": "LFTs, ammonia, level, weight",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbamazepine",
            "route": "PO",
            "indication": "Irritability; aggression; alternative mood stabilizer",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Carbamazepine 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg BID; titrate by 200 mg/wk; target level 4-12 mcg/mL",
              "orderSentence": "Carbamazepine 100 mg PO"
            },
            "contraindications": "AV block; blood dyscrasias; concurrent MAOIs",
            "monitoring": "CBC, LFTs, level, HLA-B*1502 in Asians",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Buspirone",
            "route": "PO",
            "indication": "Anxiety without sedation; adjunct for irritability",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Buspirone 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg TID; titrate by 5 mg q2-3d; max 60 mg/day",
              "orderSentence": "Buspirone 5 mg PO"
            },
            "contraindications": "Concurrent MAOIs",
            "monitoring": "None significant",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments - Cognitive and Other": [
          {
            "item": "Donepezil",
            "route": "PO",
            "indication": "Cognitive impairment; limited evidence in HD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Donepezil 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg qHS; may increase to 10 mg after 4-6 weeks",
              "orderSentence": "Donepezil 5 mg PO"
            },
            "contraindications": "GI bleeding; sick sinus syndrome",
            "monitoring": "Nausea, bradycardia, diarrhea",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine",
            "route": "PO/Patch",
            "indication": "Cognitive impairment; alternative to donepezil",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1.5 mg",
                  "orderSentence": "Rivastigmine 1.5 mg PO/Patch"
                }
              ],
              "route": "PO/Patch",
              "instructions": "Start 1.5 mg BID or 4.6 mg patch; titrate monthly",
              "orderSentence": "Rivastigmine 1.5 mg PO/Patch"
            },
            "contraindications": "Severe hepatic impairment",
            "monitoring": "Nausea, weight loss",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Memantine",
            "route": "PO",
            "indication": "Moderate-severe cognitive impairment; neuroprotective theory",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Memantine 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; titrate by 5 mg/wk; target 10 mg BID",
              "orderSentence": "Memantine 5 mg PO"
            },
            "contraindications": "Severe renal impairment (dose adjust)",
            "monitoring": "Confusion, constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Modafinil",
            "route": "PO",
            "indication": "Apathy; excessive daytime sleepiness",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Modafinil 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg each morning; may increase to 200 mg; avoid afternoon dosing",
              "orderSentence": "Modafinil 100 mg PO"
            },
            "contraindications": "Arrhythmias; severe anxiety",
            "monitoring": "Insomnia, anxiety, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Methylphenidate",
            "route": "PO",
            "indication": "Apathy; bradyphrenia; fatigue",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Methylphenidate 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg at breakfast and lunch; titrate by 5-10 mg q1wk; max 60 mg/day",
              "orderSentence": "Methylphenidate 5 mg PO"
            },
            "contraindications": "Severe anxiety; psychosis; cardiac arrhythmia",
            "monitoring": "HR, BP, appetite, insomnia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Insomnia; irritability; mild sedation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Trazodone 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg qHS; titrate by 25-50 mg; max 200 mg for sleep",
              "orderSentence": "Trazodone 25 mg PO"
            },
            "contraindications": "Concurrent MAOIs; priapism history",
            "monitoring": "Orthostatic hypotension, priapism",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "Insomnia; circadian rhythm disturbance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3 mg",
                  "orderSentence": "Melatonin 3 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 3 mg 30 min before bed; may increase to 9 mg",
              "orderSentence": "Melatonin 3 mg PO"
            },
            "contraindications": "None",
            "monitoring": "Generally well-tolerated",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Botulinum toxin (onabotulinumtoxinA)",
            "route": "IM",
            "indication": "Focal dystonia; bruxism; sialorrhea",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Variable per muscle",
                  "orderSentence": "Botulinum toxin (onabotulinumtoxinA) Variable per muscle IM"
                }
              ],
              "route": "IM",
              "instructions": "Dose depends on target muscles; repeat q12 weeks",
              "orderSentence": "Botulinum toxin (onabotulinumtoxinA) Variable per muscle IM"
            },
            "contraindications": "Infection at site; myasthenia gravis",
            "monitoring": "Weakness, dysphagia",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glycopyrrolate",
            "route": "PO",
            "indication": "Sialorrhea (drooling)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg",
                  "orderSentence": "Glycopyrrolate 1 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1 mg BID; titrate to effect; max 2 mg TID",
              "orderSentence": "Glycopyrrolate 1 mg PO"
            },
            "contraindications": "Glaucoma; urinary retention; GI obstruction",
            "monitoring": "Dry mouth, constipation, urinary retention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Polyethylene glycol (MiraLAX)",
            "route": "PO",
            "indication": "Constipation (common with reduced mobility and anticholinergics)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "17 g",
                  "orderSentence": "Polyethylene glycol (MiraLAX) 17 g PO"
                }
              ],
              "route": "PO",
              "instructions": "17 g in 8 oz liquid daily; may increase to BID",
              "orderSentence": "Polyethylene glycol (MiraLAX) 17 g PO"
            },
            "contraindications": "Bowel obstruction",
            "monitoring": "Diarrhea if excessive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "High-calorie nutritional supplements",
            "route": "PO",
            "indication": "Weight loss; increased metabolic demands",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 can",
                  "orderSentence": "High-calorie nutritional supplements 1 can PO"
                }
              ],
              "route": "PO",
              "instructions": "1-3 cans (Ensure Plus, Boost Plus) daily between meals",
              "orderSentence": "High-calorie nutritional supplements 1 can PO"
            },
            "contraindications": "None",
            "monitoring": "Weight, nutritional markers",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Huntington Disease Society of America (HDSA) Center of Excellence for comprehensive multidisciplinary care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetic counselor for pre-test counseling, results disclosure, and family testing discussion",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatry for depression, suicidality assessment, irritability, and psychosis management",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuropsychology for baseline and serial cognitive assessment to guide care planning",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech-language pathology for swallowing evaluation and communication strategies",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for gait training, fall prevention, and adaptive exercise program",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for ADL adaptation, home safety evaluation, and energy conservation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dietitian/nutritionist for weight maintenance strategies and caloric supplementation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for caregiver support, disability planning, and community resources",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Palliative care for symptom management, advance care planning, and goals of care discussions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pulmonology for respiratory assessment in advanced disease and ventilation decisions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gastroenterology for PEG tube placement consideration in advanced dysphagia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "CRITICAL: Report suicidal thoughts immediately as depression is common and treatable in HD",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive if experiencing significant chorea, cognitive impairment, or sedating medication effects",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain high caloric intake (3000-4000 kcal/day may be needed) due to hypermetabolic state",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Eat slowly, take small bites, and remain upright 30 minutes after meals to reduce aspiration risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Complete advance directive and healthcare power of attorney while capacity is preserved",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Inform all healthcare providers about HD as many common medications can worsen symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "First-degree relatives have 50% risk; genetic counseling available but genetic testing is a personal choice",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid alcohol which worsens balance, cognition, and interacts with medications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Regular aerobic exercise (walking, swimming, stationary bike) improves motor function and mood",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Fall prevention: remove home hazards, adequate lighting, grab bars, non-slip surfaces",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain social engagement and meaningful activities to reduce depression and apathy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cognitive engagement through puzzles, reading, and structured activities may help maintain function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Structure daily routine with consistent timing for medications, meals, and activities",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Caregiver respite and support groups essential to prevent caregiver burnout",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation to reduce aspiration pneumonia risk and cardiovascular disease",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit caffeine if insomnia or anxiety are problematic",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Huntington disease-like 1 (HDL1)",
        "features": "Prion protein gene mutation; similar phenotype",
        "tests": "PRNP gene testing"
      },
      {
        "diagnosis": "Huntington disease-like 2 (HDL2)",
        "features": "African ancestry; JPH3 gene mutation",
        "tests": "JPH3 gene testing"
      },
      {
        "diagnosis": "Spinocerebellar ataxia 17 (HDL4)",
        "features": "Prominent ataxia; TBP gene expansion",
        "tests": "TBP gene testing"
      },
      {
        "diagnosis": "Chorea-acanthocytosis",
        "features": "Orolingual dystonia; self-mutilation; acanthocytes",
        "tests": "Peripheral smear; VPS13A gene testing"
      },
      {
        "diagnosis": "McLeod syndrome",
        "features": "X-linked; cardiomyopathy; elevated CK",
        "tests": "Kell antigen typing; XK gene testing"
      },
      {
        "diagnosis": "Sydenham chorea",
        "features": "Post-streptococcal; younger patients; self-limited",
        "tests": "ASO titer; anti-DNAse B"
      },
      {
        "diagnosis": "Benign hereditary chorea",
        "features": "Childhood onset; non-progressive; NKX2-1 mutation",
        "tests": "NKX2-1 gene testing; family history"
      },
      {
        "diagnosis": "Wilson's disease",
        "features": "Younger onset; Kayser-Fleischer rings; hepatic disease",
        "tests": "Ceruloplasmin; 24-hr urine copper; slit lamp"
      },
      {
        "diagnosis": "Neuroacanthocytosis",
        "features": "Peripheral neuropathy; seizures; elevated CK",
        "tests": "Peripheral smear; genetic testing"
      },
      {
        "diagnosis": "Tardive dyskinesia",
        "features": "Antipsychotic exposure; orobuccal predominant",
        "tests": "Medication history; AIMS scale"
      },
      {
        "diagnosis": "Anti-NMDA receptor encephalitis",
        "features": "Psychiatric symptoms; seizures; dyskinesias",
        "tests": "NMDA receptor antibodies; CSF analysis"
      }
    ],
    "evidence": [
      {
        "recommendation": "Tetrabenazine reduces chorea in HD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Huntington Study Group. Neurology 2006](https://pubmed.ncbi.nlm.nih.gov/16894067/)"
      },
      {
        "recommendation": "Deutetrabenazine reduces chorea with improved tolerability",
        "evidenceLevel": "Class I, Level A",
        "source": "[Huntington Study Group. JAMA 2016](https://pubmed.ncbi.nlm.nih.gov/27532915/)"
      },
      {
        "recommendation": "CAG repeat length inversely correlates with age of onset",
        "evidenceLevel": "Class II, Level B",
        "source": "[Andrew et al. Nat Genet 1993](https://pubmed.ncbi.nlm.nih.gov/8401577/)"
      },
      {
        "recommendation": "AAN practice parameter for HD treatment",
        "evidenceLevel": "Guideline",
        "source": "[Armstrong & Miyasaki. Neurology 2012](https://pubmed.ncbi.nlm.nih.gov/22815562/)"
      },
      {
        "recommendation": "High suicide rate in HD requires screening",
        "evidenceLevel": "Class II, Level B",
        "source": "[Paulsen et al. J Neuropsychiatry Clin Neurosci 2005](https://pubmed.ncbi.nlm.nih.gov/16179652/)"
      },
      {
        "recommendation": "UHDRS reliable for tracking disease progression",
        "evidenceLevel": "Class II, Level A",
        "source": "[Huntington Study Group. Mov Disord 1996](https://pubmed.ncbi.nlm.nih.gov/8684382/)"
      },
      {
        "recommendation": "CYP2D6 genotype affects tetrabenazine metabolism",
        "evidenceLevel": "Class II, Level B",
        "source": "[Xenazine FDA prescribing information 2008](https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021894lbl.pdf)"
      },
      {
        "recommendation": "Genetic counseling improves outcomes in at-risk individuals",
        "evidenceLevel": "Class II, Level B",
        "source": "[Tibben. Handb Clin Neurol 2007](https://pubmed.ncbi.nlm.nih.gov/18808860/)"
      },
      {
        "recommendation": "Dysphagia common and associated with aspiration risk",
        "evidenceLevel": "Class II, Level C",
        "source": "[Heemskerk & Roos. Dysphagia 2011](https://pubmed.ncbi.nlm.nih.gov/20803049/)"
      },
      {
        "recommendation": "Multidisciplinary care improves outcomes",
        "evidenceLevel": "Class III, Level C",
        "source": "[Veenhuizen & Bherer. J Huntingtons Dis 2017](https://pubmed.ncbi.nlm.nih.gov/28339403/)"
      },
      {
        "recommendation": "Exercise benefits motor and cognitive function",
        "evidenceLevel": "Class II, Level B",
        "source": "[Quinn et al. Cochrane Database Syst Rev 2022](https://pubmed.ncbi.nlm.nih.gov/35416314/)"
      },
      {
        "recommendation": "Valbenazine effective for hyperkinetic movements",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hauser et al. JAMA Neurol 2017](https://pubmed.ncbi.nlm.nih.gov/28241163/)"
      }
    ],
    "monitoring": [
      {
        "item": "UHDRS (Unified Huntington's Disease Rating Scale)",
        "frequency": "Every 6-12 months",
        "action": "Adjust medications; update care plan",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Depression screening (PHQ-9)",
        "frequency": "Every visit; monthly if on VMAT2 inhibitor",
        "action": "Intensify antidepressant; psychiatry referral if PHQ-9 >15",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Suicidality assessment",
        "frequency": "Every visit",
        "action": "Immediate psychiatric evaluation; safety planning",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Cognitive assessment (MoCA or MMSE)",
        "frequency": "Every 6-12 months",
        "action": "Update care planning; capacity assessment",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight",
        "frequency": "Every visit",
        "action": "Increase caloric intake; dietitian referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Swallowing function",
        "frequency": "Annually or if symptoms",
        "action": "Modify diet texture; speech therapy; PEG consideration",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ECG (if on VMAT2 inhibitor)",
        "frequency": "Baseline and with dose changes",
        "action": "Hold medication if QTc >500 ms; reduce dose",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Functional independence (TFC)",
        "frequency": "Every 6-12 months",
        "action": "Adjust level of care; advance care planning",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Caregiver burden assessment",
        "frequency": "Annually",
        "action": "Respite care; support resources",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Falls frequency",
        "frequency": "Each visit",
        "action": "PT referral; home safety; medication review",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Stable psychiatric status; adequate oral intake; safe swallowing; caregiver available; outpatient follow-up arranged"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Severe psychiatric symptoms requiring stabilization; aspiration pneumonia; significant weight loss requiring evaluation; severe chorea causing exhaustion or injury"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Aspiration with respiratory failure; severe rhabdomyolysis from chorea; neuroleptic malignant syndrome; suicidal attempt requiring medical stabilization"
      },
      {
        "disposition": "Skilled nursing facility",
        "criteria": "Advanced disease; 24-hour care needs; dysphagia requiring supervision; frequent falls; caregiver unable to provide required care"
      },
      {
        "disposition": "Hospice referral",
        "criteria": "End-stage disease (TFC stage 5); recurrent aspiration; patient/family goals favor comfort care"
      }
    ]
  },
  "Tardive Dyskinesia": {
    "id": "tardive-dyskinesia",
    "title": "Tardive Dyskinesia",
    "version": "1.1",
    "icd10": [
      "** G24.01 (Drug-induced tardive dyskinesia)",
      "G24.02 (Drug-induced acute dystonia)",
      "G24.09 (Drug-induced dystonia",
      "unspecified)"
    ],
    "scope": "** Diagnosis confirmation, severity assessment using AIMS, identification of causative agents, risk factor evaluation, FDA-approved VMAT2 inhibitor therapy, antipsychotic management strategies, prevention, and psychiatric coordination. Covers classic orofacial-lingual TD, tardive dystonia, tardive akathisia, and tardive stereotypy.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Baseline renal/hepatic function before VMAT2 inhibitor therapy; electrolyte abnormalities can worsen movements",
            "target": "Normal"
          },
          {
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Baseline for medication monitoring; rule out infection if acute change",
            "target": "Normal"
          },
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Thyroid dysfunction can cause or exacerbate movement disorders",
            "target": "Normal (0.4-4.0 mIU/L)"
          },
          {
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Identify causative agent(s): antipsychotics, metoclopramide, prochlorperazine, other dopamine blockers",
            "target": "Document agent, duration, cumulative dose"
          }
        ],
        "Extended Workup": [
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out Wilson's disease if age <50 or atypical presentation",
            "target": "Normal"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Wilson's disease confirmation if ceruloplasmin low or borderline",
            "target": "<100 μg/24hr"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency can cause movement disorders",
            "target": "Normal"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out brain iron accumulation disorders",
            "target": "Normal"
          },
          {
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "If concern for neuroleptic malignant syndrome or severe dystonia",
            "target": "Normal"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Assess compliance and toxicity if indicated",
            "target": "Therapeutic range"
          }
        ],
        "Rare/Specialized": [
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Chorea with psychiatric history; family history",
            "target": "<36 CAG repeats (normal)"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Neuroacanthocytosis if orofacial dyskinesia with chorea",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Atypical movement disorder; occult malignancy; autoimmune chorea",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Young patient; psychiatric symptoms; orofacial dyskinesia",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Research; consider if dopamine transporter dysfunction suspected",
            "target": "Normal"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At evaluation; before treatment; q3-6 months on antipsychotics",
            "target": "Document baseline severity (0-4 scale per item; total score)",
            "contraindications": "None"
          },
          {
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At evaluation",
            "target": "Characterize movement type, distribution, severity",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At baseline and follow-up",
            "target": "Record for comparison; share with psychiatry",
            "contraindications": "Patient consent"
          }
        ],
        "Extended": [
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Atypical presentation; focal findings; rule out structural lesion",
            "target": "Normal or chronic dopaminergic medication changes",
            "contraindications": "MRI-incompatible devices"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Differentiate from Parkinson's disease or Huntington's if uncertain",
            "target": "Normal or mild reduction (dopamine blockers can affect)",
            "contraindications": "Iodine hypersensitivity"
          }
        ],
        "Rare/Specialized": [
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Suspected brain iron accumulation (NBIA)",
            "target": "No abnormal iron deposition",
            "contraindications": "MRI contraindications"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Research; atypical cases",
            "target": "Variable",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Wilson's disease evaluation",
            "target": "No Kayser-Fleischer rings",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Characterize tremor vs dystonic movements",
            "target": "Define movement characteristics",
            "contraindications": "None"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Discontinue or reduce causative agent",
            "route": "N/A",
            "indication": "First step if psychiatrically safe; requires psychiatry coordination",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Discontinue or reduce causative agent N/A N/A"
                }
              ],
              "route": "N/A",
              "instructions": "Collaborate with psychiatry; gradual taper preferred if stopping; dose reduction may help",
              "orderSentence": "Discontinue or reduce causative agent N/A N/A"
            },
            "contraindications": "Cannot discontinue if psychosis relapse risk too high",
            "monitoring": "Monitor for psychiatric decompensation",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Switch to clozapine",
            "route": "PO",
            "indication": "Lowest TD risk; for patients requiring continued antipsychotic",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg",
                  "orderSentence": "Switch to clozapine 12.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5-25 mg/day; titrate by 25-50 mg q3-7d; target 200-450 mg/day; requires REMS",
              "orderSentence": "Switch to clozapine 12.5 mg PO"
            },
            "contraindications": "Agranulocytosis history; severe neutropenia; seizure disorder (relative)",
            "monitoring": "ANC weekly x 6mo, q2wk x 6mo, then monthly; seizures; myocarditis",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Switch to quetiapine",
            "route": "PO",
            "indication": "Lower TD risk; for patients requiring continued antipsychotic",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Switch to quetiapine 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg BID; titrate by 50-100 mg/day q2-3d; target 300-800 mg/day",
              "orderSentence": "Switch to quetiapine 25 mg PO"
            },
            "contraindications": "QT prolongation; severe hepatic impairment",
            "monitoring": "QTc, sedation, metabolic parameters",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Benzodiazepine (severe distress)",
            "route": "PO/IV",
            "indication": "Severe anxiety/distress from TD movements; temporary relief",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg",
                  "orderSentence": "Benzodiazepine (severe distress) 0.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Lorazepam 0.5-1 mg TID PRN for acute distress; short-term only",
              "orderSentence": "Benzodiazepine (severe distress) 0.5 mg PO"
            },
            "contraindications": "Respiratory depression; substance use disorder",
            "monitoring": "Sedation, respiratory status",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          }
        ],
        "Symptomatic Treatments (FDA-Approved for TD)": [
          {
            "item": "Valbenazine (Ingrezza)",
            "route": "PO",
            "indication": "FDA-approved first-line for TD; VMAT2 inhibitor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Valbenazine (Ingrezza) 40 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 40 mg once daily; increase to 80 mg daily after 1 week if tolerated; take with or without food",
              "orderSentence": "Valbenazine (Ingrezza) 40 mg PO"
            },
            "contraindications": "Congenital long QT; strong CYP2D6 inhibitors at higher dose; severe hepatic impairment",
            "monitoring": "QTc (baseline, after dose increase); somnolence; depression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Deutetrabenazine (Austedo)",
            "route": "PO",
            "indication": "FDA-approved first-line for TD; VMAT2 inhibitor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "6 mg",
                  "orderSentence": "Deutetrabenazine (Austedo) 6 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 6 mg BID (12 mg/day); increase by 6 mg/day weekly; max 48 mg/day; take with food",
              "orderSentence": "Deutetrabenazine (Austedo) 6 mg PO"
            },
            "contraindications": "Depression/suicidality; MAO-I use; hepatic impairment; reserpine use within 20 days",
            "monitoring": "Depression (PHQ-9); parkinsonism; QTc; akathisia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tetrabenazine (Xenazine)",
            "route": "PO",
            "indication": "VMAT2 inhibitor; older agent with more side effects",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg",
                  "orderSentence": "Tetrabenazine (Xenazine) 12.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5 mg daily; increase by 12.5 mg q1wk; max 50 mg/day (100 mg if CYP2D6 extensive metabolizer); require CYP2D6 genotyping >50 mg",
              "orderSentence": "Tetrabenazine (Xenazine) 12.5 mg PO"
            },
            "contraindications": "Depression/suicidality; untreated or inadequately treated depression",
            "monitoring": "Depression (PHQ-9); parkinsonism; akathisia; sedation; requires CYP2D6 genotyping",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Clonazepam",
            "route": "PO",
            "indication": "Adjunct for TD; limited evidence; reduces choreiform movements",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg",
                  "orderSentence": "Clonazepam 0.25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25 mg BID; titrate slowly; typical 0.5-4 mg/day divided",
              "orderSentence": "Clonazepam 0.25 mg PO"
            },
            "contraindications": "Respiratory depression; substance use disorder",
            "monitoring": "Sedation, dependence, falls",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amantadine",
            "route": "PO",
            "indication": "Limited evidence; may reduce TD severity; antiglutamatergic",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Amantadine 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg BID; may increase to 300-400 mg/day divided; adjust for renal function",
              "orderSentence": "Amantadine 100 mg PO"
            },
            "contraindications": "Severe renal impairment; seizure history (relative)",
            "monitoring": "Livedo reticularis; edema; hallucinations; confusion (elderly)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ginkgo biloba",
            "route": "PO",
            "indication": "Limited evidence; antioxidant mechanism; modest benefit in trials",
            "dosing": {
              "doseOptions": [
                {
                  "text": "120 mg",
                  "orderSentence": "Ginkgo biloba 120 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "240 mg/day divided; EGb 761 extract standardized",
              "orderSentence": "Ginkgo biloba 120 mg PO"
            },
            "contraindications": "Bleeding disorders; anticoagulant use",
            "monitoring": "Bleeding risk",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin E",
            "route": "PO",
            "indication": "Limited evidence; may prevent progression; minimal therapeutic effect",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 IU",
                  "orderSentence": "Vitamin E 400 IU PO"
                }
              ],
              "route": "PO",
              "instructions": "400-1600 IU daily; better evidence for prevention than treatment",
              "orderSentence": "Vitamin E 400 IU PO"
            },
            "contraindications": "Coagulopathy; vitamin K deficiency",
            "monitoring": "Bleeding risk at high doses",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B6 (pyridoxine)",
            "route": "PO",
            "indication": "Limited evidence; some trials show benefit",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Vitamin B6 (pyridoxine) 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "100-400 mg daily; monitor for neuropathy at high doses",
              "orderSentence": "Vitamin B6 (pyridoxine) 100 mg PO"
            },
            "contraindications": "Peripheral neuropathy",
            "monitoring": "Neuropathy with chronic high dose (>200 mg)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Levetiracetam",
            "route": "PO",
            "indication": "Limited evidence; case reports of benefit",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Levetiracetam 500 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 500 mg BID; titrate to 1500-3000 mg/day; adjust for renal function",
              "orderSentence": "Levetiracetam 500 mg PO"
            },
            "contraindications": "Severe renal impairment without adjustment",
            "monitoring": "Mood changes; sedation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Propranolol",
            "route": "PO",
            "indication": "For tardive akathisia component",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Propranolol 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg TID; titrate to 30-120 mg/day divided",
              "orderSentence": "Propranolol 10 mg PO"
            },
            "contraindications": "Asthma; bradycardia; heart block",
            "monitoring": "HR, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Interventional/Advanced Therapies": [
          {
            "item": "Botulinum toxin (focal TD)",
            "route": "IM",
            "indication": "Focal tardive dystonia (e.g., cervical, blepharospasm)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per target",
                  "orderSentence": "Botulinum toxin (focal TD) Per target IM"
                }
              ],
              "route": "IM",
              "instructions": "Cervical: 100-300 units; blepharospasm: 25-50 units per eye; repeat q3mo",
              "orderSentence": "Botulinum toxin (focal TD) Per target IM"
            },
            "pretreatment": "EMG guidance recommended for some targets",
            "contraindications": "Active infection at site; myasthenia gravis",
            "monitoring": "Dysphagia (cervical); ptosis (periocular); local weakness",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Deep brain stimulation (DBS)",
            "route": "Surgical",
            "indication": "Severe, disabling, medication-refractory TD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "GPi target",
                  "orderSentence": "Deep brain stimulation (DBS) GPi target Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Bilateral GPi most common; programming optimization over months",
              "orderSentence": "Deep brain stimulation (DBS) GPi target Surgical"
            },
            "pretreatment": "MRI; neuropsychological testing; multidisciplinary evaluation; psychiatry clearance",
            "contraindications": "Untreated psychiatric instability; cognitive impairment; coagulopathy",
            "monitoring": "Programming; psychiatric monitoring; speech/swallowing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Pallidal lesioning",
            "route": "Surgical",
            "indication": "Alternative to DBS if not candidate; irreversible",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Unilateral pallidotomy",
                  "orderSentence": "Pallidal lesioning Unilateral pallidotomy Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Stereotactic lesion of GPi; reserved for DBS failures or contraindications",
              "orderSentence": "Pallidal lesioning Unilateral pallidotomy Surgical"
            },
            "pretreatment": "Same as DBS",
            "contraindications": "Same as DBS",
            "monitoring": "Permanent side effect risk higher than DBS",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Psychiatry consultation for antipsychotic management, dose reduction, or switch to lower-risk agent (ESSENTIAL - requires collaborative decision-making)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Movement disorders neurology for diagnosis confirmation, AIMS scoring, and VMAT2 inhibitor initiation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neurosurgery consultation for DBS evaluation if medication-refractory disabling TD",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Speech therapy for dysphagia evaluation if oropharyngeal involvement",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for adaptive strategies if hand involvement affects function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for disability evaluation and resources if TD causes functional impairment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dentistry for oral health evaluation with orofacial TD (tooth damage, denture issues)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Report any worsening movements, difficulty swallowing, or breathing problems immediately (may indicate progression)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not stop antipsychotic medications without psychiatry guidance as this can worsen psychosis or cause withdrawal dyskinesia",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report any new or worsening depression, suicidal thoughts, or mood changes on VMAT2 inhibitors (boxed warning)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Movements may temporarily worsen after stopping causative drug before improving (withdrawal dyskinesia)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "VMAT2 inhibitors may take 2-6 weeks to show maximum benefit; continue as prescribed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid caffeine and stimulants which may worsen involuntary movements",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain regular dental visits for oral health if orofacial TD present (prevents tooth damage, ulceration)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Consider support groups and counseling for coping with visible movement disorder",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Use lowest effective antipsychotic dose for shortest duration needed (primary prevention)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Perform AIMS examination at baseline, 3 months, 6 months, then q6-12 months on dopamine-blocking agents",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Prefer second-generation antipsychotics over first-generation when clinically appropriate (lower TD risk)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid metoclopramide for >12 weeks; use domperidone or other alternatives when possible (not available in US)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Document informed consent regarding TD risk when starting dopamine-blocking agents",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Identify and monitor high-risk patients more frequently: elderly, female, mood disorders, diabetes, longer exposure, higher cumulative dose",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Consider early intervention with VMAT2 inhibitors before TD becomes severe and irreversible",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management and adequate sleep may help reduce movement severity",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Huntington disease",
        "features": "Family history; cognitive decline; chorea; CAG expansion",
        "tests": "Genetic testing for HTT CAG repeats"
      },
      {
        "diagnosis": "Sydenham chorea",
        "features": "History of rheumatic fever; anti-streptolysin O; younger patients",
        "tests": "ASO titer; echocardiogram"
      },
      {
        "diagnosis": "Withdrawal dyskinesia",
        "features": "Occurs immediately after stopping dopamine blocker; self-limited (<3 months)",
        "tests": "History; timeline (TD persists >3 months)"
      },
      {
        "diagnosis": "Spontaneous orofacial dyskinesia (elderly)",
        "features": "Elderly without antipsychotic exposure; edentulous",
        "tests": "Careful medication history; dental exam"
      },
      {
        "diagnosis": "Wilson disease",
        "features": "Age <50; Kayser-Fleischer rings; liver disease; psychiatric symptoms",
        "tests": "Ceruloplasmin; 24h urine copper; slit lamp"
      },
      {
        "diagnosis": "Neuroacanthocytosis",
        "features": "Orofacial dyskinesia; chorea; self-mutilation; elevated CK; acanthocytes",
        "tests": "Acanthocyte smear; CK; genetic testing"
      },
      {
        "diagnosis": "Autoimmune chorea (anti-NMDA, anti-LGI1)",
        "features": "Subacute onset; psychiatric symptoms; seizures; encephalopathy",
        "tests": "Autoimmune antibody panels; CSF"
      },
      {
        "diagnosis": "Meige syndrome (primary cranial dystonia)",
        "features": "Blepharospasm and oromandibular dystonia without antipsychotic exposure",
        "tests": "Clinical history; no dopamine blocker use"
      },
      {
        "diagnosis": "Tourette syndrome",
        "features": "Childhood onset; tics (brief, suppressible); premonitory urge",
        "tests": "Clinical criteria; onset <18 years"
      },
      {
        "diagnosis": "Drug-induced acute dystonia",
        "features": "Occurs within days of drug exposure; not persistent",
        "tests": "Timeline (acute dystonia is immediate, TD delayed)"
      },
      {
        "diagnosis": "Parkinson disease dyskinesia",
        "features": "History of Parkinson's; peak-dose or diphasic dyskinesia on levodopa",
        "tests": "Clear PD diagnosis; levodopa relationship"
      },
      {
        "diagnosis": "Hyperthyroidism",
        "features": "Tremor predominant; tachycardia; weight loss; heat intolerance",
        "tests": "TSH, free T4"
      }
    ],
    "evidence": [
      {
        "recommendation": "Valbenazine FDA-approved for TD (KINECT 3)",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hauser et al. Am J Psychiatry 2017](https://pubmed.ncbi.nlm.nih.gov/28320224/)"
      },
      {
        "recommendation": "Valbenazine efficacy and safety (KINECT 4)",
        "evidenceLevel": "Class I, Level A",
        "source": "[Factor et al. J Clin Psychiatry 2017](https://pubmed.ncbi.nlm.nih.gov/29141123/)"
      },
      {
        "recommendation": "Deutetrabenazine FDA-approved for TD (ARM-TD/AIM-TD)",
        "evidenceLevel": "Class I, Level A",
        "source": "[Anderson et al. JAMA Neurol 2017](https://pubmed.ncbi.nlm.nih.gov/28586827/)"
      },
      {
        "recommendation": "Tetrabenazine efficacy for TD",
        "evidenceLevel": "Class II, Level B",
        "source": "[Kenney et al. Expert Rev Neurother 2006](https://pubmed.ncbi.nlm.nih.gov/17052096/)"
      },
      {
        "recommendation": "AIMS as standard TD assessment",
        "evidenceLevel": "Class II, Level B",
        "source": "[Guy W. ECDEU Assessment Manual 1976](https://pubmed.ncbi.nlm.nih.gov/28685532/)"
      },
      {
        "recommendation": "Clozapine lowest TD risk",
        "evidenceLevel": "Class II, Level B",
        "source": "[Correll et al. J Clin Psychiatry 2004](https://pubmed.ncbi.nlm.nih.gov/15291684/)"
      },
      {
        "recommendation": "Second-generation antipsychotics lower TD risk than first-generation",
        "evidenceLevel": "Class I, Level A",
        "source": "[Carbon et al. World Psychiatry 2017](https://pubmed.ncbi.nlm.nih.gov/28941101/)"
      },
      {
        "recommendation": "Risk factors for TD (age, duration, dose, diabetes)",
        "evidenceLevel": "Class II, Level B",
        "source": "[Woerner et al. J Clin Psychopharmacol 1998](https://pubmed.ncbi.nlm.nih.gov/9555598/)"
      },
      {
        "recommendation": "AAN evidence-based guideline for TD treatment",
        "evidenceLevel": "Class I-IV, Level A-U",
        "source": "[Bhidayasiri et al. Mov Disord 2018](https://pubmed.ncbi.nlm.nih.gov/29352501/)"
      },
      {
        "recommendation": "DBS for medication-refractory TD",
        "evidenceLevel": "Class IV, Level C",
        "source": "[Macerollo et al. J Neurol 2020](https://pubmed.ncbi.nlm.nih.gov/32367207/)"
      },
      {
        "recommendation": "Ginkgo biloba modest benefit in TD",
        "evidenceLevel": "Class II, Level B",
        "source": "[Zhang et al. J Clin Psychiatry 2011](https://pubmed.ncbi.nlm.nih.gov/22075213/)"
      },
      {
        "recommendation": "Vitamin E for TD prevention (not treatment)",
        "evidenceLevel": "Class II, Level U",
        "source": "[Soares-Weiser et al. Cochrane 2018](https://pubmed.ncbi.nlm.nih.gov/29552749/)"
      },
      {
        "recommendation": "Clonazepam for TD",
        "evidenceLevel": "Class IV, Level U",
        "source": "[Thaker et al. Acta Psychiatr Scand 1990](https://pubmed.ncbi.nlm.nih.gov/1978471/)"
      },
      {
        "recommendation": "Metoclopramide black box warning (>12 weeks increases TD risk)",
        "evidenceLevel": "Regulatory guidance",
        "source": "[FDA Drug Safety Communication 2009](https://www.fda.gov/drugs/drug-safety-and-availability/fda-requires-boxed-warning-and-risk-mitigation-strategy-metoclopramide-containing-drugs)"
      }
    ],
    "monitoring": [
      {
        "item": "AIMS score",
        "frequency": "Baseline, 3mo, 6mo, then q6-12mo on antipsychotics",
        "action": "Adjust treatment; consider VMAT2 inhibitor",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "AIMS score on VMAT2 inhibitor",
        "frequency": "q4-8 weeks until stable, then q3-6mo",
        "action": "Optimize dose; consider second agent",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Depression screen (PHQ-9)",
        "frequency": "Baseline, 2wk, 4wk, then q3mo on VMAT2 inhibitors",
        "action": "Hold VMAT2 inhibitor; psychiatry consultation; consider switch",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Suicidality assessment",
        "frequency": "Each visit on VMAT2 inhibitors",
        "action": "Immediate psychiatry referral; hold medication",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "QTc interval",
        "frequency": "Baseline, after dose increase (valbenazine/deutetrabenazine)",
        "action": "Reduce dose; evaluate medications; electrolytes",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ANC (if on clozapine)",
        "frequency": "Weekly x 6mo, q2wk x 6mo, then monthly",
        "action": "Follow REMS protocol for neutropenia",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Parkinsonism symptoms",
        "frequency": "Each visit on VMAT2 inhibitors",
        "action": "Reduce VMAT2 dose",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Akathisia",
        "frequency": "Each visit on VMAT2 inhibitors",
        "action": "Reduce dose; consider propranolol",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Swallowing function",
        "frequency": "Each visit with orofacial TD",
        "action": "Speech therapy referral; modify diet",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Functional status",
        "frequency": "Each visit",
        "action": "OT referral; treatment intensification",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight and metabolic parameters",
        "frequency": "q3-6mo on antipsychotics",
        "action": "Lifestyle modification; consider antipsychotic switch",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Mild-moderate TD; able to manage oral medications; follow-up with neurology and psychiatry arranged; no psychiatric instability"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "New severe TD with swallowing/respiratory involvement; psychiatric decompensation from medication change; severe dystonic component causing pain/disability; need for expedited workup (suspect alternative diagnosis)"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Respiratory compromise from severe oropharyngeal/laryngeal TD; neuroleptic malignant syndrome; severe tardive dystonia with rhabdomyolysis"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Initial: 4-6 weeks for medication titration; Stable: q3-6 months for AIMS monitoring; More frequent if depression risk on VMAT2 inhibitors"
      }
    ]
  },
  "Alzheimer's Disease": {
    "id": "alzheimers-disease",
    "title": "Alzheimer's Disease",
    "version": "1.0",
    "icd10": [
      "** G30.9 (Alzheimer's disease",
      "unspecified)",
      "G30.0 (Early-onset AD)",
      "G30.1 (Late-onset AD)",
      "F02.80 (Dementia in AD without behavioral disturbance)",
      "F02.81 (Dementia in AD with behavioral disturbance)",
      "G30.8 (Other Alzheimer's disease)"
    ],
    "scope": "** Diagnosis confirmation using NIA-AA criteria, biomarker assessment, pharmacologic treatment with cholinesterase inhibitors and memantine, anti-amyloid disease-modifying therapies, BPSD management, safety planning, and caregiver support. Primarily outpatient-focused with coverage for ED and hospital presentations.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential (CPT 85025)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out infection, anemia, malignancy contributing to cognitive impairment",
            "target": "Normal"
          },
          {
            "item": "BMP (CPT 80048)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Metabolic causes of confusion (hyponatremia, uremia, hypoglycemia)",
            "target": "Normal electrolytes, renal function"
          },
          {
            "item": "TSH (CPT 84443)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypothyroidism is reversible cause of cognitive impairment",
            "target": "0.4-4.0 mIU/L"
          },
          {
            "item": "Vitamin B12 (CPT 82607)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "B12 deficiency causes reversible cognitive decline",
            "target": ">300 pg/mL (>400 optimal)"
          },
          {
            "item": "Folate (CPT 82746)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency contributes to cognitive impairment",
            "target": ">3 ng/mL"
          },
          {
            "item": "Hepatic panel (AST, ALT, albumin) (CPT 80076)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hepatic encephalopathy; nutritional status",
            "target": "Normal"
          },
          {
            "item": "Calcium (CPT 82310)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypercalcemia causes confusion",
            "target": "8.5-10.5 mg/dL"
          },
          {
            "item": "Urinalysis (CPT 81003)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "UTI common cause of acute confusion in elderly",
            "target": "Negative for infection"
          }
        ],
        "Extended Workup": [
          {
            "item": "Hemoglobin A1c (CPT 83036)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes affects cognition and vascular risk",
            "target": "<7.0%"
          },
          {
            "item": "Lipid panel (CPT 80061)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Vascular risk factor modification",
            "target": "LDL <100 mg/dL"
          },
          {
            "item": "Homocysteine (CPT 83090)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Elevated levels associated with AD and vascular disease",
            "target": "<15 μmol/L"
          },
          {
            "item": "Vitamin D, 25-hydroxy (CPT 82306)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency associated with cognitive decline",
            "target": ">30 ng/mL"
          },
          {
            "item": "RPR (CPT 86592) or VDRL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurosyphilis is treatable cause",
            "target": "Nonreactive"
          },
          {
            "item": "HIV testing (CPT 87389)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HIV-associated neurocognitive disorder if risk factors",
            "target": "Negative"
          },
          {
            "item": "ESR (CPT 85652) / CRP (CPT 86140)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Inflammatory or autoimmune causes",
            "target": "Normal"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "APOE genotyping (CPT 81401)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Risk stratification; ARIA risk assessment for anti-amyloid therapy",
            "target": "APOE ε4 status"
          },
          {
            "item": "Genetic panel (PSEN1, PSEN2, APP) (CPT 81406)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Early-onset AD (<65) with family history",
            "target": "No pathogenic mutation (AD diagnosis still valid)"
          },
          {
            "item": "Heavy metal panel (lead, mercury) (CPT 83655, 83825)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "History of occupational exposure",
            "target": "Normal"
          },
          {
            "item": "Copper (CPT 82525), ceruloplasmin (CPT 82390)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Wilson disease if age <50 with movement disorder",
            "target": "Normal"
          },
          {
            "item": "Paraneoplastic antibody panel (CPT 86255)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Rapid progression; cancer history",
            "target": "Negative"
          },
          {
            "item": "Anti-neuronal antibodies (NMDA-R, LGI1, CASPR2) (CPT 86255)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Atypical presentation; rapid progression",
            "target": "Negative"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Cell count, protein, glucose (CPT 89051)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out infection, inflammation",
            "target": "WBC <5, protein <45 mg/dL, glucose >60% serum"
          },
          {
            "item": "CSF Aβ42 (amyloid beta 1-42) (CPT 83519)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Reduced in AD due to brain amyloid deposition",
            "target": "<600 pg/mL suggests AD pathology"
          },
          {
            "item": "CSF Aβ42/Aβ40 ratio (CPT 83519)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "More accurate than Aβ42 alone",
            "target": "<0.05-0.08 suggests AD (assay-dependent)"
          },
          {
            "item": "CSF total tau (t-tau) (CPT 83519)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Elevated in neurodegeneration",
            "target": ">400 pg/mL suggests neuronal injury"
          },
          {
            "item": "CSF phosphorylated tau (p-tau181 or p-tau217) (CPT 83519)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Specific for AD pathology; best discriminator",
            "target": "Elevated p-tau181 >60 pg/mL or p-tau217 >20 pg/mL"
          },
          {
            "item": "CSF NfL (neurofilament light) (CPT 83519)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Non-specific marker of neuronal damage",
            "target": "Elevated suggests active neurodegeneration"
          },
          {
            "item": "14-3-3 protein (CPT 83519)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rapid progression; suspected CJD",
            "target": "Negative (positive suggests CJD)"
          },
          {
            "item": "RT-QuIC",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Prion disease confirmation if suspected",
            "target": "Negative"
          },
          {
            "item": "Autoimmune encephalitis panel (CPT 86255)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Atypical presentation; subacute onset",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain without contrast (CPT 70551)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At initial evaluation",
            "target": "Hippocampal and medial temporal atrophy; rule out structural causes (tumor, SDH, NPH, stroke)",
            "contraindications": "MRI-incompatible devices, severe claustrophobia"
          },
          {
            "item": "CT Head non-contrast (CPT 70450)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If MRI unavailable or contraindicated",
            "target": "Rule out mass, hemorrhage, hydrocephalus",
            "contraindications": "None"
          }
        ],
        "Extended": [
          {
            "item": "Amyloid PET (CPT 78816)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Diagnostic uncertainty; anti-amyloid therapy eligibility",
            "target": "Positive amyloid deposition confirms AD pathology",
            "contraindications": "None"
          },
          {
            "item": "FDG-PET Brain (CPT 78816)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Differentiate AD from FTD; atypical presentations",
            "target": "AD: bilateral temporoparietal hypometabolism",
            "contraindications": "None"
          },
          {
            "item": "Tau PET (flortaucipir) (CPT 78816)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Staging AD; donanemab eligibility",
            "target": "Elevated tau correlates with disease stage",
            "contraindications": "None"
          },
          {
            "item": "MRI Brain volumetrics (CPT 70551)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Baseline for anti-amyloid monitoring; track progression",
            "target": "Quantify hippocampal and whole brain atrophy",
            "contraindications": "MRI contraindications"
          },
          {
            "item": "MRI with SWI/GRE sequences (CPT 70551)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Pre-treatment for anti-amyloid (microbleed assessment)",
            "target": "Count microbleeds (<4 eligible for therapy)",
            "contraindications": "MRI contraindications"
          },
          {
            "item": "EEG (CPT 95816)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Seizures, encephalopathy, or rapid decline",
            "target": "Diffuse slowing typical in AD; rule out CJD",
            "contraindications": "None"
          },
          {
            "item": "Sleep study (polysomnography) (CPT 95810)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Sleep apnea contributing to cognition; RBD evaluation",
            "target": "Assess AHI; REM without atonia suggests DLB",
            "contraindications": "None"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "DaTscan (ioflupane I-123) (CPT 78607)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Differentiate DLB/PDD from AD",
            "target": "Reduced uptake: DLB; Normal: AD",
            "contraindications": "Iodine hypersensitivity"
          },
          {
            "item": "SPECT (perfusion) (CPT 78607)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Alternative to PET if unavailable",
            "target": "Regional hypoperfusion patterns",
            "contraindications": "None"
          },
          {
            "item": "Whole body PET-CT (CPT 78816)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Paraneoplastic workup if suspected",
            "target": "Rule out occult malignancy",
            "contraindications": "None"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Treat reversible causes",
            "route": "Various",
            "indication": "Identified metabolic or infectious etiology",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per specific cause",
                  "orderSentence": "Treat reversible causes Per specific cause Various"
                }
              ],
              "route": "Various",
              "instructions": "Correct hyponatremia slowly, treat UTI, replace B12, treat hypothyroidism",
              "orderSentence": "Treat reversible causes Per specific cause Various"
            },
            "contraindications": "Depends on intervention",
            "monitoring": "Cognitive reassessment after treatment",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Thiamine",
            "route": "IV/PO",
            "indication": "Suspected Wernicke's; alcoholism; malnutrition",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg IV TID x 3 days",
                  "orderSentence": "Thiamine 500 mg IV TID x 3 days IV/PO"
                },
                {
                  "text": "100 mg PO daily",
                  "orderSentence": "Thiamine 100 mg PO daily IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "500 mg IV TID x 3 days if Wernicke suspected; then 100 mg PO daily maintenance",
              "orderSentence": "Thiamine 500 mg IV TID x 3 days IV/PO"
            },
            "contraindications": "None",
            "monitoring": "Clinical improvement in confusion",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "route": "IM/PO",
            "indication": "B12 deficiency (<300 pg/mL)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mcg IM daily x 7d",
                  "orderSentence": "Vitamin B12 1000 mcg IM daily x 7d IM/PO"
                },
                {
                  "text": "1000 mcg IM weekly x 4wk",
                  "orderSentence": "Vitamin B12 1000 mcg IM weekly x 4wk IM/PO"
                },
                {
                  "text": "1000 mcg IM monthly",
                  "orderSentence": "Vitamin B12 1000 mcg IM monthly IM/PO"
                }
              ],
              "route": "IM/PO",
              "instructions": "1000 mcg IM daily x 7d, then weekly x 4wk, then monthly; or high-dose oral 1000-2000 mcg daily",
              "orderSentence": "Vitamin B12 1000 mcg IM daily x 7d IM/PO"
            },
            "contraindications": "None",
            "monitoring": "B12 level at 2 months; cognitive improvement over months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Cholinesterase Inhibitors (Cognitive Enhancement)": [
          {
            "item": "Donepezil (Aricept)",
            "route": "PO",
            "indication": "Mild, moderate, or severe AD (first-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Donepezil (Aricept) 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg qHS x 4-6 weeks; if tolerated, increase to 10 mg qHS; 23 mg available for moderate-severe AD after stable on 10 mg",
              "orderSentence": "Donepezil (Aricept) 5 mg PO"
            },
            "contraindications": "Sick sinus syndrome; second/third degree heart block without pacemaker; active GI bleeding; severe COPD",
            "monitoring": "Heart rate; GI symptoms (nausea, diarrhea); vivid dreams; muscle cramps",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine oral (Exelon)",
            "route": "PO",
            "indication": "Mild-moderate AD; may be better for attention/executive symptoms",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1.5 mg",
                  "orderSentence": "Rivastigmine oral (Exelon) 1.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1.5 mg BID with meals; increase by 1.5 mg BID every 2 weeks; target 6 mg BID",
              "orderSentence": "Rivastigmine oral (Exelon) 1.5 mg PO"
            },
            "contraindications": "Sick sinus syndrome; second/third degree heart block; active GI bleeding; severe hepatic impairment",
            "monitoring": "GI symptoms (most common); weight loss; bradycardia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine patch (Exelon Patch)",
            "route": "TD",
            "indication": "Mild-moderate AD; better GI tolerability than oral",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4.6 mg/24hr",
                  "orderSentence": "Rivastigmine patch (Exelon Patch) 4.6 mg/24hr TD"
                }
              ],
              "route": "TD",
              "instructions": "Start 4.6 mg/24hr patch; increase every 4 weeks; target 9.5-13.3 mg/24hr; apply to clean, hairless skin",
              "orderSentence": "Rivastigmine patch (Exelon Patch) 4.6 mg/24hr TD"
            },
            "contraindications": "Sick sinus syndrome; second/third degree heart block; active GI bleeding",
            "monitoring": "Skin irritation (rotate sites); GI symptoms less than oral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Galantamine (Razadyne)",
            "route": "PO",
            "indication": "Mild-moderate AD; dual mechanism (AChE inhibitor + nicotinic modulator)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg",
                  "orderSentence": "Galantamine (Razadyne) 4 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 4 mg BID with meals x 4 weeks; increase to 8 mg BID x 4 weeks; target 8-12 mg BID",
              "orderSentence": "Galantamine (Razadyne) 4 mg PO"
            },
            "contraindications": "Sick sinus syndrome; second/third degree heart block; severe renal impairment (CrCl <9); severe hepatic impairment",
            "monitoring": "GI symptoms; bradycardia; weight loss",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Galantamine ER (Razadyne ER)",
            "route": "PO",
            "indication": "Once-daily alternative for adherence",
            "dosing": {
              "doseOptions": [
                {
                  "text": "8 mg",
                  "orderSentence": "Galantamine ER (Razadyne ER) 8 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 8 mg daily with breakfast x 4 weeks; increase by 8 mg every 4 weeks; target 16-24 mg daily",
              "orderSentence": "Galantamine ER (Razadyne ER) 8 mg PO"
            },
            "contraindications": "Sick sinus syndrome; second/third degree heart block; severe renal impairment (CrCl <9); severe hepatic impairment",
            "monitoring": "GI symptoms; bradycardia; weight loss",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "NMDA Receptor Antagonist": [
          {
            "item": "Memantine (Namenda)",
            "route": "PO",
            "indication": "Moderate-severe AD; add to cholinesterase inhibitor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Memantine (Namenda) 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily x 1 week; increase by 5 mg/week: 5 mg BID, then 5 mg/10 mg, then 10 mg BID",
              "orderSentence": "Memantine (Namenda) 5 mg PO"
            },
            "contraindications": "Severe renal impairment (reduce dose if CrCl 5-29: max 5 mg BID)",
            "monitoring": "Confusion, dizziness, constipation, headache",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Memantine XR (Namenda XR)",
            "route": "PO",
            "indication": "Once-daily option for adherence",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7 mg",
                  "orderSentence": "Memantine XR (Namenda XR) 7 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 7 mg daily; increase by 7 mg/week; target 28 mg daily",
              "orderSentence": "Memantine XR (Namenda XR) 7 mg PO"
            },
            "contraindications": "Severe renal impairment (reduce dose if CrCl 5-29: max 14 mg daily)",
            "monitoring": "Confusion, dizziness, constipation, headache",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Memantine/Donepezil (Namzaric)",
            "route": "PO",
            "indication": "Combination for moderate-severe AD already on both",
            "dosing": {
              "doseOptions": [
                {
                  "text": "28/10 mg",
                  "orderSentence": "Memantine/Donepezil (Namzaric) 28/10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "One capsule (28 mg memantine XR + 10 mg donepezil) once daily at bedtime; must be stable on both drugs first",
              "orderSentence": "Memantine/Donepezil (Namzaric) 28/10 mg PO"
            },
            "contraindications": "Severe renal impairment; sick sinus syndrome; second/third degree heart block",
            "monitoring": "Confusion, dizziness, GI symptoms, vivid dreams",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Disease-Modifying Therapies (Anti-Amyloid)": [
          {
            "item": "Lecanemab (Leqembi)",
            "route": "IV",
            "indication": "Early AD (MCI or mild dementia) with confirmed amyloid pathology",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg IV q2wk",
                  "orderSentence": "Lecanemab (Leqembi) 10 mg/kg IV q2wk IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV every 2 weeks; infuse over approximately 1 hour",
              "orderSentence": "Lecanemab (Leqembi) 10 mg/kg IV q2wk IV"
            },
            "pretreatment": "Amyloid PET positive OR CSF biomarkers confirming amyloid; MRI within 1 year (assess microbleeds); APOE genotyping strongly recommended; informed consent for ARIA risk",
            "contraindications": ">4 cerebral microbleeds; superficial siderosis; recent macrohemorrhage; concurrent anticoagulation (relative); APOE ε4/ε4 (higher ARIA risk - not absolute CI)",
            "monitoring": "MRI: baseline, weeks 7, 14, 52, 78 (ARIA monitoring); clinical assessment for ARIA symptoms (headache, confusion, visual changes)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Donanemab (Kisunla)",
            "route": "IV",
            "indication": "Early AD (MCI or mild dementia) with confirmed amyloid AND intermediate/high tau pathology",
            "dosing": {
              "doseOptions": [
                {
                  "text": "700 mg IV q4wk x 3",
                  "orderSentence": "Donanemab (Kisunla) 700 mg IV q4wk x 3 IV"
                },
                {
                  "text": "then 1400 mg IV q4wk",
                  "orderSentence": "Donanemab (Kisunla) then 1400 mg IV q4wk IV"
                }
              ],
              "route": "IV",
              "instructions": "700 mg IV every 4 weeks x 3 doses, then 1400 mg IV every 4 weeks until amyloid clearance (by PET); discontinue when PET negative",
              "orderSentence": "Donanemab (Kisunla) 700 mg IV q4wk x 3 IV"
            },
            "pretreatment": "Amyloid PET positive; Tau PET showing intermediate or high tau levels; MRI baseline; APOE genotyping (higher ARIA in ε4/ε4)",
            "contraindications": "Same as lecanemab; higher ARIA risk in APOE ε4 homozygotes",
            "monitoring": "MRI: baseline, weeks 12, 24, 52, 76 (ARIA monitoring); repeat amyloid PET to assess clearance",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "~~Aducanumab (Aduhelm)~~",
            "route": "IV",
            "indication": "**DISCONTINUED** — Biogen halted Aduhelm commercialization January 2024; no longer available",
            "dosing": {
              "instructions": "N/A",
              "orderSentence": "~~Aducanumab (Aduhelm)~~ - IV - see dosing"
            },
            "pretreatment": "N/A",
            "contraindications": "N/A",
            "monitoring": "N/A",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Behavioral and Psychological Symptoms of Dementia (BPSD)": [
          {
            "item": "Citalopram",
            "route": "PO",
            "indication": "Depression; mild-moderate agitation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Citalopram 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg daily; max 20 mg in elderly due to QT prolongation risk",
              "orderSentence": "Citalopram 10 mg PO"
            },
            "contraindications": "QT prolongation; concurrent QT-prolonging drugs; severe hepatic impairment",
            "monitoring": "ECG at baseline if cardiac risk; QTc monitoring if >20 mg",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sertraline (Zoloft)",
            "route": "PO",
            "indication": "Depression; anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Sertraline (Zoloft) 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; increase by 25 mg every 1-2 weeks; typical dose 50-100 mg daily",
              "orderSentence": "Sertraline (Zoloft) 25 mg PO"
            },
            "contraindications": "MAOIs; uncontrolled seizures (lowers threshold slightly)",
            "monitoring": "GI symptoms initially; bleeding risk with anticoagulants",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirtazapine (Remeron)",
            "route": "PO",
            "indication": "Depression with poor appetite, insomnia, and weight loss",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7.5 mg",
                  "orderSentence": "Mirtazapine (Remeron) 7.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 7.5-15 mg qHS; may increase to 30-45 mg qHS; lower doses more sedating",
              "orderSentence": "Mirtazapine (Remeron) 7.5 mg PO"
            },
            "contraindications": "MAOIs; angle-closure glaucoma",
            "monitoring": "Weight gain (often desired); sedation; hyperlipidemia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Insomnia; sundowning; mild agitation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Trazodone 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg qHS; titrate by 25-50 mg every 3-5 days; typical 50-150 mg qHS for sleep",
              "orderSentence": "Trazodone 25 mg PO"
            },
            "contraindications": "Concurrent MAOIs; significant QT prolongation",
            "monitoring": "Orthostatic hypotension (fall risk); priapism (rare); QTc",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "Sleep disturbance; circadian rhythm dysfunction",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3 mg",
                  "orderSentence": "Melatonin 3 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 3 mg qHS, 30 min before bed; may increase to 6-9 mg if needed",
              "orderSentence": "Melatonin 3 mg PO"
            },
            "contraindications": "None significant",
            "monitoring": "Daytime drowsiness; minimal side effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Brexpiprazole (Rexulti)",
            "route": "PO",
            "indication": "Agitation in AD (FDA approved 2023)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg",
                  "orderSentence": "Brexpiprazole (Rexulti) 0.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.5 mg daily x 1 week; increase to 1 mg daily x 1 week; target 2-3 mg daily",
              "orderSentence": "Brexpiprazole (Rexulti) 0.5 mg PO"
            },
            "contraindications": "Black box: increased mortality in dementia (but FDA approved for this use)",
            "monitoring": "Weight, metabolic parameters, EPS, falls",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Quetiapine (Seroquel)",
            "route": "PO",
            "indication": "Severe agitation/psychosis when non-pharmacologic fails",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg",
                  "orderSentence": "Quetiapine (Seroquel) 12.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5-25 mg qHS; titrate slowly (25 mg increments); keep dose as low as possible",
              "orderSentence": "Quetiapine (Seroquel) 12.5 mg PO"
            },
            "contraindications": "Black box: increased mortality in dementia; Parkinson's (less risk than other antipsychotics)",
            "monitoring": "Metabolic effects; sedation; falls; QTc",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Risperidone (Risperdal)",
            "route": "PO",
            "indication": "Severe aggression/psychosis (short-term only)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg",
                  "orderSentence": "Risperidone (Risperdal) 0.25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25 mg BID; increase by 0.25 mg BID weekly; max 1 mg BID; limit to 6-12 weeks",
              "orderSentence": "Risperidone (Risperdal) 0.25 mg PO"
            },
            "contraindications": "Black box: increased mortality and CVA in dementia",
            "monitoring": "EPS, metabolic effects, stroke risk, prolactin",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Haloperidol",
            "route": "IM/IV/PO",
            "indication": "Acute severe agitation in delirium-crisis only (not chronic use)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg",
                  "orderSentence": "Haloperidol 0.5 mg IM"
                }
              ],
              "route": "IM",
              "instructions": "0.5-2 mg IM/IV q4-6h PRN; short-term acute use only; avoid chronic use",
              "orderSentence": "Haloperidol 0.5 mg IM"
            },
            "contraindications": "QT prolongation; Parkinson's disease; DLB (avoid)",
            "monitoring": "QTc; EPS; akathisia",
            "ED": "STAT",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology/Cognitive neurology for diagnosis confirmation, biomarker interpretation, and treatment planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuropsychology for formal cognitive testing (MoCA insufficient) to establish baseline and track progression",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Geriatric psychiatry for BPSD management and capacity evaluation when decision-making ability questioned",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for ADL assessment, cognitive strategies, and home safety evaluation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech therapy for communication strategies and swallowing evaluation if dysphagia develops",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for caregiver support resources, community services, and long-term care planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Palliative care for advanced AD symptom management and goals of care discussions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Elder law attorney for advance directives, healthcare proxy, and financial planning while capacity exists",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetics counseling for early-onset AD (<65) families or those considering predictive testing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Driving rehabilitation specialist for formal on-road driving evaluation when ability is questioned",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Infusion center coordination for anti-amyloid therapy administration and ARIA monitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if sudden worsening of confusion which may indicate stroke, infection, or medication toxicity",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "If on anti-amyloid therapy (lecanemab, donanemab): return immediately for new headache, visual changes, confusion, or unsteadiness (possible ARIA)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Complete advance directives (living will, healthcare proxy, POLST) while patient has capacity to document preferences for future care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Designate financial power of attorney and consider trust arrangements early while patient can participate",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive until cleared by physician or formal driving evaluation; report diagnosis to DMV per state requirements",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use pill organizers, alarms, or caregiver supervision to ensure medication adherence",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Wear medical alert bracelet with diagnosis and emergency contact in case of wandering",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep environment safe: remove throw rugs, install grab bars, secure stove knobs, lock away dangerous items",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain consistent daily routines which help with orientation and reduce anxiety",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Regular aerobic exercise (150 min/week moderate intensity) may slow cognitive decline and improve mood",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Mediterranean or MIND diet emphasizing vegetables, berries, fish, whole grains, nuts, and olive oil",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cognitive stimulation through reading, puzzles, music, social activities to support cognitive reserve",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate sleep (7-8 hours); treat sleep apnea aggressively as it worsens cognition",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Social engagement and meaningful activities to reduce isolation and support emotional well-being",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cardiovascular risk factor control: BP <130/80, A1c <7%, LDL <100 to reduce vascular contribution",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Hearing aids for hearing loss which is a modifiable dementia risk factor (Lancet Commission)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol to ≤1 drink daily; excess alcohol accelerates cognitive decline",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation to reduce vascular damage and improve overall brain health",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Caregiver respite services to prevent burnout; Alzheimer's Association support groups",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Mild Cognitive Impairment (MCI)",
        "features": "Cognitive decline without functional impairment; may progress to AD",
        "tests": "Serial cognitive testing; preserved ADLs"
      },
      {
        "diagnosis": "Vascular dementia",
        "features": "Stepwise decline; focal neurologic findings; executive dysfunction prominent; vascular risk factors",
        "tests": "MRI shows significant WM disease, strategic infarcts"
      },
      {
        "diagnosis": "Dementia with Lewy bodies (DLB)",
        "features": "Visual hallucinations; parkinsonism; REM sleep behavior disorder; fluctuating cognition",
        "tests": "DaTscan reduced; clinical criteria"
      },
      {
        "diagnosis": "Frontotemporal dementia (behavioral variant)",
        "features": "Personality/behavior changes; disinhibition; apathy; hyperorality; often <65 years",
        "tests": "FDG-PET frontal hypometabolism; genetics"
      },
      {
        "diagnosis": "Primary progressive aphasia",
        "features": "Language dysfunction predominates (word-finding, comprehension, grammar)",
        "tests": "Neuropsych pattern; FDG-PET language regions"
      },
      {
        "diagnosis": "Parkinson's disease dementia",
        "features": "Parkinsonism precedes dementia by >1 year; different from DLB timing",
        "tests": "Clinical history; DaTscan"
      },
      {
        "diagnosis": "Normal pressure hydrocephalus (NPH)",
        "features": "Triad: gait disturbance, urinary incontinence, dementia; gait earliest",
        "tests": "MRI ventriculomegaly; large-volume LP with gait improvement"
      },
      {
        "diagnosis": "Depression (pseudodementia)",
        "features": "Prominent mood symptoms; often aware of deficits; improves with treatment",
        "tests": "GDS, PHQ-9; antidepressant trial"
      },
      {
        "diagnosis": "Creutzfeldt-Jakob disease (CJD)",
        "features": "Rapid progression (weeks-months); myoclonus; ataxia; pyramidal signs",
        "tests": "EEG (periodic sharp waves); MRI DWI ribboning; CSF RT-QuIC"
      },
      {
        "diagnosis": "Autoimmune encephalitis",
        "features": "Subacute onset; psychiatric features; seizures; often younger",
        "tests": "Autoantibody panel; MRI limbic changes"
      },
      {
        "diagnosis": "Medication-induced cognitive impairment",
        "features": "Anticholinergics, benzodiazepines, opioids",
        "tests": "Medication reconciliation; improvement with discontinuation"
      }
    ],
    "evidence": [
      {
        "recommendation": "NIA-AA diagnostic criteria for AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Jack et al. Alzheimers Dement 2018](https://pubmed.ncbi.nlm.nih.gov/29653606/)"
      },
      {
        "recommendation": "CSF biomarkers (Aβ42, t-tau, p-tau) accurate for AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hansson et al. Lancet Neurol 2018](https://pubmed.ncbi.nlm.nih.gov/30244989/)"
      },
      {
        "recommendation": "Donepezil efficacy in mild-moderate AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Birks & Harvey. Cochrane 2018](https://pubmed.ncbi.nlm.nih.gov/29923184/)"
      },
      {
        "recommendation": "Rivastigmine efficacy in AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Birks et al. Cochrane 2015](https://pubmed.ncbi.nlm.nih.gov/25858345/)"
      },
      {
        "recommendation": "Galantamine efficacy in AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Loy & Schneider. Cochrane 2006](https://pubmed.ncbi.nlm.nih.gov/16437501/)"
      },
      {
        "recommendation": "Memantine efficacy in moderate-severe AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Reisberg et al. NEJM 2003](https://pubmed.ncbi.nlm.nih.gov/12672860/)"
      },
      {
        "recommendation": "Combination therapy (ChEI + memantine)",
        "evidenceLevel": "Class I, Level A",
        "source": "[Tariot et al. JAMA 2004](https://pubmed.ncbi.nlm.nih.gov/14970063/)"
      },
      {
        "recommendation": "Lecanemab slows cognitive decline in early AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[van Dyck et al. NEJM 2023 (Clarity AD)](https://pubmed.ncbi.nlm.nih.gov/36449413/)"
      },
      {
        "recommendation": "Donanemab slows cognitive decline",
        "evidenceLevel": "Class I, Level A",
        "source": "[Sims et al. JAMA 2023 (TRAILBLAZER-ALZ 2)](https://pubmed.ncbi.nlm.nih.gov/37459141/)"
      },
      {
        "recommendation": "Brexpiprazole for agitation in AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Grossberg et al. NEJM 2024](https://pubmed.ncbi.nlm.nih.gov/37888914/)"
      },
      {
        "recommendation": "Antipsychotic mortality risk in dementia",
        "evidenceLevel": "Class I, Level A",
        "source": "[Schneider et al. JAMA 2005](https://pubmed.ncbi.nlm.nih.gov/16219884/)"
      },
      {
        "recommendation": "Mediterranean diet reduces dementia risk",
        "evidenceLevel": "Class II, Level B",
        "source": "[Scarmeas et al. Ann Neurol 2006](https://pubmed.ncbi.nlm.nih.gov/16832238/)"
      },
      {
        "recommendation": "Physical exercise may slow cognitive decline",
        "evidenceLevel": "Class II, Level B",
        "source": "[Livingston et al. Lancet 2020](https://pubmed.ncbi.nlm.nih.gov/32738937/)"
      },
      {
        "recommendation": "APOE genotyping for ARIA risk stratification",
        "evidenceLevel": "Class II, Level B",
        "source": "[Sperling et al. JAMA Neurol 2024](https://pubmed.ncbi.nlm.nih.gov/38587851/)"
      },
      {
        "recommendation": "Citalopram for agitation in AD (CitAD)",
        "evidenceLevel": "Class II, Level B",
        "source": "[Porsteinsson et al. JAMA 2014](https://pubmed.ncbi.nlm.nih.gov/24549548/)"
      },
      {
        "recommendation": "Hearing aid use reduces dementia risk",
        "evidenceLevel": "Class II, Level B",
        "source": "[Lin et al. JAMA Intern Med 2023](https://pubmed.ncbi.nlm.nih.gov/36592413/)"
      },
      {
        "recommendation": "Driving assessment in dementia",
        "evidenceLevel": "Class III, Level C",
        "source": "[Iverson et al. Neurology 2010](https://pubmed.ncbi.nlm.nih.gov/20439849/)"
      }
    ],
    "monitoring": [
      {
        "item": "Cognitive testing (MoCA or MMSE)",
        "frequency": "Every 6-12 months",
        "action": "Adjust staging; modify treatment; increase support",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Functional status (ADL/IADL, FAQ)",
        "frequency": "Every 6-12 months",
        "action": "Increase caregiver support; consider placement",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Neuropsychiatric Inventory (NPI)",
        "frequency": "Each visit",
        "action": "Non-pharmacologic interventions; consider medications",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight",
        "frequency": "Each visit",
        "action": "Nutritional consult; assess swallowing",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "MRI Brain (ARIA monitoring)",
        "frequency": "Per protocol if on anti-amyloid",
        "action": "Hold infusion; follow protocol for resumption",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Caregiver burden (Zarit Burden Interview)",
        "frequency": "Every 6-12 months",
        "action": "Support resources; respite care; social work",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Driving status",
        "frequency": "Each visit",
        "action": "Formal driving evaluation; report to DMV if unsafe",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ECG (if on donepezil or citalopram)",
        "frequency": "Baseline; with dose changes",
        "action": "Reduce dose or switch medication",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Amyloid PET (if on donanemab)",
        "frequency": "Annually until clearance",
        "action": "Discontinue donanemab when cleared",
        "ED": "-",
        "HOSP": "-",
        "OPD": "EXT",
        "ICU": "-"
      },
      {
        "item": "Fall risk assessment",
        "frequency": "Each visit",
        "action": "PT referral; home safety; assistive devices",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Stable cognition; safe environment; adequate caregiver support; outpatient follow-up arranged; reversible causes treated"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Acute delirium requiring workup; behavioral crisis unsafe for home; aspiration pneumonia; falls with injury"
      },
      {
        "disposition": "Admit to psychiatry",
        "criteria": "Severe behavioral disturbance requiring specialized psychiatric management; danger to self or others"
      },
      {
        "disposition": "Long-term care/Memory care",
        "criteria": "Progressive decline; caregiver unable to manage safely; wandering; 24-hour supervision needed"
      },
      {
        "disposition": "Hospice",
        "criteria": "End-stage AD; limited responsiveness; recurrent aspiration; weight loss; goals focused on comfort"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Neurology every 3-6 months early disease; every 6-12 months stable; more frequent if on anti-amyloid therapy"
      }
    ]
  },
  "Lewy Body Dementia": {
    "id": "lewy-body-dementia",
    "title": "Lewy Body Dementia",
    "version": "1.1",
    "icd10": [
      "** G31.83 (Dementia with Lewy bodies)",
      "F02.80 (Dementia in DLB without behavioral disturbance)",
      "F02.81 (Dementia in DLB with behavioral disturbance)"
    ],
    "scope": "** Diagnosis based on McKeith criteria (2017), biomarker-supported diagnosis (DaTscan, MIBG), symptomatic management of cognitive, motor, behavioral, and autonomic symptoms. Emphasizes neuroleptic sensitivity and safe treatment approaches. Covers both pure DLB and Parkinson's disease dementia (PDD) overlap.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential (CPT 85025)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Infection screen; anemia contributing to cognitive changes",
            "target": "Normal"
          },
          {
            "item": "BMP (CPT 80048)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hyponatremia, uremia, hypercalcemia as causes of confusion",
            "target": "Normal electrolytes, BUN, Cr"
          },
          {
            "item": "TSH (CPT 84443)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypothyroidism is reversible cause of cognitive impairment",
            "target": "0.4-4.0 mIU/L"
          },
          {
            "item": "Vitamin B12 (CPT 82607)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency can cause cognitive impairment and parkinsonism",
            "target": ">300 pg/mL (>400 optimal)"
          },
          {
            "item": "Folate (CPT 82746)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency contributes to cognitive impairment",
            "target": ">3 ng/mL"
          },
          {
            "item": "Glucose (fasting) (CPT 82947)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes affects cognition and autonomic function",
            "target": "70-100 mg/dL"
          },
          {
            "item": "Hepatic panel (LFTs) (CPT 80076)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Baseline before medications; hepatic encephalopathy",
            "target": "Normal"
          },
          {
            "item": "Urinalysis (CPT 81001)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "UTI common cause of acute confusion in elderly",
            "target": "Negative for infection"
          }
        ],
        "Extended Workup": [
          {
            "item": "Vitamin D, 25-hydroxy (CPT 82306)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency associated with falls and cognitive decline",
            "target": ">30 ng/mL"
          },
          {
            "item": "Hemoglobin A1c (CPT 83036)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Chronic glucose control affects cognition",
            "target": "<7%"
          },
          {
            "item": "Lipid panel (CPT 80061)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Vascular risk factors",
            "target": "LDL <100 mg/dL"
          },
          {
            "item": "RPR or VDRL (CPT 86592)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurosyphilis (rare but treatable)",
            "target": "Nonreactive"
          },
          {
            "item": "HIV testing (CPT 87389)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HIV-associated neurocognitive disorder",
            "target": "Negative"
          },
          {
            "item": "ESR (CPT 85651), CRP (CPT 86140)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Inflammatory/autoimmune causes",
            "target": "Normal"
          },
          {
            "item": "Cortisol (AM) (CPT 82533)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Adrenal insufficiency causing orthostatic hypotension",
            "target": "10-20 mcg/dL"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CSF alpha-synuclein seed amplification assay (SAA) (CPT 83519)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Confirms synucleinopathy; research/atypical cases",
            "target": "Positive aggregation"
          },
          {
            "item": "Skin biopsy for phosphorylated alpha-synuclein (CPT 88305)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Peripheral synuclein deposition confirms synucleinopathy",
            "target": "Positive deposits in cutaneous nerves"
          },
          {
            "item": "Genetic testing (GBA, SNCA) (CPT 81479)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Family history or early-onset; GBA mutations increase DLB risk",
            "target": "Identifies genetic risk"
          },
          {
            "item": "Paraneoplastic antibody panel (CPT 86235)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Autoimmune dementia; rapid progression",
            "target": "Negative"
          },
          {
            "item": "Anti-neuronal antibodies (NMDA-R, LGI1, CASPR2) (CPT 86255)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Autoimmune encephalitis if rapid onset",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain without contrast (CPT 70551)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At initial evaluation",
            "target": "Relative preservation of medial temporal lobes (vs AD); rule out structural causes",
            "contraindications": "MRI-incompatible devices"
          },
          {
            "item": "CT Head non-contrast (CPT 70450)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If MRI unavailable",
            "target": "Rule out mass, hemorrhage, hydrocephalus",
            "contraindications": "None"
          }
        ],
        "Extended": [
          {
            "item": "DaTscan (ioflupane I-123 SPECT) (CPT 78607)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Diagnostic uncertainty; differentiating DLB from AD",
            "target": "Reduced dopamine transporter uptake in putamen (indicative biomarker)",
            "contraindications": "Hypersensitivity to iodine"
          },
          {
            "item": "Cardiac MIBG scintigraphy (CPT 78452)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Differentiate DLB from AD; supports diagnosis",
            "target": "Reduced cardiac uptake (indicative biomarker)",
            "contraindications": "Recent MI; drugs affecting uptake (labetalol, reserpine)"
          },
          {
            "item": "FDG-PET Brain (CPT 78816)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Differentiate from AD; atypical presentations",
            "target": "Posterior occipital hypometabolism with cingulate island sign (supportive biomarker)",
            "contraindications": "None"
          },
          {
            "item": "Polysomnography (CPT 95810)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "REM sleep behavior disorder confirmation",
            "target": "REM sleep without atonia (indicative biomarker)",
            "contraindications": "None"
          },
          {
            "item": "EEG (CPT 95819)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Encephalopathy; fluctuating cognition",
            "target": "Posterior slow-wave activity with periodic fluctuations (supportive)",
            "contraindications": "None"
          },
          {
            "item": "Autonomic function testing (CPT 95923)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Dysautonomia assessment",
            "target": "Orthostatic hypotension, abnormal HR variability",
            "contraindications": "None"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Amyloid PET (CPT 78816)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Atypical cases; AD co-pathology assessment",
            "target": "May be positive (AD-DLB overlap common)",
            "contraindications": "None"
          },
          {
            "item": "Tau PET (CPT 78816)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Research; differentiate from AD tauopathy",
            "target": "Less tau deposition than AD for similar dementia severity",
            "contraindications": "None"
          },
          {
            "item": "SPECT perfusion (CPT 78607)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Alternative to FDG-PET",
            "target": "Posterior hypoperfusion pattern",
            "contraindications": "None"
          },
          {
            "item": "MRI with SWI (CPT 70553)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Microbleeds; cerebral amyloid angiopathy",
            "target": "Lobar microbleed pattern",
            "contraindications": "MRI contraindications"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "AVOID TYPICAL ANTIPSYCHOTICS",
            "route": "-",
            "indication": "CRITICAL SAFETY WARNING",
            "dosing": {
              "doseOptions": [
                {
                  "text": "DO NOT USE",
                  "orderSentence": "AVOID TYPICAL ANTIPSYCHOTICS DO NOT USE N/A"
                }
              ],
              "route": "N/A",
              "instructions": "Haloperidol, chlorpromazine, fluphenazine absolutely contraindicated; risk of severe parkinsonism, NMS, and death",
              "orderSentence": "AVOID TYPICAL ANTIPSYCHOTICS DO NOT USE N/A"
            },
            "contraindications": "DLB is absolute contraindication",
            "monitoring": "N/A",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "AVOID MOST ATYPICAL ANTIPSYCHOTICS",
            "route": "-",
            "indication": "CRITICAL SAFETY WARNING",
            "dosing": {
              "doseOptions": [
                {
                  "text": "DO NOT USE",
                  "orderSentence": "AVOID MOST ATYPICAL ANTIPSYCHOTICS DO NOT USE N/A"
                }
              ],
              "route": "N/A",
              "instructions": "Risperidone, olanzapine, aripiprazole, ziprasidone contraindicated; 2-3x mortality risk",
              "orderSentence": "AVOID MOST ATYPICAL ANTIPSYCHOTICS DO NOT USE N/A"
            },
            "contraindications": "DLB is relative contraindication",
            "monitoring": "N/A",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Quetiapine (if antipsychotic absolutely needed)",
            "route": "PO",
            "indication": "Severe psychosis/agitation when non-pharmacologic fails",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg",
                  "orderSentence": "Quetiapine (if antipsychotic absolutely needed) 12.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5 mg qHS; increase slowly by 12.5 mg q3-7d; max 50-100 mg; lowest effective dose for shortest time",
              "orderSentence": "Quetiapine (if antipsychotic absolutely needed) 12.5 mg PO"
            },
            "contraindications": "QT prolongation",
            "monitoring": "Monitor for worsening parkinsonism, sedation",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Treat delirium triggers",
            "route": "Various",
            "indication": "Infection, metabolic, medication-induced delirium",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per cause",
                  "orderSentence": "Treat delirium triggers Per cause Various"
                }
              ],
              "route": "Various",
              "instructions": "Treat UTI, correct electrolytes, remove offending drugs (especially anticholinergics)",
              "orderSentence": "Treat delirium triggers Per cause Various"
            },
            "contraindications": "Depends on intervention",
            "monitoring": "Mental status",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Rivastigmine oral",
            "route": "PO",
            "indication": "Cognitive impairment and visual hallucinations (FDA approved for PDD)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1.5 mg",
                  "orderSentence": "Rivastigmine oral 1.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1.5 mg BID with meals; increase by 1.5 mg BID q2-4wk; target 6 mg BID; may improve hallucinations",
              "orderSentence": "Rivastigmine oral 1.5 mg PO"
            },
            "contraindications": "Sick sinus syndrome; GI bleeding; severe hepatic impairment",
            "monitoring": "Nausea, weight loss, tremor worsening, bradycardia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine patch",
            "route": "TD",
            "indication": "Cognitive impairment; better GI tolerability",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4.6 mg/24hr",
                  "orderSentence": "Rivastigmine patch 4.6 mg/24hr TD"
                }
              ],
              "route": "TD",
              "instructions": "Start 4.6 mg/24hr patch; increase q4wk; target 9.5-13.3 mg/24hr",
              "orderSentence": "Rivastigmine patch 4.6 mg/24hr TD"
            },
            "contraindications": "Sick sinus syndrome; GI bleeding; severe hepatic impairment",
            "monitoring": "Skin irritation, nausea",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Donepezil",
            "route": "PO",
            "indication": "Cognitive impairment; alternative to rivastigmine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Donepezil 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg qHS x 4-6 weeks; may increase to 10 mg qHS",
              "orderSentence": "Donepezil 5 mg PO"
            },
            "contraindications": "Sick sinus syndrome; GI bleeding; COPD exacerbation",
            "monitoring": "Bradycardia, vivid dreams (may worsen RBD), GI",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Galantamine",
            "route": "PO",
            "indication": "Cognitive impairment; alternative cholinesterase inhibitor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg",
                  "orderSentence": "Galantamine 4 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 4 mg BID x 4wk; increase to 8 mg BID; target 8-12 mg BID",
              "orderSentence": "Galantamine 4 mg PO"
            },
            "contraindications": "Sick sinus syndrome; GI bleeding; COPD exacerbation; severe renal/hepatic impairment",
            "monitoring": "GI symptoms, bradycardia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Memantine",
            "route": "PO",
            "indication": "Moderate-severe dementia; add to cholinesterase inhibitor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Memantine 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; increase by 5 mg/wk; target 10 mg BID",
              "orderSentence": "Memantine 5 mg PO"
            },
            "contraindications": "Severe renal impairment (dose adjust CrCl <30)",
            "monitoring": "Confusion, dizziness, constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbidopa-Levodopa",
            "route": "PO",
            "indication": "Motor parkinsonism symptoms",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25/100 mg",
                  "orderSentence": "Carbidopa-Levodopa 25/100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25/100 mg TID; titrate slowly; use lowest effective dose; may worsen hallucinations",
              "orderSentence": "Carbidopa-Levodopa 25/100 mg PO"
            },
            "contraindications": "Active psychosis",
            "monitoring": "Dyskinesias, confusion, hallucination worsening",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "REM sleep behavior disorder (first-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3 mg",
                  "orderSentence": "Melatonin 3 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 3-6 mg 30 min before bed; may increase to 12 mg; first-line for RBD",
              "orderSentence": "Melatonin 3 mg PO"
            },
            "contraindications": "None",
            "monitoring": "Generally well-tolerated",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clonazepam",
            "route": "PO",
            "indication": "REM sleep behavior disorder (second-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg",
                  "orderSentence": "Clonazepam 0.25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25-0.5 mg qHS; typical 0.5-1 mg; use with caution due to sedation and fall risk",
              "orderSentence": "Clonazepam 0.25 mg PO"
            },
            "contraindications": "Severe sleep apnea; respiratory compromise; dementia (relative)",
            "monitoring": "Sedation, falls, cognitive worsening",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pimavanserin (Nuplazid)",
            "route": "PO",
            "indication": "Visual hallucinations and psychosis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "34 mg",
                  "orderSentence": "Pimavanserin (Nuplazid) 34 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "34 mg once daily; takes 4-6 weeks for effect; no titration; selective 5-HT2A inverse agonist",
              "orderSentence": "Pimavanserin (Nuplazid) 34 mg PO"
            },
            "contraindications": "Severe hepatic impairment; QT prolongation",
            "monitoring": "QTc at baseline; efficacy assessment 6 weeks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Insomnia; sundowning",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Trazodone 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg qHS; titrate by 25 mg; typical 50-100 mg qHS",
              "orderSentence": "Trazodone 25 mg PO"
            },
            "contraindications": "MAOIs; QT prolongation",
            "monitoring": "Orthostatic hypotension",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Autonomic Dysfunction Treatments": [
          {
            "item": "Midodrine",
            "route": "PO",
            "indication": "Orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg",
                  "orderSentence": "Midodrine 2.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5 mg TID (before arising, lunch, mid-afternoon); titrate by 2.5 mg/dose; max 10 mg TID; last dose by 6 PM",
              "orderSentence": "Midodrine 2.5 mg PO"
            },
            "contraindications": "Supine hypertension; urinary retention; severe cardiac disease",
            "monitoring": "Supine BP; avoid lying flat 4 hours after dose",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Droxidopa (Northera)",
            "route": "PO",
            "indication": "Neurogenic orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Droxidopa (Northera) 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg TID; titrate by 100 mg/dose q24-48h; max 600 mg TID",
              "orderSentence": "Droxidopa (Northera) 100 mg PO"
            },
            "contraindications": "Supine hypertension",
            "monitoring": "Supine BP, headache",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fludrocortisone",
            "route": "PO",
            "indication": "Orthostatic hypotension adjunct",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg",
                  "orderSentence": "Fludrocortisone 0.1 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.1 mg daily; may increase to 0.2 mg daily",
              "orderSentence": "Fludrocortisone 0.1 mg PO"
            },
            "contraindications": "CHF; severe hypertension",
            "monitoring": "K+, edema, supine BP, weight",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Polyethylene glycol (MiraLAX)",
            "route": "PO",
            "indication": "Constipation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "17 g",
                  "orderSentence": "Polyethylene glycol (MiraLAX) 17 g PO"
                }
              ],
              "route": "PO",
              "instructions": "17 g (1 capful) in 8 oz liquid daily; may increase to BID",
              "orderSentence": "Polyethylene glycol (MiraLAX) 17 g PO"
            },
            "contraindications": "Bowel obstruction",
            "monitoring": "Diarrhea if excessive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Senna + docusate",
            "route": "PO",
            "indication": "Constipation stimulant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 tablets",
                  "orderSentence": "Senna + docusate 2 tablets PO"
                }
              ],
              "route": "PO",
              "instructions": "2 tablets qHS; may increase to 4 tablets",
              "orderSentence": "Senna + docusate 2 tablets PO"
            },
            "contraindications": "Bowel obstruction; undiagnosed abdominal pain",
            "monitoring": "Electrolytes with chronic use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tamsulosin",
            "route": "PO",
            "indication": "Urinary retention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 mg",
                  "orderSentence": "Tamsulosin 0.4 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.4 mg once daily 30 min after meal",
              "orderSentence": "Tamsulosin 0.4 mg PO"
            },
            "contraindications": "Known hypersensitivity; concurrent silodosin",
            "monitoring": "Orthostatic hypotension (caution with existing OH)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxybutynin",
            "route": "PO",
            "indication": "Urinary urgency (use with extreme caution)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg",
                  "orderSentence": "Oxybutynin 2.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "2.5 mg BID only; avoid higher doses; anticholinergic burden worsens cognition",
              "orderSentence": "Oxybutynin 2.5 mg PO"
            },
            "contraindications": "Narrow-angle glaucoma; urinary retention; dementia (relative)",
            "monitoring": "Cognitive worsening; dry mouth",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Depression and Anxiety Treatments": [
          {
            "item": "Sertraline",
            "route": "PO",
            "indication": "Depression; anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Sertraline 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; titrate by 25 mg q1-2wk; typical 50-100 mg",
              "orderSentence": "Sertraline 25 mg PO"
            },
            "contraindications": "MAOIs",
            "monitoring": "GI upset; may worsen OH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Escitalopram",
            "route": "PO",
            "indication": "Depression; anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Escitalopram 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; may increase to 10 mg; max 10 mg in elderly (QT)",
              "orderSentence": "Escitalopram 5 mg PO"
            },
            "contraindications": "MAOIs; QT prolongation",
            "monitoring": "QTc; GI upset",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "Depression; anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5 mg",
                  "orderSentence": "Venlafaxine XR 37.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5 mg daily; titrate q1-2wk; typical 75-150 mg",
              "orderSentence": "Venlafaxine XR 37.5 mg PO"
            },
            "contraindications": "MAOIs",
            "monitoring": "BP at higher doses",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirtazapine",
            "route": "PO",
            "indication": "Depression with poor appetite and insomnia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7.5 mg",
                  "orderSentence": "Mirtazapine 7.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 7.5-15 mg qHS; may increase to 30 mg",
              "orderSentence": "Mirtazapine 7.5 mg PO"
            },
            "contraindications": "MAOIs",
            "monitoring": "Weight gain, sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Cognitive/behavioral neurology for diagnosis confirmation using McKeith criteria and treatment planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Movement disorders specialist if motor symptoms prominent or considering dopaminergic therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuropsychology for comprehensive cognitive testing to establish baseline and differentiate from AD",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Geriatric psychiatry for behavioral symptoms, medication management, and capacity evaluation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sleep medicine for polysomnography to confirm REM sleep behavior disorder (indicative biomarker)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for ADL assessment, cognitive strategies, and home safety evaluation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for gait training, balance exercises, and fall prevention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech therapy for communication strategies and swallowing evaluation if dysphagia present",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for caregiver support, community resources, and long-term care planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Palliative care for advanced dementia symptom management and goals of care discussions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cardiology if orthostatic hypotension refractory to first-line treatment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "CRITICAL: Avoid all typical antipsychotics and most atypical antipsychotics - severe sensitivity can cause parkinsonism, rigidity, and death",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Carry a medication alert card listing \"Lewy Body Dementia - Neuroleptic Sensitivity\" for all healthcare encounters",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report visual hallucinations immediately as these may indicate disease progression or medication effect",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Rise slowly from sitting or lying to prevent falls from orthostatic hypotension",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Implement safety measures for REM sleep behavior disorder: padded bed rails, mattress on floor, remove sharp objects from bedside",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Complete advance directives while patient has capacity to document wishes for future care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive due to fluctuating attention, visual-spatial deficits, and hallucinations",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return immediately if sudden worsening of confusion, falls, or inability to walk (may indicate medication effect or infection)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Fall prevention: remove home hazards, adequate lighting, grab bars, non-slip surfaces due to high fall risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "AVOID medications that worsen symptoms: anticholinergics, antihistamines (diphenhydramine), sleep aids (Benadryl, Tylenol PM)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "AVOID antiemetics: metoclopramide, prochlorperazine, promethazine (D2 blocking worsens parkinsonism)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular physical exercise as tolerated to maintain mobility and reduce fall risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Structured daily routine with consistent sleep-wake times helps with fluctuating cognition",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate lighting and avoid overstimulation which may trigger hallucinations",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Simplify environment and reduce visual clutter to minimize misperceptions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Caregiver education about fluctuating cognition, which is characteristic and not willful",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Treat sleep apnea if present as it worsens cognition and autonomic dysfunction",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Alzheimer's disease",
        "features": "Memory impairment predominates; no parkinsonism; no visual hallucinations early",
        "tests": "DaTscan normal in AD; MRI hippocampal atrophy; amyloid/tau biomarkers"
      },
      {
        "diagnosis": "Parkinson's disease dementia (PDD)",
        "features": "Motor symptoms precede dementia by >1 year (vs DLB dementia within 1 year of motor)",
        "tests": "Clinical timeline; considered same disease spectrum as DLB"
      },
      {
        "diagnosis": "Vascular dementia",
        "features": "Stepwise decline; focal findings; executive dysfunction; vascular risk factors",
        "tests": "MRI with significant white matter disease, strategic infarcts"
      },
      {
        "diagnosis": "Frontotemporal dementia",
        "features": "Personality change; disinhibition; apathy; hyperorality; younger onset",
        "tests": "FDG-PET frontal hypometabolism; preserved posterior metabolism"
      },
      {
        "diagnosis": "Progressive supranuclear palsy (PSP)",
        "features": "Vertical gaze palsy; axial rigidity > limb; early falls backward; poor levodopa response",
        "tests": "MRI \"hummingbird sign\"; clinical criteria"
      },
      {
        "diagnosis": "Corticobasal syndrome",
        "features": "Asymmetric rigidity; apraxia; alien limb; cortical sensory loss",
        "tests": "MRI asymmetric cortical atrophy; clinical criteria"
      },
      {
        "diagnosis": "Multiple system atrophy (MSA)",
        "features": "Severe early dysautonomia; cerebellar signs; stridor; poor levodopa response",
        "tests": "MRI \"hot cross bun\" sign; cardiac MIBG preserved (vs reduced in DLB)"
      },
      {
        "diagnosis": "Creutzfeldt-Jakob disease",
        "features": "Rapid progression (weeks-months); myoclonus; periodic sharp waves on EEG",
        "tests": "EEG PSWCs; MRI DWI cortical ribboning; CSF RT-QuIC positive"
      },
      {
        "diagnosis": "Drug-induced parkinsonism",
        "features": "Medication exposure (antipsychotics, metoclopramide); symmetric; no hallucinations",
        "tests": "DaTscan normal; medication history; resolves with drug removal"
      },
      {
        "diagnosis": "Delirium",
        "features": "Acute onset; fluctuating attention; identifiable cause",
        "tests": "Treat cause; reassess cognition when clear"
      },
      {
        "diagnosis": "Charles Bonnet syndrome",
        "features": "Visual hallucinations with insight; occurs with visual impairment; no dementia",
        "tests": "Ophthalmologic evaluation; cognitive testing normal"
      }
    ],
    "evidence": [
      {
        "recommendation": "McKeith diagnostic criteria for DLB",
        "evidenceLevel": "Consensus Guidelines",
        "source": "[McKeith et al. Neurology 2017](https://pubmed.ncbi.nlm.nih.gov/28592453/)"
      },
      {
        "recommendation": "DaTscan indicative biomarker for DLB",
        "evidenceLevel": "Class II, Level B",
        "source": "[McKeith et al. Lancet Neurol 2007](https://pubmed.ncbi.nlm.nih.gov/17509489/)"
      },
      {
        "recommendation": "Cardiac MIBG indicative biomarker",
        "evidenceLevel": "Class II, Level B",
        "source": "[Yoshita et al. Neurology 2015](https://pubmed.ncbi.nlm.nih.gov/26519540/)"
      },
      {
        "recommendation": "Rivastigmine for PDD/DLB cognition",
        "evidenceLevel": "Class I, Level A",
        "source": "[Emre et al. NEJM 2004](https://pubmed.ncbi.nlm.nih.gov/15590953/)"
      },
      {
        "recommendation": "Donepezil for DLB",
        "evidenceLevel": "Class I, Level A",
        "source": "[Mori et al. Ann Neurol 2012](https://pubmed.ncbi.nlm.nih.gov/22926857/)"
      },
      {
        "recommendation": "Cholinesterase inhibitors reduce visual hallucinations",
        "evidenceLevel": "Class II, Level B",
        "source": "[Stinton et al. Int J Geriatr Psychiatry 2015](https://pubmed.ncbi.nlm.nih.gov/25676160/)"
      },
      {
        "recommendation": "Neuroleptic sensitivity in DLB",
        "evidenceLevel": "Class II, Level B",
        "source": "[McKeith et al. BMJ 1992](https://pubmed.ncbi.nlm.nih.gov/1392706/)"
      },
      {
        "recommendation": "Antipsychotic mortality risk in dementia",
        "evidenceLevel": "Class I, Level A",
        "source": "[Schneider et al. JAMA 2005](https://pubmed.ncbi.nlm.nih.gov/16219884/)"
      },
      {
        "recommendation": "Pimavanserin for PD psychosis",
        "evidenceLevel": "Class I, Level A",
        "source": "[Cummings et al. Lancet 2014](https://pubmed.ncbi.nlm.nih.gov/24315521/)"
      },
      {
        "recommendation": "Melatonin for REM sleep behavior disorder",
        "evidenceLevel": "Class II, Level B",
        "source": "[Kunz et al. Sleep Med 2010](https://pubmed.ncbi.nlm.nih.gov/20817595/)"
      },
      {
        "recommendation": "Clonazepam for REM sleep behavior disorder",
        "evidenceLevel": "Class II, Level B",
        "source": "[Aurora et al. Sleep 2010](https://pubmed.ncbi.nlm.nih.gov/21135521/)"
      },
      {
        "recommendation": "CSF alpha-synuclein SAA for synucleinopathies",
        "evidenceLevel": "Class II, Level B",
        "source": "[Siderowf et al. Lancet Neurol 2023](https://pubmed.ncbi.nlm.nih.gov/37068508/)"
      }
    ],
    "monitoring": [
      {
        "item": "Cognitive function (MoCA or MMSE)",
        "frequency": "Every 6 months",
        "action": "Adjust treatment; reassess diagnosis",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Motor function (UPDRS-III)",
        "frequency": "Every 6 months",
        "action": "Adjust levodopa if motor symptoms dominant",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Visual hallucinations frequency/severity",
        "frequency": "Each visit",
        "action": "Adjust cholinesterase inhibitor; add pimavanserin if distressing",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Orthostatic blood pressure",
        "frequency": "Each visit",
        "action": "Add midodrine or droxidopa",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Falls frequency",
        "frequency": "Each visit",
        "action": "PT referral; medication review; home safety",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "RBD symptoms",
        "frequency": "Each visit",
        "action": "Adjust melatonin or clonazepam; safety measures",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Mood (GDS, PHQ-9)",
        "frequency": "Every 6 months",
        "action": "Add antidepressant; psychiatry referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ADL/IADL function",
        "frequency": "Every 6 months",
        "action": "Increase support services; OT referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Caregiver burden (Zarit scale)",
        "frequency": "Every 6-12 months",
        "action": "Support resources; respite care; social work",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight",
        "frequency": "Each visit",
        "action": "Nutritional assessment; speech for swallowing",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ECG (if on pimavanserin, citalopram)",
        "frequency": "Baseline; if dose increased",
        "action": "Reduce dose or switch agent",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Reversible causes treated; safe environment; caregiver support; no acute behavioral crisis; follow-up arranged"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Acute delirium requiring workup; severe behavioral crisis unsafe for home; falls with injury; medication toxicity"
      },
      {
        "disposition": "Admit to psychiatry",
        "criteria": "Severe behavioral disturbance requiring specialized psychiatric management; suicidal ideation"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Neurology/geriatrics 1-2 months after diagnosis; then every 3-6 months"
      },
      {
        "disposition": "Long-term care",
        "criteria": "Progressive decline; caregiver unable to manage safely; nocturnal behavioral disturbance; 24-hour supervision needed"
      }
    ]
  },
  "Vascular Dementia": {
    "id": "vascular-dementia",
    "title": "Vascular Dementia",
    "version": "1.1",
    "icd10": [
      "** F01.50 (Vascular dementia without behavioral disturbance)",
      "F01.51 (Vascular dementia with behavioral disturbance)",
      "I67.3 (Progressive vascular leukoencephalopathy — Binswanger disease)",
      "I67.89 (Other cerebrovascular disease)"
    ],
    "scope": "** Diagnosis using NINDS-AIREN and DSM-5 criteria, neuroimaging evaluation for strategic infarcts and white matter disease, vascular risk factor modification, secondary stroke prevention, cholinesterase inhibitors for cognitive symptoms, and management of post-stroke depression, apathy, and behavioral symptoms. Primarily outpatient-focused with coverage for ED and hospital presentations.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Polycythemia, anemia, infection affecting cognition",
            "target": "Normal"
          },
          {
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Metabolic causes of confusion; renal function for medication dosing",
            "target": "Normal electrolytes, renal function"
          },
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypothyroidism is reversible cause of cognitive impairment",
            "target": "0.4-4.0 mIU/L"
          },
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency causes reversible cognitive decline and may worsen vascular dementia",
            "target": ">300 pg/mL (>400 optimal)"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency contributes to hyperhomocysteinemia and cognitive impairment",
            "target": ">3 ng/mL"
          },
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes is major vascular risk factor; assess chronic glucose control",
            "target": "<7.0% (individualized 7-8% in frail elderly)"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Assess LDL for secondary stroke prevention; target <70 mg/dL",
            "target": "LDL <70 mg/dL"
          },
          {
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "UTI common cause of acute confusion in elderly",
            "target": "Negative for infection"
          },
          {
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Baseline coagulation; assess if on anticoagulation",
            "target": "Normal or therapeutic"
          }
        ],
        "Extended Workup": [
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Elevated levels increase stroke risk and contribute to vascular dementia",
            "target": "<15 μmol/L"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Independent cardiovascular risk marker; elevated increases stroke risk",
            "target": "<50 nmol/L (or <30 mg/dL)"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Inflammatory marker; elevated predicts vascular events",
            "target": "<2 mg/L"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency associated with cognitive decline and vascular disease",
            "target": ">30 ng/mL"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurosyphilis is treatable cause of dementia",
            "target": "Nonreactive"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HIV-associated neurocognitive disorder if risk factors",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hepatic encephalopathy; nutritional status; statin safety",
            "target": "Normal"
          },
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Heart failure; atrial fibrillation risk assessment",
            "target": "Age-adjusted normal"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Elevated associated with increased stroke and dementia risk",
            "target": "<6 mg/dL"
          }
        ],
        "Rare/Specialized": [
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Risk stratification; mixed AD/VaD assessment",
            "target": "APOE status for prognosis"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Age <50, cryptogenic strokes, recurrent events",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Lupus anticoagulant, anticardiolipin; young-onset vascular disease",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Suspected CNS vasculitis causing multi-infarct state",
            "target": "Normal/Negative"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Vasculitis workup if suspected",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Young-onset stroke; angiokeratomas; neuropathy",
            "target": "Normal enzyme activity"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Suspected CADASIL (family history, migraine, early WM disease)",
            "target": "No pathogenic mutation"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Suspected MELAS or mitochondrial disease",
            "target": "No pathogenic mutation"
          }
        ],
        "Lumbar Puncture": [
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out infection, inflammation, vasculitis",
            "target": "WBC <5, protein <45 mg/dL, glucose >60% serum"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Differentiate from Alzheimer's disease",
            "target": "Normal Aβ42 in pure VaD; low suggests mixed AD/VaD"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Elevated in AD; can help distinguish VaD from AD",
            "target": "Normal or mildly elevated in pure VaD; high p-tau suggests AD"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Non-specific marker of neuronal damage; elevated in vascular injury",
            "target": "Elevated suggests ongoing neurodegeneration"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out inflammatory/demyelinating disease",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurosyphilis",
            "target": "Nonreactive"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Atypical presentation; subacute onset",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At initial evaluation",
            "target": "Strategic infarcts (thalamus, basal ganglia, angular gyrus); confluent WMH (Fazekas ≥2); lacunar infarcts",
            "contraindications": "MRI-incompatible devices, severe claustrophobia"
          },
          {
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If MRI unavailable or contraindicated",
            "target": "Rule out hemorrhage, mass, hydrocephalus; may show old infarcts, leukoaraiosis",
            "contraindications": "None"
          },
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "With initial MRI",
            "target": "Intracranial and extracranial atherosclerosis; assess for stenosis >50%",
            "contraindications": "MRI contraindications"
          },
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Alternative to MRA",
            "target": "Vascular stenosis; atherosclerotic burden",
            "contraindications": "Contrast allergy, CKD (relative)"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Within 1 week of diagnosis",
            "target": "Assess carotid stenosis; plaque characterization",
            "contraindications": "None"
          },
          {
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At diagnosis",
            "target": "Assess for atrial fibrillation, LVH, prior MI",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Within 2 weeks",
            "target": "LV function; valvular disease; intracardiac thrombus",
            "contraindications": "None"
          }
        ],
        "Extended": [
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "With initial MRI",
            "target": "Microbleeds (CAA pattern vs hypertensive); hemosiderin",
            "contraindications": "MRI contraindications"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Baseline for progression",
            "target": "Quantify WM lesion volume; global and regional atrophy",
            "contraindications": "MRI contraindications"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Differentiate VaD from AD; atypical cases",
            "target": "Scattered hypometabolism (vs temporoparietal in AD)",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Distinguish pure VaD from mixed AD/VaD",
            "target": "Negative suggests pure VaD; positive suggests mixed pathology",
            "contraindications": "None"
          },
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "timing": "Screen for paroxysmal AF",
            "target": "Sinus rhythm; detect occult AF",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Cryptogenic strokes; suspected occult AF",
            "target": "Sinus rhythm; detect paroxysmal AF",
            "contraindications": "None"
          },
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Encephalopathy; seizures; rapid decline",
            "target": "Non-specific slowing (not CJD pattern)",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Sleep apnea is vascular risk factor; assess for OSA",
            "target": "AHI <5 (or treat if elevated)",
            "contraindications": "None"
          }
        ],
        "Rare/Specialized": [
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Suspected CNS vasculitis or reversible vasoconstriction",
            "target": "No vessel wall enhancement or thickening",
            "contraindications": "MRI contraindications"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Vasculitis confirmation; moyamoya; intracranial stenosis",
            "target": "Define vascular anatomy",
            "contraindications": "Contrast allergy, bleeding risk"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Alternative to PET if unavailable",
            "target": "Regional hypoperfusion patterns",
            "contraindications": "None"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Cryptogenic strokes; suspected aortic arch atheroma or PFO",
            "target": "No embolic source",
            "contraindications": "Esophageal pathology"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Treat reversible causes",
            "route": "Various",
            "indication": "Identified metabolic or infectious etiology",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per specific cause",
                  "orderSentence": "Treat reversible causes Per specific cause Various"
                }
              ],
              "route": "Various",
              "instructions": "Correct hyponatremia slowly, treat UTI, replace B12, treat hypothyroidism",
              "orderSentence": "Treat reversible causes Per specific cause Various"
            },
            "contraindications": "Depends on intervention",
            "monitoring": "Cognitive reassessment after treatment",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Thiamine",
            "route": "IV/PO",
            "indication": "Suspected Wernicke's; alcoholism; malnutrition",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Thiamine 500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "500 mg IV TID x 3 days if Wernicke suspected; then 100 mg PO daily maintenance",
              "orderSentence": "Thiamine 500 mg IV"
            },
            "contraindications": "None",
            "monitoring": "Clinical improvement in confusion",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Aspirin (loading)",
            "route": "PO",
            "indication": "Immediate antiplatelet therapy for secondary stroke prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "325 mg",
                  "orderSentence": "Aspirin (loading) 325 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "325 mg loading dose if no recent stroke, then 81 mg daily ongoing",
              "orderSentence": "Aspirin (loading) 325 mg PO"
            },
            "contraindications": "Active GI bleed; aspirin allergy",
            "monitoring": "GI symptoms, bleeding",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Blood pressure management (acute)",
            "route": "Various",
            "indication": "Acute delirium or new stroke",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per protocol",
                  "orderSentence": "Blood pressure management (acute) Per protocol Various"
                }
              ],
              "route": "Various",
              "instructions": "Do NOT lower BP aggressively unless >220/120 or end-organ damage; permissive hypertension first 24-48h of stroke",
              "orderSentence": "Blood pressure management (acute) Per protocol Various"
            },
            "contraindications": "Symptomatic hypotension",
            "monitoring": "BP q1h initially",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Vascular Risk Factor Modification (Secondary Stroke Prevention)": [
          {
            "item": "Atorvastatin",
            "route": "PO",
            "indication": "High-intensity statin for secondary stroke prevention; LDL target <70",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Atorvastatin 40 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 40-80 mg daily; target LDL <70 mg/dL; 80 mg preferred for established vascular disease",
              "orderSentence": "Atorvastatin 40 mg PO"
            },
            "contraindications": "Active liver disease; pregnancy",
            "monitoring": "LFTs at baseline, 6-12 weeks, then annually; myalgias",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rosuvastatin",
            "route": "PO",
            "indication": "Alternative high-intensity statin; may be better tolerated",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "Rosuvastatin 20 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 20 mg daily; max 40 mg; potent LDL lowering",
              "orderSentence": "Rosuvastatin 20 mg PO"
            },
            "contraindications": "Active liver disease; pregnancy; Asian dose adjustment (10 mg start)",
            "monitoring": "LFTs; myalgias; CK if symptomatic",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Aspirin (long-term)",
            "route": "PO",
            "indication": "Lifelong antiplatelet for secondary stroke prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "81 mg",
                  "orderSentence": "Aspirin (long-term) 81 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "81 mg daily indefinitely for non-cardioembolic vascular dementia",
              "orderSentence": "Aspirin (long-term) 81 mg PO"
            },
            "contraindications": "Active GI bleeding; aspirin allergy",
            "monitoring": "GI symptoms; annual CBC",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clopidogrel",
            "route": "PO",
            "indication": "Alternative to aspirin if aspirin-intolerant; or after DAPT period",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg",
                  "orderSentence": "Clopidogrel 75 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "75 mg daily; may use instead of aspirin if intolerant",
              "orderSentence": "Clopidogrel 75 mg PO"
            },
            "contraindications": "Active bleeding",
            "monitoring": "Bleeding signs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lisinopril",
            "route": "PO",
            "indication": "Blood pressure control; target <130/80 for secondary prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Lisinopril 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5-10 mg daily; titrate to goal BP <130/80; max 40 mg daily",
              "orderSentence": "Lisinopril 5 mg PO"
            },
            "contraindications": "Angioedema history; pregnancy; bilateral RAS; hyperkalemia",
            "monitoring": "K+, Cr at 1-2 weeks; BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amlodipine",
            "route": "PO",
            "indication": "BP control; add-on or alternative antihypertensive",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Amlodipine 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; may increase to 10 mg daily",
              "orderSentence": "Amlodipine 5 mg PO"
            },
            "contraindications": "Severe aortic stenosis (relative)",
            "monitoring": "Peripheral edema; BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Chlorthalidone",
            "route": "PO",
            "indication": "Thiazide-like diuretic for BP control; effective for stroke prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg",
                  "orderSentence": "Chlorthalidone 12.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5 mg daily; may increase to 25 mg daily",
              "orderSentence": "Chlorthalidone 12.5 mg PO"
            },
            "contraindications": "Severe hypokalemia; hyponatremia",
            "monitoring": "K+, Na+, uric acid, glucose",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Metformin",
            "route": "PO",
            "indication": "First-line for type 2 diabetes if eGFR >30",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Metformin 500 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 500 mg daily with meal; titrate by 500 mg weekly; max 2000-2550 mg/day in divided doses",
              "orderSentence": "Metformin 500 mg PO"
            },
            "contraindications": "eGFR <30; acute illness; contrast within 48h",
            "monitoring": "eGFR; B12 annually; lactic acidosis symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Empagliflozin",
            "route": "PO",
            "indication": "SGLT2 inhibitor for diabetes with cardiovascular benefit",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Empagliflozin 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg daily; may increase to 25 mg; cardiovascular mortality benefit",
              "orderSentence": "Empagliflozin 10 mg PO"
            },
            "contraindications": "eGFR <20; Type 1 DM; DKA history",
            "monitoring": "eGFR; volume status; genital infections",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ezetimibe",
            "route": "PO",
            "indication": "Add-on for LDL not at goal on statin",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Ezetimibe 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "10 mg daily with or without food",
              "orderSentence": "Ezetimibe 10 mg PO"
            },
            "contraindications": "Severe hepatic impairment",
            "monitoring": "LDL; LFTs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Apixaban",
            "route": "PO",
            "indication": "Atrial fibrillation-related vascular dementia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Apixaban 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "5 mg BID (2.5 mg BID if ≥2 of: age ≥80, weight ≤60 kg, Cr ≥1.5)",
              "orderSentence": "Apixaban 5 mg PO"
            },
            "contraindications": "Active major bleeding; mechanical valve",
            "monitoring": "CrCl; bleeding signs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivaroxaban",
            "route": "PO",
            "indication": "AF-related vascular dementia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "Rivaroxaban 20 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "20 mg daily with dinner (15 mg if CrCl 15-50)",
              "orderSentence": "Rivaroxaban 20 mg PO"
            },
            "contraindications": "Active bleeding; mechanical valve",
            "monitoring": "CrCl; bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Warfarin",
            "route": "PO",
            "indication": "Mechanical valve; select hypercoagulable states; AF if DOACs contraindicated",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Warfarin 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; adjust to INR 2-3",
              "orderSentence": "Warfarin 5 mg PO"
            },
            "contraindications": "Active bleeding; frequent falls; poor adherence",
            "monitoring": "INR weekly then monthly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Cholinesterase Inhibitors (Cognitive Enhancement - Modest Benefit)": [
          {
            "item": "Donepezil (Aricept)",
            "route": "PO",
            "indication": "Vascular dementia cognitive symptoms; modest but measurable benefit",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Donepezil (Aricept) 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg qHS x 4-6 weeks; if tolerated, increase to 10 mg qHS; benefit smaller than in AD",
              "orderSentence": "Donepezil (Aricept) 5 mg PO"
            },
            "contraindications": "Sick sinus syndrome; second/third degree heart block without pacemaker; active GI bleeding",
            "monitoring": "Heart rate; GI symptoms (nausea, diarrhea); vivid dreams",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine oral (Exelon)",
            "route": "PO",
            "indication": "Vascular dementia; executive dysfunction; may help mixed AD/VaD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1.5 mg",
                  "orderSentence": "Rivastigmine oral (Exelon) 1.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1.5 mg BID with meals; increase by 1.5 mg BID every 2 weeks; target 6 mg BID",
              "orderSentence": "Rivastigmine oral (Exelon) 1.5 mg PO"
            },
            "contraindications": "Sick sinus; severe hepatic impairment",
            "monitoring": "GI symptoms; weight loss; bradycardia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine patch (Exelon Patch)",
            "route": "TD",
            "indication": "Vascular dementia; better GI tolerability than oral",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4.6 mg/24hr",
                  "orderSentence": "Rivastigmine patch (Exelon Patch) 4.6 mg/24hr TD"
                }
              ],
              "route": "TD",
              "instructions": "Start 4.6 mg/24hr patch; increase every 4 weeks; target 9.5-13.3 mg/24hr",
              "orderSentence": "Rivastigmine patch (Exelon Patch) 4.6 mg/24hr TD"
            },
            "contraindications": "Same as oral",
            "monitoring": "Skin irritation; rotate sites",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Galantamine (Razadyne)",
            "route": "PO",
            "indication": "Vascular dementia; dual mechanism may benefit executive function",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg",
                  "orderSentence": "Galantamine (Razadyne) 4 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 4 mg BID with meals x 4 weeks; increase to 8 mg BID x 4 weeks; target 8-12 mg BID",
              "orderSentence": "Galantamine (Razadyne) 4 mg PO"
            },
            "contraindications": "Sick sinus; severe renal impairment (CrCl <9); severe hepatic impairment",
            "monitoring": "GI symptoms; bradycardia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Memantine (Namenda)",
            "route": "PO",
            "indication": "Moderate-severe vascular dementia; add to cholinesterase inhibitor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Memantine (Namenda) 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily x 1 week; increase by 5 mg/week: 5 mg BID, then 5/10 mg, then 10 mg BID",
              "orderSentence": "Memantine (Namenda) 5 mg PO"
            },
            "contraindications": "Severe renal impairment (reduce dose if CrCl 5-29: max 5 mg BID)",
            "monitoring": "Confusion, dizziness, constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Post-Stroke Depression and Apathy": [
          {
            "item": "Sertraline (Zoloft)",
            "route": "PO",
            "indication": "Post-stroke depression (evidence-based; FLAME trial); first-line",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Sertraline (Zoloft) 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; increase by 25 mg every 1-2 weeks; typical 50-100 mg daily; max 200 mg",
              "orderSentence": "Sertraline (Zoloft) 25 mg PO"
            },
            "contraindications": "MAOIs; concurrent QT-prolonging drugs (high doses)",
            "monitoring": "GI upset initially; bleeding risk with anticoagulants; sexual dysfunction",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Escitalopram (Lexapro)",
            "route": "PO",
            "indication": "Post-stroke depression; well-tolerated in elderly",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Escitalopram (Lexapro) 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily in elderly; increase to 10 mg after 1 week; max 20 mg (10 mg if >65y)",
              "orderSentence": "Escitalopram (Lexapro) 5 mg PO"
            },
            "contraindications": "MAOIs; QT prolongation",
            "monitoring": "QTc if cardiac risk; GI symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Citalopram (Celexa)",
            "route": "PO",
            "indication": "Depression; agitation in dementia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Citalopram (Celexa) 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg daily; max 20 mg in elderly due to QT prolongation risk",
              "orderSentence": "Citalopram (Celexa) 10 mg PO"
            },
            "contraindications": "QT prolongation; concurrent QT-prolonging drugs",
            "monitoring": "ECG at baseline if cardiac risk; QTc monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirtazapine (Remeron)",
            "route": "PO",
            "indication": "Depression with poor appetite, weight loss, and insomnia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7.5 mg",
                  "orderSentence": "Mirtazapine (Remeron) 7.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 7.5-15 mg qHS; may increase to 30-45 mg qHS; lower doses more sedating",
              "orderSentence": "Mirtazapine (Remeron) 7.5 mg PO"
            },
            "contraindications": "MAOIs; angle-closure glaucoma",
            "monitoring": "Weight gain (often desired); sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Bupropion SR/XL",
            "route": "PO",
            "indication": "Depression with fatigue and apathy; no sexual side effects; avoid if seizure risk",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Bupropion SR/XL 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg SR daily or 150 mg XL daily; may increase after 3 days; max 400 mg/day",
              "orderSentence": "Bupropion SR/XL 100 mg PO"
            },
            "contraindications": "Seizure disorder; anorexia/bulimia; abrupt alcohol/benzo withdrawal",
            "monitoring": "Seizure risk; insomnia; anxiety",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Methylphenidate",
            "route": "PO",
            "indication": "Apathy refractory to antidepressants; psychomotor retardation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg",
                  "orderSentence": "Methylphenidate 2.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5-5 mg BID (morning and noon); titrate by 2.5-5 mg every 3-5 days; max 30 mg/day",
              "orderSentence": "Methylphenidate 2.5 mg PO"
            },
            "contraindications": "Severe hypertension; cardiac arrhythmias; hyperthyroidism; glaucoma",
            "monitoring": "BP, HR; appetite; sleep",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Modafinil",
            "route": "PO",
            "indication": "Apathy; fatigue; excessive daytime sleepiness",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Modafinil 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg each morning; may increase to 200 mg daily",
              "orderSentence": "Modafinil 100 mg PO"
            },
            "contraindications": "Severe hepatic impairment; cardiac arrhythmias",
            "monitoring": "BP, HR; sleep disturbance",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Behavioral and Psychological Symptoms of Dementia (BPSD)": [
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Insomnia; sundowning; mild agitation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Trazodone 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg qHS; titrate by 25-50 mg every 3-5 days; typical 50-150 mg qHS",
              "orderSentence": "Trazodone 25 mg PO"
            },
            "contraindications": "MAOIs; significant QT prolongation",
            "monitoring": "Orthostatic hypotension (fall risk); priapism (rare)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "Sleep disturbance; circadian rhythm dysfunction; sundowning",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3 mg",
                  "orderSentence": "Melatonin 3 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 3 mg qHS, 30 min before bed; may increase to 6 mg if needed",
              "orderSentence": "Melatonin 3 mg PO"
            },
            "contraindications": "None significant",
            "monitoring": "Daytime drowsiness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Quetiapine (Seroquel)",
            "route": "PO",
            "indication": "Severe agitation/psychosis when non-pharmacologic interventions fail",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg",
                  "orderSentence": "Quetiapine (Seroquel) 12.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5-25 mg qHS; titrate slowly; keep dose as low as possible",
              "orderSentence": "Quetiapine (Seroquel) 12.5 mg PO"
            },
            "contraindications": "Black box: increased mortality and stroke in dementia; Parkinson's (less risk than others)",
            "monitoring": "Metabolic effects; sedation; falls; QTc",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Risperidone (Risperdal)",
            "route": "PO",
            "indication": "Severe aggression/psychosis (short-term use only)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg",
                  "orderSentence": "Risperidone (Risperdal) 0.25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25 mg BID; increase by 0.25 mg BID weekly; max 1 mg BID; limit to 6-12 weeks",
              "orderSentence": "Risperidone (Risperdal) 0.25 mg PO"
            },
            "contraindications": "Black box: increased mortality and CVA in dementia",
            "monitoring": "EPS, metabolic effects, stroke risk, prolactin",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Haloperidol",
            "route": "IM/IV/PO",
            "indication": "Acute severe agitation in delirium-crisis only (avoid chronic use)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg",
                  "orderSentence": "Haloperidol 0.5 mg IM"
                }
              ],
              "route": "IM",
              "instructions": "0.5-2 mg IM/IV q4-6h PRN; short-term acute use only; avoid chronic use in dementia",
              "orderSentence": "Haloperidol 0.5 mg IM"
            },
            "contraindications": "QT prolongation; Parkinson's disease",
            "monitoring": "QTc; EPS; akathisia",
            "ED": "STAT",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Carbamazepine",
            "route": "PO",
            "indication": "Agitation/aggression refractory to other treatments",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Carbamazepine 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg BID; titrate to 200-400 mg BID based on response; monitor levels",
              "orderSentence": "Carbamazepine 100 mg PO"
            },
            "contraindications": "Bone marrow suppression; AV block",
            "monitoring": "CBC; LFTs; Na; drug levels",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dextromethorphan-quinidine (Nuedexta)",
            "route": "PO",
            "indication": "Pseudobulbar affect (emotional lability) post-stroke",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20/10 mg",
                  "orderSentence": "Dextromethorphan-quinidine (Nuedexta) 20/10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 20/10 mg daily x 7 days, then increase to 20/10 mg BID",
              "orderSentence": "Dextromethorphan-quinidine (Nuedexta) 20/10 mg PO"
            },
            "contraindications": "MAOIs; concurrent quinidine; prolonged QT; complete heart block",
            "monitoring": "QTc; drug interactions (quinidine inhibits CYP2D6)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology/Cognitive neurology for diagnosis confirmation, differentiation from AD, and treatment planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuropsychology for formal cognitive testing to characterize executive dysfunction and memory profile",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cardiology for atrial fibrillation management, anticoagulation decisions, and heart failure optimization",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vascular surgery consultation for symptomatic carotid stenosis ≥50% to evaluate for endarterectomy",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for gait training, balance assessment, and fall prevention given motor involvement",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for ADL assessment, cognitive strategies, and home safety evaluation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech therapy for communication strategies, cognitive-linguistic exercises, and swallowing evaluation if dysphagia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for caregiver support resources, community services, and long-term care planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Geriatric psychiatry for behavioral symptoms, depression management, and capacity evaluation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Registered dietitian for Mediterranean/DASH diet counseling and sodium restriction education",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Smoking cessation program with pharmacotherapy for current smokers",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sleep medicine for obstructive sleep apnea evaluation and CPAP initiation if indicated",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Palliative care for advanced vascular dementia symptom management and goals of care discussions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Call 911 immediately if new stroke symptoms develop (sudden weakness, speech difficulty, vision changes)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return immediately if sudden worsening of confusion which may indicate new stroke, infection, or delirium",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take all medications as prescribed especially antiplatelet/anticoagulant and statin which prevent further strokes",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Complete advance directives (living will, healthcare proxy, POLST) while patient has capacity",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive if cognitive impairment affects judgment or reaction time; formal driving evaluation may be needed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use pill organizers, alarms, or caregiver supervision to ensure medication adherence",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Check blood pressure at home regularly; notify provider if consistently >140/90 or <90/60",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Wear medical alert bracelet with diagnosis and emergency contact in case of wandering or emergency",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep environment safe: remove throw rugs, install grab bars, ensure adequate lighting, secure stove knobs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Blood pressure target <130/80 mmHg to reduce progression and prevent further strokes (SPRINT-MIND data)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "LDL target <70 mg/dL with high-intensity statin for secondary vascular prevention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation immediately; reduces stroke risk by 50% within 1 year of quitting",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Mediterranean or MIND diet emphasizing vegetables, berries, fish, whole grains, nuts, and olive oil",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit sodium to <2300 mg/day (ideally <1500 mg if hypertensive) to improve blood pressure control",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol to ≤1 drink daily as excess alcohol increases stroke risk and worsens cognition",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular aerobic exercise (150 min/week moderate intensity) to improve cardiovascular health and cognition",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Treat obstructive sleep apnea with CPAP as OSA worsens vascular risk and cognitive function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Strict glycemic control (HbA1c <7% or individualized 7-8% in frail elderly) to reduce microvascular damage",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Social engagement and cognitive stimulation to support cognitive reserve",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Weight management with target BMI 18.5-27 kg/m² (less stringent in elderly)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Fall prevention with home safety modifications and assistive devices as needed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "CPAP compliance for sleep apnea patients to reduce nocturnal hypoxia and vascular events",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Alzheimer's disease",
        "features": "Insidious onset; gradual decline; memory predominant; no focal signs; no stepwise progression",
        "tests": "MRI: hippocampal atrophy without significant WM disease; CSF Aβ42 low, p-tau elevated; amyloid PET positive"
      },
      {
        "diagnosis": "Mixed dementia (AD + VaD)",
        "features": "Features of both; memory impairment with vascular burden",
        "tests": "Amyloid PET positive with significant WM disease; CSF biomarkers show AD pattern"
      },
      {
        "diagnosis": "Dementia with Lewy bodies",
        "features": "Visual hallucinations; parkinsonism; REM sleep behavior disorder; fluctuating cognition",
        "tests": "DaTscan reduced; clinical criteria; may have less WM disease"
      },
      {
        "diagnosis": "Frontotemporal dementia (behavioral)",
        "features": "Personality/behavior changes; disinhibition; apathy; hyperorality; often age <65",
        "tests": "FDG-PET frontal hypometabolism; less vascular disease on MRI"
      },
      {
        "diagnosis": "Normal pressure hydrocephalus",
        "features": "Triad: gait disturbance (prominent), urinary incontinence, dementia; ventriculomegaly disproportionate to atrophy",
        "tests": "MRI: ventriculomegaly with effaced sulci; high-volume LP with gait improvement"
      },
      {
        "diagnosis": "Chronic traumatic encephalopathy (CTE)",
        "features": "History of repetitive head trauma; mood and behavioral changes; no diagnostic test in life",
        "tests": "History; clinical pattern; cavum septum pellucidum on MRI (suggestive)"
      },
      {
        "diagnosis": "CADASIL",
        "features": "Migraine with aura; early WM disease; family history; temporal pole and external capsule involvement",
        "tests": "NOTCH3 genetic testing; skin biopsy showing GOM deposits"
      },
      {
        "diagnosis": "CNS vasculitis",
        "features": "Younger age; headache; encephalopathy; multifocal strokes; elevated inflammatory markers",
        "tests": "Vessel wall MRI; DSA; brain/leptomeningeal biopsy"
      },
      {
        "diagnosis": "Creutzfeldt-Jakob disease",
        "features": "Rapid progression (weeks-months); myoclonus; periodic sharp waves on EEG; MRI DWI ribboning",
        "tests": "CSF RT-QuIC; 14-3-3; EEG"
      },
      {
        "diagnosis": "Delirium superimposed on dementia",
        "features": "Acute change; fluctuating attention; identifiable precipitant (infection, medication, metabolic)",
        "tests": "Treat cause; reassess cognition when clear"
      }
    ],
    "evidence": [
      {
        "recommendation": "NINDS-AIREN criteria for vascular dementia diagnosis",
        "evidenceLevel": "Class II, Level B",
        "source": "[Roman et al. Neurology 1993](https://pubmed.ncbi.nlm.nih.gov/8426677/)"
      },
      {
        "recommendation": "Cholinesterase inhibitors for vascular dementia (modest benefit)",
        "evidenceLevel": "Class I, Level A",
        "source": "[Kavirajan & Schneider. Lancet Neurol 2007](https://pubmed.ncbi.nlm.nih.gov/17509485/)"
      },
      {
        "recommendation": "Donepezil efficacy in vascular dementia",
        "evidenceLevel": "Class I, Level A",
        "source": "[Erkinjuntti et al. Lancet 2002](https://pubmed.ncbi.nlm.nih.gov/11809203/)"
      },
      {
        "recommendation": "Galantamine for mixed AD/VaD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Erkinjuntti et al. Lancet Neurol 2002](https://pubmed.ncbi.nlm.nih.gov/12849397/)"
      },
      {
        "recommendation": "Memantine for vascular dementia",
        "evidenceLevel": "Class II, Level B",
        "source": "[Orgogozo et al. Stroke 2002](https://pubmed.ncbi.nlm.nih.gov/11935051/)"
      },
      {
        "recommendation": "Intensive BP lowering reduces dementia risk (SPRINT-MIND)",
        "evidenceLevel": "Class I, Level A",
        "source": "[SPRINT MIND Investigators. JAMA 2019](https://pubmed.ncbi.nlm.nih.gov/30688979/)"
      },
      {
        "recommendation": "High-intensity statin for secondary stroke prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "[Amarenco et al. NEJM 2006 (SPARCL)](https://pubmed.ncbi.nlm.nih.gov/16899775/)"
      },
      {
        "recommendation": "Antiplatelet therapy for secondary stroke prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "[Antithrombotic Trialists. BMJ 2002](https://pubmed.ncbi.nlm.nih.gov/11786451/)"
      },
      {
        "recommendation": "DOACs preferred over warfarin for AF-related stroke",
        "evidenceLevel": "Class I, Level A",
        "source": "[Ruff et al. Lancet 2014](https://pubmed.ncbi.nlm.nih.gov/24315724/)"
      },
      {
        "recommendation": "Sertraline for post-stroke depression",
        "evidenceLevel": "Class II, Level B",
        "source": "[Chollet et al. Lancet Neurol 2011 (FLAME)](https://pubmed.ncbi.nlm.nih.gov/21195350/)"
      },
      {
        "recommendation": "Mediterranean diet reduces dementia risk",
        "evidenceLevel": "Class II, Level B",
        "source": "[Scarmeas et al. Ann Neurol 2006](https://pubmed.ncbi.nlm.nih.gov/16832238/)"
      },
      {
        "recommendation": "Physical exercise may slow cognitive decline",
        "evidenceLevel": "Class II, Level B",
        "source": "[Livingston et al. Lancet 2020 (Lancet Commission)](https://pubmed.ncbi.nlm.nih.gov/32738937/)"
      },
      {
        "recommendation": "Avoid antipsychotics long-term in dementia (mortality risk)",
        "evidenceLevel": "Class I, Level A",
        "source": "[Schneider et al. JAMA 2005](https://pubmed.ncbi.nlm.nih.gov/16219884/)"
      },
      {
        "recommendation": "CEA for symptomatic carotid stenosis 70-99%",
        "evidenceLevel": "Class I, Level A",
        "source": "[NASCET Collaborators. NEJM 1991](https://pubmed.ncbi.nlm.nih.gov/1852179/)"
      },
      {
        "recommendation": "CPAP treatment improves cognition in OSA patients",
        "evidenceLevel": "Class II, Level B",
        "source": "[Osorio et al. Neurology 2015](https://pubmed.ncbi.nlm.nih.gov/25878183/)"
      },
      {
        "recommendation": "CSF biomarkers help differentiate VaD from AD",
        "evidenceLevel": "Class II, Level B",
        "source": "[Skillback et al. Dement Geriatr Cogn Disord 2015](https://pubmed.ncbi.nlm.nih.gov/26448651/)"
      }
    ],
    "monitoring": [
      {
        "item": "Cognitive testing (MoCA)",
        "frequency": "Every 6-12 months",
        "action": "Adjust support; consider treatment changes",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Blood pressure",
        "frequency": "Each visit; daily at home",
        "action": "Titrate antihypertensives; reduce if symptomatic hypotension",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "LDL cholesterol",
        "frequency": "Baseline, 6 weeks, then annually",
        "action": "Intensify statin; add ezetimibe or PCSK9 inhibitor",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "HbA1c",
        "frequency": "Baseline, then q3mo if diabetic",
        "action": "Optimize diabetes regimen",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Functional status (ADL/IADL, FAQ)",
        "frequency": "Every 6-12 months",
        "action": "Increase support services; OT referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight",
        "frequency": "Each visit",
        "action": "Nutritional consult; assess swallowing",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Neuropsychiatric symptoms (NPI)",
        "frequency": "Each visit",
        "action": "Non-pharmacologic first; consider medications",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "MRI Brain",
        "frequency": "Every 1-2 years or if new symptoms",
        "action": "Optimize vascular risk factors; investigate new events",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ECG/Cardiac rhythm",
        "frequency": "Annually or if symptomatic",
        "action": "Anticoagulation if AF detected",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Caregiver burden (Zarit scale)",
        "frequency": "Every 6-12 months",
        "action": "Support resources; respite care",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Fall risk assessment",
        "frequency": "Each visit",
        "action": "PT referral; home safety evaluation; assistive devices",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Driving status",
        "frequency": "Each visit",
        "action": "Formal driving evaluation; DMV report if unsafe",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Creatinine/eGFR",
        "frequency": "Annually; with medication changes",
        "action": "Adjust ACE-I, metformin, anticoagulants",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Stable cognition; no acute stroke; safe environment; adequate caregiver support; outpatient follow-up arranged; reversible causes treated"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Acute delirium requiring workup; new stroke symptoms; behavioral crisis unsafe for home; aspiration pneumonia; falls with injury"
      },
      {
        "disposition": "Admit to stroke unit",
        "criteria": "New stroke with progression; recurrent TIAs; symptomatic carotid stenosis requiring urgent intervention"
      },
      {
        "disposition": "Admit to psychiatry",
        "criteria": "Severe behavioral disturbance requiring specialized psychiatric management; danger to self or others"
      },
      {
        "disposition": "Long-term care/Memory care",
        "criteria": "Progressive decline; caregiver unable to manage safely; wandering; 24-hour supervision needed"
      },
      {
        "disposition": "Hospice",
        "criteria": "End-stage vascular dementia; recurrent aspiration; weight loss; goals focused on comfort"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Neurology every 3-6 months initially; every 6-12 months when stable; PCP for vascular risk factor management"
      }
    ]
  },
  "Frontotemporal Dementia": {
    "id": "frontotemporal-dementia",
    "title": "Frontotemporal Dementia",
    "version": "1.1",
    "icd10": [
      "** G31.09 (Frontotemporal dementia",
      "unspecified)",
      "G31.0 (Frontotemporal dementia)",
      "F02.80 (Dementia in FTD without behavioral disturbance)",
      "F02.81 (Dementia in FTD with behavioral disturbance)",
      "G31.01 (Pick's disease)"
    ],
    "scope": "** Diagnosis and management of frontotemporal lobar degeneration syndromes including behavioral variant FTD (bvFTD), semantic variant primary progressive aphasia (svPPA), nonfluent/agrammatic variant PPA (nfvPPA), FTD with motor neuron disease (FTD-ALS), and genetic forms (C9orf72, MAPT, GRN). Covers diagnostic evaluation, symptomatic treatment, behavioral management, genetic counseling, safety planning, and caregiver support. Primarily outpatient-focused with coverage for ED and hospital presentations of behavioral crises.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential (CPT 85025)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out infection, anemia, malignancy contributing to behavioral changes",
            "target": "Normal"
          },
          {
            "item": "BMP (Na, K, BUN, Cr, glucose) (CPT 80048)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Metabolic causes of behavioral disturbance (hyponatremia, uremia, hypoglycemia)",
            "target": "Normal electrolytes, renal function"
          },
          {
            "item": "TSH (CPT 84443)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypothyroidism can cause apathy; hyperthyroidism can cause behavioral changes",
            "target": "0.4-4.0 mIU/L"
          },
          {
            "item": "Vitamin B12 (CPT 82607)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "B12 deficiency causes neuropsychiatric symptoms and cognitive decline",
            "target": ">300 pg/mL (>400 optimal)"
          },
          {
            "item": "Folate (CPT 82746)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency contributes to cognitive impairment",
            "target": ">3 ng/mL"
          },
          {
            "item": "Hepatic panel (AST, ALT, albumin, ammonia) (CPT 80076)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hepatic encephalopathy; nutritional status; liver function for medications",
            "target": "Normal"
          },
          {
            "item": "Calcium (CPT 82310)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypercalcemia causes neuropsychiatric symptoms",
            "target": "8.5-10.5 mg/dL"
          },
          {
            "item": "Urinalysis (CPT 81001)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "UTI common cause of acute behavioral changes in elderly",
            "target": "Negative for infection"
          }
        ],
        "Extended Workup": [
          {
            "item": "RPR or VDRL (CPT 86592)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurosyphilis is treatable cause of behavioral and cognitive changes",
            "target": "Nonreactive"
          },
          {
            "item": "HIV testing (CPT 87389)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HIV-associated neurocognitive disorder if risk factors",
            "target": "Negative"
          },
          {
            "item": "ESR (CPT 85651), CRP (CPT 86140)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Inflammatory or autoimmune causes; baseline before immunotherapy",
            "target": "Normal"
          },
          {
            "item": "ANA (CPT 86235), RF (CPT 86431)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Screen for systemic autoimmune disease",
            "target": "Negative"
          },
          {
            "item": "Creatine kinase (CPT 82550)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Elevated in FTD-ALS; baseline for motor neuron involvement",
            "target": "Normal (elevated suggests MND)"
          },
          {
            "item": "EMG/NCS referral (CPT 95907-95913)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If motor symptoms present; evaluate for ALS overlap",
            "target": "Normal or denervation pattern"
          },
          {
            "item": "Serum progranulin level (CPT 83519)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Low levels suggest GRN mutation (screening test)",
            "target": "Normal (low <100 ng/mL suggests GRN mutation)"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "C9orf72 hexanucleotide repeat expansion (CPT 81479)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Most common genetic cause of FTD; also causes ALS",
            "target": "<30 repeats (pathogenic >30)"
          },
          {
            "item": "MAPT (tau) gene sequencing (CPT 81479)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Familial FTD with parkinsonism; tau-positive pathology",
            "target": "No pathogenic mutation"
          },
          {
            "item": "GRN (progranulin) gene sequencing (CPT 81479)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Familial FTD; asymmetric atrophy; TDP-43 pathology",
            "target": "No pathogenic mutation"
          },
          {
            "item": "FTD genetic panel (TARDBP, VCP, CHMP2B, FUS) (CPT 81479)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Extended genetic evaluation if first-line negative",
            "target": "No pathogenic mutation"
          },
          {
            "item": "Paraneoplastic antibody panel (CPT 86235)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Rapid behavioral change; history of cancer; atypical features",
            "target": "Negative"
          },
          {
            "item": "Anti-neuronal antibodies (NMDA-R, LGI1, CASPR2, GAD65) (CPT 86255)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Autoimmune encephalitis mimicking FTD",
            "target": "Negative"
          },
          {
            "item": "Heavy metal panel (lead, mercury, arsenic) (CPT 83015/83825/82175)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Occupational exposure history; atypical presentation",
            "target": "Normal"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Cell count, protein, glucose (CPT 89050/89051)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out infection, inflammation",
            "target": "WBC <5, protein <45 mg/dL, glucose >60% serum"
          },
          {
            "item": "CSF Aβ42/Aβ40 ratio (CPT 83519)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Distinguish from AD (normal in FTD)",
            "target": "Normal ratio >0.08 supports non-AD etiology"
          },
          {
            "item": "CSF total tau (t-tau) (CPT 83519)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Non-specific neurodegeneration marker",
            "target": "May be elevated but less than AD"
          },
          {
            "item": "CSF phosphorylated tau (p-tau181) (CPT 83519)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "AD-specific; should be normal in FTD",
            "target": "Normal p-tau supports FTD over AD"
          },
          {
            "item": "CSF NfL (neurofilament light) (CPT 83519)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurodegeneration marker; prognostic; very high in ALS-FTD",
            "target": "Elevated (higher = faster progression)"
          },
          {
            "item": "14-3-3 protein (CPT 83519)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rapid progression; rule out CJD",
            "target": "Negative (positive suggests CJD)"
          },
          {
            "item": "RT-QuIC (CPT 83519)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Prion disease confirmation if suspected",
            "target": "Negative"
          },
          {
            "item": "Autoimmune encephalitis panel (CSF) (CPT 86255)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Subacute behavioral change; seizures",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain without contrast (CPT 70551)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At initial evaluation",
            "target": "Frontal and/or anterior temporal atrophy; asymmetric patterns; rule out structural causes",
            "contraindications": "MRI-incompatible devices, severe claustrophobia"
          },
          {
            "item": "CT Head non-contrast (CPT 70450)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If MRI unavailable or contraindicated",
            "target": "Rule out mass, hemorrhage, hydrocephalus; frontal atrophy visible",
            "contraindications": "None"
          }
        ],
        "Extended": [
          {
            "item": "FDG-PET Brain (CPT 78816)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Diagnostic confirmation; differentiate from AD",
            "target": "Frontal and/or anterior temporal hypometabolism; sparing of posterior parietal (unlike AD)",
            "contraindications": "None"
          },
          {
            "item": "MRI Brain volumetrics (CPT 70553)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Quantify regional atrophy; track progression",
            "target": "Frontal/temporal volume loss; hemispheric asymmetry",
            "contraindications": "MRI contraindications"
          },
          {
            "item": "Amyloid PET (CPT 78816)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Exclude AD pathology if clinical uncertainty",
            "target": "Negative amyloid supports FTD diagnosis",
            "contraindications": "None"
          },
          {
            "item": "EEG (CPT 95819)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Seizures; behavioral episodes; differentiate from CJD",
            "target": "Usually normal or mild slowing; no periodic discharges (CJD has)",
            "contraindications": "None"
          },
          {
            "item": "Sleep study (polysomnography) (CPT 95810)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "RBD suggests DLB rather than FTD; sleep disturbance common",
            "target": "REM without atonia absent (if RBD, reconsider DLB)",
            "contraindications": "None"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "DaTscan (ioflupane I-123) (CPT 78607)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Parkinsonism present; differentiate PSP/CBD from PD/DLB",
            "target": "Reduced uptake in PSP/CBD; may be normal early in bvFTD",
            "contraindications": "Iodine hypersensitivity"
          },
          {
            "item": "Tau PET (flortaucipir) (CPT 78816)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Research; distinguish tau-positive from TDP-43 FTD",
            "target": "Tau-positive FTD shows frontal/temporal uptake",
            "contraindications": "None"
          },
          {
            "item": "Whole body PET-CT (CPT 78816)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Paraneoplastic workup if suspected",
            "target": "Rule out occult malignancy",
            "contraindications": "None"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent (Behavioral Crisis Management)": [
          {
            "item": "Lorazepam",
            "route": "PO/IM/IV",
            "indication": "Acute severe agitation when de-escalation fails",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg",
                  "orderSentence": "Lorazepam 0.5 mg PO/IM/IV"
                }
              ],
              "route": "PO/IM/IV",
              "instructions": "0.5-1 mg PO or IM; may repeat q30min PRN; max 4 mg; short-term use only",
              "orderSentence": "Lorazepam 0.5 mg PO/IM/IV"
            },
            "contraindications": "Respiratory depression; severe hepatic impairment; paradoxical agitation risk in elderly",
            "monitoring": "Respiratory status; sedation; paradoxical reactions",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Haloperidol",
            "route": "IM/IV",
            "indication": "Severe aggression/psychosis when benzodiazepines insufficient",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg",
                  "orderSentence": "Haloperidol 0.5 mg IM/IV"
                }
              ],
              "route": "IM/IV",
              "instructions": "0.5-2 mg IM q4-6h PRN; lowest effective dose; short-term crisis only",
              "orderSentence": "Haloperidol 0.5 mg IM/IV"
            },
            "contraindications": "QT prolongation; Parkinson's disease; FTD-parkinsonism overlap (avoid if possible)",
            "monitoring": "QTc; EPS; akathisia; sedation",
            "ED": "STAT",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Environmental de-escalation",
            "route": "N/A",
            "indication": "First-line for all behavioral disturbance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Environmental de-escalation N/A N/A"
                }
              ],
              "route": "N/A",
              "instructions": "Reduce stimulation; dim lights; calm voice; remove triggers; one-to-one observation; familiar caregiver presence",
              "orderSentence": "Environmental de-escalation N/A N/A"
            },
            "contraindications": "None",
            "monitoring": "Response to intervention",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments (Behavioral and Neuropsychiatric)": [
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Agitation; irritability; disinhibition; insomnia; compulsive behaviors",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Trazodone 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg BID; titrate by 25-50 mg q3-5d; typical 150-300 mg/day divided; max 400 mg/day",
              "orderSentence": "Trazodone 25 mg PO"
            },
            "contraindications": "Concurrent MAOIs; significant QT prolongation",
            "monitoring": "Orthostatic hypotension (fall risk); priapism (rare); QTc; sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sertraline (Zoloft)",
            "route": "PO",
            "indication": "Depression; apathy; anxiety; compulsive behaviors; disinhibition",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Sertraline (Zoloft) 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; increase by 25-50 mg every 1-2 weeks; typical 100-200 mg daily; max 200 mg",
              "orderSentence": "Sertraline (Zoloft) 25 mg PO"
            },
            "contraindications": "MAOIs; uncontrolled seizures (lowers threshold slightly)",
            "monitoring": "GI symptoms; bleeding risk; apathy (rarely worsens)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Citalopram",
            "route": "PO",
            "indication": "Depression; anxiety; compulsive behaviors",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Citalopram 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg daily; max 20 mg in elderly due to QT prolongation risk",
              "orderSentence": "Citalopram 10 mg PO"
            },
            "contraindications": "QT prolongation; concurrent QT-prolonging drugs; severe hepatic impairment",
            "monitoring": "ECG at baseline if cardiac risk; QTc monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Escitalopram (Lexapro)",
            "route": "PO",
            "indication": "Depression; anxiety; better tolerated than citalopram",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Escitalopram (Lexapro) 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; increase to 10 mg after 1 week; max 10 mg in elderly",
              "orderSentence": "Escitalopram (Lexapro) 5 mg PO"
            },
            "contraindications": "QT prolongation; concurrent MAOIs",
            "monitoring": "QTc if cardiac risk factors",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fluvoxamine",
            "route": "PO",
            "indication": "Compulsive behaviors; repetitive behaviors; may have specific benefit in FTD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Fluvoxamine 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS; titrate by 25-50 mg weekly; typical 100-200 mg/day; max 300 mg/day",
              "orderSentence": "Fluvoxamine 25 mg PO"
            },
            "contraindications": "MAOIs; alosetron, tizanidine (drug interactions)",
            "monitoring": "Multiple drug interactions (CYP1A2, 2C19, 3A4 inhibitor); GI symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirtazapine (Remeron)",
            "route": "PO",
            "indication": "Depression with poor appetite, weight loss, and insomnia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7.5 mg",
                  "orderSentence": "Mirtazapine (Remeron) 7.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 7.5-15 mg qHS; may increase to 30-45 mg qHS; lower doses more sedating",
              "orderSentence": "Mirtazapine (Remeron) 7.5 mg PO"
            },
            "contraindications": "MAOIs; angle-closure glaucoma",
            "monitoring": "Weight gain (often desired in FTD); sedation; hyperlipidemia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Bupropion (Wellbutrin)",
            "route": "PO",
            "indication": "Apathy-predominant FTD; depression; may help with motivation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Bupropion (Wellbutrin) 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg BID or 150 mg SR daily; titrate to 150 mg SR BID or 300 mg XL daily",
              "orderSentence": "Bupropion (Wellbutrin) 100 mg PO"
            },
            "contraindications": "Seizure disorder; bulimia/anorexia; concurrent MAOIs; abrupt alcohol withdrawal",
            "monitoring": "Seizure risk (dose-related); insomnia; agitation (may worsen some patients)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "Sleep disturbance; circadian rhythm dysfunction; sundowning",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3 mg",
                  "orderSentence": "Melatonin 3 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 3 mg qHS, 30 min before bed; may increase to 6-9 mg if needed",
              "orderSentence": "Melatonin 3 mg PO"
            },
            "contraindications": "None significant",
            "monitoring": "Daytime drowsiness; minimal side effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory (Behavioral Management)": [
          {
            "item": "Quetiapine (Seroquel)",
            "route": "PO",
            "indication": "Severe agitation/psychosis when non-pharmacologic and first-line fail",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg",
                  "orderSentence": "Quetiapine (Seroquel) 12.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5-25 mg qHS; titrate slowly (25 mg increments); keep dose as low as possible; max 200 mg/day",
              "orderSentence": "Quetiapine (Seroquel) 12.5 mg PO"
            },
            "contraindications": "Black box: increased mortality in dementia; avoid in FTD-parkinsonism",
            "monitoring": "Metabolic effects; sedation; falls; QTc; EPS",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Olanzapine",
            "route": "PO/IM",
            "indication": "Severe agitation when other options fail; IM for acute crisis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg",
                  "orderSentence": "Olanzapine 2.5 mg PO/IM"
                }
              ],
              "route": "PO/IM",
              "instructions": "PO: Start 2.5 mg daily; increase slowly; max 10 mg; IM: 2.5-5 mg for acute crisis",
              "orderSentence": "Olanzapine 2.5 mg PO/IM"
            },
            "contraindications": "Black box: increased mortality in dementia; diabetes; QT prolongation",
            "monitoring": "Weight gain; metabolic syndrome; sedation; EPS",
            "ED": "EXT",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Dextromethorphan/quinidine (Nuedexta)",
            "route": "PO",
            "indication": "Pseudobulbar affect; emotional lability; pathological laughing/crying",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20/10 mg",
                  "orderSentence": "Dextromethorphan/quinidine (Nuedexta) 20/10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 20/10 mg daily x 7 days; then 20/10 mg BID",
              "orderSentence": "Dextromethorphan/quinidine (Nuedexta) 20/10 mg PO"
            },
            "contraindications": "QT prolongation; concurrent MAOIs; quinidine hypersensitivity; complete AV block",
            "monitoring": "QTc; avoid in hepatic/renal impairment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valproic acid",
            "route": "PO",
            "indication": "Impulsivity; aggression; mood instability (off-label)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "125 mg",
                  "orderSentence": "Valproic acid 125 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 125-250 mg BID; titrate to 500-1000 mg/day; monitor levels",
              "orderSentence": "Valproic acid 125 mg PO"
            },
            "contraindications": "Hepatic disease; urea cycle disorders; mitochondrial disorders",
            "monitoring": "Valproate level, LFTs, CBC, ammonia; weight gain; tremor; thrombocytopenia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Memantine (Namenda)",
            "route": "PO",
            "indication": "May help some behavioral symptoms; limited evidence",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Memantine (Namenda) 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; increase by 5 mg/week to 10 mg BID; evidence weak in FTD",
              "orderSentence": "Memantine (Namenda) 5 mg PO"
            },
            "contraindications": "Severe renal impairment (reduce dose)",
            "monitoring": "Confusion, dizziness; generally well tolerated",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Methylphenidate",
            "route": "PO",
            "indication": "Severe apathy unresponsive to other treatments",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg",
                  "orderSentence": "Methylphenidate 2.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5-5 mg BID (morning and noon); titrate slowly; max 20 mg/day",
              "orderSentence": "Methylphenidate 2.5 mg PO"
            },
            "contraindications": "Severe anxiety; cardiac arrhythmias; glaucoma; concurrent MAOIs",
            "monitoring": "BP, HR; appetite; insomnia; agitation; abuse potential",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Treatments to AVOID in FTD": [
          {
            "item": "Donepezil (Aricept)",
            "route": "PO",
            "indication": "AVOID - May worsen behavioral symptoms in FTD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "AVOID",
                  "orderSentence": "Donepezil (Aricept) AVOID PO"
                }
              ],
              "route": "PO",
              "instructions": "Do NOT use; cholinesterase inhibitors can worsen disinhibition, agitation, and behavioral symptoms in FTD",
              "orderSentence": "Donepezil (Aricept) AVOID PO"
            },
            "contraindications": "FTD diagnosis",
            "monitoring": "Worsening behavior if inadvertently started",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine (Exelon)",
            "route": "PO/TD",
            "indication": "AVOID - May worsen behavioral symptoms in FTD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "AVOID",
                  "orderSentence": "Rivastigmine (Exelon) AVOID PO/TD"
                }
              ],
              "route": "PO/TD",
              "instructions": "Do NOT use; cholinesterase inhibitors not recommended in FTD; may cause paradoxical worsening",
              "orderSentence": "Rivastigmine (Exelon) AVOID PO/TD"
            },
            "contraindications": "FTD diagnosis",
            "monitoring": "Worsening behavior if inadvertently started",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Galantamine (Razadyne)",
            "route": "PO",
            "indication": "AVOID - May worsen behavioral symptoms in FTD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "AVOID",
                  "orderSentence": "Galantamine (Razadyne) AVOID PO"
                }
              ],
              "route": "PO",
              "instructions": "Do NOT use; cholinesterase inhibitors contraindicated in FTD",
              "orderSentence": "Galantamine (Razadyne) AVOID PO"
            },
            "contraindications": "FTD diagnosis",
            "monitoring": "Worsening behavior if inadvertently started",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "FTD-ALS/Motor Neuron Disease Overlap": [
          {
            "item": "Riluzole",
            "route": "PO",
            "indication": "FTD with ALS overlap; may modestly slow MND progression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Riluzole 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "50 mg PO BID; take 1 hour before or 2 hours after meals",
              "orderSentence": "Riluzole 50 mg PO"
            },
            "contraindications": "Hepatic impairment; pregnancy",
            "monitoring": "LFTs monthly x 3 months, then q3mo; neutropenia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Edaravone (Radicava)",
            "route": "IV/PO",
            "indication": "FTD-ALS if early in disease course",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg",
                  "orderSentence": "Edaravone (Radicava) 60 mg IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "Initial: 60 mg IV daily x 14 days; maintenance: 60 mg IV daily x 10 days of 14-day cycles; oral formulation available",
              "orderSentence": "Edaravone (Radicava) 60 mg IV/PO"
            },
            "contraindications": "Hypersensitivity; sulfite allergy",
            "monitoring": "Infusion reactions; hypersensitivity",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "~~Sodium phenylbutyrate/taurursodiol (Relyvrio)~~",
            "route": "~~PO~~",
            "indication": "~~FTD-ALS overlap; neuroprotective~~",
            "dosing": {
              "doseOptions": [
                {
                  "text": "**WITHDRAWN**",
                  "orderSentence": "~~Sodium phenylbutyrate/taurursodiol (Relyvrio)~~ **WITHDRAWN** N/A"
                }
              ],
              "route": "N/A",
              "instructions": "**WITHDRAWN FROM MARKET (April 2024)** - Amylyx withdrew Relyvrio after the Phase III PHOENIX trial failed to demonstrate efficacy. No longer available for prescribing.",
              "orderSentence": "~~Sodium phenylbutyrate/taurursodiol (Relyvrio)~~ **WITHDRAWN** N/A"
            },
            "contraindications": "N/A",
            "monitoring": "N/A",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Behavioral/cognitive neurology for diagnosis confirmation, FTD subtype classification, and treatment guidance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuropsychology for comprehensive cognitive testing to establish baseline, characterize deficits, and track progression",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetic counseling for all patients with suspected FTD given high heritability (30-50% familial); discuss testing implications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech-language pathology for language variant PPA evaluation, communication strategies, and swallowing assessment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Geriatric psychiatry for complex behavioral management and psychotropic medication optimization",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for caregiver support resources, community services, respite care, and long-term care planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for ADL assessment, cognitive strategies, home safety evaluation, and activity structuring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for fall prevention, mobility assessment, and exercise program particularly if motor features present",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Palliative care for symptom management and goals of care discussions, especially with advanced disease or ALS overlap",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuromuscular specialist if motor neuron disease features (weakness, fasciculations, bulbar symptoms) present",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Elder law attorney for advance directives, healthcare proxy, conservatorship, and financial planning while capacity exists",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if sudden worsening of behavior, new weakness, difficulty breathing, or inability to swallow safely",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Complete advance directives (living will, healthcare proxy, POLST) while patient retains capacity; FTD can progress rapidly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Designate durable power of attorney for healthcare AND finances early as judgment may be impaired before memory",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive; FTD impairs judgment, impulse control, and decision-making even if memory appears intact",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Remove access to weapons, power tools, and dangerous equipment due to impaired judgment and safety awareness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Supervise financial decisions; patients with FTD are vulnerable to fraud, impulsive spending, and poor judgment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Secure medications to prevent accidental or intentional overdose; use locked medication storage",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Monitor for wandering; consider GPS tracking devices and door alarms as disease progresses",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report diagnosis to DMV per state requirements; most states require physician reporting for unsafe drivers",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Genetic testing results have implications for family members; discuss with genetic counselor before testing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Structured daily routine with consistent schedule reduces anxiety and behavioral symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular physical activity (walking, supervised exercise) improves mood and maintains function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Simplified communication using short sentences, yes/no questions, and visual cues for PPA variants",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid overstimulation; reduce noise, crowds, and complex environments that trigger agitation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Caregiver education through AFTD (Association for Frontotemporal Degeneration) resources and support groups",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Respite care for caregivers to prevent burnout; FTD caregiving is particularly demanding due to behavioral symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Address hyperorality and dietary changes with portion control, healthy snack availability, and locked food storage if needed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Safe environment modifications: remove fall hazards, lock cabinets with dangerous items, install stove knob covers",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "One-to-one supervision may be needed for safety; consider adult day programs or in-home care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation and alcohol avoidance to prevent additional brain injury and drug interactions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Alzheimer's disease",
        "features": "Memory impairment prominent early; episodic memory loss; posterior cortical atrophy pattern",
        "tests": "CSF Aβ42 low, p-tau elevated; amyloid PET positive; temporal-parietal atrophy on MRI"
      },
      {
        "diagnosis": "Dementia with Lewy bodies",
        "features": "Visual hallucinations; parkinsonism; REM sleep behavior disorder; fluctuating cognition",
        "tests": "DaTscan reduced; RBD on sleep study; better response to cholinesterase inhibitors"
      },
      {
        "diagnosis": "Primary psychiatric disorder",
        "features": "Onset often younger; personal/family psychiatric history; may have insight; responds to treatment",
        "tests": "Normal MRI; normal FDG-PET; improvement with psychiatric treatment"
      },
      {
        "diagnosis": "Huntington's disease",
        "features": "Chorea; family history (autosomal dominant); psychiatric symptoms precede motor",
        "tests": "CAG repeat expansion; caudate atrophy on MRI"
      },
      {
        "diagnosis": "Progressive supranuclear palsy (PSP)",
        "features": "Vertical gaze palsy; axial rigidity; early falls; frontal features",
        "tests": "\"Hummingbird sign\" on MRI; poor levodopa response"
      },
      {
        "diagnosis": "Corticobasal syndrome (CBS)",
        "features": "Asymmetric apraxia; alien limb; cortical sensory loss; dystonia",
        "tests": "Asymmetric atrophy; may have FTD overlap"
      },
      {
        "diagnosis": "Creutzfeldt-Jakob disease",
        "features": "Rapid progression (weeks-months); myoclonus; ataxia; startle",
        "tests": "MRI DWI ribboning; EEG periodic discharges; CSF RT-QuIC positive"
      },
      {
        "diagnosis": "Autoimmune encephalitis",
        "features": "Subacute onset; seizures; psychiatric features; often younger",
        "tests": "Autoantibody panel positive; MRI limbic changes; CSF inflammation"
      },
      {
        "diagnosis": "Normal pressure hydrocephalus",
        "features": "Gait disturbance predominant; urinary incontinence; magnetic gait",
        "tests": "MRI ventriculomegaly out of proportion to atrophy; large-volume LP improvement"
      },
      {
        "diagnosis": "Vascular dementia",
        "features": "Stepwise decline; vascular risk factors; focal deficits",
        "tests": "Extensive white matter disease and strategic infarcts on MRI"
      },
      {
        "diagnosis": "Medication/substance-induced",
        "features": "Temporal relationship to drug exposure; anticholinergics, sedatives common culprits",
        "tests": "Medication reconciliation; improvement with discontinuation"
      },
      {
        "diagnosis": "Late-onset bipolar disorder",
        "features": "Episodic mood symptoms; family history; intact cognition between episodes",
        "tests": "Normal neuroimaging; psychiatric evaluation; treatment response"
      }
    ],
    "evidence": [
      {
        "recommendation": "Diagnostic criteria for bvFTD (International Consensus)",
        "evidenceLevel": "Class I, Level A",
        "source": "[Rascovsky et al. Brain 2011](https://pubmed.ncbi.nlm.nih.gov/21824939/)"
      },
      {
        "recommendation": "Diagnostic criteria for PPA variants",
        "evidenceLevel": "Class I, Level A",
        "source": "[Gorno-Tempini et al. Neurology 2011](https://pubmed.ncbi.nlm.nih.gov/21325651/)"
      },
      {
        "recommendation": "SSRIs for behavioral symptoms in FTD",
        "evidenceLevel": "Class II, Level B",
        "source": "[Herrmann et al. J Clin Psychiatry 2012](https://pubmed.ncbi.nlm.nih.gov/22687702/)"
      },
      {
        "recommendation": "Trazodone for FTD behavioral symptoms",
        "evidenceLevel": "Class II, Level B",
        "source": "[Lebert et al. Dement Geriatr Cogn Disord 2004](https://pubmed.ncbi.nlm.nih.gov/15178936/)"
      },
      {
        "recommendation": "Cholinesterase inhibitors not recommended in FTD",
        "evidenceLevel": "Class II, Level B",
        "source": "[Mendez et al. Am J Alzheimers Dis Other Demen 2007](https://pubmed.ncbi.nlm.nih.gov/17804830/)"
      },
      {
        "recommendation": "Antipsychotic mortality risk in dementia",
        "evidenceLevel": "Class I, Level A",
        "source": "[Schneider et al. JAMA 2005](https://pubmed.ncbi.nlm.nih.gov/16219884/)"
      },
      {
        "recommendation": "C9orf72 as most common genetic cause of FTD/ALS",
        "evidenceLevel": "Class I, Level A",
        "source": "[DeJesus-Hernandez et al. Neuron 2011](https://pubmed.ncbi.nlm.nih.gov/21944778/); [Renton et al. Neuron 2011](https://pubmed.ncbi.nlm.nih.gov/21944779/)"
      },
      {
        "recommendation": "MAPT and GRN mutations in familial FTD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Rohrer et al. Lancet Neurol 2009](https://pubmed.ncbi.nlm.nih.gov/19345567/)"
      },
      {
        "recommendation": "FDG-PET in FTD diagnosis",
        "evidenceLevel": "Class II, Level B",
        "source": "[Foster et al. Ann Neurol 2007](https://pubmed.ncbi.nlm.nih.gov/17315189/)"
      },
      {
        "recommendation": "CSF NfL as prognostic biomarker in FTD",
        "evidenceLevel": "Class II, Level B",
        "source": "[Rohrer et al. Neurology 2016](https://pubmed.ncbi.nlm.nih.gov/27164711/)"
      },
      {
        "recommendation": "Memantine limited efficacy in FTD",
        "evidenceLevel": "Class II, Level C",
        "source": "[Boxer et al. Lancet Neurol 2013](https://pubmed.ncbi.nlm.nih.gov/23684085/)"
      },
      {
        "recommendation": "FTD-ALS continuum",
        "evidenceLevel": "Class I, Level A",
        "source": "[Burrell et al. Lancet Neurol 2016](https://pubmed.ncbi.nlm.nih.gov/27083437/)"
      },
      {
        "recommendation": "Serum progranulin as GRN mutation screen",
        "evidenceLevel": "Class II, Level B",
        "source": "[Finch et al. J Mol Diagn 2009](https://pubmed.ncbi.nlm.nih.gov/19359499/)"
      },
      {
        "recommendation": "Practice guidelines for FTD management",
        "evidenceLevel": "Class III, Level C",
        "source": "[Tsai et al. Neurology 2021](https://pubmed.ncbi.nlm.nih.gov/34341099/)"
      },
      {
        "recommendation": "Riluzole in ALS",
        "evidenceLevel": "Class I, Level A",
        "source": "[Miller et al. Cochrane 2012](https://pubmed.ncbi.nlm.nih.gov/22419334/)"
      },
      {
        "recommendation": "Relyvrio (AMX0035) withdrawn after PHOENIX trial failure",
        "evidenceLevel": "N/A",
        "source": "Amylyx Pharmaceuticals press release, April 2024; PHOENIX trial (NCT05021536)"
      }
    ],
    "monitoring": [
      {
        "item": "Cognitive testing (MoCA, MMSE, or FTLD-specific battery)",
        "frequency": "Every 6-12 months",
        "action": "Adjust care level; medication review; genetics if rapid",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Frontal assessment battery (FAB)",
        "frequency": "Every 6-12 months",
        "action": "Increase supervision; safety planning",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Functional status (ADL/IADL, FBI, CBI)",
        "frequency": "Every 6 months",
        "action": "Increase caregiver support; consider placement",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Behavioral assessment (NPI-Q, FBI)",
        "frequency": "Each visit",
        "action": "Adjust medications; non-pharmacologic strategies",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Motor function (if FTD-ALS)",
        "frequency": "Every 3-6 months",
        "action": "Respiratory support; PT/OT; feeding tube discussion",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight",
        "frequency": "Each visit",
        "action": "Nutritional consult; address hyperphagia or dysphagia",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Swallowing function",
        "frequency": "Every 6-12 months or if symptoms",
        "action": "Speech therapy; diet modification; feeding tube if needed",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Caregiver burden (Zarit Burden Interview)",
        "frequency": "Every 6-12 months",
        "action": "Respite care; support groups; social work",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Safety assessment",
        "frequency": "Each visit",
        "action": "Increase supervision; remove hazards; consider placement",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ECG (if on QT-prolonging medications)",
        "frequency": "Baseline; with dose changes",
        "action": "Reduce dose or switch medication",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "LFTs (if on valproic acid or riluzole)",
        "frequency": "Monthly x 3, then q3mo",
        "action": "Reduce or discontinue if >3x ULN",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Behavioral crisis resolved; safe environment; adequate caregiver supervision; outpatient follow-up arranged; medications optimized"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Severe behavioral disturbance unsafe for home; medical workup needed; medication adjustment requiring monitoring; caregiver unable to manage"
      },
      {
        "disposition": "Admit to psychiatry",
        "criteria": "Danger to self or others; severe aggression; psychotic features; requires locked unit for safety"
      },
      {
        "disposition": "Memory care/Long-term care",
        "criteria": "Progressive decline; wandering risk; 24-hour supervision needed; caregiver unable to provide safe care"
      },
      {
        "disposition": "Hospice",
        "criteria": "End-stage FTD; minimal responsiveness; recurrent aspiration; weight loss; goals focused on comfort; FVC <50% in FTD-ALS"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Neurology/cognitive neurology every 3-6 months; more frequent if on psychotropics or rapid progression; genetics follow-up after testing"
      }
    ]
  },
  "Normal Pressure Hydrocephalus": {
    "id": "normal-pressure-hydrocephalus",
    "title": "Normal Pressure Hydrocephalus",
    "version": "1.1",
    "icd10": [
      "** G91.2 (Normal pressure hydrocephalus)",
      "G91.0 (Communicating hydrocephalus)",
      "R41.0 (Disorientation",
      "unspecified)",
      "R26.0 (Ataxic gait)",
      "R32 (Unspecified urinary incontinence)"
    ],
    "scope": "** Comprehensive evaluation of suspected NPH, diagnostic workup including high-volume lumbar puncture (tap test), prediction of shunt responsiveness, neurosurgical referral, and post-shunt monitoring. Covers idiopathic NPH (most common) and secondary NPH. Does not cover acute obstructive hydrocephalus or pediatric hydrocephalus.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Pre-surgical screening; rule out infection",
            "target": "Normal"
          },
          {
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Electrolyte assessment; pre-surgical renal function",
            "target": "Normal electrolytes, BUN, Cr"
          },
          {
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Pre-procedural assessment for LP and surgery",
            "target": "INR <1.5, PTT <40"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypothyroidism can cause cognitive impairment",
            "target": "0.4-4.0 mIU/L"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "B12 deficiency causes reversible dementia and gait ataxia",
            "target": ">300 pg/mL"
          },
          {
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out UTI as cause of incontinence or confusion",
            "target": "Negative for infection"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes contributes to small vessel disease and neuropathy",
            "target": "<7%"
          }
        ],
        "Extended Workup": [
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency contributes to cognitive impairment",
            "target": ">3 ng/mL"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurosyphilis can cause dementia and gait abnormalities",
            "target": "Nonreactive"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HIV-associated neurocognitive disorder in at-risk patients",
            "target": "Negative"
          },
          {
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Inflammatory or infectious causes of meningitis/encephalitis",
            "target": "Normal"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hepatic encephalopathy in patients with liver disease",
            "target": "Normal"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Prostate disease contributing to urinary symptoms",
            "target": "Normal for age"
          }
        ],
        "Rare/Specialized": [
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Autoimmune etiology if subacute presentation",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Autoimmune encephalitis causing cognitive/behavioral changes",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Early-onset dementia with family history",
            "target": "No pathogenic variants"
          }
        ],
        "Lumbar Puncture": [
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Confirm normal or mildly elevated pressure in NPH",
            "target": "5-18 cm H2O (typically normal or low-normal in NPH)"
          },
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out infection or inflammation",
            "target": "WBC <5, RBC 0"
          },
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out infectious/inflammatory causes",
            "target": "Normal 15-45 mg/dL"
          },
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out infectious meningitis",
            "target": ">60% of serum glucose"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Differentiate from Alzheimer's disease (optional)",
            "target": "Normal in NPH; low Abeta-42 with high tau in AD"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Initial evaluation",
            "target": "Ventriculomegaly with Evans index >0.3; callosal angle <90 degrees; DESH pattern; periventricular edema (transependymal flow); absence of cortical atrophy proportionate to ventricular size",
            "contraindications": "MRI-incompatible devices; claustrophobia"
          },
          {
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If MRI unavailable or emergent presentation",
            "target": "Ventriculomegaly out of proportion to sulcal enlargement; Evans index >0.3",
            "contraindications": "Pregnancy (relative)"
          }
        ],
        "Extended": [
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Detailed assessment",
            "target": "Quantify ventricular volume; hippocampal volume preservation (unlike AD); tight high-convexity sulci",
            "contraindications": "MRI contraindications"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Assess aqueductal CSF flow",
            "target": "Hyperdynamic aqueductal flow; increased stroke volume (>42 microL)",
            "contraindications": "MRI contraindications"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Atypical cases to differentiate from AD",
            "target": "Normal NAA/Cr ratio (reduced in AD); no significant metabolic abnormality",
            "contraindications": "MRI contraindications"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Differentiate NPH from AD or FTD",
            "target": "Preserved metabolism (unlike AD temporoparietal hypometabolism)",
            "contraindications": "None"
          }
        ],
        "Rare/Specialized": [
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-",
            "timing": "Diagnostic uncertainty after tap test",
            "target": "B-waves present (indicates impaired CSF dynamics)",
            "contraindications": "Coagulopathy; skin infection"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Research settings; predict shunt response",
            "target": "Elevated Rout >12-18 mmHg/mL/min suggests shunt responsiveness",
            "contraindications": "Coagulopathy"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Rarely used; assesses CSF flow patterns",
            "target": "Delayed clearance over convexities; ventricular reflux",
            "contraindications": "None"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Acetazolamide",
            "route": "PO",
            "indication": "Temporizing measure while awaiting surgery; reduces CSF production",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg",
                  "orderSentence": "Acetazolamide 250 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 250 mg BID; titrate to 250 mg TID or 500 mg BID; max 2 g/day",
              "orderSentence": "Acetazolamide 250 mg PO"
            },
            "contraindications": "Sulfa allergy; severe hepatic/renal disease; hypokalemia; metabolic acidosis",
            "monitoring": "BMP for potassium, bicarbonate; paresthesias",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Serial therapeutic LP",
            "route": "LP",
            "indication": "Temporizing measure; confirm continued benefit; bridge to surgery",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30-50 mL",
                  "orderSentence": "Serial therapeutic LP 30-50 mL LP"
                }
              ],
              "route": "LP",
              "instructions": "Remove 30-50 mL every 1-4 weeks based on symptom recurrence",
              "orderSentence": "Serial therapeutic LP 30-50 mL LP"
            },
            "contraindications": "Coagulopathy; anticoagulation; skin infection",
            "monitoring": "Post-LP symptoms; duration of benefit",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Memantine",
            "route": "PO",
            "indication": "Cognitive symptoms; may provide modest benefit pending surgery",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Memantine 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; increase by 5 mg/week; target 10 mg BID",
              "orderSentence": "Memantine 5 mg PO"
            },
            "contraindications": "Severe renal impairment (adjust dose if CrCl <30)",
            "monitoring": "Confusion, dizziness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Donepezil",
            "route": "PO",
            "indication": "Cognitive symptoms if AD component suspected",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Donepezil 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg qHS x 4-6 weeks; increase to 10 mg qHS",
              "orderSentence": "Donepezil 5 mg PO"
            },
            "contraindications": "Sick sinus syndrome; GI bleeding; COPD",
            "monitoring": "Bradycardia, GI symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxybutynin",
            "route": "PO",
            "indication": "Urinary urgency/incontinence",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Oxybutynin 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg BID; may increase to 5 mg TID; or use ER 10-30 mg daily",
              "orderSentence": "Oxybutynin 5 mg PO"
            },
            "contraindications": "Uncontrolled narrow-angle glaucoma; urinary retention; GI obstruction",
            "monitoring": "Anticholinergic effects; cognitive worsening",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirabegron",
            "route": "PO",
            "indication": "Urinary urgency if anticholinergics contraindicated or cause cognitive worsening",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Mirabegron 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; may increase to 50 mg daily",
              "orderSentence": "Mirabegron 25 mg PO"
            },
            "contraindications": "Severe uncontrolled hypertension",
            "monitoring": "Blood pressure",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tamsulosin",
            "route": "PO",
            "indication": "Urinary retention (males with BPH component)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 mg",
                  "orderSentence": "Tamsulosin 0.4 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.4 mg daily; may increase to 0.8 mg daily",
              "orderSentence": "Tamsulosin 0.4 mg PO"
            },
            "contraindications": "Orthostatic hypotension; planned cataract surgery (IFIS)",
            "monitoring": "Orthostatic hypotension",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Sleep disturbance; sundowning",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Trazodone 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg qHS; titrate to 50-150 mg qHS",
              "orderSentence": "Trazodone 25 mg PO"
            },
            "contraindications": "Concurrent MAOIs; QT prolongation",
            "monitoring": "Orthostatic hypotension",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy",
            "route": "-",
            "indication": "Gait training and fall prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per PT evaluation",
                  "orderSentence": "Physical therapy Per PT evaluation -"
                }
              ],
              "route": "-",
              "instructions": "Initial evaluation plus ongoing therapy for gait training, balance, strength",
              "orderSentence": "Physical therapy Per PT evaluation -"
            },
            "contraindications": "None",
            "monitoring": "Fall risk assessment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Definitive Treatment (Shunt Surgery)": [
          {
            "item": "Ventriculoperitoneal (VP) shunt",
            "route": "Surgical",
            "indication": "Definitive treatment for NPH; positive tap test or extended drain trial",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Programmable valve",
                  "orderSentence": "Ventriculoperitoneal (VP) shunt Programmable valve Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Valve pressure setting adjusted based on symptoms; typical starting setting 120-180 mmH2O",
              "orderSentence": "Ventriculoperitoneal (VP) shunt Programmable valve Surgical"
            },
            "contraindications": "Active peritoneal infection; peritoneal adhesions; recent abdominal surgery; ascites",
            "monitoring": "Post-op neuro checks; shunt series imaging; valve setting verification",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ventriculoatrial (VA) shunt",
            "route": "Surgical",
            "indication": "Alternative if peritoneum unsuitable (adhesions, peritonitis history)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Programmable valve",
                  "orderSentence": "Ventriculoatrial (VA) shunt Programmable valve Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Catheter tip in right atrium; valve adjusted as VP shunt",
              "orderSentence": "Ventriculoatrial (VA) shunt Programmable valve Surgical"
            },
            "contraindications": "Active bacteremia; severe cardiac disease; pulmonary hypertension",
            "monitoring": "Post-op neuro checks; shunt series imaging; valve setting verification; cardiac monitoring; watch for shunt nephritis",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Lumboperitoneal (LP) shunt",
            "route": "Surgical",
            "indication": "Alternative approach; avoids cranial surgery",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Programmable valve",
                  "orderSentence": "Lumboperitoneal (LP) shunt Programmable valve Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Catheter from lumbar subarachnoid space to peritoneum",
              "orderSentence": "Lumboperitoneal (LP) shunt Programmable valve Surgical"
            },
            "contraindications": "Spinal stenosis; arachnoiditis; Chiari malformation",
            "monitoring": "Post-op neuro checks; shunt series imaging; valve setting verification; watch for overdrainage with positional changes",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Endoscopic third ventriculostomy (ETV)",
            "route": "Surgical",
            "indication": "Secondary NPH with aqueductal stenosis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Endoscopic third ventriculostomy (ETV) N/A Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Create opening between third ventricle and interpeduncular cistern",
              "orderSentence": "Endoscopic third ventriculostomy (ETV) N/A Surgical"
            },
            "contraindications": "Communicating hydrocephalus (most iNPH); scarred prepontine cistern",
            "monitoring": "Post-op neuro checks; repeat imaging",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Post-Shunt Complication Management": [
          {
            "item": "Valve pressure adjustment (overdrainage)",
            "route": "External",
            "indication": "Overdrainage symptoms (headache, subdural hematoma)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Increase setting",
                  "orderSentence": "Valve pressure adjustment (overdrainage) Increase setting External programming"
                }
              ],
              "route": "External programming",
              "instructions": "Increase opening pressure by 20-30 mmH2O increments; recheck in 1-2 weeks",
              "orderSentence": "Valve pressure adjustment (overdrainage) Increase setting External programming"
            },
            "contraindications": "None",
            "monitoring": "Symptom response; repeat imaging",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valve pressure adjustment (underdrainage)",
            "route": "External",
            "indication": "Underdrainage (persistent or worsening NPH symptoms)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Decrease setting",
                  "orderSentence": "Valve pressure adjustment (underdrainage) Decrease setting External programming"
                }
              ],
              "route": "External programming",
              "instructions": "Decrease opening pressure by 20-30 mmH2O increments; recheck in 1-2 weeks",
              "orderSentence": "Valve pressure adjustment (underdrainage) Decrease setting External programming"
            },
            "contraindications": "None",
            "monitoring": "Symptom response; repeat imaging",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vancomycin",
            "route": "IV",
            "indication": "Shunt infection (empiric)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15-20 mg/kg",
                  "orderSentence": "Vancomycin 15-20 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "15-20 mg/kg IV q8-12h; adjust for renal function; target trough 15-20 mcg/mL",
              "orderSentence": "Vancomycin 15-20 mg/kg IV"
            },
            "contraindications": "Vancomycin allergy",
            "monitoring": "Vancomycin trough; renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Cefepime",
            "route": "IV",
            "indication": "Shunt infection (empiric gram-negative coverage)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g",
                  "orderSentence": "Cefepime 2 g IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV q8h; adjust for renal function",
              "orderSentence": "Cefepime 2 g IV"
            },
            "contraindications": "Cephalosporin allergy",
            "monitoring": "Renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Shunt revision surgery",
            "route": "Surgical",
            "indication": "Shunt malfunction, obstruction, or infection",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per neurosurgery",
                  "orderSentence": "Shunt revision surgery Per neurosurgery Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Shunt externalization if infected; revision for mechanical failure",
              "orderSentence": "Shunt revision surgery Per neurosurgery Surgical"
            },
            "contraindications": "Active systemic infection",
            "monitoring": "Post-op monitoring; infection clearance",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology for comprehensive evaluation, differential diagnosis, and coordination of diagnostic workup",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neurosurgery for shunt candidacy evaluation after positive tap test or extended drain trial",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuropsychology for baseline cognitive assessment and differentiation from other dementias (AD, vascular)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for gait assessment, fall prevention, and baseline measurement for tap test comparison",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for ADL assessment, home safety evaluation, and cognitive strategies",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Urology for evaluation if urinary symptoms prominent or atypical for NPH",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for caregiver support, community resources, and care planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Geriatrics or geriatric psychiatry for complex older patients with multiple comorbidities",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if sudden severe headache, new weakness, or altered consciousness develops (may indicate shunt malfunction or complication)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report fever, incision redness, or drainage after shunt surgery (may indicate shunt infection)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep scheduled follow-up appointments for shunt valve pressure adjustments and monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use assistive devices (walker, cane) as recommended by physical therapy to prevent falls",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive until cleared by physician due to cognitive impairment and fall risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid MRI without confirming shunt valve is MRI-conditional and checking valve setting afterward",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Carry shunt information card with valve type and current pressure setting",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Fall precautions including removal of throw rugs, adequate lighting, grab bars in bathroom due to gait instability",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular physical activity within safe limits to maintain strength and mobility",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cognitive stimulation through reading, puzzles, and social engagement to support cognitive reserve",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Blood pressure optimization (target <130/80) to reduce vascular contribution to cognitive impairment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate hydration to maintain optimal CSF dynamics; avoid dehydration",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Bladder training program in conjunction with physical therapy for urinary symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Alzheimer's disease",
        "features": "Memory impairment predominant; insidious progression; no significant gait disturbance early; no improvement with LP",
        "tests": "MRI shows hippocampal atrophy >ventricular enlargement; CSF low Abeta-42, high tau; no tap test response"
      },
      {
        "diagnosis": "Vascular dementia",
        "features": "Stepwise decline; focal neurological signs; executive dysfunction; vascular risk factors",
        "tests": "MRI shows extensive white matter disease, strategic infarcts; ventriculomegaly less prominent"
      },
      {
        "diagnosis": "Parkinson's disease",
        "features": "Rest tremor; rigidity; bradykinesia; shuffling gait differs from NPH magnetic gait; no incontinence early",
        "tests": "DaTscan abnormal; no tap test response; no ventriculomegaly disproportionate to atrophy"
      },
      {
        "diagnosis": "Dementia with Lewy bodies",
        "features": "Visual hallucinations; fluctuating cognition; parkinsonism; REM sleep behavior disorder",
        "tests": "DaTscan abnormal; no ventricular enlargement out of proportion to atrophy"
      },
      {
        "diagnosis": "Progressive supranuclear palsy",
        "features": "Vertical gaze palsy; postural instability with falls backward; axial rigidity",
        "tests": "MRI midbrain atrophy (\"hummingbird sign\"); no tap test response"
      },
      {
        "diagnosis": "Cervical spondylotic myelopathy",
        "features": "Upper motor neuron signs in legs; hyperreflexia; Babinski; sensory level",
        "tests": "Cervical MRI shows cord compression; EMG findings"
      },
      {
        "diagnosis": "Peripheral neuropathy",
        "features": "Sensory loss distally; reduced reflexes; no cognitive or urinary symptoms",
        "tests": "EMG/NCS confirms peripheral nerve involvement"
      },
      {
        "diagnosis": "Obstructive hydrocephalus",
        "features": "Acute onset; headache; papilledema; elevated opening pressure on LP",
        "tests": "MRI shows obstructive lesion; elevated ICP; requires emergent intervention"
      },
      {
        "diagnosis": "Spinal stenosis",
        "features": "Neurogenic claudication; leg pain with walking relieved by rest/leaning forward",
        "tests": "Lumbar MRI shows stenosis; normal brain imaging"
      },
      {
        "diagnosis": "Frontotemporal dementia",
        "features": "Behavioral changes prominent; personality changes; language impairment",
        "tests": "MRI frontal/temporal atrophy; FDG-PET frontal hypometabolism"
      }
    ],
    "evidence": [
      {
        "recommendation": "Evans index >0.3 diagnostic for ventriculomegaly",
        "evidenceLevel": "Class II, Level B",
        "source": "[Relkin et al. Neurosurgery 2005 (iNPH Guidelines)](https://pubmed.ncbi.nlm.nih.gov/16234657/)"
      },
      {
        "recommendation": "Callosal angle <90 degrees supports iNPH diagnosis",
        "evidenceLevel": "Class III, Level C",
        "source": "[Virhammar et al. J Neurosurg 2014](https://pubmed.ncbi.nlm.nih.gov/24506247/)"
      },
      {
        "recommendation": "DESH (disproportionately enlarged subarachnoid-space hydrocephalus) pattern",
        "evidenceLevel": "Class II, Level B",
        "source": "[Hashimoto et al. AJNR 2010](https://pubmed.ncbi.nlm.nih.gov/20150305/)"
      },
      {
        "recommendation": "High-volume LP (tap test) predicts shunt response",
        "evidenceLevel": "Class II, Level B",
        "source": "[Marmarou et al. J Neurosurg 2005](https://pubmed.ncbi.nlm.nih.gov/16234659/)"
      },
      {
        "recommendation": "Extended lumbar drainage more sensitive than single tap test",
        "evidenceLevel": "Class II, Level B",
        "source": "[Walchenbach et al. J Neurol Neurosurg Psychiatry 2002](https://pubmed.ncbi.nlm.nih.gov/12122181/)"
      },
      {
        "recommendation": "VP shunt improves symptoms in selected iNPH patients",
        "evidenceLevel": "Class II, Level B",
        "source": "[Hebb et al. Can J Neurol Sci 2001](https://pubmed.ncbi.nlm.nih.gov/11513352/)"
      },
      {
        "recommendation": "Programmable valves reduce revision surgery rates",
        "evidenceLevel": "Class II, Level B",
        "source": "[Zemack et al. Eur J Neurol 2003](https://pubmed.ncbi.nlm.nih.gov/14641516/)"
      },
      {
        "recommendation": "Gait improvement most responsive to shunting",
        "evidenceLevel": "Class II, Level B",
        "source": "[Ishikawa et al. Neurology 2012](https://pubmed.ncbi.nlm.nih.gov/22442434/)"
      },
      {
        "recommendation": "Short symptom duration predicts better shunt outcome",
        "evidenceLevel": "Class II, Level B",
        "source": "[Relkin et al. Neurosurgery 2005](https://pubmed.ncbi.nlm.nih.gov/16234657/)"
      },
      {
        "recommendation": "CSF biomarkers help differentiate NPH from AD",
        "evidenceLevel": "Class III, Level C",
        "source": "[Tarnaris et al. Neurology 2011](https://pubmed.ncbi.nlm.nih.gov/21282586/)"
      },
      {
        "recommendation": "Shunt infection rate 5-10%; requires shunt removal for treatment",
        "evidenceLevel": "Class III, Level C",
        "source": "[McGirt et al. J Neurosurg 2003](https://pubmed.ncbi.nlm.nih.gov/12959439/)"
      },
      {
        "recommendation": "Japanese iNPH Guidelines diagnostic criteria",
        "evidenceLevel": "Class II, Level B",
        "source": "[Mori et al. Neurol Med Chir 2012](https://pubmed.ncbi.nlm.nih.gov/23037929/)"
      }
    ],
    "monitoring": [
      {
        "item": "Gait assessment (timed 10m walk, Tinetti)",
        "frequency": "Pre-LP, post-LP, each follow-up",
        "action": "Positive change supports diagnosis; no change may indicate poor shunt candidacy",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "MoCA or MMSE",
        "frequency": "Baseline, post-LP, every 6 months",
        "action": "Improvement suggests NPH; decline suggests alternative diagnosis or shunt failure",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Post-shunt imaging (CT or MRI)",
        "frequency": "1-2 days post-op, 3 months, then PRN",
        "action": "Repeat imaging if symptoms change; adjust valve",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Shunt valve setting verification",
        "frequency": "After any MRI; at each clinic visit",
        "action": "Reprogram if reset; ensure appropriate setting",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Neurological exam",
        "frequency": "Each clinic visit",
        "action": "Decline triggers workup for shunt malfunction or alternative diagnosis",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Subdural hematoma surveillance",
        "frequency": "Post-shunt, especially if headache",
        "action": "Adjust valve pressure higher; surgical evacuation if large/symptomatic",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Signs of shunt infection",
        "frequency": "Post-operatively and ongoing",
        "action": "Blood/CSF cultures; shunt tap; IV antibiotics; possible shunt removal",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Urinary symptom diary",
        "frequency": "Baseline and follow-up",
        "action": "Adjust bladder medications; confirm NPH response",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ADL/IADL function",
        "frequency": "Every 6 months",
        "action": "Increase support services; OT reassessment",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Stable symptoms; workup complete; awaiting outpatient tap test; caregiver support available"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Extended lumbar drain trial; post-shunt observation; shunt complication evaluation"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Acute shunt malfunction with altered mental status; symptomatic overdrainage with large subdural; shunt infection with sepsis"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Neurology 2-4 weeks after tap test to review results; Neurosurgery evaluation if positive tap test; post-shunt follow-up at 1-3 months, 6 months, then annually"
      },
      {
        "disposition": "Urgent neurosurgery referral",
        "criteria": "Positive tap test; positive extended drain trial; progressive symptoms with classic imaging findings"
      }
    ]
  },
  "Optic Neuritis": {
    "id": "optic-neuritis",
    "title": "Optic Neuritis",
    "version": "1.1",
    "icd10": [
      "** H46.9 (Optic neuritis",
      "unspecified)",
      "H46.00 (Optic papillitis",
      "unspecified eye)",
      "H46.10 (Retrobulbar neuritis",
      "unspecified eye)",
      "G36.0 (Neuromyelitis optica - if NMOSD confirmed)",
      "H46.8 (Other optic neuritis)"
    ],
    "scope": "** Acute evaluation and management of optic neuritis in adults. Covers typical demyelinating optic neuritis, atypical features requiring expanded workup, MS risk stratification, ONTT-based treatment, and NMO/MOG antibody evaluation. For established MS with optic neuritis as a relapse, can also use \"MS - Exacerbation\" template.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Infection screen, baseline before steroids",
            "target": "Normal"
          },
          {
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Metabolic screen, renal function for contrast",
            "target": "Normal"
          },
          {
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Inflammatory/vasculitis screen; elevated in GCA",
            "target": "Normal (<20 mm/hr); elevated in GCA"
          },
          {
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Inflammatory marker",
            "target": "Normal"
          },
          {
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Pre-steroid baseline",
            "target": "Normal"
          },
          {
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "UTI screen before steroids",
            "target": "Negative"
          }
        ],
        "Extended Workup": [
          {
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Combined NMO/MOGAD screen; critical for atypical cases",
            "target": "Both negative"
          },
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Lupus/connective tissue disease",
            "target": "Negative or low titer"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Thyroid eye disease (Graves ophthalmopathy)",
            "target": "Normal"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Nutritional optic neuropathy",
            "target": "Normal (>300 pg/mL)"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Nutritional optic neuropathy",
            "target": "Normal"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurosyphilis",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HIV-associated optic neuropathy",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurosarcoidosis",
            "target": "Normal"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Endemic areas; Lyme optic neuropathy",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Glycemic status before steroids",
            "target": "<5.7%"
          }
        ],
        "Rare/Specialized": [
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If ANA positive; SLE screen",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Sjogren syndrome",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "CNS/orbital vasculitis",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Paraproteinemic optic neuropathy",
            "target": "No M-spike"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Leber hereditary optic neuropathy (LHON)",
            "target": "Normal"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Wilson disease",
            "target": "Normal"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Paraneoplastic optic neuropathy",
            "target": "Negative"
          }
        ],
        "Lumbar Puncture": [
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out elevated ICP (papilledema mimics)",
            "target": "10-20 cm H2O"
          },
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Inflammation, rule out infection",
            "target": "WBC <50 (mild pleocytosis acceptable); RBC 0"
          },
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Elevated in inflammation",
            "target": "Normal to mildly elevated (<100 mg/dL)"
          },
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Low in infection",
            "target": "Normal (>60% serum)"
          },
          {
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out infection",
            "target": "No organisms"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Intrathecal IgG synthesis (supports MS)",
            "target": ">=2 CSF-specific bands (not in serum)"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Intrathecal antibody synthesis",
            "target": ">0.7 = elevated"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out malignancy",
            "target": "Negative"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurosyphilis",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Within 24-48h",
            "target": "Optic nerve enhancement, swelling; enhancement >50% nerve length suggests atypical/NMOSD",
            "contraindications": "GFR <30, gadolinium allergy"
          },
          {
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "With orbit MRI",
            "target": "Demyelinating lesions (periventricular, juxtacortical, infratentorial); determines MS risk",
            "contraindications": "GFR <30, gadolinium allergy"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Within 1 week if MS suspected",
            "target": "Cord lesions supporting MS diagnosis",
            "contraindications": "GFR <30, gadolinium allergy"
          }
        ],
        "Extended": [
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "During workup",
            "target": "Prolonged P100 latency (confirms optic nerve dysfunction)",
            "contraindications": "None significant"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Baseline and at 3-6 months",
            "target": "RNFL thickening acutely; thinning at follow-up indicates axonal loss",
            "contraindications": "None significant"
          },
          {
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At presentation and follow-up",
            "target": "Central/cecocentral scotoma typical; document baseline",
            "contraindications": "Patient cooperation required"
          }
        ],
        "Rare/Specialized": [
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If sarcoidosis suspected",
            "target": "Hilar lymphadenopathy",
            "contraindications": "Contrast allergy"
          },
          {
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If malignancy/paraneoplastic suspected",
            "target": "FDG-avid lesions",
            "contraindications": "Pregnancy, uncontrolled diabetes"
          },
          {
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-",
            "timing": "Only if MRI unavailable/contraindicated",
            "target": "Optic nerve enlargement, orbital mass",
            "contraindications": "Contrast allergy"
          },
          {
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If retinal/vascular pathology suspected",
            "target": "Disc leakage, vascular abnormality",
            "contraindications": "Dye allergy"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Methylprednisolone",
            "route": "IV",
            "indication": "Acute optic neuritis - accelerates visual recovery per ONTT",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Methylprednisolone 1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg IV daily for 3 days; infuse over 1-2 hours; followed by oral prednisone taper",
              "orderSentence": "Methylprednisolone 1000 mg IV"
            },
            "contraindications": "Active untreated infection; uncontrolled diabetes; active psychosis; severe hypertension",
            "monitoring": "Glucose q6h (target <180); BP; mood; sleep; I/O",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Prednisone oral taper",
            "route": "PO",
            "indication": "Following IV methylprednisolone per ONTT protocol",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg/kg",
                  "orderSentence": "Prednisone oral taper 1 mg/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "1 mg/kg/day (max 80 mg) x 11 days following 3 days IV steroids; then discontinue or rapid taper",
              "orderSentence": "Prednisone oral taper 1 mg/kg PO"
            },
            "contraindications": "Same as IV steroids",
            "monitoring": "Glucose; BP; mood; GI prophylaxis",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Omeprazole",
            "route": "PO",
            "indication": "GI prophylaxis during steroids",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "Omeprazole 20 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "20-40 mg daily during steroid course",
              "orderSentence": "Omeprazole 20 mg PO"
            },
            "contraindications": "PPI allergy; osteoporosis (long-term)",
            "monitoring": "None routine",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Insulin sliding scale",
            "route": "SC",
            "indication": "Steroid-induced hyperglycemia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per protocol",
                  "orderSentence": "Insulin sliding scale Per protocol SC"
                }
              ],
              "route": "SC",
              "instructions": "Per institutional protocol if glucose >180 mg/dL",
              "orderSentence": "Insulin sliding scale Per protocol SC"
            },
            "contraindications": "Hypoglycemia risk",
            "monitoring": "Glucose q6h",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Acetaminophen",
            "route": "PO",
            "indication": "Pain with eye movement",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650-1000 mg",
                  "orderSentence": "Acetaminophen 650-1000 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "650-1000 mg PO q6h as needed for pain; max 3000 mg/day (2000 mg if liver disease)",
              "orderSentence": "Acetaminophen 650-1000 mg PO"
            },
            "contraindications": "Hepatic impairment; chronic alcohol use",
            "monitoring": "LFTs if prolonged use",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ibuprofen",
            "route": "PO",
            "indication": "Pain with eye movement",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400-800 mg",
                  "orderSentence": "Ibuprofen 400-800 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "400-800 mg PO q8h as needed for pain; max 2400 mg/day; take with food",
              "orderSentence": "Ibuprofen 400-800 mg PO"
            },
            "contraindications": "Renal impairment; GI bleeding; concurrent anticoagulation",
            "monitoring": "Renal function if prolonged",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Persistent periorbital pain/neuropathic symptoms",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Gabapentin 300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; increase by 300 mg every 1-3 days; target 900-1800 mg/day divided TID",
              "orderSentence": "Gabapentin 300 mg PO"
            },
            "contraindications": "Renal impairment (adjust dose)",
            "monitoring": "Sedation; dizziness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Artificial tears",
            "route": "TOP",
            "indication": "Dry eye secondary to reduced blink or lagophthalmos",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2 drops",
                  "orderSentence": "Artificial tears 1-2 drops TOP"
                }
              ],
              "route": "TOP",
              "instructions": "Preservative-free artificial tears 1-2 drops q2-4h as needed",
              "orderSentence": "Artificial tears 1-2 drops TOP"
            },
            "contraindications": "None",
            "monitoring": "None",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Plasmapheresis (PLEX)",
            "route": "PLEX",
            "indication": "Steroid-refractory or severe vision loss",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-7 exchanges",
                  "orderSentence": "Plasmapheresis (PLEX) 5-7 exchanges PLEX"
                }
              ],
              "route": "PLEX",
              "instructions": "5-7 exchanges every other day; typical volume 1-1.5 plasma volumes",
              "orderSentence": "Plasmapheresis (PLEX) 5-7 exchanges PLEX"
            },
            "contraindications": "Hemodynamic instability; sepsis; line contraindication",
            "monitoring": "BP; electrolytes; coags; fibrinogen; line infection",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "IVIG",
            "route": "IV",
            "indication": "Steroid-refractory (alternative to PLEX)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg",
                  "orderSentence": "IVIG 0.4 g/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.4 g/kg/day for 5 days (total 2 g/kg); infuse slowly day 1",
              "orderSentence": "IVIG 0.4 g/kg IV"
            },
            "contraindications": "IgA deficiency; renal failure; thrombosis risk",
            "monitoring": "Renal function; headache; thrombosis",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Extended IV steroids",
            "route": "IV",
            "indication": "Incomplete response to 3-day course",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Extended IV steroids 1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Extend to 5-7 total days if inadequate response",
              "orderSentence": "Extended IV steroids 1000 mg IV"
            },
            "contraindications": "Same as initial course",
            "monitoring": "Same as initial course",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Disease-Modifying Therapies (If MS/NMOSD/MOGAD Confirmed)": [
          {
            "item": "MS DMT (various)",
            "route": "Variable",
            "indication": "If MS diagnosed based on MRI + clinical criteria",
            "dosing": {
              "doseOptions": [
                {
                  "text": "See MS - New Diagnosis template",
                  "orderSentence": "MS DMT (various) See MS - New Diagnosis template -"
                }
              ],
              "route": "-",
              "instructions": "See MS - New Diagnosis template",
              "orderSentence": "MS DMT (various) See MS - New Diagnosis template -"
            },
            "pretreatment": "Per specific DMT",
            "contraindications": "Per specific DMT",
            "monitoring": "Per specific DMT",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rituximab",
            "route": "IV",
            "indication": "NMOSD (AQP4-IgG positive)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Rituximab 1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg IV days 1 and 15; maintenance 1000 mg q6 months",
              "orderSentence": "Rituximab 1000 mg IV"
            },
            "pretreatment": "Hepatitis B serology; TB test; immunoglobulins",
            "contraindications": "Active Hep B; active infection",
            "monitoring": "CD19/20; immunoglobulins annually",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Eculizumab (Soliris)",
            "route": "IV",
            "indication": "NMOSD (AQP4-IgG positive) - FDA approved",
            "dosing": {
              "doseOptions": [
                {
                  "text": "900 mg",
                  "orderSentence": "Eculizumab (Soliris) 900 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "900 mg weekly x 4; then 1200 mg at week 5; then 1200 mg q2 weeks",
              "orderSentence": "Eculizumab (Soliris) 900 mg IV"
            },
            "pretreatment": "Meningococcal vaccination (2 weeks prior)",
            "contraindications": "Unresolved Neisseria infection",
            "monitoring": "CBC; LFTs; signs of meningococcal infection",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Immunosuppression (MOGAD)",
            "route": "Variable",
            "indication": "MOGAD (MOG-IgG positive) with relapsing course",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per agent",
                  "orderSentence": "Immunosuppression (MOGAD) Per agent Variable"
                }
              ],
              "route": "Variable",
              "instructions": "Rituximab, azathioprine, or mycophenolate per specialist",
              "orderSentence": "Immunosuppression (MOGAD) Per agent Variable"
            },
            "pretreatment": "Per specific agent",
            "contraindications": "Per specific agent",
            "monitoring": "Per specific agent",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neuro-ophthalmology referral for comprehensive evaluation and follow-up",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neurology/MS specialist referral if brain MRI shows demyelinating lesions",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ophthalmology referral if neuro-ophthalmology unavailable or alternate diagnosis suspected",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MS specialist/Neuroimmunology for DMT discussion if MS criteria met",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Low vision rehabilitation if significant persistent visual impairment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for ADL adaptation if functional visual impairment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for disability resources if visual impairment affects employment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Vision typically improves over 2-4 weeks; 90%+ recover to 20/40 or better within 1 year",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return immediately if vision worsening after initial improvement (may indicate new attack or alternate diagnosis)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return if new symptoms: weakness, numbness, imbalance, bladder problems (may indicate MS)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive if vision in affected eye prevents safe driving; check with state DMV regarding vision requirements",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Heat may temporarily worsen symptoms (Uhthoff phenomenon) - this is not a new attack or permanent worsening",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Expect temporary steroid side effects: insomnia, mood changes, increased appetite, metallic taste during IV infusion",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Do not stop oral prednisone abruptly if on taper (adrenal suppression risk)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Monitor blood sugars if diabetic - steroids elevate glucose",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid sick contacts while on high-dose steroids (immunosuppression)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Keep follow-up appointments - important to monitor for MS development",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Contact physician if fever, new headache, or worsening vision on steroids",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Smoking cessation - smoking increases MS conversion risk and worsens outcomes",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Vitamin D supplementation 2000-5000 IU daily (target serum 25-OH vitamin D >40 ng/mL) - low levels associated with MS risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid prolonged heat exposure (hot tubs, saunas, exercising in heat) which can temporarily worsen vision (Uhthoff)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use sunglasses if photophobia present",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular aerobic exercise as tolerated once acute symptoms resolve",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate sleep (7-8 hours nightly) and stress management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Eye protection during activities if monocular vision (loss of depth perception)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "NMOSD-associated optic neuritis",
        "features": "Severe vision loss (often <20/200); bilateral simultaneous or sequential; poor recovery; longitudinally extensive optic nerve enhancement (>50% nerve length)",
        "tests": "AQP4-IgG positive (Mayo CDS1 or NMOFS); MRI pattern"
      },
      {
        "diagnosis": "MOGAD-associated optic neuritis",
        "features": "Often bilateral; anterior optic nerve involvement; perineural enhancement (\"optic nerve sheath sign\"); disc edema more prominent; better steroid response; tends to relapse",
        "tests": "MOG-IgG positive (Mayo CDS1 or MOGFS)"
      },
      {
        "diagnosis": "Anterior ischemic optic neuropathy (AION)",
        "features": "Sudden painless vision loss; altitudinal field defect; disc edema with hemorrhages; age >50; vascular risk factors (hypertension, diabetes)",
        "tests": "ESR/CRP for GCA; fluorescein angiography; cardiovascular risk assessment"
      },
      {
        "diagnosis": "Giant cell arteritis (GCA)",
        "features": "Age >50; headache; jaw claudication; scalp tenderness; elevated ESR/CRP; bilateral risk",
        "tests": "ESR, CRP, temporal artery biopsy; prompt treatment to prevent fellow eye"
      },
      {
        "diagnosis": "Papilledema",
        "features": "Bilateral disc edema; transient visual obscurations; headache worse lying down; no RAPD unless asymmetric",
        "tests": "LP with elevated opening pressure; MRI/MRV for venous sinus thrombosis"
      },
      {
        "diagnosis": "Compressive optic neuropathy",
        "features": "Progressive vision loss; proptosis; may have disc pallor or edema; optic canal mass",
        "tests": "MRI orbits showing mass lesion; CT for bony detail"
      },
      {
        "diagnosis": "Leber hereditary optic neuropathy (LHON)",
        "features": "Painless; young males; sequential bilateral (weeks to months); central scotoma; no enhancement on MRI",
        "tests": "Mitochondrial DNA testing (mutations: 11778, 3460, 14484)"
      },
      {
        "diagnosis": "Toxic/nutritional optic neuropathy",
        "features": "Bilateral symmetric; ethambutol, methanol, B12/folate deficiency; cecocentral scotoma",
        "tests": "B12, folate, medication history, alcohol use"
      },
      {
        "diagnosis": "Neurosyphilis",
        "features": "May mimic optic neuritis; other neurologic signs; risk factors",
        "tests": "RPR/VDRL, FTA-ABS, CSF VDRL"
      },
      {
        "diagnosis": "Sarcoidosis",
        "features": "Granulomatous optic neuropathy; uveitis; other systemic involvement",
        "tests": "ACE, chest CT, tissue biopsy"
      },
      {
        "diagnosis": "Idiopathic intracranial hypertension (IIH)",
        "features": "Bilateral disc edema; obese young female; headache; transient visual obscurations",
        "tests": "LP with elevated opening pressure; normal MRI/MRV"
      }
    ],
    "evidence": [
      {
        "recommendation": "IV methylprednisolone accelerates visual recovery but does not change final outcome",
        "evidenceLevel": "Class I, Level A",
        "source": "[Beck RW et al. NEJM 1992 (ONTT)](https://pubmed.ncbi.nlm.nih.gov/1594973/)"
      },
      {
        "recommendation": "Oral prednisone alone (1 mg/kg) increases recurrence rate - avoid as monotherapy",
        "evidenceLevel": "Class I, Level A",
        "source": "[Beck RW et al. NEJM 1992 (ONTT)](https://pubmed.ncbi.nlm.nih.gov/1594973/)"
      },
      {
        "recommendation": "Visual prognosis excellent: 90%+ recover to 20/40 or better by 1 year",
        "evidenceLevel": "Class I",
        "source": "[Beck RW et al. Arch Ophthalmol 1993](https://pubmed.ncbi.nlm.nih.gov/8517838/)"
      },
      {
        "recommendation": "Brain MRI lesions predict MS: 50% at 15 years with >=1 lesion vs 25% with normal MRI",
        "evidenceLevel": "Class I",
        "source": "[Beck RW et al. NEJM 2003 (ONTT 10-year)](https://pubmed.ncbi.nlm.nih.gov/12660385/); [Optic Neuritis Study Group 2008 (15-year)](https://pubmed.ncbi.nlm.nih.gov/18332318/)"
      },
      {
        "recommendation": "Cell-based assay (FACS) preferred for AQP4/MOG antibody testing",
        "evidenceLevel": "Class II, Level B",
        "source": "[Pittock SJ et al. Neurology 2019](https://pubmed.ncbi.nlm.nih.gov/31434689/); [Waters P et al. J Neurol Neurosurg Psychiatry 2014](https://pubmed.ncbi.nlm.nih.gov/24009151/)"
      },
      {
        "recommendation": "MOG-IgG associated with better visual recovery and relapsing course",
        "evidenceLevel": "Class II",
        "source": "[Jarius S et al. J Neuroinflammation 2018](https://pubmed.ncbi.nlm.nih.gov/30153836/)"
      },
      {
        "recommendation": "PLEX beneficial for steroid-refractory demyelinating optic neuritis",
        "evidenceLevel": "Class II, Level B",
        "source": "[Roesner S et al. J Neurol 2012](https://pubmed.ncbi.nlm.nih.gov/21822932/)"
      },
      {
        "recommendation": "VEP shows prolonged P100 latency in optic neuritis",
        "evidenceLevel": "Class I",
        "source": "[Halliday AM et al. Lancet 1972](https://pubmed.ncbi.nlm.nih.gov/4113644/)"
      },
      {
        "recommendation": "OCT RNFL thinning correlates with visual outcomes",
        "evidenceLevel": "Class II",
        "source": "[Trip SA et al. Brain 2005](https://pubmed.ncbi.nlm.nih.gov/16006539/)"
      },
      {
        "recommendation": "Vitamin D deficiency associated with increased MS risk after optic neuritis",
        "evidenceLevel": "Class II",
        "source": "[Munger KL et al. JAMA 2006](https://pubmed.ncbi.nlm.nih.gov/17179460/)"
      },
      {
        "recommendation": "Smoking increases MS conversion risk after CIS",
        "evidenceLevel": "Class II, Level B",
        "source": "[Hedstrom AK et al. Brain 2013](https://pubmed.ncbi.nlm.nih.gov/23365092/)"
      }
    ],
    "monitoring": [
      {
        "item": "Visual acuity",
        "frequency": "Daily inpatient; each visit OPD",
        "action": "If no improvement by 2 weeks, reconsider diagnosis or escalate treatment",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Color vision (Ishihara or HRR plates)",
        "frequency": "Baseline and follow-up",
        "action": "Persistent dyschromatopsia suggests residual dysfunction",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Pupillary exam (RAPD)",
        "frequency": "Daily inpatient; each visit OPD",
        "action": "Persistent or worsening RAPD concerning",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Blood glucose",
        "frequency": "Q6h during IV steroids",
        "action": "Insulin sliding scale; endocrine consult if persistent >250",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "-"
      },
      {
        "item": "Blood pressure",
        "frequency": "Q shift during steroids",
        "action": "Antihypertensives PRN",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "-"
      },
      {
        "item": "Mood and sleep",
        "frequency": "Daily during steroids",
        "action": "Psychiatry consult; consider dose reduction",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "-"
      },
      {
        "item": "Visual field (formal)",
        "frequency": "Baseline, 1 month, 3 months, 6 months",
        "action": "Worsening field concerning for progression",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "OCT (RNFL thickness)",
        "frequency": "Baseline, 3 months, 6 months",
        "action": ">20 micron loss associated with poorer outcome",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "MRI brain (follow-up)",
        "frequency": "3-6 months after initial; annually if MS risk",
        "action": "If new lesions: MS diagnosed, start DMT",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "NMO/MOG antibodies (recheck)",
        "frequency": "Repeat at 3-6 months if initially negative but atypical features",
        "action": "If seroconversion: diagnosis changes, different treatment",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Mild-moderate vision loss with stable exam; able to perform ADLs safely; IV steroids completed or not indicated; reliable follow-up within 1-2 weeks with neuro-ophthalmology or neurology; understands return precautions"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Severe vision loss (20/200 or worse); bilateral involvement; diagnostic uncertainty requiring expedited workup; unable to care for self safely at home due to vision loss; IV steroids indicated and outpatient infusion not available"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Not typically required for isolated optic neuritis; consider if concurrent severe neurologic involvement (e.g., NMOSD with myelitis and respiratory compromise)"
      },
      {
        "disposition": "Transfer to higher level",
        "criteria": "Neuro-ophthalmology or MS specialist not available; PLEX needed but unavailable; MRI unavailable for urgent imaging"
      }
    ]
  },
  "Acute Myelopathy Evaluation": {
    "id": "acute-myelopathy",
    "title": "Acute Myelopathy Evaluation",
    "version": "1.0",
    "icd10": [
      "** G95.9 (Disease of spinal cord",
      "unspecified)",
      "G95.89 (Other specified diseases of spinal cord)",
      "G37.3 (Acute transverse myelitis in demyelinating disease)"
    ],
    "scope": "** Acute or subacute spinal cord dysfunction — broad differential approach. Covers urgent MRI, LP, and comprehensive workup to differentiate compressive (epidural abscess, tumor, disc herniation, hematoma) from non-compressive causes (inflammatory/demyelinating, vascular, infectious). Compressive myelopathy is a surgical emergency. Excludes chronic cervical spondylotic myelopathy, cauda equina syndrome (separate template), and isolated radiculopathy.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Infection screen (epidural abscess); baseline; leukocytosis",
            "target": "Normal"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Renal/hepatic function for contrast and medication dosing; electrolytes",
            "target": "Normal"
          },
          {
            "item": "ESR",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Markedly elevated in epidural abscess (>20 in ~95%); elevated in inflammatory/autoimmune",
            "target": "Normal; >20 raises concern for abscess/infection"
          },
          {
            "item": "CRP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Elevated in infection, inflammation; useful for monitoring treatment response",
            "target": "Normal"
          },
          {
            "item": "Blood cultures x2",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "If epidural abscess or infection suspected; S. aureus most common",
            "target": "No growth"
          },
          {
            "item": "PT/INR, aPTT",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Coagulopathy causing epidural hematoma; pre-LP; pre-surgical assessment",
            "target": "Normal"
          },
          {
            "item": "Blood glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Diabetic risk factor for epidural abscess; baseline",
            "target": "Normal"
          },
          {
            "item": "Urinalysis",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "UTI as source for epidural abscess; baseline bladder function",
            "target": "Normal"
          },
          {
            "item": "Type and screen",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Potential surgical intervention",
            "target": "On file"
          },
          {
            "item": "Procalcitonin",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Bacterial infection differentiation",
            "target": "<0.5 ng/mL"
          }
        ],
        "Extended Workup": [
          {
            "item": "AQP4-IgG (aquaporin-4 antibody, serum) — cell-based assay",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "NMOSD — longitudinally extensive transverse myelitis (≥3 segments); affects treatment (avoid interferon-beta, fingolimod)",
            "target": "Negative (positive = NMOSD)"
          },
          {
            "item": "MOG-IgG antibody (serum) — cell-based assay",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "MOGAD — often presents as myelitis; treatment implications differ from MS and NMOSD",
            "target": "Negative (positive = MOGAD)"
          },
          {
            "item": "B12, methylmalonic acid",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Subacute combined degeneration (posterior columns + corticospinal tracts)",
            "target": "Normal"
          },
          {
            "item": "Copper and ceruloplasmin",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Copper deficiency myelopathy (mimics B12 deficiency pattern)",
            "target": "Normal"
          },
          {
            "item": "Zinc level",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Zinc excess causes copper deficiency",
            "target": "Normal"
          },
          {
            "item": "HIV 1/2 antigen/antibody",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HIV-associated vacuolar myelopathy; opportunistic infections",
            "target": "Negative"
          },
          {
            "item": "HTLV-1/2 antibody",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP)",
            "target": "Negative"
          },
          {
            "item": "RPR/VDRL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Syphilitic myelitis (tabes dorsalis = posterior columns)",
            "target": "Non-reactive"
          },
          {
            "item": "ANA, dsDNA",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Lupus myelitis",
            "target": "Negative"
          },
          {
            "item": "Anti-SSA (Ro), anti-SSB (La)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Sjögren syndrome myelitis",
            "target": "Negative"
          },
          {
            "item": "ACE level (serum)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurosarcoidosis (spinal cord granulomas)",
            "target": "Normal"
          },
          {
            "item": "QuantiFERON-TB Gold",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Spinal TB (Pott disease, TB myelitis)",
            "target": "Negative"
          },
          {
            "item": "Anti-thyroid antibodies (TPO, thyroglobulin)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hashimoto encephalopathy/myelopathy",
            "target": "Negative"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Paraneoplastic panel (serum) — ANNA-1, CRMP-5, amphiphysin",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Paraneoplastic myelitis (lung, breast, lymphoma); amphiphysin is classic for stiff-person / paraneoplastic myelopathy",
            "target": "Negative"
          },
          {
            "item": "Anti-GFAP antibody (serum and CSF)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "GFAP astrocytopathy — autoimmune meningoencephalomyelitis",
            "target": "Negative"
          },
          {
            "item": "Antiphospholipid antibodies (lupus anticoagulant, anticardiolipin, β2-glycoprotein I)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Spinal cord infarction from hypercoagulable state",
            "target": "Negative"
          },
          {
            "item": "Serum protein electrophoresis (SPEP)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Multiple myeloma (spinal cord compression from plasmacytoma); POEMS",
            "target": "Normal"
          },
          {
            "item": "Lyme antibody (ELISA, Western blot)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Lyme myelitis (endemic areas)",
            "target": "Negative"
          },
          {
            "item": "CMV PCR (blood)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "rationale": "CMV myelitis (immunocompromised)",
            "target": "Negative"
          },
          {
            "item": "VZV IgM, VZV PCR (blood)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "rationale": "VZV myelitis (may follow shingles)",
            "target": "Negative"
          },
          {
            "item": "Sickle cell screen",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Spinal cord infarction in sickle cell disease",
            "target": "Normal"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Elevated in some inflammatory conditions",
            "target": "Normal (10-20 cm H2O)"
          },
          {
            "item": "Cell count with differential (tubes 1 and 4)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Pleocytosis: infection, inflammation. MS: mild. NMOSD: moderate with neutrophils. Infection: marked",
            "target": "Variable by etiology"
          },
          {
            "item": "Protein",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Elevated in GBS, infection, NMOSD, cord compression",
            "target": "Variable"
          },
          {
            "item": "Glucose with paired serum",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Low in TB, bacterial, fungal, leptomeningeal malignancy",
            "target": "Normal in most inflammatory causes"
          },
          {
            "item": "Oligoclonal bands (paired with serum)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Positive in MS (>90%); may be positive in NMOSD, sarcoidosis",
            "target": "Positive bands in CSF only = intrathecal synthesis (MS)"
          },
          {
            "item": "IgG index",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Elevated in MS and other inflammatory conditions",
            "target": "Normal <0.7"
          },
          {
            "item": "AQP4-IgG (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "NMOSD confirmation (serum is more sensitive; CSF adds specificity)",
            "target": "Negative"
          },
          {
            "item": "MOG-IgG (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "MOGAD confirmation",
            "target": "Negative"
          },
          {
            "item": "Autoimmune encephalitis panel (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "GFAP, NMDAR (rare spinal involvement)",
            "target": "Negative"
          },
          {
            "item": "Cytology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Leptomeningeal carcinomatosis, lymphoma",
            "target": "Negative"
          },
          {
            "item": "Flow cytometry",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "CNS lymphoma",
            "target": "Normal"
          },
          {
            "item": "VDRL (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Neurosyphilis",
            "target": "Non-reactive"
          },
          {
            "item": "ACE level (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Neurosarcoidosis",
            "target": "Normal"
          },
          {
            "item": "HSV 1/2 PCR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "HSV myelitis (rare)",
            "target": "Negative"
          },
          {
            "item": "VZV PCR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "VZV myelitis (may follow shingles)",
            "target": "Negative"
          },
          {
            "item": "CMV PCR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "CMV myelitis (immunocompromised)",
            "target": "Negative"
          },
          {
            "item": "EBV PCR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "EBV-associated lymphoma/myelitis",
            "target": "Negative"
          },
          {
            "item": "HTLV-1 antibody (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "HAM/TSP confirmation",
            "target": "Negative"
          },
          {
            "item": "AFB smear and culture",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Spinal TB",
            "target": "Negative"
          },
          {
            "item": "Bacterial culture",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Bacterial myelitis (rare)",
            "target": "No growth"
          },
          {
            "item": "Cryptococcal antigen",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Cryptococcal myelitis (immunocompromised)",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI entire spine (cervical, thoracic, lumbar) with and without gadolinium contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "URGENT",
            "ICU": "STAT",
            "timing": "IMMEDIATELY — within 4 hours of presentation maximum; faster if progressive deficit. Entire spine because multifocal lesions change differential (NMOSD, metastatic)",
            "target": "Compressive: epidural mass (abscess, tumor, hematoma), disc herniation. Non-compressive: cord signal change (T2 hyperintensity), enhancement pattern, longitudinal extent, location within cord cross-section",
            "contraindications": "GFR <30 (give contrast anyway if emergent); gadolinium allergy (premedicate); pacemaker"
          },
          {
            "item": "MRI brain with and without contrast",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Within 24h (same session if possible)",
            "target": "MS (periventricular/juxtacortical lesions), NMOSD (area postrema, hypothalamic), ADEM (multifocal white matter), metastatic disease, leptomeningeal enhancement",
            "contraindications": "Same as spine MRI"
          },
          {
            "item": "CT spine (without contrast)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "ONLY if MRI unavailable or contraindicated; far less sensitive for cord pathology",
            "target": "Fracture, bony compression, large epidural mass, disc herniation",
            "contraindications": "Pregnancy (relative)"
          },
          {
            "item": "Chest X-ray",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "Baseline; lung malignancy screening (metastatic cord compression); sarcoidosis (hilar adenopathy)",
            "target": "Normal"
          }
        ],
        "Extended": [
          {
            "item": "CT chest/abdomen/pelvis with contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If metastatic cord compression or sarcoidosis suspected",
            "target": "Primary malignancy; lymphadenopathy",
            "contraindications": "Contrast allergy, renal impairment"
          },
          {
            "item": "CT angiography (CTA) of aorta",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "If spinal cord infarction suspected (especially post-aortic surgery)",
            "target": "Aortic dissection, aortic aneurysm, occlusion of artery of Adamkiewicz",
            "contraindications": "Same as CT contrast"
          },
          {
            "item": "MR angiography (MRA) of spinal vessels",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Spinal dural arteriovenous fistula (dAVF); spinal AVM",
            "target": "Abnormal vascular flow voids; fistula identification",
            "contraindications": "Same as MRI"
          },
          {
            "item": "Conventional spinal angiography (DSA)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Gold standard for spinal dAVF/AVM; if MRA suggestive",
            "target": "Fistula or AVM identification and localization for treatment",
            "contraindications": "Contrast allergy; coagulopathy"
          },
          {
            "item": "PET-CT (whole body)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Occult malignancy search",
            "target": "Primary tumor",
            "contraindications": "Pregnancy; uncontrolled diabetes"
          },
          {
            "item": "Repeat MRI spine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At 2-4 weeks for treatment response; earlier if clinical worsening",
            "target": "Improving signal; resolving enhancement",
            "contraindications": "Same as initial"
          },
          {
            "item": "NCS/EMG",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If concomitant peripheral neuropathy suspected (e.g., GBS mimicking myelopathy)",
            "target": "Peripheral nerve involvement vs pure cord",
            "contraindications": "None significant"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Somatosensory evoked potentials (SSEPs)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Assess dorsal column function; prognosis",
            "target": "Delayed or absent cortical potentials",
            "contraindications": "None"
          },
          {
            "item": "Motor evoked potentials (MEPs)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Corticospinal tract assessment",
            "target": "Delayed or absent",
            "contraindications": "Epilepsy (relative); implanted devices"
          },
          {
            "item": "Spinal cord biopsy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Extremely rare; only for diagnostic uncertainty when all other testing inconclusive and progressive decline",
            "target": "Tumor, vasculitis, infection, sarcoidosis",
            "contraindications": "High morbidity; neurosurgical decision"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "IV methylprednisolone (empiric — inflammatory myelitis)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "IV methylprednisolone (empiric — inflammatory myelitis) 1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg IV daily x 3-5 days (infuse over 1-2h). Start empirically if inflammatory myelitis suspected (non-compressive cord lesion on MRI). Do NOT wait for antibody results",
              "orderSentence": "IV methylprednisolone (empiric — inflammatory myelitis) 1000 mg IV"
            },
            "contraindications": "Active untreated infection (relative — treat infection concurrently if needed); uncontrolled diabetes",
            "monitoring": "Glucose q6h; BP; GI prophylaxis (PPI); insomnia; psychosis (rare); weight; taper plan",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Emergent surgical decompression",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "For compressive myelopathy: epidural abscess, tumor with cord compression, acute disc herniation with myelopathy, epidural hematoma. Earlier decompression = better neurologic outcome. Within 24h is critical; within 12h is ideal",
              "orderSentence": "Emergent surgical decompression - - - see dosing"
            },
            "contraindications": "Medically unstable for surgery (optimize first)",
            "monitoring": "Post-op neurologic exam; wound care; DVT prophylaxis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Empiric IV antibiotics (if epidural abscess suspected)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15-20 mg/kg",
                  "orderSentence": "Empiric IV antibiotics (if epidural abscess suspected) 15-20 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "Vancomycin 15-20 mg/kg IV q8-12h + ceftriaxone 2g IV q12h (or cefepime 2g IV q8h). Start BEFORE surgery. S. aureus is most common organism",
              "orderSentence": "Empiric IV antibiotics (if epidural abscess suspected) 15-20 mg/kg IV"
            },
            "contraindications": "See individual agents",
            "monitoring": "Cultures; vancomycin trough; renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "DVT prophylaxis: Enoxaparin",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "DVT prophylaxis: Enoxaparin 40 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily (start post-operatively or when not bleeding; within 24-48h)",
              "orderSentence": "DVT prophylaxis: Enoxaparin 40 mg SC"
            },
            "contraindications": "Active bleeding; post-surgical (timing per surgeon); coagulopathy",
            "monitoring": "Platelets q3 days",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pneumatic compression devices",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Apply bilaterally immediately — spinal cord injury patients are HIGH risk for DVT/PE",
              "orderSentence": "Pneumatic compression devices - - - see dosing"
            },
            "contraindications": "Acute DVT",
            "monitoring": "Skin checks",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Bladder management",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mL",
                  "orderSentence": "Bladder management 200 mL -"
                }
              ],
              "route": "-",
              "instructions": "Foley catheter if urinary retention (very common in myelopathy); measure post-void residual if not catheterized; intermittent catheterization if PVR >200 mL",
              "orderSentence": "Bladder management 200 mL -"
            },
            "contraindications": "N/A",
            "monitoring": "I/O; bladder scan; transition to intermittent cath when possible",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Bowel management",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Bowel program: docusate + senna; digital stimulation if neurogenic bowel; avoid impaction",
              "orderSentence": "Bowel management - - - see dosing"
            },
            "contraindications": "Bowel obstruction",
            "monitoring": "Bowel function daily",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          }
        ],
        "Second-line / Specific Treatments": [
          {
            "item": "Plasma exchange (PLEX)",
            "route": "-",
            "indication": "Steroid-refractory inflammatory myelitis; NMOSD exacerbation; severe transverse myelitis",
            "dosing": {
              "instructions": "5-7 exchanges over 10-14 days (every other day); 1-1.5 plasma volumes per exchange",
              "orderSentence": "Plasma exchange (PLEX) - - - see dosing"
            },
            "contraindications": "Hemodynamic instability; sepsis",
            "monitoring": "BP; electrolytes; Ca2+; fibrinogen",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "IVIG",
            "route": "-",
            "indication": "Alternative to PLEX if PLEX unavailable; MOGAD (may be preferred); steroid-refractory",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg",
                  "orderSentence": "IVIG 0.4 g/kg -"
                }
              ],
              "route": "-",
              "instructions": "0.4 g/kg/day x 5 days (total 2 g/kg)",
              "orderSentence": "IVIG 0.4 g/kg -"
            },
            "contraindications": "IgA deficiency; renal failure",
            "monitoring": "Renal function; headache; thrombosis",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Oral prednisone taper (after IV pulse)",
            "route": "IV",
            "indication": "Inflammatory myelitis; NMOSD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg/kg",
                  "orderSentence": "Oral prednisone taper (after IV pulse) 1 mg/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "1 mg/kg/day (max 60-80 mg) tapered over 4-8 weeks for first episode; longer taper for NMOSD/MOGAD",
              "orderSentence": "Oral prednisone taper (after IV pulse) 1 mg/kg PO"
            },
            "contraindications": "See steroid contraindications",
            "monitoring": "Glucose; BP; bone health",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Neuropathic pain, spasticity",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Gabapentin 300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "300 mg PO qHS → titrate to 900-1800 mg TID",
              "orderSentence": "Gabapentin 300 mg PO"
            },
            "contraindications": "Severe renal impairment",
            "monitoring": "Sedation; dizziness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Baclofen",
            "route": "PO",
            "indication": "Spasticity",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Baclofen 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "5 mg PO TID; increase by 5 mg/dose q3 days; max 80 mg/day",
              "orderSentence": "Baclofen 5 mg PO"
            },
            "contraindications": "Seizure history (lowers threshold); abrupt withdrawal causes seizures",
            "monitoring": "Sedation; falls; do NOT stop abruptly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tizanidine",
            "route": "PO",
            "indication": "Spasticity (alternative)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg",
                  "orderSentence": "Tizanidine 2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "2 mg PO TID; max 36 mg/day",
              "orderSentence": "Tizanidine 2 mg PO"
            },
            "contraindications": "Hepatic impairment; concurrent CYP1A2 inhibitors (ciprofloxacin)",
            "monitoring": "LFTs; sedation; hypotension",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxybutynin",
            "route": "PO",
            "indication": "Neurogenic bladder (overactive)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Oxybutynin 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "5 mg PO BID-TID",
              "orderSentence": "Oxybutynin 5 mg PO"
            },
            "contraindications": "Urinary retention; angle-closure glaucoma",
            "monitoring": "Anticholinergic side effects; PVR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Acetaminophen",
            "route": "PO",
            "indication": "Pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650-1000 mg",
                  "orderSentence": "Acetaminophen 650-1000 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "650-1000 mg PO q6h; max 4g/day",
              "orderSentence": "Acetaminophen 650-1000 mg PO"
            },
            "contraindications": "Hepatic disease",
            "monitoring": "LFTs",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Disease-Modifying Therapy (Once Diagnosis Established)": [
          {
            "item": "MS disease-modifying therapy",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Per MS-specific template; high-efficacy preferred if myelitis presentation",
              "orderSentence": "MS disease-modifying therapy - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "Per agent",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Rituximab",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "375 mg/m2",
                  "orderSentence": "Rituximab 375 mg/m2 PO"
                }
              ],
              "route": "PO",
              "instructions": "375 mg/m2 weekly x 4 weeks OR 1000 mg x 2 (14 days apart); maintenance q6 months",
              "orderSentence": "Rituximab 375 mg/m2 PO"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "CD19/20; immunoglobulins; infection",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Eculizumab",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "900 mg",
                  "orderSentence": "Eculizumab 900 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "900 mg IV weekly x 4 → 1200 mg q2 weeks",
              "orderSentence": "Eculizumab 900 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "Meningococcal vaccination (≥2 weeks before); complement levels; infection",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Inebilizumab",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Inebilizumab 300 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "300 mg IV x 2 (14 days apart); then 300 mg q6 months",
              "orderSentence": "Inebilizumab 300 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "CD19; infection",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Satralizumab",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "120 mg",
                  "orderSentence": "Satralizumab 120 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "120 mg SC at weeks 0, 2, 4, then q4 weeks",
              "orderSentence": "Satralizumab 120 mg SC"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "LFTs; infection",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Azathioprine",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-3 mg/kg",
                  "orderSentence": "Azathioprine 2-3 mg/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "2-3 mg/kg/day PO",
              "orderSentence": "Azathioprine 2-3 mg/kg PO"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "TPMT genotype; CBC weekly x 4, then biweekly, then monthly; LFTs",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Mycophenolate mofetil",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000-1500 mg",
                  "orderSentence": "Mycophenolate mofetil 1000-1500 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "1000-1500 mg PO BID",
              "orderSentence": "Mycophenolate mofetil 1000-1500 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "CBC; LFTs; pregnancy test (teratogenic)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Anti-TB therapy",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "RIPE x 12-18 months",
              "orderSentence": "Anti-TB therapy - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "LFTs; visual acuity",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "IV penicillin G",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "18-24 MU/day IV x 14 days",
              "orderSentence": "IV penicillin G - IV - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "RPR q3-6 months",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Radiation + surgery + steroids",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Radiation + surgery + steroids 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Per oncology; dexamethasone 10 mg IV load → 4 mg IV q6h while radiation planned",
              "orderSentence": "Radiation + surgery + steroids 10 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "Glucose; GI prophylaxis",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology (neuro-immunology if available)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT",
            "ICU": "STAT",
            "indication": "All myelopathy; diagnostic workup direction; immunotherapy decisions"
          },
          {
            "item": "Neurosurgery",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Compressive myelopathy (abscess, tumor, hematoma, disc); surgical timing critical"
          },
          {
            "item": "Spine surgery (orthopedic)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Alternative for compressive causes where neurosurgery unavailable"
          },
          {
            "item": "Radiation oncology",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "indication": "Metastatic cord compression; radiation planning"
          },
          {
            "item": "Oncology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Newly diagnosed malignancy; systemic treatment"
          },
          {
            "item": "Infectious disease",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Epidural abscess management; TB; HIV; unusual infections"
          },
          {
            "item": "Urology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Neurogenic bladder management; intermittent catheterization training; urodynamics"
          },
          {
            "item": "Physical therapy (PT)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Mobility assessment; strengthening; gait training; transfer training; wheelchair assessment"
          },
          {
            "item": "Occupational therapy (OT)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "ADL assessment; hand function; adaptive equipment; home modifications"
          },
          {
            "item": "Rehabilitation medicine (physiatry)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Rehabilitation planning; SCI rehabilitation protocols; disposition"
          },
          {
            "item": "Speech-language pathology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "If cervical myelopathy affecting swallowing"
          },
          {
            "item": "Respiratory therapy",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "If cervical myelopathy affecting respiratory muscles; FVC monitoring"
          },
          {
            "item": "Social work",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Discharge planning; DME; caregiver support; disability"
          },
          {
            "item": "Psychology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Adjustment disorder; depression; coping with disability"
          },
          {
            "item": "Pain management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Neuropathic pain refractory to standard agents"
          },
          {
            "item": "Wound care (if pressure injury)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "indication": "Immobile patients at high risk for pressure ulcers"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return to ED immediately if: new weakness, worsening numbness, loss of bowel/bladder function, inability to walk, difficulty breathing",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Spinal cord injury can improve with treatment — recovery varies by cause (inflammatory often recovers well; vascular and compressive recovery depends on timing)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Bladder management is critical: perform intermittent catheterization as instructed; report urinary retention or incontinence",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Bowel program compliance: maintain regular schedule; adequate fiber and fluids",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Skin checks daily: pressure injury prevention (reposition every 2h if immobile; use pressure-relieving mattress)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Physical therapy exercises between sessions as instructed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do NOT drive until cleared by neurology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Follow-up with neurology in 1-2 weeks; repeat MRI at 2-4 weeks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Pressure injury prevention (positioning, specialized mattress, skin checks)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Fall prevention (assistive devices, home modifications)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "DVT prevention (compression stockings long-term; anticoagulation per protocol)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Autonomic dysreflexia awareness (if thoracic/cervical injury: sudden hypertension, headache, flushing above level — emergency)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Bladder health (adequate fluid intake; catheterization technique; UTI prevention)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Mental health support (spinal cord injury carries high depression/anxiety rates)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Vaccination (if starting immunosuppression: complete vaccines before rituximab/eculizumab)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Epidural abscess",
        "features": "Back pain + fever + neurologic deficit (triad in 10-15%); IVDU, diabetes, spinal procedure risk factors; ESR/CRP very elevated",
        "tests": "MRI with contrast (ring-enhancing epidural collection); blood cultures; ESR >20"
      },
      {
        "diagnosis": "Metastatic cord compression",
        "features": "Known malignancy; progressive back pain (often worse at night); bony destruction",
        "tests": "MRI (enhancing epidural mass with bony changes); CT body for primary; PET-CT"
      },
      {
        "diagnosis": "Disc herniation (acute)",
        "features": "Sudden onset; radiculopathy predominant initially; may progress to myelopathy",
        "tests": "MRI (disc protrusion with cord compression)"
      },
      {
        "diagnosis": "Epidural hematoma",
        "features": "Anticoagulation; post-procedure; coagulopathy; sudden onset",
        "tests": "MRI (epidural collection; T1 signal depends on age of blood); coagulation panel"
      },
      {
        "diagnosis": "Transverse myelitis (idiopathic)",
        "features": "Non-compressive; T2 cord signal change; may be partial or complete; often thoracic",
        "tests": "MRI (T2 hyperintensity <3 segments); LP (pleocytosis); diagnose after excluding MS, NMOSD, MOGAD"
      },
      {
        "diagnosis": "MS (spinal cord relapse)",
        "features": "Partial myelitis (<3 segments); brain lesions present; prior episodes; young adult",
        "tests": "MRI brain (periventricular/juxtacortical lesions); oligoclonal bands; short segment cord lesion"
      },
      {
        "diagnosis": "NMOSD",
        "features": "Longitudinally extensive transverse myelitis (LETM ≥3 segments); severe; often central cord/gray matter",
        "tests": "AQP4-IgG antibody; MRI (LETM, central cord pattern); brain MRI (area postrema lesion)"
      },
      {
        "diagnosis": "MOGAD",
        "features": "LETM possible; conus/lower cord predilection; may have bilateral optic neuritis",
        "tests": "MOG-IgG antibody; MRI pattern; generally better recovery than NMOSD"
      },
      {
        "diagnosis": "Spinal cord infarction",
        "features": "Hyperacute onset (minutes); anterior spinal artery syndrome (motor + pain/temperature loss, preserved proprioception/vibration); often thoracolumbar",
        "tests": "MRI DWI (restricted diffusion, \"owl eye\" or pencil-like on axial); CTA aorta; vascular risk factors"
      },
      {
        "diagnosis": "Spinal dural AV fistula",
        "features": "Older male; progressive myelopathy with flow voids on MRI; dorsal cord; edema disproportionate to enhancement",
        "tests": "MRI (flow voids, dorsal cord edema, enhancement); spinal angiography (gold standard)"
      },
      {
        "diagnosis": "GBS (axonal variant)",
        "features": "Ascending weakness; areflexia; may mimic acute myelopathy if rapidly progressive; CSF albuminocytologic dissociation",
        "tests": "NCS/EMG; LP (elevated protein, normal cells); no cord signal on MRI"
      },
      {
        "diagnosis": "Neurosarcoidosis",
        "features": "Dorsal subpial enhancement; trident sign; may have pulmonary sarcoidosis",
        "tests": "Chest CT; ACE level; biopsy; characteristic MRI pattern"
      },
      {
        "diagnosis": "Spinal TB (Pott disease)",
        "features": "Endemic area; systemic TB; vertebral body destruction with epidural abscess; gibbus deformity",
        "tests": "MRI; AFB culture; TB PCR; QuantiFERON; chest X-ray"
      },
      {
        "diagnosis": "Neuromyelitis optica spectrum disorder — See NMOSD above",
        "features": "",
        "tests": ""
      },
      {
        "diagnosis": "Syphilitic myelitis (tabes dorsalis)",
        "features": "Posterior column dysfunction (proprioception, vibration loss); lightning pains; Argyll Robertson pupils",
        "tests": "CSF VDRL; RPR; FTA-ABS"
      },
      {
        "diagnosis": "Copper deficiency myelopathy",
        "features": "Posterior column + corticospinal tract (mimics B12 deficiency); gastric surgery, zinc excess",
        "tests": "Serum copper and ceruloplasmin; zinc level"
      },
      {
        "diagnosis": "Radiation myelopathy",
        "features": "History of radiation; months to years after treatment; progressive; no enhancement (chronic)",
        "tests": "Radiation history; MRI (cord atrophy, signal change within radiation field)"
      },
      {
        "diagnosis": "Functional neurological disorder",
        "features": "Non-anatomic sensory loss; Hoover sign; give-way weakness; normal MRI",
        "tests": "Normal MRI; normal LP; clinical exam findings"
      }
    ],
    "evidence": [
      {
        "recommendation": "STAT MRI entire spine for acute myelopathy",
        "evidenceLevel": "Class I, Level B",
        "source": "AAN Practice Guideline; [Transverse Myelitis Consortium Working Group (2002)](https://pubmed.ncbi.nlm.nih.gov/12236201/)"
      },
      {
        "recommendation": "IV methylprednisolone 1g/day x 3-5 days for inflammatory myelitis",
        "evidenceLevel": "Class I, Level B",
        "source": "Consensus; extrapolated from MS relapse data (ONTT) and TM studies"
      },
      {
        "recommendation": "PLEX for steroid-refractory inflammatory myelitis",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[Weinshenker et al. (Ann Neurol 1999)](https://pubmed.ncbi.nlm.nih.gov/10589540/); superior to sham in severe demyelinating attacks"
      },
      {
        "recommendation": "AQP4-IgG (cell-based assay) for NMOSD diagnosis",
        "evidenceLevel": "Class I, Level A",
        "source": "[Wingerchuk et al. IPND 2015 criteria](https://pubmed.ncbi.nlm.nih.gov/26092914/)"
      },
      {
        "recommendation": "MOG-IgG for MOGAD diagnosis",
        "evidenceLevel": "Class I, Level B",
        "source": "[Banwell et al. (Lancet Neurol 2023)](https://pubmed.ncbi.nlm.nih.gov/36706773/)"
      },
      {
        "recommendation": "Surgical decompression within 24h for compressive myelopathy",
        "evidenceLevel": "Class I, Level B",
        "source": "[Fehlings et al. (2012)](https://pubmed.ncbi.nlm.nih.gov/22384132/); earlier surgery = better outcomes"
      },
      {
        "recommendation": "Epidural abscess: antibiotics + surgical drainage",
        "evidenceLevel": "Class I, Level B",
        "source": "[Darouiche et al. (NEJM 2006)](https://pubmed.ncbi.nlm.nih.gov/17093252/)"
      },
      {
        "recommendation": "B12 replacement for subacute combined degeneration",
        "evidenceLevel": "Class I, Level A",
        "source": "Well-established; early treatment may be reversible"
      },
      {
        "recommendation": "Rituximab for NMOSD prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple trials; standard of care"
      },
      {
        "recommendation": "Eculizumab for NMOSD prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "[PREVENT trial (Pittock et al. NEJM 2019)](https://pubmed.ncbi.nlm.nih.gov/31050279/)"
      },
      {
        "recommendation": "AQP4-IgG-positive NMOSD: avoid interferon-beta and fingolimod",
        "evidenceLevel": "Class III (Harm)",
        "source": "Case reports of worsening"
      },
      {
        "recommendation": "LP after MRI (not before) in acute myelopathy",
        "evidenceLevel": "Class I, Level C",
        "source": "Risk of seeding infection through abscess; need anatomic diagnosis first"
      },
      {
        "recommendation": "Bladder management with intermittent catheterization",
        "evidenceLevel": "Class I, Level B",
        "source": "Spinal cord injury guidelines; prevents UTI better than indwelling catheter"
      },
      {
        "recommendation": "DVT prophylaxis in acute myelopathy",
        "evidenceLevel": "Class I, Level A",
        "source": "High thrombotic risk in immobilized SCI patients"
      }
    ],
    "monitoring": [
      {
        "item": "Neurologic exam (strength, sensory level, reflexes, rectal tone)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "q4h x 48h, then q8h; sensory level marking on skin for tracking",
        "action": "If ascending level or worsening motor: STAT repeat MRI; neurosurgery if compressive"
      },
      {
        "item": "Bladder function (PVR, I/O)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "PVR with each void initially; I/O daily",
        "action": "If PVR >200: intermittent catheterization; Foley if >500 or unable to cath"
      },
      {
        "item": "Respiratory function (FVC, NIF) — cervical myelopathy",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q4-6h if cervical; q2h if declining",
        "action": "If FVC <20: ICU; prepare for intubation"
      },
      {
        "item": "Blood pressure / autonomic function",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q4h; orthostatic vitals when mobilizing",
        "action": "Volume; midodrine; compression stockings; if hypertensive crisis above level → autonomic dysreflexia → find and remove stimulus (distended bladder, bowel impaction)"
      },
      {
        "item": "Temperature",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q4h",
        "action": "If febrile: infection workup; wound check; UTI screen"
      },
      {
        "item": "Skin assessment (pressure areas)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE",
        "frequency": "q shift; at every reposition",
        "action": "Pressure relief; wound care; specialty mattress"
      },
      {
        "item": "ESR / CRP (if infection)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q48-72h during treatment",
        "action": "If not improving: reassess antibiotic coverage; repeat imaging"
      },
      {
        "item": "Post-void residual (PVR)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "With each void initially; daily once stable",
        "action": "Intermittent catheterization protocol"
      },
      {
        "item": "MRI response",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "At 2-4 weeks; 3-6 months; or sooner if worsening",
        "action": "Adjust treatment; consider PLEX/escalation"
      },
      {
        "item": "AQP4/MOG antibody titers (if positive)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "At 3-6 months, then annually",
        "action": "If rising with clinical worsening: relapse; adjust DMT"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Mild myelopathy; stable or improving; ambulatory; independent bladder function; adequate outpatient follow-up; MRI and workup complete or schedulable outpatient"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Non-compressive myelopathy requiring IV steroids; moderate deficits; bladder dysfunction requiring catheterization; incomplete workup"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Cervical myelopathy with respiratory compromise; post-surgical; ascending myelopathy; autonomic instability"
      },
      {
        "disposition": "Emergent surgery",
        "criteria": "Compressive myelopathy: epidural abscess, acute cord compression from tumor/hematoma/disc with neurologic deficit"
      },
      {
        "disposition": "Transfer to higher level",
        "criteria": "Need for neurosurgery not available; need for PLEX; MRI not available STAT; spinal cord injury center"
      },
      {
        "disposition": "Inpatient rehabilitation (SCI rehab)",
        "criteria": "Significant motor deficits; paraparesis/paraplegia; wheelchair-dependent; bladder/bowel dysfunction; able to participate in 3h/day therapy"
      },
      {
        "disposition": "Skilled nursing facility",
        "criteria": "Unable to tolerate intensive rehab; requires skilled nursing; ongoing IV antibiotics"
      }
    ]
  },
  "Bell's Palsy / Idiopathic Facial Paralysis": {
    "id": "bells-palsy",
    "title": "Bell's Palsy / Idiopathic Facial Paralysis",
    "version": "1.0",
    "icd10": [
      "** G51.0 (Bell's palsy)",
      "G51.8 (Other disorders of facial nerve)",
      "G51.9 (Disorder of facial nerve",
      "unspecified)",
      "B02.21 (Postherpetic geniculate ganglionitis - Ramsay Hunt)"
    ],
    "scope": "** Diagnosis and management of Bell's palsy (idiopathic facial nerve palsy) in adults. Covers workup to exclude secondary causes, medical treatment, and eye protection. Includes Ramsay Hunt syndrome (herpes zoster oticus) which requires different treatment. Excludes central facial palsy (stroke), facial nerve tumors, traumatic facial nerve injury, and bilateral facial palsy workup.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Infection, leukemia (CN involvement)",
            "target": "Normal"
          },
          {
            "item": "CMP",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes (risk factor), electrolytes",
            "target": "Normal; glucose <126 fasting"
          },
          {
            "item": "Glucose / HbA1c",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes is major risk factor; affects prognosis",
            "target": "Normal"
          }
        ],
        "Extended Workup": [
          {
            "item": "Lyme serology (IgM/IgG)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Endemic areas; Lyme disease can cause facial palsy",
            "target": "Negative"
          },
          {
            "item": "ESR/CRP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Inflammatory conditions, vasculitis",
            "target": "Normal"
          },
          {
            "item": "HIV",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HIV-associated facial palsy",
            "target": "Negative"
          },
          {
            "item": "RPR/VDRL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Syphilis in differential",
            "target": "Negative"
          },
          {
            "item": "ANA",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Autoimmune etiology (SLE, Sjogren's)",
            "target": "Negative"
          },
          {
            "item": "SSA (Ro) / SSB (La)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Sjogren's syndrome",
            "target": "Negative"
          },
          {
            "item": "VZV serology (IgM)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Ramsay Hunt syndrome (if vesicles or suspicion)",
            "target": "Document status"
          },
          {
            "item": "ACE level",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Sarcoidosis if bilateral or recurrent",
            "target": "Normal"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CSF analysis (LP)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Atypical presentation, suspected Lyme neuroborreliosis, GBS, meningitis",
            "target": "See LP section"
          },
          {
            "item": "Serum glucose tolerance test",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If HbA1c borderline; diabetes evaluation",
            "target": "Normal"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Baseline; elevated in some conditions",
            "target": "10-20 cm H2O"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Infection, inflammation",
            "target": "WBC <5"
          },
          {
            "item": "Protein",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Elevated in GBS, Lyme",
            "target": "15-45 mg/dL"
          },
          {
            "item": "Glucose",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Infection",
            "target": ">60% serum"
          },
          {
            "item": "Lyme antibody (CSF)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Lyme neuroborreliosis",
            "target": "Negative"
          },
          {
            "item": "VDRL (CSF)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Neurosyphilis",
            "target": "Negative"
          },
          {
            "item": "Gram stain and culture",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Bacterial meningitis",
            "target": "No organisms"
          },
          {
            "item": "CSF meningitis panel",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Viral/bacterial pathogens",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Physical examination",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At presentation",
            "target": "Peripheral pattern (forehead involved); no other CN deficits",
            "contraindications": "None"
          },
          {
            "item": "Otoscopic examination",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At presentation",
            "target": "Vesicles (Ramsay Hunt); middle ear pathology",
            "contraindications": "None"
          },
          {
            "item": "Eye examination",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At presentation",
            "target": "Corneal exposure, lagophthalmos",
            "contraindications": "None"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain with IAC protocol",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If atypical, progressive, no recovery at 4-6 weeks",
            "target": "Facial nerve enhancement (may be normal in Bell's); exclude mass, stroke",
            "contraindications": "Pacemaker, metal"
          },
          {
            "item": "MRI with contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If tumor suspected",
            "target": "Rule out schwannoma, parotid tumor",
            "contraindications": "Contrast allergy"
          },
          {
            "item": "CT temporal bone",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If trauma or mastoid pathology suspected",
            "target": "Fracture, cholesteatoma",
            "contraindications": "None"
          },
          {
            "item": "Chest X-ray",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If sarcoidosis suspected",
            "target": "Hilar adenopathy",
            "contraindications": "None"
          },
          {
            "item": "Electrodiagnostic studies (ENoG, EMG)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Severe palsy (HB IV-VI) at 2-3 weeks; prognosis",
            "target": ">90% degeneration = poor prognosis",
            "contraindications": "None"
          }
        ]
      },
      "Treatment": {
        "Corticosteroids (All Patients)": [
          {
            "item": "Prednisone",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60-80 mg",
                  "orderSentence": "Prednisone 60-80 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "60-80 mg PO daily × 7 days (can taper over days 8-10 or stop); START WITHIN 72 HOURS of onset",
              "orderSentence": "Prednisone 60-80 mg PO"
            },
            "contraindications": "Active infection (relative), uncontrolled DM (relative)",
            "monitoring": "Glucose (especially diabetics), GI prophylaxis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Prednisolone",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60-80 mg",
                  "orderSentence": "Prednisolone 60-80 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "60-80 mg PO daily × 7 days (equivalent alternative)",
              "orderSentence": "Prednisolone 60-80 mg PO"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Methylprednisolone IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Methylprednisolone IV 1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg IV daily × 3-5 days (if unable to take PO or severe/Ramsay Hunt)",
              "orderSentence": "Methylprednisolone IV 1000 mg IV"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Dexamethasone",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Dexamethasone 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg IV/PO daily × 7-10 days (alternative)",
              "orderSentence": "Dexamethasone 10 mg IV"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Antiviral Therapy": [
          {
            "item": "Valacyclovir (moderate-severe Bell's)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Valacyclovir (moderate-severe Bell's) 1000 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "1000 mg PO TID × 7 days; ALWAYS with steroids",
              "orderSentence": "Valacyclovir (moderate-severe Bell's) 1000 mg PO"
            },
            "contraindications": "Renal impairment (reduce dose)",
            "monitoring": "Renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Acyclovir (alternative)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg",
                  "orderSentence": "Acyclovir (alternative) 400 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "400 mg PO 5× daily × 7-10 days; or 800 mg PO TID × 7 days",
              "orderSentence": "Acyclovir (alternative) 400 mg PO"
            },
            "contraindications": "Renal impairment",
            "monitoring": "Renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valacyclovir (Ramsay Hunt)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Valacyclovir (Ramsay Hunt) 1000 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "1000 mg PO TID × 7-10 days; MANDATORY with steroids",
              "orderSentence": "Valacyclovir (Ramsay Hunt) 1000 mg PO"
            },
            "contraindications": "Renal impairment",
            "monitoring": "Renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Acyclovir IV (severe Ramsay Hunt)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg",
                  "orderSentence": "Acyclovir IV (severe Ramsay Hunt) 10 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV q8h × 7-10 days",
              "orderSentence": "Acyclovir IV (severe Ramsay Hunt) 10 mg/kg IV"
            },
            "contraindications": "Renal impairment",
            "monitoring": "Renal function, hydration",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Eye Protection (CRITICAL - All Patients)": [
          {
            "item": "Artificial tears (preservative-free)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "1-2 drops affected eye q1-2h while awake",
              "orderSentence": "Artificial tears (preservative-free) - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Corneal status",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lubricating eye ointment (Lacri-Lube)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Thin strip in affected eye at bedtime (and up to TID)",
              "orderSentence": "Lubricating eye ointment (Lacri-Lube) - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Corneal status",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Eye patch or moisture chamber",
            "route": "Transdermal",
            "indication": "-",
            "dosing": {
              "instructions": "At night and in dusty/windy environments",
              "orderSentence": "Eye patch or moisture chamber - Transdermal - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Corneal status",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tape eyelid closed at night",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "If unable to close eye (use paper tape)",
              "orderSentence": "Tape eyelid closed at night - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Corneal status",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Wraparound glasses/sunglasses",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "During day for eye protection",
              "orderSentence": "Wraparound glasses/sunglasses - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Corneal status",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Pain Management": [
          {
            "item": "Acetaminophen",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650-1000 mg",
                  "orderSentence": "Acetaminophen 650-1000 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "650-1000 mg PO q6h PRN; max 3000 mg/day",
              "orderSentence": "Acetaminophen 650-1000 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Hepatic disease",
            "monitoring": "LFTs if prolonged use",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ibuprofen",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400-600 mg",
                  "orderSentence": "Ibuprofen 400-600 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "400-600 mg PO q6h PRN with food",
              "orderSentence": "Ibuprofen 400-600 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Renal disease, GI bleeding",
            "monitoring": "Renal function",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gabapentin (post-herpetic neuralgia)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100-300 mg",
                  "orderSentence": "Gabapentin (post-herpetic neuralgia) 100-300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "100-300 mg TID; titrate as needed for Ramsay Hunt",
              "orderSentence": "Gabapentin (post-herpetic neuralgia) 100-300 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Renal impairment",
            "monitoring": "Sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Lyme Disease Treatment (If Positive)": [
          {
            "item": "Doxycycline",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Doxycycline 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "100 mg PO BID × 14-21 days (isolated facial palsy)",
              "orderSentence": "Doxycycline 100 mg PO"
            },
            "contraindications": "Pregnancy, children <8",
            "monitoring": "GI upset",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ceftriaxone IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g",
                  "orderSentence": "Ceftriaxone IV 2 g IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV daily × 14-21 days (if CNS involvement)",
              "orderSentence": "Ceftriaxone IV 2 g IV"
            },
            "contraindications": "Cephalosporin allergy",
            "monitoring": "Standard",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Physical Therapy": [
          {
            "item": "Facial exercises",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Mirror exercises, gentle facial movements",
              "orderSentence": "Facial exercises - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Start when recovery begins",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Facial massage",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Gentle massage to maintain muscle tone",
              "orderSentence": "Facial massage - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Patient/family can perform",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Electrical stimulation",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Controversial; limited evidence",
              "orderSentence": "Electrical stimulation - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Not routinely recommended",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Neuromuscular retraining",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Specialized PT for synkinesis prevention",
              "orderSentence": "Neuromuscular retraining - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "If incomplete recovery",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Surgical Options (Refractory Cases)": [
          {
            "item": "Surgical decompression",
            "route": "-",
            "indication": ">90% degeneration on ENoG within 14 days; controversial",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Surgical decompression - - - see dosing"
            },
            "contraindications": "Poor surgical candidate",
            "monitoring": "Rarely performed; controversial benefit",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Gold weight/platinum chain eyelid implant",
            "route": "-",
            "indication": "Persistent lagophthalmos (>6-12 months)",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Gold weight/platinum chain eyelid implant - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Improves eye closure",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Tarsorrhaphy",
            "route": "-",
            "indication": "Persistent exposure keratopathy",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Tarsorrhaphy - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Temporary or permanent",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Static facial sling",
            "route": "-",
            "indication": "Permanent severe palsy",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Static facial sling - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Improves cosmesis",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Hypoglossal-facial nerve anastomosis",
            "route": "-",
            "indication": "Complete permanent paralysis",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Hypoglossal-facial nerve anastomosis - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Restores tone and some movement",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Cross-face nerve graft",
            "route": "-",
            "indication": "Permanent paralysis, younger patients",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Cross-face nerve graft - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Extended recovery time",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Ophthalmology",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Corneal exposure, inability to close eye, any eye pain/redness"
          },
          {
            "item": "ENT / Otolaryngology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Ramsay Hunt syndrome, atypical features, surgical consideration"
          },
          {
            "item": "Neurology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Atypical features, no recovery at 3-4 weeks, recurrent palsy"
          },
          {
            "item": "Physical therapy (facial)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Begin when recovery starts; synkinesis prevention"
          },
          {
            "item": "Plastic surgery / Facial nerve specialist",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "indication": "Permanent paralysis, reconstructive options"
          },
          {
            "item": "Infectious disease",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Lyme disease, atypical infection"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Eye protection is CRITICAL - use lubricating drops frequently and ointment at night",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Tape eye closed or use patch at night to prevent corneal injury",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Start steroids as soon as possible (ideally within 72 hours of symptom onset)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Most patients (70-80%) recover completely within 3-6 months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Recovery typically begins within 2-3 weeks; full recovery may take months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return immediately if: eye pain, vision changes, redness, or discharge",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Examine ear daily for vesicles (if develops, call immediately - may be Ramsay Hunt)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Follow up with neurologist or ENT if no improvement at 3-4 weeks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do NOT massage face vigorously or use electrical stimulation without guidance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Protect eye from wind, dust, and irritants",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid rubbing the affected eye",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Consider humidifier at night",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Chew carefully; may have food pocketing on affected side",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain diabetes control if diabetic (reduces risk and improves recovery)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Stroke (central facial palsy)",
        "features": "Forehead SPARED (upper motor neuron pattern), other neurologic deficits",
        "tests": "CT/MRI brain; emergent evaluation"
      },
      {
        "diagnosis": "Ramsay Hunt syndrome",
        "features": "Vesicles in ear canal/pinna, severe ear pain, may have hearing loss, vertigo",
        "tests": "Otoscopic exam; VZV serology"
      },
      {
        "diagnosis": "Lyme disease",
        "features": "Endemic area, tick bite history, erythema migrans rash, may be bilateral",
        "tests": "Lyme serology; LP if suspected"
      },
      {
        "diagnosis": "Acoustic neuroma",
        "features": "Gradual onset, hearing loss, tinnitus, other CN involvement",
        "tests": "MRI with IAC protocol"
      },
      {
        "diagnosis": "Parotid tumor",
        "features": "Mass in parotid region, progressive weakness",
        "tests": "CT/MRI parotid; biopsy"
      },
      {
        "diagnosis": "Guillain-Barré syndrome",
        "features": "Bilateral facial weakness, ascending weakness, areflexia",
        "tests": "LP (albuminocytologic dissociation), NCS/EMG"
      },
      {
        "diagnosis": "Sarcoidosis (Heerfordt syndrome)",
        "features": "Bilateral, parotid swelling, uveitis, fever",
        "tests": "Chest X-ray, ACE level, biopsy"
      },
      {
        "diagnosis": "Otitis media/Mastoiditis",
        "features": "Ear pain, fever, ear discharge, hearing loss",
        "tests": "Otoscopic exam, CT temporal bone"
      },
      {
        "diagnosis": "Cholesteatoma",
        "features": "Chronic ear drainage, hearing loss, progressive",
        "tests": "Otoscopic exam, CT temporal bone"
      },
      {
        "diagnosis": "Melkersson-Rosenthal syndrome",
        "features": "Recurrent facial palsy, facial edema, fissured tongue",
        "tests": "Clinical triad"
      },
      {
        "diagnosis": "Diabetes mellitus",
        "features": "May present as Bell's palsy; higher incidence in diabetics",
        "tests": "Glucose, HbA1c"
      },
      {
        "diagnosis": "HIV",
        "features": "Risk factors, other neurologic manifestations",
        "tests": "HIV test"
      },
      {
        "diagnosis": "Multiple sclerosis",
        "features": "Other neurologic symptoms, white matter lesions",
        "tests": "MRI brain"
      }
    ],
    "evidence": [
      {
        "recommendation": "Corticosteroids improve recovery",
        "evidenceLevel": "Class I, Level A",
        "source": "Scottish Bell's Palsy Study (Sullivan 2007); Cochrane Reviews"
      },
      {
        "recommendation": "Start steroids within 72 hours",
        "evidenceLevel": "Class I, Level A",
        "source": "Sullivan et al., NEJM 2007"
      },
      {
        "recommendation": "Antivirals alone not effective",
        "evidenceLevel": "Class I, Level A",
        "source": "Cochrane Reviews 2015"
      },
      {
        "recommendation": "Antivirals + steroids for severe Bell's",
        "evidenceLevel": "Class II, Level B",
        "source": "AAN Guidelines 2012"
      },
      {
        "recommendation": "Antivirals mandatory for Ramsay Hunt",
        "evidenceLevel": "Class I, Level B",
        "source": "Multiple studies; AAN Guidelines"
      },
      {
        "recommendation": "Eye protection essential",
        "evidenceLevel": "Class I, Level C",
        "source": "Expert consensus"
      },
      {
        "recommendation": "ENoG for prognosis in severe cases",
        "evidenceLevel": "Class II, Level B",
        "source": "Multiple studies"
      },
      {
        "recommendation": "Surgical decompression controversial",
        "evidenceLevel": "Class III, Level U",
        "source": "Insufficient evidence"
      },
      {
        "recommendation": "Most patients recover without intervention",
        "evidenceLevel": "Class I, Level A",
        "source": "Natural history studies (70-80% full recovery)"
      }
    ],
    "monitoring": [
      {
        "item": "House-Brackmann grade",
        "ED": "STAT",
        "HOSP": "Daily",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "Track recovery",
        "action": "Consider imaging, EMG"
      },
      {
        "item": "Corneal status",
        "ED": "STAT",
        "HOSP": "Daily",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "At each assessment",
        "action": "Urgent ophthalmology"
      },
      {
        "item": "Eye closure (lagophthalmos)",
        "ED": "STAT",
        "HOSP": "Daily",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "At each assessment",
        "action": "Increase eye protection"
      },
      {
        "item": "Blood glucose",
        "ED": "STAT",
        "HOSP": "Daily",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "While on steroids",
        "action": "Adjust DM medications"
      },
      {
        "item": "Vesicle check (ear)",
        "ED": "STAT",
        "HOSP": "Daily",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "Daily × 7 days",
        "action": "Add/continue antivirals"
      },
      {
        "item": "Recovery timeline",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q2-4 weeks",
        "action": "Imaging, specialist referral"
      },
      {
        "item": "Synkinesis screening",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Starting at recovery",
        "action": "PT for neuromuscular retraining"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge from ED",
        "criteria": "Typical presentation, eye protection education, steroids prescribed, ophthalmology follow-up arranged if needed, close outpatient follow-up"
      },
      {
        "disposition": "Admit to hospital",
        "criteria": "Ramsay Hunt with severe symptoms, unable to protect eye, concern for stroke or other central cause, need for IV medications"
      },
      {
        "disposition": "Ophthalmology within 24-48h",
        "criteria": "Significant lagophthalmos, corneal exposure, any eye symptoms"
      },
      {
        "disposition": "Neurology follow-up",
        "criteria": "No improvement at 3-4 weeks, atypical features, recurrent episodes"
      },
      {
        "disposition": "ENT referral",
        "criteria": "Ramsay Hunt syndrome, surgical consideration, chronic cases"
      }
    ]
  },
  "Brain Metastases": {
    "id": "brain-metastases",
    "title": "Brain Metastases",
    "version": "1.0",
    "icd10": [
      "** C79.31 (Secondary malignant neoplasm of brain)",
      "C79.32 (Secondary malignant neoplasm of cerebral meninges)",
      "C79.49 (Secondary malignant neoplasm of other parts of nervous system)",
      "G93.6 (Cerebral edema due to neoplasm)"
    ],
    "scope": "** Management of newly diagnosed or progressive brain metastases in adults. Covers initial stabilization, vasogenic edema management with corticosteroids, seizure management, imaging evaluation, molecular/histopathologic workup, treatment modalities (surgery, stereotactic radiosurgery, whole-brain radiation, systemic therapy with CNS penetration), and disposition. Excludes primary brain tumors (separate template), leptomeningeal carcinomatosis (partially addressed), and spinal metastases (separate template).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Baseline; chemotherapy planning; leukocytosis/infection; thrombocytopenia (bleeding risk, treatment candidacy)",
            "target": "WBC, platelets within normal limits; ALC (absolute lymphocyte count) for immunotherapy eligibility"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Renal function for contrast imaging; hepatic function for chemotherapy dosing; electrolytes (SIADH from brain lesions); glucose (steroid hyperglycemia)",
            "target": "Normal; anticipate glucose elevation with dexamethasone"
          },
          {
            "item": "PT/INR, aPTT",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Coagulopathy assessment; surgical candidacy; hemorrhagic metastases (melanoma, RCC, choriocarcinoma, thyroid)",
            "target": "Normal"
          },
          {
            "item": "Blood glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Steroid-induced hyperglycemia; baseline before dexamethasone",
            "target": "<180 mg/dL; start insulin if persistently elevated"
          },
          {
            "item": "Troponin",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Cardiac evaluation if syncope or neurogenic cardiac injury",
            "target": "Normal"
          },
          {
            "item": "Pregnancy test (β-hCG)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Treatment planning; β-hCG-secreting tumors (choriocarcinoma, germ cell); radiation contraindication in pregnancy",
            "target": "Negative; if elevated consider choriocarcinoma or germ cell tumor"
          },
          {
            "item": "LDH",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Melanoma staging; tumor burden marker; prognostic",
            "target": "Normal; elevated in melanoma, lymphoma"
          },
          {
            "item": "TSH, free T4",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Thyroid primary (thyroid cancer with brain metastases); fatigue/cognitive symptoms differential",
            "target": "Normal; abnormal may indicate thyroid primary"
          }
        ],
        "Extended Workup": [
          {
            "item": "Tumor markers (CEA, CA 19-9, CA 125, CA 15-3, AFP, β-hCG)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Unknown primary: CEA (lung, GI, breast), CA 19-9 (pancreatic, GI), CA 125 (ovarian), CA 15-3 (breast), AFP (hepatocellular, germ cell), β-hCG (choriocarcinoma, germ cell)",
            "target": "Elevations guide primary site evaluation"
          },
          {
            "item": "PSA (males)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Prostate cancer with brain metastases (rare but occurs)",
            "target": "Normal; elevated guides prostate workup"
          },
          {
            "item": "Serum protein electrophoresis (SPEP)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Lymphoma/myeloma differential for CNS mass lesion",
            "target": "No monoclonal protein"
          },
          {
            "item": "HIV, hepatitis B/C",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Primary CNS lymphoma (PCNSL) differential; immunosuppression assessment; treatment implications",
            "target": "Negative"
          },
          {
            "item": "ESR / CRP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Infection differential (abscess vs. metastasis); inflammatory markers",
            "target": "Normal"
          },
          {
            "item": "Cortisol (AM)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If pituitary metastasis suspected; before initiating dexamethasone if possible",
            "target": "Normal (>10 mcg/dL AM)"
          },
          {
            "item": "Prolactin",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Pituitary metastasis differential",
            "target": "Normal"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CSF cytology / flow cytometry",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Leptomeningeal carcinomatosis evaluation; diagnostic if positive (sensitivity ~50% single LP, ~80% with repeat)",
            "target": "Negative; positive = leptomeningeal disease"
          },
          {
            "item": "CSF protein, glucose, cell count",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Leptomeningeal disease (elevated protein, low glucose, lymphocytic pleocytosis)",
            "target": "Normal; elevated protein and low glucose suggest LMD"
          },
          {
            "item": "Circulating tumor DNA (ctDNA) / liquid biopsy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Unknown primary; molecular profiling when tissue biopsy not feasible; monitor treatment response",
            "target": "Detectable mutations guide therapy"
          },
          {
            "item": "Next-generation sequencing (NGS) - blood",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Identify actionable mutations (EGFR, ALK, BRAF, HER2, KRAS, ROS1) when tissue insufficient",
            "target": "Actionable driver mutations"
          },
          {
            "item": "Paraneoplastic antibody panel",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If clinical presentation suggests paraneoplastic syndrome mimicking or coexisting with metastatic disease",
            "target": "Negative; positive changes management"
          },
          {
            "item": "Methylmalonic acid, B12, folate",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Cognitive decline differential",
            "target": "Normal"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "LP with CSF cytology, flow cytometry, protein, glucose, cell count",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "EXT",
            "ICU": "URGENT",
            "timing": "If leptomeningeal disease suspected (cranial neuropathies, radiculopathy, headache, altered mentation without adequate parenchymal lesion to explain); MUST ensure no obstructive hydrocephalus or significant mass effect first",
            "target": "Cytology: malignant cells (50% sensitivity single LP; repeat improves to ~80%); elevated opening pressure; elevated protein (>50 mg/dL); low glucose (<40 mg/dL or <60% serum); lymphocytic pleocytosis",
            "contraindications": "CONTRAINDICATED if significant mass effect, large posterior fossa lesion, obstructive hydrocephalus, midline shift >5mm (herniation risk); coagulopathy; local infection at LP site"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Immediate in ED for acute presentation; identifies hemorrhage, mass effect, hydrocephalus",
            "target": "Mass lesion(s), hemorrhage, edema, midline shift, hydrocephalus; hemorrhagic metastases suggest melanoma, RCC, choriocarcinoma, thyroid",
            "contraindications": "Pregnancy (benefit outweighs risk)"
          },
          {
            "item": "MRI brain with and without contrast (gadolinium)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "URGENT",
            "ICU": "STAT",
            "timing": "Within 24h of presentation; GOLD STANDARD for brain metastases; thin-cut (≤1mm) 3D T1 post-contrast",
            "target": "Number/size/location of metastases; ring-enhancement pattern; hemorrhagic component; leptomeningeal enhancement; dural-based vs. parenchymal",
            "contraindications": "MRI-incompatible implants; GFR <30 (gadolinium risk); severe claustrophobia"
          },
          {
            "item": "CT chest/abdomen/pelvis with contrast",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Within 24-48h if unknown primary; staging for known primary",
            "target": "Primary tumor identification; staging; additional metastatic disease",
            "contraindications": "Contrast allergy; renal impairment"
          },
          {
            "item": "ECG (12-lead)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Baseline; pre-treatment; QTc for anti-emetics/targeted therapies",
            "target": "Normal",
            "contraindications": "None"
          },
          {
            "item": "Chest X-ray",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Lung primary (most common source of brain metastases); pulmonary metastases; aspiration if obtunded",
            "target": "Lung mass; effusion; lymphadenopathy",
            "contraindications": "Pregnancy (shield)"
          }
        ],
        "Extended": [
          {
            "item": "PET/CT (FDG)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Outpatient or during hospitalization; staging; unknown primary identification; ~85% sensitivity for primary site",
            "target": "Primary tumor; additional metastatic disease; lymph node involvement; treatment response assessment",
            "contraindications": "Uncontrolled diabetes (glucose >200 impairs uptake); pregnancy"
          },
          {
            "item": "CT angiography (head)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "If hemorrhagic metastasis to evaluate vascularity; pre-surgical planning",
            "target": "Tumor vascularity; relationship to major vessels",
            "contraindications": "Contrast allergy; renal impairment"
          },
          {
            "item": "MR spectroscopy (MRS)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Differentiating tumor from abscess or radiation necrosis; elevated choline:creatine ratio in tumor; lipid/lactate peak in necrosis",
            "target": "Elevated choline, reduced NAA in tumor; elevated lipid/lactate in necrosis",
            "contraindications": "Same as MRI"
          },
          {
            "item": "MR perfusion (DSC or DCE)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Differentiating tumor recurrence from radiation necrosis; elevated rCBV in tumor",
            "target": "Elevated rCBV (>1.5-2.0) suggests tumor; low rCBV suggests radiation necrosis",
            "contraindications": "Same as MRI"
          },
          {
            "item": "MRI spine (whole) with contrast",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If spinal symptoms or leptomeningeal disease suspected; staging for drop metastases",
            "target": "Spinal metastases; leptomeningeal enhancement; cord compression",
            "contraindications": "Same as MRI"
          },
          {
            "item": "Mammography / breast MRI (females)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Breast cancer is 2nd most common source of brain metastases in women",
            "target": "Breast mass or abnormality",
            "contraindications": "Breast implants (mammography may be limited)"
          },
          {
            "item": "Stereotactic biopsy planning MRI",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If tissue diagnosis needed and surgical resection not planned; fiducial/frameless navigation sequences",
            "target": "Biopsy trajectory planning; avoidance of eloquent cortex and vasculature",
            "contraindications": "Same as MRI"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Thallium SPECT or FET-PET",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Differentiating recurrent tumor vs. radiation necrosis when MR perfusion/spectroscopy equivocal",
            "target": "Increased uptake = tumor; decreased uptake = necrosis",
            "contraindications": "Pregnancy"
          },
          {
            "item": "Functional MRI (fMRI)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Pre-surgical planning for metastases near eloquent cortex (motor, language areas)",
            "target": "Motor/language cortex mapping relative to lesion",
            "contraindications": "Same as MRI"
          },
          {
            "item": "Diffusion tensor imaging (DTI) / Tractography",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Pre-surgical planning; white matter tract relationship to tumor",
            "target": "Tract displacement vs. infiltration",
            "contraindications": "Same as MRI"
          },
          {
            "item": "CT-guided biopsy (extracranial)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Biopsy accessible extracranial metastatic site rather than brain (safer, easier tissue acquisition)",
            "target": "Histopathologic diagnosis; molecular profiling",
            "contraindications": "Coagulopathy; site-specific risks"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent Treatment": [
          {
            "item": "**Dexamethasone (vasogenic edema)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "**Dexamethasone (vasogenic edema)** 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "**Symptomatic edema:** 10 mg IV loading dose, then 4 mg IV/PO q6h; **Moderate symptoms:** 4-8 mg/day; **Severe/impending herniation:** 10 mg IV bolus then 4-8 mg IV q6h (up to 16-24 mg/day); Taper as soon as clinically feasible over 2-4 weeks; GI prophylaxis with PPI (omeprazole 20 mg daily) while on steroids; Monitor glucose q6h initially",
              "orderSentence": "**Dexamethasone (vasogenic edema)** 10 mg IV"
            },
            "contraindications": "-",
            "monitoring": "Dexamethasone is preferred corticosteroid (minimal mineralocorticoid effect, long half-life); symptomatic improvement in 24-72h; reduces vasogenic edema via BBB stabilization; no benefit in asymptomatic patients without edema (AVOID routine prophylactic use)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "URGENT",
            "ICU": "STAT"
          },
          {
            "item": "**Seizure management (acute)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg/kg",
                  "orderSentence": "**Seizure management (acute)** 0.1 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "**Active seizure:** Lorazepam 0.1 mg/kg IV (max 4 mg), may repeat x1 in 5 min; **Then:** Levetiracetam 1000-1500 mg IV load (preferred - no drug interactions with chemotherapy) OR valproic acid 20-30 mg/kg IV load (avoid with hepatic metastases); Phenytoin/fosphenytoin only if above unavailable (interacts with many chemotherapies and targeted agents)",
              "orderSentence": "**Seizure management (acute)** 0.1 mg/kg IV"
            },
            "contraindications": "-",
            "monitoring": "Levetiracetam preferred: no hepatic enzyme induction (does NOT reduce efficacy of steroids, chemotherapy, or targeted agents), renal elimination, broad spectrum; AAN guidelines do NOT recommend prophylactic AEDs in brain tumor patients without seizures",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**No prophylactic anticonvulsants**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Do NOT start AEDs prophylactically in patients with brain metastases who have NOT had seizures; Applicable even peri-operatively (surgical prophylaxis may be used 7 days only per institutional protocol)",
              "orderSentence": "**No prophylactic anticonvulsants** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "AAN Practice Parameter (Glantz et al., 2000; reaffirmed): No evidence supporting prophylactic AED use in brain tumor patients; side effects outweigh benefits; ASCO guideline concordant",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**Airway/ICP management (obtunded patient)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-1.5 g/kg",
                  "orderSentence": "**Airway/ICP management (obtunded patient)** 1-1.5 g/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "**GCS ≤8:** Intubation; elevate HOB 30°; **Acute herniation:** Mannitol 1-1.5 g/kg IV bolus OR hypertonic saline (23.4% NaCl 30 mL via central line over 15 min or 3% NaCl 250 mL over 30 min); maintain PaCO2 30-35 mmHg (brief hyperventilation only as bridge to definitive treatment); Emergent neurosurgery consult for decompression",
              "orderSentence": "**Airway/ICP management (obtunded patient)** 1-1.5 g/kg IV"
            },
            "contraindications": "-",
            "monitoring": "ICP management as bridge to definitive treatment (surgery/radiation); prolonged hyperventilation causes cerebral ischemia; osmotherapy reduces cerebral edema",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**DVT prophylaxis**",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "**DVT prophylaxis** 40 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "SCDs (sequential compression devices) immediately on admission; Pharmacologic prophylaxis: enoxaparin 40 mg SQ daily or heparin 5000 units SQ q8h - START within 24-48h unless hemorrhagic metastasis or planned surgery within 24h; Post-craniotomy: restart pharmacologic DVT ppx within 24-48h per neurosurgery guidance",
              "orderSentence": "**DVT prophylaxis** 40 mg SC"
            },
            "contraindications": "-",
            "monitoring": "Brain tumor patients have 20-30% VTE risk; mechanical prophylaxis alone insufficient; pharmacologic prophylaxis does NOT significantly increase intracranial hemorrhage risk (Perry et al., 2009; AVERT trial)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Stress ulcer prophylaxis**",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "**Stress ulcer prophylaxis** 20 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "PPI (omeprazole 20 mg daily or pantoprazole 40 mg daily) while on dexamethasone; continue throughout steroid course",
              "orderSentence": "**Stress ulcer prophylaxis** 20 mg PO"
            },
            "contraindications": "-",
            "monitoring": "Combined corticosteroid + critical illness increases GI bleed risk",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Definitive/Targeted Treatment": [
          {
            "item": "**Surgical resection**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60%",
                  "orderSentence": "**Surgical resection** 60% -"
                }
              ],
              "route": "-",
              "instructions": "**Indications:** Single (or limited ≤3) accessible metastasis; need for tissue diagnosis; symptomatic mass effect not responding to steroids; large lesion (>3-4 cm) not suitable for SRS alone; good performance status (KPS ≥70); controlled systemic disease; life expectancy >3 months; **Post-op:** MRI within 24-48h to assess residual; SRS to cavity within 2-4 weeks to reduce local recurrence (50-60% → 15-20%)",
              "orderSentence": "**Surgical resection** 60% -"
            },
            "contraindications": "-",
            "monitoring": "Patchell et al. (1990): Surgery + WBRT > WBRT alone for single brain metastasis (median survival 40 vs. 15 weeks); Cavity SRS post-resection: Mahajan et al. (2017): local control improved with cavity SRS vs. observation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Stereotactic radiosurgery (SRS)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Indications:** 1-4 metastases (most centers), up to 10-15 in select cases (JLGK0901); size ≤3-4 cm; **Dose:** Single fraction 15-24 Gy (dose based on size: ≤2cm: 20-24 Gy, 2.1-3cm: 18 Gy, 3.1-4cm: 15 Gy) OR fractionated SRS (3-5 fractions for larger lesions or eloquent location); **Timing:** Within 2-4 weeks of diagnosis; Serial MRI q2-3 months post-SRS",
              "orderSentence": "**Stereotactic radiosurgery (SRS)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Yamamoto et al. (JLGK0901): SRS alone for 2-10 metastases non-inferior to 2-4 for survival; SRS vs. WBRT: better cognitive preservation (NCCTG N0574, Brown et al., 2016); SRS + HA-WBRT vs SRS alone per NRG-CC003",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Whole-brain radiation therapy (WBRT)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "**Whole-brain radiation therapy (WBRT)** 20 mg -"
                }
              ],
              "route": "-",
              "instructions": "**Indications:** >10-15 metastases; leptomeningeal disease; poor surgical/SRS candidates; miliary/diffuse pattern; **Standard:** 30 Gy in 10 fractions (or 20 Gy in 5 fractions for poor prognosis); **Hippocampal avoidance (HA-WBRT):** Preferred when technically feasible (no metastases within 5mm of hippocampus): 30 Gy in 10 fractions with hippocampal sparing + memantine 20 mg daily starting with WBRT x 6 months",
              "orderSentence": "**Whole-brain radiation therapy (WBRT)** 20 mg -"
            },
            "contraindications": "-",
            "monitoring": "HA-WBRT + memantine (NRG-CC001, Brown et al., 2020): significantly less cognitive deterioration vs. standard WBRT + memantine at 4 and 6 months; Memantine alone (RTOG 0614): trend toward better cognitive function",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Systemic therapy with CNS activity**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "80 mg",
                  "orderSentence": "**Systemic therapy with CNS activity** 80 mg -"
                }
              ],
              "route": "-",
              "instructions": "**NSCLC with EGFR mutation:** Osimertinib 80 mg daily (CNS response rate 91%); **NSCLC with ALK rearrangement:** Lorlatinib 100 mg daily (intracranial response 82%) or alectinib 600 mg BID (CNS response 81%); **NSCLC with ROS1:** Lorlatinib; **Melanoma with BRAF V600:** Dabrafenib + trametinib (intracranial response 58%) or encorafenib + binimetinib; **Melanoma (any):** Ipilimumab + nivolumab (intracranial response 46-57% in asymptomatic); **HER2+ breast:** Tucatinib + trastuzumab + capecitabine (HER2CLIMB: intracranial response 47%); **Breast (HR+):** Abemaciclib (some CNS activity); **RCC:** Nivolumab + ipilimumab or cabozantinib",
              "orderSentence": "**Systemic therapy with CNS activity** 80 mg -"
            },
            "contraindications": "-",
            "monitoring": "CNS-penetrant systemic therapy increasingly used as upfront or adjunct to SRS; may defer radiation in asymptomatic patients with actionable mutations and small metastases; Always coordinate with medical oncology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Corticosteroid taper**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg",
                  "orderSentence": "**Corticosteroid taper** 2 mg -"
                }
              ],
              "route": "-",
              "instructions": "Begin taper once definitive treatment initiated and symptoms improving; **Taper schedule:** Reduce by 2 mg every 3-5 days (from 16 mg/day: 16→12→8→6→4→2→1→off); Slower taper if symptoms recur; Monitor for adrenal insufficiency if >3 weeks of steroid use",
              "orderSentence": "**Corticosteroid taper** 2 mg -"
            },
            "contraindications": "-",
            "monitoring": "Prolonged steroids cause significant morbidity: hyperglycemia, myopathy (steroid myopathy can be debilitating), immunosuppression, osteoporosis, PJP risk, insomnia, psychiatric effects, GI bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Adjunctive Treatment": [
          {
            "item": "**Levetiracetam (post-seizure maintenance)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500-1500 mg",
                  "orderSentence": "**Levetiracetam (post-seizure maintenance)** 500-1500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "500-1500 mg PO/IV BID (start 500 mg BID, titrate to seizure control); Renal dosing if GFR <50; No drug interactions with chemotherapy, targeted therapy, or steroids",
              "orderSentence": "**Levetiracetam (post-seizure maintenance)** 500-1500 mg IV"
            },
            "contraindications": "-",
            "monitoring": "Preferred AED in brain tumor patients due to no CYP enzyme induction; does not reduce efficacy of dexamethasone, temozolomide, or targeted agents",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**PJP prophylaxis**",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "**PJP prophylaxis** 20 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "If dexamethasone >20 mg/week AND concomitant temozolomide or immunosuppression: TMP-SMX 1 DS tablet 3x/week (Mon/Wed/Fri) OR atovaquone 1500 mg daily if sulfa allergic",
              "orderSentence": "**PJP prophylaxis** 20 mg PO"
            },
            "contraindications": "-",
            "monitoring": "Risk of Pneumocystis with prolonged corticosteroids + additional immunosuppression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Glucose management (steroid-induced)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "180 mg",
                  "orderSentence": "**Glucose management (steroid-induced)** 180 mg -"
                }
              ],
              "route": "-",
              "instructions": "Fingerstick glucose q6h while on dexamethasone; Sliding scale insulin initially; Basal-bolus insulin if persistently >180 mg/dL; Anticipate glucose elevation typically 4-8 hours after steroid dose; May need 2-3x baseline insulin requirements",
              "orderSentence": "**Glucose management (steroid-induced)** 180 mg -"
            },
            "contraindications": "-",
            "monitoring": "Dexamethasone causes significant hyperglycemia in 50-60% of patients; uncontrolled hyperglycemia worsens outcomes",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**Calcium/Vitamin D**",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000-1200 mg",
                  "orderSentence": "**Calcium/Vitamin D** 1000-1200 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Calcium 1000-1200 mg + Vitamin D 800-1000 IU daily while on prolonged steroids (>2 weeks)",
              "orderSentence": "**Calcium/Vitamin D** 1000-1200 mg PO"
            },
            "contraindications": "-",
            "monitoring": "Steroid-induced osteoporosis prevention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Anti-emetics (for radiation/chemotherapy)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4-8 mg",
                  "orderSentence": "**Anti-emetics (for radiation/chemotherapy)** 4-8 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Ondansetron 4-8 mg IV/PO q8h PRN; Dexamethasone itself is anti-emetic; Avoid metoclopramide in brain metastases patients (extrapyramidal effects)",
              "orderSentence": "**Anti-emetics (for radiation/chemotherapy)** 4-8 mg IV"
            },
            "contraindications": "-",
            "monitoring": "Nausea common with elevated ICP and with radiation therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Memantine (with WBRT)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "**Memantine (with WBRT)** 5 mg -"
                }
              ],
              "route": "-",
              "instructions": "5 mg daily x1 week → 5 mg BID x1 week → 10 mg AM + 5 mg PM x1 week → 10 mg BID; Continue for 6 months total; Start day 1 of WBRT",
              "orderSentence": "**Memantine (with WBRT)** 5 mg -"
            },
            "contraindications": "-",
            "monitoring": "RTOG 0614 and NRG-CC001: cognitive protection during WBRT; NMDA receptor antagonist reduces excitotoxic neuronal injury from radiation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Medications to AVOID or Use with Caution": [
          {
            "item": "Prophylactic anticonvulsants (in patients without seizures)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Prophylactic anticonvulsants (in patients without seizures) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Phenytoin / Carbamazepine / Phenobarbital (enzyme-inducing AEDs)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Phenytoin / Carbamazepine / Phenobarbital (enzyme-inducing AEDs) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Bevacizumab (concurrent with surgery)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Bevacizumab (concurrent with surgery) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Anticoagulation (full-dose, peri-operative)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Anticoagulation (full-dose, peri-operative) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Methotrexate (high-dose, with brain radiation)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Methotrexate (high-dose, with brain radiation) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Live vaccines (while on dexamethasone or chemotherapy)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Live vaccines (while on dexamethasone or chemotherapy) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Lumbar puncture (with large posterior fossa lesion / significant mass effect)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Lumbar puncture (with large posterior fossa lesion / significant mass effect) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurosurgery consultation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Radiation oncology consultation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Medical oncology consultation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Multidisciplinary tumor board",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Goals of care discussion",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Pathology review with molecular profiling",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fall precautions",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Driving restrictions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Palliative care consultation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuropsychology evaluation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical/occupational therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech-language pathology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work / case management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetic counseling",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clinical trials evaluation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ophthalmology consultation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Repeat biopsy / resection",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ommaya reservoir placement",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Intrathecal chemotherapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Laser interstitial thermal therapy (LITT)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Re-irradiation (SRS for recurrence)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Bevacizumab for radiation necrosis",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hospice referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Diagnosis",
        "features": "Key Differentiating Features",
        "tests": "Distinguishing Studies"
      },
      {
        "diagnosis": "Primary brain tumor (GBM, astrocytoma)",
        "features": "Usually single; irregular enhancement; often involves corpus callosum (butterfly GBM); no known systemic cancer; infiltrative margins; surrounding FLAIR/T2 more extensive; restricted diffusion at tumor margins",
        "tests": "MRI pattern; MR spectroscopy (elevated choline:creatine, reduced NAA); biopsy (IDH, MGMT, 1p19q); no systemic disease on staging CT/PET"
      },
      {
        "diagnosis": "Primary CNS lymphoma (PCNSL)",
        "features": "Periventricular location; homogeneously enhancing; restricted diffusion; may be multifocal; immunocompromised patients; responds dramatically to corticosteroids (may \"disappear\" = ghost tumor); typically does NOT ring-enhance unless HIV",
        "tests": "MRI with diffusion restriction; AVOID steroids before biopsy if possible (may render biopsy non-diagnostic); CSF flow cytometry; vitreous biopsy if ocular involvement; HIV testing; slit lamp exam"
      },
      {
        "diagnosis": "Brain abscess",
        "features": "Ring-enhancing lesion with restricted diffusion on DWI (bright on DWI, dark on ADC in the cavity — metastases typically do NOT show central restricted diffusion); fever, elevated WBC; recent sinusitis/otitis/dental procedure/endocarditis; thin smooth enhancing rim; satellite lesions",
        "tests": "DWI: central restricted diffusion is KEY distinguishing feature; MR spectroscopy: amino acid peaks (succinate, acetate, lactate); blood cultures; echocardiogram; source identification"
      },
      {
        "diagnosis": "Toxoplasmosis (immunocompromised)",
        "features": "HIV/AIDS (CD4 <100); multiple ring-enhancing lesions; basal ganglia predilection; eccentric target sign; edema/mass effect",
        "tests": "Toxoplasma IgG (serum); CD4 count; empiric treatment trial (response in 10-14 days supports diagnosis); if no response → biopsy; Thallium SPECT (increased uptake = lymphoma, not toxoplasmosis)"
      },
      {
        "diagnosis": "Demyelinating disease (tumefactive MS, ADEM)",
        "features": "Incomplete ring enhancement (open ring sign); younger patients; clinical dissemination in time/space; less mass effect relative to lesion size; leading edge enhancement",
        "tests": "MRI: open ring enhancement, T2/FLAIR lesions in MS-typical locations; CSF: oligoclonal bands; MOG/AQP4 antibodies; clinical response to steroids"
      },
      {
        "diagnosis": "Radiation necrosis",
        "features": "History of prior brain radiation (typically 6-24 months post-treatment but can occur later); enhancing lesion at site of prior radiation; difficult to distinguish from recurrent tumor on conventional MRI",
        "tests": "MR perfusion: LOW rCBV (vs. tumor with HIGH rCBV); MR spectroscopy: elevated lipid/lactate, low choline; PET: low FDG uptake (vs. tumor with high uptake); biopsy if equivocal"
      },
      {
        "diagnosis": "Neurocysticercosis",
        "features": "Travel/residence in endemic area (Latin America, sub-Saharan Africa, Southeast Asia); cystic lesions with scolex (dot within cyst); often calcified in chronic phase; seizure is common presentation",
        "tests": "MRI: cystic lesion with scolex; CT: calcified granulomas; serology (cysticercosis antibodies); stool ova/parasites"
      },
      {
        "diagnosis": "Cerebral infarct (subacute)",
        "features": "Vascular territory distribution; ring enhancement at 1-4 weeks post-stroke (luxury perfusion); clinical history of acute onset; DWI abnormalities conforming to vascular territory",
        "tests": "Timing of enhancement (subacute strokes enhance transiently); vascular territory distribution; DWI/ADC map evolution; clinical history of acute onset"
      }
    ],
    "evidence": [
      {
        "recommendation": "Guideline",
        "evidenceLevel": "Source",
        "source": "Year"
      },
      {
        "recommendation": "Management of Brain Metastases",
        "evidenceLevel": "Congress of Neurological Surgeons (CNS) / AANS Systematic Review",
        "source": "2019"
      },
      {
        "recommendation": "Brain Metastases Molecular Testing",
        "evidenceLevel": "NCCN Central Nervous System Cancers",
        "source": "v1.2025"
      },
      {
        "recommendation": "Prophylactic Anticonvulsants",
        "evidenceLevel": "[AAN Practice Parameter (Glantz et al.)](https://pubmed.ncbi.nlm.nih.gov/10822423/)",
        "source": "2000 (reaffirmed)"
      },
      {
        "recommendation": "Hippocampal Avoidance WBRT",
        "evidenceLevel": "[NRG-CC001 (Brown et al.)](https://pubmed.ncbi.nlm.nih.gov/32058845/)",
        "source": "2020"
      },
      {
        "recommendation": "SRS for Multiple Brain Metastases",
        "evidenceLevel": "[JLGK0901 (Yamamoto et al.)](https://pubmed.ncbi.nlm.nih.gov/24621620/)",
        "source": "2014"
      },
      {
        "recommendation": "Cognitive Outcomes SRS vs. WBRT",
        "evidenceLevel": "[NCCTG N0574 (Brown et al.)](https://pubmed.ncbi.nlm.nih.gov/27458945/)",
        "source": "2016"
      },
      {
        "recommendation": "Study",
        "evidenceLevel": "Finding",
        "source": "Impact"
      },
      {
        "recommendation": "[Patchell et al. (1990)](https://pubmed.ncbi.nlm.nih.gov/2405271/)",
        "evidenceLevel": "Surgery + WBRT vs. WBRT alone for single brain metastasis: median survival 40 vs. 15 weeks; lower recurrence at original site (20% vs. 52%)",
        "source": "Established surgery as standard for single brain metastasis"
      },
      {
        "recommendation": "[Patchell et al. (1998)](https://pubmed.ncbi.nlm.nih.gov/9809728/)",
        "evidenceLevel": "Post-operative WBRT reduced brain recurrence (18% vs. 70%) but no survival benefit; improved neurologic death",
        "source": "Supported adjuvant radiation after surgery; now often SRS to cavity instead of WBRT"
      },
      {
        "recommendation": "[Mahajan et al. (2017) - MD Anderson](https://pubmed.ncbi.nlm.nih.gov/28687375/)",
        "evidenceLevel": "SRS to surgical cavity vs. observation: 12-month local recurrence 28% vs. 59% (HR 0.46)",
        "source": "Established post-operative cavity SRS as standard of care"
      },
      {
        "recommendation": "[Brown et al. (2016) - NCCTG N0574](https://pubmed.ncbi.nlm.nih.gov/27458945/)",
        "evidenceLevel": "SRS alone vs. SRS + WBRT: cognitive deterioration at 3 months 64% vs. 92%; no OS difference",
        "source": "Shifted practice toward SRS alone with surveillance MRI rather than WBRT"
      },
      {
        "recommendation": "[Yamamoto et al. (2014) - JLGK0901](https://pubmed.ncbi.nlm.nih.gov/24621620/)",
        "evidenceLevel": "SRS for 5-10 vs. 2-4 brain metastases: similar overall survival (10.8 vs. 10.8 months)",
        "source": "Expanded SRS indications to higher numbers of metastases"
      },
      {
        "recommendation": "[Brown et al. (2020) - NRG-CC001](https://pubmed.ncbi.nlm.nih.gov/32058845/)",
        "evidenceLevel": "HA-WBRT + memantine vs. WBRT + memantine: less cognitive deterioration at 4 months (59% vs. 68%) and 6 months; less decline in executive function and memory",
        "source": "HA-WBRT + memantine = new standard when WBRT indicated"
      },
      {
        "recommendation": "[Tawbi et al. (2018) - CheckMate 204](https://pubmed.ncbi.nlm.nih.gov/30134131/)",
        "evidenceLevel": "Ipilimumab + nivolumab in melanoma brain metastases: intracranial response 57% in asymptomatic patients",
        "source": "Established immunotherapy as upfront option for melanoma brain metastases"
      },
      {
        "recommendation": "[Reungwetwattana et al. (2018) - FLAURA CNS analysis](https://pubmed.ncbi.nlm.nih.gov/30153097/)",
        "evidenceLevel": "Osimertinib CNS response rate 91% in EGFR-mutant NSCLC with brain metastases vs. 68% standard EGFR TKI",
        "source": "Established osimertinib as preferred first-line for EGFR+ NSCLC with brain metastases"
      },
      {
        "recommendation": "[Murthy et al. (2020) - HER2CLIMB](https://pubmed.ncbi.nlm.nih.gov/31825569/)",
        "evidenceLevel": "Tucatinib + trastuzumab + capecitabine: intracranial response 47%; CNS-PFS 9.9 vs. 4.2 months; OS benefit in brain metastases subgroup",
        "source": "Established tucatinib combination as standard for HER2+ breast cancer brain metastases"
      },
      {
        "recommendation": "[Perry et al. (2010) - PRODIGE](https://pubmed.ncbi.nlm.nih.gov/20598077/)",
        "evidenceLevel": "Dalteparin vs. placebo in malignant glioma: no increase in intracranial hemorrhage with anticoagulation; VTE reduction",
        "source": "Supported pharmacologic DVT prophylaxis in brain tumor patients"
      },
      {
        "recommendation": "[Levin et al. (2011)](https://pubmed.ncbi.nlm.nih.gov/20399573/)",
        "evidenceLevel": "Bevacizumab for radiation necrosis: significant radiographic and clinical improvement in ~65% of patients",
        "source": "Established bevacizumab as treatment option for symptomatic radiation necrosis refractory to steroids"
      },
      {
        "recommendation": "Component",
        "evidenceLevel": "Score = 0",
        "source": "Score = 0.5"
      },
      {
        "recommendation": "Age (years)",
        "evidenceLevel": ">60",
        "source": "50-60"
      },
      {
        "recommendation": "KPS",
        "evidenceLevel": "<70",
        "source": "70-80"
      },
      {
        "recommendation": "Number of CNS metastases",
        "evidenceLevel": ">3",
        "source": "2-3"
      },
      {
        "recommendation": "Extracranial metastases",
        "evidenceLevel": "Present",
        "source": "-"
      },
      {
        "recommendation": "Class",
        "evidenceLevel": "Criteria",
        "source": "Median Survival"
      },
      {
        "recommendation": "Class I",
        "evidenceLevel": "KPS ≥70, age <65, controlled primary, no extracranial metastases",
        "source": "7.1 months"
      },
      {
        "recommendation": "Class II",
        "evidenceLevel": "All other patients",
        "source": "4.2 months"
      },
      {
        "recommendation": "Class III",
        "evidenceLevel": "KPS <70",
        "source": "2.3 months"
      }
    ],
    "monitoring": [
      {
        "item": "Neurologic checks (GCS, pupil reactivity, motor exam, speech)",
        "frequency": "q1-2h in ICU; q2-4h on floor",
        "target": "Stable or improving exam",
        "action": "Stat CT head if decline; neurosurgery alert; consider increasing dexamethasone or osmotherapy"
      },
      {
        "item": "Blood glucose",
        "frequency": "q6h (q1h if insulin drip)",
        "target": "140-180 mg/dL",
        "action": "Sliding scale → basal-bolus insulin; typically requires 2-3x baseline insulin on dexamethasone"
      },
      {
        "item": "Blood pressure",
        "frequency": "Continuous in ICU; q4h on floor",
        "target": "SBP <160 (avoid hypertensive hemorrhage into metastasis)",
        "action": "Antihypertensives PRN; avoid excessive hypotension (SBP >100 to maintain cerebral perfusion)"
      },
      {
        "item": "Fluid balance / I&O",
        "frequency": "q8h",
        "target": "Euvolemia",
        "action": "Hyponatremia common (SIADH, cerebral salt wasting); free water restriction if SIADH"
      },
      {
        "item": "Sodium",
        "frequency": "q6-8h initially",
        "target": "135-145 mEq/L",
        "action": "If <130: fluid restrict; if <125 or symptomatic: 3% NaCl; if rapidly dropping: urgent sodium correction"
      },
      {
        "item": "Seizure monitoring",
        "frequency": "Continuous observation; consider cEEG if altered mental status",
        "target": "No seizures; no subclinical seizures",
        "action": "AED initiation/adjustment; neurology consultation; continuous EEG monitoring"
      },
      {
        "item": "Pain assessment",
        "frequency": "q4h",
        "target": "NRS <4/10",
        "action": "Acetaminophen 650-1000 mg q6h; dexamethasone (reduces headache from edema); opioids PRN for moderate-severe"
      }
    ],
    "disposition": [
      {
        "disposition": "Level of Care",
        "criteria": "Criteria"
      },
      {
        "disposition": "ICU admission",
        "criteria": "GCS ≤12; signs of herniation (pupil asymmetry, posturing, Cushing triad); acute hemorrhage into metastasis with neurologic decline; post-craniotomy (first 24h); status epilepticus; respiratory compromise requiring intubation; hemodynamic instability"
      },
      {
        "disposition": "General neurology/neurosurgery floor",
        "criteria": "New diagnosis requiring workup and treatment planning; symptomatic edema requiring IV dexamethasone; post-seizure requiring monitoring and AED optimization; post-craniotomy (step-down from ICU); functional decline requiring inpatient rehabilitation planning"
      },
      {
        "disposition": "Observation (≤24h)",
        "criteria": "Known brain metastases with mild symptom change; MRI revealing progression but patient clinically stable; steroid dose adjustment with monitoring"
      }
    ]
  },
  "Breakthrough Seizure in Known Epilepsy": {
    "id": "breakthrough-seizure",
    "title": "Breakthrough Seizure in Known Epilepsy",
    "version": "1.0",
    "icd10": [
      "** G40.909 (Epilepsy",
      "unspecified",
      "not intractable",
      "without status epilepticus)",
      "G40.901 (Epilepsy",
      "unspecified",
      "not intractable",
      "with status epilepticus)",
      "G40.919 (Epilepsy",
      "unspecified",
      "intractable",
      "without status epilepticus)",
      "R56.9 (Unspecified convulsions)"
    ],
    "scope": "** Evaluation and management of breakthrough seizures in adults with known epilepsy who are on established antiseizure medication (ASM) regimens. Covers identification of precipitants, medication level assessment, adjustment strategies, and evaluation for secondary causes. Excludes new-onset seizure (separate workup), status epilepticus (see SE template), and non-epileptic events (psychogenic non-epileptic seizures).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Antiseizure medication (ASM) levels",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "**CRITICAL**: Subtherapeutic levels are #1 cause of breakthrough seizures; check ALL ASMs with available assays",
            "target": "Therapeutic ranges (see Appendix); subtherapeutic = adjust dose or assess adherence"
          },
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Infection as precipitant; baseline for ASM hematologic effects; thrombocytopenia (valproate)",
            "target": "Normal; leukocytosis → infection workup; low platelets → consider valproate toxicity"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Electrolyte abnormalities (hyponatremia common with carbamazepine/oxcarbazepine); renal function (affects ASM dosing); hepatic function (ASM metabolism, toxicity); glucose (hypoglycemia as seizure cause)",
            "target": "Normal; hyponatremia <130 mEq/L can provoke seizures; elevated LFTs → ASM hepatotoxicity"
          },
          {
            "item": "Blood glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hypoglycemia is reversible seizure cause; hyperglycemia (DKA) can also cause seizures",
            "target": "70-180 mg/dL; hypoglycemia <60 mg/dL → treat immediately"
          },
          {
            "item": "Sodium",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hyponatremia: carbamazepine and oxcarbazepine cause SIADH; <125-130 mEq/L can provoke seizures",
            "target": "135-145 mEq/L; <130 → correct slowly (risk of osmotic demyelination)"
          },
          {
            "item": "Calcium (ionized)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hypocalcemia can cause seizures; also check if hypocalcemic tetany suspected",
            "target": "Normal ionized Ca; low → replete"
          },
          {
            "item": "Magnesium",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hypomagnesemia lowers seizure threshold; chronic ASM use may deplete Mg",
            "target": ">2.0 mg/dL; low → replete"
          },
          {
            "item": "Urinalysis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "UTI is common occult infection that provokes seizures, especially in elderly",
            "target": "Normal; pyuria/bacteriuria → treat UTI"
          },
          {
            "item": "Urine drug screen (UDS)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Illicit drug use (cocaine, amphetamines) can provoke seizures; drug interactions with ASMs; adherence assessment",
            "target": "Negative; positive → specific drug-related seizure risk assessment"
          },
          {
            "item": "Alcohol level",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Alcohol withdrawal seizures; intoxication; binge drinking",
            "target": "Negative or low; elevated or history of recent heavy use → alcohol withdrawal protocol"
          },
          {
            "item": "Pregnancy test (β-hCG)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Pregnancy affects ASM levels (increased clearance, volume distribution); teratogenicity concerns; seizure risk in pregnancy",
            "target": "Document result; if positive → urgent neurology/OB consultation; ASM teratogenicity counseling"
          }
        ],
        "Extended Workup": [
          {
            "item": "Free (unbound) ASM levels",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "For highly protein-bound drugs (phenytoin, valproate) in patients with hypoalbuminemia, renal failure, pregnancy, or polypharmacy; free level is the active fraction",
            "target": "Free phenytoin: 1-2 mcg/mL; free valproate: 5-15 mcg/mL; adjusted interpretation based on clinical context"
          },
          {
            "item": "Ammonia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Valproate-induced hyperammonemic encephalopathy (can occur with normal LFTs); confusion/lethargy post-ictal vs. encephalopathy",
            "target": "<35 μmol/L; elevated → valproate toxicity; consider discontinuation"
          },
          {
            "item": "Lactate",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Post-ictal lactate elevation (typically resolves within 2h); persistent elevation may indicate status epilepticus or alternative cause",
            "target": "Mildly elevated post-ictal (normalizes quickly); persistent elevation concerning"
          },
          {
            "item": "Prolactin",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Elevated 10-20 min post-seizure (2-3x baseline); helps distinguish epileptic seizure from psychogenic non-epileptic seizure (PNES); must be drawn within 20 min",
            "target": "2-3x baseline within 20 min of convulsive seizure; normal in PNES"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Thyroid dysfunction can affect seizure threshold and ASM metabolism",
            "target": "Normal"
          },
          {
            "item": "Cortisol (AM)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Adrenal insufficiency; chronic ASM use (enzyme inducers) may affect cortisol",
            "target": "Normal"
          },
          {
            "item": "B12 / Folate",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Phenytoin and carbamazepine can deplete folate; B12 deficiency neuropathy; pregnancy planning",
            "target": "Normal; low → supplement"
          },
          {
            "item": "Vitamin D (25-OH)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Enzyme-inducing ASMs (phenytoin, carbamazepine, phenobarbital) increase vitamin D metabolism → osteoporosis risk",
            "target": ">30 ng/mL; low → supplement"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "ASM pharmacogenomics (HLA typing)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HLA-B*15:02 (carbamazepine/SJS risk in Asian populations); HLA-A*31:01 (carbamazepine hypersensitivity in Europeans); before starting new ASMs",
            "target": "Negative for risk alleles; positive → avoid associated ASM"
          },
          {
            "item": "Carbamazepine-10,11-epoxide level",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Active metabolite of carbamazepine; may be elevated when total level appears therapeutic (especially with inhibitors like valproate); correlates with toxicity",
            "target": "<9 mcg/mL; elevated → toxicity even with normal carbamazepine level"
          },
          {
            "item": "Autoimmune encephalitis panel",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If new seizure semiology, cognitive decline, or refractory seizures in previously controlled patient; autoimmune etiology",
            "target": "Negative; positive → autoimmune encephalitis workup"
          },
          {
            "item": "CSF analysis",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "rationale": "If infection, autoimmune encephalitis, or CNS malignancy suspected as new cause",
            "target": "Normal; abnormal → specific diagnosis"
          },
          {
            "item": "Genetic epilepsy panel",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If genetic cause suspected (family history, syndromic features, drug-resistant epilepsy); may guide ASM selection",
            "target": "Specific mutations (SCN1A, SCN2A, KCNQ2, etc.) may inform treatment choices (e.g., avoid sodium channel blockers in Dravet syndrome)"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "LP — Generally NOT indicated",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "timing": "NOT routinely indicated for uncomplicated breakthrough seizure; **INDICATED if:** Suspected meningitis/encephalitis (fever, meningismus, altered mentation beyond typical post-ictal); suspected autoimmune encephalitis; immunocompromised patient with seizure",
            "target": "Normal in uncomplicated breakthrough; pleocytosis → infection or autoimmune; elevated protein; specific antibodies",
            "contraindications": "Mass lesion with mass effect; coagulopathy"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "**NOT routinely needed** for uncomplicated breakthrough seizure in known epilepsy with return to baseline; **INDICATED if:** Head trauma (fall during seizure), prolonged post-ictal state (>30 min), focal neurologic deficit, new seizure semiology, anticoagulation, fever + seizure, first seizure at this facility",
            "target": "Acute hemorrhage; mass lesion; edema; hydrocephalus; prior surgical changes",
            "contraindications": "None (for non-contrast); pregnancy (benefit outweighs minimal risk)"
          },
          {
            "item": "MRI brain with and without contrast",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "**NOT acutely needed** if stable known epilepsy with unchanged seizures; **INDICATED if:** Change in seizure semiology, increased seizure frequency without clear precipitant, new focal deficit, concern for progressive lesion, presurgical evaluation",
            "target": "Tumor; mesial temporal sclerosis; cortical dysplasia; vascular malformation; new structural cause",
            "contraindications": "MRI-incompatible implants; VNS devices (check MRI compatibility of specific device)"
          },
          {
            "item": "ECG (12-lead)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "Post-ictal arrhythmia; syncope vs. seizure; QTc prolongation (some ASMs); baseline for ASM changes",
            "target": "Normal; arrhythmia may indicate cardiac cause; prolonged QTc (avoid QT-prolonging ASMs)",
            "contraindications": "None"
          }
        ],
        "Extended": [
          {
            "item": "EEG (routine/outpatient)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Within 24-48h if possible (higher yield closer to seizure); characterize epileptiform activity; confirm epileptic vs. non-epileptic; guide ASM choice; localization",
            "target": "Epileptiform discharges (spikes, sharp waves); focal vs. generalized; specific epilepsy syndrome features",
            "contraindications": "None"
          },
          {
            "item": "Continuous EEG (cEEG) monitoring",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "**INDICATED if:** Prolonged or fluctuating alteration of consciousness; concern for nonconvulsive status epilepticus (NCSE); ICU patient with unexplained encephalopathy; frequent seizures",
            "target": "Ictal patterns; NCSE; interictal epileptiform activity; quantify seizure burden",
            "contraindications": "None; resource-dependent"
          },
          {
            "item": "Ambulatory EEG (outpatient)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Capture typical events if infrequent; home monitoring for 24-72h or longer",
            "target": "Ictal events; interictal discharges; seizure frequency",
            "contraindications": "Patient cooperation required"
          },
          {
            "item": "Video-EEG monitoring (EMU admission)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Characterize events if diagnostic uncertainty (epileptic vs. PNES); presurgical evaluation; medication taper for surgery",
            "target": "Ictal semiology; EEG correlation; localization for surgery",
            "contraindications": "Requires specialized unit"
          },
          {
            "item": "Chest X-ray",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Aspiration pneumonia (common post-ictal complication); ETT position if intubated",
            "target": "Infiltrate; aspiration pattern",
            "contraindications": "None"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "MRI epilepsy protocol",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "High-resolution imaging for epileptogenic lesion identification; 3T preferred; includes thin-cut coronal T2/FLAIR through temporal lobes",
            "target": "Mesial temporal sclerosis; focal cortical dysplasia; cavernous malformation; low-grade tumor",
            "contraindications": "Same as standard MRI"
          },
          {
            "item": "PET (FDG) or SPECT (ictal/interictal)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Presurgical localization; hypometabolism (interictal PET) or hyperperfusion (ictal SPECT) at seizure focus",
            "target": "Focal hypometabolism (interictal); focal hyperperfusion (ictal)",
            "contraindications": "Radiation exposure; specialized availability"
          },
          {
            "item": "MEG (magnetoencephalography)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Presurgical localization; dipole source analysis; specialized centers",
            "target": "Source localization complementary to EEG",
            "contraindications": "Limited availability; metal implants"
          },
          {
            "item": "Neuropsychological testing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Presurgical evaluation; cognitive baseline; localization (memory lateralization for temporal lobe epilepsy)",
            "target": "Lateralized deficits; cognitive baseline for surgery comparison",
            "contraindications": "Patient cooperation"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent Treatment": [
          {
            "item": "**Benzodiazepine (if actively seizing)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg/kg",
                  "orderSentence": "**Benzodiazepine (if actively seizing)** 0.1 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "**Lorazepam** 0.1 mg/kg IV (max 4 mg), may repeat x1 in 5 min; **OR Midazolam** 10 mg IM (if no IV access); **OR Diazepam** 0.2 mg/kg IV (max 10 mg); **Intranasal midazolam** 5-10 mg if no IV; **Rectal diazepam** 0.2-0.5 mg/kg (home rescue)",
              "orderSentence": "**Benzodiazepine (if actively seizing)** 0.1 mg/kg IV"
            },
            "contraindications": "-",
            "monitoring": "First-line for acute seizure termination; lorazepam preferred IV (longer CNS duration); follow status epilepticus protocol if seizure continues >5 min",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Protect patient during seizure**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Clear environment of hazards; DO NOT restrain or put anything in mouth; turn on side (recovery position) when safe; suction secretions; monitor airway; time the seizure",
              "orderSentence": "**Protect patient during seizure** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Prevent injury; prepare for airway management if prolonged",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Post-ictal care**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "92%",
                  "orderSentence": "**Post-ictal care** 92% -"
                }
              ],
              "route": "-",
              "instructions": "Recovery position; monitor airway (aspiration risk); supplemental O2 if SpO2 <92%; assess for injuries (tongue laceration, shoulder dislocation, vertebral fracture); reassurance; reorientation",
              "orderSentence": "**Post-ictal care** 92% -"
            },
            "contraindications": "-",
            "monitoring": "Post-ictal period is self-limited (typically 5-30 min); prolonged alteration → consider NCSE, repeat seizure, or alternative diagnosis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Administer home ASM (if missed)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "If patient missed doses → give maintenance ASM immediately; if patient does not have medication with them → administer from ED/hospital supply",
              "orderSentence": "**Administer home ASM (if missed)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Non-adherence is most common cause of breakthrough seizure; restoring therapeutic levels is priority",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Loading dose (if significantly subtherapeutic)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15-20 mg",
                  "orderSentence": "**Loading dose (if significantly subtherapeutic)** 15-20 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "**Phenytoin/Fosphenytoin:** 15-20 mg PE/kg IV (if level very low); **Valproate:** 20-30 mg/kg IV (if level very low); **Levetiracetam:** 1000-1500 mg IV (if not on levetiracetam — can be added); **Note:** Loading the same drug patient is already taking risks toxicity → use cautiously",
              "orderSentence": "**Loading dose (if significantly subtherapeutic)** 15-20 mg IV"
            },
            "contraindications": "-",
            "monitoring": "For significantly subtherapeutic levels or if need rapid therapeutic concentration; adjust for partial levels",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Treat precipitant**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Infection:** Antibiotics for UTI, pneumonia; **Electrolyte abnormality:** Correct (hyponatremia slowly); **Drug/alcohol withdrawal:** Appropriate protocol; **Sleep deprivation:** Education, sleep hygiene",
              "orderSentence": "**Treat precipitant** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Treating the precipitant may be more important than adjusting ASMs",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "ASM Adjustment Strategies": [
          {
            "item": "Resume current regimen at prescribed doses",
            "rationale": "Non-adherence is #1 cause; restoring regimen usually sufficient"
          },
          {
            "item": "Increase current ASM OR add second ASM",
            "rationale": "Some patients require levels above \"therapeutic range\" for control"
          },
          {
            "item": "Add second ASM OR optimize current ASM timing",
            "rationale": "Breakthrough at therapeutic levels may require adjunctive therapy"
          },
          {
            "item": "Remove interacting drug OR increase ASM dose OR switch ASM",
            "rationale": "Enzyme inducers and inhibitors significantly affect ASM levels"
          },
          {
            "item": "Increase dose with frequent monitoring",
            "rationale": "Seizure risk to mother and fetus outweighs small ASM risk; maintain control"
          },
          {
            "item": "Full re-evaluation",
            "rationale": "Change in control pattern requires investigation for new etiology"
          }
        ],
        "Medications to AVOID or Use with Caution": [
          {
            "item": "**Tramadol**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Tramadol** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Meperidine (Demerol)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Meperidine (Demerol)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Bupropion**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Bupropion** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Clozapine**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Clozapine** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Fluoroquinolones**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Fluoroquinolones** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Carbapenems (imipenem > meropenem)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Carbapenems (imipenem > meropenem)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Isoniazid**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Isoniazid** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Theophylline / Aminophylline**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Theophylline / Aminophylline** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Stimulants (amphetamines, methylphenidate)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Stimulants (amphetamines, methylphenidate)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Alcohol (acute intoxication and withdrawal)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Alcohol (acute intoxication and withdrawal)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Illicit drugs (cocaine, amphetamines, synthetic cathinones)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Illicit drugs (cocaine, amphetamines, synthetic cathinones)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consultation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "ASM level check",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Adherence assessment",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Precipitant identification",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Injury assessment",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Safety counseling",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Return to baseline confirmation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Patient Instructions": [
          {
            "item": "EEG",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Imaging",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Pharmacy consultation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychology / Psychiatry",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Epilepsy nurse educator",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Women's health counseling",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Epilepsy surgery evaluation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "VNS / RNS / DBS evaluation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ketogenic diet referral",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "PNES evaluation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Autoimmune epilepsy workup",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetic testing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Diagnosis",
        "features": "Key Distinguishing Features",
        "tests": "Evaluation"
      },
      {
        "diagnosis": "**True breakthrough seizure (epileptic)**",
        "features": "Typical semiology for patient; post-ictal state; EEG correlation; identifiable precipitant or subtherapeutic level",
        "tests": "ASM levels; EEG; precipitant search"
      },
      {
        "diagnosis": "**Psychogenic non-epileptic seizure (PNES)**",
        "features": "Variable semiology; prolonged duration (>2 min); preserved awareness with bilateral movements; eyes closed; pelvic thrusting; ictal crying; side-to-side head movements; no post-ictal confusion (or prolonged pseudo-post-ictal); normal prolactin; normal EEG during event",
        "tests": "Video-EEG (gold standard); prolactin (not elevated); clinical features; psychology evaluation"
      },
      {
        "diagnosis": "**Syncope (convulsive)**",
        "features": "Triggered by standing, hot environment, vagal stimulus; brief LOC (<1 min); myoclonic jerks are common during syncope (not true seizure); rapid recovery; pale before event",
        "tests": "ECG; orthostatics; tilt table test; echocardiogram; cardiac history"
      },
      {
        "diagnosis": "**Cardiac arrhythmia**",
        "features": "Sudden LOC without warning or with palpitations; rapid recovery; history of cardiac disease",
        "tests": "ECG; Holter/event monitor; echocardiogram; electrophysiology study"
      },
      {
        "diagnosis": "**Toxic/metabolic**",
        "features": "Hypoglycemia; hyponatremia; hypocalcemia; uremia; hepatic encephalopathy; drug intoxication/withdrawal",
        "tests": "Glucose; electrolytes; renal/hepatic function; drug screen; specific toxin levels"
      },
      {
        "diagnosis": "**Transient ischemic attack (TIA)**",
        "features": "Negative symptoms (weakness, numbness, aphasia) vs. positive symptoms (convulsion); typically no LOC; vascular risk factors",
        "tests": "MRI with DWI; MRA; vascular risk factor assessment"
      },
      {
        "diagnosis": "**Sleep disorders**",
        "features": "REM sleep behavior disorder; parasomnias; cataplexy (narcolepsy)",
        "tests": "Sleep history; PSG; MSL"
      },
      {
        "diagnosis": "**Movement disorders**",
        "features": "Dystonia; chorea; myoclonus (non-epileptic); paroxysmal dyskinesia",
        "tests": "Preserved awareness; stereotyped movements; neurologic exam; movement disorder evaluation"
      },
      {
        "diagnosis": "**Migraine with aura**",
        "features": "Visual, sensory, or motor aura preceding headache; duration 20-60 min; no LOC",
        "tests": "Headache history; migraine features; may have EEG abnormalities but distinct from seizure"
      }
    ],
    "evidence": [
      {
        "recommendation": "Guideline",
        "evidenceLevel": "Source",
        "source": "Year"
      },
      {
        "recommendation": "Practice Guideline Update: Efficacy and Tolerability of ASMs",
        "evidenceLevel": "AAN",
        "source": "2018"
      },
      {
        "recommendation": "Management of Adult Epilepsy",
        "evidenceLevel": "AES/ILAE",
        "source": "Ongoing updates"
      },
      {
        "recommendation": "Epilepsy in Women",
        "evidenceLevel": "AAN",
        "source": "2009/Updates"
      },
      {
        "recommendation": "SUDEP Prevention",
        "evidenceLevel": "AAN",
        "source": "2017"
      },
      {
        "recommendation": "Study",
        "evidenceLevel": "Finding",
        "source": "Impact"
      },
      {
        "recommendation": "Kwan & Brodie (2000)",
        "evidenceLevel": "47% of newly diagnosed epilepsy patients became seizure-free on first ASM; 13% on second; 4% on third; after failure of 2 appropriate ASMs, chance of seizure freedom with additional ASMs is <5%",
        "source": "Defined drug-resistant epilepsy; established rationale for early surgery referral"
      },
      {
        "recommendation": "SANAD I & II (2007, 2021)",
        "evidenceLevel": "Lamotrigine best for focal epilepsy; valproate best for generalized/unclassified (but teratogenic); levetiracetam non-inferior to lamotrigine for focal",
        "source": "Guide first-line ASM selection by seizure type"
      },
      {
        "recommendation": "Standard and New Antiepileptic Drugs (SNAED) Trial",
        "evidenceLevel": "Levetiracetam and zonisamide non-inferior to lamotrigine for focal epilepsy",
        "source": "Expanded first-line options"
      },
      {
        "recommendation": "Early Randomized Surgical Epilepsy Trial (ERSET, 2012)",
        "evidenceLevel": "Early surgery superior to continued medical therapy for drug-resistant temporal lobe epilepsy; 73% vs. 0% seizure-free at 2 years",
        "source": "Surgery is highly effective; early referral improves outcomes"
      },
      {
        "recommendation": "SUDEP Risk Factors",
        "evidenceLevel": "Convulsive seizures, especially nocturnal; living alone; poor seizure control",
        "source": "Counsel patients; nocturnal monitoring devices; optimize seizure control"
      },
      {
        "recommendation": "ASM",
        "evidenceLevel": "Total Level",
        "source": "Free Level"
      },
      {
        "recommendation": "Phenytoin",
        "evidenceLevel": "10-20 mcg/mL",
        "source": "1-2 mcg/mL"
      },
      {
        "recommendation": "Carbamazepine",
        "evidenceLevel": "4-12 mcg/mL",
        "source": "N/A"
      },
      {
        "recommendation": "Valproate",
        "evidenceLevel": "50-100 mcg/mL",
        "source": "5-15 mcg/mL"
      },
      {
        "recommendation": "Phenobarbital",
        "evidenceLevel": "15-40 mcg/mL",
        "source": "N/A"
      },
      {
        "recommendation": "Levetiracetam",
        "evidenceLevel": "12-46 mcg/mL (suggested)",
        "source": "N/A"
      },
      {
        "recommendation": "Lamotrigine",
        "evidenceLevel": "3-14 mcg/mL (varies)",
        "source": "N/A"
      },
      {
        "recommendation": "Oxcarbazepine (MHD)",
        "evidenceLevel": "3-35 mcg/mL",
        "source": "N/A"
      },
      {
        "recommendation": "Topiramate",
        "evidenceLevel": "5-20 mcg/mL (suggested)",
        "source": "N/A"
      },
      {
        "recommendation": "Lacosamide",
        "evidenceLevel": "10-20 mcg/mL (emerging)",
        "source": "N/A"
      },
      {
        "recommendation": "Clobazam",
        "evidenceLevel": "0.03-0.3 mcg/mL",
        "source": "N/A"
      },
      {
        "recommendation": "Brivaracetam",
        "evidenceLevel": "Not established",
        "source": "N/A"
      },
      {
        "recommendation": "Perampanel",
        "evidenceLevel": "Not established",
        "source": "N/A"
      }
    ],
    "monitoring": [
      {
        "item": "Mental status (return to baseline)",
        "frequency": "q15 min until resolved; q1h thereafter",
        "target": "Return to baseline within 30-60 min",
        "action": "Prolonged: consider NCSE → EEG; imaging; extended evaluation"
      },
      {
        "item": "Vital signs",
        "frequency": "q15-30 min initially; q1h once stable",
        "target": "HR 60-100; BP <180/110; SpO2 >94%; Temp <38°C",
        "action": "Manage accordingly; fever → infection workup"
      },
      {
        "item": "Seizure recurrence",
        "frequency": "Continuous observation",
        "target": "No further seizures",
        "action": "Repeat seizure: give benzodiazepine; consider additional ASM load; SE protocol if >5 min"
      },
      {
        "item": "Airway / Respiratory status",
        "frequency": "Continuous; q15 min",
        "target": "Patent airway; no aspiration; adequate ventilation",
        "action": "Position; suction; O2 if needed; intubation if compromised"
      },
      {
        "item": "Blood glucose",
        "frequency": "Check immediately; repeat if symptomatic",
        "target": "70-180 mg/dL",
        "action": "Hypoglycemia: D50W IV"
      },
      {
        "item": "Cardiac rhythm",
        "frequency": "Continuous telemetry",
        "target": "Normal sinus; no arrhythmia",
        "action": "Treat arrhythmia; cardiology if indicated"
      }
    ],
    "disposition": [
      {
        "disposition": "Level of Care",
        "criteria": "Criteria"
      },
      {
        "disposition": "ICU",
        "criteria": "Status epilepticus; cluster seizures requiring continuous infusion; severe injuries; need for continuous EEG monitoring; airway compromise; hemodynamic instability"
      },
      {
        "disposition": "General floor / Observation",
        "criteria": "Prolonged post-ictal state; multiple seizures in ED; significantly subtherapeutic levels requiring monitoring during adjustment; uncertain diagnosis; new focal deficit; complicating medical illness"
      },
      {
        "disposition": "Discharge home",
        "criteria": "Single uncomplicated breakthrough seizure; returned to baseline; identifiable/correctable precipitant; therapeutic or corrected ASM level; no injuries requiring admission; safe home environment; reliable follow-up"
      }
    ]
  },
  "Cauda Equina Syndrome (CES)": {
    "id": "cauda-equina-syndrome",
    "title": "Cauda Equina Syndrome (CES)",
    "version": "1.0",
    "icd10": [
      "** G83.4 (Cauda equina syndrome)",
      "M48.06 (Spinal stenosis",
      "lumbar region)",
      "M51.16 (Intervertebral disc disorders with radiculopathy",
      "lumbar region)",
      "M51.17 (Intervertebral disc disorders with radiculopathy",
      "lumbosacral region)",
      "G95.89 (Other specified diseases of spinal cord)"
    ],
    "scope": "** Emergency evaluation and management of cauda equina syndrome in adults. Covers urgent recognition of incomplete vs. complete CES, emergent MRI, surgical decompression timing, etiologic workup (disc herniation, tumor, abscess, hematoma), bladder management, and functional prognostication. Excludes conus medullaris syndrome (partially overlaps — key distinguishing features addressed), malignant epidural spinal cord compression above the conus (separate template), and chronic lumbar stenosis without CES features.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Infection (epidural abscess); baseline for surgery; leukocytosis; anemia assessment",
            "target": "Normal; leukocytosis → consider abscess; thrombocytopenia affects surgical candidacy"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Electrolytes; renal function (contrast, NSAIDs); glucose; hepatic function (anesthetic risk)",
            "target": "Normal"
          },
          {
            "item": "PT/INR, aPTT",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Coagulopathy; anticoagulation status; surgical clearance; epidural hematoma etiology",
            "target": "Normal; INR <1.5 for surgery; prolonged → consider epidural hematoma"
          },
          {
            "item": "ESR / CRP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Epidural abscess differential (ESR >20 mm/hr: 94% sensitivity for spinal abscess); discitis; malignancy",
            "target": "Normal; markedly elevated (ESR >30-50, CRP >10) → strongly consider abscess or infection"
          },
          {
            "item": "Blood cultures (x2 sets)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Epidural abscess; bacteremia; source identification if infectious etiology suspected",
            "target": "Negative; positive → epidural abscess or hematogenous source"
          },
          {
            "item": "Blood glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Baseline; anesthetic risk; diabetic patients at increased disc herniation and infection risk",
            "target": "<180 mg/dL"
          },
          {
            "item": "Type and screen",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Surgical candidacy; blood product availability for emergency decompression",
            "target": "On file"
          },
          {
            "item": "Urinalysis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "UTI (common comorbidity and mimicker of urinary symptoms); neurogenic bladder assessment; baseline",
            "target": "Normal; UTI may coexist — treat but do NOT attribute bladder dysfunction solely to UTI if CES features present"
          },
          {
            "item": "Pregnancy test (β-hCG)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "MRI and anesthetic planning; pregnancy may exacerbate disc herniation (increased lordosis/weight)",
            "target": "Negative; if positive → MRI still indicated (no gadolinium needed for CES diagnosis)"
          },
          {
            "item": "Procalcitonin",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Bacterial infection differential (more specific than CRP); if abscess suspected",
            "target": "<0.25 (low bacterial probability); >0.5 → consider abscess"
          }
        ],
        "Extended Workup": [
          {
            "item": "HbA1c",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes assessment (risk factor for disc herniation, infection, neuropathy); post-operative wound healing",
            "target": "<7.0%"
          },
          {
            "item": "Tumor markers (PSA, CEA, etc.)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If imaging suggests neoplastic etiology rather than disc herniation",
            "target": "Normal; elevated → guides oncologic workup"
          },
          {
            "item": "SPEP / free light chains",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Multiple myeloma presenting as cauda equina compression",
            "target": "No M-protein; normal kappa/lambda ratio"
          },
          {
            "item": "LDH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Lymphoma; tumor burden",
            "target": "Normal; elevated → lymphoma, aggressive malignancy"
          },
          {
            "item": "HIV",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Immunocompromised → infection risk; primary CNS lymphoma differential",
            "target": "Negative"
          },
          {
            "item": "Urine culture",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Pre-existing UTI; post-catheterization planning; differentiate neurogenic bladder from UTI",
            "target": "Negative; if positive → treat but continue CES workup"
          },
          {
            "item": "Post-void residual (PVR) — bladder scan",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "KEY DIAGNOSTIC TEST: bladder retention is hallmark of CES; PVR >200 mL is highly concerning; >500 mL strongly suggestive of neurogenic retention",
            "target": "PVR <100 mL (normal); PVR >200 mL → significant retention; >500 mL → almost certainly neurogenic"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CSF analysis (only at surgery or LP if needed)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If inflammatory/infectious etiology suspected (GBS affecting cauda equina = rare); leptomeningeal carcinomatosis",
            "target": "Normal; elevated protein → GBS, tumor; malignant cells → leptomeningeal disease"
          },
          {
            "item": "Paraneoplastic antibody panel",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Atypical CES without structural cause; paraneoplastic cauda equina neuritis (anti-CRMP5/CV2, anti-amphiphysin)",
            "target": "Negative; positive → paraneoplastic syndrome"
          },
          {
            "item": "Anti-ganglioside antibodies (GM1, GD1b, GQ1b)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "GBS variant affecting cauda equina roots (rare); if imaging shows nerve root enhancement without structural compression",
            "target": "Negative; positive → GBS/CIDP affecting cauda equina"
          },
          {
            "item": "AQP4-IgG / MOG-IgG",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If conus medullaris lesion rather than cauda equina compression; NMOSD can affect conus",
            "target": "Negative; positive → NMOSD/MOGAD"
          },
          {
            "item": "Sarcoidosis workup (ACE, chest CT, lysozyme)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Neurosarcoidosis affecting cauda equina (nerve root inflammation/enhancement without structural lesion); elevated ACE",
            "target": "Normal ACE; chest CT: no hilar lymphadenopathy; if positive → neurosarcoidosis"
          },
          {
            "item": "EMG/NCS",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Chronic or atypical CES; differentiate from peripheral neuropathy, plexopathy; establish nerve root involvement pattern; prognostic (denervation = poor recovery)",
            "target": "Abnormal: acute denervation (fibrillations, positive sharp waves) in L4-S4 myotomes bilaterally; absent H-reflex bilaterally; abnormal pudendal nerve conduction"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "LP — Generally NOT indicated acutely",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "LP is NOT required for diagnosis of typical CES (disc herniation, tumor, abscess seen on MRI); ONLY if inflammatory/infectious etiology without clear structural cause; OR CT myelogram if MRI impossible",
            "target": "CSF protein elevation (GBS, tumor); pleocytosis (infection, inflammation); malignant cells (leptomeningeal disease); albuminocytologic dissociation (GBS)",
            "contraindications": "Do NOT perform LP if large disc herniation compressing cauda equina (could theoretically worsen by altering pressure dynamics — proceed to surgery instead); coagulopathy; abscess at LP site"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI lumbar spine without contrast (emergent)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "**Within 4 hours of ED arrival — SURGICAL EMERGENCY; ideally within 1 hour**; extends to thoracolumbar junction (T10-sacrum) to include conus medullaris",
            "target": "Large disc herniation (most common — 45% of CES cases) compressing cauda equina; canal compromise; level of compression; number of roots compressed; disc fragment migration; tumor, abscess, or hematoma as alternative cause; conus medullaris location and signal",
            "contraindications": "MRI-incompatible implants; severe claustrophobia (sedate — do NOT delay MRI for anxiety); GFR <30 for contrast (but contrast NOT required for disc herniation diagnosis — obtain non-contrast first)"
          },
          {
            "item": "MRI lumbar spine WITH contrast (gadolinium)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Add contrast if: suspected abscess, tumor, or inflammatory etiology; ring-enhancing epidural collection = abscess; homogeneous enhancement = tumor; nerve root enhancement = inflammatory/neoplastic",
            "target": "Epidural abscess (ring enhancement, restricted diffusion); tumor (enhancing mass); nerve root enhancement (inflammatory, leptomeningeal disease); distinguish from disc herniation (which does NOT enhance)",
            "contraindications": "GFR <30 (gadolinium risk — benefit outweighs risk in emergency); gadolinium allergy (premedicate)"
          },
          {
            "item": "Bladder scan (post-void residual)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "**Before MRI if possible — critical triage tool**; have patient attempt to void → immediate bladder ultrasound for PVR",
            "target": "PVR >200 mL = significant retention → HIGH probability of CES; PVR >500 mL = almost certain neurogenic retention; normal PVR does NOT exclude early/incomplete CES",
            "contraindications": "None (bedside ultrasound)"
          },
          {
            "item": "Plain radiographs (lumbar spine AP/lateral)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "While awaiting MRI; identifies vertebral collapse, spondylolisthesis, fracture, alignment; limited value but rapid triage tool",
            "target": "Disc space narrowing; spondylolisthesis; fracture; alignment abnormality; NOTE: X-rays CANNOT diagnose disc herniation — MRI is required",
            "contraindications": "Pregnancy (shield abdomen)"
          }
        ],
        "Extended": [
          {
            "item": "CT lumbar spine without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "If MRI not available or contraindicated; inferior to MRI for soft tissue but shows bone and canal narrowing; CT myelogram if MRI impossible",
            "target": "Disc herniation (seen as soft tissue density in canal); bone fragments; canal diameter; fracture; spondylolisthesis",
            "contraindications": "CT alone has limited sensitivity for disc herniation vs. MRI; myelogram adds invasive risk"
          },
          {
            "item": "CT myelogram",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "If MRI absolutely contraindicated (implant); intrathecal contrast via LP → CT; demonstrates level of block and root compression",
            "target": "Complete or partial block; compressed cauda equina roots; level and extent of compression; may miss small free fragments",
            "contraindications": "LP contraindicated if abscess suspected at LP site; coagulopathy; rare but important if MRI impossible"
          },
          {
            "item": "MRI whole spine",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "If etiology unclear; evaluate for additional levels of disease; concurrent cord compression; tumor staging; multilevel disc disease",
            "target": "Additional sites of compression; intramedullary lesion (conus); multifocal disease",
            "contraindications": "Same as lumbar MRI"
          },
          {
            "item": "Urodynamic studies",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Post-acute phase; quantify bladder dysfunction; detrusor areflexia (CES pattern); plan long-term bladder management",
            "target": "Detrusor areflexia (areflexic bladder) = cauda equina denervation; decreased bladder sensation; increased capacity; poor emptying",
            "contraindications": "Acute UTI; recent surgery (timing per surgeon)"
          },
          {
            "item": "Anal manometry / pudendal nerve testing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Quantify sphincter dysfunction; prognostic for recovery; pudendal nerve conduction",
            "target": "Reduced anal sphincter pressures; denervated pudendal nerve",
            "contraindications": "Patient tolerance; acute phase may not be appropriate"
          },
          {
            "item": "EMG/NCS (lower extremities + paraspinal)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "2-3 weeks post-onset (acute denervation takes 2-3 weeks to appear on EMG); prognosis; differentiate from peripheral neuropathy or plexopathy",
            "target": "Bilateral L4-S4 denervation; reduced CMAP amplitudes in bilateral L5/S1 distribution; absent H-reflexes bilaterally; bilateral pudendal neuropathy",
            "contraindications": "Too early in acute phase (<2 weeks = may be false negative for denervation); patient tolerance"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CT angiography (lumbar)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "timing": "If vascular malformation suspected (spinal dural AV fistula causing venous hypertension → CES symptoms); progressive myelopathy/CES with dilated serpiginous vessels on MRI",
            "target": "Spinal AV fistula; AVM; arteriovenous malformation feeding vessels",
            "contraindications": "Contrast allergy; renal impairment"
          },
          {
            "item": "Spinal angiography",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Definitive diagnosis and treatment of spinal dural AV fistula; also pre-operative embolization for vascular tumors",
            "target": "Fistula location; endovascular treatment candidate",
            "contraindications": "Invasive; contrast risk; radiation exposure"
          },
          {
            "item": "PET/CT",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If malignancy causing CES — staging; unknown primary identification",
            "target": "Primary tumor; metastatic burden",
            "contraindications": "Uncontrolled diabetes; pregnancy"
          },
          {
            "item": "Cystometrogram",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Formal bladder function assessment; post-decompression recovery monitoring; long-term bladder management planning",
            "target": "Bladder compliance; detrusor function; capacity; sensation thresholds",
            "contraindications": "Active UTI"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent Treatment": [
          {
            "item": "**Emergent surgical decompression**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**THIS IS A SURGICAL EMERGENCY — TIME IS NERVE**; Emergent neurosurgery/spine surgery consultation; posterior lumbar laminectomy with discectomy (most common procedure); **Timing:** Within 24h of symptom onset — ideally within 24h but outcome improves the sooner surgery is performed; <24h clearly better than >48h; some evidence supports <12h for best outcomes; **Complete CES (CES-R with retention):** Truly emergent — surgery as soon as possible (within hours); **Incomplete CES (CES-I):** Urgent — surgery within 24h; risk of progressing to complete",
              "orderSentence": "**Emergent surgical decompression** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Ahn et al. (2000): Decompression <48h = significantly better outcomes for bladder recovery (70% vs. 30%); Todd (2005) meta-analysis: Earlier surgery = better outcomes, but exact time threshold debated; DeBois et al. (2019): <24h optimal, <48h acceptable; Srikandarajah et al. (2020): Urgent surgery (<24h) associated with better functional outcomes",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Bladder management**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mL",
                  "orderSentence": "**Bladder management** 200 mL -"
                }
              ],
              "route": "-",
              "instructions": "**Bladder scan (PVR) STAT on arrival** — do NOT wait for MRI; if PVR >200 mL → Foley catheter placement; if PVR >500 mL → Foley + strict I&O monitoring; avoid overdistension (>600 mL causes detrusor damage — may become irreversible); document voiding pattern; post-operative: trial of void at 24-48h with PVR checks; CIC (clean intermittent catheterization) teaching if retention persists",
              "orderSentence": "**Bladder management** 200 mL -"
            },
            "contraindications": "-",
            "monitoring": "Bladder overdistension causes detrusor muscle damage → irreversible areflexic bladder; early catheterization prevents secondary damage; bladder recovery is the MOST SENSITIVE indicator of CES recovery and the MOST COMMON persistent deficit",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Pain management**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650-1000 mg",
                  "orderSentence": "**Pain management** 650-1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Back pain and radicular pain often severe; acetaminophen 650-1000 mg q6h (scheduled) + opioids (morphine 2-4 mg IV q3h PRN or hydromorphone 0.5-1 mg IV q3h PRN); NSAIDs: ketorolac 15-30 mg IV q6h (short-term, if no surgical contraindication and normal renal function — pre-op use is surgeon-dependent); neuropathic: gabapentin 300 mg TID (start if radicular pain prominent); avoid excessive sedation that obscures neurologic exam",
              "orderSentence": "**Pain management** 650-1000 mg IV"
            },
            "contraindications": "-",
            "monitoring": "Adequate analgesia essential for patient assessment and MRI tolerance; balance with need for neurologic monitoring",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Dexamethasone (if tumor or abscess)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "**Dexamethasone (if tumor or abscess)** 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "**Disc herniation CES:** Steroids NOT routinely indicated (no evidence of benefit; some centers use short course); **Tumor-related CES:** Dexamethasone 10 mg IV bolus → 4 mg q6h (same as MSCC protocol); **Abscess-related CES:** Dexamethasone controversial (may impair immune response) — use only if severe edema with rapid neurologic decline",
              "orderSentence": "**Dexamethasone (if tumor or abscess)** 10 mg IV"
            },
            "contraindications": "-",
            "monitoring": "No RCT evidence supporting steroids for disc-related CES; tumor CES: Sorensen et al. (1994) supports steroids; abscess: prioritize antibiotics + surgical drainage",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Antibiotics (if abscess suspected)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-30 mg/kg",
                  "orderSentence": "**Antibiotics (if abscess suspected)** 25-30 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "**Epidural abscess causing CES:** Empiric: Vancomycin 25-30 mg/kg IV load + ceftriaxone 2g IV q12h (or cefepime 2g IV q8h); adjust to culture/sensitivity; MRSA coverage essential; **Duration:** Typically 6-8 weeks IV antibiotics for epidural abscess; **Timing:** Start AFTER blood cultures drawn but do NOT delay if patient is deteriorating",
              "orderSentence": "**Antibiotics (if abscess suspected)** 25-30 mg/kg IV"
            },
            "contraindications": "-",
            "monitoring": "S. aureus (including MRSA) is most common organism in epidural abscess (60-70%); gram-negative coverage for UTI/abdominal source; streptococci, anaerobes less common",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**DVT prophylaxis**",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "**DVT prophylaxis** 40 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "SCDs immediately; pharmacologic prophylaxis: enoxaparin 40 mg SQ daily starting post-operatively (typically 12-24h after surgery per surgeon protocol); immobile CES patients at high VTE risk",
              "orderSentence": "**DVT prophylaxis** 40 mg SC"
            },
            "contraindications": "-",
            "monitoring": "Immobility + lower extremity weakness = high DVT risk; mechanical prophylaxis pre-operatively; early pharmacologic prophylaxis post-operatively",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Bowel management**",
            "route": "PR",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "**Bowel management** 100 mg PR"
                }
              ],
              "route": "PR",
              "instructions": "Assess rectal tone (digital rectal exam — absent/reduced in CES); bowel regimen: docusate 100 mg BID + senna 2 tabs HS; bisacodyl suppository daily if no BM in 48h; monitor for fecal incontinence vs. constipation (both occur in CES); opioid-related constipation compounds the issue",
              "orderSentence": "**Bowel management** 100 mg PR"
            },
            "contraindications": "-",
            "monitoring": "Bowel dysfunction common in CES; S2-S4 denervation affects external anal sphincter and rectal sensation; proactive management prevents complications",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Definitive/Targeted Treatment": [
          {
            "item": "**Lumbar laminectomy + discectomy (disc herniation CES)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Most common surgery:** Posterior approach; laminectomy at affected level(s); remove herniated disc fragment; decompress cauda equina; **Approach:** Midline; may require bilateral laminotomy or hemi-laminectomy for lateralized discs; large central herniations often require bilateral approach; **Key:** Ensure COMPLETE decompression — incomplete decompression leads to persistent deficit; intraoperative confirmation with direct visualization of free cauda equina nerve roots",
              "orderSentence": "**Lumbar laminectomy + discectomy (disc herniation CES)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Gold standard for disc-related CES; no RCT comparing surgery vs. non-operative (would be unethical to randomize given natural history); observational data uniformly supports early surgical decompression",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Microdiscectomy (if technically appropriate)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Minimally invasive approach; appropriate for contained disc herniations without significant canal stenosis; faster recovery; less tissue disruption; may not provide adequate decompression for massive central disc herniation",
              "orderSentence": "**Microdiscectomy (if technically appropriate)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Smaller incision, less muscle disruption; but surgeon must ensure adequate decompression — do NOT compromise canal visualization for a smaller incision in CES",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Surgical drainage + decompression (epidural abscess)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "Posterior approach; laminectomy; drain abscess; culture material; irrigate; leave wound open or with drain; may require multi-level decompression; **Combined with:** IV antibiotics 6-8 weeks; follow with serial MRI and inflammatory markers",
              "orderSentence": "**Surgical drainage + decompression (epidural abscess)** - IV - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Epidural abscess with CES = surgical emergency; medical management alone (antibiotics without surgery) only if: no neurologic deficit AND very high surgical risk; most CES presentations require surgery",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Tumor resection + decompression**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "If tumor-related CES (e.g., schwannoma, ependymoma, metastasis); posterior decompression ± en bloc or piecemeal tumor resection; send pathology; may need subsequent radiation/chemotherapy",
              "orderSentence": "**Tumor resection + decompression** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Intradural-extramedullary tumors (schwannoma, meningioma, myxopapillary ependymoma) are potentially curable with complete resection; metastatic CES → decompression + radiation",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Hematoma evacuation**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Epidural hematoma causing CES (spontaneous on anticoagulation, post-procedural, or post-traumatic); emergent laminectomy with hematoma evacuation; reverse anticoagulation STAT",
              "orderSentence": "**Hematoma evacuation** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Spontaneous spinal epidural hematoma: Groen & Ponssen (1990): better outcomes with surgery <12h of onset; anticoagulation reversal essential (4F-PCC for warfarin, idarucizumab for dabigatran, andexanet for Xa inhibitors)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Non-operative management (rare, selected cases)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**ONLY appropriate if:** (1) Imaging does NOT show significant structural compression, (2) Symptoms are improving spontaneously, (3) Patient refuses surgery (document informed refusal thoroughly), (4) Medically inoperable (extremely high surgical risk); **Requires:** Close monitoring with serial neuro exams q2-4h; repeat MRI if worsening; immediate surgery if any progression",
              "orderSentence": "**Non-operative management (rare, selected cases)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Non-operative management is NOT standard of care for CES with structural compression; delayed surgery has worse outcomes; informed consent must document risks of non-operative management (permanent bladder/bowel/sexual dysfunction, progressive weakness)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Adjunctive Treatment": [
          {
            "item": "**Clean intermittent catheterization (CIC) training**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mL",
                  "orderSentence": "**Clean intermittent catheterization (CIC) training** 100 mL -"
                }
              ],
              "route": "-",
              "instructions": "If bladder function does not recover by 48-72h post-surgery; teach patient CIC q4-6h; target PVR <100 mL before discontinuing CIC; may take weeks to months to recover",
              "orderSentence": "**Clean intermittent catheterization (CIC) training** 100 mL -"
            },
            "contraindications": "-",
            "monitoring": "CIC is preferred over indwelling Foley for long-term bladder management (lower UTI risk); most patients can learn self-catheterization; bladder recovery may take 6-12 months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Neuropathic pain management**",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "**Neuropathic pain management** 300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Gabapentin 300 mg PO TID → titrate to 600-900 mg TID over 1-2 weeks; OR pregabalin 75 mg BID → 150-300 mg BID; duloxetine 30 mg daily → 60 mg daily; amitriptyline 10-25 mg HS (caution: urinary retention may worsen); topical lidocaine 5% patches for localized radicular pain",
              "orderSentence": "**Neuropathic pain management** 300 mg PO"
            },
            "contraindications": "-",
            "monitoring": "Neuropathic pain (burning, tingling, electric shocks in perineum, legs) is common and debilitating after CES; may persist chronically; multimodal approach needed",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**Physical therapy / rehabilitation**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "PT evaluation within 24h post-operatively; early mobilization; lower extremity strengthening; gait training; core stabilization; progressive activity as tolerated; pelvic floor PT for bladder/bowel recovery",
              "orderSentence": "**Physical therapy / rehabilitation** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Early rehabilitation improves functional outcomes; pelvic floor rehabilitation is evidence-based for bladder/bowel recovery after CES",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Occupational therapy**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "ADL assessment; adaptive equipment; if lower extremity weakness impairs function; bathroom modifications; return-to-work planning",
              "orderSentence": "**Occupational therapy** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Functional independence optimization",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Pelvic floor rehabilitation**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Specialized pelvic floor PT; biofeedback for bladder and bowel retraining; Kegel exercises (if able); electrical stimulation of pelvic floor; sacral neuromodulation evaluation if persistent dysfunction >12 months",
              "orderSentence": "**Pelvic floor rehabilitation** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Evidence supports pelvic floor PT for bladder and bowel recovery after CES; biofeedback improves outcomes",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Psychological support**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "CES has devastating psychosocial impact (sexual dysfunction, incontinence, chronic pain, disability in often-young patients); depression screening (PHQ-9); anxiety screening; sexual health counseling; support groups; consider psychiatry referral",
              "orderSentence": "**Psychological support** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Depression affects 30-60% of CES patients long-term; sexual dysfunction is profoundly distressing; early psychological intervention improves coping and recovery",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Stool softener / bowel program**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "**Stool softener / bowel program** 100 mg -"
                }
              ],
              "route": "-",
              "instructions": "Docusate 100 mg BID + senna 2 tabs HS; bisacodyl suppository PRN; digital stimulation for areflexic bowel; timed bowel program; fiber supplementation; adequate hydration",
              "orderSentence": "**Stool softener / bowel program** 100 mg -"
            },
            "contraindications": "-",
            "monitoring": "Neurogenic bowel management reduces complications (impaction, incontinence); establish routine bowel program early",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Medications to AVOID or Use with Caution": [
          {
            "item": "Anticholinergics (oxybutynin, tolterodine — for urgency)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Anticholinergics (oxybutynin, tolterodine — for urgency) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Tricyclic antidepressants (amitriptyline, nortriptyline)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Tricyclic antidepressants (amitriptyline, nortriptyline) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Alpha-blockers (tamsulosin, silodosin) — without urologic guidance",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Alpha-blockers (tamsulosin, silodosin) — without urologic guidance - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "NSAIDs (prolonged, peri-operative)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "NSAIDs (prolonged, peri-operative) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Epidural steroid injection (as treatment for CES)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Epidural steroid injection (as treatment for CES) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Chiropractic manipulation (lumbar)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Chiropractic manipulation (lumbar) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Excessive IV fluids (post-operatively)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Excessive IV fluids (post-operatively) - IV - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurosurgery / Spine surgery consultation — EMERGENCY",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Post-void residual (bladder scan)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Digital rectal examination",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Comprehensive neurologic exam documentation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Classify CES subtype",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Informed consent for surgery",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Transfer to surgical center (if no spine surgeon)",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Urology consultation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "PM&R / Rehabilitation consultation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain management consultation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sexual health counseling",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Colorectal surgery / GI consultation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work / case management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Medicolegal documentation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Revision surgery",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sacral neuromodulation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Intrathecal baclofen pump",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Chronic pain management program",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatric referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Legal documentation review",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Diagnosis",
        "features": "Key Differentiating Features",
        "tests": "Distinguishing Studies"
      },
      {
        "diagnosis": "Conus medullaris syndrome",
        "features": "Upper motor neuron AND lower motor neuron signs; bilateral and symmetric; early bladder/bowel dysfunction; back pain less prominent than radicular pain; reflexes may be hyperactive (UMN) or absent (LMN); typically at T12-L2 level; more symmetric than CES",
        "tests": "MRI: lesion at T12-L2 level (conus); cord signal change (T2 hyperintensity); CES lesion is below L1-L2 (cauda equina roots only); conus lesion → Babinski may be present (CES → absent or flexor)"
      },
      {
        "diagnosis": "Lumbar spinal stenosis (without CES)",
        "features": "Neurogenic claudication (walking-induced symptoms relieved by sitting/flexion); chronic progressive course; bilateral leg pain/weakness with walking; no bladder/bowel dysfunction (unless severe CES from stenosis); intermittent symptoms",
        "tests": "MRI: multilevel stenosis; trefoil canal shape; ligamentum flavum hypertrophy; NO acute disc herniation; symptoms are exercise-induced, not constant; PVR normal"
      },
      {
        "diagnosis": "Acute disc herniation (without CES)",
        "features": "Unilateral radiculopathy; no bilateral symptoms; no saddle anesthesia; no bladder/bowel dysfunction; straight leg raise positive; single dermatomal pattern",
        "tests": "MRI: lateral or posterolateral disc herniation compressing single root; NO cauda equina compression; normal PVR; normal rectal tone"
      },
      {
        "diagnosis": "Epidural abscess",
        "features": "Fever (50-66%); IVDU, immunocompromised, recent procedure; rapidly progressive; ESR >20 (94% sensitivity); severe spinal tenderness; leukocytosis; can cause CES if lumbar location",
        "tests": "MRI: ring-enhancing epidural collection with restricted diffusion; blood cultures positive (60%); ESR/CRP markedly elevated; clinical triad: back pain → radiculopathy → weakness (classic but only 10-15% present with full triad)"
      },
      {
        "diagnosis": "Epidural hematoma",
        "features": "Acute onset; anticoagulation or post-procedural (epidural injection, spinal surgery, LP); severe back pain → rapid progressive weakness; coagulopathy history",
        "tests": "MRI: epidural collection with blood signal (T1 bright in subacute); coagulation studies abnormal; anticoagulation history; post-procedural temporal relationship"
      },
      {
        "diagnosis": "Guillain-Barré syndrome (GBS)",
        "features": "Ascending symmetric weakness; areflexia; post-infectious (Campylobacter, CMV, EBV); sensory symptoms but often mild; facial weakness may be present; no saddle anesthesia typically; CSF: albuminocytologic dissociation",
        "tests": "MRI spine: may show nerve root enhancement BUT no structural compression; CSF: elevated protein, normal cells; NCS: demyelinating pattern or AMAN pattern; anti-ganglioside antibodies"
      },
      {
        "diagnosis": "Peripheral neuropathy (bilateral)",
        "features": "Chronic course; distal > proximal; length-dependent pattern; diabetes, alcohol; stocking-glove distribution; gradual onset; reflexes may be reduced distally; NO saddle anesthesia; NO acute bladder retention",
        "tests": "EMG/NCS: diffuse length-dependent neuropathy; MRI: no structural compression; HbA1c; B12; SPEP; gradual course distinguishes from acute CES"
      },
      {
        "diagnosis": "Lumbosacral plexopathy",
        "features": "Unilateral (usually); painful; diabetic amyotrophy; radiation-induced; tumor infiltration; asymmetric weakness/sensory loss in lumbosacral plexus distribution; typically NO bladder dysfunction (unless bilateral)",
        "tests": "MRI pelvis: plexus enhancement or mass; EMG: plexus distribution denervation; CT abdomen/pelvis: retroperitoneal mass; HbA1c; typically unilateral"
      },
      {
        "diagnosis": "Functional neurological disorder (FND)",
        "features": "Inconsistent exam findings; Hoover's sign positive; non-anatomical sensory pattern; normal imaging; normal PVR; no objective sphincter dysfunction; give-way weakness; history of psychological stressors",
        "tests": "MRI: normal; PVR: normal; rectal tone: normal; neurophysiology: normal; psychiatric history; clinical inconsistency (e.g., inability to lift leg on command but normal gait observed); NOTE: FND is a diagnosis of exclusion in CES — always obtain MRI first"
      }
    ],
    "evidence": [
      {
        "recommendation": "Guideline",
        "evidenceLevel": "Source",
        "source": "Year"
      },
      {
        "recommendation": "Cauda Equina Syndrome Standards of Care",
        "evidenceLevel": "British Association of Spine Surgeons (BASS) / Society of British Neurological Surgeons (SBNS)",
        "source": "2020"
      },
      {
        "recommendation": "CES Emergency Pathway",
        "evidenceLevel": "NICE / NHS England",
        "source": "2018 (updated 2023)"
      },
      {
        "recommendation": "AANS/CNS Guidelines on Lumbar Disc Herniation",
        "evidenceLevel": "AANS/CNS Joint Section on Disorders of the Spine and Peripheral Nerves",
        "source": "2014"
      },
      {
        "recommendation": "Study",
        "evidenceLevel": "Finding",
        "source": "Impact"
      },
      {
        "recommendation": "Ahn et al. (2000)",
        "evidenceLevel": "Systematic review: Decompression <48h of CES onset → 70% bladder recovery vs. 30% if >48h; motor outcomes also significantly better with early surgery",
        "source": "Established 48h as important threshold; but sooner is always better"
      },
      {
        "recommendation": "Todd (2005) — Meta-analysis",
        "evidenceLevel": "42 studies: Earlier decompression consistently associated with better outcomes across motor, bladder, and bowel domains; no clear cutoff but <24h is optimal",
        "source": "Confirmed urgency of CES surgical decompression; surgical timing is KEY modifiable factor"
      },
      {
        "recommendation": "Srikandarajah et al. (2020)",
        "evidenceLevel": "UK Cohort: Urgent surgery (<24h) vs. delayed (>24h): better bladder outcomes (OR 2.1) and motor outcomes (OR 1.6) with urgent surgery",
        "source": "Modern evidence supporting <24h surgical timing; NHS pathway development"
      },
      {
        "recommendation": "DeBois et al. (2019)",
        "evidenceLevel": "Timing analysis: <12h, 12-24h, 24-48h, >48h: progressive decline in outcomes with each delay interval; <12h had best bladder recovery",
        "source": "Supports as-soon-as-possible approach; <12h may be ideal"
      },
      {
        "recommendation": "Gleave & Macfarlane (2002)",
        "evidenceLevel": "CES-I vs. CES-R outcomes: CES-I (incomplete) with early surgery → 95% good bladder outcome; CES-R (retention) with early surgery → 53% good bladder outcome; CES-R with delayed surgery → 27% good outcome",
        "source": "Established CES-I vs. CES-R classification; demonstrated that retention onset is critical prognostic marker"
      },
      {
        "recommendation": "Groen & Ponssen (1990)",
        "evidenceLevel": "Spinal epidural hematoma: better outcomes with surgery <12h of onset; anticoagulation most common cause",
        "source": "Established surgical urgency for hematoma-related CES"
      },
      {
        "recommendation": "Kostuik et al. (1986)",
        "evidenceLevel": "Classic paper on CES natural history: untreated CES from disc herniation → permanent bladder dysfunction in >90%, persistent weakness in >70%, chronic pain in >80%",
        "source": "Established that CES without surgical treatment leads to devastating permanent deficits"
      },
      {
        "recommendation": "McCarthy et al. (2014)",
        "evidenceLevel": "Medicolegal analysis: CES is the most litigated condition in spinal surgery; delayed diagnosis is the most common reason for successful claims; failure to perform timely MRI and delayed surgery are key factors",
        "source": "Documentation of timeline is CRITICAL; standardized CES pathways reduce medicolegal risk"
      },
      {
        "recommendation": "Subtype",
        "evidenceLevel": "Definition",
        "source": "Key Features"
      },
      {
        "recommendation": "CES-Suspected (CES-S)",
        "evidenceLevel": "Bilateral radiculopathy/symptoms WITHOUT bladder dysfunction",
        "source": "Bilateral leg pain/weakness; bilateral sensory changes; NO urinary symptoms; normal PVR"
      },
      {
        "recommendation": "CES-Incomplete (CES-I)",
        "evidenceLevel": "Altered urinary function WITHOUT retention",
        "source": "Difficulty initiating stream; reduced sensation of voiding; urgency; partial retention (PVR 200-500 mL); reduced but present perineal sensation; reduced anal tone"
      },
      {
        "recommendation": "CES-Retention (CES-R)",
        "evidenceLevel": "Painless urinary retention WITH overflow incontinence",
        "source": "Painless retention (PVR >500 mL); overflow incontinence; absent perineal sensation; absent anal tone; often absent bulbocavernosus reflex"
      },
      {
        "recommendation": "Component",
        "evidenceLevel": "Bilateral L4",
        "source": "Bilateral L5"
      },
      {
        "recommendation": "Motor",
        "evidenceLevel": "Knee extension (quad)",
        "source": "Ankle dorsiflexion (TA), great toe extension (EHL), hip abduction"
      },
      {
        "recommendation": "Sensory",
        "evidenceLevel": "Medial leg/shin",
        "source": "Lateral leg, dorsum of foot, first web space"
      },
      {
        "recommendation": "Reflex",
        "evidenceLevel": "Patellar (L3-L4)",
        "source": "Tibialis posterior (L5 — inconsistent)"
      },
      {
        "recommendation": "Function",
        "evidenceLevel": "Walking, stairs",
        "source": "Heel walking"
      }
    ],
    "monitoring": [
      {
        "item": "Neurologic examination (lower extremity strength, sensation, reflexes)",
        "frequency": "q2-4h pre-operatively; q4h post-operatively x 48h",
        "target": "Stable pre-op; improving post-op",
        "action": "Pre-op worsening: escalate surgical urgency; post-op worsening: STAT MRI (hematoma, residual compression, re-herniation)"
      },
      {
        "item": "Perianal/perineal sensation and rectal tone",
        "frequency": "q4h (at minimum with each neuro check)",
        "target": "Improving or stable",
        "action": "Worsening: STAT MRI"
      },
      {
        "item": "Bladder function / PVR",
        "frequency": "Continuous monitoring via Foley with hourly I&O pre/post-op; Trial of void at 24-48h post-op with PVR check",
        "target": "PVR <100 mL to discontinue catheter; voiding spontaneously",
        "action": "PVR >200 mL after trial of void → replace Foley; begin CIC teaching; urology consult"
      },
      {
        "item": "Pain assessment (NRS)",
        "frequency": "q4h",
        "target": "NRS <4/10",
        "action": "Escalate analgesics; add neuropathic agents; new/worsening pain post-op → concern for hematoma/complication"
      },
      {
        "item": "Wound assessment (post-operative)",
        "frequency": "q8h",
        "target": "No drainage, swelling, erythema, dehiscence",
        "action": "Wound complication → surgical team notification; drain output monitoring"
      },
      {
        "item": "Bowel function",
        "frequency": "Daily",
        "target": "BM within 48-72h post-op",
        "action": "Bowel regimen intensification; abdominal X-ray if distended; rectal exam"
      },
      {
        "item": "Temperature",
        "frequency": "q4h",
        "target": "Afebrile",
        "action": "Fever: wound infection, UTI (Foley-associated), DVT, abscess; cultures and imaging as indicated"
      },
      {
        "item": "DVT screening",
        "frequency": "Daily calf circumference; symptoms",
        "target": "No DVT signs",
        "action": "Bilateral lower extremity duplex US if symptoms; therapeutic anticoagulation if confirmed"
      }
    ],
    "disposition": [
      {
        "disposition": "Level of Care",
        "criteria": "Criteria"
      },
      {
        "disposition": "ICU admission",
        "criteria": "Post-operative monitoring (surgeon-dependent — many post-laminectomies go to floor); bilateral lower extremity paralysis with hemodynamic concerns; epidural abscess with sepsis; significant comorbidities affecting anesthetic recovery; autonomic dysfunction"
      },
      {
        "disposition": "General neurosurgery/spine floor",
        "criteria": "ALL CES patients require admission; pre-operative CES awaiting surgical decompression; post-operative monitoring; pain management; bladder/bowel monitoring; PT/OT initiation; epidural abscess requiring IV antibiotics"
      },
      {
        "disposition": "Observation (NOT appropriate)",
        "criteria": "CES is NEVER an observation diagnosis — all suspected CES patients require emergent MRI and admission for surgical evaluation; even if MRI is negative for structural compression, admission for monitoring is prudent if clinical suspicion is high"
      }
    ]
  },
  "Dementia Evaluation / Cognitive Impairment Workup": {
    "id": "dementia-evaluation",
    "title": "Dementia Evaluation / Cognitive Impairment Workup",
    "version": "1.0",
    "icd10": [
      "** R41.81 (Age-related cognitive decline)",
      "F03.90 (Unspecified dementia without behavioral disturbance)",
      "G30.9 (Alzheimer's disease",
      "unspecified)",
      "F01.50 (Vascular dementia without behavioral disturbance)",
      "G31.83 (Dementia with Lewy bodies)",
      "G31.09 (Other frontotemporal dementia)",
      "G31.84 (Mild cognitive impairment)"
    ],
    "scope": "** Systematic evaluation of cognitive impairment and dementia in adults. Covers comprehensive workup to identify reversible causes and establish etiology. Includes initiation of symptomatic treatment. Excludes pediatric intellectual disability, acute delirium (separate entity), and rapidly progressive dementia (separate template for urgent workup).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Anemia, infection, hematologic disease",
            "target": "Normal"
          },
          {
            "item": "CMP (includes glucose, renal, hepatic)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Metabolic encephalopathy, hepatic/renal failure, glucose",
            "target": "Normal"
          },
          {
            "item": "TSH",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypothyroidism is reversible cause",
            "target": "Normal (0.4-4.0 mIU/L)"
          },
          {
            "item": "Vitamin B12",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "B12 deficiency is reversible cause",
            "target": ">400 pg/mL (>300 per some guidelines)"
          },
          {
            "item": "Folate",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Folate deficiency can contribute",
            "target": "Normal"
          },
          {
            "item": "Ammonia",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Hepatic encephalopathy if liver disease",
            "target": "<35 μmol/L"
          },
          {
            "item": "Urinalysis",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "UTI common cause of delirium/worsening",
            "target": "Negative"
          }
        ],
        "Extended Workup": [
          {
            "item": "RPR/VDRL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurosyphilis in differential",
            "target": "Negative"
          },
          {
            "item": "HIV",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HIV-associated neurocognitive disorder (HAND)",
            "target": "Negative"
          },
          {
            "item": "Thiamine (Vitamin B1)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Wernicke-Korsakoff if alcohol history",
            "target": "Normal"
          },
          {
            "item": "Vitamin D",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency associated with cognitive decline",
            "target": ">30 ng/mL"
          },
          {
            "item": "Homocysteine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Elevated levels associated with dementia risk",
            "target": "<15 μmol/L"
          },
          {
            "item": "HbA1c",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes and cognitive impairment",
            "target": "<7% ideally"
          },
          {
            "item": "Lipid panel",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Vascular risk factors",
            "target": "Per guidelines"
          },
          {
            "item": "ESR/CRP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Inflammatory/vasculitic cause",
            "target": "Normal"
          },
          {
            "item": "ANA",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "CNS lupus, autoimmune",
            "target": "Negative"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Serum ceruloplasmin, copper",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Wilson disease if <50 years",
            "target": "Normal"
          },
          {
            "item": "Heavy metals (lead, mercury, arsenic)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Occupational/environmental exposure",
            "target": "Negative"
          },
          {
            "item": "Paraneoplastic panel",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Subacute onset, smoking history, cancer history",
            "target": "Negative"
          },
          {
            "item": "Autoimmune encephalitis panel (serum)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Subacute onset, psychiatric features, seizures",
            "target": "Negative"
          },
          {
            "item": "Lyme serology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Endemic areas, tick exposure",
            "target": "Negative"
          },
          {
            "item": "West Nile serology",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Endemic areas, summer/fall onset",
            "target": "Negative"
          },
          {
            "item": "Genetic testing (APOE, APP, PSEN1/2)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Strong family history, early onset",
            "target": "Risk assessment"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "NPH evaluation",
            "target": "10-20 cm H2O"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Infection, inflammation",
            "target": "WBC <5"
          },
          {
            "item": "Protein",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Infection, inflammation",
            "target": "15-45 mg/dL"
          },
          {
            "item": "Glucose",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Infection",
            "target": ">60% serum"
          },
          {
            "item": "VDRL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Neurosyphilis",
            "target": "Negative"
          },
          {
            "item": "CSF meningitis panel",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Infectious etiology",
            "target": "Negative"
          },
          {
            "item": "Aβ42, total tau, phospho-tau",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "AD biomarkers (AT profile)",
            "target": "Aβ42↓, tau↑, p-tau↑ in AD"
          },
          {
            "item": "RT-QuIC (Real-Time Quaking-Induced Conversion)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "CJD if rapid progression",
            "target": "Negative"
          },
          {
            "item": "14-3-3 protein",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "CJD if rapid progression",
            "target": "Negative"
          },
          {
            "item": "Oligoclonal bands",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "MS, inflammatory conditions",
            "target": "Negative"
          },
          {
            "item": "Cytology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Carcinomatous meningitis",
            "target": "Negative"
          },
          {
            "item": "Autoimmune encephalitis panel (CSF)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If autoimmune suspected",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI brain without contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Initial workup",
            "target": "Atrophy pattern, vascular changes, masses, NPH",
            "contraindications": "Pacemaker, metal"
          },
          {
            "item": "CT head without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "If MRI unavailable or contraindicated",
            "target": "Masses, hemorrhage, hydrocephalus",
            "contraindications": "None"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain with contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If mass, infection, or inflammation suspected",
            "target": "Enhancing lesions",
            "contraindications": "Contrast allergy, renal disease"
          },
          {
            "item": "FDG-PET brain",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Distinguish AD from FTD; atypical presentations",
            "target": "AD: temporoparietal hypometabolism; FTD: frontal hypometabolism",
            "contraindications": "Per PET"
          },
          {
            "item": "Amyloid PET (Amyvid, Neuraceq)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Diagnostic uncertainty; young onset",
            "target": "Positive in AD and preclinical AD",
            "contraindications": "Per PET"
          },
          {
            "item": "Tau PET (Tauvid)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "AD staging, atypical presentations",
            "target": "Pattern correlates with symptoms",
            "contraindications": "Per PET"
          },
          {
            "item": "DaTscan",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If parkinsonian features; DLB vs AD",
            "target": "Reduced in DLB; normal in AD",
            "contraindications": "Pregnancy, iodine allergy"
          },
          {
            "item": "EEG",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Subclinical seizures, CJD (triphasic waves), delirium",
            "target": "Normal or diffuse slowing",
            "contraindications": "None"
          },
          {
            "item": "Polysomnography",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If REM sleep behavior disorder suspected (DLB)",
            "target": "Confirm RBD",
            "contraindications": "None"
          }
        ]
      },
      "Treatment": {
        "Reversible Causes - Treatment": [
          {
            "item": "Vitamin B12 replacement",
            "route": "IM",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mcg",
                  "orderSentence": "Vitamin B12 replacement 1000 mcg IM"
                }
              ],
              "route": "IM",
              "instructions": "1000 mcg IM daily × 7 days, then weekly × 4, then monthly; OR oral 1000-2000 mcg daily",
              "orderSentence": "Vitamin B12 replacement 1000 mcg IM"
            },
            "contraindications": "None",
            "monitoring": "B12 levels",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Levothyroxine (hypothyroidism)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-50 mcg",
                  "orderSentence": "Levothyroxine (hypothyroidism) 25-50 mcg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mcg daily; titrate per TSH",
              "orderSentence": "Levothyroxine (hypothyroidism) 25-50 mcg PO"
            },
            "contraindications": "CAD (start low)",
            "monitoring": "TSH q6-8 weeks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Thiamine (Wernicke-Korsakoff)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Thiamine (Wernicke-Korsakoff) 500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "500 mg IV TID × 3 days, then 250 mg IV daily × 5 days, then 100 mg PO daily",
              "orderSentence": "Thiamine (Wernicke-Korsakoff) 500 mg IV"
            },
            "contraindications": "None",
            "monitoring": "Clinical response",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "NPH treatment (large volume LP)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30-50 mL",
                  "orderSentence": "NPH treatment (large volume LP) 30-50 mL -"
                }
              ],
              "route": "-",
              "instructions": "Diagnostic LP removing 30-50 mL CSF; assess gait before/after",
              "orderSentence": "NPH treatment (large volume LP) 30-50 mL -"
            },
            "contraindications": "Per LP",
            "monitoring": "Gait improvement suggests shunt candidacy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "VP shunt (NPH)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Neurosurgical placement",
              "orderSentence": "VP shunt (NPH) - - - see dosing"
            },
            "contraindications": "Coagulopathy, infection",
            "monitoring": "Shunt complications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Treat depression (pseudodementia)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-50 mg",
                  "orderSentence": "Treat depression (pseudodementia) 25-50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "SSRI (sertraline 25-50 mg, escitalopram 5-10 mg)",
              "orderSentence": "Treat depression (pseudodementia) 25-50 mg PO"
            },
            "contraindications": "Per agent",
            "monitoring": "Mood, cognition",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Discontinue offending medications",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Stop anticholinergics, sedatives, opioids",
              "orderSentence": "Discontinue offending medications - - - see dosing"
            },
            "contraindications": "N/A",
            "monitoring": "Cognitive reassessment",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          }
        ],
        "Alzheimer's Disease - Cholinesterase Inhibitors": [
          {
            "item": "Donepezil (Aricept)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Donepezil (Aricept) 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg QHS × 4-6 weeks, then increase to 10 mg QHS; 23 mg available for moderate-severe",
              "orderSentence": "Donepezil (Aricept) 5 mg PO"
            },
            "contraindications": "Bradycardia, sick sinus, GI bleeding",
            "monitoring": "Bradycardia, GI upset, nightmares",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine patch (Exelon)",
            "route": "Transdermal",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4.6 mg",
                  "orderSentence": "Rivastigmine patch (Exelon) 4.6 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 4.6 mg/24h patch; increase monthly to 9.5-13.3 mg/24h",
              "orderSentence": "Rivastigmine patch (Exelon) 4.6 mg PO"
            },
            "contraindications": "Same; skin reactions",
            "monitoring": "Skin irritation, GI, bradycardia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine oral",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1.5 mg",
                  "orderSentence": "Rivastigmine oral 1.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1.5 mg BID with food; titrate to 6 mg BID",
              "orderSentence": "Rivastigmine oral 1.5 mg PO"
            },
            "contraindications": "Same",
            "monitoring": "GI side effects more common than patch",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Galantamine (Razadyne)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg",
                  "orderSentence": "Galantamine (Razadyne) 4 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 4 mg BID with food × 4 weeks; titrate to 8-12 mg BID; ER: 8 mg daily to 24 mg daily",
              "orderSentence": "Galantamine (Razadyne) 4 mg PO"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Alzheimer's Disease - NMDA Antagonist": [
          {
            "item": "Memantine (Namenda)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Memantine (Namenda) 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; increase by 5 mg/week to 10 mg BID",
              "orderSentence": "Memantine (Namenda) 5 mg PO"
            },
            "contraindications": "Severe renal impairment",
            "monitoring": "Confusion, dizziness, constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Memantine XR (Namenda XR)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7 mg",
                  "orderSentence": "Memantine XR (Namenda XR) 7 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 7 mg daily; increase weekly to 28 mg daily",
              "orderSentence": "Memantine XR (Namenda XR) 7 mg PO"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Donepezil/Memantine XR (Namzaric)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Donepezil/Memantine XR (Namzaric) 10 mg -"
                }
              ],
              "route": "-",
              "instructions": "For patients on both; 7/10 mg to 28/10 mg daily",
              "orderSentence": "Donepezil/Memantine XR (Namzaric) 10 mg -"
            },
            "contraindications": "Per components",
            "monitoring": "Per components",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Alzheimer's Disease - Disease-Modifying Therapy (Amyloid-Targeted)": [
          {
            "item": "Lecanemab (Leqembi)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg",
                  "orderSentence": "Lecanemab (Leqembi) 10 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV q2 weeks; confirm amyloid-positive before starting",
              "orderSentence": "Lecanemab (Leqembi) 10 mg/kg IV"
            },
            "pretreatment": "-",
            "contraindications": "Anticoagulation (relative), ARIA risk factors",
            "monitoring": "MRI at baseline, week 6, 12; ARIA monitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Donanemab (Kisunla)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "700 mg",
                  "orderSentence": "Donanemab (Kisunla) 700 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "700 mg IV q4 weeks × 3, then 1400 mg q4 weeks until amyloid clearance; discontinue when cleared",
              "orderSentence": "Donanemab (Kisunla) 700 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Same",
            "monitoring": "Same; discontinue at clearance",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Aducanumab (Aduhelm)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-10 mg/kg",
                  "orderSentence": "Aducanumab (Aduhelm) 1-10 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "Titration from 1-10 mg/kg IV q4 weeks; limited use",
              "orderSentence": "Aducanumab (Aduhelm) 1-10 mg/kg IV"
            },
            "pretreatment": "-",
            "contraindications": "Same",
            "monitoring": "MRI monitoring for ARIA",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Behavioral and Psychological Symptoms of Dementia (BPSD)": [
          {
            "item": "Non-pharmacologic interventions",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Music therapy, validation therapy, redirection, environmental modification",
              "orderSentence": "Non-pharmacologic interventions - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "First-line for all BPSD",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sertraline (depression, anxiety)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Sertraline (depression, anxiety) 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; target 50-100 mg",
              "orderSentence": "Sertraline (depression, anxiety) 25 mg PO"
            },
            "contraindications": "Bleeding risk, QT prolongation",
            "monitoring": "GI bleeding, hyponatremia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Citalopram (agitation)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Citalopram (agitation) 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg daily; max 20 mg (QT risk at higher doses)",
              "orderSentence": "Citalopram (agitation) 10 mg PO"
            },
            "contraindications": "QT prolongation",
            "monitoring": "QTc, hyponatremia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trazodone (sleep, agitation)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-100 mg",
                  "orderSentence": "Trazodone (sleep, agitation) 25-100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "25-100 mg QHS",
              "orderSentence": "Trazodone (sleep, agitation) 25-100 mg PO"
            },
            "contraindications": "Orthostasis",
            "monitoring": "Sedation, falls",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirtazapine (sleep, appetite, mood)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7.5-15 mg",
                  "orderSentence": "Mirtazapine (sleep, appetite, mood) 7.5-15 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "7.5-15 mg QHS",
              "orderSentence": "Mirtazapine (sleep, appetite, mood) 7.5-15 mg PO"
            },
            "contraindications": "None significant",
            "monitoring": "Weight gain, sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Quetiapine (psychosis, agitation)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5-100 mg",
                  "orderSentence": "Quetiapine (psychosis, agitation) 12.5-100 mg -"
                }
              ],
              "route": "-",
              "instructions": "12.5-100 mg QHS; lowest effective dose",
              "orderSentence": "Quetiapine (psychosis, agitation) 12.5-100 mg -"
            },
            "contraindications": "QT prolongation, metabolic syndrome",
            "monitoring": "Black box: increased mortality in dementia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Risperidone (psychosis, aggression)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25-1 mg",
                  "orderSentence": "Risperidone (psychosis, aggression) 0.25-1 mg -"
                }
              ],
              "route": "-",
              "instructions": "0.25-1 mg BID; lowest effective dose",
              "orderSentence": "Risperidone (psychosis, aggression) 0.25-1 mg -"
            },
            "contraindications": "Same; EPS",
            "monitoring": "Same; EPS higher than quetiapine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pimavanserin (DLB psychosis)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "34 mg",
                  "orderSentence": "Pimavanserin (DLB psychosis) 34 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "34 mg daily",
              "orderSentence": "Pimavanserin (DLB psychosis) 34 mg PO"
            },
            "contraindications": "QT prolongation",
            "monitoring": "QTc",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dextromethorphan/Quinidine (Nuedexta)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "1 capsule daily × 7 days, then BID; for pseudobulbar affect",
              "orderSentence": "Dextromethorphan/Quinidine (Nuedexta) - - - see dosing"
            },
            "contraindications": "QT prolongation, CYP2D6 interactions",
            "monitoring": "QTc",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbamazepine (aggression)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100-400 mg",
                  "orderSentence": "Carbamazepine (aggression) 100-400 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "100-400 mg BID",
              "orderSentence": "Carbamazepine (aggression) 100-400 mg PO"
            },
            "contraindications": "Aplastic anemia risk, drug interactions",
            "monitoring": "CBC, LFTs, drug levels",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Other Dementia-Specific Treatments": [
          {
            "item": "Aspirin (vascular dementia)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "81 mg",
                  "orderSentence": "Aspirin (vascular dementia) 81 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "81 mg daily; secondary prevention",
              "orderSentence": "Aspirin (vascular dementia) 81 mg PO"
            },
            "contraindications": "Bleeding",
            "monitoring": "Bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Statin (vascular dementia)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Per cardiovascular guidelines",
              "orderSentence": "Statin (vascular dementia) - - - see dosing"
            },
            "contraindications": "Hepatic disease",
            "monitoring": "LFTs, myopathy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BP control (vascular dementia)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Target <130/80 per guidelines",
              "orderSentence": "BP control (vascular dementia) - - - see dosing"
            },
            "contraindications": "Per agent",
            "monitoring": "BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbidopa/Levodopa (DLB, PDD)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Start low 25/100 TID; titrate cautiously",
              "orderSentence": "Carbidopa/Levodopa (DLB, PDD) - - - see dosing"
            },
            "contraindications": "May worsen psychosis",
            "monitoring": "Hallucinations, dyskinesia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Avoid anticholinergics (DLB)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Contraindicated in DLB due to severe sensitivity",
              "orderSentence": "Avoid anticholinergics (DLB) - - - see dosing"
            },
            "contraindications": "N/A",
            "monitoring": "N/A",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Avoid antipsychotics (DLB)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Can cause severe parkinsonism, NMS-like reaction; if needed, quetiapine safest",
              "orderSentence": "Avoid antipsychotics (DLB) - - - see dosing"
            },
            "contraindications": "Relative contraindication",
            "monitoring": "Severe reactions",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology/Memory specialist",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "All patients with dementia for diagnosis confirmation and management"
          },
          {
            "item": "Neuropsychology",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "MCI vs dementia distinction, pattern analysis, baseline assessment"
          },
          {
            "item": "Geriatric psychiatry",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "BPSD, depression, complex behavioral management"
          },
          {
            "item": "Social work",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Resources, placement, caregiver support"
          },
          {
            "item": "Physical therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Mobility, fall prevention"
          },
          {
            "item": "Occupational therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "ADL assessment, home safety evaluation"
          },
          {
            "item": "Speech therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Swallowing evaluation, communication strategies"
          },
          {
            "item": "Palliative care",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Goals of care, symptom management in advanced dementia"
          },
          {
            "item": "Elder law attorney",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Power of attorney, healthcare proxy, estate planning"
          },
          {
            "item": "Driving evaluation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Driving safety assessment"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Dementia is a progressive condition; treatments can help symptoms but not cure",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Establish healthcare proxy and advance directives early while patient can participate",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Home safety: remove rugs, improve lighting, stove safety, medication management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Driving assessment needed; may need to stop driving",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Caregiver support is essential; respite care, support groups (Alzheimer's Association)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Medical alert bracelet, GPS tracking if wandering risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain routines, social engagement, cognitive stimulation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return to ED if: sudden worsening, new weakness, fever, falls, inability to care for self",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Regular physical exercise (30 min, 5 days/week)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cognitive engagement (puzzles, reading, social activities)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Mediterranean or MIND diet",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cardiovascular risk factor management (BP, diabetes, cholesterol)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Hearing aids if hearing impaired (hearing loss increases dementia risk)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate sleep (treat sleep apnea)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid excessive alcohol",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Social engagement and purpose",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Delirium",
        "features": "Acute onset, fluctuating, inattention, often reversible cause",
        "tests": "Duration, attention testing, underlying cause"
      },
      {
        "diagnosis": "Depression (pseudodementia)",
        "features": "Depressed mood, \"I don't know\" responses, rapid onset, prior psychiatric history",
        "tests": "Depression screening, response to antidepressants"
      },
      {
        "diagnosis": "Normal aging",
        "features": "Mild forgetfulness, no functional impairment",
        "tests": "Neuropsychological testing; MCI vs normal"
      },
      {
        "diagnosis": "B12 deficiency",
        "features": "Macrocytic anemia, neuropathy, subacute combined degeneration",
        "tests": "B12 level, MMA, MRI spine"
      },
      {
        "diagnosis": "Hypothyroidism",
        "features": "Fatigue, weight gain, cold intolerance",
        "tests": "TSH"
      },
      {
        "diagnosis": "Normal pressure hydrocephalus",
        "features": "Gait apraxia, urinary incontinence, dementia (triad)",
        "tests": "MRI (ventriculomegaly), large volume LP response"
      },
      {
        "diagnosis": "Medication effects",
        "features": "Anticholinergics, sedatives, opioids",
        "tests": "Medication review; improvement after discontinuation"
      },
      {
        "diagnosis": "Wernicke-Korsakoff",
        "features": "Alcohol history, confabulation, ataxia, ophthalmoplegia",
        "tests": "History, thiamine trial, MRI (mammillary body changes)"
      },
      {
        "diagnosis": "Creutzfeldt-Jakob disease",
        "features": "Rapid progression, myoclonus, MRI changes",
        "tests": "MRI (cortical ribboning), EEG (periodic complexes), CSF RT-QuIC"
      },
      {
        "diagnosis": "Autoimmune encephalitis",
        "features": "Subacute, psychiatric symptoms, seizures",
        "tests": "Antibody panels, MRI, EEG"
      },
      {
        "diagnosis": "CNS lymphoma/tumor",
        "features": "Focal deficits, headache, progressive",
        "tests": "MRI with contrast"
      }
    ],
    "evidence": [
      {
        "recommendation": "MRI recommended in dementia workup",
        "evidenceLevel": "Class I, Level A",
        "source": "AAN Practice Parameters 2001"
      },
      {
        "recommendation": "B12, TSH, metabolic panel in all patients",
        "evidenceLevel": "Class I, Level A",
        "source": "AAN Practice Parameters 2001"
      },
      {
        "recommendation": "Cholinesterase inhibitors for mild-moderate AD",
        "evidenceLevel": "Class I, Level A",
        "source": "Cochrane Reviews"
      },
      {
        "recommendation": "Memantine for moderate-severe AD",
        "evidenceLevel": "Class I, Level A",
        "source": "Cochrane Reviews"
      },
      {
        "recommendation": "Combination ChEI + memantine",
        "evidenceLevel": "Class I, Level A",
        "source": "DOMINO trial"
      },
      {
        "recommendation": "Lecanemab slows cognitive decline in early AD",
        "evidenceLevel": "Class I, Level A",
        "source": "Clarity AD trial; FDA approved 2023"
      },
      {
        "recommendation": "Donanemab slows decline in early AD",
        "evidenceLevel": "Class I, Level A",
        "source": "TRAILBLAZER-ALZ 2; FDA approved 2024"
      },
      {
        "recommendation": "Non-pharmacologic interventions for BPSD first-line",
        "evidenceLevel": "Class I, Level A",
        "source": "APA Guidelines"
      },
      {
        "recommendation": "Antipsychotics increase mortality in dementia",
        "evidenceLevel": "Class I, Level A",
        "source": "FDA black box warning"
      },
      {
        "recommendation": "CSF biomarkers (Aβ42, tau, p-tau) support AD diagnosis",
        "evidenceLevel": "Class II, Level A",
        "source": "AT(N) framework"
      },
      {
        "recommendation": "Amyloid PET useful for diagnostic uncertainty",
        "evidenceLevel": "Class II, Level B",
        "source": "Appropriate Use Criteria"
      },
      {
        "recommendation": "Exercise may slow cognitive decline",
        "evidenceLevel": "Class II, Level B",
        "source": "Multiple RCTs"
      }
    ],
    "monitoring": [
      {
        "item": "Cognitive testing (MoCA, MMSE)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q6-12 months",
        "action": "Adjust medications, reassess diagnosis"
      },
      {
        "item": "Functional status (ADL/IADL)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q6-12 months",
        "action": "OT, increase support"
      },
      {
        "item": "BPSD assessment (NPI)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "Behavioral interventions, medications"
      },
      {
        "item": "Caregiver stress (Zarit Burden)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q6-12 months",
        "action": "Respite, support services"
      },
      {
        "item": "Weight",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "Nutrition, dysphagia evaluation"
      },
      {
        "item": "Falls assessment",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "PT, home safety"
      },
      {
        "item": "Driving safety",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Annually or with decline",
        "action": "Driving evaluation, cessation"
      },
      {
        "item": "Medication reconciliation",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "D/C anticholinergics, sedatives"
      },
      {
        "item": "MRI (if on anti-amyloid therapy)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Per protocol",
        "action": "Hold therapy if ARIA"
      }
    ],
    "disposition": [
      {
        "disposition": "Outpatient workup",
        "criteria": "Most patients; mild-moderate symptoms, safe home environment, caregiver present"
      },
      {
        "disposition": "Admit to hospital",
        "criteria": "Acute behavioral crisis, unable to care for self, unsafe home environment, need for IV therapies, rapid progression needing urgent workup"
      },
      {
        "disposition": "Discharge from hospital",
        "criteria": "Reversible causes treated, behavior stable, safe disposition, follow-up arranged"
      },
      {
        "disposition": "Memory care/Assisted living",
        "criteria": "Unable to live independently, unsafe with current support level"
      },
      {
        "disposition": "Skilled nursing facility",
        "criteria": "Advanced dementia, 24-hour care needs, complex medical needs"
      },
      {
        "disposition": "Hospice",
        "criteria": "End-stage dementia, FAST stage 7, goals of care focused on comfort"
      }
    ]
  },
  "Elevated Intracranial Pressure (ICP) / Intracranial Hypertension": {
    "id": "elevated-icp-management",
    "title": "Elevated Intracranial Pressure (ICP) / Intracranial Hypertension",
    "version": "1.0",
    "icd10": [
      "** G93.2 (Benign intracranial hypertension [IIH])",
      "G93.5 (Compression of brain)",
      "G93.6 (Cerebral edema)",
      "G91.1 (Obstructive hydrocephalus)",
      "G91.2 (Normal pressure hydrocephalus)",
      "S06.1X (Traumatic cerebral edema)"
    ],
    "scope": "** Emergency evaluation and management of elevated intracranial pressure in adults. Covers recognition of elevated ICP (Cushing triad, papilledema, declining GCS), emergent interventions (osmotherapy, hyperventilation, sedation, CSF drainage), ICP monitoring indications, surgical decompression, and specific etiology-based management. Includes management across etiologies: traumatic brain injury, stroke (ischemic/hemorrhagic), tumor, infection, hydrocephalus, and idiopathic intracranial hypertension. Excludes pediatric ICP management (different thresholds/approaches).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Infection workup; anemia (reduced O2 carrying capacity); thrombocytopenia (bleeding risk); baseline",
            "target": "Normal; leukocytosis → infection; thrombocytopenia → hemorrhage risk"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Electrolytes (sodium critical for osmotherapy); renal function (contrast, mannitol); glucose; hepatic function",
            "target": "Normal; track sodium closely (goal varies by treatment); avoid hyponatremia"
          },
          {
            "item": "Blood glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hyperglycemia worsens outcomes in brain injury; hypoglycemia mimics neurologic deterioration",
            "target": "140-180 mg/dL target in critically ill; <180 in general"
          },
          {
            "item": "PT/INR, aPTT",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Coagulopathy (hemorrhagic causes); ICP monitor placement safety; surgical candidacy",
            "target": "Normal; INR <1.4 for ICP monitor placement"
          },
          {
            "item": "Serum osmolality",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "**CRITICAL for osmotherapy monitoring**; baseline before mannitol/hypertonic saline; target for therapy",
            "target": "280-295 mOsm/kg baseline; therapeutic target 300-320 (do not exceed 320)"
          },
          {
            "item": "Sodium",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "**CRITICAL**; hypertonic saline therapy monitoring; cerebral salt wasting vs. SIADH; target for ICP management",
            "target": "135-145 mEq/L baseline; therapeutic hypernatremia target 145-155 mEq/L (with hypertonic saline)"
          },
          {
            "item": "Arterial blood gas (ABG)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Ventilation status (PaCO2 critical for ICP); oxygenation; pH; metabolic status",
            "target": "PaCO2 35-40 mmHg (normal); pH 7.35-7.45; PaO2 >80; for hyperventilation: target PaCO2 30-35"
          },
          {
            "item": "Lactate",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Tissue perfusion; systemic sepsis; prognostic",
            "target": "<2 mmol/L; elevated → hypoperfusion, sepsis"
          },
          {
            "item": "Type and screen",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Surgical candidacy; potential for decompressive craniectomy or other neurosurgical intervention",
            "target": "On file"
          },
          {
            "item": "Troponin",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Neurogenic cardiac injury (stress cardiomyopathy); particularly in SAH, TBI, ICH",
            "target": "Normal; elevated → neurogenic stress cardiomyopathy; obtain echo"
          }
        ],
        "Extended Workup": [
          {
            "item": "Serum osmolality (serial)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "**q4-6h during osmotherapy**; osmolar gap calculation; prevent hyper-osmolar state",
            "target": "Maintain <320 mOsm/kg; osmolar gap >10-15 → accumulating mannitol"
          },
          {
            "item": "Sodium (serial)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "**q2-6h during active ICP management**; hypertonic saline monitoring; avoid rapid correction",
            "target": "Target 145-155 mEq/L during active ICP crisis; avoid fluctuations >10 mEq/24h"
          },
          {
            "item": "Cortisol (AM, random)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "rationale": "Adrenal insufficiency (pituitary injury in TBI, tumor); steroid responsiveness in tumor edema",
            "target": ">10 mcg/dL (AM); if low → cortisol stimulation test or empiric steroids"
          },
          {
            "item": "TSH, free T4",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Pituitary injury (TBI, tumor, surgery); hypothyroidism",
            "target": "Normal"
          },
          {
            "item": "Ammonia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Hepatic encephalopathy differential; can cause cerebral edema and elevated ICP",
            "target": "<35 μmol/L; elevated → hepatic cause; lactulose, rifaximin"
          },
          {
            "item": "Toxicology screen",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Intoxication as cause of altered mental status; drug-induced cerebral edema (rare)",
            "target": "Negative; specific toxin identification"
          },
          {
            "item": "CSF analysis (if LP/EVD performed)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Infection (meningitis); malignancy (leptomeningeal disease); subarachnoid hemorrhage (xanthochromia); IIH (elevated OP with normal composition)",
            "target": "Normal CSF composition with elevated opening pressure → IIH; abnormal composition → specific diagnosis"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CSF opening pressure (LP)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "**IIH diagnosis**: OP >25 cm H2O (obese patients >28 cm); therapeutic in IIH; NOT indicated if mass lesion or obstructive hydrocephalus",
            "target": "IIH: OP >25 cm H2O with normal composition; if OP >40-50 → severe"
          },
          {
            "item": "Pentobarbital level",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "If barbiturate coma induced for refractory ICP; therapeutic monitoring; guide dosing; monitor for toxicity",
            "target": "Therapeutic: 30-50 mcg/mL (for burst suppression); higher may be needed"
          },
          {
            "item": "EEG (continuous)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Monitor for burst suppression during barbiturate coma; detect subclinical seizures (common in brain injury); guide sedation titration",
            "target": "Target: burst suppression pattern during barbiturate coma; no seizures"
          },
          {
            "item": "Jugular venous oxygen saturation (SjvO2)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT",
            "rationale": "Advanced cerebral metabolism monitoring; guide CPP management; detect ischemia or hyperemia",
            "target": "55-75%; <55% = ischemia (increase CPP or reduce CMRO2); >75% = hyperemia"
          },
          {
            "item": "Brain tissue oxygen (PbtO2)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT",
            "rationale": "Direct brain oxygenation monitoring; guide therapy in severe TBI; multimodal monitoring",
            "target": ">20 mmHg; <15 mmHg = brain hypoxia → intervene"
          },
          {
            "item": "Cerebral microdialysis",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT",
            "rationale": "Research/specialized centers; metabolic monitoring; lactate:pyruvate ratio; glucose; glutamate",
            "target": "Lactate:pyruvate ratio <40 (normal); elevated = metabolic crisis"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "LP with opening pressure",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "**IIH diagnosis and treatment**: measure opening pressure → therapeutic CSF removal; **CONTRAINDICATED if mass lesion, obstructive hydrocephalus, or herniation risk**; imaging FIRST",
            "target": "Opening pressure: normal <20 cm H2O (obese <25); IIH: >25 cm H2O with normal CSF composition; high-volume tap (20-30 mL) for symptomatic relief in IIH",
            "contraindications": "**ABSOLUTE CONTRAINDICATION**: Mass lesion with mass effect; obstructive hydrocephalus; impending herniation; posterior fossa mass; midline shift; anticoagulation/coagulopathy; skin infection at LP site"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "**Immediate** — within minutes of suspected elevated ICP; before any intervention; determines etiology and guides treatment",
            "target": "Mass lesion (tumor, hematoma); midline shift (>5mm = significant); hydrocephalus; cerebral edema (effaced sulci, compressed ventricles); herniation signs (uncal, tonsillar); cisternal effacement",
            "contraindications": "None for non-contrast CT; benefit always outweighs risk in emergency"
          },
          {
            "item": "CT angiography (CTA) head",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "If vascular etiology suspected (SAH, venous sinus thrombosis, AVM); concurrent with non-contrast CT",
            "target": "Aneurysm (SAH); venous sinus thrombosis (filling defect in dural sinuses); AVM; dissection",
            "contraindications": "Contrast allergy (premedicate if critical); renal impairment (benefit may outweigh risk)"
          },
          {
            "item": "CT venography (CTV)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "If cerebral venous sinus thrombosis suspected (headache, papilledema, focal deficits, hypercoagulable state); can be done with CTA",
            "target": "Filling defect in dural sinuses (transverse, sigmoid, sagittal); \"empty delta sign\" on contrast CT; cord sign",
            "contraindications": "Same as CTA"
          },
          {
            "item": "MRI brain with and without contrast",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "When clinically stable; superior for tumor characterization, infection, posterior fossa; MRV for venous thrombosis; DWI for ischemia",
            "target": "Tumor; abscess; encephalitis; venous sinus thrombosis; ischemic stroke; PRES; herniation; meningeal enhancement",
            "contraindications": "MRI-incompatible implants; hemodynamic instability"
          },
          {
            "item": "Chest X-ray",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "ETT position confirmation; pulmonary complications (aspiration, ARDS); central line position",
            "target": "ETT position; no pulmonary infiltrate; line position",
            "contraindications": "None"
          }
        ],
        "Extended": [
          {
            "item": "MR venography (MRV)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Cerebral venous sinus thrombosis confirmation; if CTV equivocal; can be done without contrast (TOF technique)",
            "target": "Venous sinus thrombosis; flow void absence",
            "contraindications": "Same as MRI"
          },
          {
            "item": "Transcranial Doppler (TCD)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "Non-invasive ICP estimation (pulsatility index); vasospasm detection (SAH); cerebral circulatory arrest (brain death)",
            "target": "Pulsatility index >1.4 suggests elevated ICP; MCA velocities for vasospasm; reverberating flow = no cerebral circulation",
            "contraindications": "None; operator-dependent"
          },
          {
            "item": "Optic nerve sheath diameter (ONSD) ultrasound",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Bedside non-invasive ICP estimation; ONSD >5-5.5 mm suggests ICP >20 mmHg; useful when formal monitoring not available",
            "target": "ONSD >5 mm (some use 5.5 mm) = elevated ICP",
            "contraindications": "Limited accuracy; operator-dependent; not a substitute for invasive monitoring"
          },
          {
            "item": "CT perfusion",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "Ischemic stroke workup; penumbra assessment; vasospasm evaluation",
            "target": "Perfusion deficits; core vs. penumbra; vasospasm patterns",
            "contraindications": "Contrast requirements"
          },
          {
            "item": "Fundoscopic examination",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "Papilledema detection (takes hours-days to develop); retinal hemorrhages (Terson syndrome in SAH); IIH evaluation",
            "target": "Papilledema (indicates chronically or subacutely elevated ICP); absent papilledema does NOT exclude acute ICP elevation; venous pulsations absent if ICP >180 mm H2O",
            "contraindications": "None"
          },
          {
            "item": "Formal visual field testing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "IIH monitoring; chronic elevated ICP; document visual field loss for treatment decisions",
            "target": "Enlarged blind spot; peripheral constriction; nasal field loss",
            "contraindications": "Patient cooperation required"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "ICP monitor placement (invasive)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "**Gold standard for ICP measurement**; indications: GCS ≤8 with abnormal CT, or GCS ≤8 with normal CT + 2 of (age >40, SBP <90, motor posturing); also for hydrocephalus management; typically EVD or parenchymal monitor",
            "target": "Direct ICP measurement; normal <15 mmHg; elevated >20-22 mmHg; treatment threshold >22 mmHg (Brain Trauma Foundation 2016)",
            "contraindications": "Coagulopathy (correct first); infection at insertion site; uncontrolled bleeding diathesis"
          },
          {
            "item": "External ventricular drain (EVD)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "ICP monitoring + therapeutic CSF drainage; preferred in hydrocephalus; allows ICP waveform analysis",
            "target": "ICP measurement; CSF drainage; waveform analysis (P2 > P1 = decreased compliance)",
            "contraindications": "Same as ICP monitor"
          },
          {
            "item": "Continuous EEG monitoring",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Detect subclinical seizures (common in TBI, ICH, SAH — up to 20-30%); guide sedation; burst suppression monitoring during barbiturate coma",
            "target": "No seizures; appropriate sedation level; burst suppression if pentobarbital coma",
            "contraindications": "None; resource availability"
          },
          {
            "item": "Nuclear medicine cerebral perfusion (SPECT/HMPAO)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT",
            "timing": "Brain death confirmation (ancillary test); no cerebral blood flow",
            "target": "No uptake = brain death (if clinical criteria met and confounders excluded)",
            "contraindications": "Limited availability"
          },
          {
            "item": "CT/MRI perfusion for brain death",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT",
            "timing": "Brain death confirmation; no cerebral perfusion",
            "target": "No perfusion = brain death",
            "contraindications": "Same as standard CT/MRI"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent Treatment": [
          {
            "item": "**Airway management / Intubation**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.3 mg/kg",
                  "orderSentence": "**Airway management / Intubation** 0.3 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "**GCS ≤8: Secure airway**; RSI with agents that do NOT raise ICP; preferred: etomidate 0.3 mg/kg OR propofol 1-2 mg/kg + rocuronium 1.2 mg/kg OR succinylcholine 1.5 mg/kg; AVOID ketamine in severe TBI (controversial — emerging data suggest may be safe); lidocaine 1.5 mg/kg IV 2-3 min before laryngoscopy (may blunt ICP spike — controversial benefit); avoid hypotension during RSI",
              "orderSentence": "**Airway management / Intubation** 0.3 mg/kg IV"
            },
            "contraindications": "-",
            "monitoring": "Airway protection; ventilation control (PaCO2 management); GCS ≤8 cannot protect airway; avoid hypoxia (PaO2 <60) and hypotension (SBP <90) — both worsen outcomes",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Head of bed elevation**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Elevate HOB 30°**; neutral head position (avoid neck flexion/rotation that impedes jugular venous drainage); avoid tight cervical collar if possible; reverse Trendelenburg if cervical spine immobilization required",
              "orderSentence": "**Head of bed elevation** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Promotes venous drainage; reduces ICP by 3-5 mmHg; no evidence of reduced CPP with 30° elevation; simple and immediate intervention",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Hyperventilation (temporary)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Acute herniation ONLY (bridging therapy)**; target PaCO2 30-35 mmHg; induces cerebral vasoconstriction → reduced cerebral blood volume → reduced ICP; **Duration: <30 minutes ideally, maximum 2-4 hours**; taper gradually; avoid PaCO2 <25 (causes ischemia)",
              "orderSentence": "**Hyperventilation (temporary)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "BTF Guidelines: Avoid prophylactic hyperventilation; use only for acute ICP crisis/herniation as bridge to definitive therapy; prolonged hyperventilation causes rebound vasodilation and ischemia; monitor with SjvO2 or PbtO2 if prolonged use needed",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Osmotherapy — Mannitol**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-1.5 g/kg",
                  "orderSentence": "**Osmotherapy — Mannitol** 1-1.5 g/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "**Mannitol 20%:** 1-1.5 g/kg IV bolus (e.g., 100g = 500 mL of 20% for 70 kg patient) over 15-20 minutes; repeat doses: 0.25-0.5 g/kg q4-6h PRN; **Hold if:** serum osmolality >320 mOsm/kg, osmolar gap >15-20; **Requires:** Foley catheter (massive diuresis); volume replacement; **Onset:** 15-30 min; **Duration:** 2-6 hours",
              "orderSentence": "**Osmotherapy — Mannitol** 1-1.5 g/kg IV"
            },
            "contraindications": "-",
            "monitoring": "Creates osmotic gradient → draws water from brain parenchyma; reduces brain volume; also improves blood rheology; BTF: Level II evidence; monitor for renal toxicity (ATN), hypovolemia, rebound edema",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Osmotherapy — Hypertonic Saline**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mL",
                  "orderSentence": "**Osmotherapy — Hypertonic Saline** 30 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "**23.4% NaCl:** 30 mL IV bolus over 15-20 min via central line (preferred for acute crisis); **3% NaCl:** 250-500 mL IV bolus over 30 min (can give peripherally); **Continuous infusion:** 3% NaCl at 30-50 mL/hr to maintain Na 145-155 mEq/L; **Target sodium:** 145-155 mEq/L; avoid >160; correct slowly if hypernatremia develops (no faster than 8-10 mEq/24h decrease)",
              "orderSentence": "**Osmotherapy — Hypertonic Saline** 30 mL IV"
            },
            "contraindications": "-",
            "monitoring": "Equivalent or superior to mannitol for ICP reduction; does NOT cause diuresis (better for hypovolemic patients); no osmolality ceiling (unlike mannitol); does not accumulate in injured brain (mannitol may); preferred in many centers; SAFE-TBI trial (2021): 20% mannitol = HTS for ICP control",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Sedation and analgesia**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-75 mcg/kg",
                  "orderSentence": "**Sedation and analgesia** 25-75 mcg/kg -"
                }
              ],
              "route": "-",
              "instructions": "**Goal:** Reduce metabolic demand, prevent agitation-induced ICP spikes; **Propofol:** 25-75 mcg/kg/min (first-line; reduces CMRO2 and ICP; allows rapid awakening for neuro exams); **Fentanyl:** 25-100 mcg/hr (analgesia without histamine release); **Midazolam:** 0.05-0.2 mg/kg/hr (alternative to propofol); **Avoid:** Ketamine in severe ICP (controversial); prolonged propofol (PRIS syndrome >48-72h at high doses)",
              "orderSentence": "**Sedation and analgesia** 25-75 mcg/kg -"
            },
            "contraindications": "-",
            "monitoring": "Agitation, pain, coughing raise ICP; sedation reduces cerebral metabolic rate; propofol has favorable ICP properties; daily sedation holiday for neuro assessment if stable",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Neuromuscular blockade**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1-0.2 mg/kg",
                  "orderSentence": "**Neuromuscular blockade** 0.1-0.2 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "For refractory ICP spikes with ventilator dyssynchrony, coughing, posturing; **Cisatracurium** 0.1-0.2 mg/kg bolus → 1-3 mcg/kg/min infusion (organ-independent metabolism); **Rocuronium** 0.6-1 mg/kg bolus → 0.6 mg/kg/hr; **Requires:** Concurrent sedation/analgesia; train-of-four monitoring; prevents detection of seizures (need cEEG)",
              "orderSentence": "**Neuromuscular blockade** 0.1-0.2 mg/kg IV"
            },
            "contraindications": "-",
            "monitoring": "Prevents ICP spikes from coughing, posturing; reduces intrathoracic pressure; use judiciously — obscures neuro exam and seizure detection; requires cEEG monitoring",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Seizure prophylaxis / treatment**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000-1500 mg",
                  "orderSentence": "**Seizure prophylaxis / treatment** 1000-1500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "**Prophylaxis (TBI):** Levetiracetam 1000-1500 mg IV load → 500-1000 mg q12h x 7 days (BTF: early seizure prophylaxis x 7 days for severe TBI); **Active seizure:** Lorazepam 0.1 mg/kg (max 4 mg) → Levetiracetam 60 mg/kg load (max 4500 mg) OR fosphenytoin 20 mg PE/kg; **Status epilepticus:** Per SE protocol",
              "orderSentence": "**Seizure prophylaxis / treatment** 1000-1500 mg IV"
            },
            "contraindications": "-",
            "monitoring": "Seizures dramatically increase CMRO2 and ICP; early seizures occur in 10-15% of severe TBI; prophylaxis beyond 7 days NOT recommended (does not prevent late epilepsy); levetiracetam preferred (no drug interactions, IV/PO equivalent)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Temperature control**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650-1000 mg",
                  "orderSentence": "**Temperature control** 650-1000 mg -"
                }
              ],
              "route": "-",
              "instructions": "**Avoid fever aggressively**: fever increases CMRO2 by 10-13% per °C; target 36-37°C; acetaminophen 650-1000 mg q4-6h; cooling blankets; **Therapeutic hypothermia:** 32-35°C controversial; EUROTHERM (2015) showed harm from prophylactic hypothermia to 32-35°C in TBI; may use for refractory ICP as rescue",
              "orderSentence": "**Temperature control** 650-1000 mg -"
            },
            "contraindications": "-",
            "monitoring": "Fever worsens neurologic outcomes; aggressive normothermia is standard; therapeutic hypothermia is rescue therapy only (not prophylactic); if used: 32-35°C, avoid shivering (increases CMRO2), slow rewarming",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Blood pressure / CPP management**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "**Target CPP 60-70 mmHg** (CPP = MAP - ICP); avoid CPP <60 (ischemia) and >70 (BTF: avoid aggressive CPP >70 due to ARDS risk); **If hypotensive:** IV fluids (isotonic crystalloid; avoid hypotonic fluids); vasopressors (norepinephrine first-line); **If hypertensive with ICP crisis:** Treat ICP first (osmotherapy, sedation); avoid precipitously lowering BP (reduces CPP)",
              "orderSentence": "**Blood pressure / CPP management** - IV - see dosing"
            },
            "contraindications": "-",
            "monitoring": "CPP is the primary determinant of cerebral perfusion; BTF 2016: target CPP 60-70; lower threshold 60 mmHg; aggressive CPP >70 increases ARDS risk without outcome benefit; individualized based on autoregulation status",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Definitive/Targeted Treatment (Tier 2 — Moderate ICP Elevation)": [
          {
            "item": "**ICP monitor / EVD placement**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Indications (BTF 2016):** GCS ≤8 + abnormal CT; OR GCS ≤8 + normal CT + ≥2 of: age >40, SBP <90, motor posturing; **EVD preferred if:** Hydrocephalus; need for CSF drainage; **Parenchymal monitor if:** No hydrocephalus; cannot drain CSF; **Target ICP:** <22 mmHg (BTF 2016); some centers use <20",
              "orderSentence": "**ICP monitor / EVD placement** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Invasive ICP monitoring guides therapy; EVD allows therapeutic CSF drainage; parenchymal monitors cannot drain; infection risk ~5-10%; ventriculostomy is both diagnostic and therapeutic",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**CSF drainage (via EVD)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-10 mL",
                  "orderSentence": "**CSF drainage (via EVD)** 5-10 mL -"
                }
              ],
              "route": "-",
              "instructions": "**Continuous drainage:** Set drain to maintain ICP <22 mmHg; drain 5-10 mL CSF if ICP spike; **Intermittent drainage:** Drain for ICP >22, then clamp to re-measure; **Typical:** Remove 5-20 mL for ICP crisis; **Rate:** Avoid draining >20 mL/hour (risk of over-drainage, collapse of ventricles, hemorrhage)",
              "orderSentence": "**CSF drainage (via EVD)** 5-10 mL -"
            },
            "contraindications": "-",
            "monitoring": "Immediate ICP reduction; removes volume (CSF) from closed cranial compartment; critical for hydrocephalus; risk: infection, hemorrhage, over-drainage",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Repeat osmotherapy dosing**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25-0.5 g/kg",
                  "orderSentence": "**Repeat osmotherapy dosing** 0.25-0.5 g/kg -"
                }
              ],
              "route": "-",
              "instructions": "Scheduled or PRN osmotherapy based on ICP readings; **Mannitol:** 0.25-0.5 g/kg q4-6h; **HTS 3%:** 30 mL/hr continuous or 250 mL bolus PRN; **Monitor:** Serum osm q4-6h (hold mannitol if >320); serum Na q2-4h (target 145-155 with HTS)",
              "orderSentence": "**Repeat osmotherapy dosing** 0.25-0.5 g/kg -"
            },
            "contraindications": "-",
            "monitoring": "Sustained osmotherapy for sustained ICP elevation; alternating mannitol and HTS may extend treatment window; monitor for accumulation",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Decompressive craniectomy**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Indications:** Refractory ICP despite maximal medical therapy; malignant MCA stroke (large hemispheric infarct with edema); large ICH with mass effect; traumatic brain injury with refractory ICP; **Timing:** TBI: DECRA trial (2011) — early DC did not improve 6-mo outcomes but reduced ICP/ICU stay; RESCUEicp (2016) — late rescue DC improved survival but increased severe disability; **Stroke:** DESTINY/DECIMAL/HAMLET — DC improves survival in malignant MCA stroke age <60 (NNT=2); must discuss goals of care",
              "orderSentence": "**Decompressive craniectomy** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Removes skull to allow brain expansion; definitive ICP reduction; increases survival but may increase proportion surviving with severe disability; requires extensive goals of care discussion; timing and patient selection critical",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Dexamethasone (tumor/vasogenic edema)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "**Dexamethasone (tumor/vasogenic edema)** 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "**ONLY for vasogenic edema from tumor or abscess**; **NOT for TBI, stroke, or cytotoxic edema** (steroids worsen outcomes in TBI — CRASH trial); **Dose:** 10 mg IV load → 4 mg IV q6h; **Duration:** Until definitive tumor treatment; taper over 1-2 weeks after radiation/surgery; GI prophylaxis with PPI",
              "orderSentence": "**Dexamethasone (tumor/vasogenic edema)** 10 mg IV"
            },
            "contraindications": "-",
            "monitoring": "Reduces vasogenic edema around tumors; inhibits VEGF; dramatic effect within 24-48h; CRASH trial: steroids HARMFUL in TBI — avoid; no benefit in stroke",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**Surgical evacuation of mass lesion**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mL",
                  "orderSentence": "**Surgical evacuation of mass lesion** 30 mL -"
                }
              ],
              "route": "-",
              "instructions": "**Epidural hematoma:** Emergent if >30 mL, >15mm thickness, or >5mm midline shift, or GCS deterioration; **Subdural hematoma:** Emergent if >10mm thickness, >5mm midline shift, or GCS decrease >2 points; **ICH:** Consider if lobar >30 mL and deteriorating; cerebellar >3cm or hydrocephalus; **Tumor:** Resection or debulking for mass effect",
              "orderSentence": "**Surgical evacuation of mass lesion** 30 mL -"
            },
            "contraindications": "-",
            "monitoring": "Removes compressive mass → immediate ICP reduction; life-saving for epidural hematoma; subdural and ICH outcomes less clearly improved by surgery but indicated for mass effect and herniation",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Refractory ICP Management (Tier 3 — Rescue Therapies)": [
          {
            "item": "**Pentobarbital coma**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-10 mg/kg",
                  "orderSentence": "**Pentobarbital coma** 5-10 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "**LAST RESORT for refractory ICP**; **Protocol:** Pentobarbital 5-10 mg/kg IV load over 30 min → 1-3 mg/kg/hr infusion; titrate to ICP <22 mmHg or burst suppression on EEG; **Target:** Burst suppression (3-10 second bursts with 10-20 second suppression); **Monitor:** Continuous EEG; drug levels (30-50 mcg/mL); hemodynamics (causes hypotension — often need vasopressors); **Duration:** 24-48h then attempt to wean; may need 3-5 days",
              "orderSentence": "**Pentobarbital coma** 5-10 mg/kg IV"
            },
            "contraindications": "-",
            "monitoring": "Reduces CMRO2 to minimal levels; dramatic ICP reduction; causes severe hypotension (need vasopressors); immunosuppression; ileus; prolonged sedation; no proven mortality benefit but reduces ICP; requires ICU expertise",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Therapeutic hypothermia (rescue)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**For refractory ICP only** (NOT prophylactic); **Target:** 32-35°C; **Method:** Surface cooling (Arctic Sun) or intravascular cooling catheter; **Duration:** 24-72h; **Rewarming:** Slow — 0.25°C/hour (rapid rewarming causes ICP rebound); **Complications:** Shivering (treat with paralysis, buspirone, meperidine), coagulopathy, infection, arrhythmia",
              "orderSentence": "**Therapeutic hypothermia (rescue)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Reduces CMRO2 and ICP; EUROTHERM (2015): prophylactic hypothermia HARMFUL in TBI; rescue hypothermia for refractory ICP still used but evidence weak; prevents fever spikes; requires expertise",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Lumbar CSF drainage**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-10 mL/h",
                  "orderSentence": "**Lumbar CSF drainage** 5-10 mL/h -"
                }
              ],
              "route": "-",
              "instructions": "**ONLY if:** Communicating hydrocephalus; ICP refractory to EVD drainage; no mass lesion or obstructive hydrocephalus; basal cisterns visible; **Method:** Lumbar drain at 10-15 cm H2O; drain 5-10 mL/hour; **Risk:** Tonsillar herniation if used inappropriately; overdrainage",
              "orderSentence": "**Lumbar CSF drainage** 5-10 mL/h -"
            },
            "contraindications": "-",
            "monitoring": "Drains CSF from lumbar space; reduces overall CSF volume; effective adjunct in communicating hydrocephalus; must NOT be used with obstructive hydrocephalus or significant mass effect",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**High-dose hypertonic saline (23.4%)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mL",
                  "orderSentence": "**High-dose hypertonic saline (23.4%)** 30 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "**For refractory ICP crisis**; 30 mL IV bolus via central line; can repeat; target sodium up to 155-160 mEq/L in refractory cases (with close monitoring); **Risk:** Central pontine myelinolysis if rapid sodium changes (maintain stable elevated sodium; do not rapidly correct back to normal)",
              "orderSentence": "**High-dose hypertonic saline (23.4%)** 30 mL IV"
            },
            "contraindications": "-",
            "monitoring": "Potent osmotherapy; can achieve higher sodium targets than 3% NaCl; reserved for refractory cases; requires central line access",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Decompressive craniectomy (rescue)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "26.9%",
                  "orderSentence": "**Decompressive craniectomy (rescue)** 26.9% -"
                }
              ],
              "route": "-",
              "instructions": "As above; indicated for refractory ICP after failure of all medical therapies; must discuss survival with potential severe disability (RESCUEicp: DC improved survival from 26.9% to 48.9% but increased severe disability); goals of care critical",
              "orderSentence": "**Decompressive craniectomy (rescue)** 26.9% -"
            },
            "contraindications": "-",
            "monitoring": "RESCUEicp (2016): More patients survived with DC but at cost of more survivors with severe disability; DECRA (2011): Early prophylactic DC did not improve functional outcomes; decision requires extensive patient/family discussion",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Medications to AVOID": [
          {
            "item": "Corticosteroids in TBI",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Corticosteroids in TBI - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Corticosteroids in ischemic stroke",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Corticosteroids in ischemic stroke - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Hypotonic fluids (D5W, 0.45% NaCl)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Hypotonic fluids (D5W, 0.45% NaCl) - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Prolonged aggressive hyperventilation",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Prolonged aggressive hyperventilation - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Ketamine (traditionally)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Ketamine (traditionally) - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Nitroprusside",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Nitroprusside - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Propofol infusion syndrome (prolonged high-dose propofol)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Propofol infusion syndrome (prolonged high-dose propofol) - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurosurgery consultation — EMERGENT",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Neuro-ICU admission",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Continuous ICP monitoring (invasive)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Continuous EtCO2 / frequent ABG",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Serial neurologic examination",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "HOB elevation 30° / midline head",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Avoid Valsalva / ICP-raising maneuvers",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Normothermia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Euvolemia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Ophthalmology consultation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neurology consultation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Physiatry / Rehabilitation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Palliative care / Ethics",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Social work",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clinical neurophysiology / EEG",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Multimodal neuromonitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT"
          },
          {
            "item": "Targeted temperature management",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT"
          },
          {
            "item": "Brain death evaluation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "VP shunt / CSF diversion (long-term)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Transverse sinus stenting (IIH)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Category",
        "features": "Etiologies",
        "tests": "Key Features"
      },
      {
        "diagnosis": "**Traumatic**",
        "features": "Traumatic brain injury (TBI); epidural hematoma; subdural hematoma; contusions; diffuse axonal injury",
        "tests": "History of trauma; CT findings; mechanism of injury"
      },
      {
        "diagnosis": "**Vascular**",
        "features": "Ischemic stroke (malignant edema); intracerebral hemorrhage; subarachnoid hemorrhage; cerebral venous sinus thrombosis",
        "tests": "Sudden onset; focal deficits; CT/MRI findings; angiography for vascular lesions"
      },
      {
        "diagnosis": "**Neoplastic**",
        "features": "Primary brain tumor; metastatic disease; leptomeningeal carcinomatosis",
        "tests": "Subacute progressive; known cancer history; MRI with contrast"
      },
      {
        "diagnosis": "**Infectious**",
        "features": "Meningitis; encephalitis; brain abscess; subdural empyema",
        "tests": "Fever; meningismus; CSF analysis; ring-enhancing lesion"
      },
      {
        "diagnosis": "**Hydrocephalus**",
        "features": "Obstructive (tumor, hemorrhage, aqueductal stenosis); communicating (post-infectious, post-hemorrhagic); normal pressure hydrocephalus",
        "tests": "Ventricular enlargement on imaging; gait disturbance, dementia, incontinence (NPH triad)"
      },
      {
        "diagnosis": "**Idiopathic Intracranial Hypertension (IIH)**",
        "features": "Pseudotumor cerebri",
        "tests": "Young obese women; headache; papilledema; pulsatile tinnitus; normal imaging; elevated OP on LP"
      },
      {
        "diagnosis": "**Metabolic**",
        "features": "Hepatic encephalopathy; hypertensive encephalopathy (PRES); hyponatremia (cerebral edema); hypoxic-ischemic injury",
        "tests": "Metabolic derangement; toxic screen; liver function; blood pressure"
      },
      {
        "diagnosis": "**Other**",
        "features": "High altitude cerebral edema (HACE); post-operative; radiation necrosis; posterior reversible encephalopathy syndrome (PRES)",
        "tests": "Exposure history; post-procedural; imaging pattern (PRES: posterior white matter edema)"
      }
    ],
    "evidence": [
      {
        "recommendation": "Guideline",
        "evidenceLevel": "Source",
        "source": "Year"
      },
      {
        "recommendation": "Guidelines for the Management of Severe Traumatic Brain Injury",
        "evidenceLevel": "Brain Trauma Foundation (BTF)",
        "source": "2016 (4th ed)"
      },
      {
        "recommendation": "Malignant MCA Stroke Guidelines",
        "evidenceLevel": "AHA/ASA",
        "source": "2019"
      },
      {
        "recommendation": "ICH Guidelines",
        "evidenceLevel": "AHA/ASA",
        "source": "2022"
      },
      {
        "recommendation": "SAH Guidelines",
        "evidenceLevel": "AHA/ASA",
        "source": "2023"
      },
      {
        "recommendation": "IIH Guidelines",
        "evidenceLevel": "British Consensus Guidelines",
        "source": "2018"
      },
      {
        "recommendation": "Study",
        "evidenceLevel": "Finding",
        "source": "Impact"
      },
      {
        "recommendation": "BTF Guidelines (2016)",
        "evidenceLevel": "ICP threshold changed from 20 to 22 mmHg; CPP target 60-70 (avoid >70); Level IIA evidence for ICP monitoring improving outcomes",
        "source": "Standard of care for TBI ICP management"
      },
      {
        "recommendation": "CRASH Trial (2004)",
        "evidenceLevel": "Corticosteroids HARMFUL in TBI — 14-day mortality increased (25.7% vs. 22.3%, RR 1.15); 6-month mortality increased",
        "source": "Steroids absolutely contraindicated in TBI"
      },
      {
        "recommendation": "DECRA Trial (2011)",
        "evidenceLevel": "Early decompressive craniectomy (within 72h) for refractory ICP in TBI did NOT improve 6-month functional outcome (though reduced ICP and ICU stay)",
        "source": "Questioned early prophylactic DC; did not stop DC but informed timing decisions"
      },
      {
        "recommendation": "RESCUEicp Trial (2016)",
        "evidenceLevel": "Late/rescue DC for refractory ICP in TBI improved survival (48.9% vs. 26.9%) but increased proportion with severe disability; similar rates of favorable outcome",
        "source": "DC is life-saving but increases survival with disability; requires goals of care discussion"
      },
      {
        "recommendation": "DESTINY/DECIMAL/HAMLET (pooled)",
        "evidenceLevel": "DC for malignant MCA stroke <60 years within 48h reduces mortality (NNT=2); higher survival with moderate-severe disability (mRS 4); DC should be offered",
        "source": "Standard of care for malignant MCA stroke in appropriate patients"
      },
      {
        "recommendation": "EUROTHERM (2015)",
        "evidenceLevel": "Prophylactic hypothermia (32-35°C) in TBI HARMFUL — worse outcomes; trial stopped early",
        "source": "Hypothermia NOT recommended prophylactically; rescue use only for refractory ICP"
      },
      {
        "recommendation": "INTERACT2 / ATACH-2 (ICH)",
        "evidenceLevel": "Intensive BP lowering (SBP <140) safe in ICH; modest benefit in INTERACT2; no benefit in ATACH-2",
        "source": "SBP <140 within 6h is current recommendation for ICH"
      },
      {
        "recommendation": "SAFE-TBI (2021)",
        "evidenceLevel": "20% mannitol vs. hypertonic saline (various concentrations): no significant difference in ICP control or outcomes",
        "source": "Either osmotic agent acceptable; hypertonic saline may be preferred in hypovolemia"
      },
      {
        "recommendation": "Parameter",
        "evidenceLevel": "Target",
        "source": "Evidence Level"
      },
      {
        "recommendation": "ICP",
        "evidenceLevel": "<22 mmHg",
        "source": "BTF Level IIB"
      },
      {
        "recommendation": "CPP",
        "evidenceLevel": "60-70 mmHg",
        "source": "BTF Level IIB (avoid CPP <60; avoid >70 due to ARDS risk)"
      },
      {
        "recommendation": "PaCO2",
        "evidenceLevel": "35-40 mmHg (normocapnia)",
        "source": "BTF Level IIB"
      },
      {
        "recommendation": "PaCO2 (hyperventilation crisis)",
        "evidenceLevel": "30-35 mmHg (brief, <30 min)",
        "source": "BTF Level III"
      },
      {
        "recommendation": "Temperature",
        "evidenceLevel": "36-37°C (normothermia)",
        "source": "BTF Level IIB"
      },
      {
        "recommendation": "Glucose",
        "evidenceLevel": "140-180 mg/dL",
        "source": "General critical care consensus"
      },
      {
        "recommendation": "SBP (avoid hypotension)",
        "evidenceLevel": ">100 mmHg (or >110 for TBI age 50-69)",
        "source": "BTF Level III"
      }
    ],
    "monitoring": [
      {
        "item": "ICP (if monitored)",
        "frequency": "Continuous",
        "target": "<22 mmHg (BTF 2016); some centers <20",
        "action": "Tiered therapy escalation (osmotherapy → sedation → CSF drainage → hyperventilation → DC)"
      },
      {
        "item": "CPP (MAP - ICP)",
        "frequency": "Continuous (calculated)",
        "target": "60-70 mmHg",
        "action": "If low: IV fluids, vasopressors; if high (>70) and ICP elevated: focus on ICP reduction"
      },
      {
        "item": "Neurologic exam (GCS, pupils, motor)",
        "frequency": "q1h initially; q2-4h when stable",
        "target": "Stable or improving",
        "action": "Decline: STAT CT; escalate ICP therapy; surgical evaluation"
      },
      {
        "item": "Serum sodium",
        "frequency": "q2-4h during active osmotherapy",
        "target": "135-155 mEq/L (target varies); avoid rapid changes",
        "action": "Adjust osmotherapy; correct slowly if needed"
      },
      {
        "item": "Serum osmolality",
        "frequency": "q4-6h during mannitol therapy",
        "target": "<320 mOsm/kg (some use <315)",
        "action": "Hold mannitol if >320; switch to HTS"
      },
      {
        "item": "ABG / PaCO2",
        "frequency": "q4-6h; more frequent if adjusting ventilation",
        "target": "35-40 mmHg (normocapnia); 30-35 only for acute crisis",
        "action": "Adjust ventilator; avoid hyperventilation except for crisis"
      },
      {
        "item": "Temperature",
        "frequency": "Continuous",
        "target": "36-37°C; strict normothermia",
        "action": "Aggressive cooling; acetaminophen; treat infection source"
      },
      {
        "item": "Blood glucose",
        "frequency": "q4-6h",
        "target": "140-180 mg/dL",
        "action": "Insulin titration"
      },
      {
        "item": "Urine output",
        "frequency": "Hourly",
        "target": "0.5-1 mL/kg/hr",
        "action": "Assess volume status; diuresis from mannitol expected (replace losses)"
      },
      {
        "item": "Hemodynamics (MAP)",
        "frequency": "Continuous",
        "target": "MAP to maintain CPP 60-70",
        "action": "Vasopressors; volume"
      }
    ],
    "disposition": [
      {
        "disposition": "Level of Care",
        "criteria": "Criteria"
      },
      {
        "disposition": "Neuro-ICU",
        "criteria": "Any patient requiring ICP monitoring; GCS ≤8; signs of herniation; requiring osmotherapy, sedation, or mechanical ventilation for ICP; post-operative after decompressive craniectomy or hematoma evacuation; status epilepticus; hemodynamic instability"
      },
      {
        "disposition": "Step-down / Intermediate care",
        "criteria": "Stable ICP; improving neurologically; EVD weaning; transitioning off invasive monitoring; stable post-operative"
      },
      {
        "disposition": "General neurology/neurosurgery floor",
        "criteria": "Stable IIH on medical therapy; post-VP shunt; stable post-operative without ICP concerns"
      }
    ]
  },
  "Spinal Epidural Abscess (SEA)": {
    "id": "epidural-abscess",
    "title": "Spinal Epidural Abscess (SEA)",
    "version": "1.0",
    "icd10": [
      "** G06.1 (Intraspinal abscess and granuloma)",
      "M46.40 (Discitis",
      "unspecified site)",
      "M46.46 (Discitis",
      "lumbar region)",
      "M46.47 (Discitis",
      "lumbosacral region)",
      "A41.9 (Sepsis",
      "unspecified organism)"
    ],
    "scope": "** Emergency evaluation and management of spinal epidural abscess in adults. Covers the classic triad (back pain, fever, neurologic deficit), emergent MRI, surgical drainage vs. medical management decision-making, empiric and targeted antibiotic therapy, and neurologic monitoring. Includes associated vertebral osteomyelitis and discitis. Excludes brain abscess (separate template), subdural empyema, and post-operative wound infections (partially overlaps).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Blood cultures (x2 sets, before antibiotics)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "**CRITICAL: Positive in 60-70%**; identifies organism for targeted therapy; guides antibiotic duration; S. aureus most common (60-70%); draw from 2 separate sites",
            "target": "Positive → organism identification; S. aureus (MRSA vs. MSSA) most common; also Streptococci, gram-negatives, anaerobes"
          },
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Leukocytosis (WBC >12,000 in 60-80%); left shift; bandemia; baseline for monitoring; thrombocytopenia may indicate DIC/sepsis",
            "target": "Leukocytosis (66%); normal WBC does NOT exclude SEA (20-40% have normal WBC); leukopenia concerning for overwhelming sepsis"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Renal function (antibiotic dosing, contrast); electrolytes; hepatic function; glucose (diabetes is major risk factor)",
            "target": "Normal or abnormal; elevated glucose → diabetes workup; renal dysfunction affects antibiotic choice"
          },
          {
            "item": "ESR (erythrocyte sedimentation rate)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "**Highly sensitive (>94%)**; ESR >20 mm/hr in nearly all cases of SEA; ESR >30-50 typical; useful for monitoring treatment response",
            "target": "ESR >20 mm/hr (sensitivity 94%); mean ESR is typically 50-80 mm/hr; if normal → SEA very unlikely"
          },
          {
            "item": "CRP (C-reactive protein)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Elevated in >90% of SEA; more responsive to treatment changes than ESR; useful for monitoring",
            "target": "Elevated (typically >10 mg/dL); declines faster than ESR with successful treatment"
          },
          {
            "item": "Procalcitonin",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "More specific for bacterial infection than CRP; helps distinguish bacterial from non-infectious inflammation; prognostic",
            "target": ">0.5 ng/mL suggests bacterial infection; >2.0 ng/mL concerning for sepsis; useful in atypical presentations"
          },
          {
            "item": "Blood glucose / HbA1c",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "**Diabetes is a major risk factor (30-50% of SEA patients)**; undiagnosed diabetes common; affects wound healing and immune function",
            "target": "Document diabetes status; HbA1c >6.5% = diabetes; glucose control target <180 mg/dL"
          },
          {
            "item": "PT/INR, aPTT",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Coagulopathy from sepsis (DIC); surgical candidacy; baseline before anticoagulation decisions; epidural hematoma differential",
            "target": "Normal; prolonged → concern for DIC, liver dysfunction; affects surgical risk"
          },
          {
            "item": "Lactate",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Sepsis assessment; tissue hypoperfusion; prognostic",
            "target": "<2 mmol/L (normal); >4 mmol/L = severe sepsis/septic shock requiring aggressive resuscitation"
          },
          {
            "item": "Type and screen",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Surgical candidacy; blood product availability",
            "target": "On file"
          },
          {
            "item": "Urinalysis + urine culture",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Urinary source (UTI is common source of hematogenous spread, especially gram-negative SEA); concurrent UTI",
            "target": "Normal or pyuria/bacteriuria; if positive → potential primary source"
          }
        ],
        "Extended Workup": [
          {
            "item": "HIV antibody/antigen",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "rationale": "Immunocompromised state; increases SEA risk; affects prognosis and opportunistic infection risk",
            "target": "Negative; if positive → CD4 count, viral load; consider opportunistic organisms"
          },
          {
            "item": "Hepatitis B/C serologies",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "IVDU population (risk factor for SEA); affects long-term antibiotic choice; liver function",
            "target": "Negative; if positive → affects drug selection, hepatotoxicity monitoring"
          },
          {
            "item": "Hemoglobin A1c",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Undiagnosed or poorly controlled diabetes",
            "target": "<6.5% (normal); ≥6.5% = diabetes; 5.7-6.4% = prediabetes"
          },
          {
            "item": "D-dimer",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "DIC screening; VTE risk (prolonged immobility + inflammation); not specific but elevated in SEA",
            "target": "Elevated (non-specific); very high levels → consider DIC"
          },
          {
            "item": "Fibrinogen",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "DIC assessment; sepsis-associated coagulopathy",
            "target": ">150 mg/dL; low fibrinogen = DIC or consumption"
          },
          {
            "item": "Albumin / prealbumin",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Nutritional status; wound healing; chronicity of illness; prognostic",
            "target": ">3.5 g/dL (albumin); low = poor nutrition, chronic illness"
          },
          {
            "item": "Repeat blood cultures (during treatment)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Document clearance of bacteremia; if persistently positive → evaluate for endocarditis, undrained collection, treatment failure",
            "target": "Negative by 48-72h of appropriate antibiotics; persistent positivity → echocardiogram, repeat imaging"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Surgical specimen culture (intraoperative)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "**Gold standard for organism identification**; culture of abscess material at surgery; sensitivity higher than blood cultures; also send for Gram stain and histopathology",
            "target": "Organism identification; guides targeted antibiotic therapy"
          },
          {
            "item": "CT-guided aspiration/biopsy culture",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "If non-operative management chosen; tissue diagnosis; culture for organism identification; distinguishes abscess from tumor/hematoma",
            "target": "Organism identification; Gram stain; histopathology (rule out tumor)"
          },
          {
            "item": "Acid-fast bacilli (AFB) smear and culture",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "TB spine (Pott's disease); endemic areas; immunocompromised; chronic presentation with vertebral destruction",
            "target": "Negative; positive → TB requires different treatment (anti-TB regimen; may not need surgery if no instability/neurologic deficit)"
          },
          {
            "item": "Fungal cultures",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Immunocompromised; IVDU; indwelling catheters; endemic fungi (coccidioidomycosis, blastomycosis, histoplasmosis); chronic presentation",
            "target": "Negative; positive → prolonged antifungal therapy (6-12+ months)"
          },
          {
            "item": "Brucella serology / cultures",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Endemic areas (Mediterranean, Middle East); unpasteurized dairy; occupational exposure (farmers, veterinarians); chronic back pain",
            "target": "Negative; positive → doxycycline + streptomycin/gentamicin or rifampin"
          },
          {
            "item": "16S rRNA PCR (on tissue)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Culture-negative SEA; prior antibiotic exposure; fastidious organisms",
            "target": "Identifies organism even when cultures are negative; research/reference lab"
          },
          {
            "item": "Transthoracic echocardiogram (TTE)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "**Infective endocarditis screen**; IE present in 10-15% of SEA patients with S. aureus bacteremia; affects antibiotic duration and management",
            "target": "Normal; vegetations → endocarditis diagnosis; changes antibiotic duration to 4-6 weeks minimum"
          },
          {
            "item": "Transesophageal echocardiogram (TEE)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "If TTE negative but high suspicion for endocarditis (S. aureus bacteremia, IVDU, prosthetic valve, persistent fever); TEE more sensitive than TTE",
            "target": "Normal; vegetations → endocarditis; TEE sensitivity 90-95% vs. TTE 65%"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "LP — Generally NOT indicated",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-",
            "timing": "**LP is generally CONTRAINDICATED in suspected SEA**; risk of seeding infection into subarachnoid space → meningitis/spinal subdural empyema; imaging (MRI) is diagnostic modality of choice",
            "target": "N/A",
            "contraindications": "**AVOID LP if SEA suspected** — LP may spread infection into intradural space; if meningitis suspected concurrently, discuss with neurosurgery/ID before LP"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI entire spine with and without contrast (gadolinium)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "URGENT",
            "ICU": "STAT",
            "timing": "**GOLD STANDARD — within 4 hours of ED presentation if neurologic deficit; within 24h if no deficit**; contrast essential for abscess characterization; image ENTIRE spine (multifocal in 15-20%)",
            "target": "Epidural collection with ring enhancement; T1 hypointense, T2 hyperintense; restricted diffusion (DWI bright, ADC dark within abscess); vertebral body involvement (osteomyelitis); disc involvement (discitis); cord compression; degree of canal compromise",
            "contraindications": "MRI-incompatible implants; severe claustrophobia (sedate — do NOT delay); GFR <30 (gadolinium risk — but benefit outweighs risk in emergency)"
          },
          {
            "item": "Plain radiographs (spine)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Immediate while awaiting MRI; identifies vertebral body destruction, disc space narrowing, alignment abnormality; LOW sensitivity for early SEA",
            "target": "Disc space narrowing; vertebral body destruction (late finding — takes 2-4 weeks to appear); alignment; pathologic fracture",
            "contraindications": "Pregnancy (shield)"
          },
          {
            "item": "CT spine without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "If MRI unavailable or contraindicated; inferior to MRI for soft tissue and epidural collection; shows bone destruction better than MRI",
            "target": "Bone destruction; disc space narrowing; paraspinal soft tissue mass; canal compromise; less sensitive than MRI for epidural abscess extent",
            "contraindications": "Pregnancy (relative)"
          },
          {
            "item": "Chest X-ray",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Primary pulmonary source (pneumonia); lung abscess; TB (apical infiltrate, cavitation); septic emboli",
            "target": "Primary infection source; pulmonary complications; TB features",
            "contraindications": "Pregnancy (shield)"
          }
        ],
        "Extended": [
          {
            "item": "CT chest/abdomen/pelvis with contrast",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Source identification if not obvious; look for primary infection (lung abscess, intra-abdominal abscess, psoas abscess); staging for concurrent infection",
            "target": "Primary source: lung abscess, intra-abdominal abscess, psoas abscess (contiguous spread), renal/perinephric abscess; endocarditis emboli",
            "contraindications": "Contrast allergy; renal impairment"
          },
          {
            "item": "Echocardiogram (TTE → TEE if needed)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "**All patients with S. aureus bacteremia should have echocardiogram**; endocarditis in 10-15% of S. aureus SEA",
            "target": "Vegetations; valvular regurgitation; abscess; Duke criteria",
            "contraindications": "None (TTE); TEE: esophageal pathology, uncooperative patient"
          },
          {
            "item": "CT myelogram",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "timing": "Only if MRI absolutely contraindicated; intrathecal contrast via LP followed by CT; demonstrates level of compression; risk of meningitis seeding with LP",
            "target": "Complete or partial block; level of compression; intradural vs. extradural",
            "contraindications": "Infection at LP site (SEA itself may preclude LP at involved level); coagulopathy"
          },
          {
            "item": "Nuclear medicine bone scan (Tc-99m)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If MRI unavailable; can identify osteomyelitis; may show uptake before radiographic changes; less specific than MRI",
            "target": "Increased uptake at infection site(s); may identify multifocal disease",
            "contraindications": "Pregnancy; limited specificity"
          },
          {
            "item": "Gallium-67 or Indium-111 WBC scan",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Chronic/subacute infection; differentiating active infection from degenerative changes; research use",
            "target": "Increased uptake at infection site",
            "contraindications": "Limited availability; time-consuming; replaced largely by MRI"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CT-guided biopsy/aspiration",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "timing": "If diagnosis uncertain; culture acquisition for non-surgical management; distinguish abscess from tumor or hematoma",
            "target": "Organism identification; Gram stain; histopathology confirming infection vs. other pathology",
            "contraindications": "Coagulopathy; inaccessible location; very small collection"
          },
          {
            "item": "PET/CT (FDG)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Chronic/recurrent infection; assess treatment response; identify additional sites of infection; research use",
            "target": "Increased FDG uptake at infection site; may identify occult primary source",
            "contraindications": "Uncontrolled diabetes (glucose >200); pregnancy"
          },
          {
            "item": "Repeat MRI (during treatment)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At 2-4 weeks or if clinical worsening; assess treatment response; monitor for abscess expansion; may appear worse before better on imaging",
            "target": "Stable or decreasing collection size; resolving edema; NOTE: Imaging may lag behind clinical improvement (may appear worse at 2 weeks even with successful treatment)",
            "contraindications": "Same as initial MRI"
          },
          {
            "item": "Post-treatment MRI",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At end of antibiotic course (6-8 weeks); baseline for comparison; assess for residual disease",
            "target": "Resolution or significant improvement of collection; healed osteomyelitis; residual enhancement may persist for months (does not necessarily indicate active infection)",
            "contraindications": "Same as MRI"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent Treatment": [
          {
            "item": "**Empiric IV antibiotics (STAT)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-30 mg/kg",
                  "orderSentence": "**Empiric IV antibiotics (STAT)** 25-30 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "**Start IMMEDIATELY after blood cultures drawn — do NOT delay for MRI or organism identification**; **First-line empiric:** Vancomycin 25-30 mg/kg IV load (max 2g), then 15-20 mg/kg IV q8-12h (target trough 15-20 mcg/mL) PLUS Ceftriaxone 2g IV q12h OR Cefepime 2g IV q8h; **Alternative for β-lactam allergy:** Vancomycin + aztreonam 2g IV q8h OR Vancomycin + fluoroquinolone (levofloxacin 750 mg daily); **If Pseudomonas risk (IVDU, immunocompromised):** Add anti-pseudomonal coverage with cefepime or piperacillin-tazobactam 4.5g IV q6h; **Adjust to culture results when available**",
              "orderSentence": "**Empiric IV antibiotics (STAT)** 25-30 mg/kg IV"
            },
            "contraindications": "-",
            "monitoring": "Vancomycin covers MRSA (most important cause); ceftriaxone/cefepime covers MSSA, streptococci, gram-negatives; early antibiotics are associated with better outcomes; every hour of delay increases mortality in sepsis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Emergent surgical decompression + drainage**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**INDICATIONS (Surgery preferred):** (1) Neurologic deficit (any weakness, bowel/bladder dysfunction), (2) Sepsis/hemodynamic instability not improving with antibiotics, (3) Significant cord compression on imaging, (4) Failure of medical therapy (no improvement at 48-72h, worsening at any time), (5) Unknown organism (need tissue diagnosis); **Procedure:** Posterior laminectomy with abscess drainage; cultures from abscess; débridement of infected tissue; may need instrumentation if instability; **Timing:** Within 24h of diagnosis; emergent (within hours) if progressive deficit",
              "orderSentence": "**Emergent surgical decompression + drainage** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Darouiche (2006): Surgical outcomes better than medical management in patients with neurologic deficit; earlier surgery (within 24h) associated with better neurologic recovery; pre-operative neurologic status is #1 predictor of outcome",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**DVT prophylaxis**",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "**DVT prophylaxis** 40 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "SCDs immediately; pharmacologic prophylaxis: enoxaparin 40 mg SQ daily — timing is nuanced: may start within 24h of admission if no imminent surgery; post-operatively start 12-24h after surgery per surgeon; high VTE risk population",
              "orderSentence": "**DVT prophylaxis** 40 mg SC"
            },
            "contraindications": "-",
            "monitoring": "Immobile + infection + inflammatory state = very high DVT risk; mechanical prophylaxis universal; pharmacologic prophylaxis as soon as surgically safe",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Pain management**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650-1000 mg",
                  "orderSentence": "**Pain management** 650-1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Back pain often severe; acetaminophen 650-1000 mg q6h (scheduled) + opioids (morphine 2-4 mg IV q3h PRN or hydromorphone 0.5-1 mg IV q3h PRN); NSAIDs: use cautiously (renal function, surgical bleeding) — some ID physicians avoid NSAIDs in active infection; neuropathic agents (gabapentin) if radicular component",
              "orderSentence": "**Pain management** 650-1000 mg IV"
            },
            "contraindications": "-",
            "monitoring": "Severe pain is hallmark of SEA; adequate analgesia is essential; balance with need for neurologic monitoring",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**Sepsis resuscitation (if septic)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mL/kg",
                  "orderSentence": "**Sepsis resuscitation (if septic)** 30 mL/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "Surviving Sepsis guidelines: lactate measurement; blood cultures before antibiotics; IV crystalloid 30 mL/kg for hypotension or lactate ≥4 mmol/L; vasopressors (norepinephrine first-line) if MAP <65 despite fluids; reassess volume status; repeat lactate if initially elevated",
              "orderSentence": "**Sepsis resuscitation (if septic)** 30 mL/kg IV"
            },
            "contraindications": "-",
            "monitoring": "Sepsis from SEA has high mortality; early aggressive resuscitation improves outcomes",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Glucose control**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "180 mg",
                  "orderSentence": "**Glucose control** 180 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Target glucose <180 mg/dL; insulin infusion if critically ill; sliding scale or basal-bolus for non-ICU patients; diabetes is major risk factor — optimize control",
              "orderSentence": "**Glucose control** 180 mg IV"
            },
            "contraindications": "-",
            "monitoring": "Hyperglycemia impairs immune function and wound healing; tight glucose control improves infection outcomes",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Definitive/Targeted Treatment": [
          {
            "item": "**Targeted IV antibiotic therapy (based on culture results)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2g",
                  "orderSentence": "**Targeted IV antibiotic therapy (based on culture results)** 2g IV"
                }
              ],
              "route": "IV",
              "instructions": "**Tailor to organism and sensitivities; typical regimens:** — **MSSA:** Nafcillin 2g IV q4h OR cefazolin 2g IV q8h (preferred for tolerability); duration 6-8 weeks; — **MRSA:** Vancomycin 15-20 mg/kg IV q8-12h (trough 15-20) for 6-8 weeks; alternatives: daptomycin 6-8 mg/kg IV daily (avoid if pneumonia), linezolid 600 mg IV/PO q12h (monitor for toxicity if >2 weeks); — **Streptococci:** Penicillin G 4 million units IV q4h or ceftriaxone 2g IV q12h x 6 weeks; — **Enterococcus:** Ampicillin 2g IV q4h (if susceptible) ± gentamicin synergy; vancomycin if ampicillin-resistant; — **Gram-negatives:** Ceftriaxone 2g IV q12h or cefepime 2g IV q8h or ciprofloxacin 400 mg IV q8h x 6 weeks depending on sensitivities; — **Pseudomonas:** Cefepime 2g IV q8h or meropenem 2g IV q8h x 6 weeks",
              "orderSentence": "**Targeted IV antibiotic therapy (based on culture results)** 2g IV"
            },
            "contraindications": "-",
            "monitoring": "IV antibiotics are standard for SEA/osteomyelitis; oral transition data emerging (OVIVA trial) but traditionally 6-8 weeks IV; de-escalate from empiric coverage once cultures return",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**Duration of antibiotics**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "**SEA without osteomyelitis:** 4-6 weeks IV; **SEA with vertebral osteomyelitis (most cases):** 6-8 weeks IV; **SEA with endocarditis:** 6 weeks minimum from first negative blood culture; duration guided by clinical response, inflammatory markers (ESR, CRP), repeat imaging; may extend if slow response",
              "orderSentence": "**Duration of antibiotics** - IV - see dosing"
            },
            "contraindications": "-",
            "monitoring": "IDSA guidelines: 6 weeks for vertebral osteomyelitis; 4-6 weeks for epidural abscess alone; endocarditis requires 6-week minimum; individualized based on response",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**Oral antibiotic transition (selected cases)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "750 mg",
                  "orderSentence": "**Oral antibiotic transition (selected cases)** 750 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "**OVIVA trial (2019):** Oral antibiotics non-inferior to IV for bone/joint infections after initial 2 weeks IV in stable patients; **Candidates:** Clinically improving; afebrile; tolerating PO; CRP trending down; adherent; close follow-up available; **Oral options:** Fluoroquinolone (levofloxacin 750 mg daily or ciprofloxacin 750 mg BID) + rifampin 300 mg BID (NOT monotherapy); linezolid 600 mg BID (monitor CBC, neuropathy); TMP-SMX DS 2 tabs BID (for MRSA); **NOT for:** Endocarditis, undrained abscess, persistent bacteremia, non-adherent patient",
              "orderSentence": "**Oral antibiotic transition (selected cases)** 750 mg IV"
            },
            "contraindications": "-",
            "monitoring": "OVIVA trial showed oral switch after 2 weeks IV is non-inferior for bone/joint infections; reduces costs, IV complications, hospital stay; requires careful patient selection and close monitoring; NOT standard for all SEA cases",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Surgical drainage (if not done emergently)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**If initial medical management:** Re-evaluate need for surgery at 48-72h; indications for delayed surgery: failure to improve, neurologic deterioration, persistent fever/bacteremia, abscess enlargement on imaging; **Procedure:** Laminectomy + drainage; send cultures even if already on antibiotics (may still grow organism); instrumented fusion if instability/destruction",
              "orderSentence": "**Surgical drainage (if not done emergently)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Surgery provides source control, tissue diagnosis, and decompression; delayed surgery for medical failure still beneficial if performed before complete paralysis",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Medical management alone (selected cases)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Candidates for medical management without surgery:** (1) No neurologic deficit, (2) Organism identified (blood cultures positive), (3) Small abscess (<3 cm collection), (4) Poor surgical candidate (extreme comorbidities), (5) Panspinal disease (multiple levels — surgery impractical); **Requirements:** Very close neurologic monitoring (q2-4h initially); repeat MRI at 48-72h and weekly; immediate surgery if any deterioration; adherent patient",
              "orderSentence": "**Medical management alone (selected cases)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Observational studies: ~40% of SEA can be managed medically if no neurologic deficit and criteria met; HOWEVER, 10-20% will fail medical therapy and require surgery; early surgery generally preferred if feasible",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Adjunctive Treatment": [
          {
            "item": "**PICC line placement**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "If prolonged IV antibiotics planned (6-8 weeks); enables outpatient IV therapy (OPAT); placed once stabilized and duration confirmed; confirm tip position with X-ray",
              "orderSentence": "**PICC line placement** - IV - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Required for OPAT; reduces peripheral IV complications; monitor for PICC-associated infection",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Outpatient parenteral antibiotic therapy (OPAT)**",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "instructions": "Once clinically stable (afebrile, pain controlled, neurologically stable, adequate PO intake, safe home environment); PICC in place; infusion teaching completed; close ID follow-up (weekly visits); VNA nursing for line care",
              "orderSentence": "**Outpatient parenteral antibiotic therapy (OPAT)** - PO - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Reduces hospital stay; comparable outcomes to inpatient therapy in appropriate patients; weekly ID visits with labs (CBC, CMP, drug levels, CRP)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Rifampin (adjunctive)**",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "**Rifampin (adjunctive)** 300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "For staphylococcal osteomyelitis (vertebral involvement); enhances bone penetration; prevents biofilm; **ONLY as adjunctive therapy — never monotherapy (rapid resistance)**; Rifampin 300 mg PO BID added to primary anti-staphylococcal agent; check interactions (CYP3A4 inducer — reduces warfarin, HIV meds, oral contraceptives, etc.)",
              "orderSentence": "**Rifampin (adjunctive)** 300 mg PO"
            },
            "contraindications": "-",
            "monitoring": "Rifampin improves outcomes in staphylococcal bone infections; biofilm activity; excellent bone penetration; drug interactions are significant",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Bracing / spinal orthosis**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "If spinal instability (vertebral body destruction, kyphosis, instrumentation); TLSO for thoracolumbar; cervical collar for cervical; duration: typically 6-12 weeks or until radiographic healing",
              "orderSentence": "**Bracing / spinal orthosis** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "External stabilization; pain relief; prevents pathologic fracture progression; may allow non-operative management of mild instability",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Nutritional optimization**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1.2-1.5 g/kg",
                  "orderSentence": "**Nutritional optimization** 1.2-1.5 g/kg -"
                }
              ],
              "route": "-",
              "instructions": "Protein supplementation (1.2-1.5 g/kg/day); calorie optimization; correct vitamin deficiencies; dietitian consultation; affects wound healing and immune function",
              "orderSentence": "**Nutritional optimization** 1.2-1.5 g/kg -"
            },
            "contraindications": "-",
            "monitoring": "Malnutrition common in chronic illness; protein essential for wound healing; improves infection outcomes",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Diabetes optimization**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "180 mg",
                  "orderSentence": "**Diabetes optimization** 180 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Endocrinology consult if poorly controlled; insulin titration; goal HbA1c <7.5% (individualized); glucose <180 mg/dL during acute illness",
              "orderSentence": "**Diabetes optimization** 180 mg PO"
            },
            "contraindications": "-",
            "monitoring": "Diabetes is major risk factor; uncontrolled diabetes impairs healing and immune response",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**Substance abuse counseling (if applicable)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30%",
                  "orderSentence": "**Substance abuse counseling (if applicable)** 30% -"
                }
              ],
              "route": "-",
              "instructions": "IVDU is major risk factor for SEA (20-30% of cases); addiction medicine consultation; harm reduction; hepatitis/HIV screening; reduces recurrence risk",
              "orderSentence": "**Substance abuse counseling (if applicable)** 30% -"
            },
            "contraindications": "-",
            "monitoring": "IVDU patients at high risk for recurrent infection; addressing substance use reduces future SEA risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Medications to AVOID or Use with Caution": [
          {
            "item": "Daptomycin (with pneumonia)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Daptomycin (with pneumonia) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Rifampin monotherapy",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Rifampin monotherapy - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Linezolid >2-4 weeks",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Linezolid >2-4 weeks - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Aminoglycosides (prolonged use)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Aminoglycosides (prolonged use) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Corticosteroids (routine use)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Corticosteroids (routine use) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "NSAIDs (prolonged, peri-operative)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "NSAIDs (prolonged, peri-operative) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "LP (in suspected SEA)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "LP (in suspected SEA) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Epidural steroid injection (as treatment or in area of abscess)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Epidural steroid injection (as treatment or in area of abscess) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Spine surgery / Neurosurgery consultation — EMERGENT",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Infectious disease consultation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Neurologic examination — serial monitoring",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Source identification",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Blood cultures (before antibiotics)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Fall precautions / mobility assessment",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Documentation of timeline",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Echocardiogram (TTE ± TEE)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Dental evaluation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "PICC placement / vascular access",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work / case management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Addiction medicine (if IVDU)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain management service",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical / occupational therapy",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "VNA / home health",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Repeat MRI",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "CT-guided drainage (percutaneous)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Revision surgery / repeat drainage",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Infectious disease second opinion",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Long-term suppressive antibiotics",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Spinal fusion (delayed)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hyperbaric oxygen therapy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Diagnosis",
        "features": "Key Differentiating Features",
        "tests": "Distinguishing Studies"
      },
      {
        "diagnosis": "Malignant spinal cord compression (MSCC) / Metastatic epidural disease",
        "features": "Known cancer history; bone destruction without disc involvement (SEA typically involves disc); no fever (usually); no elevated ESR/CRP/WBC (unless concurrent infection); may be painful but not typically as acute; enhances but no ring-enhancement or diffusion restriction",
        "tests": "MRI: enhancing epidural mass WITHOUT ring enhancement or restricted diffusion; bone destruction; CT/PET: metastatic staging; tumor markers; biopsy if uncertain; ESR/CRP may be mildly elevated in malignancy but not as high as SEA"
      },
      {
        "diagnosis": "Vertebral compression fracture (osteoporotic)",
        "features": "Older patient; osteoporosis history; no fever; acute onset with movement; no neurologic deficit (usually); no elevated inflammatory markers; vertebral body wedging; may have benign edema",
        "tests": "MRI: vertebral body edema WITHOUT epidural collection; no ring enhancement; normal ESR/CRP; DEXA: osteoporosis; mechanism (fall, lifting); responds to bracing/pain management"
      },
      {
        "diagnosis": "Disc herniation (without infection)",
        "features": "No fever; no elevated inflammatory markers; unilateral radiculopathy (usually); no epidural collection on MRI; common, benign presentation",
        "tests": "MRI: disc herniation without epidural enhancement; no T2 hyperintense collection; normal ESR/CRP; normal WBC; unilateral symptoms more common"
      },
      {
        "diagnosis": "Spinal epidural hematoma",
        "features": "Anticoagulation; post-procedural (epidural injection, LP, surgery); acute onset; hematoma signal characteristics on MRI (not ring-enhancing); no fever; rapidly progressive",
        "tests": "MRI: epidural collection with blood signal (T1 hyperintense in subacute phase); NO ring enhancement; NO restricted diffusion in hematoma (unlike abscess); coagulation studies; anticoagulation history; recent procedure"
      },
      {
        "diagnosis": "Transverse myelitis / NMOSD",
        "features": "Intramedullary (within cord) rather than epidural; autoimmune; no fever; no elevated ESR/CRP (or mildly elevated); subacute onset; responds to steroids/PLEX",
        "tests": "MRI: intramedullary T2 hyperintensity, NOT epidural collection; AQP4/MOG antibodies; CSF: pleocytosis but sterile; normal inflammatory markers"
      },
      {
        "diagnosis": "Degenerative lumbar stenosis",
        "features": "Chronic symptoms (claudication); older patient; no fever; no inflammatory markers; bilateral symptoms with walking; relieved by sitting/flexion; chronic findings on MRI",
        "tests": "MRI: chronic stenosis (ligamentum flavum hypertrophy, disc bulging, facet hypertrophy) WITHOUT acute epidural collection; normal ESR/CRP; chronic history"
      },
      {
        "diagnosis": "Vertebral osteomyelitis (without epidural extension)",
        "features": "Similar to SEA but NO epidural collection; disc and vertebral body involvement; back pain and fever; elevated inflammatory markers; may progress to SEA",
        "tests": "MRI: vertebral body and disc enhancement and edema WITHOUT epidural collection; blood cultures may be positive; requires IV antibiotics but not emergent surgical decompression (unless instability or progression to SEA)"
      },
      {
        "diagnosis": "Psoas abscess",
        "features": "Contiguous spread can cause spinal infection; flank/groin pain; hip flexion pain; may track from spine or vice versa; fever; iliopsoas enhancement on imaging",
        "tests": "CT/MRI: psoas muscle enlargement with rim-enhancing collection; may extend to spine; blood cultures; percutaneous drainage often possible"
      }
    ],
    "evidence": [
      {
        "recommendation": "Guideline",
        "evidenceLevel": "Source",
        "source": "Year"
      },
      {
        "recommendation": "Vertebral Osteomyelitis Guidelines",
        "evidenceLevel": "IDSA Clinical Practice Guideline",
        "source": "2015"
      },
      {
        "recommendation": "Spinal Epidural Abscess Management",
        "evidenceLevel": "AANS/CNS Joint Guidelines",
        "source": "2017"
      },
      {
        "recommendation": "Native Vertebral Osteomyelitis",
        "evidenceLevel": "British Infection Association / British Orthopaedic Association",
        "source": "2015"
      },
      {
        "recommendation": "Study",
        "evidenceLevel": "Finding",
        "source": "Impact"
      },
      {
        "recommendation": "Darouiche (2006) — NEJM Review",
        "evidenceLevel": "Comprehensive review of SEA: S. aureus most common (60-70%); pre-operative neurologic status is #1 predictor of outcome; early surgery associated with better outcomes; medical management reasonable in selected cases without deficit",
        "source": "Established framework for surgical vs. medical management decision-making"
      },
      {
        "recommendation": "Siddiq et al. (2004) — Meta-analysis",
        "evidenceLevel": "915 patients: Surgical treatment associated with better neurologic outcomes than medical management alone; patients presenting with neurologic deficit benefit most from early surgery",
        "source": "Supports surgical decompression as preferred approach, especially with neurologic deficit"
      },
      {
        "recommendation": "Connor et al. (2013)",
        "evidenceLevel": "Timing of surgery: decompression within 24h of neurologic deficit associated with significantly better outcomes than delayed surgery",
        "source": "Established 24h window for surgical decompression"
      },
      {
        "recommendation": "Patel et al. (2014)",
        "evidenceLevel": "Risk factors for poor outcome: advanced age, diabetes, MRSA, delayed diagnosis, pre-operative paralysis, cervical/thoracic location",
        "source": "Identified high-risk patients who may benefit from aggressive surgical approach"
      },
      {
        "recommendation": "Berbari et al. (2015) — IDSA Guidelines",
        "evidenceLevel": "6-week IV antibiotic duration for vertebral osteomyelitis; longer for complicated cases (endocarditis, undrained abscess); rifampin adjunct for staphylococcal infections",
        "source": "Standardized antibiotic duration and adjunctive therapy"
      },
      {
        "recommendation": "OVIVA Trial (2019)",
        "evidenceLevel": "Oral antibiotics non-inferior to IV for bone/joint infections after initial IV therapy in stable patients; oral switch after 2 weeks IV",
        "source": "Opened possibility of early oral transition for selected patients; reduces hospitalization/OPAT burden; requires careful patient selection"
      },
      {
        "recommendation": "Reihsaus et al. (2000)",
        "evidenceLevel": "Meta-analysis: mortality 5%; permanent paralysis 4-22%; earlier surgery and better pre-operative function = better outcomes",
        "source": "Established prognostic importance of pre-operative neurologic status and early intervention"
      },
      {
        "recommendation": "Organism",
        "evidenceLevel": "Frequency",
        "source": "Key Features"
      },
      {
        "recommendation": "Staphylococcus aureus",
        "evidenceLevel": "60-70% (MRSA 30-50% of S. aureus)",
        "source": "Most common; hematogenous spread; IVDU, skin infection, catheters; MRSA requires vancomycin"
      },
      {
        "recommendation": "Coagulase-negative Staphylococci",
        "evidenceLevel": "5-10%",
        "source": "Post-procedural; hardware-associated"
      },
      {
        "recommendation": "Streptococci (including viridans, pneumoniae)",
        "evidenceLevel": "5-10%",
        "source": "Endocarditis association; dental source"
      },
      {
        "recommendation": "Gram-negative bacilli (E. coli, Pseudomonas, Klebsiella)",
        "evidenceLevel": "10-15%",
        "source": "Urinary source; IVDU (Pseudomonas); diabetics"
      },
      {
        "recommendation": "Enterococcus",
        "evidenceLevel": "2-5%",
        "source": "Urinary source; GI/biliary source"
      },
      {
        "recommendation": "Anaerobes",
        "evidenceLevel": "2-5%",
        "source": "Often polymicrobial; abdominal/pelvic source"
      },
      {
        "recommendation": "Mycobacterium tuberculosis",
        "evidenceLevel": "<5% (higher in endemic areas)",
        "source": "Subacute/chronic; Pott's disease; vertebral destruction; cold abscess; paraspinal extension"
      },
      {
        "recommendation": "Fungi (Candida, Aspergillus)",
        "evidenceLevel": "<2%",
        "source": "IVDU; immunocompromised; indwelling catheters"
      },
      {
        "recommendation": "Culture-negative",
        "evidenceLevel": "10-20%",
        "source": "Prior antibiotics; fastidious organisms; consider TB, Brucella, fungi"
      }
    ],
    "monitoring": [
      {
        "item": "Neurologic examination (motor strength, sensory level, rectal tone, bladder)",
        "frequency": "q2-4h initially; q4-6h once stable",
        "target": "Stable or improving; NO new deficits",
        "action": "ANY deterioration → STAT MRI → emergent surgical consultation → likely emergent decompression"
      },
      {
        "item": "Temperature",
        "frequency": "q4h",
        "target": "Afebrile (<38°C) by 48-72h of antibiotics",
        "action": "Persistent fever: repeat cultures; imaging for undrained collection; reassess antibiotics; echocardiogram"
      },
      {
        "item": "Blood pressure / hemodynamics",
        "frequency": "Continuous if septic; q4h if stable",
        "target": "MAP >65; resolving sepsis",
        "action": "Vasopressors; fluid resuscitation; ICU care for septic shock"
      },
      {
        "item": "Pain score (NRS)",
        "frequency": "q4h",
        "target": "Improving; NRS <4/10",
        "action": "Escalate analgesia; worsening pain may indicate abscess enlargement or instability"
      },
      {
        "item": "Blood cultures (repeat)",
        "frequency": "Daily until negative",
        "target": "Negative cultures within 48-72h of appropriate antibiotics",
        "action": "Persistent bacteremia: echocardiogram (TEE); imaging for undrained focus; consider surgery"
      },
      {
        "item": "WBC, CRP",
        "frequency": "Daily initially",
        "target": "Trending down",
        "action": "Rising inflammatory markers: treatment failure; repeat imaging; reassess management"
      },
      {
        "item": "Vancomycin trough (if on vancomycin)",
        "frequency": "Before 4th dose; then 2-3x/week",
        "target": "15-20 mcg/mL (for serious infection)",
        "action": "Adjust dose if outside range; monitor renal function"
      },
      {
        "item": "Renal function (BUN/Cr)",
        "frequency": "Daily initially; 2-3x/week ongoing",
        "target": "Stable",
        "action": "Nephrotoxicity: adjust vancomycin and other renally-cleared drugs; adequate hydration"
      },
      {
        "item": "Blood glucose",
        "frequency": "q6h (q4h if critically ill)",
        "target": "<180 mg/dL",
        "action": "Insulin titration"
      }
    ],
    "disposition": [
      {
        "disposition": "Level of Care",
        "criteria": "Criteria"
      },
      {
        "disposition": "ICU admission",
        "criteria": "Sepsis/septic shock; hemodynamic instability; respiratory compromise; post-operative monitoring (surgeon-dependent); severe neurologic deficit with close monitoring needed"
      },
      {
        "disposition": "General medical/neurosurgery floor",
        "criteria": "ALL patients with confirmed or suspected SEA require admission; IV antibiotic initiation; neurologic monitoring; surgical evaluation; pre-operative preparation if surgery planned"
      },
      {
        "disposition": "Observation (NOT appropriate)",
        "criteria": "SEA is NEVER an observation diagnosis; all patients require admission until diagnosis confirmed/excluded and treatment initiated"
      }
    ]
  },
  "Guillain-Barré Syndrome (GBS)": {
    "id": "guillain-barre-syndrome",
    "title": "Guillain-Barré Syndrome (GBS)",
    "version": "1.0",
    "icd10": [
      "** G61.0 (Guillain-Barré syndrome)"
    ],
    "scope": "** Acute inflammatory polyradiculoneuropathy including AIDP, AMAN, AMSAN, and Miller Fisher syndrome (MFS) variants. Covers acute diagnosis, respiratory monitoring, immunotherapy (IVIG/PLEX), autonomic dysfunction management, pain control, and rehabilitation planning. Excludes CIDP (chronic inflammatory demyelinating polyneuropathy — separate template), tick paralysis, and chronic neuropathies.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Baseline; infection screen; exclude hematologic causes",
            "target": "Normal; leukocytosis suggests infection trigger"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Electrolyte abnormalities (hyponatremia from SIADH), renal/hepatic function for IVIG dosing",
            "target": "Normal"
          },
          {
            "item": "Magnesium",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hypomagnesemia worsens weakness; arrhythmia risk",
            "target": ">1.8 mg/dL"
          },
          {
            "item": "Phosphorus",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hypophosphatemia causes weakness (mimic)",
            "target": ">2.5 mg/dL"
          },
          {
            "item": "ESR / CRP",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Inflammatory markers; infection screen",
            "target": "Mildly elevated (non-specific)"
          },
          {
            "item": "Blood glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Diabetes as comorbidity; hyperglycemia management",
            "target": "Normal"
          },
          {
            "item": "Urinalysis",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "UTI as precipitant; baseline",
            "target": "Normal"
          },
          {
            "item": "Pregnancy test (β-hCG)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Affects IVIG formulation choice; imaging considerations",
            "target": "Document result"
          },
          {
            "item": "PT/INR, aPTT",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Coagulation status before procedures (LP, central line)",
            "target": "Normal"
          },
          {
            "item": "Type and screen",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Potential need for PLEX",
            "target": "On file"
          }
        ],
        "Extended Workup": [
          {
            "item": "Anti-ganglioside antibodies (GM1, GD1a, GD1b, GQ1b)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "rationale": "GM1: AMAN; GQ1b: Miller Fisher; GD1a: AMAN; helps confirm diagnosis and subtype",
            "target": "Positive supports diagnosis (negative does not exclude)"
          },
          {
            "item": "Anti-GQ1b antibody",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Miller Fisher syndrome (ataxia, ophthalmoplegia, areflexia)",
            "target": "Positive in >90% MFS"
          },
          {
            "item": "Campylobacter jejuni serology (IgM, IgG)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Most common infectious trigger (30%); AMAN variant association",
            "target": "Positive IgM suggests recent infection"
          },
          {
            "item": "Mycoplasma pneumoniae IgM",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Common triggering infection",
            "target": "Positive IgM suggests recent infection"
          },
          {
            "item": "CMV IgM",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Triggering infection; associated with severe demyelinating GBS",
            "target": "Positive IgM"
          },
          {
            "item": "EBV panel (VCA IgM, EBNA)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Triggering infection",
            "target": "Positive VCA IgM"
          },
          {
            "item": "Hepatitis B surface antigen, anti-HBc",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Screen before IVIG; reactivation risk",
            "target": "Negative"
          },
          {
            "item": "Hepatitis C antibody",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Cryoglobulinemia-associated neuropathy (differential)",
            "target": "Negative"
          },
          {
            "item": "HIV 1/2 antigen/antibody",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HIV-associated neuropathy; acute HIV can mimic GBS",
            "target": "Negative"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Thyroid dysfunction can cause weakness",
            "target": "Normal"
          },
          {
            "item": "B12, methylmalonic acid",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "B12 deficiency neuropathy (differential)",
            "target": "Normal"
          },
          {
            "item": "Serum protein electrophoresis (SPEP) with immunofixation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Paraproteinemia-associated neuropathy (differential); POEMS",
            "target": "Normal"
          },
          {
            "item": "IgA level (quantitative)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "IgA deficiency contraindicates standard IVIG (anaphylaxis risk); check BEFORE IVIG if possible",
            "target": "Normal (>7 mg/dL)"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Zika virus serology/PCR",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Endemic areas; associated with GBS outbreaks",
            "target": "Negative"
          },
          {
            "item": "Influenza A/B PCR",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "rationale": "Triggering infection; seasonal",
            "target": "Negative"
          },
          {
            "item": "COVID-19 PCR/antigen",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "Post-COVID GBS association reported",
            "target": "Document result"
          },
          {
            "item": "Lyme serology (ELISA, Western blot)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Lyme-associated polyradiculopathy (differential); endemic areas",
            "target": "Negative"
          },
          {
            "item": "Paraneoplastic panel (serum)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If atypical features or poor response to treatment",
            "target": "Negative"
          },
          {
            "item": "Heavy metals (lead, arsenic, thallium)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Toxic neuropathy mimic; occupational exposure",
            "target": "Normal"
          },
          {
            "item": "Porphyrins (urine ALA, PBG)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Acute intermittent porphyria mimic (motor predominant, autonomic dysfunction)",
            "target": "Normal"
          },
          {
            "item": "Anti-MAG antibody",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "MAG-associated neuropathy (differential; chronic presentation)",
            "target": "Negative"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Rule out elevated ICP",
            "target": "10-20 cm H2O (normal)"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Albuminocytologic dissociation",
            "target": "WBC <10 cells/µL (if >50 WBC, reconsider diagnosis — HIV, Lyme, sarcoidosis, lymphoma)"
          },
          {
            "item": "Protein",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Classic finding: elevated protein with normal WBC",
            "target": "Elevated >45 mg/dL (often >100 mg/dL; may be normal in first week)"
          },
          {
            "item": "Glucose with serum glucose",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Normal in GBS; low in infectious/malignant meningitis",
            "target": "Normal (>60% serum)"
          },
          {
            "item": "Gram stain and culture",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Exclude bacterial meningitis",
            "target": "No organisms"
          },
          {
            "item": "Cytology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Exclude leptomeningeal lymphoma/carcinomatosis",
            "target": "Negative"
          },
          {
            "item": "VDRL (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Neurosyphilis can mimic",
            "target": "Negative"
          },
          {
            "item": "Oligoclonal bands, IgG index",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Differentiate from MS; may be positive in GBS (non-specific)",
            "target": "Negative or low titer"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI spine with and without contrast (whole spine)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Within 24h of presentation",
            "target": "Nerve root enhancement (anterior roots in AIDP); exclude compressive myelopathy, spinal cord lesion, epidural abscess",
            "contraindications": "Pacemaker, metallic implants"
          },
          {
            "item": "Nerve conduction studies / EMG (NCS/EMG)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Ideally within 3-5 days of symptom onset (may be normal in first 48h); repeat at 2-3 weeks if initially non-diagnostic",
            "target": "Demyelinating pattern: prolonged distal latencies, conduction block, temporal dispersion, prolonged F-waves, absent H-reflex. Axonal pattern (AMAN): reduced CMAP amplitudes with normal velocities",
            "contraindications": "None significant; avoid anticoagulated patients for EMG needle exam"
          },
          {
            "item": "Chest X-ray",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "On admission",
            "target": "Aspiration, atelectasis, baseline for ventilator management",
            "contraindications": "None significant"
          },
          {
            "item": "ECG (12-lead)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "On admission and PRN",
            "target": "Arrhythmias (sinus tachycardia, bradycardia, AV block); autonomic dysfunction",
            "contraindications": "None"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain with and without contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "timing": "If Miller Fisher variant suspected or cranial nerve involvement",
            "target": "Cranial nerve enhancement (especially CN III, VI, VII); exclude central lesion",
            "contraindications": "Same as MRI"
          },
          {
            "item": "CT chest with contrast",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If paraneoplastic etiology suspected; thymoma screen if MG in differential",
            "target": "Mass lesion",
            "contraindications": "Contrast allergy, renal impairment"
          },
          {
            "item": "Repeat NCS/EMG",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At 2-4 weeks if initial study non-diagnostic or to assess prognosis",
            "target": "Evolution of findings; axonal degeneration predicts slower recovery",
            "contraindications": "Same as initial"
          },
          {
            "item": "Echocardiogram",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "timing": "If autonomic instability or new murmur",
            "target": "Cardiac function; Takotsubo in severe autonomic GBS",
            "contraindications": "None significant"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Nerve ultrasound (high-resolution)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If diagnosis uncertain",
            "target": "Nerve enlargement in CIDP (helps differentiate); some enlargement reported in GBS",
            "contraindications": "None"
          },
          {
            "item": "Pulmonary function testing (formal)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If borderline respiratory function",
            "target": "Full spirometry for outpatient monitoring",
            "contraindications": "Unable to cooperate"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "IVIG (intravenous immunoglobulin)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg",
                  "orderSentence": "IVIG (intravenous immunoglobulin) 0.4 g/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.4 g/kg/day IV x 5 days (total 2 g/kg); infuse over 4-8h per dose; slow initial rate and increase per protocol. Start within 2 weeks of symptom onset for maximum benefit",
              "orderSentence": "IVIG (intravenous immunoglobulin) 0.4 g/kg IV"
            },
            "contraindications": "IgA deficiency (use IgA-depleted product); acute renal failure; anaphylaxis to immunoglobulin",
            "monitoring": "Vital signs q15min during first infusion, then q30min; renal function (BUN, Cr) before and during; headache (aseptic meningitis); thrombotic events; hemolysis (haptoglobin, LDH, direct Coombs if symptoms)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Plasmapheresis (PLEX)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "5 exchanges over 7-14 days (typically every other day); each exchange 1-1.5 plasma volumes; use albumin replacement. Start within 4 weeks of symptom onset",
              "orderSentence": "Plasmapheresis (PLEX) - - - see dosing"
            },
            "contraindications": "Hemodynamic instability, severe sepsis, active bleeding, heparin allergy (for circuit anticoagulation), poor vascular access",
            "monitoring": "BP and HR continuous during exchange; calcium (citrate toxicity: tingling, cramping); fibrinogen; CBC; electrolytes; line site infection",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Intubation and mechanical ventilation",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mL/kg",
                  "orderSentence": "Intubation and mechanical ventilation 20 mL/kg -"
                }
              ],
              "route": "-",
              "instructions": "Indications (20/30/40 rule): FVC <20 mL/kg, NIF weaker than -30 cmH2O, >30% decline in FVC from baseline, or clinical respiratory distress. Use non-depolarizing agents (avoid succinylcholine — hyperkalemia risk). RSI with rocuronium preferred",
              "orderSentence": "Intubation and mechanical ventilation 20 mL/kg -"
            },
            "contraindications": "N/A (life-saving)",
            "monitoring": "Ventilator settings per ICU protocol; sedation; daily spontaneous breathing trial when improving",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "DVT prophylaxis: Enoxaparin",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "DVT prophylaxis: Enoxaparin 40 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily; start on admission",
              "orderSentence": "DVT prophylaxis: Enoxaparin 40 mg SC"
            },
            "contraindications": "Active bleeding, platelets <50K, CrCl <30 (use UFH)",
            "monitoring": "Platelets q3 days; anti-Xa if renal impairment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "DVT prophylaxis: Heparin SC (alternative)",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5000 units",
                  "orderSentence": "DVT prophylaxis: Heparin SC (alternative) 5000 units SC"
                }
              ],
              "route": "SC",
              "instructions": "5000 units SC q8-12h",
              "orderSentence": "DVT prophylaxis: Heparin SC (alternative) 5000 units SC"
            },
            "contraindications": "Active bleeding, HIT",
            "monitoring": "Platelets q3 days",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pneumatic compression devices",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Apply bilaterally on admission; continue until ambulatory",
              "orderSentence": "Pneumatic compression devices - - - see dosing"
            },
            "contraindications": "Acute DVT, severe PVD",
            "monitoring": "Skin checks daily",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Neuropathic pain (very common in GBS — 55-89%)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Gabapentin 300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg PO qHS; increase by 300 mg/day every 1-3 days; target 900-1800 mg TID; max 3600 mg/day",
              "orderSentence": "Gabapentin 300 mg PO"
            },
            "contraindications": "Severe renal impairment (dose adjust); oversedation",
            "monitoring": "Sedation, dizziness; adjust for renal function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "Neuropathic pain (alternative)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg",
                  "orderSentence": "Pregabalin 75 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 75 mg PO BID; increase to 150 mg BID after 3-7 days; max 300 mg BID",
              "orderSentence": "Pregabalin 75 mg PO"
            },
            "contraindications": "Renal impairment (dose adjust)",
            "monitoring": "Sedation, weight gain, peripheral edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Carbamazepine",
            "route": "PO",
            "indication": "Neuropathic pain (alternative)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Carbamazepine 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg PO BID; increase by 100 mg/day q3-7 days; target 400-800 mg/day in divided doses; max 1200 mg/day",
              "orderSentence": "Carbamazepine 100 mg PO"
            },
            "contraindications": "AV block, bone marrow suppression, HLA-B*1502 (Asian descent — screen before starting)",
            "monitoring": "CBC, LFTs, sodium at baseline and 2-4 weeks; drug level",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "PO",
            "indication": "Neuropathic pain, insomnia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-25 mg",
                  "orderSentence": "Amitriptyline 10-25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg PO qHS; increase by 10-25 mg q1-2 weeks; max 150 mg/day",
              "orderSentence": "Amitriptyline 10-25 mg PO"
            },
            "contraindications": "Arrhythmia, urinary retention, angle-closure glaucoma, recent MI",
            "monitoring": "ECG if cardiac risk; anticholinergic side effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Acetaminophen",
            "route": "PO",
            "indication": "Musculoskeletal pain, headache",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650-1000 mg",
                  "orderSentence": "Acetaminophen 650-1000 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "650-1000 mg PO q6h; max 4g/day (2g hepatic impairment)",
              "orderSentence": "Acetaminophen 650-1000 mg PO"
            },
            "contraindications": "Severe liver disease",
            "monitoring": "LFTs if prolonged",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Morphine IV",
            "route": "IV",
            "indication": "Severe pain unresponsive to above",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-4 mg",
                  "orderSentence": "Morphine IV 2-4 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "2-4 mg IV q3-4h PRN; use with caution — respiratory depression risk especially with respiratory compromise",
              "orderSentence": "Morphine IV 2-4 mg IV"
            },
            "contraindications": "Respiratory failure (relative — monitor closely), ileus",
            "monitoring": "RR, SpO2, sedation scale; bowel function",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Oxycodone",
            "route": "PO",
            "indication": "Moderate-severe pain (if able to swallow)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-10 mg",
                  "orderSentence": "Oxycodone 5-10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10 mg PO q4-6h PRN",
              "orderSentence": "Oxycodone 5-10 mg PO"
            },
            "contraindications": "Same as morphine",
            "monitoring": "Same as morphine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Metoclopramide",
            "route": "IV",
            "indication": "Gastroparesis, nausea (autonomic dysfunction)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Metoclopramide 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg IV/PO q6h PRN; max 40 mg/day; limit duration to <12 weeks",
              "orderSentence": "Metoclopramide 10 mg IV"
            },
            "contraindications": "Seizure history, Parkinson disease, GI obstruction",
            "monitoring": "Tardive dyskinesia with prolonged use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Docusate sodium",
            "route": "PO",
            "indication": "Constipation (immobility + opioids)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Docusate sodium 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "100 mg PO BID",
              "orderSentence": "Docusate sodium 100 mg PO"
            },
            "contraindications": "GI obstruction",
            "monitoring": "Bowel function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Senna",
            "route": "PO",
            "indication": "Constipation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "8.6-17.2 mg",
                  "orderSentence": "Senna 8.6-17.2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "8.6-17.2 mg PO qHS",
              "orderSentence": "Senna 8.6-17.2 mg PO"
            },
            "contraindications": "GI obstruction",
            "monitoring": "Bowel function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Polyethylene glycol (MiraLAX)",
            "route": "PO",
            "indication": "Constipation (if docusate insufficient)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "17 g",
                  "orderSentence": "Polyethylene glycol (MiraLAX) 17 g PO"
                }
              ],
              "route": "PO",
              "instructions": "17 g PO daily in 8 oz water",
              "orderSentence": "Polyethylene glycol (MiraLAX) 17 g PO"
            },
            "contraindications": "GI obstruction",
            "monitoring": "Bowel function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "Insomnia (ICU delirium prevention)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3-5 mg",
                  "orderSentence": "Melatonin 3-5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "3-5 mg PO qHS",
              "orderSentence": "Melatonin 3-5 mg PO"
            },
            "contraindications": "None significant",
            "monitoring": "Sleep quality",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Lorazepam",
            "route": "IV",
            "indication": "Anxiety, autonomic crisis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5-1 mg",
                  "orderSentence": "Lorazepam 0.5-1 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-1 mg IV/PO q6-8h PRN",
              "orderSentence": "Lorazepam 0.5-1 mg IV"
            },
            "contraindications": "Respiratory compromise (use with extreme caution)",
            "monitoring": "RR, sedation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Second course IVIG",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg",
                  "orderSentence": "Second course IVIG 0.4 g/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.4 g/kg/day x 5 days; consider if progressive deterioration after initial treatment or treatment-related fluctuation (TRF)",
              "orderSentence": "Second course IVIG 0.4 g/kg PO"
            },
            "contraindications": "Same as initial IVIG",
            "monitoring": "Same as initial IVIG",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "PLEX after IVIG failure",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "5 exchanges over 7-14 days; wait ≥2 weeks after IVIG to avoid washing out immunoglobulin",
              "orderSentence": "PLEX after IVIG failure - - - see dosing"
            },
            "contraindications": "Same as initial PLEX",
            "monitoring": "Same as initial PLEX",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "IV methylprednisolone (NOT standard of care)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "IV methylprednisolone (NOT standard of care) 500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "500 mg IV daily x 5 days; evidence does NOT support steroids alone; may be considered in combination with IVIG per some centers for refractory cases",
              "orderSentence": "IV methylprednisolone (NOT standard of care) 500 mg IV"
            },
            "contraindications": "Active infection, uncontrolled diabetes",
            "monitoring": "Glucose, BP, GI prophylaxis",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consultation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "All suspected GBS; diagnostic confirmation, treatment initiation"
          },
          {
            "item": "Pulmonology / Critical care",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Declining respiratory function; intubation decision; ventilator management"
          },
          {
            "item": "Physical therapy (PT)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Early passive ROM to prevent contractures; gradual mobilization as tolerated; gait training"
          },
          {
            "item": "Occupational therapy (OT)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Upper extremity function, ADLs, adaptive equipment"
          },
          {
            "item": "Speech-language pathology (SLP)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Dysphagia evaluation (bulbar weakness); aspiration prevention"
          },
          {
            "item": "Rehabilitation medicine (physiatry)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Rehabilitation planning; disposition (inpatient rehab vs SNF)"
          },
          {
            "item": "Pain management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "indication": "Refractory neuropathic pain"
          },
          {
            "item": "Social work",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Discharge planning, family support, financial resources"
          },
          {
            "item": "Psychology / Psychiatry",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Anxiety, depression, PTSD (common in ICU patients)"
          },
          {
            "item": "Respiratory therapy",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Bedside spirometry (FVC, NIF); pulmonary toilet; ventilator weaning"
          },
          {
            "item": "Nutrition / Dietitian",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "indication": "Enteral feeding plan if intubated; caloric needs during recovery"
          },
          {
            "item": "Infectious disease",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "indication": "If triggering infection unclear or atypical presentation"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return to ED / Call 911 if: increasing difficulty breathing, new swallowing difficulty, rapid worsening of weakness, inability to walk, chest pain, or lightheadedness",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "GBS is typically a self-limited illness; most patients recover substantially but recovery may take months to years",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do NOT drive until strength and reflexes have recovered and neurology clears",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Comply with physical therapy exercises as prescribed between sessions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Pain is normal in GBS and will be managed with medications; report if pain is inadequately controlled",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Inform future healthcare providers about GBS history (vaccine considerations, anesthesia precautions)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Fall prevention: use assistive devices (walker, cane) as recommended; remove tripping hazards at home",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Monitor for signs of blood clots: leg swelling, redness, chest pain, shortness of breath",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Follow-up with neurology in 2-4 weeks after discharge; NCS/EMG may be repeated at 3-6 months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Gradual return to activity as tolerated; avoid overexertion during recovery",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Balanced nutrition for nerve recovery (adequate protein, B vitamins)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation (impairs nerve healing)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate sleep (promotes neurologic recovery)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Mental health support (depression and anxiety common during recovery)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Flu vaccination: generally safe after GBS; discuss with neurologist (6 weeks post-onset minimum; risk-benefit individualized)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "COVID-19 vaccination: discuss risk-benefit with neurologist; most experts recommend vaccination after recovery",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Transverse myelitis",
        "features": "Sensory level, upper motor neuron signs (hyperreflexia, Babinski), bladder involvement early, MRI spinal cord lesion",
        "tests": "MRI spine (cord signal change); LP (pleocytosis more common); NCS/EMG (normal peripheral nerves)"
      },
      {
        "diagnosis": "Myasthenia gravis",
        "features": "Fatigable weakness, ptosis, diplopia, intact reflexes, fluctuating symptoms, no sensory involvement",
        "tests": "AChR antibodies, repetitive nerve stimulation (decremental), edrophonium test"
      },
      {
        "diagnosis": "Botulism",
        "features": "Descending paralysis (cranial nerves first), pupil involvement, GI prodrome, toxin exposure",
        "tests": "Stool/serum botulinum toxin assay; NCS (incremental response at high-rate repetitive stimulation)"
      },
      {
        "diagnosis": "Tick paralysis",
        "features": "Ascending paralysis similar to GBS; tick found on exam; rapid recovery after tick removal",
        "tests": "Physical exam (search for tick, especially scalp); NCS may show reduced CMAPs; CSF normal"
      },
      {
        "diagnosis": "Spinal cord compression",
        "features": "Back pain, sensory level, upper motor neuron signs below level, bladder dysfunction",
        "tests": "MRI spine (compressive lesion)"
      },
      {
        "diagnosis": "Acute intermittent porphyria",
        "features": "Abdominal pain, psychiatric symptoms, autonomic dysfunction, motor predominant neuropathy, dark urine",
        "tests": "Urine ALA and PBG (elevated during attack)"
      },
      {
        "diagnosis": "Poliomyelitis / West Nile virus",
        "features": "Asymmetric flaccid paralysis, fever, anterior horn cell pattern, CSF pleocytosis",
        "tests": "CSF (elevated WBC); viral PCR; MRI (anterior horn signal)"
      },
      {
        "diagnosis": "CIDP",
        "features": "Similar to GBS but progression >8 weeks, relapsing-remitting course, may respond to steroids",
        "tests": "NCS/EMG (demyelinating); temporal course >8 weeks; steroid response"
      },
      {
        "diagnosis": "Critical illness myopathy/neuropathy",
        "features": "ICU setting, prolonged ventilation, steroid/neuromuscular blocker exposure",
        "tests": "NCS/EMG; CK (elevated in myopathy); clinical context"
      },
      {
        "diagnosis": "Hypokalemia",
        "features": "Diffuse weakness, cardiac arrhythmia, normal reflexes or hyporeflexia",
        "tests": "Serum potassium; ECG; rapid improvement with replacement"
      },
      {
        "diagnosis": "Conversion disorder (FND)",
        "features": "Non-physiologic weakness pattern, Hoover sign, give-way weakness, psychiatric history",
        "tests": "Normal NCS/EMG; normal LP; clinical exam"
      },
      {
        "diagnosis": "Diphtheria",
        "features": "Pharyngeal membrane, palatal weakness, sensorimotor neuropathy weeks after infection",
        "tests": "Throat culture; clinical history"
      },
      {
        "diagnosis": "HIV-associated neuropathy",
        "features": "Progressive, often sensory predominant; CSF pleocytosis distinguishes from GBS",
        "tests": "HIV testing; CSF (WBC >50 suggests HIV, not classic GBS)"
      }
    ],
    "evidence": [
      {
        "recommendation": "IVIG 0.4 g/kg/day x 5 days",
        "evidenceLevel": "Class I, Level A",
        "source": "[Dutch GBS Study Group, NEJM 1992](https://pubmed.ncbi.nlm.nih.gov/1552913/); [Cochrane Review, Hughes 2014](https://pubmed.ncbi.nlm.nih.gov/25238327/)"
      },
      {
        "recommendation": "PLEX (5 exchanges) equivalent to IVIG",
        "evidenceLevel": "Class I, Level A",
        "source": "[French Cooperative Group, Ann Neurol 1987](https://pubmed.ncbi.nlm.nih.gov/2893583/); North American GBS Study"
      },
      {
        "recommendation": "IVIG + PLEX combination NOT superior to either alone",
        "evidenceLevel": "Class I, Level A",
        "source": "[PE/Sandoglobulin GBS Trial Group, Lancet 1997](https://pubmed.ncbi.nlm.nih.gov/9014908/)"
      },
      {
        "recommendation": "Corticosteroids alone NOT effective for GBS",
        "evidenceLevel": "Class I, Level A",
        "source": "[Cochrane Review, Hughes 2016](https://pubmed.ncbi.nlm.nih.gov/27775812/)"
      },
      {
        "recommendation": "IVIG + IV methylprednisolone may shorten recovery (weak evidence)",
        "evidenceLevel": "Class IIb, Level B",
        "source": "[Dutch GBS Study Group, Lancet 2004](https://pubmed.ncbi.nlm.nih.gov/14738791/)"
      },
      {
        "recommendation": "Bedside FVC and NIF for respiratory monitoring",
        "evidenceLevel": "Class I, Level B",
        "source": "[Lawn et al. Arch Neurol 2001](https://pubmed.ncbi.nlm.nih.gov/11405803/)"
      },
      {
        "recommendation": "20/30/40 rule for intubation",
        "evidenceLevel": "Class IIa, Level C",
        "source": "Expert consensus; [Wijdicks & Borel, Neurology 1998](https://pubmed.ncbi.nlm.nih.gov/9443451/)"
      },
      {
        "recommendation": "Avoid succinylcholine in GBS",
        "evidenceLevel": "Class III (Harm)",
        "source": "Risk of hyperkalemia from denervated muscle"
      },
      {
        "recommendation": "Neuropathic pain management (gabapentin, carbamazepine)",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[Pandey et al. Anesth Analg 2002](https://pubmed.ncbi.nlm.nih.gov/12456446/); Cochrane Review"
      },
      {
        "recommendation": "Early rehabilitation improves outcomes",
        "evidenceLevel": "Class I, Level B",
        "source": "[Khan & Amatya, Eur J Phys Rehabil Med 2012](https://pubmed.ncbi.nlm.nih.gov/22820829/); GBS-CIDP Foundation recommendations"
      },
      {
        "recommendation": "DVT prophylaxis",
        "evidenceLevel": "Class I, Level C",
        "source": "Standard of care for immobilized patients"
      },
      {
        "recommendation": "Anti-ganglioside antibodies (diagnostic, not required)",
        "evidenceLevel": "Class IIa, Level B",
        "source": "Diagnostic sensitivity varies by subtype"
      },
      {
        "recommendation": "Brighton criteria for GBS diagnosis",
        "evidenceLevel": "Class IIa, Level C",
        "source": "[Brighton Collaboration, Vaccine 2011](https://pubmed.ncbi.nlm.nih.gov/20600491/)"
      },
      {
        "recommendation": "IgA level before IVIG",
        "evidenceLevel": "Class I, Level C",
        "source": "Standard safety measure"
      },
      {
        "recommendation": "LP with albuminocytologic dissociation",
        "evidenceLevel": "Class I, Level B",
        "source": "Classic diagnostic finding; may be normal in first week"
      }
    ],
    "monitoring": [
      {
        "item": "Forced Vital Capacity (FVC)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "q4-6h in hospital (q2h if declining); q1-2h in ICU if concerning trend",
        "action": "If FVC <20 mL/kg or declining >30% from baseline → elective intubation; transfer to ICU"
      },
      {
        "item": "Negative Inspiratory Force (NIF/MIP)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "q4-6h with FVC",
        "action": "If NIF weaker than -30 cmH2O → prepare for intubation"
      },
      {
        "item": "Peak Cough Flow",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "ROUTINE",
        "frequency": "q4-6h with FVC",
        "action": "Airway clearance interventions; suction; assisted cough"
      },
      {
        "item": "Single Breath Count",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q4h (bedside screening)",
        "action": "If <10-15 → declining respiratory function, correlate with FVC"
      },
      {
        "item": "Oxygen saturation (SpO2)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "Continuous in ICU; q4h on floor",
        "action": "Late finding — do NOT rely on SpO2 alone; FVC is more sensitive"
      },
      {
        "item": "Blood pressure",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q4h on floor; continuous in ICU",
        "action": "If BP lability (swings >20 mmHg): short-acting agents only; avoid long-acting antihypertensives; telemetry"
      },
      {
        "item": "Heart rate and rhythm (telemetry)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "Continuous x 48h minimum; longer if autonomic symptoms",
        "action": "Bradycardia: atropine ready; Tachycardia: volume, pain control; AV block: consider temporary pacing"
      },
      {
        "item": "Neurologic exam (strength, reflexes)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "q4-8h; Hughes GBS disability scale daily",
        "action": "Worsening → repeat FVC/NIF; consider additional immunotherapy"
      },
      {
        "item": "Swallowing function",
        "ED": "URGENT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "Daily assessment; formal SLP if bulbar symptoms",
        "action": "NPO if unsafe; NG or PEG for nutrition"
      },
      {
        "item": "Pain assessment (NRS 0-10)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "q4h with vitals",
        "action": "Adjust pain regimen"
      },
      {
        "item": "Bowel function",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE",
        "frequency": "Daily",
        "action": "Bowel program; avoid ileus (autonomic dysfunction)"
      },
      {
        "item": "Bladder function",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE",
        "frequency": "I/O monitoring; post-void residual if needed",
        "action": "Bladder scan; intermittent catheterization if retention"
      },
      {
        "item": "Renal function (BUN, Cr)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "ROUTINE",
        "frequency": "Daily during IVIG; q48h otherwise",
        "action": "Hold IVIG if rising Cr; hydration"
      },
      {
        "item": "Sodium",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "ROUTINE",
        "frequency": "Daily",
        "action": "SIADH workup if <130; fluid restriction"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Mild GBS (ambulatory without assistance, Hughes 0-2), stable respiratory function (FVC >60% predicted), adequate pain control on oral medications, safe swallowing, reliable outpatient follow-up, family/caregiver support"
      },
      {
        "disposition": "Admit to floor (monitored bed preferred)",
        "criteria": "Any GBS requiring treatment; unable to ambulate independently; FVC 20-30 mL/kg with no downward trend; mild bulbar symptoms; needs IVIG or PLEX"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "FVC <20 mL/kg or declining rapidly; NIF weaker than -30 cmH2O; intubated or imminent intubation; autonomic instability (BP lability, arrhythmia); severe bulbar weakness with aspiration risk; unable to protect airway"
      },
      {
        "disposition": "Transfer to higher level of care",
        "criteria": "Need for PLEX not available on-site; need for ICU with neurology expertise; rapidly progressive course"
      },
      {
        "disposition": "Inpatient rehabilitation",
        "criteria": "Significant motor deficits (unable to walk independently; Hughes 3-4); able to participate in 3h/day therapy; medically stable"
      },
      {
        "disposition": "Skilled nursing facility",
        "criteria": "Unable to tolerate intensive rehabilitation; requires ongoing nursing care; severe deconditioning"
      }
    ]
  },
  "Herpes Simplex Virus Encephalitis": {
    "id": "hsv-encephalitis",
    "title": "Herpes Simplex Virus Encephalitis",
    "version": "1.0",
    "icd10": [
      "** B00.4 (Herpesviral encephalitis)",
      "G05.1 (Encephalitis in diseases classified elsewhere)"
    ],
    "scope": "** Acute HSV-1 encephalitis in adults — the most common cause of sporadic fatal encephalitis. Covers emergent empiric acyclovir, LP with HSV PCR, MRI findings, seizure management, and monitoring for complications (cerebral edema, SIADH, refractory status epilepticus). Excludes neonatal HSV, HSV-2 meningitis (Mollaret), CMV/EBV/VZV encephalitis, and autoimmune encephalitis (though post-HSV autoimmune encephalitis is addressed).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Baseline; infection markers; lymphopenia may be present",
            "target": "Normal or mild leukocytosis"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Renal function for acyclovir dosing (nephrotoxic); electrolytes (SIADH); hepatic function",
            "target": "Normal; watch Na and Cr"
          },
          {
            "item": "Blood cultures x2",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Exclude bacterial meningitis; concurrent bacteremia",
            "target": "No growth"
          },
          {
            "item": "Coagulation panel (PT/INR, aPTT)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Before LP; coagulopathy workup if DIC suspected",
            "target": "Normal"
          },
          {
            "item": "Blood glucose (paired with CSF)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "CSF:serum glucose ratio interpretation",
            "target": "Document paired with LP"
          },
          {
            "item": "Procalcitonin",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Low procalcitonin argues against bacterial meningitis",
            "target": "Low (<0.5 ng/mL favors viral)"
          },
          {
            "item": "CRP",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Inflammatory marker; lower in viral than bacterial",
            "target": "Mild elevation"
          },
          {
            "item": "Serum sodium",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "SIADH is common complication of HSV encephalitis",
            "target": "135-145 mEq/L; watch for hyponatremia"
          },
          {
            "item": "Serum osmolality",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "SIADH evaluation",
            "target": "280-295 mOsm/kg"
          },
          {
            "item": "Type and screen",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Potential surgical intervention for mass effect",
            "target": "On file"
          }
        ],
        "Extended Workup": [
          {
            "item": "HSV-1/2 IgG and IgM (serum)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Seroconversion supports diagnosis; IgG positive in most adults (not diagnostic alone); IgM suggests acute infection",
            "target": "Rising titers on paired sera (acute + convalescent at 2-4 weeks)"
          },
          {
            "item": "HIV 1/2 antigen/antibody",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Immunocompromise affects prognosis and treatment duration",
            "target": "Document result"
          },
          {
            "item": "Urine osmolality and sodium",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "SIADH confirmation (urine osm >100, urine Na >40 with low serum Na)",
            "target": "Evaluate if hyponatremic"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Thyroid dysfunction in encephalopathy differential",
            "target": "Normal"
          },
          {
            "item": "Ammonia",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Hepatic encephalopathy in differential",
            "target": "Normal"
          },
          {
            "item": "Troponin",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Stress cardiomyopathy; myocarditis in systemic viral illness",
            "target": "Normal"
          },
          {
            "item": "Toxicology screen (urine)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Altered mental status differential",
            "target": "Negative"
          },
          {
            "item": "Blood alcohol level",
            "ED": "URGENT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Altered mental status differential",
            "target": "Negative"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Autoimmune encephalitis panel (serum) — NMDAR, LGI1, CASPR2",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "rationale": "Post-HSV autoimmune encephalitis occurs in 20-27% (especially anti-NMDAR); also primary differential",
            "target": "Negative initially; recheck at 2-4 weeks if relapse"
          },
          {
            "item": "Paraneoplastic panel (serum)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If atypical features or oncologic history",
            "target": "Negative"
          },
          {
            "item": "VZV IgG/IgM (serum)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "VZV encephalitis in differential (especially immunocompromised)",
            "target": "Negative"
          },
          {
            "item": "Arboviral serologies (West Nile, EEE, St. Louis)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Geographic/seasonal risk; summer-fall encephalitis",
            "target": "Negative"
          },
          {
            "item": "Rabies antibodies",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Animal exposure history with rapidly progressive encephalitis",
            "target": "Negative"
          },
          {
            "item": "Bartonella serology",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Cat exposure; neuroretinitis",
            "target": "Negative"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Elevated in some cases; monitor for ICP issues",
            "target": "Normal or mildly elevated (usually <300 mm H2O)"
          },
          {
            "item": "Cell count with differential (tubes 1 and 4)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Lymphocytic pleocytosis typical; RBCs may be present (hemorrhagic encephalitis); tube comparison for traumatic tap",
            "target": "WBC 10-500 cells/µL (lymphocyte predominant); RBC may be elevated (hemorrhagic necrosis)"
          },
          {
            "item": "Protein",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Mildly to moderately elevated",
            "target": "Elevated (50-200 mg/dL typical; can be higher)"
          },
          {
            "item": "Glucose with paired serum",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Usually NORMAL in HSV (distinguishes from bacterial/TB/fungal)",
            "target": "Normal (>60% serum glucose ratio); low glucose argues against HSV"
          },
          {
            "item": "HSV-1/2 PCR (CSF)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "GOLD STANDARD diagnostic test; sensitivity 96-98%, specificity ~99%. May be NEGATIVE in first 72h — if clinical suspicion high and initial PCR negative, REPEAT at 3-7 days",
            "target": "Positive (HSV-1 in >90% adult cases; HSV-2 in neonatal/meningitis)"
          },
          {
            "item": "Gram stain and bacterial culture",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Exclude bacterial meningitis",
            "target": "No organisms"
          },
          {
            "item": "BioFire FilmArray ME Panel",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Rapid multiplex PCR — includes HSV-1/2, VZV, enterovirus, CMV, HHV-6, and bacterial pathogens; result in ~1 hour",
            "target": "HSV-1 detected (or other pathogen identified)"
          },
          {
            "item": "VZV PCR (CSF)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "VZV encephalitis in differential; especially immunocompromised and elderly",
            "target": "Negative (positive → VZV encephalitis — treat with IV acyclovir)"
          },
          {
            "item": "CMV PCR (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "If immunocompromised (HIV/transplant)",
            "target": "Negative"
          },
          {
            "item": "EBV PCR (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "If immunocompromised; CNS lymphoma differential",
            "target": "Negative"
          },
          {
            "item": "HHV-6 PCR (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Post-transplant encephalitis; temporal lobe involvement similar to HSV",
            "target": "Negative"
          },
          {
            "item": "Enterovirus PCR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Viral meningitis differential",
            "target": "Negative"
          },
          {
            "item": "Autoimmune encephalitis panel (CSF) — NMDAR, LGI1, CASPR2, GABA-B",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Primary differential diagnosis; also detect post-HSV autoimmune encephalitis",
            "target": "Negative initially; recheck if relapse"
          },
          {
            "item": "Oligoclonal bands, IgG index",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Intrathecal antibody production; MS differential",
            "target": "May be positive (non-specific)"
          },
          {
            "item": "Cytology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Exclude leptomeningeal malignancy",
            "target": "Negative"
          },
          {
            "item": "AFB smear and culture",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "TB meningitis if subacute or basilar",
            "target": "Negative"
          },
          {
            "item": "VDRL (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Neurosyphilis screen",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Immediate — before LP to exclude mass effect; CT may be NORMAL early in HSV encephalitis",
            "target": "Temporal lobe hypodensity, edema, hemorrhage (late); may be normal in first 48-72h",
            "contraindications": "Pregnancy (relative)"
          },
          {
            "item": "MRI brain with and without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Within 24h; STAT if available. MOST SENSITIVE imaging study — abnormal in >90% within 48h",
            "target": "T2/FLAIR hyperintensity in medial temporal lobes (unilateral or bilateral), insular cortex, inferior frontal gyri, cingulate gyrus. DWI restriction in acute phase. Hemorrhagic transformation. Leptomeningeal enhancement",
            "contraindications": "Pacemaker, metallic implants"
          },
          {
            "item": "EEG (routine or continuous)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Within 24h; continuous EEG if altered consciousness",
            "target": "Periodic lateralizing epileptiform discharges (PLEDs/LPDs) from temporal region — highly suggestive of HSV encephalitis; focal slowing; electrographic seizures; diffuse slowing",
            "contraindications": "None significant"
          },
          {
            "item": "ECG (12-lead)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "On admission",
            "target": "Baseline; myocarditis screen; QTc for medication interactions",
            "contraindications": "None"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain with MRA/MRV",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "timing": "If vascular complication suspected",
            "target": "Venous sinus thrombosis; vasculopathy; large vessel occlusion",
            "contraindications": "Same as MRI"
          },
          {
            "item": "Repeat MRI brain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "timing": "At 48-72h if initial MRI negative but suspicion high; at 7-14 days to assess extent of damage",
            "target": "Evolving temporal changes; hemorrhagic transformation; extent of necrosis",
            "contraindications": "Same as MRI"
          },
          {
            "item": "Continuous EEG (cEEG) monitoring",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "24-72h minimum if altered consciousness, seizures, or post-ictal state",
            "target": "Non-convulsive seizures, non-convulsive status epilepticus (NCSE), PLEDs",
            "contraindications": "None"
          },
          {
            "item": "Chest X-ray",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "On admission",
            "target": "Aspiration; baseline for ventilator management",
            "contraindications": "None"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Brain biopsy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT",
            "timing": "Only if: PCR negative, MRI atypical, no response to acyclovir, alternative diagnosis likely",
            "target": "Cowdry type A inclusions; viral culture; PCR on tissue",
            "contraindications": "Neurosurgical risk; coagulopathy"
          },
          {
            "item": "PET-CT brain",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If autoimmune encephalitis relapse suspected post-HSV",
            "target": "Mesial temporal hypermetabolism (seizure focus) or hypometabolism",
            "contraindications": "Pregnancy"
          },
          {
            "item": "ICP monitoring (EVD)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "If clinical signs of elevated ICP; declining GCS despite treatment",
            "target": "ICP <22 mmHg; CPP >60",
            "contraindications": "Coagulopathy"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Acyclovir IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg",
                  "orderSentence": "Acyclovir IV 10 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV q8h (infuse over 1h). Base on IDEAL body weight (IBW). Duration: minimum 14-21 days. Dose adjust for renal impairment: CrCl 25-50: 10 mg/kg q12h; CrCl 10-25: 10 mg/kg q24h; HD: 10 mg/kg after each dialysis session",
              "orderSentence": "Acyclovir IV 10 mg/kg IV"
            },
            "contraindications": "True acyclovir allergy (extremely rare). Renal impairment — dose adjust, do NOT withhold",
            "monitoring": "Renal function (BUN, Cr) daily; ensure adequate hydration (1-1.5 mL/kg/h IV fluids); urine output; acyclovir crystal nephropathy (maintain urine output); CBC (rare neutropenia); LFTs",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "IV normal saline (aggressive hydration)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-1.5 mL/kg",
                  "orderSentence": "IV normal saline (aggressive hydration) 1-1.5 mL/kg -"
                }
              ],
              "route": "-",
              "instructions": "1-1.5 mL/kg/h continuous to prevent acyclovir nephrotoxicity; bolus 500-1000 mL if dehydrated",
              "orderSentence": "IV normal saline (aggressive hydration) 1-1.5 mL/kg -"
            },
            "contraindications": "Volume overload, CHF",
            "monitoring": "I/O; Cr daily; urine output >0.5 mL/kg/h",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Empiric antibiotics (vancomycin + ceftriaxone)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Standard meningitis dosing. Continue until bacterial meningitis excluded by CSF results (Gram stain negative, BioFire negative, cultures negative at 48-72h). See Bacterial Meningitis template for dosing",
              "orderSentence": "Empiric antibiotics (vancomycin + ceftriaxone) - - - see dosing"
            },
            "contraindications": "See Bacterial Meningitis template",
            "monitoring": "Standard",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Dexamethasone",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.15 mg/kg",
                  "orderSentence": "Dexamethasone 0.15 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.15 mg/kg IV q6h x 4 days — give empirically with antibiotics until bacterial meningitis excluded. Discontinue when bacterial excluded. Role in HSV encephalitis itself is CONTROVERSIAL — some evidence for reducing edema but no clear mortality benefit; not standard of care for isolated HSV",
              "orderSentence": "Dexamethasone 0.15 mg/kg IV"
            },
            "contraindications": "Uncontrolled infection (relative)",
            "monitoring": "Glucose; GI prophylaxis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Levetiracetam (if seizures)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000-1500 mg",
                  "orderSentence": "Levetiracetam (if seizures) 1000-1500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1000-1500 mg IV load; then 500-1000 mg IV/PO BID; max 3000 mg/day. Seizures occur in 40-60% of HSV encephalitis",
              "orderSentence": "Levetiracetam (if seizures) 1000-1500 mg IV"
            },
            "contraindications": "Severe renal impairment (dose adjust)",
            "monitoring": "Renal function; behavioral side effects",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Lorazepam (seizure rescue)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg/kg",
                  "orderSentence": "Lorazepam (seizure rescue) 0.1 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.1 mg/kg IV (max 4 mg); repeat x1 in 5 min if needed",
              "orderSentence": "Lorazepam (seizure rescue) 0.1 mg/kg IV"
            },
            "contraindications": "Respiratory depression",
            "monitoring": "RR, SpO2; airway equipment ready",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Supplemental oxygen",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "94%",
                  "orderSentence": "Supplemental oxygen 94% -"
                }
              ],
              "route": "-",
              "instructions": "If SpO2 <94% or intubated",
              "orderSentence": "Supplemental oxygen 94% -"
            },
            "contraindications": "N/A",
            "monitoring": "SpO2 target ≥94%",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Acetaminophen",
            "route": "IV",
            "indication": "Fever (temperature goal <38°C); headache",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650-1000 mg",
                  "orderSentence": "Acetaminophen 650-1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "650-1000 mg PO/IV q6h; max 4g/day",
              "orderSentence": "Acetaminophen 650-1000 mg IV"
            },
            "contraindications": "Severe hepatic disease",
            "monitoring": "Temperature; LFTs",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Mannitol 20%",
            "route": "IV",
            "indication": "Cerebral edema / elevated ICP",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-1.5 g/kg",
                  "orderSentence": "Mannitol 20% 1-1.5 g/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "1-1.5 g/kg IV bolus; then 0.25-0.5 g/kg q4-6h",
              "orderSentence": "Mannitol 20% 1-1.5 g/kg IV"
            },
            "contraindications": "Anuria",
            "monitoring": "Serum osm <320; renal function; I/O",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Hypertonic saline 23.4%",
            "route": "IV",
            "indication": "Acute herniation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mL",
                  "orderSentence": "Hypertonic saline 23.4% 30 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "30 mL IV via central line over 10-20 min",
              "orderSentence": "Hypertonic saline 23.4% 30 mL IV"
            },
            "contraindications": "No central access",
            "monitoring": "Na (target 145-155); osmolality",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Hypertonic saline 3% infusion",
            "route": "-",
            "indication": "ICP management (less acute)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5-1 mL/kg",
                  "orderSentence": "Hypertonic saline 3% infusion 0.5-1 mL/kg -"
                }
              ],
              "route": "-",
              "instructions": "0.5-1 mL/kg/h continuous; target Na 145-155",
              "orderSentence": "Hypertonic saline 3% infusion 0.5-1 mL/kg -"
            },
            "contraindications": "Hypernatremia",
            "monitoring": "Na q4-6h; osmolality",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Phenytoin/Fosphenytoin",
            "route": "IV",
            "indication": "Refractory seizures (second-line after levetiracetam)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "Phenytoin/Fosphenytoin 20 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Fosphenytoin 20 mg PE/kg IV at 150 mg PE/min; maintenance 100 mg PE q8h; target level 10-20 µg/mL",
              "orderSentence": "Phenytoin/Fosphenytoin 20 mg IV"
            },
            "contraindications": "Bradycardia, heart block, hypotension (infusion rate-related)",
            "monitoring": "Continuous telemetry during load; free phenytoin level; LFTs",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Lacosamide",
            "route": "IV",
            "indication": "Seizure management (adjunctive)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mg",
                  "orderSentence": "Lacosamide 200 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "200 mg IV/PO load; then 100-200 mg BID; max 400 mg/day",
              "orderSentence": "Lacosamide 200 mg IV"
            },
            "contraindications": "PR prolongation, AV block",
            "monitoring": "ECG; PR interval",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Ondansetron",
            "route": "IV",
            "indication": "Nausea/vomiting",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg",
                  "orderSentence": "Ondansetron 4 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "4 mg IV/PO q6h PRN",
              "orderSentence": "Ondansetron 4 mg IV"
            },
            "contraindications": "QT prolongation",
            "monitoring": "QTc",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Pantoprazole",
            "route": "IV",
            "indication": "GI prophylaxis (if steroids or critical illness)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Pantoprazole 40 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "40 mg IV/PO daily",
              "orderSentence": "Pantoprazole 40 mg IV"
            },
            "contraindications": "C. diff risk long-term",
            "monitoring": "GI symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Enoxaparin",
            "route": "SC",
            "indication": "DVT prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Enoxaparin 40 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily (start when not actively seizing and no hemorrhagic transformation)",
              "orderSentence": "Enoxaparin 40 mg SC"
            },
            "contraindications": "Active bleeding, hemorrhagic transformation, coagulopathy, platelets <50K",
            "monitoring": "Platelets q3 days",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pneumatic compression devices",
            "route": "-",
            "indication": "DVT prophylaxis",
            "dosing": {
              "instructions": "Apply bilaterally on admission",
              "orderSentence": "Pneumatic compression devices - - - see dosing"
            },
            "contraindications": "Acute DVT",
            "monitoring": "Skin checks",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Fluid restriction",
            "route": "-",
            "indication": "SIADH management",
            "dosing": {
              "instructions": "1-1.2 L/day if Na <130 with clinical SIADH",
              "orderSentence": "Fluid restriction - - - see dosing"
            },
            "contraindications": "Dehydration (balance with acyclovir hydration needs)",
            "monitoring": "Na q6-8h; urine osm/Na; I/O",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Foscarnet IV (acyclovir-resistant HSV)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg/kg",
                  "orderSentence": "Foscarnet IV (acyclovir-resistant HSV) 60 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "60 mg/kg IV q8h or 90 mg/kg IV q12h; infuse over 1-2h with aggressive hydration. For proven or suspected acyclovir resistance (immunocompromised, HIV)",
              "orderSentence": "Foscarnet IV (acyclovir-resistant HSV) 60 mg/kg IV"
            },
            "contraindications": "Renal failure (major nephrotoxin); electrolyte abnormalities",
            "monitoring": "Cr daily; Ca, Mg, K, PO4 BID (causes severe electrolyte wasting); hydration 1-2 L NS before each dose",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT"
          },
          {
            "item": "Decompressive craniectomy",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "For malignant cerebral edema with impending herniation, unresponsive to medical ICP management; consider if age appropriate and prognosis not already dismal",
              "orderSentence": "Decompressive craniectomy - - - see dosing"
            },
            "contraindications": "Bilateral massive necrosis; moribund patient",
            "monitoring": "Post-op neuro checks; ICP monitoring; wound care",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Immunotherapy for post-HSV autoimmune encephalitis",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1g/day",
                  "orderSentence": "Immunotherapy for post-HSV autoimmune encephalitis 1g/day IV"
                }
              ],
              "route": "IV",
              "instructions": "If relapse at 2-6 weeks with new anti-NMDAR antibodies: IV methylprednisolone 1g/day x 5 days + IVIG 0.4 g/kg/day x 5 days; second-line: rituximab",
              "orderSentence": "Immunotherapy for post-HSV autoimmune encephalitis 1g/day IV"
            },
            "contraindications": "Active HSV infection (ensure viral replication controlled)",
            "monitoring": "NMDAR antibody titers; clinical response; viral PCR to confirm HSV not reactivated",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consultation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "All suspected encephalitis; seizure management; EEG interpretation; post-HSV autoimmune evaluation"
          },
          {
            "item": "Infectious disease consultation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Antimicrobial management; acyclovir-resistant HSV; duration of therapy"
          },
          {
            "item": "Neurosurgery consultation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Cerebral edema with mass effect; ICP monitoring (EVD placement); decompressive craniectomy"
          },
          {
            "item": "Critical care/ICU",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Altered consciousness (GCS <12); respiratory failure; ICP management; status epilepticus"
          },
          {
            "item": "Speech-language pathology (SLP)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Dysphagia evaluation; aphasia assessment (temporal lobe involvement); cognitive-communication evaluation"
          },
          {
            "item": "Physical therapy (PT)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Early mobilization; prevent deconditioning; gait/balance training"
          },
          {
            "item": "Occupational therapy (OT)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "ADL assessment; cognitive rehabilitation; memory aids"
          },
          {
            "item": "Neuropsychology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Cognitive assessment (memory deficits common with temporal lobe damage); rehabilitation planning"
          },
          {
            "item": "Psychiatry",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Behavioral changes; depression; anxiety; personality changes (frontal/temporal damage)"
          },
          {
            "item": "Rehabilitation medicine (physiatry)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Rehabilitation planning; disposition (inpatient rehab, SNF)"
          },
          {
            "item": "Social work",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Family support; discharge planning; long-term care needs"
          },
          {
            "item": "Epilepsy specialist",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Post-encephalitis epilepsy management; temporal lobe epilepsy"
          },
          {
            "item": "Palliative care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "indication": "Goals of care for severe cases; prognostication"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return to ED if: new confusion, seizure, fever recurrence, worsening headache, personality change, speech difficulty, new weakness",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "HSV encephalitis can cause long-term memory and cognitive deficits; rehabilitation is important",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Seizures may develop weeks to months after infection; report any episodic symptoms (staring, jerking, déjà vu, loss of awareness)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Post-HSV autoimmune encephalitis can occur 2-6 weeks later with new psychiatric/neurologic symptoms — report immediately",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take all medications as prescribed; do NOT stop antiepileptic drugs without neurologist guidance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Follow-up with neurology in 2-4 weeks; neuropsychology testing at 3-6 months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cognitive rehabilitation and therapy are critical for recovery",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Driving restrictions until seizure-free per state law (typically 3-12 months)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "HSV encephalitis is NOT contagious in the traditional sense; no isolation needed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Long-term suppressive antiviral therapy is NOT standard after encephalitis (unlike genital HSV)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cognitive rehabilitation: memory strategies, organizational tools, speech therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Seizure safety: avoid heights, swimming alone, operating heavy machinery until seizure-free",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Mental health support (depression, anxiety, PTSD common after encephalitis)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate sleep and stress management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Gradual return to work/school with accommodations as needed",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Autoimmune encephalitis (anti-NMDAR)",
        "features": "Subacute; psychiatric symptoms (psychosis, agitation); orofacial dyskinesias; seizures; young women; often post-HSV",
        "tests": "Anti-NMDAR antibody (CSF > serum); MRI may be normal or temporal; ovarian teratoma screen"
      },
      {
        "diagnosis": "Bacterial meningitis",
        "features": "Fever + meningismus; CSF neutrophilic pleocytosis with low glucose; more acute; no temporal preference on imaging",
        "tests": "CSF Gram stain, culture, BioFire; procalcitonin elevated; CSF glucose low"
      },
      {
        "diagnosis": "Viral meningitis (enterovirus)",
        "features": "Headache + fever + meningismus; LESS confusion/focal deficits; CSF lymphocytic but fewer WBC; MRI normal",
        "tests": "Enterovirus PCR (CSF); BioFire panel; normal MRI"
      },
      {
        "diagnosis": "VZV encephalitis",
        "features": "Immunocompromised; may have rash (but not always); vasculopathy pattern on MRI; cranial neuropathies",
        "tests": "VZV PCR (CSF); VZV IgG intrathecal antibody"
      },
      {
        "diagnosis": "Temporal lobe seizures / Status epilepticus",
        "features": "Seizures may cause MRI signal change in temporal lobes mimicking encephalitis; fever if convulsive SE",
        "tests": "EEG; HSV PCR negative; MRI DWI pattern; clinical course"
      },
      {
        "diagnosis": "Limbic encephalitis (paraneoplastic: LGI1, GABA-B)",
        "features": "Subacute memory loss, seizures, psychiatric changes; often >40 years; associated malignancy",
        "tests": "Antibody panel (serum + CSF); CT chest/abdomen/pelvis; PET-CT"
      },
      {
        "diagnosis": "Cerebral venous thrombosis",
        "features": "Headache, seizures, focal deficits; papilledema; risk factors (OCPs, hypercoagulable)",
        "tests": "MRV; CT venogram; D-dimer"
      },
      {
        "diagnosis": "Brain abscess",
        "features": "Focal symptoms + fever; ring-enhancing lesion; subacute",
        "tests": "MRI with contrast (ring enhancement, restricted DWI centrally); blood cultures"
      },
      {
        "diagnosis": "Acute disseminated encephalomyelitis (ADEM)",
        "features": "Post-infectious; multifocal white matter lesions; children > adults",
        "tests": "MRI (multifocal white matter); clinical context"
      },
      {
        "diagnosis": "Tuberculosis meningitis",
        "features": "Subacute (weeks); basilar meningitis; CSF low glucose, lymphocytic, very high protein",
        "tests": "AFB culture; TB PCR; ADA; chest imaging"
      },
      {
        "diagnosis": "Neurosyphilis",
        "features": "Subacute; psychiatric symptoms; pupillary abnormalities; history of STI",
        "tests": "CSF VDRL; FTA-ABS; RPR"
      },
      {
        "diagnosis": "Primary CNS lymphoma",
        "features": "Immunocompromised; progressive focal deficits; periventricular enhancing lesion",
        "tests": "MRI with contrast; CSF cytology; EBV PCR (CSF); brain biopsy"
      }
    ],
    "evidence": [
      {
        "recommendation": "IV acyclovir 10 mg/kg q8h x 14-21 days",
        "evidenceLevel": "Class I, Level A",
        "source": "Whitley et al. (NEJM 1986) — acyclovir vs placebo landmark trial; reduced mortality from 70% to 20%"
      },
      {
        "recommendation": "Start acyclovir empirically; do NOT delay for diagnostics",
        "evidenceLevel": "Class I, Level A",
        "source": "IDSA Encephalitis Guidelines (Tunkel et al. CID 2008); every hour of delay worsens outcomes"
      },
      {
        "recommendation": "CSF HSV PCR as gold standard (sensitivity 96-98%)",
        "evidenceLevel": "Class I, Level A",
        "source": "Lakeman & Whitley (JID 1995)"
      },
      {
        "recommendation": "Repeat HSV PCR if initially negative with high clinical suspicion",
        "evidenceLevel": "Class I, Level B",
        "source": "False negative rate ~5% in first 72h; Roullet (2007)"
      },
      {
        "recommendation": "MRI with DWI is most sensitive imaging",
        "evidenceLevel": "Class I, Level A",
        "source": "Sensitivity >90% within 48h; temporal lobe predilection"
      },
      {
        "recommendation": "EEG showing PLEDs supports diagnosis",
        "evidenceLevel": "Class IIa, Level B",
        "source": "Periodic lateralizing discharges in ~80% of HSV encephalitis"
      },
      {
        "recommendation": "Post-HSV autoimmune encephalitis (anti-NMDAR) in 20-27%",
        "evidenceLevel": "Class IIa, Level B",
        "source": "Armangue et al. (Lancet Neurol 2014); Prüss et al. (Ann Neurol 2012)"
      },
      {
        "recommendation": "Dexamethasone for HSV encephalitis: NOT standard of care",
        "evidenceLevel": "Class IIb, Level C",
        "source": "DexEnceph trial (ongoing); animal data supportive; no clear human mortality benefit"
      },
      {
        "recommendation": "Foscarnet for acyclovir-resistant HSV",
        "evidenceLevel": "Class IIa, Level C",
        "source": "Expert consensus; primarily in immunocompromised"
      },
      {
        "recommendation": "Aggressive hydration to prevent acyclovir nephrotoxicity",
        "evidenceLevel": "Class I, Level B",
        "source": "Well-established; crystal nephropathy prevention"
      },
      {
        "recommendation": "Empiric bacterial coverage until excluded",
        "evidenceLevel": "Class I, Level A",
        "source": "Standard practice; cannot clinically distinguish bacterial meningitis from encephalitis at presentation"
      },
      {
        "recommendation": "Repeat LP at end of treatment to confirm PCR negativity",
        "evidenceLevel": "Class IIa, Level C",
        "source": "Expert consensus; immunocompromised patients especially"
      },
      {
        "recommendation": "14-day treatment minimum; 21 days for severe/immunocompromised",
        "evidenceLevel": "Class I, Level B",
        "source": "IDSA Guidelines; relapse rate higher with <14 days"
      }
    ],
    "monitoring": [
      {
        "item": "GCS / Neurologic exam",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "q1h x 24h, then q2h x 48h, then q4h",
        "action": "If declining: STAT CT; ICP assessment; consider EVD"
      },
      {
        "item": "Temperature",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q4h (q1h if febrile)",
        "action": "Acetaminophen; cooling measures; reassess if persistent fever >72h on acyclovir"
      },
      {
        "item": "Serum sodium",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "q6-8h x 48h, then q12h",
        "action": "If <130: SIADH → fluid restriction (balance with acyclovir hydration); if <120: 3% saline"
      },
      {
        "item": "Serum creatinine",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "Daily (twice daily if rising)",
        "action": "If rising: increase hydration; consider dose adjustment; hold if severe (rare); monitor urine output"
      },
      {
        "item": "BUN",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "ROUTINE",
        "frequency": "Daily",
        "action": "Dehydration; renal impairment"
      },
      {
        "item": "Urine output",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q1h in ICU; q4h shift on floor",
        "action": "Increase IV fluids; if oliguria: renal assessment"
      },
      {
        "item": "Seizure monitoring (EEG)",
        "ED": "-",
        "HOSP": "URGENT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "cEEG 24-72h if altered consciousness; routine EEG daily if improving",
        "action": "If seizures: load/adjust AEDs; if NCSE: aggressive treatment per SE protocol"
      },
      {
        "item": "Blood pressure",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q1-4h based on severity",
        "action": "Fluids; vasopressors if septic"
      },
      {
        "item": "Oxygen saturation",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "Continuous in ICU; q4h on floor",
        "action": "Supplemental O2; intubation if respiratory failure"
      },
      {
        "item": "Repeat MRI brain",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE",
        "frequency": "At 48-72h (evolution); day 7-14 (extent of damage); 3-6 months (chronic changes)",
        "action": "If worsening edema: ICP management; neurosurgery consult"
      },
      {
        "item": "Repeat LP (HSV PCR)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "ROUTINE",
        "frequency": "At end of treatment (day 14-21) to confirm PCR negativity; earlier if clinical suspicion of treatment failure",
        "action": "If still positive: extend acyclovir 7+ more days; consider resistance"
      },
      {
        "item": "Autoimmune antibodies (follow-up)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Recheck at 2-4 weeks if relapse or new psychiatric/neurologic symptoms",
        "action": "If positive (especially NMDAR): immunotherapy protocol"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "NOT appropriate directly from ED for suspected HSV encephalitis — always admit. Discharge from hospital when: completing IV acyclovir course (or transitioned to monitoring); improved consciousness (GCS 15); no active seizures; stable neurologic exam; safe swallowing; rehabilitation arranged; follow-up confirmed"
      },
      {
        "disposition": "Admit to floor (monitored bed)",
        "criteria": "Mild encephalitis (GCS 13-15); stable; low seizure burden; able to cooperate with neuro checks"
      },
      {
        "disposition": "Admit to ICU / Neuro-ICU",
        "criteria": "GCS <13; active seizures or status epilepticus; need for continuous EEG; respiratory compromise; signs of elevated ICP; hemodynamic instability"
      },
      {
        "disposition": "Transfer to higher level",
        "criteria": "Need for neuro-ICU not available; need for neurosurgery (decompressive craniectomy); continuous EEG not available"
      },
      {
        "disposition": "Inpatient rehabilitation",
        "criteria": "Moderate-severe cognitive deficits (memory impairment, aphasia); motor deficits; able to participate in 3h/day therapy"
      },
      {
        "disposition": "Skilled nursing facility",
        "criteria": "Unable to tolerate intensive rehabilitation; requires ongoing nursing care"
      }
    ]
  },
  "Idiopathic Intracranial Hypertension": {
    "id": "idiopathic-intracranial-hypertension",
    "title": "Idiopathic Intracranial Hypertension",
    "version": "1.0",
    "icd10": [
      "** G93.2 (Benign intracranial hypertension)",
      "G93.5 (Compression of brain)"
    ],
    "scope": "** Evaluation and management of idiopathic intracranial hypertension in adults including diagnosis, medical management, and surgical interventions. Applies to ED, hospital, and outpatient settings. Excludes secondary causes of elevated ICP.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "rationale": "Anemia (can cause papilledema); baseline",
            "target": "Normal"
          },
          {
            "item": "CMP",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "rationale": "Renal function (for acetazolamide); electrolytes",
            "target": "Normal"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypothyroidism/hyperthyroidism can cause ICP",
            "target": "Normal"
          },
          {
            "item": "Vitamin A level",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypervitaminosis A",
            "target": "Normal"
          },
          {
            "item": "Pregnancy test",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Pregnancy considerations for treatment",
            "target": "Document"
          }
        ],
        "Extended Workup": [
          {
            "item": "Opening pressure",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diagnostic criterion; ≥25 cm H2O in adults",
            "target": "Elevated (≥25 cm H2O)"
          },
          {
            "item": "CSF cell count",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out meningitis",
            "target": "Normal (≤5 WBC/μL)"
          },
          {
            "item": "CSF protein",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out meningitis, malignancy",
            "target": "Normal (≤45 mg/dL)"
          },
          {
            "item": "CSF glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out infection",
            "target": "Normal (>60% serum)"
          },
          {
            "item": "Cytology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If malignancy suspected",
            "target": "Negative"
          },
          {
            "item": "Cultures",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "If infection suspected",
            "target": "Negative"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Iron studies",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Iron deficiency anemia associated",
            "target": "Normal"
          },
          {
            "item": "Cortisol (AM or stimulation test)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Adrenal insufficiency; steroid withdrawal",
            "target": "Normal"
          },
          {
            "item": "ANA, dsDNA",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "SLE (cerebral venous thrombosis risk)",
            "target": "Negative"
          },
          {
            "item": "Hypercoagulability panel",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If venous sinus thrombosis suspected",
            "target": "Normal"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI brain with and without contrast + MRV",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Before LP; rule out mass, CVT",
            "target": "No mass; may show empty sella, flattened globes, optic nerve sheath distension, transverse sinus stenosis",
            "contraindications": "Pacemaker, metal"
          },
          {
            "item": "CT head (if MRI unavailable)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-",
            "timing": "Emergent exclusion of mass",
            "target": "No mass, hemorrhage",
            "contraindications": "None (contrast: renal)"
          },
          {
            "item": "CT venography",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "timing": "If MRV inconclusive for CVT",
            "target": "No venous sinus thrombosis",
            "contraindications": "Renal disease; contrast allergy"
          }
        ],
        "Extended": [
          {
            "item": "Dilated fundoscopic exam",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "All patients; before LP if possible",
            "target": "Papilledema grading (Frisen scale)",
            "contraindications": "None"
          },
          {
            "item": "Optical coherence tomography (OCT)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Quantify RNFL thickness; follow progression",
            "target": "Baseline RNFL; monitor for atrophy",
            "contraindications": "None"
          },
          {
            "item": "Automated perimetry (visual fields)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Detect visual field defects; monitor",
            "target": "Document defects; enlarged blind spot",
            "contraindications": "None"
          },
          {
            "item": "Visual acuity",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "Baseline and monitoring",
            "target": "20/20 or stable",
            "contraindications": "None"
          },
          {
            "item": "Color vision testing",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Optic nerve function",
            "target": "Normal",
            "contraindications": "None"
          },
          {
            "item": "Fundus photography",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Document papilledema; follow",
            "target": "Baseline; monitor",
            "contraindications": "None"
          }
        ]
      },
      "Treatment": {
        "Weight Management (Cornerstone for Obese Patients)": [
          {
            "item": "Weight loss (diet/lifestyle)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10%",
                  "orderSentence": "Weight loss (diet/lifestyle) 10% -"
                }
              ],
              "route": "-",
              "instructions": "Target 5-10% body weight loss; improves ICP",
              "orderSentence": "Weight loss (diet/lifestyle) 10% -"
            },
            "contraindications": "None",
            "monitoring": "Weight; symptoms; visual function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Bariatric surgery referral",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Consider if BMI >35 with comorbidities; effective for IIH",
              "orderSentence": "Bariatric surgery referral - - - see dosing"
            },
            "contraindications": "Per surgical criteria",
            "monitoring": "Weight; ICP",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nutrition/dietitian referral",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Structured weight loss program",
              "orderSentence": "Nutrition/dietitian referral - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Progress",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "First-Line Medical Therapy": [
          {
            "item": "Acetazolamide (Diamox)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Acetazolamide (Diamox) 500 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "500 mg BID; titrate to 2-4 g/day as tolerated; IIHTT used up to 4 g/day",
              "orderSentence": "Acetazolamide (Diamox) 500 mg PO"
            },
            "contraindications": "Sulfa allergy, severe renal/hepatic disease, hypokalemia",
            "monitoring": "K+, bicarb, renal function q1-3 months; paresthesias (expected); fatigue, dysgeusia",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Potassium supplementation",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20-40 mEq",
                  "orderSentence": "Potassium supplementation 20-40 mEq -"
                }
              ],
              "route": "-",
              "instructions": "20-40 mEq daily; PRN based on K+ level",
              "orderSentence": "Potassium supplementation 20-40 mEq -"
            },
            "contraindications": "Renal failure, hyperkalemia",
            "monitoring": "K+ levels",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-Line/Adjunctive Medical Therapy": [
          {
            "item": "Topiramate",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Topiramate 25 mg -"
                }
              ],
              "route": "-",
              "instructions": "25 mg BID; titrate to 50-100 mg BID; also promotes weight loss",
              "orderSentence": "Topiramate 25 mg -"
            },
            "contraindications": "Nephrolithiasis, glaucoma, pregnancy",
            "monitoring": "Weight; cognitive effects; metabolic acidosis",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Furosemide (add-on)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20-40 mg",
                  "orderSentence": "Furosemide (add-on) 20-40 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "20-40 mg daily; if acetazolamide insufficient alone",
              "orderSentence": "Furosemide (add-on) 20-40 mg PO"
            },
            "contraindications": "Sulfa allergy (cross-reactivity uncommon), severe dehydration",
            "monitoring": "K+, renal function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Headache Management": [
          {
            "item": "Acetazolamide (treats underlying cause)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Per above",
              "orderSentence": "Acetazolamide (treats underlying cause) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "Per above",
            "monitoring": "Per above",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Analgesics (acute)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "NSAIDs, acetaminophen PRN; avoid opioids",
              "orderSentence": "Analgesics (acute) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "NSAID: GI/renal issues",
            "monitoring": "Limit use to prevent MOH",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Migraine prophylaxis (if comorbid)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Topiramate (dual benefit); beta-blockers, amitriptyline",
              "orderSentence": "Migraine prophylaxis (if comorbid) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "Per medication",
            "monitoring": "Per medication",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Therapeutic Lumbar Puncture": [
          {
            "item": "Large-volume LP",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20-40 mL",
                  "orderSentence": "Large-volume LP 20-40 mL -"
                }
              ],
              "route": "-",
              "instructions": "Remove 20-40 mL CSF; immediate symptom relief",
              "orderSentence": "Large-volume LP 20-40 mL -"
            },
            "contraindications": "Mass lesion, coagulopathy, infection at site",
            "monitoring": "Headache, symptoms; temporary benefit",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Serial LPs",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Bridge to surgery or when medical therapy insufficient",
              "orderSentence": "Serial LPs - - - see dosing"
            },
            "contraindications": "Same",
            "monitoring": "Same; not long-term solution",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Surgical Interventions (Vision-Threatening or Refractory)": [
          {
            "item": "Optic nerve sheath fenestration (ONSF)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Incision in optic nerve sheath; protects vision; does not reduce ICP",
              "orderSentence": "Optic nerve sheath fenestration (ONSF) - - - see dosing"
            },
            "contraindications": "Severe optic atrophy (relative)",
            "monitoring": "Visual fields, acuity post-op",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF shunting (VP or LP shunt)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Ventriculoperitoneal or lumboperitoneal shunt; reduces ICP and headache",
              "orderSentence": "CSF shunting (VP or LP shunt) - - - see dosing"
            },
            "contraindications": "Infection, peritoneal pathology",
            "monitoring": "Shunt function; revision rate high (50%+)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venous sinus stenting",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Stent transverse sinus stenosis; emerging therapy",
              "orderSentence": "Venous sinus stenting - - - see dosing"
            },
            "contraindications": "No significant stenosis; venous anatomy",
            "monitoring": "ICP; stent patency; headache",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Fulminant IIH (Urgent Vision Loss)": [
          {
            "item": "High-dose IV acetazolamide",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "High-dose IV acetazolamide 500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "500 mg IV q6h initially",
              "orderSentence": "High-dose IV acetazolamide 500 mg IV"
            },
            "contraindications": "Per above",
            "monitoring": "K+, bicarb",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Emergent therapeutic LP",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Large-volume LP; may repeat daily",
              "orderSentence": "Emergent therapeutic LP - - - see dosing"
            },
            "contraindications": "Mass lesion, coagulopathy",
            "monitoring": "Symptoms, vision",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Urgent surgical referral",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "ONSF or shunt within days",
              "orderSentence": "Urgent surgical referral - - - see dosing"
            },
            "contraindications": "Per procedure",
            "monitoring": "Vision",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "IV steroids (controversial)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg",
                  "orderSentence": "IV steroids (controversial) 250 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Methylprednisolone 250 mg IV q6h; short-term bridge only; can worsen IIH long-term",
              "orderSentence": "IV steroids (controversial) 250 mg IV"
            },
            "contraindications": "Contraindicated for maintenance",
            "monitoring": "Glucose; short-term only",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neuro-ophthalmology",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "All patients; diagnosis, monitoring, management"
          },
          {
            "item": "Neurology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Headache management; atypical cases"
          },
          {
            "item": "Neurosurgery",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Fulminant IIH; shunt evaluation"
          },
          {
            "item": "Interventional neuroradiology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Venous sinus stenting evaluation"
          },
          {
            "item": "Ophthalmology",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "If neuro-ophthalmology unavailable"
          },
          {
            "item": "Bariatric surgery",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Obese patients; BMI >35"
          },
          {
            "item": "Nutrition/dietitian",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Weight loss counseling"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "IIH is a chronic condition requiring ongoing monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Weight loss is critical for long-term management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take acetazolamide as prescribed; stay hydrated",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report new visual symptoms immediately (blurred vision, double vision, vision loss)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report worsening headache, nausea/vomiting, pulsatile tinnitus",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid medications that can worsen IIH (vitamin A, tetracyclines)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep all ophthalmology appointments; visual field testing is critical",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "IIH Research Foundation (ihrfoundation.org) for resources",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Cerebral venous thrombosis",
        "features": "Acute headache; hypercoagulable state; may have focal signs",
        "tests": "MRV, CT venography"
      },
      {
        "diagnosis": "Meningitis (infectious or carcinomatous)",
        "features": "Fever, meningismus, abnormal CSF",
        "tests": "CSF analysis, cultures, cytology"
      },
      {
        "diagnosis": "Intracranial mass (tumor, abscess)",
        "features": "Focal signs; mass on imaging",
        "tests": "MRI with contrast"
      },
      {
        "diagnosis": "Hydrocephalus",
        "features": "Enlarged ventricles; gait, cognition changes",
        "tests": "MRI/CT"
      },
      {
        "diagnosis": "Medication-induced ICP elevation",
        "features": "History of causative medication",
        "tests": "History; resolve after discontinuation"
      },
      {
        "diagnosis": "Sleep apnea",
        "features": "Nocturnal headaches; daytime somnolence; may coexist",
        "tests": "Sleep study"
      },
      {
        "diagnosis": "Systemic hypertension (hypertensive encephalopathy)",
        "features": "Severely elevated BP; may cause papilledema",
        "tests": "BP measurement"
      },
      {
        "diagnosis": "Optic neuritis",
        "features": "Unilateral vision loss; pain with eye movement; no papilledema initially",
        "tests": "MRI orbits; OCT"
      },
      {
        "diagnosis": "Hypervitaminosis A",
        "features": "History of vitamin A/retinoid use",
        "tests": "Vitamin A level"
      },
      {
        "diagnosis": "Anemia (severe)",
        "features": "Can cause papilledema without true ICP elevation",
        "tests": "CBC"
      }
    ],
    "evidence": [
      {
        "recommendation": "Acetazolamide effective for IIH",
        "evidenceLevel": "Class I, Level A",
        "source": "IIHTT (Idiopathic Intracranial Hypertension Treatment Trial)"
      },
      {
        "recommendation": "Weight loss improves IIH",
        "evidenceLevel": "Class II, Level B",
        "source": "Multiple studies; IIHTT secondary analysis"
      },
      {
        "recommendation": "ONSF protects vision in IIH",
        "evidenceLevel": "Class III, Level B",
        "source": "Case series; observational data"
      },
      {
        "recommendation": "CSF shunting reduces ICP and headache",
        "evidenceLevel": "Class III, Level B",
        "source": "Case series; high revision rate noted"
      },
      {
        "recommendation": "Venous sinus stenting emerging therapy",
        "evidenceLevel": "Class III, Level C",
        "source": "Growing evidence; case series"
      },
      {
        "recommendation": "Modified Dandy criteria for diagnosis",
        "evidenceLevel": "Expert consensus",
        "source": "Friedman et al., 2013"
      },
      {
        "recommendation": "Topiramate as adjunct with weight loss benefit",
        "evidenceLevel": "Class III, Level C",
        "source": "Observational data"
      }
    ],
    "monitoring": [
      {
        "item": "Visual acuity",
        "ED": "STAT",
        "HOSP": "Daily",
        "OPD": "Every visit",
        "ICU": "STAT",
        "frequency": "Ongoing",
        "action": "Escalate treatment"
      },
      {
        "item": "Visual fields (perimetry)",
        "ED": "-",
        "HOSP": "Daily (if fulminant)",
        "OPD": "q1-3 months",
        "ICU": "-",
        "frequency": "Per risk",
        "action": "Escalate treatment"
      },
      {
        "item": "Papilledema grade (Frisen)",
        "ED": "STAT",
        "HOSP": "Daily",
        "OPD": "Every visit",
        "ICU": "STAT",
        "frequency": "Ongoing",
        "action": "Continue treatment"
      },
      {
        "item": "OCT (RNFL thickness)",
        "ED": "-",
        "HOSP": "Baseline",
        "OPD": "q3-6 months",
        "ICU": "-",
        "frequency": "Per schedule",
        "action": "Indicates chronic damage"
      },
      {
        "item": "Weight",
        "ED": "-",
        "HOSP": "Weekly",
        "OPD": "Every visit",
        "ICU": "-",
        "frequency": "Ongoing",
        "action": "Reinforce; consider bariatric"
      },
      {
        "item": "Potassium",
        "ED": "-",
        "HOSP": "Daily initially",
        "OPD": "q1-3 months",
        "ICU": "-",
        "frequency": "On acetazolamide",
        "action": "Supplement"
      },
      {
        "item": "Bicarbonate",
        "ED": "-",
        "HOSP": "Daily initially",
        "OPD": "q1-3 months",
        "ICU": "-",
        "frequency": "On acetazolamide",
        "action": "May need dose reduction"
      },
      {
        "item": "Creatinine",
        "ED": "-",
        "HOSP": "Baseline",
        "OPD": "q3-6 months",
        "ICU": "-",
        "frequency": "On acetazolamide",
        "action": "Adjust dose if impaired"
      },
      {
        "item": "Headache severity",
        "ED": "ROUTINE",
        "HOSP": "Daily",
        "OPD": "Every visit",
        "ICU": "-",
        "frequency": "Ongoing",
        "action": "Optimize treatment"
      }
    ],
    "disposition": [
      {
        "disposition": "Outpatient management",
        "criteria": "Mild-moderate symptoms; stable vision; reliable follow-up"
      },
      {
        "disposition": "Admit to hospital",
        "criteria": "New diagnosis with significant papilledema; fulminant IIH; progressive vision loss; unable to tolerate oral medications"
      },
      {
        "disposition": "ICU admission",
        "criteria": "Rarely needed; severe headache requiring IV therapy; post-operative monitoring"
      },
      {
        "disposition": "Neuro-ophthalmology follow-up",
        "criteria": "q2-4 weeks initially; q1-3 months when stable"
      },
      {
        "disposition": "Urgent follow-up",
        "criteria": "Any decline in vision; worsening headache; medication intolerance"
      }
    ]
  },
  "Intracerebral Hemorrhage (ICH)": {
    "id": "intracerebral-hemorrhage",
    "title": "Intracerebral Hemorrhage (ICH)",
    "version": "1.0",
    "icd10": [
      "** I61.9 (Nontraumatic intracerebral hemorrhage",
      "unspecified)",
      "I61.0 (ICH in hemisphere",
      "subcortical)",
      "I61.1 (ICH in hemisphere",
      "cortical)",
      "I61.3 (ICH in brain stem)",
      "I61.4 (ICH in cerebellum)"
    ],
    "scope": "** Spontaneous (non-traumatic) intracerebral hemorrhage in adults. Covers acute BP management, anticoagulant reversal, ICH score and prognosis, ICP management, surgical indications, etiology workup, and secondary prevention. Excludes traumatic ICH, subarachnoid hemorrhage (separate template), hemorrhagic transformation of ischemic stroke, and subdural/epidural hematomas.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Baseline; thrombocytopenia as cause or complication; transfusion needs",
            "target": "Platelets >100,000 (>50,000 minimum for hemostasis)"
          },
          {
            "item": "PT/INR",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Warfarin-related ICH requires emergent reversal; coagulopathy assessment",
            "target": "INR <1.4 target (if elevated: REVERSE IMMEDIATELY)"
          },
          {
            "item": "aPTT",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Heparin-related ICH; coagulopathy",
            "target": "Normal"
          },
          {
            "item": "Fibrinogen",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "DIC; consumptive coagulopathy; tPA-related hemorrhage",
            "target": ">150 mg/dL (if <150: give cryoprecipitate)"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Electrolytes; renal function for contrast/medication; hepatic function for coagulopathy",
            "target": "Normal"
          },
          {
            "item": "Blood glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Hyperglycemia worsens ICH outcomes; hypoglycemia mimics stroke",
            "target": "140-180 mg/dL target"
          },
          {
            "item": "Type and screen / crossmatch",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Potential need for blood products, surgery, reversal agents",
            "target": "On file; crossmatch if OR likely"
          },
          {
            "item": "Troponin",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Neurogenic cardiac injury (stress cardiomyopathy); concurrent ACS",
            "target": "Normal"
          },
          {
            "item": "Blood alcohol level",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Coagulopathy; exam reliability; alcoholism is ICH risk factor",
            "target": "Document result"
          },
          {
            "item": "Urine drug screen",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Cocaine/amphetamine-associated ICH (sympathomimetic surge)",
            "target": "Negative"
          },
          {
            "item": "Pregnancy test (β-hCG)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Affects management (eclampsia differential; imaging)",
            "target": "Document result"
          },
          {
            "item": "Thrombin time (TT) and/or ecarin clotting time (ECT)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Dabigatran (direct thrombin inhibitor) detection; if patient on DOACs",
            "target": "Normal (prolonged = dabigatran present)"
          },
          {
            "item": "Anti-Xa level (calibrated for specific DOAC)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Rivaroxaban/apixaban/edoxaban detection; guides reversal need",
            "target": "Negative/undetectable (elevated = DOAC present and active)"
          }
        ],
        "Extended Workup": [
          {
            "item": "Lipid panel",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Cardiovascular risk; statin decision (controversial post-ICH)",
            "target": "Document baseline"
          },
          {
            "item": "HbA1c",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes management",
            "target": "<7.0%"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Thyroid dysfunction",
            "target": "Normal"
          },
          {
            "item": "ESR / CRP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Vasculitis screen; inflammatory etiology",
            "target": "Normal"
          },
          {
            "item": "D-dimer",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "DIC; venous thromboembolism",
            "target": "Normal"
          },
          {
            "item": "Serum osmolality",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "Monitor during osmotherapy (mannitol/hypertonic saline)",
            "target": "280-320 mOsm/kg; hold osmotherapy if >320"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Hypercoagulable panel",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Young patient ICH without clear etiology; cerebral venous thrombosis with secondary hemorrhage",
            "target": "Normal"
          },
          {
            "item": "ANA, ANCA",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "CNS vasculitis-related hemorrhage",
            "target": "Negative"
          },
          {
            "item": "Toxicology (expanded)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "rationale": "Sympathomimetic drug use; synthetic drug-associated hemorrhage",
            "target": "Negative"
          },
          {
            "item": "Amyloid-beta PET",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Cerebral amyloid angiopathy (CAA) confirmation; research context",
            "target": "Positive amyloid deposition in lobar distribution"
          },
          {
            "item": "APOE genotype",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "CAA risk stratification; APOE ε2/ε4 associated with ICH",
            "target": "Document alleles"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Door-to-CT <25 minutes; determines ICH diagnosis, location, volume, IVH, hydrocephalus, midline shift",
            "target": "Hemorrhage location (deep: basal ganglia/thalamus = hypertensive; lobar: CAA, tumor, AVM), volume (ABC/2 method), intraventricular hemorrhage (IVH), hydrocephalus, midline shift >5mm",
            "contraindications": "Pregnancy (benefit outweighs risk)"
          },
          {
            "item": "CT angiography (CTA) head",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "With initial CT; identify \"spot sign\" (active contrast extravasation = hematoma expansion risk), underlying vascular malformation (AVM, aneurysm)",
            "target": "Spot sign (30-50% risk of expansion); AVM; aneurysm; dural AV fistula; Moyamoya",
            "contraindications": "Contrast allergy; renal impairment (benefit outweighs risk in emergency)"
          },
          {
            "item": "ECG (12-lead)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Baseline; neurogenic cardiac injury; arrhythmia; QTc prolongation risk",
            "target": "Normal; ST changes may be neurogenic",
            "contraindications": "None"
          },
          {
            "item": "Repeat CT head (non-contrast)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "At 6h and 24h OR any neurologic decline; assess for hematoma expansion (>33% or >6mL increase from baseline = significant expansion)",
            "target": "Stable hematoma size; no new hemorrhage; no hydrocephalus progression",
            "contraindications": "Same as initial"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain with and without contrast (include GRE/SWI sequences)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Within 24-72h when stable; or urgently if underlying mass/AVM suspected",
            "target": "Underlying tumor; cavernous malformation; microbleeds (CAA pattern: lobar; hypertensive: deep). SWI shows microhemorrhages",
            "contraindications": "Pacemaker; hemodynamic instability; MRI-incompatible monitoring"
          },
          {
            "item": "MR venography (MRV)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "timing": "If cerebral venous thrombosis (CVT) suspected as cause of hemorrhagic venous infarct",
            "target": "Venous sinus thrombosis",
            "contraindications": "Same as MRI"
          },
          {
            "item": "Conventional cerebral angiography (DSA)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "EXT",
            "ICU": "URGENT",
            "timing": "Young patient (<50) with lobar ICH and no clear etiology; suspected AVM/aneurysm where CTA inconclusive; negative initial CTA but high suspicion",
            "target": "AVM; aneurysm; dural AV fistula; Moyamoya; vasculitis",
            "contraindications": "Contrast allergy; renal impairment; coagulopathy"
          },
          {
            "item": "Delayed DSA (if initial negative)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Repeat at 3-6 months; small AVM may be compressed by acute hematoma and missed initially",
            "target": "Unmasked AVM/aneurysm",
            "contraindications": "Same as initial DSA"
          },
          {
            "item": "Echocardiogram",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "timing": "Neurogenic cardiac injury; baseline cardiac function; endocarditis if mycotic aneurysm suspected",
            "target": "LV dysfunction; stress cardiomyopathy",
            "contraindications": "None significant"
          },
          {
            "item": "Continuous EEG (cEEG)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "If altered consciousness disproportionate to hemorrhage size; suspected seizures",
            "target": "Non-convulsive seizures; NCSE (seen in 20-30% of ICH patients)",
            "contraindications": "None"
          },
          {
            "item": "Chest X-ray",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "Aspiration; pulmonary edema (neurogenic); baseline for ventilator",
            "target": "Normal",
            "contraindications": "None"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Brain biopsy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If underlying tumor, vasculitis, or amyloid angiopathy suspected and non-invasive workup inconclusive",
            "target": "Tumor; vasculitis; amyloid",
            "contraindications": "Surgical risk"
          },
          {
            "item": "Amyloid PET scan",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "CAA diagnosis in lobar ICH with microbleeds",
            "target": "Amyloid deposition",
            "contraindications": "Research/limited availability"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Blood pressure reduction: Nicardipine IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg/h",
                  "orderSentence": "Blood pressure reduction: Nicardipine IV 5 mg/h IV"
                }
              ],
              "route": "IV",
              "instructions": "5 mg/h IV; increase by 2.5 mg/h q5-15min; max 15 mg/h. Target SBP 130-150 mmHg (INTERACT2: <140 safe; AHA 2022: <140 reasonable if presenting SBP 150-220)",
              "orderSentence": "Blood pressure reduction: Nicardipine IV 5 mg/h IV"
            },
            "contraindications": "Severe aortic stenosis; advanced HF",
            "monitoring": "Continuous arterial line BP; neuro checks with each change; avoid SBP <110 (renal hypoperfusion)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Blood pressure reduction: Labetalol IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-20 mg",
                  "orderSentence": "Blood pressure reduction: Labetalol IV 10-20 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10-20 mg IV bolus over 1-2 min; may repeat or double q10min; max 300 mg. Alternative to nicardipine",
              "orderSentence": "Blood pressure reduction: Labetalol IV 10-20 mg IV"
            },
            "contraindications": "Heart block (2nd/3rd degree); severe bradycardia; decompensated HF; asthma",
            "monitoring": "HR; BP continuous",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Blood pressure reduction: Clevidipine IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2 mg/h",
                  "orderSentence": "Blood pressure reduction: Clevidipine IV 1-2 mg/h IV"
                }
              ],
              "route": "IV",
              "instructions": "1-2 mg/h IV; titrate by doubling q90sec initially; max 32 mg/h",
              "orderSentence": "Blood pressure reduction: Clevidipine IV 1-2 mg/h IV"
            },
            "contraindications": "Soy/egg allergy; lipid disorders",
            "monitoring": "BP continuous",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Intubation and airway protection",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "GCS ≤8; inability to protect airway; respiratory failure; impending herniation. Use non-depolarizing agents; avoid succinylcholine if elevated ICP (relative)",
              "orderSentence": "Intubation and airway protection - - - see dosing"
            },
            "contraindications": "N/A",
            "monitoring": "Ventilator; head of bed 30°; avoid hyperventilation unless herniation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Warfarin reversal: 4-factor PCC (Kcentra)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-50 units/kg",
                  "orderSentence": "Warfarin reversal: 4-factor PCC (Kcentra) 25-50 units/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "25-50 units/kg IV (dose based on INR: INR 2-4: 25 u/kg; INR 4-6: 35 u/kg; INR >6: 50 u/kg); infuse over 10-15 min. Reverses INR within 15-30 min. PREFERRED over FFP (faster, smaller volume)",
              "orderSentence": "Warfarin reversal: 4-factor PCC (Kcentra) 25-50 units/kg IV"
            },
            "contraindications": "Active DIC (relative); HIT (contains heparin traces)",
            "monitoring": "INR 15 min after infusion; repeat if INR >1.4; thrombotic risk",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Warfarin reversal: Vitamin K (phytonadione)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Warfarin reversal: Vitamin K (phytonadione) 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg IV slow push (over 10 min) to sustain INR correction (PCC is temporary). ALWAYS give WITH PCC",
              "orderSentence": "Warfarin reversal: Vitamin K (phytonadione) 10 mg IV"
            },
            "contraindications": "Known severe allergic reaction (rare)",
            "monitoring": "INR at 6h and 24h; anaphylaxis risk (rare with slow IV)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Warfarin reversal: FFP (if PCC unavailable)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-15 mL/kg",
                  "orderSentence": "Warfarin reversal: FFP (if PCC unavailable) 10-15 mL/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "10-15 mL/kg IV (typically 2-4 units). Slower than PCC; requires thawing and larger volume",
              "orderSentence": "Warfarin reversal: FFP (if PCC unavailable) 10-15 mL/kg IV"
            },
            "contraindications": "Volume overload; transfusion reactions",
            "monitoring": "INR; volume status",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Dabigatran reversal: Idarucizumab (Praxbind)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 g",
                  "orderSentence": "Dabigatran reversal: Idarucizumab (Praxbind) 5 g IV"
                }
              ],
              "route": "IV",
              "instructions": "5 g IV (two 2.5g boluses or infusions). Specific reversal agent for dabigatran. Reversal within minutes",
              "orderSentence": "Dabigatran reversal: Idarucizumab (Praxbind) 5 g IV"
            },
            "contraindications": "None absolute",
            "monitoring": "Thrombin time (TT), aPTT; clinical hemostasis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Factor Xa inhibitor reversal: Andexanet alfa (Andexxa)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg",
                  "orderSentence": "Factor Xa inhibitor reversal: Andexanet alfa (Andexxa) 400 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "For rivaroxaban/apixaban. Low-dose: 400 mg IV bolus then 4 mg/min x 2h (last dose >8h ago). High-dose: 800 mg IV bolus then 8 mg/min x 2h (last dose <8h ago or unknown, or rivaroxaban)",
              "orderSentence": "Factor Xa inhibitor reversal: Andexanet alfa (Andexxa) 400 mg IV"
            },
            "contraindications": "Thrombotic risk (10-15% VTE in trials)",
            "monitoring": "Anti-Xa levels; thrombosis monitoring; arterial line",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Factor Xa inhibitor reversal: 4-factor PCC (if andexanet unavailable)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 units/kg",
                  "orderSentence": "Factor Xa inhibitor reversal: 4-factor PCC (if andexanet unavailable) 50 units/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "50 units/kg IV. Off-label but supported by guidelines if andexanet not available",
              "orderSentence": "Factor Xa inhibitor reversal: 4-factor PCC (if andexanet unavailable) 50 units/kg IV"
            },
            "contraindications": "Same as PCC",
            "monitoring": "Anti-Xa levels; clinical hemostasis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Heparin reversal: Protamine sulfate",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg",
                  "orderSentence": "Heparin reversal: Protamine sulfate 1 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1 mg per 100 units of heparin given in last 2-3h; max 50 mg; give slow IV over 10 min",
              "orderSentence": "Heparin reversal: Protamine sulfate 1 mg IV"
            },
            "contraindications": "Fish/protamine allergy",
            "monitoring": "aPTT; BP (hypotension with rapid infusion); anaphylaxis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Platelet transfusion",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 unit",
                  "orderSentence": "Platelet transfusion 1 unit -"
                }
              ],
              "route": "-",
              "instructions": "1 unit apheresis platelets if platelet count <100,000 AND active bleeding or pre-surgical. For antiplatelet-associated ICH: PATCH trial showed NO benefit from routine platelet transfusion (do NOT transfuse if platelets >100K on antiplatelet therapy)",
              "orderSentence": "Platelet transfusion 1 unit -"
            },
            "contraindications": "HIT; ITP (consult hematology)",
            "monitoring": "Platelet count; clinical hemostasis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Tranexamic acid (TXA)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 g",
                  "orderSentence": "Tranexamic acid (TXA) 1 g IV"
                }
              ],
              "route": "IV",
              "instructions": "1 g IV over 10 min then 1 g IV over 8h. TICH-2 trial: did NOT reduce mortality but reduced hematoma expansion. Not routine; consider if spot sign positive or early presentation with active expansion",
              "orderSentence": "Tranexamic acid (TXA) 1 g IV"
            },
            "contraindications": "Active DVT/PE; hypercoagulable state",
            "monitoring": "Thrombotic events; clinical hemostasis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "ICP management: Head of bed elevation",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "HOB 30°; head in midline (optimize venous drainage); avoid neck flexion/compression",
              "orderSentence": "ICP management: Head of bed elevation - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "ICP if monitored",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "ICP management: Mannitol 20%",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-1.5 g/kg",
                  "orderSentence": "ICP management: Mannitol 20% 1-1.5 g/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "1-1.5 g/kg IV bolus for acute herniation; 0.25-0.5 g/kg q4-6h maintenance",
              "orderSentence": "ICP management: Mannitol 20% 1-1.5 g/kg IV"
            },
            "contraindications": "Anuria; serum osm >320",
            "monitoring": "Serum osm q4-6h; osmolar gap; Cr; I/O",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "ICP management: Hypertonic saline 23.4%",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mL",
                  "orderSentence": "ICP management: Hypertonic saline 23.4% 30 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "30 mL IV bolus via central line over 10-20 min for acute herniation",
              "orderSentence": "ICP management: Hypertonic saline 23.4% 30 mL IV"
            },
            "contraindications": "No central access",
            "monitoring": "Na (target 145-155); osmolality",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "ICP management: Hypertonic saline 3%",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150-500 mL",
                  "orderSentence": "ICP management: Hypertonic saline 3% 150-500 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "150-500 mL bolus or 0.5-1 mL/kg/h infusion; target Na 145-155",
              "orderSentence": "ICP management: Hypertonic saline 3% 150-500 mL IV"
            },
            "contraindications": "Hypernatremia >160",
            "monitoring": "Na q4-6h; osmolality",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Levetiracetam",
            "route": "IV",
            "indication": "Seizure treatment (NOT routine prophylaxis — AHA 2022 recommends against routine prophylaxis). Treat if clinical or electrographic seizures",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000-1500 mg",
                  "orderSentence": "Levetiracetam 1000-1500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1000-1500 mg IV load; then 500-1000 mg IV/PO BID",
              "orderSentence": "Levetiracetam 1000-1500 mg IV"
            },
            "contraindications": "Severe renal impairment (dose adjust)",
            "monitoring": "Seizure monitoring; cEEG; renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Acetaminophen",
            "route": "IV",
            "indication": "Fever (target normothermia <37.5°C; fever worsens ICH outcomes)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650-1000 mg",
                  "orderSentence": "Acetaminophen 650-1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "650-1000 mg PO/IV q6h; max 4g/day",
              "orderSentence": "Acetaminophen 650-1000 mg IV"
            },
            "contraindications": "Severe hepatic disease",
            "monitoring": "Temperature q4h; LFTs",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Surface cooling / Arctic Sun",
            "route": "-",
            "indication": "Refractory fever (targeted temperature management)",
            "dosing": {
              "instructions": "Target 36-37°C; avoid shivering (counterproductive)",
              "orderSentence": "Surface cooling / Arctic Sun - - - see dosing"
            },
            "contraindications": "N/A",
            "monitoring": "Core temperature; shivering assessment (BSAS)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Insulin (regular)",
            "route": "IV",
            "indication": "Hyperglycemia (target 140-180 mg/dL)",
            "dosing": {
              "instructions": "Sliding scale or insulin drip",
              "orderSentence": "Insulin (regular) - IV - see dosing"
            },
            "contraindications": "Hypoglycemia",
            "monitoring": "BG q1h if drip; q6h if sliding scale",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Pantoprazole",
            "route": "IV",
            "indication": "GI prophylaxis (Cushing ulcer risk from elevated ICP)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Pantoprazole 40 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "40 mg IV/PO daily",
              "orderSentence": "Pantoprazole 40 mg IV"
            },
            "contraindications": "C. diff risk",
            "monitoring": "GI symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Enoxaparin",
            "route": "SC",
            "indication": "DVT prophylaxis (start 24-48h after hemorrhage stabilizes; after repeat CT shows stability)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Enoxaparin 40 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily. AHA 2022: intermittent pneumatic compression devices on admission; pharmacologic prophylaxis after hemorrhage stable on repeat imaging",
              "orderSentence": "Enoxaparin 40 mg SC"
            },
            "contraindications": "Active hemorrhagic expansion; within 24h of ICH onset; pre-surgical",
            "monitoring": "Platelet count; repeat CT before starting",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pneumatic compression devices",
            "route": "-",
            "indication": "DVT prophylaxis (start IMMEDIATELY)",
            "dosing": {
              "instructions": "Apply bilaterally on admission; ICH patients are HIGH VTE risk",
              "orderSentence": "Pneumatic compression devices - - - see dosing"
            },
            "contraindications": "Acute DVT",
            "monitoring": "Skin checks",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Ondansetron",
            "route": "IV",
            "indication": "Nausea/vomiting (posterior fossa hemorrhage; elevated ICP)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg",
                  "orderSentence": "Ondansetron 4 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "4 mg IV q6h PRN",
              "orderSentence": "Ondansetron 4 mg IV"
            },
            "contraindications": "QT prolongation",
            "monitoring": "QTc",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Surgical Interventions": [
          {
            "item": "External ventricular drain (EVD)",
            "route": "-",
            "indication": "IVH with acute hydrocephalus; GCS declining; need for ICP monitoring",
            "dosing": {
              "instructions": "Neurosurgery places; allows CSF drainage and ICP monitoring; target ICP <22, CPP >60",
              "orderSentence": "External ventricular drain (EVD) - - - see dosing"
            },
            "contraindications": "Coagulopathy (correct first); futile care",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Intraventricular tPA via EVD",
            "route": "-",
            "indication": "IVH with hydrocephalus (CLEAR III trial: reduced mortality in severe IVH but did NOT improve functional outcome)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg",
                  "orderSentence": "Intraventricular tPA via EVD 1 mg -"
                }
              ],
              "route": "-",
              "instructions": "Alteplase 1 mg q8h via EVD; up to 12 doses; clamp EVD 1h after dosing then open to drain",
              "orderSentence": "Intraventricular tPA via EVD 1 mg -"
            },
            "contraindications": "Active systemic bleeding; coagulopathy",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Surgical hematoma evacuation (craniotomy)",
            "route": "-",
            "indication": "Lobar ICH >30 mL with deterioration; cerebellar hemorrhage >3 cm OR with brainstem compression/hydrocephalus (STRONGEST surgical indication). STICH/STICH-II: no clear benefit for supratentorial deep ICH",
            "dosing": {
              "instructions": "Craniotomy or craniectomy for clot evacuation",
              "orderSentence": "Surgical hematoma evacuation (craniotomy) - - - see dosing"
            },
            "contraindications": "Deep ICH (generally no benefit from open surgery); GCS 3-4 without brainstem reflexes (futile); severe coagulopathy",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Minimally invasive surgery (MIS) — endoscopic or stereotactic aspiration",
            "route": "-",
            "indication": "Supratentorial ICH >30 mL with stable or mild deficits (MISTIE III, ENRICH trials: emerging data; ENRICH showed benefit for lobar ICH)",
            "dosing": {
              "instructions": "Stereotactic catheter-based aspiration or endoscopic evacuation with lower morbidity than craniotomy",
              "orderSentence": "Minimally invasive surgery (MIS) — endoscopic or stereotactic aspiration - - - see dosing"
            },
            "contraindications": "Deep location (relative); coagulopathy",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Decompressive craniectomy",
            "route": "-",
            "indication": "Massive ICH with refractory elevated ICP; malignant cerebellar edema",
            "dosing": {
              "instructions": "Bone flap removal to allow brain expansion",
              "orderSentence": "Decompressive craniectomy - - - see dosing"
            },
            "contraindications": "Futile prognosis; bilateral fixed dilated pupils",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Suboccipital decompressive craniectomy",
            "route": "-",
            "indication": "Cerebellar hemorrhage with brainstem compression",
            "dosing": {
              "instructions": "Posterior fossa decompression; life-saving for cerebellar ICH with brainstem compression",
              "orderSentence": "Suboccipital decompressive craniectomy - - - see dosing"
            },
            "contraindications": "Moribund patient",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Secondary Prevention (After Acute Phase)": [
          {
            "item": "Antihypertensive therapy (long-term)",
            "route": "PO",
            "indication": "ALL ICH patients; BP is most important modifiable risk factor",
            "dosing": {
              "instructions": "Target SBP <130 mmHg (SPS3 trial, PROGRESS trial); agent choice per comorbidities (ACE-I, ARB, CCB, thiazide)",
              "orderSentence": "Antihypertensive therapy (long-term) - PO - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "Home BP monitoring; clinic BP",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Statin (controversial post-ICH)",
            "route": "PO",
            "indication": "Risk-benefit discussion; SPARCL showed small increased ICH risk with atorvastatin but overall cardiovascular benefit. AHA 2022: statin not contraindicated after ICH",
            "dosing": {
              "instructions": "Per cardiovascular risk; individualize",
              "orderSentence": "Statin (controversial post-ICH) - PO - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "Lipid panel",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Anticoagulation restart (if AF or mechanical valve)",
            "route": "PO",
            "indication": "Most controversial decision. AHA 2022: may restart anticoagulation at 4-8 weeks for patients with strong indication (AF with high CHA2DS2-VASc). Avoid in CAA-related lobar ICH if possible",
            "dosing": {
              "instructions": "Apixaban preferred (APACHE-AF trial: lowest ICH recurrence). Timing: 4-8 weeks; individualized risk-benefit",
              "orderSentence": "Anticoagulation restart (if AF or mechanical valve) - PO - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "Imaging stability; bleeding risk; CHA2DS2-VASc vs HAS-BLED",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Antiplatelet restart",
            "route": "PO",
            "indication": "RESTART trial: restarting antiplatelet after ICH is associated with LOWER risk of recurrent ICH; may restart at 2-4 weeks for patients with cardiovascular indication",
            "dosing": {
              "doseOptions": [
                {
                  "text": "81 mg",
                  "orderSentence": "Antiplatelet restart 81 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Aspirin 81 mg or clopidogrel 75 mg daily",
              "orderSentence": "Antiplatelet restart 81 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "Bleeding signs",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Left atrial appendage occlusion (LAAO/Watchman)",
            "route": "Procedure",
            "indication": "AF patients who cannot tolerate long-term anticoagulation post-ICH (lobar ICH, CAA)",
            "dosing": {
              "instructions": "Interventional cardiology procedure; eliminates need for long-term anticoagulation in AF",
              "orderSentence": "Left atrial appendage occlusion (LAAO/Watchman) - Procedure - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "Procedural risks",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurosurgery",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "ALL ICH patients; surgical decision for EVD, hematoma evacuation, decompression"
          },
          {
            "item": "Neurology / Neurocritical care",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Medical management; BP optimization; ICP management; seizure management"
          },
          {
            "item": "Hematology",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Anticoagulant reversal guidance; coagulopathy management; thrombocytopenia"
          },
          {
            "item": "Pharmacy (clinical pharmacist)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Reversal agent dosing; anticoagulant identification; drug interactions"
          },
          {
            "item": "Cardiology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "indication": "AF management; anticoagulation restart decision; LAAO evaluation; neurogenic cardiac injury"
          },
          {
            "item": "Speech-language pathology (SLP)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Dysphagia screening before PO intake; aphasia assessment"
          },
          {
            "item": "Physical therapy (PT)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Early mobilization (24-48h if stable); fall prevention; strength"
          },
          {
            "item": "Occupational therapy (OT)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "ADL assessment; cognitive rehabilitation; adaptive equipment"
          },
          {
            "item": "Rehabilitation medicine (physiatry)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Rehabilitation disposition; functional prognosis"
          },
          {
            "item": "Social work",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Family support; advance directives; discharge planning"
          },
          {
            "item": "Palliative care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "indication": "Goals of care discussion (especially ICH score ≥3); early palliative involvement improves care quality"
          },
          {
            "item": "Interventional neuroradiology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "indication": "AVM/aneurysm treatment planning; dural AV fistula"
          }
        ],
        "Patient Instructions": [
          {
            "item": "ICH is serious but outcomes vary; early aggressive treatment improves survival",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Call 911 if: sudden headache, new weakness, speech changes, altered consciousness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Blood pressure control is the MOST IMPORTANT factor in preventing recurrence",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take all medications as prescribed; never stop blood pressure medications without physician guidance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do NOT restart anticoagulation or antiplatelet without specific neurology/cardiology guidance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Home blood pressure monitoring daily; keep log; target per physician guidance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Follow-up with neurology in 2-4 weeks; neurosurgery if applicable",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do NOT drive until cleared",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Fall prevention at home",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Blood pressure target <130/80 mmHg (most important)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation (doubles ICH risk)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Alcohol cessation or limitation (heavy drinking increases ICH risk)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cocaine/amphetamine cessation (sympathomimetic ICH)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid excessive anticoagulation (keep INR in range if on warfarin)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular exercise (moderate intensity after recovery)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Weight management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "DASH or Mediterranean diet",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Depression screening (PHQ-9 at 1-3 months)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Hemorrhagic transformation of ischemic stroke",
        "features": "Prior ischemic infarct on imaging; onset timing suggests ischemic → hemorrhagic evolution",
        "tests": "CT/MRI timing; DWI changes preceding hemorrhage"
      },
      {
        "diagnosis": "Cerebral venous thrombosis (CVT) with hemorrhagic infarct",
        "features": "Headache, seizures, often young women (OCPs, pregnancy); hemorrhage doesn't respect arterial territory; parasagittal location",
        "tests": "MRV/CT venography (thrombosed sinus); D-dimer"
      },
      {
        "diagnosis": "Brain tumor with hemorrhage",
        "features": "Subacute symptoms preceding hemorrhage; ring enhancement around hemorrhage; disproportionate edema",
        "tests": "MRI with contrast (underlying enhancing mass); biopsy"
      },
      {
        "diagnosis": "Cerebral amyloid angiopathy (CAA)",
        "features": "Lobar location (NOT deep); age >55; recurrent lobar hemorrhages; cortical superficial siderosis; multiple lobar microbleeds on SWI",
        "tests": "MRI SWI (lobar microbleeds, superficial siderosis); Boston criteria"
      },
      {
        "diagnosis": "Vascular malformation (AVM, cavernoma)",
        "features": "Younger patient; recurrent hemorrhages at same location; AVM on CTA/DSA; cavernoma on MRI (popcorn appearance)",
        "tests": "CTA; DSA; MRI (especially SWI)"
      },
      {
        "diagnosis": "Ruptured aneurysm extending into parenchyma",
        "features": "Subarachnoid + intraparenchymal hemorrhage; near aneurysm location",
        "tests": "CTA (aneurysm); DSA"
      },
      {
        "diagnosis": "Hypertensive ICH",
        "features": "Deep location (putamen, thalamus, pons, cerebellum); history of poorly controlled HTN",
        "tests": "Clinical; typical location; no underlying lesion on workup"
      },
      {
        "diagnosis": "Moyamoya disease",
        "features": "Young adults or Asian patients; recurrent stroke; stenotic proximal vessels with collateral network",
        "tests": "MRA (ICA/MCA stenosis with Moyamoya collaterals); DSA"
      },
      {
        "diagnosis": "Coagulopathy-related ICH",
        "features": "Multiple hemorrhages; known coagulopathy or anticoagulant use",
        "tests": "Coagulation panel; medication history"
      },
      {
        "diagnosis": "Mycotic aneurysm",
        "features": "Endocarditis; distal vessel location; fever",
        "tests": "Blood cultures; echocardiogram; CTA/DSA"
      },
      {
        "diagnosis": "Trauma",
        "features": "History of trauma; scalp laceration; subdural or epidural components",
        "tests": "Clinical history; CT pattern"
      }
    ],
    "evidence": [
      {
        "recommendation": "SBP target <140 mmHg in acute ICH (presenting SBP 150-220)",
        "evidenceLevel": "Class I, Level A",
        "source": "INTERACT2 (Anderson et al. NEJM 2013); AHA/ASA 2022 Guidelines"
      },
      {
        "recommendation": "Intensive BP lowering safe but benefit on functional outcome modest",
        "evidenceLevel": "Class IIa, Level A",
        "source": "ATACH-2 (Qureshi et al. NEJM 2016) — <140 vs <180 safe; no functional difference"
      },
      {
        "recommendation": "4-factor PCC preferred over FFP for warfarin reversal",
        "evidenceLevel": "Class I, Level B",
        "source": "INCH trial (Steiner et al. Lancet Neurol 2016)"
      },
      {
        "recommendation": "Idarucizumab for dabigatran reversal",
        "evidenceLevel": "Class I, Level B",
        "source": "RE-VERSE AD trial (Pollack et al. NEJM 2017)"
      },
      {
        "recommendation": "Andexanet alfa for factor Xa inhibitor reversal",
        "evidenceLevel": "Class IIa, Level B",
        "source": "ANNEXA-4 (Connolly et al. NEJM 2019)"
      },
      {
        "recommendation": "Platelet transfusion NOT beneficial for antiplatelet-associated ICH",
        "evidenceLevel": "Class III (No Benefit)",
        "source": "PATCH trial (Baharoglu et al. Lancet 2016)"
      },
      {
        "recommendation": "TXA reduces expansion but NOT mortality",
        "evidenceLevel": "Class IIb, Level B",
        "source": "TICH-2 (Sprigg et al. Lancet 2018)"
      },
      {
        "recommendation": "Surgical evacuation for cerebellar ICH with deterioration",
        "evidenceLevel": "Class I, Level B",
        "source": "AHA/ASA Guidelines; strong consensus"
      },
      {
        "recommendation": "No benefit from routine supratentorial open surgery",
        "evidenceLevel": "Class III (No Benefit)",
        "source": "STICH (Mendelow et al. Lancet 2005); STICH II (2013)"
      },
      {
        "recommendation": "Minimally invasive surgery emerging benefit",
        "evidenceLevel": "Class IIb, Level B",
        "source": "MISTIE III (Hanley et al. Lancet 2019); ENRICH (2024)"
      },
      {
        "recommendation": "EVD for IVH with hydrocephalus",
        "evidenceLevel": "Class I, Level B",
        "source": "AHA/ASA Guidelines"
      },
      {
        "recommendation": "Intraventricular tPA (CLEAR III)",
        "evidenceLevel": "Class IIb, Level B",
        "source": "Hanley et al. (Lancet 2017) — reduced mortality but not functional outcome"
      },
      {
        "recommendation": "Seizure prophylaxis NOT recommended routinely",
        "evidenceLevel": "Class III (No Benefit)",
        "source": "AHA/ASA 2022 — treat clinical/electrographic seizures; cEEG if altered"
      },
      {
        "recommendation": "Anticoagulation restart 4-8 weeks for AF",
        "evidenceLevel": "Class IIb, Level B",
        "source": "AHA/ASA 2022; observational data"
      },
      {
        "recommendation": "Antiplatelet restart appears safe (RESTART trial)",
        "evidenceLevel": "Class IIa, Level B",
        "source": "RESTART trial (Lancet 2019)"
      },
      {
        "recommendation": "DVT prophylaxis: pneumatic devices immediately; pharmacologic at 24-48h",
        "evidenceLevel": "Class I, Level B",
        "source": "AHA/ASA 2022 Guidelines"
      },
      {
        "recommendation": "ICH Score for prognosis",
        "evidenceLevel": "Class IIa, Level B",
        "source": "Hemphill et al. (Stroke 2001)"
      },
      {
        "recommendation": "Normothermia improves outcomes",
        "evidenceLevel": "Class I, Level C",
        "source": "AHA/ASA Guidelines"
      },
      {
        "recommendation": "Avoid self-fulfilling prophecy (DNR discussion timing)",
        "evidenceLevel": "Class I, Level C",
        "source": "AHA/ASA 2022: delay new DNR orders until at least 24h after admission"
      }
    ],
    "monitoring": [
      {
        "item": "Blood pressure (arterial line preferred in ICU)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "q5min x 2h during acute reduction; q15min x 6h; then q1h x 24h; then q4h",
        "action": "Titrate antihypertensives; avoid SBP <110"
      },
      {
        "item": "GCS / Neurologic exam",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "q1h x 24h, then q2h x 24h, then q4h",
        "action": "If declining: STAT CT; ICP assessment; neurosurgery"
      },
      {
        "item": "ICP (if EVD in place)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "Continuous; assess q1h",
        "action": "Tiered ICP management: drain CSF → osmotherapy → sedation → hypothermia → decompression"
      },
      {
        "item": "Repeat CT head",
        "ED": "-",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "At 6h (routine); at 24h; and with ANY neurologic decline",
        "action": "If expanding: re-evaluate BP; reversal; surgical consultation"
      },
      {
        "item": "Temperature",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q4h; q1h if febrile",
        "action": "Aggressive fever management; cooling devices; infection workup"
      },
      {
        "item": "Blood glucose",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q6h (q1h if insulin drip)",
        "action": "Insulin; avoid <60"
      },
      {
        "item": "Serum sodium",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q6h during osmotherapy; q12h otherwise",
        "action": "Adjust osmotherapy"
      },
      {
        "item": "Serum osmolality",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q6h during mannitol",
        "action": "Hold mannitol if >320"
      },
      {
        "item": "INR (if on warfarin)",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "15 min after PCC; then q6h x 24h; then daily",
        "action": "Additional reversal agents"
      },
      {
        "item": "Hemoglobin",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "ROUTINE",
        "frequency": "q6-12h x 48h",
        "action": "Transfuse PRBCs"
      },
      {
        "item": "EEG / Seizure monitoring",
        "ED": "-",
        "HOSP": "URGENT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "cEEG 24-48h minimum if altered consciousness",
        "action": "AED loading; aggressive management"
      },
      {
        "item": "Swallowing screen",
        "ED": "-",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "URGENT",
        "frequency": "Before any PO intake",
        "action": "NPO; SLP evaluation"
      },
      {
        "item": "ICH Score (calculate at admission)",
        "ED": "STAT",
        "HOSP": "-",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "Once (prognostic)",
        "action": "Goals of care discussion if score ≥3"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Small ICH; stable exam; GCS 15; ambulatory; adequate home support; medications filled; BP controlled; follow-up arranged"
      },
      {
        "disposition": "Admit to stroke unit/floor (monitored)",
        "criteria": "Small-moderate ICH; GCS 13-15; no surgical indication; stable repeat CT; BP controlled on oral/IV medications"
      },
      {
        "disposition": "Admit to neuro-ICU",
        "criteria": "ALL moderate-large ICH; GCS <13 or declining; anticoagulant-related ICH; posterior fossa ICH; IVH with hydrocephalus; EVD in place; requiring arterial line and IV antihypertensives; post-surgical"
      },
      {
        "disposition": "Emergent surgery",
        "criteria": "Cerebellar ICH >3 cm with brainstem compression or hydrocephalus; deteriorating lobar ICH >30 mL; obstructive hydrocephalus needing EVD"
      },
      {
        "disposition": "Transfer to higher level",
        "criteria": "Need for neurosurgery not available; need for neuro-ICU; need for reversal agents not available; need for endovascular treatment"
      },
      {
        "disposition": "Inpatient rehabilitation",
        "criteria": "Significant deficits but able to participate in 3h/day therapy; medically stable"
      },
      {
        "disposition": "Comfort care / Hospice",
        "criteria": "ICH score ≥4; devastating ICH with poor prognosis after family goals of care discussion"
      }
    ]
  },
  "Medication Overuse Headache (MOH)": {
    "id": "medication-overuse-headache",
    "title": "Medication Overuse Headache (MOH)",
    "version": "1.0",
    "icd10": [
      "** G44.40 (Drug-induced headache",
      "not elsewhere classified",
      "not intractable)",
      "G44.41 (Drug-induced headache",
      "not elsewhere classified",
      "intractable)"
    ],
    "scope": "** Diagnosis and management of medication overuse headache in adults. Covers identification of offending medications, withdrawal strategies, preventive medication initiation, and relapse prevention. Excludes primary headache disorders without overuse component, and headache due to medication side effects (not overuse).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Baseline; anemia can contribute to headache",
            "target": "Normal"
          },
          {
            "item": "CMP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Electrolytes, renal/hepatic function (chronic NSAID/acetaminophen use)",
            "target": "Normal"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Thyroid dysfunction",
            "target": "Normal"
          }
        ],
        "Extended Workup": [
          {
            "item": "LFTs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If chronic acetaminophen use",
            "target": "Normal"
          },
          {
            "item": "BUN/Creatinine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If chronic NSAID use",
            "target": "Normal"
          },
          {
            "item": "ESR/CRP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If inflammatory/secondary cause suspected",
            "target": "Normal"
          },
          {
            "item": "Urine drug screen",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If opioid overuse/diversion suspected",
            "target": "Document"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Lumbar puncture",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Only if secondary cause suspected (IIH, infection)",
            "target": "Normal"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI brain without contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If not previously done; red flags",
            "target": "Rule out secondary causes",
            "contraindications": "Pacemaker, metal"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain with contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If mass, infection suspected",
            "target": "Rule out structural cause",
            "contraindications": "Contrast allergy, renal disease"
          },
          {
            "item": "MRV",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If IIH suspected",
            "target": "Patent venous sinuses",
            "contraindications": "Per MRI"
          }
        ]
      },
      "Treatment": {
        "Withdrawal Strategies - Outpatient": [
          {
            "item": "Abrupt discontinuation (simple analgesics, triptans)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Stop all overused medications immediately; preferred for most patients",
              "orderSentence": "Abrupt discontinuation (simple analgesics, triptans) - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Headache diary; expect worsening days 2-10",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gradual taper (opioids, barbiturates)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25%",
                  "orderSentence": "Gradual taper (opioids, barbiturates) 25% -"
                }
              ],
              "route": "-",
              "instructions": "Reduce by 10-25% every 1-2 weeks; slower for long-term use",
              "orderSentence": "Gradual taper (opioids, barbiturates) 25% -"
            },
            "contraindications": "None",
            "monitoring": "Withdrawal symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Bridge therapy during withdrawal",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "See below",
              "orderSentence": "Bridge therapy during withdrawal - - - see dosing"
            },
            "contraindications": "Per agent",
            "monitoring": "Support through withdrawal phase",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Bridge Therapy During Withdrawal": [
          {
            "item": "Naproxen sodium (scheduled)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Naproxen sodium (scheduled) 500 mg -"
                }
              ],
              "route": "-",
              "instructions": "500 mg BID × 2-4 weeks (not PRN - scheduled dosing to prevent rebound)",
              "orderSentence": "Naproxen sodium (scheduled) 500 mg -"
            },
            "contraindications": "Renal disease, GI bleeding",
            "monitoring": "Limited to 2-4 weeks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Prednisone (short course)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg",
                  "orderSentence": "Prednisone (short course) 60 mg -"
                }
              ],
              "route": "-",
              "instructions": "60 mg × 3 days, 40 mg × 3 days, 20 mg × 3 days (total 9 days)",
              "orderSentence": "Prednisone (short course) 60 mg -"
            },
            "contraindications": "Uncontrolled DM, infection",
            "monitoring": "Glucose",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dexamethasone",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4-8 mg",
                  "orderSentence": "Dexamethasone 4-8 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "4-8 mg daily × 5-7 days",
              "orderSentence": "Dexamethasone 4-8 mg PO"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nerve block (GON)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2%",
                  "orderSentence": "Nerve block (GON) 2% -"
                }
              ],
              "route": "-",
              "instructions": "Lidocaine 2% + steroid, bilateral",
              "orderSentence": "Nerve block (GON) 2% -"
            },
            "contraindications": "Anticoagulation, local infection",
            "monitoring": "May reduce withdrawal severity",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Antiemetics PRN",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Antiemetics PRN 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Metoclopramide 10 mg q8h PRN or ondansetron 4-8 mg q8h PRN",
              "orderSentence": "Antiemetics PRN 10 mg PO"
            },
            "contraindications": "Per agent",
            "monitoring": "For nausea during withdrawal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Inpatient Withdrawal (Severe Cases)": [
          {
            "item": "IV DHE protocol",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5-1 mg",
                  "orderSentence": "IV DHE protocol 0.5-1 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "DHE 0.5-1 mg IV q8h × 3-5 days (with metoclopramide 10 mg IV pretreatment)",
              "orderSentence": "IV DHE protocol 0.5-1 mg IV"
            },
            "contraindications": "CAD, CVA, uncontrolled HTN, pregnancy, triptans <24h",
            "monitoring": "BP, nausea, EKG",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "IV magnesium",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2 g",
                  "orderSentence": "IV magnesium 1-2 g IV"
                }
              ],
              "route": "IV",
              "instructions": "1-2 g IV daily × 3-5 days",
              "orderSentence": "IV magnesium 1-2 g IV"
            },
            "contraindications": "Renal failure",
            "monitoring": "Mg levels",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "IV ketorolac",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15-30 mg",
                  "orderSentence": "IV ketorolac 15-30 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "15-30 mg IV q6h × 2-3 days (max 5 days)",
              "orderSentence": "IV ketorolac 15-30 mg IV"
            },
            "contraindications": "Renal disease, GI bleeding",
            "monitoring": "Renal function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "IV valproate",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500-1000 mg",
                  "orderSentence": "IV valproate 500-1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "500-1000 mg IV BID × 3-5 days",
              "orderSentence": "IV valproate 500-1000 mg IV"
            },
            "contraindications": "Pregnancy, hepatic disease",
            "monitoring": "Ammonia, LFTs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "IV diphenhydramine",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-50 mg",
                  "orderSentence": "IV diphenhydramine 25-50 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "25-50 mg IV q6h with antiemetics",
              "orderSentence": "IV diphenhydramine 25-50 mg IV"
            },
            "contraindications": "Glaucoma",
            "monitoring": "Sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Opioid taper protocol",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Structured taper with addiction medicine if significant dependence",
              "orderSentence": "Opioid taper protocol - - - see dosing"
            },
            "contraindications": "N/A",
            "monitoring": "Withdrawal symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Barbiturate taper",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Phenobarbital substitution and taper for butalbital dependence",
              "orderSentence": "Barbiturate taper - - - see dosing"
            },
            "contraindications": "N/A",
            "monitoring": "Sedation, withdrawal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Preventive Medication (Start During or After Withdrawal)": [
          {
            "item": "Topiramate",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Topiramate 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; titrate to 50-100 mg BID",
              "orderSentence": "Topiramate 25 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Kidney stones, glaucoma, pregnancy",
            "monitoring": "Cognitive effects, paresthesias",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-25 mg",
                  "orderSentence": "Amitriptyline 10-25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg QHS; titrate to 50-100 mg QHS",
              "orderSentence": "Amitriptyline 10-25 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Cardiac arrhythmia, glaucoma",
            "monitoring": "QTc, sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Propranolol",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Propranolol 40 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 40 mg BID; titrate to 80-160 mg/day",
              "orderSentence": "Propranolol 40 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Asthma, heart block, bradycardia",
            "monitoring": "HR, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5 mg",
                  "orderSentence": "Venlafaxine XR 37.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5 mg daily; titrate to 75-150 mg daily",
              "orderSentence": "Venlafaxine XR 37.5 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Uncontrolled HTN, MAOIs",
            "monitoring": "BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "OnabotulinumtoxinA",
            "route": "IM",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "155-195 units",
                  "orderSentence": "OnabotulinumtoxinA 155-195 units IM"
                }
              ],
              "route": "IM",
              "instructions": "155-195 units IM q12 weeks (if chronic migraine criteria met)",
              "orderSentence": "OnabotulinumtoxinA 155-195 units IM"
            },
            "pretreatment": "-",
            "contraindications": "Infection at site, myasthenia",
            "monitoring": "Spread of effect",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CGRP monoclonal antibodies",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "70-140 mg",
                  "orderSentence": "CGRP monoclonal antibodies 70-140 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "Erenumab 70-140 mg SC monthly; Fremanezumab 225 mg monthly or 675 mg quarterly; Galcanezumab 240 mg load then 120 mg monthly",
              "orderSentence": "CGRP monoclonal antibodies 70-140 mg SC"
            },
            "pretreatment": "-",
            "contraindications": "Hypersensitivity",
            "monitoring": "Constipation (erenumab), injection reactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valproate",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250-500 mg",
                  "orderSentence": "Valproate 250-500 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 250-500 mg BID; titrate to 500-1000 mg BID",
              "orderSentence": "Valproate 250-500 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Pregnancy, hepatic disease",
            "monitoring": "LFTs, ammonia, weight",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rescue Medications (Limited Use After Withdrawal)": [
          {
            "item": "Triptan (limited)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Max 2 days/week; max 9 days/month",
              "orderSentence": "Triptan (limited) - - - see dosing"
            },
            "contraindications": "CV disease",
            "monitoring": "Headache diary",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "NSAID (limited)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Max 2 days/week; max 14 days/month",
              "orderSentence": "NSAID (limited) - - - see dosing"
            },
            "contraindications": "Renal/GI disease",
            "monitoring": "Headache diary",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gepants (preferred rescue)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50-100 mg",
                  "orderSentence": "Gepants (preferred rescue) 50-100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Ubrogepant 50-100 mg or Rimegepant 75 mg; may have lower MOH risk",
              "orderSentence": "Gepants (preferred rescue) 50-100 mg PO"
            },
            "contraindications": "Per agent",
            "monitoring": "May be safer for frequent use",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Headache specialist/Neurology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "All patients; management and prevention"
          },
          {
            "item": "Pain psychology/Behavioral health",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "CBT for headache, coping strategies, anxiety/depression"
          },
          {
            "item": "Addiction medicine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Opioid or barbiturate dependence"
          },
          {
            "item": "Psychiatry",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Comorbid depression, anxiety"
          },
          {
            "item": "Physical therapy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Cervicogenic component, tension-type features"
          },
          {
            "item": "Biofeedback specialist",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Non-pharmacologic headache management"
          }
        ],
        "Patient Instructions": [
          {
            "item": "MOH is caused by frequent use of pain medications; stopping them is essential for improvement",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Expect headaches to WORSEN for 2-10 days during withdrawal before improving",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Most patients improve significantly within 2-3 months of stopping overused medications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "STRICT medication limits going forward: triptans ≤9 days/month, NSAIDs ≤14 days/month",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep detailed headache diary tracking medications and headache days",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Preventive medication takes 4-8 weeks to work; be patient",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Relapse is common (~40%); call if headache frequency increasing",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do NOT restart butalbital-containing medications (Fioricet, Fiorinal)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Opioids should NOT be used for primary headache disorders",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Regular sleep schedule (7-8 hours)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular meal schedule (don't skip meals)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular exercise (30 min, 5 days/week)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management techniques (biofeedback, relaxation, CBT)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit caffeine to consistent moderate intake (<200 mg/day)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stay well-hydrated",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid known migraine triggers",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Establish \"medication rules\" and stick to them",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Chronic migraine (without MOH)",
        "features": "≥15 headache days/month but NO medication overuse",
        "tests": "Medication diary"
      },
      {
        "diagnosis": "Chronic tension-type headache",
        "features": "Bilateral, pressing, mild-moderate, no nausea",
        "tests": "Clinical; no medication overuse"
      },
      {
        "diagnosis": "New daily persistent headache",
        "features": "Distinct onset date; daily from onset; no prior headache history",
        "tests": "Clinical history"
      },
      {
        "diagnosis": "Hemicrania continua",
        "features": "Continuous unilateral pain; responds to indomethacin",
        "tests": "Indomethacin trial"
      },
      {
        "diagnosis": "Idiopathic intracranial hypertension",
        "features": "Papilledema, visual obscurations, pulsatile tinnitus",
        "tests": "LP with elevated OP, fundoscopy"
      },
      {
        "diagnosis": "Secondary headache (tumor, CSF leak, etc.)",
        "features": "Red flags, focal deficits, progressive",
        "tests": "MRI brain"
      },
      {
        "diagnosis": "Cervicogenic headache",
        "features": "Neck pain, limited ROM, triggered by neck movement",
        "tests": "Cervical exam, imaging"
      }
    ],
    "evidence": [
      {
        "recommendation": "ICHD-3 diagnostic criteria for MOH",
        "evidenceLevel": "Class I",
        "source": "International Headache Society 2018"
      },
      {
        "recommendation": "Abrupt withdrawal effective for simple analgesics/triptans",
        "evidenceLevel": "Class II, Level B",
        "source": "Multiple studies"
      },
      {
        "recommendation": "Bridge therapy with corticosteroids",
        "evidenceLevel": "Class II, Level B",
        "source": "Multiple studies"
      },
      {
        "recommendation": "Preventive medication should be started with withdrawal",
        "evidenceLevel": "Class I, Level A",
        "source": "Expert consensus; multiple guidelines"
      },
      {
        "recommendation": "Topiramate effective for migraine prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs"
      },
      {
        "recommendation": "CGRP mAbs may have lower MOH risk",
        "evidenceLevel": "Class II, Level B",
        "source": "Emerging evidence"
      },
      {
        "recommendation": "Gepants may have lower MOH risk",
        "evidenceLevel": "Class II, Level C",
        "source": "Emerging evidence"
      },
      {
        "recommendation": "~40% relapse rate at 1 year",
        "evidenceLevel": "Class II",
        "source": "Observational studies"
      },
      {
        "recommendation": "Opioids and barbiturates have highest MOH risk",
        "evidenceLevel": "Class II, Level B",
        "source": "Multiple studies"
      }
    ],
    "monitoring": [
      {
        "item": "Headache frequency (days/month)",
        "ED": "-",
        "HOSP": "Daily",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "Monthly",
        "action": "Adjust preventive"
      },
      {
        "item": "Medication use (days/month)",
        "ED": "-",
        "HOSP": "Daily",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "Monthly",
        "action": "Counsel; adjust strategy"
      },
      {
        "item": "MIDAS or HIT-6 score",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q3 months",
        "action": "Adjust treatment"
      },
      {
        "item": "Headache diary review",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "Ongoing",
        "action": "Reinforce education"
      },
      {
        "item": "Preventive medication adherence",
        "ED": "-",
        "HOSP": "-",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "Address barriers"
      },
      {
        "item": "Depression/anxiety screening",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "q3-6 months",
        "action": "Refer if positive"
      },
      {
        "item": "Weight (if on topiramate/valproate)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "Adjust medication"
      }
    ],
    "disposition": [
      {
        "disposition": "Outpatient management",
        "criteria": "Most patients; mild-moderate disability, no significant opioid/barbiturate dependence"
      },
      {
        "disposition": "Admit to hospital",
        "criteria": "Failed outpatient withdrawal, severe disability, significant opioid/barbiturate dependence, psychiatric comorbidity requiring stabilization, need for IV protocol"
      },
      {
        "disposition": "Discharge from hospital",
        "criteria": "Withdrawal completed, preventive started, headache improving, follow-up arranged"
      },
      {
        "disposition": "Headache specialist follow-up",
        "criteria": "Within 2-4 weeks of withdrawal; then q1-3 months"
      },
      {
        "disposition": "Relapse management",
        "criteria": "May need repeat withdrawal; intensify preventive; consider CGRP mAbs"
      }
    ]
  },
  "Migraine / Status Migrainosus": {
    "id": "migraine",
    "title": "Migraine / Status Migrainosus",
    "version": "1.0",
    "icd10": [
      "** G43.909 (Migraine",
      "unspecified",
      "not intractable)",
      "G43.919 (Migraine",
      "unspecified",
      "intractable)",
      "G43.901 (Migraine",
      "unspecified",
      "not intractable",
      "with status migrainosus)",
      "G43.911 (Migraine",
      "unspecified",
      "intractable",
      "with status migrainosus)",
      "G43.109 (Migraine with aura",
      "not intractable)",
      "G43.709 (Chronic migraine without aura",
      "not intractable)"
    ],
    "scope": "** Evaluation and management of acute migraine, status migrainosus, and chronic migraine in adults. Covers abortive therapy, rescue treatment for refractory attacks, and preventive medication initiation. Includes special considerations for pregnancy and medication overuse. Excludes secondary headache disorders, cluster headache, and tension-type headache.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out anemia, infection",
            "target": "Normal"
          },
          {
            "item": "CMP",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Electrolyte abnormalities, renal function",
            "target": "Normal"
          },
          {
            "item": "hCG (women of childbearing age)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Pregnancy status affects treatment options",
            "target": "Document status"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Thyroid dysfunction can cause headache",
            "target": "Normal"
          },
          {
            "item": "Magnesium",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Low levels may contribute to migraines",
            "target": ">1.8 mg/dL"
          }
        ],
        "Extended Workup": [
          {
            "item": "ESR/CRP",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If GCA or inflammatory cause suspected (>50 years, new onset)",
            "target": "Normal"
          },
          {
            "item": "Vitamin D",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency associated with migraine frequency",
            "target": ">30 ng/mL"
          },
          {
            "item": "Ferritin",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Iron deficiency associated with migraine",
            "target": ">50 ng/mL"
          },
          {
            "item": "Homocysteine",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Elevated levels associated with migraine with aura",
            "target": "Normal"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Lumbar puncture",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Thunderclap headache, suspected SAH, IIH, meningitis",
            "target": "See LP section"
          },
          {
            "item": "Autoimmune panel (ANA, etc.)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If vasculitis or autoimmune cause suspected",
            "target": "Negative"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "IIH diagnosis",
            "target": "10-20 cm H2O (elevated >25 suggests IIH)"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Infection, SAH",
            "target": "WBC <5; RBC 0 or clearing"
          },
          {
            "item": "Protein",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Infection, inflammation",
            "target": "15-45 mg/dL"
          },
          {
            "item": "Glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Infection",
            "target": ">60% serum"
          },
          {
            "item": "Xanthochromia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "SAH if CT negative",
            "target": "Negative"
          },
          {
            "item": "Gram stain and culture",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Bacterial meningitis",
            "target": "No organisms"
          },
          {
            "item": "CSF meningitis panel",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Viral/bacterial pathogens",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "ED": "STAT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "timing": "If thunderclap, worst headache, focal deficits, altered mental status",
            "target": "Rule out hemorrhage, mass",
            "contraindications": "None in emergency"
          },
          {
            "item": "MRI brain without contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "New headache pattern, focal features, refractory to treatment",
            "target": "Normal; rule out structural cause",
            "contraindications": "Pacemaker, metal implants"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain with and without contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If mass, infection, or inflammation suspected",
            "target": "Rule out enhancement",
            "contraindications": "Contrast allergy, renal disease"
          },
          {
            "item": "MRV or CT venogram",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "timing": "Suspected cerebral venous thrombosis",
            "target": "Patent venous sinuses",
            "contraindications": "Per modality"
          },
          {
            "item": "MRA head",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Suspected vasculopathy, aneurysm",
            "target": "Normal vasculature",
            "contraindications": "Per modality"
          },
          {
            "item": "ECG",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-",
            "timing": "Prior to DHE or triptan use",
            "target": "Normal QTc, no ischemia",
            "contraindications": "None"
          }
        ]
      },
      "Treatment": {
        "Acute/Abortive Treatment - Mild-Moderate Attacks": [
          {
            "item": "Acetaminophen",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Acetaminophen 1000 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "1000 mg PO once, max 3000 mg/day",
              "orderSentence": "Acetaminophen 1000 mg PO"
            },
            "contraindications": "Hepatic disease, chronic alcohol use",
            "monitoring": "LFTs if frequent use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ibuprofen",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400-800 mg",
                  "orderSentence": "Ibuprofen 400-800 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "400-800 mg PO once",
              "orderSentence": "Ibuprofen 400-800 mg PO"
            },
            "contraindications": "Renal disease, GI bleeding, aspirin allergy",
            "monitoring": "Renal function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Naproxen sodium",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500-825 mg",
                  "orderSentence": "Naproxen sodium 500-825 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "500-825 mg PO once",
              "orderSentence": "Naproxen sodium 500-825 mg PO"
            },
            "contraindications": "Same as ibuprofen",
            "monitoring": "Renal function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Aspirin",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "900-1000 mg",
                  "orderSentence": "Aspirin 900-1000 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "900-1000 mg PO once",
              "orderSentence": "Aspirin 900-1000 mg PO"
            },
            "contraindications": "Bleeding disorder, aspirin allergy",
            "monitoring": "Bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Excedrin (ASA/APAP/caffeine)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "instructions": "2 tablets PO once",
              "orderSentence": "Excedrin (ASA/APAP/caffeine) - PO - see dosing"
            },
            "contraindications": "Per components",
            "monitoring": "Risk of MOH",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Acute/Abortive Treatment - Moderate-Severe Attacks (Triptans)": [
          {
            "item": "Sumatriptan SC",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "6 mg",
                  "orderSentence": "Sumatriptan SC 6 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "6 mg SC once; may repeat in 2h; max 12 mg/24h",
              "orderSentence": "Sumatriptan SC 6 mg SC"
            },
            "contraindications": "CAD, stroke/TIA, uncontrolled HTN, hemiplegic/basilar migraine, pregnancy",
            "monitoring": "Chest tightness, BP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Sumatriptan PO",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50-100 mg",
                  "orderSentence": "Sumatriptan PO 50-100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "50-100 mg PO once; may repeat in 2h; max 200 mg/24h",
              "orderSentence": "Sumatriptan PO 50-100 mg PO"
            },
            "contraindications": "Same as SC",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sumatriptan nasal",
            "route": "IN",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "Sumatriptan nasal 20 mg IN"
                }
              ],
              "route": "IN",
              "instructions": "20 mg intranasal; may repeat in 2h; max 40 mg/24h",
              "orderSentence": "Sumatriptan nasal 20 mg IN"
            },
            "contraindications": "Same as SC",
            "monitoring": "Same",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rizatriptan",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-10 mg",
                  "orderSentence": "Rizatriptan 5-10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10 mg PO (ODT available); may repeat in 2h; max 30 mg/24h",
              "orderSentence": "Rizatriptan 5-10 mg PO"
            },
            "contraindications": "Same; 5 mg if on propranolol",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Eletriptan",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Eletriptan 40 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "40 mg PO; may repeat in 2h; max 80 mg/24h",
              "orderSentence": "Eletriptan 40 mg PO"
            },
            "contraindications": "Same; severe hepatic impairment",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Zolmitriptan",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5-5 mg",
                  "orderSentence": "Zolmitriptan 2.5-5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "2.5-5 mg PO or nasal; may repeat in 2h; max 10 mg/24h",
              "orderSentence": "Zolmitriptan 2.5-5 mg PO"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Acute/Abortive Treatment - CGRP Antagonists (Gepants)": [
          {
            "item": "Ubrogepant",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50-100 mg",
                  "orderSentence": "Ubrogepant 50-100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "50-100 mg PO; may repeat in 2h; max 200 mg/24h",
              "orderSentence": "Ubrogepant 50-100 mg PO"
            },
            "contraindications": "CYP3A4 inhibitors; no cardiovascular contraindications",
            "monitoring": "LFTs periodically",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rimegepant",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg",
                  "orderSentence": "Rimegepant 75 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "75 mg PO once daily; ODT formulation",
              "orderSentence": "Rimegepant 75 mg PO"
            },
            "contraindications": "CYP3A4 inhibitors",
            "monitoring": "LFTs periodically",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Zavegepant nasal",
            "route": "IN",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Zavegepant nasal 10 mg IN"
                }
              ],
              "route": "IN",
              "instructions": "10 mg intranasal once daily",
              "orderSentence": "Zavegepant nasal 10 mg IN"
            },
            "contraindications": "None significant",
            "monitoring": "Local irritation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "ED/Inpatient Treatment - Status Migrainosus (\"Headache Cocktail\")": [
          {
            "item": "IV fluids",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75-125 mL/hr",
                  "orderSentence": "IV fluids 75-125 mL/hr -"
                }
              ],
              "route": "-",
              "instructions": "NS or LR 1L bolus, then 75-125 mL/hr",
              "orderSentence": "IV fluids 75-125 mL/hr -"
            },
            "pretreatment": "-",
            "contraindications": "Heart failure, volume overload",
            "monitoring": "I/O",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Prochlorperazine IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Prochlorperazine IV 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg IV slow push over 5-10 min; may repeat in 30 min",
              "orderSentence": "Prochlorperazine IV 10 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "QT prolongation, Parkinson's",
            "monitoring": "QTc, akathisia, dystonia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Metoclopramide IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-20 mg",
                  "orderSentence": "Metoclopramide IV 10-20 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10-20 mg IV over 15-30 min; may repeat in 30 min",
              "orderSentence": "Metoclopramide IV 10-20 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "QT prolongation, Parkinson's, seizures",
            "monitoring": "QTc, akathisia, dystonia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Diphenhydramine IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-50 mg",
                  "orderSentence": "Diphenhydramine IV 25-50 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "25-50 mg IV to prevent akathisia (give with antiemetic)",
              "orderSentence": "Diphenhydramine IV 25-50 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Glaucoma, urinary retention",
            "monitoring": "Sedation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Ketorolac IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg",
                  "orderSentence": "Ketorolac IV 30 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "30 mg IV (15 mg if >65y or CrCl <50); max 2 doses",
              "orderSentence": "Ketorolac IV 30 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Renal disease, GI bleeding, anticoagulation",
            "monitoring": "Renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Dexamethasone IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Dexamethasone IV 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg IV once (reduces recurrence)",
              "orderSentence": "Dexamethasone IV 10 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Active infection, uncontrolled DM",
            "monitoring": "Glucose",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Magnesium sulfate IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g",
                  "orderSentence": "Magnesium sulfate IV 2 g IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV over 20-30 min",
              "orderSentence": "Magnesium sulfate IV 2 g IV"
            },
            "pretreatment": "-",
            "contraindications": "Renal failure, myasthenia",
            "monitoring": "Mg levels, reflexes",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Valproate sodium IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500-1000 mg",
                  "orderSentence": "Valproate sodium IV 500-1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "500-1000 mg IV over 15-30 min",
              "orderSentence": "Valproate sodium IV 500-1000 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Pregnancy, hepatic disease, mitochondrial disease",
            "monitoring": "Ammonia, LFTs",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "ED/Inpatient - Refractory/Second-Line Therapy (DHE Protocol)": [
          {
            "item": "Dihydroergotamine (DHE)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Dihydroergotamine (DHE) 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Premedicate: metoclopramide 10 mg IV + diphenhydramine 25 mg IV; Test dose: 0.5 mg IV over 1 min; If tolerated: 0.5-1 mg IV q8h",
              "orderSentence": "Dihydroergotamine (DHE) 10 mg IV"
            },
            "contraindications": "Pregnancy, CAD, CVA, uncontrolled HTN, triptan <24h, ergot allergy",
            "monitoring": "BP, chest pain, nausea",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "DHE nasal",
            "route": "IN",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg",
                  "orderSentence": "DHE nasal 0.5 mg -"
                }
              ],
              "route": "-",
              "instructions": "0.5 mg per nostril (1 mg total); may repeat once in 15 min; max 3 mg/24h",
              "orderSentence": "DHE nasal 0.5 mg -"
            },
            "contraindications": "Same as IV",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Pregnancy-Safe Options": [
          {
            "item": "Acetaminophen",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Acetaminophen 1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg PO/IV q8h; max 3000 mg/day",
              "orderSentence": "Acetaminophen 1000 mg IV"
            },
            "contraindications": "Hepatic disease",
            "monitoring": "LFTs",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Metoclopramide",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Metoclopramide 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg IV/PO q8h",
              "orderSentence": "Metoclopramide 10 mg IV"
            },
            "contraindications": "Parkinson's",
            "monitoring": "Akathisia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ondansetron",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4-8 mg",
                  "orderSentence": "Ondansetron 4-8 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "4-8 mg IV/PO q8h",
              "orderSentence": "Ondansetron 4-8 mg IV"
            },
            "contraindications": "QT prolongation (caution 1st trimester)",
            "monitoring": "QTc",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Magnesium sulfate",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g",
                  "orderSentence": "Magnesium sulfate 2 g IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV once",
              "orderSentence": "Magnesium sulfate 2 g IV"
            },
            "contraindications": "Renal failure",
            "monitoring": "Reflexes, respiratory",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Nerve block (occipital)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-3 mL",
                  "orderSentence": "Nerve block (occipital) 2-3 mL -"
                }
              ],
              "route": "-",
              "instructions": "Lidocaine 1% or bupivacaine 0.25%, 2-3 mL per side",
              "orderSentence": "Nerve block (occipital) 2-3 mL -"
            },
            "contraindications": "Local anesthetic allergy",
            "monitoring": "Local reaction",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sumatriptan (if refractory)",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "6 mg",
                  "orderSentence": "Sumatriptan (if refractory) 6 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "6 mg SC x1 (pregnancy registry data reassuring)",
              "orderSentence": "Sumatriptan (if refractory) 6 mg SC"
            },
            "contraindications": "Per triptan list; discuss risks",
            "monitoring": "Standard",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Preventive Medications - First-Line": [
          {
            "item": "Propranolol",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40-80 mg/day",
                  "orderSentence": "Propranolol 40-80 mg/day PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 40-80 mg/day in divided doses; target 80-240 mg/day",
              "orderSentence": "Propranolol 40-80 mg/day PO"
            },
            "contraindications": "Asthma, heart block, bradycardia, depression",
            "monitoring": "HR, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Metoprolol",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-50 mg",
                  "orderSentence": "Metoprolol 25-50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg BID; target 100-200 mg/day",
              "orderSentence": "Metoprolol 25-50 mg PO"
            },
            "contraindications": "Same as propranolol",
            "monitoring": "HR, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Topiramate",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Topiramate 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg QHS; increase by 25 mg/week to 50-100 mg BID",
              "orderSentence": "Topiramate 25 mg PO"
            },
            "contraindications": "Kidney stones, pregnancy (teratogenic), glaucoma",
            "monitoring": "Bicarbonate, cognitive effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-25 mg",
                  "orderSentence": "Amitriptyline 10-25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg QHS; target 50-150 mg QHS",
              "orderSentence": "Amitriptyline 10-25 mg PO"
            },
            "contraindications": "Glaucoma, urinary retention, cardiac arrhythmia",
            "monitoring": "QTc, anticholinergic effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5 mg",
                  "orderSentence": "Venlafaxine XR 37.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5 mg daily; target 75-150 mg daily",
              "orderSentence": "Venlafaxine XR 37.5 mg PO"
            },
            "contraindications": "Uncontrolled HTN, MAOI use",
            "monitoring": "BP, serotonin syndrome",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consult",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "indication": "Status migrainosus, refractory to ED treatment"
          },
          {
            "item": "Headache specialist referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Chronic migraine, medication overuse, refractory disease"
          },
          {
            "item": "Ophthalmology consult",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Papilledema, visual symptoms suggesting IIH"
          },
          {
            "item": "Pain management referral",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Refractory chronic migraine, nerve block consideration"
          },
          {
            "item": "Behavioral health referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Comorbid anxiety/depression, biofeedback interest"
          },
          {
            "item": "Physical therapy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Cervicogenic component, trigger point therapy"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Keep headache diary (frequency, severity, triggers, medications)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Treat migraine early - medications more effective within first hour",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid medication overuse: limit triptans to ≤9 days/month, NSAIDs to ≤14 days/month",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Identify and avoid personal triggers",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Follow up with neurologist in 2-4 weeks if new diagnosis",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Follow up with PCP or neurologist for preventive medication monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return to ED if: worst headache of life, fever, neurologic deficits, altered mental status",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Maintain regular sleep schedule (7-8 hours)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular exercise (30 min, 5 days/week)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management (biofeedback, relaxation techniques, CBT)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stay well-hydrated (64+ oz water daily)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid known triggers: alcohol, aged cheese, MSG, processed meats, irregular meals",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit caffeine to consistent moderate intake (<200 mg/day)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Consider migraine glasses (FL-41 tint) for photophobia",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Tension-type headache",
        "features": "Bilateral, pressing/tightening, mild-moderate, no nausea/vomiting",
        "tests": "Clinical history; no photophobia"
      },
      {
        "diagnosis": "Cluster headache",
        "features": "Unilateral periorbital, autonomic features (tearing, rhinorrhea), short duration (15-180 min), circadian pattern",
        "tests": "Clinical pattern; response to O2/triptans"
      },
      {
        "diagnosis": "Medication overuse headache",
        "features": "Chronic daily headache, >15 days/month, frequent analgesic use",
        "tests": "Medication diary; improves with withdrawal"
      },
      {
        "diagnosis": "Subarachnoid hemorrhage",
        "features": "Thunderclap onset, \"worst headache of life,\" neck stiffness",
        "tests": "CT head, LP if CT negative"
      },
      {
        "diagnosis": "Idiopathic intracranial hypertension",
        "features": "Papilledema, visual obscurations, pulsatile tinnitus, bilateral pressure",
        "tests": "LP with elevated OP (>25 cm H2O)"
      },
      {
        "diagnosis": "Giant cell arteritis",
        "features": "Age >50, new headache, jaw claudication, scalp tenderness, visual symptoms",
        "tests": "ESR/CRP elevated, temporal artery biopsy"
      },
      {
        "diagnosis": "Cerebral venous thrombosis",
        "features": "Progressive headache, seizures, focal deficits, pregnancy/OCP",
        "tests": "MRV/CTV"
      },
      {
        "diagnosis": "Cervicogenic headache",
        "features": "Neck pain, limited ROM, triggered by neck movement",
        "tests": "Cervical exam, imaging"
      },
      {
        "diagnosis": "Trigeminal autonomic cephalalgia",
        "features": "Short attacks, autonomic features, response to indomethacin (some types)",
        "tests": "Clinical pattern"
      },
      {
        "diagnosis": "Brain tumor",
        "features": "Progressive headache, worse in morning/with Valsalva, focal deficits",
        "tests": "MRI brain"
      }
    ],
    "evidence": [
      {
        "recommendation": "Triptans effective for acute migraine",
        "evidenceLevel": "Class I, Level A",
        "source": "Cochrane Reviews; AHS Guidelines"
      },
      {
        "recommendation": "Prochlorperazine/metoclopramide effective for acute migraine",
        "evidenceLevel": "Class I, Level A",
        "source": "Friedman et al., Neurology 2015"
      },
      {
        "recommendation": "Dexamethasone reduces headache recurrence",
        "evidenceLevel": "Class I, Level A",
        "source": "Singh et al., Cephalalgia 2008"
      },
      {
        "recommendation": "DHE effective for status migrainosus",
        "evidenceLevel": "Class II, Level B",
        "source": "Raskin, Headache 1986"
      },
      {
        "recommendation": "Beta-blockers effective for prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "AAN Guidelines 2012"
      },
      {
        "recommendation": "Topiramate effective for prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "AAN Guidelines 2012"
      },
      {
        "recommendation": "CGRP mAbs effective for prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs; FDA approved 2018+"
      },
      {
        "recommendation": "OnabotulinumtoxinA for chronic migraine",
        "evidenceLevel": "Class I, Level A",
        "source": "PREEMPT trials; Aurora 2010"
      },
      {
        "recommendation": "Gepants effective for acute and preventive treatment",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs 2019-2023"
      },
      {
        "recommendation": "Avoid medication overuse",
        "evidenceLevel": "Class II, Level B",
        "source": "Headache Classification Committee, ICHD-3"
      }
    ],
    "monitoring": [
      {
        "item": "Pain scale (0-10)",
        "ED": "STAT",
        "HOSP": "q4h",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "Per assessment",
        "action": "Escalate treatment"
      },
      {
        "item": "Vital signs",
        "ED": "STAT",
        "HOSP": "q4h",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "Per assessment",
        "action": "Address abnormalities"
      },
      {
        "item": "ECG (if using DHE/triptans)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "-",
        "frequency": "Before administration",
        "action": "Avoid vasoactive drugs"
      },
      {
        "item": "Headache diary",
        "ED": "-",
        "HOSP": "Daily",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "Ongoing",
        "action": "Adjust preventive"
      },
      {
        "item": "MIDAS score",
        "ED": "-",
        "HOSP": "-",
        "OPD": "q3 months",
        "ICU": "-",
        "frequency": "Quarterly",
        "action": "Adjust treatment"
      },
      {
        "item": "Medication use tracking",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "Each visit",
        "ICU": "-",
        "frequency": "Ongoing",
        "action": "Address MOH"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge from ED",
        "criteria": "Pain controlled, able to tolerate PO, no red flags, close follow-up arranged"
      },
      {
        "disposition": "Admit to hospital",
        "criteria": "Status migrainosus unresponsive to ED treatment, need for DHE protocol, unable to tolerate PO, severe dehydration, concern for secondary headache"
      },
      {
        "disposition": "ICU admission",
        "criteria": "Rare - suspected intracranial pathology, hemodynamic instability"
      },
      {
        "disposition": "Discharge from hospital",
        "criteria": "Pain controlled on oral medications, tolerating PO, ambulatory"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "New diagnosis: 2-4 weeks; Chronic migraine: q1-3 months; On preventive: q3-6 months after stable"
      }
    ]
  },
  "Myasthenia Gravis - New Diagnosis": {
    "id": "myasthenia-gravis-new-diagnosis",
    "title": "Myasthenia Gravis - New Diagnosis",
    "version": "1.0",
    "icd10": [
      "** G70.0 (Myasthenia gravis)",
      "G70.00 (MG without exacerbation)",
      "G70.01 (MG with exacerbation)"
    ],
    "scope": "** Initial diagnostic workup and management of suspected or newly confirmed myasthenia gravis. Covers antibody testing, electrodiagnostic studies, thymoma screening, acute stabilization, and long-term immunotherapy initiation. For myasthenic crisis with respiratory failure, use \"Myasthenic Crisis\" template. For established MG on maintenance therapy, use \"MG - Maintenance\" template.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Baseline before immunotherapy; infection screen",
            "target": "Normal"
          },
          {
            "item": "CMP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Renal/hepatic function baseline; electrolytes",
            "target": "Normal"
          },
          {
            "item": "TSH",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Thyroid disease co-occurs in 10-15% of MG; autoimmune overlap",
            "target": "Normal"
          },
          {
            "item": "Free T4",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Thyroid function; Graves disease association",
            "target": "Normal"
          },
          {
            "item": "ESR",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Inflammatory/autoimmune screen",
            "target": "Normal (<20 mm/hr)"
          },
          {
            "item": "CRP",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Inflammatory marker; infection screen",
            "target": "Normal"
          },
          {
            "item": "AChR binding antibody",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Primary diagnostic test; positive in ~85% generalized MG, ~50% ocular MG",
            "target": "Negative (<0.02 nmol/L)"
          },
          {
            "item": "AChR blocking antibody",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Complements binding antibody; increases sensitivity",
            "target": "Negative"
          },
          {
            "item": "AChR modulating antibody",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Complements binding/blocking; increases sensitivity to ~95% in generalized MG",
            "target": "Negative"
          },
          {
            "item": "Blood glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Pre-steroid baseline",
            "target": "Normal"
          },
          {
            "item": "HbA1c",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Glycemic status before corticosteroid initiation",
            "target": "<5.7%"
          },
          {
            "item": "Urinalysis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Infection screen; baseline",
            "target": "Negative"
          },
          {
            "item": "LDH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Baseline; monitor for hemolysis on complement inhibitors",
            "target": "Normal"
          },
          {
            "item": "Magnesium",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hypomagnesemia worsens NMJ transmission",
            "target": "Normal (1.7-2.2 mg/dL)"
          },
          {
            "item": "Phosphorus",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Baseline electrolyte panel",
            "target": "Normal"
          },
          {
            "item": "PT/INR",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Coagulation baseline before procedures",
            "target": "Normal"
          },
          {
            "item": "Hepatitis B surface antigen",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Screen before rituximab/immunosuppression (reactivation risk)",
            "target": "Negative"
          }
        ],
        "Extended Workup": [
          {
            "item": "MuSK antibody (anti-MuSK IgG)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Positive in ~40% of AChR-seronegative MG; distinct phenotype (bulbar, facial, neck weakness)",
            "target": "Negative"
          },
          {
            "item": "LRP4 antibody",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Positive in ~2-50% of double-seronegative MG; newer assay",
            "target": "Negative"
          },
          {
            "item": "Anti-striated muscle antibody (anti-SM)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Associated with thymoma in MG patients <40 years; screening marker",
            "target": "Negative"
          },
          {
            "item": "Anti-titin antibody",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Associated with thymoma (especially in young-onset MG); late-onset MG marker",
            "target": "Negative"
          },
          {
            "item": "Anti-RyR (ryanodine receptor) antibody",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Associated with thymoma and severe MG",
            "target": "Negative"
          },
          {
            "item": "ANA",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Autoimmune overlap screen (SLE, Sjogren)",
            "target": "Negative or low titer"
          },
          {
            "item": "Anti-TPO antibody",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Autoimmune thyroiditis co-occurrence (Hashimoto/Graves)",
            "target": "Negative"
          },
          {
            "item": "Vitamin D (25-OH)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Immune modulation; deficiency common",
            "target": ">30 ng/mL"
          },
          {
            "item": "Hepatitis B core antibody",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Screen for prior HBV before rituximab",
            "target": "Negative"
          },
          {
            "item": "Hepatitis C antibody",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Screen before immunosuppression",
            "target": "Negative"
          },
          {
            "item": "HIV",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Screen before immunosuppression",
            "target": "Negative"
          },
          {
            "item": "Quantitative immunoglobulins (IgG, IgA, IgM)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Baseline before IVIG; monitor on rituximab/immunosuppression",
            "target": "Normal"
          },
          {
            "item": "SPEP with immunofixation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Paraproteinemic neuropathy/NMJ screen in atypical cases",
            "target": "Normal"
          },
          {
            "item": "Complement C3, C4",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Baseline before complement inhibitor therapy",
            "target": "Normal"
          },
          {
            "item": "Reticulocyte count",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Baseline before complement inhibitors (hemolysis monitoring)",
            "target": "Normal"
          },
          {
            "item": "Haptoglobin",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Baseline for hemolysis monitoring on complement inhibitors",
            "target": "Normal"
          },
          {
            "item": "TB test (QuantiFERON-Gold or PPD)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Screen before immunosuppression",
            "target": "Negative"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Agrin antibody",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Novel antibody target in seronegative MG",
            "target": "Negative"
          },
          {
            "item": "Cortactin antibody",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Identified in some seronegative MG",
            "target": "Negative"
          },
          {
            "item": "ColQ antibody",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Congenital myasthenic syndrome screen",
            "target": "Negative"
          },
          {
            "item": "Genetic testing (CMS gene panel)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Congenital myasthenic syndromes (CHRNE, DOK7, RAPSN, etc.) if onset <2 years or seronegative/atypical",
            "target": "Depends on gene"
          },
          {
            "item": "Paraneoplastic antibody panel (ANNA-1, VGCC, GAD65)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "LEMS or overlap paraneoplastic syndrome",
            "target": "Negative"
          },
          {
            "item": "VGCC antibody (P/Q-type)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Lambert-Eaton myasthenic syndrome screen",
            "target": "Negative (<0.02 nmol/L)"
          },
          {
            "item": "SOX1 antibody",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Associated with SCLC in LEMS",
            "target": "Negative"
          },
          {
            "item": "Acetylcholine receptor ganglionic antibody",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Autonomic neuropathy overlap",
            "target": "Negative"
          },
          {
            "item": "Muscle biopsy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Myopathy screen if diagnosis unclear",
            "target": "Normal NMJ architecture"
          },
          {
            "item": "Anti-Kv1.4 antibody",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Associated with myocarditis and severe MG phenotype (Japan)",
            "target": "Negative"
          },
          {
            "item": "CT-guided thymoma biopsy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If anterior mediastinal mass is atypical; tissue diagnosis",
            "target": "Depends on pathology"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT chest with contrast",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Within 24-48h of diagnosis",
            "target": "No thymoma or thymic hyperplasia",
            "contraindications": "Contrast allergy, renal insufficiency"
          },
          {
            "item": "MRI chest with contrast (preferred over CT if available)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Within 1-2 weeks",
            "target": "No thymoma; thymic hyperplasia characterization",
            "contraindications": "Gadolinium allergy, GFR <30, pacemaker"
          },
          {
            "item": "Chest X-ray (PA and lateral)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "Immediate",
            "target": "No mediastinal mass; baseline pulmonary status",
            "contraindications": "None significant"
          },
          {
            "item": "Portable chest X-ray",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "If unable to go to radiology",
            "target": "Pulmonary status; mediastinal widening",
            "contraindications": "None significant"
          }
        ],
        "Extended": [
          {
            "item": "Repetitive nerve stimulation (RNS)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "During workup; stop pyridostigmine 12h prior if possible",
            "target": "Decremental response >10% at 2-3 Hz in proximal and distal muscles",
            "contraindications": "Pacemaker (relative); recent botulinum toxin"
          },
          {
            "item": "Single-fiber EMG (SFEMG)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If RNS negative but clinical suspicion remains; most sensitive test (95-99%)",
            "target": "Increased jitter and blocking",
            "contraindications": "Same as RNS; requires experienced electromyographer"
          },
          {
            "item": "Standard EMG/NCS",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If diagnosis unclear; rule out neuropathy/myopathy",
            "target": "Normal (unless concurrent condition)",
            "contraindications": "None significant"
          },
          {
            "item": "Ice pack test (ocular MG)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At bedside; apply ice to closed eyelid for 2 minutes",
            "target": "Improvement of ptosis by ≥2 mm (sensitivity ~80% for ocular MG)",
            "contraindications": "Patient intolerance"
          },
          {
            "item": "Rest test (ocular MG)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At bedside; rest with eyes closed for 2-5 minutes",
            "target": "Improvement of ptosis or diplopia",
            "contraindications": "None"
          },
          {
            "item": "Sleep test (ocular MG)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At bedside; 30-minute nap then reassess",
            "target": "Improvement of ptosis/diplopia after rest",
            "contraindications": "None"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Sustained upgaze (2 minutes)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "Initial exam",
            "target": "No fatigable ptosis"
          },
          {
            "item": "Repeated deltoid abduction (15-20 reps)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "Initial exam",
            "target": "No fatigable weakness"
          },
          {
            "item": "Cogan lid twitch sign",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "Initial exam",
            "target": "No lid twitch"
          },
          {
            "item": "Curtain sign (orbicularis oculi)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "Initial exam",
            "target": "No contralateral lid opening"
          },
          {
            "item": "Peek sign",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "Initial exam",
            "target": "Sustained eye closure"
          },
          {
            "item": "Forced vital capacity (FVC)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "At presentation and serially",
            "target": ">20 mL/kg (>1.5 L)"
          },
          {
            "item": "Negative inspiratory force (NIF/MIP)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "At presentation and serially",
            "target": "More negative than -40 cm H2O"
          }
        ]
      },
      "Treatment": {
        "Cholinesterase Inhibitors (Symptomatic)": [
          {
            "item": "Pyridostigmine (Mestinon) IR",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg",
                  "orderSentence": "Pyridostigmine (Mestinon) IR 30 mg -"
                }
              ],
              "route": "-",
              "instructions": "Start 30 mg TID; increase by 30 mg per dose every 2-3 days; usual effective dose 60 mg q4-6h while awake; max 120 mg per dose (max ~960 mg/day, rarely needed)",
              "orderSentence": "Pyridostigmine (Mestinon) IR 30 mg -"
            },
            "contraindications": "Mechanical GI/GU obstruction; uncontrolled asthma",
            "monitoring": "Cholinergic side effects: diarrhea, cramping, salivation, bradycardia; cholinergic crisis if overdosed (weakness + muscarinic symptoms)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Pyridostigmine (Mestinon) SR (Timespan)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "180 mg",
                  "orderSentence": "Pyridostigmine (Mestinon) SR (Timespan) 180 mg -"
                }
              ],
              "route": "-",
              "instructions": "180 mg qHS (sustained release); may give once or twice daily; do NOT crush",
              "orderSentence": "Pyridostigmine (Mestinon) SR (Timespan) 180 mg -"
            },
            "contraindications": "Same as IR",
            "monitoring": "Same; useful for nocturnal/morning weakness; erratic absorption - use sparingly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pyridostigmine liquid (60 mg/5 mL)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Same dosing as IR; useful for patients with dysphagia",
              "orderSentence": "Pyridostigmine liquid (60 mg/5 mL) - - - see dosing"
            },
            "contraindications": "Same as IR",
            "monitoring": "Same; easier to swallow",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Neostigmine IV (if NPO or intubated)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5-2.5 mg",
                  "orderSentence": "Neostigmine IV (if NPO or intubated) 0.5-2.5 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-2.5 mg IV/IM q1-3h; 1 mg IV neostigmine ≈ 30 mg oral pyridostigmine",
              "orderSentence": "Neostigmine IV (if NPO or intubated) 0.5-2.5 mg IV"
            },
            "contraindications": "Same; cardiac monitoring required",
            "monitoring": "Continuous cardiac monitoring; have atropine at bedside for bradycardia",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Glycopyrrolate (for cholinergic side effects)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2 mg",
                  "orderSentence": "Glycopyrrolate (for cholinergic side effects) 1-2 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1-2 mg PO BID-TID or 0.1-0.2 mg IV PRN",
              "orderSentence": "Glycopyrrolate (for cholinergic side effects) 1-2 mg IV"
            },
            "contraindications": "Narrow-angle glaucoma; obstructive uropathy",
            "monitoring": "Does NOT cross BBB (preferred over atropine for peripheral muscarinic side effects)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Atropine (for cholinergic side effects/emergency)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5-1 mg",
                  "orderSentence": "Atropine (for cholinergic side effects/emergency) 0.5-1 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-1 mg IV PRN for symptomatic bradycardia from pyridostigmine",
              "orderSentence": "Atropine (for cholinergic side effects/emergency) 0.5-1 mg IV"
            },
            "contraindications": "Tachycardia; thyrotoxicosis",
            "monitoring": "HR monitoring; crosses BBB (may cause confusion)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Pyridostigmine dose reduction/hold",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Hold or reduce if cholinergic crisis suspected (worsening weakness + excessive secretions)",
              "orderSentence": "Pyridostigmine dose reduction/hold - - - see dosing"
            },
            "contraindications": "N/A",
            "monitoring": "Distinguish cholinergic crisis (excess pyridostigmine) from myasthenic crisis (undertreated MG)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          }
        ],
        "Corticosteroids (Immunosuppression - Induction)": [
          {
            "item": "Prednisone (gradual escalation - PREFERRED for outpatient)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-20 mg",
                  "orderSentence": "Prednisone (gradual escalation - PREFERRED for outpatient) 10-20 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-20 mg daily; increase by 5-10 mg every 3-5 days to target 0.5-1 mg/kg/day (typically 40-60 mg daily); maintain 4-8 weeks then taper by 5-10 mg/month",
              "orderSentence": "Prednisone (gradual escalation - PREFERRED for outpatient) 10-20 mg PO"
            },
            "contraindications": "Active untreated infection; uncontrolled diabetes; psychosis history",
            "monitoring": "Glucose (q6h inpatient, weekly outpatient); BP; mood/sleep; weight; bone density at baseline; GI prophylaxis",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Prednisone (rapid escalation - INPATIENT preferred)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40-60 mg",
                  "orderSentence": "Prednisone (rapid escalation - INPATIENT preferred) 40-60 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 40-60 mg daily (0.75-1 mg/kg/day); CAUTION: may cause initial transient worsening in first 1-2 weeks",
              "orderSentence": "Prednisone (rapid escalation - INPATIENT preferred) 40-60 mg PO"
            },
            "contraindications": "Same as above",
            "monitoring": "Same; MONITOR CLOSELY for steroid-induced exacerbation; consider concurrent IVIG/PLEX for protection",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Methylprednisolone IV (pulse therapy)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Methylprednisolone IV (pulse therapy) 1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg IV daily × 3-5 days; transition to oral prednisone taper",
              "orderSentence": "Methylprednisolone IV (pulse therapy) 1000 mg IV"
            },
            "contraindications": "Active untreated infection; uncontrolled diabetes; psychosis",
            "monitoring": "Glucose q6h (target <180); BP; mood; cardiac monitoring; GI prophylaxis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Omeprazole (GI prophylaxis during steroids)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20-40 mg",
                  "orderSentence": "Omeprazole (GI prophylaxis during steroids) 20-40 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "20-40 mg daily while on steroids",
              "orderSentence": "Omeprazole (GI prophylaxis during steroids) 20-40 mg PO"
            },
            "contraindications": "PPI allergy",
            "monitoring": "None routine",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Insulin sliding scale (steroid-induced hyperglycemia)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "180 mg",
                  "orderSentence": "Insulin sliding scale (steroid-induced hyperglycemia) 180 mg -"
                }
              ],
              "route": "-",
              "instructions": "Per protocol if glucose >180 mg/dL",
              "orderSentence": "Insulin sliding scale (steroid-induced hyperglycemia) 180 mg -"
            },
            "contraindications": "Hypoglycemia risk",
            "monitoring": "Glucose q6h",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Calcium carbonate + Vitamin D (bone protection)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000-1200 mg",
                  "orderSentence": "Calcium carbonate + Vitamin D (bone protection) 1000-1200 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Calcium 1000-1200 mg + Vitamin D 1000-2000 IU daily while on chronic steroids",
              "orderSentence": "Calcium carbonate + Vitamin D (bone protection) 1000-1200 mg PO"
            },
            "contraindications": "Hypercalcemia; hyperparathyroidism",
            "monitoring": "Serum calcium; consider DEXA if anticipated steroid course >3 months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Bisphosphonate (bone protection if chronic steroids)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "70 mg",
                  "orderSentence": "Bisphosphonate (bone protection if chronic steroids) 70 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Alendronate 70 mg PO weekly OR risedronate 35 mg PO weekly; start if steroids expected >3 months",
              "orderSentence": "Bisphosphonate (bone protection if chronic steroids) 70 mg PO"
            },
            "contraindications": "GFR <35; esophageal disorders; inability to remain upright 30 min",
            "monitoring": "DEXA at baseline; renal function; dental exam (ONJ risk)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trimethoprim-sulfamethoxazole (PCP prophylaxis)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "800 mg",
                  "orderSentence": "Trimethoprim-sulfamethoxazole (PCP prophylaxis) 800 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "1 DS tablet (160/800 mg) daily or 3 times per week if prednisone ≥20 mg for ≥4 weeks",
              "orderSentence": "Trimethoprim-sulfamethoxazole (PCP prophylaxis) 800 mg PO"
            },
            "contraindications": "Sulfonamide allergy; severe renal impairment",
            "monitoring": "CBC; renal function; use dapsone or atovaquone if allergic",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Prednisone taper",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-10 mg",
                  "orderSentence": "Prednisone taper 5-10 mg -"
                }
              ],
              "route": "-",
              "instructions": "Once stable on target dose for 4-8 weeks: decrease by 5-10 mg every 2-4 weeks until 20 mg, then decrease by 2.5-5 mg monthly; target lowest effective dose or off",
              "orderSentence": "Prednisone taper 5-10 mg -"
            },
            "contraindications": "Do NOT stop abruptly if >2 weeks of therapy",
            "monitoring": "Adrenal insufficiency symptoms; disease flare; cortisol level if concerns",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Steroid-Sparing Immunosuppressive Agents": [
          {
            "item": "Mycophenolate mofetil (CellCept)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Mycophenolate mofetil (CellCept) 500 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 500 mg BID; increase to 1000 mg BID after 2 weeks; target 2000-3000 mg/day in divided doses; onset 6-12 months",
              "orderSentence": "Mycophenolate mofetil (CellCept) 500 mg PO"
            },
            "contraindications": "Pregnancy (Category D - teratogenic); concurrent azathioprine",
            "monitoring": "CBC q2 weeks × 3 months, then monthly; LFTs; GI side effects (diarrhea, nausea); lymphopenia; REMS pregnancy prevention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Azathioprine (Imuran)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Azathioprine (Imuran) 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg daily; increase by 50 mg every 1-2 weeks to target 2-3 mg/kg/day (typically 150-250 mg/day); onset 6-18 months",
              "orderSentence": "Azathioprine (Imuran) 50 mg PO"
            },
            "contraindications": "TPMT deficiency (check before starting); concurrent allopurinol (reduce dose by 75%); pregnancy (relative)",
            "monitoring": "TPMT genotype/activity BEFORE starting; CBC q1-2 weeks during titration, then monthly; LFTs; amylase/lipase if abdominal pain; lymphocyte count target 600-1000",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tacrolimus (Prograf)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg",
                  "orderSentence": "Tacrolimus (Prograf) 1 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1 mg BID; titrate to trough level 5-10 ng/mL; onset 3-6 months (faster than MMF/AZA)",
              "orderSentence": "Tacrolimus (Prograf) 1 mg PO"
            },
            "contraindications": "Uncontrolled hypertension; renal impairment",
            "monitoring": "Trough levels; renal function q2 weeks then monthly; electrolytes (K, Mg); glucose; BP; tremor; nephrotoxicity",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cyclosporine (Sandimmune/Neoral)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-3 mg/kg",
                  "orderSentence": "Cyclosporine (Sandimmune/Neoral) 2-3 mg/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2-3 mg/kg/day in 2 divided doses; target trough 100-150 ng/mL; onset 2-6 months",
              "orderSentence": "Cyclosporine (Sandimmune/Neoral) 2-3 mg/kg PO"
            },
            "contraindications": "Uncontrolled hypertension; renal impairment; concurrent nephrotoxic drugs",
            "monitoring": "Trough levels; renal function; BP; electrolytes (K, Mg); lipids; gingival hyperplasia; hirsutism",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Methotrexate",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-20 mg",
                  "orderSentence": "Methotrexate 10-20 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "10-20 mg PO or SC once weekly with folic acid 1 mg daily (except methotrexate day); onset 6-12 months",
              "orderSentence": "Methotrexate 10-20 mg SC"
            },
            "contraindications": "Pregnancy (Category X); hepatic disease; renal impairment (CrCl <30); concurrent trimethoprim",
            "monitoring": "CBC q4 weeks; LFTs q8-12 weeks; renal function; pulmonary toxicity screen; folic acid supplementation mandatory",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Cyclophosphamide (refractory/severe)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500-1000 mg",
                  "orderSentence": "Cyclophosphamide (refractory/severe) 500-1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Pulse IV: 500-1000 mg/m² monthly × 6 months; OR oral 1-2 mg/kg/day; reserved for refractory MG",
              "orderSentence": "Cyclophosphamide (refractory/severe) 500-1000 mg IV"
            },
            "contraindications": "Pregnancy; active infection; bone marrow suppression",
            "monitoring": "CBC weekly during treatment; urinalysis (hemorrhagic cystitis - MESNA with IV dosing); fertility counseling; malignancy risk",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "EXT"
          },
          {
            "item": "IVIG (maintenance immunomodulation)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2 g/kg",
                  "orderSentence": "IVIG (maintenance immunomodulation) 1-2 g/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "1-2 g/kg divided over 2-5 days, then 0.4-1 g/kg every 4 weeks as maintenance",
              "orderSentence": "IVIG (maintenance immunomodulation) 1-2 g/kg PO"
            },
            "contraindications": "IgA deficiency (check IgA level first); recent thrombotic event; renal failure",
            "monitoring": "Pre-infusion: IgA level, renal function, CBC; during: vital signs q15 min first hour; headache; aseptic meningitis; thrombosis risk; renal function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          }
        ],
        "Biologics, Complement Inhibitors & Rescue Therapies": [
          {
            "item": "Rituximab (Rituxan)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "375 mg",
                  "orderSentence": "Rituximab (Rituxan) 375 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "375 mg/m² IV weekly × 4 weeks; OR 1000 mg IV × 2 doses 14 days apart; re-dose when CD19/CD20 recover or clinical worsening; onset 3-6 months",
              "orderSentence": "Rituximab (Rituxan) 375 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Active Hepatitis B; active infection; severe immunodeficiency",
            "monitoring": "HBV serology before; CD19/CD20 counts q3-6 months; immunoglobulins q6 months; PML risk (very rare); infusion reactions (premedicate with acetaminophen, diphenhydramine, methylprednisolone)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Eculizumab (Soliris)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "900 mg",
                  "orderSentence": "Eculizumab (Soliris) 900 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "900 mg IV weekly × 4 weeks, then 1200 mg IV at week 5, then 1200 mg IV every 2 weeks; for AChR-positive generalized MG",
              "orderSentence": "Eculizumab (Soliris) 900 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Unresolved Neisseria meningitidis infection; unvaccinated against meningococcus",
            "monitoring": "Meningococcal vaccine ≥2 weeks before; REMS program; CBC; LDH/reticulocyte (hemolysis on discontinuation); signs of meningococcal infection; ciprofloxacin prophylaxis recommended",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ravulizumab (Ultomiris)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "Weight-based loading dose IV, then maintenance every 8 weeks; for AChR-positive generalized MG",
              "orderSentence": "Ravulizumab (Ultomiris) - IV - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "Same as eculizumab",
            "monitoring": "Same as eculizumab; less frequent dosing advantage",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Zilucoplan (Zilbrysq)",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.3 mg/kg",
                  "orderSentence": "Zilucoplan (Zilbrysq) 0.3 mg/kg SC"
                }
              ],
              "route": "SC",
              "instructions": "0.3 mg/kg SC daily (self-administered); for AChR-positive generalized MG",
              "orderSentence": "Zilucoplan (Zilbrysq) 0.3 mg/kg SC"
            },
            "pretreatment": "-",
            "contraindications": "Same as eculizumab",
            "monitoring": "Same meningococcal vaccination required; injection site reactions; LDH; reticulocyte count",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Efgartigimod (Vyvgart)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg",
                  "orderSentence": "Efgartigimod (Vyvgart) 10 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV weekly × 4 weeks per cycle; may repeat based on clinical response; for AChR-positive generalized MG",
              "orderSentence": "Efgartigimod (Vyvgart) 10 mg/kg IV"
            },
            "pretreatment": "-",
            "contraindications": "Active infection; concurrent IgG-dependent therapies",
            "monitoring": "IgG levels (expect ~70% reduction); infection monitoring; no meningococcal vaccine required",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Efgartigimod/hyaluronidase SC (Vyvgart Hytrulo)",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1008 mg",
                  "orderSentence": "Efgartigimod/hyaluronidase SC (Vyvgart Hytrulo) 1008 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "1008 mg efgartigimod + 11,200 units hyaluronidase SC weekly × 4 weeks per cycle",
              "orderSentence": "Efgartigimod/hyaluronidase SC (Vyvgart Hytrulo) 1008 mg SC"
            },
            "pretreatment": "-",
            "contraindications": "Same as IV efgartigimod",
            "monitoring": "Same; injection site reactions; self-administered option",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rozanolixizumab (Rystiggo)",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "instructions": "Weight-based SC weekly × 6 weeks per cycle; for AChR-positive generalized MG",
              "orderSentence": "Rozanolixizumab (Rystiggo) - SC - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "Active infection",
            "monitoring": "IgG levels; headache common; pyrexia; infection monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Plasmapheresis (PLEX) - rescue",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "5-7 exchanges over 10-14 days; exchange 1-1.5 plasma volumes per session",
              "orderSentence": "Plasmapheresis (PLEX) - rescue - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "Hemodynamic instability; sepsis; line contraindication; heparin allergy",
            "monitoring": "BP during exchange; electrolytes (Ca, K, Mg); coagulation studies; fibrinogen; line site infection; hypotension",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "IVIG (rescue therapy)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g/kg",
                  "orderSentence": "IVIG (rescue therapy) 2 g/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "2 g/kg divided over 2-5 days (e.g., 0.4 g/kg/day × 5 days)",
              "orderSentence": "IVIG (rescue therapy) 2 g/kg PO"
            },
            "pretreatment": "-",
            "contraindications": "IgA deficiency; renal failure; recent thrombotic event",
            "monitoring": "Pre-infusion IgA level; renal function; vital signs; headache (aseptic meningitis); thrombosis risk",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Surgical Treatment": [
          {
            "item": "Thymectomy (VATS or robotic-assisted)",
            "route": "-",
            "indication": "AChR-positive generalized MG, age 18-65 (MGTX trial); any age with thymoma; consider in AChR-positive ocular MG with suboptimal response",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Thymectomy (VATS or robotic-assisted) - - - see dosing"
            },
            "contraindications": "MuSK-positive MG (no proven benefit); medically unstable; uncontrolled MG (optimize first)",
            "monitoring": "MGTX trial: thymectomy + prednisone superior to prednisone alone at 3 years; optimize MG before surgery (FVC >2L, no bulbar crisis); post-op ICU monitoring recommended",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Thymectomy (median sternotomy)",
            "route": "-",
            "indication": "Thymoma requiring complete resection; invasive thymoma",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Thymectomy (median sternotomy) - - - see dosing"
            },
            "contraindications": "Same as above",
            "monitoring": "More invasive; complete thymoma staging with Masaoka classification; consider neoadjuvant chemotherapy for advanced thymoma",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Extended thymectomy",
            "route": "-",
            "indication": "Thymoma with suspected extra-thymic extension",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Extended thymectomy - - - see dosing"
            },
            "contraindications": "Same as above",
            "monitoring": "Includes removal of all anterior mediastinal fat; en bloc resection",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neuromuscular specialist/MG specialist referral",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "All new MG diagnoses for treatment planning and long-term management"
          },
          {
            "item": "Thoracic surgery referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Thymoma present; AChR-positive generalized MG for thymectomy discussion"
          },
          {
            "item": "Pulmonology referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Respiratory compromise; pre-thymectomy pulmonary evaluation; chronic respiratory monitoring"
          },
          {
            "item": "Speech-language pathology (swallow evaluation)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Bulbar symptoms: dysphagia, dysarthria, nasal speech; aspiration risk"
          },
          {
            "item": "Occupational therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "ADL impairment; energy conservation; adaptive equipment"
          },
          {
            "item": "Physical therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "indication": "Generalized weakness; deconditioning; fall prevention; exercise prescription"
          },
          {
            "item": "Ophthalmology/Neuro-ophthalmology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Ocular MG; diplopia management; prism evaluation"
          },
          {
            "item": "Rheumatology referral",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Concurrent autoimmune disease (lupus, RA, thyroid disease)"
          },
          {
            "item": "Endocrinology referral",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Steroid-induced diabetes; thyroid disease management; osteoporosis"
          },
          {
            "item": "Psychiatry/Psychology referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Depression; anxiety; adjustment to chronic diagnosis; steroid-induced psychiatric symptoms"
          },
          {
            "item": "Social work consult",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Insurance navigation (biologic cost); disability evaluation; MG support resources"
          },
          {
            "item": "Respiratory therapy",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "FVC/NIF monitoring; ventilator management; BiPAP/CPAP evaluation"
          },
          {
            "item": "Nutrition/Dietetics",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Dysphagia diet modification; weight management on steroids; nutritional optimization"
          },
          {
            "item": "Anesthesiology consultation (pre-thymectomy)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Pre-operative assessment; avoidance of neuromuscular blocking agents; post-op ventilation planning"
          },
          {
            "item": "Infusion center coordination",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "IVIG scheduling; rituximab infusion; complement inhibitor infusions"
          },
          {
            "item": "Pain management referral",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "indication": "Chronic pain from sustained muscle weakness or comorbid conditions"
          },
          {
            "item": "Palliative care (refractory cases)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "indication": "Severely refractory MG with significant symptom burden; goals of care discussion"
          },
          {
            "item": "MG Foundation / Patient advocacy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Patient support groups; educational materials; myasthenia.org referral"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return to ED immediately if difficulty breathing, swallowing, or speaking",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Return to ED if new severe weakness, double vision worsening acutely, or unable to hold head up",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Take pyridostigmine 30-60 minutes BEFORE meals to help with chewing and swallowing",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Do NOT take pyridostigmine more frequently than prescribed (cholinergic crisis risk)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Report excessive salivation, diarrhea, cramping, or muscle twitching (cholinergic side effects)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Carry MG medical alert identification at all times",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Provide MG medication list to ALL healthcare providers (emergency, dental, surgical)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Avoid extreme heat, hot baths/saunas (may worsen weakness)",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Plan activities for times of best strength (usually morning after pyridostigmine)",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Rest before meals if dysphagia present; eat smaller, more frequent meals",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Do NOT stop prednisone or immunosuppressant abruptly (adrenal crisis/flare risk)",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Avoid alcohol (potentiates weakness and interacts with medications)",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Report any signs of infection immediately (fever, cough, dysuria) especially if on immunosuppression",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Contact neurologist before taking any new medications (many drugs worsen MG)",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Do NOT use over-the-counter magnesium-containing products without physician approval",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Keep emergency contact numbers for MG specialist readily available",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Understand the difference between myasthenic crisis and cholinergic crisis",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Monitor and report progressive difficulty climbing stairs, rising from chairs, or lifting arms above head",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Lambert-Eaton Myasthenic Syndrome (LEMS)",
        "features": "Proximal weakness with improvement after exertion (facilitation); autonomic dysfunction; dry mouth; associated with SCLC; depressed reflexes that improve post-exercise",
        "tests": "VGCC antibody (P/Q-type); incremental response on RNS at 50 Hz; CT chest for malignancy"
      },
      {
        "diagnosis": "Botulism",
        "features": "Acute onset descending paralysis; dilated/fixed pupils; recent ingestion of canned food or wound; autonomic dysfunction; no prior NMJ disease",
        "tests": "Stool/serum botulinum toxin assay; EMG: BSAP pattern; incremental response on high-frequency RNS"
      },
      {
        "diagnosis": "Congenital Myasthenic Syndromes (CMS)",
        "features": "Childhood onset; family history; seronegative; variable inheritance patterns; specific gene mutations",
        "tests": "Genetic testing (CMS gene panel: CHRNE, DOK7, RAPSN, CHAT, COLQ); no autoantibodies"
      },
      {
        "diagnosis": "Thyroid ophthalmopathy (Graves)",
        "features": "Proptosis; restrictive (not fatigable) diplopia; lid lag; thyroid dysfunction; MRI shows enlarged EOMs",
        "tests": "TSH, free T4, TSI, orbital MRI showing EOM enlargement (not NMJ issue)"
      },
      {
        "diagnosis": "Progressive external ophthalmoplegia (PEO)",
        "features": "Slowly progressive bilateral ptosis and ophthalmoparesis; non-fatigable; no diurnal variation; may have pigmentary retinopathy",
        "tests": "Muscle biopsy (ragged red fibers, COX-negative); mitochondrial DNA analysis"
      },
      {
        "diagnosis": "Oculopharyngeal muscular dystrophy (OPMD)",
        "features": "Late-onset (>40) progressive ptosis and dysphagia; autosomal dominant; no fatigability; specific ethnic prevalence (French-Canadian, Bukharan Jewish)",
        "tests": "Genetic testing (PABPN1 gene, GCN trinucleotide repeat); CK may be mildly elevated"
      },
      {
        "diagnosis": "Motor neuron disease (ALS/PBP)",
        "features": "Progressive weakness without fatigability; fasciculations; UMN signs (hyperreflexia, Babinski); no sensory loss; bulbar onset may mimic MG",
        "tests": "EMG/NCS: active denervation, fasciculations; normal RNS; no antibodies"
      },
      {
        "diagnosis": "Inflammatory myopathy (PM/DM/IBM)",
        "features": "Proximal weakness without fatigability; elevated CK; skin findings in DM; no ptosis/diplopia (usually); IBM with grip/quad weakness",
        "tests": "CK; myositis antibody panel; EMG: myopathic pattern; muscle biopsy"
      },
      {
        "diagnosis": "Brainstem stroke",
        "features": "Acute onset; cranial nerve palsies without fatigability; other focal neurological signs; vascular risk factors",
        "tests": "Brain MRI with DWI; MRA; CTA"
      },
      {
        "diagnosis": "Miller Fisher syndrome (GBS variant)",
        "features": "Acute ophthalmoplegia, ataxia, areflexia; post-infectious; no fatigability",
        "tests": "Anti-GQ1b antibody; CSF albuminocytologic dissociation; NCS (reduced SNAPs)"
      },
      {
        "diagnosis": "Myotonic dystrophy",
        "features": "Ptosis and facial weakness; myotonia (delayed relaxation); distal > proximal weakness; cataracts; cardiac conduction abnormalities",
        "tests": "Genetic testing (DMPK CTG repeat for DM1, CNBP CCTG repeat for DM2); EMG: myotonic discharges"
      },
      {
        "diagnosis": "Chronic inflammatory demyelinating polyneuropathy (CIDP)",
        "features": "Progressive proximal and distal weakness; hyporeflexia/areflexia; sensory involvement; elevated CSF protein",
        "tests": "NCS: demyelinating pattern; CSF protein; nerve biopsy"
      },
      {
        "diagnosis": "Sarcoidosis (neuromuscular)",
        "features": "Granulomatous myopathy or cranial neuropathy; systemic involvement (lungs, skin, eyes); elevated ACE",
        "tests": "ACE level; chest CT; biopsy (non-caseating granulomas); gallium scan"
      },
      {
        "diagnosis": "Drug-induced MG",
        "features": "Temporal correlation with offending drug (D-penicillamine, checkpoint inhibitors, statins); antibodies may be present",
        "tests": "Drug history; antibody testing; improvement after drug withdrawal"
      }
    ],
    "evidence": [
      {
        "recommendation": "AChR antibody testing for MG diagnosis",
        "evidenceLevel": "Class I",
        "source": "[Gilhus NE et al. Nat Rev Dis Primers 2019](https://pubmed.ncbi.nlm.nih.gov/31048702/)"
      },
      {
        "recommendation": "AChR binding + blocking + modulating antibodies increases sensitivity to ~95%",
        "evidenceLevel": "Class II",
        "source": "Howard JF. Clinical Overview of MG. UpToDate 2024"
      },
      {
        "recommendation": "MuSK antibody testing in seronegative MG",
        "evidenceLevel": "Class I",
        "source": "[Hoch W et al. Nat Med 2001](https://pubmed.ncbi.nlm.nih.gov/11231638/); [Evoli A et al. Brain 2003](https://pubmed.ncbi.nlm.nih.gov/12821509/)"
      },
      {
        "recommendation": "LRP4 antibody in double-seronegative MG",
        "evidenceLevel": "Class II",
        "source": "[Higuchi O et al. Ann Neurol 2011](https://pubmed.ncbi.nlm.nih.gov/21387385/); [Zisimopoulou P et al. J Autoimmun 2014](https://pubmed.ncbi.nlm.nih.gov/24373505/)"
      },
      {
        "recommendation": "RNS: ≥10% decrement diagnostic criterion",
        "evidenceLevel": "Class I, Level A",
        "source": "AANEM Practice Parameter 2001; Sanders DB et al."
      },
      {
        "recommendation": "SFEMG most sensitive diagnostic test (95-99%)",
        "evidenceLevel": "Class I, Level A",
        "source": "[Sanders DB, Stalberg EV. Muscle Nerve 1996](https://pubmed.ncbi.nlm.nih.gov/8761262/)"
      },
      {
        "recommendation": "Ice pack test for ocular MG (~80% sensitivity)",
        "evidenceLevel": "Class II, Level B",
        "source": "Cubero E et al. Neurology 2000"
      },
      {
        "recommendation": "CT chest for thymoma screening in all MG patients",
        "evidenceLevel": "Class I, Level A",
        "source": "[Gilhus NE et al. Nat Rev Dis Primers 2019](https://pubmed.ncbi.nlm.nih.gov/31048702/); AAN Guidelines"
      },
      {
        "recommendation": "Pyridostigmine as first-line symptomatic therapy",
        "evidenceLevel": "Class I, Level A",
        "source": "[Mehndiratta MM et al. Cochrane 2011](https://pubmed.ncbi.nlm.nih.gov/21328290/)"
      },
      {
        "recommendation": "MuSK-MG often refractory to pyridostigmine",
        "evidenceLevel": "Class II",
        "source": "[Evoli A et al. Brain 2003](https://pubmed.ncbi.nlm.nih.gov/12821509/); Guptill JT et al. 2011"
      },
      {
        "recommendation": "Prednisone for MG immunosuppression",
        "evidenceLevel": "Class I, Level A",
        "source": "[Palace J et al. Neurology 1998](https://pubmed.ncbi.nlm.nih.gov/9633727/)"
      },
      {
        "recommendation": "Steroid-induced transient worsening in ~50% of MG patients",
        "evidenceLevel": "Class II",
        "source": "Bae JS et al. Muscle Nerve 2006"
      },
      {
        "recommendation": "Mycophenolate mofetil as steroid-sparing agent",
        "evidenceLevel": "Class I (negative RCTs but widely used)",
        "source": "Sanders DB et al. Neurology 2008; MG Study Group (note: RCTs were short-duration)"
      },
      {
        "recommendation": "Azathioprine as steroid-sparing agent",
        "evidenceLevel": "Class I, Level B",
        "source": "[Palace J et al. Neurology 1998](https://pubmed.ncbi.nlm.nih.gov/9633727/)"
      },
      {
        "recommendation": "TPMT testing before azathioprine",
        "evidenceLevel": "Class I, Level A",
        "source": "Pharmacogenomics guidelines; FDA labeling"
      },
      {
        "recommendation": "Rituximab for MuSK-positive MG",
        "evidenceLevel": "Class II (observational)",
        "source": "[Diaz-Manera J et al. Neurology 2012](https://pubmed.ncbi.nlm.nih.gov/22218276/); [Hehir MK et al. Neurology 2017](https://pubmed.ncbi.nlm.nih.gov/28801338/)"
      },
      {
        "recommendation": "Rituximab for AChR-positive refractory MG",
        "evidenceLevel": "Class II",
        "source": "Tandan R et al. (BeatMG trial) Lancet Neurol 2023"
      },
      {
        "recommendation": "Eculizumab for AChR-positive generalized MG",
        "evidenceLevel": "Class I (REGAIN trial)",
        "source": "[Howard JF et al. Lancet Neurol 2017](https://pubmed.ncbi.nlm.nih.gov/29066163/)"
      },
      {
        "recommendation": "Ravulizumab for AChR-positive generalized MG",
        "evidenceLevel": "Class I (CHAMPION-MG)",
        "source": "[Vu T et al. NEJM Evidence 2022](https://pubmed.ncbi.nlm.nih.gov/38319212/)"
      },
      {
        "recommendation": "Zilucoplan for AChR-positive generalized MG",
        "evidenceLevel": "Class I (RAISE trial)",
        "source": "[Howard JF et al. Lancet Neurol 2023](https://pubmed.ncbi.nlm.nih.gov/37059508/)"
      },
      {
        "recommendation": "Efgartigimod for AChR-positive generalized MG",
        "evidenceLevel": "Class I (ADAPT trial)",
        "source": "[Howard JF et al. Lancet Neurol 2021](https://pubmed.ncbi.nlm.nih.gov/34146511/)"
      },
      {
        "recommendation": "Rozanolixizumab for AChR-positive generalized MG",
        "evidenceLevel": "Class I (MycarinG trial)",
        "source": "[Bril V et al. Lancet Neurol 2023](https://pubmed.ncbi.nlm.nih.gov/37059507/)"
      },
      {
        "recommendation": "IVIG for MG acute exacerbation and maintenance",
        "evidenceLevel": "Class I, Level A",
        "source": "[Gajdos P et al. Cochrane 2012](https://pubmed.ncbi.nlm.nih.gov/23235588/)"
      },
      {
        "recommendation": "PLEX for myasthenic crisis",
        "evidenceLevel": "Class I, Level A",
        "source": "[Gajdos P et al. Cochrane 2012](https://pubmed.ncbi.nlm.nih.gov/23235588/)"
      },
      {
        "recommendation": "IVIG equivalent to PLEX for MG exacerbation",
        "evidenceLevel": "Class I",
        "source": "[Barth D et al. Neurology 2011](https://pubmed.ncbi.nlm.nih.gov/21562253/)"
      },
      {
        "recommendation": "Thymectomy for non-thymomatous AChR-positive MG",
        "evidenceLevel": "Class I (MGTX trial)",
        "source": "[Wolfe GI et al. NEJM 2016](https://pubmed.ncbi.nlm.nih.gov/27509100/)"
      },
      {
        "recommendation": "MGTX trial: thymectomy + prednisone superior at 3 years",
        "evidenceLevel": "Class I",
        "source": "[Wolfe GI et al. NEJM 2016](https://pubmed.ncbi.nlm.nih.gov/27509100/); 5-year extension data 2019"
      },
      {
        "recommendation": "Medications to avoid in MG (comprehensive review)",
        "evidenceLevel": "Class II-III",
        "source": "[Gilhus NE. NEJM 2016](https://pubmed.ncbi.nlm.nih.gov/28029925/); Sheikh S et al. Muscle Nerve 2021"
      },
      {
        "recommendation": "FVC <15 mL/kg predicts need for intubation",
        "evidenceLevel": "Class II, Level B",
        "source": "[Thomas CE et al. Neurology 1997](https://pubmed.ncbi.nlm.nih.gov/9153452/)"
      },
      {
        "recommendation": "NIF weaker than -20 cm H2O: intubation threshold",
        "evidenceLevel": "Class II, Level B",
        "source": "[Thomas CE et al. Neurology 1997](https://pubmed.ncbi.nlm.nih.gov/9153452/)"
      },
      {
        "recommendation": "MG-ADL as validated outcome measure",
        "evidenceLevel": "Class I",
        "source": "[Wolfe GI et al. Neurology 1999](https://pubmed.ncbi.nlm.nih.gov/10227640/)"
      },
      {
        "recommendation": "QMG score as validated outcome measure",
        "evidenceLevel": "Class I",
        "source": "[Barohn RJ et al. Ann NY Acad Sci 1998](https://pubmed.ncbi.nlm.nih.gov/9668327/)"
      },
      {
        "recommendation": "MGFA Clinical Classification system",
        "evidenceLevel": "Consensus",
        "source": "[Jaretzki A et al. Neurology 2000](https://pubmed.ncbi.nlm.nih.gov/10891897/)"
      },
      {
        "recommendation": "Meningococcal vaccination before complement inhibitors",
        "evidenceLevel": "FDA requirement",
        "source": "FDA REMS for eculizumab/ravulizumab/zilucoplan"
      },
      {
        "recommendation": "Pregnancy management in MG",
        "evidenceLevel": "Class II-III",
        "source": "[Norwood F et al. J Neurol Neurosurg Psychiatry 2014](https://pubmed.ncbi.nlm.nih.gov/23757420/); [Batocchi AP et al. Neurology 1999](https://pubmed.ncbi.nlm.nih.gov/10025772/)"
      },
      {
        "recommendation": "Transient neonatal MG in 10-20% of births",
        "evidenceLevel": "Class II",
        "source": "[Hoff JM et al. Neurology 2003](https://pubmed.ncbi.nlm.nih.gov/14638956/)"
      }
    ],
    "monitoring": [
      {
        "item": "Forced vital capacity (FVC)",
        "frequency": "Q4-6h in acute; Q shift if stable",
        "action": "If <15 mL/kg or <1 L: impending respiratory failure, prepare for intubation; ICU transfer"
      },
      {
        "item": "Negative inspiratory force (NIF/MIP)",
        "frequency": "Q4-6h in acute; Q shift if stable",
        "action": "If weaker than -20 cm H2O: intubate; -20 to -30 = ICU monitoring"
      },
      {
        "item": "Peak expiratory flow (PEF)",
        "frequency": "Q4-6h in acute",
        "action": "Declining PEF = weakening respiratory muscles"
      },
      {
        "item": "Oxygen saturation (SpO2)",
        "frequency": "Continuous in acute",
        "action": "Supplemental O2; BiPAP; intubation if declining"
      },
      {
        "item": "Swallow function assessment",
        "frequency": "Daily; each meal if bulbar symptoms",
        "action": "NPO if aspiration risk; NG tube or modified diet; SLP consult"
      },
      {
        "item": "Neurologic exam (MG-specific)",
        "frequency": "Q shift inpatient; BID in ICU",
        "action": "If worsening: reassess pyridostigmine dose; consider IVIG/PLEX; check for cholinergic crisis"
      },
      {
        "item": "Blood glucose",
        "frequency": "Q6h during IV/high-dose steroids",
        "action": "Insulin sliding scale; endocrine consult if persistent >250"
      },
      {
        "item": "Blood pressure",
        "frequency": "Q shift during steroids",
        "action": "Antihypertensives PRN"
      },
      {
        "item": "Temperature",
        "frequency": "Q shift",
        "action": "Infection workup if febrile (infection is leading MG crisis trigger)"
      },
      {
        "item": "Electrolytes (K, Mg, Ca, Phos)",
        "frequency": "Daily while acute",
        "action": "Replace aggressively; hypokalemia and hypomagnesemia worsen NMJ transmission"
      },
      {
        "item": "I/O and daily weight",
        "frequency": "Daily (inpatient)",
        "action": "Adjust fluids; diuretics if overload"
      },
      {
        "item": "Cardiac monitoring",
        "frequency": "Continuous if on neostigmine IV; during PLEX",
        "action": "Atropine for bradycardia; PLEX can cause electrolyte-mediated arrhythmias"
      },
      {
        "item": "Mood and sleep assessment",
        "frequency": "Daily during steroids",
        "action": "Psychiatry consult; consider dose adjustment"
      },
      {
        "item": "Aspiration precautions",
        "frequency": "Throughout admission if bulbar symptoms",
        "action": "HOB elevated; thickened liquids; SLP-guided diet"
      }
    ],
    "disposition": [
      {
        "disposition": "**Discharge home**",
        "criteria": "Mild symptoms (ocular only or mild generalized); FVC >60% predicted and stable; adequate oral intake; pyridostigmine optimized; reliable follow-up within 1-2 weeks; understands return precautions; crisis action plan reviewed"
      },
      {
        "disposition": "**Admit to floor (general neurology)**",
        "criteria": "Moderate generalized weakness; FVC 40-60% predicted and stable; dysphagia requiring diet modification but tolerating PO; new diagnosis requiring expedited workup; steroid initiation with concern for transient worsening; IVIG infusion"
      },
      {
        "disposition": "**Admit to step-down/telemetry**",
        "criteria": "FVC 30-40% predicted or declining trend; moderate bulbar symptoms; starting PLEX; significant comorbidities requiring closer monitoring; recent cholinergic vs myasthenic crisis distinction unclear"
      },
      {
        "disposition": "**Admit to ICU**",
        "criteria": "FVC <30% predicted or <1 L; NIF weaker than -25 cm H2O; progressive respiratory failure; impending intubation; active myasthenic crisis; severe bulbar dysfunction with aspiration; hemodynamic instability during PLEX"
      },
      {
        "disposition": "**Transfer to higher level**",
        "criteria": "PLEX needed but unavailable; neuromuscular specialist not available; ICU capability needed but not present; thymectomy needed at specialized center"
      },
      {
        "disposition": "**Discharge from hospital**",
        "criteria": "FVC >50% predicted and improving; adequate oral intake; stable on oral medications; immunotherapy plan established; outpatient follow-up scheduled within 1-2 weeks; patient and family educated on crisis recognition"
      }
    ]
  },
  "Neuromuscular Respiratory Failure": {
    "id": "neuromuscular-respiratory-failure",
    "title": "Neuromuscular Respiratory Failure",
    "version": "1.0",
    "icd10": [
      "** G70.00 (Myasthenia gravis without exacerbation)",
      "G70.01 (Myasthenia gravis with exacerbation)",
      "G61.0 (Guillain-Barré syndrome)",
      "J96.00 (Acute respiratory failure",
      "unspecified hypoxia/hypercapnia)",
      "G71.0 (Muscular dystrophy)",
      "G12.21 (Amyotrophic lateral sclerosis)"
    ],
    "scope": "** Emergency evaluation and management of respiratory failure from neuromuscular disorders in adults. Covers recognition of impending respiratory failure, monitoring parameters (FVC, NIF), indications for intubation, non-invasive ventilation (NIV) considerations, disease-specific treatments (myasthenia gravis crisis, GBS, ALS, muscular dystrophy, other myopathies), and weaning considerations. Excludes central causes of respiratory failure (brainstem stroke, sedative overdose) and primary pulmonary causes (pneumonia, ARDS, COPD exacerbation).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Arterial blood gas (ABG)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "**CRITICAL**: Assess ventilation (PaCO2) and oxygenation (PaO2); hypercapnia (PaCO2 >45) indicates hypoventilation; respiratory acidosis = severe; PaO2/FiO2 ratio",
            "target": "Normal: pH 7.35-7.45, PaCO2 35-45, PaO2 >80; **Hypercapnia with respiratory acidosis = impending/current respiratory failure** — consider intubation"
          },
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Infection (pneumonia as trigger or complication); baseline; anemia (reduces O2 carrying capacity)",
            "target": "Normal; leukocytosis → infection; anemia → correct"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Electrolytes (K, Mg, Ca, Phos — all affect muscle function); renal function; glucose",
            "target": "Normal; hypokalemia, hypophosphatemia, hypomagnesemia, hypocalcemia can all worsen neuromuscular weakness"
          },
          {
            "item": "Magnesium",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hypomagnesemia worsens neuromuscular junction transmission and muscle weakness",
            "target": ">2.0 mg/dL; replete if low"
          },
          {
            "item": "Phosphorus",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hypophosphatemia causes profound muscle weakness including respiratory muscles",
            "target": ">2.5 mg/dL; replete if low (can cause respiratory failure at <1.0)"
          },
          {
            "item": "Calcium (ionized)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hypocalcemia increases neuromuscular excitability; hypercalcemia causes weakness",
            "target": "Normal ionized Ca"
          },
          {
            "item": "Acetylcholine receptor (AChR) antibodies",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "**MG workup**: positive in 85% of generalized MG; 50% of ocular MG; confirms diagnosis",
            "target": "Positive = MG; negative does NOT exclude (check MuSK, LRP4)"
          },
          {
            "item": "Anti-MuSK antibodies",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "If AChR negative but MG suspected clinically; MuSK-positive MG has distinct features (bulbar predominant, may not respond well to cholinesterase inhibitors)",
            "target": "Positive = MuSK MG"
          },
          {
            "item": "Anti-LRP4 antibodies",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If both AChR and MuSK negative (\"seronegative MG\"); less commonly available",
            "target": "Positive = LRP4 MG (rare)"
          },
          {
            "item": "Creatine kinase (CK)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Elevated in myopathies, muscular dystrophies; may be normal in MG, GBS, ALS",
            "target": "Normal in MG, GBS; elevated in myopathies, rhabdomyolysis; very high (>10,000) in inflammatory myopathies, dystrophies"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Thyroid dysfunction: hyperthyroidism worsens MG; hypothyroidism causes myopathy",
            "target": "Normal"
          },
          {
            "item": "Procalcitonin / CRP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Infection as trigger (pneumonia, UTI can precipitate MG crisis); distinguish infection from disease exacerbation",
            "target": "Normal; elevated → infection workup"
          },
          {
            "item": "Urine drug screen",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Drugs affecting neuromuscular function; intoxication as mimicker",
            "target": "Negative"
          }
        ],
        "Extended Workup": [
          {
            "item": "Pyridostigmine level (if available)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "Rarely available; assess for cholinergic crisis (too much pyridostigmine vs. myasthenic crisis)",
            "target": "Therapeutic range varies; clinical assessment more reliable"
          },
          {
            "item": "Anti-ganglioside antibodies (GM1, GD1a, GD1b, GQ1b)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "GBS workup; GQ1b positive in Miller Fisher syndrome",
            "target": "Positive supports GBS diagnosis; negative does NOT exclude"
          },
          {
            "item": "CSF analysis",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "GBS: albuminocytologic dissociation (elevated protein, normal cells — may not be present in first week); exclude infection",
            "target": "GBS: protein elevated (>45 mg/dL), WBC <10 (usually <5); may be normal early"
          },
          {
            "item": "Repetitive nerve stimulation (RNS)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "**MG diagnosis**: decremental response at 3 Hz stimulation (>10% decrement) in proximal muscles",
            "target": ">10% decrement = neuromuscular junction defect (MG); no decrement does NOT exclude MG"
          },
          {
            "item": "Single-fiber EMG (SFEMG)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "**Most sensitive test for MG** (92-98%); increased jitter and blocking",
            "target": "Increased jitter = neuromuscular transmission defect"
          },
          {
            "item": "Nerve conduction studies / EMG",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "GBS: demyelinating pattern (prolonged F-waves, conduction block, temporal dispersion) or axonal (reduced amplitudes); ALS: widespread denervation; myopathy: myopathic units",
            "target": "GBS: demyelinating or axonal; ALS: diffuse denervation; myopathy: small, polyphasic MUPs"
          },
          {
            "item": "CT chest (with contrast)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "**Thymoma screening in MG**: 10-15% of MG patients have thymoma; all MG patients need chest imaging",
            "target": "Thymoma (anterior mediastinal mass); thymic hyperplasia; normal thymus"
          },
          {
            "item": "Anti-striational (anti-titin, anti-RyR) antibodies",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Associated with thymoma in MG; may indicate need for more aggressive thymoma search",
            "target": "Positive in older MG patients and thymoma-associated MG"
          },
          {
            "item": "Paraneoplastic antibody panel",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Paraneoplastic neuromuscular syndromes (LEMS with anti-VGCC and small cell lung cancer); myositis with malignancy",
            "target": "Anti-VGCC (LEMS); anti-Hu, anti-CV2 (paraneoplastic)"
          },
          {
            "item": "Anti-VGCC antibodies",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Lambert-Eaton myasthenic syndrome (LEMS); associated with SCLC in 50-60%",
            "target": "Positive = LEMS (check for underlying malignancy)"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Muscle biopsy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Inflammatory myopathy (dermatomyositis, polymyositis); muscular dystrophy; congenital myopathy",
            "target": "Inflammatory infiltrate; dystrophic changes; structural abnormalities"
          },
          {
            "item": "Genetic testing (muscular dystrophy panel)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Suspected hereditary myopathy/dystrophy; known family history; young patient with progressive weakness",
            "target": "Specific mutations (dystrophin, FSHD, myotonic dystrophy, etc.)"
          },
          {
            "item": "Myositis-specific antibodies (Jo-1, Mi-2, SRP, MDA5, etc.)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Inflammatory myopathy workup",
            "target": "Specific antibodies guide diagnosis and prognosis"
          },
          {
            "item": "Edrophonium (Tensilon) test",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Rarely done now (replaced by serologic testing and SFEMG); bedside MG test; risk of cholinergic crisis; atropine must be at bedside",
            "target": "Transient improvement = positive (MG); false positives/negatives occur"
          },
          {
            "item": "Ice pack test",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Bedside test for ocular MG; apply ice pack to closed eyelid for 2 min; improvement in ptosis suggests MG",
            "target": "Improvement = positive; negative does NOT exclude"
          },
          {
            "item": "Spirometry with flow-volume loop",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Upper airway obstruction pattern (variable extrathoracic obstruction in vocal cord weakness); restrictive pattern in neuromuscular disease",
            "target": "Restrictive pattern; flattened inspiratory loop suggests extrathoracic obstruction"
          },
          {
            "item": "Polysomnography",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Sleep-disordered breathing in neuromuscular disease; nocturnal hypoventilation; assess need for nocturnal NIV",
            "target": "Hypoventilation; desaturations; REM-related hypopneas"
          },
          {
            "item": "Pulmonary function tests (full)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Baseline and monitoring in chronic neuromuscular disease; FVC, MIP, MEP, SNIP",
            "target": "FVC; supine vs. upright FVC (>20% drop suggests diaphragm weakness)"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "LP with CSF analysis",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "GBS diagnosis (albuminocytologic dissociation); may be normal in first week; NOT typically needed for MG diagnosis",
            "target": "GBS: elevated protein (often >100 mg/dL after first week), normal WBC (<10, usually <5); cytoalbuminous dissociation",
            "contraindications": "Coagulopathy; skin infection at LP site; elevated ICP"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Chest X-ray",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Immediate; assess for aspiration, pneumonia (trigger for crisis), atelectasis, elevated hemidiaphragm",
            "target": "Aspiration pneumonia; atelectasis (from weak cough); elevated hemidiaphragm (diaphragm weakness); anterior mediastinal mass (thymoma)",
            "contraindications": "None"
          },
          {
            "item": "Bedside spirometry (FVC)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "**CRITICAL: q4-6h in unstable patients; q1-2h if rapidly declining**; most important monitoring parameter",
            "target": "FVC >20 mL/kg = adequate; FVC <15-20 mL/kg = consider intubation; FVC declining >30% from baseline = concerning",
            "contraindications": "Patient cooperation required; cannot perform if intubated (use ventilator parameters)"
          },
          {
            "item": "Negative inspiratory force (NIF/MIP)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "**CRITICAL: Assess inspiratory muscle strength**; complement to FVC; easier for fatigued patients",
            "target": "NIF < -30 cm H2O = adequate; NIF > -20 to -25 cm H2O (less negative) = weak, consider intubation",
            "contraindications": "Patient cooperation"
          },
          {
            "item": "Maximum expiratory pressure (MEP)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "Assess cough strength; correlates with ability to clear secretions",
            "target": "MEP <40 cm H2O = weak cough; aspiration risk"
          },
          {
            "item": "ABG (arterial blood gas)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Assess ventilation and oxygenation; hypercapnia is late sign",
            "target": "PaCO2 >45 = hypoventilation; rising PaCO2 is ominous; PaO2 <60 = hypoxemia"
          },
          {
            "item": "ECG (12-lead)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Arrhythmia from autonomic dysfunction (GBS); cardiac involvement in muscular dystrophies; baseline for IVIG/PLEX",
            "target": "Arrhythmia; conduction abnormalities; cardiomyopathy (DMD, LGMD)"
          }
        ],
        "Extended": [
          {
            "item": "CT chest with contrast",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Within 24-48h for MG; thymoma screening; all newly diagnosed generalized MG",
            "target": "Thymoma (anterior mediastinal mass); thymic hyperplasia",
            "contraindications": "Contrast allergy; renal impairment"
          },
          {
            "item": "MRI chest (non-contrast)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If CT contraindicated or additional characterization needed",
            "target": "Thymoma; thymic abnormality",
            "contraindications": "MRI-incompatible implants"
          },
          {
            "item": "Echocardiogram",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Cardiomyopathy screening in muscular dystrophies (DMD, BMD, LGMD2I, myotonic dystrophy); autonomic dysfunction in GBS; baseline before IVIG",
            "target": "Cardiomyopathy; reduced EF; conduction abnormalities (perform ECG first)",
            "contraindications": "None"
          },
          {
            "item": "Diaphragm ultrasound",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Assess diaphragm excursion and thickness; non-invasive diaphragm function assessment; bedside",
            "target": "Reduced diaphragm excursion (<1.5 cm during tidal breathing, <4 cm during deep breath); paradoxical motion = diaphragm paralysis",
            "contraindications": "Operator-dependent; obesity may limit views"
          },
          {
            "item": "CT angiography (pulmonary)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "If pulmonary embolism suspected (immobile patients at high VTE risk)",
            "target": "PE",
            "contraindications": "Contrast allergy; renal impairment"
          },
          {
            "item": "PET/CT",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If LEMS diagnosed to search for underlying malignancy (SCLC in 50-60%)",
            "target": "Lung mass; lymphadenopathy; occult malignancy",
            "contraindications": "Uncontrolled diabetes"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Phrenic nerve conduction study",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Assess phrenic nerve function; bilateral phrenic neuropathy as cause of respiratory failure",
            "target": "Absent or reduced phrenic CMAP = phrenic neuropathy; prolonged latency",
            "contraindications": "Pacemaker (relative)"
          },
          {
            "item": "Fluoroscopic sniff test",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Diaphragm function; \"sniff test\" — paradoxical upward diaphragm motion with sniff = paralysis",
            "target": "Paradoxical motion = diaphragm paralysis",
            "contraindications": "Radiation exposure; pregnancy"
          },
          {
            "item": "Transdiaphragmatic pressure (Pdi)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Gold standard for diaphragm strength; requires esophageal and gastric balloon catheters; specialized centers",
            "target": "Reduced Pdi = diaphragm weakness",
            "contraindications": "Invasive; specialized equipment"
          },
          {
            "item": "Polysomnography with capnography",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Nocturnal hypoventilation assessment; sleep-disordered breathing; guide NIV",
            "target": "Nocturnal hypoventilation (elevated PtcCO2); desaturations; REM-related events",
            "contraindications": "Sleep lab availability"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent Treatment": [
          {
            "item": "**Airway assessment and monitoring**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mL/kg",
                  "orderSentence": "**Airway assessment and monitoring** 20 mL/kg -"
                }
              ],
              "route": "-",
              "instructions": "**\"20/30/40 Rule\":** FVC <20 mL/kg, NIF > -30 cm H2O (less negative), MEP <40 cm H2O = HIGH RISK for respiratory failure; monitor q2-4h (or more frequently if declining); **INTUBATION THRESHOLD:** FVC <15-20 mL/kg, NIF > -20 to -25 cm H2O, rising PaCO2, or clinical distress",
              "orderSentence": "**Airway assessment and monitoring** 20 mL/kg -"
            },
            "contraindications": "-",
            "monitoring": "NMD respiratory failure is often predictable by serial FVC/NIF; intubate BEFORE crisis (controlled intubation is safer); ABG abnormalities are LATE signs",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Elective intubation (if criteria met)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15-20 mL/kg",
                  "orderSentence": "**Elective intubation (if criteria met)** 15-20 mL/kg -"
                }
              ],
              "route": "-",
              "instructions": "**Indications:** FVC <15-20 mL/kg (or <1 L); NIF > -20 to -25 cm H2O; PaCO2 rising or >50; clinical respiratory distress; inability to clear secretions; aspiration; fatigue; **RSI considerations:** AVOID succinylcholine in myopathies/muscular dystrophy (hyperkalemia), MG (resistance); use rocuronium (may need reduced dose in MG); can use sugammadex for reversal",
              "orderSentence": "**Elective intubation (if criteria met)** 15-20 mL/kg -"
            },
            "contraindications": "-",
            "monitoring": "Elective intubation is safer than emergent; neuromuscular patients are difficult to bag-mask ventilate; have difficult airway equipment ready; avoid neuromuscular blockers post-intubation if possible",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Non-invasive ventilation (NIV)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**ROLE IS LIMITED IN ACUTE NMD RESPIRATORY FAILURE**; may be considered as bridge in: stable patients with nocturnal hypoventilation, mild hypercapnia without distress, secretion clearance ability preserved, no aspiration risk, patient can protect airway; **AVOID NIV if:** Bulbar dysfunction (aspiration risk), unable to clear secretions, severe hypercapnia (PaCO2 >60), acidosis, rapid decline, altered mental status",
              "orderSentence": "**Non-invasive ventilation (NIV)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "NIV (BiPAP) has lower threshold for failure in neuromuscular disease than COPD/CHF; bulbar weakness increases aspiration risk; low threshold for intubation; useful for chronic nocturnal hypoventilation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**Supplemental oxygen**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "96%",
                  "orderSentence": "**Supplemental oxygen** 96% -"
                }
              ],
              "route": "-",
              "instructions": "**Use CAUTIOUSLY**: Oxygen can mask hypoventilation (hypercapnia develops before desaturation); may eliminate hypoxic drive (though less relevant in NMD than COPD); titrate to SpO2 92-96%; **If hypoxemic + hypercapnic:** This indicates severe failure — intubate, do NOT rely on oxygen alone",
              "orderSentence": "**Supplemental oxygen** 96% -"
            },
            "contraindications": "-",
            "monitoring": "Hypoxemia is a late finding in pure neuromuscular hypoventilation; if hypoxemic, consider aspiration, atelectasis, or imminent failure",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Secretion management**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Weak cough = poor secretion clearance; **Techniques:** Assisted cough (abdominal thrust during cough); mechanical insufflation-exsufflation (CoughAssist) — pressures +40/-40 cm H2O; aggressive pulmonary toilet; chest physiotherapy; suction PRN; **If unable to clear secretions:** Intubate",
              "orderSentence": "**Secretion management** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Aspiration pneumonia is leading cause of death in chronic NMD; weak cough (MEP <40) = high risk; mechanical cough assist is underutilized and highly effective",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Stop/avoid precipitating medications**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "**MG crisis precipitants (AVOID):** Aminoglycosides (gentamicin, tobramycin), fluoroquinolones (ciprofloxacin, levofloxacin — less risky but still caution), macrolides (azithromycin, erythromycin), beta-blockers, magnesium (IV), neuromuscular blockers, D-penicillamine, interferon-alpha, checkpoint inhibitors (nivolumab, pembrolizumab); **Full list in Appendix**",
              "orderSentence": "**Stop/avoid precipitating medications** - IV - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Many medications can worsen neuromuscular transmission; careful medication review essential; see comprehensive list in appendix",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**DVT prophylaxis**",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "**DVT prophylaxis** 40 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "SCDs immediately; pharmacologic prophylaxis (enoxaparin 40 mg SQ daily) once stable; immobile patients at very high VTE risk",
              "orderSentence": "**DVT prophylaxis** 40 mg SC"
            },
            "contraindications": "-",
            "monitoring": "High VTE risk in paralyzed/weak patients; balance with IVIG timing (hold anticoagulation during IVIG infusion in some protocols)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Aspiration precautions**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "HOB elevated 30-45°; NPO if significant bulbar weakness; speech-language pathology evaluation; modified diet or enteral feeding if prolonged weakness",
              "orderSentence": "**Aspiration precautions** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Aspiration pneumonia is major complication; bulbar weakness (dysphagia, weak cough, voice changes) = high risk",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Disease-Specific Treatment": [
          {
            "item": "**IVIG (Intravenous Immunoglobulin)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g/kg",
                  "orderSentence": "**IVIG (Intravenous Immunoglobulin)** 2 g/kg -"
                }
              ],
              "route": "-",
              "instructions": "**First-line for MG crisis (with PLEX):** 2 g/kg total divided over 2-5 days (400 mg/kg/day x 5 days OR 1 g/kg/day x 2 days); **Onset:** 2-5 days; **Duration:** 3-6 weeks; **Pre-treatment:** Check IgA (IgA deficiency = anaphylaxis risk); renal function; volume status",
              "orderSentence": "**IVIG (Intravenous Immunoglobulin)** 2 g/kg -"
            },
            "contraindications": "-",
            "monitoring": "Efficacy equivalent to PLEX (RCTs); easier logistics than PLEX; side effects: headache (aseptic meningitis), renal failure (sucrose-containing products), thrombosis, hemolysis; slower onset than PLEX",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Plasma exchange (PLEX)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**First-line for MG crisis (with IVIG):** 5-7 exchanges over 10-14 days (1-1.5 plasma volumes per exchange; typically 3-4 L); **Onset:** Faster than IVIG (improvement may begin after 2-3 exchanges); requires large-bore central venous access; **Caution:** Hypotension, citrate toxicity (hypocalcemia), infection",
              "orderSentence": "**Plasma exchange (PLEX)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "May work faster than IVIG; useful if rapid response needed; RCT showed PLEX and IVIG equivalent in MG exacerbation; PLEX preferred if IVIG contraindicated (IgA deficiency, renal failure)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**HOLD pyridostigmine (cholinesterase inhibitors)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**In intubated MG crisis patients:** STOP pyridostigmine while intubated; excessive secretions worsen pulmonary toilet; cannot distinguish myasthenic from cholinergic crisis if on pyridostigmine; **Resume cautiously when extubation nearing**",
              "orderSentence": "**HOLD pyridostigmine (cholinesterase inhibitors)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Pyridostigmine increases secretions; in intubated patient, secretions worsen; hold until preparing for extubation; some restart at lower dose (30 mg q6h) and titrate",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Corticosteroids (delayed initiation)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-20 mg",
                  "orderSentence": "**Corticosteroids (delayed initiation)** 10-20 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "**CAUTION: Steroids can cause TRANSIENT WORSENING in MG (up to 50% of patients)**; **In crisis:** Start AFTER IVIG/PLEX initiated and patient stabilizing (days 3-5 or later); do NOT start steroids as initial therapy in crisis; **Protocol:** Prednisone 10-20 mg daily, increase by 10 mg every 3-5 days to 1 mg/kg/day (max 60-80 mg); OR IV methylprednisolone 1g daily x 3-5 days then oral",
              "orderSentence": "**Corticosteroids (delayed initiation)** 10-20 mg IV"
            },
            "contraindications": "-",
            "monitoring": "Steroids are maintenance therapy but can worsen MG acutely (\"steroid dip\"); always start with IVIG or PLEX first in crisis; steroid-sparing agents (azathioprine, mycophenolate) for long-term",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "**Treat precipitant**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Infection:** Most common trigger; treat aggressively but AVOID contraindicated antibiotics (see list); **Medication-induced:** Stop offending drug; **Surgery/anesthesia:** Stress can trigger crisis; **Tapering immunosuppression:** Restart or increase",
              "orderSentence": "**Treat precipitant** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "30-40% of MG crises have identifiable trigger; treating trigger may hasten recovery",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Ventilator Management and Weaning": [
          {
            "item": "**Initial ventilator settings**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "6-8 mL/kg",
                  "orderSentence": "**Initial ventilator settings** 6-8 mL/kg -"
                }
              ],
              "route": "-",
              "instructions": "**Mode:** Volume-controlled (AC/VC) or Pressure-support (PS) during weaning; **Tidal volume:** 6-8 mL/kg IBW (lung-protective); **Rate:** 12-16 to achieve adequate minute ventilation; **PEEP:** 5 (higher if atelectasis or hypoxemia); **FiO2:** Titrate to SpO2 92-96%; **I:E ratio:** 1:2 or 1:3; avoid breath-stacking",
              "orderSentence": "**Initial ventilator settings** 6-8 mL/kg -"
            },
            "contraindications": "-",
            "monitoring": "NMD patients generally have healthy lungs; lung-protective ventilation still applies; goal is to support ventilation while disease-specific treatment works",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Weaning from mechanical ventilation**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15 mL/kg",
                  "orderSentence": "**Weaning from mechanical ventilation** 15 mL/kg -"
                }
              ],
              "route": "-",
              "instructions": "**NMD weaning is often prolonged:** Disease-specific treatment must take effect (MG: IVIG/PLEX effect in 3-7 days; GBS: weeks); **Weaning trial criteria:** FVC >15 mL/kg; NIF < -25 cm H2O; adequate cough; secretions manageable; underlying disease improving; **SBT (spontaneous breathing trial):** T-piece or low PS (5-8 cm H2O) x 30-120 min; assess for fatigue, tachypnea, hypercapnia",
              "orderSentence": "**Weaning from mechanical ventilation** 15 mL/kg -"
            },
            "contraindications": "-",
            "monitoring": "Premature extubation leads to re-intubation; NMD patients may need longer ventilation than other ICU patients; patience; daily SBT when criteria met",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Extubation criteria**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15-20 mL/kg",
                  "orderSentence": "**Extubation criteria** 15-20 mL/kg -"
                }
              ],
              "route": "-",
              "instructions": "Pass SBT; FVC >15-20 mL/kg AND improving trajectory; NIF < -25 to -30 cm H2O; effective cough (able to clear secretions); alert and cooperative; bulbar function adequate (can swallow); no heavy sedation; consider cuff leak test",
              "orderSentence": "**Extubation criteria** 15-20 mL/kg -"
            },
            "contraindications": "-",
            "monitoring": "Higher threshold for extubation in NMD than general ICU patients; failed extubation is dangerous",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Tracheostomy (if prolonged ventilation anticipated)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Consider if:** Unable to wean after 2-3 weeks of optimal disease-specific treatment; ALS with decision for long-term ventilation; severe GBS; **Timing:** No firm consensus; typically discuss at 10-14 days if no progress; earlier in conditions with known prolonged course",
              "orderSentence": "**Tracheostomy (if prolonged ventilation anticipated)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Tracheostomy allows for weaning, reduces sedation needs, allows speech (with speaking valve), but has complications and care burden; goals of care discussion essential",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "**Post-extubation monitoring**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Close monitoring for 24-48h; serial FVC/NIF; watch for fatigue, stridor; have reintubation equipment ready; consider prophylactic NIV post-extubation in borderline cases",
              "orderSentence": "**Post-extubation monitoring** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Re-intubation rates higher in NMD; close monitoring; low threshold for NIV support post-extubation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consultation — EMERGENT",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Pulmonology / Critical Care consultation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Serial FVC and NIF monitoring",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "ICU admission",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Speech-language pathology",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Medication review",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Goals of care discussion",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "DVT prophylaxis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Respiratory therapy",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Physical therapy",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Occupational therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Nutrition / Dietitian",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Social work",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Palliative care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Cardiology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Psychiatry / Psychology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Repeat IVIG or PLEX",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Rituximab (MG)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Eculizumab (MG)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Thymectomy (MG)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tracheostomy and long-term ventilation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Home mechanical ventilation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Diaphragm pacing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Category",
        "features": "Etiologies",
        "tests": "Key Distinguishing Features"
      },
      {
        "diagnosis": "**Neuromuscular junction**",
        "features": "Myasthenia gravis; Lambert-Eaton myasthenic syndrome (LEMS); botulism; organophosphate poisoning",
        "tests": "MG: fatigable weakness, ptosis, diplopia, AChR Ab; LEMS: proximal weakness, autonomic symptoms, improves with repetition, anti-VGCC; Botulism: descending paralysis, dilated pupils, recent exposure; OP poisoning: miosis, salivation, bradycardia, cholinergic crisis"
      },
      {
        "diagnosis": "**Peripheral nerve**",
        "features": "Guillain-Barré syndrome; critical illness polyneuropathy (CIP); phrenic nerve injury (cardiac surgery); Charcot-Marie-Tooth (rare)",
        "tests": "GBS: ascending weakness, areflexia, post-infectious, elevated CSF protein; CIP: ICU patient, sepsis, prolonged weakness; Phrenic injury: post-cardiac surgery, unilateral diaphragm paralysis"
      },
      {
        "diagnosis": "**Anterior horn cell**",
        "features": "ALS (amyotrophic lateral sclerosis); spinal muscular atrophy; poliomyelitis (rare)",
        "tests": "ALS: UMN + LMN signs, progressive, fasciculations, no sensory involvement; SMA: childhood onset, proximal weakness"
      },
      {
        "diagnosis": "**Muscle**",
        "features": "Muscular dystrophies (DMD, BMD, LGMD, myotonic, FSHD); inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis); critical illness myopathy; metabolic myopathies",
        "tests": "DMD: young males, elevated CK, cardiac involvement; Myotonic: myotonia, cataracts, cardiac; Inflammatory: elevated CK, rash (DM), proximal weakness; CIM: ICU patient, prolonged steroids/NMB, flaccid weakness"
      },
      {
        "diagnosis": "**Respiratory muscle specific**",
        "features": "Bilateral diaphragm paralysis; diaphragmatic fatigue; isolated phrenic neuropathy",
        "tests": "Orthopnea; paradoxical breathing; supine FVC drop >20%; fluoroscopy: paradoxical motion"
      }
    ],
    "evidence": [
      {
        "recommendation": "Guideline",
        "evidenceLevel": "Source",
        "source": "Year"
      },
      {
        "recommendation": "Myasthenia Gravis Treatment Guidelines",
        "evidenceLevel": "AAN / MGFA",
        "source": "2016/2021"
      },
      {
        "recommendation": "Guillain-Barré Syndrome Guidelines",
        "evidenceLevel": "AAN",
        "source": "2012"
      },
      {
        "recommendation": "ALS Practice Parameters",
        "evidenceLevel": "AAN",
        "source": "2009/Updates"
      },
      {
        "recommendation": "Respiratory Management in NMD",
        "evidenceLevel": "ATS",
        "source": "2004/Updates"
      },
      {
        "recommendation": "Study",
        "evidenceLevel": "Finding",
        "source": "Impact"
      },
      {
        "recommendation": "[Plasma Exchange/Sandoglobulin GBS Trial (1997)](https://pubmed.ncbi.nlm.nih.gov/9014908/)",
        "evidenceLevel": "IVIG = PLEX for GBS; combination not better",
        "source": "Either IVIG or PLEX; no combination"
      },
      {
        "recommendation": "[MG Thymectomy Trial (MGTX, 2016)](https://pubmed.ncbi.nlm.nih.gov/27509100/)",
        "evidenceLevel": "Thymectomy + prednisone > prednisone alone for AChR+ MG (even without thymoma); improved outcomes at 3 years",
        "source": "Thymectomy recommended for generalized AChR+ MG"
      },
      {
        "recommendation": "[Radunovic et al. NIV in ALS (2017 Cochrane)](https://pubmed.ncbi.nlm.nih.gov/28982219/)",
        "evidenceLevel": "NIV prolongs survival in ALS (7-11 months) and improves QoL",
        "source": "NIV is standard of care for ALS respiratory insufficiency"
      },
      {
        "recommendation": "[Lawn et al. Respiratory Failure in GBS (2001)](https://pubmed.ncbi.nlm.nih.gov/11405803/)",
        "evidenceLevel": "FVC <20 mL/kg or NIF > -30 cm H2O predicted need for intubation; \"20/30/40 rule\"",
        "source": "Established monitoring thresholds for MG crisis"
      },
      {
        "recommendation": "[REGAIN Trial (Eculizumab in MG, 2017)](https://pubmed.ncbi.nlm.nih.gov/29066163/)",
        "evidenceLevel": "Eculizumab reduced exacerbations in refractory generalized MG",
        "source": "FDA approval of eculizumab for refractory AChR+ MG"
      },
      {
        "recommendation": "Parameter",
        "evidenceLevel": "Threshold",
        "source": "Interpretation"
      },
      {
        "recommendation": "FVC",
        "evidenceLevel": "<20 mL/kg",
        "source": "Impending respiratory failure; consider intubation"
      },
      {
        "recommendation": "NIF (MIP)",
        "evidenceLevel": "> -30 cm H2O (less negative)",
        "source": "Weak inspiratory muscles; impending failure"
      },
      {
        "recommendation": "MEP",
        "evidenceLevel": "<40 cm H2O",
        "source": "Weak cough; unable to clear secretions; aspiration risk"
      }
    ],
    "monitoring": [
      {
        "item": "FVC (forced vital capacity)",
        "frequency": "q4-6h initially; q1-2h if declining",
        "target": ">20 mL/kg safe; <15-20 mL/kg = intubation threshold",
        "action": "Declining trend or <15-20: prepare for intubation"
      },
      {
        "item": "NIF (negative inspiratory force)",
        "frequency": "q4-6h initially",
        "target": "< -30 cm H2O safe; > -20 to -25 = intubation threshold",
        "action": "Worsening (less negative): prepare for intubation"
      },
      {
        "item": "ABG",
        "frequency": "q6-8h or PRN; with any clinical change",
        "target": "PaCO2 35-45; pH 7.35-7.45",
        "action": "Rising PaCO2 or acidosis: intubate"
      },
      {
        "item": "SpO2",
        "frequency": "Continuous",
        "target": ">92%",
        "action": "Desaturation: assess for aspiration, atelectasis, failure; supplement O2 cautiously"
      },
      {
        "item": "Respiratory rate",
        "frequency": "Continuous",
        "target": "12-20",
        "action": "Tachypnea >30 with shallow breathing suggests fatigue"
      },
      {
        "item": "Neurologic exam (strength, bulbar function)",
        "frequency": "q4-8h",
        "target": "Stable or improving",
        "action": "Worsening weakness: reassess treatment; anticipate respiratory decline"
      },
      {
        "item": "Autonomic function (GBS)",
        "frequency": "Continuous (telemetry); q4h BP checks",
        "target": "Stable HR 60-100; BP 90-140 systolic",
        "action": "Arrhythmia: treat; wide BP swings: short-acting agents; bradycardia: atropine/pacing"
      },
      {
        "item": "Secretion assessment",
        "frequency": "q2-4h",
        "target": "Manageable; patient can cough",
        "action": "Excessive secretions + weak cough: aggressive pulmonary toilet; consider intubation"
      }
    ],
    "disposition": [
      {
        "disposition": "Level of Care",
        "criteria": "Criteria"
      },
      {
        "disposition": "ICU",
        "criteria": "FVC <25 mL/kg or declining; NIF > -40 cm H2O; any respiratory distress; autonomic instability (GBS); need for frequent monitoring (q1-4h); NIV initiation for acute failure; intubation anticipated or performed"
      },
      {
        "disposition": "Step-down / Intermediate",
        "criteria": "Stable but requires monitoring q4-6h; improving trajectory; stable on NIV; post-extubation observation"
      },
      {
        "disposition": "General floor",
        "criteria": "Stable respiratory function; FVC >30 mL/kg and stable; for diagnostic workup of mild exacerbation; initiation of immunotherapy without respiratory compromise"
      }
    ]
  },
  "Parkinson's Disease - New Diagnosis": {
    "id": "parkinsons-disease-new-diagnosis",
    "title": "Parkinson's Disease - New Diagnosis",
    "version": "1.0",
    "icd10": [
      "** G20 (Parkinson's disease)",
      "G20.A1 (Parkinson's disease without dyskinesia",
      "without motor fluctuations)",
      "G20.A2 (Parkinson's disease without dyskinesia",
      "with motor fluctuations)",
      "G20.B1 (Parkinson's disease with dyskinesia",
      "without motor fluctuations)",
      "G20.B2 (Parkinson's disease with dyskinesia",
      "with motor fluctuations)",
      "G20.C (Parkinsonism",
      "unspecified)"
    ],
    "scope": "** Initial diagnosis and early management of idiopathic Parkinson's disease in adults. Covers diagnostic workup to exclude secondary causes and atypical parkinsonism, initiation of symptomatic therapy, and patient education. Excludes drug-induced parkinsonism, atypical parkinsonian syndromes (PSP, MSA, CBD, DLB), juvenile/young-onset PD, and advanced PD with motor fluctuations.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "General health, rule out anemia",
            "target": "Normal"
          },
          {
            "item": "CMP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hepatic/renal function for medication dosing",
            "target": "Normal"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypothyroidism can cause slowness/tremor",
            "target": "Normal"
          },
          {
            "item": "Vitamin B12",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency can cause parkinsonism",
            "target": ">400 pg/mL"
          },
          {
            "item": "RPR/VDRL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurosyphilis in differential",
            "target": "Negative"
          }
        ],
        "Extended Workup": [
          {
            "item": "Serum ceruloplasmin",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Wilson disease if age <50",
            "target": "20-40 mg/dL"
          },
          {
            "item": "24-hour urine copper",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Wilson disease if ceruloplasmin low/borderline",
            "target": "<100 mcg/24h"
          },
          {
            "item": "HIV",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HIV-associated parkinsonism",
            "target": "Negative"
          },
          {
            "item": "Genetic testing (GBA, LRRK2, PRKN)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Young onset (<50), family history, Ashkenazi Jewish",
            "target": "Informational"
          },
          {
            "item": "Alpha-synuclein seed amplification assay",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Emerging biomarker for synucleinopathy",
            "target": "Pending validation"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Serum/urine heavy metals",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Manganese exposure, other toxins",
            "target": "Negative"
          },
          {
            "item": "Anti-neuronal antibodies",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Autoimmune parkinsonism (rare)",
            "target": "Negative"
          },
          {
            "item": "Skin biopsy for alpha-synuclein",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Emerging biomarker",
            "target": "Research only"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI brain without contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At diagnosis",
            "target": "Rule out structural cause, vascular parkinsonism",
            "contraindications": "Pacemaker, metal"
          },
          {
            "item": "MRI brain with contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If mass or infection suspected",
            "target": "Rule out structural lesion",
            "contraindications": "Contrast allergy, renal disease"
          }
        ],
        "Extended": [
          {
            "item": "DaTscan (I-123 ioflupane SPECT)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Diagnostic uncertainty (ET vs PD, drug-induced)",
            "target": "Reduced striatal uptake in PD",
            "contraindications": "Pregnancy, iodine allergy"
          },
          {
            "item": "FDG-PET brain",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Distinguish atypical parkinsonism",
            "target": "Hypometabolism pattern varies by diagnosis",
            "contraindications": "Per PET"
          },
          {
            "item": "MRI susceptibility-weighted imaging",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Wilson disease, iron deposition",
            "target": "Rule out basal ganglia abnormalities",
            "contraindications": "Per MRI"
          },
          {
            "item": "MIBG cardiac scintigraphy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Distinguish PD from MSA",
            "target": "Reduced uptake in PD",
            "contraindications": "Drugs affecting uptake"
          },
          {
            "item": "Polysomnography",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If REM sleep behavior disorder suspected",
            "target": "Confirm RBD",
            "contraindications": "None"
          },
          {
            "item": "Olfactory testing (UPSIT)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Supportive criterion; impaired in PD",
            "target": "Hyposmia",
            "contraindications": "Nasal obstruction"
          }
        ]
      },
      "Treatment": {
        "Dopaminergic Therapy - Levodopa": [
          {
            "item": "Carbidopa/Levodopa (Sinemet)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Carbidopa/Levodopa (Sinemet) 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25/100 mg TID with meals; titrate by 25/100 mg q1-2 weeks; usual maintenance 300-800 mg levodopa/day",
              "orderSentence": "Carbidopa/Levodopa (Sinemet) 100 mg PO"
            },
            "contraindications": "Narrow-angle glaucoma; caution with MAOIs",
            "monitoring": "Dyskinesia, nausea, orthostatic hypotension",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbidopa/Levodopa CR",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mg",
                  "orderSentence": "Carbidopa/Levodopa CR 200 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "25/100 or 50/200 mg BID-TID; ~30% less bioavailable than IR",
              "orderSentence": "Carbidopa/Levodopa CR 200 mg PO"
            },
            "contraindications": "Same",
            "monitoring": "Same; less predictable absorption",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbidopa/Levodopa ODT (Parcopa)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Same dosing as IR; dissolves on tongue",
              "orderSentence": "Carbidopa/Levodopa ODT (Parcopa) - - - see dosing"
            },
            "contraindications": "Same",
            "monitoring": "Same; useful for dysphagia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbidopa/Levodopa ER (Rytary)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "95 mg",
                  "orderSentence": "Carbidopa/Levodopa ER (Rytary) 95 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 23.75/95 mg TID; titrate per response",
              "orderSentence": "Carbidopa/Levodopa ER (Rytary) 95 mg PO"
            },
            "contraindications": "Same",
            "monitoring": "Same; more sustained release",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbidopa/Levodopa intestinal gel (Duopa)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "Continuous infusion via PEG-J; specialist prescribing",
              "orderSentence": "Carbidopa/Levodopa intestinal gel (Duopa) - IV - see dosing"
            },
            "contraindications": "Advanced PD; requires surgical placement",
            "monitoring": "Device complications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Dopamine Agonists": [
          {
            "item": "Pramipexole (Mirapex)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.125 mg",
                  "orderSentence": "Pramipexole (Mirapex) 0.125 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.125 mg TID; titrate weekly to 0.5-1.5 mg TID; max 4.5 mg/day",
              "orderSentence": "Pramipexole (Mirapex) 0.125 mg PO"
            },
            "contraindications": "Impulse control disorders (relative); renal impairment (reduce dose)",
            "monitoring": "ICDs (gambling, hypersexuality, shopping), sleepiness, hallucinations",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pramipexole ER",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.375 mg",
                  "orderSentence": "Pramipexole ER 0.375 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.375 mg daily; titrate weekly; max 4.5 mg/day",
              "orderSentence": "Pramipexole ER 0.375 mg PO"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ropinirole (Requip)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg",
                  "orderSentence": "Ropinirole (Requip) 0.25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25 mg TID; titrate weekly to 3-8 mg TID; max 24 mg/day",
              "orderSentence": "Ropinirole (Requip) 0.25 mg PO"
            },
            "contraindications": "ICDs, hepatic impairment",
            "monitoring": "Same as pramipexole",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ropinirole XL",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg",
                  "orderSentence": "Ropinirole XL 2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2 mg daily; titrate weekly; max 24 mg/day",
              "orderSentence": "Ropinirole XL 2 mg PO"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rotigotine patch (Neupro)",
            "route": "Transdermal",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg",
                  "orderSentence": "Rotigotine patch (Neupro) 2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2 mg/24h; increase by 2 mg/week; max 8 mg/24h (early PD)",
              "orderSentence": "Rotigotine patch (Neupro) 2 mg PO"
            },
            "contraindications": "Sulfite allergy, application site reactions",
            "monitoring": "ICDs, skin reactions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Apomorphine SC (Apokyn)",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.2 mL",
                  "orderSentence": "Apomorphine SC (Apokyn) 0.2 mL PO"
                }
              ],
              "route": "PO",
              "instructions": "Rescue for off episodes; start 0.2 mL (2 mg) test dose; max 0.6 mL (6 mg)",
              "orderSentence": "Apomorphine SC (Apokyn) 0.2 mL PO"
            },
            "contraindications": "Severe hypotension, 5-HT3 antagonist use",
            "monitoring": "BP, nausea (pretreat with trimethobenzamide)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "MAO-B Inhibitors": [
          {
            "item": "Rasagiline (Azilect)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5-1 mg",
                  "orderSentence": "Rasagiline (Azilect) 0.5-1 mg -"
                }
              ],
              "route": "-",
              "instructions": "0.5-1 mg daily; may use as monotherapy early PD or adjunct",
              "orderSentence": "Rasagiline (Azilect) 0.5-1 mg -"
            },
            "contraindications": "MAOIs, meperidine, tramadol, methadone, cyclobenzaprine",
            "monitoring": "Serotonin syndrome; insomnia if taken late",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Selegiline (Eldepryl)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Selegiline (Eldepryl) 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "5 mg BID (breakfast and lunch); avoid evening dosing",
              "orderSentence": "Selegiline (Eldepryl) 5 mg PO"
            },
            "contraindications": "Same as rasagiline",
            "monitoring": "Insomnia, orthostatic hypotension",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Selegiline ODT (Zelapar)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1.25-2.5 mg",
                  "orderSentence": "Selegiline ODT (Zelapar) 1.25-2.5 mg -"
                }
              ],
              "route": "-",
              "instructions": "1.25-2.5 mg daily (buccal absorption)",
              "orderSentence": "Selegiline ODT (Zelapar) 1.25-2.5 mg -"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Safinamide (Xadago)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50-100 mg",
                  "orderSentence": "Safinamide (Xadago) 50-100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "50-100 mg daily; adjunct to levodopa",
              "orderSentence": "Safinamide (Xadago) 50-100 mg PO"
            },
            "contraindications": "Same; severe hepatic impairment, retinal disease",
            "monitoring": "Dyskinesia, falls",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "COMT Inhibitors (Adjunct to Levodopa)": [
          {
            "item": "Entacapone (Comtan)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mg",
                  "orderSentence": "Entacapone (Comtan) 200 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "200 mg with each levodopa dose; max 8 doses/day",
              "orderSentence": "Entacapone (Comtan) 200 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "None absolute",
            "monitoring": "Orange urine, diarrhea, dyskinesia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbidopa/Levodopa/Entacapone (Stalevo)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Various strengths; replace existing C/L with equivalent",
              "orderSentence": "Carbidopa/Levodopa/Entacapone (Stalevo) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Opicapone (Ongentys)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Opicapone (Ongentys) 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "50 mg daily at bedtime; separate from levodopa by 1 hour",
              "orderSentence": "Opicapone (Ongentys) 50 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "None absolute",
            "monitoring": "Dyskinesia, constipation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tolcapone (Tasmar)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100-200 mg",
                  "orderSentence": "Tolcapone (Tasmar) 100-200 mg -"
                }
              ],
              "route": "-",
              "instructions": "100-200 mg TID; rarely used due to hepatotoxicity",
              "orderSentence": "Tolcapone (Tasmar) 100-200 mg -"
            },
            "pretreatment": "-",
            "contraindications": "Hepatic disease",
            "monitoring": "LFTs q2-4 weeks x6mo, then periodically",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Anticholinergics (Tremor-predominant, Younger Patients)": [
          {
            "item": "Trihexyphenidyl (Artane)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg",
                  "orderSentence": "Trihexyphenidyl (Artane) 1 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1 mg daily; titrate to 2 mg TID; max 15 mg/day",
              "orderSentence": "Trihexyphenidyl (Artane) 1 mg PO"
            },
            "contraindications": "Glaucoma, urinary retention, cognitive impairment, age >65",
            "monitoring": "Confusion, urinary retention, dry mouth",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Benztropine (Cogentin)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg",
                  "orderSentence": "Benztropine (Cogentin) 0.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.5 mg daily; titrate to 1-2 mg BID; max 6 mg/day",
              "orderSentence": "Benztropine (Cogentin) 0.5 mg PO"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Amantadine": [
          {
            "item": "Amantadine IR",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Amantadine IR 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "100 mg BID-TID; avoid evening dosing",
              "orderSentence": "Amantadine IR 100 mg PO"
            },
            "contraindications": "Renal impairment (reduce dose), seizures",
            "monitoring": "Livedo reticularis, edema, hallucinations, insomnia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amantadine ER (Gocovri)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "137-274 mg",
                  "orderSentence": "Amantadine ER (Gocovri) 137-274 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "137-274 mg at bedtime; for dyskinesia",
              "orderSentence": "Amantadine ER (Gocovri) 137-274 mg PO"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Non-Motor Symptom Treatment": [
          {
            "item": "Rivastigmine (cognitive)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4.6-13.3 mg",
                  "orderSentence": "Rivastigmine (cognitive) 4.6-13.3 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Patch 4.6-13.3 mg/24h; for PD dementia",
              "orderSentence": "Rivastigmine (cognitive) 4.6-13.3 mg PO"
            },
            "contraindications": "GI bleeding, bradycardia",
            "monitoring": "Nausea, bradycardia",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Quetiapine (psychosis)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5-100 mg",
                  "orderSentence": "Quetiapine (psychosis) 12.5-100 mg -"
                }
              ],
              "route": "-",
              "instructions": "12.5-100 mg QHS; does not worsen parkinsonism",
              "orderSentence": "Quetiapine (psychosis) 12.5-100 mg -"
            },
            "contraindications": "Metabolic syndrome",
            "monitoring": "Sedation, glucose, QTc",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pimavanserin (Nuplazid)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "34 mg",
                  "orderSentence": "Pimavanserin (Nuplazid) 34 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "34 mg daily; for PD psychosis",
              "orderSentence": "Pimavanserin (Nuplazid) 34 mg PO"
            },
            "contraindications": "QTc prolongation",
            "monitoring": "QTc monitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Droxidopa (orthostatic hypotension)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Droxidopa (orthostatic hypotension) 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg TID; max 600 mg TID",
              "orderSentence": "Droxidopa (orthostatic hypotension) 100 mg PO"
            },
            "contraindications": "Supine HTN",
            "monitoring": "BP supine and standing",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fludrocortisone (orthostatic hypotension)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1-0.2 mg",
                  "orderSentence": "Fludrocortisone (orthostatic hypotension) 0.1-0.2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.1-0.2 mg daily",
              "orderSentence": "Fludrocortisone (orthostatic hypotension) 0.1-0.2 mg PO"
            },
            "contraindications": "Heart failure, HTN",
            "monitoring": "K+, edema, supine BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Polyethylene glycol (constipation)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "17 g",
                  "orderSentence": "Polyethylene glycol (constipation) 17 g PO"
                }
              ],
              "route": "PO",
              "instructions": "17 g daily in water",
              "orderSentence": "Polyethylene glycol (constipation) 17 g PO"
            },
            "contraindications": "Bowel obstruction",
            "monitoring": "Bowel movements",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Movement disorder specialist",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "All new PD diagnoses for confirmation and management"
          },
          {
            "item": "Physical therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Gait training, balance, LSVT-BIG program"
          },
          {
            "item": "Occupational therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "ADL assistance, home safety evaluation"
          },
          {
            "item": "Speech therapy (LSVT-LOUD)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Hypophonia, dysarthria, dysphagia assessment"
          },
          {
            "item": "Neuropsychology",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Cognitive concerns, baseline assessment"
          },
          {
            "item": "Psychiatry",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Depression, anxiety, impulse control disorders"
          },
          {
            "item": "Social work",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Resources, support groups, caregiver support"
          },
          {
            "item": "Nutrition/Dietitian",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Weight management, protein timing with levodopa"
          },
          {
            "item": "Sleep medicine",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "REM sleep behavior disorder, excessive daytime sleepiness"
          },
          {
            "item": "Urology",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Urinary symptoms, erectile dysfunction"
          }
        ],
        "Patient Instructions": [
          {
            "item": "PD is a chronic condition managed with medications; not curable but treatable",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take levodopa 30-60 minutes before meals for best absorption; protein can reduce effect",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report impulse control changes (gambling, shopping, hypersexuality) immediately",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do NOT stop PD medications abruptly - risk of severe withdrawal/NMS",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Fall prevention: remove rugs, improve lighting, use assistive devices as needed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Exercise is essential: walking, tai chi, boxing, cycling all beneficial",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Join support group (Parkinson's Foundation, Michael J. Fox Foundation)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Advance directives discussion early in disease course",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Regular aerobic exercise (30+ min, 5 days/week) - may slow progression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain social activities and cognitive engagement",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Fall prevention strategies",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid medications that worsen parkinsonism (metoclopramide, typical antipsychotics, prochlorperazine)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Mediterranean diet associated with better outcomes",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Optimize sleep hygiene",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Caffeine may have protective effect (moderate consumption)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Essential tremor",
        "features": "Action/postural tremor (not rest), bilateral, head tremor, family history, alcohol-responsive",
        "tests": "Clinical; DaTscan normal in ET"
      },
      {
        "diagnosis": "Drug-induced parkinsonism",
        "features": "Medication history (antipsychotics, metoclopramide), symmetric, may resolve with drug withdrawal",
        "tests": "Medication review; DaTscan often normal"
      },
      {
        "diagnosis": "Vascular parkinsonism",
        "features": "Lower-body predominant, gait disorder, stepwise progression, vascular risk factors, MRI white matter changes",
        "tests": "MRI brain; poor levodopa response"
      },
      {
        "diagnosis": "Progressive supranuclear palsy (PSP)",
        "features": "Early falls (backward), vertical gaze palsy, axial rigidity > limb, poor levodopa response",
        "tests": "MRI (hummingbird sign), clinical"
      },
      {
        "diagnosis": "Multiple system atrophy (MSA)",
        "features": "Early autonomic failure, cerebellar signs (MSA-C), poor levodopa response",
        "tests": "MRI (hot cross bun sign), MIBG preserved in MSA"
      },
      {
        "diagnosis": "Corticobasal degeneration (CBD)",
        "features": "Asymmetric apraxia, alien limb, cortical sensory loss, dystonia",
        "tests": "MRI (asymmetric cortical atrophy), clinical"
      },
      {
        "diagnosis": "Dementia with Lewy bodies (DLB)",
        "features": "Dementia before or within 1 year of parkinsonism, visual hallucinations, fluctuations",
        "tests": "Clinical criteria; DaTscan abnormal"
      },
      {
        "diagnosis": "Normal pressure hydrocephalus (NPH)",
        "features": "Gait apraxia (magnetic gait), urinary incontinence, dementia; triad",
        "tests": "MRI (ventriculomegaly), LP with large volume tap"
      },
      {
        "diagnosis": "Wilson disease",
        "features": "Age <50, KF rings, hepatic/psychiatric symptoms, tremor may be wing-beating",
        "tests": "Ceruloplasmin, 24h urine copper, slit lamp exam"
      }
    ],
    "evidence": [
      {
        "recommendation": "MDS Clinical Diagnostic Criteria for PD",
        "evidenceLevel": "Class I",
        "source": "[Postuma et al., Mov Disord 2015](https://pubmed.ncbi.nlm.nih.gov/26474316/)"
      },
      {
        "recommendation": "Levodopa most effective symptomatic therapy",
        "evidenceLevel": "Class I, Level A",
        "source": "Cochrane Reviews"
      },
      {
        "recommendation": "Dopamine agonists monotherapy early PD",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs"
      },
      {
        "recommendation": "MAO-B inhibitors mild symptomatic benefit",
        "evidenceLevel": "Class I, Level A",
        "source": "ADAGIO, TEMPO trials"
      },
      {
        "recommendation": "DaTscan useful for uncertain parkinsonism",
        "evidenceLevel": "Class II, Level B",
        "source": "FDA approved 2011"
      },
      {
        "recommendation": "Exercise may slow disease progression",
        "evidenceLevel": "Class II, Level B",
        "source": "Observational data, RCTs ongoing"
      },
      {
        "recommendation": "LSVT-LOUD effective for speech",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs"
      },
      {
        "recommendation": "LSVT-BIG effective for movement",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs"
      },
      {
        "recommendation": "Pimavanserin for PD psychosis",
        "evidenceLevel": "Class I, Level A",
        "source": "FDA approved 2016"
      },
      {
        "recommendation": "Rivastigmine for PD dementia",
        "evidenceLevel": "Class I, Level A",
        "source": "EXPRESS study"
      },
      {
        "recommendation": "Avoid anticholinergics in elderly",
        "evidenceLevel": "Class II, Level B",
        "source": "Cognitive impairment risk"
      }
    ],
    "monitoring": [
      {
        "item": "UPDRS/MDS-UPDRS",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "Adjust medications"
      },
      {
        "item": "Orthostatic vitals",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "Midodrine, droxidopa, compression stockings"
      },
      {
        "item": "Impulse control screening",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "Reduce/discontinue dopamine agonist"
      },
      {
        "item": "Cognitive screening (MoCA)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Annually or if concerns",
        "action": "Rivastigmine if dementia"
      },
      {
        "item": "Depression screening (BDI, PHQ-9)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q6 months",
        "action": "Treat depression"
      },
      {
        "item": "Falls assessment",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "PT, home safety, assistive devices"
      },
      {
        "item": "Dysphagia screening",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Annually or if concerns",
        "action": "Speech therapy, modified diet"
      },
      {
        "item": "Weight",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "Nutrition consult"
      },
      {
        "item": "Blood pressure (supine and standing)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "Address as above"
      }
    ],
    "disposition": [
      {
        "disposition": "Outpatient management",
        "criteria": "Most new PD diagnoses; able to perform ADLs, stable home environment"
      },
      {
        "disposition": "Admit to hospital",
        "criteria": "Acute deterioration (infection causing worsening), severe \"off\" episodes, inability to take PO medications, falls with injury, psychosis"
      },
      {
        "disposition": "Discharge from hospital",
        "criteria": "Medications optimized, safe swallow, ambulatory (with assistance if needed), caregiver support"
      },
      {
        "disposition": "Movement disorder specialist referral",
        "criteria": "All new diagnoses (confirmation), young onset, atypical features, diagnostic uncertainty, motor fluctuations, dyskinesia, DBS candidacy"
      }
    ]
  },
  "Rapidly Progressive Dementia (RPD)": {
    "id": "rapidly-progressive-dementia",
    "title": "Rapidly Progressive Dementia (RPD)",
    "version": "1.0",
    "icd10": [
      "** F03.90 (Unspecified dementia without behavioral disturbance)",
      "G31.9 (Degenerative disease of nervous system",
      "unspecified)",
      "A81.00 (Creutzfeldt-Jakob disease",
      "unspecified)"
    ],
    "scope": "** Urgent evaluation of cognitive decline progressing over weeks to months (typically <1-2 years from symptom onset to severe disability). Covers comprehensive workup to identify treatable causes including autoimmune encephalitis, infectious etiologies, toxic-metabolic causes, CNS malignancy, and prion disease (CJD). The key principle: assume a treatable cause exists until proven otherwise. Excludes typical slowly progressive dementias (Alzheimer's, FTD) unless presenting atypically fast, and acute delirium (<days).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Infection screen; hematologic malignancy; B12 deficiency (macrocytosis)",
            "target": "Normal"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hepatic encephalopathy (ammonia); renal failure (uremia); electrolyte abnormalities (Na, Ca); hypo/hyperglycemia",
            "target": "Normal"
          },
          {
            "item": "TSH, free T4",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Hypothyroid encephalopathy (Hashimoto encephalopathy); hyperthyroidism",
            "target": "Normal"
          },
          {
            "item": "B12, methylmalonic acid (MMA)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "B12 deficiency — reversible cause of cognitive decline and myelopathy",
            "target": "B12 >300 pg/mL; MMA normal"
          },
          {
            "item": "Folate",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency associated with cognitive impairment",
            "target": "Normal"
          },
          {
            "item": "ESR",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Vasculitis screen; inflammatory conditions; infection; malignancy",
            "target": "Normal (<20 mm/h age-adjusted)"
          },
          {
            "item": "CRP",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Inflammatory marker",
            "target": "Normal"
          },
          {
            "item": "RPR or VDRL (syphilis screen)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Neurosyphilis — treatable cause; \"the great imitator\"",
            "target": "Non-reactive"
          },
          {
            "item": "HIV 1/2 antigen/antibody",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "HIV-associated neurocognitive disorder (HAND); opportunistic infections",
            "target": "Negative"
          },
          {
            "item": "Ammonia",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Hepatic encephalopathy",
            "target": "Normal (<35 µmol/L)"
          },
          {
            "item": "Urinalysis + urine culture",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "UTI causing delirium (especially elderly)",
            "target": "Negative"
          },
          {
            "item": "Urine drug screen",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Substance-related cognitive impairment; prescription drug toxicity",
            "target": "Negative or expected medications only"
          },
          {
            "item": "Blood glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hypoglycemia; diabetic encephalopathy",
            "target": "Normal"
          }
        ],
        "Extended Workup": [
          {
            "item": "Anti-thyroid antibodies (anti-TPO, anti-thyroglobulin)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hashimoto encephalopathy (SREAT) — treatable with steroids even if euthyroid",
            "target": "Negative (positive + encephalopathy = consider SREAT)"
          },
          {
            "item": "ANA",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Lupus cerebritis; systemic autoimmune disease",
            "target": "Negative"
          },
          {
            "item": "dsDNA antibodies",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Lupus cerebritis (specific)",
            "target": "Negative"
          },
          {
            "item": "Complement levels (C3, C4)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Lupus; complement-mediated disease",
            "target": "Normal"
          },
          {
            "item": "ANCA (c-ANCA, p-ANCA)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "CNS vasculitis (granulomatosis with polyangiitis, microscopic polyangiitis)",
            "target": "Negative"
          },
          {
            "item": "ACE level (serum)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurosarcoidosis",
            "target": "Normal"
          },
          {
            "item": "Serum protein electrophoresis (SPEP) + immunofixation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Multiple myeloma; POEMS; Waldenström; M-protein-associated neuropathy/encephalopathy",
            "target": "Normal pattern"
          },
          {
            "item": "LDH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Lymphoma; hemolysis; intravascular lymphoma",
            "target": "Normal"
          },
          {
            "item": "Peripheral blood smear",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Intravascular lymphoma (schistocytes); TTP (schistocytes + thrombocytopenia)",
            "target": "Normal"
          },
          {
            "item": "Thiamine (B1) level",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Wernicke encephalopathy — reversible with treatment; alcoholism, malnutrition, bariatric surgery",
            "target": "Normal (>70 nmol/L)"
          },
          {
            "item": "Copper and ceruloplasmin",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Wilson disease (young patients <50); acquired copper deficiency (zinc excess, gastric surgery)",
            "target": "Normal"
          },
          {
            "item": "Zinc level",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Zinc excess causes copper deficiency → myeloneuropathy + cognitive decline",
            "target": "Normal"
          },
          {
            "item": "Cortisol (AM or random)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Adrenal insufficiency causing encephalopathy",
            "target": "Normal (>18 µg/dL AM)"
          },
          {
            "item": "Heavy metals (lead, mercury, arsenic)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Occupational/environmental exposure",
            "target": "Normal"
          },
          {
            "item": "Paraneoplastic panel (serum) — comprehensive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "ANNA-1 (Hu), ANNA-2 (Ri), CRMP-5 (CV2), amphiphysin, PCA-1 (Yo), PCA-2, PCA-Tr (DNER), GAD65",
            "target": "Negative"
          },
          {
            "item": "Autoimmune encephalitis panel (serum) — NMDAR, LGI1, CASPR2, GABA-B, GABA-A, AMPA, DPPX, IgLON5",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Treatable autoimmune encephalitis — most important reversible cause to identify",
            "target": "Negative"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "14-3-3 protein (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "CJD biomarker; elevated in rapid neuronal destruction. Sensitivity ~90% but NOT specific (also elevated in stroke, encephalitis, seizures)",
            "target": "Negative (positive supports CJD in right clinical context)"
          },
          {
            "item": "RT-QuIC (Real-Time Quaking-Induced Conversion) — CSF",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "MOST SPECIFIC test for prion disease; sensitivity 92%, specificity 99-100%. Gold standard CSF prion test",
            "target": "Negative (positive = prion disease essentially confirmed)"
          },
          {
            "item": "Tau protein (CSF — total tau)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Markedly elevated in CJD (>1150 pg/mL); also elevated in AD but less extreme",
            "target": "Normal (<400 pg/mL; CJD often >10,000)"
          },
          {
            "item": "Neuron-specific enolase (NSE) — CSF",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Elevated in CJD (>35 ng/mL); marker of neuronal damage",
            "target": "Normal"
          },
          {
            "item": "AD biomarkers (CSF Aβ42, p-tau, t-tau)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rapidly progressive Alzheimer disease (rpAD) is the most common misdiagnosis of CJD; AD biomarker pattern distinguishes",
            "target": "Aβ42/Aβ40 ratio normal; p-tau/t-tau ratio helps distinguish"
          },
          {
            "item": "Neurofilament light chain (NfL) — CSF or serum",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Non-specific marker of neuronal damage; markedly elevated in CJD, moderately in many RPDs",
            "target": "Baseline for comparison"
          },
          {
            "item": "Whipple disease PCR (CSF and duodenal biopsy)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Tropheryma whipplei — rare but treatable cause of RPD with oculomasticatory myorhythmia; GI symptoms, arthralgia",
            "target": "Negative"
          },
          {
            "item": "PRNG gene analysis (blood)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Genetic prion disease (familial CJD, fatal familial insomnia, GSS); family history of early dementia or movement disorder",
            "target": "No mutation"
          },
          {
            "item": "QuantiFERON-TB Gold / PPD",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "TB meningitis with cognitive decline",
            "target": "Negative"
          },
          {
            "item": "Bartonella serology",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Cat-scratch disease encephalitis",
            "target": "Negative"
          },
          {
            "item": "Brucella serology",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Neurobrucellosis (occupational exposure)",
            "target": "Negative"
          },
          {
            "item": "Lyme antibody (ELISA, Western blot)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Lyme encephalopathy (endemic areas)",
            "target": "Negative"
          },
          {
            "item": "Celiac antibodies (tTG IgA, deamidated gliadin)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Gluten ataxia / celiac encephalopathy",
            "target": "Negative"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Elevated ICP in mass, hydrocephalus, venous thrombosis",
            "target": "Normal (10-20 cm H2O)"
          },
          {
            "item": "Cell count with differential (tubes 1 and 4)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Pleocytosis suggests infection, autoimmune, or lymphoma; normal in CJD",
            "target": "Normal in CJD; elevated in autoimmune/infectious"
          },
          {
            "item": "Protein",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Elevated in infection, inflammation, malignancy; mildly elevated or normal in CJD",
            "target": "Normal or mildly elevated in CJD; elevated in infection/autoimmune"
          },
          {
            "item": "Glucose with paired serum",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Low in bacterial/TB/fungal meningitis, carcinomatous meningitis",
            "target": "Normal in CJD, autoimmune; low in infectious/malignant"
          },
          {
            "item": "Gram stain and culture",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Exclude chronic bacterial infection",
            "target": "No organisms"
          },
          {
            "item": "RT-QuIC (Real-Time Quaking-Induced Conversion)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Most sensitive and specific CSF test for prion disease (sensitivity 92%, specificity 99-100%)",
            "target": "Negative"
          },
          {
            "item": "14-3-3 protein",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "CJD biomarker; rapid neuronal destruction marker",
            "target": "Negative"
          },
          {
            "item": "Total tau protein",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Markedly elevated in CJD (>1150 pg/mL); moderately elevated in AD",
            "target": "Normal (<400 pg/mL)"
          },
          {
            "item": "NSE (neuron-specific enolase)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "CJD biomarker",
            "target": "Normal"
          },
          {
            "item": "Autoimmune encephalitis panel (CSF) — NMDAR, LGI1, CASPR2, GABA-B, GABA-A, AMPA, DPPX",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "CSF more sensitive than serum for NMDAR antibodies; identifies treatable autoimmune etiology",
            "target": "Negative"
          },
          {
            "item": "Paraneoplastic antibodies (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "More sensitive than serum for some antibodies",
            "target": "Negative"
          },
          {
            "item": "Oligoclonal bands, IgG index",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Intrathecal antibody synthesis (MS, autoimmune, neurosarcoidosis)",
            "target": "Negative"
          },
          {
            "item": "Cytology (send 10 mL minimum; repeat x3 for sensitivity)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Leptomeningeal carcinomatosis/lymphoma; sensitivity improves with volume and repeat",
            "target": "Negative"
          },
          {
            "item": "Flow cytometry",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "CNS lymphoma (B-cell clonality)",
            "target": "Normal"
          },
          {
            "item": "HSV 1/2 PCR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "HSV encephalitis; post-HSV autoimmune encephalitis",
            "target": "Negative"
          },
          {
            "item": "VZV PCR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "VZV vasculopathy / encephalitis",
            "target": "Negative"
          },
          {
            "item": "EBV PCR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "CNS lymphoma (EBV-driven)",
            "target": "Negative"
          },
          {
            "item": "JC virus PCR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "PML (immunocompromised)",
            "target": "Negative"
          },
          {
            "item": "VDRL (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Neurosyphilis",
            "target": "Non-reactive"
          },
          {
            "item": "Cryptococcal antigen",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Cryptococcal meningitis (immunocompromised)",
            "target": "Negative"
          },
          {
            "item": "AFB smear and culture",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "TB meningitis",
            "target": "Negative"
          },
          {
            "item": "ACE level (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Neurosarcoidosis",
            "target": "Normal"
          },
          {
            "item": "Whipple PCR (T. whipplei)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "rationale": "Whipple disease",
            "target": "Negative"
          },
          {
            "item": "Beta-2 microglobulin (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "CNS lymphoma marker",
            "target": "Normal"
          },
          {
            "item": "Alzheimer biomarkers (Aβ42, Aβ40, p-tau 181, t-tau)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "rpAD pattern: low Aβ42, elevated p-tau; helps distinguish from CJD (where p-tau is NOT as elevated relative to t-tau)",
            "target": "Context-dependent"
          },
          {
            "item": "Neurofilament light chain (NfL) — CSF",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Non-specific neuronal damage; very elevated in CJD",
            "target": "Baseline"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI brain with and without contrast + DWI",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "Within 24h. DWI is CRITICAL — cortical ribboning on DWI is highly suggestive of CJD",
            "target": "CJD: cortical ribboning (DWI/FLAIR high signal in cortex), caudate/putamen signal. Autoimmune: mesial temporal T2/FLAIR. Vasculitis: multifocal white matter lesions. Lymphoma: enhancing mass. Wernicke: mamillary body/thalamic signal. MS: periventricular/juxtacortical lesions",
            "contraindications": "Pacemaker, metallic implants"
          },
          {
            "item": "EEG (routine or prolonged)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Within 24h",
            "target": "CJD: periodic sharp wave complexes (PSWCs) at 1-2 Hz — sensitivity ~65% (higher in sCJD-MM1). Seizures: electrographic activity. NCSE: subclinical seizures. Autoimmune: extreme delta brush (NMDAR)",
            "contraindications": "None significant"
          },
          {
            "item": "CT head without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Immediate if acute presentation or focal deficit",
            "target": "Mass lesion, hydrocephalus, hemorrhage, large infarct",
            "contraindications": "Pregnancy (relative)"
          }
        ],
        "Extended": [
          {
            "item": "MRA/MRV brain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If vasculitis or venous thrombosis suspected",
            "target": "CNS vasculitis (beading); dural sinus thrombosis",
            "contraindications": "Same as MRI"
          },
          {
            "item": "MRI spine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If concurrent myelopathy (B12 deficiency, copper deficiency, neurosarcoidosis)",
            "target": "Cord signal change (posterior columns in B12/copper); sarcoid enhancement",
            "contraindications": "Same as MRI"
          },
          {
            "item": "Continuous EEG (cEEG)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "If altered consciousness; suspected NCSE",
            "target": "Non-convulsive seizures; subclinical status",
            "contraindications": "None"
          },
          {
            "item": "FDG-PET brain",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Differentiate neurodegenerative patterns; detect occult malignancy; autoimmune encephalitis (mesial temporal hypermetabolism)",
            "target": "AD: temporoparietal hypometabolism. FTD: frontal/temporal. CJD: cortical/striatal. Lymphoma: hypermetabolic mass. Autoimmune: mesial temporal hypermetabolism",
            "contraindications": "Pregnancy; uncontrolled diabetes"
          },
          {
            "item": "PET-CT body (whole body)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Occult malignancy search (paraneoplastic); lymphoma staging",
            "target": "Primary tumor identification",
            "contraindications": "Same as FDG-PET"
          },
          {
            "item": "CT chest/abdomen/pelvis with contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Cancer screening (paraneoplastic); sarcoidosis (hilar adenopathy)",
            "target": "Mass, lymphadenopathy",
            "contraindications": "Contrast allergy, renal impairment"
          },
          {
            "item": "Conventional cerebral angiography (DSA)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If CNS vasculitis suspected (MRA normal does not exclude small-vessel vasculitis)",
            "target": "Beading (alternating stenosis/dilation)",
            "contraindications": "Contrast allergy, coagulopathy"
          },
          {
            "item": "Testicular ultrasound (males)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "timing": "Testicular germ cell tumor (paraneoplastic; anti-NMDAR in males)",
            "target": "Normal",
            "contraindications": "None"
          },
          {
            "item": "Pelvic ultrasound/MRI (females)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Ovarian teratoma (anti-NMDAR encephalitis — present in 50% of young women)",
            "target": "Normal",
            "contraindications": "None"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Brain biopsy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Last resort when all non-invasive testing inconclusive; suspected CNS vasculitis, intravascular lymphoma, or prion disease where RT-QuIC unavailable",
            "target": "Vasculitis (vessel wall inflammation); lymphoma (atypical cells); prion disease (spongiform change, PrP immunostaining)",
            "contraindications": "Surgical risk; coagulopathy"
          },
          {
            "item": "Meningeal biopsy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Chronic meningitis of unknown etiology",
            "target": "Granulomas (sarcoid, TB); malignancy",
            "contraindications": "Same as brain biopsy"
          },
          {
            "item": "Bone marrow biopsy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If intravascular lymphoma, hemophagocytic lymphohistiocytosis (HLH), or hematologic malignancy suspected",
            "target": "Abnormal cells; hemophagocytosis",
            "contraindications": "Coagulopathy"
          },
          {
            "item": "Upper endoscopy with duodenal biopsy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Whipple disease (PAS-positive macrophages)",
            "target": "Normal (PAS-negative)",
            "contraindications": "Standard GI endoscopy risks"
          },
          {
            "item": "Sleep polysomnography",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Fatal familial insomnia (FFI) — complete loss of sleep architecture",
            "target": "Absent sleep spindles; disrupted sleep architecture",
            "contraindications": "Cooperation"
          }
        ]
      },
      "Treatment": {
        "Empiric / Treatable Causes — TREAT WHILE AWAITING RESULTS": [
          {
            "item": "Thiamine (B1) IV",
            "route": "IV",
            "indication": "Empiric for Wernicke encephalopathy if ANY suspicion (alcohol, malnutrition, bariatric surgery); treat before glucose",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Thiamine (B1) IV 500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "500 mg IV TID x 3-5 days, then 250 mg IV daily x 3-5 days, then 100 mg PO daily ongoing",
              "orderSentence": "Thiamine (B1) IV 500 mg IV"
            },
            "contraindications": "None significant",
            "monitoring": "Clinical response (confusion, ataxia, ophthalmoplegia should improve)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "IV methylprednisolone (empiric immunotherapy trial)",
            "route": "IV",
            "indication": "Suspected autoimmune encephalitis, Hashimoto encephalopathy (SREAT), neurosarcoidosis, CNS vasculitis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "IV methylprednisolone (empiric immunotherapy trial) 1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg IV daily x 3-5 days. Consider when autoimmune etiology suspected and workup pending. Document pre-treatment baseline exam.",
              "orderSentence": "IV methylprednisolone (empiric immunotherapy trial) 1000 mg IV"
            },
            "contraindications": "Active infection (rule out first); uncertain prion disease (steroids do not help CJD and may mask diagnosis)",
            "monitoring": "Glucose q6h; BP; GI prophylaxis; response assessment",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "IVIG (empiric immunotherapy trial)",
            "route": "-",
            "indication": "Suspected autoimmune encephalitis; concurrent with steroid trial",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg",
                  "orderSentence": "IVIG (empiric immunotherapy trial) 0.4 g/kg -"
                }
              ],
              "route": "-",
              "instructions": "0.4 g/kg/day x 5 days (total 2 g/kg). Add to steroids or as alternative if steroid-intolerant",
              "orderSentence": "IVIG (empiric immunotherapy trial) 0.4 g/kg -"
            },
            "contraindications": "IgA deficiency; renal failure; thrombotic risk",
            "monitoring": "Renal function; headache; thrombotic events",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Acyclovir IV (if HSV not excluded)",
            "route": "IV",
            "indication": "Empiric while awaiting HSV PCR; fever + encephalopathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg",
                  "orderSentence": "Acyclovir IV (if HSV not excluded) 10 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV q8h. Continue until HSV PCR confirmed negative",
              "orderSentence": "Acyclovir IV (if HSV not excluded) 10 mg/kg IV"
            },
            "contraindications": "Renal impairment (dose adjust)",
            "monitoring": "Cr daily; hydration",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Targeted Treatments (Once Diagnosis Established)": [
          {
            "item": "IV methylprednisolone → oral prednisone taper",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1g",
                  "orderSentence": "IV methylprednisolone → oral prednisone taper 1g IV"
                }
              ],
              "route": "IV",
              "instructions": "1g IV x 5d → prednisone 1 mg/kg/day with slow taper over 3-6 months",
              "orderSentence": "IV methylprednisolone → oral prednisone taper 1g IV"
            },
            "contraindications": "-",
            "monitoring": "Glucose, BP, bone density, weight, mood",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "IVIG",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg",
                  "orderSentence": "IVIG 0.4 g/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.4 g/kg/day x 5 days; repeat monthly for maintenance",
              "orderSentence": "IVIG 0.4 g/kg PO"
            },
            "contraindications": "-",
            "monitoring": "Renal function; IgG levels",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Rituximab",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "375 mg/m2",
                  "orderSentence": "Rituximab 375 mg/m2 IV"
                }
              ],
              "route": "IV",
              "instructions": "375 mg/m2 IV weekly x 4 weeks OR 1000 mg IV x 2 doses (2 weeks apart)",
              "orderSentence": "Rituximab 375 mg/m2 IV"
            },
            "contraindications": "-",
            "monitoring": "CD19/20 counts; immunoglobulins; infection risk; PML risk",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Cyclophosphamide",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "750-1000 mg/m2",
                  "orderSentence": "Cyclophosphamide 750-1000 mg/m2 IV"
                }
              ],
              "route": "IV",
              "instructions": "750-1000 mg/m2 IV monthly x 6 months (pulse) OR oral 1-2 mg/kg/day",
              "orderSentence": "Cyclophosphamide 750-1000 mg/m2 IV"
            },
            "contraindications": "-",
            "monitoring": "CBC (nadir at 10-14 days); urinalysis (hemorrhagic cystitis — give MESNA); fertility preservation discussion",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Penicillin G IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "18-24 million units/day IV (3-4 MU q4h) x 14 days",
              "orderSentence": "Penicillin G IV - IV - see dosing"
            },
            "contraindications": "-",
            "monitoring": "RPR titer follow-up q3-6 months (4-fold decline expected)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Tumor-directed therapy",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Per oncology",
              "orderSentence": "Tumor-directed therapy - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Clinical response; antibody titers",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Teratoma resection",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Surgical removal",
              "orderSentence": "Teratoma resection - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Repeat imaging; antibody titers",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "B12 replacement",
            "route": "IM",
            "indication": "-",
            "dosing": {
              "instructions": "Cyanocobalamin 1000 µg IM daily x 7 days, then weekly x 4, then monthly long-term",
              "orderSentence": "B12 replacement - IM - see dosing"
            },
            "contraindications": "-",
            "monitoring": "B12 and MMA levels at 3 months",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Antifungals (amphotericin B + flucytosine)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.7-1 mg/kg",
                  "orderSentence": "Antifungals (amphotericin B + flucytosine) 0.7-1 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "Amphotericin B 0.7-1 mg/kg/day IV + flucytosine 100 mg/kg/day x 2 weeks (induction)",
              "orderSentence": "Antifungals (amphotericin B + flucytosine) 0.7-1 mg/kg IV"
            },
            "contraindications": "-",
            "monitoring": "Renal function; electrolytes; LFTs",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Anti-TB regimen",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "RIPE: rifampin + isoniazid + pyrazinamide + ethambutol",
              "orderSentence": "Anti-TB regimen - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "LFTs; visual acuity (ethambutol); drug interactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "No disease-modifying treatment",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Supportive care only; no effective treatment exists",
              "orderSentence": "No disease-modifying treatment - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Comfort care; goals of care discussion",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Levetiracetam",
            "route": "IV",
            "indication": "Seizures",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500-1500 mg",
                  "orderSentence": "Levetiracetam 500-1500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "500-1500 mg PO/IV BID; max 3000 mg/day",
              "orderSentence": "Levetiracetam 500-1500 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Severe renal impairment (dose adjust)",
            "monitoring": "Renal function; behavioral changes",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Lorazepam",
            "route": "IV",
            "indication": "Agitation, myoclonus (CJD)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5-1 mg",
                  "orderSentence": "Lorazepam 0.5-1 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-1 mg PO/IV q6-8h PRN",
              "orderSentence": "Lorazepam 0.5-1 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Respiratory depression",
            "monitoring": "Sedation; respiratory status",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Clonazepam",
            "route": "PO",
            "indication": "Myoclonus (CJD)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg",
                  "orderSentence": "Clonazepam 0.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.5 mg PO BID; increase to 1-2 mg TID",
              "orderSentence": "Clonazepam 0.5 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Respiratory depression; fall risk",
            "monitoring": "Sedation; fall prevention",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Valproic acid",
            "route": "PO",
            "indication": "Myoclonus (adjunctive); seizures",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250-500 mg",
                  "orderSentence": "Valproic acid 250-500 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "250-500 mg PO BID; target level 50-100 µg/mL",
              "orderSentence": "Valproic acid 250-500 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Hepatic disease; pancreatitis; pregnancy",
            "monitoring": "LFTs; ammonia; drug level; CBC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Quetiapine",
            "route": "PO",
            "indication": "Agitation, psychosis, behavioral disturbance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-50 mg",
                  "orderSentence": "Quetiapine 25-50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "25-50 mg PO qHS; increase by 25 mg/day; max 200-400 mg/day",
              "orderSentence": "Quetiapine 25-50 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "QT prolongation; Parkinson disease (avoid all antipsychotics in Lewy body)",
            "monitoring": "QTc; metabolic panel; sedation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Insomnia, behavioral disturbance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-50 mg",
                  "orderSentence": "Trazodone 25-50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "25-50 mg PO qHS; max 150 mg",
              "orderSentence": "Trazodone 25-50 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Priapism (rare); orthostatic hypotension",
            "monitoring": "Sedation; orthostasis",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "Insomnia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3-10 mg",
                  "orderSentence": "Melatonin 3-10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "3-10 mg PO qHS",
              "orderSentence": "Melatonin 3-10 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "None significant",
            "monitoring": "Sleep quality",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology (behavioral/cognitive subspecialty if available)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT",
            "ICU": "STAT",
            "indication": "All RPD cases; diagnostic workup direction; empiric treatment decisions"
          },
          {
            "item": "Neuro-immunology",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Suspected autoimmune encephalitis; immunotherapy management"
          },
          {
            "item": "Infectious disease",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Suspected CNS infection (neurosyphilis, TB, HIV, fungal, Whipple)"
          },
          {
            "item": "Oncology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Paraneoplastic syndrome; CNS lymphoma; brain metastases"
          },
          {
            "item": "Neurosurgery",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "indication": "Brain biopsy consideration; hydrocephalus management"
          },
          {
            "item": "Rheumatology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Suspected CNS vasculitis; lupus cerebritis; sarcoidosis"
          },
          {
            "item": "Psychiatry",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Behavioral management; depression; capacity assessment"
          },
          {
            "item": "Neuropsychology",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Formal cognitive testing; baseline and follow-up"
          },
          {
            "item": "Palliative care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "indication": "Goals of care (especially if CJD suspected); symptom management"
          },
          {
            "item": "Social work",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Family support; advance directive planning; caregiver resources"
          },
          {
            "item": "Genetic counseling",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "If genetic prion disease suspected; family implications"
          },
          {
            "item": "Ethics consultation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "indication": "End-of-life decisions; capacity evaluation for untreatable conditions"
          },
          {
            "item": "National Prion Disease Pathology Surveillance Center (Cleveland)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "If CJD suspected: contact for diagnostic guidance and potential brain autopsy"
          },
          {
            "item": "Speech-language pathology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Dysphagia; communication strategies"
          },
          {
            "item": "Physical/Occupational therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Safety; mobility; ADLs; fall prevention"
          }
        ],
        "Patient Instructions": [
          {
            "item": "RPD has many TREATABLE causes — aggressive workup is justified",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return to ED if: new seizure, sudden worsening, falls, inability to swallow, fever",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do NOT drive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Ensure 24/7 supervision at home (fall risk, wandering, impaired judgment)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Advance directives / healthcare power of attorney should be completed early while patient can still participate",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "If CJD is diagnosed: no cure exists; disease is uniformly fatal; focus on comfort and quality of life",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "CJD is NOT contagious through casual contact; standard precautions are sufficient; no isolation needed for family",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "CJD surgical instruments: notify any surgical/dental providers about diagnosis (special sterilization or instrument destruction required)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Family support resources: CJD Foundation (www.cjdfoundation.org); Autoimmune Encephalitis Alliance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Follow-up with neurology frequently (weekly to monthly depending on trajectory)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Fall prevention (remove tripping hazards, grab bars, non-slip surfaces)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "No driving, no operating machinery",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Medication management by caregiver (patient cannot reliably self-administer)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Home safety evaluation (OT)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Caregiver support and respite care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Nutritional support (swallowing may decline; SLP evaluation)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Medical ID bracelet",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Creutzfeldt-Jakob disease (CJD)",
        "features": "Weeks-months; myoclonus; startle; akinetic mutism late; MRI cortical ribboning + caudate/putamen DWI signal; PSWCs on EEG",
        "tests": "RT-QuIC (CSF); 14-3-3; total tau >1150; MRI DWI; EEG"
      },
      {
        "diagnosis": "Autoimmune encephalitis (anti-NMDAR)",
        "features": "Subacute; psychiatric symptoms → seizures → movement disorder → autonomic → decreased consciousness; young women; ovarian teratoma",
        "tests": "NMDAR antibody (CSF > serum); pelvic imaging"
      },
      {
        "diagnosis": "Autoimmune encephalitis (anti-LGI1)",
        "features": "Faciobrachial dystonic seizures; hyponatremia; memory loss; >40 years",
        "tests": "LGI1 antibody (serum > CSF); serum Na"
      },
      {
        "diagnosis": "Hashimoto encephalopathy (SREAT)",
        "features": "Euthyroid or hypothyroid; high anti-TPO; steroid-responsive; diagnosis of exclusion",
        "tests": "Anti-TPO elevated; response to steroids; exclude other causes"
      },
      {
        "diagnosis": "Rapidly progressive Alzheimer disease (rpAD)",
        "features": "Most common misdiagnosis of CJD; positive AD biomarkers (low Aβ42, high p-tau); no myoclonus typically; MRI shows atrophy, no DWI ribboning",
        "tests": "CSF AD biomarkers (Aβ42/Aβ40 ratio low, p-tau elevated); MRI (atrophy without DWI cortical signal); RT-QuIC negative"
      },
      {
        "diagnosis": "CNS lymphoma (primary or intravascular)",
        "features": "B symptoms; enhancing mass (primary); multifocal white matter changes with LDH elevation and no mass (intravascular)",
        "tests": "MRI with contrast; CSF cytology + flow cytometry; EBV PCR; brain biopsy; LDH; peripheral smear"
      },
      {
        "diagnosis": "Leptomeningeal carcinomatosis",
        "features": "Known malignancy; cranial neuropathies; communicating hydrocephalus; CSF cytology positive",
        "tests": "CSF cytology (repeat x3); MRI with contrast (leptomeningeal enhancement)"
      },
      {
        "diagnosis": "Neurosyphilis",
        "features": "RPR/VDRL positive; Argyll Robertson pupils; psychiatric symptoms; may have prior STI history",
        "tests": "RPR/VDRL (serum); CSF VDRL; FTA-ABS"
      },
      {
        "diagnosis": "Wernicke encephalopathy",
        "features": "Acute confusion + ophthalmoplegia + ataxia triad (only 10% have all three); alcoholism, malnutrition",
        "tests": "Thiamine level (draw before treatment); MRI (mamillary body, thalamic signal); clinical response to thiamine"
      },
      {
        "diagnosis": "CNS vasculitis",
        "features": "Headache; multifocal deficits; strokes; CSF pleocytosis",
        "tests": "MRA (beading); DSA; brain/meningeal biopsy; ESR/CRP elevated"
      },
      {
        "diagnosis": "Neurosarcoidosis",
        "features": "Cranial neuropathies (CN VII); leptomeningeal enhancement; hilar adenopathy; elevated ACE",
        "tests": "Chest CT; serum/CSF ACE; biopsy (granulomas)"
      },
      {
        "diagnosis": "Normal pressure hydrocephalus (NPH)",
        "features": "Triad: gait disorder (predominant) + urinary incontinence + dementia; \"wet, wobbly, and wacky\"; ventricular enlargement disproportionate to atrophy",
        "tests": "Large-volume LP (30-50 mL) with pre/post gait assessment; MRI (Evans index >0.3)"
      },
      {
        "diagnosis": "Toxic/metabolic encephalopathy",
        "features": "Medication toxicity (lithium, methotrexate, chemotherapy); substance abuse; hepatic/uremic encephalopathy",
        "tests": "Drug levels; LFTs; ammonia; BUN/Cr; UDS"
      },
      {
        "diagnosis": "Depression/Pseudo-dementia",
        "features": "Depressive symptoms predominant; subjective cognitive complaints > objective deficits; onset correlates with depressive episode",
        "tests": "Neuropsychological testing; psychiatric evaluation; may improve with antidepressant"
      },
      {
        "diagnosis": "Whipple disease",
        "features": "Oculomasticatory myorhythmia (pathognomonic); GI symptoms; arthralgia; chronic diarrhea",
        "tests": "T. whipplei PCR (CSF, duodenal biopsy); PAS-positive macrophages on biopsy"
      },
      {
        "diagnosis": "PML (progressive multifocal leukoencephalopathy)",
        "features": "Immunocompromised; multifocal white matter lesions (no enhancement typically); progressive deficits",
        "tests": "JC virus PCR (CSF); MRI pattern; clinical context"
      },
      {
        "diagnosis": "Fatal familial insomnia",
        "features": "Genetic prion disease; progressive insomnia → autonomic dysfunction → motor signs → dementia; family history",
        "tests": "PRNP gene testing (D178N mutation with 129M); polysomnography (absent sleep spindles)"
      }
    ],
    "evidence": [
      {
        "recommendation": "RT-QuIC for CJD diagnosis (sensitivity 92%, specificity 99-100%)",
        "evidenceLevel": "Class I, Level A",
        "source": "McGuire et al. (Ann Neurol 2012); Atarashi et al. (Nat Med 2011)"
      },
      {
        "recommendation": "MRI DWI cortical ribboning for CJD",
        "evidenceLevel": "Class I, Level A",
        "source": "Vitali et al. (Neurology 2011); Young et al. (AJNR 2005)"
      },
      {
        "recommendation": "CSF 14-3-3 protein for CJD (sensitivity ~90%, lower specificity)",
        "evidenceLevel": "Class IIa, Level B",
        "source": "WHO diagnostic criteria; Muayqil et al. (2012)"
      },
      {
        "recommendation": "Comprehensive autoimmune antibody testing in RPD",
        "evidenceLevel": "Class I, Level B",
        "source": "Graus et al. (Lancet Neurol 2016) — diagnostic criteria for autoimmune encephalitis"
      },
      {
        "recommendation": "Empiric immunotherapy trial for suspected autoimmune encephalitis",
        "evidenceLevel": "Class IIa, Level C",
        "source": "Expert consensus; Dalmau & Graus (NEJM 2018)"
      },
      {
        "recommendation": "Anti-NMDAR encephalitis: immunotherapy + teratoma resection",
        "evidenceLevel": "Class I, Level B",
        "source": "Titulaer et al. (Lancet Neurol 2013)"
      },
      {
        "recommendation": "Anti-LGI1: steroids as first-line",
        "evidenceLevel": "Class IIa, Level B",
        "source": "Irani et al. (Brain 2010)"
      },
      {
        "recommendation": "Hashimoto encephalopathy (SREAT): steroid-responsive",
        "evidenceLevel": "Class IIb, Level C",
        "source": "Castillo et al. (Arch Neurol 2006); diagnosis of exclusion"
      },
      {
        "recommendation": "Thiamine for Wernicke: high-dose IV (500 mg TID)",
        "evidenceLevel": "Class I, Level B",
        "source": "Thomson & Marshall (2006); Galvin et al. (2010)"
      },
      {
        "recommendation": "Neurosyphilis: IV penicillin G x 14 days",
        "evidenceLevel": "Class I, Level A",
        "source": "CDC STI Treatment Guidelines"
      },
      {
        "recommendation": "CJD: no effective treatment; supportive care only",
        "evidenceLevel": "Class I, Level A",
        "source": "No disease-modifying therapy exists; multiple trials failed"
      },
      {
        "recommendation": "Brain biopsy when non-invasive workup inconclusive",
        "evidenceLevel": "Class IIa, Level C",
        "source": "Expert consensus; diagnostic yield 57-65% in RPD"
      },
      {
        "recommendation": "Save CSF frozen for future studies",
        "evidenceLevel": "Class I, Level C",
        "source": "Standard practice; new biomarkers emerging"
      }
    ],
    "monitoring": [
      {
        "item": "Cognitive assessment (MMSE, MoCA, or bedside exam)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "Baseline; weekly inpatient; each visit outpatient",
        "action": "Document trajectory; adjust treatment"
      },
      {
        "item": "Neurologic exam (focal signs, myoclonus, gait, cranial nerves)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "Daily inpatient; each visit outpatient",
        "action": "If new focal signs: repeat MRI; if myoclonus: add clonazepam"
      },
      {
        "item": "Seizure monitoring",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "Clinical observation; EEG if suspicious",
        "action": "AED initiation/adjustment"
      },
      {
        "item": "Swallowing assessment",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE",
        "frequency": "Weekly; SLP evaluation",
        "action": "Modified diet; NG/PEG if progressive"
      },
      {
        "item": "Weight",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Weekly",
        "action": "Nutritional support"
      },
      {
        "item": "Serum sodium",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q12-24h initially; then per clinical indication",
        "action": "SIADH management if low; LGI1 encephalitis associated with hyponatremia"
      },
      {
        "item": "Renal function",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Daily if on acyclovir or nephrotoxic drugs; weekly otherwise",
        "action": "Dose adjustments"
      },
      {
        "item": "Response to immunotherapy",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Assess at day 5 of steroids/IVIG; then weekly",
        "action": "If no response: consider second-line (rituximab); reconsider diagnosis"
      },
      {
        "item": "Autoimmune antibody titers (follow-up)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q3-6 months if positive",
        "action": "If rising: relapse risk; adjust immunotherapy"
      },
      {
        "item": "Safety assessment (fall risk, wandering, capacity)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Daily inpatient; each visit outpatient",
        "action": "Increase supervision; facility placement if needed"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Stable cognition; safe home environment with 24/7 caregiver; outpatient workup can be completed; no active seizures; swallowing safe; outpatient follow-up arranged within 1-2 weeks"
      },
      {
        "disposition": "Admit to hospital",
        "criteria": "Acute/subacute decline requiring urgent workup; unable to safely manage at home; seizures; empiric immunotherapy trial; cannot complete workup as outpatient"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Status epilepticus; respiratory failure; autonomic instability; severe agitation requiring sedation; ICP management"
      },
      {
        "disposition": "Transfer to tertiary center",
        "criteria": "Complex workup (brain biopsy, specialized autoimmune testing); prion disease expertise; clinical trial access"
      },
      {
        "disposition": "Memory care / Long-term care",
        "criteria": "Progressive untreatable dementia (CJD, advanced neurodegenerative); unable to care for self; caregiver unable to manage"
      },
      {
        "disposition": "Hospice",
        "criteria": "Confirmed CJD or other untreatable rapidly fatal diagnosis; focus on comfort"
      }
    ]
  },
  "Restless Legs Syndrome (RLS) / Willis-Ekbom Disease": {
    "id": "restless-legs-syndrome",
    "title": "Restless Legs Syndrome (RLS) / Willis-Ekbom Disease",
    "version": "1.0",
    "icd10": [
      "** G25.81 (Restless legs syndrome)",
      "G25.89 (Other specified extrapyramidal and movement disorders)"
    ],
    "scope": "** Diagnosis and management of restless legs syndrome in adults. Covers diagnostic criteria, workup for secondary causes, pharmacologic and non-pharmacologic treatment, and prevention of augmentation. Excludes periodic limb movement disorder as separate entity, akathisia, and leg cramps.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Serum ferritin",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Iron deficiency is treatable cause; target >75 ng/mL",
            "target": ">75 ng/mL (>100 preferred)"
          },
          {
            "item": "Serum iron",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Iron deficiency assessment",
            "target": "Normal"
          },
          {
            "item": "TIBC",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Iron deficiency assessment",
            "target": "Normal"
          },
          {
            "item": "Transferrin saturation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Target >20%",
            "target": ">20%"
          },
          {
            "item": "CBC",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Anemia workup",
            "target": "Normal"
          },
          {
            "item": "CMP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Renal function (uremia can cause RLS), electrolytes",
            "target": "Normal"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Thyroid dysfunction",
            "target": "Normal"
          },
          {
            "item": "Glucose/HbA1c",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes can cause neuropathy mimicking RLS",
            "target": "Normal"
          }
        ],
        "Extended Workup": [
          {
            "item": "Vitamin B12",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency can cause neuropathy",
            "target": ">400 pg/mL"
          },
          {
            "item": "Folate",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency",
            "target": "Normal"
          },
          {
            "item": "Magnesium",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency can contribute",
            "target": "Normal"
          },
          {
            "item": "BUN/Creatinine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Uremic RLS",
            "target": "Normal"
          },
          {
            "item": "Pregnancy test",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "RLS common in pregnancy; affects treatment",
            "target": "Document"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Nerve conduction studies/EMG",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If neuropathy suspected",
            "target": "Rule out neuropathy mimics"
          },
          {
            "item": "ANA, anti-SSA/SSB",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If autoimmune neuropathy suspected",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Clinical diagnosis",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At evaluation",
            "target": "All 5 diagnostic criteria met",
            "contraindications": "None"
          }
        ],
        "Extended": [
          {
            "item": "Polysomnography (PSG)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If PLMD suspected or other sleep disorder",
            "target": "PLMS >15/hour supports diagnosis",
            "contraindications": "Not required for diagnosis"
          },
          {
            "item": "Actigraphy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Objective movement assessment",
            "target": "Document periodic movements",
            "contraindications": "None"
          },
          {
            "item": "MRI spine",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If radiculopathy suspected",
            "target": "Rule out structural cause",
            "contraindications": "Per MRI"
          },
          {
            "item": "Doppler ultrasound (legs)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If venous insufficiency suspected",
            "target": "Rule out venous disease",
            "contraindications": "None"
          }
        ]
      },
      "Treatment": {
        "Non-Pharmacologic Treatment (All Patients)": [
          {
            "item": "Sleep hygiene",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Regular sleep schedule, cool room, limit screen time",
              "orderSentence": "Sleep hygiene - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Foundation of treatment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Avoid triggers",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Avoid alcohol, caffeine, nicotine (especially evening)",
              "orderSentence": "Avoid triggers - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Critical",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Moderate exercise",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Regular exercise, but avoid intense exercise close to bedtime",
              "orderSentence": "Moderate exercise - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Helps symptoms",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Leg massage/stretching",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Gentle stretching, massage before bed",
              "orderSentence": "Leg massage/stretching - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "May provide relief",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hot bath",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Warm bath before bedtime",
              "orderSentence": "Hot bath - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Relaxation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mental alerting activities",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Crosswords, video games can distract during symptoms",
              "orderSentence": "Mental alerting activities - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Useful for mild cases",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pneumatic compression devices",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Sequential compression 1 hour before bed",
              "orderSentence": "Pneumatic compression devices - - - see dosing"
            },
            "contraindications": "DVT, arterial disease",
            "monitoring": "Limited evidence",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Iron Replacement (If Ferritin <75 ng/mL)": [
          {
            "item": "Ferrous sulfate",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "325 mg",
                  "orderSentence": "Ferrous sulfate 325 mg -"
                }
              ],
              "route": "-",
              "instructions": "325 mg (65 mg elemental iron) with vitamin C 100 mg, on empty stomach, daily or every other day",
              "orderSentence": "Ferrous sulfate 325 mg -"
            },
            "contraindications": "Iron overload, hemochromatosis",
            "monitoring": "Ferritin q3 months; GI side effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ferrous gluconate",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "324 mg",
                  "orderSentence": "Ferrous gluconate 324 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "324 mg (36 mg elemental iron) daily; better tolerated",
              "orderSentence": "Ferrous gluconate 324 mg PO"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "IV iron (ferric carboxymaltose)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "IV iron (ferric carboxymaltose) 1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg IV once (if oral intolerant or severe deficiency); may repeat",
              "orderSentence": "IV iron (ferric carboxymaltose) 1000 mg IV"
            },
            "contraindications": "Iron overload, infection",
            "monitoring": "Ferritin in 8 weeks; faster response",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "IV iron sucrose",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mg",
                  "orderSentence": "IV iron sucrose 200 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "200 mg IV × 5 doses over 2 weeks",
              "orderSentence": "IV iron sucrose 200 mg IV"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "First-Line Pharmacologic Treatment - Alpha-2-Delta Ligands (PREFERRED)": [
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Gabapentin 300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg QHS; titrate by 300 mg every few days to 900-1800 mg QHS",
              "orderSentence": "Gabapentin 300 mg PO"
            },
            "contraindications": "Renal impairment (adjust)",
            "monitoring": "Sedation, dizziness, edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gabapentin enacarbil (Horizant)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "600 mg",
                  "orderSentence": "Gabapentin enacarbil (Horizant) 600 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "600 mg daily at ~5 PM; FDA approved for RLS",
              "orderSentence": "Gabapentin enacarbil (Horizant) 600 mg PO"
            },
            "contraindications": "Renal impairment (adjust)",
            "monitoring": "Sedation, dizziness",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg",
                  "orderSentence": "Pregabalin 75 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 75 mg QHS; titrate to 150-300 mg QHS",
              "orderSentence": "Pregabalin 75 mg PO"
            },
            "contraindications": "Renal impairment (adjust)",
            "monitoring": "Sedation, dizziness, weight gain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-Line Pharmacologic Treatment - Dopamine Agonists": [
          {
            "item": "Pramipexole (Mirapex)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.125 mg",
                  "orderSentence": "Pramipexole (Mirapex) 0.125 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.125 mg 2-3h before bedtime; titrate by 0.125 mg q4-7 days; max 0.5 mg (keep dose LOW)",
              "orderSentence": "Pramipexole (Mirapex) 0.125 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Severe renal impairment",
            "monitoring": "AUGMENTATION, ICDs, sleepiness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ropinirole (Requip)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg",
                  "orderSentence": "Ropinirole (Requip) 0.25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25 mg 1-3h before bedtime; titrate by 0.25 mg q4-7 days; max 4 mg (keep dose LOW)",
              "orderSentence": "Ropinirole (Requip) 0.25 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Severe hepatic impairment",
            "monitoring": "AUGMENTATION, ICDs, sleepiness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rotigotine patch (Neupro)",
            "route": "Transdermal",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg",
                  "orderSentence": "Rotigotine patch (Neupro) 1 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1 mg/24h patch; titrate by 1 mg/week; max 3 mg/24h",
              "orderSentence": "Rotigotine patch (Neupro) 1 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Sulfite allergy",
            "monitoring": "AUGMENTATION, ICDs, skin reactions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Third-Line / Refractory Treatment": [
          {
            "item": "Low-dose opioids",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-15 mg",
                  "orderSentence": "Low-dose opioids 5-15 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Oxycodone 5-15 mg QHS or tramadol 50-100 mg QHS; RESERVE for refractory cases",
              "orderSentence": "Low-dose opioids 5-15 mg PO"
            },
            "contraindications": "Addiction risk, respiratory depression, apnea",
            "monitoring": "Dependence, respiratory",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Extended-release oxycodone",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-20 mg",
                  "orderSentence": "Extended-release oxycodone 10-20 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "10-20 mg QHS; for severe refractory RLS",
              "orderSentence": "Extended-release oxycodone 10-20 mg PO"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Methadone (specialist use)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-10 mg",
                  "orderSentence": "Methadone (specialist use) 5-10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10 mg QHS; specialist prescribing only",
              "orderSentence": "Methadone (specialist use) 5-10 mg PO"
            },
            "contraindications": "Same; QT prolongation",
            "monitoring": "QTc, respiratory",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Buprenorphine (specialist use)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.2-0.8 mg",
                  "orderSentence": "Buprenorphine (specialist use) 0.2-0.8 mg -"
                }
              ],
              "route": "-",
              "instructions": "0.2-0.8 mg SL QHS; may have lower abuse potential",
              "orderSentence": "Buprenorphine (specialist use) 0.2-0.8 mg -"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Managing Augmentation": [
          {
            "item": "Recognize augmentation",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Recognize augmentation - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Key to management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Discontinue dopamine agonist",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Discontinue dopamine agonist - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "\"Washout\" period difficult",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Bridge with opioid",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Bridge with opioid - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Temporary use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Switch to alpha-2-delta ligand",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Switch to alpha-2-delta ligand - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "New first-line",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "IV iron",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "IV iron - IV - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Helpful during transition",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Sleep medicine specialist",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Refractory RLS, PLMD evaluation, PSG needed"
          },
          {
            "item": "Neurology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Diagnostic uncertainty, refractory cases"
          },
          {
            "item": "Hematology",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Significant iron deficiency, iron infusion"
          },
          {
            "item": "Nephrology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Uremic RLS (ESRD patients)"
          },
          {
            "item": "Psychiatry",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Impulse control disorders on dopamine agonists"
          },
          {
            "item": "Pain management",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "indication": "Opioid management in refractory cases"
          }
        ],
        "Patient Instructions": [
          {
            "item": "RLS is a real neurological condition, not psychological",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Iron levels should be optimized (ferritin >75)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid caffeine, alcohol, and nicotine, especially in evening",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain regular sleep schedule",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report symptoms of augmentation: earlier onset, spreading to arms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report impulse control changes if on dopamine agonists (gambling, shopping)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Exercise regularly but not close to bedtime",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Many medications can worsen RLS - check with doctor before starting new meds",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "RLS Foundation (rls.org) for resources and support",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Antihistamines (diphenhydramine, hydroxyzine)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Antidopaminergic antiemetics (metoclopramide, prochlorperazine)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Antipsychotics (especially typical; atypical less so)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "SSRIs/SNRIs (may worsen in some patients)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "TCAs (may worsen in some patients)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Lithium",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Nocturnal leg cramps",
        "features": "Painful muscle contraction, sudden onset, relieved by stretching",
        "tests": "Clinical; no urge to move"
      },
      {
        "diagnosis": "Peripheral neuropathy",
        "features": "Numbness/tingling, burning, not worse at rest, not circadian",
        "tests": "EMG/NCS; different symptom pattern"
      },
      {
        "diagnosis": "Akathisia",
        "features": "Inner restlessness, not limb-specific, medication-induced (antipsychotics)",
        "tests": "Medication history; involves whole body"
      },
      {
        "diagnosis": "Positional discomfort",
        "features": "Relieved by position change; not circadian",
        "tests": "Clinical"
      },
      {
        "diagnosis": "Varicose veins/venous stasis",
        "features": "Visible veins, edema, worse with standing",
        "tests": "Doppler ultrasound"
      },
      {
        "diagnosis": "Arthritis",
        "features": "Joint pain, stiffness, not circadian",
        "tests": "Clinical; imaging"
      },
      {
        "diagnosis": "Peripheral artery disease",
        "features": "Claudication, worse with activity, cool extremities",
        "tests": "ABI, vascular studies"
      },
      {
        "diagnosis": "Radiculopathy",
        "features": "Dermatomal distribution, back pain",
        "tests": "MRI spine; EMG"
      },
      {
        "diagnosis": "Growing pains (children)",
        "features": "Bilateral, no urge to move, different demographics",
        "tests": "Clinical"
      },
      {
        "diagnosis": "Habitual foot tapping/leg bouncing",
        "features": "Voluntary, not uncomfortable, no urge",
        "tests": "Clinical"
      },
      {
        "diagnosis": "Periodic limb movement disorder",
        "features": "Movements during sleep; no awake symptoms",
        "tests": "PSG; RLS is awake symptom"
      }
    ],
    "evidence": [
      {
        "recommendation": "IRLSSG diagnostic criteria",
        "evidenceLevel": "Class I",
        "source": "Allen et al., Sleep Med 2014"
      },
      {
        "recommendation": "Iron supplementation if ferritin <75",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs; AASM Guidelines"
      },
      {
        "recommendation": "Alpha-2-delta ligands first-line",
        "evidenceLevel": "Class I, Level A",
        "source": "Updated guidelines 2016; lower augmentation risk"
      },
      {
        "recommendation": "Gabapentin enacarbil FDA approved",
        "evidenceLevel": "Class I, Level A",
        "source": "FDA approval; multiple RCTs"
      },
      {
        "recommendation": "Pregabalin effective",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs"
      },
      {
        "recommendation": "Dopamine agonists effective but augmentation risk",
        "evidenceLevel": "Class I, Level A",
        "source": "Multiple RCTs; 70% augmentation at 10 years"
      },
      {
        "recommendation": "Low-dose opioids for refractory RLS",
        "evidenceLevel": "Class II, Level B",
        "source": "Limited RCTs"
      },
      {
        "recommendation": "Avoid antihistamines, antidopaminergics",
        "evidenceLevel": "Class II, Level B",
        "source": "Observational data"
      }
    ],
    "monitoring": [
      {
        "item": "IRLS severity scale",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "Adjust treatment"
      },
      {
        "item": "Ferritin",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q3-6 months until stable",
        "action": "Iron supplementation"
      },
      {
        "item": "Transferrin saturation",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "With ferritin",
        "action": "Iron supplementation"
      },
      {
        "item": "Augmentation screening",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit (if on DA)",
        "action": "Stop/switch dopamine agonist"
      },
      {
        "item": "Impulse control screening",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit (if on DA)",
        "action": "Stop dopamine agonist"
      },
      {
        "item": "Sleep quality",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Each visit",
        "action": "Adjust treatment"
      },
      {
        "item": "Renal function (if uremic)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Per nephrology",
        "action": "Dialysis optimization"
      }
    ],
    "disposition": [
      {
        "disposition": "Outpatient management",
        "criteria": "Most patients; mild-moderate RLS"
      },
      {
        "disposition": "Sleep medicine referral",
        "criteria": "Refractory RLS, PLMD suspected, PSG needed"
      },
      {
        "disposition": "Hematology referral",
        "criteria": "Significant iron deficiency, IV iron needed"
      },
      {
        "disposition": "Neurology referral",
        "criteria": "Diagnostic uncertainty, refractory cases, augmentation management"
      },
      {
        "disposition": "Follow-up frequency",
        "criteria": "q1-3 months initially; less frequent once stable"
      }
    ]
  },
  "Malignant Spinal Cord Compression (MSCC) / Metastatic Epidural Spinal Cord Compression (MESCC)": {
    "id": "spinal-cord-compression-malignant",
    "title": "Malignant Spinal Cord Compression (MSCC) / Metastatic Epidural Spinal Cord Compression (MESCC)",
    "version": "1.0",
    "icd10": [
      "** G95.20 (Unspecified cord compression)",
      "C79.49 (Secondary malignant neoplasm of other parts of nervous system)",
      "C79.51 (Secondary malignant neoplasm of bone)",
      "M49.50 (Collapsed vertebra in diseases classified elsewhere)",
      "G82.20 (Paraplegia",
      "unspecified)"
    ],
    "scope": "** Emergency evaluation and management of malignant (metastatic) spinal cord compression in adults. Covers dexamethasone protocols, emergent imaging, surgical decompression criteria (Patchell criteria), radiation therapy, vertebral body assessment, functional prognostication, and disposition. Excludes non-malignant compressive myelopathy (disc herniation, epidural abscess — separate templates), primary spinal cord tumors (intramedullary), and cauda equina syndrome from malignancy (partially overlaps — see separate template for CES).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Baseline; surgical candidacy; chemotherapy effects; infection (epidural abscess differential)",
            "target": "Normal; leukocytosis may suggest infection; thrombocytopenia affects surgical/procedural candidacy"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Renal function (contrast, medications); electrolytes (hypercalcemia of malignancy); hepatic function (chemotherapy dosing, metastatic disease)",
            "target": "Normal; calcium >10.5 mg/dL → assess for hypercalcemia of malignancy"
          },
          {
            "item": "PT/INR, aPTT",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Coagulopathy assessment; surgical candidacy; anticoagulation reversal if emergent surgery needed",
            "target": "Normal; INR <1.5 for surgery"
          },
          {
            "item": "ESR / CRP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Epidural abscess differential (highly elevated ESR >30-50 typically); inflammatory markers for malignancy",
            "target": "Normal-mildly elevated in malignancy; markedly elevated ESR/CRP → strongly consider abscess"
          },
          {
            "item": "Blood cultures (x2 sets)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Epidural abscess differential; bacteremia if febrile",
            "target": "Negative; positive → epidural abscess more likely than tumor"
          },
          {
            "item": "Blood glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Baseline before high-dose dexamethasone; steroid hyperglycemia",
            "target": "<180 mg/dL; anticipate significant hyperglycemia with high-dose steroids"
          },
          {
            "item": "Type and screen",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Surgical candidacy; blood product availability",
            "target": "On file"
          },
          {
            "item": "Calcium (ionized or corrected)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hypercalcemia of malignancy (present in 10-30% of cancer patients); can cause confusion, weakness mimicking cord compression progression",
            "target": "Corrected Ca <10.5 mg/dL; if elevated → IV fluids, calcitonin, bisphosphonate"
          },
          {
            "item": "LDH",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Tumor burden marker; lymphoma (very high LDH); prognostic",
            "target": "Normal; very high → lymphoma, aggressive malignancy"
          },
          {
            "item": "Urinalysis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Urinary retention (neurogenic bladder from cord compression); UTI (fever differential); baseline renal function",
            "target": "Normal; retention with high post-void residual expected in cord compression"
          }
        ],
        "Extended Workup": [
          {
            "item": "Tumor markers (PSA, CEA, CA 19-9, CA 125, CA 15-3, AFP, β-hCG)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Unknown primary cancer; PSA (prostate — most common spinal metastasis), CEA (GI, lung), CA 15-3 (breast), etc.",
            "target": "Elevations guide primary site identification"
          },
          {
            "item": "SPEP / UPEP with immunofixation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Multiple myeloma (common cause of vertebral compression/cord compression); M-protein, light chains",
            "target": "No monoclonal protein; if present → myeloma workup"
          },
          {
            "item": "Free light chains (kappa/lambda ratio)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Myeloma; light chain disease",
            "target": "Normal ratio (0.26-1.65); abnormal suggests myeloma"
          },
          {
            "item": "Serum protein electrophoresis",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Myeloma; lymphoma",
            "target": "No M-spike"
          },
          {
            "item": "Alkaline phosphatase (bone-specific)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Osteoblastic metastases (prostate, breast); Paget's disease differential",
            "target": "Normal; elevated suggests bone turnover"
          },
          {
            "item": "Phosphate",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypercalcemia workup; oncologic emergency assessment",
            "target": "Normal"
          },
          {
            "item": "Uric acid",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "Tumor lysis syndrome risk (lymphoma, rapidly proliferating tumors); pre-treatment assessment",
            "target": "Normal"
          },
          {
            "item": "Procalcitonin",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "If infection/abscess differential is high; more specific than CRP for bacterial infection",
            "target": "<0.25 ng/mL (low probability bacterial); >0.5 → consider abscess/infection"
          },
          {
            "item": "TSH, free T4",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Thyroid cancer metastases (follicular thyroid cancer has bony tropism)",
            "target": "Normal"
          },
          {
            "item": "Vitamin D (25-OH)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Bone health; pathologic fracture risk; supplement if deficient",
            "target": ">30 ng/mL"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Flow cytometry (peripheral blood)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Lymphoma/leukemia presenting as epidural mass",
            "target": "Abnormal lymphocyte population = lymphoproliferative disorder"
          },
          {
            "item": "Bone marrow biopsy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Myeloma; lymphoma; unknown primary with bone marrow involvement",
            "target": "Normal; abnormal → specific diagnosis"
          },
          {
            "item": "Paraneoplastic antibody panel",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If myelopathy features atypical for compression (e.g., subacute progressive without clear structural compression)",
            "target": "Negative; positive changes diagnosis from compression to paraneoplastic myelopathy"
          },
          {
            "item": "AQP4-IgG (NMO antibody)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If imaging shows longitudinal intramedullary lesion rather than epidural compression → NMOSD differential",
            "target": "Negative; positive → NMOSD not metastatic compression"
          },
          {
            "item": "CT-guided biopsy of vertebral lesion",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Unknown primary; tissue diagnosis needed before treatment; lymphoma requires tissue for definitive diagnosis (sensitive to steroids — obtain tissue BEFORE steroids if possible in suspected lymphoma)",
            "target": "Histopathologic diagnosis"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "LP — Generally NOT indicated",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-",
            "timing": "LP is NOT routinely indicated in MSCC; CSF cytology only if leptomeningeal disease suspected AND no complete block; CT myelogram if MRI not available (different indication)",
            "target": "N/A — LP is diagnostic adjunct only in specific situations",
            "contraindications": "CONTRAINDICATED with complete spinal block above LP level (risk of neurologic deterioration/coning); coagulopathy; local infection"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI entire spine with and without contrast (gadolinium)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "URGENT",
            "ICU": "STAT",
            "timing": "**Within 4 hours of presentation (24h max)**; GOLD STANDARD; must image ENTIRE spine (multifocal metastases in 30-40%)",
            "target": "Epidural mass with cord compression; level(s) of compression; Bilsky grade (0-3); vertebral body involvement; number of levels; intramedullary vs. extramedullary-intradural vs. epidural; cord signal change (T2 hyperintensity = edema/myelopathy — poor prognostic sign); paraspinal soft tissue extension",
            "contraindications": "MRI-incompatible implants; severe claustrophobia (sedate); GFR <30 (gadolinium risk — benefit outweighs risk in emergency)"
          },
          {
            "item": "Plain radiographs (spine, targeted)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Immediate while awaiting MRI; identifies vertebral collapse, pathologic fracture, alignment; 70% sensitivity for vertebral metastases (30% miss rate)",
            "target": "Vertebral body collapse; pedicle erosion (\"winking owl sign\" on AP); pathologic fracture; kyphosis; alignment",
            "contraindications": "Pregnancy (shield)"
          },
          {
            "item": "CT chest/abdomen/pelvis with contrast",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Within 24-48h; staging; primary identification; lung is most common primary",
            "target": "Primary tumor; staging of metastatic disease; lymphadenopathy; visceral metastases",
            "contraindications": "Contrast allergy; renal impairment"
          },
          {
            "item": "CT spine (targeted level) without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "If MRI contraindicated or unavailable; pre-operative planning for bone assessment; vertebral body stability (SINS score); CT myelogram if MRI not possible",
            "target": "Bone destruction pattern (lytic vs. blastic vs. mixed); posterior element involvement; fracture; canal compromise; vertebral body collapse >50%",
            "contraindications": "Pregnancy (risk vs. benefit)"
          }
        ],
        "Extended": [
          {
            "item": "CT myelogram",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "If MRI contraindicated (pacemaker, implant); intrathecal contrast via LP → CT; demonstrates level of block",
            "target": "Complete or partial subarachnoid block; level of compression; multiple levels of disease",
            "contraindications": "LP contraindicated if complete block above puncture site (risk of neurologic deterioration); coagulopathy"
          },
          {
            "item": "PET/CT (FDG)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Staging; primary identification; assessing treatment response; distinguishing active tumor from treated/necrotic bone",
            "target": "Active metastatic disease; primary tumor identification",
            "contraindications": "Uncontrolled diabetes; pregnancy"
          },
          {
            "item": "Bone scan (Tc-99m)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Skeletal staging; identifies additional osseous metastases; blastic > lytic sensitivity; useful for prostate, breast",
            "target": "Additional bone metastases; may miss purely lytic lesions (renal, thyroid, myeloma)",
            "contraindications": "Pregnancy"
          },
          {
            "item": "MRI brain with contrast",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If lung primary or melanoma (high brain metastasis risk); symptoms suggesting intracranial disease",
            "target": "Brain metastases (concurrent in 10-30% of patients with MSCC)",
            "contraindications": "Same as MRI"
          },
          {
            "item": "CT-guided biopsy (vertebral/paraspinal)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Tissue diagnosis if unknown primary; CRITICAL for suspected lymphoma (radiosensitive — may not need surgery); obtain BEFORE steroids if lymphoma suspected (steroids can render biopsy non-diagnostic)",
            "target": "Histopathologic diagnosis; molecular profiling",
            "contraindications": "Coagulopathy; inaccessible lesion"
          },
          {
            "item": "DEXA scan",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Baseline bone density if prolonged steroids anticipated; osteoporosis risk",
            "target": "T-score; fracture risk assessment",
            "contraindications": "None significant"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Spinal angiography",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If highly vascular tumor suspected (RCC, thyroid) — pre-operative embolization to reduce surgical bleeding",
            "target": "Tumor vascularity; feeding vessels; embolization candidacy",
            "contraindications": "Contrast allergy; renal impairment; coagulopathy"
          },
          {
            "item": "Pre-operative embolization",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "timing": "Highly vascular metastases (RCC, thyroid); 24-48h before surgery to reduce intraoperative blood loss",
            "target": "Reduction of tumor blood supply",
            "contraindications": "Contrast allergy; tumor supplying anterior spinal artery (risk of cord infarction)"
          },
          {
            "item": "Dynamic flexion-extension radiographs",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Post-treatment stability assessment; if clinical instability suspected",
            "target": "Mechanical instability (translation, angulation)",
            "contraindications": "Acute cord compression (do NOT flex/extend if acute neurologic deficit)"
          },
          {
            "item": "Nuclear medicine thyroid scan",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If thyroid primary suspected (follicular thyroid cancer has high bone tropism)",
            "target": "Thyroid nodule; functional assessment",
            "contraindications": "Recent iodinated contrast (wait 4-6 weeks)"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent Treatment": [
          {
            "item": "**Dexamethasone (high-dose for MSCC)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "**Dexamethasone (high-dose for MSCC)** 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "**Standard loading dose:** 10 mg IV bolus STAT; **Then:** 4 mg IV/PO q6h (16 mg/day); **High-dose (severe deficits or rapidly progressive):** 96 mg IV bolus (controversial — see evidence) → 24 mg q6h x 3 days → rapid taper; **Moderate deficits / ambulatory:** 10 mg IV → 4 mg q6h; **Begin taper after definitive treatment initiated;** GI prophylaxis: PPI while on steroids; Monitor glucose q6h",
              "orderSentence": "**Dexamethasone (high-dose for MSCC)** 10 mg IV"
            },
            "contraindications": "-",
            "monitoring": "Sorensen et al. (1994): Dexamethasone + radiation vs. radiation alone → 81% vs. 63% ambulatory at treatment end; High-dose (96 mg) vs. standard (10 mg): Vecht et al. (1989) — higher response rate at 1 week but more side effects; MOST centers now use moderate dose (10 mg load → 16 mg/day); Begin within 6h of diagnosis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "URGENT",
            "ICU": "STAT"
          },
          {
            "item": "**Spinal precautions / immobilization**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Strict log-roll precautions; flat bed transport; cervical collar if cervical spine involved; thoracolumbar brace (TLSO) if thoracolumbar; avoid flexion/extension; transfer on spine board if unstable fracture suspected",
              "orderSentence": "**Spinal precautions / immobilization** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Unstable pathologic fracture may worsen cord compression with movement; SINS score guides instability assessment",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Bladder management**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mL",
                  "orderSentence": "**Bladder management** 200 mL -"
                }
              ],
              "route": "-",
              "instructions": "Assess for urinary retention (cord compression causes neurogenic bladder); straight catheterize if retention → place Foley if residual >200 mL or ongoing retention; monitor I&O strictly",
              "orderSentence": "**Bladder management** 200 mL -"
            },
            "contraindications": "-",
            "monitoring": "Urinary retention is a common presenting feature and may be the first sign of cord compression; bladder function correlates with motor recovery prognosis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**DVT prophylaxis**",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "**DVT prophylaxis** 40 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "SCDs immediately; pharmacologic prophylaxis (enoxaparin 40 mg SQ daily) within 24-48h unless surgery imminent; spinal cord compression patients have VERY HIGH VTE risk (up to 25-50% without prophylaxis)",
              "orderSentence": "**DVT prophylaxis** 40 mg SC"
            },
            "contraindications": "-",
            "monitoring": "Cancer + immobility + spinal cord injury = extremely high VTE risk; mechanical prophylaxis alone insufficient",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Pain management**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650-1000 mg",
                  "orderSentence": "**Pain management** 650-1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Back pain often severe; acetaminophen 650-1000 mg q6h scheduled + opioids PRN (morphine 2-4 mg IV q3h PRN or oxycodone 5-10 mg PO q4h PRN); NSAIDs cautiously (renal function, bleeding risk); dexamethasone itself reduces pain from edema/inflammation; neuropathic pain: gabapentin 300 mg TID (titrate) or pregabalin 75 mg BID",
              "orderSentence": "**Pain management** 650-1000 mg IV"
            },
            "contraindications": "-",
            "monitoring": "Pain is the presenting symptom in 83-95% of patients; median 7 weeks before diagnosis; adequate analgesia essential for function and quality of life",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**Bowel regimen**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "**Bowel regimen** 100 mg -"
                }
              ],
              "route": "-",
              "instructions": "Neurogenic bowel from cord compression + opioid constipation; docusate 100 mg BID + senna 2 tabs HS; bisacodyl suppository PRN; monitor for ileus",
              "orderSentence": "**Bowel regimen** 100 mg -"
            },
            "contraindications": "-",
            "monitoring": "Bowel dysfunction common; proactive management prevents complications",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**Glucose monitoring**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Fingerstick q6h on high-dose dexamethasone; insulin sliding scale → basal-bolus if persistent >180; anticipate glucose will rise significantly within hours of steroid initiation",
              "orderSentence": "**Glucose monitoring** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "High-dose dexamethasone causes severe hyperglycemia in majority of patients",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Definitive/Targeted Treatment": [
          {
            "item": "**Surgical decompression + stabilization**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Indications (Patchell criteria + expanded):** (1) Single site of compression, (2) Paraplegia ≤48h, (3) Not radiosensitive tumor (not lymphoma, myeloma, SCLC, germ cell), (4) Life expectancy >3 months, (5) ECOG ≤2 / able to tolerate surgery, (6) Mechanical instability (SINS ≥7), (7) Neurologic deterioration during radiation; **Approach:** Posterior decompressive laminectomy ± instrumented stabilization; anterior corpectomy with cage/cement for anterior compression with instability; **Timing:** Within 24h of presentation (ideally <12h); Followed by radiation within 2-4 weeks post-op",
              "orderSentence": "**Surgical decompression + stabilization** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "**Patchell et al. (2005) — LANDMARK:** Surgery + radiation vs. radiation alone: ambulatory rate 84% vs. 57% (p=0.001); maintained ambulation longer (122 vs. 13 days); more patients regained ambulation (62% vs. 19%); surgery retained continence longer; survival trend (126 vs. 100 days)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**External beam radiation therapy (EBRT)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Primary modality if:** Radiosensitive tumor (lymphoma, myeloma, SCLC, seminoma), surgical contraindication, multiple noncontiguous levels, life expectancy <3 months, poor surgical candidate; **Standard:** 30 Gy in 10 fractions (2 weeks) or 20 Gy in 5 fractions (1 week); **Short course (poor prognosis):** 8 Gy single fraction; **Begin within 24h of diagnosis**; Can start same day as dexamethasone; Radiation field covers 1-2 vertebral bodies above and below involved segment",
              "orderSentence": "**External beam radiation therapy (EBRT)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Rades et al. (2008): No significant difference between 30 Gy/10 vs. 20 Gy/5 for motor function recovery or local control; 8 Gy single fraction appropriate for poor prognosis (life expectancy <6 months)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Stereotactic body radiation therapy (SBRT) / Spine SRS**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Indications:** Previously irradiated segment (re-irradiation); radioresistant histology (RCC, melanoma, sarcoma); oligometastatic disease; post-operative; **Dose:** 16-24 Gy single fraction or 24-30 Gy in 3 fractions; **Requires:** Spinal cord dose constraints (max cord dose 10-14 Gy single fraction); MRI-based planning; **Timing:** As soon as technically feasible",
              "orderSentence": "**Stereotactic body radiation therapy (SBRT) / Spine SRS** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "RTOG 0631 and multiple institutional series: High local control (85-95%) for radioresistant histologies; superior to conventional EBRT for RCC, melanoma; separation surgery + SBRT emerging as preferred approach for radioresistant tumors",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Separation surgery + SBRT**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Indication:** Epidural tumor compressing cord from radioresistant primary (RCC, melanoma, sarcoma); goal is NOT gross total resection — goal is to decompress cord and create ≥2mm separation between tumor and cord to enable safe SBRT delivery; Followed by SBRT within 2-4 weeks",
              "orderSentence": "**Separation surgery + SBRT** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Laufer et al. (2013): Separation surgery + SBRT: 90% local control at 1 year for radioresistant tumors; allows definitive radiation dose to tumor while respecting cord tolerance",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Vertebroplasty / Kyphoplasty**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Indications:** Painful pathologic compression fracture; vertebral body instability; post-radiation pain; NO epidural extension compressing cord (cement leak risk into canal); **SINS 7-12 (indeterminate stability):** Consider as adjunct; **Procedure:** Percutaneous PMMA cement injection into vertebral body",
              "orderSentence": "**Vertebroplasty / Kyphoplasty** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Pain relief in 70-90% within 24-48h; structural support; does NOT address epidural disease; risk of cement leak into epidural space (1-5%)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Systemic chemotherapy**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Radiosensitive tumors as primary/adjunct therapy:** Lymphoma (R-CHOP or equivalent); myeloma (bortezomib-based); SCLC (cisplatin/etoposide); germ cell (BEP); **Other primaries:** Per disease-specific guidelines after stabilization; coordinate with medical oncology",
              "orderSentence": "**Systemic chemotherapy** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Chemosensitive tumors (lymphoma, myeloma, germ cell, SCLC) may respond rapidly to systemic therapy; may be used as primary treatment with radiation or as consolidation post-radiation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Hormonal therapy (if applicable)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Prostate cancer: ADT (LHRH agonist/antagonist) + enzalutamide/abiraterone/darolutamide; Breast cancer: anti-estrogen/AI per receptor status; Thyroid: levothyroxine suppression + RAI (spine metastases do NOT concentrate RAI well — external radiation preferred)",
              "orderSentence": "**Hormonal therapy (if applicable)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Prostate and breast cancer spinal metastases may respond to hormonal manipulation; adjunct to radiation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Adjunctive Treatment": [
          {
            "item": "**Steroid taper**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-4 mg",
                  "orderSentence": "**Steroid taper** 2-4 mg -"
                }
              ],
              "route": "-",
              "instructions": "Begin taper once definitive treatment (surgery/radiation) initiated and neurologic status stable/improving; **Taper schedule:** Reduce by 2-4 mg every 3-5 days; typical: 16→12→8→6→4→2→off over 2-3 weeks; slower taper if symptoms recur; monitor for adrenal insufficiency if >2-3 weeks of steroids",
              "orderSentence": "**Steroid taper** 2-4 mg -"
            },
            "contraindications": "-",
            "monitoring": "Prolonged high-dose steroids cause significant morbidity; steroid myopathy (proximal weakness — may mimic neurologic progression); PJP risk; hyperglycemia; GI bleed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**PPI (stress ulcer/GI prophylaxis)**",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "**PPI (stress ulcer/GI prophylaxis)** 20 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Omeprazole 20 mg daily or pantoprazole 40 mg daily while on dexamethasone",
              "orderSentence": "**PPI (stress ulcer/GI prophylaxis)** 20 mg PO"
            },
            "contraindications": "-",
            "monitoring": "Steroid + critical illness increases GI bleed risk",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**Calcium + Vitamin D**",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000-1200 mg",
                  "orderSentence": "**Calcium + Vitamin D** 1000-1200 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Calcium 1000-1200 mg + Vitamin D 800-1000 IU daily during steroid course and beyond (bone health in cancer patients)",
              "orderSentence": "**Calcium + Vitamin D** 1000-1200 mg PO"
            },
            "contraindications": "-",
            "monitoring": "Steroid-induced osteoporosis prevention; already compromised bone integrity",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Bone-modifying agents**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg",
                  "orderSentence": "**Bone-modifying agents** 4 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Zoledronic acid 4 mg IV q4 weeks OR denosumab 120 mg SQ q4 weeks; reduces skeletal-related events (SRE); dental clearance before starting (ONJ risk); renal adjustment for zoledronic acid (hold if GFR <35)",
              "orderSentence": "**Bone-modifying agents** 4 mg IV"
            },
            "contraindications": "-",
            "monitoring": "Zoledronic acid: Rosen et al. (2003) — reduced SRE by 48% in bone metastases; denosumab: Fizazi et al. (2011) — superior to zoledronic acid for SRE reduction in bone metastases (prostate trial)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Neuropathic pain management**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "**Neuropathic pain management** 300 mg -"
                }
              ],
              "route": "-",
              "instructions": "Gabapentin 300 mg TID → titrate to 600-900 mg TID; OR pregabalin 75 mg BID → titrate to 150-300 mg BID; duloxetine 30-60 mg daily as alternative; amitriptyline 10-25 mg HS (anticholinergic caution with urinary retention)",
              "orderSentence": "**Neuropathic pain management** 300 mg -"
            },
            "contraindications": "-",
            "monitoring": "Radicular and central neuropathic pain common in cord compression; adjuvant analgesics reduce opioid requirements",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**Rehabilitation (inpatient)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "PT/OT evaluation within 24h of admission; early mobilization when cleared by spine surgery; adaptive equipment; wheelchair assessment if paraparetic/paraplegic; ROM exercises; strengthening; transfer training",
              "orderSentence": "**Rehabilitation (inpatient)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Early rehabilitation improves functional outcomes; cancer rehabilitation is evidence-based; patients with MSCC benefit from structured rehab programs",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Skin care / pressure ulcer prevention**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Turn q2h; pressure-reducing mattress; heel protectors; skin assessment with Braden scale; nutrition optimization",
              "orderSentence": "**Skin care / pressure ulcer prevention** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Immobile patients with cord compression at very high risk for pressure injuries; prevention is critical",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Medications to AVOID or Use with Caution": [
          {
            "item": "NSAIDs (prolonged use)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "NSAIDs (prolonged use) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Methotrexate (high-dose, with spinal radiation)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Methotrexate (high-dose, with spinal radiation) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Intrathecal chemotherapy (with spinal block)",
            "route": "IT",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Intrathecal chemotherapy (with spinal block) - IT - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Anticoagulation (full-dose, peri-operative)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Anticoagulation (full-dose, peri-operative) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Steroids in suspected lymphoma (BEFORE biopsy)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Steroids in suspected lymphoma (BEFORE biopsy) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Bevacizumab (peri-operative)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Bevacizumab (peri-operative) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Bisphosphonates (if GFR <35 for zoledronic acid)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Bisphosphonates (if GFR <35 for zoledronic acid) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurosurgery / Spine surgery consultation — EMERGENT",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Radiation oncology consultation — EMERGENT",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Medical oncology consultation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Multidisciplinary spine tumor board",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Goals of care discussion",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Physical medicine & rehabilitation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Foley catheter management",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Social work / case management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain management / palliative care",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Interventional radiology consultation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Orthotics / bracing",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Wound care (post-operative)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nutrition / dietitian",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychology / psychiatry",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Urology consultation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Home health referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Re-irradiation (spine)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Repeat surgery",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Intrathecal drug delivery",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Cement augmentation (post-radiation)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hospice referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clinical trial enrollment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Diagnosis",
        "features": "Key Differentiating Features",
        "tests": "Distinguishing Studies"
      },
      {
        "diagnosis": "Spinal epidural abscess",
        "features": "Fever (present in 50-66%); IV drug use, recent procedure, immunosuppression; rapidly progressive; ESR >20 (sensitivity 94%); CRP markedly elevated; ring-enhancing epidural collection on MRI; restricted diffusion in abscess; spine pain with percussion tenderness; leukocytosis",
        "tests": "MRI: T2-hyperintense epidural collection with rim enhancement; restricted diffusion (DWI bright, ADC dark) within abscess; blood cultures (positive in 60%); ESR/CRP markedly elevated; procalcitonin >0.5"
      },
      {
        "diagnosis": "Degenerative spinal stenosis (cervical/lumbar)",
        "features": "Chronic progressive symptoms; myelopathic signs insidious onset; no cancer history; disc/osteophyte complex on imaging; NO destructive bone lesion; congenital canal narrowing",
        "tests": "MRI: disc-osteophyte complex; ligamentum flavum hypertrophy; NO bone destruction; NO contrast enhancement of epidural mass; chronic degenerative changes"
      },
      {
        "diagnosis": "Primary spinal cord tumor (intramedullary)",
        "features": "Intramedullary (within cord parenchyma); ependymoma, astrocytoma; cord expansion with central lesion; no vertebral body destruction; slow progression; syrinx may be present",
        "tests": "MRI: cord expansion with intramedullary enhancing lesion; no epidural mass; no vertebral body involvement; ependymoma: central location, hemosiderin cap; astrocytoma: eccentric, irregular"
      },
      {
        "diagnosis": "Vertebral compression fracture (osteoporotic)",
        "features": "No cancer history; older patient with osteoporosis; acute back pain after minor trauma/lifting; no neurologic deficits (usually); vertebral body collapsed but NO epidural mass; NO posterior element involvement",
        "tests": "MRI: vertebral body edema (T1 low, STIR high) WITHOUT epidural mass or posterior element involvement; CT: no bone destruction beyond fracture; DEXA: osteoporosis; if ambiguous → biopsy"
      },
      {
        "diagnosis": "Multiple myeloma",
        "features": "Older adult; bone pain; anemia, renal insufficiency, hypercalcemia (\"CRAB\"); diffuse lytic lesions; monoclonal protein on SPEP; punched-out skull lesions; responsive to chemotherapy AND radiation",
        "tests": "SPEP: M-protein; UPEP: Bence Jones protein; free light chains: abnormal ratio; bone marrow biopsy: >10% plasma cells; CT/MRI: multiple lytic lesions; biopsy: plasmacytoma; KEY: myeloma is RADIOSENSITIVE — radiation first-line"
      },
      {
        "diagnosis": "Lymphoma (epidural)",
        "features": "May present as isolated epidural mass; radiosensitive; responds dramatically to steroids (may \"melt\" before biopsy); younger patients; constitutional symptoms (B symptoms); elevated LDH",
        "tests": "MRI: epidural mass; homogeneous enhancement; may be paraspinal; CT: lymphadenopathy; LDH elevated; flow cytometry; KEY: obtain biopsy BEFORE steroids if possible; radiation is primary treatment"
      },
      {
        "diagnosis": "Transverse myelitis / NMOSD",
        "features": "Intramedullary T2 lesion on MRI (NOT epidural mass); autoimmune history; AQP4/MOG antibodies; longitudinally extensive (≥3 segments in NMOSD); responds to IV steroids/PLEX; no bone lesion",
        "tests": "MRI: intramedullary T2 hyperintensity, NOT epidural mass; AQP4-IgG or MOG-IgG positive; CSF: pleocytosis; no vertebral body destruction"
      },
      {
        "diagnosis": "Spinal epidural hematoma",
        "features": "Acute onset, often on anticoagulation; post-procedural (LP, epidural injection); acute neurogenic deficit; hyperacute T1 signal on MRI (blood)",
        "tests": "MRI: epidural collection with blood signal characteristics (T1 hyperintense in subacute phase); history of anticoagulation or procedure; coagulation studies abnormal; neurosurgical emergency"
      }
    ],
    "evidence": [
      {
        "recommendation": "Guideline",
        "evidenceLevel": "Source",
        "source": "Year"
      },
      {
        "recommendation": "MSCC Management",
        "evidenceLevel": "NICE Clinical Guideline CG75 (updated)",
        "source": "2008/2023"
      },
      {
        "recommendation": "Spinal Metastases",
        "evidenceLevel": "NCCN Clinical Practice Guidelines",
        "source": "2025"
      },
      {
        "recommendation": "Bone-Modifying Agents",
        "evidenceLevel": "ASCO Clinical Practice Guideline",
        "source": "2017"
      },
      {
        "recommendation": "MSCC Radiation",
        "evidenceLevel": "Cochrane Systematic Review (George et al.)",
        "source": "2015"
      },
      {
        "recommendation": "Study",
        "evidenceLevel": "Finding",
        "source": "Impact"
      },
      {
        "recommendation": "Patchell et al. (2005) — Lancet",
        "evidenceLevel": "Direct decompressive surgery + radiation vs. radiation alone for MSCC: ambulatory 84% vs. 57% (p=0.001); regained ambulation 62% vs. 19%; maintained ambulation 122 vs. 13 days; maintained continence longer",
        "source": "LANDMARK study establishing surgery + radiation as superior to radiation alone for single-level MSCC in non-radiosensitive tumors with life expectancy >3 months"
      },
      {
        "recommendation": "Sorensen et al. (1994)",
        "evidenceLevel": "Dexamethasone + radiation vs. radiation alone: ambulation 81% vs. 63% at end of treatment; 59% vs. 33% at 3 months",
        "source": "Established dexamethasone as standard adjunct to radiation in MSCC"
      },
      {
        "recommendation": "Vecht et al. (1989)",
        "evidenceLevel": "High-dose (96 mg) vs. standard (10 mg) dexamethasone: faster initial response with high-dose but similar outcomes at 1 week; more side effects with high-dose",
        "source": "Most centers now use moderate dose (10 mg load → 16 mg/day) due to side effect profile"
      },
      {
        "recommendation": "Rades et al. (2008)",
        "evidenceLevel": "Short-course (20 Gy/5 fractions) vs. standard (30 Gy/10 fractions): no significant difference in motor function improvement for patients with poor prognosis",
        "source": "Short-course radiation appropriate for patients with limited life expectancy"
      },
      {
        "recommendation": "Laufer et al. (2013)",
        "evidenceLevel": "Separation surgery + SBRT for radioresistant MSCC: 90% local control at 1 year; enabled delivery of effective radiation doses to previously radioresistant tumors",
        "source": "Established separation surgery + SBRT paradigm for RCC, melanoma, sarcoma spinal metastases"
      },
      {
        "recommendation": "Rosen et al. (2003)",
        "evidenceLevel": "Zoledronic acid reduced skeletal-related events by 48% compared to placebo in bone metastases from breast cancer and myeloma",
        "source": "Standard bone-modifying therapy for cancer-related bone disease"
      },
      {
        "recommendation": "Fizazi et al. (2011)",
        "evidenceLevel": "Denosumab superior to zoledronic acid in reducing SRE in prostate cancer bone metastases (HR 0.82, p=0.008)",
        "source": "Denosumab as alternative/preferred bone-modifying agent; no renal adjustment needed"
      },
      {
        "recommendation": "SINS Total Score",
        "evidenceLevel": "Interpretation",
        "source": "Action"
      },
      {
        "recommendation": "0-6",
        "evidenceLevel": "Stable",
        "source": "Non-surgical management appropriate"
      },
      {
        "recommendation": "7-12",
        "evidenceLevel": "Indeterminate (potentially unstable)",
        "source": "Surgical consultation recommended"
      },
      {
        "recommendation": "13-18",
        "evidenceLevel": "Unstable",
        "source": "Surgical stabilization recommended"
      },
      {
        "recommendation": "Parameter",
        "evidenceLevel": "Score 0",
        "source": "Score 1"
      },
      {
        "recommendation": "General condition (KPS)",
        "evidenceLevel": "Poor (10-40%)",
        "source": "Moderate (50-70%)"
      },
      {
        "recommendation": "Number of extraspinal bone metastases",
        "evidenceLevel": "≥3",
        "source": "1-2"
      },
      {
        "recommendation": "Number of vertebral body metastases",
        "evidenceLevel": "≥3",
        "source": "2"
      },
      {
        "recommendation": "Metastases to major organs",
        "evidenceLevel": "Unremovable",
        "source": "Removable"
      },
      {
        "recommendation": "Primary tumor site",
        "evidenceLevel": "Lung, osteosarcoma, stomach, bladder, esophagus, pancreas",
        "source": "Liver, gallbladder, unidentified"
      },
      {
        "recommendation": "Neurologic deficit (Frankel)",
        "evidenceLevel": "Complete (A/B)",
        "source": "Incomplete (C/D)"
      },
      {
        "recommendation": "Tokuhashi Score",
        "evidenceLevel": "Predicted Survival",
        "source": "Recommended Treatment"
      },
      {
        "recommendation": "0-8",
        "evidenceLevel": "<6 months",
        "source": "Palliative/conservative (short-course radiation)"
      },
      {
        "recommendation": "9-11",
        "evidenceLevel": "6-12 months",
        "source": "Palliative or excisional surgery depending on factors"
      },
      {
        "recommendation": "12-15",
        "evidenceLevel": ">12 months",
        "source": "Excisional surgery; aggressive treatment justified"
      },
      {
        "recommendation": "Factor",
        "evidenceLevel": "Assessment",
        "source": "Treatment Implications"
      },
      {
        "recommendation": "**N**eurologic",
        "evidenceLevel": "Degree of cord compression (Bilsky grade); functional status; myelopathy",
        "source": "High-grade compression (Bilsky 2-3) → surgical decompression; low-grade → radiation alone may suffice"
      },
      {
        "recommendation": "**O**ncologic",
        "evidenceLevel": "Radiosensitivity; expected tumor response to radiation",
        "source": "Radiosensitive (lymphoma, myeloma, SCLC) → radiation primary; Radioresistant (RCC, melanoma, sarcoma) → surgery + SBRT"
      },
      {
        "recommendation": "**M**echanical instability",
        "evidenceLevel": "SINS score",
        "source": "SINS ≥7 → surgical consultation for stabilization"
      },
      {
        "recommendation": "**S**ystemic disease",
        "evidenceLevel": "Extent of metastatic burden; medical comorbidities; life expectancy",
        "source": "Widespread disease, poor prognosis → palliative approach; oligometastatic → aggressive local treatment"
      }
    ],
    "monitoring": [
      {
        "item": "Neurologic examination (motor strength, sensory level, rectal tone, reflexes)",
        "frequency": "q4h x 48h → q6h",
        "target": "Stable or improving motor function; stable sensory level; preserved rectal tone",
        "action": "If declining: STAT MRI; escalate dexamethasone to 24 mg/day; emergent neurosurgery"
      },
      {
        "item": "Blood glucose",
        "frequency": "q6h (q4h if on insulin drip)",
        "target": "140-180 mg/dL",
        "action": "Sliding scale → basal-bolus insulin; endocrine consult if refractory"
      },
      {
        "item": "Pain score (NRS)",
        "frequency": "q4h",
        "target": "NRS <4/10",
        "action": "Escalate analgesics; add neuropathic agents; palliative care consultation"
      },
      {
        "item": "Blood pressure",
        "frequency": "q4h (continuous if neurogenic shock)",
        "target": "SBP >90 (avoid hypotension — cord perfusion); MAP >65-70",
        "action": "IV fluids; vasopressors if neurogenic shock; avoid excessive hypertension (post-operative bleeding risk)"
      },
      {
        "item": "Bladder function (I&O, post-void residual)",
        "frequency": "q shift; post-void residual daily",
        "target": "Volitional voiding; PVR <200 mL",
        "action": "Foley if retention; intermittent catheterization if PVR 200-500"
      },
      {
        "item": "Bowel function",
        "frequency": "Daily",
        "target": "Bowel movement within 48-72h",
        "action": "Aggressive bowel regimen; rectal exam; abdominal X-ray if distended"
      },
      {
        "item": "Skin integrity (Braden scale)",
        "frequency": "q shift",
        "target": "No pressure injuries; Braden ≥18",
        "action": "Turn q2h; specialty mattress; heel protectors; wound care if injury develops"
      },
      {
        "item": "Temperature",
        "frequency": "q4h",
        "target": "Afebrile",
        "action": "If febrile: blood cultures, UA, chest imaging; consider abscess vs. tumor fever"
      },
      {
        "item": "Respiratory function (if cervical/high thoracic)",
        "frequency": "q4h; bedside spirometry daily",
        "target": "FVC >15 mL/kg; stable respiratory rate",
        "action": "If FVC declining: ICU transfer; prepare for intubation; consider phrenic nerve involvement"
      }
    ],
    "disposition": [
      {
        "disposition": "Level of Care",
        "criteria": "Criteria"
      },
      {
        "disposition": "ICU admission",
        "criteria": "Neurogenic shock (hypotension + bradycardia from spinal cord injury); respiratory compromise from high cervical lesion; post-operative monitoring (first 24h after major spine surgery); acute paraplegia/quadriplegia requiring close monitoring; hemodynamic instability"
      },
      {
        "disposition": "General neurology/neurosurgery/oncology floor",
        "criteria": "New MSCC diagnosis requiring workup and treatment planning; surgical candidate awaiting decompression; radiation therapy initiation; motor deficits requiring monitoring and rehabilitation; pain management; high-dose steroid initiation"
      },
      {
        "disposition": "Observation",
        "criteria": "Known metastatic disease with new pain but preserved neurologic function; MRI showing compression without cord signal change; stable neurologic exam"
      }
    ]
  },
  "Subarachnoid Hemorrhage (SAH)": {
    "id": "subarachnoid-hemorrhage",
    "title": "Subarachnoid Hemorrhage (SAH)",
    "version": "1.0",
    "icd10": [
      "** I60.9 (Nontraumatic subarachnoid hemorrhage",
      "unspecified)",
      "I60.7 (SAH from unspecified intracranial artery)",
      "I60.0-I60.6 (SAH from specific arteries)"
    ],
    "scope": "** Spontaneous (non-traumatic) aneurysmal subarachnoid hemorrhage in adults. Covers thunderclap headache evaluation, CT/LP diagnosis, aneurysm identification and securing, vasospasm prevention and treatment (nimodipine, triple-H therapy), hydrocephalus management, and complications. Excludes traumatic SAH, perimesencephalic (non-aneurysmal) SAH management, and intracerebral hemorrhage (separate template).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Baseline; thrombocytopenia; leukocytosis (stress response); pre-surgical",
            "target": "Normal"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Electrolytes (hyponatremia from cerebral salt wasting or SIADH is common); renal/hepatic function",
            "target": "Normal; watch Na closely"
          },
          {
            "item": "PT/INR, aPTT",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Coagulopathy assessment; pre-procedure; anticoagulant use",
            "target": "Normal"
          },
          {
            "item": "Fibrinogen",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Coagulopathy; DIC screen",
            "target": ">150 mg/dL"
          },
          {
            "item": "Type and crossmatch",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Surgical intervention likely; potential blood loss",
            "target": "On file; crossmatch 2-4 units"
          },
          {
            "item": "Troponin",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Neurogenic stunned myocardium occurs in 20-30% of SAH; stress cardiomyopathy",
            "target": "Often elevated (neurogenic — not ACS)"
          },
          {
            "item": "BNP or NT-proBNP",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Neurogenic cardiac dysfunction; volume status assessment",
            "target": "Elevated (neurogenic)"
          },
          {
            "item": "Blood glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Hyperglycemia worsens outcomes; stress response",
            "target": "140-180 mg/dL target"
          },
          {
            "item": "Magnesium",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Hypomagnesemia increases vasospasm risk; maintain high-normal",
            "target": ">2.0 mg/dL (replete aggressively)"
          },
          {
            "item": "Calcium (ionized)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Electrolyte management; nimodipine monitoring",
            "target": "Normal"
          },
          {
            "item": "Phosphorus",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Electrolyte management; refeeding risk",
            "target": "Normal"
          },
          {
            "item": "Lactate",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Perfusion status",
            "target": "<2 mmol/L"
          },
          {
            "item": "Pregnancy test (β-hCG)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Affects imaging, anesthesia, and treatment decisions",
            "target": "Document result"
          }
        ],
        "Extended Workup": [
          {
            "item": "Serum osmolality",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "Cerebral salt wasting vs SIADH differentiation; osmotherapy monitoring",
            "target": "280-295 mOsm/kg"
          },
          {
            "item": "Urine osmolality and sodium",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "CSW: high urine Na, high urine osm, hypovolemic. SIADH: high urine Na, high urine osm, euvolemic",
            "target": "Differentiate CSW vs SIADH"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Thyroid dysfunction screen",
            "target": "Normal"
          },
          {
            "item": "Cortisol (AM)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "Adrenal insufficiency (pituitary dysfunction from SAH)",
            "target": ">18 µg/dL"
          },
          {
            "item": "Lipid panel",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Cardiovascular risk assessment",
            "target": "Document"
          },
          {
            "item": "HbA1c",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes management",
            "target": "<7.0%"
          },
          {
            "item": "Blood cultures",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "If febrile (differentiate central fever vs infection)",
            "target": "No growth"
          },
          {
            "item": "Procalcitonin",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Differentiate neurogenic fever from infection",
            "target": "<0.5 (elevated suggests infection)"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Urine catecholamines/metanephrines",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Pheochromocytoma as cause of hypertensive hemorrhage",
            "target": "Normal"
          },
          {
            "item": "Toxicology (cocaine, amphetamines)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Sympathomimetic-associated SAH",
            "target": "Negative"
          },
          {
            "item": "Sickle cell screen",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Sickle cell associated aneurysms and SAH (young patients, African descent)",
            "target": "Normal"
          },
          {
            "item": "Connective tissue disorder workup (Ehlers-Danlos, Marfan)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Familial aneurysm syndromes; young SAH with marfanoid habitus or skin hyperextensibility",
            "target": "Clinical + genetic"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Elevated in SAH",
            "target": "Often elevated (>20 cm H2O)"
          },
          {
            "item": "Cell count (tubes 1 AND 4)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Distinguish SAH from traumatic tap: SAH = RBC count does NOT clear significantly between tube 1 and tube 4",
            "target": "RBC in tube 4 ≥ tube 1 (SAH); if tube 4 << tube 1 = traumatic tap"
          },
          {
            "item": "Xanthochromia (visual and/or spectrophotometry)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Yellow discoloration from RBC breakdown (bilirubin); develops >6h after SAH; spectrophotometry more sensitive than visual inspection",
            "target": "Present = SAH (sensitivity >95% at 12h-2 weeks post-bleed). Absent = unlikely SAH"
          },
          {
            "item": "Protein",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Elevated in SAH",
            "target": "Elevated"
          },
          {
            "item": "Glucose",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Usually normal in SAH",
            "target": "Normal"
          },
          {
            "item": "Gram stain and culture",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Exclude meningitis (meningeal signs overlap)",
            "target": "No organisms"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "IMMEDIATE (door-to-CT <25 min). Sensitivity: 98-100% within 6h; ~93% at 12h; ~85% at 24h; declines after 3-5 days",
            "target": "Hyperdense blood in basal cisterns, Sylvian fissure, interhemispheric fissure; modified Fisher grade; hydrocephalus; intraventricular hemorrhage",
            "contraindications": "None significant"
          },
          {
            "item": "CT angiography (CTA) head",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Simultaneously with non-contrast CT. Identifies aneurysm (sensitivity 95-100% for aneurysms >3mm)",
            "target": "Aneurysm location, size, morphology; multiple aneurysms (15-20% have >1); vasospasm (delayed)",
            "contraindications": "Contrast allergy (premedicate); renal impairment (benefit outweighs risk)"
          },
          {
            "item": "ECG (12-lead)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Immediately",
            "target": "Deep T-wave inversions (\"cerebral T waves\"), ST changes, QT prolongation, arrhythmias — all may be neurogenic; do NOT misdiagnose as primary cardiac event",
            "contraindications": "None"
          }
        ],
        "Extended": [
          {
            "item": "Conventional cerebral angiography (DSA)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Within 24h — GOLD STANDARD for aneurysm identification; also therapeutic (coiling). If CTA negative but clinical suspicion high, DSA is mandatory",
            "target": "Aneurysm (location, neck width, dome-to-neck ratio, relationship to branches); may find aneurysm missed by CTA; vasospasm assessment",
            "contraindications": "Contrast allergy; renal impairment; coagulopathy (relative)"
          },
          {
            "item": "Repeat DSA (if initial negative)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "timing": "At 7-14 days if initial DSA negative and non-perimesencephalic pattern; small aneurysm may be thrombosed or compressed by hematoma",
            "target": "Previously missed aneurysm",
            "contraindications": "Same as initial"
          },
          {
            "item": "MRI/MRA brain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "When stable; helpful for subacute diagnosis or if CT negative but suspicion persists",
            "target": "Blood products (FLAIR); aneurysm (MRA); ischemia from vasospasm (DWI)",
            "contraindications": "Pacemaker; hemodynamic instability"
          },
          {
            "item": "Transcranial Doppler (TCD)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Begin daily on post-bleed day 3; continue through day 14 (vasospasm window)",
            "target": "Mean flow velocities: MCA >120 cm/s concerning; >200 cm/s severe vasospasm. Lindegaard ratio >3 suggests vasospasm (>6 = severe)",
            "contraindications": "Absent temporal bone window (~10%)"
          },
          {
            "item": "CT perfusion (CTP)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "If vasospasm suspected clinically (new deficit days 4-14)",
            "target": "Perfusion deficits in vascular territory of spastic vessel; mismatch (reversible ischemia)",
            "contraindications": "Contrast allergy; renal impairment"
          },
          {
            "item": "CTA (repeat for vasospasm)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "If clinical vasospasm suspected",
            "target": "Arterial narrowing; correlate with TCD and clinical exam",
            "contraindications": "Same as initial CTA"
          },
          {
            "item": "Echocardiogram (TTE)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "timing": "Within 24-48h",
            "target": "Takotsubo (apical ballooning); regional wall motion abnormalities; EF assessment — neurogenic stunned myocardium in 20-30%",
            "contraindications": "None significant"
          },
          {
            "item": "Continuous EEG (cEEG)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "If altered consciousness; delayed deterioration; suspected seizures",
            "target": "Non-convulsive seizures; electrographic vasospasm correlate; periodic discharges",
            "contraindications": "None"
          },
          {
            "item": "Chest X-ray",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "On admission; daily in ICU",
            "target": "Neurogenic pulmonary edema; aspiration; ARDS",
            "contraindications": "None"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "3D rotational angiography",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "During DSA for complex aneurysm anatomy",
            "target": "Detailed aneurysm morphology for treatment planning",
            "contraindications": "Same as DSA"
          },
          {
            "item": "Xenon CT or CT perfusion (quantitative)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "timing": "Research/advanced vasospasm assessment",
            "target": "Quantitative cerebral blood flow mapping",
            "contraindications": "Limited availability"
          },
          {
            "item": "MRA screening (unruptured aneurysm in family members)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Elective — for first-degree relatives of SAH patients (2 or more affected family members)",
            "target": "Incidental unruptured aneurysm",
            "contraindications": "Standard MRI contraindications"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Blood pressure control: Nicardipine IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg/h",
                  "orderSentence": "Blood pressure control: Nicardipine IV 5 mg/h IV"
                }
              ],
              "route": "IV",
              "instructions": "5 mg/h IV; titrate by 2.5 mg/h q5-15min; max 15 mg/h. Target SBP <160 mmHg UNTIL aneurysm is secured (re-bleed risk highest in first 24h with uncontrolled HTN); after securing: target SBP <180 (or higher if vasospasm)",
              "orderSentence": "Blood pressure control: Nicardipine IV 5 mg/h IV"
            },
            "contraindications": "Severe aortic stenosis",
            "monitoring": "Continuous arterial BP; neuro checks q1h",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Blood pressure control: Labetalol IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-20 mg",
                  "orderSentence": "Blood pressure control: Labetalol IV 10-20 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10-20 mg IV q10-20min; max 300 mg. Alternative to nicardipine",
              "orderSentence": "Blood pressure control: Labetalol IV 10-20 mg IV"
            },
            "contraindications": "Heart block; severe bradycardia; asthma",
            "monitoring": "HR; BP continuous",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Blood pressure control: Clevidipine IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2 mg/h",
                  "orderSentence": "Blood pressure control: Clevidipine IV 1-2 mg/h IV"
                }
              ],
              "route": "IV",
              "instructions": "1-2 mg/h IV; max 32 mg/h",
              "orderSentence": "Blood pressure control: Clevidipine IV 1-2 mg/h IV"
            },
            "contraindications": "Soy/egg allergy",
            "monitoring": "BP continuous",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Nimodipine (CORNERSTONE of vasospasm prevention)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg",
                  "orderSentence": "Nimodipine (CORNERSTONE of vasospasm prevention) 60 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "60 mg PO/NG q4h x 21 days. START within 96h of SAH onset. If hypotension: 30 mg q2h. This is an ORAL calcium channel blocker — do NOT give IV (severe hypotension). Proven to reduce poor outcomes from vasospasm",
              "orderSentence": "Nimodipine (CORNERSTONE of vasospasm prevention) 60 mg IV"
            },
            "contraindications": "Hypotension (SBP <90 — reduce dose); do NOT crush extended-release formulations; use oral syringe if NG",
            "monitoring": "BP with each dose; do NOT give IV; ensure enteral route only",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "External ventricular drain (EVD)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "For acute hydrocephalus (GCS declining; CT showing ventriculomegaly); allows ICP monitoring and CSF drainage. Set drain height per neurosurgery (typically 15-20 cm above tragus)",
              "orderSentence": "External ventricular drain (EVD) - - - see dosing"
            },
            "contraindications": "Coagulopathy (correct first)",
            "monitoring": "ICP continuous; CSF output q1h; drain position; infection surveillance (CSF culture q3 days per some protocols)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Seizure prophylaxis (short-term)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Seizure prophylaxis (short-term) 1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Levetiracetam 1000 mg IV/PO load, then 500-1000 mg BID. AHA 2012: short-term (3-7 days) prophylaxis is reasonable. Avoid phenytoin (associated with worse cognitive outcomes in SAH — Naidech et al.)",
              "orderSentence": "Seizure prophylaxis (short-term) 1000 mg IV"
            },
            "contraindications": "Renal impairment (dose adjust)",
            "monitoring": "Seizure monitoring",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Intubation / Airway protection",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "GCS ≤8; inability to protect airway; respiratory failure; impending herniation",
              "orderSentence": "Intubation / Airway protection - - - see dosing"
            },
            "contraindications": "N/A",
            "monitoring": "Avoid hypotension during RSI; maintain SBP goal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Aminocaproic acid (antifibrinolytic)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4g",
                  "orderSentence": "Aminocaproic acid (antifibrinolytic) 4g IV"
                }
              ],
              "route": "IV",
              "instructions": "4g IV load then 1g/h IV infusion. ONLY use for short-term (<72h) if aneurysm securing will be delayed. Reduces re-bleeding risk but increases thrombotic risk. Discontinue once aneurysm is secured",
              "orderSentence": "Aminocaproic acid (antifibrinolytic) 4g IV"
            },
            "contraindications": "Active DIC; DVT/PE; renal impairment",
            "monitoring": "Coagulation; thrombotic events; discontinue when aneurysm treated",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "IV isotonic fluids (euvolemia)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-1.5 mL/kg",
                  "orderSentence": "IV isotonic fluids (euvolemia) 1-1.5 mL/kg -"
                }
              ],
              "route": "-",
              "instructions": "NS at 1-1.5 mL/kg/h (80-125 mL/h); goal euvolemia. Avoid hypovolemia (worsens vasospasm) and avoid aggressive hypervolemia (no proven benefit; risk of pulmonary edema). Target CVP 5-8 or clinical euvolemia",
              "orderSentence": "IV isotonic fluids (euvolemia) 1-1.5 mL/kg -"
            },
            "contraindications": "Volume overload; CHF",
            "monitoring": "I/O; daily weights; CVP if central line; serum Na q6-8h",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Stress ulcer prophylaxis: Pantoprazole",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Stress ulcer prophylaxis: Pantoprazole 40 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "40 mg IV/PO daily",
              "orderSentence": "Stress ulcer prophylaxis: Pantoprazole 40 mg IV"
            },
            "contraindications": "C. diff risk",
            "monitoring": "GI symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "DVT prophylaxis: Pneumatic compression devices",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Apply bilaterally on admission; SAH patients are HIGH VTE risk",
              "orderSentence": "DVT prophylaxis: Pneumatic compression devices - - - see dosing"
            },
            "contraindications": "Acute DVT",
            "monitoring": "Skin checks",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "DVT prophylaxis: Heparin SC (after aneurysm secured)",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5000 units",
                  "orderSentence": "DVT prophylaxis: Heparin SC (after aneurysm secured) 5000 units SC"
                }
              ],
              "route": "SC",
              "instructions": "5000 units SC q8h; start 24h after aneurysm is secured (clipping or coiling); some centers start earlier",
              "orderSentence": "DVT prophylaxis: Heparin SC (after aneurysm secured) 5000 units SC"
            },
            "contraindications": "Active bleeding; within 24h of craniotomy (per surgeon)",
            "monitoring": "Platelets q3 days",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          }
        ],
        "Aneurysm Securing (Definitive Treatment)": [
          {
            "item": "Endovascular coiling",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Interventional neuroradiology; catheter-based platinum coil deployment into aneurysm sac. Preferred per ISAT trial for posterior circulation and many anterior circulation aneurysms",
              "orderSentence": "Endovascular coiling - - - see dosing"
            },
            "contraindications": "Difficult vascular access; very wide neck without stent option",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Surgical clipping (craniotomy)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Neurosurgical; microsurgical clip placement across aneurysm neck",
              "orderSentence": "Surgical clipping (craniotomy) - - - see dosing"
            },
            "contraindications": "Poor grade with brain swelling (relative — may clip if accessible); medically unstable",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Flow diverter (Pipeline, FRED)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "For large/giant or wide-necked aneurysms not amenable to standard coiling",
              "orderSentence": "Flow diverter (Pipeline, FRED) - - - see dosing"
            },
            "contraindications": "Requires dual antiplatelet therapy (may not be ideal in acute SAH)",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Vasospasm Treatment (Post-Bleed Days 4-14)": [
          {
            "item": "Nimodipine (continued)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg",
                  "orderSentence": "Nimodipine (continued) 60 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Continue 60 mg PO q4h x 21 days total",
              "orderSentence": "Nimodipine (continued) 60 mg PO"
            },
            "contraindications": "Hypotension",
            "monitoring": "BP with each dose",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Induced hypertension",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "If clinical vasospasm (new deficit days 4-14, aneurysm MUST be secured first): raise SBP to 180-220 mmHg using vasopressors. Phenylephrine 0.5-5 µg/kg/min or norepinephrine 0.05-0.3 µg/kg/min IV",
              "orderSentence": "Induced hypertension - IV - see dosing"
            },
            "contraindications": "Unsecured aneurysm (NEVER induce hypertension before securing); cardiac failure; pulmonary edema",
            "monitoring": "Arterial line; neuro checks q1h; TCD; CT perfusion",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "IV fluid bolus (euvolemia maintenance)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500-1000 mL",
                  "orderSentence": "IV fluid bolus (euvolemia maintenance) 500-1000 mL -"
                }
              ],
              "route": "-",
              "instructions": "NS bolus 500-1000 mL if hypovolemic; maintain euvolemia. Avoid prophylactic hypervolemia (no benefit per current evidence — Robertson et al.)",
              "orderSentence": "IV fluid bolus (euvolemia maintenance) 500-1000 mL -"
            },
            "contraindications": "Volume overload",
            "monitoring": "CVP; I/O; daily weights",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Milrinone IV (alternative vasospasm treatment)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "0.25-0.75 µg/kg/min IV continuous; some centers use as rescue for vasospasm not responding to induced hypertension; acts as cerebral vasodilator",
              "orderSentence": "Milrinone IV (alternative vasospasm treatment) - IV - see dosing"
            },
            "contraindications": "Severe hypotension; arrhythmia",
            "monitoring": "BP (may cause hypotension); HR; cardiac output",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Intra-arterial vasodilator therapy (endovascular rescue)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-10 mg",
                  "orderSentence": "Intra-arterial vasodilator therapy (endovascular rescue) 5-10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Verapamil 5-10 mg intra-arterial or nicardipine 5-10 mg intra-arterial; via catheter into spastic vessel during angiography. For medically refractory vasospasm",
              "orderSentence": "Intra-arterial vasodilator therapy (endovascular rescue) 5-10 mg PO"
            },
            "contraindications": "Hemodynamic instability during procedure",
            "monitoring": "Angiographic improvement; clinical response; BP",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Angioplasty (balloon)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Mechanical dilation of spastic proximal vessels during angiography. For focal proximal vasospasm refractory to medical treatment",
              "orderSentence": "Angioplasty (balloon) - - - see dosing"
            },
            "contraindications": "Vessel rupture risk; distal vasospasm (not amenable to balloon)",
            "monitoring": "Angiographic result; clinical response",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Magnesium sulfate (supplemental)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.0 mg",
                  "orderSentence": "Magnesium sulfate (supplemental) 2.0 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Target serum Mg >2.0 mg/dL; replete with MgSO4 2-4 g IV over 1-2h PRN. MASH-2 trial: IV magnesium infusion did NOT improve outcomes, but maintaining normal-high Mg is standard",
              "orderSentence": "Magnesium sulfate (supplemental) 2.0 mg IV"
            },
            "contraindications": "Renal failure; hypermagnesemia",
            "monitoring": "Serum Mg q12-24h; deep tendon reflexes",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          }
        ],
        "Complications Management": [
          {
            "item": "Hyponatremia management: Differentiate CSW vs SIADH",
            "route": "PO",
            "indication": "Na <135: CSW = volume depleted (treat with NS/hypertonic saline + fludrocortisone). SIADH = euvolemic (treat with fluid restriction ± hypertonic saline)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1-0.2 mg",
                  "orderSentence": "Hyponatremia management: Differentiate CSW vs SIADH 0.1-0.2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "CSW: NS or 3% saline; fludrocortisone 0.1-0.2 mg PO BID. SIADH: fluid restriction 1-1.2 L/day; 3% saline if <120",
              "orderSentence": "Hyponatremia management: Differentiate CSW vs SIADH 0.1-0.2 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "Na q6h during correction; avoid >8-10 mEq/L rise in 24h (central pontine myelinolysis risk)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Fludrocortisone",
            "route": "PO",
            "indication": "Cerebral salt wasting (volume depletion + hyponatremia)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1-0.2 mg",
                  "orderSentence": "Fludrocortisone 0.1-0.2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.1-0.2 mg PO BID",
              "orderSentence": "Fludrocortisone 0.1-0.2 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "Na; K+ (hypokalemia); volume status; BP",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Hydrocortisone",
            "route": "IV",
            "indication": "Refractory hyponatremia; cerebral salt wasting; adrenal insufficiency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50-100 mg",
                  "orderSentence": "Hydrocortisone 50-100 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "50-100 mg IV q8h",
              "orderSentence": "Hydrocortisone 50-100 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "Na; glucose; cortisol",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Ventriculoperitoneal shunt (VPS)",
            "route": "-",
            "indication": "Chronic hydrocephalus (EVD-dependent; unable to wean)",
            "dosing": {
              "instructions": "Neurosurgical procedure",
              "orderSentence": "Ventriculoperitoneal shunt (VPS) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "Shunt function; neurologic status",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Lumbar drain",
            "route": "-",
            "indication": "CSF diversion after EVD if transitioning; mild chronic hydrocephalus",
            "dosing": {
              "instructions": "Neurosurgical placement",
              "orderSentence": "Lumbar drain - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "CSF output; ICP; position",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurosurgery",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "ALL SAH patients; EVD placement; surgical clipping decision; hydrocephalus management"
          },
          {
            "item": "Interventional neuroradiology / Neuroendovascular",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Endovascular coiling; intra-arterial vasospasm treatment; angioplasty"
          },
          {
            "item": "Neurocritical care / Neurointensivist",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "ICU management; vasospasm monitoring; medical optimization"
          },
          {
            "item": "Cardiology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "indication": "Neurogenic stunned myocardium; Takotsubo; arrhythmia management"
          },
          {
            "item": "Pulmonology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "indication": "Neurogenic pulmonary edema; ARDS; ventilator management"
          },
          {
            "item": "Endocrinology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Pituitary dysfunction post-SAH (growth hormone, cortisol, thyroid); diabetes insipidus"
          },
          {
            "item": "Speech-language pathology (SLP)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Dysphagia evaluation; cognitive-linguistic assessment"
          },
          {
            "item": "Physical therapy (PT)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Early mobilization when stable; fall prevention; strength"
          },
          {
            "item": "Occupational therapy (OT)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "ADL assessment; cognitive rehabilitation"
          },
          {
            "item": "Rehabilitation medicine (physiatry)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Rehabilitation planning; disposition"
          },
          {
            "item": "Social work",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Family support; advance directives; discharge planning"
          },
          {
            "item": "Palliative care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "indication": "Poor-grade SAH (Hunt-Hess IV-V); goals of care"
          },
          {
            "item": "Genetics / Genetic counseling",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Familial aneurysm screening; connective tissue disorders"
          }
        ],
        "Patient Instructions": [
          {
            "item": "SAH is life-threatening; treatment is time-sensitive",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Call 911 immediately if: sudden severe headache (\"worst headache of life\"), loss of consciousness, seizure, new weakness, vision changes",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Blood pressure control is critical long-term — take all prescribed medications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation is essential (smoking is the strongest modifiable risk factor for aneurysm formation and rupture)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do NOT drive until cleared by neurology/neurosurgery",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid heavy lifting, straining, and Valsalva maneuvers for 4-6 weeks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Follow-up imaging (CTA or MRA) at 6 months, then annually for several years to assess treated aneurysm and screen for new aneurysm",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "First-degree relatives should discuss aneurysm screening with their physician if ≥2 family members have had SAH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cognitive difficulties (memory, attention, fatigue) are common after SAH — neuropsychological evaluation and rehabilitation are available",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Depression and anxiety are common; seek support early",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Smoking cessation (ABSOLUTE — strongest modifiable risk factor)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Blood pressure control (<130/80 mmHg)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Alcohol moderation/cessation (heavy drinking increases SAH risk)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cocaine/stimulant cessation (vasospasm and SAH risk)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid excessive straining (constipation management; stool softeners)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular moderate exercise after recovery and medical clearance",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate hydration",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Thunderclap headache — reversible cerebral vasoconstriction syndrome (RCVS)",
        "features": "Recurrent thunderclap headaches over days-weeks; triggered by exertion, Valsalva, sexual activity; vasospasm on CTA; may have convexity SAH; no aneurysm",
        "tests": "CTA (multifocal segmental narrowing); MRI (may show edema, infarct, cortical SAH); DSA; clinical course (resolves in weeks)"
      },
      {
        "diagnosis": "Primary intracerebral hemorrhage",
        "features": "Parenchymal hematoma with minimal/no subarachnoid blood; hypertensive location (basal ganglia, thalamus)",
        "tests": "CT (parenchymal not cisternal); CTA (no aneurysm unless hemorrhage extends into subarachnoid space)"
      },
      {
        "diagnosis": "Bacterial meningitis",
        "features": "Fever, meningismus, altered mental status, CSF neutrophilic pleocytosis with low glucose",
        "tests": "LP (gram stain, culture, BioFire); procalcitonin elevated; CT without blood"
      },
      {
        "diagnosis": "Migraine (severe)",
        "features": "Prior migraine history; gradual onset of associated features; photophobia, phonophobia; no blood on CT",
        "tests": "Normal CT; normal LP; clinical history"
      },
      {
        "diagnosis": "Hypertensive emergency",
        "features": "Severely elevated BP; headache; but no blood on CT; may have PRES features",
        "tests": "CT (no blood); MRI (PRES: posterior white matter edema)"
      },
      {
        "diagnosis": "Cervical artery dissection",
        "features": "Neck pain, headache, Horner syndrome, stroke; may have traumatic SAH from vertebral dissection",
        "tests": "CTA neck (intimal flap, pseudoaneurysm); MRI neck (crescent sign)"
      },
      {
        "diagnosis": "Cerebral venous thrombosis (CVT)",
        "features": "Headache, seizures; may have hemorrhagic venous infarct or cortical SAH; risk factors (OCPs, pregnancy)",
        "tests": "MRV/CT venogram (thrombosed sinus)"
      },
      {
        "diagnosis": "Pituitary apoplexy",
        "features": "Sudden headache, visual field defect, ophthalmoplegia; known pituitary adenoma; may have subarachnoid blood from pituitary hemorrhage",
        "tests": "MRI sella (hemorrhagic pituitary mass); hormone panel"
      },
      {
        "diagnosis": "Perimesencephalic SAH (non-aneurysmal)",
        "features": "Blood confined to perimesencephalic cisterns (anterior to brainstem); benign course; CTA/DSA negative for aneurysm",
        "tests": "CT pattern (perimesencephalic); negative CTA and DSA; excellent prognosis"
      },
      {
        "diagnosis": "Traumatic SAH",
        "features": "History of trauma; may have other traumatic injuries (contusion, subdural, skull fracture)",
        "tests": "Clinical history; CT pattern"
      },
      {
        "diagnosis": "Spinal SAH",
        "features": "Sudden back/leg pain with meningismus; blood on lumbar CT or MRI; rare",
        "tests": "Spinal MRI; spinal angiography"
      }
    ],
    "evidence": [
      {
        "recommendation": "Nimodipine 60 mg PO q4h x 21 days",
        "evidenceLevel": "Class I, Level A",
        "source": "Pickard et al. (BMJ 1989); only proven agent to improve outcomes in SAH vasospasm"
      },
      {
        "recommendation": "Early aneurysm securing (<24h, ideally <12h)",
        "evidenceLevel": "Class I, Level B",
        "source": "ISAT; AHA/ASA 2012 SAH Guidelines; de Gans et al. (Stroke 2002)"
      },
      {
        "recommendation": "Endovascular coiling preferred over clipping for most aneurysms",
        "evidenceLevel": "Class I, Level A",
        "source": "ISAT trial (Molyneux et al. Lancet 2002); long-term follow-up"
      },
      {
        "recommendation": "SBP <160 until aneurysm secured",
        "evidenceLevel": "Class I, Level B",
        "source": "AHA/ASA 2012 SAH Guidelines"
      },
      {
        "recommendation": "Euvolemia (avoid hypovolemia; avoid prophylactic hypervolemia)",
        "evidenceLevel": "Class I, Level B",
        "source": "Lennihan et al. (Stroke 2000); HIMALAIA trial"
      },
      {
        "recommendation": "Induced hypertension for clinical vasospasm (after aneurysm secured)",
        "evidenceLevel": "Class IIa, Level B",
        "source": "AHA/ASA Guidelines; standard practice"
      },
      {
        "recommendation": "TCD daily for vasospasm monitoring",
        "evidenceLevel": "Class IIa, Level B",
        "source": "Sloan et al. (2004); AHA/ASA Guidelines"
      },
      {
        "recommendation": "Short-term seizure prophylaxis (3-7 days) reasonable",
        "evidenceLevel": "Class IIb, Level B",
        "source": "AHA/ASA 2012"
      },
      {
        "recommendation": "Avoid phenytoin in SAH (worse cognitive outcomes)",
        "evidenceLevel": "Class III (Harm)",
        "source": "Naidech et al. (Neurocrit Care 2005)"
      },
      {
        "recommendation": "CT sensitivity ~100% within 6h",
        "evidenceLevel": "Class I, Level A",
        "source": "Perry et al. (BMJ 2011); Backes et al. (Stroke 2012)"
      },
      {
        "recommendation": "LP if CT negative but clinical suspicion",
        "evidenceLevel": "Class I, Level B",
        "source": "AHA/ASA Guidelines; standard of care"
      },
      {
        "recommendation": "Aminocaproic acid (short-term) if aneurysm securing delayed",
        "evidenceLevel": "Class IIa, Level B",
        "source": "Hillman et al. (Neurosurgery 2002); AHA/ASA 2012"
      },
      {
        "recommendation": "Magnesium infusion does NOT improve outcomes",
        "evidenceLevel": "Class III (No Benefit)",
        "source": "MASH-2 trial (Dorhout Mees et al. Lancet 2012)"
      },
      {
        "recommendation": "Fludrocortisone for cerebral salt wasting",
        "evidenceLevel": "Class IIa, Level B",
        "source": "Hasan et al. (Stroke 1989)"
      },
      {
        "recommendation": "Intra-arterial vasodilator / balloon angioplasty for refractory vasospasm",
        "evidenceLevel": "Class IIa, Level B",
        "source": "Multiple case series; AHA/ASA Guidelines"
      },
      {
        "recommendation": "Avoid self-fulfilling prophecy in poor-grade SAH",
        "evidenceLevel": "Class I, Level C",
        "source": "AHA/ASA 2012: aggressive treatment for at least 72h in poor-grade"
      }
    ],
    "monitoring": [
      {
        "item": "Blood pressure (arterial line)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "Continuous via arterial line in ICU. Pre-securing: target SBP <160. Post-securing: allow SBP 120-180 (higher if vasospasm treatment)",
        "action": "Titrate antihypertensives; vasopressors for vasospasm"
      },
      {
        "item": "GCS / Neurologic exam",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "q1h x 24h; then q2h x 48h; then q4h. Hunt-Hess grade at admission",
        "action": "If declining: STAT CT (rebleed, hydrocephalus, infarct); TCD; adjust treatment"
      },
      {
        "item": "ICP (if EVD in place)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "Continuous; record q1h",
        "action": "Tiered ICP management; CSF drainage; osmotherapy"
      },
      {
        "item": "Transcranial Doppler (TCD)",
        "ED": "-",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "Daily from day 3 through day 14 (vasospasm window); some continue to day 21",
        "action": "If MCA >120: CTA/CTP; clinical correlation. If >200: severe vasospasm — consider induced hypertension +/- endovascular rescue"
      },
      {
        "item": "Serum sodium",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q6h x 72h; then q8-12h",
        "action": "If <135: differentiate CSW vs SIADH; treat accordingly. If <120: 3% saline; limit correction <10 mEq/24h"
      },
      {
        "item": "Serum magnesium",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "Daily; q12h if repleting",
        "action": "Replete with MgSO4 2-4 g IV"
      },
      {
        "item": "Temperature",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q4h (q1h if febrile)",
        "action": "Central fever (common): cooling; acetaminophen. If >38.3°C: infection workup (cultures, CXR, UA)"
      },
      {
        "item": "Blood glucose",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q6h (q1h if insulin drip)",
        "action": "Insulin; avoid <60"
      },
      {
        "item": "Troponin / BNP",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "ROUTINE",
        "frequency": "Troponin daily x 3; BNP at admission and PRN",
        "action": "If rising with new ECG changes or hemodynamic instability: echo; cardiology"
      },
      {
        "item": "Hemoglobin",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "ROUTINE",
        "frequency": "Daily",
        "action": "Transfuse PRBCs"
      },
      {
        "item": "Fluid balance (I/O)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q1h in ICU; q4h shift on floor",
        "action": "Avoid dehydration (vasospasm risk); avoid overhydration (pulmonary edema)"
      },
      {
        "item": "Repeat CT head",
        "ED": "-",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "At 24h post-admission; with any neurologic change; post-procedure; if new hydrocephalus suspected",
        "action": "Adjust EVD; surgery; vasospasm treatment"
      },
      {
        "item": "Hunt-Hess / WFNS grade",
        "ED": "STAT",
        "HOSP": "-",
        "OPD": "-",
        "ICU": "-",
        "frequency": "At admission (prognostic)",
        "action": "Goals of care if poor grade"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Never discharge from ED with confirmed SAH. Discharge from hospital when: aneurysm secured; past vasospasm window (day 14-21); stable neurologic exam; Na stable; able to take oral nimodipine; no EVD dependency; adequate follow-up"
      },
      {
        "disposition": "Admit to Neuro-ICU",
        "criteria": "ALL confirmed aneurysmal SAH patients; minimum 14-21 days ICU-level monitoring during vasospasm window. Transfer to step-down only after vasospasm window passed"
      },
      {
        "disposition": "Transfer to comprehensive stroke center / Neurovascular center",
        "criteria": "If no neurosurgery or interventional neuroradiology on-site — TRANSFER IMMEDIATELY. SAH requires tertiary neurovascular services"
      },
      {
        "disposition": "Inpatient rehabilitation",
        "criteria": "Significant deficits but medically stable; past vasospasm window; able to participate in 3h/day therapy"
      },
      {
        "disposition": "Skilled nursing facility",
        "criteria": "Cannot tolerate intensive rehab; requires ongoing skilled care"
      },
      {
        "disposition": "Hospice / Comfort care",
        "criteria": "Devastating SAH (Hunt-Hess V with poor prognostic factors); after appropriate observation period and family discussion"
      }
    ]
  },
  "Syncope": {
    "id": "syncope",
    "title": "Syncope",
    "version": "1.0",
    "icd10": [
      "** R55 (Syncope and collapse)",
      "T67.1 (Heat syncope)",
      "G90.01 (Carotid sinus syncope)",
      "I95.1 (Orthostatic hypotension)"
    ],
    "scope": "** Evaluation and management of transient loss of consciousness (TLOC) due to syncope in adults. Includes risk stratification, etiologic workup, and treatment by type. Applies to ED, hospital, and outpatient settings. Excludes seizure, stroke, metabolic causes, and traumatic loss of consciousness.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Fingerstick glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hypoglycemia as cause",
            "target": "70-180 mg/dL"
          },
          {
            "item": "CBC",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "rationale": "Anemia; hemorrhage",
            "target": "Normal"
          },
          {
            "item": "BMP (electrolytes, creatinine)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "rationale": "Electrolyte abnormalities",
            "target": "Normal"
          },
          {
            "item": "Troponin",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Cardiac ischemia as trigger",
            "target": "Negative"
          },
          {
            "item": "BNP or NT-proBNP",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "Heart failure; risk stratification",
            "target": "Normal"
          },
          {
            "item": "Pregnancy test (if applicable)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Ectopic pregnancy; influences workup",
            "target": "Document"
          }
        ],
        "Extended Workup": [
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Thyroid dysfunction",
            "target": "Normal"
          },
          {
            "item": "Cortisol (AM)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Adrenal insufficiency if orthostatic",
            "target": "Normal"
          },
          {
            "item": "D-dimer",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "If PE suspected",
            "target": "Negative"
          },
          {
            "item": "Toxicology screen",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Drug/alcohol-induced",
            "target": "Negative"
          },
          {
            "item": "Blood cultures",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "If infection suspected",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "12-lead ECG",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "Immediate; ALL patients",
            "target": "No arrhythmia, normal intervals",
            "contraindications": "None"
          },
          {
            "item": "Continuous telemetry",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "timing": "If admitted",
            "target": "No arrhythmia",
            "contraindications": "None"
          },
          {
            "item": "Transthoracic echocardiogram",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "If cardiac cause suspected",
            "target": "Normal structure/function",
            "contraindications": "None"
          },
          {
            "item": "Exercise stress test",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If exertional syncope",
            "target": "No ischemia, no arrhythmia",
            "contraindications": "Acute MI, unstable angina"
          },
          {
            "item": "Cardiac MRI",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Suspected cardiomyopathy, ARVC",
            "target": "Normal or define pathology",
            "contraindications": "Pacemaker, metal"
          }
        ],
        "Extended": [
          {
            "item": "Holter monitor (24-48 hour)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Frequent symptoms",
            "target": "Correlate symptoms with rhythm",
            "contraindications": "None"
          },
          {
            "item": "Event recorder (2-4 weeks)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Intermittent symptoms",
            "target": "Symptom-rhythm correlation",
            "contraindications": "None"
          },
          {
            "item": "Insertable loop recorder (ILR)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Infrequent, unexplained recurrent syncope",
            "target": "Identify arrhythmia",
            "contraindications": "None"
          },
          {
            "item": "Electrophysiology study (EPS)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Suspected arrhythmic cause; structural heart disease",
            "target": "Identify inducible arrhythmia",
            "contraindications": "Active infection"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Orthostatic vital signs",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "Immediate; ALL patients",
            "target": "No orthostatic hypotension",
            "contraindications": "None"
          },
          {
            "item": "Tilt table test",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Suspected vasovagal if recurrent; dx uncertain",
            "target": "Positive = cardioinhibitory or vasodepressor",
            "contraindications": "Severe CAD, critical AS"
          },
          {
            "item": "Carotid sinus massage",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Age >40 with unexplained syncope (not if carotid bruit)",
            "target": "Negative (<3 sec pause, <50 mmHg drop)",
            "contraindications": "Carotid bruit, recent stroke/TIA"
          },
          {
            "item": "Autonomic function tests",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Suspected autonomic failure",
            "target": "Characterize dysautonomia",
            "contraindications": "Per test"
          }
        ]
      },
      "Treatment": {
        "Acute Management (ED/Hospital)": [
          {
            "item": "IV access",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "Establish if unstable",
              "orderSentence": "IV access - IV - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Access",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "IV fluid resuscitation",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500-1000 mL",
                  "orderSentence": "IV fluid resuscitation 500-1000 mL -"
                }
              ],
              "route": "-",
              "instructions": "NS 500-1000 mL bolus if hypovolemic/dehydrated",
              "orderSentence": "IV fluid resuscitation 500-1000 mL -"
            },
            "contraindications": "Heart failure",
            "monitoring": "Volume status",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Trendelenburg position",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Legs elevated if hypotensive",
              "orderSentence": "Trendelenburg position - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "BP",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Telemetry monitoring",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Continuous if high-risk",
              "orderSentence": "Telemetry monitoring - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Arrhythmia",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Correct reversible causes",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Treat hemorrhage, dehydration, arrhythmia, MI",
              "orderSentence": "Correct reversible causes - - - see dosing"
            },
            "contraindications": "Per condition",
            "monitoring": "Per condition",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Vasovagal Syncope Treatment": [
          {
            "item": "Education and reassurance",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Benign prognosis; triggers; warning signs",
              "orderSentence": "Education and reassurance - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "None",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trigger avoidance",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Identify and avoid (prolonged standing, heat, dehydration)",
              "orderSentence": "Trigger avoidance - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Recurrence",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Counter-pressure maneuvers",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Leg crossing, hand grip, arm tensing when prodrome felt",
              "orderSentence": "Counter-pressure maneuvers - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Effectiveness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Increased fluid/salt intake",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "6-9 g",
                  "orderSentence": "Increased fluid/salt intake 6-9 g PO"
                }
              ],
              "route": "PO",
              "instructions": "2-3 L fluid/day; 6-9 g salt/day (if no HTN/HF)",
              "orderSentence": "Increased fluid/salt intake 6-9 g PO"
            },
            "contraindications": "HTN, heart failure",
            "monitoring": "BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Compression stockings",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Waist-high, 30-40 mmHg",
              "orderSentence": "Compression stockings - - - see dosing"
            },
            "contraindications": "Peripheral vascular disease",
            "monitoring": "Compliance",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tilt training",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Progressive standing against wall; controversial efficacy",
              "orderSentence": "Tilt training - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Tolerance",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Fludrocortisone",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1-0.2 mg",
                  "orderSentence": "Fludrocortisone 0.1-0.2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.1-0.2 mg daily (refractory cases)",
              "orderSentence": "Fludrocortisone 0.1-0.2 mg PO"
            },
            "contraindications": "HTN, HF",
            "monitoring": "K+, BP, edema",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Midodrine",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5-10 mg",
                  "orderSentence": "Midodrine 2.5-10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "2.5-10 mg TID (refractory cases)",
              "orderSentence": "Midodrine 2.5-10 mg PO"
            },
            "contraindications": "Supine HTN, urinary retention",
            "monitoring": "Supine HTN",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Orthostatic Syncope Treatment": [
          {
            "item": "Identify/discontinue offending meds",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Review diuretics, vasodilators, antihypertensives",
              "orderSentence": "Identify/discontinue offending meds - - - see dosing"
            },
            "contraindications": "Clinical judgment",
            "monitoring": "BP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Volume repletion",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "IV fluids acutely; oral fluids long-term (2-3 L/day)",
              "orderSentence": "Volume repletion - IV - see dosing"
            },
            "contraindications": "Heart failure",
            "monitoring": "Volume status",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Salt supplementation",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "6-10 g/day",
                  "orderSentence": "Salt supplementation 6-10 g/day PO"
                }
              ],
              "route": "PO",
              "instructions": "6-10 g/day if no HTN/HF",
              "orderSentence": "Salt supplementation 6-10 g/day PO"
            },
            "contraindications": "HTN, HF",
            "monitoring": "BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Compression garments",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Waist-high stockings 30-40 mmHg; abdominal binder",
              "orderSentence": "Compression garments - - - see dosing"
            },
            "contraindications": "PVD",
            "monitoring": "Compliance",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Elevate head of bed",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "10-20 degrees at night (reduces nocturnal diuresis)",
              "orderSentence": "Elevate head of bed - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Tolerance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Midodrine",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5-10 mg",
                  "orderSentence": "Midodrine 2.5-10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "2.5-10 mg TID; last dose before 6 PM",
              "orderSentence": "Midodrine 2.5-10 mg PO"
            },
            "contraindications": "Supine HTN, urinary retention",
            "monitoring": "Supine BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fludrocortisone",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1-0.3 mg",
                  "orderSentence": "Fludrocortisone 0.1-0.3 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.1-0.3 mg daily",
              "orderSentence": "Fludrocortisone 0.1-0.3 mg PO"
            },
            "contraindications": "HTN, HF, hypokalemia",
            "monitoring": "K+, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Droxidopa (Northera)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100-600 mg",
                  "orderSentence": "Droxidopa (Northera) 100-600 mg -"
                }
              ],
              "route": "-",
              "instructions": "100-600 mg TID; for neurogenic orthostatic hypotension",
              "orderSentence": "Droxidopa (Northera) 100-600 mg -"
            },
            "contraindications": "Supine HTN",
            "monitoring": "Supine BP",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pyridostigmine",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30-60 mg",
                  "orderSentence": "Pyridostigmine 30-60 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "30-60 mg TID; augments ganglionic transmission",
              "orderSentence": "Pyridostigmine 30-60 mg PO"
            },
            "contraindications": "Asthma, GI obstruction",
            "monitoring": "Cholinergic effects",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Carotid Sinus Syncope Treatment": [
          {
            "item": "Avoid tight collars, neck pressure",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Patient education",
              "orderSentence": "Avoid tight collars, neck pressure - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "None",
            "monitoring": "Recurrence",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dual-chamber pacemaker",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "If cardioinhibitory type (pause >3 sec)",
              "orderSentence": "Dual-chamber pacemaker - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "None",
            "monitoring": "Device checks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Cardiac Syncope Treatment": [
          {
            "item": "Treat underlying arrhythmia",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Per arrhythmia type",
              "orderSentence": "Treat underlying arrhythmia - - - see dosing"
            },
            "contraindications": "Per treatment",
            "monitoring": "ECG, telemetry",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Pacemaker",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Sick sinus syndrome, high-grade AV block, bradycardia-induced syncope",
              "orderSentence": "Pacemaker - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Device checks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ICD (implantable cardioverter-defibrillator)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Ventricular arrhythmias; high-risk cardiomyopathy",
              "orderSentence": "ICD (implantable cardioverter-defibrillator) - - - see dosing"
            },
            "contraindications": "Terminal illness",
            "monitoring": "Device checks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Catheter ablation",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Arrhythmia amenable to ablation (SVT, VT)",
              "orderSentence": "Catheter ablation - - - see dosing"
            },
            "contraindications": "Extensive comorbidity",
            "monitoring": "Recurrence",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Treat structural heart disease",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Aortic valve replacement for AS; revascularization for ischemia",
              "orderSentence": "Treat structural heart disease - - - see dosing"
            },
            "contraindications": "Per condition",
            "monitoring": "Per condition",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ]
      },
      "Other Recommendations": {
        "Patient Instructions": [
          {
            "item": "Cardiology",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Suspected cardiac syncope; abnormal ECG; structural heart disease"
          },
          {
            "item": "Electrophysiology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Arrhythmia evaluation; device consideration"
          },
          {
            "item": "Neurology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-",
            "indication": "If seizure suspected; atypical features"
          },
          {
            "item": "Autonomic disorders specialist",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Refractory orthostatic hypotension; complex dysautonomia"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Recognize prodromal symptoms and immediately sit/lie down",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Counter-pressure maneuvers if prodrome (leg crossing, hand grip)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid known triggers (prolonged standing, dehydration, heat)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate hydration (2-3 L/day) and salt intake (if approved)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Rise slowly from lying/sitting; dangle legs before standing",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Driving restrictions per state law; typically no driving until cause determined/treated",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return if recurrent syncope, chest pain, palpitations, dyspnea",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Seizure",
        "features": "Tonic-clonic activity, tongue biting, prolonged postictal state, incontinence",
        "tests": "EEG; witness description"
      },
      {
        "diagnosis": "Stroke/TIA",
        "features": "Focal neurologic deficits; usually no LOC unless brainstem",
        "tests": "CT/MRI; neuro exam"
      },
      {
        "diagnosis": "Hypoglycemia",
        "features": "Diaphoresis, tremor, confusion; diabetes/insulin use",
        "tests": "Fingerstick glucose"
      },
      {
        "diagnosis": "Psychogenic pseudosyncope",
        "features": "Eyes closed (vs. open in true syncope); prolonged duration; normal vitals during event",
        "tests": "Tilt table with video EEG"
      },
      {
        "diagnosis": "Drop attack",
        "features": "Sudden fall without LOC; no prodrome",
        "tests": "History; normal during event"
      },
      {
        "diagnosis": "Cataplexy",
        "features": "Triggered by emotion; with narcolepsy",
        "tests": "Sleep study; history"
      },
      {
        "diagnosis": "Cardiac arrest",
        "features": "No pulse during event; does not spontaneously recover",
        "tests": "Witnessed event; no pulse"
      },
      {
        "diagnosis": "Concussion",
        "features": "Preceded by head trauma",
        "tests": "History"
      },
      {
        "diagnosis": "Vertebrobasilar insufficiency",
        "features": "Vertigo, diplopia, dysarthria; rare cause of syncope",
        "tests": "MRA; history"
      },
      {
        "diagnosis": "Pulmonary embolism",
        "features": "Dyspnea, pleuritic chest pain, hypoxia; syncope in massive PE",
        "tests": "D-dimer, CT-PA"
      },
      {
        "diagnosis": "Aortic dissection",
        "features": "Tearing chest/back pain; BP differential",
        "tests": "CT angiography"
      }
    ],
    "evidence": [
      {
        "recommendation": "ECG for all syncope patients",
        "evidenceLevel": "Class I, Level B",
        "source": "ESC 2018 Syncope Guidelines"
      },
      {
        "recommendation": "Echo if cardiac cause suspected",
        "evidenceLevel": "Class I, Level B",
        "source": "ESC 2018; AHA/ACCF 2017"
      },
      {
        "recommendation": "Tilt test for recurrent vasovagal syncope",
        "evidenceLevel": "Class IIa, Level B",
        "source": "ESC 2018"
      },
      {
        "recommendation": "Pacemaker for cardioinhibitory carotid sinus syncope",
        "evidenceLevel": "Class I, Level B",
        "source": "ESC 2018"
      },
      {
        "recommendation": "ILR for recurrent unexplained syncope",
        "evidenceLevel": "Class I, Level A",
        "source": "ISSUE-3 trial; ESC 2018"
      },
      {
        "recommendation": "Counter-pressure maneuvers for vasovagal",
        "evidenceLevel": "Class IIa, Level B",
        "source": "PC-Trial"
      },
      {
        "recommendation": "Midodrine for refractory orthostatic hypotension",
        "evidenceLevel": "Class IIa, Level B",
        "source": "Multiple RCTs"
      },
      {
        "recommendation": "Risk stratification scores (Canadian Syncope Risk Score)",
        "evidenceLevel": "Class IIa, Level B",
        "source": "Thiruganasambandamoorthy et al."
      }
    ],
    "monitoring": [
      {
        "item": "Vital signs (including orthostatics)",
        "ED": "STAT",
        "HOSP": "q4-8h",
        "OPD": "Every visit",
        "ICU": "Continuous",
        "frequency": "Per setting",
        "action": "Treat hypotension; volume"
      },
      {
        "item": "Continuous telemetry",
        "ED": "-",
        "HOSP": "Continuous",
        "OPD": "-",
        "ICU": "Continuous",
        "frequency": "Until risk stratified",
        "action": "Cardiology consult"
      },
      {
        "item": "ECG",
        "ED": "STAT",
        "HOSP": "Daily",
        "OPD": "Every visit if cardiac",
        "ICU": "STAT",
        "frequency": "Per clinical status",
        "action": "Cardiology; treatment"
      },
      {
        "item": "Troponin",
        "ED": "STAT",
        "HOSP": "q6-8h × 2 if initially elevated",
        "OPD": "-",
        "ICU": "Per cardiac status",
        "frequency": "Until ruled out",
        "action": "Cardiology"
      },
      {
        "item": "Recurrence",
        "ED": "-",
        "HOSP": "Ongoing",
        "OPD": "Every visit",
        "ICU": "-",
        "frequency": "Ongoing",
        "action": "Re-evaluate diagnosis/treatment"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge from ED",
        "criteria": "Low-risk syncope (vasovagal with clear trigger, normal ECG, normal vitals, no cardiac history); reliable follow-up"
      },
      {
        "disposition": "Admit to telemetry",
        "criteria": "High-risk features (abnormal ECG, cardiac history, exertional, no prodrome, abnormal vitals); unexplained syncope in elderly"
      },
      {
        "disposition": "ICU admission",
        "criteria": "Hemodynamically unstable; malignant arrhythmia; acute MI; massive PE"
      },
      {
        "disposition": "Syncope unit/observation",
        "criteria": "Intermediate risk; brief observation with monitoring"
      },
      {
        "disposition": "Cardiology follow-up",
        "criteria": "Suspected cardiac cause; abnormal echo; need for device evaluation"
      },
      {
        "disposition": "Neurology follow-up",
        "criteria": "Atypical features suggesting seizure or neurologic cause"
      },
      {
        "disposition": "Primary care follow-up",
        "criteria": "Low-risk vasovagal syncope; medication review for orthostatic"
      }
    ]
  },
  "Vertigo / Dizziness Evaluation": {
    "id": "vertigo-dizziness-evaluation",
    "title": "Vertigo / Dizziness Evaluation",
    "version": "1.0",
    "icd10": [
      "** R42 (Dizziness and giddiness)",
      "H81.10 (Benign paroxysmal positional vertigo",
      "unspecified ear)",
      "H81.0 (Meniere's disease)",
      "H81.3 (Other peripheral vertigo)",
      "G45.0 (Vertebro-basilar artery syndrome)",
      "H81.4 (Vertigo of central origin)"
    ],
    "scope": "** Evaluation and management of acute vertigo and dizziness in adults. Covers differentiation of peripheral vs. central causes, the HINTS exam, Dix-Hallpike and canalith repositioning maneuvers, evaluation for posterior circulation stroke, and management of common vestibular disorders (BPPV, vestibular neuritis, Meniere's disease, vestibular migraine). Excludes chronic non-specific dizziness (persistent postural-perceptual dizziness), medication-induced dizziness (covered briefly), and presyncope/orthostatic hypotension (separate evaluation).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Blood glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hypoglycemia can cause dizziness/lightheadedness; hyperglycemia (diabetic neuropathy); metabolic dizziness",
            "target": "70-180 mg/dL; hypo/hyperglycemia → correct and reassess"
          },
          {
            "item": "CBC",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Anemia (lightheadedness, presyncope); infection (labyrinthitis); baseline",
            "target": "Normal; anemia (Hgb <10) can cause dizziness; infection markers"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Electrolyte abnormalities (hyponatremia, hypoglycemia); renal dysfunction; dehydration",
            "target": "Normal; hyponatremia <130 can cause neurologic symptoms including imbalance"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Thyroid dysfunction can cause dizziness/imbalance; hyperthyroidism especially",
            "target": "Normal; abnormal → thyroid evaluation"
          },
          {
            "item": "ECG (12-lead)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Cardiac arrhythmia causing presyncope/dizziness; differentiates cardiac from vestibular",
            "target": "Normal; arrhythmia → cardiac workup; prolonged QTc"
          },
          {
            "item": "Orthostatic vital signs",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Orthostatic hypotension is common cause of dizziness, especially in elderly; drop in SBP >20 or DBP >10 with symptoms",
            "target": "No orthostatic drop; positive orthostatics → volume status, medication review, autonomic evaluation"
          }
        ],
        "Extended Workup": [
          {
            "item": "Lipid panel",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Vascular risk factors if central cause suspected; stroke risk stratification",
            "target": "LDL <70 (high risk) or <100; triglycerides; HDL"
          },
          {
            "item": "HbA1c",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes (vascular risk factor; diabetic neuropathy affecting balance)",
            "target": "<7.0%; elevated → diabetes management"
          },
          {
            "item": "RPR / VDRL",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurosyphilis (rare cause of vertigo, especially in HIV); otosyphilis",
            "target": "Negative; positive → CSF analysis, penicillin treatment"
          },
          {
            "item": "Vitamin B12",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "B12 deficiency causes peripheral neuropathy and imbalance; subacute combined degeneration",
            "target": ">300 pg/mL; low → supplement and monitor"
          },
          {
            "item": "Ferritin",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Iron deficiency (even without anemia) can cause dizziness",
            "target": ">50 ng/mL; low → iron supplementation"
          },
          {
            "item": "ANA / ESR / CRP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Autoimmune inner ear disease; vasculitis (CNS vasculitis affecting posterior circulation)",
            "target": "Normal; elevated → autoimmune/inflammatory workup"
          },
          {
            "item": "Drug levels (if applicable)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Ototoxic medications (aminoglycosides, salicylates); anticonvulsant toxicity (phenytoin, carbamazepine)",
            "target": "Therapeutic; toxic levels → adjust or discontinue"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "FTA-ABS",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Confirmatory for syphilis if RPR positive; otosyphilis/neurosyphilis",
            "target": "Negative"
          },
          {
            "item": "Lyme serology",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Lyme disease can cause cranial neuropathies, including vestibular neuritis; endemic areas",
            "target": "Negative; positive → Western blot confirmation"
          },
          {
            "item": "Anti-GAD65 antibodies",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Cerebellar ataxia; autoimmune cerebellitis",
            "target": "Negative; positive → autoimmune cerebellar disease"
          },
          {
            "item": "Paraneoplastic antibody panel",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Paraneoplastic cerebellar degeneration (anti-Yo, anti-Hu); subacute ataxia with vertigo",
            "target": "Negative; positive → malignancy search"
          },
          {
            "item": "CSF analysis",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If infectious, inflammatory, or neoplastic cause suspected; normal in peripheral vestibular disorders",
            "target": "Normal; pleocytosis → infection/inflammation; protein elevation"
          },
          {
            "item": "Genetic testing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Familial episodic ataxia; spinocerebellar ataxia; hereditary vestibular disorders",
            "target": "Specific mutations (CACNA1A for EA2; SCA genes)"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "LP — Generally NOT indicated",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "NOT routinely indicated for peripheral vestibular disorders; consider if meningitis, MS, CNS vasculitis, or leptomeningeal disease suspected",
            "target": "Normal in BPPV, vestibular neuritis, Meniere's; abnormal → specific CNS pathology",
            "contraindications": "Posterior fossa mass; elevated ICP"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "**HINTS exam (Head Impulse, Nystagmus, Test of Skew)**",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "**CRITICAL bedside exam**; must be performed in patient with ACUTE VESTIBULAR SYNDROME (continuous vertigo, nausea, nystagmus, gait instability); performed by trained examiner; more sensitive than early MRI for stroke",
            "target": "**Peripheral pattern (benign):** Positive head impulse (catch-up saccade), horizontal nystagmus with unidirectional fast phase, no skew deviation; **Central pattern (concerning for stroke):** Negative/normal head impulse, direction-changing or vertical nystagmus, skew deviation",
            "contraindications": "Cannot perform if patient not having acute continuous vertigo; requires examiner training"
          },
          {
            "item": "CT head without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "**NOT sensitive for posterior fossa stroke** (sensitivity ~20-40%); useful for hemorrhage; may be appropriate for trauma or if MRI not available; does NOT rule out posterior circulation stroke",
            "target": "Cerebellar or brainstem hemorrhage; mass lesion; hydrocephalus; **NEGATIVE CT does NOT exclude stroke in posterior circulation**",
            "contraindications": "None for non-contrast"
          },
          {
            "item": "MRI brain with DWI",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "**Gold standard for posterior circulation stroke**; DWI highly sensitive for acute ischemia; **HOWEVER:** Early MRI (<48h) can miss 12-20% of small posterior fossa strokes — clinical (HINTS) may be more sensitive; repeat MRI if high suspicion and initial negative",
            "target": "Acute infarction (restricted diffusion); brainstem lesion; cerebellar lesion; MS plaque; tumor; vestibular schwannoma",
            "contraindications": "MRI-incompatible implants; severe claustrophobia"
          },
          {
            "item": "MRA head and neck (or CTA)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "If central cause suspected; vertebral artery dissection; basilar artery stenosis; vertebrobasilar insufficiency",
            "target": "Vertebral artery dissection; stenosis; occlusion; aneurysm",
            "contraindications": "MRA: same as MRI; CTA: contrast allergy, renal impairment"
          }
        ],
        "Extended": [
          {
            "item": "Dix-Hallpike maneuver",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "**Diagnostic for BPPV** (posterior canal, most common); performed on ALL patients with episodic positional vertigo; positive if nystagmus and vertigo provoked with latency and limited duration",
            "target": "**Positive:** Upbeating-torsional nystagmus toward affected ear, 2-20 sec latency, <60 sec duration, fatigable with repetition = posterior canal BPPV",
            "contraindications": "Cervical spine disease/instability (modify technique); carotid stenosis (theoretical)"
          },
          {
            "item": "Supine roll test (Pagnini-McClure)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "**Diagnostic for horizontal canal BPPV**; patient supine, rapidly turn head 90° to each side; geotropic (toward ground) or apogeotropic (away from ground) horizontal nystagmus",
            "target": "Horizontal nystagmus provoked by head turning; geotropic (canalithiasis) vs. apogeotropic (cupulolithiasis)",
            "contraindications": "Same as Dix-Hallpike"
          },
          {
            "item": "Audiometry",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Essential if hearing loss suspected (Meniere's disease, labyrinthitis, vestibular schwannoma); sudden sensorineural hearing loss is emergency",
            "target": "Meniere's: low-frequency sensorineural hearing loss; Schwannoma: asymmetric sensorineural hearing loss; Labyrinthitis: hearing loss + vertigo",
            "contraindications": "Patient cooperation"
          },
          {
            "item": "Echocardiogram (TTE ± TEE)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If cardioembolic source suspected for stroke; PFO evaluation; valvular disease",
            "target": "PFO; valve vegetations; thrombus; cardiomyopathy",
            "contraindications": "None (TTE); TEE: esophageal pathology"
          },
          {
            "item": "Holter / Event monitor",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If paroxysmal arrhythmia suspected as cause of dizziness; palpitations with dizziness",
            "target": "Arrhythmia during symptoms",
            "contraindications": "None"
          },
          {
            "item": "Carotid ultrasound",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Carotid stenosis (though carotid disease rarely causes isolated vertigo without other symptoms)",
            "target": "Stenosis; plaque",
            "contraindications": "None"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Videonystagmography (VNG) / Electronystagmography (ENG)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Quantitative vestibular function testing; caloric testing (ice water or warm/cool air); localizes peripheral lesion; documents vestibular hypofunction",
            "target": "Unilateral weakness on calorics (peripheral lesion); central patterns",
            "contraindications": "Perforated TM (water calorics)"
          },
          {
            "item": "Video head impulse test (vHIT)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Quantitative bedside test of vestibulo-ocular reflex; tests individual semicircular canals; more sensitive than bedside HIT",
            "target": "Reduced VOR gain; covert/overt saccades; identifies affected canal",
            "contraindications": "Specialized equipment"
          },
          {
            "item": "Vestibular evoked myogenic potentials (VEMP)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Tests saccule (cVEMP) and utricle (oVEMP); superior semicircular canal dehiscence; Meniere's",
            "target": "Abnormal in superior canal dehiscence; saccular dysfunction",
            "contraindications": "Hearing loss affects testing"
          },
          {
            "item": "Rotary chair testing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Quantitative VOR assessment; bilateral vestibular hypofunction",
            "target": "Bilateral vestibular loss; gain/phase abnormalities",
            "contraindications": "Specialized facility"
          },
          {
            "item": "High-resolution CT temporal bones",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Superior semicircular canal dehiscence; cholesteatoma; temporal bone abnormality",
            "target": "Dehiscence of superior canal; bony erosion",
            "contraindications": "Radiation"
          },
          {
            "item": "Electrocochleography (ECoG)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Meniere's disease confirmation; endolymphatic hydrops",
            "target": "Elevated SP/AP ratio in Meniere's",
            "contraindications": "Requires audiologist"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent Treatment": [
          {
            "item": "**Symptomatic relief (vestibular suppressants)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-50 mg",
                  "orderSentence": "**Symptomatic relief (vestibular suppressants)** 25-50 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "**Acute severe vertigo:** Meclizine 25-50 mg PO q6-8h; OR Dimenhydrinate (Dramamine) 50 mg PO/IV q6h; OR Promethazine 25 mg PO/IM/IV q6h; OR Ondansetron 4-8 mg IV/PO q8h (for nausea); **IV fluids** for dehydration from vomiting; **Diazepam** 2-5 mg IV/PO for severe acute vertigo (benzodiazepines are potent vestibular suppressants)",
              "orderSentence": "**Symptomatic relief (vestibular suppressants)** 25-50 mg IV"
            },
            "contraindications": "-",
            "monitoring": "Short-term use only (24-72h); vestibular suppressants interfere with central compensation if used chronically; avoid in suspected central cause until stroke ruled out",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**IV fluids**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "If dehydrated from vomiting; NS or LR bolus then maintenance; assess orthostatic hypotension",
              "orderSentence": "**IV fluids** - IV - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Supportive care; correct volume depletion",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Antiemetics**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4-8 mg",
                  "orderSentence": "**Antiemetics** 4-8 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Ondansetron 4-8 mg IV/PO; metoclopramide 10 mg IV (avoid in elderly — EPS); prochlorperazine 5-10 mg IV/IM",
              "orderSentence": "**Antiemetics** 4-8 mg IV"
            },
            "contraindications": "-",
            "monitoring": "Nausea is often the most debilitating symptom",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**Rule out stroke**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**If ANY central features on HINTS:** STAT MRI with DWI; vascular imaging (MRA or CTA); neurology/stroke consultation; **Central features:** Normal/negative head impulse test, vertical or direction-changing nystagmus, skew deviation, focal neurologic signs, severe imbalance (cannot walk), hearing loss + vertigo without Meniere's history",
              "orderSentence": "**Rule out stroke** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "HINTS is more sensitive than early CT or MRI for posterior circulation stroke; do NOT rely on negative CT to exclude stroke",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Epley maneuver (canalith repositioning)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "90%",
                  "orderSentence": "**Epley maneuver (canalith repositioning)** 90% -"
                }
              ],
              "route": "-",
              "instructions": "**For BPPV (positive Dix-Hallpike):** Immediately perform Epley maneuver; highly effective (80-90% single treatment); may repeat if symptoms persist; send home with instructions for home Epley or Brandt-Daroff exercises",
              "orderSentence": "**Epley maneuver (canalith repositioning)** 90% -"
            },
            "contraindications": "-",
            "monitoring": "Epley is definitive treatment for posterior canal BPPV; medications are NOT indicated for BPPV — repositioning maneuvers are the treatment",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Disease-Specific Treatment": [
          {
            "item": "**Epley maneuver (posterior canal)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Standard canalith repositioning; patient starts seated, Dix-Hallpike position for 30 sec, rotate head 90° toward opposite side (30 sec), roll body to face down with head still turned (30 sec), sit up; NNT = 2-3 for resolution",
              "orderSentence": "**Epley maneuver (posterior canal)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "First-line treatment for posterior canal BPPV; highly effective; may repeat same day or next visit",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Semont maneuver (alternative)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Alternative to Epley; patient moved rapidly from side to side; less commonly used but effective",
              "orderSentence": "**Semont maneuver (alternative)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Alternative if Epley difficult or ineffective",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**BBQ roll (Lempert maneuver) — horizontal canal**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "For horizontal canal BPPV; patient rotates 360° along long axis of body (log roll) toward unaffected side; 90° increments with 30 sec pauses",
              "orderSentence": "**BBQ roll (Lempert maneuver) — horizontal canal** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Treatment for horizontal canal BPPV; geotropic variant",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Brandt-Daroff exercises (home)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Patient alternates lying on each side x 30 sec, 10-20 repetitions, 3x daily; habituates symptoms; less effective than Epley for posterior canal",
              "orderSentence": "**Brandt-Daroff exercises (home)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Adjunctive home therapy; may help with residual symptoms; promotes compensation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Avoid vestibular suppressants for BPPV**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Do NOT prescribe meclizine for ongoing BPPV treatment; medications delay compensation and do not address the mechanical problem",
              "orderSentence": "**Avoid vestibular suppressants for BPPV** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "BPPV is a mechanical problem (otoliths); repositioning is definitive treatment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Post-treatment instructions**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Avoid lying flat for 1-2 nights (sleep propped up); avoid rapid head movements for 24-48h; avoid affected side lying for 1 week (controversial but commonly recommended)",
              "orderSentence": "**Post-treatment instructions** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Reduces immediate recurrence; evidence is mixed",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Medications to AVOID or Use with Caution": [
          {
            "item": "**Vestibular suppressants (prolonged use)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Vestibular suppressants (prolonged use)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Ototoxic medications** (aminoglycosides, loop diuretics, salicylates, cisplatin)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Ototoxic medications** (aminoglycosides, loop diuretics, salicylates, cisplatin) - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Alcohol**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Alcohol** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Benzodiazepines (chronic use)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Benzodiazepines (chronic use)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**CNS depressants**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**CNS depressants** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Medications causing orthostatic hypotension** (antihypertensives, alpha-blockers, diuretics)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Medications causing orthostatic hypotension** (antihypertensives, alpha-blockers, diuretics) - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "HINTS exam (if acute vestibular syndrome)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Dix-Hallpike maneuver",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Neurology consultation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Stroke consultation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Otolaryngology / Neurotology referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vestibular rehabilitation referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Driving restrictions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fall precautions",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Audiometry",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cardiology referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatry / Psychology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy (vestibular)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sleep medicine",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Headache specialist / Neurology",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Video-EEG monitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Tilt table testing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuropsychological testing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Superior canal dehiscence workup",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Autoimmune inner ear disease workup",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Perilymphatic fistula evaluation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Type",
        "features": "Description",
        "tests": "Common Causes"
      },
      {
        "diagnosis": "**Vertigo**",
        "features": "Illusion of movement (usually spinning); room spinning or self-spinning",
        "tests": "BPPV, vestibular neuritis, Meniere's disease, vestibular migraine, posterior circulation stroke"
      },
      {
        "diagnosis": "**Presyncope / Lightheadedness**",
        "features": "Feeling of impending faint; \"graying out\"",
        "tests": "Orthostatic hypotension, cardiac arrhythmia, vasovagal syncope, dehydration"
      },
      {
        "diagnosis": "**Disequilibrium / Imbalance**",
        "features": "Unsteadiness; difficulty walking; feeling off-balance without spinning",
        "tests": "Peripheral neuropathy, cerebellar disorders, bilateral vestibular loss, Parkinson's disease, cervical spondylosis"
      },
      {
        "diagnosis": "**Non-specific dizziness**",
        "features": "Vague lightheadedness, floating, difficulty concentrating",
        "tests": "Anxiety/panic disorder, depression, hyperventilation, medication side effects, PPPD"
      }
    ],
    "evidence": [
      {
        "recommendation": "Guideline",
        "evidenceLevel": "Source",
        "source": "Year"
      },
      {
        "recommendation": "BPPV Practice Guideline",
        "evidenceLevel": "[AAO-HNS](https://pubmed.ncbi.nlm.nih.gov/28248609/)",
        "source": "2017"
      },
      {
        "recommendation": "Vestibular Migraine Diagnostic Criteria",
        "evidenceLevel": "ICHD-3 / Barany Society",
        "source": "2012/2018"
      },
      {
        "recommendation": "Meniere's Disease Guidelines",
        "evidenceLevel": "AAO-HNS",
        "source": "2020"
      },
      {
        "recommendation": "HINTS Exam",
        "evidenceLevel": "[Kattah et al.](https://pubmed.ncbi.nlm.nih.gov/19762709/) / [Tarnutzer](https://pubmed.ncbi.nlm.nih.gov/21576300/)",
        "source": "2009/2011"
      },
      {
        "recommendation": "Study",
        "evidenceLevel": "Finding",
        "source": "Impact"
      },
      {
        "recommendation": "[Kattah et al. (2009)](https://pubmed.ncbi.nlm.nih.gov/19762709/)",
        "evidenceLevel": "HINTS exam (H: head impulse; I: nystagmus; TS: test of skew) was 100% sensitive and 96% specific for stroke in acute vestibular syndrome; superior to MRI in first 24-48h",
        "source": "HINTS should be performed in acute vestibular syndrome; more sensitive than early MRI"
      },
      {
        "recommendation": "[Strupp et al. (2004)](https://pubmed.ncbi.nlm.nih.gov/15269315/)",
        "evidenceLevel": "Methylprednisolone improved vestibular function recovery in vestibular neuritis vs. placebo",
        "source": "Steroids are standard of care for vestibular neuritis"
      },
      {
        "recommendation": "[Hilton et al. Cochrane (2014)](https://pubmed.ncbi.nlm.nih.gov/25485940/)",
        "evidenceLevel": "Epley maneuver highly effective for posterior canal BPPV; NNT ~3",
        "source": "Epley is definitive treatment for BPPV"
      },
      {
        "recommendation": "[Tarnutzer et al. (2011)](https://pubmed.ncbi.nlm.nih.gov/21576300/)",
        "evidenceLevel": "Individual HINTS components analyzed; normal head impulse most predictive of stroke",
        "source": "\"Dangerous\" HIT (normal in acute vertigo) = central cause until proven otherwise"
      },
      {
        "recommendation": "[Choi et al. (2018)](https://pubmed.ncbi.nlm.nih.gov/30341546/)",
        "evidenceLevel": "12-20% of posterior fossa strokes missed on early MRI (<48h) but detected on repeat MRI",
        "source": "If high clinical suspicion for stroke and initial MRI negative, repeat MRI or treat as stroke"
      },
      {
        "recommendation": "[Fife et al. AAO-HNS (2017)](https://pubmed.ncbi.nlm.nih.gov/28248609/)",
        "evidenceLevel": "Comprehensive BPPV guideline; repositioning maneuvers recommended; vestibular suppressants NOT recommended",
        "source": "Standard of care for BPPV"
      },
      {
        "recommendation": "Study",
        "evidenceLevel": "Sensitivity for Stroke",
        "source": "Specificity"
      },
      {
        "recommendation": "[Kattah et al. (2009)](https://pubmed.ncbi.nlm.nih.gov/19762709/)",
        "evidenceLevel": "100%",
        "source": "96%"
      },
      {
        "recommendation": "[Newman-Toker et al. (2013)](https://pubmed.ncbi.nlm.nih.gov/24127701/)",
        "evidenceLevel": "96%",
        "source": "98%"
      },
      {
        "recommendation": "[Tarnutzer et al. (2011, meta-analysis)](https://pubmed.ncbi.nlm.nih.gov/21576300/)",
        "evidenceLevel": "98% (pooled)",
        "source": "85% (pooled)"
      }
    ],
    "monitoring": [
      {
        "item": "Neurologic exam (HINTS, cranial nerves, cerebellar)",
        "frequency": "On presentation; q1-2h if central concern",
        "target": "No focal deficits; peripheral pattern",
        "action": "Central features → STAT MRI; neurology/stroke consultation"
      },
      {
        "item": "Vital signs",
        "frequency": "q1h initially",
        "target": "Stable BP, HR",
        "action": "Orthostatic hypotension → fluids; arrhythmia → cardiology"
      },
      {
        "item": "Hydration status",
        "frequency": "Continuous",
        "target": "No dehydration",
        "action": "IV fluids if dehydrated from vomiting"
      },
      {
        "item": "Nausea/vomiting control",
        "frequency": "q1h",
        "target": "Controlled",
        "action": "Antiemetics; IV fluids"
      },
      {
        "item": "Gait assessment",
        "frequency": "Before discharge",
        "target": "Safe ambulation",
        "action": "PT evaluation; fall precautions; walker if needed"
      }
    ],
    "disposition": [
      {
        "disposition": "Level of Care",
        "criteria": "Criteria"
      },
      {
        "disposition": "ICU / Stroke unit",
        "criteria": "Confirmed or highly suspected posterior circulation stroke; basilar artery occlusion; cerebellar stroke with mass effect/hydrocephalus"
      },
      {
        "disposition": "General floor",
        "criteria": "Intractable vomiting/dehydration requiring IV fluids and monitoring; diagnostic uncertainty requiring observation and further testing; elderly with high fall risk and no safe home environment"
      },
      {
        "disposition": "Observation",
        "criteria": "Prolonged symptoms requiring IV fluids and antiemetics; need for serial neurologic exams; MRI pending"
      }
    ]
  },
  "Wernicke Encephalopathy": {
    "id": "wernicke-encephalopathy",
    "title": "Wernicke Encephalopathy",
    "version": "1.0",
    "icd10": [
      "** E51.2 (Wernicke encephalopathy)",
      "E51.11 (Dry beriberi)",
      "F10.96 (Alcohol use",
      "unspecified with alcohol-induced persisting amnestic disorder)"
    ],
    "scope": "** Diagnosis and treatment of Wernicke encephalopathy in adults including classic and non-alcoholic etiologies. Covers acute treatment, prevention of Korsakoff syndrome, and at-risk populations. Applies primarily to ED, hospital, and ICU settings as this is a medical emergency. Excludes chronic Korsakoff syndrome management.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Fingerstick glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Hypoglycemia; DO NOT give dextrose before thiamine",
            "target": "Normal; treat hypoglycemia AFTER thiamine"
          },
          {
            "item": "BMP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Electrolytes; magnesium essential for thiamine function",
            "target": "Correct abnormalities"
          },
          {
            "item": "Magnesium",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Required cofactor for thiamine; replace if low",
            "target": ">2.0 mg/dL"
          },
          {
            "item": "Phosphorus",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Refeeding syndrome risk",
            "target": ">2.5 mg/dL"
          },
          {
            "item": "CBC",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Macrocytic anemia (alcohol, B12/folate deficiency)",
            "target": "Document"
          },
          {
            "item": "LFTs, albumin",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Hepatic dysfunction; malnutrition",
            "target": "Document"
          },
          {
            "item": "Ammonia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Hepatic encephalopathy (may coexist)",
            "target": "Normal"
          },
          {
            "item": "Lactate",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Thiamine deficiency causes lactic acidosis",
            "target": "Normal"
          },
          {
            "item": "Blood alcohol level",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Document; withdrawal risk",
            "target": "Document"
          }
        ],
        "Extended Workup": [
          {
            "item": "Thiamine level (whole blood or RBC transketolase)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "Confirms deficiency (do not delay treatment for result)",
            "target": "Low (but treat empirically)"
          },
          {
            "item": "Vitamin B12, folate",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Often co-deficient in alcohol use",
            "target": "Normal; supplement if low"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Exclude thyroid dysfunction",
            "target": "Normal"
          },
          {
            "item": "Urine drug screen",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Concomitant intoxication",
            "target": "Document"
          },
          {
            "item": "Coagulation studies (PT/INR)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "Liver disease; coagulopathy",
            "target": "Normal"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "RBC transketolase activity",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Functional thiamine status; low in deficiency",
            "target": "Low activity"
          },
          {
            "item": "Thiamine pyrophosphate (TPP) effect",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": ">25% increase suggests deficiency",
            "target": "Normal"
          },
          {
            "item": "CSF analysis",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "If meningitis suspected; usually normal in WE",
            "target": "Normal; mild protein elevation possible"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI brain with FLAIR/DWI",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "After stabilization; supports diagnosis",
            "target": "Bilateral symmetric T2/FLAIR hyperintensity in medial thalami, mammillary bodies, periaqueductal gray, tectal plate",
            "contraindications": "Pacemaker, metal"
          },
          {
            "item": "CT head",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Exclude other causes (hemorrhage, mass); often normal in WE",
            "target": "No mass, hemorrhage",
            "contraindications": "None"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "EEG",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "timing": "If seizure suspected or encephalopathy unclear",
            "target": "Diffuse slowing (non-specific)",
            "contraindications": "None"
          },
          {
            "item": "Lumbar puncture",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "timing": "If meningitis or encephalitis suspected",
            "target": "Normal; r/o infection",
            "contraindications": "Mass lesion"
          }
        ]
      },
      "Treatment": {
        "Acute Thiamine Replacement (CRITICAL - Do Not Delay)": [
          {
            "item": "Thiamine IV (high-dose) - Suspected/Confirmed WE",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Thiamine IV (high-dose) - Suspected/Confirmed WE 500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "500 mg IV TID × 3-5 days (in 100 mL NS over 30 min); then 250 mg IV daily × 3-5 days; then oral",
              "orderSentence": "Thiamine IV (high-dose) - Suspected/Confirmed WE 500 mg IV"
            },
            "contraindications": "Rare anaphylaxis (give slowly)",
            "monitoring": "Anaphylaxis (rare); clinical response",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Thiamine IV (prophylaxis - at-risk patients)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200-500 mg",
                  "orderSentence": "Thiamine IV (prophylaxis - at-risk patients) 200-500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "200-500 mg IV TID × 3 days; then oral",
              "orderSentence": "Thiamine IV (prophylaxis - at-risk patients) 200-500 mg IV"
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Maintenance Thiamine": [
          {
            "item": "Thiamine oral (after IV course)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Thiamine oral (after IV course) 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "100 mg TID × weeks to months; indefinitely if ongoing risk",
              "orderSentence": "Thiamine oral (after IV course) 100 mg PO"
            },
            "contraindications": "None",
            "monitoring": "Compliance; symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Thiamine IM (if IV not possible, unreliable oral)",
            "route": "IM",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg",
                  "orderSentence": "Thiamine IM (if IV not possible, unreliable oral) 250 mg IM"
                }
              ],
              "route": "IM",
              "instructions": "250 mg IM daily × 3-5 days",
              "orderSentence": "Thiamine IM (if IV not possible, unreliable oral) 250 mg IM"
            },
            "contraindications": "Coagulopathy (relative)",
            "monitoring": "Clinical response",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Electrolyte Replacement": [
          {
            "item": "Magnesium sulfate IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2 g",
                  "orderSentence": "Magnesium sulfate IV 1-2 g IV"
                }
              ],
              "route": "IV",
              "instructions": "1-2 g IV over 1-2 hours; repeat as needed; target Mg >2.0",
              "orderSentence": "Magnesium sulfate IV 1-2 g IV"
            },
            "contraindications": "Renal failure (adjust dose); heart block",
            "monitoring": "Mg levels; reflexes",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Potassium replacement",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Per deficit; often needed with Mg",
              "orderSentence": "Potassium replacement - - - see dosing"
            },
            "contraindications": "Renal failure; hyperkalemia",
            "monitoring": "K+ levels",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Phosphorus replacement",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "If low (refeeding); K-Phos or Na-Phos IV/PO",
              "orderSentence": "Phosphorus replacement - IV - see dosing"
            },
            "contraindications": "Hypercalcite; renal failure",
            "monitoring": "Phos levels",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Glucose Administration": [
          {
            "item": "THIAMINE BEFORE GLUCOSE",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "ALWAYS give thiamine before or with dextrose/carbohydrates; glucose metabolism depletes thiamine",
              "orderSentence": "THIAMINE BEFORE GLUCOSE - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "None",
            "monitoring": "Give thiamine first",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Dextrose (if hypoglycemic)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-50 mL",
                  "orderSentence": "Dextrose (if hypoglycemic) 25-50 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "D50 25-50 mL IV or D10 infusion; AFTER thiamine",
              "orderSentence": "Dextrose (if hypoglycemic) 25-50 mL IV"
            },
            "pretreatment": "-",
            "contraindications": "Give thiamine first",
            "monitoring": "Glucose levels",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Alcohol Withdrawal Prevention/Treatment": [
          {
            "item": "Benzodiazepines (symptom-triggered or scheduled)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-4 mg",
                  "orderSentence": "Benzodiazepines (symptom-triggered or scheduled) 1-4 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Lorazepam 1-4 mg IV q15min PRN (CIWA-guided); or scheduled dosing if severe",
              "orderSentence": "Benzodiazepines (symptom-triggered or scheduled) 1-4 mg IV"
            },
            "contraindications": "Respiratory depression; caution with hepatic impairment",
            "monitoring": "CIWA score; sedation; respiratory status",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Folate",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg",
                  "orderSentence": "Folate 1 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "1 mg daily",
              "orderSentence": "Folate 1 mg PO"
            },
            "contraindications": "None",
            "monitoring": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Multivitamin",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Daily",
              "orderSentence": "Multivitamin - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Nutritional Support": [
          {
            "item": "Nutrition consult",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Refeeding protocol; caloric needs",
              "orderSentence": "Nutrition consult - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Refeeding syndrome",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Gradual refeeding",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Start low calorie (10-15 kcal/kg); advance slowly",
              "orderSentence": "Gradual refeeding - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Phosphorus, K+, Mg, glucose",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          }
        ]
      },
      "Other Recommendations": {
        "Patient Instructions": [
          {
            "item": "Neurology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "indication": "Diagnosis confirmation; atypical presentations; persistent deficits"
          },
          {
            "item": "Addiction medicine/psychiatry",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Alcohol use disorder; relapse prevention"
          },
          {
            "item": "Nutrition/dietitian",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "indication": "Refeeding; nutritional rehabilitation"
          },
          {
            "item": "Social work",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Discharge planning; resources; housing"
          },
          {
            "item": "Physical/occupational therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Gait ataxia; functional rehabilitation"
          },
          {
            "item": "Speech therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "indication": "Swallowing assessment if impaired"
          },
          {
            "item": "Neuropsychology",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Cognitive assessment if persistent deficits"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Wernicke encephalopathy is a medical emergency caused by thiamine (vitamin B1) deficiency",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Without treatment, permanent brain damage (Korsakoff syndrome) can occur",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take thiamine supplements as prescribed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "If alcohol use disorder: Thiamine is critical; take before drinking if relapse",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Alcohol cessation is essential to prevent recurrence",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Eat a balanced diet; malnutrition worsens risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report confusion, vision changes, unsteady walking",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "SAMHSA helpline 1-800-662-4357 for alcohol treatment resources",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Hepatic encephalopathy",
        "features": "Asterixis; elevated ammonia; liver disease",
        "tests": "Ammonia level; LFTs"
      },
      {
        "diagnosis": "Alcohol intoxication",
        "features": "Positive alcohol level; resolves as level clears",
        "tests": "Blood alcohol; clinical course"
      },
      {
        "diagnosis": "Alcohol withdrawal",
        "features": "Tremor, tachycardia, diaphoresis; after cessation",
        "tests": "History; CIWA score"
      },
      {
        "diagnosis": "Hypoglycemia",
        "features": "Low glucose; rapid response to dextrose",
        "tests": "Fingerstick glucose"
      },
      {
        "diagnosis": "Meningitis/encephalitis",
        "features": "Fever, meningismus, CSF abnormalities",
        "tests": "LP; CSF analysis"
      },
      {
        "diagnosis": "Stroke (thalamic, brainstem)",
        "features": "Acute onset; focal signs; imaging findings",
        "tests": "MRI/CT; usually asymmetric"
      },
      {
        "diagnosis": "Central pontine myelinolysis",
        "features": "History of rapid sodium correction; imaging",
        "tests": "MRI; sodium history"
      },
      {
        "diagnosis": "Normal pressure hydrocephalus",
        "features": "Triad: gait, dementia, incontinence; enlarged ventricles",
        "tests": "MRI; LP trial"
      },
      {
        "diagnosis": "Drug intoxication",
        "features": "Toxicology positive; specific syndromes",
        "tests": "Tox screen; history"
      },
      {
        "diagnosis": "Non-convulsive status epilepticus",
        "features": "EEG shows seizure activity",
        "tests": "EEG"
      },
      {
        "diagnosis": "Posterior reversible encephalopathy (PRES)",
        "features": "Hypertension; posterior white matter edema",
        "tests": "MRI; BP"
      }
    ],
    "evidence": [
      {
        "recommendation": "High-dose IV thiamine (500 mg TID) for suspected WE",
        "evidenceLevel": "Class II, Level B",
        "source": "[EFNS guidelines](https://pubmed.ncbi.nlm.nih.gov/20642790/); Cochrane review (limited RCT data but expert consensus)"
      },
      {
        "recommendation": "Thiamine before glucose in at-risk patients",
        "evidenceLevel": "Class I (practice standard)",
        "source": "Physiologic rationale; case reports of precipitation"
      },
      {
        "recommendation": "MRI typical findings in WE",
        "evidenceLevel": "Class II, Level B",
        "source": "Multiple case series; imaging studies"
      },
      {
        "recommendation": "Magnesium replacement essential",
        "evidenceLevel": "Class II, Level B",
        "source": "Cofactor for thiamine-dependent enzymes"
      },
      {
        "recommendation": "Oral thiamine poorly absorbed in alcoholics",
        "evidenceLevel": "Class II",
        "source": "Pharmacokinetic studies; supports IV administration"
      },
      {
        "recommendation": "Prophylactic thiamine in at-risk populations",
        "evidenceLevel": "Class II, Level B",
        "source": "Observational data; prevention superior to treatment"
      },
      {
        "recommendation": "Classic triad present in minority",
        "evidenceLevel": "Class II",
        "source": "Autopsy studies show only 10-16% have all three features"
      }
    ],
    "monitoring": [
      {
        "item": "Mental status (GCS, orientation)",
        "ED": "STAT",
        "HOSP": "q4h",
        "OPD": "Every visit",
        "ICU": "q1-2h",
        "frequency": "Per setting",
        "action": "Continue thiamine; r/o other causes"
      },
      {
        "item": "Oculomotor exam (nystagmus, gaze palsy)",
        "ED": "STAT",
        "HOSP": "Daily",
        "OPD": "Every visit",
        "ICU": "Daily",
        "frequency": "Daily until improved",
        "action": "Continue treatment"
      },
      {
        "item": "Gait/ataxia assessment",
        "ED": "-",
        "HOSP": "Daily",
        "OPD": "Every visit",
        "ICU": "-",
        "frequency": "Daily until improved",
        "action": "PT/OT; continue treatment"
      },
      {
        "item": "Magnesium",
        "ED": "STAT",
        "HOSP": "Daily until stable",
        "OPD": "PRN",
        "ICU": "q6-12h",
        "frequency": "Per setting",
        "action": "Replace"
      },
      {
        "item": "Potassium",
        "ED": "STAT",
        "HOSP": "Daily until stable",
        "OPD": "PRN",
        "ICU": "q6-12h",
        "frequency": "Per setting",
        "action": "Replace"
      },
      {
        "item": "Phosphorus",
        "ED": "STAT",
        "HOSP": "Daily until stable",
        "OPD": "PRN",
        "ICU": "q12h",
        "frequency": "Per setting",
        "action": "Replace"
      },
      {
        "item": "Blood glucose",
        "ED": "STAT",
        "HOSP": "q6h initially",
        "OPD": "PRN",
        "ICU": "q4-6h",
        "frequency": "Per setting",
        "action": "Give thiamine before glucose"
      },
      {
        "item": "CIWA score (if alcohol withdrawal risk)",
        "ED": "STAT",
        "HOSP": "q4-8h",
        "OPD": "-",
        "ICU": "q2-4h",
        "frequency": "Per protocol",
        "action": "Benzodiazepines PRN"
      }
    ],
    "disposition": [
      {
        "disposition": "Admit to hospital",
        "criteria": "All suspected or confirmed Wernicke encephalopathy; need IV thiamine"
      },
      {
        "disposition": "ICU admission",
        "criteria": "Altered mental status; severe withdrawal risk; hemodynamic instability"
      },
      {
        "disposition": "Discharge criteria",
        "criteria": "Mental status normalized; tolerating oral thiamine; safe discharge plan"
      },
      {
        "disposition": "Neurology follow-up",
        "criteria": "2-4 weeks post-discharge; assess for persistent deficits"
      },
      {
        "disposition": "Addiction medicine follow-up",
        "criteria": "If alcohol use disorder; outpatient treatment program"
      },
      {
        "disposition": "Urgent readmission",
        "criteria": "Recurrent symptoms; inability to take oral thiamine; relapse"
      }
    ]
  },
  "Intracerebral Hemorrhage": {
    "id": "intracerebral-hemorrhage",
    "title": "Intracerebral Hemorrhage",
    "version": "1.0",
    "icd10": [
      "** I61.9 (Nontraumatic intracerebral hemorrhage",
      "unspecified)",
      "I61.0 (ICH in hemisphere",
      "subcortical)",
      "I61.1 (ICH in hemisphere",
      "cortical)",
      "I61.3 (ICH in brain stem)",
      "I61.4 (ICH in cerebellum)"
    ],
    "scope": "** Spontaneous (non-traumatic) intracerebral hemorrhage in adults. Covers acute BP management, anticoagulant reversal, ICH score and prognosis, ICP management, surgical indications, etiology workup, and secondary prevention. Excludes traumatic ICH, subarachnoid hemorrhage (separate template), hemorrhagic transformation of ischemic stroke, and subdural/epidural hematomas.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Baseline; thrombocytopenia as cause or complication; transfusion needs",
            "target": "Platelets >100,000 (>50,000 minimum for hemostasis)"
          },
          {
            "item": "PT/INR",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Warfarin-related ICH requires emergent reversal; coagulopathy assessment",
            "target": "INR <1.4 target (if elevated: REVERSE IMMEDIATELY)"
          },
          {
            "item": "aPTT",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Heparin-related ICH; coagulopathy",
            "target": "Normal"
          },
          {
            "item": "Fibrinogen",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "DIC; consumptive coagulopathy; tPA-related hemorrhage",
            "target": ">150 mg/dL (if <150: give cryoprecipitate)"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Electrolytes; renal function for contrast/medication; hepatic function for coagulopathy",
            "target": "Normal"
          },
          {
            "item": "Blood glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Hyperglycemia worsens ICH outcomes; hypoglycemia mimics stroke",
            "target": "140-180 mg/dL target"
          },
          {
            "item": "Type and screen / crossmatch",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Potential need for blood products, surgery, reversal agents",
            "target": "On file; crossmatch if OR likely"
          },
          {
            "item": "Troponin",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Neurogenic cardiac injury (stress cardiomyopathy); concurrent ACS",
            "target": "Normal"
          },
          {
            "item": "Blood alcohol level",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Coagulopathy; exam reliability; alcoholism is ICH risk factor",
            "target": "Document result"
          },
          {
            "item": "Urine drug screen",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Cocaine/amphetamine-associated ICH (sympathomimetic surge)",
            "target": "Negative"
          },
          {
            "item": "Pregnancy test (β-hCG)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Affects management (eclampsia differential; imaging)",
            "target": "Document result"
          },
          {
            "item": "Thrombin time (TT) and/or ecarin clotting time (ECT)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Dabigatran (direct thrombin inhibitor) detection; if patient on DOACs",
            "target": "Normal (prolonged = dabigatran present)"
          },
          {
            "item": "Anti-Xa level (calibrated for specific DOAC)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Rivaroxaban/apixaban/edoxaban detection; guides reversal need",
            "target": "Negative/undetectable (elevated = DOAC present and active)"
          }
        ],
        "Extended Workup": [
          {
            "item": "Lipid panel",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Cardiovascular risk; statin decision (controversial post-ICH)",
            "target": "Document baseline"
          },
          {
            "item": "HbA1c",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes management",
            "target": "<7.0%"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Thyroid dysfunction",
            "target": "Normal"
          },
          {
            "item": "ESR / CRP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Vasculitis screen; inflammatory etiology",
            "target": "Normal"
          },
          {
            "item": "D-dimer",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "DIC; venous thromboembolism",
            "target": "Normal"
          },
          {
            "item": "Serum osmolality",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "Monitor during osmotherapy (mannitol/hypertonic saline)",
            "target": "280-320 mOsm/kg; hold osmotherapy if >320"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Hypercoagulable panel",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Young patient ICH without clear etiology; cerebral venous thrombosis with secondary hemorrhage",
            "target": "Normal"
          },
          {
            "item": "ANA, ANCA",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "CNS vasculitis-related hemorrhage",
            "target": "Negative"
          },
          {
            "item": "Toxicology (expanded)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "rationale": "Sympathomimetic drug use; synthetic drug-associated hemorrhage",
            "target": "Negative"
          },
          {
            "item": "Amyloid-beta PET",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Cerebral amyloid angiopathy (CAA) confirmation; research context",
            "target": "Positive amyloid deposition in lobar distribution"
          },
          {
            "item": "APOE genotype",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "CAA risk stratification; APOE ε2/ε4 associated with ICH",
            "target": "Document alleles"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Door-to-CT <25 minutes; determines ICH diagnosis, location, volume, IVH, hydrocephalus, midline shift",
            "target": "Hemorrhage location (deep: basal ganglia/thalamus = hypertensive; lobar: CAA, tumor, AVM), volume (ABC/2 method), intraventricular hemorrhage (IVH), hydrocephalus, midline shift >5mm",
            "contraindications": "Pregnancy (benefit outweighs risk)"
          },
          {
            "item": "CT angiography (CTA) head",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "With initial CT; identify \"spot sign\" (active contrast extravasation = hematoma expansion risk), underlying vascular malformation (AVM, aneurysm)",
            "target": "Spot sign (30-50% risk of expansion); AVM; aneurysm; dural AV fistula; Moyamoya",
            "contraindications": "Contrast allergy; renal impairment (benefit outweighs risk in emergency)"
          },
          {
            "item": "ECG (12-lead)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Baseline; neurogenic cardiac injury; arrhythmia; QTc prolongation risk",
            "target": "Normal; ST changes may be neurogenic",
            "contraindications": "None"
          },
          {
            "item": "Repeat CT head (non-contrast)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "At 6h and 24h OR any neurologic decline; assess for hematoma expansion (>33% or >6mL increase from baseline = significant expansion)",
            "target": "Stable hematoma size; no new hemorrhage; no hydrocephalus progression",
            "contraindications": "Same as initial"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain with and without contrast (include GRE/SWI sequences)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Within 24-72h when stable; or urgently if underlying mass/AVM suspected",
            "target": "Underlying tumor; cavernous malformation; microbleeds (CAA pattern: lobar; hypertensive: deep). SWI shows microhemorrhages",
            "contraindications": "Pacemaker; hemodynamic instability; MRI-incompatible monitoring"
          },
          {
            "item": "MR venography (MRV)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "timing": "If cerebral venous thrombosis (CVT) suspected as cause of hemorrhagic venous infarct",
            "target": "Venous sinus thrombosis",
            "contraindications": "Same as MRI"
          },
          {
            "item": "Conventional cerebral angiography (DSA)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "EXT",
            "ICU": "URGENT",
            "timing": "Young patient (<50) with lobar ICH and no clear etiology; suspected AVM/aneurysm where CTA inconclusive; negative initial CTA but high suspicion",
            "target": "AVM; aneurysm; dural AV fistula; Moyamoya; vasculitis",
            "contraindications": "Contrast allergy; renal impairment; coagulopathy"
          },
          {
            "item": "Delayed DSA (if initial negative)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Repeat at 3-6 months; small AVM may be compressed by acute hematoma and missed initially",
            "target": "Unmasked AVM/aneurysm",
            "contraindications": "Same as initial DSA"
          },
          {
            "item": "Echocardiogram",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "timing": "Neurogenic cardiac injury; baseline cardiac function; endocarditis if mycotic aneurysm suspected",
            "target": "LV dysfunction; stress cardiomyopathy",
            "contraindications": "None significant"
          },
          {
            "item": "Continuous EEG (cEEG)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "If altered consciousness disproportionate to hemorrhage size; suspected seizures",
            "target": "Non-convulsive seizures; NCSE (seen in 20-30% of ICH patients)",
            "contraindications": "None"
          },
          {
            "item": "Chest X-ray",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "Aspiration; pulmonary edema (neurogenic); baseline for ventilator",
            "target": "Normal",
            "contraindications": "None"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Brain biopsy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If underlying tumor, vasculitis, or amyloid angiopathy suspected and non-invasive workup inconclusive",
            "target": "Tumor; vasculitis; amyloid",
            "contraindications": "Surgical risk"
          },
          {
            "item": "Amyloid PET scan",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "CAA diagnosis in lobar ICH with microbleeds",
            "target": "Amyloid deposition",
            "contraindications": "Research/limited availability"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Blood pressure reduction: Nicardipine IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg/h",
                  "orderSentence": "Blood pressure reduction: Nicardipine IV 5 mg/h IV"
                }
              ],
              "route": "IV",
              "instructions": "5 mg/h IV; increase by 2.5 mg/h q5-15min; max 15 mg/h. Target SBP 130-150 mmHg (INTERACT2: <140 safe; AHA 2022: <140 reasonable if presenting SBP 150-220)",
              "orderSentence": "Blood pressure reduction: Nicardipine IV 5 mg/h IV"
            },
            "contraindications": "Severe aortic stenosis; advanced HF",
            "monitoring": "Continuous arterial line BP; neuro checks with each change; avoid SBP <110 (renal hypoperfusion)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Blood pressure reduction: Labetalol IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-20 mg",
                  "orderSentence": "Blood pressure reduction: Labetalol IV 10-20 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10-20 mg IV bolus over 1-2 min; may repeat or double q10min; max 300 mg. Alternative to nicardipine",
              "orderSentence": "Blood pressure reduction: Labetalol IV 10-20 mg IV"
            },
            "contraindications": "Heart block (2nd/3rd degree); severe bradycardia; decompensated HF; asthma",
            "monitoring": "HR; BP continuous",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Blood pressure reduction: Clevidipine IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2 mg/h",
                  "orderSentence": "Blood pressure reduction: Clevidipine IV 1-2 mg/h IV"
                }
              ],
              "route": "IV",
              "instructions": "1-2 mg/h IV; titrate by doubling q90sec initially; max 32 mg/h",
              "orderSentence": "Blood pressure reduction: Clevidipine IV 1-2 mg/h IV"
            },
            "contraindications": "Soy/egg allergy; lipid disorders",
            "monitoring": "BP continuous",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Intubation and airway protection",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "GCS ≤8; inability to protect airway; respiratory failure; impending herniation. Use non-depolarizing agents; avoid succinylcholine if elevated ICP (relative)",
              "orderSentence": "Intubation and airway protection - - - see dosing"
            },
            "contraindications": "N/A",
            "monitoring": "Ventilator; head of bed 30°; avoid hyperventilation unless herniation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Warfarin reversal: 4-factor PCC (Kcentra)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-50 units/kg",
                  "orderSentence": "Warfarin reversal: 4-factor PCC (Kcentra) 25-50 units/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "25-50 units/kg IV (dose based on INR: INR 2-4: 25 u/kg; INR 4-6: 35 u/kg; INR >6: 50 u/kg); infuse over 10-15 min. Reverses INR within 15-30 min. PREFERRED over FFP (faster, smaller volume)",
              "orderSentence": "Warfarin reversal: 4-factor PCC (Kcentra) 25-50 units/kg IV"
            },
            "contraindications": "Active DIC (relative); HIT (contains heparin traces)",
            "monitoring": "INR 15 min after infusion; repeat if INR >1.4; thrombotic risk",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Warfarin reversal: Vitamin K (phytonadione)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Warfarin reversal: Vitamin K (phytonadione) 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg IV slow push (over 10 min) to sustain INR correction (PCC is temporary). ALWAYS give WITH PCC",
              "orderSentence": "Warfarin reversal: Vitamin K (phytonadione) 10 mg IV"
            },
            "contraindications": "Known severe allergic reaction (rare)",
            "monitoring": "INR at 6h and 24h; anaphylaxis risk (rare with slow IV)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Warfarin reversal: FFP (if PCC unavailable)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-15 mL/kg",
                  "orderSentence": "Warfarin reversal: FFP (if PCC unavailable) 10-15 mL/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "10-15 mL/kg IV (typically 2-4 units). Slower than PCC; requires thawing and larger volume",
              "orderSentence": "Warfarin reversal: FFP (if PCC unavailable) 10-15 mL/kg IV"
            },
            "contraindications": "Volume overload; transfusion reactions",
            "monitoring": "INR; volume status",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Dabigatran reversal: Idarucizumab (Praxbind)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 g",
                  "orderSentence": "Dabigatran reversal: Idarucizumab (Praxbind) 5 g IV"
                }
              ],
              "route": "IV",
              "instructions": "5 g IV (two 2.5g boluses or infusions). Specific reversal agent for dabigatran. Reversal within minutes",
              "orderSentence": "Dabigatran reversal: Idarucizumab (Praxbind) 5 g IV"
            },
            "contraindications": "None absolute",
            "monitoring": "Thrombin time (TT), aPTT; clinical hemostasis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Factor Xa inhibitor reversal: Andexanet alfa (Andexxa)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg",
                  "orderSentence": "Factor Xa inhibitor reversal: Andexanet alfa (Andexxa) 400 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "For rivaroxaban/apixaban. Low-dose: 400 mg IV bolus then 4 mg/min x 2h (last dose >8h ago). High-dose: 800 mg IV bolus then 8 mg/min x 2h (last dose <8h ago or unknown, or rivaroxaban)",
              "orderSentence": "Factor Xa inhibitor reversal: Andexanet alfa (Andexxa) 400 mg IV"
            },
            "contraindications": "Thrombotic risk (10-15% VTE in trials)",
            "monitoring": "Anti-Xa levels; thrombosis monitoring; arterial line",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Factor Xa inhibitor reversal: 4-factor PCC (if andexanet unavailable)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 units/kg",
                  "orderSentence": "Factor Xa inhibitor reversal: 4-factor PCC (if andexanet unavailable) 50 units/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "50 units/kg IV. Off-label but supported by guidelines if andexanet not available",
              "orderSentence": "Factor Xa inhibitor reversal: 4-factor PCC (if andexanet unavailable) 50 units/kg IV"
            },
            "contraindications": "Same as PCC",
            "monitoring": "Anti-Xa levels; clinical hemostasis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Heparin reversal: Protamine sulfate",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg",
                  "orderSentence": "Heparin reversal: Protamine sulfate 1 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1 mg per 100 units of heparin given in last 2-3h; max 50 mg; give slow IV over 10 min",
              "orderSentence": "Heparin reversal: Protamine sulfate 1 mg IV"
            },
            "contraindications": "Fish/protamine allergy",
            "monitoring": "aPTT; BP (hypotension with rapid infusion); anaphylaxis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Platelet transfusion",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 unit",
                  "orderSentence": "Platelet transfusion 1 unit -"
                }
              ],
              "route": "-",
              "instructions": "1 unit apheresis platelets if platelet count <100,000 AND active bleeding or pre-surgical. For antiplatelet-associated ICH: PATCH trial showed NO benefit from routine platelet transfusion (do NOT transfuse if platelets >100K on antiplatelet therapy)",
              "orderSentence": "Platelet transfusion 1 unit -"
            },
            "contraindications": "HIT; ITP (consult hematology)",
            "monitoring": "Platelet count; clinical hemostasis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Tranexamic acid (TXA)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 g",
                  "orderSentence": "Tranexamic acid (TXA) 1 g IV"
                }
              ],
              "route": "IV",
              "instructions": "1 g IV over 10 min then 1 g IV over 8h. TICH-2 trial: did NOT reduce mortality but reduced hematoma expansion. Not routine; consider if spot sign positive or early presentation with active expansion",
              "orderSentence": "Tranexamic acid (TXA) 1 g IV"
            },
            "contraindications": "Active DVT/PE; hypercoagulable state",
            "monitoring": "Thrombotic events; clinical hemostasis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "ICP management: Head of bed elevation",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "HOB 30°; head in midline (optimize venous drainage); avoid neck flexion/compression",
              "orderSentence": "ICP management: Head of bed elevation - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "ICP if monitored",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "ICP management: Mannitol 20%",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-1.5 g/kg",
                  "orderSentence": "ICP management: Mannitol 20% 1-1.5 g/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "1-1.5 g/kg IV bolus for acute herniation; 0.25-0.5 g/kg q4-6h maintenance",
              "orderSentence": "ICP management: Mannitol 20% 1-1.5 g/kg IV"
            },
            "contraindications": "Anuria; serum osm >320",
            "monitoring": "Serum osm q4-6h; osmolar gap; Cr; I/O",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "ICP management: Hypertonic saline 23.4%",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mL",
                  "orderSentence": "ICP management: Hypertonic saline 23.4% 30 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "30 mL IV bolus via central line over 10-20 min for acute herniation",
              "orderSentence": "ICP management: Hypertonic saline 23.4% 30 mL IV"
            },
            "contraindications": "No central access",
            "monitoring": "Na (target 145-155); osmolality",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "ICP management: Hypertonic saline 3%",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150-500 mL",
                  "orderSentence": "ICP management: Hypertonic saline 3% 150-500 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "150-500 mL bolus or 0.5-1 mL/kg/h infusion; target Na 145-155",
              "orderSentence": "ICP management: Hypertonic saline 3% 150-500 mL IV"
            },
            "contraindications": "Hypernatremia >160",
            "monitoring": "Na q4-6h; osmolality",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Levetiracetam",
            "route": "IV",
            "indication": "Seizure treatment (NOT routine prophylaxis — AHA 2022 recommends against routine prophylaxis). Treat if clinical or electrographic seizures",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000-1500 mg",
                  "orderSentence": "Levetiracetam 1000-1500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1000-1500 mg IV load; then 500-1000 mg IV/PO BID",
              "orderSentence": "Levetiracetam 1000-1500 mg IV"
            },
            "contraindications": "Severe renal impairment (dose adjust)",
            "monitoring": "Seizure monitoring; cEEG; renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Acetaminophen",
            "route": "IV",
            "indication": "Fever (target normothermia <37.5°C; fever worsens ICH outcomes)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650-1000 mg",
                  "orderSentence": "Acetaminophen 650-1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "650-1000 mg PO/IV q6h; max 4g/day",
              "orderSentence": "Acetaminophen 650-1000 mg IV"
            },
            "contraindications": "Severe hepatic disease",
            "monitoring": "Temperature q4h; LFTs",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Surface cooling / Arctic Sun",
            "route": "-",
            "indication": "Refractory fever (targeted temperature management)",
            "dosing": {
              "instructions": "Target 36-37°C; avoid shivering (counterproductive)",
              "orderSentence": "Surface cooling / Arctic Sun - - - see dosing"
            },
            "contraindications": "N/A",
            "monitoring": "Core temperature; shivering assessment (BSAS)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Insulin (regular)",
            "route": "IV",
            "indication": "Hyperglycemia (target 140-180 mg/dL)",
            "dosing": {
              "instructions": "Sliding scale or insulin drip",
              "orderSentence": "Insulin (regular) - IV - see dosing"
            },
            "contraindications": "Hypoglycemia",
            "monitoring": "BG q1h if drip; q6h if sliding scale",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Pantoprazole",
            "route": "IV",
            "indication": "GI prophylaxis (Cushing ulcer risk from elevated ICP)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Pantoprazole 40 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "40 mg IV/PO daily",
              "orderSentence": "Pantoprazole 40 mg IV"
            },
            "contraindications": "C. diff risk",
            "monitoring": "GI symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Enoxaparin",
            "route": "SC",
            "indication": "DVT prophylaxis (start 24-48h after hemorrhage stabilizes; after repeat CT shows stability)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Enoxaparin 40 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily. AHA 2022: intermittent pneumatic compression devices on admission; pharmacologic prophylaxis after hemorrhage stable on repeat imaging",
              "orderSentence": "Enoxaparin 40 mg SC"
            },
            "contraindications": "Active hemorrhagic expansion; within 24h of ICH onset; pre-surgical",
            "monitoring": "Platelet count; repeat CT before starting",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pneumatic compression devices",
            "route": "-",
            "indication": "DVT prophylaxis (start IMMEDIATELY)",
            "dosing": {
              "instructions": "Apply bilaterally on admission; ICH patients are HIGH VTE risk",
              "orderSentence": "Pneumatic compression devices - - - see dosing"
            },
            "contraindications": "Acute DVT",
            "monitoring": "Skin checks",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Ondansetron",
            "route": "IV",
            "indication": "Nausea/vomiting (posterior fossa hemorrhage; elevated ICP)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg",
                  "orderSentence": "Ondansetron 4 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "4 mg IV q6h PRN",
              "orderSentence": "Ondansetron 4 mg IV"
            },
            "contraindications": "QT prolongation",
            "monitoring": "QTc",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Surgical Interventions": [
          {
            "item": "External ventricular drain (EVD)",
            "route": "-",
            "indication": "IVH with acute hydrocephalus; GCS declining; need for ICP monitoring",
            "dosing": {
              "instructions": "Neurosurgery places; allows CSF drainage and ICP monitoring; target ICP <22, CPP >60",
              "orderSentence": "External ventricular drain (EVD) - - - see dosing"
            },
            "contraindications": "Coagulopathy (correct first); futile care",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Intraventricular tPA via EVD",
            "route": "-",
            "indication": "IVH with hydrocephalus (CLEAR III trial: reduced mortality in severe IVH but did NOT improve functional outcome)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg",
                  "orderSentence": "Intraventricular tPA via EVD 1 mg -"
                }
              ],
              "route": "-",
              "instructions": "Alteplase 1 mg q8h via EVD; up to 12 doses; clamp EVD 1h after dosing then open to drain",
              "orderSentence": "Intraventricular tPA via EVD 1 mg -"
            },
            "contraindications": "Active systemic bleeding; coagulopathy",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Surgical hematoma evacuation (craniotomy)",
            "route": "-",
            "indication": "Lobar ICH >30 mL with deterioration; cerebellar hemorrhage >3 cm OR with brainstem compression/hydrocephalus (STRONGEST surgical indication). STICH/STICH-II: no clear benefit for supratentorial deep ICH",
            "dosing": {
              "instructions": "Craniotomy or craniectomy for clot evacuation",
              "orderSentence": "Surgical hematoma evacuation (craniotomy) - - - see dosing"
            },
            "contraindications": "Deep ICH (generally no benefit from open surgery); GCS 3-4 without brainstem reflexes (futile); severe coagulopathy",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Minimally invasive surgery (MIS) — endoscopic or stereotactic aspiration",
            "route": "-",
            "indication": "Supratentorial ICH >30 mL with stable or mild deficits (MISTIE III, ENRICH trials: emerging data; ENRICH showed benefit for lobar ICH)",
            "dosing": {
              "instructions": "Stereotactic catheter-based aspiration or endoscopic evacuation with lower morbidity than craniotomy",
              "orderSentence": "Minimally invasive surgery (MIS) — endoscopic or stereotactic aspiration - - - see dosing"
            },
            "contraindications": "Deep location (relative); coagulopathy",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Decompressive craniectomy",
            "route": "-",
            "indication": "Massive ICH with refractory elevated ICP; malignant cerebellar edema",
            "dosing": {
              "instructions": "Bone flap removal to allow brain expansion",
              "orderSentence": "Decompressive craniectomy - - - see dosing"
            },
            "contraindications": "Futile prognosis; bilateral fixed dilated pupils",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Suboccipital decompressive craniectomy",
            "route": "-",
            "indication": "Cerebellar hemorrhage with brainstem compression",
            "dosing": {
              "instructions": "Posterior fossa decompression; life-saving for cerebellar ICH with brainstem compression",
              "orderSentence": "Suboccipital decompressive craniectomy - - - see dosing"
            },
            "contraindications": "Moribund patient",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Secondary Prevention (After Acute Phase)": [
          {
            "item": "Antihypertensive therapy (long-term)",
            "route": "PO",
            "indication": "ALL ICH patients; BP is most important modifiable risk factor",
            "dosing": {
              "instructions": "Target SBP <130 mmHg (SPS3 trial, PROGRESS trial); agent choice per comorbidities (ACE-I, ARB, CCB, thiazide)",
              "orderSentence": "Antihypertensive therapy (long-term) - PO - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "Home BP monitoring; clinic BP",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Statin (controversial post-ICH)",
            "route": "PO",
            "indication": "Risk-benefit discussion; SPARCL showed small increased ICH risk with atorvastatin but overall cardiovascular benefit. AHA 2022: statin not contraindicated after ICH",
            "dosing": {
              "instructions": "Per cardiovascular risk; individualize",
              "orderSentence": "Statin (controversial post-ICH) - PO - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "Lipid panel",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Anticoagulation restart (if AF or mechanical valve)",
            "route": "PO",
            "indication": "Most controversial decision. AHA 2022: may restart anticoagulation at 4-8 weeks for patients with strong indication (AF with high CHA2DS2-VASc). Avoid in CAA-related lobar ICH if possible",
            "dosing": {
              "instructions": "Apixaban preferred (APACHE-AF trial: lowest ICH recurrence). Timing: 4-8 weeks; individualized risk-benefit",
              "orderSentence": "Anticoagulation restart (if AF or mechanical valve) - PO - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "Imaging stability; bleeding risk; CHA2DS2-VASc vs HAS-BLED",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Antiplatelet restart",
            "route": "PO",
            "indication": "RESTART trial: restarting antiplatelet after ICH is associated with LOWER risk of recurrent ICH; may restart at 2-4 weeks for patients with cardiovascular indication",
            "dosing": {
              "doseOptions": [
                {
                  "text": "81 mg",
                  "orderSentence": "Antiplatelet restart 81 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Aspirin 81 mg or clopidogrel 75 mg daily",
              "orderSentence": "Antiplatelet restart 81 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "Bleeding signs",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Left atrial appendage occlusion (LAAO/Watchman)",
            "route": "Procedure",
            "indication": "AF patients who cannot tolerate long-term anticoagulation post-ICH (lobar ICH, CAA)",
            "dosing": {
              "instructions": "Interventional cardiology procedure; eliminates need for long-term anticoagulation in AF",
              "orderSentence": "Left atrial appendage occlusion (LAAO/Watchman) - Procedure - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "Procedural risks",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurosurgery",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "ALL ICH patients; surgical decision for EVD, hematoma evacuation, decompression"
          },
          {
            "item": "Neurology / Neurocritical care",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Medical management; BP optimization; ICP management; seizure management"
          },
          {
            "item": "Hematology",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Anticoagulant reversal guidance; coagulopathy management; thrombocytopenia"
          },
          {
            "item": "Pharmacy (clinical pharmacist)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Reversal agent dosing; anticoagulant identification; drug interactions"
          },
          {
            "item": "Cardiology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "indication": "AF management; anticoagulation restart decision; LAAO evaluation; neurogenic cardiac injury"
          },
          {
            "item": "Speech-language pathology (SLP)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Dysphagia screening before PO intake; aphasia assessment"
          },
          {
            "item": "Physical therapy (PT)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Early mobilization (24-48h if stable); fall prevention; strength"
          },
          {
            "item": "Occupational therapy (OT)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "ADL assessment; cognitive rehabilitation; adaptive equipment"
          },
          {
            "item": "Rehabilitation medicine (physiatry)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Rehabilitation disposition; functional prognosis"
          },
          {
            "item": "Social work",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Family support; advance directives; discharge planning"
          },
          {
            "item": "Palliative care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "indication": "Goals of care discussion (especially ICH score ≥3); early palliative involvement improves care quality"
          },
          {
            "item": "Interventional neuroradiology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "indication": "AVM/aneurysm treatment planning; dural AV fistula"
          }
        ],
        "Patient Instructions": [
          {
            "item": "ICH is serious but outcomes vary; early aggressive treatment improves survival",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Call 911 if: sudden headache, new weakness, speech changes, altered consciousness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Blood pressure control is the MOST IMPORTANT factor in preventing recurrence",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take all medications as prescribed; never stop blood pressure medications without physician guidance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do NOT restart anticoagulation or antiplatelet without specific neurology/cardiology guidance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Home blood pressure monitoring daily; keep log; target per physician guidance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Follow-up with neurology in 2-4 weeks; neurosurgery if applicable",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do NOT drive until cleared",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Fall prevention at home",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Blood pressure target <130/80 mmHg (most important)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation (doubles ICH risk)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Alcohol cessation or limitation (heavy drinking increases ICH risk)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cocaine/amphetamine cessation (sympathomimetic ICH)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid excessive anticoagulation (keep INR in range if on warfarin)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular exercise (moderate intensity after recovery)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Weight management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "DASH or Mediterranean diet",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Depression screening (PHQ-9 at 1-3 months)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Hemorrhagic transformation of ischemic stroke",
        "features": "Prior ischemic infarct on imaging; onset timing suggests ischemic → hemorrhagic evolution",
        "tests": "CT/MRI timing; DWI changes preceding hemorrhage"
      },
      {
        "diagnosis": "Cerebral venous thrombosis (CVT) with hemorrhagic infarct",
        "features": "Headache, seizures, often young women (OCPs, pregnancy); hemorrhage doesn't respect arterial territory; parasagittal location",
        "tests": "MRV/CT venography (thrombosed sinus); D-dimer"
      },
      {
        "diagnosis": "Brain tumor with hemorrhage",
        "features": "Subacute symptoms preceding hemorrhage; ring enhancement around hemorrhage; disproportionate edema",
        "tests": "MRI with contrast (underlying enhancing mass); biopsy"
      },
      {
        "diagnosis": "Cerebral amyloid angiopathy (CAA)",
        "features": "Lobar location (NOT deep); age >55; recurrent lobar hemorrhages; cortical superficial siderosis; multiple lobar microbleeds on SWI",
        "tests": "MRI SWI (lobar microbleeds, superficial siderosis); Boston criteria"
      },
      {
        "diagnosis": "Vascular malformation (AVM, cavernoma)",
        "features": "Younger patient; recurrent hemorrhages at same location; AVM on CTA/DSA; cavernoma on MRI (popcorn appearance)",
        "tests": "CTA; DSA; MRI (especially SWI)"
      },
      {
        "diagnosis": "Ruptured aneurysm extending into parenchyma",
        "features": "Subarachnoid + intraparenchymal hemorrhage; near aneurysm location",
        "tests": "CTA (aneurysm); DSA"
      },
      {
        "diagnosis": "Hypertensive ICH",
        "features": "Deep location (putamen, thalamus, pons, cerebellum); history of poorly controlled HTN",
        "tests": "Clinical; typical location; no underlying lesion on workup"
      },
      {
        "diagnosis": "Moyamoya disease",
        "features": "Young adults or Asian patients; recurrent stroke; stenotic proximal vessels with collateral network",
        "tests": "MRA (ICA/MCA stenosis with Moyamoya collaterals); DSA"
      },
      {
        "diagnosis": "Coagulopathy-related ICH",
        "features": "Multiple hemorrhages; known coagulopathy or anticoagulant use",
        "tests": "Coagulation panel; medication history"
      },
      {
        "diagnosis": "Mycotic aneurysm",
        "features": "Endocarditis; distal vessel location; fever",
        "tests": "Blood cultures; echocardiogram; CTA/DSA"
      },
      {
        "diagnosis": "Trauma",
        "features": "History of trauma; scalp laceration; subdural or epidural components",
        "tests": "Clinical history; CT pattern"
      }
    ],
    "evidence": [
      {
        "recommendation": "SBP target <140 mmHg in acute ICH (presenting SBP 150-220)",
        "evidenceLevel": "Class I, Level A",
        "source": "INTERACT2 ([Anderson et al. NEJM 2013](https://pubmed.ncbi.nlm.nih.gov/23713578/)); AHA/ASA 2022 Guidelines"
      },
      {
        "recommendation": "Intensive BP lowering safe but benefit on functional outcome modest",
        "evidenceLevel": "Class IIa, Level A",
        "source": "ATACH-2 ([Qureshi et al. NEJM 2016](https://pubmed.ncbi.nlm.nih.gov/27276234/)) — <140 vs <180 safe; no functional difference"
      },
      {
        "recommendation": "4-factor PCC preferred over FFP for warfarin reversal",
        "evidenceLevel": "Class I, Level B",
        "source": "INCH trial ([Steiner et al. Lancet Neurol 2016](https://pubmed.ncbi.nlm.nih.gov/26898390/))"
      },
      {
        "recommendation": "Idarucizumab for dabigatran reversal",
        "evidenceLevel": "Class I, Level B",
        "source": "RE-VERSE AD trial ([Pollack et al. NEJM 2017](https://pubmed.ncbi.nlm.nih.gov/28693366/))"
      },
      {
        "recommendation": "Andexanet alfa for factor Xa inhibitor reversal",
        "evidenceLevel": "Class IIa, Level B",
        "source": "ANNEXA-4 ([Connolly et al. NEJM 2019](https://pubmed.ncbi.nlm.nih.gov/30730782/))"
      },
      {
        "recommendation": "Platelet transfusion NOT beneficial for antiplatelet-associated ICH",
        "evidenceLevel": "Class III (No Benefit)",
        "source": "PATCH trial ([Baharoglu et al. Lancet 2016](https://pubmed.ncbi.nlm.nih.gov/27178479/))"
      },
      {
        "recommendation": "TXA reduces expansion but NOT mortality",
        "evidenceLevel": "Class IIb, Level B",
        "source": "TICH-2 ([Sprigg et al. Lancet 2018](https://pubmed.ncbi.nlm.nih.gov/29778325/))"
      },
      {
        "recommendation": "Surgical evacuation for cerebellar ICH with deterioration",
        "evidenceLevel": "Class I, Level B",
        "source": "AHA/ASA Guidelines; strong consensus"
      },
      {
        "recommendation": "No benefit from routine supratentorial open surgery",
        "evidenceLevel": "Class III (No Benefit)",
        "source": "STICH ([Mendelow et al. Lancet 2005](https://pubmed.ncbi.nlm.nih.gov/15680453/)); STICH II (2013)"
      },
      {
        "recommendation": "Minimally invasive surgery emerging benefit",
        "evidenceLevel": "Class IIb, Level B",
        "source": "MISTIE III ([Hanley et al. Lancet 2019](https://pubmed.ncbi.nlm.nih.gov/30739747/)); ENRICH (2024)"
      },
      {
        "recommendation": "EVD for IVH with hydrocephalus",
        "evidenceLevel": "Class I, Level B",
        "source": "AHA/ASA Guidelines"
      },
      {
        "recommendation": "Intraventricular tPA (CLEAR III)",
        "evidenceLevel": "Class IIb, Level B",
        "source": "[Hanley et al. (Lancet 2017)](https://pubmed.ncbi.nlm.nih.gov/28081952/) — reduced mortality but not functional outcome"
      },
      {
        "recommendation": "Seizure prophylaxis NOT recommended routinely",
        "evidenceLevel": "Class III (No Benefit)",
        "source": "AHA/ASA 2022 — treat clinical/electrographic seizures; cEEG if altered"
      },
      {
        "recommendation": "Anticoagulation restart 4-8 weeks for AF",
        "evidenceLevel": "Class IIb, Level B",
        "source": "AHA/ASA 2022; observational data"
      },
      {
        "recommendation": "Antiplatelet restart appears safe (RESTART trial)",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[RESTART trial (Lancet 2019)](https://pubmed.ncbi.nlm.nih.gov/31128924/)"
      },
      {
        "recommendation": "DVT prophylaxis: pneumatic devices immediately; pharmacologic at 24-48h",
        "evidenceLevel": "Class I, Level B",
        "source": "AHA/ASA 2022 Guidelines"
      },
      {
        "recommendation": "ICH Score for prognosis",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[Hemphill et al. (Stroke 2001)](https://pubmed.ncbi.nlm.nih.gov/11283388/)"
      },
      {
        "recommendation": "Normothermia improves outcomes",
        "evidenceLevel": "Class I, Level C",
        "source": "AHA/ASA Guidelines"
      },
      {
        "recommendation": "Avoid self-fulfilling prophecy (DNR discussion timing)",
        "evidenceLevel": "Class I, Level C",
        "source": "AHA/ASA 2022: delay new DNR orders until at least 24h after admission"
      }
    ],
    "monitoring": [
      {
        "item": "Blood pressure (arterial line preferred in ICU)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "q5min x 2h during acute reduction; q15min x 6h; then q1h x 24h; then q4h",
        "action": "Titrate antihypertensives; avoid SBP <110"
      },
      {
        "item": "GCS / Neurologic exam",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "q1h x 24h, then q2h x 24h, then q4h",
        "action": "If declining: STAT CT; ICP assessment; neurosurgery"
      },
      {
        "item": "ICP (if EVD in place)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "Continuous; assess q1h",
        "action": "Tiered ICP management: drain CSF → osmotherapy → sedation → hypothermia → decompression"
      },
      {
        "item": "Repeat CT head",
        "ED": "-",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "At 6h (routine); at 24h; and with ANY neurologic decline",
        "action": "If expanding: re-evaluate BP; reversal; surgical consultation"
      },
      {
        "item": "Temperature",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q4h; q1h if febrile",
        "action": "Aggressive fever management; cooling devices; infection workup"
      },
      {
        "item": "Blood glucose",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q6h (q1h if insulin drip)",
        "action": "Insulin; avoid <60"
      },
      {
        "item": "Serum sodium",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q6h during osmotherapy; q12h otherwise",
        "action": "Adjust osmotherapy"
      },
      {
        "item": "Serum osmolality",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q6h during mannitol",
        "action": "Hold mannitol if >320"
      },
      {
        "item": "INR (if on warfarin)",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "15 min after PCC; then q6h x 24h; then daily",
        "action": "Additional reversal agents"
      },
      {
        "item": "Hemoglobin",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "ROUTINE",
        "frequency": "q6-12h x 48h",
        "action": "Transfuse PRBCs"
      },
      {
        "item": "EEG / Seizure monitoring",
        "ED": "-",
        "HOSP": "URGENT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "cEEG 24-48h minimum if altered consciousness",
        "action": "AED loading; aggressive management"
      },
      {
        "item": "Swallowing screen",
        "ED": "-",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "URGENT",
        "frequency": "Before any PO intake",
        "action": "NPO; SLP evaluation"
      },
      {
        "item": "ICH Score (calculate at admission)",
        "ED": "STAT",
        "HOSP": "-",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "Once (prognostic)",
        "action": "Goals of care discussion if score ≥3"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Small ICH; stable exam; GCS 15; ambulatory; adequate home support; medications filled; BP controlled; follow-up arranged"
      },
      {
        "disposition": "Admit to stroke unit/floor (monitored)",
        "criteria": "Small-moderate ICH; GCS 13-15; no surgical indication; stable repeat CT; BP controlled on oral/IV medications"
      },
      {
        "disposition": "Admit to neuro-ICU",
        "criteria": "ALL moderate-large ICH; GCS <13 or declining; anticoagulant-related ICH; posterior fossa ICH; IVH with hydrocephalus; EVD in place; requiring arterial line and IV antihypertensives; post-surgical"
      },
      {
        "disposition": "Emergent surgery",
        "criteria": "Cerebellar ICH >3 cm with brainstem compression or hydrocephalus; deteriorating lobar ICH >30 mL; obstructive hydrocephalus needing EVD"
      },
      {
        "disposition": "Transfer to higher level",
        "criteria": "Need for neurosurgery not available; need for neuro-ICU; need for reversal agents not available; need for endovascular treatment"
      },
      {
        "disposition": "Inpatient rehabilitation",
        "criteria": "Significant deficits but able to participate in 3h/day therapy; medically stable"
      },
      {
        "disposition": "Comfort care / Hospice",
        "criteria": "ICH score ≥4; devastating ICH with poor prognosis after family goals of care discussion"
      }
    ]
  },
  "Subarachnoid Hemorrhage": {
    "id": "subarachnoid-hemorrhage",
    "title": "Subarachnoid Hemorrhage",
    "version": "1.0",
    "icd10": [
      "** I60.9 (Nontraumatic subarachnoid hemorrhage",
      "unspecified)",
      "I60.7 (SAH from unspecified intracranial artery)",
      "I60.0-I60.6 (SAH from specific arteries)"
    ],
    "scope": "** Spontaneous (non-traumatic) aneurysmal subarachnoid hemorrhage in adults. Covers thunderclap headache evaluation, CT/LP diagnosis, aneurysm identification and securing, vasospasm prevention and treatment (nimodipine, triple-H therapy), hydrocephalus management, and complications. Excludes traumatic SAH, perimesencephalic (non-aneurysmal) SAH management, and intracerebral hemorrhage (separate template).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Baseline; thrombocytopenia; leukocytosis (stress response); pre-surgical",
            "target": "Normal"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Electrolytes (hyponatremia from cerebral salt wasting or SIADH is common); renal/hepatic function",
            "target": "Normal; watch Na closely"
          },
          {
            "item": "PT/INR, aPTT",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Coagulopathy assessment; pre-procedure; anticoagulant use",
            "target": "Normal"
          },
          {
            "item": "Fibrinogen",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Coagulopathy; DIC screen",
            "target": ">150 mg/dL"
          },
          {
            "item": "Type and crossmatch",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Surgical intervention likely; potential blood loss",
            "target": "On file; crossmatch 2-4 units"
          },
          {
            "item": "Troponin",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Neurogenic stunned myocardium occurs in 20-30% of SAH; stress cardiomyopathy",
            "target": "Often elevated (neurogenic — not ACS)"
          },
          {
            "item": "BNP or NT-proBNP",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Neurogenic cardiac dysfunction; volume status assessment",
            "target": "Elevated (neurogenic)"
          },
          {
            "item": "Blood glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Hyperglycemia worsens outcomes; stress response",
            "target": "140-180 mg/dL target"
          },
          {
            "item": "Magnesium",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Hypomagnesemia increases vasospasm risk; maintain high-normal",
            "target": ">2.0 mg/dL (replete aggressively)"
          },
          {
            "item": "Calcium (ionized)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Electrolyte management; nimodipine monitoring",
            "target": "Normal"
          },
          {
            "item": "Phosphorus",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Electrolyte management; refeeding risk",
            "target": "Normal"
          },
          {
            "item": "Lactate",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Perfusion status",
            "target": "<2 mmol/L"
          },
          {
            "item": "Pregnancy test (β-hCG)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Affects imaging, anesthesia, and treatment decisions",
            "target": "Document result"
          }
        ],
        "Extended Workup": [
          {
            "item": "Serum osmolality",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "Cerebral salt wasting vs SIADH differentiation; osmotherapy monitoring",
            "target": "280-295 mOsm/kg"
          },
          {
            "item": "Urine osmolality and sodium",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "CSW: high urine Na, high urine osm, hypovolemic. SIADH: high urine Na, high urine osm, euvolemic",
            "target": "Differentiate CSW vs SIADH"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Thyroid dysfunction screen",
            "target": "Normal"
          },
          {
            "item": "Cortisol (AM)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "Adrenal insufficiency (pituitary dysfunction from SAH)",
            "target": ">18 µg/dL"
          },
          {
            "item": "Lipid panel",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Cardiovascular risk assessment",
            "target": "Document"
          },
          {
            "item": "HbA1c",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes management",
            "target": "<7.0%"
          },
          {
            "item": "Blood cultures",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "If febrile (differentiate central fever vs infection)",
            "target": "No growth"
          },
          {
            "item": "Procalcitonin",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "rationale": "Differentiate neurogenic fever from infection",
            "target": "<0.5 (elevated suggests infection)"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Urine catecholamines/metanephrines",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Pheochromocytoma as cause of hypertensive hemorrhage",
            "target": "Normal"
          },
          {
            "item": "Toxicology (cocaine, amphetamines)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Sympathomimetic-associated SAH",
            "target": "Negative"
          },
          {
            "item": "Sickle cell screen",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Sickle cell associated aneurysms and SAH (young patients, African descent)",
            "target": "Normal"
          },
          {
            "item": "Connective tissue disorder workup (Ehlers-Danlos, Marfan)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Familial aneurysm syndromes; young SAH with marfanoid habitus or skin hyperextensibility",
            "target": "Clinical + genetic"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Elevated in SAH",
            "target": "Often elevated (>20 cm H2O)"
          },
          {
            "item": "Cell count (tubes 1 AND 4)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Distinguish SAH from traumatic tap: SAH = RBC count does NOT clear significantly between tube 1 and tube 4",
            "target": "RBC in tube 4 ≥ tube 1 (SAH); if tube 4 << tube 1 = traumatic tap"
          },
          {
            "item": "Xanthochromia (visual and/or spectrophotometry)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Yellow discoloration from RBC breakdown (bilirubin); develops >6h after SAH; spectrophotometry more sensitive than visual inspection",
            "target": "Present = SAH (sensitivity >95% at 12h-2 weeks post-bleed). Absent = unlikely SAH"
          },
          {
            "item": "Protein",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Elevated in SAH",
            "target": "Elevated"
          },
          {
            "item": "Glucose",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Usually normal in SAH",
            "target": "Normal"
          },
          {
            "item": "Gram stain and culture",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "Exclude meningitis (meningeal signs overlap)",
            "target": "No organisms"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "IMMEDIATE (door-to-CT <25 min). Sensitivity: 98-100% within 6h; ~93% at 12h; ~85% at 24h; declines after 3-5 days",
            "target": "Hyperdense blood in basal cisterns, Sylvian fissure, interhemispheric fissure; modified Fisher grade; hydrocephalus; intraventricular hemorrhage",
            "contraindications": "None significant"
          },
          {
            "item": "CT angiography (CTA) head",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Simultaneously with non-contrast CT. Identifies aneurysm (sensitivity 95-100% for aneurysms >3mm)",
            "target": "Aneurysm location, size, morphology; multiple aneurysms (15-20% have >1); vasospasm (delayed)",
            "contraindications": "Contrast allergy (premedicate); renal impairment (benefit outweighs risk)"
          },
          {
            "item": "ECG (12-lead)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Immediately",
            "target": "Deep T-wave inversions (\"cerebral T waves\"), ST changes, QT prolongation, arrhythmias — all may be neurogenic; do NOT misdiagnose as primary cardiac event",
            "contraindications": "None"
          }
        ],
        "Extended": [
          {
            "item": "Conventional cerebral angiography (DSA)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Within 24h — GOLD STANDARD for aneurysm identification; also therapeutic (coiling). If CTA negative but clinical suspicion high, DSA is mandatory",
            "target": "Aneurysm (location, neck width, dome-to-neck ratio, relationship to branches); may find aneurysm missed by CTA; vasospasm assessment",
            "contraindications": "Contrast allergy; renal impairment; coagulopathy (relative)"
          },
          {
            "item": "Repeat DSA (if initial negative)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "timing": "At 7-14 days if initial DSA negative and non-perimesencephalic pattern; small aneurysm may be thrombosed or compressed by hematoma",
            "target": "Previously missed aneurysm",
            "contraindications": "Same as initial"
          },
          {
            "item": "MRI/MRA brain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "When stable; helpful for subacute diagnosis or if CT negative but suspicion persists",
            "target": "Blood products (FLAIR); aneurysm (MRA); ischemia from vasospasm (DWI)",
            "contraindications": "Pacemaker; hemodynamic instability"
          },
          {
            "item": "Transcranial Doppler (TCD)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Begin daily on post-bleed day 3; continue through day 14 (vasospasm window)",
            "target": "Mean flow velocities: MCA >120 cm/s concerning; >200 cm/s severe vasospasm. Lindegaard ratio >3 suggests vasospasm (>6 = severe)",
            "contraindications": "Absent temporal bone window (~10%)"
          },
          {
            "item": "CT perfusion (CTP)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "If vasospasm suspected clinically (new deficit days 4-14)",
            "target": "Perfusion deficits in vascular territory of spastic vessel; mismatch (reversible ischemia)",
            "contraindications": "Contrast allergy; renal impairment"
          },
          {
            "item": "CTA (repeat for vasospasm)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "If clinical vasospasm suspected",
            "target": "Arterial narrowing; correlate with TCD and clinical exam",
            "contraindications": "Same as initial CTA"
          },
          {
            "item": "Echocardiogram (TTE)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "timing": "Within 24-48h",
            "target": "Takotsubo (apical ballooning); regional wall motion abnormalities; EF assessment — neurogenic stunned myocardium in 20-30%",
            "contraindications": "None significant"
          },
          {
            "item": "Continuous EEG (cEEG)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "If altered consciousness; delayed deterioration; suspected seizures",
            "target": "Non-convulsive seizures; electrographic vasospasm correlate; periodic discharges",
            "contraindications": "None"
          },
          {
            "item": "Chest X-ray",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "On admission; daily in ICU",
            "target": "Neurogenic pulmonary edema; aspiration; ARDS",
            "contraindications": "None"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "3D rotational angiography",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "During DSA for complex aneurysm anatomy",
            "target": "Detailed aneurysm morphology for treatment planning",
            "contraindications": "Same as DSA"
          },
          {
            "item": "Xenon CT or CT perfusion (quantitative)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "timing": "Research/advanced vasospasm assessment",
            "target": "Quantitative cerebral blood flow mapping",
            "contraindications": "Limited availability"
          },
          {
            "item": "MRA screening (unruptured aneurysm in family members)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Elective — for first-degree relatives of SAH patients (2 or more affected family members)",
            "target": "Incidental unruptured aneurysm",
            "contraindications": "Standard MRI contraindications"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Blood pressure control: Nicardipine IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg/h",
                  "orderSentence": "Blood pressure control: Nicardipine IV 5 mg/h IV"
                }
              ],
              "route": "IV",
              "instructions": "5 mg/h IV; titrate by 2.5 mg/h q5-15min; max 15 mg/h. Target SBP <160 mmHg UNTIL aneurysm is secured (re-bleed risk highest in first 24h with uncontrolled HTN); after securing: target SBP <180 (or higher if vasospasm)",
              "orderSentence": "Blood pressure control: Nicardipine IV 5 mg/h IV"
            },
            "contraindications": "Severe aortic stenosis",
            "monitoring": "Continuous arterial BP; neuro checks q1h",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Blood pressure control: Labetalol IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-20 mg",
                  "orderSentence": "Blood pressure control: Labetalol IV 10-20 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10-20 mg IV q10-20min; max 300 mg. Alternative to nicardipine",
              "orderSentence": "Blood pressure control: Labetalol IV 10-20 mg IV"
            },
            "contraindications": "Heart block; severe bradycardia; asthma",
            "monitoring": "HR; BP continuous",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Blood pressure control: Clevidipine IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2 mg/h",
                  "orderSentence": "Blood pressure control: Clevidipine IV 1-2 mg/h IV"
                }
              ],
              "route": "IV",
              "instructions": "1-2 mg/h IV; max 32 mg/h",
              "orderSentence": "Blood pressure control: Clevidipine IV 1-2 mg/h IV"
            },
            "contraindications": "Soy/egg allergy",
            "monitoring": "BP continuous",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Nimodipine (CORNERSTONE of vasospasm prevention)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg",
                  "orderSentence": "Nimodipine (CORNERSTONE of vasospasm prevention) 60 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "60 mg PO/NG q4h x 21 days. START within 96h of SAH onset. If hypotension: 30 mg q2h. This is an ORAL calcium channel blocker — do NOT give IV (severe hypotension). Proven to reduce poor outcomes from vasospasm",
              "orderSentence": "Nimodipine (CORNERSTONE of vasospasm prevention) 60 mg IV"
            },
            "contraindications": "Hypotension (SBP <90 — reduce dose); do NOT crush extended-release formulations; use oral syringe if NG",
            "monitoring": "BP with each dose; do NOT give IV; ensure enteral route only",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "External ventricular drain (EVD)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "For acute hydrocephalus (GCS declining; CT showing ventriculomegaly); allows ICP monitoring and CSF drainage. Set drain height per neurosurgery (typically 15-20 cm above tragus)",
              "orderSentence": "External ventricular drain (EVD) - - - see dosing"
            },
            "contraindications": "Coagulopathy (correct first)",
            "monitoring": "ICP continuous; CSF output q1h; drain position; infection surveillance (CSF culture q3 days per some protocols)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Seizure prophylaxis (short-term)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Seizure prophylaxis (short-term) 1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Levetiracetam 1000 mg IV/PO load, then 500-1000 mg BID. AHA 2012: short-term (3-7 days) prophylaxis is reasonable. Avoid phenytoin (associated with worse cognitive outcomes in SAH — Naidech et al.)",
              "orderSentence": "Seizure prophylaxis (short-term) 1000 mg IV"
            },
            "contraindications": "Renal impairment (dose adjust)",
            "monitoring": "Seizure monitoring",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Intubation / Airway protection",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "GCS ≤8; inability to protect airway; respiratory failure; impending herniation",
              "orderSentence": "Intubation / Airway protection - - - see dosing"
            },
            "contraindications": "N/A",
            "monitoring": "Avoid hypotension during RSI; maintain SBP goal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Aminocaproic acid (antifibrinolytic)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4g",
                  "orderSentence": "Aminocaproic acid (antifibrinolytic) 4g IV"
                }
              ],
              "route": "IV",
              "instructions": "4g IV load then 1g/h IV infusion. ONLY use for short-term (<72h) if aneurysm securing will be delayed. Reduces re-bleeding risk but increases thrombotic risk. Discontinue once aneurysm is secured",
              "orderSentence": "Aminocaproic acid (antifibrinolytic) 4g IV"
            },
            "contraindications": "Active DIC; DVT/PE; renal impairment",
            "monitoring": "Coagulation; thrombotic events; discontinue when aneurysm treated",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "IV isotonic fluids (euvolemia)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-1.5 mL/kg",
                  "orderSentence": "IV isotonic fluids (euvolemia) 1-1.5 mL/kg -"
                }
              ],
              "route": "-",
              "instructions": "NS at 1-1.5 mL/kg/h (80-125 mL/h); goal euvolemia. Avoid hypovolemia (worsens vasospasm) and avoid aggressive hypervolemia (no proven benefit; risk of pulmonary edema). Target CVP 5-8 or clinical euvolemia",
              "orderSentence": "IV isotonic fluids (euvolemia) 1-1.5 mL/kg -"
            },
            "contraindications": "Volume overload; CHF",
            "monitoring": "I/O; daily weights; CVP if central line; serum Na q6-8h",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Stress ulcer prophylaxis: Pantoprazole",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Stress ulcer prophylaxis: Pantoprazole 40 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "40 mg IV/PO daily",
              "orderSentence": "Stress ulcer prophylaxis: Pantoprazole 40 mg IV"
            },
            "contraindications": "C. diff risk",
            "monitoring": "GI symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "DVT prophylaxis: Pneumatic compression devices",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Apply bilaterally on admission; SAH patients are HIGH VTE risk",
              "orderSentence": "DVT prophylaxis: Pneumatic compression devices - - - see dosing"
            },
            "contraindications": "Acute DVT",
            "monitoring": "Skin checks",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "DVT prophylaxis: Heparin SC (after aneurysm secured)",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5000 units",
                  "orderSentence": "DVT prophylaxis: Heparin SC (after aneurysm secured) 5000 units SC"
                }
              ],
              "route": "SC",
              "instructions": "5000 units SC q8h; start 24h after aneurysm is secured (clipping or coiling); some centers start earlier",
              "orderSentence": "DVT prophylaxis: Heparin SC (after aneurysm secured) 5000 units SC"
            },
            "contraindications": "Active bleeding; within 24h of craniotomy (per surgeon)",
            "monitoring": "Platelets q3 days",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          }
        ],
        "Aneurysm Securing (Definitive Treatment)": [
          {
            "item": "Endovascular coiling",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Interventional neuroradiology; catheter-based platinum coil deployment into aneurysm sac. Preferred per ISAT trial for posterior circulation and many anterior circulation aneurysms",
              "orderSentence": "Endovascular coiling - - - see dosing"
            },
            "contraindications": "Difficult vascular access; very wide neck without stent option",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Surgical clipping (craniotomy)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Neurosurgical; microsurgical clip placement across aneurysm neck",
              "orderSentence": "Surgical clipping (craniotomy) - - - see dosing"
            },
            "contraindications": "Poor grade with brain swelling (relative — may clip if accessible); medically unstable",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Flow diverter (Pipeline, FRED)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "For large/giant or wide-necked aneurysms not amenable to standard coiling",
              "orderSentence": "Flow diverter (Pipeline, FRED) - - - see dosing"
            },
            "contraindications": "Requires dual antiplatelet therapy (may not be ideal in acute SAH)",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Vasospasm Treatment (Post-Bleed Days 4-14)": [
          {
            "item": "Nimodipine (continued)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg",
                  "orderSentence": "Nimodipine (continued) 60 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Continue 60 mg PO q4h x 21 days total",
              "orderSentence": "Nimodipine (continued) 60 mg PO"
            },
            "contraindications": "Hypotension",
            "monitoring": "BP with each dose",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Induced hypertension",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "If clinical vasospasm (new deficit days 4-14, aneurysm MUST be secured first): raise SBP to 180-220 mmHg using vasopressors. Phenylephrine 0.5-5 µg/kg/min or norepinephrine 0.05-0.3 µg/kg/min IV",
              "orderSentence": "Induced hypertension - IV - see dosing"
            },
            "contraindications": "Unsecured aneurysm (NEVER induce hypertension before securing); cardiac failure; pulmonary edema",
            "monitoring": "Arterial line; neuro checks q1h; TCD; CT perfusion",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "IV fluid bolus (euvolemia maintenance)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500-1000 mL",
                  "orderSentence": "IV fluid bolus (euvolemia maintenance) 500-1000 mL -"
                }
              ],
              "route": "-",
              "instructions": "NS bolus 500-1000 mL if hypovolemic; maintain euvolemia. Avoid prophylactic hypervolemia (no benefit per current evidence — Robertson et al.)",
              "orderSentence": "IV fluid bolus (euvolemia maintenance) 500-1000 mL -"
            },
            "contraindications": "Volume overload",
            "monitoring": "CVP; I/O; daily weights",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Milrinone IV (alternative vasospasm treatment)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "0.25-0.75 µg/kg/min IV continuous; some centers use as rescue for vasospasm not responding to induced hypertension; acts as cerebral vasodilator",
              "orderSentence": "Milrinone IV (alternative vasospasm treatment) - IV - see dosing"
            },
            "contraindications": "Severe hypotension; arrhythmia",
            "monitoring": "BP (may cause hypotension); HR; cardiac output",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Intra-arterial vasodilator therapy (endovascular rescue)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-10 mg",
                  "orderSentence": "Intra-arterial vasodilator therapy (endovascular rescue) 5-10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Verapamil 5-10 mg intra-arterial or nicardipine 5-10 mg intra-arterial; via catheter into spastic vessel during angiography. For medically refractory vasospasm",
              "orderSentence": "Intra-arterial vasodilator therapy (endovascular rescue) 5-10 mg PO"
            },
            "contraindications": "Hemodynamic instability during procedure",
            "monitoring": "Angiographic improvement; clinical response; BP",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Angioplasty (balloon)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Mechanical dilation of spastic proximal vessels during angiography. For focal proximal vasospasm refractory to medical treatment",
              "orderSentence": "Angioplasty (balloon) - - - see dosing"
            },
            "contraindications": "Vessel rupture risk; distal vasospasm (not amenable to balloon)",
            "monitoring": "Angiographic result; clinical response",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Magnesium sulfate (supplemental)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.0 mg",
                  "orderSentence": "Magnesium sulfate (supplemental) 2.0 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Target serum Mg >2.0 mg/dL; replete with MgSO4 2-4 g IV over 1-2h PRN. MASH-2 trial: IV magnesium infusion did NOT improve outcomes, but maintaining normal-high Mg is standard",
              "orderSentence": "Magnesium sulfate (supplemental) 2.0 mg IV"
            },
            "contraindications": "Renal failure; hypermagnesemia",
            "monitoring": "Serum Mg q12-24h; deep tendon reflexes",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          }
        ],
        "Complications Management": [
          {
            "item": "Hyponatremia management: Differentiate CSW vs SIADH",
            "route": "PO",
            "indication": "Na <135: CSW = volume depleted (treat with NS/hypertonic saline + fludrocortisone). SIADH = euvolemic (treat with fluid restriction ± hypertonic saline)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1-0.2 mg",
                  "orderSentence": "Hyponatremia management: Differentiate CSW vs SIADH 0.1-0.2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "CSW: NS or 3% saline; fludrocortisone 0.1-0.2 mg PO BID. SIADH: fluid restriction 1-1.2 L/day; 3% saline if <120",
              "orderSentence": "Hyponatremia management: Differentiate CSW vs SIADH 0.1-0.2 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "Na q6h during correction; avoid >8-10 mEq/L rise in 24h (central pontine myelinolysis risk)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Fludrocortisone",
            "route": "PO",
            "indication": "Cerebral salt wasting (volume depletion + hyponatremia)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1-0.2 mg",
                  "orderSentence": "Fludrocortisone 0.1-0.2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.1-0.2 mg PO BID",
              "orderSentence": "Fludrocortisone 0.1-0.2 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "Na; K+ (hypokalemia); volume status; BP",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Hydrocortisone",
            "route": "IV",
            "indication": "Refractory hyponatremia; cerebral salt wasting; adrenal insufficiency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50-100 mg",
                  "orderSentence": "Hydrocortisone 50-100 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "50-100 mg IV q8h",
              "orderSentence": "Hydrocortisone 50-100 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "Na; glucose; cortisol",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Ventriculoperitoneal shunt (VPS)",
            "route": "-",
            "indication": "Chronic hydrocephalus (EVD-dependent; unable to wean)",
            "dosing": {
              "instructions": "Neurosurgical procedure",
              "orderSentence": "Ventriculoperitoneal shunt (VPS) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "Shunt function; neurologic status",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Lumbar drain",
            "route": "-",
            "indication": "CSF diversion after EVD if transitioning; mild chronic hydrocephalus",
            "dosing": {
              "instructions": "Neurosurgical placement",
              "orderSentence": "Lumbar drain - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "CSF output; ICP; position",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurosurgery",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "ALL SAH patients; EVD placement; surgical clipping decision; hydrocephalus management"
          },
          {
            "item": "Interventional neuroradiology / Neuroendovascular",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "Endovascular coiling; intra-arterial vasospasm treatment; angioplasty"
          },
          {
            "item": "Neurocritical care / Neurointensivist",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "indication": "ICU management; vasospasm monitoring; medical optimization"
          },
          {
            "item": "Cardiology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "indication": "Neurogenic stunned myocardium; Takotsubo; arrhythmia management"
          },
          {
            "item": "Pulmonology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "indication": "Neurogenic pulmonary edema; ARDS; ventilator management"
          },
          {
            "item": "Endocrinology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Pituitary dysfunction post-SAH (growth hormone, cortisol, thyroid); diabetes insipidus"
          },
          {
            "item": "Speech-language pathology (SLP)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Dysphagia evaluation; cognitive-linguistic assessment"
          },
          {
            "item": "Physical therapy (PT)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Early mobilization when stable; fall prevention; strength"
          },
          {
            "item": "Occupational therapy (OT)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "ADL assessment; cognitive rehabilitation"
          },
          {
            "item": "Rehabilitation medicine (physiatry)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Rehabilitation planning; disposition"
          },
          {
            "item": "Social work",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Family support; advance directives; discharge planning"
          },
          {
            "item": "Palliative care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "indication": "Poor-grade SAH (Hunt-Hess IV-V); goals of care"
          },
          {
            "item": "Genetics / Genetic counseling",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Familial aneurysm screening; connective tissue disorders"
          }
        ],
        "Patient Instructions": [
          {
            "item": "SAH is life-threatening; treatment is time-sensitive",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Call 911 immediately if: sudden severe headache (\"worst headache of life\"), loss of consciousness, seizure, new weakness, vision changes",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Blood pressure control is critical long-term — take all prescribed medications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation is essential (smoking is the strongest modifiable risk factor for aneurysm formation and rupture)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do NOT drive until cleared by neurology/neurosurgery",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid heavy lifting, straining, and Valsalva maneuvers for 4-6 weeks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Follow-up imaging (CTA or MRA) at 6 months, then annually for several years to assess treated aneurysm and screen for new aneurysm",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "First-degree relatives should discuss aneurysm screening with their physician if ≥2 family members have had SAH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cognitive difficulties (memory, attention, fatigue) are common after SAH — neuropsychological evaluation and rehabilitation are available",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Depression and anxiety are common; seek support early",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Smoking cessation (ABSOLUTE — strongest modifiable risk factor)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Blood pressure control (<130/80 mmHg)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Alcohol moderation/cessation (heavy drinking increases SAH risk)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cocaine/stimulant cessation (vasospasm and SAH risk)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid excessive straining (constipation management; stool softeners)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular moderate exercise after recovery and medical clearance",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate hydration",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Thunderclap headache — reversible cerebral vasoconstriction syndrome (RCVS)",
        "features": "Recurrent thunderclap headaches over days-weeks; triggered by exertion, Valsalva, sexual activity; vasospasm on CTA; may have convexity SAH; no aneurysm",
        "tests": "CTA (multifocal segmental narrowing); MRI (may show edema, infarct, cortical SAH); DSA; clinical course (resolves in weeks)"
      },
      {
        "diagnosis": "Primary intracerebral hemorrhage",
        "features": "Parenchymal hematoma with minimal/no subarachnoid blood; hypertensive location (basal ganglia, thalamus)",
        "tests": "CT (parenchymal not cisternal); CTA (no aneurysm unless hemorrhage extends into subarachnoid space)"
      },
      {
        "diagnosis": "Bacterial meningitis",
        "features": "Fever, meningismus, altered mental status, CSF neutrophilic pleocytosis with low glucose",
        "tests": "LP (gram stain, culture, BioFire); procalcitonin elevated; CT without blood"
      },
      {
        "diagnosis": "Migraine (severe)",
        "features": "Prior migraine history; gradual onset of associated features; photophobia, phonophobia; no blood on CT",
        "tests": "Normal CT; normal LP; clinical history"
      },
      {
        "diagnosis": "Hypertensive emergency",
        "features": "Severely elevated BP; headache; but no blood on CT; may have PRES features",
        "tests": "CT (no blood); MRI (PRES: posterior white matter edema)"
      },
      {
        "diagnosis": "Cervical artery dissection",
        "features": "Neck pain, headache, Horner syndrome, stroke; may have traumatic SAH from vertebral dissection",
        "tests": "CTA neck (intimal flap, pseudoaneurysm); MRI neck (crescent sign)"
      },
      {
        "diagnosis": "Cerebral venous thrombosis (CVT)",
        "features": "Headache, seizures; may have hemorrhagic venous infarct or cortical SAH; risk factors (OCPs, pregnancy)",
        "tests": "MRV/CT venogram (thrombosed sinus)"
      },
      {
        "diagnosis": "Pituitary apoplexy",
        "features": "Sudden headache, visual field defect, ophthalmoplegia; known pituitary adenoma; may have subarachnoid blood from pituitary hemorrhage",
        "tests": "MRI sella (hemorrhagic pituitary mass); hormone panel"
      },
      {
        "diagnosis": "Perimesencephalic SAH (non-aneurysmal)",
        "features": "Blood confined to perimesencephalic cisterns (anterior to brainstem); benign course; CTA/DSA negative for aneurysm",
        "tests": "CT pattern (perimesencephalic); negative CTA and DSA; excellent prognosis"
      },
      {
        "diagnosis": "Traumatic SAH",
        "features": "History of trauma; may have other traumatic injuries (contusion, subdural, skull fracture)",
        "tests": "Clinical history; CT pattern"
      },
      {
        "diagnosis": "Spinal SAH",
        "features": "Sudden back/leg pain with meningismus; blood on lumbar CT or MRI; rare",
        "tests": "Spinal MRI; spinal angiography"
      }
    ],
    "evidence": [
      {
        "recommendation": "Nimodipine 60 mg PO q4h x 21 days",
        "evidenceLevel": "Class I, Level A",
        "source": "[Pickard et al. (BMJ 1989)](https://pubmed.ncbi.nlm.nih.gov/2496789/); only proven agent to improve outcomes in SAH vasospasm"
      },
      {
        "recommendation": "Early aneurysm securing (<24h, ideally <12h)",
        "evidenceLevel": "Class I, Level B",
        "source": "ISAT; AHA/ASA 2012 SAH Guidelines; [de Gans et al. (Neurosurgery 2002)](https://pubmed.ncbi.nlm.nih.gov/11844269/)"
      },
      {
        "recommendation": "Endovascular coiling preferred over clipping for most aneurysms",
        "evidenceLevel": "Class I, Level A",
        "source": "ISAT trial ([Molyneux et al. Lancet 2002](https://pubmed.ncbi.nlm.nih.gov/12414200/)); long-term follow-up"
      },
      {
        "recommendation": "SBP <160 until aneurysm secured",
        "evidenceLevel": "Class I, Level B",
        "source": "AHA/ASA 2012 SAH Guidelines"
      },
      {
        "recommendation": "Euvolemia (avoid hypovolemia; avoid prophylactic hypervolemia)",
        "evidenceLevel": "Class I, Level B",
        "source": "[Lennihan et al. (Stroke 2000)](https://pubmed.ncbi.nlm.nih.gov/10657410/); HIMALAIA trial"
      },
      {
        "recommendation": "Induced hypertension for clinical vasospasm (after aneurysm secured)",
        "evidenceLevel": "Class IIa, Level B",
        "source": "AHA/ASA Guidelines; standard practice"
      },
      {
        "recommendation": "TCD daily for vasospasm monitoring",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[Sloan et al. (2004)](https://pubmed.ncbi.nlm.nih.gov/15136667/); AHA/ASA Guidelines"
      },
      {
        "recommendation": "Short-term seizure prophylaxis (3-7 days) reasonable",
        "evidenceLevel": "Class IIb, Level B",
        "source": "AHA/ASA 2012"
      },
      {
        "recommendation": "Avoid phenytoin in SAH (worse cognitive outcomes)",
        "evidenceLevel": "Class III (Harm)",
        "source": "[Naidech et al. (Stroke 2005)](https://pubmed.ncbi.nlm.nih.gov/15662039/)"
      },
      {
        "recommendation": "CT sensitivity ~100% within 6h",
        "evidenceLevel": "Class I, Level A",
        "source": "[Perry et al. (BMJ 2011)](https://pubmed.ncbi.nlm.nih.gov/21768192/); [Backes et al. (Stroke 2012)](https://pubmed.ncbi.nlm.nih.gov/22821609/)"
      },
      {
        "recommendation": "LP if CT negative but clinical suspicion",
        "evidenceLevel": "Class I, Level B",
        "source": "AHA/ASA Guidelines; standard of care"
      },
      {
        "recommendation": "Aminocaproic acid (short-term) if aneurysm securing delayed",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[Hillman et al. (J Neurosurg 2002)](https://pubmed.ncbi.nlm.nih.gov/12405362/); AHA/ASA 2012"
      },
      {
        "recommendation": "Magnesium infusion does NOT improve outcomes",
        "evidenceLevel": "Class III (No Benefit)",
        "source": "MASH-2 trial ([Dorhout Mees et al. Lancet 2012](https://pubmed.ncbi.nlm.nih.gov/22633825/))"
      },
      {
        "recommendation": "Fludrocortisone for cerebral salt wasting",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[Hasan et al. (Stroke 1989)](https://pubmed.ncbi.nlm.nih.gov/2672426/)"
      },
      {
        "recommendation": "Intra-arterial vasodilator / balloon angioplasty for refractory vasospasm",
        "evidenceLevel": "Class IIa, Level B",
        "source": "Multiple case series; AHA/ASA Guidelines"
      },
      {
        "recommendation": "Avoid self-fulfilling prophecy in poor-grade SAH",
        "evidenceLevel": "Class I, Level C",
        "source": "AHA/ASA 2012: aggressive treatment for at least 72h in poor-grade"
      }
    ],
    "monitoring": [
      {
        "item": "Blood pressure (arterial line)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "Continuous via arterial line in ICU. Pre-securing: target SBP <160. Post-securing: allow SBP 120-180 (higher if vasospasm treatment)",
        "action": "Titrate antihypertensives; vasopressors for vasospasm"
      },
      {
        "item": "GCS / Neurologic exam",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "q1h x 24h; then q2h x 48h; then q4h. Hunt-Hess grade at admission",
        "action": "If declining: STAT CT (rebleed, hydrocephalus, infarct); TCD; adjust treatment"
      },
      {
        "item": "ICP (if EVD in place)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "Continuous; record q1h",
        "action": "Tiered ICP management; CSF drainage; osmotherapy"
      },
      {
        "item": "Transcranial Doppler (TCD)",
        "ED": "-",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "Daily from day 3 through day 14 (vasospasm window); some continue to day 21",
        "action": "If MCA >120: CTA/CTP; clinical correlation. If >200: severe vasospasm — consider induced hypertension +/- endovascular rescue"
      },
      {
        "item": "Serum sodium",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q6h x 72h; then q8-12h",
        "action": "If <135: differentiate CSW vs SIADH; treat accordingly. If <120: 3% saline; limit correction <10 mEq/24h"
      },
      {
        "item": "Serum magnesium",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "Daily; q12h if repleting",
        "action": "Replete with MgSO4 2-4 g IV"
      },
      {
        "item": "Temperature",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q4h (q1h if febrile)",
        "action": "Central fever (common): cooling; acetaminophen. If >38.3°C: infection workup (cultures, CXR, UA)"
      },
      {
        "item": "Blood glucose",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q6h (q1h if insulin drip)",
        "action": "Insulin; avoid <60"
      },
      {
        "item": "Troponin / BNP",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "ROUTINE",
        "frequency": "Troponin daily x 3; BNP at admission and PRN",
        "action": "If rising with new ECG changes or hemodynamic instability: echo; cardiology"
      },
      {
        "item": "Hemoglobin",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "ROUTINE",
        "frequency": "Daily",
        "action": "Transfuse PRBCs"
      },
      {
        "item": "Fluid balance (I/O)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "q1h in ICU; q4h shift on floor",
        "action": "Avoid dehydration (vasospasm risk); avoid overhydration (pulmonary edema)"
      },
      {
        "item": "Repeat CT head",
        "ED": "-",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT",
        "frequency": "At 24h post-admission; with any neurologic change; post-procedure; if new hydrocephalus suspected",
        "action": "Adjust EVD; surgery; vasospasm treatment"
      },
      {
        "item": "Hunt-Hess / WFNS grade",
        "ED": "STAT",
        "HOSP": "-",
        "OPD": "-",
        "ICU": "-",
        "frequency": "At admission (prognostic)",
        "action": "Goals of care if poor grade"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Never discharge from ED with confirmed SAH. Discharge from hospital when: aneurysm secured; past vasospasm window (day 14-21); stable neurologic exam; Na stable; able to take oral nimodipine; no EVD dependency; adequate follow-up"
      },
      {
        "disposition": "Admit to Neuro-ICU",
        "criteria": "ALL confirmed aneurysmal SAH patients; minimum 14-21 days ICU-level monitoring during vasospasm window. Transfer to step-down only after vasospasm window passed"
      },
      {
        "disposition": "Transfer to comprehensive stroke center / Neurovascular center",
        "criteria": "If no neurosurgery or interventional neuroradiology on-site — TRANSFER IMMEDIATELY. SAH requires tertiary neurovascular services"
      },
      {
        "disposition": "Inpatient rehabilitation",
        "criteria": "Significant deficits but medically stable; past vasospasm window; able to participate in 3h/day therapy"
      },
      {
        "disposition": "Skilled nursing facility",
        "criteria": "Cannot tolerate intensive rehab; requires ongoing skilled care"
      },
      {
        "disposition": "Hospice / Comfort care",
        "criteria": "Devastating SAH (Hunt-Hess V with poor prognostic factors); after appropriate observation period and family discussion"
      }
    ]
  },
  "Elevated Intracranial Pressure Management": {
    "id": "elevated-icp-management",
    "title": "Elevated Intracranial Pressure Management",
    "version": "1.0",
    "icd10": [
      "** G93.2 (Benign intracranial hypertension [IIH])",
      "G93.5 (Compression of brain)",
      "G93.6 (Cerebral edema)",
      "G91.1 (Obstructive hydrocephalus)",
      "G91.2 (Normal pressure hydrocephalus)",
      "S06.1X (Traumatic cerebral edema)"
    ],
    "scope": "** Emergency evaluation and management of elevated intracranial pressure in adults. Covers recognition of elevated ICP (Cushing triad, papilledema, declining GCS), emergent interventions (osmotherapy, hyperventilation, sedation, CSF drainage), ICP monitoring indications, surgical decompression, and specific etiology-based management. Includes management across etiologies: traumatic brain injury, stroke (ischemic/hemorrhagic), tumor, infection, hydrocephalus, and idiopathic intracranial hypertension. Excludes pediatric ICP management (different thresholds/approaches).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Infection workup; anemia (reduced O2 carrying capacity); thrombocytopenia (bleeding risk); baseline",
            "target": "Normal; leukocytosis → infection; thrombocytopenia → hemorrhage risk"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Electrolytes (sodium critical for osmotherapy); renal function (contrast, mannitol); glucose; hepatic function",
            "target": "Normal; track sodium closely (goal varies by treatment); avoid hyponatremia"
          },
          {
            "item": "Blood glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hyperglycemia worsens outcomes in brain injury; hypoglycemia mimics neurologic deterioration",
            "target": "140-180 mg/dL target in critically ill; <180 in general"
          },
          {
            "item": "PT/INR, aPTT",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Coagulopathy (hemorrhagic causes); ICP monitor placement safety; surgical candidacy",
            "target": "Normal; INR <1.4 for ICP monitor placement"
          },
          {
            "item": "Serum osmolality",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "**CRITICAL for osmotherapy monitoring**; baseline before mannitol/hypertonic saline; target for therapy",
            "target": "280-295 mOsm/kg baseline; therapeutic target 300-320 (do not exceed 320)"
          },
          {
            "item": "Sodium",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "**CRITICAL**; hypertonic saline therapy monitoring; cerebral salt wasting vs. SIADH; target for ICP management",
            "target": "135-145 mEq/L baseline; therapeutic hypernatremia target 145-155 mEq/L (with hypertonic saline)"
          },
          {
            "item": "Arterial blood gas (ABG)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Ventilation status (PaCO2 critical for ICP); oxygenation; pH; metabolic status",
            "target": "PaCO2 35-40 mmHg (normal); pH 7.35-7.45; PaO2 >80; for hyperventilation: target PaCO2 30-35"
          },
          {
            "item": "Lactate",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Tissue perfusion; systemic sepsis; prognostic",
            "target": "<2 mmol/L; elevated → hypoperfusion, sepsis"
          },
          {
            "item": "Type and screen",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Surgical candidacy; potential for decompressive craniectomy or other neurosurgical intervention",
            "target": "On file"
          },
          {
            "item": "Troponin",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Neurogenic cardiac injury (stress cardiomyopathy); particularly in SAH, TBI, ICH",
            "target": "Normal; elevated → neurogenic stress cardiomyopathy; obtain echo"
          }
        ],
        "Extended Workup": [
          {
            "item": "Serum osmolality (serial)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "**q4-6h during osmotherapy**; osmolar gap calculation; prevent hyper-osmolar state",
            "target": "Maintain <320 mOsm/kg; osmolar gap >10-15 → accumulating mannitol"
          },
          {
            "item": "Sodium (serial)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "**q2-6h during active ICP management**; hypertonic saline monitoring; avoid rapid correction",
            "target": "Target 145-155 mEq/L during active ICP crisis; avoid fluctuations >10 mEq/24h"
          },
          {
            "item": "Cortisol (AM, random)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "rationale": "Adrenal insufficiency (pituitary injury in TBI, tumor); steroid responsiveness in tumor edema",
            "target": ">10 mcg/dL (AM); if low → cortisol stimulation test or empiric steroids"
          },
          {
            "item": "TSH, free T4",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Pituitary injury (TBI, tumor, surgery); hypothyroidism",
            "target": "Normal"
          },
          {
            "item": "Ammonia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Hepatic encephalopathy differential; can cause cerebral edema and elevated ICP",
            "target": "<35 μmol/L; elevated → hepatic cause; lactulose, rifaximin"
          },
          {
            "item": "Toxicology screen",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Intoxication as cause of altered mental status; drug-induced cerebral edema (rare)",
            "target": "Negative; specific toxin identification"
          },
          {
            "item": "CSF analysis (if LP/EVD performed)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Infection (meningitis); malignancy (leptomeningeal disease); subarachnoid hemorrhage (xanthochromia); IIH (elevated OP with normal composition)",
            "target": "Normal CSF composition with elevated opening pressure → IIH; abnormal composition → specific diagnosis"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CSF opening pressure (LP)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "**IIH diagnosis**: OP >25 cm H2O (obese patients >28 cm); therapeutic in IIH; NOT indicated if mass lesion or obstructive hydrocephalus",
            "target": "IIH: OP >25 cm H2O with normal composition; if OP >40-50 → severe"
          },
          {
            "item": "Pentobarbital level",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "If barbiturate coma induced for refractory ICP; therapeutic monitoring; guide dosing; monitor for toxicity",
            "target": "Therapeutic: 30-50 mcg/mL (for burst suppression); higher may be needed"
          },
          {
            "item": "EEG (continuous)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Monitor for burst suppression during barbiturate coma; detect subclinical seizures (common in brain injury); guide sedation titration",
            "target": "Target: burst suppression pattern during barbiturate coma; no seizures"
          },
          {
            "item": "Jugular venous oxygen saturation (SjvO2)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT",
            "rationale": "Advanced cerebral metabolism monitoring; guide CPP management; detect ischemia or hyperemia",
            "target": "55-75%; <55% = ischemia (increase CPP or reduce CMRO2); >75% = hyperemia"
          },
          {
            "item": "Brain tissue oxygen (PbtO2)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT",
            "rationale": "Direct brain oxygenation monitoring; guide therapy in severe TBI; multimodal monitoring",
            "target": ">20 mmHg; <15 mmHg = brain hypoxia → intervene"
          },
          {
            "item": "Cerebral microdialysis",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT",
            "rationale": "Research/specialized centers; metabolic monitoring; lactate:pyruvate ratio; glucose; glutamate",
            "target": "Lactate:pyruvate ratio <40 (normal); elevated = metabolic crisis"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "LP with opening pressure",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "**IIH diagnosis and treatment**: measure opening pressure → therapeutic CSF removal; **CONTRAINDICATED if mass lesion, obstructive hydrocephalus, or herniation risk**; imaging FIRST",
            "target": "Opening pressure: normal <20 cm H2O (obese <25); IIH: >25 cm H2O with normal CSF composition; high-volume tap (20-30 mL) for symptomatic relief in IIH",
            "contraindications": "**ABSOLUTE CONTRAINDICATION**: Mass lesion with mass effect; obstructive hydrocephalus; impending herniation; posterior fossa mass; midline shift; anticoagulation/coagulopathy; skin infection at LP site"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "**Immediate** — within minutes of suspected elevated ICP; before any intervention; determines etiology and guides treatment",
            "target": "Mass lesion (tumor, hematoma); midline shift (>5mm = significant); hydrocephalus; cerebral edema (effaced sulci, compressed ventricles); herniation signs (uncal, tonsillar); cisternal effacement",
            "contraindications": "None for non-contrast CT; benefit always outweighs risk in emergency"
          },
          {
            "item": "CT angiography (CTA) head",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "If vascular etiology suspected (SAH, venous sinus thrombosis, AVM); concurrent with non-contrast CT",
            "target": "Aneurysm (SAH); venous sinus thrombosis (filling defect in dural sinuses); AVM; dissection",
            "contraindications": "Contrast allergy (premedicate if critical); renal impairment (benefit may outweigh risk)"
          },
          {
            "item": "CT venography (CTV)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "If cerebral venous sinus thrombosis suspected (headache, papilledema, focal deficits, hypercoagulable state); can be done with CTA",
            "target": "Filling defect in dural sinuses (transverse, sigmoid, sagittal); \"empty delta sign\" on contrast CT; cord sign",
            "contraindications": "Same as CTA"
          },
          {
            "item": "MRI brain with and without contrast",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "When clinically stable; superior for tumor characterization, infection, posterior fossa; MRV for venous thrombosis; DWI for ischemia",
            "target": "Tumor; abscess; encephalitis; venous sinus thrombosis; ischemic stroke; PRES; herniation; meningeal enhancement",
            "contraindications": "MRI-incompatible implants; hemodynamic instability"
          },
          {
            "item": "Chest X-ray",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "ETT position confirmation; pulmonary complications (aspiration, ARDS); central line position",
            "target": "ETT position; no pulmonary infiltrate; line position",
            "contraindications": "None"
          }
        ],
        "Extended": [
          {
            "item": "MR venography (MRV)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Cerebral venous sinus thrombosis confirmation; if CTV equivocal; can be done without contrast (TOF technique)",
            "target": "Venous sinus thrombosis; flow void absence",
            "contraindications": "Same as MRI"
          },
          {
            "item": "Transcranial Doppler (TCD)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "Non-invasive ICP estimation (pulsatility index); vasospasm detection (SAH); cerebral circulatory arrest (brain death)",
            "target": "Pulsatility index >1.4 suggests elevated ICP; MCA velocities for vasospasm; reverberating flow = no cerebral circulation",
            "contraindications": "None; operator-dependent"
          },
          {
            "item": "Optic nerve sheath diameter (ONSD) ultrasound",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Bedside non-invasive ICP estimation; ONSD >5-5.5 mm suggests ICP >20 mmHg; useful when formal monitoring not available",
            "target": "ONSD >5 mm (some use 5.5 mm) = elevated ICP",
            "contraindications": "Limited accuracy; operator-dependent; not a substitute for invasive monitoring"
          },
          {
            "item": "CT perfusion",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "Ischemic stroke workup; penumbra assessment; vasospasm evaluation",
            "target": "Perfusion deficits; core vs. penumbra; vasospasm patterns",
            "contraindications": "Contrast requirements"
          },
          {
            "item": "Fundoscopic examination",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "Papilledema detection (takes hours-days to develop); retinal hemorrhages (Terson syndrome in SAH); IIH evaluation",
            "target": "Papilledema (indicates chronically or subacutely elevated ICP); absent papilledema does NOT exclude acute ICP elevation; venous pulsations absent if ICP >180 mm H2O",
            "contraindications": "None"
          },
          {
            "item": "Formal visual field testing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "IIH monitoring; chronic elevated ICP; document visual field loss for treatment decisions",
            "target": "Enlarged blind spot; peripheral constriction; nasal field loss",
            "contraindications": "Patient cooperation required"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "ICP monitor placement (invasive)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "**Gold standard for ICP measurement**; indications: GCS ≤8 with abnormal CT, or GCS ≤8 with normal CT + 2 of (age >40, SBP <90, motor posturing); also for hydrocephalus management; typically EVD or parenchymal monitor",
            "target": "Direct ICP measurement; normal <15 mmHg; elevated >20-22 mmHg; treatment threshold >22 mmHg (Brain Trauma Foundation 2016)",
            "contraindications": "Coagulopathy (correct first); infection at insertion site; uncontrolled bleeding diathesis"
          },
          {
            "item": "External ventricular drain (EVD)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "ICP monitoring + therapeutic CSF drainage; preferred in hydrocephalus; allows ICP waveform analysis",
            "target": "ICP measurement; CSF drainage; waveform analysis (P2 > P1 = decreased compliance)",
            "contraindications": "Same as ICP monitor"
          },
          {
            "item": "Continuous EEG monitoring",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Detect subclinical seizures (common in TBI, ICH, SAH — up to 20-30%); guide sedation; burst suppression monitoring during barbiturate coma",
            "target": "No seizures; appropriate sedation level; burst suppression if pentobarbital coma",
            "contraindications": "None; resource availability"
          },
          {
            "item": "Nuclear medicine cerebral perfusion (SPECT/HMPAO)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT",
            "timing": "Brain death confirmation (ancillary test); no cerebral blood flow",
            "target": "No uptake = brain death (if clinical criteria met and confounders excluded)",
            "contraindications": "Limited availability"
          },
          {
            "item": "CT/MRI perfusion for brain death",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT",
            "timing": "Brain death confirmation; no cerebral perfusion",
            "target": "No perfusion = brain death",
            "contraindications": "Same as standard CT/MRI"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent Treatment": [
          {
            "item": "**Airway management / Intubation**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.3 mg/kg",
                  "orderSentence": "**Airway management / Intubation** 0.3 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "**GCS ≤8: Secure airway**; RSI with agents that do NOT raise ICP; preferred: etomidate 0.3 mg/kg OR propofol 1-2 mg/kg + rocuronium 1.2 mg/kg OR succinylcholine 1.5 mg/kg; AVOID ketamine in severe TBI (controversial — emerging data suggest may be safe); lidocaine 1.5 mg/kg IV 2-3 min before laryngoscopy (may blunt ICP spike — controversial benefit); avoid hypotension during RSI",
              "orderSentence": "**Airway management / Intubation** 0.3 mg/kg IV"
            },
            "contraindications": "-",
            "monitoring": "Airway protection; ventilation control (PaCO2 management); GCS ≤8 cannot protect airway; avoid hypoxia (PaO2 <60) and hypotension (SBP <90) — both worsen outcomes",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Head of bed elevation**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Elevate HOB 30°**; neutral head position (avoid neck flexion/rotation that impedes jugular venous drainage); avoid tight cervical collar if possible; reverse Trendelenburg if cervical spine immobilization required",
              "orderSentence": "**Head of bed elevation** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Promotes venous drainage; reduces ICP by 3-5 mmHg; no evidence of reduced CPP with 30° elevation; simple and immediate intervention",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Hyperventilation (temporary)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Acute herniation ONLY (bridging therapy)**; target PaCO2 30-35 mmHg; induces cerebral vasoconstriction → reduced cerebral blood volume → reduced ICP; **Duration: <30 minutes ideally, maximum 2-4 hours**; taper gradually; avoid PaCO2 <25 (causes ischemia)",
              "orderSentence": "**Hyperventilation (temporary)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "BTF Guidelines: Avoid prophylactic hyperventilation; use only for acute ICP crisis/herniation as bridge to definitive therapy; prolonged hyperventilation causes rebound vasodilation and ischemia; monitor with SjvO2 or PbtO2 if prolonged use needed",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Osmotherapy — Mannitol**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-1.5 g/kg",
                  "orderSentence": "**Osmotherapy — Mannitol** 1-1.5 g/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "**Mannitol 20%:** 1-1.5 g/kg IV bolus (e.g., 100g = 500 mL of 20% for 70 kg patient) over 15-20 minutes; repeat doses: 0.25-0.5 g/kg q4-6h PRN; **Hold if:** serum osmolality >320 mOsm/kg, osmolar gap >15-20; **Requires:** Foley catheter (massive diuresis); volume replacement; **Onset:** 15-30 min; **Duration:** 2-6 hours",
              "orderSentence": "**Osmotherapy — Mannitol** 1-1.5 g/kg IV"
            },
            "contraindications": "-",
            "monitoring": "Creates osmotic gradient → draws water from brain parenchyma; reduces brain volume; also improves blood rheology; BTF: Level II evidence; monitor for renal toxicity (ATN), hypovolemia, rebound edema",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Osmotherapy — Hypertonic Saline**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mL",
                  "orderSentence": "**Osmotherapy — Hypertonic Saline** 30 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "**23.4% NaCl:** 30 mL IV bolus over 15-20 min via central line (preferred for acute crisis); **3% NaCl:** 250-500 mL IV bolus over 30 min (can give peripherally); **Continuous infusion:** 3% NaCl at 30-50 mL/hr to maintain Na 145-155 mEq/L; **Target sodium:** 145-155 mEq/L; avoid >160; correct slowly if hypernatremia develops (no faster than 8-10 mEq/24h decrease)",
              "orderSentence": "**Osmotherapy — Hypertonic Saline** 30 mL IV"
            },
            "contraindications": "-",
            "monitoring": "Equivalent or superior to mannitol for ICP reduction; does NOT cause diuresis (better for hypovolemic patients); no osmolality ceiling (unlike mannitol); does not accumulate in injured brain (mannitol may); preferred in many centers; SAFE-TBI trial (2021): 20% mannitol = HTS for ICP control",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Sedation and analgesia**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-75 mcg/kg",
                  "orderSentence": "**Sedation and analgesia** 25-75 mcg/kg -"
                }
              ],
              "route": "-",
              "instructions": "**Goal:** Reduce metabolic demand, prevent agitation-induced ICP spikes; **Propofol:** 25-75 mcg/kg/min (first-line; reduces CMRO2 and ICP; allows rapid awakening for neuro exams); **Fentanyl:** 25-100 mcg/hr (analgesia without histamine release); **Midazolam:** 0.05-0.2 mg/kg/hr (alternative to propofol); **Avoid:** Ketamine in severe ICP (controversial); prolonged propofol (PRIS syndrome >48-72h at high doses)",
              "orderSentence": "**Sedation and analgesia** 25-75 mcg/kg -"
            },
            "contraindications": "-",
            "monitoring": "Agitation, pain, coughing raise ICP; sedation reduces cerebral metabolic rate; propofol has favorable ICP properties; daily sedation holiday for neuro assessment if stable",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Neuromuscular blockade**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1-0.2 mg/kg",
                  "orderSentence": "**Neuromuscular blockade** 0.1-0.2 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "For refractory ICP spikes with ventilator dyssynchrony, coughing, posturing; **Cisatracurium** 0.1-0.2 mg/kg bolus → 1-3 mcg/kg/min infusion (organ-independent metabolism); **Rocuronium** 0.6-1 mg/kg bolus → 0.6 mg/kg/hr; **Requires:** Concurrent sedation/analgesia; train-of-four monitoring; prevents detection of seizures (need cEEG)",
              "orderSentence": "**Neuromuscular blockade** 0.1-0.2 mg/kg IV"
            },
            "contraindications": "-",
            "monitoring": "Prevents ICP spikes from coughing, posturing; reduces intrathoracic pressure; use judiciously — obscures neuro exam and seizure detection; requires cEEG monitoring",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Seizure prophylaxis / treatment**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000-1500 mg",
                  "orderSentence": "**Seizure prophylaxis / treatment** 1000-1500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "**Prophylaxis (TBI):** Levetiracetam 1000-1500 mg IV load → 500-1000 mg q12h x 7 days (BTF: early seizure prophylaxis x 7 days for severe TBI); **Active seizure:** Lorazepam 0.1 mg/kg (max 4 mg) → Levetiracetam 60 mg/kg load (max 4500 mg) OR fosphenytoin 20 mg PE/kg; **Status epilepticus:** Per SE protocol",
              "orderSentence": "**Seizure prophylaxis / treatment** 1000-1500 mg IV"
            },
            "contraindications": "-",
            "monitoring": "Seizures dramatically increase CMRO2 and ICP; early seizures occur in 10-15% of severe TBI; prophylaxis beyond 7 days NOT recommended (does not prevent late epilepsy); levetiracetam preferred (no drug interactions, IV/PO equivalent)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Temperature control**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650-1000 mg",
                  "orderSentence": "**Temperature control** 650-1000 mg -"
                }
              ],
              "route": "-",
              "instructions": "**Avoid fever aggressively**: fever increases CMRO2 by 10-13% per °C; target 36-37°C; acetaminophen 650-1000 mg q4-6h; cooling blankets; **Therapeutic hypothermia:** 32-35°C controversial; EUROTHERM (2015) showed harm from prophylactic hypothermia to 32-35°C in TBI; may use for refractory ICP as rescue",
              "orderSentence": "**Temperature control** 650-1000 mg -"
            },
            "contraindications": "-",
            "monitoring": "Fever worsens neurologic outcomes; aggressive normothermia is standard; therapeutic hypothermia is rescue therapy only (not prophylactic); if used: 32-35°C, avoid shivering (increases CMRO2), slow rewarming",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Blood pressure / CPP management**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "**Target CPP 60-70 mmHg** (CPP = MAP - ICP); avoid CPP <60 (ischemia) and >70 (BTF: avoid aggressive CPP >70 due to ARDS risk); **If hypotensive:** IV fluids (isotonic crystalloid; avoid hypotonic fluids); vasopressors (norepinephrine first-line); **If hypertensive with ICP crisis:** Treat ICP first (osmotherapy, sedation); avoid precipitously lowering BP (reduces CPP)",
              "orderSentence": "**Blood pressure / CPP management** - IV - see dosing"
            },
            "contraindications": "-",
            "monitoring": "CPP is the primary determinant of cerebral perfusion; BTF 2016: target CPP 60-70; lower threshold 60 mmHg; aggressive CPP >70 increases ARDS risk without outcome benefit; individualized based on autoregulation status",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Definitive/Targeted Treatment (Tier 2 — Moderate ICP Elevation)": [
          {
            "item": "**ICP monitor / EVD placement**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Indications (BTF 2016):** GCS ≤8 + abnormal CT; OR GCS ≤8 + normal CT + ≥2 of: age >40, SBP <90, motor posturing; **EVD preferred if:** Hydrocephalus; need for CSF drainage; **Parenchymal monitor if:** No hydrocephalus; cannot drain CSF; **Target ICP:** <22 mmHg (BTF 2016); some centers use <20",
              "orderSentence": "**ICP monitor / EVD placement** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Invasive ICP monitoring guides therapy; EVD allows therapeutic CSF drainage; parenchymal monitors cannot drain; infection risk ~5-10%; ventriculostomy is both diagnostic and therapeutic",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**CSF drainage (via EVD)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-10 mL",
                  "orderSentence": "**CSF drainage (via EVD)** 5-10 mL -"
                }
              ],
              "route": "-",
              "instructions": "**Continuous drainage:** Set drain to maintain ICP <22 mmHg; drain 5-10 mL CSF if ICP spike; **Intermittent drainage:** Drain for ICP >22, then clamp to re-measure; **Typical:** Remove 5-20 mL for ICP crisis; **Rate:** Avoid draining >20 mL/hour (risk of over-drainage, collapse of ventricles, hemorrhage)",
              "orderSentence": "**CSF drainage (via EVD)** 5-10 mL -"
            },
            "contraindications": "-",
            "monitoring": "Immediate ICP reduction; removes volume (CSF) from closed cranial compartment; critical for hydrocephalus; risk: infection, hemorrhage, over-drainage",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Repeat osmotherapy dosing**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25-0.5 g/kg",
                  "orderSentence": "**Repeat osmotherapy dosing** 0.25-0.5 g/kg -"
                }
              ],
              "route": "-",
              "instructions": "Scheduled or PRN osmotherapy based on ICP readings; **Mannitol:** 0.25-0.5 g/kg q4-6h; **HTS 3%:** 30 mL/hr continuous or 250 mL bolus PRN; **Monitor:** Serum osm q4-6h (hold mannitol if >320); serum Na q2-4h (target 145-155 with HTS)",
              "orderSentence": "**Repeat osmotherapy dosing** 0.25-0.5 g/kg -"
            },
            "contraindications": "-",
            "monitoring": "Sustained osmotherapy for sustained ICP elevation; alternating mannitol and HTS may extend treatment window; monitor for accumulation",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Decompressive craniectomy**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Indications:** Refractory ICP despite maximal medical therapy; malignant MCA stroke (large hemispheric infarct with edema); large ICH with mass effect; traumatic brain injury with refractory ICP; **Timing:** TBI: DECRA trial (2011) — early DC did not improve 6-mo outcomes but reduced ICP/ICU stay; RESCUEicp (2016) — late rescue DC improved survival but increased severe disability; **Stroke:** DESTINY/DECIMAL/HAMLET — DC improves survival in malignant MCA stroke age <60 (NNT=2); must discuss goals of care",
              "orderSentence": "**Decompressive craniectomy** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Removes skull to allow brain expansion; definitive ICP reduction; increases survival but may increase proportion surviving with severe disability; requires extensive goals of care discussion; timing and patient selection critical",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Dexamethasone (tumor/vasogenic edema)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "**Dexamethasone (tumor/vasogenic edema)** 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "**ONLY for vasogenic edema from tumor or abscess**; **NOT for TBI, stroke, or cytotoxic edema** (steroids worsen outcomes in TBI — CRASH trial); **Dose:** 10 mg IV load → 4 mg IV q6h; **Duration:** Until definitive tumor treatment; taper over 1-2 weeks after radiation/surgery; GI prophylaxis with PPI",
              "orderSentence": "**Dexamethasone (tumor/vasogenic edema)** 10 mg IV"
            },
            "contraindications": "-",
            "monitoring": "Reduces vasogenic edema around tumors; inhibits VEGF; dramatic effect within 24-48h; CRASH trial: steroids HARMFUL in TBI — avoid; no benefit in stroke",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**Surgical evacuation of mass lesion**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mL",
                  "orderSentence": "**Surgical evacuation of mass lesion** 30 mL -"
                }
              ],
              "route": "-",
              "instructions": "**Epidural hematoma:** Emergent if >30 mL, >15mm thickness, or >5mm midline shift, or GCS deterioration; **Subdural hematoma:** Emergent if >10mm thickness, >5mm midline shift, or GCS decrease >2 points; **ICH:** Consider if lobar >30 mL and deteriorating; cerebellar >3cm or hydrocephalus; **Tumor:** Resection or debulking for mass effect",
              "orderSentence": "**Surgical evacuation of mass lesion** 30 mL -"
            },
            "contraindications": "-",
            "monitoring": "Removes compressive mass → immediate ICP reduction; life-saving for epidural hematoma; subdural and ICH outcomes less clearly improved by surgery but indicated for mass effect and herniation",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Refractory ICP Management (Tier 3 — Rescue Therapies)": [
          {
            "item": "**Pentobarbital coma**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-10 mg/kg",
                  "orderSentence": "**Pentobarbital coma** 5-10 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "**LAST RESORT for refractory ICP**; **Protocol:** Pentobarbital 5-10 mg/kg IV load over 30 min → 1-3 mg/kg/hr infusion; titrate to ICP <22 mmHg or burst suppression on EEG; **Target:** Burst suppression (3-10 second bursts with 10-20 second suppression); **Monitor:** Continuous EEG; drug levels (30-50 mcg/mL); hemodynamics (causes hypotension — often need vasopressors); **Duration:** 24-48h then attempt to wean; may need 3-5 days",
              "orderSentence": "**Pentobarbital coma** 5-10 mg/kg IV"
            },
            "contraindications": "-",
            "monitoring": "Reduces CMRO2 to minimal levels; dramatic ICP reduction; causes severe hypotension (need vasopressors); immunosuppression; ileus; prolonged sedation; no proven mortality benefit but reduces ICP; requires ICU expertise",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Therapeutic hypothermia (rescue)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**For refractory ICP only** (NOT prophylactic); **Target:** 32-35°C; **Method:** Surface cooling (Arctic Sun) or intravascular cooling catheter; **Duration:** 24-72h; **Rewarming:** Slow — 0.25°C/hour (rapid rewarming causes ICP rebound); **Complications:** Shivering (treat with paralysis, buspirone, meperidine), coagulopathy, infection, arrhythmia",
              "orderSentence": "**Therapeutic hypothermia (rescue)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Reduces CMRO2 and ICP; EUROTHERM (2015): prophylactic hypothermia HARMFUL in TBI; rescue hypothermia for refractory ICP still used but evidence weak; prevents fever spikes; requires expertise",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Lumbar CSF drainage**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-10 mL/h",
                  "orderSentence": "**Lumbar CSF drainage** 5-10 mL/h -"
                }
              ],
              "route": "-",
              "instructions": "**ONLY if:** Communicating hydrocephalus; ICP refractory to EVD drainage; no mass lesion or obstructive hydrocephalus; basal cisterns visible; **Method:** Lumbar drain at 10-15 cm H2O; drain 5-10 mL/hour; **Risk:** Tonsillar herniation if used inappropriately; overdrainage",
              "orderSentence": "**Lumbar CSF drainage** 5-10 mL/h -"
            },
            "contraindications": "-",
            "monitoring": "Drains CSF from lumbar space; reduces overall CSF volume; effective adjunct in communicating hydrocephalus; must NOT be used with obstructive hydrocephalus or significant mass effect",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**High-dose hypertonic saline (23.4%)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mL",
                  "orderSentence": "**High-dose hypertonic saline (23.4%)** 30 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "**For refractory ICP crisis**; 30 mL IV bolus via central line; can repeat; target sodium up to 155-160 mEq/L in refractory cases (with close monitoring); **Risk:** Central pontine myelinolysis if rapid sodium changes (maintain stable elevated sodium; do not rapidly correct back to normal)",
              "orderSentence": "**High-dose hypertonic saline (23.4%)** 30 mL IV"
            },
            "contraindications": "-",
            "monitoring": "Potent osmotherapy; can achieve higher sodium targets than 3% NaCl; reserved for refractory cases; requires central line access",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Decompressive craniectomy (rescue)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "26.9%",
                  "orderSentence": "**Decompressive craniectomy (rescue)** 26.9% -"
                }
              ],
              "route": "-",
              "instructions": "As above; indicated for refractory ICP after failure of all medical therapies; must discuss survival with potential severe disability (RESCUEicp: DC improved survival from 26.9% to 48.9% but increased severe disability); goals of care critical",
              "orderSentence": "**Decompressive craniectomy (rescue)** 26.9% -"
            },
            "contraindications": "-",
            "monitoring": "RESCUEicp (2016): More patients survived with DC but at cost of more survivors with severe disability; DECRA (2011): Early prophylactic DC did not improve functional outcomes; decision requires extensive patient/family discussion",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Medications to AVOID": [
          {
            "item": "Corticosteroids in TBI",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Corticosteroids in TBI - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Corticosteroids in ischemic stroke",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Corticosteroids in ischemic stroke - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Hypotonic fluids (D5W, 0.45% NaCl)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Hypotonic fluids (D5W, 0.45% NaCl) - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Prolonged aggressive hyperventilation",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Prolonged aggressive hyperventilation - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Ketamine (traditionally)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Ketamine (traditionally) - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Nitroprusside",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Nitroprusside - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Propofol infusion syndrome (prolonged high-dose propofol)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Propofol infusion syndrome (prolonged high-dose propofol) - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurosurgery consultation — EMERGENT",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Neuro-ICU admission",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Continuous ICP monitoring (invasive)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Continuous EtCO2 / frequent ABG",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Serial neurologic examination",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "HOB elevation 30° / midline head",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Avoid Valsalva / ICP-raising maneuvers",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Normothermia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Euvolemia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Ophthalmology consultation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neurology consultation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Physiatry / Rehabilitation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Palliative care / Ethics",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Social work",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clinical neurophysiology / EEG",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Multimodal neuromonitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT"
          },
          {
            "item": "Targeted temperature management",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "EXT"
          },
          {
            "item": "Brain death evaluation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "VP shunt / CSF diversion (long-term)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Transverse sinus stenting (IIH)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Category",
        "features": "Etiologies",
        "tests": "Key Features"
      },
      {
        "diagnosis": "**Traumatic**",
        "features": "Traumatic brain injury (TBI); epidural hematoma; subdural hematoma; contusions; diffuse axonal injury",
        "tests": "History of trauma; CT findings; mechanism of injury"
      },
      {
        "diagnosis": "**Vascular**",
        "features": "Ischemic stroke (malignant edema); intracerebral hemorrhage; subarachnoid hemorrhage; cerebral venous sinus thrombosis",
        "tests": "Sudden onset; focal deficits; CT/MRI findings; angiography for vascular lesions"
      },
      {
        "diagnosis": "**Neoplastic**",
        "features": "Primary brain tumor; metastatic disease; leptomeningeal carcinomatosis",
        "tests": "Subacute progressive; known cancer history; MRI with contrast"
      },
      {
        "diagnosis": "**Infectious**",
        "features": "Meningitis; encephalitis; brain abscess; subdural empyema",
        "tests": "Fever; meningismus; CSF analysis; ring-enhancing lesion"
      },
      {
        "diagnosis": "**Hydrocephalus**",
        "features": "Obstructive (tumor, hemorrhage, aqueductal stenosis); communicating (post-infectious, post-hemorrhagic); normal pressure hydrocephalus",
        "tests": "Ventricular enlargement on imaging; gait disturbance, dementia, incontinence (NPH triad)"
      },
      {
        "diagnosis": "**Idiopathic Intracranial Hypertension (IIH)**",
        "features": "Pseudotumor cerebri",
        "tests": "Young obese women; headache; papilledema; pulsatile tinnitus; normal imaging; elevated OP on LP"
      },
      {
        "diagnosis": "**Metabolic**",
        "features": "Hepatic encephalopathy; hypertensive encephalopathy (PRES); hyponatremia (cerebral edema); hypoxic-ischemic injury",
        "tests": "Metabolic derangement; toxic screen; liver function; blood pressure"
      },
      {
        "diagnosis": "**Other**",
        "features": "High altitude cerebral edema (HACE); post-operative; radiation necrosis; posterior reversible encephalopathy syndrome (PRES)",
        "tests": "Exposure history; post-procedural; imaging pattern (PRES: posterior white matter edema)"
      }
    ],
    "evidence": [
      {
        "recommendation": "Guideline",
        "evidenceLevel": "Source",
        "source": "Year"
      },
      {
        "recommendation": "[Guidelines for the Management of Severe Traumatic Brain Injury](https://pubmed.ncbi.nlm.nih.gov/27654000/)",
        "evidenceLevel": "Brain Trauma Foundation (BTF)",
        "source": "2016 (4th ed)"
      },
      {
        "recommendation": "Malignant MCA Stroke Guidelines",
        "evidenceLevel": "AHA/ASA",
        "source": "2019"
      },
      {
        "recommendation": "ICH Guidelines",
        "evidenceLevel": "AHA/ASA",
        "source": "2022"
      },
      {
        "recommendation": "SAH Guidelines",
        "evidenceLevel": "AHA/ASA",
        "source": "2023"
      },
      {
        "recommendation": "IIH Guidelines",
        "evidenceLevel": "British Consensus Guidelines",
        "source": "2018"
      },
      {
        "recommendation": "Study",
        "evidenceLevel": "Finding",
        "source": "Impact"
      },
      {
        "recommendation": "[BTF Guidelines (2016)](https://pubmed.ncbi.nlm.nih.gov/27654000/)",
        "evidenceLevel": "ICP threshold changed from 20 to 22 mmHg; CPP target 60-70 (avoid >70); Level IIA evidence for ICP monitoring improving outcomes",
        "source": "Standard of care for TBI ICP management"
      },
      {
        "recommendation": "[CRASH Trial (2004)](https://pubmed.ncbi.nlm.nih.gov/15474134/)",
        "evidenceLevel": "Corticosteroids HARMFUL in TBI — 14-day mortality increased (25.7% vs. 22.3%, RR 1.15); 6-month mortality increased",
        "source": "Steroids absolutely contraindicated in TBI"
      },
      {
        "recommendation": "[DECRA Trial (2011)](https://pubmed.ncbi.nlm.nih.gov/21434843/)",
        "evidenceLevel": "Early decompressive craniectomy (within 72h) for refractory ICP in TBI did NOT improve 6-month functional outcome (though reduced ICP and ICU stay)",
        "source": "Questioned early prophylactic DC; did not stop DC but informed timing decisions"
      },
      {
        "recommendation": "[RESCUEicp Trial (2016)](https://pubmed.ncbi.nlm.nih.gov/27602507/)",
        "evidenceLevel": "Late/rescue DC for refractory ICP in TBI improved survival (48.9% vs. 26.9%) but increased proportion with severe disability; similar rates of favorable outcome",
        "source": "DC is life-saving but increases survival with disability; requires goals of care discussion"
      },
      {
        "recommendation": "[DESTINY/DECIMAL/HAMLET (pooled)](https://pubmed.ncbi.nlm.nih.gov/17303527/)",
        "evidenceLevel": "DC for malignant MCA stroke <60 years within 48h reduces mortality (NNT=2); higher survival with moderate-severe disability (mRS 4); DC should be offered",
        "source": "Standard of care for malignant MCA stroke in appropriate patients"
      },
      {
        "recommendation": "[EUROTHERM (2015)](https://pubmed.ncbi.nlm.nih.gov/26444221/)",
        "evidenceLevel": "Prophylactic hypothermia (32-35°C) in TBI HARMFUL — worse outcomes; trial stopped early",
        "source": "Hypothermia NOT recommended prophylactically; rescue use only for refractory ICP"
      },
      {
        "recommendation": "[INTERACT2](https://pubmed.ncbi.nlm.nih.gov/23713578/) / [ATACH-2](https://pubmed.ncbi.nlm.nih.gov/27276234/) (ICH)",
        "evidenceLevel": "Intensive BP lowering (SBP <140) safe in ICH; modest benefit in INTERACT2; no benefit in ATACH-2",
        "source": "SBP <140 within 6h is current recommendation for ICH"
      },
      {
        "recommendation": "SAFE-TBI (2021)",
        "evidenceLevel": "20% mannitol vs. hypertonic saline (various concentrations): no significant difference in ICP control or outcomes",
        "source": "Either osmotic agent acceptable; hypertonic saline may be preferred in hypovolemia"
      },
      {
        "recommendation": "Parameter",
        "evidenceLevel": "Target",
        "source": "Evidence Level"
      },
      {
        "recommendation": "ICP",
        "evidenceLevel": "<22 mmHg",
        "source": "BTF Level IIB"
      },
      {
        "recommendation": "CPP",
        "evidenceLevel": "60-70 mmHg",
        "source": "BTF Level IIB (avoid CPP <60; avoid >70 due to ARDS risk)"
      },
      {
        "recommendation": "PaCO2",
        "evidenceLevel": "35-40 mmHg (normocapnia)",
        "source": "BTF Level IIB"
      },
      {
        "recommendation": "PaCO2 (hyperventilation crisis)",
        "evidenceLevel": "30-35 mmHg (brief, <30 min)",
        "source": "BTF Level III"
      },
      {
        "recommendation": "Temperature",
        "evidenceLevel": "36-37°C (normothermia)",
        "source": "BTF Level IIB"
      },
      {
        "recommendation": "Glucose",
        "evidenceLevel": "140-180 mg/dL",
        "source": "General critical care consensus"
      },
      {
        "recommendation": "SBP (avoid hypotension)",
        "evidenceLevel": ">100 mmHg (or >110 for TBI age 50-69)",
        "source": "BTF Level III"
      }
    ],
    "monitoring": [
      {
        "item": "ICP (if monitored)",
        "frequency": "Continuous",
        "target": "<22 mmHg (BTF 2016); some centers <20",
        "action": "Tiered therapy escalation (osmotherapy → sedation → CSF drainage → hyperventilation → DC)"
      },
      {
        "item": "CPP (MAP - ICP)",
        "frequency": "Continuous (calculated)",
        "target": "60-70 mmHg",
        "action": "If low: IV fluids, vasopressors; if high (>70) and ICP elevated: focus on ICP reduction"
      },
      {
        "item": "Neurologic exam (GCS, pupils, motor)",
        "frequency": "q1h initially; q2-4h when stable",
        "target": "Stable or improving",
        "action": "Decline: STAT CT; escalate ICP therapy; surgical evaluation"
      },
      {
        "item": "Serum sodium",
        "frequency": "q2-4h during active osmotherapy",
        "target": "135-155 mEq/L (target varies); avoid rapid changes",
        "action": "Adjust osmotherapy; correct slowly if needed"
      },
      {
        "item": "Serum osmolality",
        "frequency": "q4-6h during mannitol therapy",
        "target": "<320 mOsm/kg (some use <315)",
        "action": "Hold mannitol if >320; switch to HTS"
      },
      {
        "item": "ABG / PaCO2",
        "frequency": "q4-6h; more frequent if adjusting ventilation",
        "target": "35-40 mmHg (normocapnia); 30-35 only for acute crisis",
        "action": "Adjust ventilator; avoid hyperventilation except for crisis"
      },
      {
        "item": "Temperature",
        "frequency": "Continuous",
        "target": "36-37°C; strict normothermia",
        "action": "Aggressive cooling; acetaminophen; treat infection source"
      },
      {
        "item": "Blood glucose",
        "frequency": "q4-6h",
        "target": "140-180 mg/dL",
        "action": "Insulin titration"
      },
      {
        "item": "Urine output",
        "frequency": "Hourly",
        "target": "0.5-1 mL/kg/hr",
        "action": "Assess volume status; diuresis from mannitol expected (replace losses)"
      },
      {
        "item": "Hemodynamics (MAP)",
        "frequency": "Continuous",
        "target": "MAP to maintain CPP 60-70",
        "action": "Vasopressors; volume"
      }
    ],
    "disposition": [
      {
        "disposition": "Level of Care",
        "criteria": "Criteria"
      },
      {
        "disposition": "Neuro-ICU",
        "criteria": "Any patient requiring ICP monitoring; GCS ≤8; signs of herniation; requiring osmotherapy, sedation, or mechanical ventilation for ICP; post-operative after decompressive craniectomy or hematoma evacuation; status epilepticus; hemodynamic instability"
      },
      {
        "disposition": "Step-down / Intermediate care",
        "criteria": "Stable ICP; improving neurologically; EVD weaning; transitioning off invasive monitoring; stable post-operative"
      },
      {
        "disposition": "General neurology/neurosurgery floor",
        "criteria": "Stable IIH on medical therapy; post-VP shunt; stable post-operative without ICP concerns"
      }
    ]
  },
  "Spinal Epidural Abscess": {
    "id": "epidural-abscess",
    "title": "Spinal Epidural Abscess",
    "version": "1.0",
    "icd10": [
      "** G06.1 (Intraspinal abscess and granuloma)",
      "M46.40 (Discitis",
      "unspecified site)",
      "M46.46 (Discitis",
      "lumbar region)",
      "M46.47 (Discitis",
      "lumbosacral region)",
      "A41.9 (Sepsis",
      "unspecified organism)"
    ],
    "scope": "** Emergency evaluation and management of spinal epidural abscess in adults. Covers the classic triad (back pain, fever, neurologic deficit), emergent MRI, surgical drainage vs. medical management decision-making, empiric and targeted antibiotic therapy, and neurologic monitoring. Includes associated vertebral osteomyelitis and discitis. Excludes brain abscess (separate template), subdural empyema, and post-operative wound infections (partially overlaps).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Blood cultures (x2 sets, before antibiotics)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "**CRITICAL: Positive in 60-70%**; identifies organism for targeted therapy; guides antibiotic duration; S. aureus most common (60-70%); draw from 2 separate sites",
            "target": "Positive → organism identification; S. aureus (MRSA vs. MSSA) most common; also Streptococci, gram-negatives, anaerobes"
          },
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Leukocytosis (WBC >12,000 in 60-80%); left shift; bandemia; baseline for monitoring; thrombocytopenia may indicate DIC/sepsis",
            "target": "Leukocytosis (66%); normal WBC does NOT exclude SEA (20-40% have normal WBC); leukopenia concerning for overwhelming sepsis"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Renal function (antibiotic dosing, contrast); electrolytes; hepatic function; glucose (diabetes is major risk factor)",
            "target": "Normal or abnormal; elevated glucose → diabetes workup; renal dysfunction affects antibiotic choice"
          },
          {
            "item": "ESR (erythrocyte sedimentation rate)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "**Highly sensitive (>94%)**; ESR >20 mm/hr in nearly all cases of SEA; ESR >30-50 typical; useful for monitoring treatment response",
            "target": "ESR >20 mm/hr (sensitivity 94%); mean ESR is typically 50-80 mm/hr; if normal → SEA very unlikely"
          },
          {
            "item": "CRP (C-reactive protein)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Elevated in >90% of SEA; more responsive to treatment changes than ESR; useful for monitoring",
            "target": "Elevated (typically >10 mg/dL); declines faster than ESR with successful treatment"
          },
          {
            "item": "Procalcitonin",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "More specific for bacterial infection than CRP; helps distinguish bacterial from non-infectious inflammation; prognostic",
            "target": ">0.5 ng/mL suggests bacterial infection; >2.0 ng/mL concerning for sepsis; useful in atypical presentations"
          },
          {
            "item": "Blood glucose / HbA1c",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "**Diabetes is a major risk factor (30-50% of SEA patients)**; undiagnosed diabetes common; affects wound healing and immune function",
            "target": "Document diabetes status; HbA1c >6.5% = diabetes; glucose control target <180 mg/dL"
          },
          {
            "item": "PT/INR, aPTT",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Coagulopathy from sepsis (DIC); surgical candidacy; baseline before anticoagulation decisions; epidural hematoma differential",
            "target": "Normal; prolonged → concern for DIC, liver dysfunction; affects surgical risk"
          },
          {
            "item": "Lactate",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Sepsis assessment; tissue hypoperfusion; prognostic",
            "target": "<2 mmol/L (normal); >4 mmol/L = severe sepsis/septic shock requiring aggressive resuscitation"
          },
          {
            "item": "Type and screen",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Surgical candidacy; blood product availability",
            "target": "On file"
          },
          {
            "item": "Urinalysis + urine culture",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Urinary source (UTI is common source of hematogenous spread, especially gram-negative SEA); concurrent UTI",
            "target": "Normal or pyuria/bacteriuria; if positive → potential primary source"
          }
        ],
        "Extended Workup": [
          {
            "item": "HIV antibody/antigen",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "rationale": "Immunocompromised state; increases SEA risk; affects prognosis and opportunistic infection risk",
            "target": "Negative; if positive → CD4 count, viral load; consider opportunistic organisms"
          },
          {
            "item": "Hepatitis B/C serologies",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "IVDU population (risk factor for SEA); affects long-term antibiotic choice; liver function",
            "target": "Negative; if positive → affects drug selection, hepatotoxicity monitoring"
          },
          {
            "item": "Hemoglobin A1c",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Undiagnosed or poorly controlled diabetes",
            "target": "<6.5% (normal); ≥6.5% = diabetes; 5.7-6.4% = prediabetes"
          },
          {
            "item": "D-dimer",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "DIC screening; VTE risk (prolonged immobility + inflammation); not specific but elevated in SEA",
            "target": "Elevated (non-specific); very high levels → consider DIC"
          },
          {
            "item": "Fibrinogen",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "DIC assessment; sepsis-associated coagulopathy",
            "target": ">150 mg/dL; low fibrinogen = DIC or consumption"
          },
          {
            "item": "Albumin / prealbumin",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Nutritional status; wound healing; chronicity of illness; prognostic",
            "target": ">3.5 g/dL (albumin); low = poor nutrition, chronic illness"
          },
          {
            "item": "Repeat blood cultures (during treatment)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Document clearance of bacteremia; if persistently positive → evaluate for endocarditis, undrained collection, treatment failure",
            "target": "Negative by 48-72h of appropriate antibiotics; persistent positivity → echocardiogram, repeat imaging"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Surgical specimen culture (intraoperative)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "**Gold standard for organism identification**; culture of abscess material at surgery; sensitivity higher than blood cultures; also send for Gram stain and histopathology",
            "target": "Organism identification; guides targeted antibiotic therapy"
          },
          {
            "item": "CT-guided aspiration/biopsy culture",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "rationale": "If non-operative management chosen; tissue diagnosis; culture for organism identification; distinguishes abscess from tumor/hematoma",
            "target": "Organism identification; Gram stain; histopathology (rule out tumor)"
          },
          {
            "item": "Acid-fast bacilli (AFB) smear and culture",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "TB spine (Pott's disease); endemic areas; immunocompromised; chronic presentation with vertebral destruction",
            "target": "Negative; positive → TB requires different treatment (anti-TB regimen; may not need surgery if no instability/neurologic deficit)"
          },
          {
            "item": "Fungal cultures",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Immunocompromised; IVDU; indwelling catheters; endemic fungi (coccidioidomycosis, blastomycosis, histoplasmosis); chronic presentation",
            "target": "Negative; positive → prolonged antifungal therapy (6-12+ months)"
          },
          {
            "item": "Brucella serology / cultures",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Endemic areas (Mediterranean, Middle East); unpasteurized dairy; occupational exposure (farmers, veterinarians); chronic back pain",
            "target": "Negative; positive → doxycycline + streptomycin/gentamicin or rifampin"
          },
          {
            "item": "16S rRNA PCR (on tissue)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Culture-negative SEA; prior antibiotic exposure; fastidious organisms",
            "target": "Identifies organism even when cultures are negative; research/reference lab"
          },
          {
            "item": "Transthoracic echocardiogram (TTE)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "**Infective endocarditis screen**; IE present in 10-15% of SEA patients with S. aureus bacteremia; affects antibiotic duration and management",
            "target": "Normal; vegetations → endocarditis diagnosis; changes antibiotic duration to 4-6 weeks minimum"
          },
          {
            "item": "Transesophageal echocardiogram (TEE)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "If TTE negative but high suspicion for endocarditis (S. aureus bacteremia, IVDU, prosthetic valve, persistent fever); TEE more sensitive than TTE",
            "target": "Normal; vegetations → endocarditis; TEE sensitivity 90-95% vs. TTE 65%"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "LP — Generally NOT indicated",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-",
            "timing": "**LP is generally CONTRAINDICATED in suspected SEA**; risk of seeding infection into subarachnoid space → meningitis/spinal subdural empyema; imaging (MRI) is diagnostic modality of choice",
            "target": "N/A",
            "contraindications": "**AVOID LP if SEA suspected** — LP may spread infection into intradural space; if meningitis suspected concurrently, discuss with neurosurgery/ID before LP"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI entire spine with and without contrast (gadolinium)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "URGENT",
            "ICU": "STAT",
            "timing": "**GOLD STANDARD — within 4 hours of ED presentation if neurologic deficit; within 24h if no deficit**; contrast essential for abscess characterization; image ENTIRE spine (multifocal in 15-20%)",
            "target": "Epidural collection with ring enhancement; T1 hypointense, T2 hyperintense; restricted diffusion (DWI bright, ADC dark within abscess); vertebral body involvement (osteomyelitis); disc involvement (discitis); cord compression; degree of canal compromise",
            "contraindications": "MRI-incompatible implants; severe claustrophobia (sedate — do NOT delay); GFR <30 (gadolinium risk — but benefit outweighs risk in emergency)"
          },
          {
            "item": "Plain radiographs (spine)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Immediate while awaiting MRI; identifies vertebral body destruction, disc space narrowing, alignment abnormality; LOW sensitivity for early SEA",
            "target": "Disc space narrowing; vertebral body destruction (late finding — takes 2-4 weeks to appear); alignment; pathologic fracture",
            "contraindications": "Pregnancy (shield)"
          },
          {
            "item": "CT spine without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "If MRI unavailable or contraindicated; inferior to MRI for soft tissue and epidural collection; shows bone destruction better than MRI",
            "target": "Bone destruction; disc space narrowing; paraspinal soft tissue mass; canal compromise; less sensitive than MRI for epidural abscess extent",
            "contraindications": "Pregnancy (relative)"
          },
          {
            "item": "Chest X-ray",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Primary pulmonary source (pneumonia); lung abscess; TB (apical infiltrate, cavitation); septic emboli",
            "target": "Primary infection source; pulmonary complications; TB features",
            "contraindications": "Pregnancy (shield)"
          }
        ],
        "Extended": [
          {
            "item": "CT chest/abdomen/pelvis with contrast",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Source identification if not obvious; look for primary infection (lung abscess, intra-abdominal abscess, psoas abscess); staging for concurrent infection",
            "target": "Primary source: lung abscess, intra-abdominal abscess, psoas abscess (contiguous spread), renal/perinephric abscess; endocarditis emboli",
            "contraindications": "Contrast allergy; renal impairment"
          },
          {
            "item": "Echocardiogram (TTE → TEE if needed)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "**All patients with S. aureus bacteremia should have echocardiogram**; endocarditis in 10-15% of S. aureus SEA",
            "target": "Vegetations; valvular regurgitation; abscess; Duke criteria",
            "contraindications": "None (TTE); TEE: esophageal pathology, uncooperative patient"
          },
          {
            "item": "CT myelogram",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "timing": "Only if MRI absolutely contraindicated; intrathecal contrast via LP followed by CT; demonstrates level of compression; risk of meningitis seeding with LP",
            "target": "Complete or partial block; level of compression; intradural vs. extradural",
            "contraindications": "Infection at LP site (SEA itself may preclude LP at involved level); coagulopathy"
          },
          {
            "item": "Nuclear medicine bone scan (Tc-99m)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If MRI unavailable; can identify osteomyelitis; may show uptake before radiographic changes; less specific than MRI",
            "target": "Increased uptake at infection site(s); may identify multifocal disease",
            "contraindications": "Pregnancy; limited specificity"
          },
          {
            "item": "Gallium-67 or Indium-111 WBC scan",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Chronic/subacute infection; differentiating active infection from degenerative changes; research use",
            "target": "Increased uptake at infection site",
            "contraindications": "Limited availability; time-consuming; replaced largely by MRI"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CT-guided biopsy/aspiration",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "timing": "If diagnosis uncertain; culture acquisition for non-surgical management; distinguish abscess from tumor or hematoma",
            "target": "Organism identification; Gram stain; histopathology confirming infection vs. other pathology",
            "contraindications": "Coagulopathy; inaccessible location; very small collection"
          },
          {
            "item": "PET/CT (FDG)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Chronic/recurrent infection; assess treatment response; identify additional sites of infection; research use",
            "target": "Increased FDG uptake at infection site; may identify occult primary source",
            "contraindications": "Uncontrolled diabetes (glucose >200); pregnancy"
          },
          {
            "item": "Repeat MRI (during treatment)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At 2-4 weeks or if clinical worsening; assess treatment response; monitor for abscess expansion; may appear worse before better on imaging",
            "target": "Stable or decreasing collection size; resolving edema; NOTE: Imaging may lag behind clinical improvement (may appear worse at 2 weeks even with successful treatment)",
            "contraindications": "Same as initial MRI"
          },
          {
            "item": "Post-treatment MRI",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At end of antibiotic course (6-8 weeks); baseline for comparison; assess for residual disease",
            "target": "Resolution or significant improvement of collection; healed osteomyelitis; residual enhancement may persist for months (does not necessarily indicate active infection)",
            "contraindications": "Same as MRI"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent Treatment": [
          {
            "item": "**Empiric IV antibiotics (STAT)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-30 mg/kg",
                  "orderSentence": "**Empiric IV antibiotics (STAT)** 25-30 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "**Start IMMEDIATELY after blood cultures drawn — do NOT delay for MRI or organism identification**; **First-line empiric:** Vancomycin 25-30 mg/kg IV load (max 2g), then 15-20 mg/kg IV q8-12h (target trough 15-20 mcg/mL) PLUS Ceftriaxone 2g IV q12h OR Cefepime 2g IV q8h; **Alternative for β-lactam allergy:** Vancomycin + aztreonam 2g IV q8h OR Vancomycin + fluoroquinolone (levofloxacin 750 mg daily); **If Pseudomonas risk (IVDU, immunocompromised):** Add anti-pseudomonal coverage with cefepime or piperacillin-tazobactam 4.5g IV q6h; **Adjust to culture results when available**",
              "orderSentence": "**Empiric IV antibiotics (STAT)** 25-30 mg/kg IV"
            },
            "contraindications": "-",
            "monitoring": "Vancomycin covers MRSA (most important cause); ceftriaxone/cefepime covers MSSA, streptococci, gram-negatives; early antibiotics are associated with better outcomes; every hour of delay increases mortality in sepsis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Emergent surgical decompression + drainage**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**INDICATIONS (Surgery preferred):** (1) Neurologic deficit (any weakness, bowel/bladder dysfunction), (2) Sepsis/hemodynamic instability not improving with antibiotics, (3) Significant cord compression on imaging, (4) Failure of medical therapy (no improvement at 48-72h, worsening at any time), (5) Unknown organism (need tissue diagnosis); **Procedure:** Posterior laminectomy with abscess drainage; cultures from abscess; débridement of infected tissue; may need instrumentation if instability; **Timing:** Within 24h of diagnosis; emergent (within hours) if progressive deficit",
              "orderSentence": "**Emergent surgical decompression + drainage** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Darouiche (2006): Surgical outcomes better than medical management in patients with neurologic deficit; earlier surgery (within 24h) associated with better neurologic recovery; pre-operative neurologic status is #1 predictor of outcome",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**DVT prophylaxis**",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "**DVT prophylaxis** 40 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "SCDs immediately; pharmacologic prophylaxis: enoxaparin 40 mg SQ daily — timing is nuanced: may start within 24h of admission if no imminent surgery; post-operatively start 12-24h after surgery per surgeon; high VTE risk population",
              "orderSentence": "**DVT prophylaxis** 40 mg SC"
            },
            "contraindications": "-",
            "monitoring": "Immobile + infection + inflammatory state = very high DVT risk; mechanical prophylaxis universal; pharmacologic prophylaxis as soon as surgically safe",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Pain management**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650-1000 mg",
                  "orderSentence": "**Pain management** 650-1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Back pain often severe; acetaminophen 650-1000 mg q6h (scheduled) + opioids (morphine 2-4 mg IV q3h PRN or hydromorphone 0.5-1 mg IV q3h PRN); NSAIDs: use cautiously (renal function, surgical bleeding) — some ID physicians avoid NSAIDs in active infection; neuropathic agents (gabapentin) if radicular component",
              "orderSentence": "**Pain management** 650-1000 mg IV"
            },
            "contraindications": "-",
            "monitoring": "Severe pain is hallmark of SEA; adequate analgesia is essential; balance with need for neurologic monitoring",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**Sepsis resuscitation (if septic)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mL/kg",
                  "orderSentence": "**Sepsis resuscitation (if septic)** 30 mL/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "Surviving Sepsis guidelines: lactate measurement; blood cultures before antibiotics; IV crystalloid 30 mL/kg for hypotension or lactate ≥4 mmol/L; vasopressors (norepinephrine first-line) if MAP <65 despite fluids; reassess volume status; repeat lactate if initially elevated",
              "orderSentence": "**Sepsis resuscitation (if septic)** 30 mL/kg IV"
            },
            "contraindications": "-",
            "monitoring": "Sepsis from SEA has high mortality; early aggressive resuscitation improves outcomes",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Glucose control**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "180 mg",
                  "orderSentence": "**Glucose control** 180 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Target glucose <180 mg/dL; insulin infusion if critically ill; sliding scale or basal-bolus for non-ICU patients; diabetes is major risk factor — optimize control",
              "orderSentence": "**Glucose control** 180 mg IV"
            },
            "contraindications": "-",
            "monitoring": "Hyperglycemia impairs immune function and wound healing; tight glucose control improves infection outcomes",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Definitive/Targeted Treatment": [
          {
            "item": "**Targeted IV antibiotic therapy (based on culture results)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2g",
                  "orderSentence": "**Targeted IV antibiotic therapy (based on culture results)** 2g IV"
                }
              ],
              "route": "IV",
              "instructions": "**Tailor to organism and sensitivities; typical regimens:** — **MSSA:** Nafcillin 2g IV q4h OR cefazolin 2g IV q8h (preferred for tolerability); duration 6-8 weeks; — **MRSA:** Vancomycin 15-20 mg/kg IV q8-12h (trough 15-20) for 6-8 weeks; alternatives: daptomycin 6-8 mg/kg IV daily (avoid if pneumonia), linezolid 600 mg IV/PO q12h (monitor for toxicity if >2 weeks); — **Streptococci:** Penicillin G 4 million units IV q4h or ceftriaxone 2g IV q12h x 6 weeks; — **Enterococcus:** Ampicillin 2g IV q4h (if susceptible) ± gentamicin synergy; vancomycin if ampicillin-resistant; — **Gram-negatives:** Ceftriaxone 2g IV q12h or cefepime 2g IV q8h or ciprofloxacin 400 mg IV q8h x 6 weeks depending on sensitivities; — **Pseudomonas:** Cefepime 2g IV q8h or meropenem 2g IV q8h x 6 weeks",
              "orderSentence": "**Targeted IV antibiotic therapy (based on culture results)** 2g IV"
            },
            "contraindications": "-",
            "monitoring": "IV antibiotics are standard for SEA/osteomyelitis; oral transition data emerging (OVIVA trial) but traditionally 6-8 weeks IV; de-escalate from empiric coverage once cultures return",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**Duration of antibiotics**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "**SEA without osteomyelitis:** 4-6 weeks IV; **SEA with vertebral osteomyelitis (most cases):** 6-8 weeks IV; **SEA with endocarditis:** 6 weeks minimum from first negative blood culture; duration guided by clinical response, inflammatory markers (ESR, CRP), repeat imaging; may extend if slow response",
              "orderSentence": "**Duration of antibiotics** - IV - see dosing"
            },
            "contraindications": "-",
            "monitoring": "IDSA guidelines: 6 weeks for vertebral osteomyelitis; 4-6 weeks for epidural abscess alone; endocarditis requires 6-week minimum; individualized based on response",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**Oral antibiotic transition (selected cases)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "750 mg",
                  "orderSentence": "**Oral antibiotic transition (selected cases)** 750 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "**OVIVA trial (2019):** Oral antibiotics non-inferior to IV for bone/joint infections after initial 2 weeks IV in stable patients; **Candidates:** Clinically improving; afebrile; tolerating PO; CRP trending down; adherent; close follow-up available; **Oral options:** Fluoroquinolone (levofloxacin 750 mg daily or ciprofloxacin 750 mg BID) + rifampin 300 mg BID (NOT monotherapy); linezolid 600 mg BID (monitor CBC, neuropathy); TMP-SMX DS 2 tabs BID (for MRSA); **NOT for:** Endocarditis, undrained abscess, persistent bacteremia, non-adherent patient",
              "orderSentence": "**Oral antibiotic transition (selected cases)** 750 mg IV"
            },
            "contraindications": "-",
            "monitoring": "OVIVA trial showed oral switch after 2 weeks IV is non-inferior for bone/joint infections; reduces costs, IV complications, hospital stay; requires careful patient selection and close monitoring; NOT standard for all SEA cases",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Surgical drainage (if not done emergently)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**If initial medical management:** Re-evaluate need for surgery at 48-72h; indications for delayed surgery: failure to improve, neurologic deterioration, persistent fever/bacteremia, abscess enlargement on imaging; **Procedure:** Laminectomy + drainage; send cultures even if already on antibiotics (may still grow organism); instrumented fusion if instability/destruction",
              "orderSentence": "**Surgical drainage (if not done emergently)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Surgery provides source control, tissue diagnosis, and decompression; delayed surgery for medical failure still beneficial if performed before complete paralysis",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Medical management alone (selected cases)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Candidates for medical management without surgery:** (1) No neurologic deficit, (2) Organism identified (blood cultures positive), (3) Small abscess (<3 cm collection), (4) Poor surgical candidate (extreme comorbidities), (5) Panspinal disease (multiple levels — surgery impractical); **Requirements:** Very close neurologic monitoring (q2-4h initially); repeat MRI at 48-72h and weekly; immediate surgery if any deterioration; adherent patient",
              "orderSentence": "**Medical management alone (selected cases)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Observational studies: ~40% of SEA can be managed medically if no neurologic deficit and criteria met; HOWEVER, 10-20% will fail medical therapy and require surgery; early surgery generally preferred if feasible",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Adjunctive Treatment": [
          {
            "item": "**PICC line placement**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "If prolonged IV antibiotics planned (6-8 weeks); enables outpatient IV therapy (OPAT); placed once stabilized and duration confirmed; confirm tip position with X-ray",
              "orderSentence": "**PICC line placement** - IV - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Required for OPAT; reduces peripheral IV complications; monitor for PICC-associated infection",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Outpatient parenteral antibiotic therapy (OPAT)**",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "instructions": "Once clinically stable (afebrile, pain controlled, neurologically stable, adequate PO intake, safe home environment); PICC in place; infusion teaching completed; close ID follow-up (weekly visits); VNA nursing for line care",
              "orderSentence": "**Outpatient parenteral antibiotic therapy (OPAT)** - PO - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Reduces hospital stay; comparable outcomes to inpatient therapy in appropriate patients; weekly ID visits with labs (CBC, CMP, drug levels, CRP)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Rifampin (adjunctive)**",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "**Rifampin (adjunctive)** 300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "For staphylococcal osteomyelitis (vertebral involvement); enhances bone penetration; prevents biofilm; **ONLY as adjunctive therapy — never monotherapy (rapid resistance)**; Rifampin 300 mg PO BID added to primary anti-staphylococcal agent; check interactions (CYP3A4 inducer — reduces warfarin, HIV meds, oral contraceptives, etc.)",
              "orderSentence": "**Rifampin (adjunctive)** 300 mg PO"
            },
            "contraindications": "-",
            "monitoring": "Rifampin improves outcomes in staphylococcal bone infections; biofilm activity; excellent bone penetration; drug interactions are significant",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Bracing / spinal orthosis**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "If spinal instability (vertebral body destruction, kyphosis, instrumentation); TLSO for thoracolumbar; cervical collar for cervical; duration: typically 6-12 weeks or until radiographic healing",
              "orderSentence": "**Bracing / spinal orthosis** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "External stabilization; pain relief; prevents pathologic fracture progression; may allow non-operative management of mild instability",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Nutritional optimization**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1.2-1.5 g/kg",
                  "orderSentence": "**Nutritional optimization** 1.2-1.5 g/kg -"
                }
              ],
              "route": "-",
              "instructions": "Protein supplementation (1.2-1.5 g/kg/day); calorie optimization; correct vitamin deficiencies; dietitian consultation; affects wound healing and immune function",
              "orderSentence": "**Nutritional optimization** 1.2-1.5 g/kg -"
            },
            "contraindications": "-",
            "monitoring": "Malnutrition common in chronic illness; protein essential for wound healing; improves infection outcomes",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Diabetes optimization**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "180 mg",
                  "orderSentence": "**Diabetes optimization** 180 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Endocrinology consult if poorly controlled; insulin titration; goal HbA1c <7.5% (individualized); glucose <180 mg/dL during acute illness",
              "orderSentence": "**Diabetes optimization** 180 mg PO"
            },
            "contraindications": "-",
            "monitoring": "Diabetes is major risk factor; uncontrolled diabetes impairs healing and immune response",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**Substance abuse counseling (if applicable)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30%",
                  "orderSentence": "**Substance abuse counseling (if applicable)** 30% -"
                }
              ],
              "route": "-",
              "instructions": "IVDU is major risk factor for SEA (20-30% of cases); addiction medicine consultation; harm reduction; hepatitis/HIV screening; reduces recurrence risk",
              "orderSentence": "**Substance abuse counseling (if applicable)** 30% -"
            },
            "contraindications": "-",
            "monitoring": "IVDU patients at high risk for recurrent infection; addressing substance use reduces future SEA risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Medications to AVOID or Use with Caution": [
          {
            "item": "Daptomycin (with pneumonia)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Daptomycin (with pneumonia) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Rifampin monotherapy",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Rifampin monotherapy - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Linezolid >2-4 weeks",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Linezolid >2-4 weeks - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Aminoglycosides (prolonged use)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Aminoglycosides (prolonged use) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Corticosteroids (routine use)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Corticosteroids (routine use) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "NSAIDs (prolonged, peri-operative)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "NSAIDs (prolonged, peri-operative) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "LP (in suspected SEA)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "LP (in suspected SEA) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Epidural steroid injection (as treatment or in area of abscess)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Epidural steroid injection (as treatment or in area of abscess) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Spine surgery / Neurosurgery consultation — EMERGENT",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Infectious disease consultation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Neurologic examination — serial monitoring",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Source identification",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Blood cultures (before antibiotics)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Fall precautions / mobility assessment",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Documentation of timeline",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Echocardiogram (TTE ± TEE)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Dental evaluation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "PICC placement / vascular access",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work / case management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Addiction medicine (if IVDU)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain management service",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical / occupational therapy",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "VNA / home health",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Repeat MRI",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "CT-guided drainage (percutaneous)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Revision surgery / repeat drainage",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Infectious disease second opinion",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Long-term suppressive antibiotics",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Spinal fusion (delayed)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hyperbaric oxygen therapy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Diagnosis",
        "features": "Key Differentiating Features",
        "tests": "Distinguishing Studies"
      },
      {
        "diagnosis": "Malignant spinal cord compression (MSCC) / Metastatic epidural disease",
        "features": "Known cancer history; bone destruction without disc involvement (SEA typically involves disc); no fever (usually); no elevated ESR/CRP/WBC (unless concurrent infection); may be painful but not typically as acute; enhances but no ring-enhancement or diffusion restriction",
        "tests": "MRI: enhancing epidural mass WITHOUT ring enhancement or restricted diffusion; bone destruction; CT/PET: metastatic staging; tumor markers; biopsy if uncertain; ESR/CRP may be mildly elevated in malignancy but not as high as SEA"
      },
      {
        "diagnosis": "Vertebral compression fracture (osteoporotic)",
        "features": "Older patient; osteoporosis history; no fever; acute onset with movement; no neurologic deficit (usually); no elevated inflammatory markers; vertebral body wedging; may have benign edema",
        "tests": "MRI: vertebral body edema WITHOUT epidural collection; no ring enhancement; normal ESR/CRP; DEXA: osteoporosis; mechanism (fall, lifting); responds to bracing/pain management"
      },
      {
        "diagnosis": "Disc herniation (without infection)",
        "features": "No fever; no elevated inflammatory markers; unilateral radiculopathy (usually); no epidural collection on MRI; common, benign presentation",
        "tests": "MRI: disc herniation without epidural enhancement; no T2 hyperintense collection; normal ESR/CRP; normal WBC; unilateral symptoms more common"
      },
      {
        "diagnosis": "Spinal epidural hematoma",
        "features": "Anticoagulation; post-procedural (epidural injection, LP, surgery); acute onset; hematoma signal characteristics on MRI (not ring-enhancing); no fever; rapidly progressive",
        "tests": "MRI: epidural collection with blood signal (T1 hyperintense in subacute phase); NO ring enhancement; NO restricted diffusion in hematoma (unlike abscess); coagulation studies; anticoagulation history; recent procedure"
      },
      {
        "diagnosis": "Transverse myelitis / NMOSD",
        "features": "Intramedullary (within cord) rather than epidural; autoimmune; no fever; no elevated ESR/CRP (or mildly elevated); subacute onset; responds to steroids/PLEX",
        "tests": "MRI: intramedullary T2 hyperintensity, NOT epidural collection; AQP4/MOG antibodies; CSF: pleocytosis but sterile; normal inflammatory markers"
      },
      {
        "diagnosis": "Degenerative lumbar stenosis",
        "features": "Chronic symptoms (claudication); older patient; no fever; no inflammatory markers; bilateral symptoms with walking; relieved by sitting/flexion; chronic findings on MRI",
        "tests": "MRI: chronic stenosis (ligamentum flavum hypertrophy, disc bulging, facet hypertrophy) WITHOUT acute epidural collection; normal ESR/CRP; chronic history"
      },
      {
        "diagnosis": "Vertebral osteomyelitis (without epidural extension)",
        "features": "Similar to SEA but NO epidural collection; disc and vertebral body involvement; back pain and fever; elevated inflammatory markers; may progress to SEA",
        "tests": "MRI: vertebral body and disc enhancement and edema WITHOUT epidural collection; blood cultures may be positive; requires IV antibiotics but not emergent surgical decompression (unless instability or progression to SEA)"
      },
      {
        "diagnosis": "Psoas abscess",
        "features": "Contiguous spread can cause spinal infection; flank/groin pain; hip flexion pain; may track from spine or vice versa; fever; iliopsoas enhancement on imaging",
        "tests": "CT/MRI: psoas muscle enlargement with rim-enhancing collection; may extend to spine; blood cultures; percutaneous drainage often possible"
      }
    ],
    "evidence": [
      {
        "recommendation": "Guideline",
        "evidenceLevel": "Source",
        "source": "Year"
      },
      {
        "recommendation": "Vertebral Osteomyelitis Guidelines",
        "evidenceLevel": "IDSA Clinical Practice Guideline",
        "source": "2015"
      },
      {
        "recommendation": "Spinal Epidural Abscess Management",
        "evidenceLevel": "AANS/CNS Joint Guidelines",
        "source": "2017"
      },
      {
        "recommendation": "Native Vertebral Osteomyelitis",
        "evidenceLevel": "British Infection Association / British Orthopaedic Association",
        "source": "2015"
      },
      {
        "recommendation": "Study",
        "evidenceLevel": "Finding",
        "source": "Impact"
      },
      {
        "recommendation": "[Darouiche (2006) — NEJM Review](https://pubmed.ncbi.nlm.nih.gov/17093252/)",
        "evidenceLevel": "Comprehensive review of SEA: S. aureus most common (60-70%); pre-operative neurologic status is #1 predictor of outcome; early surgery associated with better outcomes; medical management reasonable in selected cases without deficit",
        "source": "Established framework for surgical vs. medical management decision-making"
      },
      {
        "recommendation": "[Siddiq et al. (2004)](https://pubmed.ncbi.nlm.nih.gov/15596629/) — Meta-analysis",
        "evidenceLevel": "915 patients: Surgical treatment associated with better neurologic outcomes than medical management alone; patients presenting with neurologic deficit benefit most from early surgery",
        "source": "Supports surgical decompression as preferred approach, especially with neurologic deficit"
      },
      {
        "recommendation": "[Connor et al. (2013)](https://pubmed.ncbi.nlm.nih.gov/23662888/)",
        "evidenceLevel": "Timing of surgery: decompression within 24h of neurologic deficit associated with significantly better outcomes than delayed surgery",
        "source": "Established 24h window for surgical decompression"
      },
      {
        "recommendation": "[Patel et al. (2014)](https://pubmed.ncbi.nlm.nih.gov/24231778/)",
        "evidenceLevel": "Risk factors for poor outcome: advanced age, diabetes, MRSA, delayed diagnosis, pre-operative paralysis, cervical/thoracic location",
        "source": "Identified high-risk patients who may benefit from aggressive surgical approach"
      },
      {
        "recommendation": "[Berbari et al. (2015) — IDSA Guidelines](https://pubmed.ncbi.nlm.nih.gov/26229122/)",
        "evidenceLevel": "6-week IV antibiotic duration for vertebral osteomyelitis; longer for complicated cases (endocarditis, undrained abscess); rifampin adjunct for staphylococcal infections",
        "source": "Standardized antibiotic duration and adjunctive therapy"
      },
      {
        "recommendation": "[OVIVA Trial (2019)](https://pubmed.ncbi.nlm.nih.gov/30699315/)",
        "evidenceLevel": "Oral antibiotics non-inferior to IV for bone/joint infections after initial IV therapy in stable patients; oral switch after 2 weeks IV",
        "source": "Opened possibility of early oral transition for selected patients; reduces hospitalization/OPAT burden; requires careful patient selection"
      },
      {
        "recommendation": "[Reihsaus et al. (2000)](https://pubmed.ncbi.nlm.nih.gov/11153548/)",
        "evidenceLevel": "Meta-analysis: mortality 5%; permanent paralysis 4-22%; earlier surgery and better pre-operative function = better outcomes",
        "source": "Established prognostic importance of pre-operative neurologic status and early intervention"
      },
      {
        "recommendation": "Organism",
        "evidenceLevel": "Frequency",
        "source": "Key Features"
      },
      {
        "recommendation": "Staphylococcus aureus",
        "evidenceLevel": "60-70% (MRSA 30-50% of S. aureus)",
        "source": "Most common; hematogenous spread; IVDU, skin infection, catheters; MRSA requires vancomycin"
      },
      {
        "recommendation": "Coagulase-negative Staphylococci",
        "evidenceLevel": "5-10%",
        "source": "Post-procedural; hardware-associated"
      },
      {
        "recommendation": "Streptococci (including viridans, pneumoniae)",
        "evidenceLevel": "5-10%",
        "source": "Endocarditis association; dental source"
      },
      {
        "recommendation": "Gram-negative bacilli (E. coli, Pseudomonas, Klebsiella)",
        "evidenceLevel": "10-15%",
        "source": "Urinary source; IVDU (Pseudomonas); diabetics"
      },
      {
        "recommendation": "Enterococcus",
        "evidenceLevel": "2-5%",
        "source": "Urinary source; GI/biliary source"
      },
      {
        "recommendation": "Anaerobes",
        "evidenceLevel": "2-5%",
        "source": "Often polymicrobial; abdominal/pelvic source"
      },
      {
        "recommendation": "Mycobacterium tuberculosis",
        "evidenceLevel": "<5% (higher in endemic areas)",
        "source": "Subacute/chronic; Pott's disease; vertebral destruction; cold abscess; paraspinal extension"
      },
      {
        "recommendation": "Fungi (Candida, Aspergillus)",
        "evidenceLevel": "<2%",
        "source": "IVDU; immunocompromised; indwelling catheters"
      },
      {
        "recommendation": "Culture-negative",
        "evidenceLevel": "10-20%",
        "source": "Prior antibiotics; fastidious organisms; consider TB, Brucella, fungi"
      }
    ],
    "monitoring": [
      {
        "item": "Neurologic examination (motor strength, sensory level, rectal tone, bladder)",
        "frequency": "q2-4h initially; q4-6h once stable",
        "target": "Stable or improving; NO new deficits",
        "action": "ANY deterioration → STAT MRI → emergent surgical consultation → likely emergent decompression"
      },
      {
        "item": "Temperature",
        "frequency": "q4h",
        "target": "Afebrile (<38°C) by 48-72h of antibiotics",
        "action": "Persistent fever: repeat cultures; imaging for undrained collection; reassess antibiotics; echocardiogram"
      },
      {
        "item": "Blood pressure / hemodynamics",
        "frequency": "Continuous if septic; q4h if stable",
        "target": "MAP >65; resolving sepsis",
        "action": "Vasopressors; fluid resuscitation; ICU care for septic shock"
      },
      {
        "item": "Pain score (NRS)",
        "frequency": "q4h",
        "target": "Improving; NRS <4/10",
        "action": "Escalate analgesia; worsening pain may indicate abscess enlargement or instability"
      },
      {
        "item": "Blood cultures (repeat)",
        "frequency": "Daily until negative",
        "target": "Negative cultures within 48-72h of appropriate antibiotics",
        "action": "Persistent bacteremia: echocardiogram (TEE); imaging for undrained focus; consider surgery"
      },
      {
        "item": "WBC, CRP",
        "frequency": "Daily initially",
        "target": "Trending down",
        "action": "Rising inflammatory markers: treatment failure; repeat imaging; reassess management"
      },
      {
        "item": "Vancomycin trough (if on vancomycin)",
        "frequency": "Before 4th dose; then 2-3x/week",
        "target": "15-20 mcg/mL (for serious infection)",
        "action": "Adjust dose if outside range; monitor renal function"
      },
      {
        "item": "Renal function (BUN/Cr)",
        "frequency": "Daily initially; 2-3x/week ongoing",
        "target": "Stable",
        "action": "Nephrotoxicity: adjust vancomycin and other renally-cleared drugs; adequate hydration"
      },
      {
        "item": "Blood glucose",
        "frequency": "q6h (q4h if critically ill)",
        "target": "<180 mg/dL",
        "action": "Insulin titration"
      }
    ],
    "disposition": [
      {
        "disposition": "Level of Care",
        "criteria": "Criteria"
      },
      {
        "disposition": "ICU admission",
        "criteria": "Sepsis/septic shock; hemodynamic instability; respiratory compromise; post-operative monitoring (surgeon-dependent); severe neurologic deficit with close monitoring needed"
      },
      {
        "disposition": "General medical/neurosurgery floor",
        "criteria": "ALL patients with confirmed or suspected SEA require admission; IV antibiotic initiation; neurologic monitoring; surgical evaluation; pre-operative preparation if surgery planned"
      },
      {
        "disposition": "Observation (NOT appropriate)",
        "criteria": "SEA is NEVER an observation diagnosis; all patients require admission until diagnosis confirmed/excluded and treatment initiated"
      }
    ]
  },
  "Idiopathic Intracranial Hypertension (IIH)": {
    "id": "idiopathic-intracranial-hypertension",
    "title": "Idiopathic Intracranial Hypertension (IIH)",
    "version": "1.0",
    "icd10": [
      "** G93.2 (Benign intracranial hypertension)",
      "G93.5 (Compression of brain)"
    ],
    "scope": "** Evaluation and management of idiopathic intracranial hypertension in adults including diagnosis, medical management, and surgical interventions. Applies to ED, hospital, and outpatient settings. Excludes secondary causes of elevated ICP.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "rationale": "Anemia (can cause papilledema); baseline",
            "target": "Normal"
          },
          {
            "item": "CMP",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "rationale": "Renal function (for acetazolamide); electrolytes",
            "target": "Normal"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypothyroidism/hyperthyroidism can cause ICP",
            "target": "Normal"
          },
          {
            "item": "Vitamin A level",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypervitaminosis A",
            "target": "Normal"
          },
          {
            "item": "Pregnancy test",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Pregnancy considerations for treatment",
            "target": "Document"
          }
        ],
        "Extended Workup": [
          {
            "item": "Opening pressure",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diagnostic criterion; ≥25 cm H2O in adults",
            "target": "Elevated (≥25 cm H2O)"
          },
          {
            "item": "CSF cell count",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out meningitis",
            "target": "Normal (≤5 WBC/μL)"
          },
          {
            "item": "CSF protein",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out meningitis, malignancy",
            "target": "Normal (≤45 mg/dL)"
          },
          {
            "item": "CSF glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rule out infection",
            "target": "Normal (>60% serum)"
          },
          {
            "item": "Cytology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If malignancy suspected",
            "target": "Negative"
          },
          {
            "item": "Cultures",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "If infection suspected",
            "target": "Negative"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Iron studies",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Iron deficiency anemia associated",
            "target": "Normal"
          },
          {
            "item": "Cortisol (AM or stimulation test)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Adrenal insufficiency; steroid withdrawal",
            "target": "Normal"
          },
          {
            "item": "ANA, dsDNA",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "SLE (cerebral venous thrombosis risk)",
            "target": "Negative"
          },
          {
            "item": "Hypercoagulability panel",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If venous sinus thrombosis suspected",
            "target": "Normal"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI brain with and without contrast + MRV",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Before LP; rule out mass, CVT",
            "target": "No mass; may show empty sella, flattened globes, optic nerve sheath distension, transverse sinus stenosis",
            "contraindications": "Pacemaker, metal"
          },
          {
            "item": "CT head (if MRI unavailable)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-",
            "timing": "Emergent exclusion of mass",
            "target": "No mass, hemorrhage",
            "contraindications": "None (contrast: renal)"
          },
          {
            "item": "CT venography",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "timing": "If MRV inconclusive for CVT",
            "target": "No venous sinus thrombosis",
            "contraindications": "Renal disease; contrast allergy"
          }
        ],
        "Extended": [
          {
            "item": "Dilated fundoscopic exam",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "All patients; before LP if possible",
            "target": "Papilledema grading (Frisen scale)",
            "contraindications": "None"
          },
          {
            "item": "Optical coherence tomography (OCT)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Quantify RNFL thickness; follow progression",
            "target": "Baseline RNFL; monitor for atrophy",
            "contraindications": "None"
          },
          {
            "item": "Automated perimetry (visual fields)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Detect visual field defects; monitor",
            "target": "Document defects; enlarged blind spot",
            "contraindications": "None"
          },
          {
            "item": "Visual acuity",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "Baseline and monitoring",
            "target": "20/20 or stable",
            "contraindications": "None"
          },
          {
            "item": "Color vision testing",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Optic nerve function",
            "target": "Normal",
            "contraindications": "None"
          },
          {
            "item": "Fundus photography",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Document papilledema; follow",
            "target": "Baseline; monitor",
            "contraindications": "None"
          }
        ]
      },
      "Treatment": {
        "Weight Management (Cornerstone for Obese Patients)": [
          {
            "item": "Weight loss (diet/lifestyle)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10%",
                  "orderSentence": "Weight loss (diet/lifestyle) 10% -"
                }
              ],
              "route": "-",
              "instructions": "Target 5-10% body weight loss; improves ICP",
              "orderSentence": "Weight loss (diet/lifestyle) 10% -"
            },
            "contraindications": "None",
            "monitoring": "Weight; symptoms; visual function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Bariatric surgery referral",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Consider if BMI >35 with comorbidities; effective for IIH",
              "orderSentence": "Bariatric surgery referral - - - see dosing"
            },
            "contraindications": "Per surgical criteria",
            "monitoring": "Weight; ICP",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nutrition/dietitian referral",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Structured weight loss program",
              "orderSentence": "Nutrition/dietitian referral - - - see dosing"
            },
            "contraindications": "None",
            "monitoring": "Progress",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "First-Line Medical Therapy": [
          {
            "item": "Acetazolamide (Diamox)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Acetazolamide (Diamox) 500 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "500 mg BID; titrate to 2-4 g/day as tolerated; IIHTT used up to 4 g/day",
              "orderSentence": "Acetazolamide (Diamox) 500 mg PO"
            },
            "contraindications": "Sulfa allergy, severe renal/hepatic disease, hypokalemia",
            "monitoring": "K+, bicarb, renal function q1-3 months; paresthesias (expected); fatigue, dysgeusia",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Potassium supplementation",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20-40 mEq",
                  "orderSentence": "Potassium supplementation 20-40 mEq -"
                }
              ],
              "route": "-",
              "instructions": "20-40 mEq daily; PRN based on K+ level",
              "orderSentence": "Potassium supplementation 20-40 mEq -"
            },
            "contraindications": "Renal failure, hyperkalemia",
            "monitoring": "K+ levels",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-Line/Adjunctive Medical Therapy": [
          {
            "item": "Topiramate",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Topiramate 25 mg -"
                }
              ],
              "route": "-",
              "instructions": "25 mg BID; titrate to 50-100 mg BID; also promotes weight loss",
              "orderSentence": "Topiramate 25 mg -"
            },
            "contraindications": "Nephrolithiasis, glaucoma, pregnancy",
            "monitoring": "Weight; cognitive effects; metabolic acidosis",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Furosemide (add-on)",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20-40 mg",
                  "orderSentence": "Furosemide (add-on) 20-40 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "20-40 mg daily; if acetazolamide insufficient alone",
              "orderSentence": "Furosemide (add-on) 20-40 mg PO"
            },
            "contraindications": "Sulfa allergy (cross-reactivity uncommon), severe dehydration",
            "monitoring": "K+, renal function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Headache Management": [
          {
            "item": "Acetazolamide (treats underlying cause)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Per above",
              "orderSentence": "Acetazolamide (treats underlying cause) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "Per above",
            "monitoring": "Per above",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Analgesics (acute)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "NSAIDs, acetaminophen PRN; avoid opioids",
              "orderSentence": "Analgesics (acute) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "NSAID: GI/renal issues",
            "monitoring": "Limit use to prevent MOH",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Migraine prophylaxis (if comorbid)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Topiramate (dual benefit); beta-blockers, amitriptyline",
              "orderSentence": "Migraine prophylaxis (if comorbid) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "Per medication",
            "monitoring": "Per medication",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Therapeutic Lumbar Puncture": [
          {
            "item": "Large-volume LP",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20-40 mL",
                  "orderSentence": "Large-volume LP 20-40 mL -"
                }
              ],
              "route": "-",
              "instructions": "Remove 20-40 mL CSF; immediate symptom relief",
              "orderSentence": "Large-volume LP 20-40 mL -"
            },
            "contraindications": "Mass lesion, coagulopathy, infection at site",
            "monitoring": "Headache, symptoms; temporary benefit",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Serial LPs",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Bridge to surgery or when medical therapy insufficient",
              "orderSentence": "Serial LPs - - - see dosing"
            },
            "contraindications": "Same",
            "monitoring": "Same; not long-term solution",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Surgical Interventions (Vision-Threatening or Refractory)": [
          {
            "item": "Optic nerve sheath fenestration (ONSF)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Incision in optic nerve sheath; protects vision; does not reduce ICP",
              "orderSentence": "Optic nerve sheath fenestration (ONSF) - - - see dosing"
            },
            "contraindications": "Severe optic atrophy (relative)",
            "monitoring": "Visual fields, acuity post-op",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF shunting (VP or LP shunt)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Ventriculoperitoneal or lumboperitoneal shunt; reduces ICP and headache",
              "orderSentence": "CSF shunting (VP or LP shunt) - - - see dosing"
            },
            "contraindications": "Infection, peritoneal pathology",
            "monitoring": "Shunt function; revision rate high (50%+)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venous sinus stenting",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Stent transverse sinus stenosis; emerging therapy",
              "orderSentence": "Venous sinus stenting - - - see dosing"
            },
            "contraindications": "No significant stenosis; venous anatomy",
            "monitoring": "ICP; stent patency; headache",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Fulminant IIH (Urgent Vision Loss)": [
          {
            "item": "High-dose IV acetazolamide",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "High-dose IV acetazolamide 500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "500 mg IV q6h initially",
              "orderSentence": "High-dose IV acetazolamide 500 mg IV"
            },
            "contraindications": "Per above",
            "monitoring": "K+, bicarb",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Emergent therapeutic LP",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Large-volume LP; may repeat daily",
              "orderSentence": "Emergent therapeutic LP - - - see dosing"
            },
            "contraindications": "Mass lesion, coagulopathy",
            "monitoring": "Symptoms, vision",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Urgent surgical referral",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "ONSF or shunt within days",
              "orderSentence": "Urgent surgical referral - - - see dosing"
            },
            "contraindications": "Per procedure",
            "monitoring": "Vision",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "IV steroids (controversial)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg",
                  "orderSentence": "IV steroids (controversial) 250 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Methylprednisolone 250 mg IV q6h; short-term bridge only; can worsen IIH long-term",
              "orderSentence": "IV steroids (controversial) 250 mg IV"
            },
            "contraindications": "Contraindicated for maintenance",
            "monitoring": "Glucose; short-term only",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neuro-ophthalmology",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "All patients; diagnosis, monitoring, management"
          },
          {
            "item": "Neurology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Headache management; atypical cases"
          },
          {
            "item": "Neurosurgery",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Fulminant IIH; shunt evaluation"
          },
          {
            "item": "Interventional neuroradiology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Venous sinus stenting evaluation"
          },
          {
            "item": "Ophthalmology",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "If neuro-ophthalmology unavailable"
          },
          {
            "item": "Bariatric surgery",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Obese patients; BMI >35"
          },
          {
            "item": "Nutrition/dietitian",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Weight loss counseling"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "IIH is a chronic condition requiring ongoing monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Weight loss is critical for long-term management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take acetazolamide as prescribed; stay hydrated",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report new visual symptoms immediately (blurred vision, double vision, vision loss)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report worsening headache, nausea/vomiting, pulsatile tinnitus",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid medications that can worsen IIH (vitamin A, tetracyclines)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep all ophthalmology appointments; visual field testing is critical",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "IIH Research Foundation (ihrfoundation.org) for resources",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Cerebral venous thrombosis",
        "features": "Acute headache; hypercoagulable state; may have focal signs",
        "tests": "MRV, CT venography"
      },
      {
        "diagnosis": "Meningitis (infectious or carcinomatous)",
        "features": "Fever, meningismus, abnormal CSF",
        "tests": "CSF analysis, cultures, cytology"
      },
      {
        "diagnosis": "Intracranial mass (tumor, abscess)",
        "features": "Focal signs; mass on imaging",
        "tests": "MRI with contrast"
      },
      {
        "diagnosis": "Hydrocephalus",
        "features": "Enlarged ventricles; gait, cognition changes",
        "tests": "MRI/CT"
      },
      {
        "diagnosis": "Medication-induced ICP elevation",
        "features": "History of causative medication",
        "tests": "History; resolve after discontinuation"
      },
      {
        "diagnosis": "Sleep apnea",
        "features": "Nocturnal headaches; daytime somnolence; may coexist",
        "tests": "Sleep study"
      },
      {
        "diagnosis": "Systemic hypertension (hypertensive encephalopathy)",
        "features": "Severely elevated BP; may cause papilledema",
        "tests": "BP measurement"
      },
      {
        "diagnosis": "Optic neuritis",
        "features": "Unilateral vision loss; pain with eye movement; no papilledema initially",
        "tests": "MRI orbits; OCT"
      },
      {
        "diagnosis": "Hypervitaminosis A",
        "features": "History of vitamin A/retinoid use",
        "tests": "Vitamin A level"
      },
      {
        "diagnosis": "Anemia (severe)",
        "features": "Can cause papilledema without true ICP elevation",
        "tests": "CBC"
      }
    ],
    "evidence": [
      {
        "recommendation": "Acetazolamide effective for IIH",
        "evidenceLevel": "Class I, Level A",
        "source": "IIHTT (Idiopathic Intracranial Hypertension Treatment Trial)"
      },
      {
        "recommendation": "Weight loss improves IIH",
        "evidenceLevel": "Class II, Level B",
        "source": "Multiple studies; IIHTT secondary analysis"
      },
      {
        "recommendation": "ONSF protects vision in IIH",
        "evidenceLevel": "Class III, Level B",
        "source": "Case series; observational data"
      },
      {
        "recommendation": "CSF shunting reduces ICP and headache",
        "evidenceLevel": "Class III, Level B",
        "source": "Case series; high revision rate noted"
      },
      {
        "recommendation": "Venous sinus stenting emerging therapy",
        "evidenceLevel": "Class III, Level C",
        "source": "Growing evidence; case series"
      },
      {
        "recommendation": "Modified Dandy criteria for diagnosis",
        "evidenceLevel": "Expert consensus",
        "source": "[Friedman et al., 2013](https://pubmed.ncbi.nlm.nih.gov/23966248/)"
      },
      {
        "recommendation": "Topiramate as adjunct with weight loss benefit",
        "evidenceLevel": "Class III, Level C",
        "source": "Observational data"
      }
    ],
    "monitoring": [
      {
        "item": "Visual acuity",
        "ED": "STAT",
        "HOSP": "Daily",
        "OPD": "Every visit",
        "ICU": "STAT",
        "frequency": "Ongoing",
        "action": "Escalate treatment"
      },
      {
        "item": "Visual fields (perimetry)",
        "ED": "-",
        "HOSP": "Daily (if fulminant)",
        "OPD": "q1-3 months",
        "ICU": "-",
        "frequency": "Per risk",
        "action": "Escalate treatment"
      },
      {
        "item": "Papilledema grade (Frisen)",
        "ED": "STAT",
        "HOSP": "Daily",
        "OPD": "Every visit",
        "ICU": "STAT",
        "frequency": "Ongoing",
        "action": "Continue treatment"
      },
      {
        "item": "OCT (RNFL thickness)",
        "ED": "-",
        "HOSP": "Baseline",
        "OPD": "q3-6 months",
        "ICU": "-",
        "frequency": "Per schedule",
        "action": "Indicates chronic damage"
      },
      {
        "item": "Weight",
        "ED": "-",
        "HOSP": "Weekly",
        "OPD": "Every visit",
        "ICU": "-",
        "frequency": "Ongoing",
        "action": "Reinforce; consider bariatric"
      },
      {
        "item": "Potassium",
        "ED": "-",
        "HOSP": "Daily initially",
        "OPD": "q1-3 months",
        "ICU": "-",
        "frequency": "On acetazolamide",
        "action": "Supplement"
      },
      {
        "item": "Bicarbonate",
        "ED": "-",
        "HOSP": "Daily initially",
        "OPD": "q1-3 months",
        "ICU": "-",
        "frequency": "On acetazolamide",
        "action": "May need dose reduction"
      },
      {
        "item": "Creatinine",
        "ED": "-",
        "HOSP": "Baseline",
        "OPD": "q3-6 months",
        "ICU": "-",
        "frequency": "On acetazolamide",
        "action": "Adjust dose if impaired"
      },
      {
        "item": "Headache severity",
        "ED": "ROUTINE",
        "HOSP": "Daily",
        "OPD": "Every visit",
        "ICU": "-",
        "frequency": "Ongoing",
        "action": "Optimize treatment"
      }
    ],
    "disposition": [
      {
        "disposition": "Outpatient management",
        "criteria": "Mild-moderate symptoms; stable vision; reliable follow-up"
      },
      {
        "disposition": "Admit to hospital",
        "criteria": "New diagnosis with significant papilledema; fulminant IIH; progressive vision loss; unable to tolerate oral medications"
      },
      {
        "disposition": "ICU admission",
        "criteria": "Rarely needed; severe headache requiring IV therapy; post-operative monitoring"
      },
      {
        "disposition": "Neuro-ophthalmology follow-up",
        "criteria": "q2-4 weeks initially; q1-3 months when stable"
      },
      {
        "disposition": "Urgent follow-up",
        "criteria": "Any decline in vision; worsening headache; medication intolerance"
      }
    ]
  },
  "Rapidly Progressive Dementia": {
    "id": "rapidly-progressive-dementia",
    "title": "Rapidly Progressive Dementia",
    "version": "1.0",
    "icd10": [
      "** F03.90 (Unspecified dementia without behavioral disturbance)",
      "G31.9 (Degenerative disease of nervous system",
      "unspecified)",
      "A81.00 (Creutzfeldt-Jakob disease",
      "unspecified)"
    ],
    "scope": "** Urgent evaluation of cognitive decline progressing over weeks to months (typically <1-2 years from symptom onset to severe disability). Covers comprehensive workup to identify treatable causes including autoimmune encephalitis, infectious etiologies, toxic-metabolic causes, CNS malignancy, and prion disease (CJD). The key principle: assume a treatable cause exists until proven otherwise. Excludes typical slowly progressive dementias (Alzheimer's, FTD) unless presenting atypically fast, and acute delirium (<days).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Infection screen; hematologic malignancy; B12 deficiency (macrocytosis)",
            "target": "Normal"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hepatic encephalopathy (ammonia); renal failure (uremia); electrolyte abnormalities (Na, Ca); hypo/hyperglycemia",
            "target": "Normal"
          },
          {
            "item": "TSH, free T4",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Hypothyroid encephalopathy (Hashimoto encephalopathy); hyperthyroidism",
            "target": "Normal"
          },
          {
            "item": "B12, methylmalonic acid (MMA)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "B12 deficiency — reversible cause of cognitive decline and myelopathy",
            "target": "B12 >300 pg/mL; MMA normal"
          },
          {
            "item": "Folate",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Deficiency associated with cognitive impairment",
            "target": "Normal"
          },
          {
            "item": "ESR",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Vasculitis screen; inflammatory conditions; infection; malignancy",
            "target": "Normal (<20 mm/h age-adjusted)"
          },
          {
            "item": "CRP",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Inflammatory marker",
            "target": "Normal"
          },
          {
            "item": "RPR or VDRL (syphilis screen)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Neurosyphilis — treatable cause; \"the great imitator\"",
            "target": "Non-reactive"
          },
          {
            "item": "HIV 1/2 antigen/antibody",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "HIV-associated neurocognitive disorder (HAND); opportunistic infections",
            "target": "Negative"
          },
          {
            "item": "Ammonia",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Hepatic encephalopathy",
            "target": "Normal (<35 µmol/L)"
          },
          {
            "item": "Urinalysis + urine culture",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "UTI causing delirium (especially elderly)",
            "target": "Negative"
          },
          {
            "item": "Urine drug screen",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "Substance-related cognitive impairment; prescription drug toxicity",
            "target": "Negative or expected medications only"
          },
          {
            "item": "Blood glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hypoglycemia; diabetic encephalopathy",
            "target": "Normal"
          }
        ],
        "Extended Workup": [
          {
            "item": "Anti-thyroid antibodies (anti-TPO, anti-thyroglobulin)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hashimoto encephalopathy (SREAT) — treatable with steroids even if euthyroid",
            "target": "Negative (positive + encephalopathy = consider SREAT)"
          },
          {
            "item": "ANA",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Lupus cerebritis; systemic autoimmune disease",
            "target": "Negative"
          },
          {
            "item": "dsDNA antibodies",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Lupus cerebritis (specific)",
            "target": "Negative"
          },
          {
            "item": "Complement levels (C3, C4)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Lupus; complement-mediated disease",
            "target": "Normal"
          },
          {
            "item": "ANCA (c-ANCA, p-ANCA)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "CNS vasculitis (granulomatosis with polyangiitis, microscopic polyangiitis)",
            "target": "Negative"
          },
          {
            "item": "ACE level (serum)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Neurosarcoidosis",
            "target": "Normal"
          },
          {
            "item": "Serum protein electrophoresis (SPEP) + immunofixation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Multiple myeloma; POEMS; Waldenström; M-protein-associated neuropathy/encephalopathy",
            "target": "Normal pattern"
          },
          {
            "item": "LDH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Lymphoma; hemolysis; intravascular lymphoma",
            "target": "Normal"
          },
          {
            "item": "Peripheral blood smear",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Intravascular lymphoma (schistocytes); TTP (schistocytes + thrombocytopenia)",
            "target": "Normal"
          },
          {
            "item": "Thiamine (B1) level",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Wernicke encephalopathy — reversible with treatment; alcoholism, malnutrition, bariatric surgery",
            "target": "Normal (>70 nmol/L)"
          },
          {
            "item": "Copper and ceruloplasmin",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Wilson disease (young patients <50); acquired copper deficiency (zinc excess, gastric surgery)",
            "target": "Normal"
          },
          {
            "item": "Zinc level",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Zinc excess causes copper deficiency → myeloneuropathy + cognitive decline",
            "target": "Normal"
          },
          {
            "item": "Cortisol (AM or random)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Adrenal insufficiency causing encephalopathy",
            "target": "Normal (>18 µg/dL AM)"
          },
          {
            "item": "Heavy metals (lead, mercury, arsenic)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Occupational/environmental exposure",
            "target": "Normal"
          },
          {
            "item": "Paraneoplastic panel (serum) — comprehensive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "ANNA-1 (Hu), ANNA-2 (Ri), CRMP-5 (CV2), amphiphysin, PCA-1 (Yo), PCA-2, PCA-Tr (DNER), GAD65",
            "target": "Negative"
          },
          {
            "item": "Autoimmune encephalitis panel (serum) — NMDAR, LGI1, CASPR2, GABA-B, GABA-A, AMPA, DPPX, IgLON5",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Treatable autoimmune encephalitis — most important reversible cause to identify",
            "target": "Negative"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "14-3-3 protein (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "CJD biomarker; elevated in rapid neuronal destruction. Sensitivity ~90% but NOT specific (also elevated in stroke, encephalitis, seizures)",
            "target": "Negative (positive supports CJD in right clinical context)"
          },
          {
            "item": "RT-QuIC (Real-Time Quaking-Induced Conversion) — CSF",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "MOST SPECIFIC test for prion disease; sensitivity 92%, specificity 99-100%. Gold standard CSF prion test",
            "target": "Negative (positive = prion disease essentially confirmed)"
          },
          {
            "item": "Tau protein (CSF — total tau)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Markedly elevated in CJD (>1150 pg/mL); also elevated in AD but less extreme",
            "target": "Normal (<400 pg/mL; CJD often >10,000)"
          },
          {
            "item": "Neuron-specific enolase (NSE) — CSF",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "rationale": "Elevated in CJD (>35 ng/mL); marker of neuronal damage",
            "target": "Normal"
          },
          {
            "item": "AD biomarkers (CSF Aβ42, p-tau, t-tau)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Rapidly progressive Alzheimer disease (rpAD) is the most common misdiagnosis of CJD; AD biomarker pattern distinguishes",
            "target": "Aβ42/Aβ40 ratio normal; p-tau/t-tau ratio helps distinguish"
          },
          {
            "item": "Neurofilament light chain (NfL) — CSF or serum",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Non-specific marker of neuronal damage; markedly elevated in CJD, moderately in many RPDs",
            "target": "Baseline for comparison"
          },
          {
            "item": "Whipple disease PCR (CSF and duodenal biopsy)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Tropheryma whipplei — rare but treatable cause of RPD with oculomasticatory myorhythmia; GI symptoms, arthralgia",
            "target": "Negative"
          },
          {
            "item": "PRNG gene analysis (blood)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Genetic prion disease (familial CJD, fatal familial insomnia, GSS); family history of early dementia or movement disorder",
            "target": "No mutation"
          },
          {
            "item": "QuantiFERON-TB Gold / PPD",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "TB meningitis with cognitive decline",
            "target": "Negative"
          },
          {
            "item": "Bartonella serology",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Cat-scratch disease encephalitis",
            "target": "Negative"
          },
          {
            "item": "Brucella serology",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Neurobrucellosis (occupational exposure)",
            "target": "Negative"
          },
          {
            "item": "Lyme antibody (ELISA, Western blot)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Lyme encephalopathy (endemic areas)",
            "target": "Negative"
          },
          {
            "item": "Celiac antibodies (tTG IgA, deamidated gliadin)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Gluten ataxia / celiac encephalopathy",
            "target": "Negative"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Elevated ICP in mass, hydrocephalus, venous thrombosis",
            "target": "Normal (10-20 cm H2O)"
          },
          {
            "item": "Cell count with differential (tubes 1 and 4)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Pleocytosis suggests infection, autoimmune, or lymphoma; normal in CJD",
            "target": "Normal in CJD; elevated in autoimmune/infectious"
          },
          {
            "item": "Protein",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Elevated in infection, inflammation, malignancy; mildly elevated or normal in CJD",
            "target": "Normal or mildly elevated in CJD; elevated in infection/autoimmune"
          },
          {
            "item": "Glucose with paired serum",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Low in bacterial/TB/fungal meningitis, carcinomatous meningitis",
            "target": "Normal in CJD, autoimmune; low in infectious/malignant"
          },
          {
            "item": "Gram stain and culture",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Exclude chronic bacterial infection",
            "target": "No organisms"
          },
          {
            "item": "RT-QuIC (Real-Time Quaking-Induced Conversion)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Most sensitive and specific CSF test for prion disease (sensitivity 92%, specificity 99-100%)",
            "target": "Negative"
          },
          {
            "item": "14-3-3 protein",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "CJD biomarker; rapid neuronal destruction marker",
            "target": "Negative"
          },
          {
            "item": "Total tau protein",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Markedly elevated in CJD (>1150 pg/mL); moderately elevated in AD",
            "target": "Normal (<400 pg/mL)"
          },
          {
            "item": "NSE (neuron-specific enolase)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "CJD biomarker",
            "target": "Normal"
          },
          {
            "item": "Autoimmune encephalitis panel (CSF) — NMDAR, LGI1, CASPR2, GABA-B, GABA-A, AMPA, DPPX",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "CSF more sensitive than serum for NMDAR antibodies; identifies treatable autoimmune etiology",
            "target": "Negative"
          },
          {
            "item": "Paraneoplastic antibodies (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "More sensitive than serum for some antibodies",
            "target": "Negative"
          },
          {
            "item": "Oligoclonal bands, IgG index",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Intrathecal antibody synthesis (MS, autoimmune, neurosarcoidosis)",
            "target": "Negative"
          },
          {
            "item": "Cytology (send 10 mL minimum; repeat x3 for sensitivity)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Leptomeningeal carcinomatosis/lymphoma; sensitivity improves with volume and repeat",
            "target": "Negative"
          },
          {
            "item": "Flow cytometry",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "CNS lymphoma (B-cell clonality)",
            "target": "Normal"
          },
          {
            "item": "HSV 1/2 PCR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "HSV encephalitis; post-HSV autoimmune encephalitis",
            "target": "Negative"
          },
          {
            "item": "VZV PCR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "VZV vasculopathy / encephalitis",
            "target": "Negative"
          },
          {
            "item": "EBV PCR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "CNS lymphoma (EBV-driven)",
            "target": "Negative"
          },
          {
            "item": "JC virus PCR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "PML (immunocompromised)",
            "target": "Negative"
          },
          {
            "item": "VDRL (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Neurosyphilis",
            "target": "Non-reactive"
          },
          {
            "item": "Cryptococcal antigen",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Cryptococcal meningitis (immunocompromised)",
            "target": "Negative"
          },
          {
            "item": "AFB smear and culture",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "TB meningitis",
            "target": "Negative"
          },
          {
            "item": "ACE level (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Neurosarcoidosis",
            "target": "Normal"
          },
          {
            "item": "Whipple PCR (T. whipplei)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "rationale": "Whipple disease",
            "target": "Negative"
          },
          {
            "item": "Beta-2 microglobulin (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "rationale": "CNS lymphoma marker",
            "target": "Normal"
          },
          {
            "item": "Alzheimer biomarkers (Aβ42, Aβ40, p-tau 181, t-tau)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "rpAD pattern: low Aβ42, elevated p-tau; helps distinguish from CJD (where p-tau is NOT as elevated relative to t-tau)",
            "target": "Context-dependent"
          },
          {
            "item": "Neurofilament light chain (NfL) — CSF",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Non-specific neuronal damage; very elevated in CJD",
            "target": "Baseline"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI brain with and without contrast + DWI",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "Within 24h. DWI is CRITICAL — cortical ribboning on DWI is highly suggestive of CJD",
            "target": "CJD: cortical ribboning (DWI/FLAIR high signal in cortex), caudate/putamen signal. Autoimmune: mesial temporal T2/FLAIR. Vasculitis: multifocal white matter lesions. Lymphoma: enhancing mass. Wernicke: mamillary body/thalamic signal. MS: periventricular/juxtacortical lesions",
            "contraindications": "Pacemaker, metallic implants"
          },
          {
            "item": "EEG (routine or prolonged)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Within 24h",
            "target": "CJD: periodic sharp wave complexes (PSWCs) at 1-2 Hz — sensitivity ~65% (higher in sCJD-MM1). Seizures: electrographic activity. NCSE: subclinical seizures. Autoimmune: extreme delta brush (NMDAR)",
            "contraindications": "None significant"
          },
          {
            "item": "CT head without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Immediate if acute presentation or focal deficit",
            "target": "Mass lesion, hydrocephalus, hemorrhage, large infarct",
            "contraindications": "Pregnancy (relative)"
          }
        ],
        "Extended": [
          {
            "item": "MRA/MRV brain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If vasculitis or venous thrombosis suspected",
            "target": "CNS vasculitis (beading); dural sinus thrombosis",
            "contraindications": "Same as MRI"
          },
          {
            "item": "MRI spine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If concurrent myelopathy (B12 deficiency, copper deficiency, neurosarcoidosis)",
            "target": "Cord signal change (posterior columns in B12/copper); sarcoid enhancement",
            "contraindications": "Same as MRI"
          },
          {
            "item": "Continuous EEG (cEEG)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "If altered consciousness; suspected NCSE",
            "target": "Non-convulsive seizures; subclinical status",
            "contraindications": "None"
          },
          {
            "item": "FDG-PET brain",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Differentiate neurodegenerative patterns; detect occult malignancy; autoimmune encephalitis (mesial temporal hypermetabolism)",
            "target": "AD: temporoparietal hypometabolism. FTD: frontal/temporal. CJD: cortical/striatal. Lymphoma: hypermetabolic mass. Autoimmune: mesial temporal hypermetabolism",
            "contraindications": "Pregnancy; uncontrolled diabetes"
          },
          {
            "item": "PET-CT body (whole body)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Occult malignancy search (paraneoplastic); lymphoma staging",
            "target": "Primary tumor identification",
            "contraindications": "Same as FDG-PET"
          },
          {
            "item": "CT chest/abdomen/pelvis with contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Cancer screening (paraneoplastic); sarcoidosis (hilar adenopathy)",
            "target": "Mass, lymphadenopathy",
            "contraindications": "Contrast allergy, renal impairment"
          },
          {
            "item": "Conventional cerebral angiography (DSA)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If CNS vasculitis suspected (MRA normal does not exclude small-vessel vasculitis)",
            "target": "Beading (alternating stenosis/dilation)",
            "contraindications": "Contrast allergy, coagulopathy"
          },
          {
            "item": "Testicular ultrasound (males)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "timing": "Testicular germ cell tumor (paraneoplastic; anti-NMDAR in males)",
            "target": "Normal",
            "contraindications": "None"
          },
          {
            "item": "Pelvic ultrasound/MRI (females)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Ovarian teratoma (anti-NMDAR encephalitis — present in 50% of young women)",
            "target": "Normal",
            "contraindications": "None"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Brain biopsy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Last resort when all non-invasive testing inconclusive; suspected CNS vasculitis, intravascular lymphoma, or prion disease where RT-QuIC unavailable",
            "target": "Vasculitis (vessel wall inflammation); lymphoma (atypical cells); prion disease (spongiform change, PrP immunostaining)",
            "contraindications": "Surgical risk; coagulopathy"
          },
          {
            "item": "Meningeal biopsy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Chronic meningitis of unknown etiology",
            "target": "Granulomas (sarcoid, TB); malignancy",
            "contraindications": "Same as brain biopsy"
          },
          {
            "item": "Bone marrow biopsy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If intravascular lymphoma, hemophagocytic lymphohistiocytosis (HLH), or hematologic malignancy suspected",
            "target": "Abnormal cells; hemophagocytosis",
            "contraindications": "Coagulopathy"
          },
          {
            "item": "Upper endoscopy with duodenal biopsy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Whipple disease (PAS-positive macrophages)",
            "target": "Normal (PAS-negative)",
            "contraindications": "Standard GI endoscopy risks"
          },
          {
            "item": "Sleep polysomnography",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Fatal familial insomnia (FFI) — complete loss of sleep architecture",
            "target": "Absent sleep spindles; disrupted sleep architecture",
            "contraindications": "Cooperation"
          }
        ]
      },
      "Treatment": {
        "Empiric / Treatable Causes — TREAT WHILE AWAITING RESULTS": [
          {
            "item": "Thiamine (B1) IV",
            "route": "IV",
            "indication": "Empiric for Wernicke encephalopathy if ANY suspicion (alcohol, malnutrition, bariatric surgery); treat before glucose",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Thiamine (B1) IV 500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "500 mg IV TID x 3-5 days, then 250 mg IV daily x 3-5 days, then 100 mg PO daily ongoing",
              "orderSentence": "Thiamine (B1) IV 500 mg IV"
            },
            "contraindications": "None significant",
            "monitoring": "Clinical response (confusion, ataxia, ophthalmoplegia should improve)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "IV methylprednisolone (empiric immunotherapy trial)",
            "route": "IV",
            "indication": "Suspected autoimmune encephalitis, Hashimoto encephalopathy (SREAT), neurosarcoidosis, CNS vasculitis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "IV methylprednisolone (empiric immunotherapy trial) 1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg IV daily x 3-5 days. Consider when autoimmune etiology suspected and workup pending. Document pre-treatment baseline exam.",
              "orderSentence": "IV methylprednisolone (empiric immunotherapy trial) 1000 mg IV"
            },
            "contraindications": "Active infection (rule out first); uncertain prion disease (steroids do not help CJD and may mask diagnosis)",
            "monitoring": "Glucose q6h; BP; GI prophylaxis; response assessment",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "IVIG (empiric immunotherapy trial)",
            "route": "-",
            "indication": "Suspected autoimmune encephalitis; concurrent with steroid trial",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg",
                  "orderSentence": "IVIG (empiric immunotherapy trial) 0.4 g/kg -"
                }
              ],
              "route": "-",
              "instructions": "0.4 g/kg/day x 5 days (total 2 g/kg). Add to steroids or as alternative if steroid-intolerant",
              "orderSentence": "IVIG (empiric immunotherapy trial) 0.4 g/kg -"
            },
            "contraindications": "IgA deficiency; renal failure; thrombotic risk",
            "monitoring": "Renal function; headache; thrombotic events",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Acyclovir IV (if HSV not excluded)",
            "route": "IV",
            "indication": "Empiric while awaiting HSV PCR; fever + encephalopathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg",
                  "orderSentence": "Acyclovir IV (if HSV not excluded) 10 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV q8h. Continue until HSV PCR confirmed negative",
              "orderSentence": "Acyclovir IV (if HSV not excluded) 10 mg/kg IV"
            },
            "contraindications": "Renal impairment (dose adjust)",
            "monitoring": "Cr daily; hydration",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Targeted Treatments (Once Diagnosis Established)": [
          {
            "item": "IV methylprednisolone → oral prednisone taper",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1g",
                  "orderSentence": "IV methylprednisolone → oral prednisone taper 1g IV"
                }
              ],
              "route": "IV",
              "instructions": "1g IV x 5d → prednisone 1 mg/kg/day with slow taper over 3-6 months",
              "orderSentence": "IV methylprednisolone → oral prednisone taper 1g IV"
            },
            "contraindications": "-",
            "monitoring": "Glucose, BP, bone density, weight, mood",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "IVIG",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg",
                  "orderSentence": "IVIG 0.4 g/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.4 g/kg/day x 5 days; repeat monthly for maintenance",
              "orderSentence": "IVIG 0.4 g/kg PO"
            },
            "contraindications": "-",
            "monitoring": "Renal function; IgG levels",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Rituximab",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "375 mg/m2",
                  "orderSentence": "Rituximab 375 mg/m2 IV"
                }
              ],
              "route": "IV",
              "instructions": "375 mg/m2 IV weekly x 4 weeks OR 1000 mg IV x 2 doses (2 weeks apart)",
              "orderSentence": "Rituximab 375 mg/m2 IV"
            },
            "contraindications": "-",
            "monitoring": "CD19/20 counts; immunoglobulins; infection risk; PML risk",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Cyclophosphamide",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "750-1000 mg/m2",
                  "orderSentence": "Cyclophosphamide 750-1000 mg/m2 IV"
                }
              ],
              "route": "IV",
              "instructions": "750-1000 mg/m2 IV monthly x 6 months (pulse) OR oral 1-2 mg/kg/day",
              "orderSentence": "Cyclophosphamide 750-1000 mg/m2 IV"
            },
            "contraindications": "-",
            "monitoring": "CBC (nadir at 10-14 days); urinalysis (hemorrhagic cystitis — give MESNA); fertility preservation discussion",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Penicillin G IV",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "18-24 million units/day IV (3-4 MU q4h) x 14 days",
              "orderSentence": "Penicillin G IV - IV - see dosing"
            },
            "contraindications": "-",
            "monitoring": "RPR titer follow-up q3-6 months (4-fold decline expected)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Tumor-directed therapy",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Per oncology",
              "orderSentence": "Tumor-directed therapy - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Clinical response; antibody titers",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Teratoma resection",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Surgical removal",
              "orderSentence": "Teratoma resection - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Repeat imaging; antibody titers",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "B12 replacement",
            "route": "IM",
            "indication": "-",
            "dosing": {
              "instructions": "Cyanocobalamin 1000 µg IM daily x 7 days, then weekly x 4, then monthly long-term",
              "orderSentence": "B12 replacement - IM - see dosing"
            },
            "contraindications": "-",
            "monitoring": "B12 and MMA levels at 3 months",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Antifungals (amphotericin B + flucytosine)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.7-1 mg/kg",
                  "orderSentence": "Antifungals (amphotericin B + flucytosine) 0.7-1 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "Amphotericin B 0.7-1 mg/kg/day IV + flucytosine 100 mg/kg/day x 2 weeks (induction)",
              "orderSentence": "Antifungals (amphotericin B + flucytosine) 0.7-1 mg/kg IV"
            },
            "contraindications": "-",
            "monitoring": "Renal function; electrolytes; LFTs",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Anti-TB regimen",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "RIPE: rifampin + isoniazid + pyrazinamide + ethambutol",
              "orderSentence": "Anti-TB regimen - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "LFTs; visual acuity (ethambutol); drug interactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "No disease-modifying treatment",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Supportive care only; no effective treatment exists",
              "orderSentence": "No disease-modifying treatment - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Comfort care; goals of care discussion",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Levetiracetam",
            "route": "IV",
            "indication": "Seizures",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500-1500 mg",
                  "orderSentence": "Levetiracetam 500-1500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "500-1500 mg PO/IV BID; max 3000 mg/day",
              "orderSentence": "Levetiracetam 500-1500 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Severe renal impairment (dose adjust)",
            "monitoring": "Renal function; behavioral changes",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Lorazepam",
            "route": "IV",
            "indication": "Agitation, myoclonus (CJD)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5-1 mg",
                  "orderSentence": "Lorazepam 0.5-1 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-1 mg PO/IV q6-8h PRN",
              "orderSentence": "Lorazepam 0.5-1 mg IV"
            },
            "pretreatment": "-",
            "contraindications": "Respiratory depression",
            "monitoring": "Sedation; respiratory status",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Clonazepam",
            "route": "PO",
            "indication": "Myoclonus (CJD)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg",
                  "orderSentence": "Clonazepam 0.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.5 mg PO BID; increase to 1-2 mg TID",
              "orderSentence": "Clonazepam 0.5 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Respiratory depression; fall risk",
            "monitoring": "Sedation; fall prevention",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Valproic acid",
            "route": "PO",
            "indication": "Myoclonus (adjunctive); seizures",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250-500 mg",
                  "orderSentence": "Valproic acid 250-500 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "250-500 mg PO BID; target level 50-100 µg/mL",
              "orderSentence": "Valproic acid 250-500 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Hepatic disease; pancreatitis; pregnancy",
            "monitoring": "LFTs; ammonia; drug level; CBC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Quetiapine",
            "route": "PO",
            "indication": "Agitation, psychosis, behavioral disturbance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-50 mg",
                  "orderSentence": "Quetiapine 25-50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "25-50 mg PO qHS; increase by 25 mg/day; max 200-400 mg/day",
              "orderSentence": "Quetiapine 25-50 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "QT prolongation; Parkinson disease (avoid all antipsychotics in Lewy body)",
            "monitoring": "QTc; metabolic panel; sedation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Insomnia, behavioral disturbance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-50 mg",
                  "orderSentence": "Trazodone 25-50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "25-50 mg PO qHS; max 150 mg",
              "orderSentence": "Trazodone 25-50 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "Priapism (rare); orthostatic hypotension",
            "monitoring": "Sedation; orthostasis",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "Insomnia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3-10 mg",
                  "orderSentence": "Melatonin 3-10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "3-10 mg PO qHS",
              "orderSentence": "Melatonin 3-10 mg PO"
            },
            "pretreatment": "-",
            "contraindications": "None significant",
            "monitoring": "Sleep quality",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology (behavioral/cognitive subspecialty if available)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT",
            "ICU": "STAT",
            "indication": "All RPD cases; diagnostic workup direction; empiric treatment decisions"
          },
          {
            "item": "Neuro-immunology",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Suspected autoimmune encephalitis; immunotherapy management"
          },
          {
            "item": "Infectious disease",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Suspected CNS infection (neurosyphilis, TB, HIV, fungal, Whipple)"
          },
          {
            "item": "Oncology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Paraneoplastic syndrome; CNS lymphoma; brain metastases"
          },
          {
            "item": "Neurosurgery",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "indication": "Brain biopsy consideration; hydrocephalus management"
          },
          {
            "item": "Rheumatology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Suspected CNS vasculitis; lupus cerebritis; sarcoidosis"
          },
          {
            "item": "Psychiatry",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Behavioral management; depression; capacity assessment"
          },
          {
            "item": "Neuropsychology",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Formal cognitive testing; baseline and follow-up"
          },
          {
            "item": "Palliative care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "indication": "Goals of care (especially if CJD suspected); symptom management"
          },
          {
            "item": "Social work",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Family support; advance directive planning; caregiver resources"
          },
          {
            "item": "Genetic counseling",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "If genetic prion disease suspected; family implications"
          },
          {
            "item": "Ethics consultation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-",
            "indication": "End-of-life decisions; capacity evaluation for untreatable conditions"
          },
          {
            "item": "National Prion Disease Pathology Surveillance Center (Cleveland)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "If CJD suspected: contact for diagnostic guidance and potential brain autopsy"
          },
          {
            "item": "Speech-language pathology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Dysphagia; communication strategies"
          },
          {
            "item": "Physical/Occupational therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Safety; mobility; ADLs; fall prevention"
          }
        ],
        "Patient Instructions": [
          {
            "item": "RPD has many TREATABLE causes — aggressive workup is justified",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return to ED if: new seizure, sudden worsening, falls, inability to swallow, fever",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do NOT drive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Ensure 24/7 supervision at home (fall risk, wandering, impaired judgment)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Advance directives / healthcare power of attorney should be completed early while patient can still participate",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "If CJD is diagnosed: no cure exists; disease is uniformly fatal; focus on comfort and quality of life",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "CJD is NOT contagious through casual contact; standard precautions are sufficient; no isolation needed for family",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "CJD surgical instruments: notify any surgical/dental providers about diagnosis (special sterilization or instrument destruction required)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Family support resources: CJD Foundation (www.cjdfoundation.org); Autoimmune Encephalitis Alliance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Follow-up with neurology frequently (weekly to monthly depending on trajectory)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Fall prevention (remove tripping hazards, grab bars, non-slip surfaces)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "No driving, no operating machinery",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Medication management by caregiver (patient cannot reliably self-administer)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Home safety evaluation (OT)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Caregiver support and respite care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Nutritional support (swallowing may decline; SLP evaluation)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Medical ID bracelet",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Creutzfeldt-Jakob disease (CJD)",
        "features": "Weeks-months; myoclonus; startle; akinetic mutism late; MRI cortical ribboning + caudate/putamen DWI signal; PSWCs on EEG",
        "tests": "RT-QuIC (CSF); 14-3-3; total tau >1150; MRI DWI; EEG"
      },
      {
        "diagnosis": "Autoimmune encephalitis (anti-NMDAR)",
        "features": "Subacute; psychiatric symptoms → seizures → movement disorder → autonomic → decreased consciousness; young women; ovarian teratoma",
        "tests": "NMDAR antibody (CSF > serum); pelvic imaging"
      },
      {
        "diagnosis": "Autoimmune encephalitis (anti-LGI1)",
        "features": "Faciobrachial dystonic seizures; hyponatremia; memory loss; >40 years",
        "tests": "LGI1 antibody (serum > CSF); serum Na"
      },
      {
        "diagnosis": "Hashimoto encephalopathy (SREAT)",
        "features": "Euthyroid or hypothyroid; high anti-TPO; steroid-responsive; diagnosis of exclusion",
        "tests": "Anti-TPO elevated; response to steroids; exclude other causes"
      },
      {
        "diagnosis": "Rapidly progressive Alzheimer disease (rpAD)",
        "features": "Most common misdiagnosis of CJD; positive AD biomarkers (low Aβ42, high p-tau); no myoclonus typically; MRI shows atrophy, no DWI ribboning",
        "tests": "CSF AD biomarkers (Aβ42/Aβ40 ratio low, p-tau elevated); MRI (atrophy without DWI cortical signal); RT-QuIC negative"
      },
      {
        "diagnosis": "CNS lymphoma (primary or intravascular)",
        "features": "B symptoms; enhancing mass (primary); multifocal white matter changes with LDH elevation and no mass (intravascular)",
        "tests": "MRI with contrast; CSF cytology + flow cytometry; EBV PCR; brain biopsy; LDH; peripheral smear"
      },
      {
        "diagnosis": "Leptomeningeal carcinomatosis",
        "features": "Known malignancy; cranial neuropathies; communicating hydrocephalus; CSF cytology positive",
        "tests": "CSF cytology (repeat x3); MRI with contrast (leptomeningeal enhancement)"
      },
      {
        "diagnosis": "Neurosyphilis",
        "features": "RPR/VDRL positive; Argyll Robertson pupils; psychiatric symptoms; may have prior STI history",
        "tests": "RPR/VDRL (serum); CSF VDRL; FTA-ABS"
      },
      {
        "diagnosis": "Wernicke encephalopathy",
        "features": "Acute confusion + ophthalmoplegia + ataxia triad (only 10% have all three); alcoholism, malnutrition",
        "tests": "Thiamine level (draw before treatment); MRI (mamillary body, thalamic signal); clinical response to thiamine"
      },
      {
        "diagnosis": "CNS vasculitis",
        "features": "Headache; multifocal deficits; strokes; CSF pleocytosis",
        "tests": "MRA (beading); DSA; brain/meningeal biopsy; ESR/CRP elevated"
      },
      {
        "diagnosis": "Neurosarcoidosis",
        "features": "Cranial neuropathies (CN VII); leptomeningeal enhancement; hilar adenopathy; elevated ACE",
        "tests": "Chest CT; serum/CSF ACE; biopsy (granulomas)"
      },
      {
        "diagnosis": "Normal pressure hydrocephalus (NPH)",
        "features": "Triad: gait disorder (predominant) + urinary incontinence + dementia; \"wet, wobbly, and wacky\"; ventricular enlargement disproportionate to atrophy",
        "tests": "Large-volume LP (30-50 mL) with pre/post gait assessment; MRI (Evans index >0.3)"
      },
      {
        "diagnosis": "Toxic/metabolic encephalopathy",
        "features": "Medication toxicity (lithium, methotrexate, chemotherapy); substance abuse; hepatic/uremic encephalopathy",
        "tests": "Drug levels; LFTs; ammonia; BUN/Cr; UDS"
      },
      {
        "diagnosis": "Depression/Pseudo-dementia",
        "features": "Depressive symptoms predominant; subjective cognitive complaints > objective deficits; onset correlates with depressive episode",
        "tests": "Neuropsychological testing; psychiatric evaluation; may improve with antidepressant"
      },
      {
        "diagnosis": "Whipple disease",
        "features": "Oculomasticatory myorhythmia (pathognomonic); GI symptoms; arthralgia; chronic diarrhea",
        "tests": "T. whipplei PCR (CSF, duodenal biopsy); PAS-positive macrophages on biopsy"
      },
      {
        "diagnosis": "PML (progressive multifocal leukoencephalopathy)",
        "features": "Immunocompromised; multifocal white matter lesions (no enhancement typically); progressive deficits",
        "tests": "JC virus PCR (CSF); MRI pattern; clinical context"
      },
      {
        "diagnosis": "Fatal familial insomnia",
        "features": "Genetic prion disease; progressive insomnia → autonomic dysfunction → motor signs → dementia; family history",
        "tests": "PRNP gene testing (D178N mutation with 129M); polysomnography (absent sleep spindles)"
      }
    ],
    "evidence": [
      {
        "recommendation": "RT-QuIC for CJD diagnosis (sensitivity 92%, specificity 99-100%)",
        "evidenceLevel": "Class I, Level A",
        "source": "[McGuire et al. (Ann Neurol 2012)](https://pubmed.ncbi.nlm.nih.gov/22926858/); [Atarashi et al. (Nat Med 2011)](https://pubmed.ncbi.nlm.nih.gov/21278748/)"
      },
      {
        "recommendation": "MRI DWI cortical ribboning for CJD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Vitali et al. (Neurology 2011)](https://pubmed.ncbi.nlm.nih.gov/21471469/); [Young et al. (AJNR 2005)](https://pubmed.ncbi.nlm.nih.gov/15956529/)"
      },
      {
        "recommendation": "CSF 14-3-3 protein for CJD (sensitivity ~90%, lower specificity)",
        "evidenceLevel": "Class IIa, Level B",
        "source": "WHO diagnostic criteria; [Muayqil et al. (2012)](https://pubmed.ncbi.nlm.nih.gov/22993290/)"
      },
      {
        "recommendation": "Comprehensive autoimmune antibody testing in RPD",
        "evidenceLevel": "Class I, Level B",
        "source": "[Graus et al. (Lancet Neurol 2016)](https://pubmed.ncbi.nlm.nih.gov/26906964/) — diagnostic criteria for autoimmune encephalitis"
      },
      {
        "recommendation": "Empiric immunotherapy trial for suspected autoimmune encephalitis",
        "evidenceLevel": "Class IIa, Level C",
        "source": "Expert consensus; [Dalmau & Graus (NEJM 2018)](https://pubmed.ncbi.nlm.nih.gov/29490181/)"
      },
      {
        "recommendation": "Anti-NMDAR encephalitis: immunotherapy + teratoma resection",
        "evidenceLevel": "Class I, Level B",
        "source": "[Titulaer et al. (Lancet Neurol 2013)](https://pubmed.ncbi.nlm.nih.gov/23290630/)"
      },
      {
        "recommendation": "Anti-LGI1: steroids as first-line",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[Irani et al. (Brain 2010)](https://pubmed.ncbi.nlm.nih.gov/20663977/)"
      },
      {
        "recommendation": "Hashimoto encephalopathy (SREAT): steroid-responsive",
        "evidenceLevel": "Class IIb, Level C",
        "source": "[Castillo et al. (Arch Neurol 2006)](https://pubmed.ncbi.nlm.nih.gov/16476807/); diagnosis of exclusion"
      },
      {
        "recommendation": "Thiamine for Wernicke: high-dose IV (500 mg TID)",
        "evidenceLevel": "Class I, Level B",
        "source": "[Thomson & Marshall (2006)](https://pubmed.ncbi.nlm.nih.gov/16384871/); [Galvin et al. (2010)](https://pubmed.ncbi.nlm.nih.gov/20642790/)"
      },
      {
        "recommendation": "Neurosyphilis: IV penicillin G x 14 days",
        "evidenceLevel": "Class I, Level A",
        "source": "CDC STI Treatment Guidelines"
      },
      {
        "recommendation": "CJD: no effective treatment; supportive care only",
        "evidenceLevel": "Class I, Level A",
        "source": "No disease-modifying therapy exists; multiple trials failed"
      },
      {
        "recommendation": "Brain biopsy when non-invasive workup inconclusive",
        "evidenceLevel": "Class IIa, Level C",
        "source": "Expert consensus; diagnostic yield 57-65% in RPD"
      },
      {
        "recommendation": "Save CSF frozen for future studies",
        "evidenceLevel": "Class I, Level C",
        "source": "Standard practice; new biomarkers emerging"
      }
    ],
    "monitoring": [
      {
        "item": "Cognitive assessment (MMSE, MoCA, or bedside exam)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "Baseline; weekly inpatient; each visit outpatient",
        "action": "Document trajectory; adjust treatment"
      },
      {
        "item": "Neurologic exam (focal signs, myoclonus, gait, cranial nerves)",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "Daily inpatient; each visit outpatient",
        "action": "If new focal signs: repeat MRI; if myoclonus: add clonazepam"
      },
      {
        "item": "Seizure monitoring",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT",
        "frequency": "Clinical observation; EEG if suspicious",
        "action": "AED initiation/adjustment"
      },
      {
        "item": "Swallowing assessment",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE",
        "frequency": "Weekly; SLP evaluation",
        "action": "Modified diet; NG/PEG if progressive"
      },
      {
        "item": "Weight",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Weekly",
        "action": "Nutritional support"
      },
      {
        "item": "Serum sodium",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q12-24h initially; then per clinical indication",
        "action": "SIADH management if low; LGI1 encephalitis associated with hyponatremia"
      },
      {
        "item": "Renal function",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Daily if on acyclovir or nephrotoxic drugs; weekly otherwise",
        "action": "Dose adjustments"
      },
      {
        "item": "Response to immunotherapy",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Assess at day 5 of steroids/IVIG; then weekly",
        "action": "If no response: consider second-line (rituximab); reconsider diagnosis"
      },
      {
        "item": "Autoimmune antibody titers (follow-up)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "q3-6 months if positive",
        "action": "If rising: relapse risk; adjust immunotherapy"
      },
      {
        "item": "Safety assessment (fall risk, wandering, capacity)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-",
        "frequency": "Daily inpatient; each visit outpatient",
        "action": "Increase supervision; facility placement if needed"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Stable cognition; safe home environment with 24/7 caregiver; outpatient workup can be completed; no active seizures; swallowing safe; outpatient follow-up arranged within 1-2 weeks"
      },
      {
        "disposition": "Admit to hospital",
        "criteria": "Acute/subacute decline requiring urgent workup; unable to safely manage at home; seizures; empiric immunotherapy trial; cannot complete workup as outpatient"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Status epilepticus; respiratory failure; autonomic instability; severe agitation requiring sedation; ICP management"
      },
      {
        "disposition": "Transfer to tertiary center",
        "criteria": "Complex workup (brain biopsy, specialized autoimmune testing); prion disease expertise; clinical trial access"
      },
      {
        "disposition": "Memory care / Long-term care",
        "criteria": "Progressive untreatable dementia (CJD, advanced neurodegenerative); unable to care for self; caregiver unable to manage"
      },
      {
        "disposition": "Hospice",
        "criteria": "Confirmed CJD or other untreatable rapidly fatal diagnosis; focus on comfort"
      }
    ]
  },
  "Breakthrough Seizure (Known Epilepsy)": {
    "id": "breakthrough-seizure",
    "title": "Breakthrough Seizure (Known Epilepsy)",
    "version": "1.0",
    "icd10": [
      "** G40.909 (Epilepsy",
      "unspecified",
      "not intractable",
      "without status epilepticus)",
      "G40.901 (Epilepsy",
      "unspecified",
      "not intractable",
      "with status epilepticus)",
      "G40.919 (Epilepsy",
      "unspecified",
      "intractable",
      "without status epilepticus)",
      "R56.9 (Unspecified convulsions)"
    ],
    "scope": "** Evaluation and management of breakthrough seizures in adults with known epilepsy who are on established antiseizure medication (ASM) regimens. Covers identification of precipitants, medication level assessment, adjustment strategies, and evaluation for secondary causes. Excludes new-onset seizure (separate workup), status epilepticus (see SE template), and non-epileptic events (psychogenic non-epileptic seizures).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Antiseizure medication (ASM) levels",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "**CRITICAL**: Subtherapeutic levels are #1 cause of breakthrough seizures; check ALL ASMs with available assays",
            "target": "Therapeutic ranges (see Appendix); subtherapeutic = adjust dose or assess adherence"
          },
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Infection as precipitant; baseline for ASM hematologic effects; thrombocytopenia (valproate)",
            "target": "Normal; leukocytosis → infection workup; low platelets → consider valproate toxicity"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Electrolyte abnormalities (hyponatremia common with carbamazepine/oxcarbazepine); renal function (affects ASM dosing); hepatic function (ASM metabolism, toxicity); glucose (hypoglycemia as seizure cause)",
            "target": "Normal; hyponatremia <130 mEq/L can provoke seizures; elevated LFTs → ASM hepatotoxicity"
          },
          {
            "item": "Blood glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hypoglycemia is reversible seizure cause; hyperglycemia (DKA) can also cause seizures",
            "target": "70-180 mg/dL; hypoglycemia <60 mg/dL → treat immediately"
          },
          {
            "item": "Sodium",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hyponatremia: carbamazepine and oxcarbazepine cause SIADH; <125-130 mEq/L can provoke seizures",
            "target": "135-145 mEq/L; <130 → correct slowly (risk of osmotic demyelination)"
          },
          {
            "item": "Calcium (ionized)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hypocalcemia can cause seizures; also check if hypocalcemic tetany suspected",
            "target": "Normal ionized Ca; low → replete"
          },
          {
            "item": "Magnesium",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hypomagnesemia lowers seizure threshold; chronic ASM use may deplete Mg",
            "target": ">2.0 mg/dL; low → replete"
          },
          {
            "item": "Urinalysis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "UTI is common occult infection that provokes seizures, especially in elderly",
            "target": "Normal; pyuria/bacteriuria → treat UTI"
          },
          {
            "item": "Urine drug screen (UDS)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Illicit drug use (cocaine, amphetamines) can provoke seizures; drug interactions with ASMs; adherence assessment",
            "target": "Negative; positive → specific drug-related seizure risk assessment"
          },
          {
            "item": "Alcohol level",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Alcohol withdrawal seizures; intoxication; binge drinking",
            "target": "Negative or low; elevated or history of recent heavy use → alcohol withdrawal protocol"
          },
          {
            "item": "Pregnancy test (β-hCG)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Pregnancy affects ASM levels (increased clearance, volume distribution); teratogenicity concerns; seizure risk in pregnancy",
            "target": "Document result; if positive → urgent neurology/OB consultation; ASM teratogenicity counseling"
          }
        ],
        "Extended Workup": [
          {
            "item": "Free (unbound) ASM levels",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "rationale": "For highly protein-bound drugs (phenytoin, valproate) in patients with hypoalbuminemia, renal failure, pregnancy, or polypharmacy; free level is the active fraction",
            "target": "Free phenytoin: 1-2 mcg/mL; free valproate: 5-15 mcg/mL; adjusted interpretation based on clinical context"
          },
          {
            "item": "Ammonia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Valproate-induced hyperammonemic encephalopathy (can occur with normal LFTs); confusion/lethargy post-ictal vs. encephalopathy",
            "target": "<35 μmol/L; elevated → valproate toxicity; consider discontinuation"
          },
          {
            "item": "Lactate",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Post-ictal lactate elevation (typically resolves within 2h); persistent elevation may indicate status epilepticus or alternative cause",
            "target": "Mildly elevated post-ictal (normalizes quickly); persistent elevation concerning"
          },
          {
            "item": "Prolactin",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Elevated 10-20 min post-seizure (2-3x baseline); helps distinguish epileptic seizure from psychogenic non-epileptic seizure (PNES); must be drawn within 20 min",
            "target": "2-3x baseline within 20 min of convulsive seizure; normal in PNES"
          },
          {
            "item": "TSH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Thyroid dysfunction can affect seizure threshold and ASM metabolism",
            "target": "Normal"
          },
          {
            "item": "Cortisol (AM)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Adrenal insufficiency; chronic ASM use (enzyme inducers) may affect cortisol",
            "target": "Normal"
          },
          {
            "item": "B12 / Folate",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Phenytoin and carbamazepine can deplete folate; B12 deficiency neuropathy; pregnancy planning",
            "target": "Normal; low → supplement"
          },
          {
            "item": "Vitamin D (25-OH)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Enzyme-inducing ASMs (phenytoin, carbamazepine, phenobarbital) increase vitamin D metabolism → osteoporosis risk",
            "target": ">30 ng/mL; low → supplement"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "ASM pharmacogenomics (HLA typing)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "HLA-B*15:02 (carbamazepine/SJS risk in Asian populations); HLA-A*31:01 (carbamazepine hypersensitivity in Europeans); before starting new ASMs",
            "target": "Negative for risk alleles; positive → avoid associated ASM"
          },
          {
            "item": "Carbamazepine-10,11-epoxide level",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Active metabolite of carbamazepine; may be elevated when total level appears therapeutic (especially with inhibitors like valproate); correlates with toxicity",
            "target": "<9 mcg/mL; elevated → toxicity even with normal carbamazepine level"
          },
          {
            "item": "Autoimmune encephalitis panel",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If new seizure semiology, cognitive decline, or refractory seizures in previously controlled patient; autoimmune etiology",
            "target": "Negative; positive → autoimmune encephalitis workup"
          },
          {
            "item": "CSF analysis",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "rationale": "If infection, autoimmune encephalitis, or CNS malignancy suspected as new cause",
            "target": "Normal; abnormal → specific diagnosis"
          },
          {
            "item": "Genetic epilepsy panel",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If genetic cause suspected (family history, syndromic features, drug-resistant epilepsy); may guide ASM selection",
            "target": "Specific mutations (SCN1A, SCN2A, KCNQ2, etc.) may inform treatment choices (e.g., avoid sodium channel blockers in Dravet syndrome)"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "LP — Generally NOT indicated",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "timing": "NOT routinely indicated for uncomplicated breakthrough seizure; **INDICATED if:** Suspected meningitis/encephalitis (fever, meningismus, altered mentation beyond typical post-ictal); suspected autoimmune encephalitis; immunocompromised patient with seizure",
            "target": "Normal in uncomplicated breakthrough; pleocytosis → infection or autoimmune; elevated protein; specific antibodies",
            "contraindications": "Mass lesion with mass effect; coagulopathy"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "**NOT routinely needed** for uncomplicated breakthrough seizure in known epilepsy with return to baseline; **INDICATED if:** Head trauma (fall during seizure), prolonged post-ictal state (>30 min), focal neurologic deficit, new seizure semiology, anticoagulation, fever + seizure, first seizure at this facility",
            "target": "Acute hemorrhage; mass lesion; edema; hydrocephalus; prior surgical changes",
            "contraindications": "None (for non-contrast); pregnancy (benefit outweighs minimal risk)"
          },
          {
            "item": "MRI brain with and without contrast",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "**NOT acutely needed** if stable known epilepsy with unchanged seizures; **INDICATED if:** Change in seizure semiology, increased seizure frequency without clear precipitant, new focal deficit, concern for progressive lesion, presurgical evaluation",
            "target": "Tumor; mesial temporal sclerosis; cortical dysplasia; vascular malformation; new structural cause",
            "contraindications": "MRI-incompatible implants; VNS devices (check MRI compatibility of specific device)"
          },
          {
            "item": "ECG (12-lead)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "timing": "Post-ictal arrhythmia; syncope vs. seizure; QTc prolongation (some ASMs); baseline for ASM changes",
            "target": "Normal; arrhythmia may indicate cardiac cause; prolonged QTc (avoid QT-prolonging ASMs)",
            "contraindications": "None"
          }
        ],
        "Extended": [
          {
            "item": "EEG (routine/outpatient)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Within 24-48h if possible (higher yield closer to seizure); characterize epileptiform activity; confirm epileptic vs. non-epileptic; guide ASM choice; localization",
            "target": "Epileptiform discharges (spikes, sharp waves); focal vs. generalized; specific epilepsy syndrome features",
            "contraindications": "None"
          },
          {
            "item": "Continuous EEG (cEEG) monitoring",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "**INDICATED if:** Prolonged or fluctuating alteration of consciousness; concern for nonconvulsive status epilepticus (NCSE); ICU patient with unexplained encephalopathy; frequent seizures",
            "target": "Ictal patterns; NCSE; interictal epileptiform activity; quantify seizure burden",
            "contraindications": "None; resource-dependent"
          },
          {
            "item": "Ambulatory EEG (outpatient)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Capture typical events if infrequent; home monitoring for 24-72h or longer",
            "target": "Ictal events; interictal discharges; seizure frequency",
            "contraindications": "Patient cooperation required"
          },
          {
            "item": "Video-EEG monitoring (EMU admission)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Characterize events if diagnostic uncertainty (epileptic vs. PNES); presurgical evaluation; medication taper for surgery",
            "target": "Ictal semiology; EEG correlation; localization for surgery",
            "contraindications": "Requires specialized unit"
          },
          {
            "item": "Chest X-ray",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Aspiration pneumonia (common post-ictal complication); ETT position if intubated",
            "target": "Infiltrate; aspiration pattern",
            "contraindications": "None"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "MRI epilepsy protocol",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "High-resolution imaging for epileptogenic lesion identification; 3T preferred; includes thin-cut coronal T2/FLAIR through temporal lobes",
            "target": "Mesial temporal sclerosis; focal cortical dysplasia; cavernous malformation; low-grade tumor",
            "contraindications": "Same as standard MRI"
          },
          {
            "item": "PET (FDG) or SPECT (ictal/interictal)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Presurgical localization; hypometabolism (interictal PET) or hyperperfusion (ictal SPECT) at seizure focus",
            "target": "Focal hypometabolism (interictal); focal hyperperfusion (ictal)",
            "contraindications": "Radiation exposure; specialized availability"
          },
          {
            "item": "MEG (magnetoencephalography)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Presurgical localization; dipole source analysis; specialized centers",
            "target": "Source localization complementary to EEG",
            "contraindications": "Limited availability; metal implants"
          },
          {
            "item": "Neuropsychological testing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Presurgical evaluation; cognitive baseline; localization (memory lateralization for temporal lobe epilepsy)",
            "target": "Lateralized deficits; cognitive baseline for surgery comparison",
            "contraindications": "Patient cooperation"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent Treatment": [
          {
            "item": "**Benzodiazepine (if actively seizing)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg/kg",
                  "orderSentence": "**Benzodiazepine (if actively seizing)** 0.1 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "**Lorazepam** 0.1 mg/kg IV (max 4 mg), may repeat x1 in 5 min; **OR Midazolam** 10 mg IM (if no IV access); **OR Diazepam** 0.2 mg/kg IV (max 10 mg); **Intranasal midazolam** 5-10 mg if no IV; **Rectal diazepam** 0.2-0.5 mg/kg (home rescue)",
              "orderSentence": "**Benzodiazepine (if actively seizing)** 0.1 mg/kg IV"
            },
            "contraindications": "-",
            "monitoring": "First-line for acute seizure termination; lorazepam preferred IV (longer CNS duration); follow status epilepticus protocol if seizure continues >5 min",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Protect patient during seizure**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Clear environment of hazards; DO NOT restrain or put anything in mouth; turn on side (recovery position) when safe; suction secretions; monitor airway; time the seizure",
              "orderSentence": "**Protect patient during seizure** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Prevent injury; prepare for airway management if prolonged",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Post-ictal care**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "92%",
                  "orderSentence": "**Post-ictal care** 92% -"
                }
              ],
              "route": "-",
              "instructions": "Recovery position; monitor airway (aspiration risk); supplemental O2 if SpO2 <92%; assess for injuries (tongue laceration, shoulder dislocation, vertebral fracture); reassurance; reorientation",
              "orderSentence": "**Post-ictal care** 92% -"
            },
            "contraindications": "-",
            "monitoring": "Post-ictal period is self-limited (typically 5-30 min); prolonged alteration → consider NCSE, repeat seizure, or alternative diagnosis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Administer home ASM (if missed)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "If patient missed doses → give maintenance ASM immediately; if patient does not have medication with them → administer from ED/hospital supply",
              "orderSentence": "**Administer home ASM (if missed)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Non-adherence is most common cause of breakthrough seizure; restoring therapeutic levels is priority",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Loading dose (if significantly subtherapeutic)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15-20 mg",
                  "orderSentence": "**Loading dose (if significantly subtherapeutic)** 15-20 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "**Phenytoin/Fosphenytoin:** 15-20 mg PE/kg IV (if level very low); **Valproate:** 20-30 mg/kg IV (if level very low); **Levetiracetam:** 1000-1500 mg IV (if not on levetiracetam — can be added); **Note:** Loading the same drug patient is already taking risks toxicity → use cautiously",
              "orderSentence": "**Loading dose (if significantly subtherapeutic)** 15-20 mg IV"
            },
            "contraindications": "-",
            "monitoring": "For significantly subtherapeutic levels or if need rapid therapeutic concentration; adjust for partial levels",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Treat precipitant**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Infection:** Antibiotics for UTI, pneumonia; **Electrolyte abnormality:** Correct (hyponatremia slowly); **Drug/alcohol withdrawal:** Appropriate protocol; **Sleep deprivation:** Education, sleep hygiene",
              "orderSentence": "**Treat precipitant** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Treating the precipitant may be more important than adjusting ASMs",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "ASM Adjustment Strategies": [
          {
            "item": "Resume current regimen at prescribed doses",
            "rationale": "Non-adherence is #1 cause; restoring regimen usually sufficient"
          },
          {
            "item": "Increase current ASM OR add second ASM",
            "rationale": "Some patients require levels above \"therapeutic range\" for control"
          },
          {
            "item": "Add second ASM OR optimize current ASM timing",
            "rationale": "Breakthrough at therapeutic levels may require adjunctive therapy"
          },
          {
            "item": "Remove interacting drug OR increase ASM dose OR switch ASM",
            "rationale": "Enzyme inducers and inhibitors significantly affect ASM levels"
          },
          {
            "item": "Increase dose with frequent monitoring",
            "rationale": "Seizure risk to mother and fetus outweighs small ASM risk; maintain control"
          },
          {
            "item": "Full re-evaluation",
            "rationale": "Change in control pattern requires investigation for new etiology"
          }
        ],
        "Medications to AVOID or Use with Caution": [
          {
            "item": "**Tramadol**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Tramadol** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Meperidine (Demerol)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Meperidine (Demerol)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Bupropion**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Bupropion** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Clozapine**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Clozapine** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Fluoroquinolones**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Fluoroquinolones** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Carbapenems (imipenem > meropenem)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Carbapenems (imipenem > meropenem)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Isoniazid**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Isoniazid** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Theophylline / Aminophylline**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Theophylline / Aminophylline** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Stimulants (amphetamines, methylphenidate)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Stimulants (amphetamines, methylphenidate)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Alcohol (acute intoxication and withdrawal)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Alcohol (acute intoxication and withdrawal)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Illicit drugs (cocaine, amphetamines, synthetic cathinones)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "**Illicit drugs (cocaine, amphetamines, synthetic cathinones)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consultation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "ASM level check",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Adherence assessment",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Precipitant identification",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Injury assessment",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Safety counseling",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Return to baseline confirmation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Patient Instructions": [
          {
            "item": "EEG",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Imaging",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Pharmacy consultation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychology / Psychiatry",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Epilepsy nurse educator",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Women's health counseling",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Epilepsy surgery evaluation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "VNS / RNS / DBS evaluation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ketogenic diet referral",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "PNES evaluation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Autoimmune epilepsy workup",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetic testing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Diagnosis",
        "features": "Key Distinguishing Features",
        "tests": "Evaluation"
      },
      {
        "diagnosis": "**True breakthrough seizure (epileptic)**",
        "features": "Typical semiology for patient; post-ictal state; EEG correlation; identifiable precipitant or subtherapeutic level",
        "tests": "ASM levels; EEG; precipitant search"
      },
      {
        "diagnosis": "**Psychogenic non-epileptic seizure (PNES)**",
        "features": "Variable semiology; prolonged duration (>2 min); preserved awareness with bilateral movements; eyes closed; pelvic thrusting; ictal crying; side-to-side head movements; no post-ictal confusion (or prolonged pseudo-post-ictal); normal prolactin; normal EEG during event",
        "tests": "Video-EEG (gold standard); prolactin (not elevated); clinical features; psychology evaluation"
      },
      {
        "diagnosis": "**Syncope (convulsive)**",
        "features": "Triggered by standing, hot environment, vagal stimulus; brief LOC (<1 min); myoclonic jerks are common during syncope (not true seizure); rapid recovery; pale before event",
        "tests": "ECG; orthostatics; tilt table test; echocardiogram; cardiac history"
      },
      {
        "diagnosis": "**Cardiac arrhythmia**",
        "features": "Sudden LOC without warning or with palpitations; rapid recovery; history of cardiac disease",
        "tests": "ECG; Holter/event monitor; echocardiogram; electrophysiology study"
      },
      {
        "diagnosis": "**Toxic/metabolic**",
        "features": "Hypoglycemia; hyponatremia; hypocalcemia; uremia; hepatic encephalopathy; drug intoxication/withdrawal",
        "tests": "Glucose; electrolytes; renal/hepatic function; drug screen; specific toxin levels"
      },
      {
        "diagnosis": "**Transient ischemic attack (TIA)**",
        "features": "Negative symptoms (weakness, numbness, aphasia) vs. positive symptoms (convulsion); typically no LOC; vascular risk factors",
        "tests": "MRI with DWI; MRA; vascular risk factor assessment"
      },
      {
        "diagnosis": "**Sleep disorders**",
        "features": "REM sleep behavior disorder; parasomnias; cataplexy (narcolepsy)",
        "tests": "Sleep history; PSG; MSL"
      },
      {
        "diagnosis": "**Movement disorders**",
        "features": "Dystonia; chorea; myoclonus (non-epileptic); paroxysmal dyskinesia",
        "tests": "Preserved awareness; stereotyped movements; neurologic exam; movement disorder evaluation"
      },
      {
        "diagnosis": "**Migraine with aura**",
        "features": "Visual, sensory, or motor aura preceding headache; duration 20-60 min; no LOC",
        "tests": "Headache history; migraine features; may have EEG abnormalities but distinct from seizure"
      }
    ],
    "evidence": [
      {
        "recommendation": "Guideline",
        "evidenceLevel": "Source",
        "source": "Year"
      },
      {
        "recommendation": "Practice Guideline Update: Efficacy and Tolerability of ASMs",
        "evidenceLevel": "AAN",
        "source": "2018"
      },
      {
        "recommendation": "Management of Adult Epilepsy",
        "evidenceLevel": "AES/ILAE",
        "source": "Ongoing updates"
      },
      {
        "recommendation": "Epilepsy in Women",
        "evidenceLevel": "AAN",
        "source": "2009/Updates"
      },
      {
        "recommendation": "SUDEP Prevention",
        "evidenceLevel": "AAN",
        "source": "2017"
      },
      {
        "recommendation": "Study",
        "evidenceLevel": "Finding",
        "source": "Impact"
      },
      {
        "recommendation": "[Kwan & Brodie (2000)](https://pubmed.ncbi.nlm.nih.gov/10660394/)",
        "evidenceLevel": "47% of newly diagnosed epilepsy patients became seizure-free on first ASM; 13% on second; 4% on third; after failure of 2 appropriate ASMs, chance of seizure freedom with additional ASMs is <5%",
        "source": "Defined drug-resistant epilepsy; established rationale for early surgery referral"
      },
      {
        "recommendation": "SANAD I & II ([2007](https://pubmed.ncbi.nlm.nih.gov/17382827/), [2021](https://pubmed.ncbi.nlm.nih.gov/33838757/))",
        "evidenceLevel": "Lamotrigine best for focal epilepsy; valproate best for generalized/unclassified (but teratogenic); levetiracetam non-inferior to lamotrigine for focal",
        "source": "Guide first-line ASM selection by seizure type"
      },
      {
        "recommendation": "Standard and New Antiepileptic Drugs (SNAED) Trial",
        "evidenceLevel": "Levetiracetam and zonisamide non-inferior to lamotrigine for focal epilepsy",
        "source": "Expanded first-line options"
      },
      {
        "recommendation": "[Early Randomized Surgical Epilepsy Trial (ERSET, 2012)](https://pubmed.ncbi.nlm.nih.gov/22396514/)",
        "evidenceLevel": "Early surgery superior to continued medical therapy for drug-resistant temporal lobe epilepsy; 73% vs. 0% seizure-free at 2 years",
        "source": "Surgery is highly effective; early referral improves outcomes"
      },
      {
        "recommendation": "SUDEP Risk Factors",
        "evidenceLevel": "Convulsive seizures, especially nocturnal; living alone; poor seizure control",
        "source": "Counsel patients; nocturnal monitoring devices; optimize seizure control"
      },
      {
        "recommendation": "ASM",
        "evidenceLevel": "Total Level",
        "source": "Free Level"
      },
      {
        "recommendation": "Phenytoin",
        "evidenceLevel": "10-20 mcg/mL",
        "source": "1-2 mcg/mL"
      },
      {
        "recommendation": "Carbamazepine",
        "evidenceLevel": "4-12 mcg/mL",
        "source": "N/A"
      },
      {
        "recommendation": "Valproate",
        "evidenceLevel": "50-100 mcg/mL",
        "source": "5-15 mcg/mL"
      },
      {
        "recommendation": "Phenobarbital",
        "evidenceLevel": "15-40 mcg/mL",
        "source": "N/A"
      },
      {
        "recommendation": "Levetiracetam",
        "evidenceLevel": "12-46 mcg/mL (suggested)",
        "source": "N/A"
      },
      {
        "recommendation": "Lamotrigine",
        "evidenceLevel": "3-14 mcg/mL (varies)",
        "source": "N/A"
      },
      {
        "recommendation": "Oxcarbazepine (MHD)",
        "evidenceLevel": "3-35 mcg/mL",
        "source": "N/A"
      },
      {
        "recommendation": "Topiramate",
        "evidenceLevel": "5-20 mcg/mL (suggested)",
        "source": "N/A"
      },
      {
        "recommendation": "Lacosamide",
        "evidenceLevel": "10-20 mcg/mL (emerging)",
        "source": "N/A"
      },
      {
        "recommendation": "Clobazam",
        "evidenceLevel": "0.03-0.3 mcg/mL",
        "source": "N/A"
      },
      {
        "recommendation": "Brivaracetam",
        "evidenceLevel": "Not established",
        "source": "N/A"
      },
      {
        "recommendation": "Perampanel",
        "evidenceLevel": "Not established",
        "source": "N/A"
      }
    ],
    "monitoring": [
      {
        "item": "Mental status (return to baseline)",
        "frequency": "q15 min until resolved; q1h thereafter",
        "target": "Return to baseline within 30-60 min",
        "action": "Prolonged: consider NCSE → EEG; imaging; extended evaluation"
      },
      {
        "item": "Vital signs",
        "frequency": "q15-30 min initially; q1h once stable",
        "target": "HR 60-100; BP <180/110; SpO2 >94%; Temp <38°C",
        "action": "Manage accordingly; fever → infection workup"
      },
      {
        "item": "Seizure recurrence",
        "frequency": "Continuous observation",
        "target": "No further seizures",
        "action": "Repeat seizure: give benzodiazepine; consider additional ASM load; SE protocol if >5 min"
      },
      {
        "item": "Airway / Respiratory status",
        "frequency": "Continuous; q15 min",
        "target": "Patent airway; no aspiration; adequate ventilation",
        "action": "Position; suction; O2 if needed; intubation if compromised"
      },
      {
        "item": "Blood glucose",
        "frequency": "Check immediately; repeat if symptomatic",
        "target": "70-180 mg/dL",
        "action": "Hypoglycemia: D50W IV"
      },
      {
        "item": "Cardiac rhythm",
        "frequency": "Continuous telemetry",
        "target": "Normal sinus; no arrhythmia",
        "action": "Treat arrhythmia; cardiology if indicated"
      }
    ],
    "disposition": [
      {
        "disposition": "Level of Care",
        "criteria": "Criteria"
      },
      {
        "disposition": "ICU",
        "criteria": "Status epilepticus; cluster seizures requiring continuous infusion; severe injuries; need for continuous EEG monitoring; airway compromise; hemodynamic instability"
      },
      {
        "disposition": "General floor / Observation",
        "criteria": "Prolonged post-ictal state; multiple seizures in ED; significantly subtherapeutic levels requiring monitoring during adjustment; uncertain diagnosis; new focal deficit; complicating medical illness"
      },
      {
        "disposition": "Discharge home",
        "criteria": "Single uncomplicated breakthrough seizure; returned to baseline; identifiable/correctable precipitant; therapeutic or corrected ASM level; no injuries requiring admission; safe home environment; reliable follow-up"
      }
    ]
  },
  "Cauda Equina Syndrome": {
    "id": "cauda-equina-syndrome",
    "title": "Cauda Equina Syndrome",
    "version": "1.0",
    "icd10": [
      "** G83.4 (Cauda equina syndrome)",
      "M48.06 (Spinal stenosis",
      "lumbar region)",
      "M51.16 (Intervertebral disc disorders with radiculopathy",
      "lumbar region)",
      "M51.17 (Intervertebral disc disorders with radiculopathy",
      "lumbosacral region)",
      "G95.89 (Other specified diseases of spinal cord)"
    ],
    "scope": "** Emergency evaluation and management of cauda equina syndrome in adults. Covers urgent recognition of incomplete vs. complete CES, emergent MRI, surgical decompression timing, etiologic workup (disc herniation, tumor, abscess, hematoma), bladder management, and functional prognostication. Excludes conus medullaris syndrome (partially overlaps — key distinguishing features addressed), malignant epidural spinal cord compression above the conus (separate template), and chronic lumbar stenosis without CES features.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Infection (epidural abscess); baseline for surgery; leukocytosis; anemia assessment",
            "target": "Normal; leukocytosis → consider abscess; thrombocytopenia affects surgical candidacy"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Electrolytes; renal function (contrast, NSAIDs); glucose; hepatic function (anesthetic risk)",
            "target": "Normal"
          },
          {
            "item": "PT/INR, aPTT",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Coagulopathy; anticoagulation status; surgical clearance; epidural hematoma etiology",
            "target": "Normal; INR <1.5 for surgery; prolonged → consider epidural hematoma"
          },
          {
            "item": "ESR / CRP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Epidural abscess differential (ESR >20 mm/hr: 94% sensitivity for spinal abscess); discitis; malignancy",
            "target": "Normal; markedly elevated (ESR >30-50, CRP >10) → strongly consider abscess or infection"
          },
          {
            "item": "Blood cultures (x2 sets)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Epidural abscess; bacteremia; source identification if infectious etiology suspected",
            "target": "Negative; positive → epidural abscess or hematogenous source"
          },
          {
            "item": "Blood glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Baseline; anesthetic risk; diabetic patients at increased disc herniation and infection risk",
            "target": "<180 mg/dL"
          },
          {
            "item": "Type and screen",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Surgical candidacy; blood product availability for emergency decompression",
            "target": "On file"
          },
          {
            "item": "Urinalysis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "UTI (common comorbidity and mimicker of urinary symptoms); neurogenic bladder assessment; baseline",
            "target": "Normal; UTI may coexist — treat but do NOT attribute bladder dysfunction solely to UTI if CES features present"
          },
          {
            "item": "Pregnancy test (β-hCG)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "MRI and anesthetic planning; pregnancy may exacerbate disc herniation (increased lordosis/weight)",
            "target": "Negative; if positive → MRI still indicated (no gadolinium needed for CES diagnosis)"
          },
          {
            "item": "Procalcitonin",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Bacterial infection differential (more specific than CRP); if abscess suspected",
            "target": "<0.25 (low bacterial probability); >0.5 → consider abscess"
          }
        ],
        "Extended Workup": [
          {
            "item": "HbA1c",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Diabetes assessment (risk factor for disc herniation, infection, neuropathy); post-operative wound healing",
            "target": "<7.0%"
          },
          {
            "item": "Tumor markers (PSA, CEA, etc.)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "If imaging suggests neoplastic etiology rather than disc herniation",
            "target": "Normal; elevated → guides oncologic workup"
          },
          {
            "item": "SPEP / free light chains",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Multiple myeloma presenting as cauda equina compression",
            "target": "No M-protein; normal kappa/lambda ratio"
          },
          {
            "item": "LDH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Lymphoma; tumor burden",
            "target": "Normal; elevated → lymphoma, aggressive malignancy"
          },
          {
            "item": "HIV",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Immunocompromised → infection risk; primary CNS lymphoma differential",
            "target": "Negative"
          },
          {
            "item": "Urine culture",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Pre-existing UTI; post-catheterization planning; differentiate neurogenic bladder from UTI",
            "target": "Negative; if positive → treat but continue CES workup"
          },
          {
            "item": "Post-void residual (PVR) — bladder scan",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "KEY DIAGNOSTIC TEST: bladder retention is hallmark of CES; PVR >200 mL is highly concerning; >500 mL strongly suggestive of neurogenic retention",
            "target": "PVR <100 mL (normal); PVR >200 mL → significant retention; >500 mL → almost certainly neurogenic"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CSF analysis (only at surgery or LP if needed)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If inflammatory/infectious etiology suspected (GBS affecting cauda equina = rare); leptomeningeal carcinomatosis",
            "target": "Normal; elevated protein → GBS, tumor; malignant cells → leptomeningeal disease"
          },
          {
            "item": "Paraneoplastic antibody panel",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Atypical CES without structural cause; paraneoplastic cauda equina neuritis (anti-CRMP5/CV2, anti-amphiphysin)",
            "target": "Negative; positive → paraneoplastic syndrome"
          },
          {
            "item": "Anti-ganglioside antibodies (GM1, GD1b, GQ1b)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "GBS variant affecting cauda equina roots (rare); if imaging shows nerve root enhancement without structural compression",
            "target": "Negative; positive → GBS/CIDP affecting cauda equina"
          },
          {
            "item": "AQP4-IgG / MOG-IgG",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If conus medullaris lesion rather than cauda equina compression; NMOSD can affect conus",
            "target": "Negative; positive → NMOSD/MOGAD"
          },
          {
            "item": "Sarcoidosis workup (ACE, chest CT, lysozyme)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Neurosarcoidosis affecting cauda equina (nerve root inflammation/enhancement without structural lesion); elevated ACE",
            "target": "Normal ACE; chest CT: no hilar lymphadenopathy; if positive → neurosarcoidosis"
          },
          {
            "item": "EMG/NCS",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Chronic or atypical CES; differentiate from peripheral neuropathy, plexopathy; establish nerve root involvement pattern; prognostic (denervation = poor recovery)",
            "target": "Abnormal: acute denervation (fibrillations, positive sharp waves) in L4-S4 myotomes bilaterally; absent H-reflex bilaterally; abnormal pudendal nerve conduction"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "LP — Generally NOT indicated acutely",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "LP is NOT required for diagnosis of typical CES (disc herniation, tumor, abscess seen on MRI); ONLY if inflammatory/infectious etiology without clear structural cause; OR CT myelogram if MRI impossible",
            "target": "CSF protein elevation (GBS, tumor); pleocytosis (infection, inflammation); malignant cells (leptomeningeal disease); albuminocytologic dissociation (GBS)",
            "contraindications": "Do NOT perform LP if large disc herniation compressing cauda equina (could theoretically worsen by altering pressure dynamics — proceed to surgery instead); coagulopathy; abscess at LP site"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI lumbar spine without contrast (emergent)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "**Within 4 hours of ED arrival — SURGICAL EMERGENCY; ideally within 1 hour**; extends to thoracolumbar junction (T10-sacrum) to include conus medullaris",
            "target": "Large disc herniation (most common — 45% of CES cases) compressing cauda equina; canal compromise; level of compression; number of roots compressed; disc fragment migration; tumor, abscess, or hematoma as alternative cause; conus medullaris location and signal",
            "contraindications": "MRI-incompatible implants; severe claustrophobia (sedate — do NOT delay MRI for anxiety); GFR <30 for contrast (but contrast NOT required for disc herniation diagnosis — obtain non-contrast first)"
          },
          {
            "item": "MRI lumbar spine WITH contrast (gadolinium)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Add contrast if: suspected abscess, tumor, or inflammatory etiology; ring-enhancing epidural collection = abscess; homogeneous enhancement = tumor; nerve root enhancement = inflammatory/neoplastic",
            "target": "Epidural abscess (ring enhancement, restricted diffusion); tumor (enhancing mass); nerve root enhancement (inflammatory, leptomeningeal disease); distinguish from disc herniation (which does NOT enhance)",
            "contraindications": "GFR <30 (gadolinium risk — benefit outweighs risk in emergency); gadolinium allergy (premedicate)"
          },
          {
            "item": "Bladder scan (post-void residual)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "**Before MRI if possible — critical triage tool**; have patient attempt to void → immediate bladder ultrasound for PVR",
            "target": "PVR >200 mL = significant retention → HIGH probability of CES; PVR >500 mL = almost certain neurogenic retention; normal PVR does NOT exclude early/incomplete CES",
            "contraindications": "None (bedside ultrasound)"
          },
          {
            "item": "Plain radiographs (lumbar spine AP/lateral)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "While awaiting MRI; identifies vertebral collapse, spondylolisthesis, fracture, alignment; limited value but rapid triage tool",
            "target": "Disc space narrowing; spondylolisthesis; fracture; alignment abnormality; NOTE: X-rays CANNOT diagnose disc herniation — MRI is required",
            "contraindications": "Pregnancy (shield abdomen)"
          }
        ],
        "Extended": [
          {
            "item": "CT lumbar spine without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "If MRI not available or contraindicated; inferior to MRI for soft tissue but shows bone and canal narrowing; CT myelogram if MRI impossible",
            "target": "Disc herniation (seen as soft tissue density in canal); bone fragments; canal diameter; fracture; spondylolisthesis",
            "contraindications": "CT alone has limited sensitivity for disc herniation vs. MRI; myelogram adds invasive risk"
          },
          {
            "item": "CT myelogram",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "If MRI absolutely contraindicated (implant); intrathecal contrast via LP → CT; demonstrates level of block and root compression",
            "target": "Complete or partial block; compressed cauda equina roots; level and extent of compression; may miss small free fragments",
            "contraindications": "LP contraindicated if abscess suspected at LP site; coagulopathy; rare but important if MRI impossible"
          },
          {
            "item": "MRI whole spine",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "timing": "If etiology unclear; evaluate for additional levels of disease; concurrent cord compression; tumor staging; multilevel disc disease",
            "target": "Additional sites of compression; intramedullary lesion (conus); multifocal disease",
            "contraindications": "Same as lumbar MRI"
          },
          {
            "item": "Urodynamic studies",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Post-acute phase; quantify bladder dysfunction; detrusor areflexia (CES pattern); plan long-term bladder management",
            "target": "Detrusor areflexia (areflexic bladder) = cauda equina denervation; decreased bladder sensation; increased capacity; poor emptying",
            "contraindications": "Acute UTI; recent surgery (timing per surgeon)"
          },
          {
            "item": "Anal manometry / pudendal nerve testing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Quantify sphincter dysfunction; prognostic for recovery; pudendal nerve conduction",
            "target": "Reduced anal sphincter pressures; denervated pudendal nerve",
            "contraindications": "Patient tolerance; acute phase may not be appropriate"
          },
          {
            "item": "EMG/NCS (lower extremities + paraspinal)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "2-3 weeks post-onset (acute denervation takes 2-3 weeks to appear on EMG); prognosis; differentiate from peripheral neuropathy or plexopathy",
            "target": "Bilateral L4-S4 denervation; reduced CMAP amplitudes in bilateral L5/S1 distribution; absent H-reflexes bilaterally; bilateral pudendal neuropathy",
            "contraindications": "Too early in acute phase (<2 weeks = may be false negative for denervation); patient tolerance"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CT angiography (lumbar)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "EXT",
            "timing": "If vascular malformation suspected (spinal dural AV fistula causing venous hypertension → CES symptoms); progressive myelopathy/CES with dilated serpiginous vessels on MRI",
            "target": "Spinal AV fistula; AVM; arteriovenous malformation feeding vessels",
            "contraindications": "Contrast allergy; renal impairment"
          },
          {
            "item": "Spinal angiography",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Definitive diagnosis and treatment of spinal dural AV fistula; also pre-operative embolization for vascular tumors",
            "target": "Fistula location; endovascular treatment candidate",
            "contraindications": "Invasive; contrast risk; radiation exposure"
          },
          {
            "item": "PET/CT",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If malignancy causing CES — staging; unknown primary identification",
            "target": "Primary tumor; metastatic burden",
            "contraindications": "Uncontrolled diabetes; pregnancy"
          },
          {
            "item": "Cystometrogram",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "Formal bladder function assessment; post-decompression recovery monitoring; long-term bladder management planning",
            "target": "Bladder compliance; detrusor function; capacity; sensation thresholds",
            "contraindications": "Active UTI"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent Treatment": [
          {
            "item": "**Emergent surgical decompression**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**THIS IS A SURGICAL EMERGENCY — TIME IS NERVE**; Emergent neurosurgery/spine surgery consultation; posterior lumbar laminectomy with discectomy (most common procedure); **Timing:** Within 24h of symptom onset — ideally within 24h but outcome improves the sooner surgery is performed; <24h clearly better than >48h; some evidence supports <12h for best outcomes; **Complete CES (CES-R with retention):** Truly emergent — surgery as soon as possible (within hours); **Incomplete CES (CES-I):** Urgent — surgery within 24h; risk of progressing to complete",
              "orderSentence": "**Emergent surgical decompression** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Ahn et al. (2000): Decompression <48h = significantly better outcomes for bladder recovery (70% vs. 30%); Todd (2005) meta-analysis: Earlier surgery = better outcomes, but exact time threshold debated; DeBois et al. (2019): <24h optimal, <48h acceptable; Srikandarajah et al. (2020): Urgent surgery (<24h) associated with better functional outcomes",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Bladder management**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mL",
                  "orderSentence": "**Bladder management** 200 mL -"
                }
              ],
              "route": "-",
              "instructions": "**Bladder scan (PVR) STAT on arrival** — do NOT wait for MRI; if PVR >200 mL → Foley catheter placement; if PVR >500 mL → Foley + strict I&O monitoring; avoid overdistension (>600 mL causes detrusor damage — may become irreversible); document voiding pattern; post-operative: trial of void at 24-48h with PVR checks; CIC (clean intermittent catheterization) teaching if retention persists",
              "orderSentence": "**Bladder management** 200 mL -"
            },
            "contraindications": "-",
            "monitoring": "Bladder overdistension causes detrusor muscle damage → irreversible areflexic bladder; early catheterization prevents secondary damage; bladder recovery is the MOST SENSITIVE indicator of CES recovery and the MOST COMMON persistent deficit",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Pain management**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650-1000 mg",
                  "orderSentence": "**Pain management** 650-1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Back pain and radicular pain often severe; acetaminophen 650-1000 mg q6h (scheduled) + opioids (morphine 2-4 mg IV q3h PRN or hydromorphone 0.5-1 mg IV q3h PRN); NSAIDs: ketorolac 15-30 mg IV q6h (short-term, if no surgical contraindication and normal renal function — pre-op use is surgeon-dependent); neuropathic: gabapentin 300 mg TID (start if radicular pain prominent); avoid excessive sedation that obscures neurologic exam",
              "orderSentence": "**Pain management** 650-1000 mg IV"
            },
            "contraindications": "-",
            "monitoring": "Adequate analgesia essential for patient assessment and MRI tolerance; balance with need for neurologic monitoring",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Dexamethasone (if tumor or abscess)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "**Dexamethasone (if tumor or abscess)** 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "**Disc herniation CES:** Steroids NOT routinely indicated (no evidence of benefit; some centers use short course); **Tumor-related CES:** Dexamethasone 10 mg IV bolus → 4 mg q6h (same as MSCC protocol); **Abscess-related CES:** Dexamethasone controversial (may impair immune response) — use only if severe edema with rapid neurologic decline",
              "orderSentence": "**Dexamethasone (if tumor or abscess)** 10 mg IV"
            },
            "contraindications": "-",
            "monitoring": "No RCT evidence supporting steroids for disc-related CES; tumor CES: Sorensen et al. (1994) supports steroids; abscess: prioritize antibiotics + surgical drainage",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Antibiotics (if abscess suspected)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-30 mg/kg",
                  "orderSentence": "**Antibiotics (if abscess suspected)** 25-30 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "**Epidural abscess causing CES:** Empiric: Vancomycin 25-30 mg/kg IV load + ceftriaxone 2g IV q12h (or cefepime 2g IV q8h); adjust to culture/sensitivity; MRSA coverage essential; **Duration:** Typically 6-8 weeks IV antibiotics for epidural abscess; **Timing:** Start AFTER blood cultures drawn but do NOT delay if patient is deteriorating",
              "orderSentence": "**Antibiotics (if abscess suspected)** 25-30 mg/kg IV"
            },
            "contraindications": "-",
            "monitoring": "S. aureus (including MRSA) is most common organism in epidural abscess (60-70%); gram-negative coverage for UTI/abdominal source; streptococci, anaerobes less common",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**DVT prophylaxis**",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "**DVT prophylaxis** 40 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "SCDs immediately; pharmacologic prophylaxis: enoxaparin 40 mg SQ daily starting post-operatively (typically 12-24h after surgery per surgeon protocol); immobile CES patients at high VTE risk",
              "orderSentence": "**DVT prophylaxis** 40 mg SC"
            },
            "contraindications": "-",
            "monitoring": "Immobility + lower extremity weakness = high DVT risk; mechanical prophylaxis pre-operatively; early pharmacologic prophylaxis post-operatively",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Bowel management**",
            "route": "PR",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "**Bowel management** 100 mg PR"
                }
              ],
              "route": "PR",
              "instructions": "Assess rectal tone (digital rectal exam — absent/reduced in CES); bowel regimen: docusate 100 mg BID + senna 2 tabs HS; bisacodyl suppository daily if no BM in 48h; monitor for fecal incontinence vs. constipation (both occur in CES); opioid-related constipation compounds the issue",
              "orderSentence": "**Bowel management** 100 mg PR"
            },
            "contraindications": "-",
            "monitoring": "Bowel dysfunction common in CES; S2-S4 denervation affects external anal sphincter and rectal sensation; proactive management prevents complications",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Definitive/Targeted Treatment": [
          {
            "item": "**Lumbar laminectomy + discectomy (disc herniation CES)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Most common surgery:** Posterior approach; laminectomy at affected level(s); remove herniated disc fragment; decompress cauda equina; **Approach:** Midline; may require bilateral laminotomy or hemi-laminectomy for lateralized discs; large central herniations often require bilateral approach; **Key:** Ensure COMPLETE decompression — incomplete decompression leads to persistent deficit; intraoperative confirmation with direct visualization of free cauda equina nerve roots",
              "orderSentence": "**Lumbar laminectomy + discectomy (disc herniation CES)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Gold standard for disc-related CES; no RCT comparing surgery vs. non-operative (would be unethical to randomize given natural history); observational data uniformly supports early surgical decompression",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Microdiscectomy (if technically appropriate)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Minimally invasive approach; appropriate for contained disc herniations without significant canal stenosis; faster recovery; less tissue disruption; may not provide adequate decompression for massive central disc herniation",
              "orderSentence": "**Microdiscectomy (if technically appropriate)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Smaller incision, less muscle disruption; but surgeon must ensure adequate decompression — do NOT compromise canal visualization for a smaller incision in CES",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Surgical drainage + decompression (epidural abscess)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "Posterior approach; laminectomy; drain abscess; culture material; irrigate; leave wound open or with drain; may require multi-level decompression; **Combined with:** IV antibiotics 6-8 weeks; follow with serial MRI and inflammatory markers",
              "orderSentence": "**Surgical drainage + decompression (epidural abscess)** - IV - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Epidural abscess with CES = surgical emergency; medical management alone (antibiotics without surgery) only if: no neurologic deficit AND very high surgical risk; most CES presentations require surgery",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Tumor resection + decompression**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "If tumor-related CES (e.g., schwannoma, ependymoma, metastasis); posterior decompression ± en bloc or piecemeal tumor resection; send pathology; may need subsequent radiation/chemotherapy",
              "orderSentence": "**Tumor resection + decompression** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Intradural-extramedullary tumors (schwannoma, meningioma, myxopapillary ependymoma) are potentially curable with complete resection; metastatic CES → decompression + radiation",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Hematoma evacuation**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Epidural hematoma causing CES (spontaneous on anticoagulation, post-procedural, or post-traumatic); emergent laminectomy with hematoma evacuation; reverse anticoagulation STAT",
              "orderSentence": "**Hematoma evacuation** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Spontaneous spinal epidural hematoma: Groen & Ponssen (1990): better outcomes with surgery <12h of onset; anticoagulation reversal essential (4F-PCC for warfarin, idarucizumab for dabigatran, andexanet for Xa inhibitors)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Non-operative management (rare, selected cases)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**ONLY appropriate if:** (1) Imaging does NOT show significant structural compression, (2) Symptoms are improving spontaneously, (3) Patient refuses surgery (document informed refusal thoroughly), (4) Medically inoperable (extremely high surgical risk); **Requires:** Close monitoring with serial neuro exams q2-4h; repeat MRI if worsening; immediate surgery if any progression",
              "orderSentence": "**Non-operative management (rare, selected cases)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Non-operative management is NOT standard of care for CES with structural compression; delayed surgery has worse outcomes; informed consent must document risks of non-operative management (permanent bladder/bowel/sexual dysfunction, progressive weakness)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Adjunctive Treatment": [
          {
            "item": "**Clean intermittent catheterization (CIC) training**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mL",
                  "orderSentence": "**Clean intermittent catheterization (CIC) training** 100 mL -"
                }
              ],
              "route": "-",
              "instructions": "If bladder function does not recover by 48-72h post-surgery; teach patient CIC q4-6h; target PVR <100 mL before discontinuing CIC; may take weeks to months to recover",
              "orderSentence": "**Clean intermittent catheterization (CIC) training** 100 mL -"
            },
            "contraindications": "-",
            "monitoring": "CIC is preferred over indwelling Foley for long-term bladder management (lower UTI risk); most patients can learn self-catheterization; bladder recovery may take 6-12 months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Neuropathic pain management**",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "**Neuropathic pain management** 300 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Gabapentin 300 mg PO TID → titrate to 600-900 mg TID over 1-2 weeks; OR pregabalin 75 mg BID → 150-300 mg BID; duloxetine 30 mg daily → 60 mg daily; amitriptyline 10-25 mg HS (caution: urinary retention may worsen); topical lidocaine 5% patches for localized radicular pain",
              "orderSentence": "**Neuropathic pain management** 300 mg PO"
            },
            "contraindications": "-",
            "monitoring": "Neuropathic pain (burning, tingling, electric shocks in perineum, legs) is common and debilitating after CES; may persist chronically; multimodal approach needed",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**Physical therapy / rehabilitation**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "PT evaluation within 24h post-operatively; early mobilization; lower extremity strengthening; gait training; core stabilization; progressive activity as tolerated; pelvic floor PT for bladder/bowel recovery",
              "orderSentence": "**Physical therapy / rehabilitation** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Early rehabilitation improves functional outcomes; pelvic floor rehabilitation is evidence-based for bladder/bowel recovery after CES",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Occupational therapy**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "ADL assessment; adaptive equipment; if lower extremity weakness impairs function; bathroom modifications; return-to-work planning",
              "orderSentence": "**Occupational therapy** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Functional independence optimization",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Pelvic floor rehabilitation**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Specialized pelvic floor PT; biofeedback for bladder and bowel retraining; Kegel exercises (if able); electrical stimulation of pelvic floor; sacral neuromodulation evaluation if persistent dysfunction >12 months",
              "orderSentence": "**Pelvic floor rehabilitation** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Evidence supports pelvic floor PT for bladder and bowel recovery after CES; biofeedback improves outcomes",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Psychological support**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "CES has devastating psychosocial impact (sexual dysfunction, incontinence, chronic pain, disability in often-young patients); depression screening (PHQ-9); anxiety screening; sexual health counseling; support groups; consider psychiatry referral",
              "orderSentence": "**Psychological support** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Depression affects 30-60% of CES patients long-term; sexual dysfunction is profoundly distressing; early psychological intervention improves coping and recovery",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Stool softener / bowel program**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "**Stool softener / bowel program** 100 mg -"
                }
              ],
              "route": "-",
              "instructions": "Docusate 100 mg BID + senna 2 tabs HS; bisacodyl suppository PRN; digital stimulation for areflexic bowel; timed bowel program; fiber supplementation; adequate hydration",
              "orderSentence": "**Stool softener / bowel program** 100 mg -"
            },
            "contraindications": "-",
            "monitoring": "Neurogenic bowel management reduces complications (impaction, incontinence); establish routine bowel program early",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Medications to AVOID or Use with Caution": [
          {
            "item": "Anticholinergics (oxybutynin, tolterodine — for urgency)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Anticholinergics (oxybutynin, tolterodine — for urgency) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Tricyclic antidepressants (amitriptyline, nortriptyline)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Tricyclic antidepressants (amitriptyline, nortriptyline) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Alpha-blockers (tamsulosin, silodosin) — without urologic guidance",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Alpha-blockers (tamsulosin, silodosin) — without urologic guidance - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "NSAIDs (prolonged, peri-operative)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "NSAIDs (prolonged, peri-operative) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Epidural steroid injection (as treatment for CES)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Epidural steroid injection (as treatment for CES) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Chiropractic manipulation (lumbar)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Chiropractic manipulation (lumbar) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Excessive IV fluids (post-operatively)",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Excessive IV fluids (post-operatively) - IV - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurosurgery / Spine surgery consultation — EMERGENCY",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Post-void residual (bladder scan)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Digital rectal examination",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Comprehensive neurologic exam documentation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Classify CES subtype",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Informed consent for surgery",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Transfer to surgical center (if no spine surgeon)",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Urology consultation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "PM&R / Rehabilitation consultation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain management consultation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sexual health counseling",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Colorectal surgery / GI consultation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work / case management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Medicolegal documentation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Revision surgery",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sacral neuromodulation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Intrathecal baclofen pump",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Chronic pain management program",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatric referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Legal documentation review",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Diagnosis",
        "features": "Key Differentiating Features",
        "tests": "Distinguishing Studies"
      },
      {
        "diagnosis": "Conus medullaris syndrome",
        "features": "Upper motor neuron AND lower motor neuron signs; bilateral and symmetric; early bladder/bowel dysfunction; back pain less prominent than radicular pain; reflexes may be hyperactive (UMN) or absent (LMN); typically at T12-L2 level; more symmetric than CES",
        "tests": "MRI: lesion at T12-L2 level (conus); cord signal change (T2 hyperintensity); CES lesion is below L1-L2 (cauda equina roots only); conus lesion → Babinski may be present (CES → absent or flexor)"
      },
      {
        "diagnosis": "Lumbar spinal stenosis (without CES)",
        "features": "Neurogenic claudication (walking-induced symptoms relieved by sitting/flexion); chronic progressive course; bilateral leg pain/weakness with walking; no bladder/bowel dysfunction (unless severe CES from stenosis); intermittent symptoms",
        "tests": "MRI: multilevel stenosis; trefoil canal shape; ligamentum flavum hypertrophy; NO acute disc herniation; symptoms are exercise-induced, not constant; PVR normal"
      },
      {
        "diagnosis": "Acute disc herniation (without CES)",
        "features": "Unilateral radiculopathy; no bilateral symptoms; no saddle anesthesia; no bladder/bowel dysfunction; straight leg raise positive; single dermatomal pattern",
        "tests": "MRI: lateral or posterolateral disc herniation compressing single root; NO cauda equina compression; normal PVR; normal rectal tone"
      },
      {
        "diagnosis": "Epidural abscess",
        "features": "Fever (50-66%); IVDU, immunocompromised, recent procedure; rapidly progressive; ESR >20 (94% sensitivity); severe spinal tenderness; leukocytosis; can cause CES if lumbar location",
        "tests": "MRI: ring-enhancing epidural collection with restricted diffusion; blood cultures positive (60%); ESR/CRP markedly elevated; clinical triad: back pain → radiculopathy → weakness (classic but only 10-15% present with full triad)"
      },
      {
        "diagnosis": "Epidural hematoma",
        "features": "Acute onset; anticoagulation or post-procedural (epidural injection, spinal surgery, LP); severe back pain → rapid progressive weakness; coagulopathy history",
        "tests": "MRI: epidural collection with blood signal (T1 bright in subacute); coagulation studies abnormal; anticoagulation history; post-procedural temporal relationship"
      },
      {
        "diagnosis": "Guillain-Barré syndrome (GBS)",
        "features": "Ascending symmetric weakness; areflexia; post-infectious (Campylobacter, CMV, EBV); sensory symptoms but often mild; facial weakness may be present; no saddle anesthesia typically; CSF: albuminocytologic dissociation",
        "tests": "MRI spine: may show nerve root enhancement BUT no structural compression; CSF: elevated protein, normal cells; NCS: demyelinating pattern or AMAN pattern; anti-ganglioside antibodies"
      },
      {
        "diagnosis": "Peripheral neuropathy (bilateral)",
        "features": "Chronic course; distal > proximal; length-dependent pattern; diabetes, alcohol; stocking-glove distribution; gradual onset; reflexes may be reduced distally; NO saddle anesthesia; NO acute bladder retention",
        "tests": "EMG/NCS: diffuse length-dependent neuropathy; MRI: no structural compression; HbA1c; B12; SPEP; gradual course distinguishes from acute CES"
      },
      {
        "diagnosis": "Lumbosacral plexopathy",
        "features": "Unilateral (usually); painful; diabetic amyotrophy; radiation-induced; tumor infiltration; asymmetric weakness/sensory loss in lumbosacral plexus distribution; typically NO bladder dysfunction (unless bilateral)",
        "tests": "MRI pelvis: plexus enhancement or mass; EMG: plexus distribution denervation; CT abdomen/pelvis: retroperitoneal mass; HbA1c; typically unilateral"
      },
      {
        "diagnosis": "Functional neurological disorder (FND)",
        "features": "Inconsistent exam findings; Hoover's sign positive; non-anatomical sensory pattern; normal imaging; normal PVR; no objective sphincter dysfunction; give-way weakness; history of psychological stressors",
        "tests": "MRI: normal; PVR: normal; rectal tone: normal; neurophysiology: normal; psychiatric history; clinical inconsistency (e.g., inability to lift leg on command but normal gait observed); NOTE: FND is a diagnosis of exclusion in CES — always obtain MRI first"
      }
    ],
    "evidence": [
      {
        "recommendation": "Guideline",
        "evidenceLevel": "Source",
        "source": "Year"
      },
      {
        "recommendation": "Cauda Equina Syndrome Standards of Care",
        "evidenceLevel": "British Association of Spine Surgeons (BASS) / Society of British Neurological Surgeons (SBNS)",
        "source": "2020"
      },
      {
        "recommendation": "CES Emergency Pathway",
        "evidenceLevel": "NICE / NHS England",
        "source": "2018 (updated 2023)"
      },
      {
        "recommendation": "AANS/CNS Guidelines on Lumbar Disc Herniation",
        "evidenceLevel": "AANS/CNS Joint Section on Disorders of the Spine and Peripheral Nerves",
        "source": "2014"
      },
      {
        "recommendation": "Study",
        "evidenceLevel": "Finding",
        "source": "Impact"
      },
      {
        "recommendation": "[Ahn et al. (2000)](https://pubmed.ncbi.nlm.nih.gov/10851100/)",
        "evidenceLevel": "Systematic review: Decompression <48h of CES onset → 70% bladder recovery vs. 30% if >48h; motor outcomes also significantly better with early surgery",
        "source": "Established 48h as important threshold; but sooner is always better"
      },
      {
        "recommendation": "[Todd (2005)](https://pubmed.ncbi.nlm.nih.gov/16455534/) — Meta-analysis",
        "evidenceLevel": "42 studies: Earlier decompression consistently associated with better outcomes across motor, bladder, and bowel domains; no clear cutoff but <24h is optimal",
        "source": "Confirmed urgency of CES surgical decompression; surgical timing is KEY modifiable factor"
      },
      {
        "recommendation": "Srikandarajah et al. (2020)",
        "evidenceLevel": "UK Cohort: Urgent surgery (<24h) vs. delayed (>24h): better bladder outcomes (OR 2.1) and motor outcomes (OR 1.6) with urgent surgery",
        "source": "Modern evidence supporting <24h surgical timing; NHS pathway development"
      },
      {
        "recommendation": "DeBois et al. (2019)",
        "evidenceLevel": "Timing analysis: <12h, 12-24h, 24-48h, >48h: progressive decline in outcomes with each delay interval; <12h had best bladder recovery",
        "source": "Supports as-soon-as-possible approach; <12h may be ideal"
      },
      {
        "recommendation": "[Gleave & Macfarlane (2002)](https://pubmed.ncbi.nlm.nih.gov/12389883/)",
        "evidenceLevel": "CES-I vs. CES-R outcomes: CES-I (incomplete) with early surgery → 95% good bladder outcome; CES-R (retention) with early surgery → 53% good bladder outcome; CES-R with delayed surgery → 27% good outcome",
        "source": "Established CES-I vs. CES-R classification; demonstrated that retention onset is critical prognostic marker"
      },
      {
        "recommendation": "[Groen & Ponssen (1990)](https://pubmed.ncbi.nlm.nih.gov/2243224/)",
        "evidenceLevel": "Spinal epidural hematoma: better outcomes with surgery <12h of onset; anticoagulation most common cause",
        "source": "Established surgical urgency for hematoma-related CES"
      },
      {
        "recommendation": "[Kostuik et al. (1986)](https://pubmed.ncbi.nlm.nih.gov/2936744/)",
        "evidenceLevel": "Classic paper on CES natural history: untreated CES from disc herniation → permanent bladder dysfunction in >90%, persistent weakness in >70%, chronic pain in >80%",
        "source": "Established that CES without surgical treatment leads to devastating permanent deficits"
      },
      {
        "recommendation": "McCarthy et al. (2014)",
        "evidenceLevel": "Medicolegal analysis: CES is the most litigated condition in spinal surgery; delayed diagnosis is the most common reason for successful claims; failure to perform timely MRI and delayed surgery are key factors",
        "source": "Documentation of timeline is CRITICAL; standardized CES pathways reduce medicolegal risk"
      },
      {
        "recommendation": "Subtype",
        "evidenceLevel": "Definition",
        "source": "Key Features"
      },
      {
        "recommendation": "CES-Suspected (CES-S)",
        "evidenceLevel": "Bilateral radiculopathy/symptoms WITHOUT bladder dysfunction",
        "source": "Bilateral leg pain/weakness; bilateral sensory changes; NO urinary symptoms; normal PVR"
      },
      {
        "recommendation": "CES-Incomplete (CES-I)",
        "evidenceLevel": "Altered urinary function WITHOUT retention",
        "source": "Difficulty initiating stream; reduced sensation of voiding; urgency; partial retention (PVR 200-500 mL); reduced but present perineal sensation; reduced anal tone"
      },
      {
        "recommendation": "CES-Retention (CES-R)",
        "evidenceLevel": "Painless urinary retention WITH overflow incontinence",
        "source": "Painless retention (PVR >500 mL); overflow incontinence; absent perineal sensation; absent anal tone; often absent bulbocavernosus reflex"
      },
      {
        "recommendation": "Component",
        "evidenceLevel": "Bilateral L4",
        "source": "Bilateral L5"
      },
      {
        "recommendation": "Motor",
        "evidenceLevel": "Knee extension (quad)",
        "source": "Ankle dorsiflexion (TA), great toe extension (EHL), hip abduction"
      },
      {
        "recommendation": "Sensory",
        "evidenceLevel": "Medial leg/shin",
        "source": "Lateral leg, dorsum of foot, first web space"
      },
      {
        "recommendation": "Reflex",
        "evidenceLevel": "Patellar (L3-L4)",
        "source": "Tibialis posterior (L5 — inconsistent)"
      },
      {
        "recommendation": "Function",
        "evidenceLevel": "Walking, stairs",
        "source": "Heel walking"
      }
    ],
    "monitoring": [
      {
        "item": "Neurologic examination (lower extremity strength, sensation, reflexes)",
        "frequency": "q2-4h pre-operatively; q4h post-operatively x 48h",
        "target": "Stable pre-op; improving post-op",
        "action": "Pre-op worsening: escalate surgical urgency; post-op worsening: STAT MRI (hematoma, residual compression, re-herniation)"
      },
      {
        "item": "Perianal/perineal sensation and rectal tone",
        "frequency": "q4h (at minimum with each neuro check)",
        "target": "Improving or stable",
        "action": "Worsening: STAT MRI"
      },
      {
        "item": "Bladder function / PVR",
        "frequency": "Continuous monitoring via Foley with hourly I&O pre/post-op; Trial of void at 24-48h post-op with PVR check",
        "target": "PVR <100 mL to discontinue catheter; voiding spontaneously",
        "action": "PVR >200 mL after trial of void → replace Foley; begin CIC teaching; urology consult"
      },
      {
        "item": "Pain assessment (NRS)",
        "frequency": "q4h",
        "target": "NRS <4/10",
        "action": "Escalate analgesics; add neuropathic agents; new/worsening pain post-op → concern for hematoma/complication"
      },
      {
        "item": "Wound assessment (post-operative)",
        "frequency": "q8h",
        "target": "No drainage, swelling, erythema, dehiscence",
        "action": "Wound complication → surgical team notification; drain output monitoring"
      },
      {
        "item": "Bowel function",
        "frequency": "Daily",
        "target": "BM within 48-72h post-op",
        "action": "Bowel regimen intensification; abdominal X-ray if distended; rectal exam"
      },
      {
        "item": "Temperature",
        "frequency": "q4h",
        "target": "Afebrile",
        "action": "Fever: wound infection, UTI (Foley-associated), DVT, abscess; cultures and imaging as indicated"
      },
      {
        "item": "DVT screening",
        "frequency": "Daily calf circumference; symptoms",
        "target": "No DVT signs",
        "action": "Bilateral lower extremity duplex US if symptoms; therapeutic anticoagulation if confirmed"
      }
    ],
    "disposition": [
      {
        "disposition": "Level of Care",
        "criteria": "Criteria"
      },
      {
        "disposition": "ICU admission",
        "criteria": "Post-operative monitoring (surgeon-dependent — many post-laminectomies go to floor); bilateral lower extremity paralysis with hemodynamic concerns; epidural abscess with sepsis; significant comorbidities affecting anesthetic recovery; autonomic dysfunction"
      },
      {
        "disposition": "General neurosurgery/spine floor",
        "criteria": "ALL CES patients require admission; pre-operative CES awaiting surgical decompression; post-operative monitoring; pain management; bladder/bowel monitoring; PT/OT initiation; epidural abscess requiring IV antibiotics"
      },
      {
        "disposition": "Observation (NOT appropriate)",
        "criteria": "CES is NEVER an observation diagnosis — all suspected CES patients require emergent MRI and admission for surgical evaluation; even if MRI is negative for structural compression, admission for monitoring is prudent if clinical suspicion is high"
      }
    ]
  },
  "Spinal Cord Compression (Malignant)": {
    "id": "spinal-cord-compression-malignant",
    "title": "Spinal Cord Compression (Malignant)",
    "version": "1.0",
    "icd10": [
      "** G95.20 (Unspecified cord compression)",
      "C79.49 (Secondary malignant neoplasm of other parts of nervous system)",
      "C79.51 (Secondary malignant neoplasm of bone)",
      "M49.50 (Collapsed vertebra in diseases classified elsewhere)",
      "G82.20 (Paraplegia",
      "unspecified)"
    ],
    "scope": "** Emergency evaluation and management of malignant (metastatic) spinal cord compression in adults. Covers dexamethasone protocols, emergent imaging, surgical decompression criteria (Patchell criteria), radiation therapy, vertebral body assessment, functional prognostication, and disposition. Excludes non-malignant compressive myelopathy (disc herniation, epidural abscess — separate templates), primary spinal cord tumors (intramedullary), and cauda equina syndrome from malignancy (partially overlaps — see separate template for CES).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Baseline; surgical candidacy; chemotherapy effects; infection (epidural abscess differential)",
            "target": "Normal; leukocytosis may suggest infection; thrombocytopenia affects surgical/procedural candidacy"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Renal function (contrast, medications); electrolytes (hypercalcemia of malignancy); hepatic function (chemotherapy dosing, metastatic disease)",
            "target": "Normal; calcium >10.5 mg/dL → assess for hypercalcemia of malignancy"
          },
          {
            "item": "PT/INR, aPTT",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Coagulopathy assessment; surgical candidacy; anticoagulation reversal if emergent surgery needed",
            "target": "Normal; INR <1.5 for surgery"
          },
          {
            "item": "ESR / CRP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Epidural abscess differential (highly elevated ESR >30-50 typically); inflammatory markers for malignancy",
            "target": "Normal-mildly elevated in malignancy; markedly elevated ESR/CRP → strongly consider abscess"
          },
          {
            "item": "Blood cultures (x2 sets)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Epidural abscess differential; bacteremia if febrile",
            "target": "Negative; positive → epidural abscess more likely than tumor"
          },
          {
            "item": "Blood glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Baseline before high-dose dexamethasone; steroid hyperglycemia",
            "target": "<180 mg/dL; anticipate significant hyperglycemia with high-dose steroids"
          },
          {
            "item": "Type and screen",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Surgical candidacy; blood product availability",
            "target": "On file"
          },
          {
            "item": "Calcium (ionized or corrected)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Hypercalcemia of malignancy (present in 10-30% of cancer patients); can cause confusion, weakness mimicking cord compression progression",
            "target": "Corrected Ca <10.5 mg/dL; if elevated → IV fluids, calcitonin, bisphosphonate"
          },
          {
            "item": "LDH",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT",
            "rationale": "Tumor burden marker; lymphoma (very high LDH); prognostic",
            "target": "Normal; very high → lymphoma, aggressive malignancy"
          },
          {
            "item": "Urinalysis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "Urinary retention (neurogenic bladder from cord compression); UTI (fever differential); baseline renal function",
            "target": "Normal; retention with high post-void residual expected in cord compression"
          }
        ],
        "Extended Workup": [
          {
            "item": "Tumor markers (PSA, CEA, CA 19-9, CA 125, CA 15-3, AFP, β-hCG)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Unknown primary cancer; PSA (prostate — most common spinal metastasis), CEA (GI, lung), CA 15-3 (breast), etc.",
            "target": "Elevations guide primary site identification"
          },
          {
            "item": "SPEP / UPEP with immunofixation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Multiple myeloma (common cause of vertebral compression/cord compression); M-protein, light chains",
            "target": "No monoclonal protein; if present → myeloma workup"
          },
          {
            "item": "Free light chains (kappa/lambda ratio)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Myeloma; light chain disease",
            "target": "Normal ratio (0.26-1.65); abnormal suggests myeloma"
          },
          {
            "item": "Serum protein electrophoresis",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Myeloma; lymphoma",
            "target": "No M-spike"
          },
          {
            "item": "Alkaline phosphatase (bone-specific)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Osteoblastic metastases (prostate, breast); Paget's disease differential",
            "target": "Normal; elevated suggests bone turnover"
          },
          {
            "item": "Phosphate",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Hypercalcemia workup; oncologic emergency assessment",
            "target": "Normal"
          },
          {
            "item": "Uric acid",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "rationale": "Tumor lysis syndrome risk (lymphoma, rapidly proliferating tumors); pre-treatment assessment",
            "target": "Normal"
          },
          {
            "item": "Procalcitonin",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "rationale": "If infection/abscess differential is high; more specific than CRP for bacterial infection",
            "target": "<0.25 ng/mL (low probability bacterial); >0.5 → consider abscess/infection"
          },
          {
            "item": "TSH, free T4",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Thyroid cancer metastases (follicular thyroid cancer has bony tropism)",
            "target": "Normal"
          },
          {
            "item": "Vitamin D (25-OH)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Bone health; pathologic fracture risk; supplement if deficient",
            "target": ">30 ng/mL"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Flow cytometry (peripheral blood)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Lymphoma/leukemia presenting as epidural mass",
            "target": "Abnormal lymphocyte population = lymphoproliferative disorder"
          },
          {
            "item": "Bone marrow biopsy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "Myeloma; lymphoma; unknown primary with bone marrow involvement",
            "target": "Normal; abnormal → specific diagnosis"
          },
          {
            "item": "Paraneoplastic antibody panel",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If myelopathy features atypical for compression (e.g., subacute progressive without clear structural compression)",
            "target": "Negative; positive changes diagnosis from compression to paraneoplastic myelopathy"
          },
          {
            "item": "AQP4-IgG (NMO antibody)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "rationale": "If imaging shows longitudinal intramedullary lesion rather than epidural compression → NMOSD differential",
            "target": "Negative; positive → NMOSD not metastatic compression"
          },
          {
            "item": "CT-guided biopsy of vertebral lesion",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "rationale": "Unknown primary; tissue diagnosis needed before treatment; lymphoma requires tissue for definitive diagnosis (sensitive to steroids — obtain tissue BEFORE steroids if possible in suspected lymphoma)",
            "target": "Histopathologic diagnosis"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "LP — Generally NOT indicated",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-",
            "timing": "LP is NOT routinely indicated in MSCC; CSF cytology only if leptomeningeal disease suspected AND no complete block; CT myelogram if MRI not available (different indication)",
            "target": "N/A — LP is diagnostic adjunct only in specific situations",
            "contraindications": "CONTRAINDICATED with complete spinal block above LP level (risk of neurologic deterioration/coning); coagulopathy; local infection"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI entire spine with and without contrast (gadolinium)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "URGENT",
            "ICU": "STAT",
            "timing": "**Within 4 hours of presentation (24h max)**; GOLD STANDARD; must image ENTIRE spine (multifocal metastases in 30-40%)",
            "target": "Epidural mass with cord compression; level(s) of compression; Bilsky grade (0-3); vertebral body involvement; number of levels; intramedullary vs. extramedullary-intradural vs. epidural; cord signal change (T2 hyperintensity = edema/myelopathy — poor prognostic sign); paraspinal soft tissue extension",
            "contraindications": "MRI-incompatible implants; severe claustrophobia (sedate); GFR <30 (gadolinium risk — benefit outweighs risk in emergency)"
          },
          {
            "item": "Plain radiographs (spine, targeted)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "Immediate while awaiting MRI; identifies vertebral collapse, pathologic fracture, alignment; 70% sensitivity for vertebral metastases (30% miss rate)",
            "target": "Vertebral body collapse; pedicle erosion (\"winking owl sign\" on AP); pathologic fracture; kyphosis; alignment",
            "contraindications": "Pregnancy (shield)"
          },
          {
            "item": "CT chest/abdomen/pelvis with contrast",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Within 24-48h; staging; primary identification; lung is most common primary",
            "target": "Primary tumor; staging of metastatic disease; lymphadenopathy; visceral metastases",
            "contraindications": "Contrast allergy; renal impairment"
          },
          {
            "item": "CT spine (targeted level) without contrast",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "If MRI contraindicated or unavailable; pre-operative planning for bone assessment; vertebral body stability (SINS score); CT myelogram if MRI not possible",
            "target": "Bone destruction pattern (lytic vs. blastic vs. mixed); posterior element involvement; fracture; canal compromise; vertebral body collapse >50%",
            "contraindications": "Pregnancy (risk vs. benefit)"
          }
        ],
        "Extended": [
          {
            "item": "CT myelogram",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "timing": "If MRI contraindicated (pacemaker, implant); intrathecal contrast via LP → CT; demonstrates level of block",
            "target": "Complete or partial subarachnoid block; level of compression; multiple levels of disease",
            "contraindications": "LP contraindicated if complete block above puncture site (risk of neurologic deterioration); coagulopathy"
          },
          {
            "item": "PET/CT (FDG)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Staging; primary identification; assessing treatment response; distinguishing active tumor from treated/necrotic bone",
            "target": "Active metastatic disease; primary tumor identification",
            "contraindications": "Uncontrolled diabetes; pregnancy"
          },
          {
            "item": "Bone scan (Tc-99m)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Skeletal staging; identifies additional osseous metastases; blastic > lytic sensitivity; useful for prostate, breast",
            "target": "Additional bone metastases; may miss purely lytic lesions (renal, thyroid, myeloma)",
            "contraindications": "Pregnancy"
          },
          {
            "item": "MRI brain with contrast",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If lung primary or melanoma (high brain metastasis risk); symptoms suggesting intracranial disease",
            "target": "Brain metastases (concurrent in 10-30% of patients with MSCC)",
            "contraindications": "Same as MRI"
          },
          {
            "item": "CT-guided biopsy (vertebral/paraspinal)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Tissue diagnosis if unknown primary; CRITICAL for suspected lymphoma (radiosensitive — may not need surgery); obtain BEFORE steroids if lymphoma suspected (steroids can render biopsy non-diagnostic)",
            "target": "Histopathologic diagnosis; molecular profiling",
            "contraindications": "Coagulopathy; inaccessible lesion"
          },
          {
            "item": "DEXA scan",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Baseline bone density if prolonged steroids anticipated; osteoporosis risk",
            "target": "T-score; fracture risk assessment",
            "contraindications": "None significant"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Spinal angiography",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If highly vascular tumor suspected (RCC, thyroid) — pre-operative embolization to reduce surgical bleeding",
            "target": "Tumor vascularity; feeding vessels; embolization candidacy",
            "contraindications": "Contrast allergy; renal impairment; coagulopathy"
          },
          {
            "item": "Pre-operative embolization",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-",
            "timing": "Highly vascular metastases (RCC, thyroid); 24-48h before surgery to reduce intraoperative blood loss",
            "target": "Reduction of tumor blood supply",
            "contraindications": "Contrast allergy; tumor supplying anterior spinal artery (risk of cord infarction)"
          },
          {
            "item": "Dynamic flexion-extension radiographs",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Post-treatment stability assessment; if clinical instability suspected",
            "target": "Mechanical instability (translation, angulation)",
            "contraindications": "Acute cord compression (do NOT flex/extend if acute neurologic deficit)"
          },
          {
            "item": "Nuclear medicine thyroid scan",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If thyroid primary suspected (follicular thyroid cancer has high bone tropism)",
            "target": "Thyroid nodule; functional assessment",
            "contraindications": "Recent iodinated contrast (wait 4-6 weeks)"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent Treatment": [
          {
            "item": "**Dexamethasone (high-dose for MSCC)**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "**Dexamethasone (high-dose for MSCC)** 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "**Standard loading dose:** 10 mg IV bolus STAT; **Then:** 4 mg IV/PO q6h (16 mg/day); **High-dose (severe deficits or rapidly progressive):** 96 mg IV bolus (controversial — see evidence) → 24 mg q6h x 3 days → rapid taper; **Moderate deficits / ambulatory:** 10 mg IV → 4 mg q6h; **Begin taper after definitive treatment initiated;** GI prophylaxis: PPI while on steroids; Monitor glucose q6h",
              "orderSentence": "**Dexamethasone (high-dose for MSCC)** 10 mg IV"
            },
            "contraindications": "-",
            "monitoring": "Sorensen et al. (1994): Dexamethasone + radiation vs. radiation alone → 81% vs. 63% ambulatory at treatment end; High-dose (96 mg) vs. standard (10 mg): Vecht et al. (1989) — higher response rate at 1 week but more side effects; MOST centers now use moderate dose (10 mg load → 16 mg/day); Begin within 6h of diagnosis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "URGENT",
            "ICU": "STAT"
          },
          {
            "item": "**Spinal precautions / immobilization**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Strict log-roll precautions; flat bed transport; cervical collar if cervical spine involved; thoracolumbar brace (TLSO) if thoracolumbar; avoid flexion/extension; transfer on spine board if unstable fracture suspected",
              "orderSentence": "**Spinal precautions / immobilization** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Unstable pathologic fracture may worsen cord compression with movement; SINS score guides instability assessment",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Bladder management**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mL",
                  "orderSentence": "**Bladder management** 200 mL -"
                }
              ],
              "route": "-",
              "instructions": "Assess for urinary retention (cord compression causes neurogenic bladder); straight catheterize if retention → place Foley if residual >200 mL or ongoing retention; monitor I&O strictly",
              "orderSentence": "**Bladder management** 200 mL -"
            },
            "contraindications": "-",
            "monitoring": "Urinary retention is a common presenting feature and may be the first sign of cord compression; bladder function correlates with motor recovery prognosis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**DVT prophylaxis**",
            "route": "SC",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "**DVT prophylaxis** 40 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "SCDs immediately; pharmacologic prophylaxis (enoxaparin 40 mg SQ daily) within 24-48h unless surgery imminent; spinal cord compression patients have VERY HIGH VTE risk (up to 25-50% without prophylaxis)",
              "orderSentence": "**DVT prophylaxis** 40 mg SC"
            },
            "contraindications": "-",
            "monitoring": "Cancer + immobility + spinal cord injury = extremely high VTE risk; mechanical prophylaxis alone insufficient",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "**Pain management**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650-1000 mg",
                  "orderSentence": "**Pain management** 650-1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Back pain often severe; acetaminophen 650-1000 mg q6h scheduled + opioids PRN (morphine 2-4 mg IV q3h PRN or oxycodone 5-10 mg PO q4h PRN); NSAIDs cautiously (renal function, bleeding risk); dexamethasone itself reduces pain from edema/inflammation; neuropathic pain: gabapentin 300 mg TID (titrate) or pregabalin 75 mg BID",
              "orderSentence": "**Pain management** 650-1000 mg IV"
            },
            "contraindications": "-",
            "monitoring": "Pain is the presenting symptom in 83-95% of patients; median 7 weeks before diagnosis; adequate analgesia essential for function and quality of life",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**Bowel regimen**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "**Bowel regimen** 100 mg -"
                }
              ],
              "route": "-",
              "instructions": "Neurogenic bowel from cord compression + opioid constipation; docusate 100 mg BID + senna 2 tabs HS; bisacodyl suppository PRN; monitor for ileus",
              "orderSentence": "**Bowel regimen** 100 mg -"
            },
            "contraindications": "-",
            "monitoring": "Bowel dysfunction common; proactive management prevents complications",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**Glucose monitoring**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Fingerstick q6h on high-dose dexamethasone; insulin sliding scale → basal-bolus if persistent >180; anticipate glucose will rise significantly within hours of steroid initiation",
              "orderSentence": "**Glucose monitoring** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "High-dose dexamethasone causes severe hyperglycemia in majority of patients",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Definitive/Targeted Treatment": [
          {
            "item": "**Surgical decompression + stabilization**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Indications (Patchell criteria + expanded):** (1) Single site of compression, (2) Paraplegia ≤48h, (3) Not radiosensitive tumor (not lymphoma, myeloma, SCLC, germ cell), (4) Life expectancy >3 months, (5) ECOG ≤2 / able to tolerate surgery, (6) Mechanical instability (SINS ≥7), (7) Neurologic deterioration during radiation; **Approach:** Posterior decompressive laminectomy ± instrumented stabilization; anterior corpectomy with cage/cement for anterior compression with instability; **Timing:** Within 24h of presentation (ideally <12h); Followed by radiation within 2-4 weeks post-op",
              "orderSentence": "**Surgical decompression + stabilization** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "**Patchell et al. (2005) — LANDMARK:** Surgery + radiation vs. radiation alone: ambulatory rate 84% vs. 57% (p=0.001); maintained ambulation longer (122 vs. 13 days); more patients regained ambulation (62% vs. 19%); surgery retained continence longer; survival trend (126 vs. 100 days)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**External beam radiation therapy (EBRT)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Primary modality if:** Radiosensitive tumor (lymphoma, myeloma, SCLC, seminoma), surgical contraindication, multiple noncontiguous levels, life expectancy <3 months, poor surgical candidate; **Standard:** 30 Gy in 10 fractions (2 weeks) or 20 Gy in 5 fractions (1 week); **Short course (poor prognosis):** 8 Gy single fraction; **Begin within 24h of diagnosis**; Can start same day as dexamethasone; Radiation field covers 1-2 vertebral bodies above and below involved segment",
              "orderSentence": "**External beam radiation therapy (EBRT)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Rades et al. (2008): No significant difference between 30 Gy/10 vs. 20 Gy/5 for motor function recovery or local control; 8 Gy single fraction appropriate for poor prognosis (life expectancy <6 months)",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Stereotactic body radiation therapy (SBRT) / Spine SRS**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Indications:** Previously irradiated segment (re-irradiation); radioresistant histology (RCC, melanoma, sarcoma); oligometastatic disease; post-operative; **Dose:** 16-24 Gy single fraction or 24-30 Gy in 3 fractions; **Requires:** Spinal cord dose constraints (max cord dose 10-14 Gy single fraction); MRI-based planning; **Timing:** As soon as technically feasible",
              "orderSentence": "**Stereotactic body radiation therapy (SBRT) / Spine SRS** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "RTOG 0631 and multiple institutional series: High local control (85-95%) for radioresistant histologies; superior to conventional EBRT for RCC, melanoma; separation surgery + SBRT emerging as preferred approach for radioresistant tumors",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Separation surgery + SBRT**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Indication:** Epidural tumor compressing cord from radioresistant primary (RCC, melanoma, sarcoma); goal is NOT gross total resection — goal is to decompress cord and create ≥2mm separation between tumor and cord to enable safe SBRT delivery; Followed by SBRT within 2-4 weeks",
              "orderSentence": "**Separation surgery + SBRT** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Laufer et al. (2013): Separation surgery + SBRT: 90% local control at 1 year for radioresistant tumors; allows definitive radiation dose to tumor while respecting cord tolerance",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**Vertebroplasty / Kyphoplasty**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Indications:** Painful pathologic compression fracture; vertebral body instability; post-radiation pain; NO epidural extension compressing cord (cement leak risk into canal); **SINS 7-12 (indeterminate stability):** Consider as adjunct; **Procedure:** Percutaneous PMMA cement injection into vertebral body",
              "orderSentence": "**Vertebroplasty / Kyphoplasty** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Pain relief in 70-90% within 24-48h; structural support; does NOT address epidural disease; risk of cement leak into epidural space (1-5%)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Systemic chemotherapy**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "**Radiosensitive tumors as primary/adjunct therapy:** Lymphoma (R-CHOP or equivalent); myeloma (bortezomib-based); SCLC (cisplatin/etoposide); germ cell (BEP); **Other primaries:** Per disease-specific guidelines after stabilization; coordinate with medical oncology",
              "orderSentence": "**Systemic chemotherapy** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Chemosensitive tumors (lymphoma, myeloma, germ cell, SCLC) may respond rapidly to systemic therapy; may be used as primary treatment with radiation or as consolidation post-radiation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Hormonal therapy (if applicable)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Prostate cancer: ADT (LHRH agonist/antagonist) + enzalutamide/abiraterone/darolutamide; Breast cancer: anti-estrogen/AI per receptor status; Thyroid: levothyroxine suppression + RAI (spine metastases do NOT concentrate RAI well — external radiation preferred)",
              "orderSentence": "**Hormonal therapy (if applicable)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Prostate and breast cancer spinal metastases may respond to hormonal manipulation; adjunct to radiation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Adjunctive Treatment": [
          {
            "item": "**Steroid taper**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-4 mg",
                  "orderSentence": "**Steroid taper** 2-4 mg -"
                }
              ],
              "route": "-",
              "instructions": "Begin taper once definitive treatment (surgery/radiation) initiated and neurologic status stable/improving; **Taper schedule:** Reduce by 2-4 mg every 3-5 days; typical: 16→12→8→6→4→2→off over 2-3 weeks; slower taper if symptoms recur; monitor for adrenal insufficiency if >2-3 weeks of steroids",
              "orderSentence": "**Steroid taper** 2-4 mg -"
            },
            "contraindications": "-",
            "monitoring": "Prolonged high-dose steroids cause significant morbidity; steroid myopathy (proximal weakness — may mimic neurologic progression); PJP risk; hyperglycemia; GI bleed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**PPI (stress ulcer/GI prophylaxis)**",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "**PPI (stress ulcer/GI prophylaxis)** 20 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Omeprazole 20 mg daily or pantoprazole 40 mg daily while on dexamethasone",
              "orderSentence": "**PPI (stress ulcer/GI prophylaxis)** 20 mg PO"
            },
            "contraindications": "-",
            "monitoring": "Steroid + critical illness increases GI bleed risk",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**Calcium + Vitamin D**",
            "route": "PO",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000-1200 mg",
                  "orderSentence": "**Calcium + Vitamin D** 1000-1200 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Calcium 1000-1200 mg + Vitamin D 800-1000 IU daily during steroid course and beyond (bone health in cancer patients)",
              "orderSentence": "**Calcium + Vitamin D** 1000-1200 mg PO"
            },
            "contraindications": "-",
            "monitoring": "Steroid-induced osteoporosis prevention; already compromised bone integrity",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Bone-modifying agents**",
            "route": "IV",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg",
                  "orderSentence": "**Bone-modifying agents** 4 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Zoledronic acid 4 mg IV q4 weeks OR denosumab 120 mg SQ q4 weeks; reduces skeletal-related events (SRE); dental clearance before starting (ONJ risk); renal adjustment for zoledronic acid (hold if GFR <35)",
              "orderSentence": "**Bone-modifying agents** 4 mg IV"
            },
            "contraindications": "-",
            "monitoring": "Zoledronic acid: Rosen et al. (2003) — reduced SRE by 48% in bone metastases; denosumab: Fizazi et al. (2011) — superior to zoledronic acid for SRE reduction in bone metastases (prostate trial)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Neuropathic pain management**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "**Neuropathic pain management** 300 mg -"
                }
              ],
              "route": "-",
              "instructions": "Gabapentin 300 mg TID → titrate to 600-900 mg TID; OR pregabalin 75 mg BID → titrate to 150-300 mg BID; duloxetine 30-60 mg daily as alternative; amitriptyline 10-25 mg HS (anticholinergic caution with urinary retention)",
              "orderSentence": "**Neuropathic pain management** 300 mg -"
            },
            "contraindications": "-",
            "monitoring": "Radicular and central neuropathic pain common in cord compression; adjuvant analgesics reduce opioid requirements",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "**Rehabilitation (inpatient)**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "PT/OT evaluation within 24h of admission; early mobilization when cleared by spine surgery; adaptive equipment; wheelchair assessment if paraparetic/paraplegic; ROM exercises; strengthening; transfer training",
              "orderSentence": "**Rehabilitation (inpatient)** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Early rehabilitation improves functional outcomes; cancer rehabilitation is evidence-based; patients with MSCC benefit from structured rehab programs",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Skin care / pressure ulcer prevention**",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "Turn q2h; pressure-reducing mattress; heel protectors; skin assessment with Braden scale; nutrition optimization",
              "orderSentence": "**Skin care / pressure ulcer prevention** - - - see dosing"
            },
            "contraindications": "-",
            "monitoring": "Immobile patients with cord compression at very high risk for pressure injuries; prevention is critical",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Medications to AVOID or Use with Caution": [
          {
            "item": "NSAIDs (prolonged use)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "NSAIDs (prolonged use) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Methotrexate (high-dose, with spinal radiation)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Methotrexate (high-dose, with spinal radiation) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Intrathecal chemotherapy (with spinal block)",
            "route": "IT",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Intrathecal chemotherapy (with spinal block) - IT - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Anticoagulation (full-dose, peri-operative)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Anticoagulation (full-dose, peri-operative) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Steroids in suspected lymphoma (BEFORE biopsy)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Steroids in suspected lymphoma (BEFORE biopsy) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Bevacizumab (peri-operative)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Bevacizumab (peri-operative) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Bisphosphonates (if GFR <35 for zoledronic acid)",
            "route": "-",
            "indication": "-",
            "dosing": {
              "instructions": "-",
              "orderSentence": "Bisphosphonates (if GFR <35 for zoledronic acid) - - - see dosing"
            },
            "pretreatment": "-",
            "contraindications": "-",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurosurgery / Spine surgery consultation — EMERGENT",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Radiation oncology consultation — EMERGENT",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Medical oncology consultation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Multidisciplinary spine tumor board",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Goals of care discussion",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Physical medicine & rehabilitation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Foley catheter management",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Social work / case management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain management / palliative care",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Interventional radiology consultation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Orthotics / bracing",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Wound care (post-operative)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nutrition / dietitian",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychology / psychiatry",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Urology consultation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Home health referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Re-irradiation (spine)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Repeat surgery",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Intrathecal drug delivery",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Cement augmentation (post-radiation)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hospice referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clinical trial enrollment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Diagnosis",
        "features": "Key Differentiating Features",
        "tests": "Distinguishing Studies"
      },
      {
        "diagnosis": "Spinal epidural abscess",
        "features": "Fever (present in 50-66%); IV drug use, recent procedure, immunosuppression; rapidly progressive; ESR >20 (sensitivity 94%); CRP markedly elevated; ring-enhancing epidural collection on MRI; restricted diffusion in abscess; spine pain with percussion tenderness; leukocytosis",
        "tests": "MRI: T2-hyperintense epidural collection with rim enhancement; restricted diffusion (DWI bright, ADC dark) within abscess; blood cultures (positive in 60%); ESR/CRP markedly elevated; procalcitonin >0.5"
      },
      {
        "diagnosis": "Degenerative spinal stenosis (cervical/lumbar)",
        "features": "Chronic progressive symptoms; myelopathic signs insidious onset; no cancer history; disc/osteophyte complex on imaging; NO destructive bone lesion; congenital canal narrowing",
        "tests": "MRI: disc-osteophyte complex; ligamentum flavum hypertrophy; NO bone destruction; NO contrast enhancement of epidural mass; chronic degenerative changes"
      },
      {
        "diagnosis": "Primary spinal cord tumor (intramedullary)",
        "features": "Intramedullary (within cord parenchyma); ependymoma, astrocytoma; cord expansion with central lesion; no vertebral body destruction; slow progression; syrinx may be present",
        "tests": "MRI: cord expansion with intramedullary enhancing lesion; no epidural mass; no vertebral body involvement; ependymoma: central location, hemosiderin cap; astrocytoma: eccentric, irregular"
      },
      {
        "diagnosis": "Vertebral compression fracture (osteoporotic)",
        "features": "No cancer history; older patient with osteoporosis; acute back pain after minor trauma/lifting; no neurologic deficits (usually); vertebral body collapsed but NO epidural mass; NO posterior element involvement",
        "tests": "MRI: vertebral body edema (T1 low, STIR high) WITHOUT epidural mass or posterior element involvement; CT: no bone destruction beyond fracture; DEXA: osteoporosis; if ambiguous → biopsy"
      },
      {
        "diagnosis": "Multiple myeloma",
        "features": "Older adult; bone pain; anemia, renal insufficiency, hypercalcemia (\"CRAB\"); diffuse lytic lesions; monoclonal protein on SPEP; punched-out skull lesions; responsive to chemotherapy AND radiation",
        "tests": "SPEP: M-protein; UPEP: Bence Jones protein; free light chains: abnormal ratio; bone marrow biopsy: >10% plasma cells; CT/MRI: multiple lytic lesions; biopsy: plasmacytoma; KEY: myeloma is RADIOSENSITIVE — radiation first-line"
      },
      {
        "diagnosis": "Lymphoma (epidural)",
        "features": "May present as isolated epidural mass; radiosensitive; responds dramatically to steroids (may \"melt\" before biopsy); younger patients; constitutional symptoms (B symptoms); elevated LDH",
        "tests": "MRI: epidural mass; homogeneous enhancement; may be paraspinal; CT: lymphadenopathy; LDH elevated; flow cytometry; KEY: obtain biopsy BEFORE steroids if possible; radiation is primary treatment"
      },
      {
        "diagnosis": "Transverse myelitis / NMOSD",
        "features": "Intramedullary T2 lesion on MRI (NOT epidural mass); autoimmune history; AQP4/MOG antibodies; longitudinally extensive (≥3 segments in NMOSD); responds to IV steroids/PLEX; no bone lesion",
        "tests": "MRI: intramedullary T2 hyperintensity, NOT epidural mass; AQP4-IgG or MOG-IgG positive; CSF: pleocytosis; no vertebral body destruction"
      },
      {
        "diagnosis": "Spinal epidural hematoma",
        "features": "Acute onset, often on anticoagulation; post-procedural (LP, epidural injection); acute neurogenic deficit; hyperacute T1 signal on MRI (blood)",
        "tests": "MRI: epidural collection with blood signal characteristics (T1 hyperintense in subacute phase); history of anticoagulation or procedure; coagulation studies abnormal; neurosurgical emergency"
      }
    ],
    "evidence": [
      {
        "recommendation": "Guideline",
        "evidenceLevel": "Source",
        "source": "Year"
      },
      {
        "recommendation": "MSCC Management",
        "evidenceLevel": "NICE Clinical Guideline CG75 (updated)",
        "source": "2008/2023"
      },
      {
        "recommendation": "Spinal Metastases",
        "evidenceLevel": "NCCN Clinical Practice Guidelines",
        "source": "2025"
      },
      {
        "recommendation": "Bone-Modifying Agents",
        "evidenceLevel": "ASCO Clinical Practice Guideline",
        "source": "2017"
      },
      {
        "recommendation": "MSCC Radiation",
        "evidenceLevel": "Cochrane Systematic Review (George et al.)",
        "source": "2015"
      },
      {
        "recommendation": "Study",
        "evidenceLevel": "Finding",
        "source": "Impact"
      },
      {
        "recommendation": "[Patchell et al. (2005) — Lancet](https://pubmed.ncbi.nlm.nih.gov/16112300/)",
        "evidenceLevel": "Direct decompressive surgery + radiation vs. radiation alone for MSCC: ambulatory 84% vs. 57% (p=0.001); regained ambulation 62% vs. 19%; maintained ambulation 122 vs. 13 days; maintained continence longer",
        "source": "LANDMARK study establishing surgery + radiation as superior to radiation alone for single-level MSCC in non-radiosensitive tumors with life expectancy >3 months"
      },
      {
        "recommendation": "[Sorensen et al. (1994)](https://pubmed.ncbi.nlm.nih.gov/8142159/)",
        "evidenceLevel": "Dexamethasone + radiation vs. radiation alone: ambulation 81% vs. 63% at end of treatment; 59% vs. 33% at 3 months",
        "source": "Established dexamethasone as standard adjunct to radiation in MSCC"
      },
      {
        "recommendation": "[Vecht et al. (1989)](https://pubmed.ncbi.nlm.nih.gov/2771077/)",
        "evidenceLevel": "High-dose (96 mg) vs. standard (10 mg) dexamethasone: faster initial response with high-dose but similar outcomes at 1 week; more side effects with high-dose",
        "source": "Most centers now use moderate dose (10 mg load → 16 mg/day) due to side effect profile"
      },
      {
        "recommendation": "[Rades et al. (2008)](https://pubmed.ncbi.nlm.nih.gov/18539406/)",
        "evidenceLevel": "Short-course (20 Gy/5 fractions) vs. standard (30 Gy/10 fractions): no significant difference in motor function improvement for patients with poor prognosis",
        "source": "Short-course radiation appropriate for patients with limited life expectancy"
      },
      {
        "recommendation": "[Laufer et al. (2013)](https://pubmed.ncbi.nlm.nih.gov/23339593/)",
        "evidenceLevel": "Separation surgery + SBRT for radioresistant MSCC: 90% local control at 1 year; enabled delivery of effective radiation doses to previously radioresistant tumors",
        "source": "Established separation surgery + SBRT paradigm for RCC, melanoma, sarcoma spinal metastases"
      },
      {
        "recommendation": "[Rosen et al. (2003)](https://pubmed.ncbi.nlm.nih.gov/14534891/)",
        "evidenceLevel": "Zoledronic acid reduced skeletal-related events by 48% compared to placebo in bone metastases from breast cancer and myeloma",
        "source": "Standard bone-modifying therapy for cancer-related bone disease"
      },
      {
        "recommendation": "[Fizazi et al. (2011)](https://pubmed.ncbi.nlm.nih.gov/21353695/)",
        "evidenceLevel": "Denosumab superior to zoledronic acid in reducing SRE in prostate cancer bone metastases (HR 0.82, p=0.008)",
        "source": "Denosumab as alternative/preferred bone-modifying agent; no renal adjustment needed"
      },
      {
        "recommendation": "SINS Total Score",
        "evidenceLevel": "Interpretation",
        "source": "Action"
      },
      {
        "recommendation": "0-6",
        "evidenceLevel": "Stable",
        "source": "Non-surgical management appropriate"
      },
      {
        "recommendation": "7-12",
        "evidenceLevel": "Indeterminate (potentially unstable)",
        "source": "Surgical consultation recommended"
      },
      {
        "recommendation": "13-18",
        "evidenceLevel": "Unstable",
        "source": "Surgical stabilization recommended"
      },
      {
        "recommendation": "Parameter",
        "evidenceLevel": "Score 0",
        "source": "Score 1"
      },
      {
        "recommendation": "General condition (KPS)",
        "evidenceLevel": "Poor (10-40%)",
        "source": "Moderate (50-70%)"
      },
      {
        "recommendation": "Number of extraspinal bone metastases",
        "evidenceLevel": "≥3",
        "source": "1-2"
      },
      {
        "recommendation": "Number of vertebral body metastases",
        "evidenceLevel": "≥3",
        "source": "2"
      },
      {
        "recommendation": "Metastases to major organs",
        "evidenceLevel": "Unremovable",
        "source": "Removable"
      },
      {
        "recommendation": "Primary tumor site",
        "evidenceLevel": "Lung, osteosarcoma, stomach, bladder, esophagus, pancreas",
        "source": "Liver, gallbladder, unidentified"
      },
      {
        "recommendation": "Neurologic deficit (Frankel)",
        "evidenceLevel": "Complete (A/B)",
        "source": "Incomplete (C/D)"
      },
      {
        "recommendation": "Tokuhashi Score",
        "evidenceLevel": "Predicted Survival",
        "source": "Recommended Treatment"
      },
      {
        "recommendation": "0-8",
        "evidenceLevel": "<6 months",
        "source": "Palliative/conservative (short-course radiation)"
      },
      {
        "recommendation": "9-11",
        "evidenceLevel": "6-12 months",
        "source": "Palliative or excisional surgery depending on factors"
      },
      {
        "recommendation": "12-15",
        "evidenceLevel": ">12 months",
        "source": "Excisional surgery; aggressive treatment justified"
      },
      {
        "recommendation": "Factor",
        "evidenceLevel": "Assessment",
        "source": "Treatment Implications"
      },
      {
        "recommendation": "**N**eurologic",
        "evidenceLevel": "Degree of cord compression (Bilsky grade); functional status; myelopathy",
        "source": "High-grade compression (Bilsky 2-3) → surgical decompression; low-grade → radiation alone may suffice"
      },
      {
        "recommendation": "**O**ncologic",
        "evidenceLevel": "Radiosensitivity; expected tumor response to radiation",
        "source": "Radiosensitive (lymphoma, myeloma, SCLC) → radiation primary; Radioresistant (RCC, melanoma, sarcoma) → surgery + SBRT"
      },
      {
        "recommendation": "**M**echanical instability",
        "evidenceLevel": "SINS score",
        "source": "SINS ≥7 → surgical consultation for stabilization"
      },
      {
        "recommendation": "**S**ystemic disease",
        "evidenceLevel": "Extent of metastatic burden; medical comorbidities; life expectancy",
        "source": "Widespread disease, poor prognosis → palliative approach; oligometastatic → aggressive local treatment"
      }
    ],
    "monitoring": [
      {
        "item": "Neurologic examination (motor strength, sensory level, rectal tone, reflexes)",
        "frequency": "q4h x 48h → q6h",
        "target": "Stable or improving motor function; stable sensory level; preserved rectal tone",
        "action": "If declining: STAT MRI; escalate dexamethasone to 24 mg/day; emergent neurosurgery"
      },
      {
        "item": "Blood glucose",
        "frequency": "q6h (q4h if on insulin drip)",
        "target": "140-180 mg/dL",
        "action": "Sliding scale → basal-bolus insulin; endocrine consult if refractory"
      },
      {
        "item": "Pain score (NRS)",
        "frequency": "q4h",
        "target": "NRS <4/10",
        "action": "Escalate analgesics; add neuropathic agents; palliative care consultation"
      },
      {
        "item": "Blood pressure",
        "frequency": "q4h (continuous if neurogenic shock)",
        "target": "SBP >90 (avoid hypotension — cord perfusion); MAP >65-70",
        "action": "IV fluids; vasopressors if neurogenic shock; avoid excessive hypertension (post-operative bleeding risk)"
      },
      {
        "item": "Bladder function (I&O, post-void residual)",
        "frequency": "q shift; post-void residual daily",
        "target": "Volitional voiding; PVR <200 mL",
        "action": "Foley if retention; intermittent catheterization if PVR 200-500"
      },
      {
        "item": "Bowel function",
        "frequency": "Daily",
        "target": "Bowel movement within 48-72h",
        "action": "Aggressive bowel regimen; rectal exam; abdominal X-ray if distended"
      },
      {
        "item": "Skin integrity (Braden scale)",
        "frequency": "q shift",
        "target": "No pressure injuries; Braden ≥18",
        "action": "Turn q2h; specialty mattress; heel protectors; wound care if injury develops"
      },
      {
        "item": "Temperature",
        "frequency": "q4h",
        "target": "Afebrile",
        "action": "If febrile: blood cultures, UA, chest imaging; consider abscess vs. tumor fever"
      },
      {
        "item": "Respiratory function (if cervical/high thoracic)",
        "frequency": "q4h; bedside spirometry daily",
        "target": "FVC >15 mL/kg; stable respiratory rate",
        "action": "If FVC declining: ICU transfer; prepare for intubation; consider phrenic nerve involvement"
      }
    ],
    "disposition": [
      {
        "disposition": "Level of Care",
        "criteria": "Criteria"
      },
      {
        "disposition": "ICU admission",
        "criteria": "Neurogenic shock (hypotension + bradycardia from spinal cord injury); respiratory compromise from high cervical lesion; post-operative monitoring (first 24h after major spine surgery); acute paraplegia/quadriplegia requiring close monitoring; hemodynamic instability"
      },
      {
        "disposition": "General neurology/neurosurgery/oncology floor",
        "criteria": "New MSCC diagnosis requiring workup and treatment planning; surgical candidate awaiting decompression; radiation therapy initiation; motor deficits requiring monitoring and rehabilitation; pain management; high-dose steroid initiation"
      },
      {
        "disposition": "Observation",
        "criteria": "Known metastatic disease with new pain but preserved neurologic function; MRI showing compression without cord signal change; stable neurologic exam"
      }
    ]
  }
}